,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
11710,GO:0044281,7.38372834069096e-21,1,57,1974,small molecule metabolic process,BP,EBP;PDK4;PECR;PHYH;MSRA;MRI1;HSD17B3;MRAP;APOC1;EXTL1;ACSF2;PNP;ABCG1;BDH2;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;ACAT1;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;NUDT7;CPT1C;PCBD1;MDH1;PON2;IDH1;DECR1;STAR;PEPD;ACP5;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;SLC1A3;ELOVL6;ETFDH
2977,GO:0006082,1.82780519078377e-19,1,41,1031,organic acid metabolic process,BP,PDK4;PECR;PHYH;MSRA;MRI1;APOC1;EXTL1;ACSF2;PNP;BDH2;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;CPT2;HSD17B10;ETFB;HACL1;ACAT1;IDUA;ECHDC2;SARDH;HEXB;FABP3;CPT1C;PCBD1;MDH1;PON2;IDH1;DECR1;STAR;PEPD;ECI1;CYB5A;PTS;SLC1A3;ELOVL6;ETFDH
3340,GO:0006629,1.9195874115707e-19,1,44,1307,lipid metabolic process,BP,EBP;PDK4;PECR;PHYH;DPM3;ZFYVE21;HSD17B3;APOC1;HSD17B11;ACSF2;ABCG1;BDH2;ACADVL;ACSM5;RGN;FADS1;GHR;FGF18;ASAH2;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;RBP4;CYP17A1;ANG;ACAT1;ECHDC2;HEXB;FABP3;HSD3B2;NUDT7;CPT1C;PON2;IDH1;DECR1;STAR;GLA;ECI1;CYP11A1;DHCR7;ELOVL6;ETFDH
11406,GO:0043436,8.10196292798876e-19,1,40,1016,oxoacid metabolic process,BP,PDK4;PECR;PHYH;MSRA;MRI1;APOC1;EXTL1;ACSF2;BDH2;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;CPT2;HSD17B10;ETFB;HACL1;ACAT1;IDUA;ECHDC2;SARDH;HEXB;FABP3;CPT1C;PCBD1;MDH1;PON2;IDH1;DECR1;STAR;PEPD;ECI1;CYB5A;PTS;SLC1A3;ELOVL6;ETFDH
6685,GO:0019752,2.4273849677484e-18,1,38,909,carboxylic acid metabolic process,BP,PDK4;PECR;PHYH;MSRA;MRI1;APOC1;ACSF2;BDH2;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;CPT2;HSD17B10;ETFB;HACL1;ACAT1;IDUA;ECHDC2;SARDH;FABP3;CPT1C;PCBD1;MDH1;PON2;IDH1;DECR1;STAR;PEPD;ECI1;CYB5A;PTS;SLC1A3;ELOVL6;ETFDH
11692,GO:0044255,1.23249450626545e-16,1,36,1021,cellular lipid metabolic process,BP,PDK4;PECR;PHYH;DPM3;ZFYVE21;APOC1;ACSF2;ABCG1;BDH2;ACADVL;ACSM5;RGN;FADS1;GHR;FGF18;ASAH2;CPT2;PLA2G16;ETFB;HACL1;RBP4;ANG;ACAT1;ECHDC2;HEXB;FABP3;NUDT7;CPT1C;PON2;IDH1;DECR1;STAR;GLA;ECI1;ELOVL6;ETFDH
3341,GO:0006631,3.3411944538926e-16,1,23,330,fatty acid metabolic process,BP,PDK4;PECR;PHYH;APOC1;ACSF2;BDH2;ACADVL;ACSM5;RGN;FADS1;GHR;CPT2;ETFB;HACL1;ACAT1;ECHDC2;FABP3;CPT1C;PON2;DECR1;ECI1;ELOVL6;ETFDH
8735,GO:0032787,3.08203285284392e-15,1,27,540,monocarboxylic acid metabolic process,BP,PDK4;PECR;PHYH;APOC1;ACSF2;BDH2;ACADVL;ACSM5;RGN;FADS1;GHR;CPT2;ETFB;HACL1;ACAT1;IDUA;ECHDC2;FABP3;CPT1C;PON2;IDH1;DECR1;STAR;ECI1;SLC1A3;ELOVL6;ETFDH
11870,GO:0044710,3.91596440818023e-15,1,69,4067,single-organism metabolic process,BP,EBP;PDK4;PECR;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;MRI1;HSD17B3;MRAP;APOC1;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;BDH2;PYCARD;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;ANG;ACAT1;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;HSD3B2;NUDT7;CPT1C;PCBD1;MDH1;PON2;IDH1;DECR1;LDHD;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;SLC1A3;ELOVL6;ETFDH
6599,GO:0019395,6.12993925899923e-15,1,14,95,fatty acid oxidation,BP,PDK4;PHYH;BDH2;ACADVL;CPT2;ETFB;HACL1;ACAT1;ECHDC2;FABP3;CPT1C;DECR1;ECI1;ETFDH
9447,GO:0034440,9.88904159123688e-15,1,14,97,lipid oxidation,BP,PDK4;PHYH;BDH2;ACADVL;CPT2;ETFB;HACL1;ACAT1;ECHDC2;FABP3;CPT1C;DECR1;ECI1;ETFDH
7341,GO:0030258,2.04232398781114e-14,1,18,254,lipid modification,BP,PDK4;PHYH;ZFYVE21;APOC1;ABCG1;BDH2;ACADVL;FGF18;CPT2;ETFB;HACL1;ACAT1;ECHDC2;FABP3;CPT1C;DECR1;ECI1;ETFDH
2757,GO:0005739,3.02565404621762e-14,1,44,1569,mitochondrion,CC,PDK4;PECR;TMEM160;PHYH;MSRA;MRPL14;MRPL16;ACSF2;ABCG1;PYCARD;CCDC51;G0S2;ACADVL;ACSM5;FADS1;ASAH2;CPT2;HSD17B10;ETFB;CYP17A1;RNASEL;BOLA1;ACAT1;TSFM;ECHDC2;SARDH;NOL3;HSD3B2;NUDT6;CPT1C;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;LDHD;STAR;ECI1;CYP11A1;CYB5A;PTS;ETFDH
11809,GO:0044444,3.0945321294604e-14,1,101,8745,cytoplasmic part,CC,EBP;PDK4;PECR;TMEM160;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;BDH2;PYCARD;CCDC51;G0S2;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;ASAH2;TICAM1;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;DOK1;LYPLAL1;CNIH4;ELOVL6;ETFDH;TMOD4
11682,GO:0044242,3.87598988516712e-14,1,17,189,cellular lipid catabolic process,BP,PHYH;APOC1;BDH2;ACADVL;CPT2;ETFB;HACL1;ACAT1;ECHDC2;HEXB;FABP3;CPT1C;IDH1;DECR1;GLA;ECI1;ETFDH
14626,GO:0055114,6.57680543997143e-13,1,32,940,oxidation-reduction process,BP,PDK4;PECR;PHYH;IFI30;MSRA;HSD17B3;HSD17B11;BDH2;ACADVL;FADS1;CPT2;HSD17B10;ETFB;HACL1;CYP17A1;ACAT1;AOX1;ECHDC2;SARDH;FABP3;HSD3B2;CPT1C;PCBD1;MDH1;IDH1;DECR1;LDHD;ECI1;CYP11A1;DHCR7;CYB5A;ETFDH
5736,GO:0016042,6.80687344056555e-13,1,19,296,lipid catabolic process,BP,PHYH;APOC1;HSD17B11;BDH2;ACADVL;CPT2;PLA2G16;ETFB;HACL1;ACAT1;ECHDC2;HEXB;FABP3;CPT1C;IDH1;DECR1;GLA;ECI1;ETFDH
4356,GO:0009062,2.31689318012212e-12,1,12,92,fatty acid catabolic process,BP,PHYH;BDH2;ACADVL;CPT2;ETFB;HACL1;ACAT1;ECHDC2;CPT1C;DECR1;ECI1;ETFDH
16999,GO:0072329,2.63383685354236e-12,1,13,114,monocarboxylic acid catabolic process,BP,PHYH;BDH2;ACADVL;CPT2;ETFB;HACL1;ACAT1;IDUA;ECHDC2;CPT1C;DECR1;ECI1;ETFDH
11872,GO:0044712,4.87594808838511e-12,1,29,922,single-organism catabolic process,BP,PHYH;APOC1;HSD17B11;PNP;BDH2;ACADVL;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;ACAT1;IDUA;AOX1;ECHDC2;SARDH;HEXB;FABP3;NUDT7;CPT1C;PCBD1;IDH1;DECR1;PEPD;GLA;ECI1;DERA;ETFDH
4247,GO:0008610,5.10250687804436e-12,1,24,628,lipid biosynthetic process,BP,EBP;PDK4;PECR;DPM3;HSD17B3;APOC1;HSD17B11;ABCG1;ACADVL;ACSM5;RGN;FADS1;FGF18;PLA2G16;CYP17A1;ANG;HEXB;FABP3;HSD3B2;IDH1;STAR;CYP11A1;DHCR7;ELOVL6
5746,GO:0016054,1.69712890024655e-11,1,16,224,organic acid catabolic process,BP,PHYH;BDH2;ACADVL;CPT2;HSD17B10;ETFB;HACL1;ACAT1;IDUA;ECHDC2;SARDH;CPT1C;PCBD1;DECR1;ECI1;ETFDH
12625,GO:0046395,1.69712890024655e-11,1,16,224,carboxylic acid catabolic process,BP,PHYH;BDH2;ACADVL;CPT2;HSD17B10;ETFB;HACL1;ACAT1;IDUA;ECHDC2;SARDH;CPT1C;PCBD1;DECR1;ECI1;ETFDH
11871,GO:0044711,3.20953368877282e-11,1,35,1404,single-organism biosynthetic process,BP,EBP;PDK4;PECR;DPM3;MRI1;HSD17B3;MRAP;APOC1;HSD17B11;EXTL1;PNP;ABCG1;BDH2;ACADVL;MGST2;ACSM5;RGN;FADS1;FGF18;NNMT;PLA2G16;RBP4;CYP17A1;ANG;ACAT1;HEXB;FABP3;HSD3B2;MDH1;IDH1;STAR;CYP11A1;DHCR7;SLC1A3;ELOVL6
3343,GO:0006635,6.69556172633596e-11,1,10,69,fatty acid beta-oxidation,BP,BDH2;ACADVL;CPT2;ETFB;ACAT1;ECHDC2;CPT1C;DECR1;ECI1;ETFDH
11712,GO:0044283,1.48527403585436e-10,0.999999999981546,21,496,small molecule biosynthetic process,BP,EBP;PDK4;PECR;MRI1;HSD17B3;APOC1;PNP;ABCG1;BDH2;ACADVL;MGST2;ACSM5;RGN;FADS1;RBP4;ACAT1;MDH1;STAR;DHCR7;SLC1A3;ELOVL6
2756,GO:0005737,3.40483499637154e-10,0.999999999928913,105,10558,cytoplasm,CC,EBP;PDK4;PECR;TMEM160;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;BDH2;PYCARD;CCDC51;G0S2;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;ASAH2;TICAM1;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;CNIH4;ELOVL6;ETFDH;TMOD4
11711,GO:0044282,9.92481605507923e-10,0.999999999880458,17,336,small molecule catabolic process,BP,PHYH;BDH2;ACADVL;CPT2;HSD17B10;ETFB;HACL1;GALT;ACAT1;IDUA;ECHDC2;SARDH;CPT1C;PCBD1;DECR1;ECI1;ETFDH
1654,GO:0003824,1.44223682267474e-09,0.999999999537841,69,5495,catalytic activity,MF,CFB;EBP;PDK4;PECR;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;MRI1;HSD17B3;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;BDH2;PYCARD;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;FGF18;ASAH2;NNMT;CPT2;PLA2G16;HSD17B10;HACL1;GALT;CYP17A1;RNASEL;ANG;ACAT1;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;CMBL;HSD3B2;NUDT6;NUDT7;CPT1C;PCBD1;MDH1;CASP4;PON2;IDH1;DECR1;PUS1;LDHD;MDP1;PEPD;ACP5;GLA;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;LYPLAL1;ELOVL6;ETFDH
5951,GO:0016491,2.23351304325131e-09,0.999999999590813,24,701,oxidoreductase activity,MF,PECR;PHYH;IFI30;MSRA;HSD17B3;HSD17B11;BDH2;ACADVL;MGST2;FADS1;HSD17B10;CYP17A1;AOX1;SARDH;HSD3B2;PCBD1;MDH1;IDH1;DECR1;LDHD;CYP11A1;DHCR7;CYB5A;ETFDH
3415,GO:0006732,6.9737621988088e-08,0.999999990854691,14,303,coenzyme metabolic process,BP,PDK4;ACSF2;PNP;ACSM5;NNMT;ACAT1;SHPK;NUDT7;PCBD1;MDH1;IDH1;DERA;PTS;ELOVL6
13086,GO:0048037,7.62068955482731e-08,0.999999990885056,13,252,cofactor binding,MF,PHYH;BDH2;ACADVL;HACL1;ACAT1;AOX1;ACCS;MDH1;IDH1;DECR1;LDHD;DHCR7;ETFDH
13564,GO:0050662,9.26093520098123e-08,0.999999991162794,11,177,coenzyme binding,MF,BDH2;ACADVL;HACL1;ACAT1;AOX1;MDH1;IDH1;DECR1;LDHD;DHCR7;ETFDH
2773,GO:0005759,1.39294071777301e-07,0.999999975901616,17,410,mitochondrial matrix,CC,PDK4;MRPL14;MRPL16;ACSF2;ACADVL;ACSM5;HSD17B10;ETFB;RNASEL;ACAT1;TSFM;SARDH;DECR1;PUS1;ECI1;CYP11A1;ETFDH
4350,GO:0009056,1.67411243879749e-07,0.999999947445938,37,2223,catabolic process,BP,USE1;PHYH;APOC1;WDR45;TBC1D14;HSD17B11;PNP;BDH2;ACADVL;PSMB10;RGN;TICAM1;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;ACAT1;IDUA;AOX1;ECHDC2;SARDH;HEXB;FABP3;NUDT7;CPT1C;PCBD1;PON2;IDH1;DECR1;PEPD;GLA;ECI1;DERA;LYPLAL1;ETFDH
11274,GO:0043227,1.77931881299159e-07,0.999999944713024,106,11597,membrane-bounded organelle,CC,CFB;EBP;PDK4;PECR;TMEM160;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;FGF18;ASAH2;TICAM1;ARL6IP4;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;MDP1;TFPI;STAR;SNX21;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;HNF1A;DOK1;LYPLAL1;CNIH4;ELOVL6;ETFDH
13929,GO:0051186,2.37971113297086e-07,0.999999962456225,15,373,cofactor metabolic process,BP,PDK4;ACSF2;PNP;BDH2;ACSM5;NNMT;ACAT1;SHPK;NUDT7;PCBD1;MDH1;IDH1;DERA;PTS;ELOVL6
11273,GO:0043226,2.57511932464761e-07,0.999999925367782,110,12482,organelle,CC,CFB;EBP;PDK4;PECR;TMEM160;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;MDP1;TFPI;STAR;SNX21;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;HNF1A;DOK1;LYPLAL1;CNIH4;ELOVL6;ETFDH;TMOD4
12859,GO:0046890,3.02090264375817e-07,0.999999976365025,9,129,regulation of lipid biosynthetic process,BP,PDK4;APOC1;ABCG1;ACADVL;RGN;FABP3;IDH1;STAR;DHCR7
6026,GO:0016614,3.49617809651187e-07,0.999999967036354,10,135,oxidoreductase activity, acting on CH-OH group of donors,MF,HSD17B3;HSD17B11;BDH2;HSD17B10;AOX1;HSD3B2;MDH1;IDH1;LDHD;CYB5A
3452,GO:0006790,3.65520255403795e-07,0.999999944692601,14,358,sulfur compound metabolic process,BP,PDK4;MSRA;MRI1;EXTL1;ACSF2;MGST2;ACSM5;GHR;ACAT1;IDUA;HEXB;NUDT7;IDH1;ELOVL6
11805,GO:0044438,4.18154761581539e-07,0.999999972673933,8,91,microbody part,CC,PECR;PHYH;PXMP2;PXMP4;PLA2G16;HACL1;NUDT7;IDH1
11806,GO:0044439,4.18154761581539e-07,0.999999972673933,8,91,peroxisomal part,CC,PECR;PHYH;PXMP2;PXMP4;PLA2G16;HACL1;NUDT7;IDH1
6140,GO:0016829,4.80132093587592e-07,0.999999952868819,10,154,lyase activity,MF,MGST2;HACL1;CYP17A1;ACAT1;ECHDC2;PCBD1;PUS1;ECI1;DERA;PTS
10836,GO:0042446,5.87747973993107e-07,0.999999969379188,7,65,hormone biosynthetic process,BP,HSD17B3;HSD17B11;CYP17A1;HSD3B2;STAR;CYP11A1;DHCR7
18840,GO:1901575,6.88709207915622e-07,0.9999997857209,32,1816,organic substance catabolic process,BP,USE1;PHYH;APOC1;HSD17B11;PNP;BDH2;ACADVL;PSMB10;RGN;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;ACAT1;IDUA;AOX1;ECHDC2;SARDH;HEXB;FABP3;NUDT7;CPT1C;PCBD1;IDH1;DECR1;GLA;ECI1;DERA;LYPLAL1;ETFDH
11687,GO:0044248,8.18508243078566e-07,0.999999743103631,32,1867,cellular catabolic process,BP,PHYH;APOC1;WDR45;TBC1D14;PNP;BDH2;ACADVL;PSMB10;RGN;TICAM1;CPT2;HSD17B10;ETFB;HACL1;GALT;ACAT1;IDUA;AOX1;ECHDC2;SARDH;HEXB;FABP3;NUDT7;CPT1C;PCBD1;PON2;IDH1;DECR1;GLA;ECI1;DERA;ETFDH
11799,GO:0044429,8.92940034363631e-07,0.99999976444773,24,919,mitochondrial part,CC,PDK4;MRPL14;MRPL16;ACSF2;ACADVL;ACSM5;CPT2;HSD17B10;ETFB;RNASEL;ACAT1;TSFM;SARDH;HSD3B2;CPT1C;IFI27;DECR1;PUS1;LDHD;STAR;ECI1;CYP11A1;CYB5A;ETFDH
3970,GO:0008152,1.14102250911737e-06,0.999999583703252,99,10623,metabolic process,BP,CFB;EBP;PDK4;PECR;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;WDR45;TBC1D14;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;ANG;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;CMBL;FABP3;NOL3;HSD3B2;NUDT7;DEPTOR;ACCS;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;FAM46A;IDH1;DECR1;PUS1;PTMS;LDHD;MDP1;TFPI;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;RBMS3;HNF1A;LYPLAL1;SLC1A3;ELOVL6;ETFDH
17000,GO:0072330,1.25897251526794e-06,0.999999861493853,10,185,monocarboxylic acid biosynthetic process,BP,PDK4;PECR;APOC1;ACADVL;ACSM5;RGN;FADS1;STAR;SLC1A3;ELOVL6
18832,GO:1901564,1.81319568921532e-06,0.999999365618552,37,2159,organonitrogen compound metabolic process,BP,MSRA;MRPL14;MRPL16;MRI1;MRAP;APOC1;EXTL1;PNP;BDH2;MGST2;PSMB10;GHR;ASAH2;NNMT;PLA2G16;HSD17B10;ANG;ACAT1;TSFM;IDUA;AOX1;SARDH;SHPK;HEXB;FABP3;NUDT7;CPT1C;PCBD1;MDH1;IDH1;PEPD;ACP5;GLA;DERA;PTS;RBMS3;SLC1A3
5745,GO:0016053,1.91955578572638e-06,0.999999718126831,12,285,organic acid biosynthetic process,BP,PDK4;PECR;MRI1;APOC1;ACADVL;MGST2;ACSM5;RGN;FADS1;STAR;SLC1A3;ELOVL6
12624,GO:0046394,1.91955578572638e-06,0.999999718126831,12,285,carboxylic acid biosynthetic process,BP,PDK4;PECR;MRI1;APOC1;ACADVL;MGST2;ACSM5;RGN;FADS1;STAR;SLC1A3;ELOVL6
11278,GO:0043231,3.05706262772907e-06,0.999998786315826,93,9934,intracellular membrane-bounded organelle,CC,EBP;PDK4;PECR;TMEM160;USE1;ALG5;PHYH;IFI30;DPM3;MSRA;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;EXTL1;ACSF2;PNP;ABCG1;EBF1;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;FGF18;ASAH2;TICAM1;ARL6IP4;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;HEXB;NOL3;HSD3B2;NUDT6;NUDT7;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;TFPI;STAR;ACP5;GLA;ECI1;CYP11A1;DERA;S100B;DHCR7;CYB5A;PTS;HNF1A;DOK1;CNIH4;ELOVL6;ETFDH
3342,GO:0006633,3.34194746610818e-06,0.999999706997843,8,118,fatty acid biosynthetic process,BP,PDK4;PECR;APOC1;ACADVL;ACSM5;RGN;FADS1;ELOVL6
11276,GO:0043229,4.23043302083189e-06,0.999998429705591,102,11553,intracellular organelle,CC,EBP;PDK4;PECR;TMEM160;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;HEXB;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;HNF1A;DOK1;CNIH4;ELOVL6;ETFDH;TMOD4
3392,GO:0006694,4.47475619344876e-06,0.999999508321699,9,162,steroid biosynthetic process,BP,EBP;HSD17B3;HSD17B11;ABCG1;CYP17A1;HSD3B2;STAR;CYP11A1;DHCR7
2790,GO:0005777,4.67544517584208e-06,0.99999956989104,8,124,peroxisome,CC,PECR;PHYH;PXMP2;PXMP4;PLA2G16;HACL1;NUDT7;IDH1
10922,GO:0042579,4.67544517584208e-06,0.99999956989104,8,124,microbody,CC,PECR;PHYH;PXMP2;PXMP4;PLA2G16;HACL1;NUDT7;IDH1
5779,GO:0016125,6.00543626942936e-06,0.999999426145379,8,137,sterol metabolic process,BP,EBP;APOC1;ABCG1;ACADVL;CYP17A1;STAR;CYP11A1;DHCR7
11795,GO:0044424,6.91136360146952e-06,0.999997763203174,111,13251,intracellular part,CC,EBP;PDK4;PECR;TMEM160;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;CNIH4;ELOVL6;ETFDH;TMOD4
18833,GO:1901565,1.04642198231088e-05,0.99999817266173,12,346,organonitrogen compound catabolic process,BP,APOC1;PNP;HSD17B10;ACAT1;IDUA;AOX1;SARDH;HEXB;NUDT7;PCBD1;GLA;DERA
6028,GO:0016616,1.28627416299755e-05,0.999998641709354,8,115,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD17B3;HSD17B11;BDH2;HSD17B10;HSD3B2;MDH1;IDH1;CYB5A
4002,GO:0008202,1.36534133257709e-05,0.999997773567596,11,288,steroid metabolic process,BP,EBP;HSD17B3;APOC1;HSD17B11;ABCG1;ACADVL;CYP17A1;HSD3B2;STAR;CYP11A1;DHCR7
4386,GO:0009108,1.38982386433403e-05,0.999998505231506,8,143,coenzyme biosynthetic process,BP,PDK4;ACSF2;PNP;NNMT;ACAT1;PCBD1;PTS;ELOVL6
16654,GO:0071704,1.49278834553046e-05,0.99999369920513,93,10155,organic substance metabolic process,BP,CFB;EBP;PDK4;PECR;USE1;ALG5;PHYH;DPM3;ZFYVE21;MSRA;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;ANG;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;NOL3;HSD3B2;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;FAM46A;IDH1;DECR1;PUS1;PTMS;MDP1;TFPI;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;RBMS3;HNF1A;LYPLAL1;SLC1A3;ELOVL6;ETFDH
13931,GO:0051188,1.53842499075105e-05,0.999998016824242,9,184,cofactor biosynthetic process,BP,PDK4;ACSF2;PNP;BDH2;NNMT;ACAT1;PCBD1;PTS;ELOVL6
4003,GO:0008203,2.12135814139702e-05,0.999998022919005,7,119,cholesterol metabolic process,BP,EBP;APOC1;ABCG1;ACADVL;STAR;CYP11A1;DHCR7
11679,GO:0044238,2.52185643271978e-05,0.99998894796554,90,9787,primary metabolic process,BP,CFB;EBP;PDK4;PECR;USE1;ALG5;PHYH;DPM3;ZFYVE21;MSRA;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;ACADVL;KRT10;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;ANG;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;NOL3;HSD3B2;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;MDP1;TFPI;STAR;PEPD;GLA;ECI1;CYP11A1;DERA;DHCR7;CYB5A;PTS;RBMS3;HNF1A;LYPLAL1;SLC1A3;ELOVL6;ETFDH
19254,GO:1902652,2.85926536857459e-05,0.999997202887295,7,124,secondary alcohol metabolic process,BP,EBP;APOC1;ABCG1;ACADVL;STAR;CYP11A1;DHCR7
11678,GO:0044237,3.76448573191614e-05,0.999983228349852,90,9871,cellular metabolic process,BP,PDK4;PECR;ALG5;PHYH;DPM3;ZFYVE21;MSRA;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;WDR45;TBC1D14;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;ANG;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;CMBL;FABP3;NOL3;HSD3B2;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;MDP1;TFPI;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;DERA;CYB5A;PTS;RBMS3;HNF1A;LYPLAL1;SLC1A3;ELOVL6;ETFDH
2699,GO:0005622,3.82572400800878e-05,0.999986584473074,111,13536,intracellular,CC,EBP;PDK4;PECR;TMEM160;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;CNIH4;ELOVL6;ETFDH;TMOD4
9599,GO:0034754,4.07944738739209e-05,0.999995794477437,7,110,cellular hormone metabolic process,BP,HSD17B3;HSD17B11;RBP4;CYP17A1;HSD3B2;STAR;CYP11A1
9094,GO:0033539,4.44351932643787e-05,0.999999485299205,3,8,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,ACADVL;ETFB;ETFDH
17077,GO:0072524,4.4749032174285e-05,0.999995288544624,7,134,pyridine-containing compound metabolic process,BP,PNP;NNMT;AOX1;SHPK;MDH1;IDH1;DERA
4007,GO:0008209,6.20377355801648e-05,0.999997751886506,4,28,androgen metabolic process,BP,HSD17B3;HSD17B11;CYP17A1;HSD3B2
6534,GO:0019216,6.23287644303764e-05,0.99999029210947,9,269,regulation of lipid metabolic process,BP,PDK4;APOC1;ABCG1;ACADVL;RGN;FABP3;IDH1;STAR;DHCR7
6034,GO:0016628,6.23467224386419e-05,0.999997766358438,4,25,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,PECR;BDH2;DECR1;DHCR7
3345,GO:0006637,6.73210527966387e-05,0.999994080583198,6,93,acyl-CoA metabolic process,BP,PDK4;ACSF2;ACSM5;ACAT1;NUDT7;ELOVL6
9805,GO:0035383,6.73210527966387e-05,0.999994080583198,6,93,thioester metabolic process,BP,PDK4;ACSF2;ACSM5;ACAT1;NUDT7;ELOVL6
10700,GO:0042180,6.78011736337874e-05,0.999989364230539,9,217,cellular ketone metabolic process,BP,PDK4;HSD17B3;APOC1;ACADVL;PSMB10;RGN;CYP17A1;FABP3;STAR
11528,GO:0043648,8.65977427957861e-05,0.999992017523072,6,96,dicarboxylic acid metabolic process,BP,PHYH;GHR;MDH1;IDH1;STAR;SLC1A3
3398,GO:0006702,9.83309296367516e-05,0.999998337325453,3,11,androgen biosynthetic process,BP,HSD17B3;CYP17A1;HSD3B2
6033,GO:0016627,9.91380863885567e-05,0.999993282681693,5,56,oxidoreductase activity, acting on the CH-CH group of donors,MF,PECR;BDH2;ACADVL;DECR1;DHCR7
10835,GO:0042445,0.00010417328696693,0.999984958774465,8,185,hormone metabolic process,BP,HSD17B3;HSD17B11;RBP4;CYP17A1;HSD3B2;STAR;CYP11A1;DHCR7
2905,GO:0005975,0.000111646953261233,0.999973121362832,13,549,carbohydrate metabolic process,BP,PDK4;DPM3;RGN;GALT;RBP4;IDUA;SHPK;HEXB;MDH1;IDH1;GLA;DERA;CYB5A
6535,GO:0019217,0.000113683801383515,0.999991942395661,5,78,regulation of fatty acid metabolic process,BP,PDK4;APOC1;ACADVL;RGN;FABP3
2992,GO:0006103,0.000114057632652992,0.999997809256442,3,16,2-oxoglutarate metabolic process,BP,PHYH;GHR;IDH1
3245,GO:0006520,0.000125135036393092,0.999973757185517,11,349,cellular amino acid metabolic process,BP,MSRA;MRI1;PSMB10;GHR;HSD17B10;ACAT1;SARDH;PCBD1;PEPD;PTS;SLC1A3
12609,GO:0046356,0.000128123825340727,1,2,2,acetyl-CoA catabolic process,BP,ACAT1;NUDT7
10751,GO:0042304,0.000130706057168272,0.999994103795891,4,37,regulation of fatty acid biosynthetic process,BP,PDK4;APOC1;ACADVL;RGN
9083,GO:0033489,0.00015310693353647,0.999999637164708,2,3,cholesterol biosynthetic process via desmosterol,BP,EBP;DHCR7
9084,GO:0033490,0.00015310693353647,0.999999637164708,2,3,cholesterol biosynthetic process via lathosterol,BP,EBP;DHCR7
2794,GO:0005783,0.000153818241458253,0.999943358387062,24,1601,endoplasmic reticulum,CC,EBP;USE1;ALG5;DPM3;HSD17B3;MRAP;APOC1;EXTL1;ABCG1;PYCARD;MGST2;FADS1;PLA2G16;CYP17A1;NOL3;HSD3B2;CPT1C;CASP4;TMEM98;TFPI;DHCR7;CYB5A;CNIH4;ELOVL6
9190,GO:0033764,0.00015480866911882,0.999992966556927,4,25,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD17B3;HSD17B11;HSD17B10;HSD3B2
11894,GO:0044763,0.000163208878329908,0.999922182649853,89,10179,single-organism cellular process,BP,PDK4;PECR;USE1;ALG5;PHYH;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;BDH2;PYCARD;G0S2;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;RBP4;CYP17A1;RNASEL;ANG;FAM110C;ACAT1;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;GRIA3;NOL3;HSD3B2;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;TMEM176A;IDH1;DECR1;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;DOK1;SLC1A3;ELOVL6;LINGO1;ETFDH;TMOD4
1826,GO:0004095,0.000194231437012289,0.999999266840022,2,4,carnitine O-palmitoyltransferase activity,MF,CPT2;CPT1C
2969,GO:0006066,0.000198641173698735,0.999963844729268,9,289,alcohol metabolic process,BP,EBP;PECR;APOC1;ABCG1;ACADVL;RBP4;STAR;CYP11A1;DHCR7
5820,GO:0016229,0.000198666191703063,0.999990277365828,4,27,steroid dehydrogenase activity,MF,HSD17B3;HSD17B11;HSD17B10;HSD3B2
2291,GO:0004854,0.000199694150090847,0.999999990109252,1,2,xanthine dehydrogenase activity,MF,AOX1
4392,GO:0009115,0.000199694150090847,0.999999990109252,1,2,xanthine catabolic process,BP,AOX1
6080,GO:0016726,0.000199694150090847,0.999999990109252,1,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,AOX1
4857,GO:0010565,0.000204542895134561,0.999972348311249,7,156,regulation of cellular ketone metabolic process,BP,PDK4;APOC1;ACADVL;PSMB10;RGN;FABP3;STAR
5912,GO:0016416,0.000211726327510691,0.999999030704355,2,5,O-palmitoyltransferase activity,MF,CPT2;CPT1C
6163,GO:0016863,0.000222996557536987,0.999994904608715,3,12,intramolecular oxidoreductase activity, transposing C=C bonds,MF,EBP;HSD3B2;ECI1
3272,GO:0006549,0.000227538225473866,0.999998919840317,2,5,isoleucine metabolic process,BP,GHR;ACAT1
16777,GO:0071955,0.000249765985284499,0.999999984526948,1,2,recycling endosome to Golgi transport,BP,TBC1D14
18690,GO:1901136,0.000253866069532046,0.999964361567702,7,171,carbohydrate derivative catabolic process,BP,PNP;GALT;IDUA;HEXB;NUDT7;GLA;DERA
6536,GO:0019218,0.000256418604767121,0.99997836719054,5,75,regulation of steroid metabolic process,BP,APOC1;ABCG1;ACADVL;STAR;DHCR7
6145,GO:0016835,0.000263659467972211,0.999977810986112,5,62,carbon-oxygen lyase activity,MF,ECHDC2;PCBD1;PUS1;ECI1;PTS
2800,GO:0005789,0.000287700319067327,0.999908008817608,17,951,endoplasmic reticulum membrane,CC,EBP;USE1;ALG5;DPM3;HSD17B3;MRAP;EXTL1;ABCG1;MGST2;FADS1;CYP17A1;HSD3B2;CPT1C;CASP4;DHCR7;CYB5A;ELOVL6
6582,GO:0019362,0.000317625196936833,0.999962401578917,6,129,pyridine nucleotide metabolic process,BP,PNP;NNMT;SHPK;MDH1;IDH1;DERA
12673,GO:0046496,0.000317625196936833,0.999962401578917,6,129,nicotinamide nucleotide metabolic process,BP,PNP;NNMT;SHPK;MDH1;IDH1;DERA
18854,GO:1901615,0.000324790881917847,0.999923582515779,11,457,organic hydroxy compound metabolic process,BP,EBP;PECR;HSD17B3;APOC1;ABCG1;ACADVL;RBP4;CYP17A1;STAR;CYP11A1;DHCR7
10696,GO:0042175,0.000344130743270604,0.999888187098741,17,971,nuclear outer membrane-endoplasmic reticulum membrane network,CC,EBP;USE1;ALG5;DPM3;HSD17B3;MRAP;EXTL1;ABCG1;MGST2;FADS1;CYP17A1;HSD3B2;CPT1C;CASP4;DHCR7;CYB5A;ELOVL6
12586,GO:0046320,0.00034662574661358,0.999989656625054,3,27,regulation of fatty acid oxidation,BP,PDK4;ACADVL;FABP3
10102,GO:0035877,0.00034767516034978,0.999998239852221,2,4,death effector domain binding,MF,FADD;NOL3
2228,GO:0004769,0.000412279190068463,0.999998389196787,2,3,steroid delta-isomerase activity,MF,EBP;HSD3B2
4370,GO:0009081,0.000434622251992348,0.999986186648869,3,23,branched-chain amino acid metabolic process,BP,GHR;HSD17B10;ACAT1
8207,GO:0031966,0.000472340983760191,0.999854133768396,15,634,mitochondrial membrane,CC,PDK4;MRPL14;MRPL16;ACADVL;CPT2;ACAT1;HSD3B2;CPT1C;IFI27;LDHD;STAR;ECI1;CYP11A1;CYB5A;ETFDH
5902,GO:0016406,0.000500994939866404,0.999996146382044,2,6,carnitine O-acyltransferase activity,MF,CPT2;CPT1C
2793,GO:0005782,0.000503751774550371,0.999967216749671,4,43,peroxisomal matrix,CC,PHYH;HACL1;NUDT7;IDH1
8178,GO:0031907,0.000503751774550371,0.999967216749671,4,43,microbody lumen,CC,PHYH;HACL1;NUDT7;IDH1
17435,GO:0090181,0.00051477575529855,0.999982657085136,3,23,regulation of cholesterol metabolic process,BP,ABCG1;ACADVL;DHCR7
2791,GO:0005778,0.000516885326845589,0.99996562000951,4,57,peroxisomal membrane,CC,PECR;PXMP2;PXMP4;PLA2G16
8174,GO:0031903,0.000516885326845589,0.99996562000951,4,57,microbody membrane,CC,PECR;PXMP2;PXMP4;PLA2G16
11707,GO:0044273,0.000545233518657752,0.999963447663568,4,50,sulfur compound catabolic process,BP,ACAT1;IDUA;HEXB;NUDT7
12153,GO:0045350,0.00055240956666154,0.999995102025325,2,8,interferon-beta biosynthetic process,BP,TICAM1;NMI
12160,GO:0045357,0.00055240956666154,0.999995102025325,2,8,regulation of interferon-beta biosynthetic process,BP,TICAM1;NMI
21638,GO:2001236,0.000565152196683039,0.999925114389653,6,151,regulation of extrinsic apoptotic signaling pathway,BP,FADD;TRADD;PYCARD;G0S2;NOL3;DEPTOR
6160,GO:0016860,0.000577271838430801,0.999960933379277,4,45,intramolecular oxidoreductase activity,MF,EBP;MRI1;HSD3B2;ECI1
11706,GO:0044272,0.000591515224925823,0.99990397469203,7,209,sulfur compound biosynthetic process,BP,PDK4;MRI1;EXTL1;ACSF2;MGST2;ACAT1;ELOVL6
6141,GO:0016830,0.000615102811216598,0.999957606373084,4,46,carbon-carbon lyase activity,MF,HACL1;CYP17A1;ACAT1;DERA
6146,GO:0016836,0.000640385625495981,0.999955563412311,4,43,hydro-lyase activity,MF,ECHDC2;PCBD1;PUS1;ECI1
15838,GO:0070265,0.000640629785147821,0.999955257575537,4,48,necrotic cell death,BP,FADD;TRADD;TICAM1;NOL3
8429,GO:0032365,0.000644889235304736,0.999975973724994,3,30,intracellular lipid transport,BP,ABCG1;CPT2;STAR
3416,GO:0006733,0.000654372593386023,0.99991093611157,6,143,oxidoreduction coenzyme metabolic process,BP,PNP;NNMT;SHPK;MDH1;IDH1;DERA
11880,GO:0044723,0.000750962860413556,0.999819009802193,10,436,single-organism carbohydrate metabolic process,BP,PDK4;RGN;GALT;RBP4;IDUA;HEXB;MDH1;IDH1;GLA;CYB5A
12439,GO:0045940,0.000796682598140082,0.999968785625944,3,23,positive regulation of steroid metabolic process,BP,APOC1;ABCG1;STAR
15478,GO:0061370,0.000810118476860509,0.999992053582989,2,6,testosterone biosynthetic process,BP,HSD17B3;STAR
11811,GO:0044446,0.000844331886356167,0.999549618612596,74,8256,intracellular organelle part,CC,EBP;PDK4;PECR;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;MRPL14;MRPL16;MRI1;HSD17B3;MRAP;TBC1D14;PXMP2;PXMP4;EXTL1;ACSF2;PNP;ABCG1;PYCARD;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;FADS1;FGF18;TICAM1;ARL6IP4;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;CYP17A1;RNASEL;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;SARDH;HEXB;GRIA3;NOL3;HSD3B2;NUDT7;CPT1C;PCBD1;CASP4;IFI27;IDH1;DECR1;PUS1;LDHD;STAR;SNX21;GLA;ECI1;CYP11A1;RPH3AL;DERA;DHCR7;CYB5A;ELOVL6;ETFDH;TMOD4
2758,GO:0005740,0.000870264356030331,0.999714309330639,15,669,mitochondrial envelope,CC,PDK4;MRPL14;MRPL16;ACADVL;CPT2;ACAT1;HSD3B2;CPT1C;IFI27;LDHD;STAR;ECI1;CYP11A1;CYB5A;ETFDH
122,GO:0000248,0.000871877418007612,1,1,1,C-5 sterol desaturase activity,MF,FADS1
12194,GO:0045485,0.000871877418007612,1,1,1,omega-6 fatty acid desaturase activity,MF,FADS1
16095,GO:0070704,0.000871877418007612,1,1,1,sterol desaturase activity,MF,FADS1
4009,GO:0008211,0.000880526691069007,0.999964134077752,3,24,glucocorticoid metabolic process,BP,CYP17A1;HSD3B2;STAR
17785,GO:0097169,0.000898160983207274,0.999992647987069,2,4,AIM2 inflammasome complex,CC,PYCARD;CASP4
2375,GO:0004971,0.000924035768786086,0.999999682245186,1,4,AMPA glutamate receptor activity,MF,GRIA3
13995,GO:0051287,0.000942268067116956,0.99992662656406,4,53,NAD binding,MF,BDH2;AOX1;MDH1;IDH1
9806,GO:0035384,0.000943696345579011,0.999925922558856,4,63,thioester biosynthetic process,BP,PDK4;ACSF2;ACAT1;ELOVL6
16596,GO:0071616,0.000943696345579011,0.999925922558856,4,63,acyl-CoA biosynthetic process,BP,PDK4;ACSF2;ACAT1;ELOVL6
12858,GO:0046889,0.000975059013823202,0.999922937552197,4,60,positive regulation of lipid biosynthetic process,BP,ABCG1;RGN;FABP3;STAR
17101,GO:0072559,0.000982750858925022,0.999989368378377,2,6,NLRP3 inflammasome complex,CC,PYCARD;CASP4
15127,GO:0060696,0.00101561069763472,0.999988828000781,2,6,regulation of phospholipid catabolic process,BP,APOC1;IDH1
11793,GO:0044422,0.00104520127454227,0.999437065813643,75,8458,organelle part,CC,EBP;PDK4;PECR;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;MRPL14;MRPL16;MRI1;HSD17B3;MRAP;TBC1D14;PXMP2;PXMP4;EXTL1;ACSF2;PNP;ABCG1;PYCARD;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;FADS1;FGF18;TICAM1;ARL6IP4;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;CYP17A1;RNASEL;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;SARDH;HEXB;GRIA3;NOL3;HSD3B2;NUDT7;CPT1C;PCBD1;CASP4;IFI27;IDH1;DECR1;PUS1;LDHD;TFPI;STAR;SNX21;GLA;ECI1;CYP11A1;RPH3AL;DERA;DHCR7;CYB5A;ELOVL6;ETFDH;TMOD4
17868,GO:0097342,0.00104771668917199,0.999987636797841,2,7,ripoptosome,CC,FADD;TICAM1
18847,GO:1901605,0.00109256168004385,0.999803073374506,7,206,alpha-amino acid metabolic process,BP,MSRA;MRI1;GHR;ACAT1;SARDH;PCBD1;SLC1A3
12634,GO:0046434,0.00115395062207281,0.999862194448159,5,122,organophosphate catabolic process,BP,APOC1;PNP;NUDT7;IDH1;DERA
13562,GO:0050660,0.00117097953844516,0.999902030130204,4,73,flavin adenine dinucleotide binding,MF,ACADVL;AOX1;LDHD;ETFDH
2979,GO:0006084,0.0011844626328633,0.999945045890796,3,34,acetyl-CoA metabolic process,BP,PDK4;ACAT1;NUDT7
17326,GO:0089720,0.0012351672812841,0.999984992947053,2,6,caspase binding,MF,FADD;NOL3
4271,GO:0008654,0.00125038027116721,0.999768434690122,7,266,phospholipid biosynthetic process,BP,DPM3;FADS1;FGF18;PLA2G16;HEXB;FABP3;IDH1
12373,GO:0045834,0.00125464652899103,0.999847291004359,5,123,positive regulation of lipid metabolic process,BP,APOC1;ABCG1;RGN;FABP3;STAR
522,GO:0001561,0.00129806050275752,0.999982922382929,2,7,fatty acid alpha-oxidation,BP,PHYH;HACL1
9391,GO:0034356,0.00140165271885076,0.999978699472658,2,11,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,PNP;NNMT
3351,GO:0006644,0.0014283416178473,0.999655792825103,9,427,phospholipid metabolic process,BP,DPM3;ZFYVE21;APOC1;FADS1;FGF18;PLA2G16;HEXB;FABP3;IDH1
5118,GO:0010939,0.00151683818550392,0.999924782062146,3,26,regulation of necrotic cell death,BP,FADD;TRADD;NOL3
11802,GO:0044432,0.00154826586775892,0.999421575655493,17,1135,endoplasmic reticulum part,CC,EBP;USE1;ALG5;DPM3;HSD17B3;MRAP;EXTL1;ABCG1;MGST2;FADS1;CYP17A1;HSD3B2;CPT1C;CASP4;DHCR7;CYB5A;ELOVL6
8208,GO:0031967,0.00166336037268815,0.999356503838093,18,1063,organelle envelope,CC,EBP;PDK4;MRPL14;MRPL16;ACADVL;MGST2;CPT2;ACAT1;HSD3B2;CPT1C;IFI27;LDHD;STAR;ECI1;CYP11A1;DHCR7;CYB5A;ETFDH
8212,GO:0031975,0.00166336037268815,0.999356503838093,18,1063,envelope,CC,EBP;PDK4;MRPL14;MRPL16;ACADVL;MGST2;CPT2;ACAT1;HSD3B2;CPT1C;IFI27;LDHD;STAR;ECI1;CYP11A1;DHCR7;CYB5A;ETFDH
3347,GO:0006639,0.00176793518286289,0.99976760489656,5,119,acylglycerol metabolic process,BP,APOC1;RGN;PLA2G16;ANG;FABP3
3346,GO:0006638,0.00181756821213763,0.999759521599677,5,120,neutral lipid metabolic process,BP,APOC1;RGN;PLA2G16;ANG;FABP3
1755,GO:0003996,0.00183625131127762,0.999971177621786,2,7,acyl-CoA ligase activity,MF,ACSF2;ACSM5
14610,GO:0055091,0.00190025536811329,0.999967573763117,2,9,phospholipid homeostasis,BP,ABCG1;FABP3
2990,GO:0006101,0.00193280939949724,0.999893577444201,3,34,citrate metabolic process,BP,GHR;MDH1;IDH1
7842,GO:0031264,0.0019866466614423,0.999965322739357,2,9,death-inducing signaling complex,CC,FADD;TRADD
3413,GO:0006729,0.0020815767739574,0.999965168710675,2,7,tetrahydrobiopterin biosynthetic process,BP,PCBD1;PTS
12548,GO:0046146,0.0020815767739574,0.999965168710675,2,7,tetrahydrobiopterin metabolic process,BP,PCBD1;PTS
12894,GO:0046951,0.00211245525363884,0.999961954084882,2,9,ketone body biosynthetic process,BP,BDH2;ACAT1
12154,GO:0045351,0.00215341453564663,0.999958710686709,2,12,type I interferon biosynthetic process,BP,TICAM1;NMI
3420,GO:0006739,0.00216867278831502,0.999876413798806,3,31,NADP metabolic process,BP,SHPK;IDH1;DERA
12642,GO:0046449,0.00218762481360206,0.999998218068564,1,4,creatinine metabolic process,BP,GHR
8645,GO:0032648,0.0022099328863662,0.999870509384331,3,45,regulation of interferon-beta production,BP,PYCARD;TICAM1;NMI
1890,GO:0004300,0.00224175350949088,0.999959535152289,2,8,enoyl-CoA hydratase activity,MF,ECHDC2;ECI1
15839,GO:0070266,0.00236602366393366,0.999859630733969,3,36,necroptotic process,BP,FADD;TRADD;TICAM1
11051,GO:0042802,0.00239803930333058,0.999014872719063,19,1331,identical protein binding,MF,MRI1;FADD;TRADD;ABCG1;PYCARD;GHR;HACL1;ANG;NMI;ACAT1;HEXB;NOL3;ACCS;PCBD1;PON2;IDH1;GLA;S100B;PTS
12207,GO:0045540,0.00241802912407052,0.999950240409371,2,13,regulation of cholesterol biosynthetic process,BP,ABCG1;DHCR7
3434,GO:0006766,0.00246304883183002,0.999650242359006,5,126,vitamin metabolic process,BP,RGN;AOX1;ACP5;CYP11A1;CYB5A
13497,GO:0050277,0.00247865394696504,1,1,1,sedoheptulokinase activity,MF,SHPK
6657,GO:0019637,0.00249642734426362,0.999023166853996,17,1112,organophosphate metabolic process,BP,DPM3;ZFYVE21;MRAP;APOC1;PNP;FADS1;FGF18;NNMT;PLA2G16;ACAT1;SHPK;HEXB;FABP3;NUDT7;MDH1;IDH1;DERA
4006,GO:0008207,0.00250535007731723,0.999848858747429,3,34,C21-steroid hormone metabolic process,BP,CYP17A1;STAR;CYP11A1
3533,GO:0006919,0.00257565248737919,0.999732009084315,4,79,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,FADD;TRADD;PYCARD;IFI27
8617,GO:0032608,0.00260547632672429,0.999837897514728,3,47,interferon-beta production,BP,PYCARD;TICAM1;NMI
17076,GO:0072523,0.00275697152032591,0.999824556450237,3,50,purine-containing compound catabolic process,BP,PNP;AOX1;NUDT7
6740,GO:0019866,0.00279315958315786,0.999091064650437,12,506,organelle inner membrane,CC,PDK4;MRPL14;MRPL16;ACADVL;CPT2;ACAT1;HSD3B2;IFI27;LDHD;STAR;ECI1;ETFDH
16186,GO:0070900,0.00280323479573763,0.999941663353404,2,9,mitochondrial tRNA modification,BP,HSD17B10;PUS1
18646,GO:1900864,0.00280323479573763,0.999941663353404,2,9,mitochondrial RNA modification,BP,HSD17B10;PUS1
16552,GO:0071550,0.00280675085405569,0.999941552712717,2,9,death-inducing signaling complex assembly,BP,FADD;TRADD
6143,GO:0016832,0.00282945424073756,0.999940836580342,2,9,aldehyde-lyase activity,MF,CYP17A1;DERA
16286,GO:0071071,0.00283115290933014,0.999937578975389,2,12,regulation of phospholipid biosynthetic process,BP,FABP3;IDH1
17013,GO:0072350,0.00289000717532431,0.999815425379156,3,38,tricarboxylic acid metabolic process,BP,GHR;MDH1;IDH1
17797,GO:0097191,0.0029350245494114,0.999460234284835,6,209,extrinsic apoptotic signaling pathway,BP,FADD;TRADD;PYCARD;G0S2;NOL3;DEPTOR
8670,GO:0032688,0.00295060002604241,0.999933556207521,2,12,negative regulation of interferon-beta production,BP,PYCARD;NMI
3435,GO:0006767,0.00296386758993668,0.999678817656721,4,84,water-soluble vitamin metabolic process,BP,RGN;AOX1;ACP5;CYB5A
6728,GO:0019852,0.00305334926341732,0.999930996764328,2,11,L-ascorbic acid metabolic process,BP,RGN;CYB5A
12893,GO:0046950,0.00313010474954795,0.999928357495346,2,11,cellular ketone body metabolic process,BP,BDH2;ACAT1
10229,GO:0036094,0.00313324749481018,0.998550642214109,24,2314,small molecule binding,MF,PDK4;PHYH;APOC1;ACSF2;PNP;ABCG1;BDH2;ACADVL;ACSM5;HACL1;RBP4;RNASEL;AOX1;SHPK;FABP3;ACCS;MDH1;IDH1;DECR1;LDHD;STAR;DHCR7;SLC1A3;ETFDH
15611,GO:0061702,0.00318715118694914,0.99992637413523,2,11,inflammasome complex,CC,PYCARD;CASP4
11259,GO:0043202,0.00327130973817434,0.999634960762567,4,90,lysosomal lumen,CC,IFI30;IDUA;HEXB;GLA
2996,GO:0006107,0.0032861085834206,0.999921808100998,2,12,oxaloacetate metabolic process,BP,GHR;MDH1
5082,GO:0010893,0.00329707119405187,0.999919721004569,2,14,positive regulation of steroid biosynthetic process,BP,ABCG1;STAR
7305,GO:0030207,0.00334556000948945,0.999917929245508,2,14,chondroitin sulfate catabolic process,BP,IDUA;HEXB
11970,GO:0045019,0.00338040710030402,0.999918390243784,2,12,negative regulation of nitric oxide biosynthetic process,BP,RGN;GLA
20064,GO:1904406,0.00338040710030402,0.999918390243784,2,12,negative regulation of nitric oxide metabolic process,BP,RGN;GLA
16410,GO:0071345,0.00338578140856097,0.998814219427641,13,704,cellular response to cytokine stimulus,BP,IFI30;FADD;TRADD;PYCARD;PSMB10;GHR;RNASEL;NMI;SHPK;NOL3;IFI27;TFPI;STAR
15035,GO:0060547,0.00345011604519033,0.999915831712099,2,12,negative regulation of necrotic cell death,BP,FADD;NOL3
6064,GO:0016705,0.00363340899883747,0.999433737049705,5,146,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,PHYH;FADS1;CYP17A1;PCBD1;CYP11A1
19078,GO:1902224,0.00366683642836833,0.999907707018825,2,12,ketone body metabolic process,BP,BDH2;ACAT1
17854,GO:0097300,0.00385605409196623,0.999726084550567,3,41,programmed necrotic cell death,BP,FADD;TRADD;TICAM1
19751,GO:1903725,0.00385806608746192,0.999721713120386,3,59,regulation of phospholipid metabolic process,BP,APOC1;FABP3;IDH1
16337,GO:0071222,0.00390511323196672,0.999380896976304,5,148,cellular response to lipopolysaccharide,BP,PYCARD;TICAM1;SHPK;TFPI;STAR
12308,GO:0045717,0.00412471511469428,0.999887350741688,2,14,negative regulation of fatty acid biosynthetic process,BP,APOC1;ACADVL
15677,GO:0065008,0.00413095830586609,0.997829828214499,34,3394,regulation of biological quality,BP,PDK4;IFI30;DPM3;SLC31A2;FADD;HSD17B3;HSD17B11;ABCG1;BDH2;PYCARD;ACADVL;PSMB10;RGN;FXYD1;RBP4;CYP17A1;RNASEL;ANG;HEXB;FABP3;GRIA3;NOL3;HSD3B2;DEPTOR;FAM46A;TFPI;STAR;CYP11A1;RPH3AL;S100B;DHCR7;HNF1A;SLC1A3;TMOD4
4387,GO:0009109,0.00422463707277377,0.999885650894165,2,12,coenzyme catabolic process,BP,ACAT1;NUDT7
17852,GO:0097296,0.00425649276570724,0.999883002019846,2,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD;TRADD
4352,GO:0009058,0.00429588783655884,0.997524719824944,56,6057,biosynthetic process,BP,EBP;PDK4;PECR;ALG5;DPM3;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;FGF18;TICAM1;NNMT;PLA2G16;RBP4;CYP17A1;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;FABP3;HSD3B2;ACCS;PCBD1;MDH1;IFI27;IDH1;PTMS;STAR;GLA;CYP11A1;DHCR7;PTS;RBMS3;HNF1A;SLC1A3;ELOVL6
9134,GO:0033612,0.00437301875629335,0.999875903264339,2,15,receptor serine/threonine kinase binding,MF,FADD;PYCARD
17650,GO:0090646,0.00444529361279316,0.999876488235467,2,12,mitochondrial tRNA processing,BP,HSD17B10;PUS1
13563,GO:0050661,0.00444864211137456,0.999665974869349,3,45,NADP binding,MF,IDH1;DECR1;DHCR7
11203,GO:0043122,0.00450738849278843,0.999094297046825,6,234,regulation of I-kappaB kinase/NF-kappaB signaling,BP,FADD;TRADD;PYCARD;TICAM1;NOL3;S100B
18880,GO:1901658,0.00456897979100433,0.999658158835731,3,35,glycosyl compound catabolic process,BP,PNP;GLA;DERA
16334,GO:0071219,0.00461402403478934,0.999238764916592,5,154,cellular response to molecule of bacterial origin,BP,PYCARD;TICAM1;SHPK;TFPI;STAR
12663,GO:0046479,0.00465548618887776,0.999867537534324,2,12,glycosphingolipid catabolic process,BP,HEXB;GLA
17587,GO:0090407,0.00466572234488263,0.998461044491069,11,615,organophosphate biosynthetic process,BP,DPM3;MRAP;PNP;FADS1;FGF18;NNMT;PLA2G16;ACAT1;HEXB;FABP3;IDH1
2570,GO:0005319,0.00466713324387845,0.99942143719193,4,116,lipid transporter activity,MF,ABCG1;RBP4;FABP3;STAR
2980,GO:0006085,0.00467641463667058,0.999858707994908,2,20,acetyl-CoA biosynthetic process,BP,PDK4;ACAT1
8430,GO:0032366,0.00474724015146457,0.99985757623992,2,17,intracellular sterol transport,BP,ABCG1;STAR
8431,GO:0032367,0.00474724015146457,0.99985757623992,2,17,intracellular cholesterol transport,BP,ABCG1;STAR
4176,GO:0008480,0.00474960189795849,1,1,1,sarcosine dehydrogenase activity,MF,SARDH
18664,GO:1901052,0.00474960189795849,1,1,1,sarcosine metabolic process,BP,SARDH
18665,GO:1901053,0.00474960189795849,1,1,1,sarcosine catabolic process,BP,SARDH
2647,GO:0005523,0.00479068502126966,0.999858701188796,2,14,tropomyosin binding,MF,PYCARD;TMOD4
9180,GO:0033700,0.00481371926425428,0.999860659012396,2,12,phospholipid efflux,BP,APOC1;ABCG1
2761,GO:0005743,0.004854052199403,0.998394204256117,11,454,mitochondrial inner membrane,CC,PDK4;MRPL14;MRPL16;ACADVL;CPT2;ACAT1;HSD3B2;LDHD;STAR;ECI1;ETFDH
13677,GO:0050810,0.00495213804475857,0.99961157952945,3,51,regulation of steroid biosynthetic process,BP,ABCG1;STAR;DHCR7
9949,GO:0035623,0.00508542454757001,1,1,1,renal glucose absorption,BP,HNF1A
5901,GO:0016405,0.00531960454356385,0.999836005951038,2,13,CoA-ligase activity,MF,ACSF2;ACSM5
2457,GO:0005123,0.00541940492188969,0.999828261904552,2,15,death receptor binding,MF,FADD;NOL3
12183,GO:0045428,0.00548985044322129,0.999552848123022,3,52,regulation of nitric oxide biosynthetic process,BP,RGN;TICAM1;GLA
21640,GO:2001238,0.00551282481999954,0.999550996339877,3,50,positive regulation of extrinsic apoptotic signaling pathway,BP,FADD;PYCARD;G0S2
5066,GO:0010876,0.00555766429853751,0.99865271565264,7,341,lipid localization,BP,APOC1;ABCG1;CPT2;RBP4;HEXB;FABP3;STAR
12666,GO:0046486,0.00556777424040279,0.998491979830076,8,423,glycerolipid metabolic process,BP,DPM3;ZFYVE21;APOC1;RGN;FGF18;PLA2G16;ANG;FABP3
16436,GO:0071378,0.00562039558910027,0.999811332207635,2,23,cellular response to growth hormone stimulus,BP,GHR;STAR
5062,GO:0010872,0.00567361510222764,0.99982370718389,2,11,regulation of cholesterol esterification,BP,APOC1;ABCG1
12688,GO:0046523,0.00573558778968441,1,1,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,MRI1
3393,GO:0006695,0.00581346797271737,0.999517384364469,3,50,cholesterol biosynthetic process,BP,EBP;ABCG1;DHCR7
5004,GO:0010803,0.00581772537099491,0.99951690371046,3,50,regulation of tumor necrosis factor-mediated signaling pathway,BP,TRADD;PYCARD;NOL3
12684,GO:0046514,0.00584193986662484,0.999810988784422,2,13,ceramide catabolic process,BP,HEXB;GLA
3015,GO:0006145,0.0058562009377575,0.999987210654819,1,4,purine nucleobase catabolic process,BP,AOX1
2944,GO:0006029,0.00586367858222914,0.999504120662861,3,82,proteoglycan metabolic process,BP,EXTL1;IDUA;HEXB
5698,GO:0015936,0.00591067118501688,0.999805735491194,2,14,coenzyme A metabolic process,BP,ACAT1;NUDT7
3840,GO:0007548,0.00597723584707808,0.998725585227797,6,257,sex differentiation,BP,HSD17B3;RBP4;CYP17A1;ANG;IDH1;STAR
15991,GO:0070525,0.00599915831638979,0.999803222438135,2,13,tRNA threonylcarbamoyladenosine metabolic process,BP,HSD17B10;PUS1
352,GO:0000963,0.00601765191424703,0.999798721791924,2,15,mitochondrial RNA processing,BP,HSD17B10;PUS1
6595,GO:0019377,0.00610263432301414,0.999796089029569,2,14,glycolipid catabolic process,BP,HEXB;GLA
3399,GO:0006703,0.00629779827247603,0.999790592472779,2,12,estrogen biosynthetic process,BP,HSD17B11;STAR
2636,GO:0005506,0.00630155555453923,0.998881538147512,5,147,iron ion binding,MF,PHYH;CYP17A1;AOX1;ACP5;CYP11A1
4624,GO:0009720,0.00632516956035676,1,1,1,detection of hormone stimulus,BP,ABCG1
19255,GO:1902653,0.00635510580676947,0.999454787721226,3,51,secondary alcohol biosynthetic process,BP,EBP;ABCG1;DHCR7
4626,GO:0009726,0.00645931238586822,0.999986163517722,1,3,detection of endogenous stimulus,BP,ABCG1
8760,GO:0032813,0.00648588941698721,0.99944356265505,3,43,tumor necrosis factor receptor superfamily binding,MF,FADD;TRADD;NOL3
3400,GO:0006704,0.0065308479534985,0.999769055681862,2,17,glucocorticoid biosynthetic process,BP,CYP17A1;HSD3B2
16331,GO:0071216,0.0066152981123029,0.998808755858233,5,175,cellular response to biotic stimulus,BP,PYCARD;TICAM1;SHPK;TFPI;STAR
4501,GO:0009237,0.00662443311984787,1,1,1,siderophore metabolic process,BP,BDH2
6564,GO:0019290,0.00662443311984787,1,1,1,siderophore biosynthetic process,BP,BDH2
4533,GO:0009311,0.00687366895254805,0.999392042383448,3,54,oligosaccharide metabolic process,BP,IDUA;HEXB;GLA
6155,GO:0016853,0.00732223239573187,0.998653820760968,5,141,isomerase activity,MF,EBP;MRI1;HSD3B2;PUS1;ECI1
11825,GO:0044464,0.00736549765804197,0.996991054276519,117,15425,cell part,CC,CFB;EBP;PDK4;PECR;TMEM160;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;PRRT1;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH;TMOD4
8712,GO:0032760,0.0074584265789806,0.999319229428275,3,57,positive regulation of tumor necrosis factor production,BP,FADD;PYCARD;TICAM1
10908,GO:0042559,0.00762057447617579,0.999711989511048,2,15,pteridine-containing compound biosynthetic process,BP,PCBD1;PTS
16119,GO:0070777,0.00763722306651272,0.999978232240039,1,4,D-aspartate transport,BP,SLC1A3
16121,GO:0070779,0.00763722306651272,0.999978232240039,1,4,D-aspartate import,BP,SLC1A3
3348,GO:0006641,0.00773947377066564,0.998895095248851,4,104,triglyceride metabolic process,BP,APOC1;RGN;PLA2G16;FABP3
2788,GO:0005775,0.00782321377934429,0.998534833111378,5,164,vacuolar lumen,CC,IFI30;PYCARD;IDUA;HEXB;GLA
6287,GO:0017127,0.00783090895882896,0.999695802504765,2,17,cholesterol transporter activity,MF,ABCG1;STAR
6515,GO:0019184,0.0078630068729452,0.999693907198788,2,17,nonribosomal peptide biosynthetic process,BP,BDH2;MGST2
4683,GO:0009918,0.0079046162647867,1,1,1,sterol delta7 reductase activity,MF,DHCR7
5784,GO:0016131,0.0079046162647867,1,1,1,brassinosteroid metabolic process,BP,DHCR7
5785,GO:0016132,0.0079046162647867,1,1,1,brassinosteroid biosynthetic process,BP,DHCR7
13004,GO:0047598,0.0079046162647867,1,1,1,7-dehydrocholesterol reductase activity,MF,DHCR7
3729,GO:0007249,0.00810647575271518,0.998157666666705,6,260,I-kappaB kinase/NF-kappaB signaling,BP,FADD;TRADD;PYCARD;TICAM1;NOL3;S100B
21665,GO:2001269,0.00813418842899466,0.999677733016644,2,17,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD;TRADD
19668,GO:1903557,0.00815686628040181,0.999230003775743,3,59,positive regulation of tumor necrosis factor superfamily cytokine production,BP,FADD;PYCARD;TICAM1
3453,GO:0006793,0.00836710599775854,0.995475830556369,31,3069,phosphorus metabolic process,BP,PDK4;DPM3;ZFYVE21;MRAP;APOC1;ACSF2;PNP;PYCARD;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;NNMT;PLA2G16;GALT;RNASEL;ANG;ACAT1;SHPK;HEXB;FABP3;NUDT7;DEPTOR;MDH1;IDH1;MDP1;ACP5;DERA;ELOVL6
5780,GO:0016126,0.00848383352794696,0.999189580417414,3,55,sterol biosynthetic process,BP,EBP;ABCG1;DHCR7
9263,GO:0034097,0.00848713921195469,0.996672720092226,13,798,response to cytokine,BP,IFI30;FADD;TRADD;PYCARD;PSMB10;GHR;RNASEL;NMI;SHPK;NOL3;IFI27;TFPI;STAR
18841,GO:1901576,0.00852201101956439,0.994900244142729,54,5982,organic substance biosynthetic process,BP,EBP;PDK4;PECR;ALG5;DPM3;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;FGF18;TICAM1;NNMT;PLA2G16;RBP4;CYP17A1;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;FABP3;HSD3B2;PCBD1;MDH1;IFI27;IDH1;PTMS;STAR;CYP11A1;DHCR7;PTS;RBMS3;HNF1A;SLC1A3;ELOVL6
9441,GO:0034433,0.00864334020868164,0.999654126687455,2,14,steroid esterification,BP,APOC1;ABCG1
9442,GO:0034434,0.00864334020868164,0.999654126687455,2,14,sterol esterification,BP,APOC1;ABCG1
9443,GO:0034435,0.00864334020868164,0.999654126687455,2,14,cholesterol esterification,BP,APOC1;ABCG1
3278,GO:0006555,0.0086468474230983,0.999641160815265,2,20,methionine metabolic process,BP,MSRA;MRI1
2700,GO:0005623,0.00869936464737652,0.996392922418843,117,15450,cell,CC,CFB;EBP;PDK4;PECR;TMEM160;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;GLA;ECI1;CYP11A1;RPH3AL;PRRT1;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH;TMOD4
11316,GO:0043280,0.00870201132136804,0.998712900066956,4,113,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,FADD;TRADD;PYCARD;IFI27
3460,GO:0006809,0.00874567497819075,0.999151443330775,3,63,nitric oxide biosynthetic process,BP,RGN;TICAM1;GLA
4439,GO:0009166,0.00892272009367073,0.999127502442753,3,64,nucleotide catabolic process,BP,PNP;NUDT7;DERA
3297,GO:0006575,0.00892870331281873,0.998273993176719,5,161,cellular modified amino acid metabolic process,BP,MGST2;GHR;PLA2G16;SARDH;IDH1
3017,GO:0006148,0.00898724849676211,1,1,1,inosine catabolic process,BP,PNP
3419,GO:0006738,0.00898724849676211,1,1,1,nicotinamide riboside catabolic process,BP,PNP
12672,GO:0046495,0.00898724849676211,1,1,1,nicotinamide riboside metabolic process,BP,PNP
16055,GO:0070637,0.00898724849676211,1,1,1,pyridine nucleoside metabolic process,BP,PNP
16056,GO:0070638,0.00898724849676211,1,1,1,pyridine nucleoside catabolic process,BP,PNP
11432,GO:0043496,0.0090258310987233,0.999616994324083,2,20,regulation of protein homodimerization activity,BP,TICAM1;PCBD1
15032,GO:0060544,0.00911801718359376,0.999612713949838,2,19,regulation of necroptotic process,BP,FADD;TRADD
19606,GO:1903427,0.00914944239869891,0.999610683511358,2,19,negative regulation of reactive oxygen species biosynthetic process,BP,RGN;GLA
9244,GO:0034041,0.00920508065699111,0.999978887887639,1,2,sterol-transporting ATPase activity,MF,ABCG1
9243,GO:0034040,0.00920508608770777,0.999971865054451,1,3,lipid-transporting ATPase activity,MF,ABCG1
2203,GO:0004731,0.00921355163413686,0.999978848921982,1,2,purine-nucleoside phosphorylase activity,MF,PNP
6290,GO:0017133,0.00924239325038213,1,1,1,mitochondrial electron transfer flavoprotein complex,CC,ETFDH
11549,GO:0043783,0.00924239325038213,1,1,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,ETFDH
12109,GO:0045251,0.00924239325038213,1,1,1,electron transfer flavoprotein complex,CC,ETFDH
13530,GO:0050508,0.00926657917370262,0.999971487106239,1,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,EXTL1
17770,GO:0097153,0.00931859184929769,0.999609027311856,2,15,cysteine-type endopeptidase activity involved in apoptotic process,MF,PYCARD;CASP4
9086,GO:0033500,0.00932841331486516,0.99817132975464,5,204,carbohydrate homeostasis,BP,PDK4;RBP4;STAR;RPH3AL;HNF1A
10934,GO:0042593,0.00932841331486516,0.99817132975464,5,204,glucose homeostasis,BP,PDK4;RBP4;STAR;RPH3AL;HNF1A
4372,GO:0009083,0.00941051312023207,0.999591911924442,2,20,branched-chain amino acid catabolic process,BP,HSD17B10;ACAT1
12567,GO:0046209,0.00950957429029057,0.999046972813861,3,67,nitric oxide metabolic process,BP,RGN;TICAM1;GLA
6090,GO:0016746,0.0096178242528933,0.997734905025666,6,247,transferase activity, transferring acyl groups,MF,ACSM5;CPT2;PLA2G16;ACAT1;CPT1C;ELOVL6
2921,GO:0005996,0.0096865380483829,0.997713769958436,6,262,monosaccharide metabolic process,BP,PDK4;RGN;GALT;RBP4;MDH1;CYB5A
9445,GO:0034437,0.00971289663180483,0.999976488195077,1,2,glycoprotein transporter activity,MF,ABCG1
9409,GO:0034375,0.00971583329832217,0.999583403010845,2,15,high-density lipoprotein particle remodeling,BP,APOC1;ABCG1
1716,GO:0003940,0.00989021775620997,1,1,1,L-iduronidase activity,MF,IDUA
7307,GO:0030209,0.00989021775620997,1,1,1,dermatan sulfate catabolic process,BP,IDUA
2988,GO:0006098,0.0100457123631138,0.999558579939522,2,16,pentose-phosphate shunt,BP,SHPK;DERA
1779,GO:0004031,0.0100703511979065,0.99997472119772,1,2,aldehyde oxidase activity,MF,AOX1
16801,GO:0072019,0.0101008402954264,1,1,1,proximal convoluted tubule development,BP,ACAT1
16944,GO:0072229,0.0101008402954264,1,1,1,metanephric proximal convoluted tubule development,BP,ACAT1
19323,GO:1902858,0.0101008402954264,1,1,1,propionyl-CoA metabolic process,BP,ACAT1
19324,GO:1902860,0.0101008402954264,1,1,1,propionyl-CoA biosynthetic process,BP,ACAT1
16949,GO:0072237,0.0101008458748687,0.999974567475345,1,2,metanephric proximal tubule development,BP,ACAT1
11052,GO:0042803,0.0103707989729987,0.99617785780552,11,705,protein homodimerization activity,MF,ABCG1;PYCARD;GHR;ANG;ACAT1;HEXB;ACCS;IDH1;GLA;S100B;PTS
4357,GO:0009063,0.0104796342888309,0.998365944681658,4,108,cellular amino acid catabolic process,BP,HSD17B10;ACAT1;SARDH;PCBD1
12921,GO:0046997,0.0105235410418898,0.999972388434947,1,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,SARDH
12423,GO:0045922,0.0105416776928801,0.999511430758251,2,22,negative regulation of fatty acid metabolic process,BP,APOC1;ACADVL
4115,GO:0008386,0.0106993080442064,1,1,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,CYP11A1
4567,GO:0009435,0.0107103019825212,0.999497896599065,2,23,NAD biosynthetic process,BP,PNP;NNMT
1923,GO:0004341,0.0108449279390969,1,1,1,gluconolactonase activity,MF,RGN
19695,GO:1903610,0.0108449279390969,1,1,1,regulation of calcium-dependent ATPase activity,BP,RGN
19696,GO:1903611,0.0108449279390969,1,1,1,negative regulation of calcium-dependent ATPase activity,BP,RGN
19705,GO:1903627,0.0108449279390969,1,1,1,regulation of dUTP diphosphatase activity,BP,RGN
19706,GO:1903629,0.0108449279390969,1,1,1,positive regulation of dUTP diphosphatase activity,BP,RGN
19708,GO:1903631,0.0108449279390969,1,1,1,negative regulation of aminoacyl-tRNA ligase activity,BP,RGN
19710,GO:1903633,0.0108449279390969,1,1,1,regulation of leucine-tRNA ligase activity,BP,RGN
19711,GO:1903634,0.0108449279390969,1,1,1,negative regulation of leucine-tRNA ligase activity,BP,RGN
3910,GO:0008049,0.0109078228939376,1,1,1,male courtship behavior,BP,HEXB
21562,GO:2001056,0.0109132681131049,0.998274042906589,4,122,positive regulation of cysteine-type endopeptidase activity,BP,FADD;TRADD;PYCARD;IFI27
18396,GO:0102009,0.0109491817081923,1,1,1,proline dipeptidase activity,MF,PEPD
1674,GO:0003858,0.010954260589488,0.999970075396674,1,2,3-hydroxybutyrate dehydrogenase activity,MF,BDH2
2036,GO:0004508,0.0110243186350252,1,1,1,steroid 17-alpha-monooxygenase activity,MF,CYP17A1
12988,GO:0047442,0.0110243186350252,1,1,1,17-alpha-hydroxyprogesterone aldolase activity,MF,CYP17A1
21228,GO:2000454,0.0110887484976281,1,1,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
21563,GO:2001057,0.0111304957744249,0.99881692739957,3,70,reactive nitrogen species metabolic process,BP,RGN;TICAM1;GLA
19129,GO:1902311,0.0113169856682127,1,1,1,regulation of copper ion transmembrane transport,BP,SLC31A2
1856,GO:0004139,0.0114404476155389,1,1,1,deoxyribose-phosphate aldolase activity,MF,DERA
2202,GO:0004730,0.0115953159609431,1,1,1,pseudouridylate synthase activity,MF,PUS1
16188,GO:0070902,0.0115953159609431,1,1,1,mitochondrial tRNA pseudouridine synthesis,BP,PUS1
13152,GO:0048244,0.0116002817887758,1,1,1,phytanoyl-CoA dioxygenase activity,MF,PHYH
3396,GO:0006700,0.011737128111549,0.999422833194142,2,23,C21-steroid hormone biosynthetic process,BP,STAR;CYP11A1
3944,GO:0008112,0.0118083316670426,1,1,1,nicotinamide N-methyltransferase activity,MF,NNMT
7571,GO:0030760,0.0118083316670426,1,1,1,pyridine N-methyltransferase activity,MF,NNMT
3498,GO:0006869,0.0119715269549758,0.997038590067915,6,309,lipid transport,BP,APOC1;ABCG1;CPT2;RBP4;FABP3;STAR
12161,GO:0045358,0.0120016911895141,1,1,1,negative regulation of interferon-beta biosynthetic process,BP,NMI
12527,GO:0046110,0.0120870077096,0.999951427213271,1,3,xanthine metabolic process,BP,AOX1
14472,GO:0052692,0.0121152455555143,1,1,1,raffinose alpha-galactosidase activity,MF,GLA
3998,GO:0008198,0.0121201102194634,0.999395836889172,2,22,ferrous iron binding,MF,PHYH;ACP5
5303,GO:0014876,0.0121812568597491,1,1,1,response to injury involved in regulation of muscle adaptation,BP,NOL3
5247,GO:0014736,0.0121812628737521,0.999962973060877,1,2,negative regulation of muscle atrophy,BP,NOL3
3941,GO:0008108,0.0122493706108331,1,1,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,GALT
7260,GO:0030149,0.0122650416683895,0.999386946967606,2,21,sphingolipid catabolic process,BP,HEXB;GLA
11317,GO:0043281,0.0123127154034165,0.997418641372874,5,192,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,FADD;TRADD;PYCARD;NOL3;IFI27
18752,GO:1901292,0.0123161142332659,0.998640744616069,3,71,nucleoside phosphate catabolic process,BP,PNP;NUDT7;DERA
2820,GO:0005829,0.0123288889143523,0.992691020641222,42,4626,cytosol,CC,IFI30;ZFYVE21;MSRA;MRI1;FADD;TRADD;TBC1D14;HSD17B11;PNP;BDH2;PYCARD;ACADVL;KRT10;PSMB10;RGN;GHR;TICAM1;NNMT;PXK;PLA2G16;ETFB;GALT;RBP4;RNASEL;NMI;AOX1;CMBL;FABP3;NOL3;PCBD1;MDH1;CASP4;IDH1;DECR1;STAR;ACP5;DERA;DHCR7;CYB5A;PTS;DOK1;LYPLAL1
13041,GO:0047860,0.0123447748121761,1,1,1,diiodophenylpyruvate reductase activity,MF,MDH1
5904,GO:0016408,0.0124336930527939,0.999379153816872,2,19,C-acyltransferase activity,MF,ACSM5;ACAT1
2090,GO:0004581,0.0124711696559105,1,1,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,ALG5
121,GO:0000247,0.0124884219438752,1,1,1,C-8 sterol isomerase activity,MF,EBP
4580,GO:0009449,0.0125828261394098,0.999947348694014,1,3,gamma-aminobutyric acid biosynthetic process,BP,SLC1A3
5700,GO:0015938,0.0126248874128995,1,1,1,coenzyme A catabolic process,BP,NUDT7
9213,GO:0033869,0.0126248874128995,1,1,1,nucleoside bisphosphate catabolic process,BP,NUDT7
9235,GO:0034031,0.0126248874128995,1,1,1,ribonucleoside bisphosphate catabolic process,BP,NUDT7
9238,GO:0034034,0.0126248874128995,1,1,1,purine nucleoside bisphosphate catabolic process,BP,NUDT7
6727,GO:0019843,0.0126384560547888,0.998608958474012,3,49,rRNA binding,MF,MRPL16;RNASEL;ANG
4279,GO:0008709,0.0126703656209364,1,1,1,cholate 7-alpha-dehydrogenase activity,MF,HSD17B10
12924,GO:0047015,0.0126703656209364,1,1,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,HSD17B10
6663,GO:0019674,0.0126779610761047,0.99858996721563,3,64,NAD metabolic process,BP,PNP;NNMT;MDH1
1683,GO:0003874,0.0126823205220304,1,1,1,6-pyruvoyltetrahydropterin synthase activity,MF,PTS
6147,GO:0016838,0.0126823205220304,1,1,1,carbon-oxygen lyase activity, acting on phosphates,MF,PTS
9524,GO:0034632,0.0126849799844132,1,1,1,retinol transporter activity,MF,RBP4
9525,GO:0034633,0.0126849799844132,1,1,1,retinol transport,BP,RBP4
12839,GO:0046864,0.0126849799844132,1,1,1,isoprenoid transport,BP,RBP4
12840,GO:0046865,0.0126849799844132,1,1,1,terpenoid transport,BP,RBP4
6235,GO:0017024,0.0127071177442455,1,1,1,myosin I binding,MF,PYCARD
5088,GO:0010900,0.0128470512375529,1,1,1,negative regulation of phosphatidylcholine catabolic process,BP,APOC1
19605,GO:1903426,0.0129088455292928,0.99855214419811,3,68,regulation of reactive oxygen species biosynthetic process,BP,RGN;TICAM1;GLA
4120,GO:0008395,0.0129530352364046,0.999336366034886,2,20,steroid hydroxylase activity,MF,CYP17A1;CYP11A1
2209,GO:0004740,0.0130799080638741,0.999936004083413,1,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,PDK4
8382,GO:0032281,0.013117081400743,0.999309337616543,2,27,AMPA glutamate receptor complex,CC,GRIA3;CPT1C
6172,GO:0016878,0.0133160338119348,0.999296611564311,2,25,acid-thiol ligase activity,MF,ACSF2;ACSM5
18856,GO:1901617,0.0134355934588463,0.997120477456091,5,199,organic hydroxy compound biosynthetic process,BP,EBP;HSD17B3;ABCG1;STAR;DHCR7
15083,GO:0060612,0.013615347544721,0.999260235473977,2,34,adipose tissue development,BP,PLA2G16;ACAT1
6581,GO:0019359,0.0136489377430337,0.999267858974833,2,26,nicotinamide nucleotide biosynthetic process,BP,PNP;NNMT
6583,GO:0019363,0.0136489377430337,0.999267858974833,2,26,pyridine nucleotide biosynthetic process,BP,PNP;NNMT
14939,GO:0060416,0.0136804693745512,0.999253872288732,2,35,response to growth hormone,BP,GHR;STAR
9041,GO:0033306,0.0137297037883089,0.999952924194102,1,2,phytol metabolic process,BP,PECR
19475,GO:1903173,0.0137297037883089,0.999952924194102,1,2,fatty alcohol metabolic process,BP,PECR
15793,GO:0070195,0.0137676600141131,0.999952662634068,1,2,growth hormone receptor complex,CC,GHR
17005,GO:0072338,0.0138082493187954,0.999920760306248,1,6,cellular lactam metabolic process,BP,GHR
20168,GO:1904646,0.0141546942400565,0.999933325073217,1,3,cellular response to beta-amyloid,BP,CASP4
127,GO:0000255,0.0142240457309592,0.99992428186787,1,4,allantoin metabolic process,BP,GHR
1877,GO:0004174,0.0142669423282482,0.999949154083748,1,2,electron-transferring-flavoprotein dehydrogenase activity,MF,ETFDH
6044,GO:0016649,0.0142669423282482,0.999949154083748,1,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,ETFDH
6041,GO:0016645,0.0143967679956982,0.999207761975662,2,25,oxidoreductase activity, acting on the CH-NH group of donors,MF,SARDH;ETFDH
11242,GO:0043178,0.0144179171821223,0.998312152114191,3,73,alcohol binding,MF,ABCG1;RBP4;STAR
21202,GO:2000406,0.0144292563440637,0.999217673542679,2,20,positive regulation of T cell migration,BP,FADD;PYCARD
12653,GO:0046466,0.0144802410109557,0.99920285558141,2,24,membrane lipid catabolic process,BP,HEXB;GLA
6074,GO:0016717,0.0145274015471028,0.999921007584176,1,4,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,FADS1
2446,GO:0005102,0.0145415500393008,0.993005590799134,18,1400,receptor binding,MF,PECR;FADD;MRAP;TRADD;PYCARD;FGF18;HACL1;ANG;IDUA;NOL3;NUDT6;NUDT7;IDH1;GLA;S100B;DOK1;CNIH4;LINGO1
5169,GO:0012505,0.0146507879352766,0.991400398909998,37,4018,endomembrane system,CC,EBP;USE1;ALG5;DPM3;ZFYVE21;SLC31A2;HSD17B3;MRAP;APOC1;TBC1D14;EXTL1;PNP;ABCG1;PYCARD;MGST2;FADS1;TICAM1;PLA2G16;GALT;CYP17A1;HEXB;NOL3;HSD3B2;CPT1C;CASP4;IFI27;IDH1;TMEM98;TFPI;SNX21;GLA;RPH3AL;DERA;DHCR7;CYB5A;CNIH4;ELOVL6
6666,GO:0019682,0.0147346203093486,0.999192278246169,2,20,glyceraldehyde-3-phosphate metabolic process,BP,SHPK;DERA
6539,GO:0019221,0.0147375303949759,0.99458068636221,10,552,cytokine-mediated signaling pathway,BP,IFI30;FADD;TRADD;PYCARD;PSMB10;GHR;RNASEL;NMI;NOL3;IFI27
5447,GO:0015248,0.0147680468499305,0.99917082491758,2,28,sterol transporter activity,MF,ABCG1;STAR
14339,GO:0051938,0.0147743249498334,0.999903226792752,1,9,L-glutamate import,BP,SLC1A3
6349,GO:0018103,0.0147847769042134,0.999912741722575,1,5,protein C-linked glycosylation,BP,DPM3
6386,GO:0018211,0.0147847769042134,0.999912741722575,1,5,peptidyl-tryptophan modification,BP,DPM3
6407,GO:0018317,0.0147847769042134,0.999912741722575,1,5,protein C-linked glycosylation via tryptophan,BP,DPM3
6422,GO:0018406,0.0147847769042134,0.999912741722575,1,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,DPM3
19193,GO:1902524,0.0148298816650729,0.99994504664488,1,2,positive regulation of protein K48-linked ubiquitination,BP,NMI
7760,GO:0031090,0.0148834877722399,0.991778473906221,28,2705,organelle membrane,CC,PDK4;PECR;ZFYVE21;MRPL14;MRPL16;PXMP2;PXMP4;ABCG1;ACADVL;MGST2;TICAM1;CPT2;PLA2G16;ACAT1;GRIA3;HSD3B2;CPT1C;IFI27;LDHD;TFPI;STAR;SNX21;ECI1;CYP11A1;RPH3AL;DHCR7;CYB5A;ETFDH
2069,GO:0004557,0.0149864013257715,0.999943876053075,1,2,alpha-galactosidase activity,MF,GLA
13930,GO:0051187,0.0150148900998825,0.999168720737895,2,20,cofactor catabolic process,BP,ACAT1;NUDT7
6726,GO:0019842,0.0152768144519439,0.997333659226072,4,122,vitamin binding,MF,PHYH;HACL1;RBP4;ACCS
9231,GO:0033993,0.0153320341555952,0.993750982065477,12,859,response to lipid,BP,PDK4;ABCG1;PYCARD;MGST2;TICAM1;RBP4;SHPK;FABP3;IDH1;TFPI;STAR;S100B
17780,GO:0097164,0.0154070980606252,0.996585534280042,5,190,ammonium ion metabolic process,BP,APOC1;PLA2G16;SARDH;FABP3;CPT1C
21663,GO:2001267,0.0155308746994552,0.999118299535845,2,22,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD;TRADD
4349,GO:0009055,0.015558681562866,0.997282507703216,4,97,electron carrier activity,MF,ETFB;AOX1;CYB5A;ETFDH
5016,GO:0010817,0.0156337946819024,0.994930643215761,8,465,regulation of hormone levels,BP,HSD17B3;HSD17B11;RBP4;CYP17A1;HSD3B2;STAR;CYP11A1;DHCR7
7374,GO:0030301,0.0156382206785272,0.998111303881833,3,76,cholesterol transport,BP,APOC1;ABCG1;STAR
21647,GO:2001245,0.0156683089893853,0.999918247034487,1,3,regulation of phosphatidylcholine biosynthetic process,BP,FABP3
17078,GO:0072525,0.0158269792487548,0.999076662580654,2,29,pyridine-containing compound biosynthetic process,BP,PNP;NNMT
6294,GO:0017143,0.0158909436691007,0.999936867473419,1,2,insecticide metabolic process,BP,STAR
3374,GO:0006672,0.0159870418857625,0.99805457007849,3,74,ceramide metabolic process,BP,ASAH2;HEXB;GLA
21011,GO:2000116,0.0163243381259049,0.996325811024215,5,206,regulation of cysteine-type endopeptidase activity,BP,FADD;TRADD;PYCARD;NOL3;IFI27
8279,GO:0032090,0.01639749258759,0.99993276105152,1,2,Pyrin domain binding,MF,PYCARD
3354,GO:0006650,0.0164675046149155,0.995630586685081,6,337,glycerophospholipid metabolic process,BP,DPM3;ZFYVE21;APOC1;FGF18;PLA2G16;FABP3
6568,GO:0019318,0.0165315962524094,0.996263790023324,5,224,hexose metabolic process,BP,PDK4;RGN;GALT;RBP4;MDH1
4008,GO:0008210,0.0167274897025521,0.999009391488555,2,23,estrogen metabolic process,BP,HSD17B11;STAR
8211,GO:0031974,0.0169911717157957,0.989654516288013,43,4694,membrane-enclosed lumen,CC,PDK4;PHYH;IFI30;MSRA;MRPL14;MRPL16;MRI1;TBC1D14;ACSF2;PNP;PYCARD;LAGE3;ACADVL;ACSM5;PSMB10;FGF18;ARL6IP4;CPT2;HSD17B10;ETFB;HACL1;RNASEL;ANG;NMI;ACAT1;TSFM;IDUA;AOX1;SARDH;HEXB;NOL3;HSD3B2;NUDT7;PCBD1;IDH1;DECR1;PUS1;STAR;GLA;ECI1;CYP11A1;DERA;ETFDH
11280,GO:0043233,0.0169911717157957,0.989654516288013,43,4694,organelle lumen,CC,PDK4;PHYH;IFI30;MSRA;MRPL14;MRPL16;MRI1;TBC1D14;ACSF2;PNP;PYCARD;LAGE3;ACADVL;ACSM5;PSMB10;FGF18;ARL6IP4;CPT2;HSD17B10;ETFB;HACL1;RNASEL;ANG;NMI;ACAT1;TSFM;IDUA;AOX1;SARDH;HEXB;NOL3;HSD3B2;NUDT7;PCBD1;IDH1;DECR1;PUS1;STAR;GLA;ECI1;CYP11A1;DERA;ETFDH
15688,GO:0070013,0.0169911717157957,0.989654516288013,43,4694,intracellular organelle lumen,CC,PDK4;PHYH;IFI30;MSRA;MRPL14;MRPL16;MRI1;TBC1D14;ACSF2;PNP;PYCARD;LAGE3;ACADVL;ACSM5;PSMB10;FGF18;ARL6IP4;CPT2;HSD17B10;ETFB;HACL1;RNASEL;ANG;NMI;ACAT1;TSFM;IDUA;AOX1;SARDH;HEXB;NOL3;HSD3B2;NUDT7;PCBD1;IDH1;DECR1;PUS1;STAR;GLA;ECI1;CYP11A1;DERA;ETFDH
13120,GO:0048168,0.0170587929829071,0.99894294438593,2,48,regulation of neuronal synaptic plasticity,BP,STAR;S100B
5683,GO:0015918,0.0171570195336071,0.997850588012787,3,83,sterol transport,BP,APOC1;ABCG1;STAR
4082,GO:0008328,0.0173116438045336,0.998921185481494,2,45,ionotropic glutamate receptor complex,CC,GRIA3;CPT1C
14376,GO:0051990,0.0174558357613976,0.999923760164522,1,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,IDH1
14034,GO:0051352,0.0175228844333902,0.999923170727564,1,2,negative regulation of ligase activity,BP,RGN
13731,GO:0050885,0.0175340484281026,0.998895630670928,2,51,neuromuscular process controlling balance,BP,HEXB;SLC1A3
5125,GO:0010950,0.0175670867633636,0.99679830548479,4,136,positive regulation of endopeptidase activity,BP,FADD;TRADD;PYCARD;IFI27
12209,GO:0045542,0.0176681041893002,0.999875242207161,1,5,positive regulation of cholesterol biosynthetic process,BP,ABCG1
11862,GO:0044699,0.0176964179843523,0.989695689111378,100,12673,single-organism process,BP,EBP;PDK4;PECR;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;G0S2;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;CYP17A1;RNASEL;ANG;FAM110C;NMI;ACAT1;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;FABP3;GRIA3;NOL3;HSD3B2;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;FAM46A;TMEM176A;IDH1;DECR1;LDHD;TFPI;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;HNF1A;DOK1;SLC1A3;ELOVL6;LINGO1;ETFDH;TMOD4
6091,GO:0016747,0.0178204207104322,0.995898543206679,5,211,transferase activity, transferring acyl groups other than amino-acyl groups,MF,ACSM5;CPT2;ACAT1;CPT1C;ELOVL6
13909,GO:0051156,0.0180662742446183,0.998879600304552,2,25,glucose 6-phosphate metabolic process,BP,SHPK;DERA
19703,GO:1903625,0.018393963128549,0.999915304679416,1,2,negative regulation of DNA catabolic process,BP,RGN
11969,GO:0045017,0.0184148612208604,0.995718137095066,5,254,glycerolipid biosynthetic process,BP,DPM3;RGN;FGF18;ANG;FABP3
7302,GO:0030204,0.0185239919121956,0.998807590440198,2,41,chondroitin sulfate metabolic process,BP,IDUA;HEXB
1994,GO:0004458,0.0185879266633054,0.999913500470368,1,2,D-lactate dehydrogenase (cytochrome) activity,MF,LDHD
6190,GO:0016898,0.0185879266633054,0.999913500470368,1,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,LDHD
348,GO:0000959,0.0186334753404108,0.998815237158937,2,29,mitochondrial RNA metabolic process,BP,HSD17B10;PUS1
1872,GO:0004165,0.0188010614159124,0.999882119709815,1,3,dodecenoyl-CoA delta-isomerase activity,MF,ECI1
9435,GO:0034418,0.018930424739391,0.999910267741639,1,2,urate biosynthetic process,BP,PNP
3421,GO:0006740,0.0190080030142223,0.99987949910708,1,3,NADPH regeneration,BP,IDH1
13572,GO:0050671,0.0190664898860727,0.996443099340898,4,127,positive regulation of lymphocyte proliferation,BP,FADD;PNP;PYCARD;TICAM1
11977,GO:0045029,0.0195088861883045,0.999904671820684,1,2,UDP-activated nucleotide receptor activity,MF,P2RY14
21204,GO:2000409,0.0196052703585386,0.99990372280466,1,2,positive regulation of T cell extravasation,BP,FADD
21226,GO:2000451,0.0196052703585386,0.99990372280466,1,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
8843,GO:0032946,0.0196194702036485,0.996307986646455,4,128,positive regulation of mononuclear cell proliferation,BP,FADD;PNP;PYCARD;TICAM1
3874,GO:0007619,0.0197701129958937,0.999869597484615,1,3,courtship behavior,BP,HEXB
3408,GO:0006720,0.0199279673753505,0.996232858775736,4,127,isoprenoid metabolic process,BP,PECR;PHYH;RBP4;STAR
9976,GO:0035666,0.0200058660766942,0.99868176383918,2,28,TRIF-dependent toll-like receptor signaling pathway,BP,FADD;TICAM1
5087,GO:0010899,0.0205689445211588,0.999858795219214,1,3,regulation of phosphatidylcholine catabolic process,BP,APOC1
1990,GO:0004450,0.020643446277293,0.999893199599133,1,2,isocitrate dehydrogenase (NADP+) activity,MF,IDH1
2987,GO:0006097,0.020643446277293,0.999893199599133,1,2,glyoxylate cycle,BP,IDH1
13556,GO:0050654,0.0206868285741585,0.998587058990487,2,42,chondroitin sulfate proteoglycan metabolic process,BP,IDUA;HEXB
16431,GO:0071373,0.0207260896061354,0.999856619144313,1,3,cellular response to luteinizing hormone stimulus,BP,STAR
9570,GO:0034699,0.0207260973018053,0.999838790903032,1,4,response to luteinizing hormone,BP,STAR
12523,GO:0046102,0.0207708950326713,0.999891869742202,1,2,inosine metabolic process,BP,PNP
17796,GO:0097190,0.0207890164354394,0.992379713482358,9,565,apoptotic signaling pathway,BP,FADD;TRADD;PYCARD;G0S2;TICAM1;NOL3;DEPTOR;CASP4;IFI27
18215,GO:0098878,0.0208441435126097,0.998565154516334,2,47,neurotransmitter receptor complex,CC,GRIA3;CPT1C
6640,GO:0019534,0.0208518574860805,0.999826002743256,1,5,toxin transporter activity,MF,ABCG1
17734,GO:0097089,0.0208968660172696,0.999890547132632,1,2,methyl-branched fatty acid metabolic process,BP,PHYH
6615,GO:0019439,0.0209431953728691,0.992843445228735,8,420,aromatic compound catabolic process,BP,PNP;RGN;GALT;AOX1;NUDT7;PCBD1;PON2;DERA
19594,GO:1903409,0.0210105154049113,0.99715783864194,3,86,reactive oxygen species biosynthetic process,BP,RGN;TICAM1;GLA
6031,GO:0016623,0.0213374990002699,0.999847992769603,1,3,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,AOX1
19353,GO:1902930,0.0213425317541256,0.998530474988605,2,34,regulation of alcohol biosynthetic process,BP,ABCG1;DHCR7
7359,GO:0030283,0.0214121329773482,0.99988505256299,1,2,testosterone dehydrogenase [NAD(P)] activity,MF,HSD17B10
782,GO:0001959,0.0214494063247938,0.995847603376381,4,141,regulation of cytokine-mediated signaling pathway,BP,FADD;TRADD;PYCARD;NOL3
10146,GO:0035963,0.0214574624188728,0.999846270347041,1,3,cellular response to interleukin-13,BP,SHPK
3954,GO:0008124,0.0216646031154581,0.999882310674953,1,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,PCBD1
3273,GO:0006550,0.0216909530070966,0.999882022625459,1,2,isoleucine catabolic process,BP,ACAT1
14471,GO:0052689,0.0217980021641751,0.995763987889959,4,132,carboxylic ester hydrolase activity,MF,RGN;PLA2G16;PON2;LYPLAL1
9993,GO:0035698,0.0218223925614559,0.999880580448589,1,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
21227,GO:2000452,0.0218223925614559,0.999880580448589,1,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
10653,GO:0042104,0.0219360173652791,0.998485324428342,2,27,positive regulation of activated T cell proliferation,BP,FADD;PYCARD
10861,GO:0042493,0.0220209519591168,0.993030750508434,7,405,response to drug,BP,EBP;PNP;NNMT;FABP3;STAR;RPH3AL;SLC1A3
3068,GO:0006258,0.0220538759218421,0.999878019031653,1,2,UDP-glucose catabolic process,BP,GALT
16070,GO:0070665,0.0222030048334563,0.995660728306867,4,133,positive regulation of leukocyte proliferation,BP,FADD;PNP;PYCARD;TICAM1
9444,GO:0034436,0.0222324949153855,0.999834906284883,1,3,glycoprotein transport,BP,ABCG1
8136,GO:0031780,0.0224557766995076,0.999873506605306,1,2,corticotropin hormone receptor binding,MF,MRAP
8139,GO:0031783,0.0224557766995076,0.999873506605306,1,2,type 5 melanocortin receptor binding,MF,MRAP
14617,GO:0055099,0.0225509841907249,0.999830117703222,1,3,response to high density lipoprotein particle,BP,ABCG1
21200,GO:2000404,0.0225987572679519,0.998421975137732,2,25,regulation of T cell migration,BP,FADD;PYCARD
14483,GO:0052740,0.022619368217291,0.999871646105661,1,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,PLA2G16
6729,GO:0019853,0.022731638561868,0.999870361322335,1,2,L-ascorbic acid biosynthetic process,BP,RGN
142,GO:0000285,0.0227676418634905,0.999805298723263,1,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,ZFYVE21
18959,GO:1901896,0.0227749859701305,0.9998267083378,1,3,positive regulation of calcium-transporting ATPase activity,BP,RGN
21199,GO:2000403,0.022811166588498,0.998399195631391,2,25,positive regulation of lymphocyte migration,BP,FADD;PYCARD
4551,GO:0009395,0.0228904756981413,0.998360127171529,2,36,phospholipid catabolic process,BP,APOC1;IDH1
3969,GO:0008150,0.0229208987413322,0.990980751748807,120,16026,biological_process,BP,CFB;EBP;PDK4;PECR;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;WDR45;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;G0S2;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;CYP17A1;RNASEL;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;ACCS;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;FAM46A;TMEM176A;IDH1;DECR1;PUS1;PTMS;LDHD;MDP1;TFPI;STAR;SNX21;WBP1;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;PRRT1;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH;TMOD4
4579,GO:0009448,0.0230706387915181,0.999786810041844,1,5,gamma-aminobutyric acid metabolic process,BP,SLC1A3
19707,GO:1903630,0.0231275399431237,0.999865779095636,1,2,regulation of aminoacyl-tRNA ligase activity,BP,RGN
975,GO:0002277,0.023168971221235,0.999820628730929,1,3,myeloid dendritic cell activation involved in immune response,BP,PYCARD
9401,GO:0034367,0.0232631248609269,0.998350341800551,2,25,macromolecular complex remodeling,BP,APOC1;ABCG1
9402,GO:0034368,0.0232631248609269,0.998350341800551,2,25,protein-lipid complex remodeling,BP,APOC1;ABCG1
9403,GO:0034369,0.0232631248609269,0.998350341800551,2,25,plasma lipoprotein particle remodeling,BP,APOC1;ABCG1
5905,GO:0016409,0.0233757888001015,0.998304650065798,2,37,palmitoyltransferase activity,MF,CPT2;CPT1C
5246,GO:0014735,0.0234488334296428,0.999816245811205,1,3,regulation of muscle atrophy,BP,NOL3
8403,GO:0032311,0.0234567425009755,0.999861907522739,1,2,angiogenin-PRI complex,CC,ANG
12158,GO:0045355,0.023549981908301,0.999860800860559,1,2,negative regulation of interferon-alpha biosynthetic process,BP,NMI
12656,GO:0046470,0.0235585068751352,0.996679653824571,3,78,phosphatidylcholine metabolic process,BP,APOC1;PLA2G16;FABP3
20663,GO:1905953,0.02365272139109,0.998271930973146,2,38,negative regulation of lipid localization,BP,APOC1;ABCG1
3570,GO:0006979,0.0237111056975132,0.992383738260952,7,397,response to oxidative stress,BP,MSRA;RGN;NOL3;PON2;IDH1;STAR;ETFDH
12162,GO:0045359,0.0237162975147681,0.999758665394624,1,7,positive regulation of interferon-beta biosynthetic process,BP,TICAM1
1259,GO:0002756,0.0239218329554425,0.998252295889366,2,33,MyD88-independent toll-like receptor signaling pathway,BP,FADD;TICAM1
10907,GO:0042558,0.0239698935575757,0.998252131507739,2,31,pteridine-containing compound metabolic process,BP,PCBD1;PTS
4275,GO:0008670,0.0240078786389661,0.999855301171381,1,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,DECR1
3945,GO:0008113,0.0241078200191485,0.999854086457989,1,2,peptide-methionine (S)-S-oxide reductase activity,MF,MSRA
17458,GO:0090205,0.0241143512181642,0.999757341947561,1,6,positive regulation of cholesterol metabolic process,BP,ABCG1
7697,GO:0030976,0.024299147972456,0.999763381688743,1,5,thiamine pyrophosphate binding,MF,HACL1
16000,GO:0070538,0.0245120709493878,0.999849120631817,1,2,oleic acid binding,MF,FABP3
21536,GO:2001015,0.0245374020095096,0.999758695254736,1,5,negative regulation of skeletal muscle cell differentiation,BP,S100B
16159,GO:0070859,0.0246128743224148,0.999797441759145,1,3,positive regulation of bile acid biosynthetic process,BP,STAR
19998,GO:1904253,0.0246128743224148,0.999797441759145,1,3,positive regulation of bile acid metabolic process,BP,STAR
20267,GO:1904849,0.0246435582635199,0.999771709650515,1,4,positive regulation of cell chemotaxis to fibroblast growth factor,BP,FGF18
21294,GO:2000546,0.0246435582635199,0.999771709650515,1,4,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
11057,GO:0042816,0.0248037900019244,0.99975340045824,1,5,vitamin B6 metabolic process,BP,AOX1
2989,GO:0006099,0.0248330844301112,0.99815775504484,2,30,tricarboxylic acid cycle,BP,MDH1;IDH1
13028,GO:0047750,0.0249836484122311,0.99984322141534,1,2,cholestenol delta-isomerase activity,MF,EBP
15176,GO:0060759,0.0250293181235407,0.994919829138822,4,147,regulation of response to cytokine stimulus,BP,FADD;TRADD;PYCARD;NOL3
2066,GO:0004553,0.0250611067290826,0.996374298822921,3,88,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,IDUA;HEXB;GLA
17125,GO:0072593,0.0251222273371024,0.99368371519265,5,228,reactive oxygen species metabolic process,BP,PDK4;RGN;TICAM1;AOX1;GLA
1153,GO:0002582,0.0251394869671413,0.99984124675699,1,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,PYCARD
1156,GO:0002585,0.0251394869671413,0.99984124675699,1,2,positive regulation of antigen processing and presentation of peptide antigen,BP,PYCARD
1159,GO:0002588,0.0251394869671413,0.99984124675699,1,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,PYCARD
15289,GO:0060992,0.0252512602166226,0.999733800894172,1,6,response to fungicide,BP,STAR
1999,GO:0004464,0.02540317406761,0.999837877017262,1,2,leukotriene-C4 synthase activity,MF,MGST2
8545,GO:0032496,0.0254208576451469,0.992575836218987,6,299,response to lipopolysaccharide,BP,PYCARD;MGST2;TICAM1;SHPK;TFPI;STAR
11688,GO:0044249,0.0255170715302547,0.983656023742166,51,5897,cellular biosynthetic process,BP,PDK4;PECR;ALG5;DPM3;MRPL14;MRPL16;MRI1;FADD;HSD17B3;MRAP;APOC1;TRADD;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;ACADVL;MGST2;ACSM5;PSMB10;RGN;FADS1;FGF18;TICAM1;NNMT;PLA2G16;CYP17A1;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;FABP3;HSD3B2;PCBD1;IFI27;IDH1;PTMS;STAR;GLA;CYP11A1;PTS;RBMS3;HNF1A;SLC1A3;ELOVL6
12647,GO:0046460,0.0256530630895104,0.998035574674297,2,42,neutral lipid biosynthetic process,BP,RGN;ANG
12650,GO:0046463,0.0256530630895104,0.998035574674297,2,42,acylglycerol biosynthetic process,BP,RGN;ANG
12530,GO:0046113,0.0257113046560515,0.999723962274696,1,6,nucleobase catabolic process,BP,AOX1
2600,GO:0005375,0.0257588833634111,0.999722934453453,1,6,copper ion transmembrane transporter activity,MF,SLC31A2
9829,GO:0035434,0.0257588833634111,0.999722934453453,1,6,copper ion transmembrane transport,BP,SLC31A2
14750,GO:0060157,0.0257600513375506,0.999733915183575,1,5,urinary bladder development,BP,RBP4
12382,GO:0045843,0.0258345342398455,0.998021663000155,2,38,negative regulation of striated muscle tissue development,BP,RBP4;S100B
13416,GO:0048807,0.0258523963358247,0.99977639963592,1,3,female genitalia morphogenesis,BP,RBP4
10824,GO:0042426,0.026378693970605,0.999709368618386,1,6,choline catabolic process,BP,SARDH
19956,GO:1904177,0.0263959126844923,0.999720544005753,1,5,regulation of adipose tissue development,BP,PLA2G16
11097,GO:0042940,0.0264128902415041,0.999708610625315,1,6,D-amino acid transport,BP,SLC1A3
5127,GO:0010952,0.026479915131193,0.994528831280929,4,154,positive regulation of peptidase activity,BP,FADD;TRADD;PYCARD;IFI27
13415,GO:0048806,0.0266965875863485,0.997908317163229,2,44,genitalia development,BP,HSD17B3;RBP4
14023,GO:0051341,0.0268341117463936,0.996017352048801,3,86,regulation of oxidoreductase activity,BP,RGN;GLA;PTS
12018,GO:0045087,0.0268400151742507,0.988159504759625,12,808,innate immune response,BP,CFB;IFI30;FADD;PYCARD;PSMB10;TICAM1;RNASEL;NMI;CASP4;IFI27;STAR;S100B
14601,GO:0055081,0.0268446013683718,0.997895718734381,2,41,anion homeostasis,BP,ABCG1;FABP3
2004,GO:0004470,0.026949381953431,0.999726720677055,1,4,malic enzyme activity,MF,MDH1
11472,GO:0043546,0.02714420058513,0.999692161569895,1,6,molybdopterin cofactor binding,MF,AOX1
6449,GO:0018963,0.0273533458165097,0.99974951047674,1,3,phthalate metabolic process,BP,STAR
18834,GO:1901566,0.0274569511353943,0.986086675627978,17,1317,organonitrogen compound biosynthetic process,BP,MRPL14;MRPL16;MRI1;MRAP;EXTL1;PNP;BDH2;MGST2;NNMT;ANG;ACAT1;TSFM;FABP3;PCBD1;PTS;RBMS3;SLC1A3
1746,GO:0003985,0.0277158137535241,0.999742785244735,1,3,acetyl-CoA C-acetyltransferase activity,MF,ACAT1
12763,GO:0046660,0.027747632265877,0.995810159922383,3,109,female sex differentiation,BP,RBP4;ANG;IDH1
825,GO:0002020,0.0277785133547067,0.995804359200392,3,108,protease binding,MF,FADD;PYCARD;NOL3
45,GO:0000096,0.0280245710200463,0.997758562571022,2,38,sulfur amino acid metabolic process,BP,MSRA;MRI1
14689,GO:0060059,0.0281322338005448,0.999652811940126,1,8,embryonic retina morphogenesis in camera-type eye,BP,RBP4
18945,GO:1901862,0.0281641591147048,0.997736950643782,2,40,negative regulation of muscle tissue development,BP,RBP4;S100B
16797,GO:0072014,0.0282382483038991,0.999679930361984,1,5,proximal tubule development,BP,ACAT1
8209,GO:0031968,0.0283763550176953,0.994002307976892,4,174,organelle outer membrane,CC,CPT1C;IFI27;DHCR7;CYB5A
6741,GO:0019867,0.0283851823171614,0.99399904894699,4,176,outer membrane,CC,CPT1C;IFI27;DHCR7;CYB5A
780,GO:0001957,0.0285078068085499,0.999660270649567,1,6,intramembranous ossification,BP,FGF18
10218,GO:0036072,0.0285078068085499,0.999660270649567,1,6,direct ossification,BP,FGF18
4494,GO:0009227,0.0285476077749817,0.999727010935289,1,3,nucleotide-sugar catabolic process,BP,GALT
3040,GO:0006195,0.0286039738490075,0.99767120520666,2,46,purine nucleotide catabolic process,BP,PNP;NUDT7
855,GO:0002060,0.0286842289980888,0.999724374551486,1,3,purine nucleobase binding,MF,PNP
8531,GO:0032480,0.0287060371806731,0.997663692130211,2,43,negative regulation of type I interferon production,BP,PYCARD;NMI
12532,GO:0046121,0.0287061379197109,0.99972395058014,1,3,deoxyribonucleoside catabolic process,BP,DERA
6171,GO:0016877,0.0287500445920084,0.997666495090086,2,39,ligase activity, forming carbon-sulfur bonds,MF,ACSF2;ACSM5
7547,GO:0030678,0.0288496794622873,0.999721164663408,1,3,mitochondrial ribonuclease P complex,CC,HSD17B10
12895,GO:0046952,0.028919343592901,0.999685042023489,1,4,ketone body catabolic process,BP,ACAT1
13320,GO:0048635,0.0289498410155628,0.997639285351263,2,40,negative regulation of muscle organ development,BP,RBP4;S100B
17099,GO:0072557,0.0290567065082635,0.999717121629671,1,3,IPAF inflammasome complex,CC,CASP4
2033,GO:0004505,0.0292465143268774,0.999713388957058,1,3,phenylalanine 4-monooxygenase activity,MF,PCBD1
2374,GO:0004970,0.0293428794733142,0.999591152270834,1,19,ionotropic glutamate receptor activity,MF,GRIA3
955,GO:0002237,0.0293483155295905,0.991139450228809,6,314,response to molecule of bacterial origin,BP,PYCARD;MGST2;TICAM1;SHPK;TFPI;STAR
4437,GO:0009164,0.0295710885269029,0.997605044476169,2,27,nucleoside catabolic process,BP,PNP;DERA
2635,GO:0005504,0.0296714413329348,0.997603519355187,2,25,fatty acid binding,MF,APOC1;FABP3
5782,GO:0016128,0.0297342064648116,0.999703684510603,1,3,phytosteroid metabolic process,BP,DHCR7
5783,GO:0016129,0.0297342064648116,0.999703684510603,1,3,phytosteroid biosynthetic process,BP,DHCR7
13457,GO:0048878,0.0297531958617089,0.986663094469986,12,1004,chemical homeostasis,BP,PDK4;SLC31A2;ABCG1;BDH2;RGN;RBP4;HEXB;FABP3;NOL3;STAR;RPH3AL;HNF1A
14874,GO:0060337,0.0298513741756326,0.995392518897035,3,80,type I interferon signaling pathway,BP,FADD;RNASEL;IFI27
16422,GO:0071357,0.0298513741756326,0.995392518897035,3,80,cellular response to type I interferon,BP,FADD;RNASEL;IFI27
6442,GO:0018894,0.0300933042249091,0.999658780206407,1,4,dibenzo-p-dioxin metabolic process,BP,STAR
3261,GO:0006537,0.0301943188668332,0.999618627795678,1,6,glutamate biosynthetic process,BP,SLC1A3
12612,GO:0046364,0.0302035430567822,0.995312044445738,3,84,monosaccharide biosynthetic process,BP,RGN;RBP4;MDH1
9992,GO:0035697,0.030247201305297,0.999693299795268,1,3,CD8-positive, alpha-beta T cell extravasation,BP,FADD
21203,GO:2000407,0.030247201305297,0.999693299795268,1,3,regulation of T cell extravasation,BP,FADD
21225,GO:2000449,0.030247201305297,0.999693299795268,1,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
21639,GO:2001237,0.0304909936889687,0.995233765522872,3,100,negative regulation of extrinsic apoptotic signaling pathway,BP,FADD;TRADD;NOL3
15817,GO:0070236,0.030698659644851,0.999644821927024,1,4,negative regulation of activation-induced cell death of T cells,BP,FADD
18781,GO:1901361,0.0307956260594138,0.988684171703268,8,452,organic cyclic compound catabolic process,BP,HSD17B11;PNP;RGN;GALT;AOX1;NUDT7;PCBD1;DERA
19009,GO:1902042,0.0309120204058784,0.997399807203287,2,36,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD;TRADD
5349,GO:0015065,0.030956151816342,0.999678649731279,1,3,uridine nucleotide receptor activity,MF,P2RY14
16553,GO:0071553,0.030956151816342,0.999678649731279,1,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,P2RY14
17269,GO:0086036,0.0311366396828456,0.999582813023892,1,7,regulation of cardiac muscle cell membrane potential,BP,FXYD1
12668,GO:0046488,0.0312338861185675,0.993185922844308,4,213,phosphatidylinositol metabolic process,BP,DPM3;ZFYVE21;FGF18;PLA2G16
6117,GO:0016790,0.0313168723151518,0.997373991175026,2,29,thiolester hydrolase activity,MF,NUDT7;LYPLAL1
7258,GO:0030145,0.0314512774455765,0.99730383447828,2,47,manganese ion binding,MF,NUDT7;PEPD
16705,GO:0071827,0.0315744708277616,0.997316827259421,2,35,plasma lipoprotein particle organization,BP,APOC1;ABCG1
6513,GO:0019166,0.0316090702009162,0.999664850828641,1,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,PECR
16187,GO:0070901,0.0318348332584263,0.999617858305491,1,4,mitochondrial tRNA methylation,BP,HSD17B10
11152,GO:0043028,0.0319893222917043,0.997245291587354,2,41,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,PYCARD;NOL3
9210,GO:0033865,0.0323126150624546,0.997226960099656,2,33,nucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
9216,GO:0033875,0.0323126150624546,0.997226960099656,2,33,ribonucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
9236,GO:0034032,0.0323126150624546,0.997226960099656,2,33,purine nucleoside bisphosphate metabolic process,BP,ACAT1;NUDT7
8669,GO:0032687,0.0327067979172708,0.99956982555677,1,5,negative regulation of interferon-alpha production,BP,NMI
2074,GO:0004563,0.0327547159698127,0.999568555622381,1,5,beta-N-acetylhexosaminidase activity,MF,HEXB
5256,GO:0014745,0.0327784863357595,0.999527813849467,1,8,negative regulation of muscle adaptation,BP,NOL3
9054,GO:0033344,0.032928421439223,0.997122518100446,2,40,cholesterol efflux,BP,APOC1;ABCG1
10701,GO:0042181,0.0329435609966325,0.99713236893535,2,36,ketone biosynthetic process,BP,HSD17B3;STAR
11233,GO:0043168,0.0329702743754479,0.981543523976679,22,2575,anion binding,MF,PDK4;PHYH;APOC1;ACSF2;PNP;ABCG1;ACADVL;ACSM5;PXK;HACL1;RNASEL;ANG;AOX1;SHPK;FABP3;ACCS;DECR1;LDHD;SNX21;RPH3AL;SLC1A3;ETFDH
2494,GO:0005164,0.0330326559359401,0.997144401751453,2,30,tumor necrosis factor receptor binding,MF,FADD;TRADD
9381,GO:0034340,0.0331914266559111,0.994657722493751,3,84,response to type I interferon,BP,FADD;RNASEL;IFI27
12152,GO:0045349,0.0332519130987614,0.999536911353277,1,6,interferon-alpha biosynthetic process,BP,NMI
12157,GO:0045354,0.0332519130987614,0.999536911353277,1,6,regulation of interferon-alpha biosynthetic process,BP,NMI
5619,GO:0015810,0.033383990505902,0.999502395334118,1,9,aspartate transport,BP,SLC1A3
14482,GO:0052739,0.0337232600896038,0.999618147958641,1,3,phosphatidylserine 1-acylhydrolase activity,MF,PLA2G16
11204,GO:0043123,0.0337371446522553,0.992476721513429,4,178,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,FADD;TRADD;TICAM1;S100B
2001,GO:0004466,0.0338649199714771,0.999567188777839,1,4,long-chain-acyl-CoA dehydrogenase activity,MF,ACADVL
10145,GO:0035962,0.0338762300380823,0.999566897524503,1,4,response to interleukin-13,BP,SHPK
14769,GO:0060179,0.0339952114461683,0.999515832169044,1,6,male mating behavior,BP,HEXB
8530,GO:0032479,0.0341055710724251,0.994420614874207,3,115,regulation of type I interferon production,BP,PYCARD;TICAM1;NMI
2026,GO:0004497,0.034303630549429,0.99439868746065,3,91,monooxygenase activity,MF,CYP17A1;PCBD1;CYP11A1
7216,GO:0030061,0.0343562419658995,0.999525019643589,1,5,mitochondrial crista,CC,STAR
11187,GO:0043094,0.03440079881979,0.996946364457296,2,33,cellular metabolic compound salvage,BP,MRI1;PNP
4719,GO:0010033,0.0344753827269651,0.979618303010082,27,2793,response to organic substance,BP,PDK4;IFI30;FADD;TRADD;ABCG1;PYCARD;ACADVL;MGST2;PSMB10;GHR;FGF18;TICAM1;NNMT;RBP4;RNASEL;ANG;NMI;ACAT1;SHPK;FABP3;NOL3;CASP4;IFI27;IDH1;TFPI;STAR;S100B
19035,GO:1902109,0.0344873006489831,0.99960050915055,1,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,NOL3
10058,GO:0035795,0.0344873109943937,0.999551013355315,1,4,negative regulation of mitochondrial membrane permeability,BP,NOL3
20596,GO:1905709,0.0344873109943937,0.999551013355315,1,4,negative regulation of membrane permeability,BP,NOL3
2530,GO:0005234,0.0345228516465493,0.999433000428128,1,19,extracellular-glutamate-gated ion channel activity,MF,GRIA3
16249,GO:0070996,0.034530149865718,0.999599507943243,1,3,type 1 melanocortin receptor binding,MF,MRAP
11760,GO:0044351,0.0345766262889849,0.999484843079211,1,7,macropinocytosis,BP,PYCARD
7351,GO:0030274,0.0345781349155352,0.999498968266037,1,6,LIM domain binding,MF,RPH3AL
16703,GO:0071825,0.0346711185811573,0.996890874403092,2,38,protein-lipid complex subunit organization,BP,APOC1;ABCG1
18889,GO:1901671,0.0347194139705743,0.99959507040123,1,3,positive regulation of superoxide dismutase activity,BP,RGN
20258,GO:1904833,0.0347194139705743,0.99959507040123,1,3,positive regulation of removal of superoxide radicals,BP,RGN
20796,GO:1990481,0.0347917424948348,0.999542991742865,1,4,mRNA pseudouridine synthesis,BP,PUS1
9839,GO:0035457,0.0348152621916439,0.999466889614032,1,8,cellular response to interferon-alpha,BP,STAR
4107,GO:0008375,0.0349984925292638,0.996826412976427,2,45,acetylglucosaminyltransferase activity,MF,EXTL1;HEXB
12709,GO:0046573,0.035061641583901,0.99958698335634,1,3,lactonohydrolase activity,MF,PON2
18394,GO:0102007,0.035061641583901,0.99958698335634,1,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,PON2
3404,GO:0006710,0.0351165062344311,0.999534354902588,1,4,androgen catabolic process,BP,HSD17B11
5680,GO:0015914,0.0354513039368756,0.996740768242466,2,57,phospholipid transport,BP,APOC1;ABCG1
6440,GO:0018879,0.0354530786375331,0.999525317401834,1,4,biphenyl metabolic process,BP,STAR
8615,GO:0032606,0.035588456035294,0.994080574550029,3,116,type I interferon production,BP,PYCARD;TICAM1;NMI
14026,GO:0051344,0.0356127849114631,0.999489375335555,1,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,RGN
13722,GO:0050873,0.0356192627048281,0.996755713906457,2,39,brown fat cell differentiation,BP,MRAP;NUDT7
7930,GO:0031406,0.0356390493858319,0.991925320808782,4,162,carboxylic acid binding,MF,PHYH;APOC1;FABP3;SLC1A3
6637,GO:0019530,0.0358418868857648,0.999446175301156,1,7,taurine metabolic process,BP,GHR
6669,GO:0019694,0.0358418868857648,0.999446175301156,1,7,alkanesulfonate metabolic process,BP,GHR
2930,GO:0006006,0.0358773494743465,0.991840575222761,4,187,glucose metabolic process,BP,PDK4;RGN;RBP4;MDH1
12553,GO:0046165,0.035952426220171,0.994009044467479,3,102,alcohol biosynthetic process,BP,EBP;ABCG1;DHCR7
11241,GO:0043177,0.0359963561313563,0.991818349848301,4,163,organic acid binding,MF,PHYH;APOC1;FABP3;SLC1A3
6014,GO:0016595,0.0361642630455834,0.999415440103447,1,9,glutamate binding,MF,SLC1A3
8664,GO:0032680,0.0361884867887868,0.993956497404794,3,100,regulation of tumor necrosis factor production,BP,FADD;PYCARD;TICAM1
6096,GO:0016757,0.0364425857048414,0.98988836530968,5,261,transferase activity, transferring glycosyl groups,MF,ALG5;DPM3;EXTL1;PNP;HEXB
2451,GO:0005111,0.0367148064789284,0.999546772999732,1,3,type 2 fibroblast growth factor receptor binding,MF,FGF18
12933,GO:0047045,0.0368373958038421,0.999543715587922,1,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,HSD17B3
2091,GO:0004582,0.0368563001437675,0.999543243178233,1,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,DPM3
8987,GO:0033185,0.0368563001437675,0.999543243178233,1,3,dolichol-phosphate-mannose synthase complex,CC,DPM3
9910,GO:0035578,0.0371053497755823,0.993758123671329,3,88,azurophil granule lumen,CC,PYCARD;HEXB;GLA
7784,GO:0031119,0.0371463201152303,0.999478512352314,1,4,tRNA pseudouridine synthesis,BP,PUS1
13842,GO:0051055,0.0372117450092242,0.996514585982004,2,44,negative regulation of lipid biosynthetic process,BP,APOC1;ACADVL
17100,GO:0072558,0.0372308218408747,0.999476117960436,1,4,NLRP1 inflammasome complex,CC,PYCARD
2932,GO:0006011,0.0372414654535157,0.999418190669599,1,6,UDP-glucose metabolic process,BP,GALT
3355,GO:0006651,0.0373580515913857,0.999472502339952,1,4,diacylglycerol biosynthetic process,BP,ANG
6239,GO:0017040,0.0374016845392719,0.999436370476768,1,5,ceramidase activity,MF,ASAH2
2976,GO:0006081,0.0374801493749243,0.993667524284543,3,90,cellular aldehyde metabolic process,BP,SHPK;IDH1;DERA
2571,GO:0005324,0.0375308855358312,0.999432439364013,1,5,long-chain fatty acid transporter activity,MF,FABP3
8435,GO:0032371,0.0375932534279137,0.996464978398231,2,42,regulation of sterol transport,BP,APOC1;ABCG1
8438,GO:0032374,0.0375932534279137,0.996464978398231,2,42,regulation of cholesterol transport,BP,APOC1;ABCG1
4106,GO:0008374,0.0377182453797936,0.996436032041608,2,46,O-acyltransferase activity,MF,CPT2;CPT1C
6116,GO:0016788,0.0381693317047219,0.98442357377018,9,697,hydrolase activity, acting on ester bonds,MF,RGN;PLA2G16;RNASEL;ANG;NUDT7;PON2;MDP1;ACP5;LYPLAL1
8637,GO:0032640,0.0382648194149198,0.993467402524686,3,102,tumor necrosis factor production,BP,FADD;PYCARD;TICAM1
851,GO:0002054,0.0385413725059794,0.99943826914616,1,4,nucleobase binding,MF,PNP
14165,GO:0051597,0.0385630698849543,0.999358200151075,1,7,response to methylmercury,BP,S100B
19520,GO:1903273,0.038992800962218,0.999424921055817,1,4,regulation of sodium ion export,BP,FXYD1
19521,GO:1903275,0.038992800962218,0.999424921055817,1,4,positive regulation of sodium ion export,BP,FXYD1
19522,GO:1903276,0.038992800962218,0.999424921055817,1,4,regulation of sodium ion export from cell,BP,FXYD1
19523,GO:1903278,0.038992800962218,0.999424921055817,1,4,positive regulation of sodium ion export from cell,BP,FXYD1
5077,GO:0010887,0.0390156142851973,0.999360980163824,1,6,negative regulation of cholesterol storage,BP,ABCG1
5933,GO:0016453,0.0391822111573716,0.999419272999594,1,4,C-acetyltransferase activity,MF,ACAT1
13794,GO:0050999,0.0393950121910952,0.996191474294202,2,45,regulation of nitric-oxide synthase activity,BP,GLA;PTS
19666,GO:1903555,0.0394015810652419,0.993195009351098,3,103,regulation of tumor necrosis factor superfamily cytokine production,BP,FADD;PYCARD;TICAM1
2448,GO:0005105,0.0395079941238484,0.999409492753449,1,4,type 1 fibroblast growth factor receptor binding,MF,FGF18
876,GO:0002084,0.0395772599923471,0.999407402632359,1,4,protein depalmitoylation,BP,LYPLAL1
5768,GO:0016101,0.0398259843467736,0.993101571794637,3,96,diterpenoid metabolic process,BP,PECR;RBP4;STAR
6628,GO:0019509,0.0398624114414984,0.999359113011126,1,5,L-methionine salvage from methylthioadenosine,BP,MRI1
9781,GO:0035338,0.0398643482648372,0.996133551978165,2,41,long-chain fatty-acyl-CoA biosynthetic process,BP,ACSF2;ELOVL6
17713,GO:0097049,0.040211542780078,0.999301702453881,1,7,motor neuron apoptotic process,BP,FADD
14212,GO:0051694,0.0403425716275841,0.999297107869355,1,7,pointed-end actin filament capping,BP,TMOD4
12470,GO:0046006,0.0405847394316608,0.996032496800512,2,39,regulation of activated T cell proliferation,BP,FADD;PYCARD
18767,GO:1901318,0.0408388248984182,0.999368676975964,1,4,negative regulation of flagellated sperm motility,BP,RGN
1157,GO:0002586,0.0408463526109022,0.999368442157855,1,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,PYCARD
1151,GO:0002580,0.0408463642322245,0.999326808758821,1,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,PYCARD
8710,GO:0032757,0.0410065749870198,0.995954514227256,2,43,positive regulation of interleukin-8 production,BP,FADD;PYCARD
15816,GO:0070235,0.0412931754317229,0.999283538410976,1,6,regulation of activation-induced cell death of T cells,BP,FADD
20167,GO:1904645,0.0414143418641984,0.99927929237307,1,6,response to beta-amyloid,BP,CASP4
5516,GO:0015485,0.041676486050082,0.995852022943643,2,43,cholesterol binding,MF,ABCG1;STAR
11834,GO:0044539,0.0417189196582744,0.99926856271116,1,6,long-chain fatty acid import,BP,FABP3
19752,GO:1903726,0.041724121314855,0.999247731164788,1,7,negative regulation of phospholipid metabolic process,BP,APOC1
3857,GO:0007598,0.0418933144471063,0.999291548855033,1,5,blood coagulation, extrinsic pathway,BP,TFPI
21180,GO:2000378,0.0419694089200844,0.995803676666092,2,44,negative regulation of reactive oxygen species metabolic process,BP,RGN;GLA
18875,GO:1901653,0.0419714557641124,0.987888797929094,5,315,cellular response to peptide,BP,PDK4;GHR;RNASEL;CASP4;STAR
18848,GO:1901606,0.0421593143653356,0.9925374029731,3,93,alpha-amino acid catabolic process,BP,ACAT1;SARDH;PCBD1
2567,GO:0005314,0.0423131845982678,0.999226159807083,1,7,high-affinity glutamate transmembrane transporter activity,MF,SLC1A3
16024,GO:0070569,0.0425154018568243,0.999218683168508,1,7,uridylyltransferase activity,MF,GALT
12892,GO:0046949,0.0425256722481255,0.995724233693208,2,42,fatty-acyl-CoA biosynthetic process,BP,ACSF2;ELOVL6
6178,GO:0016885,0.0426286292367757,0.999198324810491,1,8,ligase activity, forming carbon-carbon bonds,MF,ACAT1
17167,GO:0072683,0.0426448251957128,0.999311066464128,1,4,T cell extravasation,BP,FADD
18888,GO:1901668,0.0427744153664831,0.999306834097087,1,4,regulation of superoxide dismutase activity,BP,RGN
16225,GO:0070970,0.0428450721387586,0.999167260310387,1,10,interleukin-2 secretion,BP,PNP
10652,GO:0042102,0.0431148489903944,0.992297800830001,3,95,positive regulation of T cell proliferation,BP,FADD;PNP;PYCARD
8491,GO:0032431,0.043482305583064,0.999283481578176,1,4,activation of phospholipase A2 activity,BP,ANG
6097,GO:0016758,0.0435113846008626,0.989483635306431,4,193,transferase activity, transferring hexosyl groups,MF,ALG5;DPM3;EXTL1;HEXB
7215,GO:0030060,0.0437596811235795,0.999274223764029,1,4,L-malate dehydrogenase activity,MF,MDH1
21615,GO:2001199,0.0438488869062463,0.999223233147442,1,5,negative regulation of dendritic cell differentiation,BP,TMEM176A
9286,GO:0034128,0.0439295373704531,0.999165375775401,1,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
13668,GO:0050798,0.043997167492822,0.995489833366085,2,43,activated T cell proliferation,BP,FADD;PYCARD
16656,GO:0071706,0.0441035516113518,0.992034149335829,3,107,tumor necrosis factor superfamily cytokine production,BP,FADD;PYCARD;TICAM1
4625,GO:0009725,0.044221410988901,0.980521360578703,10,837,response to hormone,BP,PDK4;ABCG1;GHR;RNASEL;ANG;ACAT1;FABP3;IDH1;STAR;S100B
21637,GO:2001235,0.0444078099948103,0.989211345332239,4,172,positive regulation of apoptotic signaling pathway,BP,FADD;TRADD;PYCARD;G0S2
6670,GO:0019695,0.0444998274141294,0.999112074504648,1,9,choline metabolic process,BP,SARDH
21197,GO:2000401,0.0446772400690582,0.995397695025343,2,39,regulation of lymphocyte migration,BP,FADD;PYCARD
4827,GO:0010510,0.0447437519640528,0.999074568046719,1,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,PDK4
14581,GO:0055037,0.0447567502609764,0.991836516520409,3,142,recycling endosome,CC,SLC31A2;TBC1D14;ABCG1
12769,GO:0046677,0.0448105198804259,0.995350050215764,2,46,response to antibiotic,BP,STAR;SLC1A3
4684,GO:0009922,0.0448349463310155,0.999130305295368,1,7,fatty acid elongase activity,MF,ELOVL6
6585,GO:0019367,0.0448349463310155,0.999130305295368,1,7,fatty acid elongation, saturated fatty acid,BP,ELOVL6
18403,GO:0102336,0.0448349463310155,0.999130305295368,1,7,3-oxo-arachidoyl-CoA synthase activity,MF,ELOVL6
18404,GO:0102337,0.0448349463310155,0.999130305295368,1,7,3-oxo-cerotoyl-CoA synthase activity,MF,ELOVL6
18405,GO:0102338,0.0448349463310155,0.999130305295368,1,7,3-oxo-lignoceronyl-CoA synthase activity,MF,ELOVL6
7843,GO:0031265,0.0448378635714789,0.99915404293999,1,6,CD95 death-inducing signaling complex,CC,FADD
4348,GO:0009052,0.0448759378643336,0.999186071516379,1,5,pentose-phosphate shunt, non-oxidative branch,BP,SHPK
3919,GO:0008066,0.0449410658977011,0.999019862051994,1,27,glutamate receptor activity,MF,GRIA3
9779,GO:0035336,0.0450716746477453,0.995311376852648,2,45,long-chain fatty-acyl-CoA metabolic process,BP,ACSF2;ELOVL6
6208,GO:0016936,0.0450749767444492,0.999229498996128,1,4,galactoside binding,MF,GLA
21601,GO:2001181,0.0455487636522758,0.999213054473863,1,4,positive regulation of interleukin-10 secretion,BP,PYCARD
19405,GO:1903011,0.0456521485075799,0.999079486604058,1,8,negative regulation of bone development,BP,RGN
7984,GO:0031501,0.0457241992011226,0.999206920408946,1,4,mannosyltransferase complex,CC,DPM3
3350,GO:0006643,0.0457376416232515,0.988774589053207,4,185,membrane lipid metabolic process,BP,DPM3;ASAH2;HEXB;GLA
2472,GO:0005138,0.045758913635064,0.999093758352815,1,7,interleukin-6 receptor binding,MF,PYCARD
12390,GO:0045862,0.0457874536473517,0.984644943655472,6,357,positive regulation of proteolysis,BP,FADD;TRADD;PYCARD;PSMB10;RGN;IFI27
7816,GO:0031223,0.0458686633473256,0.999027039115434,1,12,auditory behavior,BP,SLC1A3
3887,GO:0007638,0.0458686883955868,0.999014586623111,1,14,mechanosensory behavior,BP,SLC1A3
18176,GO:0098805,0.0460677966067829,0.976077840063885,15,1511,whole membrane,CC,PECR;ZFYVE21;FADD;TRADD;PXMP2;PXMP4;TICAM1;PLA2G16;GRIA3;CPT1C;IFI27;SNX21;RPH3AL;DHCR7;CYB5A
3458,GO:0006807,0.046081258469586,0.968969353142748,55,6563,nitrogen compound metabolic process,BP,MSRA;MRPL14;MRPL16;MRI1;FADD;MRAP;APOC1;TRADD;EXTL1;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;MGST2;PSMB10;RGN;FADS1;GHR;ASAH2;TICAM1;ARL6IP4;NNMT;PLA2G16;HSD17B10;GALT;RNASEL;ANG;NMI;ACAT1;TSFM;IDUA;AOX1;SARDH;SHPK;HEXB;FABP3;NOL3;NUDT7;CPT1C;PCBD1;MDH1;IFI27;IDH1;PUS1;PTMS;PEPD;ACP5;GLA;DERA;PTS;RBMS3;HNF1A;SLC1A3
9615,GO:0034774,0.0461033262198101,0.984529031647593,6,312,secretory granule lumen,CC,PNP;PYCARD;HEXB;IDH1;GLA;DERA
13798,GO:0051005,0.0461126508476451,0.999140149274641,1,5,negative regulation of lipoprotein lipase activity,BP,APOC1
1747,GO:0003986,0.0463501484492514,0.999184836252978,1,4,acetyl-CoA hydrolase activity,MF,NUDT7
14605,GO:0055086,0.0465052459370831,0.97935325099435,10,695,nucleobase-containing small molecule metabolic process,BP,MRAP;PNP;NNMT;ACAT1;AOX1;SHPK;NUDT7;MDH1;IDH1;DERA
8135,GO:0031779,0.0469187897765926,0.999164505718843,1,4,melanocortin receptor binding,MF,MRAP
8137,GO:0031781,0.0469187897765926,0.999164505718843,1,4,type 3 melanocortin receptor binding,MF,MRAP
8138,GO:0031782,0.0469187897765926,0.999164505718843,1,4,type 4 melanocortin receptor binding,MF,MRAP
11504,GO:0043603,0.0471572470120205,0.977352159415607,12,882,cellular amide metabolic process,BP,MRPL14;MRPL16;BDH2;MGST2;GHR;ASAH2;ANG;TSFM;HEXB;IDH1;GLA;RBMS3
17079,GO:0072526,0.047169395465805,0.99909989158301,1,5,pyridine-containing compound catabolic process,BP,PNP
3454,GO:0006796,0.0472916958063795,0.971155583525048,27,2984,phosphate-containing compound metabolic process,BP,PDK4;DPM3;ZFYVE21;MRAP;APOC1;PNP;PYCARD;PSMB10;RGN;FADS1;GHR;FGF18;NNMT;PLA2G16;RNASEL;ANG;ACAT1;SHPK;HEXB;FABP3;NUDT7;DEPTOR;MDH1;IDH1;MDP1;ACP5;DERA
20699,GO:1990111,0.0478178080790271,0.999074724641213,1,5,spermatoproteasome complex,CC,PSMB10
8836,GO:0032934,0.0478790968278208,0.994841607133235,2,48,sterol binding,MF,ABCG1;STAR
9529,GO:0034638,0.0479780622840474,0.999002849893029,1,7,phosphatidylcholine catabolic process,BP,APOC1
6399,GO:0018279,0.0486295897150135,0.994734399838303,2,43,protein N-linked glycosylation via asparagine,BP,ALG5;DPM3
18957,GO:1901894,0.0486368578112212,0.999003085133686,1,6,regulation of calcium-transporting ATPase activity,BP,RGN
6374,GO:0018196,0.0486529437025716,0.994726442197996,2,44,peptidyl-asparagine modification,BP,ALG5;DPM3
16091,GO:0070700,0.048808380150214,0.998930032883383,1,9,BMP receptor binding,MF,PYCARD
10679,GO:0042147,0.0488639685906762,0.994631209613926,2,67,retrograde transport, endosome to Golgi,BP,ZFYVE21;TBC1D14
12662,GO:0046477,0.0490081861038737,0.998987652168712,1,6,glycosylceramide catabolic process,BP,GLA
5974,GO:0016528,0.049038041855209,0.994603309818176,2,66,sarcoplasm,CC,FABP3;NOL3
5100,GO:0010915,0.0493565993750564,0.999074448113044,1,4,regulation of very-low-density lipoprotein particle clearance,BP,APOC1
5101,GO:0010916,0.0493565993750564,0.999074448113044,1,4,negative regulation of very-low-density lipoprotein particle clearance,BP,APOC1
17969,GO:0097527,0.0494352468008456,0.998969753367469,1,6,necroptotic signaling pathway,BP,FADD
14696,GO:0060068,0.0495902444726309,0.998895144818075,1,9,vagina development,BP,RBP4
2786,GO:0005773,0.0497715209634104,0.978677645574228,9,715,vacuole,CC,IFI30;TBC1D14;PYCARD;TICAM1;IDUA;HEXB;PON2;ACP5;GLA
16430,GO:0071372,0.0498027844726486,0.998860627924491,1,11,cellular response to follicle-stimulating hormone stimulus,BP,STAR
13679,GO:0050812,0.0499371903624018,0.998837065901467,1,13,regulation of acyl-CoA biosynthetic process,BP,PDK4
8110,GO:0031730,0.0501524776327282,0.998939332952498,1,6,CCR5 chemokine receptor binding,MF,CNIH4
15034,GO:0060546,0.0502225537037773,0.998866512817708,1,9,negative regulation of necroptotic process,BP,FADD
16288,GO:0071073,0.0502826621561003,0.998903750109443,1,7,positive regulation of phospholipid biosynthetic process,BP,FABP3
5709,GO:0015980,0.0504361408263727,0.984731264439136,5,252,energy derivation by oxidation of organic compounds,BP,ACADVL;ETFB;MDH1;IDH1;ETFDH
4171,GO:0008474,0.0504873404579542,0.998967379246558,1,5,palmitoyl-(protein) hydrolase activity,MF,LYPLAL1
18086,GO:0098599,0.0504873404579542,0.998967379246558,1,5,palmitoyl hydrolase activity,MF,LYPLAL1
18135,GO:0098734,0.0504873404579542,0.998967379246558,1,5,macromolecule depalmitoylation,BP,LYPLAL1
5583,GO:0015740,0.0506028961535972,0.998813718072054,1,12,C4-dicarboxylate transport,BP,SLC1A3
13789,GO:0050994,0.0507087074325576,0.99434316832789,2,54,regulation of lipid catabolic process,BP,APOC1;IDH1
5868,GO:0016307,0.050756986442227,0.998779729375656,1,16,phosphatidylinositol phosphate kinase activity,MF,ZFYVE21
2991,GO:0006102,0.050812788122903,0.998953881201184,1,5,isocitrate metabolic process,BP,IDH1
12665,GO:0046485,0.0508470417776703,0.998878751267952,1,7,ether lipid metabolic process,BP,PLA2G16
1672,GO:0003854,0.0509293068908412,0.998949026785465,1,5,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,HSD3B2
2692,GO:0005605,0.0509818103401381,0.998749575799129,1,21,basal lamina,CC,ANG
14877,GO:0060340,0.0510807570934236,0.998812624207416,1,10,positive regulation of type I interferon-mediated signaling pathway,BP,FADD
10039,GO:0035766,0.0511757438512528,0.998864059090878,1,7,cell chemotaxis to fibroblast growth factor,BP,FGF18
10041,GO:0035768,0.0511757438512528,0.998864059090878,1,7,endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
20265,GO:1904847,0.0511757438512528,0.998864059090878,1,7,regulation of cell chemotaxis to fibroblast growth factor,BP,FGF18
21292,GO:2000544,0.0511757438512528,0.998864059090878,1,7,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGF18
1988,GO:0004448,0.0511862003496336,0.998938283515531,1,5,isocitrate dehydrogenase activity,MF,IDH1
3366,GO:0006664,0.0512144093497202,0.990181409045715,3,111,glycolipid metabolic process,BP,DPM3;HEXB;GLA
9780,GO:0035337,0.0513775732373743,0.994246274655711,2,48,fatty-acyl-CoA metabolic process,BP,ACSF2;ELOVL6
19634,GO:1903509,0.0515392146191772,0.990092912497991,3,112,liposaccharide metabolic process,BP,DPM3;HEXB;GLA
2658,GO:0005543,0.0516664244981455,0.98421565143506,5,353,phospholipid binding,MF,APOC1;ABCG1;PXK;SNX21;RPH3AL
4057,GO:0008289,0.0517733373423062,0.978908201696688,8,631,lipid binding,MF,APOC1;ABCG1;PXK;RBP4;FABP3;STAR;SNX21;RPH3AL
10372,GO:0036462,0.0519127962139177,0.99883075980617,1,7,TRAIL-activated apoptotic signaling pathway,BP,FADD
10660,GO:0042116,0.051927521873782,0.994125547463113,2,56,macrophage activation,BP,TICAM1;SHPK
10789,GO:0042364,0.0520948847805317,0.998779539128175,1,9,water-soluble vitamin biosynthetic process,BP,RGN
8688,GO:0032722,0.0520957235620396,0.994114099244237,2,50,positive regulation of chemokine production,BP,PYCARD;TICAM1
4396,GO:0009120,0.0523892736650055,0.998841558837116,1,6,deoxyribonucleoside metabolic process,BP,DERA
8490,GO:0032430,0.0524377741507442,0.998885144131328,1,5,positive regulation of phospholipase A2 activity,BP,ANG
17162,GO:0072678,0.0526869504851825,0.994048008292604,2,41,T cell migration,BP,FADD;PYCARD
19352,GO:1902916,0.0527253932435245,0.998768741150675,1,8,positive regulation of protein polyubiquitination,BP,NMI
3387,GO:0006689,0.0528763234777581,0.99881968532143,1,6,ganglioside catabolic process,BP,HEXB
21635,GO:2001233,0.0531387265757186,0.981527801376427,6,362,regulation of apoptotic signaling pathway,BP,FADD;TRADD;PYCARD;G0S2;NOL3;DEPTOR
11698,GO:0044262,0.0532226790538559,0.986258875695128,4,234,cellular carbohydrate metabolic process,BP,PDK4;RGN;IDUA;IDH1
6079,GO:0016725,0.0532513343710799,0.9987084955747,1,10,oxidoreductase activity, acting on CH or CH2 groups,MF,AOX1
11186,GO:0043092,0.053350064688989,0.998656462110538,1,15,L-amino acid import,BP,SLC1A3
3018,GO:0006152,0.0537141866632543,0.99878156751673,1,6,purine nucleoside catabolic process,BP,PNP
12539,GO:0046130,0.0537141866632543,0.99878156751673,1,6,purine ribonucleoside catabolic process,BP,PNP
19008,GO:1902041,0.0537639735080092,0.993800327430304,2,56,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD;TRADD
3409,GO:0006721,0.0537752794078781,0.989496091773493,3,106,terpenoid metabolic process,BP,PECR;RBP4;STAR
9412,GO:0034379,0.0538282199731379,0.998716139859367,1,8,very-low-density lipoprotein particle assembly,BP,APOC1
3437,GO:0006771,0.0539495299909674,0.998736186915179,1,7,riboflavin metabolic process,BP,ACP5
3295,GO:0006573,0.053964680508788,0.998689407793288,1,9,valine metabolic process,BP,GHR
3487,GO:0006853,0.0540001478768605,0.998658344364839,1,11,carnitine shuttle,BP,CPT2
12588,GO:0046322,0.0540507324159296,0.998705390501772,1,8,negative regulation of fatty acid oxidation,BP,ACADVL
9285,GO:0034127,0.0541447074606623,0.998700836912781,1,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,TICAM1
978,GO:0002281,0.054324934392631,0.998671665486843,1,9,macrophage activation involved in immune response,BP,TICAM1
7888,GO:0031330,0.0544654845767666,0.989263809337127,3,141,negative regulation of cellular catabolic process,BP,APOC1;TBC1D14;RGN
16725,GO:0071872,0.0546690419060929,0.998603757022777,1,13,cellular response to epinephrine stimulus,BP,STAR
13796,GO:0051001,0.0547855591650523,0.998696279157899,1,7,negative regulation of nitric-oxide synthase activity,BP,GLA
3772,GO:0007341,0.0549447029446276,0.998724463564172,1,6,penetration of zona pellucida,BP,HEXB
12589,GO:0046323,0.0554645046636817,0.993453382918757,2,74,glucose import,BP,RNASEL;HNF1A
2943,GO:0006027,0.0554859054461395,0.993478559074656,2,60,glycosaminoglycan catabolic process,BP,IDUA;HEXB
13860,GO:0051092,0.0554998712654846,0.988986608144883,3,132,positive regulation of NF-kappaB transcription factor activity,BP,TRADD;PYCARD;TICAM1
17453,GO:0090199,0.0556233940609599,0.993514824087674,2,43,regulation of release of cytochrome c from mitochondria,BP,PYCARD;NOL3
3933,GO:0008092,0.0556873337549237,0.976954976196103,8,823,cytoskeletal protein binding,MF,PYCARD;PXK;ANG;FAM110C;FABP3;RPH3AL;S100B;TMOD4
1908,GO:0004321,0.0557532484475158,0.998686213645309,1,6,fatty-acyl-CoA synthase activity,MF,ACSM5
21475,GO:2000811,0.0558988296830769,0.998517150062785,1,16,negative regulation of anoikis,BP,PDK4
12644,GO:0046456,0.0560662877931426,0.993434479075925,2,43,icosanoid biosynthetic process,BP,MGST2;FADS1
18838,GO:1901570,0.0560662877931426,0.993434479075925,2,43,fatty acid derivative biosynthetic process,BP,MGST2;FADS1
10999,GO:0042726,0.056188358970191,0.998599790087224,1,8,flavin-containing compound metabolic process,BP,ACP5
8999,GO:0033209,0.056465602504419,0.98519684052728,4,162,tumor necrosis factor-mediated signaling pathway,BP,TRADD;PYCARD;PSMB10;NOL3
7457,GO:0030497,0.0567518167433254,0.998571249984442,1,8,fatty acid elongation,BP,ELOVL6
9732,GO:0035251,0.0567657026818088,0.998548247545667,1,9,UDP-glucosyltransferase activity,MF,ALG5
21671,GO:2001275,0.0573188270618492,0.998454617599584,1,14,positive regulation of glucose import in response to insulin stimulus,BP,RNASEL
10342,GO:0036376,0.0573818661911132,0.99853898817949,1,8,sodium ion export from cell,BP,FXYD1
3388,GO:0006690,0.0575607558421314,0.988456076339487,3,101,icosanoid metabolic process,BP,MGST2;FADS1;PON2
18836,GO:1901568,0.0575607558421314,0.988456076339487,3,101,fatty acid derivative metabolic process,BP,MGST2;FADS1;PON2
7633,GO:0030868,0.0576536314358506,0.998554548614134,1,7,smooth endoplasmic reticulum membrane,CC,HSD3B2
17909,GO:0097425,0.0576536314358506,0.998554548614134,1,7,smooth endoplasmic reticulum part,CC,HSD3B2
14024,GO:0051342,0.0578394330086944,0.998515327443875,1,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,RGN
16475,GO:0071436,0.0579559664188134,0.998467443823288,1,10,sodium ion export,BP,FXYD1
6122,GO:0016798,0.0581508622295026,0.988268727282712,3,113,hydrolase activity, acting on glycosyl bonds,MF,IDUA;HEXB;GLA
11192,GO:0043102,0.0582401485873757,0.998524643346634,1,7,amino acid salvage,BP,MRI1
16365,GO:0071267,0.0582401485873757,0.998524643346634,1,7,L-methionine salvage,BP,MRI1
16153,GO:0070851,0.0582700397151083,0.988211684642249,3,130,growth factor receptor binding,MF,PYCARD;FGF18;LINGO1
14782,GO:0060205,0.0582707386239291,0.979297356626863,6,329,cytoplasmic vesicle lumen,CC,PNP;PYCARD;HEXB;IDH1;GLA;DERA
14674,GO:0060044,0.0583476513693717,0.998446424555012,1,10,negative regulation of cardiac muscle cell proliferation,BP,RBP4
1749,GO:0003988,0.058364298235408,0.998558741449271,1,6,acetyl-CoA C-acyltransferase activity,MF,ACAT1
5643,GO:0015850,0.0585752773671313,0.984415571311986,4,212,organic hydroxy compound transport,BP,APOC1;ABCG1;RBP4;STAR
2994,GO:0006105,0.0587474724799553,0.998424817663176,1,10,succinate metabolic process,BP,GHR
8215,GO:0031983,0.0589577824812945,0.978992523765069,6,330,vesicle lumen,CC,PNP;PYCARD;HEXB;IDH1;GLA;DERA
11023,GO:0042759,0.0595500601140293,0.998380983925403,1,10,long-chain fatty acid biosynthetic process,BP,ELOVL6
6070,GO:0016713,0.0597126677543962,0.998448180933411,1,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,CYP11A1
8719,GO:0032768,0.0600167436158361,0.992645449404144,2,56,regulation of monooxygenase activity,BP,GLA;PTS
13032,GO:0047760,0.0601353361487044,0.998425867913433,1,7,butyrate-CoA ligase activity,MF,ACSM5
4360,GO:0009066,0.0603340890662665,0.992599331076545,2,52,aspartate family amino acid metabolic process,BP,MSRA;MRI1
18662,GO:1901033,0.0607729017987893,0.998359014472505,1,8,positive regulation of response to reactive oxygen species,BP,RGN
6683,GO:0019748,0.0608720204616229,0.992496482413419,2,52,secondary metabolic process,BP,BDH2;STAR
10684,GO:0042159,0.0608777895644314,0.998327626814934,1,9,lipoprotein catabolic process,BP,LYPLAL1
9721,GO:0035235,0.060895815558201,0.998192619341388,1,26,ionotropic glutamate receptor signaling pathway,BP,GRIA3
5689,GO:0015925,0.0610181977573866,0.998345580667961,1,8,galactosidase activity,MF,GLA
7203,GO:0030041,0.0613016820467071,0.987324957622605,3,146,actin filament polymerization,BP,PYCARD;ANG;TMOD4
15711,GO:0070064,0.0615065104930477,0.998187905827387,1,18,proline-rich region binding,MF,GHR
3457,GO:0006805,0.0617436124581716,0.987258869406185,3,103,xenobiotic metabolic process,BP,MGST2;CMBL;STAR
480,GO:0001501,0.061745384489973,0.977699375731395,6,473,skeletal system development,BP,EBP;EXTL1;RGN;FGF18;RBP4;HEXB
1154,GO:0002583,0.0618099089231436,0.998381264579609,1,6,regulation of antigen processing and presentation of peptide antigen,BP,PYCARD
20668,GO:1990001,0.0619070201867188,0.998248696648562,1,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,NOL3
4761,GO:0010243,0.0622083509803798,0.972198550124862,9,792,response to organonitrogen compound,BP,PDK4;FADD;MGST2;GHR;NNMT;RNASEL;FABP3;CASP4;STAR
7301,GO:0030203,0.062640525764607,0.986922554737356,3,159,glycosaminoglycan metabolic process,BP,EXTL1;IDUA;HEXB
2942,GO:0006026,0.0626671850573302,0.992112196800942,2,63,aminoglycan catabolic process,BP,IDUA;HEXB
6768,GO:0019915,0.0627533332217225,0.992098163640845,2,62,lipid storage,BP,ABCG1;HEXB
8214,GO:0031982,0.062763562954515,0.958441595638972,37,4076,vesicle,CC,CFB;EBP;ZFYVE21;MSRA;SLC31A2;APOC1;TBC1D14;PNP;ABCG1;BDH2;PYCARD;KRT10;TICAM1;ETFB;RBP4;ANG;ACAT1;IDUA;AOX1;HEXB;CMBL;FABP3;GRIA3;PCBD1;MDH1;IDH1;DECR1;MDP1;SNX21;PEPD;ACP5;GLA;ECI1;RPH3AL;DERA;CYB5A;LYPLAL1
17866,GO:0097340,0.0628035935523716,0.99817912517893,1,11,inhibition of cysteine-type endopeptidase activity,BP,NOL3
17867,GO:0097341,0.0628035935523716,0.99817912517893,1,11,zymogen inhibition,BP,NOL3
3996,GO:0008194,0.0629962784187449,0.986845621497929,3,133,UDP-glycosyltransferase activity,MF,ALG5;EXTL1;HEXB
11184,GO:0043090,0.0631341447391983,0.998096054142774,1,17,amino acid import,BP,SLC1A3
4623,GO:0009719,0.0631886798233152,0.965716425749647,15,1551,response to endogenous stimulus,BP,PDK4;FADD;ABCG1;MGST2;GHR;FGF18;NNMT;RNASEL;ANG;ACAT1;FABP3;CASP4;IDH1;STAR;S100B
18874,GO:1901652,0.0632713078551182,0.977018314088577,6,442,response to peptide,BP,PDK4;GHR;RNASEL;FABP3;CASP4;STAR
11025,GO:0042761,0.0635091407973766,0.998178061611549,1,9,very long-chain fatty acid biosynthetic process,BP,ELOVL6
14443,GO:0052548,0.0635481788960168,0.976921865078606,6,358,regulation of endopeptidase activity,BP,FADD;TRADD;PYCARD;NOL3;IFI27;TFPI
3367,GO:0006665,0.0635671113899139,0.986676747652019,3,134,sphingolipid metabolic process,BP,ASAH2;HEXB;GLA
6076,GO:0016722,0.063922380186091,0.998063577579308,1,15,oxidoreductase activity, oxidizing metal ions,MF,ETFDH
12679,GO:0046503,0.0639281962846484,0.991894081214243,2,54,glycerolipid catabolic process,BP,APOC1;FABP3
12139,GO:0045333,0.0640866513056231,0.982488687319009,4,165,cellular respiration,BP,ETFB;MDH1;IDH1;ETFDH
18903,GO:1901698,0.0640967219675139,0.969862053878974,10,900,response to nitrogen compound,BP,PDK4;FADD;MGST2;GHR;TICAM1;NNMT;RNASEL;FABP3;CASP4;STAR
4606,GO:0009635,0.0642246508643497,0.998201551658779,1,7,response to herbicide,BP,STAR
9454,GO:0034447,0.0644108919955885,0.998240288285576,1,6,very-low-density lipoprotein particle clearance,BP,APOC1
16157,GO:0070857,0.0644376905209943,0.998123715673403,1,9,regulation of bile acid biosynthetic process,BP,STAR
2914,GO:0005984,0.0645735225309185,0.998092616480607,1,10,disaccharide metabolic process,BP,IDUA
3900,GO:0008033,0.064722828680538,0.986377033197075,3,108,tRNA processing,BP,LAGE3;HSD17B10;PUS1
19350,GO:1902914,0.0648490209136826,0.998027791167079,1,13,regulation of protein polyubiquitination,BP,NMI
11718,GO:0044297,0.0648628657006362,0.976286975364594,6,472,cell body,CC,FADD;CYP17A1;ANG;STAR;S100B;SLC1A3
8786,GO:0032868,0.0648748387590324,0.982134118503127,4,244,response to insulin,BP,PDK4;RNASEL;FABP3;STAR
13088,GO:0048039,0.0650871959105014,0.998202641885519,1,6,ubiquinone binding,MF,ETFDH
4394,GO:0009117,0.0652224947742795,0.970612049796416,9,641,nucleotide metabolic process,BP,MRAP;PNP;NNMT;ACAT1;SHPK;NUDT7;MDH1;IDH1;DERA
13571,GO:0050670,0.0653224066862905,0.982007245069671,4,194,regulation of lymphocyte proliferation,BP,FADD;PNP;PYCARD;TICAM1
6596,GO:0019388,0.0653323731908952,0.998138149617809,1,7,galactose catabolic process,BP,GALT
5787,GO:0016139,0.065461480686451,0.998092514200792,1,8,glycoside catabolic process,BP,GLA
21599,GO:2001179,0.0656526871986839,0.998119605854286,1,7,regulation of interleukin-10 secretion,BP,PYCARD
10682,GO:0042157,0.0656842624251501,0.981863382007522,4,207,lipoprotein metabolic process,BP,DPM3;APOC1;ABCG1;LYPLAL1
1804,GO:0004064,0.0658977767041067,0.998156981747272,1,6,arylesterase activity,MF,PON2
5153,GO:0010985,0.0662176429097232,0.998086669227288,1,7,negative regulation of lipoprotein particle clearance,BP,APOC1
2566,GO:0005313,0.0662355397885383,0.997929481592516,1,14,L-glutamate transmembrane transporter activity,MF,SLC1A3
5402,GO:0015172,0.0662355397885383,0.997929481592516,1,14,acidic amino acid transmembrane transporter activity,MF,SLC1A3
17322,GO:0089711,0.0662355397885383,0.997929481592516,1,14,L-glutamate transmembrane transport,BP,SLC1A3
16497,GO:0071466,0.066255544986993,0.985923678049372,3,107,cellular response to xenobiotic stimulus,BP,MGST2;CMBL;STAR
7392,GO:0030324,0.0663418371353533,0.985815976047218,3,169,lung development,BP,FGF18;RBP4;DHCR7
8841,GO:0032944,0.0664483743423249,0.981593291168749,4,195,regulation of mononuclear cell proliferation,BP,FADD;PNP;PYCARD;TICAM1
11510,GO:0043615,0.066521540147493,0.998029408468826,1,8,astrocyte cell migration,BP,HEXB
13536,GO:0050543,0.0666404881157142,0.998114628074061,1,6,icosatetraenoic acid binding,MF,FABP3
3385,GO:0006687,0.0670422571669374,0.991238357231554,2,63,glycosphingolipid metabolic process,BP,HEXB;GLA
13326,GO:0048642,0.0671088798494037,0.997917483537591,1,11,negative regulation of skeletal muscle tissue development,BP,S100B
6071,GO:0016714,0.0671625567977191,0.998030924768945,1,7,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,PCBD1
5075,GO:0010885,0.0671909728280155,0.997880890644992,1,13,regulation of cholesterol storage,BP,ABCG1
7303,GO:0030205,0.067234520016764,0.997878107871495,1,13,dermatan sulfate metabolic process,BP,IDUA
7222,GO:0030091,0.067667145175809,0.998000820152198,1,7,protein repair,BP,MSRA
6805,GO:0020037,0.0677350547158161,0.985449868148175,3,123,heme binding,MF,CYP17A1;CYP11A1;CYB5A
13672,GO:0050804,0.0683792865887881,0.980816368551389,4,292,modulation of synaptic transmission,BP,PXK;STAR;S100B;SLC1A3
3430,GO:0006753,0.0687855020793095,0.968686752166499,9,647,nucleoside phosphate metabolic process,BP,MRAP;PNP;NNMT;ACAT1;SHPK;NUDT7;MDH1;IDH1;DERA
18906,GO:1901701,0.068840955421697,0.967206944687758,10,948,cellular response to oxygen-containing compound,BP,PDK4;PYCARD;RGN;GHR;TICAM1;RNASEL;SHPK;CASP4;TFPI;STAR
18604,GO:1900407,0.0688578762261833,0.99086576102901,2,63,regulation of cellular response to oxidative stress,BP,RGN;NOL3
16363,GO:0071265,0.0689748475032021,0.997879315363765,1,8,L-methionine biosynthetic process,BP,MRI1
6027,GO:0016615,0.0691786993179276,0.997866589032565,1,8,malate dehydrogenase activity,MF,MDH1
18992,GO:1902001,0.0692116795613702,0.997715418572995,1,16,fatty acid transmembrane transport,BP,CPT2
13115,GO:0048156,0.0693447907689609,0.997796263671947,1,10,tau protein binding,MF,S100B
2811,GO:0005811,0.0696336219608895,0.990689678207344,2,68,lipid particle,CC,HSD17B11;G0S2
7391,GO:0030323,0.0696947648278059,0.984794503548642,3,173,respiratory tube development,BP,FGF18;RBP4;DHCR7
10837,GO:0042447,0.0698416553983632,0.997764139182321,1,10,hormone catabolic process,BP,HSD17B11
2997,GO:0006108,0.0698663505317076,0.997823370781139,1,8,malate metabolic process,BP,MDH1
2939,GO:0006022,0.0698882525872735,0.984743173223333,3,164,aminoglycan metabolic process,BP,EXTL1;IDUA;HEXB
10935,GO:0042594,0.0701092736632509,0.984683258627143,3,156,response to starvation,BP,PDK4;FADS1;ACAT1
21545,GO:2001028,0.0704431302143249,0.997667910820163,1,13,positive regulation of endothelial cell chemotaxis,BP,FGF18
12931,GO:0047035,0.0705740351944868,0.997882058254895,1,6,testosterone dehydrogenase (NAD+) activity,MF,HSD17B3
17808,GO:0097202,0.0711140042541273,0.997680787012594,1,10,activation of cysteine-type endopeptidase activity,BP,FADD
13611,GO:0050714,0.071191172476695,0.97980890744175,4,214,positive regulation of protein secretion,BP,PYCARD;RBP4;ANG;RPH3AL
14793,GO:0060228,0.071570648903837,0.997820923058073,1,6,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,APOC1
15750,GO:0070125,0.0715859192682364,0.984372947508198,3,84,mitochondrial translational elongation,BP,MRPL14;MRPL16;TSFM
4334,GO:0008970,0.0716876084257915,0.997642697119807,1,10,phosphatidylcholine 1-acylhydrolase activity,MF,PLA2G16
4971,GO:0010745,0.0719710611611658,0.997564230994383,1,13,negative regulation of macrophage derived foam cell differentiation,BP,ABCG1
17134,GO:0072608,0.0720494787524348,0.997683208535479,1,8,interleukin-10 secretion,BP,PYCARD
2981,GO:0006086,0.0720687007659096,0.997531021098502,1,15,acetyl-CoA biosynthetic process from pyruvate,BP,PDK4
1993,GO:0004457,0.0722218052659053,0.997718443315787,1,7,lactate dehydrogenase activity,MF,LDHD
21535,GO:2001014,0.0722249377240512,0.997509347691783,1,16,regulation of skeletal muscle cell differentiation,BP,S100B
1752,GO:0003993,0.0723259853940969,0.99762890040133,1,9,acid phosphatase activity,MF,ACP5
12352,GO:0045792,0.0724736425883888,0.997566195549655,1,11,negative regulation of cell size,BP,DEPTOR
7681,GO:0030949,0.0726792949876212,0.997488429397116,1,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,FGF18
858,GO:0002063,0.0726914180592995,0.997426664301426,1,23,chondrocyte development,BP,FGF18
6265,GO:0017085,0.0727299730627728,0.997572662695462,1,10,response to insecticide,BP,STAR
16068,GO:0070663,0.0728013788382017,0.979209978894138,4,202,regulation of leukocyte proliferation,BP,FADD;PNP;PYCARD;TICAM1
15988,GO:0070513,0.0729618407418368,0.997586422855876,1,9,death domain binding,MF,TRADD
6762,GO:0019904,0.0730059335504037,0.970089173761011,7,652,protein domain specific binding,MF,FADD;TRADD;EBF1;PYCARD;NOL3;WBP1;RPH3AL
15709,GO:0070062,0.0733644660354747,0.953176318211152,27,2675,extracellular exosome,CC,CFB;MSRA;APOC1;PNP;BDH2;KRT10;ETFB;RBP4;ANG;ACAT1;IDUA;AOX1;HEXB;CMBL;FABP3;PCBD1;MDH1;IDH1;DECR1;MDP1;PEPD;ACP5;GLA;ECI1;DERA;CYB5A;LYPLAL1
10749,GO:0042301,0.0734453768229218,0.997499555116514,1,11,phosphate ion binding,MF,PNP
2645,GO:0005521,0.0734547857685251,0.997433795721937,1,15,lamin binding,MF,IFI27
16347,GO:0071236,0.0735936048239542,0.997423952092186,1,15,cellular response to antibiotic,BP,STAR
19702,GO:1903624,0.0736553964913172,0.997577230756914,1,8,regulation of DNA catabolic process,BP,RGN
17685,GO:0097006,0.0739254462840487,0.989819167705497,2,57,regulation of plasma lipoprotein particle levels,BP,APOC1;ABCG1
5329,GO:0015012,0.0741244189667422,0.997317844554776,1,24,heparan sulfate proteoglycan biosynthetic process,BP,EXTL1
4114,GO:0008385,0.074206459939169,0.997446714249805,1,11,IkappaB kinase complex,CC,PYCARD
16087,GO:0070696,0.0744115038340079,0.997393821171924,1,13,transmembrane receptor protein serine/threonine kinase binding,MF,PYCARD
1150,GO:0002579,0.0745174661615282,0.997480864430134,1,9,positive regulation of antigen processing and presentation,BP,PYCARD
19996,GO:1904251,0.0750519593276645,0.99741285926199,1,10,regulation of bile acid metabolic process,BP,STAR
10772,GO:0042340,0.0750759058512737,0.997364388544832,1,12,keratan sulfate catabolic process,BP,HEXB
16724,GO:0071871,0.0751969997020439,0.997297130950355,1,16,response to epinephrine,BP,STAR
14924,GO:0060397,0.0752511395778336,0.997304919300322,1,15,JAK-STAT cascade involved in growth hormone signaling pathway,BP,GHR
4562,GO:0009410,0.0752562049397895,0.983145165741128,3,113,response to xenobiotic stimulus,BP,MGST2;CMBL;STAR
5675,GO:0015909,0.0755223540754631,0.989452778273698,2,62,long-chain fatty acid transport,BP,CPT2;FABP3
6153,GO:0016846,0.0756169282651764,0.997495450869409,1,7,carbon-sulfur lyase activity,MF,MGST2
3401,GO:0006705,0.0756728146118801,0.997321698220934,1,12,mineralocorticoid biosynthetic process,BP,HSD3B2
4010,GO:0008212,0.0756728146118801,0.997321698220934,1,12,mineralocorticoid metabolic process,BP,HSD3B2
19669,GO:1903561,0.0756988995001726,0.951522898242681,27,2690,extracellular vesicle,CC,CFB;MSRA;APOC1;PNP;BDH2;KRT10;ETFB;RBP4;ANG;ACAT1;IDUA;AOX1;HEXB;CMBL;FABP3;PCBD1;MDH1;IDH1;DECR1;MDP1;PEPD;ACP5;GLA;ECI1;DERA;CYB5A;LYPLAL1
8422,GO:0032354,0.076010187187706,0.997237511180795,1,16,response to follicle-stimulating hormone,BP,STAR
11277,GO:0043230,0.0760668304147254,0.951261760255838,27,2691,extracellular organelle,CC,CFB;MSRA;APOC1;PNP;BDH2;KRT10;ETFB;RBP4;ANG;ACAT1;IDUA;AOX1;HEXB;CMBL;FABP3;PCBD1;MDH1;IDH1;DECR1;MDP1;PEPD;ACP5;GLA;ECI1;DERA;CYB5A;LYPLAL1
17451,GO:0090197,0.076125283771955,0.997310968142825,1,11,positive regulation of chemokine secretion,BP,PYCARD
12917,GO:0046983,0.076170478773246,0.959406037846404,13,1157,protein dimerization activity,MF,ABCG1;PYCARD;GHR;RBP4;ANG;ACAT1;HEXB;ACCS;IDH1;GLA;S100B;PTS;HNF1A
5065,GO:0010875,0.0762171593407533,0.997248034395035,1,14,positive regulation of cholesterol efflux,BP,ABCG1
14022,GO:0051340,0.0765448332147117,0.997380399537139,1,8,regulation of ligase activity,BP,RGN
21614,GO:2001198,0.0765783462988157,0.997337436977267,1,9,regulation of dendritic cell differentiation,BP,TMEM176A
2789,GO:0005776,0.076609438258947,0.989155840458999,2,82,autophagosome,CC,TBC1D14;TICAM1
9365,GO:0034308,0.0766223579666278,0.989252759473277,2,53,primary alcohol metabolic process,BP,PECR;RBP4
8720,GO:0032769,0.0767297108328401,0.997267458431082,1,11,negative regulation of monooxygenase activity,BP,GLA
16110,GO:0070742,0.0767950396008504,0.99719155814288,1,15,C2H2 zinc finger domain binding,MF,EBF1
9691,GO:0035112,0.0768422178806712,0.997218194910115,1,13,genitalia morphogenesis,BP,RBP4
5744,GO:0016052,0.0769523398295023,0.982548815829235,3,146,carbohydrate catabolic process,BP,GALT;HEXB;DERA
4558,GO:0009404,0.0769946529438096,0.997225904659794,1,12,toxin metabolic process,BP,STAR
3427,GO:0006749,0.0773088368215868,0.989145581487936,2,46,glutathione metabolic process,BP,MGST2;IDH1
1900,GO:0004312,0.0773991194694598,0.997218851228226,1,11,fatty acid synthase activity,MF,ELOVL6
2859,GO:0005890,0.077565036739197,0.997206735349128,1,11,sodium:potassium-exchanging ATPase complex,CC,FXYD1
9415,GO:0034382,0.0776548963718277,0.997356445879177,1,7,chylomicron remnant clearance,BP,APOC1
16706,GO:0071830,0.0776548963718277,0.997356445879177,1,7,triglyceride-rich lipoprotein particle clearance,BP,APOC1
972,GO:0002274,0.0777605248921228,0.965569248340053,8,596,myeloid leukocyte activation,BP,PNP;PYCARD;TICAM1;SHPK;HEXB;IDH1;GLA;DERA
14122,GO:0051536,0.0779617478080225,0.988915423239474,2,62,iron-sulfur cluster binding,MF,AOX1;ETFDH
14126,GO:0051540,0.0779617478080225,0.988915423239474,2,62,metal cluster binding,MF,AOX1;ETFDH
8662,GO:0032677,0.0781402385924457,0.988883997290965,2,60,regulation of interleukin-8 production,BP,FADD;PYCARD
12836,GO:0046854,0.0787627514220842,0.988648023917123,2,96,phosphatidylinositol phosphorylation,BP,ZFYVE21;FGF18
18849,GO:1901607,0.0789009960622578,0.98870998505094,2,61,alpha-amino acid biosynthetic process,BP,MRI1;SLC1A3
6052,GO:0016667,0.0792859041872076,0.988657218057171,2,54,oxidoreductase activity, acting on a sulfur group of donors,MF,IFI30;MSRA
1673,GO:0003857,0.0795388907061326,0.99712422850482,1,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,HSD17B10
7270,GO:0030162,0.0797057949445748,0.962647964782804,9,693,regulation of proteolysis,BP,CFB;FADD;TRADD;PYCARD;PSMB10;RGN;NOL3;IFI27;TFPI
11026,GO:0042762,0.0798936311650109,0.996912224503663,1,19,regulation of sulfur metabolic process,BP,PDK4
3535,GO:0006924,0.0799826001172703,0.997027115640307,1,11,activation-induced cell death of T cells,BP,FADD
12867,GO:0046906,0.080142118066764,0.981541557246399,3,132,tetrapyrrole binding,MF,CYP17A1;CYP11A1;CYB5A
5068,GO:0010878,0.0801540258270452,0.996936610164084,1,15,cholesterol storage,BP,ABCG1
19010,GO:1902043,0.0802177363954246,0.996918324774546,1,16,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD
6161,GO:0016861,0.0804606916105357,0.997100983634919,1,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,MRI1
21016,GO:2000121,0.0810666310807246,0.996974476089468,1,10,regulation of removal of superoxide radicals,BP,RGN
8709,GO:0032755,0.0810753666909955,0.988202916258418,2,65,positive regulation of interleukin-6 production,BP,PYCARD;TICAM1
12276,GO:0045651,0.0810949770242142,0.996896716890871,1,13,positive regulation of macrophage differentiation,BP,FADD
11282,GO:0043235,0.0813444393564955,0.975812300769759,4,320,receptor complex,CC,TRADD;GHR;GRIA3;CPT1C
1213,GO:0002693,0.0816034121506969,0.996857069730502,1,13,positive regulation of cellular extravasation,BP,FADD
2759,GO:0005741,0.0817793159632719,0.980974014449578,3,153,mitochondrial outer membrane,CC,CPT1C;IFI27;CYB5A
5057,GO:0010867,0.0818184177390651,0.996886860360015,1,11,positive regulation of triglyceride biosynthetic process,BP,RGN
9747,GO:0035269,0.081826750075387,0.996886216169876,1,11,protein O-linked mannosylation,BP,DPM3
21669,GO:2001273,0.0819193559358983,0.996751193971533,1,19,regulation of glucose import in response to insulin stimulus,BP,RNASEL
3319,GO:0006600,0.0821447857763263,0.996861576756907,1,11,creatine metabolic process,BP,GHR
13744,GO:0050905,0.0821975099572855,0.987862278291022,2,97,neuromuscular process,BP,HEXB;SLC1A3
5302,GO:0014874,0.0823174950720376,0.996766354216223,1,15,response to stimulus involved in regulation of muscle adaptation,BP,NOL3
12629,GO:0046415,0.0823693429194542,0.996844119108476,1,11,urate metabolic process,BP,PNP
8489,GO:0032429,0.0824330756724447,0.996869946312983,1,10,regulation of phospholipase A2 activity,BP,ANG
17450,GO:0090196,0.0824509442474518,0.996812104838099,1,12,regulation of chemokine secretion,BP,PYCARD
19332,GO:1902882,0.0826613969812571,0.987824666042989,2,69,regulation of response to oxidative stress,BP,RGN;NOL3
14442,GO:0052547,0.0830156168214854,0.967744663615221,6,384,regulation of peptidase activity,BP,FADD;TRADD;PYCARD;NOL3;IFI27;TFPI
13557,GO:0050655,0.0831112474554531,0.996688377631892,1,16,dermatan sulfate proteoglycan metabolic process,BP,IDUA
18386,GO:0101002,0.0831325566285268,0.980576697546741,3,124,ficolin-1-rich granule,CC,PNP;IDH1;DERA
20249,GO:1904813,0.0831325566285268,0.980576697546741,3,124,ficolin-1-rich granule lumen,CC,PNP;IDH1;DERA
13996,GO:0051289,0.0835052759416813,0.987629427495578,2,69,protein homotetramerization,BP,PCBD1;DECR1
11108,GO:0042977,0.0836705558499579,0.996741975091141,1,11,activation of JAK2 kinase activity,BP,GHR
9746,GO:0035268,0.0839321118326193,0.996621588986257,1,16,protein mannosylation,BP,DPM3
5589,GO:0015748,0.0843345562027426,0.987396884454797,2,82,organophosphate ester transport,BP,APOC1;ABCG1
2460,GO:0005126,0.0845138008056616,0.970418861022423,5,260,cytokine receptor binding,MF,FADD;TRADD;PYCARD;NOL3;CNIH4
5094,GO:0010906,0.0846260561778128,0.987312009935615,2,89,regulation of glucose metabolic process,BP,PDK4;RGN
10234,GO:0036109,0.084638886547979,0.996614959609583,1,13,alpha-linolenic acid metabolic process,BP,FADS1
16429,GO:0071371,0.084790868444784,0.996526145602462,1,18,cellular response to gonadotropin stimulus,BP,STAR
12602,GO:0046339,0.0850213694613942,0.996546887163579,1,15,diacylglycerol metabolic process,BP,ANG
8694,GO:0032729,0.0856968444103191,0.987141293297535,2,63,positive regulation of interferon-gamma production,BP,FADD;PYCARD
4375,GO:0009086,0.0857016759961661,0.996551447933639,1,12,methionine biosynthetic process,BP,MRI1
17449,GO:0090195,0.0857516008263614,0.996523884789438,1,13,chemokine secretion,BP,PYCARD
12774,GO:0046686,0.0857716015175869,0.987164625720573,2,55,response to cadmium ion,BP,STAR;CYB5A
691,GO:0001836,0.086074785905356,0.987099420243174,2,54,release of cytochrome c from mitochondria,BP,PYCARD;NOL3
8409,GO:0032332,0.0865396938214828,0.996368095685716,1,19,positive regulation of chondrocyte differentiation,BP,FGF18
9037,GO:0033293,0.0865687219273635,0.986977071806635,2,55,monocarboxylic acid binding,MF,APOC1;FABP3
7485,GO:0030540,0.0870379371525397,0.996348796223301,1,17,female genitalia development,BP,RBP4
8639,GO:0032642,0.0878044885276982,0.986628673647896,2,66,regulation of chemokine production,BP,PYCARD;TICAM1
11150,GO:0043025,0.0882298964399275,0.968638586404598,5,412,neuronal cell body,CC,CYP17A1;ANG;STAR;S100B;SLC1A3
4607,GO:0009636,0.0886964513685402,0.972925533067405,4,214,response to toxic substance,BP,MGST2;RGN;PON2;STAR
4381,GO:0009100,0.0888557614993765,0.968357697087073,5,396,glycoprotein metabolic process,BP,ALG5;DPM3;EXTL1;IDUA;HEXB
12011,GO:0045080,0.08896660835131,0.996344746641302,1,10,positive regulation of chemokine biosynthetic process,BP,TICAM1
10933,GO:0042592,0.0890460590374109,0.949219133954051,15,1571,homeostatic process,BP,PDK4;SLC31A2;FADD;ABCG1;BDH2;ACADVL;RGN;RBP4;ANG;HEXB;FABP3;NOL3;STAR;RPH3AL;HNF1A
13669,GO:0050801,0.0890820017982066,0.959373198338012,8,698,ion homeostasis,BP,PDK4;SLC31A2;ABCG1;BDH2;RGN;HEXB;FABP3;NOL3
3971,GO:0008154,0.0892985075340653,0.978425394146219,3,174,actin polymerization or depolymerization,BP,PYCARD;ANG;TMOD4
2933,GO:0006012,0.0893012358332349,0.996250455254993,1,12,galactose metabolic process,BP,GALT
3503,GO:0006878,0.0894372310960423,0.996213285021795,1,13,cellular copper ion homeostasis,BP,SLC31A2
7546,GO:0030677,0.0895219517358492,0.996298161293078,1,10,ribonuclease P complex,CC,HSD17B10
8635,GO:0032637,0.0896794854502099,0.986177917562864,2,66,interleukin-8 production,BP,FADD;PYCARD
11838,GO:0044548,0.0897113442951922,0.996189635218065,1,13,S100 protein binding,MF,S100B
11530,GO:0043650,0.0897126492983439,0.996167501476095,1,14,dicarboxylic acid biosynthetic process,BP,SLC1A3
12825,GO:0046834,0.0897181827486084,0.986057513392742,2,108,lipid phosphorylation,BP,ZFYVE21;FGF18
11107,GO:0042976,0.0897749142792205,0.996184139675044,1,13,activation of Janus kinase activity,BP,GHR
11014,GO:0042747,0.0898087888311067,0.996318695759284,1,9,circadian sleep/wake cycle, REM sleep,BP,STAR
7311,GO:0030214,0.0899158438434817,0.996149820880214,1,14,hyaluronan catabolic process,BP,HEXB
11774,GO:0044381,0.0901445262841905,0.996033615042868,1,21,glucose import in response to insulin stimulus,BP,RNASEL
3472,GO:0006825,0.0908734367926031,0.996000699529089,1,18,copper ion transport,BP,SLC31A2
15922,GO:0070402,0.0908739599957596,0.996088480411447,1,13,NADPH binding,MF,DECR1
5445,GO:0015245,0.0909671691092659,0.99608031123109,1,13,fatty acid transporter activity,MF,FABP3
4273,GO:0008656,0.0910407527051497,0.996031528357304,1,15,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,PYCARD
3159,GO:0006400,0.0913897648740399,0.985780826620482,2,62,tRNA modification,BP,HSD17B10;PUS1
2086,GO:0004576,0.0914652446370922,0.99613274045639,1,10,oligosaccharyl transferase activity,MF,ALG5
5699,GO:0015937,0.0915678089239513,0.99612390567307,1,10,coenzyme A biosynthetic process,BP,ACAT1
16946,GO:0072234,0.0918798208186848,0.995886747352539,1,20,metanephric nephron tubule development,BP,ACAT1
15030,GO:0060541,0.0921314693742358,0.977427564871892,3,194,respiratory system development,BP,FGF18;RBP4;DHCR7
14693,GO:0060065,0.0923418844229355,0.995844549456302,1,20,uterus development,BP,RBP4
21179,GO:2000377,0.0923815752940703,0.977396217087549,3,150,regulation of reactive oxygen species metabolic process,BP,RGN;TICAM1;GLA
1284,GO:0002793,0.0924184192289101,0.971373968678271,4,232,positive regulation of peptide secretion,BP,PYCARD;RBP4;ANG;RPH3AL
14173,GO:0051607,0.0925861694807102,0.971305318134871,4,231,defense response to virus,BP,FADD;PYCARD;TICAM1;RNASEL
7283,GO:0030176,0.0926427920259405,0.977328933000321,3,137,integral component of endoplasmic reticulum membrane,CC,DPM3;DHCR7;ELOVL6
4569,GO:0009437,0.0927544034617691,0.995921963889514,1,13,carnitine metabolic process,BP,CPT1C
3999,GO:0008199,0.0931084257208694,0.995989940734266,1,10,ferric iron binding,MF,ACP5
12691,GO:0046527,0.0931561309992548,0.995823606520852,1,16,glucosyltransferase activity,MF,ALG5
8436,GO:0032372,0.0932302209939512,0.995907019015749,1,12,negative regulation of sterol transport,BP,APOC1
8439,GO:0032375,0.0932302209939512,0.995907019015749,1,12,negative regulation of cholesterol transport,BP,APOC1
13165,GO:0048261,0.0933362397774444,0.99579121669079,1,17,negative regulation of receptor-mediated endocytosis,BP,APOC1
12372,GO:0045833,0.0933455999310715,0.985258823624204,2,71,negative regulation of lipid metabolic process,BP,APOC1;ACADVL
13241,GO:0048477,0.0935023348350123,0.985215982990732,2,72,oogenesis,BP,ANG;HEXB
5310,GO:0014889,0.0935861736817704,0.995847161686928,1,13,muscle atrophy,BP,NOL3
4535,GO:0009313,0.0940962530258283,0.995800940971396,1,13,oligosaccharide catabolic process,BP,HEXB
14575,GO:0055022,0.0941764814273673,0.995748348429259,1,15,negative regulation of cardiac muscle tissue growth,BP,RBP4
15378,GO:0061117,0.0941764814273673,0.995748348429259,1,15,negative regulation of heart growth,BP,RBP4
16003,GO:0070542,0.0943267550282006,0.984988888317814,2,78,response to fatty acid,BP,PDK4;FABP3
3557,GO:0006957,0.094621157044332,0.995728598965357,1,14,complement activation, alternative pathway,BP,CFB
14269,GO:0051798,0.0949095072619085,0.995789488204095,1,11,positive regulation of hair follicle development,BP,TRADD
17616,GO:0090533,0.095136450326929,0.995659633371257,1,15,cation-transporting ATPase complex,CC,FXYD1
10956,GO:0042632,0.0953625822650469,0.984767946843709,2,68,cholesterol homeostasis,BP,ABCG1;FABP3
14611,GO:0055092,0.0953625822650469,0.984767946843709,2,68,sterol homeostasis,BP,ABCG1;FABP3
1885,GO:0004197,0.0955251008360061,0.984681392329178,2,80,cysteine-type endopeptidase activity,MF,PYCARD;CASP4
18689,GO:1901135,0.0959703373800872,0.946916624817404,13,1210,carbohydrate derivative metabolic process,BP,ALG5;DPM3;MRAP;EXTL1;PNP;GALT;ACAT1;IDUA;SHPK;HEXB;NUDT7;GLA;DERA
3364,GO:0006662,0.0963666514942343,0.995656725109013,1,11,glycerol ether metabolic process,BP,PLA2G16
5063,GO:0010873,0.0966347281257746,0.995726206070668,1,9,positive regulation of cholesterol esterification,BP,APOC1
10959,GO:0042635,0.09663744271194,0.9955965464861,1,12,positive regulation of hair cycle,BP,TRADD
4354,GO:0009060,0.0968080739330112,0.984427983164996,2,63,aerobic respiration,BP,MDH1;IDH1
19125,GO:1902307,0.0972472599000144,0.995408928264456,1,18,positive regulation of sodium ion transmembrane transport,BP,FXYD1
3488,GO:0006855,0.0972480354496371,0.995361348526614,1,22,drug transmembrane transport,BP,EBP
18780,GO:1901360,0.0974226077315493,0.930891823633719,48,5915,organic cyclic compound metabolic process,BP,EBP;FADD;HSD17B3;MRAP;APOC1;TRADD;HSD17B11;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;ACADVL;PSMB10;RGN;FADS1;GHR;TICAM1;ARL6IP4;NNMT;HSD17B10;GALT;CYP17A1;RNASEL;ANG;NMI;ACAT1;TSFM;AOX1;SHPK;HEXB;NOL3;HSD3B2;NUDT7;PCBD1;MDH1;IFI27;IDH1;PUS1;PTMS;STAR;ACP5;CYP11A1;DERA;DHCR7;PTS;HNF1A
7354,GO:0030277,0.0976041411726236,0.99539003162922,1,17,maintenance of gastrointestinal epithelium,BP,RBP4
528,GO:0001573,0.09765665800729,0.995422205769846,1,15,ganglioside metabolic process,BP,HEXB
7820,GO:0031227,0.0977117662573422,0.975538254756218,3,142,intrinsic component of endoplasmic reticulum membrane,CC,DPM3;DHCR7;ELOVL6
6293,GO:0017137,0.097754808395605,0.984013883331783,2,129,Rab GTPase binding,MF,TBC1D14;RPH3AL
14883,GO:0060347,0.0979992505838217,0.995412195846047,1,14,heart trabecula formation,BP,RBP4
5622,GO:0015813,0.0981028280795127,0.995268470711083,1,23,L-glutamate transport,BP,SLC1A3
12660,GO:0046475,0.0984168835979017,0.995311485374887,1,17,glycerophospholipid catabolic process,BP,APOC1
973,GO:0002275,0.0985080573822797,0.956777245398306,7,524,myeloid cell activation involved in immune response,BP,PNP;PYCARD;TICAM1;HEXB;IDH1;GLA;DERA
5693,GO:0015929,0.0986458613831553,0.995376927413364,1,13,hexosaminidase activity,MF,HEXB
5610,GO:0015800,0.0989659748865615,0.995166350881808,1,25,acidic amino acid transport,BP,SLC1A3
6168,GO:0016874,0.0992404272251651,0.974945899649226,3,170,ligase activity,MF,ACSF2;ACSM5;ACAT1
8787,GO:0032869,0.0992899829195918,0.974902029815124,3,191,cellular response to insulin stimulus,BP,PDK4;RNASEL;STAR
16433,GO:0071375,0.0996242156634923,0.968288427087874,4,293,cellular response to peptide hormone stimulus,BP,PDK4;GHR;RNASEL;STAR
14923,GO:0060396,0.0996875517717084,0.995121223885009,1,22,growth hormone receptor signaling pathway,BP,GHR
7299,GO:0030201,0.100089212180913,0.995020743505674,1,30,heparan sulfate proteoglycan metabolic process,BP,EXTL1
6115,GO:0016787,0.100235468420652,0.93688967688347,21,2385,hydrolase activity,MF,CFB;ABCG1;PYCARD;PSMB10;RGN;ASAH2;PLA2G16;RNASEL;ANG;IDUA;HEXB;CMBL;NUDT6;NUDT7;CASP4;PON2;MDP1;PEPD;ACP5;GLA;LYPLAL1
3281,GO:0006558,0.100843157747164,0.995281582327144,1,10,L-phenylalanine metabolic process,BP,PCBD1
3282,GO:0006559,0.100843157747164,0.995281582327144,1,10,L-phenylalanine catabolic process,BP,PCBD1
19076,GO:1902221,0.100843157747164,0.995281582327144,1,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,PCBD1
19077,GO:1902222,0.100843157747164,0.995281582327144,1,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,PCBD1
13596,GO:0050699,0.101125850438996,0.994987707161954,1,21,WW domain binding,MF,WBP1
18606,GO:1900409,0.10113833678302,0.995107647283168,1,14,positive regulation of cellular response to oxidative stress,BP,RGN
6085,GO:0016740,0.101170928169411,0.937605006628393,19,2269,transferase activity,MF,PDK4;ALG5;DPM3;ZFYVE21;EXTL1;PNP;MGST2;ACSM5;FGF18;NNMT;CPT2;PLA2G16;GALT;RNASEL;ACAT1;SHPK;HEXB;CPT1C;ELOVL6
143,GO:0000287,0.101205761603371,0.974212152288856,3,190,magnesium ion binding,MF,HACL1;NUDT7;IDH1
21062,GO:2000209,0.10127568108502,0.994951443952911,1,23,regulation of anoikis,BP,PDK4
3223,GO:0006487,0.10143168599053,0.983219643784988,2,67,protein N-linked glycosylation,BP,ALG5;DPM3
6055,GO:0016671,0.101884638687597,0.995134538523375,1,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,MSRA
12733,GO:0046621,0.101887143864775,0.994889120405023,1,23,negative regulation of organ growth,BP,RBP4
16952,GO:0072243,0.102451402461739,0.994831255756198,1,23,metanephric nephron epithelium development,BP,ACAT1
18879,GO:1901657,0.102629663893493,0.973774014343028,3,140,glycosyl compound metabolic process,BP,PNP;GLA;DERA
4235,GO:0008585,0.102677699604284,0.982802936776275,2,91,female gonad development,BP,ANG;IDH1
3526,GO:0006907,0.103247224814252,0.994813094905835,1,18,pinocytosis,BP,PYCARD
10201,GO:0036041,0.103389085819951,0.995035304784905,1,10,long-chain fatty acid binding,MF,FABP3
8559,GO:0032515,0.103685169532546,0.994827580301202,1,15,negative regulation of phosphoprotein phosphatase activity,BP,RGN
15855,GO:0070293,0.104035925614783,0.994791820700831,1,15,renal absorption,BP,HNF1A
3375,GO:0006677,0.104427916810671,0.994777568660211,1,14,glycosylceramide metabolic process,BP,GLA
4257,GO:0008625,0.104830775291865,0.982270837288783,2,79,extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD;TRADD
16895,GO:0072170,0.104841638131822,0.994593180158126,1,22,metanephric tubule development,BP,ACAT1
11404,GO:0043434,0.105010970829,0.960726078126978,5,396,response to peptide hormone,BP,PDK4;GHR;RNASEL;FABP3;STAR
16450,GO:0071396,0.10503151931004,0.9565573167019,6,522,cellular response to lipid,BP,PDK4;PYCARD;TICAM1;SHPK;TFPI;STAR
1754,GO:0003995,0.105119852590611,0.994657579880734,1,16,acyl-CoA dehydrogenase activity,MF,ACADVL
20362,GO:1905039,0.105339066188816,0.98206918980462,2,101,carboxylic acid transmembrane transport,BP,CPT2;SLC1A3
1379,GO:0003006,0.105417971275142,0.952964172232207,7,607,developmental process involved in reproduction,BP,HSD17B3;RBP4;CYP17A1;ANG;HEXB;IDH1;STAR
21543,GO:2001026,0.10547764275678,0.994565774364023,1,19,regulation of endothelial cell chemotaxis,BP,FGF18
4702,GO:0009982,0.105595304826007,0.994688260881538,1,13,pseudouridine synthase activity,MF,PUS1
8728,GO:0032780,0.106545711115679,0.994669376254223,1,11,negative regulation of ATPase activity,BP,RGN
5078,GO:0010888,0.106865398672533,0.994454071235651,1,17,negative regulation of lipid storage,BP,ABCG1
5986,GO:0016556,0.106951463786183,0.99458461446078,1,12,mRNA modification,BP,PUS1
8437,GO:0032373,0.107094011901448,0.994394492320851,1,19,positive regulation of sterol transport,BP,ABCG1
8440,GO:0032376,0.107094011901448,0.994394492320851,1,19,positive regulation of cholesterol transport,BP,ABCG1
1892,GO:0004303,0.107788727839296,0.994594302716381,1,10,estradiol 17-beta-dehydrogenase activity,MF,HSD17B11
5056,GO:0010866,0.107811180645888,0.994374692402691,1,16,regulation of triglyceride biosynthetic process,BP,RGN
8763,GO:0032816,0.107975382703054,0.994357186887132,1,16,positive regulation of natural killer cell activation,BP,TICAM1
16411,GO:0071346,0.108080356516575,0.971778164485982,3,136,cellular response to interferon-gamma,BP,IFI30;NMI;STAR
14773,GO:0060191,0.108217107013724,0.9813589995512,2,79,regulation of lipase activity,BP,APOC1;ANG
9408,GO:0034374,0.108671704557072,0.994405224912507,1,12,low-density lipoprotein particle remodeling,BP,ABCG1
163,GO:0000315,0.108804645327144,0.981394648763903,2,49,organellar large ribosomal subunit,CC,MRPL14;MRPL16
2776,GO:0005762,0.108804645327144,0.981394648763903,2,49,mitochondrial large ribosomal subunit,CC,MRPL14;MRPL16
8611,GO:0032602,0.108849206112258,0.98121301271868,2,73,chemokine production,BP,PYCARD;TICAM1
15753,GO:0070129,0.108862236804207,0.994347295294797,1,13,regulation of mitochondrial translation,BP,TSFM
16046,GO:0070613,0.109016554620988,0.981129492332217,2,82,regulation of protein processing,BP,CFB;NOL3
19334,GO:1902884,0.10958794022096,0.994208683424591,1,15,positive regulation of response to oxidative stress,BP,RGN
8644,GO:0032647,0.109698654864581,0.994082655114154,1,21,regulation of interferon-alpha production,BP,NMI
2780,GO:0005766,0.109901566162437,0.971064059207124,3,151,primary lysosome,CC,PYCARD;HEXB;GLA
10924,GO:0042582,0.109901566162437,0.971064059207124,3,151,azurophil granule,CC,PYCARD;HEXB;GLA
12783,GO:0046700,0.110188672610505,0.953898178002904,6,406,heterocycle catabolic process,BP,PNP;RGN;GALT;AOX1;NUDT7;DERA
7904,GO:0031347,0.1108717414887,0.946973072821289,8,661,regulation of defense response,BP,CFB;FADD;PYCARD;PSMB10;TICAM1;NMI;SHPK;CASP4
19547,GO:1903317,0.11118611996617,0.980529221575413,2,83,regulation of protein maturation,BP,CFB;NOL3
10708,GO:0042221,0.111243116188713,0.922438833070065,36,4006,response to chemical,BP,EBP;PDK4;IFI30;FADD;TRADD;PNP;ABCG1;PYCARD;ACADVL;MGST2;PSMB10;RGN;GHR;FGF18;TICAM1;NNMT;RBP4;RNASEL;ANG;NMI;ACAT1;SHPK;CMBL;FABP3;NOL3;CASP4;IFI27;PON2;IDH1;TFPI;STAR;RPH3AL;S100B;CYB5A;DOK1;SLC1A3
1643,GO:0003746,0.111263968415693,0.994026303690344,1,15,translation elongation factor activity,MF,TSFM
5444,GO:0015238,0.111591860747553,0.993886976872075,1,20,drug transmembrane transporter activity,MF,EBP
13977,GO:0051259,0.111730675183139,0.953042174697678,6,478,protein oligomerization,BP,TRADD;HACL1;ACAT1;NOL3;PCBD1;DECR1
3299,GO:0006577,0.111905112594626,0.993906852772537,1,17,amino-acid betaine metabolic process,BP,CPT1C
14592,GO:0055070,0.112068552864842,0.993911643225681,1,16,copper ion homeostasis,BP,SLC31A2
18766,GO:1901317,0.112338691694547,0.994060329662086,1,11,regulation of flagellated sperm motility,BP,RGN
4269,GO:0008652,0.112458425034734,0.980209945229301,2,75,cellular amino acid biosynthetic process,BP,MRI1;SLC1A3
10667,GO:0042129,0.112693890083429,0.970018307933882,3,147,regulation of T cell proliferation,BP,FADD;PNP;PYCARD
483,GO:0001504,0.112845949526662,0.993717023830204,1,22,neurotransmitter uptake,BP,SLC1A3
12702,GO:0046545,0.112989972429474,0.979987369227008,2,95,development of primary female sexual characteristics,BP,ANG;IDH1
6443,GO:0018904,0.113132909356047,0.993884861066169,1,13,ether metabolic process,BP,PLA2G16
18905,GO:1901700,0.113201762481282,0.934271629403729,14,1464,response to oxygen-containing compound,BP,PDK4;FADD;PYCARD;MGST2;RGN;GHR;TICAM1;RBP4;RNASEL;SHPK;FABP3;CASP4;TFPI;STAR
5964,GO:0016505,0.113228653207258,0.993737832621514,1,18,peptidase activator activity involved in apoptotic process,MF,PYCARD
11704,GO:0044270,0.113347056365205,0.952217023292114,6,409,cellular nitrogen compound catabolic process,BP,PNP;RGN;GALT;AOX1;NUDT7;DERA
19927,GO:1904064,0.113531620143674,0.97982693561845,2,98,positive regulation of cation transmembrane transport,BP,RGN;FXYD1
11141,GO:0043014,0.113754115868028,0.993613280076361,1,22,alpha-tubulin binding,MF,FAM110C
13814,GO:0051024,0.114049098808125,0.993873919521643,1,11,positive regulation of immunoglobulin secretion,BP,RBP4
6127,GO:0016805,0.114334324661022,0.993657409175857,1,16,dipeptidase activity,MF,PEPD
4373,GO:0009084,0.114363413408686,0.993630170855771,1,17,glutamine family amino acid biosynthetic process,BP,SLC1A3
18467,GO:1900078,0.114488454720933,0.993493202356019,1,25,positive regulation of cellular response to insulin stimulus,BP,RNASEL
9837,GO:0035455,0.114709660547314,0.993569282810439,1,18,response to interferon-alpha,BP,STAR
11117,GO:0042987,0.115021841055476,0.993481219349277,1,21,amyloid precursor protein catabolic process,BP,ABCG1
21248,GO:2000484,0.115114635335967,0.993663820456102,1,13,positive regulation of interleukin-8 secretion,BP,PYCARD
3554,GO:0006954,0.115136132333557,0.944477355954505,8,635,inflammatory response,BP,CFB;PYCARD;TICAM1;PXK;NMI;AOX1;SHPK;CASP4
2123,GO:0004622,0.115585545746205,0.9934490614892,1,19,lysophospholipase activity,MF,LYPLAL1
11840,GO:0044550,0.115782626218343,0.993392779568125,1,21,secondary metabolite biosynthetic process,BP,BDH2
17806,GO:0097200,0.115785100603353,0.993588107905229,1,13,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,CASP4
781,GO:0001958,0.11628196921143,0.993272835133124,1,26,endochondral ossification,BP,FGF18
10219,GO:0036075,0.11628196921143,0.993272835133124,1,26,replacement ossification,BP,FGF18
13306,GO:0048608,0.116462572209681,0.955066163337078,5,412,reproductive structure development,BP,HSD17B3;RBP4;ANG;IDH1;STAR
548,GO:0001608,0.117101406231201,0.993400539270874,1,14,G-protein coupled nucleotide receptor activity,MF,P2RY14
9921,GO:0035589,0.117101406231201,0.993400539270874,1,14,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,P2RY14
11976,GO:0045028,0.117101406231201,0.993400539270874,1,14,G-protein coupled purinergic nucleotide receptor activity,MF,P2RY14
2985,GO:0006094,0.117387893247601,0.978820573036847,2,75,gluconeogenesis,BP,RBP4;MDH1
5064,GO:0010874,0.117615188994731,0.993193572591517,1,20,regulation of cholesterol efflux,BP,ABCG1
21181,GO:2000379,0.117737477491879,0.978680296641922,2,84,positive regulation of reactive oxygen species metabolic process,BP,RGN;TICAM1
3428,GO:0006750,0.117770947687844,0.993290198722658,1,15,glutathione biosynthetic process,BP,MGST2
5163,GO:0010996,0.117981783184256,0.993104966956885,1,23,response to auditory stimulus,BP,SLC1A3
7768,GO:0031100,0.118258861586207,0.97856142913466,2,77,animal organ regeneration,BP,RGN;NNMT
13961,GO:0051239,0.118432841437371,0.923794380853156,21,2576,regulation of multicellular organismal process,BP,PDK4;FADD;APOC1;TRADD;PNP;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;PLA2G16;FXYD1;RBP4;NMI;NOL3;FAM46A;TMEM176A;STAR;S100B;LINGO1
4927,GO:0010667,0.118497712125884,0.993150360933918,1,17,negative regulation of cardiac muscle cell apoptotic process,BP,NOL3
8368,GO:0032266,0.118515523774565,0.992978229780482,1,29,phosphatidylinositol-3-phosphate binding,MF,SNX21
10885,GO:0042523,0.11859737837565,0.993164315961405,1,16,positive regulation of tyrosine phosphorylation of Stat5 protein,BP,GHR
4773,GO:0010288,0.119051934925733,0.993061598946012,1,18,response to lead ion,BP,STAR
15512,GO:0061458,0.119126487476039,0.953722293212925,5,415,reproductive system development,BP,HSD17B3;RBP4;ANG;IDH1;STAR
703,GO:0001848,0.119201163256754,0.993023118188043,1,19,complement binding,MF,CFB
2295,GO:0004859,0.119215835932006,0.993292488305534,1,11,phospholipase inhibitor activity,MF,APOC1
3014,GO:0006144,0.119312260005919,0.993009807984231,1,19,purine nucleobase metabolic process,BP,AOX1
8572,GO:0032543,0.119545252891667,0.967482529669903,3,114,mitochondrial translation,BP,MRPL14;MRPL16;TSFM
11736,GO:0044321,0.119752590088285,0.992938147074726,1,20,response to leptin,BP,STAR
11531,GO:0043651,0.119848167928413,0.992989680985513,1,17,linoleic acid metabolic process,BP,FADS1
8616,GO:0032607,0.12045187345612,0.992820710985228,1,22,interferon-alpha production,BP,NMI
46,GO:0000097,0.120492107284518,0.992938954204043,1,16,sulfur amino acid biosynthetic process,BP,MRI1
16929,GO:0072207,0.120787368885304,0.992729016135556,1,26,metanephric epithelium development,BP,ACAT1
14268,GO:0051797,0.121091947562962,0.992816114348424,1,18,regulation of hair follicle development,BP,TRADD
944,GO:0002218,0.121303783305608,0.958676493086627,4,271,activation of innate immune response,BP,FADD;PYCARD;PSMB10;TICAM1
746,GO:0001916,0.121366928870413,0.99289913209988,1,14,positive regulation of T cell mediated cytotoxicity,BP,FADD
4675,GO:0009895,0.121372612569169,0.96657326878299,3,198,negative regulation of catabolic process,BP,APOC1;TBC1D14;RGN
12313,GO:0045723,0.121399762587129,0.992895197915335,1,14,positive regulation of fatty acid biosynthetic process,BP,RGN
14774,GO:0060192,0.121744855165725,0.992818609220028,1,15,negative regulation of lipase activity,BP,APOC1
12004,GO:0045073,0.122041976449359,0.992858815072998,1,13,regulation of chemokine biosynthetic process,BP,TICAM1
19404,GO:1903010,0.122345041369409,0.99264132566313,1,19,regulation of bone development,BP,RGN
19635,GO:1903510,0.12251088310429,0.977206221657592,2,112,mucopolysaccharide metabolic process,BP,IDUA;HEXB
6199,GO:0016918,0.123006933492875,0.992742674186811,1,13,retinal binding,MF,RBP4
15814,GO:0070233,0.12338305792588,0.992559846090966,1,17,negative regulation of T cell apoptotic process,BP,FADD
13659,GO:0050786,0.123495617432095,0.992789916383724,1,11,RAGE receptor binding,MF,S100B
7679,GO:0030947,0.123601108553153,0.992378155855634,1,26,regulation of vascular endothelial growth factor receptor signaling pathway,BP,FGF18
9211,GO:0033866,0.123837985615702,0.992531629726508,1,16,nucleoside bisphosphate biosynthetic process,BP,ACAT1
9234,GO:0034030,0.123837985615702,0.992531629726508,1,16,ribonucleoside bisphosphate biosynthetic process,BP,ACAT1
9237,GO:0034033,0.123837985615702,0.992531629726508,1,16,purine nucleoside bisphosphate biosynthetic process,BP,ACAT1
6569,GO:0019319,0.124366414677435,0.976775591843454,2,78,hexose biosynthetic process,BP,RBP4;MDH1
11191,GO:0043101,0.12443705645699,0.992489574185378,1,15,purine-containing compound salvage,BP,PNP
14814,GO:0060261,0.124472446479016,0.992376924021111,1,19,positive regulation of transcription initiation from RNA polymerase II promoter,BP,HNF1A
1148,GO:0002577,0.125078273738062,0.992377593371619,1,16,regulation of antigen processing and presentation,BP,PYCARD
10952,GO:0042627,0.125091851262498,0.99248837770258,1,13,chylomicron,CC,APOC1
7937,GO:0031418,0.125620822380051,0.992255129186251,1,18,L-ascorbic acid binding,MF,PHYH
7357,GO:0030280,0.125809985387814,0.992356361126615,1,14,structural constituent of epidermis,MF,KRT10
18055,GO:0098533,0.125966813305757,0.992116025918179,1,23,ATPase dependent transmembrane transport complex,CC,FXYD1
17455,GO:0090201,0.126202901292928,0.992236494423593,1,16,negative regulation of release of cytochrome c from mitochondria,BP,NOL3
5674,GO:0015908,0.126251937193786,0.97616890968765,2,88,fatty acid transport,BP,CPT2;FABP3
5946,GO:0016482,0.126336586540511,0.97603647037043,2,126,cytosolic transport,BP,ZFYVE21;TBC1D14
5107,GO:0010922,0.127132553815435,0.991914086392404,1,27,positive regulation of phosphatase activity,BP,RGN
6725,GO:0019841,0.12721410494298,0.992224801154353,1,13,retinol binding,MF,RBP4
5672,GO:0015893,0.127274563225012,0.991875014645967,1,29,drug transport,BP,EBP
9611,GO:0034767,0.127501390987799,0.975729580879449,2,107,positive regulation of ion transmembrane transport,BP,RGN;FXYD1
17601,GO:0090484,0.127603460416114,0.991904742347777,1,23,drug transporter activity,MF,EBP
12274,GO:0045649,0.128013372965483,0.991904520871497,1,20,regulation of macrophage differentiation,BP,FADD
20320,GO:1904949,0.128036523442345,0.991833580136883,1,24,ATPase complex,CC,FXYD1
4924,GO:0010664,0.12804800425619,0.991900031681274,1,20,negative regulation of striated muscle cell apoptotic process,BP,NOL3
10838,GO:0042448,0.12845711629898,0.991949580085474,1,16,progesterone metabolic process,BP,CYP17A1
2489,GO:0005158,0.128876695841833,0.991645732060298,1,31,insulin receptor binding,MF,DOK1
166,GO:0000323,0.128977481951785,0.939556860887414,7,624,lytic vacuole,CC,IFI30;PYCARD;IDUA;HEXB;PON2;ACP5;GLA
2778,GO:0005764,0.128977481951785,0.939556860887414,7,624,lysosome,CC,IFI30;PYCARD;IDUA;HEXB;PON2;ACP5;GLA
1293,GO:0002821,0.129284165007532,0.975301232074816,2,78,positive regulation of adaptive immune response,BP,FADD;PYCARD
12185,GO:0045444,0.130398632175605,0.9629545008775,3,199,fat cell differentiation,BP,MRAP;RNASEL;NUDT7
13272,GO:0048535,0.130546410155084,0.991678767828509,1,16,lymph node development,BP,FADD
14613,GO:0055094,0.130787218446715,0.991502133489674,1,22,response to lipoprotein particle,BP,ABCG1
2121,GO:0004620,0.130861572634674,0.974745060223566,2,95,phospholipase activity,MF,PLA2G16;LYPLAL1
1103,GO:0002495,0.131596668237416,0.974526806469876,2,93,antigen processing and presentation of peptide antigen via MHC class II,BP,IFI30;PYCARD
1107,GO:0002504,0.131608894720567,0.97451924309079,2,94,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,IFI30;PYCARD
5809,GO:0016202,0.13161345887558,0.974453344626826,2,115,regulation of striated muscle tissue development,BP,RBP4;S100B
18944,GO:1901861,0.131629342720769,0.974443516935997,2,117,regulation of muscle tissue development,BP,RBP4;S100B
5539,GO:0015645,0.131725780088817,0.991415839892385,1,20,fatty acid ligase activity,MF,ACSM5
10263,GO:0036149,0.131988136857733,0.991489143528823,1,16,phosphatidylinositol acyl-chain remodeling,BP,PLA2G16
13790,GO:0050995,0.132438452851394,0.991320304040387,1,20,negative regulation of lipid catabolic process,BP,APOC1
7484,GO:0030539,0.132576330929255,0.991262015429402,1,22,male genitalia development,BP,HSD17B3
18156,GO:0098773,0.132643908629021,0.974196265378655,2,95,skin epidermis development,BP,TRADD;KRT10
13969,GO:0051251,0.132794582757094,0.953300738647674,4,261,positive regulation of lymphocyte activation,BP,FADD;PNP;PYCARD;TICAM1
10619,GO:0042033,0.133026113051303,0.99142997002415,1,14,chemokine biosynthetic process,BP,TICAM1
14579,GO:0055026,0.133134319183216,0.991168988186409,1,23,negative regulation of cardiac muscle tissue development,BP,RBP4
5152,GO:0010984,0.133138228140665,0.991373062883997,1,15,regulation of lipoprotein particle clearance,BP,APOC1
19355,GO:1902932,0.133641971380408,0.991157705649557,1,20,positive regulation of alcohol biosynthetic process,BP,ABCG1
9569,GO:0034698,0.133987884500127,0.990994960645873,1,27,response to gonadotropin,BP,STAR
12019,GO:0045088,0.134052678351386,0.946042114484538,5,377,regulation of innate immune response,BP,FADD;PYCARD;PSMB10;TICAM1;NMI
17029,GO:0072376,0.13443597062968,0.973713004561952,2,79,protein activation cascade,BP,CFB;TFPI
2984,GO:0006091,0.134599308566916,0.945782767393207,5,342,generation of precursor metabolites and energy,BP,ACADVL;ETFB;MDH1;IDH1;ETFDH
8432,GO:0032368,0.134717788864055,0.973551848048558,2,95,regulation of lipid transport,BP,APOC1;ABCG1
10884,GO:0042522,0.135574168349791,0.990917406585272,1,19,regulation of tyrosine phosphorylation of Stat5 protein,BP,GHR
13674,GO:0050806,0.13558041692825,0.973203514214244,2,121,positive regulation of synaptic transmission,BP,S100B;SLC1A3
10383,GO:0036477,0.136980827014548,0.939104556738323,6,644,somatodendritic compartment,CC,CYP17A1;ANG;CPT1C;STAR;S100B;SLC1A3
16721,GO:0071868,0.137079493143058,0.990500549877129,1,33,cellular response to monoamine stimulus,BP,STAR
16723,GO:0071870,0.137079493143058,0.990500549877129,1,33,cellular response to catecholamine stimulus,BP,STAR
13113,GO:0048148,0.137102073474044,0.990705994338749,1,19,behavioral response to cocaine,BP,FADD
3469,GO:0006820,0.137289611943218,0.93895405008971,6,573,anion transport,BP,APOC1;ABCG1;CPT2;FXYD1;FABP3;SLC1A3
9767,GO:0035308,0.137323923018037,0.990607748403229,1,22,negative regulation of protein dephosphorylation,BP,RGN
3872,GO:0007617,0.137399557625171,0.990617448763368,1,21,mating behavior,BP,HEXB
19800,GO:1903825,0.137548790042134,0.97260826375024,2,111,organic acid transmembrane transport,BP,CPT2;SLC1A3
10784,GO:0042359,0.137606138964926,0.990610888416325,1,20,vitamin D metabolic process,BP,CYP11A1
13797,GO:0051004,0.138088069819841,0.990701493917929,1,15,regulation of lipoprotein lipase activity,BP,APOC1
8433,GO:0032369,0.138093538176743,0.990447624035918,1,25,negative regulation of lipid transport,BP,APOC1
3171,GO:0006414,0.138563829631084,0.959744433673804,3,130,translational elongation,BP,MRPL14;MRPL16;TSFM
2706,GO:0005640,0.138987126316439,0.990353665578869,1,23,nuclear outer membrane,CC,DHCR7
12757,GO:0046651,0.139026308205945,0.950311494986384,4,253,lymphocyte proliferation,BP,FADD;PNP;PYCARD;TICAM1
18655,GO:1901021,0.139221992398662,0.990245355083782,1,28,positive regulation of calcium ion transmembrane transporter activity,BP,RGN
6590,GO:0019372,0.139429470739955,0.990474558535602,1,16,lipoxygenase pathway,BP,PON2
5005,GO:0010804,0.13946481335053,0.990469595894508,1,16,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,NOL3
14880,GO:0060343,0.139938981779549,0.990183614145591,1,25,trabecula formation,BP,RBP4
14062,GO:0051412,0.140043778612576,0.990242813110116,1,21,response to corticosterone,BP,STAR
7812,GO:0031210,0.140563807168033,0.990217504728858,1,19,phosphatidylcholine binding,MF,APOC1
13792,GO:0050997,0.140563807168033,0.990217504728858,1,19,quaternary ammonium group binding,MF,APOC1
519,GO:0001556,0.140820833075114,0.990131247713821,1,21,oocyte maturation,BP,ANG
10958,GO:0042634,0.140838328142575,0.990053577181147,1,25,regulation of hair cycle,BP,TRADD
4930,GO:0010675,0.141025120997498,0.971488974786827,2,114,regulation of cellular carbohydrate metabolic process,BP,PDK4;RGN
8693,GO:0032728,0.141031053300693,0.989971061349953,1,29,positive regulation of interferon-beta production,BP,TICAM1
11312,GO:0043276,0.141399130930425,0.989885111164804,1,32,anoikis,BP,PDK4
8840,GO:0032943,0.141452170876748,0.949126557917865,4,255,mononuclear cell proliferation,BP,FADD;PNP;PYCARD;TICAM1
19055,GO:1902176,0.141463566293582,0.990088375337018,1,19,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,NOL3
15323,GO:0061036,0.141544087415681,0.989895969093792,1,29,positive regulation of cartilage development,BP,FGF18
4929,GO:0010669,0.141551043381388,0.989966484975414,1,24,epithelial structure maintenance,BP,RBP4
5095,GO:0010907,0.141936630096772,0.989805963962211,1,32,positive regulation of glucose metabolic process,BP,RGN
16463,GO:0071417,0.141990251677989,0.941753711409857,5,491,cellular response to organonitrogen compound,BP,PDK4;GHR;RNASEL;CASP4;STAR
5570,GO:0015711,0.142010218181352,0.941770993376337,5,437,organic anion transport,BP,APOC1;ABCG1;CPT2;FABP3;SLC1A3
10649,GO:0042098,0.142070597362057,0.958151183442304,3,171,T cell proliferation,BP,FADD;PNP;PYCARD
14870,GO:0060333,0.142446957661933,0.971146595870079,2,84,interferon-gamma-mediated signaling pathway,BP,IFI30;NMI
9410,GO:0034377,0.142642679391202,0.989891152993438,1,20,plasma lipoprotein particle assembly,BP,APOC1
2629,GO:0005496,0.142697632314119,0.971031256191031,2,91,steroid binding,MF,ABCG1;STAR
2772,GO:0005758,0.143106093576407,0.971039196378304,2,68,mitochondrial intermembrane space,CC,HSD3B2;STAR
9608,GO:0034764,0.143161175387902,0.970803580738775,2,112,positive regulation of transmembrane transport,BP,RGN;FXYD1
9281,GO:0034122,0.143204794580268,0.989663412852954,1,28,negative regulation of toll-like receptor signaling pathway,BP,TICAM1
5743,GO:0016051,0.143283569987448,0.9576051408549,3,186,carbohydrate biosynthetic process,BP,RGN;RBP4;MDH1
83,GO:0000166,0.143630498327828,0.911734655035387,15,2024,nucleotide binding,MF,PDK4;ACSF2;ABCG1;BDH2;ACADVL;ACSM5;RNASEL;AOX1;SHPK;MDH1;IDH1;DECR1;LDHD;DHCR7;ETFDH
13615,GO:0050718,0.14381975765935,0.98967212328128,1,22,positive regulation of interleukin-1 beta secretion,BP,PYCARD
13636,GO:0050755,0.144041683268355,0.989858465953507,1,15,chemokine metabolic process,BP,TICAM1
18748,GO:1901265,0.144577765394643,0.911057507979173,15,2025,nucleoside phosphate binding,MF,PDK4;ACSF2;ABCG1;BDH2;ACADVL;ACSM5;RNASEL;AOX1;SHPK;MDH1;IDH1;DECR1;LDHD;DHCR7;ETFDH
2842,GO:0005865,0.145043015466429,0.989669189948215,1,16,striated muscle thin filament,CC,TMOD4
13319,GO:0048634,0.145159540979656,0.970130894155431,2,119,regulation of muscle organ development,BP,RBP4;S100B
13119,GO:0048167,0.145484818451925,0.969968036187056,2,144,regulation of synaptic plasticity,BP,STAR;S100B
4925,GO:0010665,0.146109678479919,0.989273197339907,1,25,regulation of cardiac muscle cell apoptotic process,BP,NOL3
11542,GO:0043691,0.146442603342731,0.989423726149195,1,17,reverse cholesterol transport,BP,ABCG1
12659,GO:0046474,0.146952951592566,0.955967113055584,3,227,glycerophospholipid biosynthetic process,BP,DPM3;FGF18;FABP3
980,GO:0002283,0.147078529972565,0.933395841279299,6,474,neutrophil activation involved in immune response,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
11337,GO:0043312,0.147078529972565,0.933395841279299,6,474,neutrophil degranulation,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
4428,GO:0009154,0.147598960569531,0.9889421176415,1,33,purine ribonucleotide catabolic process,BP,NUDT7
4128,GO:0008406,0.147881218383394,0.955594350048609,3,207,gonad development,BP,ANG;IDH1;STAR
4361,GO:0009067,0.148199709427821,0.98903836630001,1,21,aspartate family amino acid biosynthetic process,BP,MRI1
14604,GO:0055085,0.148337462642382,0.913522642616472,12,1348,transmembrane transport,BP,EBP;SLC31A2;ABCG1;PSMB10;RGN;CPT2;FXYD1;RNASEL;GRIA3;NOL3;CYB5A;SLC1A3
10344,GO:0036379,0.148644471735647,0.989025664624213,1,19,myofilament,CC,TMOD4
13087,GO:0048038,0.148900191701927,0.989055120715015,1,17,quinone binding,MF,ETFDH
1611,GO:0003674,0.148956868120804,0.914243295959714,117,16005,molecular_function,MF,CFB;EBP;PDK4;PECR;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;G0S2;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;ACCS;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;FAM46A;IDH1;DECR1;PUS1;LDHD;MDP1;TFPI;STAR;SNX21;WBP1;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH;TMOD4
10040,GO:0035767,0.149232906254568,0.988779080314257,1,26,endothelial cell chemotaxis,BP,FGF18
1211,GO:0002691,0.149425457134044,0.988804949065266,1,23,regulation of cellular extravasation,BP,FADD
9382,GO:0034341,0.149597720032841,0.954952043824628,3,158,response to interferon-gamma,BP,IFI30;NMI;STAR
10264,GO:0036150,0.149656318405451,0.988815444696949,1,21,phosphatidylserine acyl-chain remodeling,BP,PLA2G16
10663,GO:0042119,0.149709115887042,0.931867376306321,6,477,neutrophil activation,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
4989,GO:0010765,0.150877639797936,0.988452881545307,1,31,positive regulation of sodium ion transport,BP,FXYD1
19176,GO:1902475,0.151277665596972,0.988415062480969,1,29,L-alpha-amino acid transmembrane transport,BP,SLC1A3
4388,GO:0009110,0.15142709028959,0.988516549934153,1,22,vitamin biosynthetic process,BP,RGN
7923,GO:0031398,0.151846758527024,0.953925966176299,3,176,positive regulation of protein ubiquitination,BP,PSMB10;TICAM1;NMI
2062,GO:0004540,0.151889982082321,0.968000674197273,2,90,ribonuclease activity,MF,RNASEL;ANG
2565,GO:0005310,0.15206253502407,0.988253847375076,1,32,dicarboxylic acid transmembrane transporter activity,MF,SLC1A3
11457,GO:0043531,0.152473016869437,0.988188470867695,1,32,ADP binding,MF,ABCG1
21024,GO:2000144,0.152825928034293,0.988215785352867,1,26,positive regulation of DNA-templated transcription, initiation,BP,HNF1A
4514,GO:0009261,0.153219612350003,0.988047641062942,1,34,ribonucleotide catabolic process,BP,NUDT7
6588,GO:0019370,0.153392291271692,0.988407140159147,1,16,leukotriene biosynthetic process,BP,MGST2
10620,GO:0042035,0.153700589180636,0.967355091002962,2,97,regulation of cytokine biosynthetic process,BP,TICAM1;NMI
21452,GO:2000778,0.154593179577169,0.988101796076636,1,19,positive regulation of interleukin-6 secretion,BP,PYCARD
4922,GO:0010662,0.154764913986509,0.987888763996054,1,27,regulation of striated muscle cell apoptotic process,BP,NOL3
3158,GO:0006399,0.154893597331254,0.952609470571314,3,166,tRNA metabolic process,BP,LAGE3;HSD17B10;PUS1
15674,GO:0065005,0.154949926977454,0.987935790126494,1,23,protein-lipid complex assembly,BP,APOC1
11173,GO:0043065,0.155068135590115,0.928685802407541,6,560,positive regulation of apoptotic process,BP,FADD;TRADD;PYCARD;G0S2;IFI27;S100B
13926,GO:0051183,0.155129717008499,0.987885247250636,1,24,vitamin transporter activity,MF,RBP4
4520,GO:0009267,0.155595221119477,0.96662505688194,2,120,cellular response to starvation,BP,PDK4;FADS1
17461,GO:0090208,0.155641276007333,0.987934911086601,1,19,positive regulation of triglyceride metabolic process,BP,RGN
16720,GO:0071867,0.155831348610679,0.987604503269141,1,36,response to monoamine,BP,STAR
16722,GO:0071869,0.155831348610679,0.987604503269141,1,36,response to catecholamine,BP,STAR
14027,GO:0051345,0.155857810153656,0.919344658402126,8,925,positive regulation of hydrolase activity,BP,FADD;TRADD;TBC1D14;PYCARD;RGN;FGF18;ANG;IFI27
11810,GO:0044445,0.156717557316335,0.941548951686017,4,228,cytosolic part,CC,FADD;PYCARD;TICAM1;CASP4
14813,GO:0060260,0.156813314274464,0.987573512755925,1,26,regulation of transcription initiation from RNA polymerase II promoter,BP,HNF1A
18113,GO:0098656,0.156988785860542,0.951519118880265,3,262,anion transmembrane transport,BP,CPT2;FXYD1;SLC1A3
14211,GO:0051693,0.15714224830729,0.987419642879627,1,33,actin filament capping,BP,TMOD4
10285,GO:0036230,0.157155659169807,0.927496574455512,6,482,granulocyte activation,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
5263,GO:0014808,0.157240470007108,0.987454755265961,1,29,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,NOL3
12049,GO:0045137,0.157362129937297,0.951418144223601,3,212,development of primary sexual characteristics,BP,ANG;IDH1;STAR
16066,GO:0070661,0.157806271635576,0.940927471560171,4,268,leukocyte proliferation,BP,FADD;PNP;PYCARD;TICAM1
4704,GO:0009987,0.157820258869725,0.893456646491408,107,14598,cellular process,BP,EBP;PDK4;PECR;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;WDR45;TBC1D14;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;G0S2;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;RBP4;CYP17A1;RNASEL;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;TMEM176A;IDH1;DECR1;PUS1;PTMS;MDP1;TFPI;STAR;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;SLC1A3;ELOVL6;LINGO1;ETFDH;TMOD4
2487,GO:0005154,0.157918279084423,0.987302982705337,1,32,epidermal growth factor receptor binding,MF,LINGO1
13613,GO:0050716,0.158379827016912,0.987356193680302,1,24,positive regulation of interleukin-1 secretion,BP,PYCARD
11176,GO:0043068,0.158595515652917,0.926598406119291,6,566,positive regulation of programmed cell death,BP,FADD;TRADD;PYCARD;G0S2;IFI27;S100B
586,GO:0001676,0.158981798931537,0.965566203142852,2,92,long-chain fatty acid metabolic process,BP,FADS1;ELOVL6
15508,GO:0061448,0.159277060088666,0.950533531195077,3,230,connective tissue development,BP,FGF18;PLA2G16;ACAT1
963,GO:0002252,0.159304386981747,0.9081876300034,11,1065,immune effector process,BP,CFB;FADD;PNP;PYCARD;TICAM1;RBP4;RNASEL;HEXB;IDH1;GLA;DERA
496,GO:0001522,0.159431655908013,0.987358062093353,1,18,pseudouridine synthesis,BP,PUS1
16,GO:0000030,0.159443983610679,0.987203256683855,1,23,mannosyltransferase activity,MF,DPM3
10841,GO:0042454,0.159655640577544,0.987362874329372,1,17,ribonucleoside catabolic process,BP,PNP
8210,GO:0031970,0.159716146399811,0.965412527334899,2,76,organelle envelope lumen,CC,HSD3B2;STAR
16787,GO:0072001,0.160626064887362,0.949870048958216,3,278,renal system development,BP,RGN;RBP4;ACAT1
14597,GO:0055076,0.160742973925292,0.964881189526163,2,108,transition metal ion homeostasis,BP,SLC31A2;BDH2
3363,GO:0006661,0.160978740746325,0.964704183878693,2,140,phosphatidylinositol biosynthetic process,BP,DPM3;FGF18
13063,GO:0048009,0.161539598081681,0.986650266410021,1,36,insulin-like growth factor receptor signaling pathway,BP,GHR
1079,GO:0002446,0.161580933579985,0.924866538831442,6,486,neutrophil mediated immunity,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
4919,GO:0010659,0.161797083455353,0.986709508439025,1,28,cardiac muscle cell apoptotic process,BP,NOL3
14673,GO:0060043,0.16213923600529,0.986569164716835,1,34,regulation of cardiac muscle cell proliferation,BP,RBP4
10872,GO:0042506,0.162225748186034,0.986764175298651,1,22,tyrosine phosphorylation of Stat5 protein,BP,GHR
10706,GO:0042219,0.163056180044938,0.986652556190516,1,21,cellular modified amino acid catabolic process,BP,SARDH
5786,GO:0016137,0.163231716233035,0.986728130416865,1,18,glycoside metabolic process,BP,GLA
8661,GO:0032675,0.163250256235389,0.964028398424756,2,101,regulation of interleukin-6 production,BP,PYCARD;TICAM1
3146,GO:0006376,0.163273165908554,0.986494467498894,1,26,mRNA splice site selection,BP,NOL3
14123,GO:0051537,0.163445094799166,0.986586740512797,1,21,2 iron, 2 sulfur cluster binding,MF,AOX1
9541,GO:0034655,0.164058439343322,0.929671646155405,5,364,nucleobase-containing compound catabolic process,BP,PNP;RGN;GALT;NUDT7;DERA
14619,GO:0055102,0.164071019391667,0.986679932825378,1,16,lipase inhibitor activity,MF,APOC1
11151,GO:0043027,0.164209028581058,0.986354791655453,1,25,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,NOL3
13813,GO:0051023,0.16464105164787,0.986534477170534,1,17,regulation of immunoglobulin secretion,BP,RBP4
14036,GO:0051354,0.164872077555012,0.986314505868978,1,22,negative regulation of oxidoreductase activity,BP,GLA
3552,GO:0006952,0.165143348597869,0.896214245525627,15,1444,defense response,BP,CFB;IFI30;FADD;PYCARD;PSMB10;TICAM1;PXK;RNASEL;NMI;AOX1;SHPK;CASP4;IFI27;STAR;S100B
744,GO:0001914,0.165213194460546,0.986285350228454,1,21,regulation of T cell mediated cytotoxicity,BP,FADD
5867,GO:0016303,0.165483478464939,0.985907514377509,1,43,1-phosphatidylinositol-3-kinase activity,MF,FGF18
8314,GO:0032148,0.165702312179783,0.986076316288386,1,26,activation of protein kinase B activity,BP,ANG
19637,GO:1903514,0.166582810741344,0.98585236922938,1,30,calcium ion transport from endoplasmic reticulum to cytosol,BP,NOL3
15487,GO:0061384,0.166730777205715,0.985784572451085,1,33,heart trabecula morphogenesis,BP,RBP4
9395,GO:0034361,0.166745525506992,0.986090619503698,1,19,very-low-density lipoprotein particle,CC,APOC1
9418,GO:0034385,0.166745525506992,0.986090619503698,1,19,triglyceride-rich plasma lipoprotein particle,CC,APOC1
7607,GO:0030835,0.166811593942263,0.985725090463361,1,37,negative regulation of actin filament depolymerization,BP,TMOD4
4517,GO:0009264,0.166875399549549,0.986108764151231,1,18,deoxyribonucleotide catabolic process,BP,DERA
21246,GO:2000482,0.167286563311908,0.985927370356622,1,21,regulation of interleukin-8 secretion,BP,PYCARD
3761,GO:0007292,0.167350476165775,0.962554436579654,2,104,female gamete generation,BP,ANG;HEXB
10896,GO:0042537,0.167936594865799,0.985884480212976,1,19,benzene-containing compound metabolic process,BP,STAR
2663,GO:0005548,0.168172835706062,0.9854027830432,1,47,phospholipid transporter activity,MF,ABCG1
3705,GO:0007202,0.168400658159219,0.985603847940301,1,26,activation of phospholipase C activity,BP,ANG
5859,GO:0016289,0.169583404462736,0.985596796067567,1,19,CoA hydrolase activity,MF,NUDT7
13976,GO:0051258,0.169994355252855,0.945644898664486,3,227,protein polymerization,BP,PYCARD;ANG;TMOD4
9571,GO:0034702,0.170007232646504,0.945576944715464,3,275,ion channel complex,CC,FXYD1;GRIA3;CPT1C
5055,GO:0010863,0.170056035718704,0.9851677831116,1,35,positive regulation of phospholipase C activity,BP,ANG
5725,GO:0016020,0.170266547978722,0.871151684786874,65,8566,membrane,CC,CFB;EBP;PDK4;PECR;TMEM160;TMEM164;USE1;ALG5;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;FADD;P2RY14;HSD17B3;MRAP;TRADD;PXMP2;PXMP4;EXTL1;ABCG1;CCDC51;ACADVL;KRT10;MGST2;FADS1;GHR;ASAH2;TICAM1;CPT2;PXK;PLA2G16;HSD17B10;FXYD1;TMEM223;CYP17A1;ACAT1;HEXB;GRIA3;NOL3;HSD3B2;CPT1C;CASP4;IFI27;PON2;TMEM176A;LDHD;TMEM98;TFPI;STAR;SNX21;ACP5;ECI1;CYP11A1;RPH3AL;PRRT1;DHCR7;CYB5A;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH
4918,GO:0010658,0.170294554337256,0.985193322424315,1,30,striated muscle cell apoptotic process,BP,NOL3
16412,GO:0071347,0.170516869927302,0.961495298213177,2,88,cellular response to interleukin-1,BP,PYCARD;TFPI
12621,GO:0046386,0.171094338991146,0.985330117788449,1,19,deoxyribose phosphate catabolic process,BP,DERA
2447,GO:0005104,0.171336593668475,0.985080208838791,1,26,fibroblast growth factor receptor binding,MF,FGF18
1216,GO:0002696,0.171379446915814,0.933840276051437,4,286,positive regulation of leukocyte activation,BP,FADD;PNP;PYCARD;TICAM1
10227,GO:0036092,0.171652085651053,0.984753337977348,1,50,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGF18
550,GO:0001614,0.172611407251466,0.984985394486085,1,21,purinergic nucleotide receptor activity,MF,P2RY14
5961,GO:0016502,0.172611407251466,0.984985394486085,1,21,nucleotide receptor activity,MF,P2RY14
9922,GO:0035590,0.172901345323225,0.984900976978872,1,22,purinergic nucleotide receptor signaling pathway,BP,P2RY14
17957,GO:0097502,0.173305471930734,0.984682447130317,1,28,mannosylation,BP,DPM3
18583,GO:1900274,0.173506077207255,0.984515903342081,1,37,regulation of phospholipase C activity,BP,ANG
8646,GO:0032649,0.17370087898639,0.960308095322205,2,92,regulation of interferon-gamma production,BP,FADD;PYCARD
1367,GO:0002931,0.17381419147137,0.984522310840841,1,32,response to ischemia,BP,NOL3
4102,GO:0008360,0.174007826158016,0.960006002635826,2,141,regulation of cell shape,BP,HEXB;S100B
9743,GO:0035264,0.174249770516209,0.959919090050285,2,140,multicellular organism growth,BP,GHR;DHCR7
12020,GO:0045089,0.17431019201732,0.932249541053482,4,313,positive regulation of innate immune response,BP,FADD;PYCARD;PSMB10;TICAM1
2801,GO:0005790,0.174712918794902,0.984341956441961,1,33,smooth endoplasmic reticulum,CC,HSD3B2
8634,GO:0032635,0.175853395611906,0.959436152275408,2,107,interleukin-6 production,BP,PYCARD;TICAM1
1882,GO:0004181,0.17597924508731,0.984255403387287,1,25,metallocarboxypeptidase activity,MF,PEPD
21,GO:0000038,0.17629070341344,0.984173903650113,1,26,very long-chain fatty acid metabolic process,BP,ELOVL6
9920,GO:0035588,0.17644394440751,0.984223051769972,1,23,G-protein coupled purinergic receptor signaling pathway,BP,P2RY14
21636,GO:2001234,0.176592717714325,0.942611416657884,3,197,negative regulation of apoptotic signaling pathway,BP,FADD;TRADD;NOL3
13058,GO:0048002,0.177202185398949,0.942369474556382,3,178,antigen processing and presentation of peptide antigen,BP,IFI30;PYCARD;PSMB10
19552,GO:1903322,0.177342953364284,0.942270236069055,3,191,positive regulation of protein modification by small protein conjugation or removal,BP,PSMB10;TICAM1;NMI
13859,GO:0051091,0.177685120855928,0.9420323269592,3,230,positive regulation of sequence-specific DNA binding transcription factor activity,BP,TRADD;PYCARD;TICAM1
3863,GO:0007605,0.177706688053247,0.958657505428157,2,131,sensory perception of sound,BP,HEXB;SLC1A3
12592,GO:0046326,0.17791405958336,0.983659140848089,1,40,positive regulation of glucose import,BP,RNASEL
6496,GO:0019098,0.178120791344358,0.983769149382458,1,29,reproductive behavior,BP,HEXB
15858,GO:0070296,0.178331754146192,0.983678269289958,1,32,sarcoplasmic reticulum calcium ion transport,BP,NOL3
4969,GO:0010743,0.178515227401118,0.983694638481686,1,29,regulation of macrophage derived foam cell differentiation,BP,ABCG1
21100,GO:2000279,0.178643410012835,0.983635127842421,1,31,negative regulation of DNA biosynthetic process,BP,RGN
16174,GO:0070887,0.179719536941916,0.876569782082824,22,2645,cellular response to chemical stimulus,BP,PDK4;IFI30;FADD;TRADD;PYCARD;ACADVL;MGST2;PSMB10;RGN;GHR;FGF18;TICAM1;RNASEL;NMI;SHPK;CMBL;NOL3;CASP4;IFI27;TFPI;STAR;S100B
4526,GO:0009303,0.179821338057154,0.983466381260572,1,28,rRNA transcription,BP,ANG
14607,GO:0055088,0.179923795110351,0.957918547854083,2,106,lipid homeostasis,BP,ABCG1;FABP3
4880,GO:0010608,0.179973157921527,0.920447026591649,5,450,posttranscriptional regulation of gene expression,BP,PSMB10;RNASEL;ANG;TSFM;RBMS3
13716,GO:0050867,0.180112300299819,0.929158482047037,4,294,positive regulation of cell activation,BP,FADD;PNP;PYCARD;TICAM1
12872,GO:0046914,0.180608580074364,0.89322581436567,11,1303,transition metal ion binding,MF,PHYH;RGN;GALT;CYP17A1;ANG;AOX1;NUDT7;PEPD;ACP5;CYP11A1;S100B
21458,GO:2000785,0.18074841311029,0.983187074170826,1,34,regulation of autophagosome assembly,BP,TBC1D14
2998,GO:0006109,0.181278132111271,0.957293544701747,2,137,regulation of carbohydrate metabolic process,BP,PDK4;RGN
14485,GO:0052742,0.181875705736272,0.982821396181614,1,49,phosphatidylinositol kinase activity,MF,FGF18
17160,GO:0072676,0.181983283574424,0.957279881785228,2,83,lymphocyte migration,BP,FADD;PYCARD
11677,GO:0044236,0.182092040409863,0.957008352301394,2,129,multicellular organism metabolic process,BP,GHR;PEPD
10932,GO:0042590,0.182469471009599,0.957146379579177,2,77,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,IFI30;PSMB10
10590,GO:0040018,0.182516623568878,0.982874926754533,1,32,positive regulation of multicellular organism growth,BP,GHR
7453,GO:0030488,0.18301135570813,0.982898549590443,1,26,tRNA methylation,BP,HSD17B10
3260,GO:0006536,0.183115443243395,0.982812103601863,1,29,glutamate metabolic process,BP,SLC1A3
578,GO:0001666,0.183245281239547,0.927418909761667,4,326,response to hypoxia,BP,PSMB10;ANG;NOL3;S100B
8696,GO:0032731,0.183323154070819,0.982752482402313,1,30,positive regulation of interleukin-1 beta production,BP,PYCARD
11112,GO:0042982,0.183992140169151,0.982603680449911,1,31,amyloid precursor protein metabolic process,BP,ABCG1
14019,GO:0051336,0.184185348492718,0.890675434567959,11,1321,regulation of hydrolase activity,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;RGN;FGF18;ANG;NOL3;IFI27;TFPI
10641,GO:0042089,0.185947634334136,0.955614239238017,2,108,cytokine biosynthetic process,BP,TICAM1;NMI
11537,GO:0043666,0.186242617244353,0.98206952092256,1,37,regulation of phosphoprotein phosphatase activity,BP,RGN
4916,GO:0010656,0.186319315419349,0.982162861073191,1,30,negative regulation of muscle cell apoptotic process,BP,NOL3
16421,GO:0071356,0.186473759622295,0.92574933533211,4,260,cellular response to tumor necrosis factor,BP,TRADD;PYCARD;PSMB10;NOL3
13191,GO:0048305,0.186723873796479,0.982329991777997,1,21,immunoglobulin secretion,BP,RBP4
10265,GO:0036151,0.187193082237843,0.982053360411042,1,27,phosphatidylcholine acyl-chain remodeling,BP,PLA2G16
6611,GO:0019430,0.187657637136023,0.982108168847056,1,22,removal of superoxide radicals,BP,RGN
4367,GO:0009074,0.187945991575431,0.982089087016021,1,21,aromatic amino acid family catabolic process,BP,PCBD1
17133,GO:0072606,0.188054024672385,0.981933725442165,1,25,interleukin-8 secretion,BP,PYCARD
19925,GO:1904062,0.188185844184518,0.936953473533668,3,245,regulation of cation transmembrane transport,BP,SLC31A2;RGN;FXYD1
5204,GO:0014047,0.188294880160504,0.981600703055933,1,42,glutamate secretion,BP,SLC1A3
12424,GO:0045923,0.188451211250513,0.981736825390748,1,30,positive regulation of fatty acid metabolic process,BP,RGN
21022,GO:2000142,0.188591429694425,0.981624549214993,1,35,regulation of DNA-templated transcription, initiation,BP,HNF1A
13603,GO:0050706,0.188595708899706,0.981749808980107,1,28,regulation of interleukin-1 beta secretion,BP,PYCARD
11869,GO:0044708,0.188752399040083,0.924332933305965,4,396,single-organism behavior,BP,FADD;STAR;S100B;SLC1A3
17544,GO:0090322,0.188827013928418,0.981808781764505,1,24,regulation of superoxide metabolic process,BP,RGN
10300,GO:0036293,0.18935092544752,0.924060664520658,4,334,response to decreased oxygen levels,BP,PSMB10;ANG;NOL3;S100B
18077,GO:0098588,0.189985193191274,0.877668335583415,15,1865,bounding membrane of organelle,CC,PECR;ZFYVE21;PXMP2;PXMP4;ABCG1;TICAM1;PLA2G16;GRIA3;HSD3B2;CPT1C;IFI27;SNX21;RPH3AL;DHCR7;CYB5A
10807,GO:0042402,0.190563246327258,0.981459758475585,1,24,cellular biogenic amine catabolic process,BP,SARDH
4532,GO:0009310,0.190563283899827,0.981429668318014,1,25,amine catabolic process,BP,SARDH
15810,GO:0070229,0.190998929930145,0.981263718502253,1,28,negative regulation of lymphocyte apoptotic process,BP,FADD
8761,GO:0032814,0.191009894523405,0.981285456709012,1,27,regulation of natural killer cell activation,BP,TICAM1
3604,GO:0007031,0.191495349052546,0.981099518663652,1,31,peroxisome organization,BP,PLA2G16
5027,GO:0010828,0.192244033852019,0.980771005270325,1,44,positive regulation of glucose transport,BP,RNASEL
7447,GO:0030449,0.192283243867434,0.980937669484938,1,31,regulation of complement activation,BP,CFB
7309,GO:0030212,0.192608469623178,0.980802769874188,1,35,hyaluronan metabolic process,BP,HEXB
13339,GO:0048667,0.192917191962747,0.921950478673651,4,512,cell morphogenesis involved in neuron differentiation,BP,S100B;DOK1;SLC1A3;LINGO1
10771,GO:0042339,0.19309393286738,0.980734180989887,1,33,keratan sulfate metabolic process,BP,HEXB
17132,GO:0072604,0.193808868957625,0.980663647440386,1,29,interleukin-6 secretion,BP,PYCARD
19207,GO:1902555,0.193814424430514,0.980765449441855,1,25,endoribonuclease complex,CC,HSD17B10
20476,GO:1905348,0.193814424430514,0.980765449441855,1,25,endonuclease complex,CC,HSD17B10
12819,GO:0046825,0.194092645777515,0.980452089502096,1,38,regulation of protein export from nucleus,BP,IFI27
11324,GO:0043299,0.194213187407467,0.90476140438315,6,519,leukocyte degranulation,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
10655,GO:0042107,0.194381496262176,0.952306942997126,2,110,cytokine metabolic process,BP,TICAM1;NMI
16395,GO:0071320,0.194388135595977,0.980295813473683,1,47,cellular response to cAMP,BP,STAR
3551,GO:0006950,0.194393803520658,0.859496307383018,29,3506,response to stress,BP,CFB;PDK4;IFI30;MSRA;FADD;PYCARD;ACADVL;PSMB10;RGN;FADS1;TICAM1;PXK;RNASEL;ANG;NMI;ACAT1;AOX1;SHPK;NOL3;CASP4;IFI27;PON2;FAM46A;IDH1;TFPI;STAR;S100B;SLC1A3;ETFDH
5227,GO:0014072,0.194639827324912,0.98044913574066,1,31,response to isoquinoline alkaloid,BP,FADD
11314,GO:0043278,0.194639827324912,0.98044913574066,1,31,response to morphine,BP,FADD
8618,GO:0032609,0.195217577207126,0.952022754371416,2,101,interferon-gamma production,BP,FADD;PYCARD
6065,GO:0016706,0.195324384482189,0.980157056700004,1,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,PHYH
14668,GO:0060038,0.195536819992477,0.980080669671977,1,44,cardiac muscle cell proliferation,BP,RBP4
16387,GO:0071310,0.195556184018813,0.868738890701703,18,2192,cellular response to organic substance,BP,PDK4;IFI30;FADD;TRADD;PYCARD;ACADVL;PSMB10;GHR;FGF18;TICAM1;RNASEL;NMI;SHPK;NOL3;CASP4;IFI27;TFPI;STAR
11232,GO:0043167,0.196275696785711,0.853265910447503,39,5840,ion binding,MF,PDK4;PHYH;ZFYVE21;APOC1;ACSF2;PNP;ABCG1;EBF1;ACADVL;ACSM5;RGN;PXK;HACL1;GALT;CYP17A1;RNASEL;ANG;ACAT1;AOX1;SHPK;FABP3;NOL3;NUDT7;ACCS;PON2;IDH1;DECR1;LDHD;MDP1;SNX21;PEPD;ACP5;CYP11A1;RPH3AL;S100B;CYB5A;PTS;SLC1A3;ETFDH
19054,GO:1902175,0.196448347633192,0.980112314501213,1,29,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,NOL3
8231,GO:0032007,0.196687437196051,0.979879931935224,1,40,negative regulation of TOR signaling,BP,DEPTOR
7887,GO:0031329,0.197147244735701,0.902844578677779,6,606,regulation of cellular catabolic process,BP,APOC1;TBC1D14;PSMB10;RGN;TICAM1;IDH1
19753,GO:1903727,0.197255440278674,0.979747215092119,1,41,positive regulation of phospholipid metabolic process,BP,FABP3
5121,GO:0010942,0.197314582888952,0.902742011648507,6,598,positive regulation of cell death,BP,FADD;TRADD;PYCARD;G0S2;IFI27;S100B
10266,GO:0036152,0.197507408171126,0.979965832756267,1,26,phosphatidylethanolamine acyl-chain remodeling,BP,PLA2G16
19651,GO:1903532,0.198167612271821,0.919150430390242,4,327,positive regulation of secretion by cell,BP,PYCARD;RBP4;ANG;RPH3AL
12041,GO:0045124,0.198194351285203,0.979644137875082,1,34,regulation of bone resorption,BP,PDK4
948,GO:0002224,0.19865418640082,0.950528687855136,2,126,toll-like receptor signaling pathway,BP,FADD;TICAM1
18660,GO:1901031,0.198709895814754,0.979569892224289,1,32,regulation of response to reactive oxygen species,BP,RGN
13963,GO:0051241,0.198912213651315,0.886706678639208,9,976,negative regulation of multicellular organismal process,BP,APOC1;PYCARD;RGN;RBP4;NMI;NOL3;TMEM176A;S100B;LINGO1
5592,GO:0015758,0.199009062201365,0.9503137141286,2,148,glucose transport,BP,RNASEL;HNF1A
796,GO:0001974,0.199063703239899,0.979347921502818,1,42,blood vessel remodeling,BP,NOL3
18209,GO:0098869,0.199492136579127,0.950384831294264,2,90,cellular oxidant detoxification,BP,MGST2;RGN
6165,GO:0016866,0.199800979056663,0.979478816698888,1,26,intramolecular transferase activity,MF,PUS1
14048,GO:0051385,0.200172186256214,0.979275967483505,1,31,response to mineralocorticoid,BP,STAR
14672,GO:0060042,0.200377794265951,0.979022190842698,1,46,retina morphogenesis in camera-type eye,BP,RBP4
13112,GO:0048147,0.200381577266907,0.979230838528982,1,31,negative regulation of fibroblast proliferation,BP,IFI30
17031,GO:0072378,0.201358737444562,0.979115740395211,1,27,blood coagulation, fibrin clot formation,BP,TFPI
4968,GO:0010742,0.201375917977398,0.978958531888869,1,34,macrophage derived foam cell differentiation,BP,ABCG1
17365,GO:0090077,0.201375917977398,0.978958531888869,1,34,foam cell differentiation,BP,ABCG1
12327,GO:0045742,0.201589940161268,0.978911970334301,1,34,positive regulation of epidermal growth factor receptor signaling pathway,BP,DOK1
21087,GO:2000257,0.201793691497522,0.978904732903268,1,32,regulation of protein activation cascade,BP,CFB
3402,GO:0006706,0.202290581271,0.978914046946921,1,27,steroid catabolic process,BP,HSD17B11
9918,GO:0035586,0.202377776399988,0.978955408000236,1,25,purinergic receptor activity,MF,P2RY14
11756,GO:0044344,0.203165541604738,0.948669545456615,2,133,cellular response to fibroblast growth factor stimulus,BP,FGF18;STAR
7471,GO:0030515,0.203368050483972,0.978652354909311,1,28,snoRNA binding,MF,NUDT7
13670,GO:0050802,0.203379687497485,0.978772128608001,1,24,circadian sleep/wake cycle, sleep,BP,STAR
20662,GO:1905952,0.203723434509646,0.948479364926959,2,123,regulation of lipid localization,BP,APOC1;ABCG1
7605,GO:0030833,0.20406382270816,0.948301090951547,2,133,regulation of actin filament polymerization,BP,PYCARD;TMOD4
8407,GO:0032330,0.204211502398878,0.978209817819817,1,43,regulation of chondrocyte differentiation,BP,FGF18
5864,GO:0016298,0.204319666447493,0.948251945181239,2,119,lipase activity,MF,PLA2G16;LYPLAL1
7869,GO:0031304,0.204468086458637,0.97850017545321,1,25,intrinsic component of mitochondrial inner membrane,CC,ETFDH
7870,GO:0031305,0.204468086458637,0.97850017545321,1,25,integral component of mitochondrial inner membrane,CC,ETFDH
13648,GO:0050771,0.20454037777666,0.978077668370011,1,49,negative regulation of axonogenesis,BP,LINGO1
20863,GO:1990748,0.204667968132612,0.948265686387414,2,92,cellular detoxification,BP,MGST2;RGN
10621,GO:0042036,0.204684093545189,0.97836364305333,1,28,negative regulation of cytokine biosynthetic process,BP,NMI
4267,GO:0008645,0.20532642578372,0.947727071413928,2,150,hexose transport,BP,RNASEL;HNF1A
6242,GO:0017046,0.205449717921714,0.978045085716807,1,35,peptide hormone binding,MF,GHR
8054,GO:0031647,0.205626656336334,0.92826107345497,3,230,regulation of protein stability,BP,IFI30;DPM3;PYCARD
572,GO:0001659,0.205799312025633,0.977934764627797,1,37,temperature homeostasis,BP,ACADVL
10916,GO:0042572,0.206203749091446,0.978027644983719,1,28,retinol metabolic process,BP,RBP4
8698,GO:0032733,0.206401636827972,0.977957636019197,1,29,positive regulation of interleukin-10 production,BP,PYCARD
784,GO:0001961,0.206564104254469,0.977814091631576,1,34,positive regulation of cytokine-mediated signaling pathway,BP,FADD
1077,GO:0002444,0.206638644181361,0.896791909160218,6,528,myeloid leukocyte mediated immunity,BP,PNP;PYCARD;HEXB;IDH1;GLA;DERA
728,GO:0001889,0.207137603671448,0.947043162456791,2,130,liver development,BP,RGN;ACAT1
4599,GO:0009615,0.207185922785038,0.914043934720478,4,310,response to virus,BP,FADD;PYCARD;TICAM1;RNASEL
16485,GO:0071450,0.2072560911981,0.977920340440428,1,24,cellular response to oxygen radical,BP,RGN
16486,GO:0071451,0.2072560911981,0.977920340440428,1,24,cellular response to superoxide,BP,RGN
9356,GO:0034260,0.207414161887051,0.977492138287094,1,43,negative regulation of GTPase activity,BP,RGN
13599,GO:0050702,0.207626320720154,0.977557756963675,1,35,interleukin-1 beta secretion,BP,PYCARD
11518,GO:0043624,0.207668589191947,0.927304234413503,3,192,cellular protein complex disassembly,BP,MRPL14;MRPL16;TMOD4
15970,GO:0070482,0.207778854891089,0.913653221724127,4,349,response to oxygen levels,BP,PSMB10;ANG;NOL3;S100B
1092,GO:0002474,0.207969713198377,0.946896616435303,2,93,antigen processing and presentation of peptide antigen via MHC class I,BP,IFI30;PSMB10
743,GO:0001913,0.208541755911832,0.977505216469191,1,28,T cell mediated cytotoxicity,BP,FADD
9511,GO:0034612,0.208669360654054,0.913242718680698,4,278,response to tumor necrosis factor,BP,TRADD;PYCARD;PSMB10;NOL3
5590,GO:0015749,0.208699796122004,0.946320722091783,2,152,monosaccharide transport,BP,RNASEL;HNF1A
2106,GO:0004602,0.209355466230067,0.977633069650742,1,20,glutathione peroxidase activity,MF,MGST2
568,GO:0001655,0.210248634427848,0.925762876122719,3,313,urogenital system development,BP,RGN;RBP4;ACAT1
18857,GO:1901618,0.210357792157695,0.97690408303897,1,37,organic hydroxy compound transmembrane transporter activity,MF,ABCG1
6612,GO:0019432,0.210887185936804,0.976738038773788,1,40,triglyceride biosynthetic process,BP,RGN
7402,GO:0030335,0.211436614255312,0.911509133884338,4,379,positive regulation of cell migration,BP,FADD;PYCARD;FGF18;FAM110C
13719,GO:0050870,0.211578009192262,0.925244941861079,3,208,positive regulation of T cell activation,BP,FADD;PNP;PYCARD
1880,GO:0004177,0.211732129386395,0.976543276731936,1,40,aminopeptidase activity,MF,PEPD
7322,GO:0030225,0.211936285815029,0.976557940638535,1,36,macrophage differentiation,BP,FADD
3209,GO:0006469,0.211940681978519,0.924992035108295,3,238,negative regulation of protein kinase activity,BP,PYCARD;RGN;DEPTOR
16418,GO:0071353,0.21241156357109,0.976548427795498,1,31,cellular response to interleukin-4,BP,SHPK
14886,GO:0060350,0.212698624525513,0.976226017074808,1,48,endochondral bone morphogenesis,BP,FGF18
13275,GO:0048538,0.213018237092769,0.976182671614203,1,45,thymus development,BP,FADD
4594,GO:0009607,0.213680779475914,0.876296965146237,9,827,response to biotic stimulus,BP,FADD;PYCARD;MGST2;TICAM1;RNASEL;SHPK;TFPI;STAR;PRRT1
7932,GO:0031410,0.213735057878587,0.856002355988055,17,2095,cytoplasmic vesicle,CC,EBP;ZFYVE21;SLC31A2;TBC1D14;PNP;ABCG1;PYCARD;TICAM1;ANG;IDUA;HEXB;GRIA3;IDH1;SNX21;GLA;RPH3AL;DERA
4911,GO:0010647,0.213770915614772,0.863777908034504,13,1530,positive regulation of cell communication,BP,FADD;TRADD;PYCARD;G0S2;PSMB10;GHR;FGF18;TICAM1;RBP4;FAM110C;S100B;DOK1;SLC1A3
2825,GO:0005839,0.213783069295867,0.976580143659531,1,21,proteasome core complex,CC,PSMB10
7100,GO:0022410,0.213820914528705,0.9763633755418,1,26,circadian sleep/wake cycle process,BP,STAR
15303,GO:0061008,0.213840533275663,0.944219742148364,2,133,hepaticobiliary system development,BP,RGN;ACAT1
13774,GO:0050954,0.213938262626078,0.94413301211965,2,146,sensory perception of mechanical stimulus,BP,HEXB;SLC1A3
13837,GO:0051050,0.214193883307049,0.880257277302537,8,889,positive regulation of transport,BP,ABCG1;PYCARD;RGN;FXYD1;RBP4;RNASEL;ANG;RPH3AL
13273,GO:0048536,0.214443062324906,0.975975755144077,1,36,spleen development,BP,FADD
7273,GO:0030166,0.214603651311214,0.975697798856562,1,58,proteoglycan biosynthetic process,BP,EXTL1
18023,GO:0097708,0.214617601727234,0.855308056534067,17,2098,intracellular vesicle,CC,EBP;ZFYVE21;SLC31A2;TBC1D14;PNP;ABCG1;PYCARD;TICAM1;ANG;IDUA;HEXB;GRIA3;IDH1;SNX21;GLA;RPH3AL;DERA
15486,GO:0061383,0.214691950175535,0.975769028463349,1,47,trabecula morphogenesis,BP,RBP4
18146,GO:0098754,0.214701500654058,0.944051595250905,2,96,detoxification,BP,MGST2;RGN
3360,GO:0006658,0.214750070440166,0.976031012454939,1,30,phosphatidylserine metabolic process,BP,PLA2G16
8697,GO:0032732,0.214905551729894,0.97586749486956,1,36,positive regulation of interleukin-1 production,BP,PYCARD
12667,GO:0046487,0.214910599972845,0.976048178757021,1,28,glyoxylate metabolic process,BP,IDH1
11625,GO:0044088,0.214931597084349,0.975745756453661,1,44,regulation of vacuole organization,BP,TBC1D14
6262,GO:0017080,0.215453131844368,0.975738973718386,1,36,sodium channel regulator activity,MF,FXYD1
11163,GO:0043043,0.215932107040711,0.884368004961716,7,605,peptide biosynthetic process,BP,MRPL14;MRPL16;BDH2;MGST2;ANG;TSFM;RBMS3
18706,GO:1901186,0.215990094279878,0.975612583532706,1,36,positive regulation of ERBB signaling pathway,BP,DOK1
15177,GO:0060760,0.216448058931253,0.975522941485064,1,35,positive regulation of response to cytokine stimulus,BP,FADD
7606,GO:0030834,0.216702991333784,0.975303701708199,1,46,regulation of actin filament depolymerization,BP,TMOD4
3395,GO:0006699,0.21671862061837,0.975478585440911,1,34,bile acid biosynthetic process,BP,STAR
5947,GO:0016485,0.217353008165599,0.922195178552523,3,222,protein processing,BP,CFB;FADD;NOL3
1231,GO:0002711,0.217420307220993,0.975379236055114,1,31,positive regulation of T cell mediated immunity,BP,FADD
16388,GO:0071312,0.218717848310476,0.974947189983047,1,37,cellular response to alkaloid,BP,STAR
7173,GO:0023056,0.218777433086709,0.859964306527736,13,1538,positive regulation of signaling,BP,FADD;TRADD;PYCARD;G0S2;PSMB10;GHR;FGF18;TICAM1;RBP4;FAM110C;S100B;DOK1;SLC1A3
13601,GO:0050704,0.218836957510836,0.97501896782366,1,32,regulation of interleukin-1 secretion,BP,PYCARD
16675,GO:0071774,0.218988172923175,0.941995849740038,2,139,response to fibroblast growth factor,BP,FGF18;STAR
4529,GO:0009306,0.219180620618654,0.896585261693324,5,480,protein secretion,BP,PNP;PYCARD;RBP4;ANG;RPH3AL
11111,GO:0042981,0.219534447296774,0.861974480909446,12,1363,regulation of apoptotic process,BP,PDK4;FADD;TRADD;PYCARD;G0S2;RGN;NOL3;DEPTOR;CASP4;IFI27;STAR;S100B
12299,GO:0045684,0.219819750276514,0.974761274133197,1,33,positive regulation of epidermis development,BP,TRADD
11154,GO:0043030,0.219867371547298,0.974822519188306,1,30,regulation of macrophage activation,BP,SHPK
18174,GO:0098802,0.220072408845292,0.941437553171653,2,169,plasma membrane receptor complex,CC,GRIA3;CPT1C
12833,GO:0046850,0.220150407153995,0.974525870162773,1,42,regulation of bone remodeling,BP,PDK4
3108,GO:0006308,0.220191948341589,0.974718906076041,1,31,DNA catabolic process,BP,RGN
3222,GO:0006486,0.220285924192915,0.920570919983199,3,261,protein glycosylation,BP,ALG5;DPM3;EXTL1
11393,GO:0043413,0.220285924192915,0.920570919983199,3,261,macromolecule glycosylation,BP,ALG5;DPM3;EXTL1
19424,GO:1903039,0.22103073168753,0.920262960430519,3,217,positive regulation of leukocyte cell-cell adhesion,BP,FADD;PNP;PYCARD
7204,GO:0030042,0.221332727498611,0.974156641805242,1,49,actin filament depolymerization,BP,TMOD4
17227,GO:0080134,0.222832207802375,0.862419049178617,11,1266,regulation of response to stress,BP,CFB;FADD;PYCARD;PSMB10;RGN;TICAM1;NMI;SHPK;NOL3;CASP4;FAM46A
3389,GO:0006691,0.2228896719073,0.974184841042562,1,27,leukotriene metabolic process,BP,MGST2
19031,GO:1902105,0.223222799894897,0.919047868016487,3,239,regulation of leukocyte differentiation,BP,FADD;PNP;TMEM176A
155,GO:0000303,0.223829388090265,0.973956624337807,1,27,response to superoxide,BP,RGN
12329,GO:0045744,0.223984802301347,0.973708066519845,1,35,negative regulation of G-protein coupled receptor protein signaling pathway,BP,RPH3AL
3866,GO:0007610,0.224310912876072,0.893288397724018,5,547,behavior,BP,FADD;HEXB;STAR;S100B;SLC1A3
12873,GO:0046915,0.224831470486136,0.973443235760311,1,38,transition metal ion transmembrane transporter activity,MF,SLC31A2
8732,GO:0032784,0.225056404485575,0.973387628601997,1,38,regulation of DNA-templated transcription, elongation,BP,TSFM
9765,GO:0035306,0.225336746596975,0.973215267076333,1,45,positive regulation of dephosphorylation,BP,RGN
4600,GO:0009617,0.225659023196152,0.884303655632946,6,497,response to bacterium,BP,PYCARD;MGST2;TICAM1;SHPK;TFPI;STAR
1033,GO:0002366,0.225709894723129,0.877618536238386,7,663,leukocyte activation involved in immune response,BP,PNP;PYCARD;TICAM1;HEXB;IDH1;GLA;DERA
10693,GO:0042168,0.225739859743844,0.973424655967583,1,29,heme metabolic process,BP,BDH2
742,GO:0001912,0.226115744986206,0.973249953967192,1,32,positive regulation of leukocyte mediated cytotoxicity,BP,FADD
11175,GO:0043067,0.226258565819804,0.856873201154003,12,1377,regulation of programmed cell death,BP,PDK4;FADD;TRADD;PYCARD;G0S2;RGN;NOL3;DEPTOR;CASP4;IFI27;STAR;S100B
13405,GO:0048771,0.226457265550876,0.938718580934502,2,144,tissue remodeling,BP,PDK4;NOL3
8371,GO:0032270,0.226466126985345,0.856711731118035,12,1396,positive regulation of cellular protein metabolic process,BP,FADD;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;ANG;NMI;IFI27;RBMS3
4264,GO:0008637,0.226737879770724,0.938734998130479,2,113,apoptotic mitochondrial changes,BP,PYCARD;NOL3
3745,GO:0007268,0.226821309571259,0.891665284703449,5,584,chemical synaptic transmission,BP,PXK;GRIA3;STAR;S100B;SLC1A3
18240,GO:0098916,0.226821309571259,0.891665284703449,5,584,anterograde trans-synaptic signaling,BP,PXK;GRIA3;STAR;S100B;SLC1A3
18335,GO:0099536,0.226828325545333,0.891659711151988,5,586,synaptic signaling,BP,PXK;GRIA3;STAR;S100B;SLC1A3
18336,GO:0099537,0.226828325545333,0.891659711151988,5,586,trans-synaptic signaling,BP,PXK;GRIA3;STAR;S100B;SLC1A3
13325,GO:0048641,0.227054330425536,0.972774047177203,1,46,regulation of skeletal muscle tissue development,BP,S100B
18605,GO:1900408,0.227162768548604,0.972863812978622,1,38,negative regulation of cellular response to oxidative stress,BP,NOL3
19333,GO:1902883,0.227162768548604,0.972863812978622,1,38,negative regulation of response to oxidative stress,BP,NOL3
19489,GO:1903202,0.227162768548604,0.972863812978622,1,38,negative regulation of oxidative stress-induced cell death,BP,NOL3
968,GO:0002263,0.22735101824344,0.876480789833848,7,665,cell activation involved in immune response,BP,PNP;PYCARD;TICAM1;HEXB;IDH1;GLA;DERA
17454,GO:0090200,0.227621311222599,0.972990527664241,1,28,positive regulation of release of cytochrome c from mitochondria,BP,PYCARD
5129,GO:0010955,0.228128764917789,0.972640058581443,1,37,negative regulation of protein processing,BP,NOL3
19548,GO:1903318,0.228128764917789,0.972640058581443,1,37,negative regulation of protein maturation,BP,NOL3
1889,GO:0004298,0.228228916638272,0.97314740773376,1,21,threonine-type endopeptidase activity,MF,PSMB10
15682,GO:0070003,0.228228916638272,0.97314740773376,1,21,threonine-type peptidase activity,MF,PSMB10
9919,GO:0035587,0.22852119456121,0.972676871312676,1,31,purinergic receptor signaling pathway,BP,P2RY14
16551,GO:0071549,0.228556432300967,0.972617399970757,1,33,cellular response to dexamethasone stimulus,BP,STAR
4390,GO:0009112,0.228626977188359,0.972514816866533,1,37,nucleobase metabolic process,BP,AOX1
16700,GO:0071822,0.22903853469161,0.852090331407981,13,1516,protein complex subunit organization,BP,MRPL14;MRPL16;FADD;TRADD;PYCARD;HACL1;ANG;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
14574,GO:0055021,0.229063982357487,0.972267272713496,1,46,regulation of cardiac muscle tissue growth,BP,RBP4
12368,GO:0045824,0.229172107921866,0.972396962040143,1,36,negative regulation of innate immune response,BP,NMI
3606,GO:0007033,0.229778044902078,0.937201876558622,2,157,vacuole organization,BP,TBC1D14;HEXB
11012,GO:0042745,0.229818875826739,0.972441465398375,1,28,circadian sleep/wake cycle,BP,STAR
2752,GO:0005730,0.229831876118392,0.869205640182897,8,861,nucleolus,CC,MRI1;PYCARD;ACADVL;FGF18;ARL6IP4;CPT2;ANG;NOL3
4593,GO:0009605,0.230434121187652,0.842782572329576,17,2000,response to external stimulus,BP,CFB;PDK4;FADD;PYCARD;MGST2;FADS1;FGF18;TICAM1;RNASEL;ACAT1;SHPK;CASP4;FAM46A;TFPI;STAR;DOK1;SLC1A3
18904,GO:1901699,0.230540224061096,0.889285090216282,5,574,cellular response to nitrogen compound,BP,PDK4;GHR;RNASEL;CASP4;STAR
19183,GO:1902495,0.230770118209926,0.914868238704147,3,310,transmembrane transporter complex,CC,FXYD1;GRIA3;CPT1C
3555,GO:0006955,0.23079975940016,0.842512249427789,17,1821,immune response,BP,CFB;IFI30;FADD;PNP;PYCARD;PSMB10;TICAM1;RNASEL;NMI;HEXB;CASP4;IFI27;IDH1;STAR;GLA;DERA;S100B
7609,GO:0030837,0.231501602599862,0.971633428725223,1,47,negative regulation of actin filament polymerization,BP,TMOD4
16014,GO:0070555,0.231501799201006,0.936618862494998,2,113,response to interleukin-1,BP,PYCARD;TFPI
2666,GO:0005575,0.231759828839274,0.896649815069076,123,16973,cellular_component,CC,CFB;EBP;PDK4;PECR;TMEM160;TMEM164;USE1;ALG5;PHYH;IFI30;DPM3;ZFYVE21;MSRA;SLC31A2;MRPL14;MRPL16;MRI1;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;HSD17B11;EXTL1;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;CCDC51;G0S2;LAGE3;ACADVL;KRT10;MGST2;ACSM5;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;ARL6IP4;NNMT;CPT2;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;TMEM223;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;ECHDC2;SARDH;F8A1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;HSD3B2;NUDT6;NUDT7;DEPTOR;CPT1C;PCBD1;MDH1;CASP4;IFI27;PON2;TMEM176A;IDH1;DECR1;PUS1;PTMS;LDHD;TMEM98;MDP1;TFPI;STAR;SNX21;WBP1;PEPD;ACP5;GLA;ECI1;CYP11A1;RPH3AL;PRRT1;DERA;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;LYPLAL1;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH;TMOD4
18901,GO:1901685,0.231817085169074,0.972196934805498,1,22,glutathione derivative metabolic process,BP,MGST2
18902,GO:1901687,0.231817085169074,0.972196934805498,1,22,glutathione derivative biosynthetic process,BP,MGST2
5963,GO:0016504,0.231975832215407,0.971684849306861,1,36,peptidase activator activity,MF,PYCARD
16521,GO:0071496,0.232217279972693,0.914139856146588,3,268,cellular response to external stimulus,BP,PDK4;FADD;FADS1
16075,GO:0070670,0.232401265586061,0.971619665260018,1,34,response to interleukin-4,BP,SHPK
4492,GO:0009225,0.232680989291223,0.971548026686128,1,34,nucleotide-sugar metabolic process,BP,GALT
161,GO:0000313,0.232892687451493,0.936300743496474,2,78,organellar ribosome,CC,MRPL14;MRPL16
2775,GO:0005761,0.232892687451493,0.936300743496474,2,78,mitochondrial ribosome,CC,MRPL14;MRPL16
1214,GO:0002694,0.23299697311113,0.887796520375394,5,446,regulation of leukocyte activation,BP,FADD;PNP;PYCARD;TICAM1;SHPK
2632,GO:0005501,0.233100532324698,0.971517075666378,1,31,retinoid binding,MF,RBP4
1781,GO:0004033,0.233493363565742,0.97162582500247,1,25,aldo-keto reductase (NADP) activity,MF,CYB5A
9425,GO:0034394,0.233688833986121,0.971013745324526,1,52,protein localization to cell surface,BP,MRAP
4931,GO:0010676,0.233845738692937,0.971016314919939,1,48,positive regulation of cellular carbohydrate metabolic process,BP,RGN
643,GO:0001773,0.234229999007193,0.971287488865393,1,29,myeloid dendritic cell activation,BP,PYCARD
4393,GO:0009116,0.234570572644993,0.935221732657056,2,116,nucleoside metabolic process,BP,PNP;DERA
11881,GO:0044724,0.234858308550514,0.934985141862287,2,138,single-organism carbohydrate catabolic process,BP,GALT;HEXB
3873,GO:0007618,0.234948837808311,0.970878869393509,1,38,mating,BP,HEXB
18991,GO:1901998,0.235184529222957,0.970857647569036,1,36,toxin transport,BP,ABCG1
13998,GO:0051291,0.235382275989249,0.934843283861901,2,118,protein heterooligomerization,BP,TRADD;PCBD1
2529,GO:0005231,0.235761338431259,0.970516414412086,1,48,excitatory extracellular ligand-gated ion channel activity,MF,GRIA3
7154,GO:0022892,0.235930407138191,0.860063651524032,9,1110,substrate-specific transporter activity,MF,SLC31A2;ABCG1;FXYD1;RBP4;FABP3;GRIA3;STAR;CYB5A;SLC1A3
19033,GO:1902107,0.236225293958699,0.934390751907823,2,132,positive regulation of leukocyte differentiation,BP,FADD;PNP
9160,GO:0033673,0.23632694025232,0.911917632371533,3,251,negative regulation of kinase activity,BP,PYCARD;RGN;DEPTOR
13334,GO:0048662,0.236559247543275,0.970499237390132,1,36,negative regulation of smooth muscle cell proliferation,BP,ANG
3358,GO:0006656,0.236694404546077,0.970485902735769,1,35,phosphatidylcholine biosynthetic process,BP,FABP3
428,GO:0001102,0.236721199652722,0.970397538325505,1,39,RNA polymerase II activating transcription factor binding,MF,IFI27
15724,GO:0070085,0.236764638766298,0.911643805060765,3,269,glycosylation,BP,ALG5;DPM3;EXTL1
5073,GO:0010883,0.236790513292388,0.970328500018714,1,42,regulation of lipid storage,BP,ABCG1
12184,GO:0045429,0.236970150748664,0.970314371636528,1,40,positive regulation of nitric oxide biosynthetic process,BP,TICAM1
20065,GO:1904407,0.236970150748664,0.970314371636528,1,40,positive regulation of nitric oxide metabolic process,BP,TICAM1
21363,GO:2000649,0.237044630472185,0.970204083178284,1,46,regulation of sodium ion transmembrane transporter activity,BP,FXYD1
4438,GO:0009165,0.237182085317779,0.89628206663255,4,309,nucleotide biosynthetic process,BP,MRAP;PNP;NNMT;ACAT1
14600,GO:0055080,0.237370048488806,0.876316775107216,6,624,cation homeostasis,BP,PDK4;SLC31A2;BDH2;RGN;HEXB;NOL3
4366,GO:0009072,0.237412204131918,0.970463014247209,1,29,aromatic amino acid family metabolic process,BP,PCBD1
7129,GO:0022824,0.237612988795047,0.970016856452561,1,49,transmitter-gated ion channel activity,MF,GRIA3
7134,GO:0022835,0.237612988795047,0.970016856452561,1,49,transmitter-gated channel activity,MF,GRIA3
9414,GO:0034381,0.237715127967461,0.97029326382258,1,32,plasma lipoprotein particle clearance,BP,APOC1
4522,GO:0009295,0.238058443515498,0.970064580064097,1,38,nucleoid,CC,ACADVL
10965,GO:0042645,0.238058443515498,0.970064580064097,1,38,mitochondrial nucleoid,CC,ACADVL
4582,GO:0009451,0.23817256304421,0.933586042879982,2,116,RNA modification,BP,HSD17B10;PUS1
3244,GO:0006518,0.238213590393157,0.863237024117867,8,735,peptide metabolic process,BP,MRPL14;MRPL16;BDH2;MGST2;ANG;TSFM;IDH1;RBMS3
3235,GO:0006506,0.238392924044446,0.970115217472591,1,32,GPI anchor biosynthetic process,BP,DPM3
11315,GO:0043279,0.239273668242106,0.932977246921379,2,137,response to alkaloid,BP,FADD;STAR
156,GO:0000305,0.239417443483378,0.969904194123205,1,30,response to oxygen radical,BP,RGN
15813,GO:0070232,0.240003728309395,0.969662693190777,1,33,regulation of T cell apoptotic process,BP,FADD
17460,GO:0090207,0.240199802303165,0.969610631047341,1,33,regulation of triglyceride metabolic process,BP,RGN
11989,GO:0045055,0.240207077637723,0.867452808208142,7,723,regulated exocytosis,BP,PNP;PYCARD;HEXB;IDH1;GLA;RPH3AL;DERA
12358,GO:0045806,0.241022597264239,0.969221469513223,1,41,negative regulation of endocytosis,BP,APOC1
4093,GO:0008347,0.241078797843635,0.969158555275066,1,44,glial cell migration,BP,HEXB
3417,GO:0006734,0.241175145479995,0.96930101081896,1,35,NADH metabolic process,BP,MDH1
1942,GO:0004364,0.24229513736433,0.969435024406743,1,23,glutathione transferase activity,MF,MGST2
21027,GO:2000147,0.242373311564798,0.892985142871844,4,393,positive regulation of cell motility,BP,FADD;PYCARD;FGF18;FAM110C
13305,GO:0048599,0.243062885719014,0.968708359801006,1,39,oocyte development,BP,ANG
3917,GO:0008064,0.243707995063071,0.930871265077351,2,152,regulation of actin polymerization or depolymerization,BP,PYCARD;TMOD4
11792,GO:0044421,0.243711606686723,0.816602510313487,32,3687,extracellular region part,CC,CFB;MSRA;APOC1;PNP;BDH2;KRT10;GHR;FGF18;ETFB;RBP4;ANG;ACAT1;IDUA;AOX1;HEXB;CMBL;FABP3;PCBD1;MDH1;IDH1;DECR1;MDP1;TFPI;PEPD;ACP5;GLA;ECI1;DERA;S100B;CYB5A;LYPLAL1;LINGO1
7604,GO:0030832,0.243715551299884,0.930864240346742,2,153,regulation of actin filament length,BP,PYCARD;TMOD4
18753,GO:1901293,0.243931351256805,0.892133163821264,4,312,nucleoside phosphate biosynthetic process,BP,MRAP;PNP;NNMT;ACAT1
6724,GO:0019840,0.244324873657575,0.96850390592019,1,33,isoprenoid binding,MF,RBP4
13834,GO:0051047,0.244432005157001,0.891754784264937,4,358,positive regulation of secretion,BP,PYCARD;RBP4;ANG;RPH3AL
9280,GO:0034121,0.244651665087211,0.968134647059966,1,48,regulation of toll-like receptor signaling pathway,BP,TICAM1
2124,GO:0004623,0.244674118548204,0.968437300178676,1,32,phospholipase A2 activity,MF,PLA2G16
9572,GO:0034703,0.244954587696414,0.930167075689087,2,197,cation channel complex,CC,GRIA3;CPT1C
14884,GO:0060348,0.245371206953005,0.930027457405943,2,174,bone development,BP,RGN;FGF18
3234,GO:0006505,0.245651008892855,0.968143468911126,1,33,GPI anchor metabolic process,BP,DPM3
11181,GO:0043085,0.246642829330945,0.841157421050077,12,1554,positive regulation of catalytic activity,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;MGST2;PSMB10;RGN;GHR;FGF18;ANG;IFI27
15380,GO:0061134,0.246778527764346,0.906202710423251,3,207,peptidase regulator activity,MF,PYCARD;NOL3;TFPI
16205,GO:0070936,0.246828540364673,0.967535880695753,1,48,protein K48-linked ubiquitination,BP,NMI
13598,GO:0050701,0.246966445664739,0.967623499511499,1,40,interleukin-1 secretion,BP,PYCARD
12764,GO:0046661,0.246970779141736,0.929336290100474,2,155,male sex differentiation,BP,HSD17B3;STAR
7649,GO:0030890,0.24725563692228,0.967583559755715,1,38,positive regulation of B cell proliferation,BP,TICAM1
9398,GO:0034364,0.247593862754638,0.967859345424583,1,26,high-density lipoprotein particle,CC,APOC1
14834,GO:0060291,0.247596895648349,0.96723284612631,1,56,long-term synaptic potentiation,BP,S100B
16368,GO:0071276,0.247707552776679,0.967639479711786,1,31,cellular response to cadmium ion,BP,STAR
13958,GO:0051235,0.247789346630442,0.905462626142943,3,284,maintenance of location,BP,ABCG1;HEXB;NOL3
5292,GO:0014855,0.247795996625268,0.967197508178724,1,54,striated muscle cell proliferation,BP,RBP4
18952,GO:1901880,0.248059098423787,0.967134873384628,1,53,negative regulation of protein depolymerization,BP,TMOD4
18154,GO:0098771,0.24810201298302,0.868944969577692,6,638,inorganic ion homeostasis,BP,PDK4;SLC31A2;BDH2;RGN;HEXB;NOL3
13132,GO:0048193,0.248586723770491,0.904952399230744,3,326,Golgi vesicle transport,BP,USE1;TBC1D14;CNIH4
2691,GO:0005604,0.248591515197914,0.966753363612175,1,89,basement membrane,CC,ANG
3715,GO:0007215,0.248794109774081,0.966755128249307,1,76,glutamate receptor signaling pathway,BP,GRIA3
17606,GO:0090501,0.24892881787749,0.928534335528148,2,127,RNA phosphodiester bond hydrolysis,BP,RNASEL;ANG
13664,GO:0050793,0.249028253175649,0.82964014292937,16,2180,regulation of developmental process,BP,FADD;TRADD;PNP;ABCG1;PSMB10;RGN;FADS1;GHR;FGF18;PLA2G16;RBP4;HEXB;TMEM176A;STAR;S100B;LINGO1
2702,GO:0005635,0.249083915437095,0.88880101062831,4,412,nuclear envelope,CC,EBP;MGST2;IFI27;DHCR7
17907,GO:0097421,0.249118132668293,0.967219522544788,1,32,liver regeneration,BP,RGN
11153,GO:0043029,0.249255847106669,0.966989052469229,1,40,T cell homeostasis,BP,FADD
14125,GO:0051539,0.25000006685323,0.966781344493598,1,40,4 iron, 4 sulfur cluster binding,MF,ETFDH
12749,GO:0046638,0.250631582559264,0.966645442013943,1,38,positive regulation of alpha-beta T cell differentiation,BP,PNP
20753,GO:1990351,0.250930731778585,0.903632031388921,3,317,transporter complex,CC,FXYD1;GRIA3;CPT1C
3204,GO:0006461,0.251397031801451,0.840684326071933,11,1312,protein complex assembly,BP,FADD;TRADD;PYCARD;HACL1;ANG;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
15843,GO:0070271,0.251397031801451,0.840684326071933,11,1312,protein complex biogenesis,BP,FADD;TRADD;PYCARD;HACL1;ANG;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
8568,GO:0032535,0.251691883297295,0.903203444323689,3,313,regulation of cellular component size,BP,PYCARD;DEPTOR;TMOD4
6667,GO:0019692,0.251911971475582,0.966542553075928,1,29,deoxyribose phosphate metabolic process,BP,DERA
16715,GO:0071855,0.251917809222151,0.966621319669702,1,27,neuropeptide receptor binding,MF,MRAP
16452,GO:0071398,0.251945389274435,0.96605385600682,1,52,cellular response to fatty acid,BP,PDK4
15751,GO:0070126,0.251968864119028,0.927430001310178,2,85,mitochondrial translational termination,BP,MRPL14;MRPL16
19200,GO:1902533,0.252112141487324,0.853035976693567,8,885,positive regulation of intracellular signal transduction,BP,FADD;TRADD;PYCARD;GHR;FGF18;TICAM1;FAM110C;S100B
13986,GO:0051272,0.252500270820794,0.886669995933304,4,403,positive regulation of cellular component movement,BP,FADD;PYCARD;FGF18;FAM110C
1640,GO:0003730,0.252935374862021,0.965719163800028,1,57,mRNA 3'-UTR binding,MF,RBMS3
6613,GO:0019433,0.253073247952892,0.966084170896057,1,33,triglyceride catabolic process,BP,FABP3
14941,GO:0060420,0.253203613547851,0.96570800556385,1,51,regulation of heart growth,BP,RBP4
10879,GO:0042517,0.253384847453259,0.965915849128488,1,36,positive regulation of tyrosine phosphorylation of Stat3 protein,BP,GHR
1881,GO:0004180,0.253812246923889,0.965770699473932,1,37,carboxypeptidase activity,MF,PEPD
7900,GO:0031343,0.254389809581146,0.965630480648031,1,36,positive regulation of cell killing,BP,FADD
4515,GO:0009262,0.255641027398827,0.96541837958399,1,31,deoxyribonucleotide metabolic process,BP,DERA
5490,GO:0015370,0.255645666467955,0.964972662200521,1,54,solute:sodium symporter activity,MF,SLC1A3
3442,GO:0006778,0.25585759618366,0.965211316023953,1,36,porphyrin-containing compound metabolic process,BP,BDH2
6843,GO:0021545,0.25586416083339,0.964984488924569,1,48,cranial nerve development,BP,SLC1A3
9335,GO:0034220,0.256410511682366,0.84982134098815,8,1015,ion transmembrane transport,BP,SLC31A2;RGN;CPT2;FXYD1;GRIA3;NOL3;CYB5A;SLC1A3
1041,GO:0002376,0.256461629340637,0.81439009713919,22,2604,immune system process,BP,CFB;EBP;IFI30;FADD;PNP;PYCARD;PSMB10;TICAM1;RBP4;RNASEL;NMI;SHPK;HEXB;CASP4;IFI27;TMEM176A;IDH1;PTMS;STAR;GLA;DERA;S100B
2703,GO:0005637,0.256623111711747,0.964725410599647,1,51,nuclear inner membrane,CC,IFI27
13605,GO:0050708,0.256730274454626,0.884020543820226,4,386,regulation of protein secretion,BP,PYCARD;RBP4;ANG;RPH3AL
13643,GO:0050766,0.256868125511046,0.96473970424352,1,45,positive regulation of phagocytosis,BP,PYCARD
7444,GO:0030431,0.256928137252276,0.964929756976705,1,35,sleep,BP,STAR
4708,GO:0009994,0.257663859338514,0.964580307163637,1,41,oocyte differentiation,BP,ANG
11182,GO:0043086,0.258106422460628,0.848640391900909,8,811,negative regulation of catalytic activity,BP,APOC1;PYCARD;PSMB10;RGN;NOL3;DEPTOR;TFPI;GLA
12191,GO:0045471,0.258866697112718,0.923766700859472,2,130,response to ethanol,BP,RBP4;STAR
12040,GO:0045123,0.259013143062936,0.964100165257107,1,46,cellular extravasation,BP,FADD
2046,GO:0004519,0.259051592586337,0.923704515823091,2,125,endonuclease activity,MF,RNASEL;ANG
13934,GO:0051193,0.259421782697391,0.963897194279736,1,52,regulation of cofactor metabolic process,BP,PDK4
13937,GO:0051196,0.259421782697391,0.963897194279736,1,52,regulation of coenzyme metabolic process,BP,PDK4
10805,GO:0042398,0.259764461228113,0.964010478309499,1,39,cellular modified amino acid biosynthetic process,BP,MGST2
1281,GO:0002790,0.260020175575719,0.869881785507297,5,511,peptide secretion,BP,PNP;PYCARD;RBP4;ANG;RPH3AL
3344,GO:0006636,0.260636068843179,0.963777963454153,1,38,unsaturated fatty acid biosynthetic process,BP,FADS1
11205,GO:0043124,0.260766650878814,0.96345526307106,1,56,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,PYCARD
14030,GO:0051348,0.261351514461608,0.881137197359159,4,345,negative regulation of transferase activity,BP,PYCARD;PSMB10;RGN;DEPTOR
18809,GO:1901505,0.262421762360554,0.963252306145017,1,38,carbohydrate derivative transporter activity,MF,ABCG1
8877,GO:0033002,0.262823539431702,0.921692181924696,2,164,muscle cell proliferation,BP,RBP4;ANG
6194,GO:0016903,0.26303602016781,0.962947698009326,1,44,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,AOX1
4561,GO:0009409,0.263205054839743,0.962897426140072,1,44,response to cold,BP,ACADVL
5572,GO:0015718,0.264115657197206,0.921125512909793,2,146,monocarboxylic acid transport,BP,CPT2;FABP3
1291,GO:0002819,0.264288177305494,0.921129058634182,2,128,regulation of adaptive immune response,BP,FADD;PYCARD
4832,GO:0010518,0.264572555683933,0.962394964167321,1,50,positive regulation of phospholipase activity,BP,ANG
7499,GO:0030574,0.265805632742789,0.961854791636663,1,66,collagen catabolic process,BP,PEPD
1848,GO:0004129,0.265941427806162,0.962629397800565,1,26,cytochrome-c oxidase activity,MF,CYB5A
5328,GO:0015002,0.265941427806162,0.962629397800565,1,26,heme-copper terminal oxidase activity,MF,CYB5A
6058,GO:0016676,0.265941427806162,0.962629397800565,1,26,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,CYB5A
15089,GO:0060627,0.26607020287932,0.877996263574471,4,441,regulation of vesicle-mediated transport,BP,APOC1;TBC1D14;PYCARD;RPH3AL
11287,GO:0043242,0.266327528620821,0.961791254335028,1,56,negative regulation of protein complex disassembly,BP,TMOD4
4262,GO:0008631,0.266381348002197,0.961945711883724,1,44,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,NOL3
3592,GO:0007015,0.267069106294041,0.894262084737632,3,328,actin filament organization,BP,PYCARD;ANG;TMOD4
1207,GO:0002687,0.267164224405418,0.919804983877985,2,113,positive regulation of leukocyte migration,BP,FADD;PYCARD
16550,GO:0071548,0.267376787941948,0.96170346379407,1,41,response to dexamethasone,BP,STAR
7158,GO:0022904,0.267682204789261,0.919685246694168,2,97,respiratory electron transport chain,BP,ETFB;ETFDH
11426,GO:0043488,0.268344068157649,0.9190786749284,2,136,regulation of mRNA stability,BP,PSMB10;RNASEL
5022,GO:0010823,0.268681059537834,0.961267113264599,1,43,negative regulation of mitochondrion organization,BP,NOL3
21003,GO:2000107,0.268710010671621,0.961278058926442,1,42,negative regulation of leukocyte apoptotic process,BP,FADD
4824,GO:0010507,0.268788974483775,0.961009114045107,1,59,negative regulation of autophagy,BP,TBC1D14
7099,GO:0022409,0.268928387739217,0.893313887650042,3,244,positive regulation of cell-cell adhesion,BP,FADD;PNP;PYCARD
13714,GO:0050865,0.269502132708766,0.86345695137344,5,479,regulation of cell activation,BP,FADD;PNP;PYCARD;TICAM1;SHPK
11286,GO:0043241,0.269605467114331,0.892957419176631,3,227,protein complex disassembly,BP,MRPL14;MRPL16;TMOD4
11804,GO:0044437,0.26966704436666,0.863309511510531,5,517,vacuolar part,CC,IFI30;PYCARD;IDUA;HEXB;GLA
9530,GO:0034641,0.27174775354625,0.786470887621906,46,6132,cellular nitrogen compound metabolic process,BP,MRPL14;MRPL16;FADD;MRAP;TRADD;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;MGST2;PSMB10;RGN;FADS1;GHR;ASAH2;TICAM1;ARL6IP4;NNMT;HSD17B10;GALT;RNASEL;ANG;NMI;ACAT1;TSFM;AOX1;SARDH;SHPK;HEXB;NOL3;NUDT7;CPT1C;PCBD1;MDH1;IFI27;IDH1;PUS1;PTMS;ACP5;GLA;DERA;PTS;RBMS3;HNF1A
1172,GO:0002639,0.27197362606514,0.960451138901378,1,35,positive regulation of immunoglobulin production,BP,RBP4
2661,GO:0005546,0.272019748152099,0.96003362081558,1,57,phosphatidylinositol-4,5-bisphosphate binding,MF,SNX21
6057,GO:0016675,0.272248594564749,0.960677275819474,1,27,oxidoreductase activity, acting on a heme group of donors,MF,CYB5A
9678,GO:0035091,0.27232445252588,0.916836091665414,2,211,phosphatidylinositol binding,MF,PXK;SNX21
10707,GO:0042220,0.272860181140838,0.959862337630167,1,50,response to cocaine,BP,FADD
9576,GO:0034707,0.273125261168996,0.959779808026349,1,50,chloride channel complex,CC,FXYD1
8071,GO:0031669,0.273349291591734,0.916431570639957,2,169,cellular response to nutrient levels,BP,PDK4;FADS1
7157,GO:0022900,0.273358065017158,0.916831168566562,2,99,electron transport chain,BP,ETFB;ETFDH
7921,GO:0031396,0.274219194099937,0.890148328243758,3,252,regulation of protein ubiquitination,BP,PSMB10;TICAM1;NMI
1649,GO:0003779,0.27429872353231,0.889891734239896,3,393,actin binding,MF,PXK;ANG;TMOD4
6746,GO:0019882,0.274301123396978,0.890175316404169,3,223,antigen processing and presentation,BP,IFI30;PYCARD;PSMB10
4920,GO:0010660,0.274450757773186,0.959413204783545,1,47,regulation of muscle cell apoptotic process,BP,NOL3
2659,GO:0005544,0.275243993428205,0.959181836883934,1,46,calcium-dependent phospholipid binding,MF,RPH3AL
5975,GO:0016529,0.275893467737123,0.958797640562405,1,59,sarcoplasmic reticulum,CC,NOL3
4005,GO:0008206,0.276131857142479,0.958920792040373,1,45,bile acid metabolic process,BP,STAR
14875,GO:0060338,0.276263382342667,0.958984131756759,1,40,regulation of type I interferon-mediated signaling pathway,BP,FADD
6306,GO:0017158,0.276577383721265,0.958522094936843,1,65,regulation of calcium ion-dependent exocytosis,BP,RPH3AL
9392,GO:0034358,0.276711621120889,0.958919814151597,1,37,plasma lipoprotein particle,CC,APOC1
20874,GO:1990777,0.276711621120889,0.958919814151597,1,37,lipoprotein particle,CC,APOC1
5108,GO:0010923,0.27739846508469,0.958260994246294,1,65,negative regulation of phosphatase activity,BP,RGN
1261,GO:0002758,0.277519304873613,0.888140992533008,3,264,innate immune response-activating signal transduction,BP,FADD;PSMB10;TICAM1
783,GO:0001960,0.27752101186914,0.958542335685672,1,42,negative regulation of cytokine-mediated signaling pathway,BP,NOL3
12590,GO:0046324,0.277743159046175,0.958189503527028,1,61,regulation of glucose import,BP,RNASEL
19607,GO:1903428,0.278792147729885,0.958041748972036,1,47,positive regulation of reactive oxygen species biosynthetic process,BP,TICAM1
946,GO:0002221,0.278950526549781,0.913594121198352,2,165,pattern recognition receptor signaling pathway,BP,FADD;TICAM1
11425,GO:0043487,0.279130298398214,0.913589651443246,2,144,regulation of RNA stability,BP,PSMB10;RNASEL
18114,GO:0098657,0.279255447465532,0.957649428245419,1,67,import into cell,BP,SLC1A3
10589,GO:0040017,0.279488560918353,0.869268863339071,4,421,positive regulation of locomotion,BP,FADD;PYCARD;FGF18;FAM110C
12414,GO:0045913,0.279533883902696,0.957606330884128,1,62,positive regulation of carbohydrate metabolic process,BP,RGN
19123,GO:1902305,0.279607836441625,0.957649232587263,1,56,regulation of sodium ion transmembrane transport,BP,FXYD1
5406,GO:0015179,0.280247322552673,0.957496995310423,1,52,L-amino acid transmembrane transporter activity,MF,SLC1A3
3439,GO:0006775,0.280514482382983,0.95761161320251,1,41,fat-soluble vitamin metabolic process,BP,CYP11A1
8650,GO:0032653,0.28177512505005,0.957183921406187,1,42,regulation of interleukin-10 production,BP,PYCARD
8648,GO:0032651,0.28192635511744,0.957053886721314,1,46,regulation of interleukin-1 beta production,BP,PYCARD
3172,GO:0006415,0.282457175586163,0.91218625256223,2,100,translational termination,BP,MRPL14;MRPL16
8473,GO:0032412,0.28269602129488,0.911600665778184,2,184,regulation of ion transmembrane transporter activity,BP,RGN;FXYD1
8372,GO:0032271,0.282748326362313,0.911633080125304,2,166,regulation of protein polymerization,BP,PYCARD;TMOD4
964,GO:0002253,0.28299964266355,0.85407843963082,5,507,activation of immune response,BP,CFB;FADD;PYCARD;PSMB10;TICAM1
12648,GO:0046461,0.283702342426307,0.956633264153968,1,39,neutral lipid catabolic process,BP,FABP3
12651,GO:0046464,0.283702342426307,0.956633264153968,1,39,acylglycerol catabolic process,BP,FABP3
10773,GO:0042345,0.28394740045833,0.9564175571241,1,45,regulation of NF-kappaB import into nucleus,BP,NOL3
10776,GO:0042348,0.28394740045833,0.9564175571241,1,45,NF-kappaB import into nucleus,BP,NOL3
9681,GO:0035094,0.284766836769735,0.956112409454034,1,47,response to nicotine,BP,STAR
4266,GO:0008643,0.28525868318536,0.910277444347866,2,181,carbohydrate transport,BP,RNASEL;HNF1A
8475,GO:0032414,0.285364503240693,0.955670633356731,1,66,positive regulation of ion transmembrane transporter activity,BP,RGN
11031,GO:0042771,0.286192627048631,0.955724830766648,1,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,PYCARD
15322,GO:0061035,0.286200393092619,0.955455896952483,1,60,regulation of cartilage development,BP,FGF18
20074,GO:1904427,0.286449650447287,0.955477326329315,1,52,positive regulation of calcium ion transmembrane transport,BP,RGN
4021,GO:0008234,0.287091162158549,0.909325670860902,2,179,cysteine-type peptidase activity,MF,PYCARD;CASP4
8045,GO:0031638,0.287844438902495,0.955226922769591,1,41,zymogen activation,BP,FADD
12888,GO:0046942,0.288491730508207,0.88139236604906,3,297,carboxylic acid transport,BP,CPT2;FABP3;SLC1A3
8873,GO:0032994,0.288781086974997,0.954968429037419,1,39,protein-lipid complex,CC,APOC1
14035,GO:0051353,0.288860055989868,0.954762409808653,1,47,positive regulation of oxidoreductase activity,BP,RGN
12884,GO:0046934,0.289237163608476,0.954384117328361,1,66,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,FGF18
10878,GO:0042516,0.289750155897761,0.954547827149157,1,43,regulation of tyrosine phosphorylation of Stat3 protein,BP,GHR
6098,GO:0016763,0.290408631279971,0.954245651825775,1,47,transferase activity, transferring pentosyl groups,MF,PNP
12189,GO:0045453,0.291088115594472,0.953948088163608,1,51,bone resorption,BP,PDK4
8622,GO:0032613,0.291900841894379,0.953805581733713,1,44,interleukin-10 production,BP,PYCARD
8781,GO:0032845,0.291943390352334,0.906773469410962,2,177,negative regulation of homeostatic process,BP,FADD;NOL3
14171,GO:0051604,0.292286646350215,0.879143414993635,3,251,protein maturation,BP,CFB;FADD;NOL3
8069,GO:0031667,0.292659689284045,0.860504905719385,4,403,response to nutrient levels,BP,PDK4;FADS1;ACAT1;STAR
4917,GO:0010657,0.292723531682614,0.953396435347898,1,51,muscle cell apoptotic process,BP,NOL3
4995,GO:0010771,0.293152092077653,0.952993083420046,1,74,negative regulation of cell morphogenesis involved in differentiation,BP,LINGO1
3611,GO:0007040,0.293380139522085,0.953113368701263,1,55,lysosome organization,BP,HEXB
17234,GO:0080171,0.293380139522085,0.953113368701263,1,55,lytic vacuole organization,BP,HEXB
14589,GO:0055065,0.293664370680493,0.846525221090018,5,537,metal ion homeostasis,BP,SLC31A2;BDH2;RGN;HEXB;NOL3
10869,GO:0042503,0.294325897311247,0.952985674358588,1,44,tyrosine phosphorylation of Stat3 protein,BP,GHR
1076,GO:0002443,0.294696302389639,0.827540410358238,7,717,leukocyte mediated immunity,BP,FADD;PNP;PYCARD;HEXB;IDH1;GLA;DERA
17701,GO:0097028,0.294707939878326,0.952953225438331,1,40,dendritic cell differentiation,BP,TMEM176A
13978,GO:0051260,0.29477329200491,0.877524566033533,3,283,protein homooligomerization,BP,ACAT1;PCBD1;DECR1
11436,GO:0043502,0.295021122873278,0.952414232728644,1,67,regulation of muscle adaptation,BP,NOL3
8373,GO:0032272,0.29512120324746,0.952479311395362,1,58,negative regulation of protein polymerization,BP,TMOD4
6234,GO:0017022,0.29535173907694,0.952413331108948,1,57,myosin binding,MF,PYCARD
9641,GO:0035004,0.295395374063032,0.952225080993263,1,74,phosphatidylinositol 3-kinase activity,MF,FGF18
11868,GO:0044707,0.295404411318601,0.76720835601829,41,5907,single-multicellular organism process,BP,EBP;PDK4;ALG5;FADD;HSD17B3;APOC1;TRADD;EXTL1;PNP;ABCG1;EBF1;PYCARD;ACADVL;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;NNMT;PLA2G16;FXYD1;RBP4;ANG;NMI;ACAT1;HEXB;NOL3;FAM46A;TMEM176A;IDH1;TFPI;STAR;PEPD;S100B;DHCR7;PTS;HNF1A;DOK1;SLC1A3;LINGO1
11632,GO:0044106,0.295553281855756,0.905153778167192,2,118,cellular amine metabolic process,BP,PSMB10;SARDH
13980,GO:0051262,0.295878936964392,0.904835801229467,2,140,protein tetramerization,BP,PCBD1;DECR1
3908,GO:0008047,0.29682275828773,0.857601411888098,4,484,enzyme activator activity,MF,APOC1;TBC1D14;PYCARD;MGST2
2517,GO:0005215,0.296900276231522,0.80878036995429,10,1294,transporter activity,MF,EBP;SLC31A2;ABCG1;FXYD1;RBP4;FABP3;GRIA3;STAR;CYB5A;SLC1A3
14499,GO:0052813,0.296974896448642,0.951722633826876,1,69,phosphatidylinositol bisphosphate kinase activity,MF,FGF18
13965,GO:0051247,0.297272598962749,0.800781012023738,12,1485,positive regulation of protein metabolic process,BP,FADD;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;ANG;NMI;IFI27;RBMS3
19780,GO:1903779,0.29825733171877,0.951268873875815,1,70,regulation of cardiac conduction,BP,FXYD1
1203,GO:0002683,0.298704628218619,0.856449021182377,4,373,negative regulation of immune system process,BP,FADD;TICAM1;NMI;TMEM176A
13690,GO:0050829,0.298765237514689,0.951563701528593,1,40,defense response to Gram-negative bacterium,BP,PYCARD
1282,GO:0002791,0.298820695225549,0.856316947130816,4,412,regulation of peptide secretion,BP,PYCARD;RBP4;ANG;RPH3AL
6230,GO:0017016,0.298942829570104,0.902816824664459,2,268,Ras GTPase binding,MF,TBC1D14;RPH3AL
6103,GO:0016773,0.300065384172527,0.841817093712867,5,752,phosphotransferase activity, alcohol group as acceptor,MF,PDK4;ZFYVE21;FGF18;RNASEL;SHPK
11505,GO:0043604,0.300291102143711,0.823310068510669,7,676,amide biosynthetic process,BP,MRPL14;MRPL16;BDH2;MGST2;ANG;TSFM;RBMS3
5120,GO:0010941,0.300532558389565,0.798115825336545,12,1470,regulation of cell death,BP,PDK4;FADD;TRADD;PYCARD;G0S2;RGN;NOL3;DEPTOR;CASP4;IFI27;STAR;S100B
7895,GO:0031338,0.301545481477078,0.950156704614624,1,66,regulation of vesicle fusion,BP,TBC1D14
13836,GO:0051049,0.301696419517083,0.793923850129003,13,1748,regulation of transport,BP,SLC31A2;APOC1;TBC1D14;ABCG1;PYCARD;RGN;FXYD1;RBP4;RNASEL;ANG;NOL3;IFI27;RPH3AL
1266,GO:0002763,0.301734666750675,0.950307598794936,1,50,positive regulation of myeloid leukocyte differentiation,BP,FADD
15178,GO:0060761,0.301926079558879,0.950318588060451,1,46,negative regulation of response to cytokine stimulus,BP,NOL3
14047,GO:0051384,0.302096355775796,0.901460130519809,2,144,response to glucocorticoid,BP,STAR;S100B
14220,GO:0051707,0.302435345912232,0.814907770409686,8,790,response to other organism,BP,FADD;PYCARD;MGST2;TICAM1;RNASEL;SHPK;TFPI;STAR
11262,GO:0043207,0.302728173975776,0.814678475669001,8,791,response to external biotic stimulus,BP,FADD;PYCARD;MGST2;TICAM1;RNASEL;SHPK;TFPI;STAR
7156,GO:0022898,0.303101542952262,0.900725285025404,2,190,regulation of transmembrane transporter activity,BP,RGN;FXYD1
12387,GO:0045859,0.303142713316996,0.829293541209748,6,723,regulation of protein kinase activity,BP,PYCARD;RGN;GHR;FGF18;ANG;DEPTOR
20957,GO:2000026,0.303372839903472,0.795749553815827,12,1660,regulation of multicellular organismal development,BP,FADD;TRADD;PNP;PSMB10;RGN;FGF18;PLA2G16;RBP4;TMEM176A;STAR;S100B;LINGO1
3798,GO:0007409,0.30359089315111,0.87178904238403,3,416,axonogenesis,BP,S100B;DOK1;LINGO1
17799,GO:0097193,0.303852414435488,0.871832132484967,3,273,intrinsic apoptotic signaling pathway,BP,PYCARD;NOL3;CASP4
14571,GO:0055017,0.303998008861354,0.949278660413259,1,67,cardiac muscle tissue growth,BP,RBP4
19488,GO:1903201,0.304126891187453,0.949396528464586,1,54,regulation of oxidative stress-induced cell death,BP,NOL3
4022,GO:0008235,0.304249773414659,0.949337567442328,1,55,metalloexopeptidase activity,MF,PEPD
14577,GO:0055024,0.304620956420298,0.949067184994454,1,66,regulation of cardiac muscle tissue development,BP,RBP4
24,GO:0000045,0.304623417722916,0.949036209816179,1,69,autophagosome assembly,BP,TBC1D14
9763,GO:0035304,0.304992732216498,0.948991464093661,1,61,regulation of protein dephosphorylation,BP,RGN
13452,GO:0048871,0.305690388361018,0.870573003011253,3,320,multicellular organismal homeostasis,BP,PDK4;ACADVL;RBP4
19740,GO:1903708,0.305777709157462,0.899362082856915,2,162,positive regulation of hemopoiesis,BP,FADD;PNP
11791,GO:0044420,0.306278761056626,0.948176412449026,1,115,extracellular matrix component,CC,ANG
3612,GO:0007041,0.306374646438115,0.948324738638071,1,79,lysosomal transport,BP,USE1
14028,GO:0051346,0.306977256305257,0.850759229614358,4,384,negative regulation of hydrolase activity,BP,APOC1;RGN;NOL3;TFPI
3532,GO:0006915,0.307055684321273,0.78660512977472,14,1763,apoptotic process,BP,PDK4;FADD;TRADD;PYCARD;G0S2;RGN;ASAH2;TICAM1;NOL3;DEPTOR;CASP4;IFI27;STAR;S100B
7277,GO:0030170,0.307222793469639,0.948419822236893,1,47,pyridoxal phosphate binding,MF,ACCS
15848,GO:0070279,0.307222793469639,0.948419822236893,1,47,vitamin B6 binding,MF,ACCS
13257,GO:0048512,0.307351452425614,0.94844129100054,1,44,circadian behavior,BP,STAR
9764,GO:0035305,0.308180613009995,0.947712835960022,1,74,negative regulation of dephosphorylation,BP,RGN
18951,GO:1901879,0.308329986796657,0.947735389162394,1,66,regulation of protein depolymerization,BP,TMOD4
10122,GO:0035914,0.308428564587659,0.947745506744163,1,62,skeletal muscle cell differentiation,BP,S100B
11683,GO:0044243,0.309442626932451,0.947254870909884,1,74,multicellular organismal catabolic process,BP,PEPD
8065,GO:0031663,0.309776649976196,0.947459083944718,1,49,lipopolysaccharide-mediated signaling pathway,BP,TICAM1
5642,GO:0015849,0.309812415346887,0.867960979175101,3,305,organic acid transport,BP,CPT2;FABP3;SLC1A3
18465,GO:1900076,0.310378724252013,0.947002409198398,1,65,regulation of cellular response to insulin stimulus,BP,RNASEL
4831,GO:0010517,0.310463552303195,0.947032314030061,1,60,regulation of phospholipase activity,BP,ANG
4382,GO:0009101,0.310745169896103,0.867315631367087,3,332,glycoprotein biosynthetic process,BP,ALG5;DPM3;EXTL1
5805,GO:0016192,0.31093792039488,0.786242500462467,13,1770,vesicle-mediated transport,BP,USE1;ZFYVE21;APOC1;TBC1D14;PNP;PYCARD;GHR;HEXB;IDH1;GLA;RPH3AL;DERA;CNIH4
6570,GO:0019320,0.311160042059663,0.946956680920534,1,49,hexose catabolic process,BP,GALT
6908,GO:0021675,0.311176692821626,0.946649096136869,1,71,nerve development,BP,SLC1A3
9135,GO:0033613,0.311730520027724,0.946519791643558,1,64,activating transcription factor binding,MF,IFI27
1558,GO:0003333,0.311768182515987,0.946472522309775,1,67,amino acid transmembrane transport,BP,SLC1A3
3877,GO:0007622,0.312170203725951,0.946675232896711,1,45,rhythmic behavior,BP,STAR
20360,GO:1905037,0.312241533677866,0.946249070817275,1,72,autophagosome organization,BP,TBC1D14
11803,GO:0044433,0.312372461113081,0.792069092058968,11,1367,cytoplasmic vesicle part,CC,ZFYVE21;PNP;PYCARD;TICAM1;HEXB;GRIA3;IDH1;SNX21;GLA;RPH3AL;DERA
15706,GO:0070059,0.31292650941435,0.946203795532929,1,55,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,CASP4
19550,GO:1903320,0.313635863756891,0.865559721290425,3,274,regulation of protein modification by small protein conjugation or removal,BP,PSMB10;TICAM1;NMI
13371,GO:0048708,0.313792490697158,0.945785626289371,1,62,astrocyte differentiation,BP,S100B
17647,GO:0090630,0.314055080088743,0.945497753144098,1,82,activation of GTPase activity,BP,TBC1D14
5616,GO:0015807,0.314211647813904,0.945618298778554,1,63,L-amino acid transport,BP,SLC1A3
7109,GO:0022604,0.315078399283612,0.864410910708412,3,414,regulation of cell morphogenesis,BP,HEXB;S100B;LINGO1
5167,GO:0012501,0.315441181452894,0.776923249643035,15,1885,programmed cell death,BP,PDK4;FADD;TRADD;PYCARD;G0S2;KRT10;RGN;ASAH2;TICAM1;NOL3;DEPTOR;CASP4;IFI27;STAR;S100B
18302,GO:0099094,0.316429596249225,0.944620633425944,1,81,ligand-gated cation channel activity,MF,GRIA3
4530,GO:0009308,0.316485311841689,0.893621480070315,2,125,amine metabolic process,BP,PSMB10;SARDH
12748,GO:0046637,0.316627238789096,0.944868365908611,1,53,regulation of alpha-beta T cell differentiation,BP,PNP
10586,GO:0040014,0.316825865843672,0.944622261133054,1,65,regulation of multicellular organism growth,BP,GHR
11234,GO:0043169,0.316940425261261,0.757920056511546,26,4015,cation binding,MF,PHYH;ZFYVE21;APOC1;EBF1;ACSM5;RGN;HACL1;GALT;CYP17A1;RNASEL;ANG;ACAT1;AOX1;NOL3;NUDT7;PON2;IDH1;MDP1;PEPD;ACP5;CYP11A1;RPH3AL;S100B;CYB5A;PTS;ETFDH
8434,GO:0032370,0.317133118793558,0.944679764256121,1,53,positive regulation of lipid transport,BP,ABCG1
12002,GO:0045071,0.31772568396016,0.94451465527616,1,50,negative regulation of viral genome replication,BP,RNASEL
4647,GO:0009791,0.317959332498647,0.944004244077379,1,87,post-embryonic development,BP,DHCR7
5273,GO:0014823,0.318715869736954,0.944021094546737,1,57,response to activity,BP,STAR
508,GO:0001541,0.319892733598485,0.943609870059329,1,55,ovarian follicle development,BP,ANG
11376,GO:0043393,0.319954069141164,0.89136642068858,2,180,regulation of protein binding,BP,TICAM1;PCBD1
8838,GO:0032940,0.322178399102305,0.783980132196403,11,1364,secretion by cell,BP,USE1;PNP;PYCARD;RBP4;ANG;HEXB;IDH1;GLA;RPH3AL;DERA;SLC1A3
12746,GO:0046635,0.322505303021459,0.942712084202646,1,50,positive regulation of alpha-beta T cell activation,BP,PNP
8729,GO:0032781,0.322719649338431,0.942797490418317,1,43,positive regulation of ATPase activity,BP,RGN
21644,GO:2001242,0.322789082509509,0.889917962796549,2,144,regulation of intrinsic apoptotic signaling pathway,BP,PYCARD;NOL3
15812,GO:0070231,0.323417374170944,0.942407268275167,1,48,T cell apoptotic process,BP,FADD
3173,GO:0006417,0.324050482764282,0.858645819270944,3,329,regulation of translation,BP,ANG;TSFM;RBMS3
13324,GO:0048640,0.324375113293867,0.941662207738966,1,74,negative regulation of developmental growth,BP,RBP4
8620,GO:0032611,0.32454339074773,0.941822303718971,1,56,interleukin-1 beta production,BP,PYCARD
9376,GO:0034332,0.325731154045507,0.940891256395657,1,114,adherens junction organization,BP,ANG
2105,GO:0004601,0.326212400436434,0.941461801145968,1,43,peroxidase activity,MF,MGST2
8628,GO:0032623,0.326737474264925,0.940959302218439,1,57,interleukin-2 production,BP,PNP
13949,GO:0051223,0.326743622057472,0.811394928524615,6,719,regulation of protein transport,BP,PYCARD;RBP4;ANG;NOL3;IFI27;RPH3AL
10401,GO:0036498,0.327191920270001,0.940682025777604,1,64,IRE1-mediated unfolded protein response,BP,ACADVL
8919,GO:0033077,0.32736239814838,0.940567306033113,1,68,T cell differentiation in thymus,BP,FADD
4873,GO:0010595,0.32746105043036,0.940517656932275,1,69,positive regulation of endothelial cell migration,BP,FGF18
5133,GO:0010959,0.327584586532088,0.856333371303662,3,313,regulation of metal ion transport,BP,SLC31A2;RGN;FXYD1
329,GO:0000904,0.328454704332944,0.835432037700925,4,634,cell morphogenesis involved in differentiation,BP,S100B;DOK1;SLC1A3;LINGO1
4698,GO:0009967,0.32854713293152,0.778677267335714,11,1402,positive regulation of signal transduction,BP,FADD;TRADD;PYCARD;G0S2;PSMB10;GHR;FGF18;TICAM1;FAM110C;S100B;DOK1
13967,GO:0051249,0.328926933457124,0.835322268246425,4,390,regulation of lymphocyte activation,BP,FADD;PNP;PYCARD;TICAM1
4674,GO:0009894,0.329933573772475,0.808931400110479,6,723,regulation of catabolic process,BP,APOC1;TBC1D14;PSMB10;RGN;TICAM1;IDH1
8866,GO:0032984,0.330140297441839,0.854756620548691,3,258,macromolecular complex disassembly,BP,MRPL14;MRPL16;TMOD4
1360,GO:0002920,0.331245440986473,0.939352005689967,1,49,regulation of humoral immune response,BP,CFB
487,GO:0001510,0.331287719410771,0.939292162235955,1,51,RNA methylation,BP,HSD17B10
740,GO:0001910,0.331411311805529,0.939264702213276,1,50,regulation of leukocyte mediated cytotoxicity,BP,FADD
7647,GO:0030888,0.331674716182989,0.939045027626128,1,56,regulation of B cell proliferation,BP,TICAM1
13622,GO:0050727,0.332600871870085,0.853054904823665,3,280,regulation of inflammatory response,BP,CFB;SHPK;CASP4
13662,GO:0050790,0.332775338144038,0.757412930697218,17,2320,regulation of catalytic activity,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;MGST2;PSMB10;RGN;GHR;FGF18;ANG;NOL3;DEPTOR;IFI27;TFPI;GLA;PTS
11350,GO:0043330,0.332918199401839,0.938818675174152,1,44,response to exogenous dsRNA,BP,TICAM1
16653,GO:0071702,0.333726187160418,0.752690485560716,19,2596,organic substance transport,BP,USE1;APOC1;TBC1D14;PNP;ABCG1;PYCARD;CPT2;RBP4;RNASEL;ANG;FABP3;NOL3;IFI27;STAR;SNX21;RPH3AL;HNF1A;SLC1A3;CNIH4
14940,GO:0060419,0.334253059665174,0.937794224613852,1,73,heart growth,BP,RBP4
8472,GO:0032411,0.334490585874697,0.937689042017245,1,74,positive regulation of transporter activity,BP,RGN
7844,GO:0031267,0.334525765753316,0.882664987715901,2,289,small GTPase binding,MF,TBC1D14;RPH3AL
10665,GO:0042127,0.334841315830008,0.769545997067596,12,1489,regulation of cell proliferation,BP,IFI30;FADD;PNP;PYCARD;RGN;FGF18;TICAM1;RBP4;ANG;FABP3;S100B;DHCR7
8470,GO:0032409,0.336655080047409,0.881594992062932,2,203,regulation of transporter activity,BP,RGN;FXYD1
4598,GO:0009612,0.338230154161491,0.880663983321134,2,202,response to mechanical stimulus,BP,FADD;SLC1A3
8204,GO:0031960,0.338844773528611,0.880473289368244,2,159,response to corticosteroid,BP,STAR;S100B
1229,GO:0002709,0.339256661702495,0.936109110649481,1,51,regulation of T cell mediated immunity,BP,FADD
12842,GO:0046872,0.339310529559959,0.73916415899576,25,3929,metal ion binding,MF,PHYH;ZFYVE21;EBF1;ACSM5;RGN;HACL1;GALT;CYP17A1;RNASEL;ANG;ACAT1;AOX1;NOL3;NUDT7;PON2;IDH1;MDP1;PEPD;ACP5;CYP11A1;RPH3AL;S100B;CYB5A;PTS;ETFDH
17075,GO:0072522,0.339590847483803,0.848408806483901,3,254,purine-containing compound biosynthetic process,BP,MRAP;PNP;ACAT1
7906,GO:0031349,0.339724629680732,0.827509769818906,4,406,positive regulation of defense response,BP,FADD;PYCARD;PSMB10;TICAM1
4706,GO:0009991,0.340578422776127,0.826851368898487,4,433,response to extracellular stimulus,BP,PDK4;FADS1;ACAT1;STAR
13074,GO:0048020,0.34080052141133,0.935948537543562,1,36,CCR chemokine receptor binding,MF,CNIH4
8364,GO:0032259,0.341359774611663,0.847064246893724,3,313,methylation,BP,NNMT;HSD17B10;ETFB
11630,GO:0044093,0.341531457978122,0.76037190859554,13,1841,positive regulation of molecular function,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;MGST2;PSMB10;RGN;GHR;FGF18;TICAM1;ANG;IFI27
6061,GO:0016684,0.342328306766132,0.934979812817385,1,46,oxidoreductase activity, acting on peroxide as acceptor,MF,MGST2
19356,GO:1902936,0.342533838627366,0.934363246926523,1,80,phosphatidylinositol bisphosphate binding,MF,SNX21
12816,GO:0046822,0.342537223908506,0.878079312453162,2,206,regulation of nucleocytoplasmic transport,BP,NOL3;IFI27
763,GO:0001938,0.342910694611134,0.934334922455254,1,68,positive regulation of endothelial cell proliferation,BP,ANG
427,GO:0001101,0.343712998426221,0.845457398185648,3,313,response to acid chemical,BP,PDK4;RBP4;FABP3
13948,GO:0051222,0.345178387833525,0.823475751410788,4,443,positive regulation of protein transport,BP,PYCARD;RBP4;ANG;RPH3AL
119,GO:0000245,0.345446484872282,0.933487909132616,1,55,spliceosomal complex assembly,BP,NOL3
2637,GO:0005507,0.346390230353769,0.933115353848414,1,54,copper ion binding,MF,ANG
9266,GO:0034103,0.346704072470868,0.93278590565906,1,66,regulation of tissue remodeling,BP,PDK4
2698,GO:0005615,0.347075599836184,0.755712778077889,13,1364,extracellular space,CC,CFB;APOC1;KRT10;GHR;FGF18;RBP4;ANG;HEXB;FABP3;MDH1;TFPI;S100B;LINGO1
16441,GO:0071385,0.347697051993857,0.932494109325761,1,58,cellular response to glucocorticoid stimulus,BP,STAR
3511,GO:0006887,0.347842747582998,0.785862841473606,7,833,exocytosis,BP,PNP;PYCARD;HEXB;IDH1;GLA;RPH3AL;DERA
11573,GO:0043933,0.348215520368072,0.74875910552449,15,1895,macromolecular complex subunit organization,BP,MRPL14;MRPL16;FADD;APOC1;TRADD;ABCG1;PYCARD;HACL1;ANG;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
8070,GO:0031668,0.348500994676856,0.874502037140541,2,198,cellular response to extracellular stimulus,BP,PDK4;FADS1
10656,GO:0042108,0.348700410557425,0.932038854288976,1,60,positive regulation of cytokine biosynthetic process,BP,TICAM1
1170,GO:0002637,0.348784006862097,0.932179384049858,1,51,regulation of immunoglobulin production,BP,RBP4
11475,GO:0043549,0.348849366818722,0.79410591023946,6,772,regulation of kinase activity,BP,PYCARD;RGN;GHR;FGF18;ANG;DEPTOR
7767,GO:0031099,0.349238012354047,0.874166564088666,2,170,regeneration,BP,RGN;NNMT
8649,GO:0032652,0.349311437385982,0.931816057037019,1,58,regulation of interleukin-1 production,BP,PYCARD
4053,GO:0008284,0.34939143901048,0.784620461293304,7,816,positive regulation of cell proliferation,BP,FADD;PNP;PYCARD;FGF18;TICAM1;ANG;S100B
12537,GO:0046128,0.35049291843398,0.931205402490052,1,65,purine ribonucleoside metabolic process,BP,PNP
15809,GO:0070228,0.350968791663232,0.931193076537423,1,54,regulation of lymphocyte apoptotic process,BP,FADD
2048,GO:0004521,0.351376711438756,0.931110097118202,1,50,endoribonuclease activity,MF,RNASEL
14593,GO:0055072,0.351434314788659,0.930764794336997,1,68,iron ion homeostasis,BP,BDH2
13641,GO:0050764,0.351765349274547,0.930679700161843,1,64,regulation of phagocytosis,BP,PYCARD
3298,GO:0006576,0.351808449898522,0.930951960748798,1,49,cellular biogenic amine metabolic process,BP,SARDH
10910,GO:0042562,0.352331610051409,0.93046920460173,1,62,hormone binding,MF,GHR
6715,GO:0019825,0.353034182311171,0.930512672522206,1,46,oxygen binding,MF,CYP17A1
966,GO:0002260,0.353280276558135,0.930048531940687,1,63,lymphocyte homeostasis,BP,FADD
733,GO:0001894,0.354016002786087,0.871159417248655,2,189,tissue homeostasis,BP,PDK4;RBP4
18118,GO:0098662,0.354079438027483,0.801545870332865,5,648,inorganic cation transmembrane transport,BP,SLC31A2;RGN;FXYD1;NOL3;CYB5A
15550,GO:0061564,0.35426277491871,0.83797571252007,3,450,axon development,BP,S100B;DOK1;LINGO1
8532,GO:0032481,0.354440313834912,0.929441161442199,1,71,positive regulation of type I interferon production,BP,TICAM1
11387,GO:0043406,0.355768456224552,0.869991773052468,2,214,positive regulation of MAP kinase activity,BP,GHR;FGF18
13565,GO:0050663,0.356181257776812,0.869886532172701,2,174,cytokine secretion,BP,PNP;PYCARD
14775,GO:0060193,0.35618511977379,0.928799613160078,1,63,positive regulation of lipase activity,BP,ANG
1878,GO:0004175,0.357505790457762,0.81439962954415,4,405,endopeptidase activity,MF,CFB;PYCARD;PSMB10;CASP4
18747,GO:1901264,0.357577230718074,0.928362415528295,1,54,carbohydrate derivative transport,BP,ABCG1
3556,GO:0006956,0.357758764043427,0.928262571251907,1,55,complement activation,BP,CFB
11289,GO:0043244,0.35784545116663,0.927878226153338,1,79,regulation of protein complex disassembly,BP,TMOD4
8240,GO:0032024,0.358183843930074,0.927932768453733,1,63,positive regulation of insulin secretion,BP,RBP4
3869,GO:0007613,0.35871693338132,0.927363516920336,1,95,memory,BP,S100B
2667,GO:0005576,0.358893673957778,0.711861745089617,37,4413,extracellular region,CC,CFB;IFI30;MSRA;APOC1;HSD17B11;PNP;BDH2;PYCARD;KRT10;GHR;FGF18;ETFB;RBP4;ANG;ACAT1;IDUA;AOX1;HEXB;CMBL;FABP3;PCBD1;MDH1;CASP4;PON2;IDH1;DECR1;MDP1;TFPI;PEPD;ACP5;GLA;ECI1;DERA;S100B;CYB5A;LYPLAL1;LINGO1
4504,GO:0009247,0.3590994615428,0.927679617908595,1,55,glycolipid biosynthetic process,BP,DPM3
12732,GO:0046620,0.359269454867772,0.927236297364134,1,81,regulation of organ growth,BP,RBP4
1219,GO:0002699,0.360279413540536,0.867400274468827,2,162,positive regulation of immune effector process,BP,FADD;RBP4
6016,GO:0016597,0.360298216153955,0.926978007309059,1,65,amino acid binding,MF,SLC1A3
3674,GO:0007166,0.36040420019708,0.73105780977114,18,2540,cell surface receptor signaling pathway,BP,PDK4;IFI30;FADD;P2RY14;TRADD;PYCARD;G0S2;PSMB10;GHR;FGF18;TICAM1;RNASEL;NMI;GRIA3;NOL3;DEPTOR;IFI27;DOK1
7226,GO:0030100,0.360578051568957,0.867032928770198,2,204,regulation of endocytosis,BP,APOC1;PYCARD
5872,GO:0016311,0.362660132644441,0.832142426847865,3,389,dephosphorylation,BP,RGN;MDP1;ACP5
3456,GO:0006801,0.363032769524509,0.925975154030549,1,54,superoxide metabolic process,BP,RGN
3477,GO:0006835,0.363860528071678,0.925162030567328,1,86,dicarboxylic acid transport,BP,SLC1A3
13163,GO:0048259,0.363877081363964,0.925211169335062,1,80,regulation of receptor-mediated endocytosis,BP,APOC1
18653,GO:1901019,0.363914520625634,0.925272213860604,1,73,regulation of calcium ion transmembrane transporter activity,BP,RGN
17374,GO:0090087,0.364015589734731,0.782006362028226,6,747,regulation of peptide transport,BP,PYCARD;RBP4;ANG;NOL3;IFI27;RPH3AL
10738,GO:0042278,0.364240385437709,0.925192614690066,1,68,purine nucleoside metabolic process,BP,PNP
10379,GO:0036473,0.364754854133487,0.924949583831767,1,69,cell death in response to oxidative stress,BP,NOL3
2544,GO:0005254,0.364992492414999,0.924713614523279,1,80,chloride channel activity,MF,FXYD1
857,GO:0002062,0.366878475996472,0.923768423940948,1,91,chondrocyte differentiation,BP,FGF18
5696,GO:0015934,0.367019091232697,0.86358970027072,2,110,large ribosomal subunit,CC,MRPL14;MRPL16
17855,GO:0097305,0.367053279324249,0.863020316899606,2,187,response to alcohol,BP,RBP4;STAR
8602,GO:0032592,0.367963484373307,0.923777946218508,1,54,integral component of mitochondrial membrane,CC,ETFDH
18069,GO:0098573,0.368314216546026,0.9235978262523,1,55,intrinsic component of mitochondrial membrane,CC,ETFDH
2528,GO:0005230,0.36943811375522,0.922766906731971,1,75,extracellular ligand-gated ion channel activity,MF,GRIA3
3462,GO:0006811,0.369556803959186,0.743819687453049,11,1514,ion transport,BP,SLC31A2;APOC1;ABCG1;RGN;CPT2;FXYD1;FABP3;GRIA3;NOL3;CYB5A;SLC1A3
16490,GO:0071456,0.369926947568233,0.861218739281285,2,181,cellular response to hypoxia,BP,PSMB10;S100B
5401,GO:0015171,0.37004371167288,0.922457568414133,1,78,amino acid transmembrane transporter activity,MF,SLC1A3
16440,GO:0071384,0.370214447028937,0.922619603360939,1,61,cellular response to corticosteroid stimulus,BP,STAR
8277,GO:0032088,0.37022160644826,0.922564778250548,1,64,negative regulation of NF-kappaB transcription factor activity,BP,PYCARD
13082,GO:0048029,0.370864734367708,0.922306412651907,1,62,monosaccharide binding,MF,PHYH
19034,GO:1902108,0.371014594163177,0.922293519058751,1,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,NOL3
5371,GO:0015108,0.37117870366065,0.921817055399134,1,91,chloride transmembrane transporter activity,MF,FXYD1
19177,GO:1902476,0.37117870366065,0.921817055399134,1,91,chloride transmembrane transport,BP,FXYD1
9759,GO:0035295,0.372538390141375,0.80285279773629,4,566,tube development,BP,FGF18;RBP4;ACAT1;DHCR7
16360,GO:0071260,0.37259741556959,0.921338269035823,1,74,cellular response to mechanical stimulus,BP,FADD
8886,GO:0033013,0.372658890608454,0.921584052158246,1,57,tetrapyrrole metabolic process,BP,BDH2
12832,GO:0046849,0.373071876339599,0.921146112010539,1,72,bone remodeling,BP,PDK4
3978,GO:0008170,0.373666514041314,0.920899936508129,1,70,N-methyltransferase activity,MF,NNMT
2782,GO:0005768,0.373784529759268,0.774053566604812,6,803,endosome,CC,ZFYVE21;SLC31A2;TBC1D14;ABCG1;TICAM1;SNX21
3737,GO:0007259,0.373880606606178,0.858760305665729,2,166,JAK-STAT cascade,BP,GHR;NMI
18021,GO:0097696,0.373880606606178,0.858760305665729,2,166,STAT cascade,BP,GHR;NMI
12613,GO:0046365,0.374214415302219,0.920850298287745,1,58,monosaccharide catabolic process,BP,GALT
7883,GO:0031325,0.375334883932439,0.713921274035332,20,2825,positive regulation of cellular metabolic process,BP,FADD;MRAP;APOC1;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;HEXB;FABP3;PCBD1;IFI27;STAR;RBMS3;HNF1A
19431,GO:1903052,0.375432656720508,0.857728637309304,2,172,positive regulation of proteolysis involved in cellular protein catabolic process,BP,PSMB10;RGN
3210,GO:0006470,0.37646110959182,0.85681272177216,2,241,protein dephosphorylation,BP,RGN;MDP1
11134,GO:0043005,0.377073238220153,0.771306095618714,6,931,neuron projection,CC,FADD;CYP17A1;ANG;CPT1C;STAR;SLC1A3
7898,GO:0031341,0.377250892951557,0.919468202039068,1,57,regulation of cell killing,BP,FADD
10301,GO:0036294,0.377356566784377,0.856409074977224,2,188,cellular response to decreased oxygen levels,BP,PSMB10;S100B
7152,GO:0022890,0.377581214237527,0.799004707528699,4,540,inorganic cation transmembrane transporter activity,MF,SLC31A2;GRIA3;CYB5A;SLC1A3
14706,GO:0060079,0.377900098487432,0.918653871577518,1,98,excitatory postsynaptic potential,BP,GRIA3
11896,GO:0044765,0.379202395707521,0.708744287754664,21,2931,single-organism transport,BP,EBP;USE1;APOC1;PNP;ABCG1;PYCARD;CPT2;RBP4;RNASEL;ANG;HEXB;FABP3;NOL3;IDH1;STAR;GLA;RPH3AL;DERA;CYB5A;HNF1A;SLC1A3
14058,GO:0051402,0.380237386596316,0.854432726622292,2,215,neuron apoptotic process,BP,FADD;STAR
10630,GO:0042058,0.380256937833723,0.917731043957624,1,78,regulation of epidermal growth factor receptor signaling pathway,BP,DOK1
15678,GO:0065009,0.38213776798445,0.707761704573739,20,2865,regulation of molecular function,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;MGST2;PSMB10;RGN;GHR;FGF18;TICAM1;FXYD1;ANG;NOL3;DEPTOR;PCBD1;IFI27;TFPI;GLA;PTS
832,GO:0002028,0.382269203303649,0.916735612088302,1,82,regulation of sodium ion transport,BP,FXYD1
8230,GO:0032006,0.382487963919064,0.916621309313577,1,83,regulation of TOR signaling,BP,DEPTOR
12297,GO:0045682,0.383524638980812,0.916303963913504,1,69,regulation of epidermis development,BP,TRADD
1205,GO:0002685,0.384092267825888,0.8521783867491,2,156,regulation of leukocyte migration,BP,FADD;PYCARD
13192,GO:0048306,0.384144209292191,0.916165876663589,1,60,calcium-dependent protein binding,MF,S100B
14885,GO:0060349,0.385151352350861,0.915330671177321,1,85,bone morphogenesis,BP,FGF18
13861,GO:0051093,0.38515186318293,0.764724863152152,6,796,negative regulation of developmental process,BP,ABCG1;RGN;RBP4;TMEM176A;S100B;LINGO1
18877,GO:1901655,0.38518995592804,0.915332709666885,1,83,cellular response to ketone,BP,STAR
5226,GO:0014070,0.385513666559005,0.754764240180127,7,908,response to organic cyclic compound,BP,FADD;TICAM1;ACAT1;IDH1;TFPI;STAR;S100B
13064,GO:0048010,0.385900662420836,0.914914825642129,1,91,vascular endothelial growth factor receptor signaling pathway,BP,FGF18
2628,GO:0005488,0.385939091483132,0.689283069865077,94,13522,binding,MF,CFB;EBP;PDK4;PECR;USE1;PHYH;IFI30;DPM3;ZFYVE21;MRPL14;MRPL16;MRI1;FADD;MRAP;APOC1;TRADD;TBC1D14;PXMP2;PXMP4;ACSF2;PNP;ABCG1;EBF1;BDH2;PYCARD;G0S2;LAGE3;ACADVL;MGST2;ACSM5;PSMB10;RGN;GHR;FGF18;TICAM1;ARL6IP4;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;CYP17A1;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;AOX1;SHPK;HEXB;FABP3;NOL3;NUDT6;NUDT7;DEPTOR;ACCS;CPT1C;PCBD1;MDH1;IFI27;PON2;FAM46A;IDH1;DECR1;PUS1;LDHD;MDP1;STAR;SNX21;WBP1;PEPD;ACP5;GLA;CYP11A1;RPH3AL;S100B;DHCR7;CYB5A;PTS;RBMS3;HNF1A;DOK1;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH;TMOD4
678,GO:0001822,0.386024916070517,0.850497542064448,2,263,kidney development,BP,RGN;ACAT1
4699,GO:0009968,0.386670072605503,0.745885358447129,8,1080,negative regulation of signal transduction,BP,FADD;TRADD;PYCARD;PSMB10;TICAM1;NOL3;DEPTOR;RPH3AL
13979,GO:0051261,0.387809157833141,0.914022129936155,1,88,protein depolymerization,BP,TMOD4
11296,GO:0043254,0.387915326349483,0.813908096597036,3,360,regulation of protein complex assembly,BP,PYCARD;HNF1A;TMOD4
8281,GO:0032092,0.387985278216153,0.914032056939595,1,79,positive regulation of protein binding,BP,TICAM1
4017,GO:0008219,0.389170678285259,0.71253497620358,15,1990,cell death,BP,PDK4;FADD;TRADD;PYCARD;G0S2;KRT10;RGN;ASAH2;TICAM1;NOL3;DEPTOR;CASP4;IFI27;STAR;S100B
10446,GO:0038034,0.389303767061943,0.913529095120602,1,69,signal transduction in absence of ligand,BP,FADD
17798,GO:0097192,0.389303767061943,0.913529095120602,1,69,extrinsic apoptotic signaling pathway in absence of ligand,BP,FADD
569,GO:0001656,0.390125291676649,0.912897802927186,1,88,metanephros development,BP,ACAT1
9609,GO:0034765,0.390224310850792,0.812139702457657,3,397,regulation of ion transmembrane transport,BP,SLC31A2;RGN;FXYD1
16038,GO:0070588,0.390807778594358,0.847326094299295,2,259,calcium ion transmembrane transport,BP,RGN;NOL3
7256,GO:0030141,0.391032681783602,0.750173239553293,7,787,secretory granule,CC,PNP;PYCARD;HEXB;IDH1;GLA;RPH3AL;DERA
3228,GO:0006493,0.39246948309084,0.911696504239259,1,94,protein O-linked glycosylation,BP,DPM3
13810,GO:0051020,0.393446306238586,0.845444527901444,2,317,GTPase binding,MF,TBC1D14;RPH3AL
7107,GO:0022602,0.393929363089933,0.911106589339894,1,81,ovulation cycle process,BP,ANG
5866,GO:0016301,0.394070613118437,0.769641035009141,5,816,kinase activity,MF,PDK4;ZFYVE21;FGF18;RNASEL;SHPK
13712,GO:0050863,0.394188428962979,0.809365451270068,3,302,regulation of T cell activation,BP,FADD;PNP;PYCARD
9778,GO:0035335,0.394569792099298,0.91063585445489,1,97,peptidyl-tyrosine dephosphorylation,BP,MDP1
10833,GO:0042440,0.39468325189581,0.910947634992561,1,66,pigment metabolic process,BP,BDH2
11434,GO:0043500,0.394744255555221,0.910692750059717,1,82,muscle adaptation,BP,NOL3
1096,GO:0002478,0.394858538698141,0.844961321891455,2,165,antigen processing and presentation of exogenous peptide antigen,BP,IFI30;PSMB10
4054,GO:0008285,0.394895756382723,0.769090829693925,5,623,negative regulation of cell proliferation,BP,IFI30;RGN;RBP4;ANG;FABP3
16837,GO:0072080,0.395276649855105,0.91032825525397,1,92,nephron tubule development,BP,ACAT1
13301,GO:0048593,0.395651081404292,0.910053904748485,1,103,camera-type eye morphogenesis,BP,RBP4
13720,GO:0050871,0.395833390919847,0.910328794333581,1,69,positive regulation of B cell activation,BP,TICAM1
8621,GO:0032612,0.395836162131272,0.910343719209155,1,68,interleukin-1 production,BP,PYCARD
11521,GO:0043627,0.39628759291445,0.910042742778136,1,73,response to estrogen,BP,STAR
5106,GO:0010921,0.396549549675672,0.909621481146218,1,101,regulation of phosphatase activity,BP,RGN
16487,GO:0071453,0.396574939044317,0.843644357846402,2,197,cellular response to oxygen levels,BP,PSMB10;S100B
6102,GO:0016772,0.396953796799138,0.754826899044303,6,955,transferase activity, transferring phosphorus-containing groups,MF,PDK4;ZFYVE21;FGF18;GALT;RNASEL;SHPK
20664,GO:1905954,0.397738368340532,0.909320725531119,1,73,positive regulation of lipid localization,BP,ABCG1
13944,GO:0051213,0.398075929282072,0.909036054313228,1,82,dioxygenase activity,MF,PHYH
10890,GO:0042531,0.398438721819373,0.909245419733743,1,58,positive regulation of tyrosine phosphorylation of STAT protein,BP,GHR
7314,GO:0030217,0.398785864505497,0.842073405282946,2,216,T cell differentiation,BP,FADD;PNP
3513,GO:0006890,0.399348892184201,0.908386829449532,1,83,retrograde vesicle-mediated transport, Golgi to ER,BP,USE1
15455,GO:0061326,0.399398781293515,0.908252183932731,1,94,renal tubule development,BP,ACAT1
19738,GO:1903706,0.399497206167711,0.805333012267611,3,323,regulation of hemopoiesis,BP,FADD;PNP;TMEM176A
2197,GO:0004725,0.399555013248854,0.908139849832757,1,98,protein tyrosine phosphatase activity,MF,MDP1
7171,GO:0023051,0.399918284409875,0.691529064084568,20,3019,regulation of signaling,BP,FADD;TRADD;PYCARD;G0S2;PSMB10;RGN;GHR;FGF18;TICAM1;PXK;FXYD1;RBP4;FAM110C;NOL3;DEPTOR;STAR;RPH3AL;S100B;DOK1;SLC1A3
5026,GO:0010827,0.401257759805257,0.907272581698439,1,99,regulation of glucose transport,BP,RNASEL
9352,GO:0034248,0.401431901610081,0.803788537451516,3,366,regulation of cellular amide metabolic process,BP,ANG;TSFM;RBMS3
7892,GO:0031334,0.401657136800529,0.8401385776415,2,210,positive regulation of protein complex assembly,BP,PYCARD;HNF1A
1634,GO:0003723,0.401729067320705,0.711345744560206,12,1541,RNA binding,MF,MRPL14;MRPL16;ARL6IP4;HSD17B10;RNASEL;ANG;TSFM;NOL3;NUDT7;FAM46A;PUS1;RBMS3
19206,GO:1902554,0.402513405611158,0.906825189436304,1,80,serine/threonine protein kinase complex,CC,PYCARD
14159,GO:0051591,0.402639902555283,0.906623028039286,1,93,response to cAMP,BP,STAR
19568,GO:1903364,0.402697132874556,0.839528755431112,2,186,positive regulation of cellular protein catabolic process,BP,PSMB10;RGN
6099,GO:0016765,0.402876680425969,0.90714500363732,1,53,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,MGST2
9470,GO:0034470,0.403466946714373,0.778925197784516,4,372,ncRNA processing,BP,LAGE3;HSD17B10;RNASEL;PUS1
15909,GO:0070374,0.403517170042058,0.839028493617758,2,174,positive regulation of ERK1 and ERK2 cascade,BP,PYCARD;FGF18
4358,GO:0009064,0.403569921355902,0.90643014265989,1,70,glutamine family amino acid metabolic process,BP,SLC1A3
6668,GO:0019693,0.403801352491011,0.76186435765936,5,535,ribose phosphate metabolic process,BP,MRAP;ACAT1;SHPK;NUDT7;DERA
3501,GO:0006875,0.403899937181333,0.778415802655745,4,472,cellular metal ion homeostasis,BP,SLC31A2;RGN;HEXB;NOL3
15798,GO:0070201,0.403984172964646,0.748992617518976,6,791,regulation of establishment of protein localization,BP,PYCARD;RBP4;ANG;NOL3;IFI27;RPH3AL
7889,GO:0031331,0.405703108231126,0.800571543201126,3,352,positive regulation of cellular catabolic process,BP,PSMB10;RGN;TICAM1
6758,GO:0019900,0.40629354257009,0.776371158244281,4,596,kinase binding,MF,TRADD;TBC1D14;GHR;TICAM1
12864,GO:0046902,0.406354307059075,0.905025148451642,1,69,regulation of mitochondrial membrane permeability,BP,NOL3
21025,GO:2000145,0.407894192918584,0.758325225954565,5,704,regulation of cell motility,BP,FADD;PYCARD;RGN;FGF18;FAM110C
12000,GO:0045069,0.408069806629132,0.903994148576843,1,79,regulation of viral genome replication,BP,RNASEL
17607,GO:0090502,0.408124824813965,0.904206494750433,1,64,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,RNASEL
18350,GO:0099565,0.408286685148593,0.90359273305904,1,110,chemical synaptic transmission, postsynaptic,BP,GRIA3
6304,GO:0017156,0.408514422146995,0.903517260392867,1,104,calcium ion regulated exocytosis,BP,RPH3AL
12268,GO:0045639,0.408896458544776,0.903566701613971,1,79,positive regulation of myeloid cell differentiation,BP,FADD
3928,GO:0008083,0.410206279986868,0.834502569959758,2,159,growth factor activity,MF,FGF18;NUDT6
2301,GO:0004866,0.410253909808593,0.834436843384545,2,164,endopeptidase inhibitor activity,MF,NOL3;TFPI
2303,GO:0004869,0.410718707612918,0.903021938747154,1,57,cysteine-type endopeptidase inhibitor activity,MF,NOL3
4825,GO:0010508,0.410940745945665,0.902286311816708,1,100,positive regulation of autophagy,BP,TICAM1
6748,GO:0019884,0.411159552935439,0.833758354083801,2,172,antigen processing and presentation of exogenous antigen,BP,IFI30;PSMB10
6118,GO:0016791,0.411607826260632,0.833144930631238,2,247,phosphatase activity,MF,MDP1;ACP5
13266,GO:0048523,0.412914347780128,0.667662074051265,29,4185,negative regulation of cellular process,BP,PDK4;IFI30;FADD;APOC1;TRADD;TBC1D14;ABCG1;PYCARD;ACADVL;PSMB10;RGN;TICAM1;PLA2G16;RBP4;RNASEL;ANG;NMI;FABP3;NOL3;DEPTOR;IFI27;TMEM176A;TFPI;STAR;GLA;RPH3AL;S100B;LINGO1;TMOD4
3607,GO:0007034,0.413045083700295,0.901175403599868,1,101,vacuolar transport,BP,USE1
18169,GO:0098797,0.413115335124906,0.832141924568332,2,230,plasma membrane protein complex,CC,FADD;TRADD
5806,GO:0016197,0.413749106756172,0.831649350173992,2,246,endosomal transport,BP,ZFYVE21;TBC1D14
13858,GO:0051090,0.413896955415781,0.79426883939673,3,362,regulation of sequence-specific DNA binding transcription factor activity,BP,TRADD;PYCARD;TICAM1
15686,GO:0070011,0.414041728404232,0.753288597945602,5,596,peptidase activity, acting on L-amino acid peptides,MF,CFB;PYCARD;PSMB10;CASP4;PEPD
14705,GO:0060078,0.414269232113803,0.900331820333273,1,133,regulation of postsynaptic membrane potential,BP,GRIA3
17628,GO:0090559,0.414614666723533,0.900650027823223,1,74,regulation of membrane permeability,BP,NOL3
13697,GO:0050848,0.415163449749816,0.900316371408578,1,77,regulation of calcium-mediated signaling,BP,RGN
1385,GO:0003012,0.415355443121749,0.79308304198989,3,397,muscle system process,BP,FXYD1;NOL3;TMOD4
8796,GO:0032879,0.41538499374743,0.685990842428996,16,2401,regulation of localization,BP,SLC31A2;FADD;APOC1;TBC1D14;ABCG1;PYCARD;RGN;FGF18;FXYD1;RBP4;RNASEL;ANG;FAM110C;NOL3;IFI27;RPH3AL
12223,GO:0045582,0.416262366050254,0.899794892693301,1,73,positive regulation of T cell differentiation,BP,PNP
15808,GO:0070227,0.41670759793234,0.899625953814142,1,69,lymphocyte apoptotic process,BP,FADD
11308,GO:0043270,0.417755909586454,0.828925746919958,2,216,positive regulation of ion transport,BP,RGN;FXYD1
19422,GO:1903037,0.418458347961062,0.790828264141613,3,317,regulation of leukocyte cell-cell adhesion,BP,FADD;PNP;PYCARD
14313,GO:0051897,0.418733734663607,0.898365053191045,1,81,positive regulation of protein kinase B signaling,BP,FAM110C
10951,GO:0042626,0.418892911627987,0.898009555586303,1,109,ATPase activity, coupled to transmembrane movement of substances,MF,ABCG1
20210,GO:1904724,0.41901576899613,0.898712934572181,1,55,tertiary granule lumen,CC,IDH1
14020,GO:0051338,0.419021366474718,0.726041358638467,7,933,regulation of transferase activity,BP,PYCARD;PSMB10;RGN;GHR;FGF18;ANG;DEPTOR
2045,GO:0004518,0.419802632693344,0.827545239802479,2,199,nuclease activity,MF,RNASEL;ANG
1194,GO:0002673,0.419980125359709,0.897863910120578,1,70,regulation of acute inflammatory response,BP,CFB
5467,GO:0015294,0.420001668691132,0.897459942912628,1,103,solute:cation symporter activity,MF,SLC1A3
328,GO:0000902,0.420326836515389,0.747822332497379,5,883,cell morphogenesis,BP,HEXB;S100B;DOK1;SLC1A3;LINGO1
11413,GO:0043462,0.420564438309404,0.897731906596491,1,61,regulation of ATPase activity,BP,RGN
13943,GO:0051209,0.421202602407132,0.896846729876525,1,99,release of sequestered calcium ion into cytosol,BP,NOL3
13992,GO:0051283,0.421202602407132,0.896846729876525,1,99,negative regulation of sequestering of calcium ion,BP,NOL3
646,GO:0001776,0.421573209740615,0.896814727660584,1,83,leukocyte homeostasis,BP,FADD
502,GO:0001533,0.422127430349488,0.89684687227259,1,63,cornified envelope,CC,KRT10
3470,GO:0006821,0.422291166776788,0.8962243340171,1,103,chloride transport,BP,FXYD1
12745,GO:0046634,0.422691562848306,0.896337554959273,1,74,regulation of alpha-beta T cell activation,BP,PNP
13991,GO:0051282,0.423549698281543,0.895566654226916,1,100,regulation of sequestering of calcium ion,BP,NOL3
9606,GO:0034762,0.423746951908495,0.78652093926675,3,411,regulation of transmembrane transport,BP,SLC31A2;RGN;FXYD1
11740,GO:0044325,0.423878170168818,0.895330923362612,1,107,ion channel binding,MF,FXYD1
17800,GO:0097194,0.424588091859066,0.895220002951091,1,80,execution phase of apoptosis,BP,CASP4
767,GO:0001942,0.42527299528654,0.894770074689164,1,86,hair follicle development,BP,TRADD
11624,GO:0044087,0.425896585404633,0.743165273374797,5,771,regulation of cellular component biogenesis,BP,TBC1D14;PYCARD;FAM110C;HNF1A;TMOD4
9929,GO:0035601,0.426338742923322,0.894070838017369,1,97,protein deacylation,BP,LYPLAL1
7094,GO:0022404,0.426558834454945,0.894043216358946,1,88,molting cycle process,BP,TRADD
7095,GO:0022405,0.426558834454945,0.894043216358946,1,88,hair cycle process,BP,TRADD
17074,GO:0072521,0.42705667850673,0.742356005738583,5,555,purine-containing compound metabolic process,BP,MRAP;PNP;ACAT1;AOX1;NUDT7
13966,GO:0051248,0.427508657981871,0.710294127296159,8,1048,negative regulation of protein metabolic process,BP,PYCARD;PSMB10;RGN;ANG;NMI;NOL3;DEPTOR;TFPI
20322,GO:1904951,0.427544262891782,0.759152041490328,4,498,positive regulation of establishment of protein localization,BP,PYCARD;RBP4;ANG;RPH3AL
2543,GO:0005253,0.428428358795648,0.892950449116408,1,94,anion channel activity,MF,FXYD1
12865,GO:0046903,0.428460104186475,0.691568977960421,11,1489,secretion,BP,USE1;PNP;PYCARD;RBP4;ANG;HEXB;IDH1;GLA;RPH3AL;DERA;SLC1A3
12133,GO:0045321,0.428603760485569,0.702406161854662,9,1129,leukocyte activation,BP,FADD;PNP;PYCARD;TICAM1;SHPK;HEXB;IDH1;GLA;DERA
5896,GO:0016363,0.429115448796963,0.89252286123377,1,99,nuclear matrix,CC,RNASEL
11430,GO:0043492,0.42913298289119,0.892331323420194,1,124,ATPase activity, coupled to movement of substances,MF,ABCG1
1217,GO:0002697,0.429585097673453,0.782079217035217,3,324,regulation of immune effector process,BP,CFB;FADD;RBP4
3959,GO:0008135,0.429930752900136,0.892286349460567,1,80,translation factor activity, RNA binding,MF,TSFM
7434,GO:0030414,0.430126508096379,0.820284125941292,2,172,peptidase inhibitor activity,MF,NOL3;TFPI
7147,GO:0022857,0.430369469952638,0.716050937799918,7,1011,transmembrane transporter activity,MF,EBP;SLC31A2;ABCG1;FXYD1;GRIA3;CYB5A;SLC1A3
15925,GO:0070405,0.430510657937034,0.892163475910176,1,68,ammonium ion binding,MF,APOC1
18704,GO:1901184,0.430678045863084,0.891736071656831,1,91,regulation of ERBB signaling pathway,BP,DOK1
12874,GO:0046916,0.43138596850007,0.891451178809937,1,82,cellular transition metal ion homeostasis,BP,SLC31A2
6136,GO:0016820,0.432077982579361,0.890777293201442,1,111,hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances,MF,ABCG1
4673,GO:0009893,0.432296702357084,0.659742720193557,21,3038,positive regulation of metabolic process,BP,FADD;MRAP;APOC1;TRADD;ABCG1;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;HEXB;FABP3;PCBD1;IFI27;STAR;RBMS3;HNF1A
15381,GO:0061135,0.432659169720615,0.818457432880436,2,170,endopeptidase regulator activity,MF,NOL3;TFPI
18134,GO:0098732,0.43288189104305,0.890435976041121,1,98,macromolecule deacylation,BP,LYPLAL1
1084,GO:0002456,0.433076109401351,0.890595937793667,1,76,T cell mediated immunity,BP,FADD
4228,GO:0008565,0.433499909827398,0.890119027473254,1,95,protein transporter activity,MF,ABCG1
6361,GO:0018149,0.433578245838101,0.890661177621219,1,59,peptide cross-linking,BP,KRT10
8181,GO:0031929,0.433650329937827,0.89000528366559,1,98,TOR signaling,BP,DEPTOR
13942,GO:0051208,0.434007605912357,0.889759465820907,1,103,sequestering of calcium ion,BP,NOL3
11120,GO:0042990,0.434684217005593,0.889518694611393,1,89,regulation of transcription factor import into nucleus,BP,NOL3
11121,GO:0042991,0.434770718515412,0.889458585926681,1,90,transcription factor import into nucleus,BP,NOL3
19348,GO:1902911,0.435264232923384,0.889137228244261,1,94,protein kinase complex,CC,PYCARD
17982,GO:0097553,0.43538007620546,0.888969532602087,1,105,calcium ion transmembrane import into cytosol,BP,NOL3
19256,GO:1902656,0.43538007620546,0.888969532602087,1,105,calcium ion import into cytosol,BP,NOL3
17002,GO:0072332,0.437434669994418,0.888082052849103,1,80,intrinsic apoptotic signaling pathway by p53 class mediator,BP,PYCARD
13322,GO:0048638,0.437532344961865,0.814464542052032,2,280,regulation of developmental growth,BP,GHR;RBP4
1228,GO:0002708,0.438073794341616,0.887830948711591,1,73,positive regulation of lymphocyte mediated immunity,BP,FADD
2941,GO:0006024,0.438293454429828,0.887277301537479,1,110,glycosaminoglycan biosynthetic process,BP,EXTL1
10874,GO:0042509,0.438846748158798,0.88750638433614,1,67,regulation of tyrosine phosphorylation of STAT protein,BP,GHR
7292,GO:0030193,0.439062299573236,0.88711485867149,1,83,regulation of blood coagulation,BP,FAM46A
18455,GO:1900046,0.439062299573236,0.88711485867149,1,83,regulation of hemostasis,BP,FAM46A
761,GO:0001936,0.439258149142931,0.886860932703356,1,95,regulation of endothelial cell proliferation,BP,ANG
13110,GO:0048145,0.441294134498508,0.885838484622621,1,83,regulation of fibroblast proliferation,BP,IFI30
7610,GO:0030838,0.441771213759557,0.885564500021814,1,83,positive regulation of actin filament polymerization,BP,PYCARD
13109,GO:0048144,0.44254230942939,0.885107201468022,1,84,fibroblast proliferation,BP,IFI30
12435,GO:0045936,0.443159291683172,0.746050355766481,4,541,negative regulation of phosphate metabolic process,BP,APOC1;PYCARD;RGN;DEPTOR
21002,GO:2000106,0.444085888170298,0.884287716404897,1,79,regulation of leukocyte apoptotic process,BP,FADD
9544,GO:0034660,0.444174846798806,0.727683088180785,5,529,ncRNA metabolic process,BP,LAGE3;HSD17B10;RNASEL;ANG;PUS1
4020,GO:0008233,0.444311519355639,0.72746952005654,5,614,peptidase activity,MF,CFB;PYCARD;PSMB10;CASP4;PEPD
2940,GO:0006023,0.444514143008715,0.883690764199685,1,111,aminoglycan biosynthetic process,BP,EXTL1
4855,GO:0010563,0.445368136411009,0.744180125509589,4,542,negative regulation of phosphorus metabolic process,BP,APOC1;PYCARD;RGN;DEPTOR
672,GO:0001816,0.445622191411583,0.726310989853618,5,635,cytokine production,BP,FADD;PNP;PYCARD;TICAM1;NMI
18116,GO:0098660,0.445652591767036,0.726200843132095,5,744,inorganic ion transmembrane transport,BP,SLC31A2;RGN;FXYD1;NOL3;CYB5A
4898,GO:0010634,0.445701914701035,0.883015447895089,1,109,positive regulation of epithelial cell migration,BP,FGF18
19032,GO:1902106,0.446116894375094,0.883036316373048,1,84,negative regulation of leukocyte differentiation,BP,TMEM176A
16793,GO:0072009,0.446472020439063,0.882557966631537,1,110,nephron epithelium development,BP,ACAT1
5020,GO:0010821,0.446560864656899,0.807971333833675,2,212,regulation of mitochondrion organization,BP,PYCARD;NOL3
11226,GO:0043154,0.447266943607998,0.882407889653977,1,81,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,NOL3
13296,GO:0048584,0.447580532363196,0.662088220548812,14,1941,positive regulation of response to stimulus,BP,CFB;FADD;TRADD;PYCARD;G0S2;PSMB10;RGN;GHR;FGF18;TICAM1;RNASEL;FAM110C;S100B;DOK1
3738,GO:0007260,0.448597409026981,0.88179818503309,1,71,tyrosine phosphorylation of STAT protein,BP,GHR
758,GO:0001933,0.448699626405372,0.766572302071295,3,389,negative regulation of protein phosphorylation,BP,PYCARD;RGN;DEPTOR
13278,GO:0048545,0.44908445960872,0.766281002621722,3,376,response to steroid hormone,BP,IDH1;STAR;S100B
4671,GO:0009891,0.44939360375843,0.667847169602948,12,1746,positive regulation of biosynthetic process,BP,FADD;MRAP;ABCG1;RGN;TICAM1;RNASEL;HEXB;FABP3;PCBD1;STAR;RBMS3;HNF1A
5147,GO:0010977,0.449539088815875,0.880697128152668,1,118,negative regulation of neuron projection development,BP,LINGO1
10633,GO:0042063,0.449760245045896,0.805463870936379,2,239,gliogenesis,BP,HEXB;S100B
18117,GO:0098661,0.449991806239284,0.880396090635046,1,123,inorganic anion transmembrane transport,BP,FXYD1
12743,GO:0046632,0.451613013001875,0.879729252447629,1,90,alpha-beta T cell differentiation,BP,PNP
1222,GO:0002702,0.451867973619015,0.879852442788498,1,72,positive regulation of production of molecular mediator of immune response,BP,RBP4
18898,GO:1901681,0.452278174774755,0.803649548328518,2,215,sulfur compound binding,MF,HACL1;ANG
7386,GO:0030317,0.453029117143651,0.879163771014987,1,72,flagellated sperm motility,BP,RGN
4603,GO:0009628,0.4530748588373,0.687241451467191,8,1129,response to abiotic stimulus,BP,FADD;ACADVL;PSMB10;ANG;NOL3;STAR;S100B;SLC1A3
13382,GO:0048732,0.453242995319574,0.762804990834773,3,415,gland development,BP,FADD;RGN;ACAT1
13886,GO:0051129,0.453636680102679,0.737093377024314,4,581,negative regulation of cellular component organization,BP,APOC1;NOL3;LINGO1;TMOD4
10904,GO:0042552,0.453684032266656,0.878322202039727,1,107,myelination,BP,HEXB
19344,GO:1902904,0.453932372249951,0.878191540322289,1,105,negative regulation of supramolecular fiber organization,BP,TMOD4
6129,GO:0016811,0.454669873025774,0.878002447589585,1,83,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,ASAH2
12251,GO:0045621,0.454954856634231,0.877817629066088,1,84,positive regulation of lymphocyte differentiation,BP,PNP
8852,GO:0032963,0.455219099403324,0.877430210955667,1,104,collagen metabolic process,BP,PEPD
1296,GO:0002824,0.455628831411142,0.877575325910931,1,74,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
8369,GO:0032268,0.455907276419655,0.648273920019383,16,2281,regulation of cellular protein metabolic process,BP,FADD;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;ANG;NMI;TSFM;NOL3;DEPTOR;IFI27;TFPI;RBMS3
6750,GO:0019886,0.456386619311255,0.876878997048431,1,90,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,IFI30
7594,GO:0030819,0.456424272820635,0.877028450154881,1,78,positive regulation of cAMP biosynthetic process,BP,MRAP
13683,GO:0050818,0.456528887293722,0.87683199482785,1,87,regulation of coagulation,BP,FAM46A
5422,GO:0015197,0.45729217183499,0.876164268789723,1,106,peptide transporter activity,MF,ABCG1
12633,GO:0046427,0.45729709885104,0.876611402907255,1,72,positive regulation of JAK-STAT cascade,BP,GHR
20295,GO:1904894,0.45729709885104,0.876611402907255,1,72,positive regulation of STAT cascade,BP,GHR
3461,GO:0006810,0.458038865519908,0.62218128830673,32,4735,transport,BP,EBP;USE1;ZFYVE21;SLC31A2;APOC1;TBC1D14;PNP;ABCG1;PYCARD;PSMB10;RGN;GHR;CPT2;FXYD1;RBP4;RNASEL;ANG;HEXB;FABP3;GRIA3;NOL3;IFI27;IDH1;STAR;SNX21;GLA;RPH3AL;DERA;CYB5A;HNF1A;SLC1A3;CNIH4
19223,GO:1902578,0.458044551892827,0.635391363678712,21,3072,single-organism localization,BP,EBP;USE1;APOC1;PNP;ABCG1;PYCARD;CPT2;RBP4;RNASEL;ANG;HEXB;FABP3;NOL3;IDH1;STAR;GLA;RPH3AL;DERA;CYB5A;HNF1A;SLC1A3
3753,GO:0007281,0.458256080075168,0.799082642052071,2,217,germ cell development,BP,ANG;HEXB
12596,GO:0046330,0.458382049610815,0.875422661866132,1,116,positive regulation of JNK cascade,BP,PYCARD
12039,GO:0045121,0.458695627718848,0.798538910827972,2,281,membrane raft,CC,FADD;TRADD
18205,GO:0098857,0.459259428567086,0.79810297953768,2,282,membrane microdomain,CC,FADD;TRADD
11394,GO:0043414,0.459420397773318,0.798065387602738,2,251,macromolecule methylation,BP,HSD17B10;ETFB
18028,GO:0097722,0.459810932922053,0.87505414661973,1,74,sperm motility,BP,RGN
3749,GO:0007272,0.459878032985413,0.874561802657828,1,110,ensheathment of neurons,BP,HEXB
4104,GO:0008366,0.459878032985413,0.874561802657828,1,110,axon ensheathment,BP,HEXB
18977,GO:1901981,0.459966218700404,0.87439680348378,1,125,phosphatidylinositol phosphate binding,MF,SNX21
13919,GO:0051174,0.460136887733167,0.662361656530662,11,1586,regulation of phosphorus metabolic process,BP,PDK4;MRAP;APOC1;PYCARD;RGN;GHR;FGF18;ANG;FABP3;DEPTOR;IDH1
6448,GO:0018958,0.460444985528551,0.874386412954429,1,93,phenol-containing compound metabolic process,BP,STAR
17505,GO:0090277,0.460792835261416,0.874307260209295,1,83,positive regulation of peptide hormone secretion,BP,RBP4
10800,GO:0042383,0.462546617427591,0.872874806740384,1,117,sarcolemma,CC,FXYD1
3667,GO:0007159,0.4633249035503,0.754571547590288,3,346,leukocyte cell-cell adhesion,BP,FADD;PNP;PYCARD
8846,GO:0032956,0.463514865004287,0.794825922693723,2,278,regulation of actin cytoskeleton organization,BP,PYCARD;TMOD4
5501,GO:0015399,0.463870962621051,0.872060248149594,1,117,primary active transmembrane transporter activity,MF,ABCG1
5503,GO:0015405,0.463870962621051,0.872060248149594,1,117,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ABCG1
243,GO:0000502,0.46425288565062,0.872535983226134,1,65,proteasome complex,CC,PSMB10
21099,GO:2000278,0.464338642247148,0.871989212252525,1,94,regulation of DNA biosynthetic process,BP,RGN
4823,GO:0010506,0.464413749098708,0.794157639896241,2,267,regulation of autophagy,BP,TBC1D14;TICAM1
7327,GO:0030234,0.464777611118535,0.685169516968652,7,961,enzyme regulator activity,MF,APOC1;TBC1D14;PYCARD;MGST2;RGN;NOL3;TFPI
15672,GO:0065003,0.465165075814885,0.65312496319408,12,1645,macromolecular complex assembly,BP,FADD;APOC1;TRADD;PYCARD;HACL1;ANG;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
11351,GO:0043331,0.465208393947372,0.871570109568681,1,85,response to dsRNA,BP,TICAM1
674,GO:0001818,0.465266371255569,0.793663287902423,2,218,negative regulation of cytokine production,BP,PYCARD;NMI
11696,GO:0044259,0.466573395938408,0.870453772754789,1,109,multicellular organismal macromolecule metabolic process,BP,PEPD
4910,GO:0010646,0.466764196666086,0.630844464260374,19,2967,regulation of cell communication,BP,FADD;TRADD;PYCARD;G0S2;PSMB10;RGN;GHR;FGF18;TICAM1;PXK;RBP4;FAM110C;NOL3;DEPTOR;STAR;RPH3AL;S100B;DOK1;SLC1A3
14108,GO:0051494,0.466845214453041,0.87025079252873,1,113,negative regulation of cytoskeleton organization,BP,TMOD4
13984,GO:0051270,0.467845725132003,0.706615391395302,5,772,regulation of cellular component movement,BP,FADD;PYCARD;RGN;FGF18;FAM110C
3246,GO:0006521,0.468550852249685,0.870015600497634,1,60,regulation of cellular amino acid metabolic process,BP,PSMB10
2429,GO:0005057,0.468862813954168,0.868823010262033,1,138,signal transducer activity, downstream of receptor,MF,DOK1
13580,GO:0050680,0.468887316585341,0.868977347177958,1,113,negative regulation of epithelial cell proliferation,BP,RGN
3509,GO:0006885,0.46900407334485,0.869036901069523,1,99,regulation of pH,BP,PDK4
20485,GO:1905369,0.469108890544431,0.869507444287798,1,66,endopeptidase complex,CC,PSMB10
13418,GO:0048812,0.469356925508727,0.749203627955973,3,561,neuron projection morphogenesis,BP,S100B;DOK1;LINGO1
19540,GO:1903305,0.469417797092149,0.868688742018833,1,108,regulation of regulated secretory pathway,BP,RPH3AL
19198,GO:1902531,0.469547411520769,0.653523817743824,11,1683,regulation of intracellular signal transduction,BP,FADD;TRADD;PYCARD;RGN;GHR;FGF18;TICAM1;FAM110C;NOL3;DEPTOR;S100B
21012,GO:2000117,0.470060957213891,0.868537690778679,1,86,negative regulation of cysteine-type endopeptidase activity,BP,NOL3
10798,GO:0042379,0.47131679764345,0.868383580048976,1,57,chemokine receptor binding,MF,CNIH4
14671,GO:0060041,0.471554905253302,0.867147786591635,1,135,retina development in camera-type eye,BP,RBP4
2640,GO:0005515,0.472554504330671,0.598429180131918,72,10444,protein binding,MF,CFB;EBP;PECR;USE1;PHYH;IFI30;DPM3;ZFYVE21;MRI1;FADD;MRAP;TRADD;TBC1D14;PXMP2;PXMP4;ACSF2;ABCG1;EBF1;PYCARD;G0S2;LAGE3;MGST2;PSMB10;GHR;FGF18;TICAM1;ARL6IP4;PXK;PLA2G16;HSD17B10;ETFB;HACL1;GALT;FXYD1;RBP4;RNASEL;BOLA1;ANG;FAM110C;NMI;ACAT1;TSFM;IDUA;HEXB;FABP3;NOL3;NUDT6;NUDT7;DEPTOR;ACCS;CPT1C;PCBD1;MDH1;IFI27;PON2;FAM46A;IDH1;LDHD;STAR;WBP1;PEPD;GLA;RPH3AL;S100B;CYB5A;PTS;HNF1A;DOK1;CNIH4;ELOVL6;LINGO1;TMOD4
19837,GO:1903901,0.473648614547635,0.866277945055608,1,86,negative regulation of viral life cycle,BP,RNASEL
340,GO:0000932,0.473798686550701,0.865996217827922,1,101,P-body,CC,GHR
2319,GO:0004896,0.475379038820167,0.865150580680932,1,88,cytokine receptor activity,MF,GHR
19343,GO:1902903,0.475866014114118,0.785144401393061,2,272,regulation of supramolecular fiber organization,BP,PYCARD;TMOD4
12349,GO:0045785,0.476675351236234,0.743227501132489,3,378,positive regulation of cell adhesion,BP,FADD;PNP;PYCARD
9429,GO:0034399,0.476830347913047,0.863885667045817,1,121,nuclear periphery,CC,RNASEL
1387,GO:0003014,0.477337885871531,0.863678683186601,1,107,renal system process,BP,HNF1A
13647,GO:0050770,0.477938680523063,0.863003907343938,1,149,regulation of axonogenesis,BP,LINGO1
13964,GO:0051246,0.47849092922806,0.624165603550803,17,2455,regulation of protein metabolic process,BP,CFB;FADD;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;ANG;NMI;TSFM;NOL3;DEPTOR;IFI27;TFPI;RBMS3
8902,GO:0033036,0.479256919556785,0.621032331161996,18,2775,macromolecule localization,BP,USE1;MRAP;APOC1;TBC1D14;PNP;ABCG1;PYCARD;CPT2;RBP4;ANG;HEXB;FABP3;NOL3;IFI27;STAR;SNX21;RPH3AL;CNIH4
14602,GO:0055082,0.479626342770473,0.696074311601612,5,690,cellular chemical homeostasis,BP,SLC31A2;RGN;HEXB;NOL3;STAR
7105,GO:0022600,0.480365467906765,0.861910888548183,1,91,digestive system process,BP,RBP4
10985,GO:0042698,0.480716205611458,0.861541847862783,1,103,ovulation cycle,BP,ANG
4872,GO:0010594,0.480807166951228,0.861370396152024,1,115,regulation of endothelial cell migration,BP,FGF18
7798,GO:0031146,0.480958368965407,0.861871973650985,1,71,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,PSMB10
4713,GO:0010008,0.481047823588322,0.739422837755883,3,411,endosome membrane,CC,ZFYVE21;TICAM1;SNX21
21645,GO:2001243,0.48130310950306,0.861406104625488,1,84,negative regulation of intrinsic apoptotic signaling pathway,BP,NOL3
8172,GO:0031901,0.481717392892705,0.860779654903926,1,115,early endosome membrane,CC,SNX21
4220,GO:0008543,0.481827402125853,0.860790497459015,1,106,fibroblast growth factor receptor signaling pathway,BP,FGF18
3783,GO:0007368,0.483646747388722,0.859566634301207,1,110,determination of left/right symmetry,BP,ALG5
3680,GO:0007173,0.484235117931858,0.859088813687694,1,121,epidermal growth factor receptor signaling pathway,BP,DOK1
7440,GO:0030426,0.484364071631829,0.858872367153766,1,141,growth cone,CC,ANG
18112,GO:0098655,0.484855126485811,0.69128045630181,5,745,cation transmembrane transport,BP,SLC31A2;RGN;FXYD1;NOL3;CYB5A
1204,GO:0002684,0.485050746965908,0.666481027879094,7,904,positive regulation of immune system process,BP,CFB;FADD;PNP;PYCARD;PSMB10;TICAM1;RBP4
7441,GO:0030427,0.485091250816913,0.858367648298284,1,146,site of polarized growth,CC,ANG
1485,GO:0003206,0.485658595955311,0.858186590664335,1,117,cardiac chamber morphogenesis,BP,RBP4
10584,GO:0040012,0.486034454522686,0.690187479279803,5,770,regulation of locomotion,BP,FADD;PYCARD;RGN;FGF18;FAM110C
7591,GO:0030816,0.486433978104494,0.858057717033171,1,84,positive regulation of cAMP metabolic process,BP,MRAP
17356,GO:0090066,0.4865138429748,0.734660464090259,3,439,regulation of anatomical structure size,BP,PYCARD;DEPTOR;TMOD4
20806,GO:1990542,0.486565683872576,0.858242140430616,1,70,mitochondrial transmembrane transport,BP,CPT2
4025,GO:0008238,0.48661664377692,0.857744112394103,1,98,exopeptidase activity,MF,PEPD
11174,GO:0043066,0.487608961754681,0.674954056143553,6,795,negative regulation of apoptotic process,BP,PDK4;FADD;TRADD;RGN;NOL3;STAR
9629,GO:0034976,0.487680647098736,0.77570235809274,2,254,response to endoplasmic reticulum stress,BP,ACADVL;CASP4
15457,GO:0061337,0.487778747519436,0.856651912437201,1,136,cardiac conduction,BP,FXYD1
13442,GO:0048858,0.487871052267642,0.733329663601317,3,575,cell projection morphogenesis,BP,S100B;DOK1;LINGO1
4912,GO:0010648,0.488048773867115,0.654808867870857,8,1182,negative regulation of cell communication,BP,FADD;TRADD;PYCARD;PSMB10;TICAM1;NOL3;DEPTOR;RPH3AL
3500,GO:0006874,0.488714942301185,0.732851609216388,3,379,cellular calcium ion homeostasis,BP,RGN;HEXB;NOL3
6641,GO:0019538,0.489124675188269,0.589125982652599,36,5268,protein metabolic process,BP,CFB;PDK4;USE1;ALG5;DPM3;MSRA;MRPL14;MRPL16;FADD;APOC1;TRADD;EXTL1;ABCG1;PYCARD;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;ETFB;RNASEL;ANG;NMI;TSFM;IDUA;HEXB;NOL3;DEPTOR;CASP4;IFI27;MDP1;TFPI;PEPD;RBMS3;LYPLAL1
1042,GO:0002377,0.489405200311502,0.856033215136678,1,88,immunoglobulin production,BP,RBP4
8206,GO:0031965,0.489560362080393,0.774093255904408,2,280,nuclear membrane,CC,IFI27;DHCR7
13805,GO:0051015,0.48959400284506,0.855428466176453,1,139,actin filament binding,MF,TMOD4
14331,GO:0051928,0.489594654176421,0.855811111996682,1,95,positive regulation of calcium ion transport,BP,RGN
1225,GO:0002705,0.490283558511312,0.855464706404342,1,87,positive regulation of leukocyte mediated immunity,BP,FADD
9762,GO:0035303,0.490931286857986,0.854587129999135,1,131,regulation of dephosphorylation,BP,RGN
10012,GO:0035725,0.491224648060564,0.85431135292416,1,144,sodium ion transmembrane transport,BP,FXYD1
18782,GO:1901362,0.491492154532018,0.591507532984419,30,4382,organic cyclic compound biosynthetic process,BP,EBP;FADD;HSD17B3;MRAP;TRADD;HSD17B11;PNP;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;NNMT;CYP17A1;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;HSD3B2;PCBD1;IFI27;STAR;CYP11A1;DHCR7;PTS;HNF1A
11629,GO:0044092,0.491730783359959,0.651385409333671,8,1056,negative regulation of molecular function,BP,APOC1;PYCARD;PSMB10;RGN;NOL3;DEPTOR;TFPI;GLA
7174,GO:0023057,0.492398159952522,0.650701378704743,8,1186,negative regulation of signaling,BP,FADD;TRADD;PYCARD;PSMB10;TICAM1;NOL3;DEPTOR;RPH3AL
15494,GO:0061418,0.492421226626158,0.854231945276965,1,76,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,PSMB10
7227,GO:0030101,0.492799728433672,0.853978728002947,1,76,natural killer cell activation,BP,TICAM1
6486,GO:0019079,0.493220786193138,0.853272531656139,1,105,viral genome replication,BP,RNASEL
760,GO:0001935,0.493421401853521,0.853077635646644,1,111,endothelial cell proliferation,BP,ANG
7891,GO:0031333,0.494209274400757,0.852519473966688,1,114,negative regulation of protein complex assembly,BP,TMOD4
11146,GO:0043021,0.494225998663749,0.852663796684043,1,99,ribonucleoprotein complex binding,MF,RNASEL
18159,GO:0098781,0.494239561619207,0.852704475170012,1,95,ncRNA transcription,BP,ANG
12317,GO:0045727,0.494362047883703,0.852560308788039,1,100,positive regulation of translation,BP,RBMS3
13300,GO:0048592,0.494916193646308,0.851857379576299,1,139,eye morphogenesis,BP,RBP4
16790,GO:0072006,0.495718295423848,0.851314360158371,1,139,nephron development,BP,ACAT1
5357,GO:0015081,0.495956413885264,0.851085613315544,1,151,sodium ion transmembrane transporter activity,MF,SLC1A3
11177,GO:0043069,0.496491485594881,0.666676850048317,6,806,negative regulation of programmed cell death,BP,PDK4;FADD;TRADD;RGN;NOL3;STAR
10737,GO:0042277,0.497017554044201,0.768128256715947,2,231,peptide binding,MF,GHR;ANG
5903,GO:0016407,0.497534213172044,0.850424796651222,1,99,acetyltransferase activity,MF,ACAT1
3966,GO:0008144,0.497888479072792,0.850221237523214,1,96,drug binding,MF,PNP
13655,GO:0050778,0.498503574089629,0.678820035888415,5,643,positive regulation of immune response,BP,CFB;FADD;PYCARD;PSMB10;TICAM1
739,GO:0001909,0.498726048194148,0.84988042474057,1,81,leukocyte mediated cytotoxicity,BP,FADD
16403,GO:0071333,0.499649167089122,0.848861323618082,1,110,cellular response to glucose stimulus,BP,STAR
9506,GO:0034599,0.500077984572118,0.765552457312611,2,240,cellular response to oxidative stress,BP,RGN;NOL3
4676,GO:0009896,0.501498003052314,0.721572166939258,3,406,positive regulation of catabolic process,BP,PSMB10;RGN;TICAM1
1202,GO:0002682,0.501860717181685,0.628153426961075,10,1306,regulation of immune system process,BP,CFB;FADD;PNP;PYCARD;PSMB10;TICAM1;RBP4;NMI;SHPK;TMEM176A
12359,GO:0045807,0.502591810758213,0.846818204996764,1,112,positive regulation of endocytosis,BP,PYCARD
4055,GO:0008286,0.502740133049652,0.846643795551223,1,120,insulin receptor signaling pathway,BP,PDK4
2803,GO:0005793,0.505302201220486,0.844968885490965,1,109,endoplasmic reticulum-Golgi intermediate compartment,CC,CNIH4
8374,GO:0032273,0.505362049527767,0.844992488368046,1,103,positive regulation of protein polymerization,BP,PYCARD
19429,GO:1903050,0.505766703327396,0.760835174240202,2,229,regulation of proteolysis involved in cellular protein catabolic process,BP,PSMB10;RGN
497,GO:0001523,0.505800818046226,0.844873863240429,1,89,retinoid metabolic process,BP,RBP4
612,GO:0001726,0.505925163511144,0.844207131695212,1,154,ruffle,CC,S100B
10766,GO:0042326,0.505929493784992,0.71760153090056,3,421,negative regulation of phosphorylation,BP,PYCARD;RGN;DEPTOR
4395,GO:0009119,0.507541611010838,0.843599603424972,1,93,ribonucleoside metabolic process,BP,PNP
13840,GO:0051053,0.507750880600543,0.843163653701625,1,119,negative regulation of DNA metabolic process,BP,RGN
14595,GO:0055074,0.507752646594298,0.716022749943519,3,392,calcium ion homeostasis,BP,RGN;HEXB;NOL3
10750,GO:0042303,0.5080150793945,0.84308382966986,1,108,molting cycle,BP,TRADD
10957,GO:0042633,0.5080150793945,0.84308382966986,1,108,hair cycle,BP,TRADD
2983,GO:0006090,0.508220320156176,0.842995303134395,1,103,pyruvate metabolic process,BP,PDK4
154,GO:0000302,0.508307882316859,0.758713335305729,2,224,response to reactive oxygen species,BP,RGN;STAR
8562,GO:0032526,0.50839878261307,0.842870057318614,1,103,response to retinoic acid,BP,RBP4
4103,GO:0008361,0.509171386480459,0.841956088454866,1,149,regulation of cell size,BP,DEPTOR
8788,GO:0032870,0.50921990851209,0.687600915754017,4,610,cellular response to hormone stimulus,BP,PDK4;GHR;RNASEL;STAR
3169,GO:0006412,0.509573723622867,0.668564067402556,5,581,translation,BP,MRPL14;MRPL16;ANG;TSFM;RBMS3
4662,GO:0009855,0.5101119835503,0.841511079900275,1,118,determination of bilateral symmetry,BP,ALG5
16830,GO:0072073,0.510165584533014,0.841307819509599,1,140,kidney epithelium development,BP,ACAT1
13332,GO:0048660,0.51051122705148,0.841285529961584,1,112,regulation of smooth muscle cell proliferation,BP,ANG
8858,GO:0032970,0.510720953172954,0.75637056948103,2,318,regulation of actin filament-based process,BP,PYCARD;TMOD4
4261,GO:0008630,0.510988336541189,0.84114740672692,1,95,intrinsic apoptotic signaling pathway in response to DNA damage,BP,PYCARD
418,GO:0001085,0.511115854440847,0.840838376842013,1,114,RNA polymerase II transcription factor binding,MF,IFI27
13297,GO:0048585,0.511209956907432,0.625333698763172,9,1339,negative regulation of response to stimulus,BP,FADD;TRADD;PYCARD;PSMB10;TICAM1;NMI;NOL3;DEPTOR;RPH3AL
7817,GO:0031224,0.511244619453846,0.56675175457024,37,5117,intrinsic component of membrane,CC,EBP;TMEM160;TMEM164;USE1;ALG5;DPM3;SLC31A2;P2RY14;MRAP;PXMP2;PXMP4;EXTL1;ABCG1;CCDC51;MGST2;FADS1;GHR;ASAH2;PLA2G16;FXYD1;TMEM223;GRIA3;HSD3B2;CPT1C;IFI27;TMEM176A;TMEM98;TFPI;ACP5;PRRT1;DHCR7;CYB5A;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH
7508,GO:0030594,0.511757572197115,0.840603059707488,1,95,neurotransmitter receptor activity,MF,GRIA3
13960,GO:0051238,0.511851184395453,0.84026242652753,1,120,sequestering of metal ion,BP,NOL3
16401,GO:0071331,0.512150653436242,0.840114438939933,1,113,cellular response to hexose stimulus,BP,STAR
8370,GO:0032269,0.512742461538401,0.640246246518815,7,986,negative regulation of cellular protein metabolic process,BP,PYCARD;PSMB10;RGN;ANG;NOL3;DEPTOR;TFPI
18155,GO:0098772,0.512985310711883,0.623606058802548,9,1372,molecular function regulator,MF,APOC1;TBC1D14;PYCARD;MGST2;RGN;FGF18;FXYD1;NOL3;TFPI
8780,GO:0032844,0.513571291385037,0.710706271263425,3,439,regulation of homeostatic process,BP,PDK4;FADD;NOL3
16399,GO:0071326,0.514221182301698,0.838630186934764,1,114,cellular response to monosaccharide stimulus,BP,STAR
12664,GO:0046483,0.514939952713541,0.561935969829542,39,5674,heterocycle metabolic process,BP,FADD;MRAP;TRADD;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;PSMB10;RGN;FADS1;GHR;TICAM1;ARL6IP4;NNMT;HSD17B10;GALT;RNASEL;ANG;NMI;ACAT1;TSFM;AOX1;SHPK;HEXB;NOL3;NUDT7;PCBD1;MDH1;IFI27;IDH1;PUS1;PTMS;STAR;ACP5;DERA;PTS;HNF1A
4651,GO:0009799,0.515672002786873,0.837545016843591,1,119,specification of symmetry,BP,ALG5
14929,GO:0060402,0.515933711711008,0.837314194976466,1,124,calcium ion transport into cytosol,BP,NOL3
5726,GO:0016021,0.516067123127827,0.562607467452513,36,4993,integral component of membrane,CC,EBP;TMEM160;TMEM164;USE1;ALG5;DPM3;SLC31A2;P2RY14;MRAP;PXMP2;PXMP4;EXTL1;ABCG1;CCDC51;MGST2;FADS1;GHR;ASAH2;PLA2G16;FXYD1;TMEM223;GRIA3;HSD3B2;CPT1C;IFI27;TMEM176A;TMEM98;ACP5;PRRT1;DHCR7;CYB5A;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH
14075,GO:0051436,0.516115758868579,0.837948894889725,1,71,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,PSMB10
5144,GO:0010972,0.516866015057469,0.837209110930645,1,80,negative regulation of G2/M transition of mitotic cell cycle,BP,PSMB10
18318,GO:0099503,0.517859196752922,0.635371784409487,7,905,secretory vesicle,CC,PNP;PYCARD;HEXB;IDH1;GLA;RPH3AL;DERA
8290,GO:0032101,0.518015361106695,0.660506563587921,5,672,regulation of response to external stimulus,BP,CFB;FGF18;SHPK;CASP4;FAM46A
3677,GO:0007169,0.518148258205065,0.679256257635506,4,671,transmembrane receptor protein tyrosine kinase signaling pathway,BP,PDK4;GHR;FGF18;DOK1
13331,GO:0048659,0.518343552962166,0.835658469147067,1,115,smooth muscle cell proliferation,BP,ANG
10650,GO:0042100,0.518558465326181,0.835845175550508,1,88,B cell proliferation,BP,TICAM1
16739,GO:0071887,0.518620401633808,0.835665178916839,1,97,leukocyte apoptotic process,BP,FADD
13957,GO:0051234,0.518872701973726,0.562763143166621,32,4853,establishment of localization,BP,EBP;USE1;ZFYVE21;SLC31A2;APOC1;TBC1D14;PNP;ABCG1;PYCARD;PSMB10;RGN;GHR;CPT2;FXYD1;RBP4;RNASEL;ANG;HEXB;FABP3;GRIA3;NOL3;IFI27;IDH1;STAR;SNX21;GLA;RPH3AL;DERA;CYB5A;HNF1A;SLC1A3;CNIH4
13578,GO:0050678,0.519077006046888,0.749301455108488,2,282,regulation of epithelial cell proliferation,BP,RGN;ANG
675,GO:0001819,0.519366652040961,0.70553772903561,3,387,positive regulation of cytokine production,BP,FADD;PYCARD;TICAM1
8791,GO:0032874,0.519429987572431,0.834692557176853,1,137,positive regulation of stress-activated MAPK cascade,BP,PYCARD
7179,GO:0030003,0.51985247095163,0.677773623571909,4,556,cellular cation homeostasis,BP,SLC31A2;RGN;HEXB;NOL3
14078,GO:0051439,0.520966577617012,0.83442756721347,1,72,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,BP,PSMB10
7097,GO:0022407,0.520967976127259,0.704072022978787,3,389,regulation of cell-cell adhesion,BP,FADD;PNP;PYCARD
8313,GO:0032147,0.521530594706864,0.747144011848144,2,294,activation of protein kinase activity,BP,GHR;ANG
12793,GO:0046717,0.521830446661786,0.833166214934651,1,111,acid secretion,BP,SLC1A3
9744,GO:0035265,0.521850239020664,0.832896836415803,1,142,organ growth,BP,RBP4
8870,GO:0032990,0.522043888592841,0.702819249026465,3,593,cell part morphogenesis,BP,S100B;DOK1;LINGO1
15863,GO:0070304,0.522301245100448,0.832593503859861,1,138,positive regulation of stress-activated protein kinase signaling cascade,BP,PYCARD
1264,GO:0002761,0.52240222337508,0.832759190346978,1,110,regulation of myeloid leukocyte differentiation,BP,FADD
9012,GO:0033238,0.522531027229205,0.833194292667177,1,76,regulation of cellular amine metabolic process,BP,PSMB10
13370,GO:0048706,0.523343126044661,0.831962704386927,1,121,embryonic skeletal system development,BP,RBP4
8869,GO:0032989,0.523691565615479,0.654918061143473,5,973,cellular component morphogenesis,BP,HEXB;S100B;DOK1;SLC1A3;LINGO1
3531,GO:0006914,0.525026800122583,0.700263148971147,3,438,autophagy,BP,WDR45;TBC1D14;TICAM1
587,GO:0001678,0.525037982166904,0.830690513310329,1,124,cellular glucose homeostasis,BP,STAR
5368,GO:0015103,0.525231405080967,0.830461719986837,1,135,inorganic anion transmembrane transporter activity,MF,FXYD1
17062,GO:0072503,0.525496021850087,0.699892124312006,3,403,cellular divalent inorganic cation homeostasis,BP,RGN;HEXB;NOL3
12231,GO:0045595,0.525671605719113,0.611225822903386,9,1471,regulation of cell differentiation,BP,FADD;PNP;ABCG1;FADS1;FGF18;TMEM176A;STAR;S100B;LINGO1
22,GO:0000041,0.526167642358123,0.830036926544174,1,106,transition metal ion transport,BP,SLC31A2
19295,GO:1902750,0.526776389314284,0.829951593487907,1,82,negative regulation of cell cycle G2/M phase transition,BP,PSMB10
4195,GO:0008509,0.527211847989541,0.742161196491651,2,304,anion transmembrane transporter activity,MF,FXYD1;SLC1A3
19473,GO:1903169,0.527531845937898,0.828900203762274,1,118,regulation of calcium ion transmembrane transport,BP,RGN
5813,GO:0016209,0.527562798161314,0.829431396623377,1,79,antioxidant activity,MF,MGST2
15907,GO:0070372,0.527755926376091,0.74188963359465,2,240,regulation of ERK1 and ERK2 cascade,BP,PYCARD;FGF18
4854,GO:0010562,0.528629529518508,0.624873333893612,7,1022,positive regulation of phosphorus metabolic process,BP,MRAP;PYCARD;RGN;GHR;FGF18;ANG;FABP3
12436,GO:0045937,0.528629529518508,0.624873333893612,7,1022,positive regulation of phosphate metabolic process,BP,MRAP;PYCARD;RGN;GHR;FGF18;ANG;FABP3
3585,GO:0007005,0.528647432519709,0.669574309522361,4,495,mitochondrion organization,BP,PYCARD;HSD17B10;NOL3;PUS1
1484,GO:0003205,0.528783191656623,0.827712471511346,1,153,cardiac chamber development,BP,RBP4
13268,GO:0048525,0.529056446942308,0.827894038783047,1,106,negative regulation of viral process,BP,RNASEL
12388,GO:0045860,0.529232670949418,0.696337343832453,3,468,positive regulation of protein kinase activity,BP,GHR;FGF18;ANG
13713,GO:0050864,0.529290431134204,0.827719700622491,1,106,regulation of B cell activation,BP,TICAM1
7401,GO:0030334,0.529385946457937,0.668695646457332,4,653,regulation of cell migration,BP,FADD;PYCARD;FGF18;FAM110C
16397,GO:0071322,0.530974392429055,0.82630493756583,1,121,cellular response to carbohydrate stimulus,BP,STAR
1097,GO:0002479,0.530983506719593,0.827001952775,1,74,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,PSMB10
14893,GO:0060359,0.531159727612023,0.826213737339526,1,116,response to ammonium ion,BP,FADD
14076,GO:0051437,0.531382970842521,0.826655573453455,1,76,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,BP,PSMB10
563,GO:0001650,0.532616070695523,0.825071714559672,1,121,fibrillar center,CC,MRI1
3495,GO:0006865,0.533189406577316,0.824524042698878,1,135,amino acid transport,BP,SLC1A3
14928,GO:0060401,0.533401681302941,0.824402279164885,1,130,cytosolic calcium ion transport,BP,NOL3
7482,GO:0030534,0.53343659775364,0.82430174162543,1,140,adult behavior,BP,FADD
2638,GO:0005509,0.533895847545742,0.664388396781951,4,676,calcium ion binding,MF,RGN;NOL3;RPH3AL;S100B
7579,GO:0030804,0.533928004141472,0.824373414830653,1,96,positive regulation of cyclic nucleotide biosynthetic process,BP,MRAP
5458,GO:0015276,0.534532519057472,0.823459162041581,1,142,ligand-gated ion channel activity,MF,GRIA3
7133,GO:0022834,0.534532519057472,0.823459162041581,1,142,ligand-gated channel activity,MF,GRIA3
4406,GO:0009132,0.534972611334082,0.82341502161876,1,109,nucleoside diphosphate metabolic process,BP,NUDT7
19199,GO:1902532,0.535345060947893,0.69067763388946,3,451,negative regulation of intracellular signal transduction,BP,PYCARD;NOL3;DEPTOR
7102,GO:0022412,0.53657887823449,0.734026183742333,2,254,cellular process involved in reproduction in multicellular organism,BP,ANG;HEXB
3499,GO:0006873,0.536604901521863,0.661902117857035,4,570,cellular ion homeostasis,BP,SLC31A2;RGN;HEXB;NOL3
18059,GO:0098542,0.537017766159325,0.661678731181589,4,451,defense response to other organism,BP,FADD;PYCARD;TICAM1;RNASEL
6299,GO:0017148,0.537156093236397,0.821412776068406,1,150,negative regulation of translation,BP,ANG
7985,GO:0031503,0.537453096026636,0.821423712245785,1,119,protein complex localization,BP,NOL3
2669,GO:0005578,0.538364369957617,0.732168376622021,2,351,proteinaceous extracellular matrix,CC,ANG;LINGO1
12320,GO:0045732,0.538707975472662,0.732133403995589,2,251,positive regulation of protein catabolic process,BP,PSMB10;RGN
5222,GO:0014066,0.538817521173797,0.820186301016556,1,143,regulation of phosphatidylinositol 3-kinase signaling,BP,FGF18
4669,GO:0009889,0.538879058171988,0.547739028668984,27,4178,regulation of biosynthetic process,BP,PDK4;FADD;MRAP;APOC1;TRADD;ABCG1;EBF1;PYCARD;ACADVL;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;FABP3;PCBD1;IFI27;IDH1;STAR;GLA;DHCR7;RBMS3;HNF1A
19037,GO:1902115,0.539064009726907,0.820010867350252,1,141,regulation of organelle assembly,BP,TBC1D14
7902,GO:0031345,0.539112043526144,0.819967131194954,1,142,negative regulation of cell projection organization,BP,LINGO1
12232,GO:0045596,0.540197284712546,0.658420817034258,4,603,negative regulation of cell differentiation,BP,ABCG1;TMEM176A;S100B;LINGO1
11820,GO:0044455,0.5405804575214,0.730840761395634,2,179,mitochondrial membrane part,CC,STAR;ETFDH
11807,GO:0044440,0.540678700923603,0.685686666731739,3,443,endosomal part,CC,ZFYVE21;TICAM1;SNX21
14312,GO:0051896,0.541137337743397,0.818587377384017,1,120,regulation of protein kinase B signaling,BP,FAM110C
13612,GO:0050715,0.541153046355949,0.818792823589131,1,101,positive regulation of cytokine secretion,BP,PYCARD
5466,GO:0015293,0.541226587192769,0.818346375067474,1,141,symporter activity,MF,SLC1A3
5831,GO:0016241,0.543582132210544,0.81660569867993,1,130,regulation of macroautophagy,BP,TBC1D14
101,GO:0000209,0.543881063388863,0.727362385247017,2,284,protein polyubiquitination,BP,PSMB10;NMI
7886,GO:0031328,0.544674899393713,0.580680237262703,11,1717,positive regulation of cellular biosynthetic process,BP,FADD;MRAP;RGN;TICAM1;RNASEL;HEXB;FABP3;PCBD1;STAR;RBMS3;HNF1A
12889,GO:0046943,0.545348007129875,0.815222174816681,1,131,carboxylic acid transmembrane transporter activity,MF,SLC1A3
13323,GO:0048639,0.545408281504683,0.815008862903354,1,155,positive regulation of developmental growth,BP,GHR
10498,GO:0038127,0.545911947079653,0.814691256923453,1,143,ERBB signaling pathway,BP,DOK1
16250,GO:0070997,0.546233966507071,0.725193064997181,2,296,neuron death,BP,FADD;STAR
336,GO:0000922,0.546423139370098,0.814381485439755,1,131,spindle pole,CC,FAM110C
5233,GO:0014706,0.546516755069321,0.724848492594311,2,331,striated muscle tissue development,BP,RBP4;S100B
17065,GO:0072507,0.546551047305791,0.680166554163047,3,422,divalent inorganic cation homeostasis,BP,RGN;HEXB;NOL3
15001,GO:0060491,0.546558573026116,0.814191893391253,1,142,regulation of cell projection assembly,BP,FAM110C
16752,GO:0071902,0.547000781798428,0.724492570458229,2,297,positive regulation of protein serine/threonine kinase activity,BP,GHR;FGF18
19566,GO:1903362,0.547069835015043,0.72458098071953,2,251,regulation of cellular protein catabolic process,BP,PSMB10;RGN
12771,GO:0046683,0.54820160324911,0.813002063997309,1,129,response to organophosphorus,BP,STAR
20174,GO:1904667,0.548256412157835,0.813703721486419,1,77,negative regulation of ubiquitin protein ligase activity,BP,PSMB10
14698,GO:0060071,0.548328428401218,0.813104439484169,1,109,Wnt signaling pathway, planar cell polarity pathway,BP,PSMB10
11454,GO:0043524,0.548372563704972,0.812834356448944,1,133,negative regulation of neuron apoptotic process,BP,STAR
17430,GO:0090175,0.548583573912268,0.812891804834626,1,110,regulation of establishment of planar polarity,BP,PSMB10
20175,GO:1904668,0.548918218763291,0.813029504253355,1,84,positive regulation of ubiquitin protein ligase activity,BP,PSMB10
3586,GO:0007006,0.550113670299318,0.811773157961573,1,103,mitochondrial membrane organization,BP,NOL3
15906,GO:0070371,0.550123873450778,0.721773586514307,2,256,ERK1 and ERK2 cascade,BP,PYCARD;FGF18
5126,GO:0010951,0.550570436560322,0.721497640315833,2,225,negative regulation of endopeptidase activity,BP,NOL3;TFPI
9354,GO:0034250,0.550739754995246,0.811121956021206,1,116,positive regulation of cellular amide metabolic process,BP,RBMS3
6759,GO:0019901,0.551174896432105,0.67560517666468,3,528,protein kinase binding,MF,TBC1D14;GHR;TICAM1
20484,GO:1905368,0.551765544600114,0.810741032378184,1,86,peptidase complex,CC,PSMB10
2302,GO:0004867,0.552117647121289,0.810369545150703,1,91,serine-type endopeptidase inhibitor activity,MF,TFPI
7691,GO:0030968,0.552779211614383,0.809470361865928,1,119,endoplasmic reticulum unfolded protein response,BP,ACADVL
12742,GO:0046631,0.552794337018691,0.809500489636617,1,115,alpha-beta T cell activation,BP,PNP
7925,GO:0031400,0.552920390566611,0.646111062094813,4,580,negative regulation of protein modification process,BP,PYCARD;PSMB10;RGN;DEPTOR
6757,GO:0019899,0.553257686888186,0.577490769181578,10,1773,enzyme binding,MF,FADD;TRADD;TBC1D14;PYCARD;GHR;TICAM1;ACAT1;NOL3;RPH3AL;CYB5A
7585,GO:0030810,0.553337910489505,0.809213604450641,1,103,positive regulation of nucleotide biosynthetic process,BP,MRAP
18596,GO:1900373,0.553337910489505,0.809213604450641,1,103,positive regulation of purine nucleotide biosynthetic process,BP,MRAP
7200,GO:0030036,0.553480258898341,0.673357946541565,3,562,actin cytoskeleton organization,BP,PYCARD;ANG;TMOD4
1641,GO:0003735,0.554400726758154,0.718488436084526,2,154,structural constituent of ribosome,MF,MRPL14;MRPL16
13299,GO:0048589,0.554828315735644,0.672073121692253,3,551,developmental growth,BP,GHR;RBP4;DHCR7
8797,GO:0032880,0.554862186364079,0.610246528034428,6,937,regulation of protein localization,BP,PYCARD;RBP4;ANG;NOL3;IFI27;RPH3AL
4288,GO:0008757,0.555185213785034,0.807557112536289,1,118,S-adenosylmethionine-dependent methyltransferase activity,MF,NNMT
7797,GO:0031145,0.555234465978588,0.808103863114541,1,80,anaphase-promoting complex-dependent catabolic process,BP,PSMB10
4903,GO:0010639,0.556552653653312,0.71567881141847,2,311,negative regulation of organelle organization,BP,NOL3;TMOD4
15027,GO:0060537,0.557358593453489,0.714851745798919,2,345,muscle tissue development,BP,RBP4;S100B
6108,GO:0016779,0.557700213075405,0.805491829307596,1,122,nucleotidyltransferase activity,MF,GALT
20980,GO:2000060,0.558036011962504,0.805648597814155,1,90,positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10
7438,GO:0030424,0.558464219171746,0.713760479555552,2,378,axon,CC,CYP17A1;CPT1C
14082,GO:0051444,0.558827404229507,0.805147194832196,1,83,negative regulation of ubiquitin-protein transferase activity,BP,PSMB10
9103,GO:0033559,0.559397437256412,0.804444882351613,1,96,unsaturated fatty acid metabolic process,BP,FADS1
18078,GO:0098589,0.560852532235049,0.711575807898075,2,355,membrane region,CC,FADD;TRADD
5228,GO:0014074,0.56184091687987,0.80195541970423,1,142,response to purine-containing compound,BP,STAR
10921,GO:0042578,0.562600395392063,0.709970640468473,2,340,phosphoric ester hydrolase activity,MF,MDP1;ACP5
673,GO:0001817,0.562607875866288,0.636585932759096,4,576,regulation of cytokine production,BP,FADD;PYCARD;TICAM1;NMI
15327,GO:0061041,0.562877224591566,0.801239943506002,1,126,regulation of wound healing,BP,FAM46A
4080,GO:0008324,0.562973486426618,0.636148941924971,4,649,cation transmembrane transporter activity,MF,SLC31A2;GRIA3;CYB5A;SLC1A3
645,GO:0001775,0.563010391733918,0.574117925771815,9,1279,cell activation,BP,FADD;PNP;PYCARD;TICAM1;SHPK;HEXB;IDH1;GLA;DERA
12221,GO:0045580,0.563074270084394,0.801158665157049,1,118,regulation of T cell differentiation,BP,PNP
17914,GO:0097435,0.563771543188651,0.66342548038073,3,534,supramolecular fiber organization,BP,PYCARD;ANG;TMOD4
12856,GO:0046887,0.564010899062516,0.800457610885077,1,112,positive regulation of hormone secretion,BP,RBP4
12594,GO:0046328,0.564049856619878,0.800024686955278,1,160,regulation of JNK cascade,BP,PYCARD
7576,GO:0030801,0.564419826882577,0.800224331088708,1,104,positive regulation of cyclic nucleotide metabolic process,BP,MRAP
8551,GO:0032502,0.564923806627133,0.513567342858651,36,5693,developmental process,BP,EBP;ALG5;FADD;HSD17B3;MRAP;TRADD;EXTL1;PNP;ABCG1;EBF1;BDH2;ACADVL;KRT10;PSMB10;RGN;FADS1;GHR;FGF18;NNMT;PLA2G16;RBP4;CYP17A1;RNASEL;ANG;ACAT1;HEXB;NUDT7;TMEM176A;IDH1;STAR;S100B;DHCR7;PTS;DOK1;SLC1A3;LINGO1
9161,GO:0033674,0.564988744320271,0.662281142450602,3,498,positive regulation of kinase activity,BP,GHR;FGF18;ANG
11796,GO:0044425,0.565290589990471,0.509523389871682,43,6187,membrane part,CC,EBP;TMEM160;TMEM164;USE1;ALG5;DPM3;SLC31A2;FADD;P2RY14;HSD17B3;MRAP;TRADD;PXMP2;PXMP4;EXTL1;ABCG1;CCDC51;MGST2;FADS1;GHR;ASAH2;PLA2G16;FXYD1;TMEM223;CYP17A1;GRIA3;HSD3B2;CPT1C;CASP4;IFI27;TMEM176A;TMEM98;TFPI;STAR;ACP5;PRRT1;DHCR7;CYB5A;SLC1A3;CNIH4;ELOVL6;LINGO1;ETFDH
9005,GO:0033218,0.566070021073762,0.706937013158799,2,260,amide binding,MF,GHR;ANG
9517,GO:0034620,0.566286921536141,0.798460525347132,1,123,cellular response to unfolded protein,BP,ACADVL
4234,GO:0008584,0.567160463930158,0.797644338906606,1,133,male gonad development,BP,STAR
12703,GO:0046546,0.567160463930158,0.797644338906606,1,133,development of primary male sexual characteristics,BP,STAR
620,GO:0001736,0.567301928823838,0.797650146773671,1,120,establishment of planar polarity,BP,PSMB10
3672,GO:0007164,0.567301928823838,0.797650146773671,1,120,establishment of tissue polarity,BP,PSMB10
16750,GO:0071900,0.568323583875803,0.659057555690406,3,467,regulation of protein serine/threonine kinase activity,BP,PYCARD;GHR;FGF18
15985,GO:0070509,0.568689989449647,0.796249754305912,1,149,calcium ion import,BP,NOL3
4048,GO:0008277,0.569766131992038,0.795567427149325,1,123,regulation of G-protein coupled receptor protein signaling pathway,BP,RPH3AL
17928,GO:0097458,0.5714012377356,0.582208079945678,7,1285,neuron part,CC,FADD;CYP17A1;ANG;CPT1C;STAR;S100B;SLC1A3
15036,GO:0060548,0.571637654936671,0.59342832754212,6,872,negative regulation of cell death,BP,PDK4;FADD;TRADD;RGN;NOL3;STAR
2294,GO:0004857,0.572828705642976,0.654796494121211,3,373,enzyme inhibitor activity,MF,APOC1;NOL3;TFPI
17529,GO:0090305,0.573693313442624,0.699652765293287,2,271,nucleic acid phosphodiester bond hydrolysis,BP,RNASEL;ANG
4808,GO:0010466,0.573962662241776,0.699541598624242,2,235,negative regulation of peptidase activity,BP,NOL3;TFPI
18691,GO:1901137,0.57403789436044,0.605573227771044,5,723,carbohydrate derivative biosynthetic process,BP,ALG5;DPM3;MRAP;EXTL1;ACAT1
13256,GO:0048511,0.574764569281638,0.698516870009775,2,306,rhythmic process,BP,ANG;STAR
525,GO:0001568,0.575455241541155,0.651892809988388,3,564,blood vessel development,BP,FGF18;ANG;DHCR7
12654,GO:0046467,0.575493993059601,0.790819451641698,1,116,membrane lipid biosynthetic process,BP,DPM3
11386,GO:0043405,0.576310723336356,0.696991865714398,2,321,regulation of MAP kinase activity,BP,GHR;FGF18
7126,GO:0022804,0.576322798604965,0.696913104283604,2,350,active transmembrane transporter activity,MF,ABCG1;SLC1A3
9353,GO:0034249,0.576657360901709,0.789449137241773,1,162,negative regulation of cellular amide metabolic process,BP,ANG
1220,GO:0002700,0.57805273052973,0.788713815916857,1,110,regulation of production of molecular mediator of immune response,BP,RBP4
580,GO:0001669,0.578385121922984,0.788541489676098,1,102,acrosomal vesicle,CC,HEXB
16751,GO:0071901,0.5790871424507,0.787677700586398,1,123,negative regulation of protein serine/threonine kinase activity,BP,PYCARD
3543,GO:0006936,0.581384781473503,0.692074415031703,2,326,muscle contraction,BP,FXYD1;TMOD4
4426,GO:0009152,0.581544864997173,0.692212788887843,2,239,purine ribonucleotide biosynthetic process,BP,MRAP;ACAT1
5221,GO:0014065,0.581958885765695,0.784901712555563,1,161,phosphatidylinositol 3-kinase signaling,BP,FGF18
11403,GO:0043433,0.582740005936427,0.784489156811937,1,127,negative regulation of sequence-specific DNA binding transcription factor activity,BP,PYCARD
2159,GO:0004672,0.582833701028628,0.644467855503493,3,624,protein kinase activity,MF,PDK4;FGF18;RNASEL
11468,GO:0043542,0.582962078089373,0.784084135945833,1,153,endothelial cell migration,BP,FGF18
10900,GO:0042542,0.582967480187208,0.784332753280427,1,123,response to hydrogen peroxide,BP,STAR
11391,GO:0043410,0.583281248460862,0.64420543043036,3,463,positive regulation of MAPK cascade,BP,PYCARD;GHR;FGF18
6538,GO:0019220,0.58346228257473,0.546800507885176,10,1573,regulation of phosphate metabolic process,BP,MRAP;APOC1;PYCARD;RGN;GHR;FGF18;ANG;FABP3;DEPTOR;IDH1
5835,GO:0016247,0.583508876036307,0.783852759766704,1,124,channel regulator activity,MF,FXYD1
3021,GO:0006163,0.58384435006036,0.615338445326243,4,523,purine nucleotide metabolic process,BP,MRAP;PNP;ACAT1;NUDT7
3525,GO:0006906,0.584083897577768,0.783116387753192,1,152,vesicle fusion,BP,TBC1D14
5564,GO:0015698,0.584729896298043,0.782453770139322,1,168,inorganic anion transport,BP,FXYD1
3559,GO:0006959,0.585136787159107,0.688936691102752,2,199,humoral immune response,BP,CFB;PSMB10
20173,GO:1904666,0.585161940694584,0.782863973891643,1,92,regulation of ubiquitin protein ligase activity,BP,PSMB10
3237,GO:0006508,0.586551962640194,0.538155777392066,11,1634,proteolysis,BP,CFB;FADD;TRADD;PYCARD;PSMB10;RGN;NOL3;CASP4;IFI27;TFPI;PEPD
2583,GO:0005342,0.5881309814111,0.779658168923257,1,141,organic acid transmembrane transporter activity,MF,SLC1A3
621,GO:0001738,0.588492705128727,0.779427339865109,1,131,morphogenesis of a polarized epithelium,BP,PSMB10
3022,GO:0006164,0.588566411229242,0.685336085243043,2,242,purine nucleotide biosynthetic process,BP,MRAP;ACAT1
14029,GO:0051347,0.589223508223277,0.609711053039594,4,635,positive regulation of transferase activity,BP,PSMB10;GHR;FGF18;ANG
3131,GO:0006354,0.589517297520698,0.778615541595619,1,122,DNA-templated transcription, elongation,BP,TSFM
3830,GO:0007519,0.589971777688083,0.777987906445461,1,147,skeletal muscle tissue development,BP,S100B
3828,GO:0007517,0.590149457817199,0.683450810233031,2,343,muscle organ development,BP,RBP4;S100B
9895,GO:0035556,0.590189286795942,0.518426384130854,15,2530,intracellular signal transduction,BP,FADD;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;FAM110C;NMI;NOL3;DEPTOR;CASP4;S100B;DOK1
1120,GO:0002521,0.591351473586088,0.636049886245222,3,462,leukocyte differentiation,BP,FADD;PNP;TMEM176A
12094,GO:0045216,0.591411700256677,0.776365228378695,1,214,cell-cell junction organization,BP,ANG
7884,GO:0031326,0.592414027193836,0.49448698754359,26,4131,regulation of cellular biosynthetic process,BP,PDK4;FADD;MRAP;APOC1;TRADD;ABCG1;EBF1;PYCARD;ACADVL;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;FABP3;PCBD1;IFI27;IDH1;STAR;GLA;RBMS3;HNF1A
19227,GO:1902582,0.592595467664404,0.606193853299982,4,694,single-organism intracellular transport,BP,ABCG1;CPT2;NOL3;STAR
4755,GO:0010212,0.593291119651447,0.775062681449622,1,144,response to ionizing radiation,BP,STAR
5353,GO:0015075,0.594861997784282,0.584137492573498,5,861,ion transmembrane transporter activity,MF,SLC31A2;FXYD1;GRIA3;CYB5A;SLC1A3
10801,GO:0042391,0.595159078640874,0.678417975564771,2,373,regulation of membrane potential,BP,FXYD1;GRIA3
10476,GO:0038095,0.596437485965335,0.772428573819875,1,124,Fc-epsilon receptor signaling pathway,BP,PSMB10
98,GO:0000187,0.596894748719237,0.77183132062687,1,144,activation of MAPK activity,BP,GHR
17429,GO:0090174,0.597535566617278,0.771157872292214,1,157,organelle membrane fusion,BP,TBC1D14
3218,GO:0006479,0.597640799087865,0.77104952820535,1,159,protein methylation,BP,ETFB
4011,GO:0008213,0.597640799087865,0.77104952820535,1,159,protein alkylation,BP,ETFB
7592,GO:0030817,0.597680345655682,0.771376939558953,1,118,regulation of cAMP biosynthetic process,BP,MRAP
729,GO:0001890,0.59820976021916,0.770652239099358,1,143,placenta development,BP,ANG
11898,GO:0044767,0.598237174170474,0.480112067387795,35,5610,single-organism developmental process,BP,EBP;ALG5;FADD;HSD17B3;MRAP;TRADD;EXTL1;PNP;ABCG1;EBF1;BDH2;ACADVL;KRT10;PSMB10;RGN;FADS1;GHR;FGF18;NNMT;PLA2G16;RBP4;RNASEL;ANG;ACAT1;HEXB;NUDT7;TMEM176A;IDH1;STAR;S100B;DHCR7;PTS;DOK1;SLC1A3;LINGO1
2194,GO:0004721,0.598896234053325,0.769845693615912,1,170,phosphoprotein phosphatase activity,MF,MDP1
1226,GO:0002706,0.599235527673396,0.769995050726002,1,116,regulation of lymphocyte mediated immunity,BP,FADD
8423,GO:0032355,0.599292315521361,0.769839889417679,1,125,response to estradiol,BP,TFPI
17493,GO:0090263,0.599579088121475,0.769647248322482,1,119,positive regulation of canonical Wnt signaling pathway,BP,PSMB10
19649,GO:1903530,0.600144785208844,0.598454547711436,4,617,regulation of secretion by cell,BP,PYCARD;RBP4;ANG;RPH3AL
4789,GO:0010389,0.602193162079011,0.767369585576272,1,111,regulation of G2/M transition of mitotic cell cycle,BP,PSMB10
14081,GO:0051443,0.602291895911802,0.767381674449852,1,104,positive regulation of ubiquitin-protein transferase activity,BP,PSMB10
10150,GO:0035967,0.602442095265895,0.766844933535469,1,138,cellular response to topologically incorrect protein,BP,ACADVL
14590,GO:0055067,0.602485411465023,0.766770901682789,1,142,monovalent inorganic cation homeostasis,BP,PDK4
20978,GO:2000058,0.602738027108341,0.766958513670681,1,105,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10
1294,GO:0002822,0.603419967691228,0.766169053334369,1,117,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
5355,GO:0015078,0.60410853531427,0.765766873477604,1,101,hydrogen ion transmembrane transporter activity,MF,CYB5A
5338,GO:0015031,0.605102505532646,0.514074671235141,12,1900,protein transport,BP,USE1;TBC1D14;PNP;ABCG1;PYCARD;RBP4;ANG;NOL3;IFI27;SNX21;RPH3AL;CNIH4
15028,GO:0060538,0.606758082067423,0.762744567365809,1,154,skeletal muscle organ development,BP,S100B
3028,GO:0006171,0.607623033837162,0.762245619119974,1,121,cAMP biosynthetic process,BP,MRAP
11512,GO:0043618,0.608351140414711,0.761711515332266,1,110,regulation of transcription from RNA polymerase II promoter in response to stress,BP,PSMB10
6674,GO:0019722,0.608450765372041,0.761226321973448,1,147,calcium-mediated signaling,BP,RGN
13654,GO:0050777,0.608914141554862,0.761057919115256,1,120,negative regulation of immune response,BP,NMI
947,GO:0002223,0.60933757609886,0.760675655259274,1,119,stimulatory C-type lectin receptor signaling pathway,BP,PSMB10
11429,GO:0043491,0.609504389459256,0.760269127816353,1,144,protein kinase B signaling,BP,FAM110C
1260,GO:0002757,0.609585913523253,0.617261469726382,3,454,immune response-activating signal transduction,BP,FADD;PSMB10;TICAM1
11779,GO:0044391,0.609871525048166,0.664373820234048,2,177,ribosomal subunit,CC,MRPL14;MRPL16
768,GO:0001944,0.610018152124935,0.616635568442045,3,587,vasculature development,BP,FGF18;ANG;DHCR7
4513,GO:0009260,0.610484613718042,0.663278132136665,2,252,ribonucleotide biosynthetic process,BP,MRAP;ACAT1
4597,GO:0009611,0.611559952186951,0.586486706799319,4,626,response to wounding,BP,NOL3;FAM46A;TFPI;SLC1A3
13574,GO:0050673,0.611705635449201,0.661751601129616,2,335,epithelial cell proliferation,BP,RGN;ANG
3411,GO:0006725,0.611754105450113,0.464240631861571,38,5710,cellular aromatic compound metabolic process,BP,FADD;MRAP;TRADD;PNP;ABCG1;EBF1;BDH2;PYCARD;LAGE3;PSMB10;RGN;FADS1;TICAM1;ARL6IP4;NNMT;HSD17B10;GALT;RNASEL;ANG;NMI;ACAT1;TSFM;AOX1;SHPK;HEXB;NOL3;NUDT7;PCBD1;MDH1;IFI27;PON2;IDH1;PUS1;PTMS;STAR;DERA;PTS;HNF1A
4703,GO:0009986,0.611972270249744,0.585998168132184,4,682,cell surface,CC,ABCG1;GHR;TFPI;SLC1A3
3744,GO:0007267,0.612092531563714,0.523292952662159,9,1519,cell-cell signaling,BP,PSMB10;FADS1;FGF18;PXK;RBP4;GRIA3;STAR;S100B;SLC1A3
4896,GO:0010632,0.612395411203203,0.757359567709474,1,173,regulation of epithelial cell migration,BP,FGF18
3478,GO:0006836,0.612907186287645,0.756822883644185,1,183,neurotransmitter transport,BP,SLC1A3
3881,GO:0007626,0.613177688531206,0.756552569083076,1,186,locomotory behavior,BP,HEXB
19237,GO:1902600,0.613296052089571,0.757178354778896,1,104,hydrogen ion transmembrane transport,BP,CYB5A
11473,GO:0043547,0.615079007629255,0.611270567168364,3,640,positive regulation of GTPase activity,BP,TBC1D14;RGN;FGF18
7224,GO:0030098,0.616676331538334,0.656674190043185,2,314,lymphocyte differentiation,BP,FADD;PNP
9958,GO:0035637,0.616840792303175,0.753060593080899,1,190,multicellular organismal signaling,BP,FXYD1
12622,GO:0046390,0.618177106715425,0.655322278832446,2,255,ribose phosphate biosynthetic process,BP,MRAP;ACAT1
945,GO:0002220,0.618248015282399,0.752246659704977,1,121,innate immune response activating cell surface receptor signaling pathway,BP,PSMB10
11514,GO:0043620,0.618350952021326,0.75222450559846,1,115,regulation of DNA-templated transcription in response to stress,BP,PSMB10
12289,GO:0045665,0.61885799089467,0.75117972174497,1,181,negative regulation of neuron differentiation,BP,LINGO1
10658,GO:0042110,0.61908888447707,0.607268926902469,3,446,T cell activation,BP,FADD;PNP;PYCARD
17018,GO:0072358,0.619101802661293,0.607056371029429,3,596,cardiovascular system development,BP,FGF18;ANG;DHCR7
7926,GO:0031401,0.619787775580607,0.531887862633937,7,1114,positive regulation of protein modification process,BP,PYCARD;PSMB10;GHR;FGF18;TICAM1;ANG;NMI
2188,GO:0004713,0.62015253549052,0.74994301259628,1,180,protein tyrosine kinase activity,MF,FGF18
19419,GO:1903034,0.62052958810733,0.749785466726992,1,149,regulation of response to wounding,BP,FAM46A
6676,GO:0019725,0.620550448382443,0.557128299897346,5,797,cellular homeostasis,BP,SLC31A2;RGN;HEXB;NOL3;STAR
737,GO:0001906,0.620704329100313,0.750101282271676,1,106,cell killing,BP,FADD
484,GO:0001505,0.620771349096403,0.749347698643899,1,180,regulation of neurotransmitter levels,BP,SLC1A3
6045,GO:0016651,0.621220482230057,0.749742284974654,1,98,oxidoreductase activity, acting on NAD(P)H,MF,DECR1
15841,GO:0070268,0.62137891557235,0.749391455505566,1,110,cornification,BP,KRT10
14715,GO:0060090,0.621500956400328,0.748655602610007,1,178,binding, bridging,MF,TRADD
13866,GO:0051098,0.621705425635705,0.651420843025382,2,318,regulation of binding,BP,TICAM1;PCBD1
12090,GO:0045211,0.622113217501027,0.747884631869842,1,217,postsynaptic membrane,CC,GRIA3
12756,GO:0046649,0.623283573103067,0.574030682391079,4,613,lymphocyte activation,BP,FADD;PNP;PYCARD;TICAM1
13385,GO:0048738,0.623302696499618,0.746869924496908,1,186,cardiac muscle tissue development,BP,RBP4
576,GO:0001664,0.62431281067662,0.648949783791235,2,245,G-protein coupled receptor binding,MF,MRAP;CNIH4
3799,GO:0007411,0.624856811247423,0.745218200894138,1,218,axon guidance,BP,DOK1
6305,GO:0017157,0.626836638606882,0.743570492931497,1,162,regulation of exocytosis,BP,RPH3AL
10461,GO:0038061,0.627184018462478,0.743646726898168,1,118,NIK/NF-kappaB signaling,BP,PSMB10
9902,GO:0035567,0.627265148190036,0.743248271294999,1,149,non-canonical Wnt signaling pathway,BP,PSMB10
17944,GO:0097485,0.627876711862113,0.742256635536539,1,220,neuron projection guidance,BP,DOK1
13653,GO:0050776,0.628234047938556,0.534279990980102,6,860,regulation of immune response,BP,CFB;FADD;PYCARD;PSMB10;TICAM1;NMI
19294,GO:1902749,0.628419032815184,0.742423372005119,1,119,regulation of cell cycle G2/M phase transition,BP,PSMB10
16353,GO:0071248,0.628999070819107,0.741605935554097,1,142,cellular response to metal ion,BP,STAR
5634,GO:0015833,0.63092955734081,0.486725963290486,12,1934,peptide transport,BP,USE1;TBC1D14;PNP;ABCG1;PYCARD;RBP4;ANG;NOL3;IFI27;SNX21;RPH3AL;CNIH4
8466,GO:0032403,0.631794495609828,0.564764285473119,4,710,protein complex binding,MF,FADD;TRADD;DOK1;TMOD4
3466,GO:0006816,0.632399730168683,0.639997991649622,2,362,calcium ion transport,BP,RGN;NOL3
12458,GO:0045981,0.632468227987981,0.738295244235132,1,130,positive regulation of nucleotide metabolic process,BP,MRAP
18621,GO:1900544,0.632468227987981,0.738295244235132,1,130,positive regulation of purine nucleotide metabolic process,BP,MRAP
10752,GO:0042306,0.632946449239316,0.737513538308681,1,166,regulation of protein import into nucleus,BP,NOL3
13686,GO:0050821,0.63309433306,0.737544363055177,1,143,protein stabilization,BP,IFI30
13667,GO:0050796,0.633524513492245,0.736951286739517,1,164,regulation of insulin secretion,BP,RBP4
17103,GO:0072562,0.633544269552887,0.737423913761953,1,114,blood microparticle,CC,CFB
13579,GO:0050679,0.634548831558516,0.735971552147659,1,158,positive regulation of epithelial cell proliferation,BP,ANG
5531,GO:0015629,0.634876741046004,0.637214110540248,2,433,actin cytoskeleton,CC,MSRA;TMOD4
7589,GO:0030814,0.63600720331132,0.734731462348514,1,133,regulation of cAMP metabolic process,BP,MRAP
3733,GO:0007254,0.636851853953322,0.733464750615275,1,190,JNK cascade,BP,PYCARD
12249,GO:0045619,0.637037843069244,0.733598719199651,1,143,regulation of lymphocyte differentiation,BP,PNP
3512,GO:0006888,0.637095872738453,0.733340510914146,1,169,ER to Golgi vesicle-mediated transport,BP,CNIH4
7194,GO:0030029,0.637258634124829,0.587479115055002,3,646,actin filament-based process,BP,PYCARD;ANG;TMOD4
13867,GO:0051099,0.638108132952347,0.732435332063506,1,153,positive regulation of binding,BP,TICAM1
11956,GO:0044877,0.638898747862534,0.537242964728709,5,880,macromolecular complex binding,MF,FADD;TRADD;RNASEL;DOK1;TMOD4
19739,GO:1903707,0.639153847497415,0.731583647710306,1,131,negative regulation of hemopoiesis,BP,TMEM176A
6128,GO:0016810,0.639782962777524,0.730864510375036,1,139,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,ASAH2
4723,GO:0010038,0.639965454425864,0.631995788498836,2,308,response to metal ion,BP,STAR;CYB5A
9374,GO:0034330,0.640780693307631,0.729277925562081,1,242,cell junction organization,BP,ANG
3156,GO:0006397,0.64090295785292,0.583717449789395,3,461,mRNA processing,BP,ARL6IP4;RNASEL;NOL3
20141,GO:1904589,0.64152674344656,0.728852998109058,1,169,regulation of protein import,BP,NOL3
12843,GO:0046873,0.643403563022873,0.627978952281162,2,436,metal ion transmembrane transporter activity,MF,SLC31A2;SLC1A3
4721,GO:0010035,0.644036180520412,0.580253439026,3,473,response to inorganic substance,BP,RGN;STAR;CYB5A
11076,GO:0042886,0.644872525314334,0.471727319545425,12,1954,amide transport,BP,USE1;TBC1D14;PNP;ABCG1;PYCARD;RBP4;ANG;NOL3;IFI27;SNX21;RPH3AL;CNIH4
4052,GO:0008283,0.645246771363208,0.471334192073387,12,1890,cell proliferation,BP,IFI30;FADD;PNP;PYCARD;RGN;FGF18;TICAM1;RBP4;ANG;FABP3;S100B;DHCR7
19345,GO:1902905,0.646089319078909,0.724245615834434,1,159,positive regulation of supramolecular fiber organization,BP,PYCARD
13759,GO:0050921,0.647413369340726,0.723204018623391,1,125,positive regulation of chemotaxis,BP,FGF18
14077,GO:0051438,0.647567870836509,0.723069029846958,1,123,regulation of ubiquitin-protein transferase activity,BP,PSMB10
10373,GO:0036464,0.648335992127759,0.721817148930337,1,174,cytoplasmic ribonucleoprotein granule,CC,GHR
13945,GO:0051216,0.649623222709485,0.720465838957959,1,176,cartilage development,BP,FGF18
2438,GO:0005088,0.649958520430761,0.719796599487707,1,249,Ras guanyl-nucleotide exchange factor activity,MF,FGF18
13069,GO:0048015,0.650021471014846,0.719914956467529,1,201,phosphatidylinositol-mediated signaling,BP,FGF18
7905,GO:0031348,0.650833256881442,0.719446162048368,1,144,negative regulation of defense response,BP,NMI
17776,GO:0097159,0.651047245998013,0.424797988360548,35,5716,organic cyclic compound binding,MF,PDK4;MRPL14;MRPL16;ACSF2;PNP;ABCG1;EBF1;BDH2;ACADVL;ACSM5;ARL6IP4;HSD17B10;HACL1;CYP17A1;RNASEL;ANG;TSFM;AOX1;SHPK;NOL3;NUDT7;ACCS;MDH1;FAM46A;IDH1;DECR1;PUS1;LDHD;STAR;CYP11A1;DHCR7;CYB5A;RBMS3;HNF1A;ETFDH
498,GO:0001525,0.651340712470197,0.619313390502908,2,400,angiogenesis,BP,FGF18;ANG
1125,GO:0002526,0.653026589281231,0.717281351841039,1,131,acute inflammatory response,BP,CFB
13237,GO:0048469,0.653393514825643,0.716708058948788,1,150,cell maturation,BP,ANG
8968,GO:0033157,0.653523978253908,0.616981789215804,2,356,regulation of intracellular protein transport,BP,NOL3;IFI27
7284,GO:0030177,0.654148803630359,0.715903905424744,1,151,positive regulation of Wnt signaling pathway,BP,PSMB10
1267,GO:0002764,0.654430307337283,0.568686037958738,3,487,immune response-regulating signaling pathway,BP,FADD;PSMB10;TICAM1
3229,GO:0006497,0.654621914057194,0.715496087904986,1,141,protein lipidation,BP,DPM3
9513,GO:0034614,0.654653982836215,0.715433482722298,1,144,cellular response to reactive oxygen species,BP,RGN
13071,GO:0048017,0.654800169807441,0.714881829562067,1,204,inositol lipid-mediated signaling,BP,FGF18
4001,GO:0008201,0.65541795635913,0.714598436868009,1,147,heparin binding,MF,ANG
2885,GO:0005938,0.655808790594361,0.713709783137642,1,229,cell cortex,CC,FAM110C
12496,GO:0046058,0.656527081555389,0.713396548567683,1,150,cAMP metabolic process,BP,MRAP
4634,GO:0009749,0.656666111342909,0.713095636023874,1,170,response to glucose,BP,STAR
5354,GO:0015077,0.658413078669079,0.611524195990621,2,354,monovalent inorganic cation transmembrane transporter activity,MF,CYB5A;SLC1A3
7577,GO:0030802,0.658821048333149,0.711068197382783,1,138,regulation of cyclic nucleotide biosynthetic process,BP,MRAP
8789,GO:0032872,0.65961209005236,0.709790184317031,1,198,regulation of stress-activated MAPK cascade,BP,PYCARD
4024,GO:0008237,0.661233684754739,0.708131109227912,1,183,metallopeptidase activity,MF,PEPD
15861,GO:0070302,0.661651370221296,0.707594614643407,1,199,regulation of stress-activated protein kinase signaling cascade,BP,PYCARD
4993,GO:0010769,0.661904778407994,0.707138199069405,1,244,regulation of cell morphogenesis involved in differentiation,BP,LINGO1
13962,GO:0051240,0.6620317137401,0.476755246051135,8,1403,positive regulation of multicellular organismal process,BP,FADD;TRADD;PNP;PYCARD;GHR;FGF18;TICAM1;STAR
3155,GO:0006396,0.664147443698833,0.494802818051427,6,872,RNA processing,BP,LAGE3;ARL6IP4;HSD17B10;RNASEL;NOL3;PUS1
6353,GO:0018108,0.664338294107478,0.604821809746322,2,360,peptidyl-tyrosine phosphorylation,BP,GHR;FGF18
3867,GO:0007611,0.664686260303023,0.704241574984844,1,214,learning or memory,BP,S100B
13265,GO:0048522,0.665508971255255,0.415196927587051,28,4576,positive regulation of cellular process,BP,FADD;MRAP;APOC1;TRADD;PNP;PYCARD;G0S2;PSMB10;RGN;GHR;FGF18;TICAM1;RBP4;RNASEL;ANG;FAM110C;NMI;HEXB;FABP3;PCBD1;IFI27;STAR;RPH3AL;S100B;RBMS3;HNF1A;DOK1;SLC1A3
4876,GO:0010604,0.666231621033677,0.432094895429589,17,2817,positive regulation of macromolecule metabolic process,BP,FADD;TRADD;PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;HEXB;PCBD1;IFI27;STAR;RBMS3;HNF1A
3326,GO:0006611,0.666733423832062,0.702213389959509,1,176,protein export from nucleus,BP,IFI27
7538,GO:0030666,0.667359251921479,0.701605419610191,1,165,endocytic vesicle membrane,CC,GRIA3
1639,GO:0003729,0.667772352738785,0.701077227936741,1,176,mRNA binding,MF,RBMS3
13833,GO:0051046,0.668035549193578,0.524542541863171,4,673,regulation of secretion,BP,PYCARD;RBP4;ANG;RPH3AL
10043,GO:0035770,0.668444257529538,0.70028508510363,1,185,ribonucleoprotein granule,CC,GHR
4633,GO:0009746,0.668847545206735,0.699904523506024,1,175,response to hexose,BP,STAR
7188,GO:0030017,0.669331183492247,0.699304796400479,1,186,sarcomere,CC,TMOD4
6387,GO:0018212,0.66934882877438,0.599102154067723,2,362,peptidyl-tyrosine modification,BP,GHR;FGF18
16343,GO:0071229,0.669878324620025,0.698679626812052,1,190,cellular response to acid chemical,BP,PDK4
11183,GO:0043087,0.670388049634927,0.550367400243335,3,695,regulation of GTPase activity,BP,TBC1D14;RGN;FGF18
11817,GO:0044452,0.670637519705661,0.698034153970936,1,161,nucleolar part,CC,MRI1
13604,GO:0050707,0.670671771298572,0.698079636603923,1,151,regulation of cytokine secretion,BP,PYCARD
2648,GO:0005524,0.671046447520199,0.48681341263096,6,1426,ATP binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
18783,GO:1901363,0.674010648411404,0.400932731849133,34,5633,heterocyclic compound binding,MF,PDK4;MRPL14;MRPL16;ACSF2;PNP;ABCG1;EBF1;BDH2;ACADVL;ACSM5;ARL6IP4;HSD17B10;HACL1;CYP17A1;RNASEL;ANG;TSFM;AOX1;SHPK;NOL3;NUDT7;ACCS;MDH1;FAM46A;IDH1;DECR1;PUS1;LDHD;CYP11A1;DHCR7;CYB5A;RBMS3;HNF1A;ETFDH
7153,GO:0022891,0.674332420403236,0.497662161920691,5,925,substrate-specific transmembrane transporter activity,MF,SLC31A2;FXYD1;GRIA3;CYB5A;SLC1A3
13295,GO:0048583,0.674405223182386,0.414941012523734,21,3506,regulation of response to stimulus,BP,CFB;FADD;TRADD;PYCARD;G0S2;PSMB10;RGN;GHR;FGF18;TICAM1;RNASEL;FAM110C;NMI;SHPK;NOL3;DEPTOR;CASP4;FAM46A;RPH3AL;S100B;DOK1
13922,GO:0051179,0.674550562975627,0.399046435093896,36,5858,localization,BP,EBP;USE1;ZFYVE21;SLC31A2;FADD;MRAP;APOC1;TBC1D14;PNP;ABCG1;PYCARD;PSMB10;RGN;GHR;FGF18;CPT2;FXYD1;RBP4;RNASEL;ANG;FAM110C;HEXB;FABP3;GRIA3;NOL3;IFI27;IDH1;STAR;SNX21;GLA;RPH3AL;DERA;CYB5A;HNF1A;SLC1A3;CNIH4
2518,GO:0005216,0.674873220745047,0.592615701458497,2,423,ion channel activity,MF,FXYD1;GRIA3
18723,GO:1901215,0.675087867643223,0.692977791274701,1,177,negative regulation of neuron death,BP,STAR
4711,GO:0010001,0.675293351077051,0.692741610017197,1,178,glial cell differentiation,BP,S100B
16348,GO:0071241,0.675429083512966,0.692680435265297,1,165,cellular response to inorganic substance,BP,STAR
18594,GO:1900371,0.676203648307321,0.69196558431968,1,147,regulation of purine nucleotide biosynthetic process,BP,MRAP
7532,GO:0030658,0.676820779625473,0.691070412986655,1,172,transport vesicle membrane,CC,RPH3AL
3142,GO:0006367,0.677509570436221,0.690289426722345,1,173,transcription initiation from RNA polymerase II promoter,BP,HNF1A
12916,GO:0046982,0.678083017870961,0.541744526817352,3,466,protein heterodimerization activity,MF,ABCG1;RBP4;HEXB
3769,GO:0007338,0.678148354787162,0.689940443507472,1,132,single fertilization,BP,HEXB
3574,GO:0006986,0.679350010198246,0.688302894237749,1,161,response to unfolded protein,BP,ACADVL
9362,GO:0034284,0.679390642661393,0.688121452310558,1,180,response to monosaccharide,BP,STAR
7583,GO:0030808,0.680244815537871,0.687403181218085,1,148,regulation of nucleotide biosynthetic process,BP,MRAP
14107,GO:0051493,0.680545835078748,0.586026331787175,2,413,regulation of cytoskeleton organization,BP,PYCARD;TMOD4
3465,GO:0006814,0.680759770360114,0.686360904215758,1,220,sodium ion transport,BP,FXYD1
7101,GO:0022411,0.681195723372925,0.538064983900014,3,500,cellular component disassembly,BP,MRPL14;MRPL16;TMOD4
17377,GO:0090090,0.681847720002879,0.685469660677988,1,161,negative regulation of canonical Wnt signaling pathway,BP,PSMB10
4199,GO:0008514,0.682035440662489,0.68508231211618,1,186,organic anion transmembrane transporter activity,MF,SLC1A3
13626,GO:0050731,0.68251740305784,0.684690811403938,1,163,positive regulation of peptidyl-tyrosine phosphorylation,BP,GHR
2826,GO:0005840,0.682743068410218,0.58411076567401,2,219,ribosome,CC,MRPL14;MRPL16
10683,GO:0042158,0.683114492661613,0.684120235790069,1,150,lipoprotein biosynthetic process,BP,DPM3
7922,GO:0031397,0.684379050358216,0.682840170008568,1,134,negative regulation of protein ubiquitination,BP,PSMB10
13262,GO:0048519,0.684581988359921,0.393594270222535,29,4623,negative regulation of biological process,BP,PDK4;IFI30;FADD;APOC1;TRADD;TBC1D14;ABCG1;PYCARD;ACADVL;PSMB10;RGN;TICAM1;PLA2G16;RBP4;RNASEL;ANG;NMI;FABP3;NOL3;DEPTOR;IFI27;TMEM176A;TFPI;STAR;GLA;RPH3AL;S100B;LINGO1;TMOD4
1223,GO:0002703,0.685265372907118,0.681629124710193,1,153,regulation of leukocyte mediated immunity,BP,FADD
17228,GO:0080135,0.686107039776553,0.532206553539857,3,579,regulation of cellular response to stress,BP,PYCARD;RGN;NOL3
13738,GO:0050896,0.686429086359827,0.37999204860102,54,8010,response to stimulus,BP,CFB;EBP;PDK4;IFI30;MSRA;FADD;P2RY14;TRADD;PNP;ABCG1;PYCARD;G0S2;ACADVL;MGST2;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;NNMT;PXK;RBP4;RNASEL;ANG;FAM110C;NMI;ACAT1;AOX1;SHPK;HEXB;CMBL;FABP3;GRIA3;NOL3;DEPTOR;CASP4;IFI27;PON2;FAM46A;IDH1;TFPI;STAR;GLA;RPH3AL;PRRT1;DERA;S100B;CYB5A;DOK1;SLC1A3;LINGO1;ETFDH
7223,GO:0030097,0.687257675263971,0.502343805550302,4,712,hemopoiesis,BP,EBP;FADD;PNP;TMEM176A
5021,GO:0010822,0.687755403069701,0.678681817931259,1,162,positive regulation of mitochondrion organization,BP,PYCARD
14463,GO:0052652,0.688078083577839,0.678393988021305,1,152,cyclic purine nucleotide metabolic process,BP,MRAP
20466,GO:1905330,0.689696702848991,0.676312082203893,1,178,regulation of morphogenesis of an epithelium,BP,PSMB10
3855,GO:0007596,0.689936763417229,0.575082792687227,2,343,blood coagulation,BP,FAM46A;TFPI
12072,GO:0045184,0.690041137288189,0.421956504532926,12,2049,establishment of protein localization,BP,USE1;TBC1D14;PNP;ABCG1;PYCARD;RBP4;ANG;NOL3;IFI27;SNX21;RPH3AL;CNIH4
20956,GO:2000021,0.690655625329455,0.675125457944649,1,189,regulation of ion homeostasis,BP,NOL3
4460,GO:0009190,0.690704313450085,0.675332844307776,1,153,cyclic nucleotide biosynthetic process,BP,MRAP
11264,GO:0043209,0.691363838771878,0.674446384721213,1,167,myelin sheath,CC,MDH1
12631,GO:0046425,0.691444733882346,0.674545041825709,1,145,regulation of JAK-STAT cascade,BP,GHR
20293,GO:1904892,0.691444733882346,0.674545041825709,1,145,regulation of STAT cascade,BP,GHR
7867,GO:0031301,0.691478749219772,0.674367760627175,1,160,integral component of organelle membrane,CC,ETFDH
14109,GO:0051495,0.691678381549545,0.673973633808236,1,182,positive regulation of cytoskeleton organization,BP,PYCARD
7136,GO:0022838,0.692588540776113,0.571723981671993,2,433,substrate-specific channel activity,MF,FXYD1;GRIA3
3480,GO:0006839,0.69337164606092,0.571118604779091,2,296,mitochondrial transport,BP,CPT2;NOL3
13381,GO:0048731,0.693375416726014,0.388341231107462,25,4323,system development,BP,EBP;FADD;HSD17B3;TRADD;EXTL1;PNP;KRT10;PSMB10;RGN;FGF18;NNMT;PLA2G16;RBP4;ANG;ACAT1;HEXB;TMEM176A;IDH1;STAR;S100B;DHCR7;PTS;DOK1;SLC1A3;LINGO1
11453,GO:0043523,0.693503886998573,0.671776984377084,1,191,regulation of neuron apoptotic process,BP,STAR
8584,GO:0032559,0.693673527437004,0.460913326819828,6,1461,adenyl ribonucleotide binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
3849,GO:0007584,0.693757589388838,0.671602044882486,1,172,response to nutrient,BP,STAR
13238,GO:0048471,0.694076804090108,0.522725957316751,3,621,perinuclear region of cytoplasm,CC,PLA2G16;S100B;DOK1
7574,GO:0030799,0.694120382301011,0.671285130724329,1,158,regulation of cyclic nucleotide metabolic process,BP,MRAP
7221,GO:0030073,0.694185471464051,0.670962988225023,1,193,insulin secretion,BP,RBP4
11814,GO:0044449,0.694516315513808,0.670518344214761,1,203,contractile fiber part,CC,TMOD4
11561,GO:0043901,0.694936607614245,0.670358068405583,1,154,negative regulation of multi-organism process,BP,RNASEL
13862,GO:0051094,0.695212153302083,0.459226139638071,6,1140,positive regulation of developmental process,BP,FADD;TRADD;PNP;GHR;FGF18;STAR
14806,GO:0060249,0.696474073456537,0.567210549451362,2,354,anatomical structure homeostasis,BP,PDK4;RBP4
13682,GO:0050817,0.696525683239048,0.567166096007265,2,347,coagulation,BP,FAM46A;TFPI
13913,GO:0051168,0.697029339596738,0.667604296805078,1,192,nuclear export,BP,IFI27
16747,GO:0071897,0.697238536996346,0.667367552179603,1,190,DNA biosynthetic process,BP,RGN
11307,GO:0043269,0.697312858004199,0.51890084849984,3,582,regulation of ion transport,BP,SLC31A2;RGN;FXYD1
16559,GO:0071560,0.697822297491989,0.666555538740789,1,212,cellular response to transforming growth factor beta stimulus,BP,STAR
16558,GO:0071559,0.698160977908415,0.666142606767241,1,214,response to transforming growth factor beta,BP,STAR
16130,GO:0070820,0.698312440836121,0.666294046866993,1,161,tertiary granule,CC,IDH1
2445,GO:0005096,0.698851018522438,0.66510731523561,1,271,GTPase activator activity,MF,TBC1D14
13258,GO:0048513,0.698886332814284,0.391730968020523,19,3169,animal organ development,BP,EBP;FADD;HSD17B3;TRADD;PNP;KRT10;PSMB10;RGN;FGF18;NNMT;PLA2G16;RBP4;ANG;ACAT1;TMEM176A;IDH1;STAR;S100B;DHCR7
13451,GO:0048870,0.699424004159814,0.443302271777321,7,1317,cell motility,BP,FADD;PYCARD;RGN;FGF18;ANG;FAM110C;HEXB
14205,GO:0051674,0.699424004159814,0.443302271777321,7,1317,localization of cell,BP,FADD;PYCARD;RGN;FGF18;ANG;FAM110C;HEXB
3858,GO:0007599,0.699475462047567,0.563591002136064,2,348,hemostasis,BP,FAM46A;TFPI
1073,GO:0002440,0.699515917791594,0.664866075459351,1,160,production of molecular mediator of immune response,BP,RBP4
11921,GO:0044801,0.699848581503236,0.664242556132184,1,192,single-organism membrane fusion,BP,TBC1D14
7177,GO:0030001,0.700121069292721,0.487116419798967,4,797,metal ion transport,BP,SLC31A2;RGN;FXYD1;NOL3
7187,GO:0030016,0.700547671801236,0.663317980752881,1,208,myofibril,CC,TMOD4
16141,GO:0070838,0.700945037827503,0.561664782111198,2,411,divalent metal ion transport,BP,RGN;NOL3
17504,GO:0090276,0.701177201842312,0.66265500546301,1,191,regulation of peptide hormone secretion,BP,RBP4
12389,GO:0045861,0.701573572469289,0.561168653684261,2,304,negative regulation of proteolysis,BP,NOL3;TFPI
17488,GO:0090257,0.701630608171314,0.662053253348179,1,201,regulation of muscle system process,BP,NOL3
3519,GO:0006897,0.70237932690241,0.512785327888787,3,603,endocytosis,BP,APOC1;PYCARD;GHR
4697,GO:0009966,0.703009761511565,0.396782016230438,15,2670,regulation of signal transduction,BP,FADD;TRADD;PYCARD;G0S2;PSMB10;RGN;GHR;FGF18;TICAM1;FAM110C;NOL3;DEPTOR;RPH3AL;S100B;DOK1
5754,GO:0016072,0.703323948938467,0.559148718379851,2,273,rRNA metabolic process,BP,RNASEL;ANG
3878,GO:0007623,0.703610878974608,0.659732937189433,1,189,circadian rhythm,BP,STAR
7496,GO:0030554,0.704749963289323,0.447990275538529,6,1472,adenyl nucleotide binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
13338,GO:0048666,0.705145895715448,0.481030301531891,4,954,neuron development,BP,S100B;DOK1;SLC1A3;LINGO1
18876,GO:1901654,0.705737114117319,0.657211134077,1,180,response to ketone,BP,STAR
19551,GO:1903321,0.705779846128856,0.657474719971168,1,143,negative regulation of protein modification by small protein conjugation or removal,BP,PSMB10
7103,GO:0022414,0.705906962695573,0.42703709924048,8,1304,reproductive process,BP,HSD17B3;RGN;RBP4;CYP17A1;ANG;HEXB;IDH1;STAR
2,GO:0000003,0.707341803382653,0.425372507234443,8,1305,reproduction,BP,HSD17B3;RGN;RBP4;CYP17A1;ANG;HEXB;IDH1;STAR
5887,GO:0016337,0.708183805828916,0.505766561262302,3,582,single organismal cell-cell adhesion,BP,FADD;PNP;PYCARD
4895,GO:0010631,0.708234186009918,0.653908383124827,1,227,epithelial cell migration,BP,FGF18
17068,GO:0072511,0.708351852561251,0.552568385437053,2,415,divalent inorganic cation transport,BP,RGN;NOL3
13261,GO:0048518,0.708980589911592,0.365154608455751,31,5094,positive regulation of biological process,BP,CFB;FADD;MRAP;APOC1;TRADD;PNP;ABCG1;PYCARD;G0S2;PSMB10;RGN;GHR;FGF18;TICAM1;FXYD1;RBP4;RNASEL;ANG;FAM110C;NMI;HEXB;FABP3;PCBD1;IFI27;STAR;RPH3AL;S100B;RBMS3;HNF1A;DOK1;SLC1A3
17723,GO:0097060,0.709712586547149,0.651894128726069,1,285,synaptic membrane,CC,GRIA3
1380,GO:0003007,0.711185368318044,0.650271175360243,1,228,heart morphogenesis,BP,RBP4
13369,GO:0048705,0.711227018391135,0.650334143667817,1,204,skeletal system morphogenesis,BP,FGF18
10149,GO:0035966,0.711282829292313,0.65042408390388,1,178,response to topologically incorrect protein,BP,ACADVL
17019,GO:0072359,0.711816621728078,0.473029161571506,4,901,circulatory system development,BP,FGF18;RBP4;ANG;DHCR7
17402,GO:0090132,0.711963252323973,0.64930431040733,1,229,epithelium migration,BP,FGF18
1146,GO:0002573,0.712042495456816,0.649436954780728,1,185,myeloid leukocyte differentiation,BP,FADD
7866,GO:0031300,0.71215122110294,0.649408359648855,1,170,intrinsic component of organelle membrane,CC,ETFDH
11702,GO:0044267,0.713390742807921,0.362024640212691,29,4698,cellular protein metabolic process,BP,PDK4;ALG5;DPM3;MSRA;MRPL14;MRPL16;FADD;TRADD;EXTL1;PYCARD;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;ETFB;RNASEL;ANG;NMI;TSFM;HEXB;NOL3;DEPTOR;IFI27;MDP1;TFPI;RBMS3;LYPLAL1
3976,GO:0008168,0.714385801630296,0.646586662502539,1,176,methyltransferase activity,MF,NNMT
11626,GO:0044089,0.714662078748273,0.544674594943298,2,441,positive regulation of cellular component biogenesis,BP,PYCARD;HNF1A
13177,GO:0048284,0.717273907131567,0.642796088984467,1,204,organelle fusion,BP,TBC1D14
4631,GO:0009743,0.718616430192645,0.641127085637183,1,200,response to carbohydrate,BP,STAR
5464,GO:0015291,0.718670604119807,0.640924718556502,1,227,secondary active transmembrane transporter activity,MF,SLC1A3
19836,GO:1903900,0.71867724611176,0.641211363618697,1,175,regulation of viral life cycle,BP,RNASEL
7818,GO:0031225,0.720347401978387,0.639294604068739,1,152,anchored component of membrane,CC,TFPI
13645,GO:0050768,0.720785690417788,0.638225046007943,1,232,negative regulation of neurogenesis,BP,LINGO1
11864,GO:0044702,0.722043844901905,0.41681989375282,7,1182,single organism reproductive process,BP,HSD17B3;RGN;RBP4;ANG;HEXB;IDH1;STAR
16655,GO:0071705,0.723035004833886,0.380549467516124,13,2230,nitrogen compound transport,BP,USE1;TBC1D14;PNP;ABCG1;PYCARD;RBP4;ANG;NOL3;IFI27;SNX21;RPH3AL;SLC1A3;CNIH4
10474,GO:0038093,0.723752136726125,0.634690922953524,1,185,Fc receptor signaling pathway,BP,PSMB10
5943,GO:0016477,0.724793798735946,0.424261537435748,6,1193,cell migration,BP,FADD;PYCARD;FGF18;ANG;FAM110C;HEXB
961,GO:0002250,0.72496326638657,0.531871911557276,2,338,adaptive immune response,BP,FADD;PYCARD
13733,GO:0050890,0.724982105206594,0.632807550892195,1,246,cognition,BP,S100B
11319,GO:0043292,0.725279103937141,0.632544822815861,1,218,contractile fiber,CC,TMOD4
2857,GO:0005887,0.726051854393295,0.403384365070524,8,1513,integral component of plasma membrane,CC,EBP;SLC31A2;P2RY14;ABCG1;GHR;FXYD1;GRIA3;CPT1C
16520,GO:0071495,0.727222677053648,0.421333949597305,6,1204,cellular response to endogenous stimulus,BP,PDK4;GHR;FGF18;RNASEL;CASP4;STAR
17400,GO:0090130,0.72786924030904,0.629124887974822,1,235,tissue migration,BP,FGF18
13271,GO:0048534,0.729671498922367,0.451259347603872,4,752,hematopoietic or lymphoid organ development,BP,EBP;FADD;PNP;TMEM176A
11517,GO:0043623,0.730038722774377,0.478691407260744,3,548,cellular protein complex assembly,BP,PYCARD;ANG;TMOD4
10583,GO:0040011,0.73036605513451,0.398260388426627,8,1541,locomotion,BP,FADD;PYCARD;RGN;FGF18;ANG;FAM110C;HEXB;DOK1
13758,GO:0050920,0.730709665268801,0.625812847899987,1,169,regulation of chemotaxis,BP,FGF18
18534,GO:1900180,0.731229995884443,0.624845300534662,1,214,regulation of protein localization to nucleus,BP,NOL3
12266,GO:0045637,0.731625998454031,0.624503211799049,1,184,regulation of myeloid cell differentiation,BP,FADD
12868,GO:0046907,0.732224824585463,0.389034090276359,9,1646,intracellular transport,BP,ZFYVE21;TBC1D14;ABCG1;CPT2;NOL3;IFI27;STAR;RPH3AL;CNIH4
14329,GO:0051924,0.732904809540754,0.62274261396908,1,197,regulation of calcium ion transport,BP,RGN
12233,GO:0045597,0.733545128440015,0.446391006545593,4,824,positive regulation of cell differentiation,BP,FADD;PNP;FGF18;STAR
17514,GO:0090287,0.734363208966766,0.620635303370253,1,234,regulation of cellular response to growth factor stimulus,BP,FGF18
4457,GO:0009187,0.734880347964968,0.620169663927751,1,192,cyclic nucleotide metabolic process,BP,MRAP
21026,GO:2000146,0.735174158802518,0.61960791784793,1,224,negative regulation of cell motility,BP,RGN
13259,GO:0048514,0.735530159411503,0.517944570634999,2,481,blood vessel morphogenesis,BP,FGF18;ANG
6086,GO:0016741,0.73577149803308,0.619022845034489,1,187,transferase activity, transferring one-carbon groups,MF,NNMT
2655,GO:0005539,0.737000796347552,0.617358623006033,1,192,glycosaminoglycan binding,MF,ANG
3891,GO:0008016,0.737064595083796,0.617095252122575,1,225,regulation of heart contraction,BP,FXYD1
7924,GO:0031399,0.737930569020453,0.382271770144002,9,1619,regulation of protein modification process,BP,PYCARD;PSMB10;RGN;GHR;FGF18;TICAM1;ANG;NMI;DEPTOR
3803,GO:0007417,0.738009689306179,0.440767389872071,4,886,central nervous system development,BP,ACAT1;STAR;S100B;PTS
10697,GO:0042176,0.739021533957295,0.513573053229947,2,371,regulation of protein catabolic process,BP,PSMB10;RGN
7285,GO:0030178,0.739641000864643,0.613828193943949,1,193,negative regulation of Wnt signaling pathway,BP,PSMB10
14355,GO:0051961,0.742235079554335,0.610056966534388,1,251,negative regulation of nervous system development,BP,LINGO1
13701,GO:0050852,0.743120163316773,0.609325510226337,1,168,T cell receptor signaling pathway,BP,PSMB10
11040,GO:0042787,0.743277616891381,0.608887090333414,1,200,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,PSMB10
7901,GO:0031344,0.74384913973917,0.506936796094702,2,527,regulation of cell projection organization,BP,FAM110C;LINGO1
4584,GO:0009566,0.744002047736712,0.608147757405707,1,166,fertilization,BP,HEXB
7119,GO:0022618,0.745332400131849,0.60620675766924,1,183,ribonucleoprotein complex assembly,BP,NOL3
7271,GO:0030163,0.745428131935465,0.431460500420257,4,792,protein catabolic process,BP,USE1;PSMB10;RGN;LYPLAL1
3527,GO:0006909,0.745763751659048,0.605457393878807,1,209,phagocytosis,BP,PYCARD
5533,GO:0015631,0.74621186478187,0.604572976955992,1,275,tubulin binding,MF,FAM110C
15312,GO:0061025,0.74645570792096,0.604441228616997,1,223,membrane fusion,BP,TBC1D14
7211,GO:0030054,0.746665016931858,0.411195419117771,5,1164,cell junction,CC,IFI30;ZFYVE21;GRIA3;CPT1C;PRRT1
5453,GO:0015267,0.747056603189076,0.502754344561059,2,461,channel activity,MF,FXYD1;GRIA3
7125,GO:0022803,0.747962180416815,0.501541799615357,2,462,passive transmembrane transporter activity,MF,FXYD1;GRIA3
7559,GO:0030695,0.748121660152133,0.601884362572719,1,300,GTPase regulator activity,MF,TBC1D14
14059,GO:0051403,0.748611376812796,0.601381621955725,1,247,stress-activated MAPK cascade,BP,PYCARD
5714,GO:0015992,0.748638320832413,0.601949014106718,1,152,proton transport,BP,CYB5A
3860,GO:0007601,0.749139352664642,0.600847290188915,1,206,visual perception,BP,RBP4
5753,GO:0016071,0.749232753166971,0.426713228691242,4,674,mRNA metabolic process,BP,ARL6IP4;RNASEL;NOL3;PUS1
4519,GO:0009266,0.749652857715439,0.600096081037328,1,214,response to temperature stimulus,BP,ACADVL
18352,GO:0099568,0.749997855125872,0.599335651044091,1,287,cytoplasmic region,CC,FAM110C
3851,GO:0007586,0.750080102054945,0.599821316538882,1,167,digestion,BP,RBP4
17818,GO:0097223,0.750217380576665,0.599666974267492,1,163,sperm part,CC,HEXB
4536,GO:0009314,0.750438796466582,0.498287522293407,2,421,response to radiation,BP,STAR;SLC1A3
12428,GO:0045927,0.750612061350391,0.598662406004366,1,237,positive regulation of growth,BP,GHR
721,GO:0001882,0.750877408285438,0.497802394303651,2,371,nucleoside binding,MF,PNP;ACSM5
18088,GO:0098602,0.750879593514809,0.451807616743833,3,633,single organism cell adhesion,BP,FADD;PNP;PYCARD
17636,GO:0090596,0.750909567044422,0.598217610246096,1,245,sensory organ morphogenesis,BP,RBP4
3468,GO:0006818,0.75141505384748,0.598096100676163,1,154,hydrogen transport,BP,CYB5A
13773,GO:0050953,0.751931287413567,0.596969421533761,1,209,sensory perception of light stimulus,BP,RBP4
13985,GO:0051271,0.752113722661678,0.59657177735401,1,239,negative regulation of cellular component movement,BP,RGN
6771,GO:0019932,0.756114534030648,0.591042517055855,1,225,second-messenger-mediated signaling,BP,RGN
4424,GO:0009150,0.756489514477113,0.444585276362441,3,507,purine ribonucleotide metabolic process,BP,MRAP;ACAT1;NUDT7
2435,GO:0005085,0.758877552704581,0.586821929149338,1,320,guanyl-nucleotide exchange factor activity,MF,FGF18
2784,GO:0005770,0.759162773927996,0.586798773005175,1,213,late endosome,CC,SLC31A2
7766,GO:0031098,0.759298630805285,0.586425569135954,1,253,stress-activated protein kinase signaling cascade,BP,PYCARD
1119,GO:0002520,0.759988771224236,0.412778574574941,4,789,immune system development,BP,EBP;FADD;PNP;TMEM176A
19182,GO:1902494,0.760458141221823,0.370172401294351,7,1259,catalytic complex,CC,DPM3;FADD;PYCARD;PSMB10;TICAM1;HSD17B10;FXYD1
7111,GO:0022607,0.761029888190766,0.332898666772279,14,2570,cellular component assembly,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;HACL1;ANG;FAM110C;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
7804,GO:0031175,0.762506417429352,0.436310521705746,3,811,neuron projection development,BP,S100B;DOK1;LINGO1
6929,GO:0021700,0.762869861074378,0.581395516166144,1,237,developmental maturation,BP,ANG
7078,GO:0022008,0.763009125901737,0.377179881204441,6,1405,neurogenesis,BP,HEXB;STAR;S100B;DOK1;SLC1A3;LINGO1
7264,GO:0030155,0.76303883639914,0.43573251720904,3,634,regulation of cell adhesion,BP,FADD;PNP;PYCARD
16439,GO:0071383,0.763651415642002,0.580260409547096,1,240,cellular response to steroid hormone stimulus,BP,STAR
3742,GO:0007265,0.767373527255421,0.574628518343929,1,318,Ras protein signal transduction,BP,DOK1
18170,GO:0098798,0.767869563315985,0.575029446790925,1,130,mitochondrial protein complex,CC,ETFDH
10948,GO:0042623,0.76803986167155,0.573691799851479,1,305,ATPase activity, coupled,MF,ABCG1
4951,GO:0010721,0.768409414576469,0.57327872826143,1,264,negative regulation of cell development,BP,LINGO1
16704,GO:0071826,0.768485193397018,0.573499100966208,1,195,ribonucleoprotein complex subunit organization,BP,NOL3
11125,GO:0042995,0.768713742145918,0.351670018978798,8,1762,cell projection,CC,MRI1;FADD;CYP17A1;ANG;CPT1C;STAR;S100B;SLC1A3
13453,GO:0048872,0.770172537544421,0.570863570640091,1,225,homeostasis of number of cells,BP,FADD
18986,GO:1901991,0.770318675949394,0.570825247990036,1,194,negative regulation of mitotic cell cycle phase transition,BP,PSMB10
7220,GO:0030072,0.770692523224629,0.570072316718129,1,231,peptide hormone secretion,BP,RBP4
6022,GO:0016604,0.770818504356676,0.425222160757441,3,686,nuclear body,CC,LAGE3;ARL6IP4;AOX1
7819,GO:0031226,0.771463383676042,0.348292672377833,8,1576,intrinsic component of plasma membrane,CC,EBP;SLC31A2;P2RY14;ABCG1;GHR;FXYD1;GRIA3;CPT1C
10585,GO:0040013,0.77390457872969,0.565240996787845,1,253,negative regulation of locomotion,BP,RGN
12085,GO:0045202,0.773964489554303,0.420871395987245,3,797,synapse,CC,GRIA3;CPT1C;PRRT1
4512,GO:0009259,0.774933700973358,0.419805661802597,3,522,ribonucleotide metabolic process,BP,MRAP;ACAT1;NUDT7
3012,GO:0006139,0.775555896598918,0.288401577448555,34,5512,nucleobase-containing compound metabolic process,BP,FADD;MRAP;TRADD;PNP;ABCG1;EBF1;PYCARD;LAGE3;PSMB10;RGN;FADS1;TICAM1;ARL6IP4;NNMT;HSD17B10;GALT;RNASEL;ANG;NMI;ACAT1;TSFM;AOX1;SHPK;HEXB;NOL3;NUDT7;PCBD1;MDH1;IFI27;IDH1;PUS1;PTMS;DERA;HNF1A
7108,GO:0022603,0.775795771036195,0.39194887807609,4,911,regulation of anatomical structure morphogenesis,BP,PSMB10;HEXB;S100B;LINGO1
10659,GO:0042113,0.776056377229381,0.56219973534721,1,218,B cell activation,BP,TICAM1
19225,GO:1902580,0.776730856225523,0.390713913850364,4,894,single-organism cellular localization,BP,ABCG1;CPT2;NOL3;STAR
13625,GO:0050730,0.776853630639248,0.561019757450429,1,216,regulation of peptidyl-tyrosine phosphorylation,BP,GHR
3530,GO:0006913,0.778960186498876,0.458683162867171,2,457,nucleocytoplasmic transport,BP,NOL3;IFI27
4677,GO:0009897,0.7790338311419,0.557765622674738,1,213,external side of plasma membrane,CC,ABCG1
11138,GO:0043010,0.780378903332165,0.555429889376541,1,288,camera-type eye development,BP,RBP4
11867,GO:0044706,0.781118178505579,0.554635607870109,1,210,multi-multicellular organism process,BP,HEXB
14677,GO:0060047,0.784373786033113,0.549467934556822,1,255,heart contraction,BP,FXYD1
18619,GO:1900542,0.784782761248861,0.54905443452366,1,210,regulation of purine nucleotide metabolic process,BP,MRAP
12427,GO:0045926,0.785250427476065,0.548293425829029,1,218,negative regulation of growth,BP,RBP4
1388,GO:0003015,0.787424359637034,0.544767417328799,1,258,heart process,BP,FXYD1
18983,GO:1901988,0.787723410033562,0.544578366793711,1,202,negative regulation of cell cycle phase transition,BP,PSMB10
4668,GO:0009888,0.787816186335258,0.315938592004346,10,1837,tissue development,BP,TRADD;BDH2;ACADVL;KRT10;PSMB10;FGF18;PLA2G16;RBP4;ACAT1;S100B
412,GO:0001077,0.787855829557834,0.544112248722272,1,255,transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,HNF1A
15606,GO:0061695,0.787985726330695,0.543939465439812,1,248,transferase complex, transferring phosphorus-containing groups,CC,PYCARD
7251,GO:0030135,0.788267031493426,0.543468250715162,1,257,coated vesicle,CC,IDUA
13914,GO:0051169,0.788829644000108,0.444414543561798,2,465,nuclear transport,BP,NOL3;IFI27
4351,GO:0009057,0.789040846886277,0.343903262141629,6,1153,macromolecule catabolic process,BP,USE1;PSMB10;RGN;IDUA;HEXB;LYPLAL1
13740,GO:0050900,0.789570583512999,0.443467601685721,2,391,leukocyte migration,BP,FADD;PYCARD
3323,GO:0006606,0.790429364110125,0.540072099715042,1,267,protein import into nucleus,BP,NOL3
11889,GO:0044744,0.790429364110125,0.540072099715042,1,267,protein targeting to nucleus,BP,NOL3
43,GO:0000086,0.791342475863124,0.53881529843667,1,227,G2/M transition of mitotic cell cycle,BP,PSMB10
15210,GO:0060828,0.791811493360011,0.53804811615456,1,234,regulation of canonical Wnt signaling pathway,BP,PSMB10
3208,GO:0006468,0.791847691311227,0.316241788318072,9,1808,protein phosphorylation,BP,PDK4;PYCARD;PSMB10;RGN;GHR;FGF18;RNASEL;ANG;DEPTOR
1087,GO:0002460,0.792329089808531,0.537345077702479,1,213,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
7832,GO:0031252,0.792534467358291,0.536559798818995,1,347,cell leading edge,CC,S100B
3751,GO:0007275,0.794383111583475,0.27181825774633,27,4864,multicellular organism development,BP,EBP;ALG5;FADD;HSD17B3;TRADD;EXTL1;PNP;EBF1;KRT10;PSMB10;RGN;FGF18;NNMT;PLA2G16;RBP4;ANG;ACAT1;HEXB;TMEM176A;IDH1;STAR;S100B;DHCR7;PTS;DOK1;SLC1A3;LINGO1
19233,GO:1902593,0.79438422884946,0.533859396271912,1,270,single-organism nuclear import,BP,NOL3
3129,GO:0006352,0.795465819496899,0.53232008458719,1,229,DNA-templated transcription, initiation,BP,HNF1A
11389,GO:0043408,0.796396873446652,0.389805020629994,3,649,regulation of MAPK cascade,BP,PYCARD;GHR;FGF18
3937,GO:0008104,0.797399450985777,0.292147767053815,13,2482,protein localization,BP,USE1;MRAP;TBC1D14;PNP;ABCG1;PYCARD;RBP4;ANG;NOL3;IFI27;SNX21;RPH3AL;CNIH4
7882,GO:0031324,0.797478309815024,0.292066238240692,13,2336,negative regulation of cellular metabolic process,BP,APOC1;TBC1D14;PYCARD;ACADVL;PSMB10;RGN;ANG;NMI;NOL3;DEPTOR;IFI27;TFPI;GLA
3013,GO:0006140,0.798628839589682,0.527350714970009,1,217,regulation of nucleotide metabolic process,BP,MRAP
13700,GO:0050851,0.799112030767855,0.526647310883583,1,205,antigen receptor-mediated signaling pathway,BP,PSMB10
12852,GO:0046883,0.799429309879681,0.525942325785548,1,243,regulation of hormone secretion,BP,RBP4
3675,GO:0007167,0.801211711202451,0.357445992059661,4,963,enzyme linked receptor protein signaling pathway,BP,PDK4;GHR;FGF18;DOK1
19643,GO:1903522,0.802020771085602,0.521669118470333,1,269,regulation of blood circulation,BP,FXYD1
1888,GO:0004252,0.802212178073472,0.521789177710636,1,186,serine-type endopeptidase activity,MF,CFB
4111,GO:0008380,0.802229121550912,0.42466872239619,2,401,RNA splicing,BP,ARL6IP4;NOL3
1082,GO:0002449,0.802411420930319,0.521296180836012,1,212,lymphocyte mediated immunity,BP,FADD
11616,GO:0044057,0.80448030697065,0.421129960443184,2,484,regulation of system process,BP,FXYD1;NOL3
5827,GO:0016236,0.805574548035907,0.5159592052602,1,252,macroautophagy,BP,TBC1D14
11936,GO:0044839,0.805941111927486,0.515429766034758,1,236,cell cycle G2/M phase transition,BP,PSMB10
18722,GO:1901214,0.806177351545901,0.514933847208568,1,262,regulation of neuron death,BP,STAR
5730,GO:0016032,0.806276698903326,0.333554874678936,5,928,viral process,BP,FADD;PYCARD;PSMB10;TICAM1;RNASEL
8450,GO:0032386,0.806433749751641,0.418174742468882,2,480,regulation of intracellular transport,BP,NOL3;IFI27
9099,GO:0033554,0.808050718246673,0.295640809135661,9,1745,cellular response to stress,BP,PDK4;PYCARD;ACADVL;PSMB10;RGN;FADS1;NOL3;CASP4;S100B
82,GO:0000165,0.808134063065984,0.347864988160692,4,846,MAPK cascade,BP,PYCARD;PSMB10;GHR;FGF18
6540,GO:0019222,0.809507636055966,0.248099993029609,36,6101,regulation of metabolic process,BP,CFB;PDK4;FADD;MRAP;APOC1;TRADD;TBC1D14;ABCG1;EBF1;PYCARD;ACADVL;PSMB10;RGN;FADS1;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;FABP3;NOL3;DEPTOR;PCBD1;IFI27;FAM46A;IDH1;TFPI;STAR;GLA;DHCR7;PTS;RBMS3;HNF1A
2546,GO:0005261,0.809710728179753,0.508956506213775,1,312,cation channel activity,MF,GRIA3
11895,GO:0044764,0.811060015286,0.327015712038725,5,934,multi-organism cellular process,BP,FADD;PYCARD;PSMB10;TICAM1;RNASEL
15067,GO:0060589,0.811871576199935,0.505301311548945,1,338,nucleoside-triphosphatase regulator activity,MF,TBC1D14
3463,GO:0006812,0.812436877496231,0.325075347442809,5,1043,cation transport,BP,SLC31A2;RGN;FXYD1;NOL3;CYB5A
17001,GO:0072331,0.815674636213591,0.499173115693723,1,255,signal transduction by p53 class mediator,BP,PYCARD
2783,GO:0005769,0.815798844464412,0.498829907103131,1,293,early endosome,CC,SNX21
13236,GO:0048468,0.816282853564205,0.291011469464886,8,1834,cell development,BP,FGF18;ANG;HEXB;STAR;S100B;DOK1;SLC1A3;LINGO1
3520,GO:0006898,0.816314303110502,0.498007076067845,1,278,receptor-mediated endocytosis,BP,APOC1
3752,GO:0007276,0.817335508881036,0.359548485845646,3,603,gamete generation,BP,RGN;ANG;HEXB
20958,GO:2000027,0.817966907663338,0.495322990227864,1,247,regulation of organ morphogenesis,BP,PSMB10
5871,GO:0016310,0.818072343243276,0.273373955857211,11,2145,phosphorylation,BP,PDK4;ZFYVE21;PYCARD;PSMB10;RGN;GHR;FGF18;RNASEL;ANG;SHPK;DEPTOR
11705,GO:0044271,0.818509412203724,0.242505212391581,28,4709,cellular nitrogen compound biosynthetic process,BP,MRPL14;MRPL16;FADD;MRAP;TRADD;PNP;ABCG1;EBF1;BDH2;PYCARD;MGST2;PSMB10;RGN;FADS1;TICAM1;NNMT;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;PCBD1;IFI27;GLA;PTS;RBMS3;HNF1A
7159,GO:0023014,0.819718622947965,0.331456011510416,4,880,signal transduction by protein phosphorylation,BP,PYCARD;PSMB10;GHR;FGF18
18425,GO:0120025,0.820845362283688,0.292288646756256,7,1661,plasma membrane bounded cell projection,CC,FADD;CYP17A1;ANG;CPT1C;STAR;S100B;SLC1A3
1630,GO:0003713,0.821508255624323,0.489095165362433,1,294,transcription coactivator activity,MF,PCBD1
13364,GO:0048699,0.821800510900196,0.312026003613985,5,1311,generation of neurons,BP,STAR;S100B;DOK1;SLC1A3;LINGO1
7533,GO:0030659,0.824326106665973,0.349059463780297,3,711,cytoplasmic vesicle membrane,CC,GRIA3;SNX21;RPH3AL
7254,GO:0030139,0.824511038935277,0.483983410139379,1,270,endocytic vesicle,CC,GRIA3
13286,GO:0048562,0.824963702845366,0.483151277738163,1,283,embryonic organ morphogenesis,BP,RBP4
2816,GO:0005819,0.825002185035435,0.483046261205326,1,295,spindle,CC,FAM110C
3537,GO:0006928,0.825753089237923,0.278517470854608,8,1768,movement of cell or subcellular component,BP,FADD;PYCARD;RGN;FGF18;ANG;FAM110C;HEXB;DOK1
17218,GO:0080090,0.826612272486713,0.230102209116964,32,5552,regulation of primary metabolic process,BP,CFB;PDK4;FADD;MRAP;APOC1;TRADD;ABCG1;EBF1;PYCARD;ACADVL;PSMB10;RGN;FADS1;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;FABP3;NOL3;DEPTOR;PCBD1;IFI27;IDH1;TFPI;STAR;DHCR7;RBMS3;HNF1A
12128,GO:0045296,0.826722870646766,0.480031018006406,1,299,cadherin binding,MF,IDH1
567,GO:0001654,0.826769834600157,0.479858317969114,1,333,eye development,BP,RBP4
4023,GO:0008236,0.827549618983225,0.478976535127353,1,207,serine-type peptidase activity,MF,CFB
16329,GO:0071214,0.828084342386051,0.477676434469036,1,288,cellular response to abiotic stimulus,BP,FADD
6003,GO:0016579,0.828443017080591,0.477085481157574,1,276,protein deubiquitination,BP,PSMB10
13915,GO:0051170,0.828623141024681,0.476728215779841,1,288,nuclear import,BP,NOL3
759,GO:0001934,0.828679119710619,0.318556719446039,4,868,positive regulation of protein phosphorylation,BP,PYCARD;GHR;FGF18;ANG
579,GO:0001667,0.830181720498646,0.473907421334797,1,311,ameboidal-type cell migration,BP,FGF18
6314,GO:0017171,0.831226122627017,0.472466513254179,1,210,serine hydrolase activity,MF,CFB
7135,GO:0022836,0.83208969054849,0.470476210042166,1,327,gated channel activity,MF,GRIA3
6180,GO:0016887,0.832091101070236,0.470315452676183,1,406,ATPase activity,MF,ABCG1
1629,GO:0003712,0.833330593864746,0.375941704676987,2,521,transcription cofactor activity,MF,NMI;PCBD1
7263,GO:0030154,0.834026158290707,0.232192718989864,20,3698,cell differentiation,BP,FADD;MRAP;PNP;ABCG1;BDH2;ACADVL;KRT10;FADS1;FGF18;RNASEL;ANG;HEXB;NUDT7;TMEM176A;STAR;S100B;DHCR7;DOK1;SLC1A3;LINGO1
5170,GO:0012506,0.834181009536606,0.334145201616322,3,727,vesicle membrane,CC,GRIA3;SNX21;RPH3AL
3070,GO:0006260,0.834938266252645,0.465508595469415,1,281,DNA replication,BP,PTMS
15343,GO:0061061,0.835012140969052,0.373165601231159,2,563,muscle structure development,BP,RBP4;S100B
18089,GO:0098609,0.835491376524295,0.332111733512517,3,771,cell-cell adhesion,BP,FADD;PNP;PYCARD
11782,GO:0044403,0.83552556253923,0.292789536829154,5,968,symbiosis, encompassing mutualism through parasitism,BP,FADD;PYCARD;PSMB10;TICAM1;RNASEL
11790,GO:0044419,0.835530351131152,0.292781786667672,5,970,interspecies interaction between organisms,BP,FADD;PYCARD;PSMB10;TICAM1;RNASEL
4566,GO:0009416,0.835623503154981,0.464247903504771,1,289,response to light stimulus,BP,SLC1A3
3706,GO:0007204,0.836546636398529,0.462691423120239,1,258,positive regulation of cytosolic calcium ion concentration,BP,NOL3
757,GO:0001932,0.837523514040376,0.278476491021954,6,1264,regulation of protein phosphorylation,BP,PYCARD;RGN;GHR;FGF18;ANG;DEPTOR
11623,GO:0044085,0.837946074658701,0.236163304531455,15,2815,cellular component biogenesis,BP,FADD;APOC1;TRADD;TBC1D14;PYCARD;HACL1;RNASEL;ANG;FAM110C;ACAT1;NOL3;PCBD1;DECR1;HNF1A;TMOD4
17882,GO:0097367,0.838387297482797,0.255899005775349,9,2130,carbohydrate derivative binding,MF,PDK4;ACSF2;PNP;ABCG1;ACSM5;RNASEL;ANG;SHPK;GLA
7885,GO:0031327,0.838438342867902,0.2684793488179,7,1445,negative regulation of cellular biosynthetic process,BP,APOC1;ACADVL;RGN;ANG;NMI;IFI27;GLA
13663,GO:0050792,0.841907691472369,0.452902698036635,1,258,regulation of viral process,BP,RNASEL
14697,GO:0060070,0.842649808487559,0.451441550972081,1,283,canonical Wnt signaling pathway,BP,PSMB10
12848,GO:0046879,0.842832366850336,0.45109749729708,1,285,hormone secretion,BP,RBP4
14949,GO:0060429,0.843164465426177,0.270578141810797,6,1200,epithelium development,BP,TRADD;BDH2;ACADVL;KRT10;PSMB10;ACAT1
11499,GO:0043588,0.84340844839455,0.359609745116051,2,398,skin development,BP,TRADD;KRT10
13440,GO:0048856,0.843967374633101,0.211180114616422,29,5288,anatomical structure development,BP,EBP;ALG5;FADD;HSD17B3;TRADD;EXTL1;PNP;EBF1;BDH2;ACADVL;KRT10;PSMB10;RGN;FGF18;NNMT;PLA2G16;RBP4;ANG;ACAT1;HEXB;TMEM176A;IDH1;STAR;S100B;DHCR7;PTS;DOK1;SLC1A3;LINGO1
7712,GO:0031012,0.844555584691378,0.35751150804085,2,517,extracellular matrix,CC,ANG;LINGO1
5145,GO:0010975,0.844733754664815,0.447315508419859,1,391,regulation of neuron projection development,BP,LINGO1
13724,GO:0050878,0.845377785813409,0.356168711222266,2,495,regulation of body fluid levels,BP,FAM46A;TFPI
16060,GO:0070646,0.845839393716556,0.445489437108632,1,291,protein modification by small protein removal,BP,PSMB10
11392,GO:0043412,0.846217709681501,0.21578927162388,21,3985,macromolecule modification,BP,PDK4;ALG5;DPM3;MSRA;EXTL1;PYCARD;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;HSD17B10;ETFB;RNASEL;ANG;NMI;DEPTOR;PUS1;MDP1;LYPLAL1
18166,GO:0098794,0.846334358828705,0.444312649667724,1,400,postsynapse,CC,GRIA3
19652,GO:1903533,0.846468790851023,0.444334963671429,1,284,regulation of protein targeting,BP,NOL3
20389,GO:1905114,0.846567373700098,0.35409793767131,2,565,cell surface receptor signaling pathway involved in cell-cell signaling,BP,PSMB10;GRIA3
3845,GO:0007568,0.84657228543057,0.444161549087485,1,278,aging,BP,RGN
10767,GO:0042327,0.847189698082517,0.291205520345447,4,904,positive regulation of phosphorylation,BP,PYCARD;GHR;FGF18;ANG
8550,GO:0032501,0.847954707692664,0.200467255442201,42,6860,multicellular organismal process,BP,EBP;PDK4;ALG5;FADD;HSD17B3;APOC1;TRADD;EXTL1;PNP;ABCG1;EBF1;PYCARD;ACADVL;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;NNMT;PLA2G16;FXYD1;RBP4;ANG;NMI;ACAT1;HEXB;NOL3;FAM46A;TMEM176A;IDH1;TFPI;STAR;PEPD;S100B;DHCR7;PTS;HNF1A;DOK1;SLC1A3;LINGO1;TMOD4
13885,GO:0051128,0.848349618493966,0.237957695043498,10,2195,regulation of cellular component organization,BP,APOC1;TBC1D14;PYCARD;FAM110C;HEXB;NOL3;S100B;HNF1A;LINGO1;TMOD4
7539,GO:0030667,0.848495043706408,0.440514211203077,1,288,secretory granule membrane,CC,RPH3AL
2852,GO:0005882,0.850013015738433,0.438133485342633,1,189,intermediate filament,CC,KRT10
4670,GO:0009890,0.850925689653223,0.251172080535987,7,1465,negative regulation of biosynthetic process,BP,APOC1;ACADVL;RGN;ANG;NMI;IFI27;GLA
13644,GO:0050767,0.852498040793995,0.344018495841556,2,647,regulation of neurogenesis,BP,STAR;LINGO1
7480,GO:0030529,0.853470255458317,0.281798316470044,4,756,intracellular ribonucleoprotein complex,CC,MRPL14;MRPL16;GHR;HSD17B10
20910,GO:1990904,0.853471717720627,0.281795406645497,4,757,ribonucleoprotein complex,CC,MRPL14;MRPL16;GHR;HSD17B10
12429,GO:0045930,0.854500622860766,0.42915162487955,1,264,negative regulation of mitotic cell cycle,BP,PSMB10
4681,GO:0009914,0.856100576459921,0.425946648568743,1,297,hormone transport,BP,RBP4
5549,GO:0015672,0.856112416708354,0.337974693253056,2,513,monovalent inorganic cation transport,BP,FXYD1;CYB5A
7234,GO:0030111,0.856679612567424,0.42480538527037,1,303,regulation of Wnt signaling pathway,BP,PSMB10
19802,GO:1903827,0.857626865155414,0.335323833237082,2,553,regulation of cellular protein localization,BP,NOL3;IFI27
5123,GO:0010948,0.858697708919271,0.42101105084724,1,262,negative regulation of cell cycle process,BP,PSMB10
6238,GO:0017038,0.861561440435185,0.415203291567003,1,316,protein import,BP,NOL3
7114,GO:0022613,0.862944307405896,0.326276871693408,2,420,ribonucleoprotein complex biogenesis,BP,RNASEL;NOL3
2814,GO:0005815,0.863748671635714,0.324621468466598,2,620,microtubule organizing center,CC,PXK;FAM110C
7335,GO:0030246,0.864269537737739,0.410022399004526,1,256,carbohydrate binding,MF,PHYH
11563,GO:0043903,0.867564580919568,0.403311072057925,1,280,regulation of symbiosis, encompassing mutualism through parasitism,BP,RNASEL
14865,GO:0060326,0.868064473000493,0.402437064205381,1,245,cell chemotaxis,BP,FGF18
3206,GO:0006464,0.868224153471938,0.190599949415192,19,3744,cellular protein modification process,BP,PDK4;ALG5;DPM3;MSRA;EXTL1;PYCARD;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;ETFB;RNASEL;ANG;NMI;DEPTOR;MDP1;LYPLAL1
10278,GO:0036211,0.868224153471938,0.190599949415192,19,3744,protein modification process,BP,PDK4;ALG5;DPM3;MSRA;EXTL1;PYCARD;KRT10;PSMB10;RGN;GHR;FGF18;TICAM1;ETFB;RNASEL;ANG;NMI;DEPTOR;MDP1;LYPLAL1
13646,GO:0050769,0.868542821411317,0.401079996228751,1,378,positive regulation of neurogenesis,BP,STAR
7881,GO:0031323,0.868669076391132,0.179224372205546,32,5697,regulation of cellular metabolic process,BP,PDK4;FADD;MRAP;APOC1;TRADD;TBC1D14;ABCG1;EBF1;PYCARD;ACADVL;PSMB10;RGN;FADS1;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;FABP3;NOL3;DEPTOR;PCBD1;IFI27;IDH1;TFPI;STAR;GLA;RBMS3;HNF1A
10632,GO:0042060,0.869006109119635,0.315437530152183,2,522,wound healing,BP,FAM46A;TFPI
371,GO:0000989,0.869288249717826,0.314872594870859,2,582,transcription factor activity, transcription factor binding,MF,NMI;PCBD1
14100,GO:0051480,0.869317214688013,0.399719298683924,1,291,regulation of cytosolic calcium ion concentration,BP,NOL3
7286,GO:0030182,0.871944966111664,0.252993091910034,4,1196,neuron differentiation,BP,S100B;DOK1;SLC1A3;LINGO1
2847,GO:0005874,0.872970227277406,0.392022829666123,1,376,microtubule,CC,FAM110C
12032,GO:0045111,0.873955216046705,0.390483079242281,1,222,intermediate filament cytoskeleton,CC,KRT10
370,GO:0000988,0.874125608222794,0.306197273983108,2,590,transcription factor activity, protein binding,MF,NMI;PCBD1
11275,GO:0043228,0.876117726398864,0.179212315571298,20,3749,non-membrane-bounded organelle,CC,MSRA;MRPL14;MRPL16;MRI1;TRADD;HSD17B11;PNP;PYCARD;G0S2;ACADVL;KRT10;GHR;FGF18;ARL6IP4;CPT2;PXK;ANG;FAM110C;NOL3;TMOD4
11279,GO:0043232,0.876117726398864,0.179212315571298,20,3749,intracellular non-membrane-bounded organelle,CC,MSRA;MRPL14;MRPL16;MRI1;TRADD;HSD17B11;PNP;PYCARD;G0S2;ACADVL;KRT10;GHR;FGF18;ARL6IP4;CPT2;PXK;ANG;FAM110C;NOL3;TMOD4
14191,GO:0051649,0.876141744523624,0.204247124702726,9,1947,establishment of localization in cell,BP,ZFYVE21;TBC1D14;ABCG1;CPT2;NOL3;IFI27;STAR;RPH3AL;CNIH4
10765,GO:0042325,0.876939603301701,0.221569226657212,6,1349,regulation of phosphorylation,BP,PYCARD;RGN;GHR;FGF18;ANG;DEPTOR
8292,GO:0032103,0.876953281881211,0.384065355639431,1,258,positive regulation of response to external stimulus,BP,FGF18
13918,GO:0051173,0.877510275744021,0.207200414453789,8,1750,positive regulation of nitrogen compound metabolic process,BP,FADD;MRAP;TICAM1;RNASEL;HEXB;PCBD1;RBMS3;HNF1A
5992,GO:0016567,0.879091946519164,0.262023553646827,3,800,protein ubiquitination,BP,PSMB10;TICAM1;NMI
3805,GO:0007420,0.879101623893175,0.297093753223718,2,666,brain development,BP,ACAT1;STAR
9485,GO:0034504,0.879951836260485,0.377459580236432,1,354,protein localization to nucleus,BP,NOL3
3542,GO:0006935,0.880104895854381,0.295365379783229,2,539,chemotaxis,BP,FGF18;DOK1
16427,GO:0071363,0.880388412254907,0.294777046744441,2,610,cellular response to growth factor stimulus,BP,FGF18;STAR
4849,GO:0010557,0.881004245709984,0.208056607651794,7,1587,positive regulation of macromolecule biosynthetic process,BP,FADD;TICAM1;RNASEL;HEXB;PCBD1;RBMS3;HNF1A
10769,GO:0042330,0.88128579462576,0.293192352928856,2,540,taxis,BP,FGF18;DOK1
4221,GO:0008544,0.882216748959097,0.291606138911068,2,440,epidermis development,BP,TRADD;KRT10
13450,GO:0048869,0.883568948193319,0.169578463441741,20,3868,cellular developmental process,BP,FADD;MRAP;PNP;ABCG1;BDH2;ACADVL;KRT10;FADS1;FGF18;RNASEL;ANG;HEXB;NUDT7;TMEM176A;STAR;S100B;DHCR7;DOK1;SLC1A3;LINGO1
5742,GO:0016050,0.883638538205749,0.369558683258473,1,365,vesicle organization,BP,TBC1D14
11009,GO:0042742,0.886815245513569,0.363148416502259,1,222,defense response to bacterium,BP,PYCARD
12350,GO:0045786,0.888354004841003,0.280025922335808,2,544,negative regulation of cell cycle,BP,PSMB10;PLA2G16
367,GO:0000982,0.888861232357483,0.3581930545754,1,366,transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,HNF1A
14354,GO:0051960,0.888994768385488,0.278675383506587,2,729,regulation of nervous system development,BP,STAR;LINGO1
12441,GO:0045944,0.889067312116906,0.225503110352461,4,1031,positive regulation of transcription from RNA polymerase II promoter,BP,FADD;RNASEL;HEXB;HNF1A
482,GO:0001503,0.889227372351661,0.35738721120357,1,366,ossification,BP,FGF18
472,GO:0001228,0.889646588985786,0.356492048718404,1,352,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,HNF1A
6024,GO:0016607,0.891157286011499,0.353141843893302,1,355,nuclear speck,CC,ARL6IP4
13916,GO:0051171,0.894220184727566,0.153698826968101,22,4223,regulation of nitrogen compound metabolic process,BP,FADD;MRAP;APOC1;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;FABP3;PCBD1;IFI27;GLA;RBMS3;HNF1A
16151,GO:0070848,0.895270635652151,0.266785792783606,2,635,response to growth factor,BP,FGF18;STAR
18985,GO:1901990,0.895633349197558,0.343219909100271,1,309,regulation of mitotic cell cycle phase transition,BP,PSMB10
14861,GO:0060322,0.89565757846798,0.265997550768068,2,699,head development,BP,ACAT1;STAR
3140,GO:0006364,0.896191022160811,0.34219433455151,1,242,rRNA processing,BP,RNASEL
7225,GO:0030099,0.896205014445691,0.341872380086964,1,329,myeloid cell differentiation,BP,FADD
7439,GO:0030425,0.896963861228946,0.339926347956215,1,454,dendrite,CC,CPT1C
2881,GO:0005925,0.897215435082373,0.3394597992349,1,384,focal adhesion,CC,ZFYVE21
14170,GO:0051603,0.898273962528557,0.260995004862296,2,617,proteolysis involved in cellular protein catabolic process,BP,PSMB10;RGN
3741,GO:0007264,0.898592429053222,0.336173170380002,1,482,small GTPase mediated signal transduction,BP,DOK1
3792,GO:0007399,0.899556689818901,0.174980808032142,8,2141,nervous system development,BP,ACAT1;HEXB;STAR;S100B;PTS;DOK1;SLC1A3;LINGO1
14356,GO:0051962,0.899737927732351,0.333601768214939,1,434,positive regulation of nervous system development,BP,STAR
2880,GO:0005924,0.89977290647392,0.333595041356167,1,387,cell-substrate adherens junction,CC,ZFYVE21
7212,GO:0030055,0.899773229857102,0.333587318068895,1,391,cell-substrate junction,CC,ZFYVE21
178,GO:0000377,0.901199387329794,0.330478544490522,1,306,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,NOL3
190,GO:0000398,0.901199387329794,0.330478544490522,1,306,mRNA splicing, via spliceosome,BP,NOL3
11798,GO:0044428,0.901726277954901,0.144770365483,21,4050,nuclear part,CC,EBP;MSRA;MRI1;TBC1D14;PYCARD;LAGE3;ACADVL;MGST2;PSMB10;FGF18;ARL6IP4;CPT2;RNASEL;ANG;NMI;AOX1;NOL3;PCBD1;IFI27;DECR1;DHCR7
7940,GO:0031424,0.901789507096121,0.329445559488169,1,220,keratinization,BP,KRT10
9960,GO:0035639,0.902885972760647,0.181793670014496,6,1749,purine ribonucleoside triphosphate binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
13330,GO:0048646,0.902896190227623,0.220475307599536,3,941,anatomical structure formation involved in morphogenesis,BP,FGF18;RBP4;ANG
1063,GO:0002429,0.9029733897613,0.326316458959608,1,318,immune response-activating cell surface receptor signaling pathway,BP,PSMB10
7195,GO:0030030,0.903220547992467,0.201840432437375,4,1276,cell projection organization,BP,FAM110C;S100B;DOK1;LINGO1
177,GO:0000375,0.903827184082685,0.324341355154222,1,309,RNA splicing, via transesterification reactions,BP,NOL3
13839,GO:0051052,0.903931428757948,0.323968294010574,1,364,regulation of DNA metabolic process,BP,RGN
2512,GO:0005198,0.904057006224256,0.218514806983657,3,677,structural molecule activity,MF,MRPL14;MRPL16;KRT10
10581,GO:0040008,0.904235462625959,0.24931007465205,2,607,regulation of growth,BP,GHR;RBP4
7621,GO:0030855,0.904574299860311,0.217559410152948,3,708,epithelial cell differentiation,BP,BDH2;ACADVL;KRT10
8907,GO:0033043,0.907784986488314,0.194089377322128,4,1117,regulation of organelle organization,BP,TBC1D14;PYCARD;NOL3;TMOD4
13307,GO:0048609,0.909304977504953,0.208917790217037,3,755,multicellular organismal reproductive process,BP,RGN;ANG;HEXB
18982,GO:1901987,0.911137567919155,0.306847879434837,1,330,regulation of cell cycle phase transition,BP,PSMB10
7249,GO:0030133,0.911824902059316,0.305110134654484,1,361,transport vesicle,CC,RPH3AL
2701,GO:0005634,0.912716815943065,0.121809985782811,38,6684,nucleus,CC,EBP;MSRA;MRI1;FADD;TRADD;TBC1D14;PNP;EBF1;PYCARD;LAGE3;ACADVL;KRT10;MGST2;PSMB10;RGN;FGF18;ARL6IP4;CPT2;RNASEL;ANG;FAM110C;NMI;TSFM;AOX1;F8A1;NOL3;NUDT6;PCBD1;IFI27;PON2;DECR1;PUS1;PTMS;DERA;S100B;DHCR7;HNF1A;DOK1
8503,GO:0032446,0.913485570052023,0.201146260259822,3,882,protein modification by small protein conjugation,BP,PSMB10;TICAM1;NMI
8580,GO:0032555,0.91382341406598,0.1644008779605,6,1791,purine ribonucleotide binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
14830,GO:0060284,0.913949179109412,0.229652442103541,2,747,regulation of cell development,BP,STAR;LINGO1
4950,GO:0010720,0.914265172351333,0.299011876616361,1,437,positive regulation of cell development,BP,STAR
8552,GO:0032504,0.914774203772002,0.198802395965395,3,764,multicellular organism reproduction,BP,RGN;ANG;HEXB
6777,GO:0019953,0.915509031911273,0.197440083076216,3,747,sexual reproduction,BP,RGN;ANG;HEXB
11694,GO:0044257,0.915986971839173,0.225516397162056,2,652,cellular protein catabolic process,BP,PSMB10;RGN
7176,GO:0023061,0.916149227870286,0.294395009613679,1,407,signal release,BP,RBP4
11229,GO:0043161,0.916545809190203,0.293471572491098,1,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,PSMB10
4893,GO:0010628,0.916856088026795,0.153557711779719,7,1687,positive regulation of gene expression,BP,FADD;RNASEL;HEXB;PCBD1;STAR;RBMS3;HNF1A
12400,GO:0045893,0.917086934817405,0.167011267663116,5,1335,positive regulation of transcription, DNA-templated,BP,FADD;RNASEL;HEXB;PCBD1;HNF1A
19633,GO:1903508,0.917086934817405,0.167011267663116,5,1335,positive regulation of nucleic acid-templated transcription,BP,FADD;RNASEL;HEXB;PCBD1;HNF1A
13694,GO:0050839,0.917555385439895,0.290844410530456,1,438,cell adhesion molecule binding,MF,IDH1
14218,GO:0051704,0.917863758521092,0.135271137974247,12,2241,multi-organism process,BP,FADD;PYCARD;MGST2;PSMB10;RGN;TICAM1;RNASEL;ANG;SHPK;HEXB;TFPI;STAR
10580,GO:0040007,0.918454729111011,0.191840525101561,3,907,growth,BP,GHR;RBP4;DHCR7
6260,GO:0017076,0.918490897052886,0.156846385032122,6,1804,purine nucleotide binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
3825,GO:0007507,0.919023982226135,0.287097171494166,1,488,heart development,BP,RBP4
8578,GO:0032553,0.919249567933301,0.15561031878528,6,1808,ribonucleotide binding,MF,PDK4;ACSF2;ABCG1;ACSM5;RNASEL;SHPK
1270,GO:0002768,0.920327941874689,0.284005518917191,1,350,immune response-regulating cell surface receptor signaling pathway,BP,PSMB10
18321,GO:0099512,0.922009368677481,0.185117405744,3,861,supramolecular fiber,CC,KRT10;FAM110C;TMOD4
18298,GO:0099081,0.922472906454164,0.184229910923115,3,868,supramolecular polymer,CC,KRT10;FAM110C;TMOD4
18297,GO:0099080,0.922473379105109,0.184228621069464,3,869,supramolecular complex,CC,KRT10;FAM110C;TMOD4
4672,GO:0009892,0.923867751212387,0.124586670218617,13,2643,negative regulation of metabolic process,BP,APOC1;TBC1D14;PYCARD;ACADVL;PSMB10;RGN;ANG;NMI;NOL3;DEPTOR;IFI27;TFPI;GLA
13291,GO:0048568,0.924157334196821,0.274079677225475,1,417,embryonic organ development,BP,RBP4
11922,GO:0044802,0.925134255049073,0.206264176986854,2,717,single-organism membrane organization,BP,TBC1D14;NOL3
4617,GO:0009653,0.925135803428358,0.132339668076063,9,2328,anatomical structure morphogenesis,BP,PSMB10;FGF18;RBP4;ANG;HEXB;S100B;DOK1;SLC1A3;LINGO1
9518,GO:0034622,0.925136025874837,0.163639872131126,4,947,cellular macromolecular complex assembly,BP,PYCARD;ANG;NOL3;TMOD4
11863,GO:0044700,0.92598503613293,0.106104877424668,33,5938,single organism signaling,BP,EBP;PDK4;IFI30;FADD;P2RY14;TRADD;PYCARD;G0S2;ACADVL;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;PXK;FXYD1;RBP4;RNASEL;FAM110C;NMI;GRIA3;NOL3;DEPTOR;CASP4;IFI27;STAR;RPH3AL;S100B;DOK1;SLC1A3;LINGO1
19263,GO:1902680,0.926602413063387,0.150815704973169,5,1357,positive regulation of RNA biosynthetic process,BP,FADD;RNASEL;HEXB;PCBD1;HNF1A
7172,GO:0023052,0.926768808223259,0.105076700208649,33,5945,signaling,BP,EBP;PDK4;IFI30;FADD;P2RY14;TRADD;PYCARD;G0S2;ACADVL;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;PXK;FXYD1;RBP4;RNASEL;FAM110C;NMI;GRIA3;NOL3;DEPTOR;CASP4;IFI27;STAR;RPH3AL;S100B;DOK1;SLC1A3;LINGO1
7196,GO:0030031,0.927102570814674,0.2663302688685,1,474,cell projection assembly,BP,FAM110C
2649,GO:0005525,0.927733262727545,0.264842499868382,1,357,GTP binding,MF,ACSM5
10721,GO:0042254,0.929328524888553,0.26077322054574,1,292,ribosome biogenesis,BP,RNASEL
8575,GO:0032550,0.929716867572428,0.259579517235159,1,360,purine ribonucleoside binding,MF,ACSM5
8574,GO:0032549,0.930011207608444,0.258787077946216,1,364,ribonucleoside binding,MF,ACSM5
4820,GO:0010498,0.930027196030328,0.258686541636205,1,398,proteasomal protein catabolic process,BP,PSMB10
4809,GO:0010467,0.931100924565179,0.101637382643045,27,5049,gene expression,BP,CFB;MRPL14;MRPL16;FADD;TRADD;ABCG1;EBF1;PYCARD;LAGE3;PSMB10;FADS1;TICAM1;ARL6IP4;HSD17B10;RNASEL;ANG;NMI;TSFM;HEXB;NOL3;PCBD1;IFI27;FAM46A;PUS1;STAR;RBMS3;HNF1A
2872,GO:0005912,0.931118338953435,0.255661504806211,1,479,adherens junction,CC,ZFYVE21
722,GO:0001883,0.931656058899666,0.25437933912194,1,363,purine nucleoside binding,MF,ACSM5
3662,GO:0007154,0.931927811673976,0.0982805274121844,33,5959,cell communication,BP,EBP;PDK4;IFI30;FADD;P2RY14;TRADD;PYCARD;G0S2;ACADVL;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;PXK;RBP4;RNASEL;ANG;FAM110C;NMI;GRIA3;NOL3;DEPTOR;CASP4;IFI27;STAR;RPH3AL;S100B;DOK1;SLC1A3;LINGO1
6359,GO:0018130,0.932752429753832,0.102167413539883,22,4246,heterocycle biosynthetic process,BP,FADD;MRAP;TRADD;PNP;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;NNMT;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;PCBD1;IFI27;PTS;HNF1A
4667,GO:0009887,0.933244929649523,0.163240159443428,3,966,animal organ morphogenesis,BP,PSMB10;FGF18;RBP4
6614,GO:0019438,0.933374006055213,0.101311326208445,22,4252,aromatic compound biosynthetic process,BP,FADD;MRAP;TRADD;PNP;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;NNMT;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;PCBD1;IFI27;PTS;HNF1A
15766,GO:0070161,0.934038931862482,0.247738169396055,1,498,anchoring junction,CC,ZFYVE21
6371,GO:0018193,0.9344063889372,0.146640454381943,4,1149,peptidyl-amino acid modification,BP,ALG5;DPM3;GHR;FGF18
12288,GO:0045664,0.934681851737211,0.245952354384781,1,529,regulation of neuron differentiation,BP,LINGO1
7313,GO:0030216,0.934735033316607,0.246192798525971,1,287,keratinocyte differentiation,BP,KRT10
8586,GO:0032561,0.934956822025718,0.245386519915791,1,375,guanyl ribonucleotide binding,MF,ACSM5
6456,GO:0019001,0.935307938487846,0.244420610192943,1,376,guanyl nucleotide binding,MF,ACSM5
3510,GO:0006886,0.936815435627449,0.142163012954015,4,1108,intracellular protein transport,BP,TBC1D14;NOL3;IFI27;RPH3AL
18322,GO:0099513,0.937114680597787,0.180050852171486,2,647,polymeric cytoskeletal fiber,CC,KRT10;FAM110C
3790,GO:0007389,0.937147037525983,0.239281227802601,1,413,pattern specification process,BP,ALG5
11560,GO:0043900,0.938063483804758,0.236790520280011,1,373,regulation of multi-organism process,BP,RNASEL
13972,GO:0051254,0.938206282703098,0.13046852254788,5,1403,positive regulation of RNA metabolic process,BP,FADD;RNASEL;HEXB;PCBD1;HNF1A
18062,GO:0098552,0.938632436432152,0.235138217340543,1,412,side of membrane,CC,ABCG1
3590,GO:0007010,0.939954569466524,0.149735368337462,3,1111,cytoskeleton organization,BP,PYCARD;ANG;TMOD4
20732,GO:1990234,0.941501611910323,0.170052106823688,2,719,transferase complex,CC,DPM3;PYCARD
11823,GO:0044459,0.94236959020687,0.102813927740988,10,2478,plasma membrane part,CC,EBP;SLC31A2;FADD;P2RY14;TRADD;ABCG1;GHR;FXYD1;GRIA3;CPT1C
5747,GO:0016055,0.942553271702145,0.223960063408444,1,461,Wnt signaling pathway,BP,PSMB10
18426,GO:0198738,0.943202104151126,0.222093526768888,1,462,cell-cell signaling by wnt,BP,PSMB10
11816,GO:0044451,0.944581214200917,0.140263912225418,3,1010,nucleoplasm part,CC,LAGE3;ARL6IP4;AOX1
3807,GO:0007423,0.944732593449021,0.217621582534066,1,504,sensory organ development,BP,RBP4
9540,GO:0034654,0.947176663531839,0.0826375147171427,21,4183,nucleobase-containing compound biosynthetic process,BP,FADD;MRAP;TRADD;PNP;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;NNMT;RNASEL;ANG;NMI;ACAT1;TSFM;HEXB;PCBD1;IFI27;HNF1A
819,GO:0002009,0.947859869113088,0.208429629699073,1,509,morphogenesis of an epithelium,BP,PSMB10
19230,GO:1902589,0.948312741652315,0.112122956128012,5,1542,single-organism organelle organization,BP,TBC1D14;PYCARD;ANG;NOL3;TMOD4
14184,GO:0051641,0.948677973488995,0.0928215286002793,10,2455,cellular localization,BP,ZFYVE21;MRAP;TBC1D14;ABCG1;CPT2;NOL3;IFI27;STAR;RPH3AL;CNIH4
2836,GO:0005856,0.949195895734257,0.10046535111057,7,1934,cytoskeleton,CC,MSRA;TRADD;PNP;KRT10;PXK;FAM110C;TMOD4
4041,GO:0008270,0.951467097077659,0.125775448548176,3,1061,zinc ion binding,MF,RGN;GALT;S100B
4680,GO:0009913,0.952127690044186,0.1958051281344,1,335,epidermal cell differentiation,BP,KRT10
18168,GO:0098796,0.952823127768721,0.143398008347992,2,631,membrane protein complex,CC,FADD;TRADD
3890,GO:0008015,0.95373823570942,0.190651541696213,1,487,blood circulation,BP,FXYD1
21580,GO:2001141,0.953820748708632,0.076626753518357,16,3508,regulation of RNA biosynthetic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
13838,GO:0051051,0.954250011435233,0.189112565679892,1,442,negative regulation of transport,BP,APOC1
15676,GO:0065007,0.954345826920214,0.0656620335351002,66,10987,biological regulation,BP,CFB;EBP;PDK4;IFI30;DPM3;SLC31A2;FADD;P2RY14;HSD17B3;MRAP;APOC1;TRADD;TBC1D14;HSD17B11;PNP;ABCG1;EBF1;BDH2;PYCARD;G0S2;ACADVL;MGST2;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;PXK;PLA2G16;FXYD1;RBP4;CYP17A1;RNASEL;ANG;FAM110C;NMI;TSFM;SHPK;HEXB;FABP3;GRIA3;NOL3;HSD3B2;DEPTOR;PCBD1;CASP4;IFI27;FAM46A;TMEM176A;IDH1;TFPI;STAR;GLA;CYP11A1;RPH3AL;S100B;DHCR7;PTS;RBMS3;HNF1A;DOK1;SLC1A3;LINGO1;TMOD4
12434,GO:0045935,0.954588744776409,0.0951348065372306,6,1645,positive regulation of nucleobase-containing compound metabolic process,BP,FADD;MRAP;RNASEL;HEXB;PCBD1;HNF1A
1386,GO:0003013,0.954877665534126,0.187112657082656,1,491,circulatory system process,BP,FXYD1
16458,GO:0071407,0.955258172716199,0.185895669910119,1,527,cellular response to organic cyclic compound,BP,STAR
5752,GO:0016070,0.956575812046373,0.068631745361825,22,4437,RNA metabolic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;LAGE3;PSMB10;RGN;FADS1;TICAM1;ARL6IP4;HSD17B10;RNASEL;ANG;NMI;TSFM;HEXB;NOL3;PCBD1;IFI27;PUS1;HNF1A
9533,GO:0034645,0.956944544177727,0.0672100968543768,24,4781,cellular macromolecule biosynthetic process,BP,ALG5;DPM3;MRPL14;MRPL16;FADD;TRADD;EXTL1;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;PCBD1;IFI27;PTMS;RBMS3;HNF1A
3958,GO:0008134,0.957638271836775,0.178402533673219,1,517,transcription factor binding,MF,IFI27
4810,GO:0010468,0.959936658016021,0.0647550692671731,20,4258,regulation of gene expression,BP,CFB;FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;FADS1;TICAM1;RNASEL;ANG;TSFM;HEXB;NOL3;PCBD1;IFI27;FAM46A;STAR;RBMS3;HNF1A
11137,GO:0043009,0.9601314181256,0.170373267160697,1,552,chordate embryonic development,BP,RBP4
4648,GO:0009792,0.960587342360047,0.168890719515494,1,555,embryo development ending in birth or egg hatching,BP,RBP4
16061,GO:0070647,0.961059824541137,0.10481799213985,3,1072,protein modification by small protein conjugation or removal,BP,PSMB10;TICAM1;NMI
8213,GO:0031981,0.962146798910857,0.0632879460994812,17,3713,nuclear lumen,CC,MSRA;MRI1;TBC1D14;PYCARD;LAGE3;ACADVL;PSMB10;FGF18;ARL6IP4;CPT2;RNASEL;ANG;NMI;AOX1;NOL3;PCBD1;DECR1
13304,GO:0048598,0.962970906883059,0.161057427923214,1,561,embryonic morphogenesis,BP,RBP4
4848,GO:0010556,0.963635440644755,0.0603842852808248,18,3946,regulation of macromolecule biosynthetic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;PCBD1;IFI27;RBMS3;HNF1A
6475,GO:0019058,0.964409352836086,0.156355937131143,1,438,viral life cycle,BP,RNASEL
14878,GO:0060341,0.964519531825986,0.113942391188438,2,811,regulation of cellular localization,BP,NOL3;IFI27
11865,GO:0044703,0.965230217155269,0.0954089411536399,3,909,multi-organism reproductive process,BP,RGN;ANG;HEXB
3239,GO:0006511,0.966416236206542,0.149468330363645,1,548,ubiquitin-dependent protein catabolic process,BP,PSMB10
13970,GO:0051252,0.96660224512924,0.0571431060996857,16,3624,regulation of RNA metabolic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
3776,GO:0007346,0.966905059805945,0.147834135248037,1,492,regulation of mitotic cell cycle,BP,PSMB10
3128,GO:0006351,0.967010588415752,0.0565085458241303,16,3617,transcription, DNA-templated,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
11902,GO:0044772,0.967205462570181,0.146794652009899,1,501,mitotic cell cycle phase transition,BP,PSMB10
13917,GO:0051172,0.967259627941682,0.0758194615060024,5,1487,negative regulation of nitrogen compound metabolic process,BP,APOC1;RGN;ANG;IFI27;GLA
16771,GO:0071944,0.967575181527726,0.051498473078799,25,5014,cell periphery,CC,CFB;EBP;SLC31A2;FADD;P2RY14;MRAP;TRADD;ABCG1;KRT10;MGST2;GHR;ASAH2;PXK;HSD17B10;FXYD1;FAM110C;GRIA3;CPT1C;CASP4;PON2;TFPI;RPH3AL;PRRT1;SLC1A3;LINGO1
21008,GO:2000112,0.967786460349906,0.0546539471200054,17,3834,regulation of cellular macromolecule biosynthetic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;TSFM;HEXB;PCBD1;IFI27;RBMS3;HNF1A
362,GO:0000977,0.96800391120556,0.14400809280087,1,542,RNA polymerase II regulatory region sequence-specific DNA binding,MF,HNF1A
388,GO:0001012,0.96800393469576,0.144007370314393,1,543,RNA polymerase II regulatory region DNA binding,MF,HNF1A
6775,GO:0019941,0.968085104335632,0.143718379960869,1,555,modification-dependent protein catabolic process,BP,PSMB10
18011,GO:0097659,0.969153035226796,0.0531641007196046,16,3636,nucleic acid-templated transcription,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
11821,GO:0044456,0.96916618522167,0.139894573078743,1,663,synapse part,CC,GRIA3
8724,GO:0032774,0.969449089928213,0.0520807535654328,17,3751,RNA biosynthetic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
11524,GO:0043632,0.969557942423015,0.138570069155787,1,561,modification-dependent macromolecule catabolic process,BP,PSMB10
2804,GO:0005794,0.970360199916269,0.075036138379168,4,1399,Golgi apparatus,CC,TBC1D14;ABCG1;GALT;GLA
13379,GO:0048729,0.970485282675783,0.13526897942575,1,607,tissue morphogenesis,BP,PSMB10
19631,GO:1903506,0.971092327868763,0.0507779673195011,15,3489,regulation of nucleic acid-templated transcription,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;FADS1;TICAM1;RNASEL;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
11900,GO:0044770,0.973376471821544,0.124900410728055,1,530,cell cycle phase transition,BP,PSMB10
4353,GO:0009059,0.97354624569324,0.0429654427854286,24,4943,macromolecule biosynthetic process,BP,ALG5;DPM3;MRPL14;MRPL16;FADD;TRADD;EXTL1;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;PCBD1;IFI27;PTMS;RBMS3;HNF1A
2856,GO:0005886,0.974795181681914,0.0410923296498888,24,4920,plasma membrane,CC,CFB;EBP;SLC31A2;FADD;P2RY14;MRAP;TRADD;ABCG1;KRT10;MGST2;GHR;ASAH2;PXK;HSD17B10;FXYD1;GRIA3;CPT1C;CASP4;PON2;TFPI;RPH3AL;PRRT1;SLC1A3;LINGO1
3754,GO:0007283,0.975535860438181,0.116942377128895,1,488,spermatogenesis,BP,RGN
13145,GO:0048232,0.975611114119446,0.11665992058976,1,489,male gamete generation,BP,RGN
4902,GO:0010638,0.976487975530085,0.113304352743531,1,584,positive regulation of organelle organization,BP,PYCARD
11235,GO:0043170,0.977183159105356,0.034661306630788,47,8633,macromolecule metabolic process,BP,CFB;PDK4;USE1;ALG5;DPM3;MSRA;MRPL14;MRPL16;FADD;APOC1;TRADD;EXTL1;ABCG1;EBF1;PYCARD;LAGE3;KRT10;PSMB10;RGN;FADS1;GHR;FGF18;TICAM1;ARL6IP4;HSD17B10;ETFB;RNASEL;ANG;NMI;TSFM;IDUA;HEXB;NOL3;DEPTOR;PCBD1;CASP4;IFI27;FAM46A;PUS1;PTMS;MDP1;TFPI;STAR;PEPD;RBMS3;HNF1A;LYPLAL1
361,GO:0000976,0.977236769816041,0.110444639896594,1,618,transcription regulatory region sequence-specific DNA binding,MF,HNF1A
2304,GO:0004871,0.978538299904629,0.0471746208653933,7,1637,signal transducer activity,MF,EBP;P2RY14;TRADD;GHR;TICAM1;GRIA3;DOK1
4856,GO:0010564,0.979094560764353,0.103299069973585,1,568,regulation of cell cycle process,BP,PSMB10
3141,GO:0006366,0.979410644555415,0.0454526975558449,7,2029,transcription from RNA polymerase II promoter,BP,FADD;PSMB10;RNASEL;NMI;HEXB;IFI27;HNF1A
5737,GO:0016043,0.979755489917041,0.033138902769636,26,5728,cellular component organization,BP,MRPL14;MRPL16;FADD;APOC1;TRADD;TBC1D14;ABCG1;PYCARD;PLA2G16;HSD17B10;HACL1;ANG;FAM110C;ACAT1;HEXB;NOL3;DEPTOR;PCBD1;DECR1;PUS1;S100B;HNF1A;DOK1;SLC1A3;LINGO1;TMOD4
3134,GO:0006357,0.980006785388715,0.0464759355823566,6,1840,regulation of transcription from RNA polymerase II promoter,BP,FADD;PSMB10;RNASEL;HEXB;IFI27;HNF1A
1381,GO:0003008,0.980149133191392,0.0423025306502901,8,1906,system process,BP,FXYD1;RBP4;HEXB;NOL3;S100B;HNF1A;SLC1A3;TMOD4
4850,GO:0010558,0.980440939241488,0.0524844999549968,4,1374,negative regulation of macromolecule biosynthetic process,BP,RGN;ANG;NMI;IFI27
3663,GO:0007155,0.980967607426045,0.0573271374117546,3,1311,cell adhesion,BP,FADD;PNP;PYCARD
16198,GO:0070925,0.980990669084298,0.0957693689920762,1,664,organelle assembly,BP,TBC1D14
11800,GO:0044430,0.981069144893672,0.0510173363493444,4,1452,cytoskeletal part,CC,KRT10;PXK;FAM110C;TMOD4
7112,GO:0022610,0.981720266261839,0.0553873737007683,3,1318,biological adhesion,BP,FADD;PNP;PYCARD
15311,GO:0061024,0.981770010203049,0.0658511806325082,2,1001,membrane organization,BP,TBC1D14;NOL3
6537,GO:0019219,0.981897813920655,0.0322733051282147,17,3966,regulation of nucleobase-containing compound metabolic process,BP,FADD;MRAP;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;TICAM1;RNASEL;NMI;TSFM;HEXB;PCBD1;IFI27;HNF1A
20893,GO:1990837,0.981983158739124,0.0917760564114938,1,653,sequence-specific double-stranded DNA binding,MF,HNF1A
9512,GO:0034613,0.982581130968208,0.0437715469918673,5,1682,cellular protein localization,BP,MRAP;TBC1D14;NOL3;IFI27;RPH3AL
5532,GO:0015630,0.982798570725192,0.0627319729893433,2,1035,microtubule cytoskeleton,CC,PXK;FAM110C
17528,GO:0090304,0.983049198655669,0.0286857444904287,23,4910,nucleic acid metabolic process,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;LAGE3;PSMB10;RGN;FADS1;TICAM1;ARL6IP4;HSD17B10;RNASEL;ANG;NMI;TSFM;HEXB;NOL3;PCBD1;IFI27;PUS1;PTMS;HNF1A
3132,GO:0006355,0.983147238782521,0.0315367082054567,14,3465,regulation of transcription, DNA-templated,BP,FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;FADS1;TICAM1;RNASEL;TSFM;HEXB;PCBD1;IFI27;HNF1A
16101,GO:0070727,0.983577852547523,0.0415656358003022,5,1692,cellular macromolecule localization,BP,MRAP;TBC1D14;NOL3;IFI27;RPH3AL
69,GO:0000139,0.983765520805761,0.0844466637540406,1,678,Golgi membrane,CC,ABCG1
16710,GO:0071840,0.985183539441015,0.0246612346920688,27,5922,cellular component organization or biogenesis,BP,MRPL14;MRPL16;FADD;APOC1;TRADD;TBC1D14;ABCG1;PYCARD;PLA2G16;HSD17B10;HACL1;RNASEL;ANG;FAM110C;ACAT1;HEXB;NOL3;DEPTOR;PCBD1;DECR1;PUS1;S100B;HNF1A;DOK1;SLC1A3;LINGO1;TMOD4
366,GO:0000981,0.985724145340284,0.07616819999249,1,676,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,HNF1A
8871,GO:0032991,0.986022705214478,0.024393615091933,21,4576,macromolecular complex,CC,DPM3;MRPL14;MRPL16;FADD;APOC1;TRADD;PXMP2;PYCARD;PSMB10;GHR;TICAM1;PXK;HSD17B10;FXYD1;RBP4;ANG;GRIA3;CPT1C;CASP4;HNF1A;ETFDH
3673,GO:0007165,0.986339096595942,0.0228689559197132,27,5449,signal transduction,BP,EBP;PDK4;IFI30;FADD;P2RY14;TRADD;PYCARD;G0S2;ACADVL;PSMB10;RGN;GHR;FGF18;ASAH2;TICAM1;RNASEL;FAM110C;NMI;GRIA3;NOL3;DEPTOR;CASP4;IFI27;RPH3AL;S100B;DOK1;LINGO1
11700,GO:0044265,0.987733683997971,0.0472341976271348,2,927,cellular macromolecule catabolic process,BP,PSMB10;RGN
6278,GO:0017111,0.987764636484552,0.0672251489532575,1,772,nucleoside-triphosphatase activity,MF,ABCG1
3069,GO:0006259,0.988083449694614,0.0460939224401486,2,927,DNA metabolic process,BP,RGN;PTMS
11281,GO:0043234,0.988297560680488,0.0240183338983303,11,2889,protein complex,CC,FADD;TRADD;PXMP2;PYCARD;PSMB10;PXK;RBP4;ANG;CASP4;HNF1A;ETFDH
4877,GO:0010605,0.988517020725989,0.0249825590364894,9,2423,negative regulation of macromolecule metabolic process,BP,PYCARD;PSMB10;RGN;ANG;NMI;NOL3;DEPTOR;IFI27;TFPI
1620,GO:0003690,0.988613669680204,0.0634233673513833,1,723,double-stranded DNA binding,MF,HNF1A
14232,GO:0051726,0.988759770708617,0.0438665149394104,2,969,regulation of cell cycle,BP,PSMB10;PLA2G16
14811,GO:0060255,0.989550486209468,0.0179264884888173,26,5664,regulation of macromolecule metabolic process,BP,CFB;FADD;TRADD;ABCG1;EBF1;PYCARD;PSMB10;RGN;FADS1;GHR;FGF18;TICAM1;RNASEL;ANG;NMI;TSFM;HEXB;NOL3;DEPTOR;PCBD1;IFI27;FAM46A;TFPI;STAR;RBMS3;HNF1A
13887,GO:0051130,0.990483432151228,0.0380750990187877,2,1116,positive regulation of cellular component organization,BP,PYCARD;HNF1A
3859,GO:0007600,0.990541463740429,0.0314428672535442,3,886,sensory perception,BP,RBP4;HEXB;SLC1A3
21009,GO:2000113,0.990563993954894,0.0313464899403922,3,1293,negative regulation of cellular macromolecule biosynthetic process,BP,RGN;ANG;IFI27
11663,GO:0044212,0.990584292642409,0.0543051064812778,1,771,transcription regulatory region DNA binding,MF,HNF1A
17126,GO:0072594,0.990607381270752,0.0542227975722746,1,641,establishment of protein localization to organelle,BP,NOL3
360,GO:0000975,0.990749837145691,0.0535213073135448,1,773,regulatory region DNA binding,MF,HNF1A
406,GO:0001067,0.99075037199219,0.0535186026216324,1,774,regulatory region nucleic acid binding,MF,HNF1A
5939,GO:0016462,0.991145537676719,0.0516302750807333,1,810,pyrophosphatase activity,MF,ABCG1
60,GO:0000122,0.991193226698164,0.0514129616003609,1,742,negative regulation of transcription from RNA polymerase II promoter,BP,IFI27
6135,GO:0016818,0.991375885562877,0.0505242525491661,1,812,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,ABCG1
13723,GO:0050877,0.991434248601818,0.025529957394055,4,1203,neurological system process,BP,RBP4;HEXB;S100B;SLC1A3
13661,GO:0050789,0.991446376276705,0.0137109054713993,58,10394,regulation of biological process,BP,CFB;EBP;PDK4;IFI30;SLC31A2;FADD;P2RY14;MRAP;APOC1;TRADD;TBC1D14;PNP;ABCG1;EBF1;PYCARD;G0S2;ACADVL;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;PXK;PLA2G16;FXYD1;RBP4;RNASEL;ANG;FAM110C;NMI;TSFM;SHPK;HEXB;FABP3;GRIA3;NOL3;DEPTOR;PCBD1;CASP4;IFI27;FAM46A;TMEM176A;IDH1;TFPI;STAR;GLA;RPH3AL;S100B;DHCR7;PTS;RBMS3;HNF1A;DOK1;SLC1A3;LINGO1;TMOD4
3322,GO:0006605,0.991485312157367,0.0500235990620675,1,662,protein targeting,BP,NOL3
6134,GO:0016817,0.991578130775192,0.0495478945294889,1,814,hydrolase activity, acting on acid anhydrides,MF,ABCG1
14225,GO:0051716,0.991956727769028,0.0135373921131703,33,6569,cellular response to stimulus,BP,EBP;PDK4;IFI30;FADD;P2RY14;TRADD;PYCARD;G0S2;ACADVL;MGST2;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;RNASEL;FAM110C;NMI;SHPK;CMBL;GRIA3;NOL3;DEPTOR;CASP4;IFI27;TFPI;STAR;RPH3AL;S100B;DOK1;LINGO1
18079,GO:0098590,0.992219385221227,0.046405080027304,1,932,plasma membrane region,CC,GRIA3
11697,GO:0044260,0.993337383346939,0.0110815947642806,40,7982,cellular macromolecule metabolic process,BP,PDK4;ALG5;DPM3;MSRA;MRPL14;MRPL16;FADD;TRADD;EXTL1;ABCG1;EBF1;PYCARD;LAGE3;KRT10;PSMB10;RGN;FADS1;GHR;FGF18;TICAM1;ARL6IP4;HSD17B10;ETFB;RNASEL;ANG;NMI;TSFM;IDUA;HEXB;NOL3;DEPTOR;PCBD1;IFI27;PUS1;PTMS;MDP1;TFPI;RBMS3;HNF1A;LYPLAL1
13665,GO:0050794,0.993461551833563,0.010666443529333,53,9810,regulation of cellular process,BP,EBP;PDK4;IFI30;FADD;P2RY14;MRAP;APOC1;TRADD;TBC1D14;PNP;ABCG1;EBF1;PYCARD;G0S2;ACADVL;PSMB10;RGN;FADS1;GHR;FGF18;ASAH2;TICAM1;PXK;PLA2G16;RBP4;RNASEL;ANG;FAM110C;NMI;TSFM;SHPK;HEXB;FABP3;GRIA3;NOL3;DEPTOR;PCBD1;CASP4;IFI27;TMEM176A;IDH1;TFPI;STAR;GLA;RPH3AL;S100B;DHCR7;RBMS3;HNF1A;DOK1;SLC1A3;LINGO1;TMOD4
2711,GO:0005654,0.993828152655487,0.0133819293821467,11,3159,nucleoplasm,CC,MSRA;MRI1;TBC1D14;LAGE3;PSMB10;ARL6IP4;CPT2;NMI;AOX1;PCBD1;DECR1
2317,GO:0004888,0.993921952846314,0.0188549225050354,4,1184,transmembrane signaling receptor activity,MF,EBP;P2RY14;GHR;GRIA3
3566,GO:0006974,0.994257314099038,0.036094794718624,1,751,cellular response to DNA damage stimulus,BP,PYCARD
18361,GO:0099600,0.995102942383811,0.0155623103746518,4,1234,transmembrane receptor activity,MF,EBP;P2RY14;GHR;GRIA3
11824,GO:0044463,0.995427614470027,0.0298138025070821,1,964,cell projection part,CC,ANG
4646,GO:0009790,0.995678687836741,0.0284352534847892,1,931,embryo development,BP,RBP4
11801,GO:0044431,0.995901612580344,0.0272003908369904,1,878,Golgi apparatus part,CC,ABCG1
4590,GO:0009593,0.996089779803898,0.0262085062114853,1,454,detection of chemical stimulus,BP,ABCG1
10437,GO:0038023,0.996245738246775,0.0122791226375091,4,1290,signaling receptor activity,MF,EBP;P2RY14;GHR;GRIA3
19262,GO:1902679,0.996606389640949,0.0156608313249227,2,1159,negative regulation of RNA biosynthetic process,BP,RGN;IFI27
19428,GO:1903047,0.996861733866327,0.0217100663936642,1,874,mitotic cell cycle process,BP,PSMB10
1612,GO:0003676,0.997260970566497,0.00590387125407849,14,3818,nucleic acid binding,MF,MRPL14;MRPL16;EBF1;ARL6IP4;HSD17B10;RNASEL;ANG;TSFM;NOL3;NUDT7;FAM46A;PUS1;RBMS3;HNF1A
13971,GO:0051253,0.997421476570576,0.0123188679371689,2,1206,negative regulation of RNA metabolic process,BP,RGN;IFI27
9059,GO:0033365,0.997730229228013,0.0164774266752154,1,884,protein localization to organelle,BP,NOL3
139,GO:0000278,0.997990897395652,0.0148411297116677,1,952,mitotic cell cycle,BP,PSMB10
11486,GO:0043565,0.998071119790834,0.0143314507162588,1,957,sequence-specific DNA binding,MF,HNF1A
2305,GO:0004872,0.99883869082703,0.00426938712694835,4,1537,receptor activity,MF,EBP;P2RY14;GHR;GRIA3
14714,GO:0060089,0.99883869082703,0.00426938712694835,4,1537,molecular transducer activity,MF,EBP;P2RY14;GHR;GRIA3
14172,GO:0051606,0.998844735453078,0.00922597740881088,1,625,detection of stimulus,BP,ABCG1
12433,GO:0045934,0.998913635767058,0.00574551633787132,2,1347,negative regulation of nucleobase-containing compound metabolic process,BP,RGN;IFI27
4894,GO:0010629,0.998936269454003,0.00453699707667568,3,1614,negative regulation of gene expression,BP,ANG;NOL3;IFI27
1625,GO:0003700,0.999375180620593,0.00538773827997734,1,1183,transcription factor activity, sequence-specific DNA binding,MF,HNF1A
409,GO:0001071,0.999380739008791,0.00534570141260159,1,1184,nucleic acid binding transcription factor activity,MF,HNF1A
12399,GO:0045892,0.99940768903912,0.0051421917496797,1,1103,negative regulation of transcription, DNA-templated,BP,IFI27
19632,GO:1903507,0.999578243142945,0.00381429823880771,1,1143,negative regulation of nucleic acid-templated transcription,BP,IFI27
3579,GO:0006996,0.999716299163608,0.000823826152416076,9,3492,organelle organization,BP,TBC1D14;PYCARD;PLA2G16;HSD17B10;ANG;HEXB;NOL3;PUS1;TMOD4
3617,GO:0007049,0.999746345761319,0.0015594463648745,2,1635,cell cycle,BP,PSMB10;PLA2G16
7093,GO:0022402,0.999758971172824,0.002323914266733,1,1261,cell cycle process,BP,PSMB10
2341,GO:0004930,0.99978038370285,0.00214329887351265,1,775,G-protein coupled receptor activity,MF,P2RY14
3691,GO:0007186,0.99987136883527,0.000843609973231477,2,1157,G-protein coupled receptor signaling pathway,BP,P2RY14;RPH3AL
1613,GO:0003677,0.99998088351602,0.000114181658407898,3,2382,DNA binding,MF,EBF1;ANG;HNF1A
17850,GO:0097286,0.999999999999989,0.94011781740032,0,12,iron ion import,BP,
16372,GO:0071281,0.999999999999999,0.927771136642354,0,10,cellular response to iron ion,BP,
15026,GO:0060536,1,0.92446963652447,0,12,cartilage morphogenesis,BP,
1,GO:0000002,1,0.873743138134631,0,25,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.990850439327305,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.984704323424068,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000012,1,0.950790762846101,0,8,single strand break repair,BP,
6,GO:0000014,1,0.967568658473269,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
7,GO:0000015,1,0.960203706306877,0,4,phosphopyruvate hydratase complex,CC,
8,GO:0000016,1,0.999999996374368,0,1,lactase activity,MF,
9,GO:0000018,1,0.68334586477371,0,63,regulation of DNA recombination,BP,
10,GO:0000019,1,0.969970829990375,0,5,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.943597977465233,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.996011057237555,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.983903288217352,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.802649708641183,0,22,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.835595409179963,0,15,ribosomal small subunit assembly,BP,
17,GO:0000032,1,0.988688643487989,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.97017429791747,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.981190382996303,0,2,acyl binding,MF,
20,GO:0000036,1,0.987192131992394,0,1,ACP phosphopantetheine attachment site binding involved in fatty acid biosynthetic process,MF,
23,GO:0000042,1,0.98016877048815,0,19,protein targeting to Golgi,BP,
25,GO:0000049,1,0.714429715158165,0,49,tRNA binding,MF,
26,GO:0000050,1,0.903467497098272,0,11,urea cycle,BP,
27,GO:0000052,1,0.959638344450347,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.988840631351649,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.900988018659642,0,12,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.9414872266346,0,7,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.94921013583852,0,6,ribosomal small subunit export from nucleus,BP,
32,GO:0000060,1,0.716899685194626,0,47,protein import into nucleus, translocation,BP,
33,GO:0000062,1,0.867923362217839,0,16,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.986035831611698,0,3,L-ornithine transmembrane transporter activity,MF,
35,GO:0000066,1,0.98603583798192,0,2,mitochondrial ornithine transport,BP,
36,GO:0000070,1,0.445033369722817,0,129,mitotic sister chromatid segregation,BP,
37,GO:0000075,1,0.237840514691458,0,214,cell cycle checkpoint,BP,
38,GO:0000076,1,0.867291826449958,0,17,DNA replication checkpoint,BP,
39,GO:0000077,1,0.386881933229559,0,145,DNA damage checkpoint,BP,
40,GO:0000079,1,0.540818091707239,0,81,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
41,GO:0000082,1,0.213115363930654,0,236,G1/S transition of mitotic cell cycle,BP,
42,GO:0000083,1,0.849934676264928,0,25,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
44,GO:0000095,1,0.990243205478651,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
47,GO:0000098,1,0.929775491996684,0,10,sulfur amino acid catabolic process,BP,
48,GO:0000099,1,0.967035042407942,0,7,sulfur amino acid transmembrane transporter activity,MF,
49,GO:0000101,1,0.967035052450037,0,6,sulfur amino acid transport,BP,
50,GO:0000103,1,0.976932822555493,0,3,sulfate assimilation,BP,
51,GO:0000104,1,0.959247947479429,0,4,succinate dehydrogenase activity,MF,
52,GO:0000105,1,0.986818111131163,0,2,histidine biosynthetic process,BP,
53,GO:0000109,1,0.895714054691019,0,15,nucleotide-excision repair complex,CC,
54,GO:0000110,1,0.983529202211212,0,3,nucleotide-excision repair factor 1 complex,CC,
55,GO:0000111,1,0.996635649694438,0,1,nucleotide-excision repair factor 2 complex,CC,
56,GO:0000117,1,0.999998328520815,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
57,GO:0000118,1,0.762052553625936,0,61,histone deacetylase complex,CC,
58,GO:0000120,1,0.96012075170329,0,5,RNA polymerase I transcription factor complex,CC,
59,GO:0000121,1,0.994393193361575,0,1,glycerol-1-phosphatase activity,MF,
61,GO:0000123,1,0.600603349352244,0,78,histone acetyltransferase complex,CC,
62,GO:0000124,1,0.911129511438516,0,11,SAGA complex,CC,
63,GO:0000125,1,0.96328920009363,0,5,PCAF complex,CC,
64,GO:0000126,1,0.996667481369714,0,2,transcription factor TFIIIB complex,CC,
65,GO:0000127,1,0.967630460004686,0,6,transcription factor TFIIIC complex,CC,
66,GO:0000132,1,0.908765723991134,0,16,establishment of mitotic spindle orientation,BP,
67,GO:0000137,1,0.967833396330207,0,6,Golgi cis cisterna,CC,
68,GO:0000138,1,0.965425166198881,0,5,Golgi trans cisterna,CC,
70,GO:0000145,1,0.915438083539093,0,18,exocyst,CC,
71,GO:0000146,1,0.996388198836048,0,22,microfilament motor activity,MF,
72,GO:0000149,1,0.5253144651009,0,114,SNARE binding,MF,
73,GO:0000150,1,0.930271460542377,0,8,recombinase activity,MF,
74,GO:0000151,1,0.178896238344618,0,286,ubiquitin ligase complex,CC,
75,GO:0000152,1,0.761325051248163,0,38,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.924487063333898,0,12,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.781837203703096,0,27,rRNA modification,BP,
78,GO:0000155,1,0.984362159674734,0,6,phosphorelay sensor kinase activity,MF,
79,GO:0000159,1,0.881797180430635,0,20,protein phosphatase type 2A complex,CC,
80,GO:0000160,1,0.981425953041403,0,7,phosphorelay signal transduction system,BP,
81,GO:0000164,1,0.949202929668551,0,10,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.987855476448624,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.99086812757605,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.99086812757605,0,2,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.988364101320566,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.839951506812769,0,28,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.89008459000974,0,11,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.924137929499374,0,10,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.836997841740254,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.960300712230106,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.960728698169497,0,10,rDNA binding,MF,
94,GO:0000183,1,0.659775987606539,0,39,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.299366101696017,0,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
96,GO:0000185,1,0.925734737547969,0,11,activation of MAPKKK activity,BP,
97,GO:0000186,1,0.821080257800352,0,49,activation of MAPKK activity,BP,
99,GO:0000188,1,0.818155155688563,0,26,inactivation of MAPK activity,BP,
100,GO:0000189,1,0.986042610310904,0,3,MAPK import into nucleus,BP,
102,GO:0000210,1,0.996070804472539,0,1,NAD+ diphosphatase activity,MF,
103,GO:0000212,1,0.936502108368166,0,11,meiotic spindle organization,BP,
104,GO:0000213,1,0.959359502864136,0,4,tRNA-intron endonuclease activity,MF,
105,GO:0000214,1,0.958746616520477,0,4,tRNA-intron endonuclease complex,CC,
106,GO:0000215,1,0.987371501774334,0,1,tRNA 2'-phosphotransferase activity,MF,
107,GO:0000217,1,0.872891967420484,0,23,DNA secondary structure binding,MF,
108,GO:0000220,1,0.959967811341498,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
109,GO:0000221,1,0.984410444132314,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
110,GO:0000224,1,0.991558429442779,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
111,GO:0000225,1,0.98750939001844,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
112,GO:0000226,1,0.107444125127168,0,418,microtubule cytoskeleton organization,BP,
113,GO:0000228,1,0.0285484558603207,0,508,nuclear chromosome,CC,
114,GO:0000229,1,0.975837866071306,0,2,cytoplasmic chromosome,CC,
115,GO:0000235,1,0.983924608888949,0,5,astral microtubule,CC,
116,GO:0000242,1,0.91882576093245,0,20,pericentriolar material,CC,
117,GO:0000243,1,0.923544656180882,0,8,commitment complex,CC,
118,GO:0000244,1,0.932919862170339,0,12,spliceosomal tri-snRNP complex assembly,BP,
120,GO:0000246,1,0.998857933040789,0,1,delta24(24-1) sterol reductase activity,MF,
123,GO:0000250,1,0.998785569571622,0,1,lanosterol synthase activity,MF,
124,GO:0000252,1,0.988245313455576,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
125,GO:0000253,1,0.963650507988278,0,3,3-keto sterol reductase activity,MF,
126,GO:0000254,1,0.991657600429728,0,1,C-4 methylsterol oxidase activity,MF,
128,GO:0000256,1,0.987936528897544,0,1,allantoin catabolic process,BP,
129,GO:0000257,1,0.987791238169804,0,1,nitrilase activity,MF,
130,GO:0000262,1,0.988233990064114,0,1,mitochondrial chromosome,CC,
131,GO:0000266,1,0.848430479720012,0,33,mitochondrial fission,BP,
132,GO:0000268,1,0.965171753931927,0,5,peroxisome targeting sequence binding,MF,
133,GO:0000270,1,0.917658940793934,0,7,peptidoglycan metabolic process,BP,
134,GO:0000271,1,0.692596417173447,0,67,polysaccharide biosynthetic process,BP,
135,GO:0000272,1,0.857079681131782,0,29,polysaccharide catabolic process,BP,
136,GO:0000274,1,0.987172763503919,0,1,mitochondrial proton-transporting ATP synthase, stator stalk,CC,
137,GO:0000275,1,0.951686961747186,0,4,mitochondrial proton-transporting ATP synthase complex, catalytic core F(1),CC,
138,GO:0000276,1,0.886677954352648,0,10,mitochondrial proton-transporting ATP synthase complex, coupling factor F(o),CC,
140,GO:0000280,1,0.0265741925748073,0,560,nuclear division,BP,
141,GO:0000281,1,0.842321753855862,0,36,mitotic cytokinesis,BP,
144,GO:0000288,1,0.618413781879464,0,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
145,GO:0000289,1,0.83427909257709,0,34,nuclear-transcribed mRNA poly(A) tail shortening,BP,
146,GO:0000290,1,0.944574078759515,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
147,GO:0000291,1,0.756438469280941,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
148,GO:0000293,1,0.984774251937019,0,3,ferric-chelate reductase activity,MF,
149,GO:0000294,1,0.992344496019035,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
150,GO:0000295,1,0.9169529516056,0,11,adenine nucleotide transmembrane transporter activity,MF,
151,GO:0000296,1,0.990492528986576,0,1,spermine transport,BP,
152,GO:0000298,1,0.968037406610311,0,4,endopolyphosphatase activity,MF,
153,GO:0000301,1,0.948750404840069,0,24,retrograde transport, vesicle recycling within Golgi,BP,
157,GO:0000306,1,0.989709988043454,0,3,extrinsic component of vacuolar membrane,CC,
158,GO:0000307,1,0.734536535355565,0,39,cyclin-dependent protein kinase holoenzyme complex,CC,
159,GO:0000308,1,0.997707846414694,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
160,GO:0000309,1,0.986245185383385,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
162,GO:0000314,1,0.729749128312265,0,26,organellar small ribosomal subunit,CC,
164,GO:0000320,1,0.997732765519509,0,3,re-entry into mitotic cell cycle,BP,
165,GO:0000322,1,0.977941134649334,0,3,storage vacuole,CC,
167,GO:0000333,1,0.998092388513033,0,2,telomerase catalytic core complex,CC,
168,GO:0000334,1,0.987677363437245,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
169,GO:0000338,1,0.904043907888501,0,10,protein deneddylation,BP,
170,GO:0000339,1,0.909945653983631,0,15,RNA cap binding,MF,
171,GO:0000340,1,0.967059206994826,0,7,RNA 7-methylguanosine cap binding,MF,
172,GO:0000346,1,0.90286502968806,0,13,transcription export complex,CC,
173,GO:0000347,1,0.946731174563944,0,6,THO complex,CC,
174,GO:0000349,1,0.990740820043039,0,1,generation of catalytic spliceosome for first transesterification step,BP,
175,GO:0000350,1,0.967402679680986,0,3,generation of catalytic spliceosome for second transesterification step,BP,
176,GO:0000354,1,0.995091370127095,0,2,cis assembly of pre-catalytic spliceosome,BP,
179,GO:0000379,1,0.969791656506936,0,3,tRNA-type intron splice site recognition and cleavage,BP,
180,GO:0000380,1,0.739453381218335,0,48,alternative mRNA splicing, via spliceosome,BP,
181,GO:0000381,1,0.79382005097377,0,37,regulation of alternative mRNA splicing, via spliceosome,BP,
182,GO:0000384,1,0.97688427117222,0,2,first spliceosomal transesterification activity,MF,
183,GO:0000386,1,0.984981762981274,0,2,second spliceosomal transesterification activity,MF,
184,GO:0000387,1,0.72248313156878,0,38,spliceosomal snRNP assembly,BP,
185,GO:0000389,1,0.960575799492792,0,6,mRNA 3'-splice site recognition,BP,
186,GO:0000390,1,0.980894650997491,0,2,spliceosomal complex disassembly,BP,
187,GO:0000393,1,0.9584429835956,0,4,spliceosomal conformational changes to generate catalytic conformation,BP,
188,GO:0000394,1,0.849259744965391,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
189,GO:0000395,1,0.952209340865412,0,6,mRNA 5'-splice site recognition,BP,
191,GO:0000400,1,0.899543877115035,0,16,four-way junction DNA binding,MF,
192,GO:0000403,1,0.991990917541387,0,4,Y-form DNA binding,MF,
193,GO:0000404,1,0.996635649694438,0,1,heteroduplex DNA loop binding,MF,
194,GO:0000405,1,0.978791141469603,0,7,bubble DNA binding,MF,
195,GO:0000407,1,0.882670477851411,0,27,pre-autophagosomal structure,CC,
196,GO:0000408,1,0.974480605885656,0,3,EKC/KEOPS complex,CC,
197,GO:0000409,1,0.999999996378124,0,1,regulation of transcription by galactose,BP,
198,GO:0000411,1,0.999999996378124,0,1,positive regulation of transcription by galactose,BP,
199,GO:0000413,1,0.689116051923709,0,38,protein peptidyl-prolyl isomerization,BP,
200,GO:0000414,1,0.990893228468872,0,4,regulation of histone H3-K36 methylation,BP,
201,GO:0000415,1,0.999999996374891,0,1,negative regulation of histone H3-K36 methylation,BP,
202,GO:0000416,1,0.997085915737165,0,1,positive regulation of histone H3-K36 methylation,BP,
203,GO:0000421,1,0.821756778427874,0,28,autophagosome membrane,CC,
204,GO:0000422,1,0.627092629647215,0,77,mitophagy,BP,
205,GO:0000423,1,0.917642439609088,0,17,macromitophagy,BP,
206,GO:0000428,1,0.412725164325662,0,125,DNA-directed RNA polymerase complex,CC,
207,GO:0000429,1,0.968342859770815,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
208,GO:0000430,1,0.968342869574816,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
209,GO:0000431,1,0.999999996378124,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
210,GO:0000432,1,0.968342869574816,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
211,GO:0000433,1,0.991008449000678,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
212,GO:0000435,1,0.999999996378124,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
213,GO:0000436,1,0.968342859770815,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
214,GO:0000437,1,0.991008449000678,0,1,carbon catabolite repression of transcription from RNA polymerase II promoter,BP,
215,GO:0000438,1,0.96625625874563,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
216,GO:0000439,1,0.935823105694864,0,8,core TFIIH complex,CC,
217,GO:0000444,1,0.969466993474251,0,4,MIS12/MIND type complex,CC,
218,GO:0000445,1,0.946731174563944,0,6,THO complex part of transcription export complex,CC,
219,GO:0000447,1,0.924286086877568,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
220,GO:0000448,1,0.990884400547803,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
221,GO:0000451,1,0.988765795927979,0,2,rRNA 2'-O-methylation,BP,
222,GO:0000453,1,0.988765795927979,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
223,GO:0000454,1,0.963780469754674,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
224,GO:0000459,1,0.957734155769704,0,5,exonucleolytic trimming involved in rRNA processing,BP,
225,GO:0000460,1,0.78893809969885,0,29,maturation of 5.8S rRNA,BP,
226,GO:0000461,1,0.974781586143117,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000462,1,0.728163818596555,0,36,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000463,1,0.915925338094652,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000466,1,0.860435606548265,0,18,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
230,GO:0000467,1,0.957734155769704,0,5,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
231,GO:0000469,1,0.83565214568331,0,23,cleavage involved in rRNA processing,BP,
232,GO:0000470,1,0.829783080526721,0,21,maturation of LSU-rRNA,BP,
233,GO:0000472,1,0.983803594165371,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000478,1,0.912796532394378,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
235,GO:0000479,1,0.912796532394378,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
236,GO:0000480,1,0.962233678537387,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
237,GO:0000481,1,0.996622882069888,0,1,maturation of 5S rRNA,BP,
238,GO:0000491,1,0.953826924598334,0,6,small nucleolar ribonucleoprotein complex assembly,BP,
239,GO:0000492,1,0.971524046591775,0,4,box C/D snoRNP assembly,BP,
240,GO:0000493,1,0.981788299493801,0,2,box H/ACA snoRNP assembly,BP,
241,GO:0000494,1,0.987526012197698,0,1,box C/D snoRNA 3'-end processing,BP,
242,GO:0000495,1,0.991741501148104,0,1,box H/ACA snoRNA 3'-end processing,BP,
244,GO:0000506,1,0.92184337573399,0,8,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
245,GO:0000578,1,0.79862861664666,0,35,embryonic axis specification,BP,
246,GO:0000700,1,0.963354345527647,0,4,mismatch base pair DNA N-glycosylase activity,MF,
247,GO:0000701,1,0.976776441701215,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
248,GO:0000702,1,0.965123061510874,0,3,oxidized base lesion DNA N-glycosylase activity,MF,
249,GO:0000703,1,0.975748056138913,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
250,GO:0000706,1,0.972626827196214,0,4,meiotic DNA double-strand break processing,BP,
251,GO:0000707,1,0.949306124242926,0,6,meiotic DNA recombinase assembly,BP,
252,GO:0000710,1,0.994202129954225,0,2,meiotic mismatch repair,BP,
253,GO:0000711,1,0.984115078590749,0,2,meiotic DNA repair synthesis,BP,
254,GO:0000712,1,0.93958851329323,0,12,resolution of meiotic recombination intermediates,BP,
255,GO:0000715,1,0.826063785628403,0,23,nucleotide-excision repair, DNA damage recognition,BP,
256,GO:0000717,1,0.849847795520484,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
257,GO:0000718,1,0.988559552384467,0,1,nucleotide-excision repair, DNA damage removal,BP,
258,GO:0000720,1,0.980588839950388,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
259,GO:0000722,1,0.775524986183976,0,36,telomere maintenance via recombination,BP,
260,GO:0000723,1,0.352458638426123,0,147,telomere maintenance,BP,
261,GO:0000724,1,0.539978519657351,0,97,double-strand break repair via homologous recombination,BP,
262,GO:0000725,1,0.53545181098323,0,98,recombinational repair,BP,
263,GO:0000726,1,0.573597148000816,0,74,non-recombinational repair,BP,
264,GO:0000727,1,0.960632815005465,0,5,double-strand break repair via break-induced replication,BP,
265,GO:0000729,1,0.882671209157429,0,23,DNA double-strand break processing,BP,
266,GO:0000730,1,0.916129410636124,0,10,DNA recombinase assembly,BP,
267,GO:0000731,1,0.678151870549587,0,68,DNA synthesis involved in DNA repair,BP,
268,GO:0000732,1,0.895491419906602,0,25,strand displacement,BP,
269,GO:0000733,1,0.957266123939225,0,9,DNA strand renaturation,BP,
270,GO:0000737,1,0.832772049496183,0,23,DNA catabolic process, endonucleolytic,BP,
271,GO:0000738,1,0.983323601425164,0,2,DNA catabolic process, exonucleolytic,BP,
272,GO:0000741,1,0.988613664589566,0,1,karyogamy,BP,
273,GO:0000768,1,0.736270213070424,0,47,syncytium formation by plasma membrane fusion,BP,
274,GO:0000773,1,0.987360893008489,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
275,GO:0000774,1,0.930567032567754,0,10,adenyl-nucleotide exchange factor activity,MF,
276,GO:0000775,1,0.340479313050515,0,176,chromosome, centromeric region,CC,
277,GO:0000776,1,0.449087196237286,0,121,kinetochore,CC,
278,GO:0000777,1,0.514042372640898,0,94,condensed chromosome kinetochore,CC,
279,GO:0000778,1,0.935101058044383,0,8,condensed nuclear chromosome kinetochore,CC,
280,GO:0000779,1,0.481458420730697,0,104,condensed chromosome, centromeric region,CC,
281,GO:0000780,1,0.896099519275242,0,14,condensed nuclear chromosome, centromeric region,CC,
282,GO:0000781,1,0.306695425977763,0,161,chromosome, telomeric region,CC,
283,GO:0000782,1,0.923791585556891,0,11,telomere cap complex,CC,
284,GO:0000783,1,0.923791585556891,0,11,nuclear telomere cap complex,CC,
285,GO:0000784,1,0.382843039373369,0,126,nuclear chromosome, telomeric region,CC,
286,GO:0000785,1,0.0378646501693349,0,459,chromatin,CC,
287,GO:0000786,1,0.302600476571862,0,101,nucleosome,CC,
288,GO:0000788,1,0.641058986225512,0,37,nuclear nucleosome,CC,
289,GO:0000789,1,0.987457453992027,0,1,cytoplasmic chromatin,CC,
290,GO:0000790,1,0.11147405554595,0,300,nuclear chromatin,CC,
291,GO:0000791,1,0.781718183038259,0,32,euchromatin,CC,
292,GO:0000792,1,0.665514103824573,0,71,heterochromatin,CC,
293,GO:0000793,1,0.274530782745004,0,192,condensed chromosome,CC,
294,GO:0000794,1,0.597636284495575,0,78,condensed nuclear chromosome,CC,
295,GO:0000795,1,0.794224701275855,0,32,synaptonemal complex,CC,
296,GO:0000796,1,0.99636489760048,0,7,condensin complex,CC,
297,GO:0000797,1,0.999696058372756,0,1,condensin core heterodimer,CC,
298,GO:0000798,1,0.9740391424928,0,5,nuclear cohesin complex,CC,
299,GO:0000799,1,0.998976170631577,0,3,nuclear condensin complex,CC,
300,GO:0000800,1,0.944317010573277,0,12,lateral element,CC,
301,GO:0000801,1,0.937610852944056,0,8,central element,CC,
302,GO:0000802,1,0.996187099332432,0,1,transverse filament,CC,
303,GO:0000803,1,0.839069556845895,0,26,sex chromosome,CC,
304,GO:0000805,1,0.950134441645989,0,7,X chromosome,CC,
305,GO:0000806,1,0.990205244911027,0,2,Y chromosome,CC,
306,GO:0000808,1,0.932130807115734,0,9,origin recognition complex,CC,
307,GO:0000811,1,0.980322672522422,0,3,GINS complex,CC,
308,GO:0000812,1,0.935083472510302,0,9,Swr1 complex,CC,
309,GO:0000813,1,0.918685118084599,0,10,ESCRT I complex,CC,
310,GO:0000814,1,0.974356142743982,0,3,ESCRT II complex,CC,
311,GO:0000815,1,0.899928404481691,0,11,ESCRT III complex,CC,
312,GO:0000819,1,0.269202755619372,0,206,sister chromatid segregation,BP,
313,GO:0000820,1,0.968065978991005,0,5,regulation of glutamine family amino acid metabolic process,BP,
314,GO:0000821,1,0.990407226426359,0,2,regulation of arginine metabolic process,BP,
315,GO:0000822,1,0.992815441897778,0,3,inositol hexakisphosphate binding,MF,
316,GO:0000823,1,0.988745589333162,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
317,GO:0000824,1,0.988745589333162,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
318,GO:0000825,1,0.988745589333162,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
319,GO:0000827,1,0.979263481030559,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
320,GO:0000828,1,0.979263481030559,0,5,inositol hexakisphosphate kinase activity,MF,
321,GO:0000829,1,0.979263481030559,0,5,inositol heptakisphosphate kinase activity,MF,
322,GO:0000831,1,0.992586385902378,0,1,inositol hexakisphosphate 6-kinase activity,MF,
323,GO:0000832,1,0.979263481030559,0,5,inositol hexakisphosphate 5-kinase activity,MF,
324,GO:0000835,1,0.974565518632352,0,6,ER ubiquitin ligase complex,CC,
325,GO:0000836,1,0.975084630123507,0,5,Hrd1p ubiquitin ligase complex,CC,
326,GO:0000839,1,0.982366060652824,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
327,GO:0000900,1,0.952091518914906,0,13,translation repressor activity, nucleic acid binding,MF,
330,GO:0000910,1,0.463571803157817,0,137,cytokinesis,BP,
331,GO:0000912,1,0.991354731435087,0,3,assembly of actomyosin apparatus involved in cytokinesis,BP,
332,GO:0000915,1,0.991354731435087,0,3,actomyosin contractile ring assembly,BP,
333,GO:0000917,1,0.988908214376503,0,1,barrier septum assembly,BP,
334,GO:0000920,1,0.863348813632928,0,17,cell separation after cytokinesis,BP,
335,GO:0000921,1,0.999651159210314,0,1,septin ring assembly,BP,
337,GO:0000923,1,0.975377205700545,0,6,equatorial microtubule organizing center,CC,
338,GO:0000930,1,0.913829467800344,0,19,gamma-tubulin complex,CC,
339,GO:0000931,1,0.966374216210094,0,7,gamma-tubulin large complex,CC,
341,GO:0000938,1,0.983365132925436,0,4,GARP complex,CC,
342,GO:0000939,1,0.979586975888494,0,2,condensed chromosome inner kinetochore,CC,
343,GO:0000940,1,0.935317117575526,0,12,condensed chromosome outer kinetochore,CC,
344,GO:0000942,1,0.966442309335958,0,4,condensed nuclear chromosome outer kinetochore,CC,
345,GO:0000956,1,0.178047540330721,0,198,nuclear-transcribed mRNA catabolic process,BP,
346,GO:0000957,1,0.982483120468473,0,4,mitochondrial RNA catabolic process,BP,
347,GO:0000958,1,0.990748959249134,0,2,mitochondrial mRNA catabolic process,BP,
349,GO:0000960,1,0.982483120468473,0,4,regulation of mitochondrial RNA catabolic process,BP,
350,GO:0000961,1,0.991657595157499,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000962,1,0.990748959249134,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
353,GO:0000964,1,0.991088444799683,0,2,mitochondrial RNA 5'-end processing,BP,
354,GO:0000965,1,0.981272313109056,0,3,mitochondrial RNA 3'-end processing,BP,
355,GO:0000966,1,0.972598102586216,0,6,RNA 5'-end processing,BP,
356,GO:0000967,1,0.983803594165371,0,3,rRNA 5'-end processing,BP,
357,GO:0000972,1,0.970881405367788,0,6,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
358,GO:0000973,1,0.982982403053752,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000974,1,0.906034753142624,0,11,Prp19 complex,CC,
363,GO:0000978,1,0.131544903400992,0,330,RNA polymerase II core promoter proximal region sequence-specific DNA binding,MF,
364,GO:0000979,1,0.71857730711806,0,59,RNA polymerase II core promoter sequence-specific DNA binding,MF,
365,GO:0000980,1,0.664848661184049,0,65,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
368,GO:0000983,1,0.907370053375217,0,22,transcription factor activity, RNA polymerase II core promoter sequence-specific,MF,
369,GO:0000987,1,0.125693404563244,0,342,core promoter proximal region sequence-specific DNA binding,MF,
372,GO:0000990,1,0.967488853194659,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.9879456857934,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.99110347790201,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.857861029919757,0,23,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.988699937621508,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.990171529304647,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0000997,1,0.997431787541536,0,1,mitochondrial RNA polymerase core promoter sequence-specific DNA binding,MF,
379,GO:0000999,1,0.991103483280367,0,1,RNA polymerase III type 1 promoter transcriptional preinitiation complex assembly,BP,
380,GO:0001002,1,0.99110347790201,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
381,GO:0001003,1,0.99110347790201,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
382,GO:0001004,1,0.991103483280367,0,1,transcription factor activity, RNA polymerase III promoter sequence-specific binding, TFIIIB recruiting,MF,
383,GO:0001005,1,0.991103483280367,0,1,transcription factor activity, RNA polymerase III type 1 promoter sequence-specific binding, TFIIIB recruiting,MF,
384,GO:0001007,1,0.977242218792373,0,5,transcription factor activity, RNA polymerase III transcription factor binding,MF,
385,GO:0001009,1,0.991103483280367,0,1,transcription from RNA polymerase III type 2 promoter,BP,
386,GO:0001010,1,0.974377806852467,0,3,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
387,GO:0001011,1,0.999999996386469,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
389,GO:0001013,1,0.961218574586379,0,8,RNA polymerase I regulatory region DNA binding,MF,
390,GO:0001016,1,0.957038248459248,0,7,RNA polymerase III regulatory region DNA binding,MF,
391,GO:0001018,1,0.997431787541536,0,1,mitochondrial RNA polymerase regulatory region DNA binding,MF,
392,GO:0001022,1,0.991103483280367,0,1,transcription initiation from RNA polymerase III type 1 promoter,BP,
393,GO:0001025,1,0.999967558200104,0,5,RNA polymerase III transcription factor binding,MF,
394,GO:0001026,1,0.996667481369714,0,2,TFIIIB-type transcription factor activity,MF,
395,GO:0001030,1,0.979903141116661,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
396,GO:0001031,1,0.979903141116661,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
397,GO:0001032,1,0.978132237489893,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
398,GO:0001034,1,0.979978513649944,0,2,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
399,GO:0001042,1,0.994495693865103,0,5,RNA polymerase I core binding,MF,
400,GO:0001044,1,0.997431787541536,0,1,mitochondrial RNA polymerase regulatory region sequence-specific DNA binding,MF,
401,GO:0001046,1,0.57498926329325,0,109,core promoter sequence-specific DNA binding,MF,
402,GO:0001047,1,0.42924816362,0,161,core promoter binding,MF,
403,GO:0001054,1,0.93242054891447,0,9,RNA polymerase I activity,MF,
404,GO:0001055,1,0.911466047868702,0,10,RNA polymerase II activity,MF,
405,GO:0001056,1,0.888818579830096,0,14,RNA polymerase III activity,MF,
407,GO:0001069,1,0.999945262556207,0,1,regulatory region RNA binding,MF,
408,GO:0001070,1,0.991607931825659,0,1,RNA binding transcription factor activity,MF,
410,GO:0001075,1,0.969801305969677,0,9,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
411,GO:0001076,1,0.45321051377398,0,146,transcription factor activity, RNA polymerase II transcription factor binding,MF,
413,GO:0001078,1,0.502046691610218,0,117,transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding,MF,
414,GO:0001079,1,0.989936963505739,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
415,GO:0001080,1,0.989936963505739,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
416,GO:0001082,1,0.99056219809714,0,1,transcription factor activity, RNA polymerase I transcription factor binding,MF,
417,GO:0001083,1,0.988628596653653,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
419,GO:0001087,1,0.999999996386469,0,1,transcription factor activity, TFIIB-class binding,MF,
420,GO:0001091,1,0.946940071877934,0,11,RNA polymerase II basal transcription factor binding,MF,
421,GO:0001093,1,0.988775946844124,0,3,TFIIB-class transcription factor binding,MF,
422,GO:0001094,1,0.960692568969493,0,7,TFIID-class transcription factor binding,MF,
423,GO:0001096,1,0.996878649427814,0,1,TFIIF-class transcription factor binding,MF,
424,GO:0001098,1,0.802183859870538,0,35,basal transcription machinery binding,MF,
425,GO:0001099,1,0.802183859870538,0,35,basal RNA polymerase II transcription machinery binding,MF,
426,GO:0001100,1,0.991657600429728,0,1,negative regulation of exit from mitosis,BP,
429,GO:0001103,1,0.842941397132267,0,28,RNA polymerase II repressing transcription factor binding,MF,
430,GO:0001104,1,0.588013756620488,0,93,RNA polymerase II transcription cofactor activity,MF,
431,GO:0001105,1,0.829677176569636,0,37,RNA polymerase II transcription coactivator activity,MF,
432,GO:0001106,1,0.852478067160102,0,27,RNA polymerase II transcription corepressor activity,MF,
433,GO:0001128,1,0.987762938457356,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
434,GO:0001129,1,0.988628602512047,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
435,GO:0001132,1,0.988628602512047,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
436,GO:0001133,1,0.989648109637414,0,1,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
437,GO:0001134,1,0.928254503350458,0,14,transcription factor activity, transcription factor recruiting,MF,
438,GO:0001135,1,0.971468243887297,0,8,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
439,GO:0001147,1,0.995939777108609,0,2,transcription termination site sequence-specific DNA binding,MF,
440,GO:0001153,1,0.991103483280367,0,1,transcription factor activity, RNA polymerase III transcription factor recruiting,MF,
441,GO:0001156,1,0.999999989166651,0,3,TFIIIC-class transcription factor binding,MF,
442,GO:0001158,1,0.597881532966712,0,83,enhancer sequence-specific DNA binding,MF,
443,GO:0001159,1,0.123458378600808,0,345,core promoter proximal region DNA binding,MF,
444,GO:0001160,1,0.995939777108609,0,2,transcription termination site DNA binding,MF,
445,GO:0001161,1,0.921047649656132,0,11,intronic transcription regulatory region sequence-specific DNA binding,MF,
446,GO:0001162,1,0.933570377111073,0,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
447,GO:0001163,1,0.961218574586379,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
448,GO:0001164,1,0.961218574586379,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
449,GO:0001165,1,0.999403026428242,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
450,GO:0001167,1,0.99056219809714,0,1,RNA polymerase I transcription factor activity, sequence-specific DNA binding,MF,
451,GO:0001169,1,0.99056219809714,0,1,transcription factor activity, RNA polymerase I CORE element sequence-specific binding,MF,
452,GO:0001172,1,0.998092388515741,0,2,transcription, RNA-templated,BP,
453,GO:0001179,1,0.988944846120766,0,1,RNA polymerase I transcription factor binding,MF,
454,GO:0001180,1,0.976871941083626,0,3,transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript,BP,
455,GO:0001181,1,0.997204835671453,0,1,transcription factor activity, core RNA polymerase I binding,MF,
456,GO:0001186,1,0.99056219809714,0,1,transcription factor activity, RNA polymerase I transcription factor recruiting,MF,
457,GO:0001187,1,0.99056219809714,0,1,transcription factor activity, RNA polymerase I CORE element binding transcription factor recruiting,MF,
458,GO:0001188,1,0.979610562670659,0,2,RNA polymerase I transcriptional preinitiation complex assembly,BP,
459,GO:0001189,1,0.979610562670659,0,2,RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript,BP,
460,GO:0001190,1,0.738625381176679,0,55,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,
461,GO:0001191,1,0.610144661908477,0,87,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
462,GO:0001205,1,0.846696963588142,0,26,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
463,GO:0001206,1,0.951331653271889,0,10,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
464,GO:0001207,1,0.994988777548835,0,1,histone displacement,BP,
465,GO:0001221,1,0.836906566300402,0,34,transcription cofactor binding,MF,
466,GO:0001222,1,0.925985007593519,0,10,transcription corepressor binding,MF,
467,GO:0001223,1,0.925617179240429,0,19,transcription coactivator binding,MF,
468,GO:0001224,1,0.994038549075555,0,3,RNA polymerase II transcription cofactor binding,MF,
469,GO:0001225,1,0.998884722267888,0,2,RNA polymerase II transcription coactivator binding,MF,
470,GO:0001226,1,0.995148460683886,0,1,RNA polymerase II transcription corepressor binding,MF,
471,GO:0001227,1,0.331723275532538,0,179,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding,MF,
473,GO:0001300,1,0.988974312152659,0,2,chronological cell aging,BP,
474,GO:0001302,1,0.968251277008846,0,6,replicative cell aging,BP,
475,GO:0001306,1,0.987384919683888,0,2,age-dependent response to oxidative stress,BP,
476,GO:0001315,1,0.987384925792003,0,1,age-dependent response to reactive oxygen species,BP,
477,GO:0001325,1,0.933440962166203,0,15,formation of extrachromosomal circular DNA,BP,
478,GO:0001401,1,0.988663406598848,0,1,mitochondrial sorting and assembly machinery complex,CC,
479,GO:0001405,1,0.978211625081754,0,3,presequence translocase-associated import motor,CC,
481,GO:0001502,1,0.863226596006051,0,21,cartilage condensation,BP,
485,GO:0001507,1,0.985620123294072,0,2,acetylcholine catabolic process in synaptic cleft,BP,
486,GO:0001508,1,0.551798439999656,0,131,action potential,BP,
488,GO:0001512,1,0.98749644272876,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
489,GO:0001514,1,0.941149899153102,0,9,selenocysteine incorporation,BP,
490,GO:0001515,1,0.956862881940122,0,4,opioid peptide activity,MF,
491,GO:0001516,1,0.823748117229772,0,23,prostaglandin biosynthetic process,BP,
492,GO:0001517,1,0.962304061151425,0,7,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
493,GO:0001518,1,0.986604909590208,0,14,voltage-gated sodium channel complex,CC,
494,GO:0001519,1,0.986128153621074,0,2,peptide amidation,BP,
495,GO:0001520,1,0.925088732523395,0,8,outer dense fiber,CC,
499,GO:0001527,1,0.951813109920779,0,10,microfibril,CC,
500,GO:0001530,1,0.848404102049802,0,21,lipopolysaccharide binding,MF,
501,GO:0001532,1,0.995038932589787,0,1,interleukin-21 receptor activity,MF,
503,GO:0001534,1,0.981658699625468,0,3,radial spoke,CC,
504,GO:0001536,1,0.988932098696548,0,2,radial spoke stalk,CC,
505,GO:0001537,1,0.959841210358847,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
506,GO:0001539,1,0.854650232160063,0,24,cilium or flagellum-dependent cell motility,BP,
507,GO:0001540,1,0.806050081572617,0,33,beta-amyloid binding,MF,
509,GO:0001542,1,0.968950525408573,0,8,ovulation from ovarian follicle,BP,
510,GO:0001543,1,0.999999996381959,0,1,ovarian follicle rupture,BP,
511,GO:0001544,1,0.999999996380602,0,1,initiation of primordial ovarian follicle growth,BP,
512,GO:0001545,1,0.986721478213753,0,2,primary ovarian follicle growth,BP,
513,GO:0001546,1,0.968772216289383,0,3,preantral ovarian follicle growth,BP,
514,GO:0001547,1,0.978037067402404,0,6,antral ovarian follicle growth,BP,
515,GO:0001550,1,0.999457075097585,0,2,ovarian cumulus expansion,BP,
516,GO:0001553,1,0.955394466672804,0,10,luteinization,BP,
517,GO:0001554,1,0.99293975272511,0,5,luteolysis,BP,
518,GO:0001555,1,0.982843731051778,0,2,oocyte growth,BP,
520,GO:0001558,1,0.0898008073359123,0,373,regulation of cell growth,BP,
521,GO:0001560,1,0.998234373265125,0,3,regulation of cell growth by extracellular stimulus,BP,
523,GO:0001562,1,0.836349404088457,0,21,response to protozoan,BP,
524,GO:0001567,1,0.976891815555729,0,2,cholesterol 25-hydroxylase activity,MF,
526,GO:0001569,1,0.84058941127718,0,30,branching involved in blood vessel morphogenesis,BP,
527,GO:0001570,1,0.698655048134213,0,71,vasculogenesis,BP,
529,GO:0001574,1,0.962071800706577,0,7,ganglioside biosynthetic process,BP,
530,GO:0001575,1,0.978905959480587,0,2,globoside metabolic process,BP,
531,GO:0001576,1,0.989713524578748,0,1,globoside biosynthetic process,BP,
532,GO:0001578,1,0.673969842799815,0,65,microtubule bundle formation,BP,
533,GO:0001579,1,0.989908997853542,0,2,medium-chain fatty acid transport,BP,
534,GO:0001580,1,0.676433088328207,0,33,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
535,GO:0001581,1,0.993980631566827,0,2,detection of chemical stimulus involved in sensory perception of sour taste,BP,
536,GO:0001582,1,0.983210307698125,0,2,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
537,GO:0001587,1,0.999614182739314,0,1,Gq/11-coupled serotonin receptor activity,MF,
538,GO:0001588,1,0.962246807553184,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
539,GO:0001591,1,0.908804566634423,0,8,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
540,GO:0001594,1,0.915761352992574,0,7,trace-amine receptor activity,MF,
541,GO:0001595,1,0.959513415570357,0,4,angiotensin receptor activity,MF,
542,GO:0001596,1,0.990640705572929,0,1,angiotensin type I receptor activity,MF,
543,GO:0001601,1,0.97824488451698,0,3,peptide YY receptor activity,MF,
544,GO:0001602,1,0.957187429706559,0,4,pancreatic polypeptide receptor activity,MF,
545,GO:0001604,1,0.987522648513861,0,1,urotensin II receptor activity,MF,
546,GO:0001605,1,0.99982915738731,0,1,adrenomedullin receptor activity,MF,
547,GO:0001607,1,0.984728193832948,0,2,neuromedin U receptor activity,MF,
549,GO:0001609,1,0.936884733476077,0,7,G-protein coupled adenosine receptor activity,MF,
551,GO:0001616,1,0.987352117519079,0,1,growth hormone secretagogue receptor activity,MF,
552,GO:0001618,1,0.709064499866484,0,64,virus receptor activity,MF,
553,GO:0001621,1,0.988005043063055,0,1,ADP receptor activity,MF,
554,GO:0001626,1,0.995091374718862,0,1,nociceptin receptor activity,MF,
555,GO:0001631,1,0.991585409969415,0,1,cysteinyl leukotriene receptor activity,MF,
556,GO:0001632,1,0.984228000837695,0,2,leukotriene B4 receptor activity,MF,
557,GO:0001635,1,0.992133533541527,0,2,calcitonin gene-related peptide receptor activity,MF,
558,GO:0001637,1,0.812347585185795,0,23,G-protein coupled chemoattractant receptor activity,MF,
559,GO:0001640,1,0.989478632853433,0,5,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
560,GO:0001641,1,0.990826851459857,0,2,group II metabotropic glutamate receptor activity,MF,
561,GO:0001642,1,0.998639412133424,0,1,group III metabotropic glutamate receptor activity,MF,
562,GO:0001649,1,0.302076630838034,0,201,osteoblast differentiation,BP,
564,GO:0001651,1,0.987526012197698,0,1,dense fibrillar component,CC,
565,GO:0001652,1,0.956928556095182,0,4,granular component,CC,
566,GO:0001653,1,0.34291995196072,0,124,peptide receptor activity,MF,
570,GO:0001657,1,0.57934919312783,0,97,ureteric bud development,BP,
571,GO:0001658,1,0.71108817834623,0,59,branching involved in ureteric bud morphogenesis,BP,
573,GO:0001660,1,0.942089226284878,0,10,fever generation,BP,
574,GO:0001661,1,0.977777422950666,0,6,conditioned taste aversion,BP,
575,GO:0001662,1,0.840982750165876,0,30,behavioral fear response,BP,
577,GO:0001665,1,0.941778844758233,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
581,GO:0001671,1,0.828426613039817,0,23,ATPase activator activity,MF,
582,GO:0001672,1,0.978588937077854,0,9,regulation of chromatin assembly or disassembly,BP,
583,GO:0001673,1,0.891560529953338,0,14,male germ cell nucleus,CC,
584,GO:0001674,1,0.980084025953186,0,3,female germ cell nucleus,CC,
585,GO:0001675,1,0.930261814238691,0,12,acrosome assembly,BP,
588,GO:0001680,1,0.990435569307827,0,1,tRNA 3'-terminal CCA addition,BP,
589,GO:0001681,1,0.992983615869936,0,1,sialate O-acetylesterase activity,MF,
590,GO:0001682,1,0.898795865472248,0,11,tRNA 5'-leader removal,BP,
591,GO:0001692,1,0.95573545420891,0,4,histamine metabolic process,BP,
592,GO:0001694,1,0.978391729418896,0,2,histamine biosynthetic process,BP,
593,GO:0001695,1,0.987299002490663,0,1,histamine catabolic process,BP,
594,GO:0001696,1,0.88308333735261,0,17,gastric acid secretion,BP,
595,GO:0001697,1,0.992875410444996,0,1,histamine-induced gastric acid secretion,BP,
596,GO:0001698,1,0.980125853568898,0,2,gastrin-induced gastric acid secretion,BP,
597,GO:0001701,1,0.177780751856651,0,307,in utero embryonic development,BP,
598,GO:0001702,1,0.871121237450564,0,28,gastrulation with mouth forming second,BP,
599,GO:0001704,1,0.53486604307742,0,118,formation of primary germ layer,BP,
600,GO:0001705,1,0.97593948579311,0,4,ectoderm formation,BP,
601,GO:0001706,1,0.737911350782803,0,54,endoderm formation,BP,
602,GO:0001707,1,0.671986872028322,0,68,mesoderm formation,BP,
603,GO:0001708,1,0.560150748213317,0,77,cell fate specification,BP,
604,GO:0001709,1,0.754041591270381,0,41,cell fate determination,BP,
605,GO:0001710,1,0.858732421276948,0,19,mesodermal cell fate commitment,BP,
606,GO:0001711,1,0.889550741867056,0,16,endodermal cell fate commitment,BP,
607,GO:0001712,1,0.985336752405424,0,3,ectodermal cell fate commitment,BP,
608,GO:0001714,1,0.916289363471386,0,9,endodermal cell fate specification,BP,
609,GO:0001715,1,0.997547154876351,0,1,ectodermal cell fate specification,BP,
610,GO:0001716,1,0.989592394852261,0,1,L-amino-acid oxidase activity,MF,
611,GO:0001725,1,0.801853306464666,0,49,stress fiber,CC,
613,GO:0001727,1,0.975349340977547,0,5,lipid kinase activity,MF,
614,GO:0001729,1,0.992624304267323,0,2,ceramide kinase activity,MF,
615,GO:0001730,1,0.984526344064458,0,3,2'-5'-oligoadenylate synthetase activity,MF,
616,GO:0001731,1,0.95532215807333,0,8,formation of translation preinitiation complex,BP,
617,GO:0001732,1,0.989217576149723,0,2,formation of cytoplasmic translation initiation complex,BP,
618,GO:0001733,1,0.963980159331197,0,4,galactosylceramide sulfotransferase activity,MF,
619,GO:0001735,1,0.991595051950065,0,2,prenylcysteine oxidase activity,MF,
622,GO:0001739,1,0.956137213949478,0,6,sex chromatin,CC,
623,GO:0001740,1,0.959535931121591,0,5,Barr body,CC,
624,GO:0001741,1,0.913619296703566,0,13,XY body,CC,
625,GO:0001743,1,0.9897696748413,0,3,optic placode formation,BP,
626,GO:0001750,1,0.620026956033394,0,78,photoreceptor outer segment,CC,
627,GO:0001754,1,0.814210365524693,0,41,eye photoreceptor cell differentiation,BP,
628,GO:0001755,1,0.801793443351092,0,35,neural crest cell migration,BP,
629,GO:0001756,1,0.666314352316061,0,66,somitogenesis,BP,
630,GO:0001757,1,0.963950788068267,0,5,somite specification,BP,
631,GO:0001758,1,0.937286653786412,0,7,retinal dehydrogenase activity,MF,
632,GO:0001759,1,0.860040887177523,0,19,organ induction,BP,
633,GO:0001760,1,0.987629738760797,0,1,aminocarboxymuconate-semialdehyde decarboxylase activity,MF,
634,GO:0001763,1,0.367275338885242,0,193,morphogenesis of a branching structure,BP,
635,GO:0001764,1,0.542701714418352,0,130,neuron migration,BP,
636,GO:0001765,1,0.917924718458372,0,10,membrane raft assembly,BP,
637,GO:0001766,1,0.927514881613663,0,9,membrane raft polarization,BP,
638,GO:0001767,1,0.949332803361501,0,9,establishment of lymphocyte polarity,BP,
639,GO:0001768,1,0.949332816781603,0,8,establishment of T cell polarity,BP,
640,GO:0001770,1,0.999999996379218,0,1,establishment of natural killer cell polarity,BP,
641,GO:0001771,1,0.920417667344705,0,13,immunological synapse formation,BP,
642,GO:0001772,1,0.808882314756118,0,33,immunological synapse,CC,
644,GO:0001774,1,0.887268267622507,0,18,microglial cell activation,BP,
647,GO:0001777,1,0.957617352875629,0,4,T cell homeostatic proliferation,BP,
648,GO:0001778,1,0.977157866710925,0,8,plasma membrane repair,BP,
649,GO:0001779,1,0.876879994435507,0,20,natural killer cell differentiation,BP,
650,GO:0001780,1,0.935116431554872,0,13,neutrophil homeostasis,BP,
651,GO:0001781,1,0.950452772959141,0,7,neutrophil apoptotic process,BP,
652,GO:0001782,1,0.847427905815694,0,28,B cell homeostasis,BP,
653,GO:0001783,1,0.853557156452078,0,23,B cell apoptotic process,BP,
654,GO:0001784,1,0.851669165003273,0,35,phosphotyrosine binding,MF,
655,GO:0001785,1,0.985155467972267,0,2,prostaglandin J receptor activity,MF,
656,GO:0001786,1,0.818262749264413,0,37,phosphatidylserine binding,MF,
657,GO:0001787,1,0.911922820800968,0,12,natural killer cell proliferation,BP,
658,GO:0001791,1,0.987766818790964,0,1,IgM binding,MF,
659,GO:0001792,1,0.998832999275075,0,1,polymeric immunoglobulin receptor activity,MF,
660,GO:0001794,1,0.987074970310905,0,2,type IIa hypersensitivity,BP,
661,GO:0001796,1,0.987074970310905,0,2,regulation of type IIa hypersensitivity,BP,
662,GO:0001798,1,0.987074970310905,0,2,positive regulation of type IIa hypersensitivity,BP,
663,GO:0001802,1,0.979230449642774,0,2,type III hypersensitivity,BP,
664,GO:0001803,1,0.979230449642774,0,2,regulation of type III hypersensitivity,BP,
665,GO:0001805,1,0.979230449642774,0,2,positive regulation of type III hypersensitivity,BP,
666,GO:0001806,1,0.971712588451753,0,4,type IV hypersensitivity,BP,
667,GO:0001807,1,0.97750580527622,0,3,regulation of type IV hypersensitivity,BP,
668,GO:0001808,1,0.989544333261598,0,2,negative regulation of type IV hypersensitivity,BP,
669,GO:0001809,1,0.987835279686974,0,1,positive regulation of type IV hypersensitivity,BP,
670,GO:0001810,1,0.967010229741479,0,3,regulation of type I hypersensitivity,BP,
671,GO:0001812,1,0.967010229741479,0,3,positive regulation of type I hypersensitivity,BP,
676,GO:0001820,1,0.9106625600185,0,11,serotonin secretion,BP,
677,GO:0001821,1,0.910275202261731,0,10,histamine secretion,BP,
679,GO:0001823,1,0.553402036220454,0,102,mesonephros development,BP,
680,GO:0001824,1,0.672726497734973,0,58,blastocyst development,BP,
681,GO:0001825,1,0.826853325628803,0,28,blastocyst formation,BP,
682,GO:0001826,1,0.96477196248356,0,8,inner cell mass cell differentiation,BP,
683,GO:0001827,1,0.98978260015471,0,3,inner cell mass cell fate commitment,BP,
684,GO:0001828,1,0.990342018284053,0,3,inner cell mass cellular morphogenesis,BP,
685,GO:0001829,1,0.90499624629422,0,14,trophectodermal cell differentiation,BP,
686,GO:0001831,1,0.989695271791831,0,2,trophectodermal cellular morphogenesis,BP,
687,GO:0001832,1,0.930127219190657,0,16,blastocyst growth,BP,
688,GO:0001833,1,0.954624408832417,0,10,inner cell mass cell proliferation,BP,
689,GO:0001834,1,0.999999996380236,0,1,trophectodermal cell proliferation,BP,
690,GO:0001835,1,0.99496246959351,0,1,blastocyst hatching,BP,
692,GO:0001837,1,0.487150696668169,0,123,epithelial to mesenchymal transition,BP,
693,GO:0001838,1,0.534348116510634,0,120,embryonic epithelial tube formation,BP,
694,GO:0001839,1,0.955953375220326,0,7,neural plate morphogenesis,BP,
695,GO:0001840,1,0.951922107883217,0,10,neural plate development,BP,
696,GO:0001841,1,0.614884980777688,0,100,neural tube formation,BP,
697,GO:0001842,1,0.96458291972906,0,6,neural fold formation,BP,
698,GO:0001843,1,0.671464814903945,0,85,neural tube closure,BP,
699,GO:0001844,1,0.788231545641943,0,31,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
700,GO:0001845,1,0.920201915026997,0,11,phagolysosome assembly,BP,
701,GO:0001846,1,0.922301830457354,0,12,opsonin binding,MF,
702,GO:0001847,1,0.970851185869942,0,4,opsonin receptor activity,MF,
704,GO:0001849,1,0.943844451882434,0,8,complement component C1q binding,MF,
705,GO:0001850,1,0.988845091828473,0,1,complement component C3a binding,MF,
706,GO:0001851,1,0.988845086018756,0,2,complement component C3b binding,MF,
707,GO:0001855,1,0.98821045789525,0,2,complement component C4b binding,MF,
708,GO:0001856,1,0.990690632200075,0,1,complement component C5a binding,MF,
709,GO:0001861,1,0.999999996391921,0,1,complement component C4b receptor activity,MF,
710,GO:0001865,1,0.967205375867893,0,8,NK T cell differentiation,BP,
711,GO:0001866,1,0.948911506961717,0,6,NK T cell proliferation,BP,
712,GO:0001867,1,0.920743875632684,0,10,complement activation, lectin pathway,BP,
713,GO:0001868,1,0.988583022983699,0,2,regulation of complement activation, lectin pathway,BP,
714,GO:0001869,1,0.988583022983699,0,2,negative regulation of complement activation, lectin pathway,BP,
715,GO:0001871,1,0.84909796503167,0,21,pattern binding,MF,
716,GO:0001872,1,0.98917953337347,0,1,(1->3)-beta-D-glucan binding,MF,
717,GO:0001875,1,0.973770144756053,0,5,lipopolysaccharide receptor activity,MF,
718,GO:0001878,1,0.943159893184748,0,6,response to yeast,BP,
719,GO:0001880,1,0.975260711721937,0,4,Mullerian duct regression,BP,
720,GO:0001881,1,0.831245428103453,0,32,receptor recycling,BP,
723,GO:0001884,1,0.991587748442403,0,2,pyrimidine nucleoside binding,MF,
724,GO:0001885,1,0.780378363419939,0,53,endothelial cell development,BP,
725,GO:0001886,1,0.958066701293817,0,10,endothelial cell morphogenesis,BP,
726,GO:0001887,1,0.974913858161988,0,4,selenium compound metabolic process,BP,
727,GO:0001888,1,0.993109051714912,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
730,GO:0001891,1,0.891401808546791,0,18,phagocytic cup,CC,
731,GO:0001892,1,0.583660339891482,0,88,embryonic placenta development,BP,
732,GO:0001893,1,0.825237453521768,0,31,maternal placenta development,BP,
734,GO:0001895,1,0.665418342027626,0,60,retina homeostasis,BP,
735,GO:0001897,1,0.98271366919633,0,2,cytolysis by symbiont of host cells,BP,
736,GO:0001905,1,0.996656277660069,0,3,activation of membrane attack complex,BP,
738,GO:0001907,1,0.970154196178863,0,4,killing by symbiont of host cells,BP,
741,GO:0001911,1,0.89906674682015,0,13,negative regulation of leukocyte mediated cytotoxicity,BP,
745,GO:0001915,1,0.972486041575228,0,5,negative regulation of T cell mediated cytotoxicity,BP,
747,GO:0001917,1,0.763990900898493,0,40,photoreceptor inner segment,CC,
748,GO:0001918,1,0.992729324129483,0,1,farnesylated protein binding,MF,
749,GO:0001919,1,0.886475691730664,0,22,regulation of receptor recycling,BP,
750,GO:0001920,1,0.974914860398347,0,4,negative regulation of receptor recycling,BP,
751,GO:0001921,1,0.940486929780726,0,13,positive regulation of receptor recycling,BP,
752,GO:0001922,1,0.997237767397686,0,3,B-1 B cell homeostasis,BP,
753,GO:0001923,1,0.985796972888843,0,3,B-1 B cell differentiation,BP,
754,GO:0001927,1,0.989457361611089,0,3,exocyst assembly,BP,
755,GO:0001928,1,0.990362895858321,0,1,regulation of exocyst assembly,BP,
756,GO:0001931,1,0.91628230353734,0,13,uropod,CC,
762,GO:0001937,1,0.839293520129862,0,31,negative regulation of endothelial cell proliferation,BP,
764,GO:0001939,1,0.953611345220281,0,8,female pronucleus,CC,
765,GO:0001940,1,0.972444774032404,0,5,male pronucleus,CC,
766,GO:0001941,1,0.858133173376735,0,30,postsynaptic membrane organization,BP,
769,GO:0001945,1,0.900036954355262,0,24,lymph vessel development,BP,
770,GO:0001946,1,0.929301786725085,0,16,lymphangiogenesis,BP,
771,GO:0001947,1,0.730657097554655,0,58,heart looping,BP,
772,GO:0001948,1,0.56532539520209,0,100,glycoprotein binding,MF,
773,GO:0001949,1,0.991068833933716,0,1,sebaceous gland cell differentiation,BP,
774,GO:0001951,1,0.983920590984654,0,4,intestinal D-glucose absorption,BP,
775,GO:0001952,1,0.645288952964113,0,94,regulation of cell-matrix adhesion,BP,
776,GO:0001953,1,0.901109929926562,0,28,negative regulation of cell-matrix adhesion,BP,
777,GO:0001954,1,0.783155911161571,0,45,positive regulation of cell-matrix adhesion,BP,
778,GO:0001955,1,0.962018982004458,0,8,blood vessel maturation,BP,
779,GO:0001956,1,0.954077435255299,0,11,positive regulation of neurotransmitter secretion,BP,
785,GO:0001963,1,0.766974642895748,0,30,synaptic transmission, dopaminergic,BP,
786,GO:0001964,1,0.881494438147279,0,25,startle response,BP,
787,GO:0001965,1,0.860175310257817,0,19,G-protein alpha-subunit binding,MF,
788,GO:0001966,1,0.987784876593026,0,1,thigmotaxis,BP,
789,GO:0001967,1,0.940588821422463,0,13,suckling behavior,BP,
790,GO:0001968,1,0.882427821962806,0,26,fibronectin binding,MF,
791,GO:0001969,1,0.996656277660069,0,3,regulation of activation of membrane attack complex,BP,
792,GO:0001970,1,0.996656281940146,0,2,positive regulation of activation of membrane attack complex,BP,
793,GO:0001971,1,0.999999996382611,0,1,negative regulation of activation of membrane attack complex,BP,
794,GO:0001972,1,0.88334654001761,0,17,retinoic acid binding,MF,
795,GO:0001973,1,0.906532741558931,0,12,adenosine receptor signaling pathway,BP,
797,GO:0001975,1,0.830881763361353,0,27,response to amphetamine,BP,
798,GO:0001976,1,0.904685216785418,0,13,neurological system process involved in regulation of systemic arterial blood pressure,BP,
799,GO:0001977,1,0.877917204804991,0,17,renal system process involved in regulation of blood volume,BP,
800,GO:0001978,1,0.977432495175652,0,2,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
801,GO:0001979,1,0.988487165786894,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
802,GO:0001980,1,0.987263598653103,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
803,GO:0001983,1,0.977432495175652,0,2,baroreceptor response to increased systemic arterial blood pressure,BP,
804,GO:0001984,1,0.987241531727259,0,1,artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure,BP,
805,GO:0001985,1,0.990065202737579,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
806,GO:0001990,1,0.751872547056735,0,38,regulation of systemic arterial blood pressure by hormone,BP,
807,GO:0001991,1,0.878531189247363,0,19,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
808,GO:0001992,1,0.965740326591983,0,5,regulation of systemic arterial blood pressure by vasopressin,BP,
809,GO:0001993,1,0.928978612363657,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
810,GO:0001994,1,0.963854779884311,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
811,GO:0001996,1,0.972102137185966,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
812,GO:0001997,1,0.983180029020636,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
813,GO:0001999,1,0.973564846480277,0,5,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
814,GO:0002001,1,0.973564846480277,0,5,renin secretion into blood stream,BP,
815,GO:0002002,1,0.908556803577309,0,13,regulation of angiotensin levels in blood,BP,
816,GO:0002003,1,0.908650220226736,0,12,angiotensin maturation,BP,
817,GO:0002005,1,0.991558694976171,0,3,angiotensin catabolic process in blood,BP,
818,GO:0002007,1,0.988487165786894,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
820,GO:0002011,1,0.80728404233944,0,49,morphogenesis of an epithelial sheet,BP,
821,GO:0002016,1,0.928052795566461,0,9,regulation of blood volume by renin-angiotensin,BP,
822,GO:0002017,1,0.982528421557195,0,2,regulation of blood volume by renal aldosterone,BP,
823,GO:0002018,1,0.964077791425134,0,4,renin-angiotensin regulation of aldosterone production,BP,
824,GO:0002019,1,0.974636660160045,0,3,regulation of renal output by angiotensin,BP,
826,GO:0002021,1,0.859389850481856,0,22,response to dietary excess,BP,
827,GO:0002023,1,0.97304589427961,0,3,reduction of food intake in response to dietary excess,BP,
828,GO:0002024,1,0.933898762535915,0,9,diet induced thermogenesis,BP,
829,GO:0002025,1,0.97481065368062,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
830,GO:0002026,1,0.8439541504762,0,27,regulation of the force of heart contraction,BP,
831,GO:0002027,1,0.606979195112327,0,88,regulation of heart rate,BP,
833,GO:0002029,1,0.878550100943338,0,14,desensitization of G-protein coupled receptor protein signaling pathway,BP,
834,GO:0002031,1,0.897275841641202,0,12,G-protein coupled receptor internalization,BP,
835,GO:0002032,1,0.978722690638693,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
836,GO:0002033,1,0.993234870960299,0,1,angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
837,GO:0002034,1,0.966443291840711,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
838,GO:0002035,1,0.976374047654548,0,4,brain renin-angiotensin system,BP,
839,GO:0002036,1,0.980318426927025,0,4,regulation of L-glutamate transport,BP,
840,GO:0002037,1,0.989842872439572,0,1,negative regulation of L-glutamate transport,BP,
841,GO:0002038,1,0.990391082169678,0,1,positive regulation of L-glutamate transport,BP,
842,GO:0002039,1,0.688901418722287,0,68,p53 binding,MF,
843,GO:0002040,1,0.755218488897559,0,67,sprouting angiogenesis,BP,
844,GO:0002041,1,0.990496611957633,0,1,intussusceptive angiogenesis,BP,
845,GO:0002042,1,0.854032305794879,0,33,cell migration involved in sprouting angiogenesis,BP,
846,GO:0002043,1,0.942240525259486,0,11,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
847,GO:0002046,1,0.964154875024181,0,3,opsin binding,MF,
848,GO:0002051,1,0.993569579320587,0,4,osteoblast fate commitment,BP,
849,GO:0002052,1,0.896706050379882,0,20,positive regulation of neuroblast proliferation,BP,
850,GO:0002053,1,0.887454658283281,0,27,positive regulation of mesenchymal cell proliferation,BP,
852,GO:0002055,1,0.987216861712719,0,1,adenine binding,MF,
853,GO:0002058,1,0.989854089448182,0,1,uracil binding,MF,
854,GO:0002059,1,0.989854089448182,0,1,thymine binding,MF,
856,GO:0002061,1,0.989854089448182,0,1,pyrimidine nucleobase binding,MF,
859,GO:0002064,1,0.365145006503302,0,190,epithelial cell development,BP,
860,GO:0002065,1,0.534655522072939,0,101,columnar/cuboidal epithelial cell differentiation,BP,
861,GO:0002066,1,0.738843686966147,0,52,columnar/cuboidal epithelial cell development,BP,
862,GO:0002067,1,0.751948550087848,0,45,glandular epithelial cell differentiation,BP,
863,GO:0002068,1,0.876831348608301,0,23,glandular epithelial cell development,BP,
864,GO:0002069,1,0.947159397269981,0,6,columnar/cuboidal epithelial cell maturation,BP,
865,GO:0002070,1,0.900949015949709,0,13,epithelial cell maturation,BP,
866,GO:0002071,1,0.981902558453956,0,2,glandular epithelial cell maturation,BP,
867,GO:0002072,1,0.983541376759566,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
868,GO:0002074,1,0.983507170835621,0,5,extraocular skeletal muscle development,BP,
869,GO:0002076,1,0.905725068140615,0,18,osteoblast development,BP,
870,GO:0002077,1,0.987799248972821,0,1,acrosome matrix dispersal,BP,
871,GO:0002079,1,0.97396813719915,0,4,inner acrosomal membrane,CC,
872,GO:0002080,1,0.806633086937432,0,25,acrosomal membrane,CC,
873,GO:0002081,1,0.967699936520917,0,4,outer acrosomal membrane,CC,
874,GO:0002082,1,0.886895523456462,0,15,regulation of oxidative phosphorylation,BP,
875,GO:0002083,1,0.988341134162893,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
877,GO:0002085,1,0.973127329838874,0,4,inhibition of neuroepithelial cell differentiation,BP,
878,GO:0002086,1,0.983825634937782,0,2,diaphragm contraction,BP,
879,GO:0002087,1,0.940920660786414,0,13,regulation of respiratory gaseous exchange by neurological system process,BP,
880,GO:0002088,1,0.704161163596339,0,63,lens development in camera-type eye,BP,
881,GO:0002089,1,0.918869223003005,0,18,lens morphogenesis in camera-type eye,BP,
882,GO:0002090,1,0.839489377877764,0,34,regulation of receptor internalization,BP,
883,GO:0002091,1,0.973059059147054,0,7,negative regulation of receptor internalization,BP,
884,GO:0002092,1,0.904437945686242,0,22,positive regulation of receptor internalization,BP,
885,GO:0002093,1,0.927983306958562,0,13,auditory receptor cell morphogenesis,BP,
886,GO:0002094,1,0.983590288877916,0,2,polyprenyltransferase activity,MF,
887,GO:0002097,1,0.911855506811853,0,13,tRNA wobble base modification,BP,
888,GO:0002098,1,0.932610989524931,0,9,tRNA wobble uridine modification,BP,
889,GO:0002100,1,0.999999996374159,0,1,tRNA wobble adenosine to inosine editing,BP,
890,GO:0002101,1,0.977756957804464,0,3,tRNA wobble cytosine modification,BP,
891,GO:0002102,1,0.868563224939794,0,30,podosome,CC,
892,GO:0002113,1,0.990476216263044,0,1,interleukin-33 binding,MF,
893,GO:0002114,1,0.987907964333115,0,2,interleukin-33 receptor activity,MF,
894,GO:0002115,1,0.956780666747396,0,10,store-operated calcium entry,BP,
895,GO:0002116,1,0.98703046437517,0,7,semaphorin receptor complex,CC,
896,GO:0002118,1,0.931792274568007,0,9,aggressive behavior,BP,
897,GO:0002121,1,0.990380887668576,0,2,inter-male aggressive behavior,BP,
898,GO:0002125,1,0.962230623696869,0,4,maternal aggressive behavior,BP,
899,GO:0002127,1,0.987913031917531,0,1,wobble base cytosine methylation,BP,
900,GO:0002133,1,0.999865012663486,0,2,polycystin complex,CC,
901,GO:0002134,1,0.991587748442403,0,2,UTP binding,MF,
902,GO:0002135,1,0.99158991158068,0,1,CTP binding,MF,
903,GO:0002138,1,0.936101341631608,0,8,retinoic acid biosynthetic process,BP,
904,GO:0002139,1,0.989487946288565,0,3,stereocilia coupling link,CC,
905,GO:0002140,1,0.99999999638094,0,1,stereocilia tip link,CC,
906,GO:0002141,1,0.989487951983213,0,2,stereocilia ankle link,CC,
907,GO:0002142,1,0.999999996408586,0,1,stereocilia ankle link complex,CC,
908,GO:0002143,1,0.969285009801396,0,3,tRNA wobble position uridine thiolation,BP,
909,GO:0002148,1,0.994823369225241,0,1,hypochlorous acid metabolic process,BP,
910,GO:0002149,1,0.994823369225241,0,1,hypochlorous acid biosynthetic process,BP,
911,GO:0002151,1,0.969191252815941,0,7,G-quadruplex RNA binding,MF,
912,GO:0002152,1,0.995782227266356,0,1,bile acid conjugation,BP,
913,GO:0002153,1,0.991040758031062,0,1,steroid receptor RNA activator RNA binding,MF,
914,GO:0002154,1,0.968563889078035,0,5,thyroid hormone mediated signaling pathway,BP,
915,GO:0002155,1,0.968563898833227,0,4,regulation of thyroid hormone mediated signaling pathway,BP,
916,GO:0002158,1,0.939092520560774,0,8,osteoclast proliferation,BP,
917,GO:0002159,1,0.987464885759876,0,4,desmosome assembly,BP,
918,GO:0002161,1,0.945812876837984,0,11,aminoacyl-tRNA editing activity,MF,
919,GO:0002162,1,0.974712858842817,0,9,dystroglycan binding,MF,
920,GO:0002169,1,0.98853215831179,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
921,GO:0002174,1,0.993433878982438,0,1,mammary stem cell proliferation,BP,
922,GO:0002175,1,0.992470397227758,0,4,protein localization to paranode region of axon,BP,
923,GO:0002176,1,0.938250797111336,0,6,male germ cell proliferation,BP,
924,GO:0002177,1,0.943037911901783,0,6,manchette,CC,
925,GO:0002178,1,0.916198387911147,0,11,palmitoyltransferase complex,CC,
926,GO:0002181,1,0.69161032788683,0,47,cytoplasmic translation,BP,
927,GO:0002182,1,0.99999634217974,0,2,cytoplasmic translational elongation,BP,
928,GO:0002183,1,0.849334448219794,0,22,cytoplasmic translational initiation,BP,
929,GO:0002184,1,0.99296916375608,0,2,cytoplasmic translational termination,BP,
930,GO:0002188,1,0.994014526525753,0,3,translation reinitiation,BP,
931,GO:0002189,1,0.970864443169133,0,3,ribose phosphate diphosphokinase complex,CC,
932,GO:0002190,1,0.887477963651964,0,15,cap-independent translational initiation,BP,
933,GO:0002191,1,0.978415438134604,0,3,cap-dependent translational initiation,BP,
934,GO:0002192,1,0.913497624311294,0,12,IRES-dependent translational initiation,BP,
935,GO:0002193,1,0.990776275945143,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
936,GO:0002194,1,0.994081846487967,0,1,hepatocyte cell migration,BP,
937,GO:0002196,1,0.989061908074489,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
938,GO:0002199,1,0.919192629487814,0,9,zona pellucida receptor complex,CC,
939,GO:0002200,1,0.703514557083327,0,58,somatic diversification of immune receptors,BP,
940,GO:0002204,1,0.767684100171198,0,40,somatic recombination of immunoglobulin genes involved in immune response,BP,
941,GO:0002208,1,0.767684100171198,0,40,somatic diversification of immunoglobulins involved in immune response,BP,
942,GO:0002209,1,0.840982750165876,0,30,behavioral defense response,BP,
943,GO:0002215,1,0.975937378930223,0,3,defense response to nematode,BP,
949,GO:0002225,1,0.940450693770981,0,5,positive regulation of antimicrobial peptide production,BP,
950,GO:0002227,1,0.78067229440507,0,21,innate immune response in mucosa,BP,
951,GO:0002228,1,0.625647880956015,0,57,natural killer cell mediated immunity,BP,
952,GO:0002230,1,0.866069215701115,0,19,positive regulation of defense response to virus by host,BP,
953,GO:0002232,1,0.96816766397929,0,3,leukocyte chemotaxis involved in inflammatory response,BP,
954,GO:0002236,1,0.990599302187582,0,1,detection of misfolded protein,BP,
956,GO:0002238,1,0.982931944710535,0,3,response to molecule of fungal origin,BP,
957,GO:0002244,1,0.587268225420486,0,95,hematopoietic progenitor cell differentiation,BP,
958,GO:0002246,1,0.955693453739424,0,6,wound healing involved in inflammatory response,BP,
959,GO:0002248,1,0.96717143186615,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
960,GO:0002249,1,0.958935827548604,0,6,lymphocyte anergy,BP,
962,GO:0002251,1,0.715199554599087,0,32,organ or tissue specific immune response,BP,
965,GO:0002254,1,0.970300488179828,0,3,kinin cascade,BP,
967,GO:0002262,1,0.451335360110651,0,124,myeloid cell homeostasis,BP,
969,GO:0002264,1,0.98884806907306,0,1,endothelial cell activation involved in immune response,BP,
970,GO:0002266,1,0.983095506256508,0,2,follicular dendritic cell activation,BP,
971,GO:0002268,1,0.983095506256508,0,2,follicular dendritic cell differentiation,BP,
974,GO:0002276,1,0.989792648350572,0,1,basophil activation involved in immune response,BP,
976,GO:0002278,1,0.942785834476994,0,6,eosinophil activation involved in immune response,BP,
977,GO:0002279,1,0.724544348557597,0,45,mast cell activation involved in immune response,BP,
979,GO:0002282,1,0.986034787390673,0,2,microglial cell activation involved in immune response,BP,
981,GO:0002285,1,0.31759839915701,0,155,lymphocyte activation involved in immune response,BP,
982,GO:0002286,1,0.47777332984131,0,92,T cell activation involved in immune response,BP,
983,GO:0002287,1,0.686744899854064,0,53,alpha-beta T cell activation involved in immune response,BP,
984,GO:0002290,1,0.993084902554068,0,1,gamma-delta T cell activation involved in immune response,BP,
985,GO:0002291,1,0.936416747183566,0,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
986,GO:0002292,1,0.654896673242317,0,59,T cell differentiation involved in immune response,BP,
987,GO:0002293,1,0.686744899854064,0,53,alpha-beta T cell differentiation involved in immune response,BP,
988,GO:0002294,1,0.69197209329776,0,52,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
989,GO:0002295,1,0.884965639106427,0,15,T-helper cell lineage commitment,BP,
990,GO:0002296,1,0.985366120129953,0,2,T-helper 1 cell lineage commitment,BP,
991,GO:0002298,1,0.97613394331001,0,2,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
992,GO:0002299,1,0.988160116733915,0,1,alpha-beta intraepithelial T cell differentiation,BP,
993,GO:0002300,1,0.988160116733915,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
994,GO:0002302,1,0.980134750276293,0,2,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
995,GO:0002304,1,0.979652205882275,0,2,gamma-delta intraepithelial T cell differentiation,BP,
996,GO:0002305,1,0.979652205882275,0,2,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
997,GO:0002309,1,0.958209041173233,0,5,T cell proliferation involved in immune response,BP,
998,GO:0002312,1,0.65914166373652,0,63,B cell activation involved in immune response,BP,
999,GO:0002313,1,0.886946934178796,0,17,mature B cell differentiation involved in immune response,BP,
1000,GO:0002314,1,0.976120747686552,0,3,germinal center B cell differentiation,BP,
1001,GO:0002315,1,0.960539779206617,0,9,marginal zone B cell differentiation,BP,
1002,GO:0002316,1,0.998807705642567,0,1,follicular B cell differentiation,BP,
1003,GO:0002317,1,0.955105177313347,0,4,plasma cell differentiation,BP,
1004,GO:0002318,1,0.973324345773563,0,7,myeloid progenitor cell differentiation,BP,
1005,GO:0002320,1,0.904368913209544,0,19,lymphoid progenitor cell differentiation,BP,
1006,GO:0002322,1,0.980889637148178,0,5,B cell proliferation involved in immune response,BP,
1007,GO:0002323,1,0.721119126119409,0,30,natural killer cell activation involved in immune response,BP,
1008,GO:0002325,1,0.953074196401118,0,4,natural killer cell differentiation involved in immune response,BP,
1009,GO:0002326,1,0.98739228925254,0,4,B cell lineage commitment,BP,
1010,GO:0002327,1,0.989908958805089,0,8,immature B cell differentiation,BP,
1011,GO:0002328,1,0.964071679222936,0,10,pro-B cell differentiation,BP,
1012,GO:0002329,1,0.989990054070261,0,5,pre-B cell differentiation,BP,
1013,GO:0002331,1,0.990991244804903,0,3,pre-B cell allelic exclusion,BP,
1014,GO:0002332,1,0.999998284657946,0,1,transitional stage B cell differentiation,BP,
1015,GO:0002333,1,0.999998284657946,0,1,transitional one stage B cell differentiation,BP,
1016,GO:0002335,1,0.873695817007019,0,21,mature B cell differentiation,BP,
1017,GO:0002337,1,0.985953230261369,0,2,B-1a B cell differentiation,BP,
1018,GO:0002339,1,0.969612812680814,0,3,B cell selection,BP,
1019,GO:0002343,1,0.991954340101245,0,1,peripheral B cell selection,BP,
1020,GO:0002344,1,0.991954340101245,0,1,B cell affinity maturation,BP,
1021,GO:0002347,1,0.871310368036052,0,16,response to tumor cell,BP,
1022,GO:0002349,1,0.947973532079667,0,6,histamine production involved in inflammatory response,BP,
1023,GO:0002351,1,0.980211682459646,0,3,serotonin production involved in inflammatory response,BP,
1024,GO:0002352,1,0.977478687540696,0,2,B cell negative selection,BP,
1025,GO:0002353,1,0.970300488179828,0,3,plasma kallikrein-kinin cascade,BP,
1026,GO:0002355,1,0.991060187839802,0,1,detection of tumor cell,BP,
1027,GO:0002357,1,0.983197071140996,0,2,defense response to tumor cell,BP,
1028,GO:0002358,1,0.978352845780734,0,2,B cell homeostatic proliferation,BP,
1029,GO:0002360,1,0.835579000681112,0,24,T cell lineage commitment,BP,
1030,GO:0002361,1,0.950592042431862,0,5,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1031,GO:0002362,1,0.990678125913674,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1032,GO:0002363,1,0.874553841547933,0,17,alpha-beta T cell lineage commitment,BP,
1034,GO:0002367,1,0.563460188405628,0,78,cytokine production involved in immune response,BP,
1035,GO:0002368,1,0.982628682774003,0,2,B cell cytokine production,BP,
1036,GO:0002369,1,0.798935631923008,0,29,T cell cytokine production,BP,
1037,GO:0002370,1,0.991225111212861,0,2,natural killer cell cytokine production,BP,
1038,GO:0002371,1,0.980506678989178,0,6,dendritic cell cytokine production,BP,
1039,GO:0002373,1,0.987321041848265,0,1,plasmacytoid dendritic cell cytokine production,BP,
1040,GO:0002374,1,0.881891044336347,0,17,cytokine secretion involved in immune response,BP,
1043,GO:0002378,1,0.990734898538917,0,3,immunoglobulin biosynthetic process,BP,
1044,GO:0002380,1,0.99926670930736,0,1,immunoglobulin secretion involved in immune response,BP,
1045,GO:0002381,1,0.72761258717373,0,46,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
1046,GO:0002384,1,0.986029251695149,0,2,hepatic immune response,BP,
1047,GO:0002385,1,0.725359011098743,0,30,mucosal immune response,BP,
1048,GO:0002386,1,0.987987656129201,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1049,GO:0002396,1,0.94093083917901,0,5,MHC protein complex assembly,BP,
1050,GO:0002397,1,0.989114637101255,0,1,MHC class I protein complex assembly,BP,
1051,GO:0002399,1,0.951290047913247,0,4,MHC class II protein complex assembly,BP,
1052,GO:0002407,1,0.820504123407932,0,25,dendritic cell chemotaxis,BP,
1053,GO:0002408,1,0.964895256444932,0,4,myeloid dendritic cell chemotaxis,BP,
1054,GO:0002414,1,0.964827961323347,0,4,immunoglobulin transcytosis in epithelial cells,BP,
1055,GO:0002415,1,0.987987656129201,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1056,GO:0002416,1,0.988656439486428,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1057,GO:0002418,1,0.895884129502445,0,13,immune response to tumor cell,BP,
1058,GO:0002420,1,0.937466315296097,0,8,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1059,GO:0002423,1,0.937466315296097,0,8,natural killer cell mediated immune response to tumor cell,BP,
1060,GO:0002424,1,0.986414041096752,0,2,T cell mediated immune response to tumor cell,BP,
1061,GO:0002426,1,0.977915752725888,0,2,immunoglobulin production in mucosal tissue,BP,
1062,GO:0002428,1,0.974139726452266,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1064,GO:0002430,1,0.911583983890852,0,11,complement receptor mediated signaling pathway,BP,
1065,GO:0002431,1,0.64961935005571,0,77,Fc receptor mediated stimulatory signaling pathway,BP,
1066,GO:0002432,1,0.999118688203619,0,1,granuloma formation,BP,
1067,GO:0002433,1,0.677666392038834,0,71,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1068,GO:0002434,1,0.978716713543473,0,2,immune complex clearance,BP,
1069,GO:0002436,1,0.978716713543473,0,2,immune complex clearance by monocytes and macrophages,BP,
1070,GO:0002437,1,0.709569704081158,0,41,inflammatory response to antigenic stimulus,BP,
1071,GO:0002438,1,0.844118740455555,0,20,acute inflammatory response to antigenic stimulus,BP,
1072,GO:0002439,1,0.955845295304131,0,4,chronic inflammatory response to antigenic stimulus,BP,
1074,GO:0002441,1,0.947973532079667,0,6,histamine secretion involved in inflammatory response,BP,
1075,GO:0002442,1,0.980211682459646,0,3,serotonin secretion involved in inflammatory response,BP,
1078,GO:0002445,1,0.987074970310905,0,2,type II hypersensitivity,BP,
1080,GO:0002447,1,0.942785834476994,0,6,eosinophil mediated immunity,BP,
1081,GO:0002448,1,0.715342258533167,0,47,mast cell mediated immunity,BP,
1083,GO:0002455,1,0.709510843094882,0,42,humoral immune response mediated by circulating immunoglobulin,BP,
1085,GO:0002457,1,0.967189307244706,0,5,T cell antigen processing and presentation,BP,
1086,GO:0002458,1,0.980579880221101,0,2,peripheral T cell tolerance induction,BP,
1088,GO:0002461,1,0.971384661097594,0,3,tolerance induction dependent upon immune response,BP,
1089,GO:0002465,1,0.980579880221101,0,2,peripheral tolerance induction,BP,
1090,GO:0002467,1,0.913853670958655,0,15,germinal center formation,BP,
1091,GO:0002468,1,0.94935861482509,0,8,dendritic cell antigen processing and presentation,BP,
1093,GO:0002475,1,0.929714215165284,0,10,antigen processing and presentation via MHC class Ib,BP,
1094,GO:0002476,1,0.98661705689783,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1095,GO:0002477,1,0.987354763056656,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1098,GO:0002480,1,0.918114625712232,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1099,GO:0002481,1,0.987354763056656,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1100,GO:0002483,1,0.953660182829404,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1101,GO:0002488,1,0.998161212044196,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1102,GO:0002489,1,0.998161212044196,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1104,GO:0002501,1,0.952851425511284,0,4,peptide antigen assembly with MHC protein complex,BP,
1105,GO:0002502,1,0.989114637101255,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1106,GO:0002503,1,0.963340823419508,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1108,GO:0002505,1,0.975273646830553,0,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,
1109,GO:0002506,1,0.975273646830553,0,2,polysaccharide assembly with MHC class II protein complex,BP,
1110,GO:0002507,1,0.841673905178734,0,24,tolerance induction,BP,
1111,GO:0002508,1,0.981893415795755,0,2,central tolerance induction,BP,
1112,GO:0002509,1,0.989807486330914,0,1,central tolerance induction to self antigen,BP,
1113,GO:0002510,1,0.992005081113284,0,1,central B cell tolerance induction,BP,
1114,GO:0002513,1,0.964667661315557,0,5,tolerance induction to self antigen,BP,
1115,GO:0002514,1,0.991521382401601,0,2,B cell tolerance induction,BP,
1116,GO:0002517,1,0.908223881159197,0,13,T cell tolerance induction,BP,
1117,GO:0002518,1,0.987564328280312,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1118,GO:0002519,1,0.979149025058958,0,2,natural killer cell tolerance induction,BP,
1121,GO:0002522,1,0.981064355564573,0,2,leukocyte migration involved in immune response,BP,
1122,GO:0002523,1,0.883472148371855,0,14,leukocyte migration involved in inflammatory response,BP,
1123,GO:0002524,1,0.930167066202813,0,9,hypersensitivity,BP,
1124,GO:0002525,1,0.972779761341603,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1126,GO:0002528,1,0.993640720700159,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1127,GO:0002532,1,0.719605034324145,0,46,production of molecular mediator involved in inflammatory response,BP,
1128,GO:0002534,1,0.840625741384017,0,27,cytokine production involved in inflammatory response,BP,
1129,GO:0002536,1,0.954371342512747,0,4,respiratory burst involved in inflammatory response,BP,
1130,GO:0002537,1,0.999998546233518,0,2,nitric oxide production involved in inflammatory response,BP,
1131,GO:0002538,1,0.98623215949323,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1132,GO:0002540,1,0.98623215949323,0,2,leukotriene production involved in inflammatory response,BP,
1133,GO:0002541,1,0.970987982587089,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1134,GO:0002542,1,0.980055712730284,0,2,Factor XII activation,BP,
1135,GO:0002543,1,0.99040255602848,0,2,activation of blood coagulation via clotting cascade,BP,
1136,GO:0002544,1,0.828801881533858,0,22,chronic inflammatory response,BP,
1137,GO:0002545,1,0.983689472007676,0,2,chronic inflammatory response to non-antigenic stimulus,BP,
1138,GO:0002548,1,0.543342825269391,0,59,monocyte chemotaxis,BP,
1139,GO:0002551,1,0.920102917530444,0,11,mast cell chemotaxis,BP,
1140,GO:0002553,1,0.947973532079667,0,6,histamine secretion by mast cell,BP,
1141,GO:0002554,1,0.980211682459646,0,3,serotonin secretion by platelet,BP,
1142,GO:0002562,1,0.728154208419538,0,52,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1143,GO:0002566,1,0.928495707733625,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1144,GO:0002568,1,0.987396812007754,0,5,somatic diversification of T cell receptor genes,BP,
1145,GO:0002572,1,0.992078908692404,0,2,pro-T cell differentiation,BP,
1147,GO:0002576,1,0.407814403700087,0,126,platelet degranulation,BP,
1149,GO:0002578,1,0.956049205552364,0,6,negative regulation of antigen processing and presentation,BP,
1152,GO:0002581,1,0.983891305245862,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1155,GO:0002584,1,0.962391367829708,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1158,GO:0002587,1,0.983891312101756,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1160,GO:0002589,1,0.978150830372741,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1161,GO:0002590,1,0.978150830372741,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1162,GO:0002604,1,0.94935861482509,0,8,regulation of dendritic cell antigen processing and presentation,BP,
1163,GO:0002605,1,0.99999999631441,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
1164,GO:0002606,1,0.949358628300753,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1165,GO:0002625,1,0.978200804806729,0,2,regulation of T cell antigen processing and presentation,BP,
1166,GO:0002626,1,0.989215679571707,0,1,negative regulation of T cell antigen processing and presentation,BP,
1167,GO:0002634,1,0.945516975858455,0,9,regulation of germinal center formation,BP,
1168,GO:0002635,1,0.99200507593334,0,2,negative regulation of germinal center formation,BP,
1169,GO:0002636,1,0.963412997305777,0,3,positive regulation of germinal center formation,BP,
1171,GO:0002638,1,0.948482621508034,0,8,negative regulation of immunoglobulin production,BP,
1173,GO:0002640,1,0.991657600429728,0,1,regulation of immunoglobulin biosynthetic process,BP,
1174,GO:0002642,1,0.991657600429728,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1175,GO:0002643,1,0.892273382330012,0,17,regulation of tolerance induction,BP,
1176,GO:0002644,1,0.98224761304061,0,2,negative regulation of tolerance induction,BP,
1177,GO:0002645,1,0.941516355046177,0,9,positive regulation of tolerance induction,BP,
1178,GO:0002646,1,0.992005081113284,0,1,regulation of central tolerance induction,BP,
1179,GO:0002648,1,0.992005081113284,0,1,positive regulation of central tolerance induction,BP,
1180,GO:0002649,1,0.99951243554381,0,1,regulation of tolerance induction to self antigen,BP,
1181,GO:0002651,1,0.99951243554381,0,1,positive regulation of tolerance induction to self antigen,BP,
1182,GO:0002652,1,0.981388962637029,0,2,regulation of tolerance induction dependent upon immune response,BP,
1183,GO:0002654,1,0.990678125913674,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1184,GO:0002658,1,0.990678125913674,0,1,regulation of peripheral tolerance induction,BP,
1185,GO:0002660,1,0.990678125913674,0,1,positive regulation of peripheral tolerance induction,BP,
1186,GO:0002661,1,0.991521382401601,0,2,regulation of B cell tolerance induction,BP,
1187,GO:0002663,1,0.991521382401601,0,2,positive regulation of B cell tolerance induction,BP,
1188,GO:0002664,1,0.924960858834974,0,11,regulation of T cell tolerance induction,BP,
1189,GO:0002665,1,0.992375915620732,0,1,negative regulation of T cell tolerance induction,BP,
1190,GO:0002666,1,0.949107539854726,0,7,positive regulation of T cell tolerance induction,BP,
1191,GO:0002667,1,0.958935827548604,0,6,regulation of T cell anergy,BP,
1192,GO:0002668,1,0.992375915620732,0,1,negative regulation of T cell anergy,BP,
1193,GO:0002669,1,0.978853729158586,0,3,positive regulation of T cell anergy,BP,
1195,GO:0002674,1,0.906895259571014,0,12,negative regulation of acute inflammatory response,BP,
1196,GO:0002675,1,0.793475308001686,0,27,positive regulation of acute inflammatory response,BP,
1197,GO:0002676,1,0.904603583802381,0,11,regulation of chronic inflammatory response,BP,
1198,GO:0002677,1,0.959873597394864,0,6,negative regulation of chronic inflammatory response,BP,
1199,GO:0002678,1,0.954281050896768,0,4,positive regulation of chronic inflammatory response,BP,
1200,GO:0002679,1,0.939865178374743,0,8,respiratory burst involved in defense response,BP,
1201,GO:0002681,1,0.987396812007754,0,5,somatic recombination of T cell receptor gene segments,BP,
1206,GO:0002686,1,0.780331409682593,0,33,negative regulation of leukocyte migration,BP,
1208,GO:0002688,1,0.399258483525921,0,101,regulation of leukocyte chemotaxis,BP,
1209,GO:0002689,1,0.905631612801895,0,14,negative regulation of leukocyte chemotaxis,BP,
1210,GO:0002690,1,0.449609287862238,0,84,positive regulation of leukocyte chemotaxis,BP,
1212,GO:0002692,1,0.947744929800144,0,8,negative regulation of cellular extravasation,BP,
1215,GO:0002695,1,0.334035926642775,0,143,negative regulation of leukocyte activation,BP,
1218,GO:0002698,1,0.463561399570347,0,102,negative regulation of immune effector process,BP,
1221,GO:0002701,1,0.792960855964624,0,30,negative regulation of production of molecular mediator of immune response,BP,
1224,GO:0002704,1,0.706562202082101,0,44,negative regulation of leukocyte mediated immunity,BP,
1227,GO:0002707,1,0.759950409602746,0,33,negative regulation of lymphocyte mediated immunity,BP,
1230,GO:0002710,1,0.871575844122836,0,16,negative regulation of T cell mediated immunity,BP,
1232,GO:0002712,1,0.712526950539537,0,43,regulation of B cell mediated immunity,BP,
1233,GO:0002713,1,0.935231436294727,0,9,negative regulation of B cell mediated immunity,BP,
1234,GO:0002714,1,0.776759829227099,0,30,positive regulation of B cell mediated immunity,BP,
1235,GO:0002715,1,0.779077089757571,0,33,regulation of natural killer cell mediated immunity,BP,
1236,GO:0002716,1,0.91372254567402,0,11,negative regulation of natural killer cell mediated immunity,BP,
1237,GO:0002717,1,0.862373466974187,0,20,positive regulation of natural killer cell mediated immunity,BP,
1238,GO:0002718,1,0.630845582658929,0,63,regulation of cytokine production involved in immune response,BP,
1239,GO:0002719,1,0.827814490484212,0,23,negative regulation of cytokine production involved in immune response,BP,
1240,GO:0002720,1,0.778973752845643,0,35,positive regulation of cytokine production involved in immune response,BP,
1241,GO:0002721,1,0.991954340101245,0,1,regulation of B cell cytokine production,BP,
1242,GO:0002724,1,0.841505153032888,0,22,regulation of T cell cytokine production,BP,
1243,GO:0002725,1,0.928082904240877,0,7,negative regulation of T cell cytokine production,BP,
1244,GO:0002726,1,0.908687162349274,0,14,positive regulation of T cell cytokine production,BP,
1245,GO:0002727,1,0.991225111212861,0,2,regulation of natural killer cell cytokine production,BP,
1246,GO:0002728,1,0.999209142242195,0,1,negative regulation of natural killer cell cytokine production,BP,
1247,GO:0002729,1,0.992009701125171,0,1,positive regulation of natural killer cell cytokine production,BP,
1248,GO:0002730,1,0.980585322054499,0,5,regulation of dendritic cell cytokine production,BP,
1249,GO:0002731,1,0.987306017759302,0,2,negative regulation of dendritic cell cytokine production,BP,
1250,GO:0002732,1,0.9992549192931,0,1,positive regulation of dendritic cell cytokine production,BP,
1251,GO:0002736,1,0.987321041848265,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1252,GO:0002737,1,0.987321041848265,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1253,GO:0002739,1,0.897808240022001,0,14,regulation of cytokine secretion involved in immune response,BP,
1254,GO:0002740,1,0.944481484338448,0,6,negative regulation of cytokine secretion involved in immune response,BP,
1255,GO:0002741,1,0.955447330985548,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1256,GO:0002752,1,0.977358777337314,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1257,GO:0002753,1,0.758578325768623,0,53,cytoplasmic pattern recognition receptor signaling pathway,BP,
1258,GO:0002755,1,0.80001465779473,0,36,MyD88-dependent toll-like receptor signaling pathway,BP,
1262,GO:0002759,1,0.927052475119048,0,7,regulation of antimicrobial humoral response,BP,
1263,GO:0002760,1,0.940450693770981,0,5,positive regulation of antimicrobial humoral response,BP,
1265,GO:0002762,1,0.767807203223242,0,44,negative regulation of myeloid leukocyte differentiation,BP,
1268,GO:0002765,1,0.947700983028129,0,6,immune response-inhibiting signal transduction,BP,
1269,GO:0002767,1,0.957717967659903,0,5,immune response-inhibiting cell surface receptor signaling pathway,BP,
1271,GO:0002769,1,0.988247587492541,0,1,natural killer cell inhibitory signaling pathway,BP,
1272,GO:0002774,1,0.980681338593077,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1273,GO:0002775,1,0.92599516373701,0,7,antimicrobial peptide production,BP,
1274,GO:0002777,1,0.974457752067809,0,2,antimicrobial peptide biosynthetic process,BP,
1275,GO:0002778,1,0.92599516373701,0,7,antibacterial peptide production,BP,
1276,GO:0002780,1,0.974457752067809,0,2,antibacterial peptide biosynthetic process,BP,
1277,GO:0002784,1,0.937478769247938,0,6,regulation of antimicrobial peptide production,BP,
1278,GO:0002785,1,0.996841434995585,0,1,negative regulation of antimicrobial peptide production,BP,
1279,GO:0002786,1,0.937478769247938,0,6,regulation of antibacterial peptide production,BP,
1280,GO:0002787,1,0.996841434995585,0,1,negative regulation of antibacterial peptide production,BP,
1283,GO:0002792,1,0.462191580650168,0,111,negative regulation of peptide secretion,BP,
1285,GO:0002803,1,0.940450693770981,0,5,positive regulation of antibacterial peptide production,BP,
1286,GO:0002805,1,0.974457752067809,0,2,regulation of antimicrobial peptide biosynthetic process,BP,
1287,GO:0002807,1,0.974457752067809,0,2,positive regulation of antimicrobial peptide biosynthetic process,BP,
1288,GO:0002808,1,0.974457752067809,0,2,regulation of antibacterial peptide biosynthetic process,BP,
1289,GO:0002815,1,0.974457752067809,0,2,biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
1290,GO:0002816,1,0.974457752067809,0,2,regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
1292,GO:0002820,1,0.737319447816731,0,38,negative regulation of adaptive immune response,BP,
1295,GO:0002823,1,0.756203358843086,0,35,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1297,GO:0002825,1,0.832739952944072,0,22,regulation of T-helper 1 type immune response,BP,
1298,GO:0002826,1,0.948804352935175,0,7,negative regulation of T-helper 1 type immune response,BP,
1299,GO:0002827,1,0.877885885203882,0,15,positive regulation of T-helper 1 type immune response,BP,
1300,GO:0002828,1,0.812774361238938,0,27,regulation of type 2 immune response,BP,
1301,GO:0002829,1,0.923852375913504,0,11,negative regulation of type 2 immune response,BP,
1302,GO:0002830,1,0.889396357630967,0,15,positive regulation of type 2 immune response,BP,
1303,GO:0002831,1,0.38718798148838,0,134,regulation of response to biotic stimulus,BP,
1304,GO:0002832,1,0.80125393632659,0,34,negative regulation of response to biotic stimulus,BP,
1305,GO:0002833,1,0.749676709880641,0,38,positive regulation of response to biotic stimulus,BP,
1306,GO:0002834,1,0.914766222657146,0,11,regulation of response to tumor cell,BP,
1307,GO:0002835,1,0.986660023079788,0,2,negative regulation of response to tumor cell,BP,
1308,GO:0002836,1,0.931077363937862,0,8,positive regulation of response to tumor cell,BP,
1309,GO:0002837,1,0.914766222657146,0,11,regulation of immune response to tumor cell,BP,
1310,GO:0002838,1,0.986660023079788,0,2,negative regulation of immune response to tumor cell,BP,
1311,GO:0002839,1,0.931077363937862,0,8,positive regulation of immune response to tumor cell,BP,
1312,GO:0002840,1,0.986414041096752,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1313,GO:0002842,1,0.990599302187582,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1314,GO:0002849,1,0.990678125913674,0,1,regulation of peripheral T cell tolerance induction,BP,
1315,GO:0002851,1,0.990678125913674,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1316,GO:0002855,1,0.937466315296097,0,8,regulation of natural killer cell mediated immune response to tumor cell,BP,
1317,GO:0002856,1,0.986660023079788,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1318,GO:0002857,1,0.950146355276431,0,6,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1319,GO:0002858,1,0.937466315296097,0,8,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1320,GO:0002859,1,0.986660023079788,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1321,GO:0002860,1,0.950146355276431,0,6,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1322,GO:0002861,1,0.830598817244921,0,21,regulation of inflammatory response to antigenic stimulus,BP,
1323,GO:0002862,1,0.913602068890952,0,10,negative regulation of inflammatory response to antigenic stimulus,BP,
1324,GO:0002863,1,0.909209280573714,0,11,positive regulation of inflammatory response to antigenic stimulus,BP,
1325,GO:0002864,1,0.908603003824522,0,12,regulation of acute inflammatory response to antigenic stimulus,BP,
1326,GO:0002865,1,0.97323114870893,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1327,GO:0002866,1,0.933608061144665,0,8,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1328,GO:0002870,1,0.958935827548604,0,6,T cell anergy,BP,
1329,GO:0002874,1,0.965014836898813,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1330,GO:0002875,1,0.988312537004459,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1331,GO:0002876,1,0.976428956228255,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1332,GO:0002877,1,0.972779761341603,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1333,GO:0002878,1,0.994574958817842,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1334,GO:0002879,1,0.978086853330291,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1335,GO:0002880,1,0.983689472007676,0,2,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1336,GO:0002881,1,0.994620898870946,0,1,negative regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1337,GO:0002882,1,0.989009921725348,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1338,GO:0002883,1,0.935714523687997,0,8,regulation of hypersensitivity,BP,
1339,GO:0002884,1,0.989544333261598,0,2,negative regulation of hypersensitivity,BP,
1340,GO:0002885,1,0.94560583199535,0,6,positive regulation of hypersensitivity,BP,
1341,GO:0002886,1,0.756957168023678,0,38,regulation of myeloid leukocyte mediated immunity,BP,
1342,GO:0002887,1,0.930942218501172,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1343,GO:0002888,1,0.866929474284641,0,18,positive regulation of myeloid leukocyte mediated immunity,BP,
1344,GO:0002889,1,0.712526950539537,0,43,regulation of immunoglobulin mediated immune response,BP,
1345,GO:0002890,1,0.935231436294727,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1346,GO:0002891,1,0.776759829227099,0,30,positive regulation of immunoglobulin mediated immune response,BP,
1347,GO:0002892,1,0.987074970310905,0,2,regulation of type II hypersensitivity,BP,
1348,GO:0002894,1,0.987074970310905,0,2,positive regulation of type II hypersensitivity,BP,
1349,GO:0002895,1,0.992005081113284,0,1,regulation of central B cell tolerance induction,BP,
1350,GO:0002897,1,0.992005081113284,0,1,positive regulation of central B cell tolerance induction,BP,
1351,GO:0002901,1,0.957888481368231,0,4,mature B cell apoptotic process,BP,
1352,GO:0002902,1,0.877375987720749,0,18,regulation of B cell apoptotic process,BP,
1353,GO:0002903,1,0.911964201542571,0,12,negative regulation of B cell apoptotic process,BP,
1354,GO:0002904,1,0.975708013645772,0,3,positive regulation of B cell apoptotic process,BP,
1355,GO:0002905,1,0.957888481368231,0,4,regulation of mature B cell apoptotic process,BP,
1356,GO:0002906,1,0.957888481368231,0,4,negative regulation of mature B cell apoptotic process,BP,
1357,GO:0002911,1,0.958935827548604,0,6,regulation of lymphocyte anergy,BP,
1358,GO:0002912,1,0.992375915620732,0,1,negative regulation of lymphocyte anergy,BP,
1359,GO:0002913,1,0.978853729158586,0,3,positive regulation of lymphocyte anergy,BP,
1361,GO:0002921,1,0.935257026442255,0,11,negative regulation of humoral immune response,BP,
1362,GO:0002922,1,0.854335183799856,0,15,positive regulation of humoral immune response,BP,
1363,GO:0002923,1,0.916099330572952,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1364,GO:0002924,1,0.960575658769329,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1365,GO:0002925,1,0.953712663946671,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1366,GO:0002930,1,0.989223350395465,0,2,trabecular meshwork development,BP,
1368,GO:0002933,1,0.952819764569089,0,5,lipid hydroxylation,BP,
1369,GO:0002934,1,0.972938555715468,0,9,desmosome organization,BP,
1370,GO:0002940,1,0.990086488293015,0,1,tRNA N2-guanine methylation,BP,
1371,GO:0002943,1,0.968282936754602,0,3,tRNA dihydrouridine synthesis,BP,
1372,GO:0002944,1,0.990425432344124,0,2,cyclin K-CDK12 complex,CC,
1373,GO:0002945,1,0.990425432336092,0,2,cyclin K-CDK13 complex,CC,
1374,GO:0002946,1,0.987913031917531,0,1,tRNA C5-cytosine methylation,BP,
1375,GO:0002947,1,0.998447738803387,0,1,tumor necrosis factor receptor superfamily complex,CC,
1376,GO:0002949,1,0.967968458916564,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1377,GO:0002950,1,0.985281119118618,0,3,ceramide phosphoethanolamine synthase activity,MF,
1378,GO:0003002,1,0.106966893576129,0,327,regionalization,BP,
1382,GO:0003009,1,0.774511379664538,0,37,skeletal muscle contraction,BP,
1383,GO:0003010,1,0.971393643262605,0,5,voluntary skeletal muscle contraction,BP,
1384,GO:0003011,1,0.983677304965226,0,3,involuntary skeletal muscle contraction,BP,
1389,GO:0003016,1,0.855869203881041,0,29,respiratory system process,BP,
1390,GO:0003017,1,0.99999999639106,0,1,lymph circulation,BP,
1391,GO:0003018,1,0.35739510890983,0,152,vascular process in circulatory system,BP,
1392,GO:0003025,1,0.96927688463848,0,4,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1393,GO:0003026,1,0.991657600429728,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1394,GO:0003027,1,0.988487165786894,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1395,GO:0003029,1,0.988487165786894,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1396,GO:0003032,1,0.985051160824572,0,2,detection of oxygen,BP,
1397,GO:0003044,1,0.68937614040914,0,48,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1398,GO:0003050,1,0.994477489117245,0,2,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1399,GO:0003051,1,0.983025241910477,0,3,angiotensin-mediated drinking behavior,BP,
1400,GO:0003056,1,0.970460652937714,0,6,regulation of vascular smooth muscle contraction,BP,
1401,GO:0003057,1,0.954947382364908,0,5,regulation of the force of heart contraction by chemical signal,BP,
1402,GO:0003058,1,0.987612795703566,0,1,hormonal regulation of the force of heart contraction,BP,
1403,GO:0003062,1,0.971597107389709,0,6,regulation of heart rate by chemical signal,BP,
1404,GO:0003064,1,0.983632333840602,0,2,regulation of heart rate by hormone,BP,
1405,GO:0003065,1,0.988734105394405,0,1,positive regulation of heart rate by epinephrine,BP,
1406,GO:0003068,1,0.987384925792003,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1407,GO:0003069,1,0.987384925792003,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1408,GO:0003070,1,0.987384925792003,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1409,GO:0003071,1,0.828332899234543,0,24,renal system process involved in regulation of systemic arterial blood pressure,BP,
1410,GO:0003072,1,0.966443291840711,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1411,GO:0003073,1,0.546021823924262,0,84,regulation of systemic arterial blood pressure,BP,
1412,GO:0003081,1,0.829276639209115,0,25,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1413,GO:0003083,1,0.987199441584784,0,1,negative regulation of renal output by angiotensin,BP,
1414,GO:0003084,1,0.933424491715707,0,9,positive regulation of systemic arterial blood pressure,BP,
1415,GO:0003085,1,0.889389739428104,0,14,negative regulation of systemic arterial blood pressure,BP,
1416,GO:0003091,1,0.835202538151912,0,35,renal water homeostasis,BP,
1417,GO:0003093,1,0.919952959865793,0,12,regulation of glomerular filtration,BP,
1418,GO:0003094,1,0.913517335953903,0,17,glomerular filtration,BP,
1419,GO:0003095,1,0.971310361000898,0,3,pressure natriuresis,BP,
1420,GO:0003096,1,0.969582664401025,0,5,renal sodium ion transport,BP,
1421,GO:0003097,1,0.96063615500395,0,6,renal water transport,BP,
1422,GO:0003099,1,0.970999550892754,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1423,GO:0003100,1,0.960890699107685,0,5,regulation of systemic arterial blood pressure by endothelin,BP,
1424,GO:0003104,1,0.972377740628377,0,4,positive regulation of glomerular filtration,BP,
1425,GO:0003105,1,0.952877100138678,0,6,negative regulation of glomerular filtration,BP,
1426,GO:0003106,1,0.987199441584784,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1427,GO:0003127,1,0.999865012638424,0,2,detection of nodal flow,BP,
1428,GO:0003128,1,0.921594882909549,0,10,heart field specification,BP,
1429,GO:0003129,1,0.953729319251153,0,5,heart induction,BP,
1430,GO:0003130,1,0.983242061399957,0,2,BMP signaling pathway involved in heart induction,BP,
1431,GO:0003131,1,0.992913843613084,0,1,mesodermal-endodermal cell signaling,BP,
1432,GO:0003133,1,0.983242061399957,0,2,endodermal-mesodermal cell signaling,BP,
1433,GO:0003134,1,0.983242061399957,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1434,GO:0003136,1,0.993409576390941,0,1,negative regulation of heart induction by canonical Wnt signaling pathway,BP,
1435,GO:0003137,1,0.98751377475558,0,1,Notch signaling pathway involved in heart induction,BP,
1436,GO:0003138,1,0.999999996374446,0,1,primary heart field specification,BP,
1437,GO:0003139,1,0.938252901300536,0,8,secondary heart field specification,BP,
1438,GO:0003140,1,0.931962271265873,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1439,GO:0003142,1,0.990724061960345,0,1,cardiogenic plate morphogenesis,BP,
1440,GO:0003143,1,0.709938419038068,0,64,embryonic heart tube morphogenesis,BP,
1441,GO:0003144,1,0.988578352180874,0,1,embryonic heart tube formation,BP,
1442,GO:0003147,1,0.987404495369061,0,1,neural crest cell migration involved in heart formation,BP,
1443,GO:0003148,1,0.886233597630168,0,22,outflow tract septum morphogenesis,BP,
1444,GO:0003149,1,0.952503471571319,0,9,membranous septum morphogenesis,BP,
1445,GO:0003150,1,0.980540712775685,0,5,muscular septum morphogenesis,BP,
1446,GO:0003151,1,0.666450681049442,0,69,outflow tract morphogenesis,BP,
1447,GO:0003156,1,0.788861061981757,0,33,regulation of animal organ formation,BP,
1448,GO:0003157,1,0.931665931244334,0,11,endocardium development,BP,
1449,GO:0003158,1,0.559040945956075,0,109,endothelium development,BP,
1450,GO:0003159,1,0.90620391606433,0,15,morphogenesis of an endothelium,BP,
1451,GO:0003160,1,0.953101786947631,0,6,endocardium morphogenesis,BP,
1452,GO:0003161,1,0.934764617333936,0,13,cardiac conduction system development,BP,
1453,GO:0003162,1,0.989133743455235,0,3,atrioventricular node development,BP,
1454,GO:0003163,1,0.98712394936143,0,3,sinoatrial node development,BP,
1455,GO:0003164,1,0.973521545908621,0,5,His-Purkinje system development,BP,
1456,GO:0003165,1,0.989132913539926,0,2,Purkinje myocyte development,BP,
1457,GO:0003166,1,0.973522612192331,0,4,bundle of His development,BP,
1458,GO:0003167,1,0.999617992584046,0,1,atrioventricular bundle cell differentiation,BP,
1459,GO:0003168,1,0.989133993605324,0,1,Purkinje myocyte differentiation,BP,
1460,GO:0003169,1,0.996211547346794,0,2,coronary vein morphogenesis,BP,
1461,GO:0003170,1,0.837062635311128,0,38,heart valve development,BP,
1462,GO:0003171,1,0.885793317520785,0,24,atrioventricular valve development,BP,
1463,GO:0003172,1,0.999999996374446,0,1,sinoatrial valve development,BP,
1464,GO:0003174,1,0.950100369737524,0,11,mitral valve development,BP,
1465,GO:0003175,1,0.971798622023478,0,6,tricuspid valve development,BP,
1466,GO:0003176,1,0.948586714434365,0,6,aortic valve development,BP,
1467,GO:0003177,1,0.940246817993407,0,12,pulmonary valve development,BP,
1468,GO:0003179,1,0.857357079883463,0,34,heart valve morphogenesis,BP,
1469,GO:0003180,1,0.948586714434365,0,6,aortic valve morphogenesis,BP,
1470,GO:0003181,1,0.910124849757605,0,21,atrioventricular valve morphogenesis,BP,
1471,GO:0003183,1,0.955317264815943,0,10,mitral valve morphogenesis,BP,
1472,GO:0003184,1,0.940246817993407,0,12,pulmonary valve morphogenesis,BP,
1473,GO:0003185,1,0.999999996374446,0,1,sinoatrial valve morphogenesis,BP,
1474,GO:0003186,1,0.983360366462296,0,5,tricuspid valve morphogenesis,BP,
1475,GO:0003188,1,0.926478244482807,0,13,heart valve formation,BP,
1476,GO:0003190,1,0.967506330698071,0,7,atrioventricular valve formation,BP,
1477,GO:0003192,1,0.994933733252406,0,3,mitral valve formation,BP,
1478,GO:0003193,1,0.982848925348778,0,2,pulmonary valve formation,BP,
1479,GO:0003195,1,0.987140586477954,0,2,tricuspid valve formation,BP,
1480,GO:0003197,1,0.809333328591569,0,39,endocardial cushion development,BP,
1481,GO:0003198,1,0.895712133503472,0,17,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1482,GO:0003199,1,0.968797206640717,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1483,GO:0003203,1,0.843569909227813,0,29,endocardial cushion morphogenesis,BP,
1486,GO:0003207,1,0.927180236695463,0,12,cardiac chamber formation,BP,
1487,GO:0003208,1,0.680386175129475,0,71,cardiac ventricle morphogenesis,BP,
1488,GO:0003209,1,0.854124638493559,0,30,cardiac atrium morphogenesis,BP,
1489,GO:0003210,1,0.98751377475558,0,1,cardiac atrium formation,BP,
1490,GO:0003211,1,0.942390262304115,0,10,cardiac ventricle formation,BP,
1491,GO:0003213,1,0.999999992763476,0,2,cardiac right atrium morphogenesis,BP,
1492,GO:0003214,1,0.918586871858246,0,14,cardiac left ventricle morphogenesis,BP,
1493,GO:0003215,1,0.90386564044772,0,19,cardiac right ventricle morphogenesis,BP,
1494,GO:0003218,1,0.985385584437832,0,2,cardiac left ventricle formation,BP,
1495,GO:0003219,1,0.968184006106591,0,4,cardiac right ventricle formation,BP,
1496,GO:0003220,1,0.999999992813708,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1497,GO:0003221,1,0.988378358566452,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1498,GO:0003222,1,0.933286504923078,0,16,ventricular trabecula myocardium morphogenesis,BP,
1499,GO:0003223,1,0.983164098544251,0,7,ventricular compact myocardium morphogenesis,BP,
1500,GO:0003226,1,0.999999996397969,0,1,right ventricular compact myocardium morphogenesis,BP,
1501,GO:0003228,1,0.950159011652873,0,7,atrial cardiac muscle tissue development,BP,
1502,GO:0003229,1,0.759164713910745,0,52,ventricular cardiac muscle tissue development,BP,
1503,GO:0003230,1,0.844325128980269,0,34,cardiac atrium development,BP,
1504,GO:0003231,1,0.570180203068776,0,116,cardiac ventricle development,BP,
1505,GO:0003235,1,0.98751377475558,0,1,sinus venosus development,BP,
1506,GO:0003236,1,0.98751377475558,0,1,sinus venosus morphogenesis,BP,
1507,GO:0003241,1,0.970110387424868,0,4,growth involved in heart morphogenesis,BP,
1508,GO:0003245,1,0.982378310065486,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1509,GO:0003247,1,0.98833394167051,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1510,GO:0003249,1,0.999999992794827,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1511,GO:0003250,1,0.999999992794827,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1512,GO:0003251,1,0.999999996388895,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1513,GO:0003252,1,0.999999996405924,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1514,GO:0003253,1,0.957552769014068,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1515,GO:0003254,1,0.800561522901878,0,41,regulation of membrane depolarization,BP,
1516,GO:0003256,1,0.975432803400458,0,7,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1517,GO:0003257,1,0.988893912739052,0,4,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1518,GO:0003259,1,0.98751377475558,0,1,cardioblast anterior-lateral migration,BP,
1519,GO:0003260,1,0.98751377475558,0,1,cardioblast migration,BP,
1520,GO:0003263,1,0.935188074807752,0,9,cardioblast proliferation,BP,
1521,GO:0003264,1,0.93518805875959,0,10,regulation of cardioblast proliferation,BP,
1522,GO:0003266,1,0.942409701961246,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1523,GO:0003270,1,0.999999996391896,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1524,GO:0003272,1,0.871800992354023,0,22,endocardial cushion formation,BP,
1525,GO:0003273,1,0.984206243252349,0,4,cell migration involved in endocardial cushion formation,BP,
1526,GO:0003274,1,0.992994015326009,0,3,endocardial cushion fusion,BP,
1527,GO:0003275,1,0.984260602944353,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1528,GO:0003278,1,0.955439744471432,0,6,apoptotic process involved in heart morphogenesis,BP,
1529,GO:0003279,1,0.665431097035619,0,95,cardiac septum development,BP,
1530,GO:0003281,1,0.786435901530082,0,62,ventricular septum development,BP,
1531,GO:0003283,1,0.916547246600424,0,19,atrial septum development,BP,
1532,GO:0003284,1,0.983551815160336,0,5,septum primum development,BP,
1533,GO:0003285,1,0.984891114964436,0,2,septum secundum development,BP,
1534,GO:0003289,1,0.988950898505525,0,4,atrial septum primum morphogenesis,BP,
1535,GO:0003290,1,0.995710883314216,0,1,atrial septum secundum morphogenesis,BP,
1536,GO:0003292,1,0.989133749208618,0,2,cardiac septum cell differentiation,BP,
1537,GO:0003294,1,0.994541078442231,0,1,atrial ventricular junction remodeling,BP,
1538,GO:0003298,1,0.888349403332804,0,19,physiological muscle hypertrophy,BP,
1539,GO:0003299,1,0.920503695138459,0,19,muscle hypertrophy in response to stress,BP,
1540,GO:0003300,1,0.725896663528042,0,66,cardiac muscle hypertrophy,BP,
1541,GO:0003301,1,0.888349403332804,0,19,physiological cardiac muscle hypertrophy,BP,
1542,GO:0003306,1,0.931537671601211,0,10,Wnt signaling pathway involved in heart development,BP,
1543,GO:0003307,1,0.953134899654303,0,5,regulation of Wnt signaling pathway involved in heart development,BP,
1544,GO:0003308,1,0.962010691017468,0,4,negative regulation of Wnt signaling pathway involved in heart development,BP,
1545,GO:0003309,1,0.87246717662911,0,23,type B pancreatic cell differentiation,BP,
1546,GO:0003310,1,0.955488874148445,0,7,pancreatic A cell differentiation,BP,
1547,GO:0003311,1,0.99613356699837,0,1,pancreatic D cell differentiation,BP,
1548,GO:0003312,1,0.981696815951069,0,2,pancreatic PP cell differentiation,BP,
1549,GO:0003318,1,0.98751377475558,0,1,cell migration to the midline involved in heart development,BP,
1550,GO:0003321,1,0.946363568183657,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1551,GO:0003322,1,0.999999996378046,0,1,pancreatic A cell development,BP,
1552,GO:0003323,1,0.893224253908623,0,19,type B pancreatic cell development,BP,
1553,GO:0003326,1,0.981696815951069,0,2,pancreatic A cell fate commitment,BP,
1554,GO:0003327,1,0.989655340272943,0,1,type B pancreatic cell fate commitment,BP,
1555,GO:0003329,1,0.981696815951069,0,2,pancreatic PP cell fate commitment,BP,
1556,GO:0003330,1,0.9721203866703,0,3,regulation of extracellular matrix constituent secretion,BP,
1557,GO:0003331,1,0.9721203866703,0,3,positive regulation of extracellular matrix constituent secretion,BP,
1559,GO:0003334,1,0.937698120495573,0,11,keratinocyte development,BP,
1560,GO:0003335,1,0.979417340535284,0,2,corneocyte development,BP,
1561,GO:0003336,1,0.991580909742357,0,1,corneocyte desquamation,BP,
1562,GO:0003337,1,0.925254975087377,0,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1563,GO:0003338,1,0.836463510094125,0,33,metanephros morphogenesis,BP,
1564,GO:0003339,1,0.949576165753348,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1565,GO:0003340,1,0.97964127938708,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1566,GO:0003341,1,0.709283326421392,0,48,cilium movement,BP,
1567,GO:0003342,1,0.983038543385665,0,2,proepicardium development,BP,
1568,GO:0003343,1,0.983038543385665,0,2,septum transversum development,BP,
1569,GO:0003344,1,0.970013733994552,0,9,pericardium morphogenesis,BP,
1570,GO:0003345,1,0.997639951666877,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1571,GO:0003348,1,0.964119970232521,0,6,cardiac endothelial cell differentiation,BP,
1572,GO:0003350,1,0.979432042372527,0,3,pulmonary myocardium development,BP,
1573,GO:0003351,1,0.882245014743574,0,19,epithelial cilium movement,BP,
1574,GO:0003352,1,0.939830171838539,0,11,regulation of cilium movement,BP,
1575,GO:0003353,1,0.993767432219604,0,1,positive regulation of cilium movement,BP,
1576,GO:0003356,1,0.945727086893394,0,10,regulation of cilium beat frequency,BP,
1577,GO:0003357,1,0.957766453597012,0,7,noradrenergic neuron differentiation,BP,
1578,GO:0003358,1,0.978191084956829,0,3,noradrenergic neuron development,BP,
1579,GO:0003359,1,0.991273856262465,0,1,noradrenergic neuron fate commitment,BP,
1580,GO:0003360,1,0.969198473083858,0,7,brainstem development,BP,
1581,GO:0003363,1,0.999999996372491,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1582,GO:0003365,1,0.999999992767257,0,2,establishment of cell polarity involved in ameboidal cell migration,BP,
1583,GO:0003366,1,0.992686354775588,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1584,GO:0003373,1,0.979475167533123,0,7,dynamin family protein polymerization involved in membrane fission,BP,
1585,GO:0003374,1,0.979475167533123,0,7,dynamin family protein polymerization involved in mitochondrial fission,BP,
1586,GO:0003376,1,0.914539191622461,0,12,sphingosine-1-phosphate signaling pathway,BP,
1587,GO:0003382,1,0.870070030649241,0,29,epithelial cell morphogenesis,BP,
1588,GO:0003383,1,0.999784124993639,0,3,apical constriction,BP,
1589,GO:0003400,1,0.990009397148328,0,1,regulation of COPII vesicle coating,BP,
1590,GO:0003401,1,0.853986922117683,0,31,axis elongation,BP,
1591,GO:0003402,1,0.977814785103736,0,6,planar cell polarity pathway involved in axis elongation,BP,
1592,GO:0003404,1,0.986714595353182,0,2,optic vesicle morphogenesis,BP,
1593,GO:0003406,1,0.984742004115675,0,4,retinal pigment epithelium development,BP,
1594,GO:0003407,1,0.745572447880824,0,57,neural retina development,BP,
1595,GO:0003408,1,0.993711369291665,0,3,optic cup formation involved in camera-type eye development,BP,
1596,GO:0003409,1,0.9952006710646,0,1,optic cup structural organization,BP,
1597,GO:0003413,1,0.954752623954152,0,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1598,GO:0003414,1,0.997487954678594,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1599,GO:0003415,1,0.988786331800416,0,4,chondrocyte hypertrophy,BP,
1600,GO:0003416,1,0.882138497889991,0,21,endochondral bone growth,BP,
1601,GO:0003417,1,0.908313994571833,0,15,growth plate cartilage development,BP,
1602,GO:0003418,1,0.967595235948231,0,6,growth plate cartilage chondrocyte differentiation,BP,
1603,GO:0003419,1,0.960360086649755,0,4,growth plate cartilage chondrocyte proliferation,BP,
1604,GO:0003420,1,0.985121128715519,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1605,GO:0003421,1,0.997652536752675,0,1,growth plate cartilage axis specification,BP,
1606,GO:0003422,1,0.995146341030078,0,2,growth plate cartilage morphogenesis,BP,
1607,GO:0003429,1,0.997487954678594,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1608,GO:0003430,1,0.99245614139515,0,2,growth plate cartilage chondrocyte growth,BP,
1609,GO:0003431,1,0.982665339167985,0,4,growth plate cartilage chondrocyte development,BP,
1610,GO:0003433,1,0.970531167300864,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1614,GO:0003678,1,0.827108094847083,0,47,DNA helicase activity,MF,
1615,GO:0003680,1,0.930944681597269,0,8,AT DNA binding,MF,
1616,GO:0003682,1,0.0689161829197358,0,470,chromatin binding,MF,
1617,GO:0003684,1,0.701576049781896,0,62,damaged DNA binding,MF,
1618,GO:0003688,1,0.909519704300857,0,13,DNA replication origin binding,MF,
1619,GO:0003689,1,0.935085780865754,0,8,DNA clamp loader activity,MF,
1621,GO:0003691,1,0.939446473076929,0,9,double-stranded telomeric DNA binding,MF,
1622,GO:0003692,1,0.990072935475726,0,1,left-handed Z-DNA binding,MF,
1623,GO:0003696,1,0.955430137288625,0,7,satellite DNA binding,MF,
1624,GO:0003697,1,0.54489260494159,0,91,single-stranded DNA binding,MF,
1626,GO:0003705,1,0.535153628743024,0,94,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
1627,GO:0003707,1,0.730133895378961,0,58,steroid hormone receptor activity,MF,
1628,GO:0003708,1,0.962812236276761,0,7,retinoic acid receptor activity,MF,
1631,GO:0003714,1,0.264976163450795,0,216,transcription corepressor activity,MF,
1632,GO:0003720,1,0.961010694277827,0,7,telomerase activity,MF,
1633,GO:0003721,1,0.998092392517714,0,1,telomerase RNA reverse transcriptase activity,MF,
1635,GO:0003724,1,0.72412621188805,0,68,RNA helicase activity,MF,
1636,GO:0003725,1,0.731976342467239,0,60,double-stranded RNA binding,MF,
1637,GO:0003726,1,0.989863923991303,0,3,double-stranded RNA adenosine deaminase activity,MF,
1638,GO:0003727,1,0.627146950943041,0,72,single-stranded RNA binding,MF,
1642,GO:0003743,1,0.686409472456344,0,50,translation initiation factor activity,MF,
1644,GO:0003747,1,0.966088416646759,0,6,translation release factor activity,MF,
1645,GO:0003755,1,0.689116051923709,0,38,peptidyl-prolyl cis-trans isomerase activity,MF,
1646,GO:0003756,1,0.897312160791585,0,18,protein disulfide isomerase activity,MF,
1647,GO:0003774,1,0.658100286766526,0,130,motor activity,MF,
1648,GO:0003777,1,0.779748001326247,0,76,microtubule motor activity,MF,
1650,GO:0003785,1,0.830733893643241,0,26,actin monomer binding,MF,
1651,GO:0003796,1,0.869759456145713,0,11,lysozyme activity,MF,
1652,GO:0003810,1,0.936103946474188,0,9,protein-glutamine gamma-glutamyltransferase activity,MF,
1653,GO:0003823,1,0.535637768029893,0,64,antigen binding,MF,
1655,GO:0003826,1,0.980789928432735,0,2,alpha-ketoacid dehydrogenase activity,MF,
1656,GO:0003827,1,0.993360996682053,0,1,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1657,GO:0003828,1,0.978253300342433,0,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1658,GO:0003829,1,0.986052498841311,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1659,GO:0003830,1,0.999840932735502,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1660,GO:0003831,1,0.9562562070377,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1661,GO:0003835,1,0.998837555525726,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1662,GO:0003836,1,0.958996934544595,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1663,GO:0003837,1,0.989648109637414,0,1,beta-ureidopropionase activity,MF,
1664,GO:0003839,1,0.955596412287285,0,4,gamma-glutamylcyclotransferase activity,MF,
1665,GO:0003840,1,0.942068790793815,0,6,gamma-glutamyltransferase activity,MF,
1666,GO:0003841,1,0.927507555954099,0,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1667,GO:0003842,1,0.99496246959351,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1668,GO:0003844,1,0.994281433998926,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1669,GO:0003845,1,0.977004328170846,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1670,GO:0003846,1,0.942173196963796,0,6,2-acylglycerol O-acyltransferase activity,MF,
1671,GO:0003847,1,0.950155098801716,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1675,GO:0003860,1,0.989161580441436,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1676,GO:0003863,1,0.980789928432735,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1677,GO:0003865,1,0.973870566324442,0,3,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1678,GO:0003867,1,0.999768569133436,0,1,4-aminobutyrate transaminase activity,MF,
1679,GO:0003868,1,0.988409662701754,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1680,GO:0003870,1,0.980286760280229,0,2,5-aminolevulinate synthase activity,MF,
1681,GO:0003872,1,0.981473246421386,0,3,6-phosphofructokinase activity,MF,
1682,GO:0003873,1,0.983769792415193,0,4,6-phosphofructo-2-kinase activity,MF,
1684,GO:0003875,1,0.984618696071961,0,2,ADP-ribosylarginine hydrolase activity,MF,
1685,GO:0003876,1,0.987159286436432,0,3,AMP deaminase activity,MF,
1686,GO:0003878,1,0.999007313619746,0,1,ATP citrate synthase activity,MF,
1687,GO:0003880,1,0.9873646893368,0,2,protein C-terminal carboxyl O-methyltransferase activity,MF,
1688,GO:0003881,1,0.988984986340941,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1689,GO:0003882,1,0.991173090363349,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1690,GO:0003883,1,0.989577931615604,0,2,CTP synthase activity,MF,
1691,GO:0003884,1,0.976673199303574,0,2,D-amino-acid oxidase activity,MF,
1692,GO:0003886,1,0.99675997309335,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1693,GO:0003887,1,0.857324221823175,0,26,DNA-directed DNA polymerase activity,MF,
1694,GO:0003896,1,0.978561550976353,0,3,DNA primase activity,MF,
1695,GO:0003899,1,0.727490744280619,0,40,DNA-directed 5'-3' RNA polymerase activity,MF,
1696,GO:0003905,1,0.987440978919977,0,1,alkylbase DNA N-glycosylase activity,MF,
1697,GO:0003906,1,0.867271070798047,0,14,DNA-(apurinic or apyrimidinic site) lyase activity,MF,
1698,GO:0003908,1,0.9876457347435,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1699,GO:0003909,1,0.956591168916757,0,7,DNA ligase activity,MF,
1700,GO:0003910,1,0.966446133941889,0,6,DNA ligase (ATP) activity,MF,
1701,GO:0003912,1,0.989546110930749,0,1,DNA nucleotidylexotransferase activity,MF,
1702,GO:0003916,1,0.968037401837015,0,7,DNA topoisomerase activity,MF,
1703,GO:0003917,1,0.979201203601261,0,4,DNA topoisomerase type I activity,MF,
1704,GO:0003918,1,0.988600971852888,0,3,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1705,GO:0003919,1,0.989304060135563,0,1,FMN adenylyltransferase activity,MF,
1706,GO:0003920,1,0.977207284934417,0,2,GMP reductase activity,MF,
1707,GO:0003921,1,0.991234328311921,0,1,GMP synthase activity,MF,
1708,GO:0003922,1,0.991234328311921,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1709,GO:0003923,1,0.961976993531414,0,5,GPI-anchor transamidase activity,MF,
1710,GO:0003924,1,0.123226023181817,0,266,GTPase activity,MF,
1711,GO:0003933,1,0.989240507280597,0,1,GTP cyclohydrolase activity,MF,
1712,GO:0003934,1,0.989240507280597,0,1,GTP cyclohydrolase I activity,MF,
1713,GO:0003937,1,0.989746516163076,0,1,IMP cyclohydrolase activity,MF,
1714,GO:0003938,1,0.980019903396695,0,2,IMP dehydrogenase activity,MF,
1715,GO:0003939,1,0.991518053072052,0,1,L-iditol 2-dehydrogenase activity,MF,
1717,GO:0003941,1,0.967756206161241,0,3,L-serine ammonia-lyase activity,MF,
1718,GO:0003943,1,0.989282906052011,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1719,GO:0003944,1,0.990160512925478,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1720,GO:0003945,1,0.968519217533246,0,4,N-acetyllactosamine synthase activity,MF,
1721,GO:0003947,1,0.993823495236553,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1722,GO:0003948,1,0.989713524578748,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1723,GO:0003950,1,0.877801610571083,0,22,NAD+ ADP-ribosyltransferase activity,MF,
1724,GO:0003951,1,0.950341909510476,0,16,NAD+ kinase activity,MF,
1725,GO:0003952,1,0.991142587041807,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1726,GO:0003953,1,0.964260867316646,0,3,NAD+ nucleosidase activity,MF,
1727,GO:0003954,1,0.635349816884007,0,38,NADH dehydrogenase activity,MF,
1728,GO:0003955,1,0.987278722645322,0,2,NAD(P)H dehydrogenase (quinone) activity,MF,
1729,GO:0003956,1,0.941198296428759,0,5,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1730,GO:0003957,1,0.999526342462488,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1731,GO:0003958,1,0.976437623506211,0,6,NADPH-hemoprotein reductase activity,MF,
1732,GO:0003960,1,0.956682302928608,0,4,NADPH:quinone reductase activity,MF,
1733,GO:0003962,1,0.988606833667475,0,1,cystathionine gamma-synthase activity,MF,
1734,GO:0003963,1,0.991657600429728,0,1,RNA-3'-phosphate cyclase activity,MF,
1735,GO:0003964,1,0.961010694277827,0,7,RNA-directed DNA polymerase activity,MF,
1736,GO:0003968,1,0.998092388515741,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1737,GO:0003973,1,0.976973766431063,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1738,GO:0003974,1,0.988275120272065,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1739,GO:0003975,1,0.989921815379994,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1740,GO:0003976,1,0.977669434476771,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1741,GO:0003977,1,0.986218975286739,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1742,GO:0003978,1,0.988275120272065,0,1,UDP-glucose 4-epimerase activity,MF,
1743,GO:0003979,1,0.994698158453636,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1744,GO:0003980,1,0.999800389308592,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1745,GO:0003983,1,0.989918033882649,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1748,GO:0003987,1,0.986949676366437,0,3,acetate-CoA ligase activity,MF,
1750,GO:0003989,1,0.999999992786115,0,2,acetyl-CoA carboxylase activity,MF,
1751,GO:0003990,1,0.982961170297872,0,2,acetylcholinesterase activity,MF,
1753,GO:0003994,1,0.988974089524886,0,2,aconitate hydratase activity,MF,
1756,GO:0003997,1,0.955525320543407,0,6,acyl-CoA oxidase activity,MF,
1757,GO:0003998,1,0.974930349766723,0,2,acylphosphatase activity,MF,
1758,GO:0003999,1,0.987216861712719,0,1,adenine phosphoribosyltransferase activity,MF,
1759,GO:0004000,1,0.940010391069661,0,10,adenosine deaminase activity,MF,
1760,GO:0004001,1,0.98959060716668,0,1,adenosine kinase activity,MF,
1761,GO:0004003,1,0.882383179496873,0,33,ATP-dependent DNA helicase activity,MF,
1762,GO:0004004,1,0.728516155354353,0,67,ATP-dependent RNA helicase activity,MF,
1763,GO:0004008,1,0.999999992762095,0,2,copper-exporting ATPase activity,MF,
1764,GO:0004012,1,0.993513690607596,0,19,phospholipid-translocating ATPase activity,MF,
1765,GO:0004013,1,0.990500696840587,0,1,adenosylhomocysteinase activity,MF,
1766,GO:0004014,1,0.995026999315685,0,1,adenosylmethionine decarboxylase activity,MF,
1767,GO:0004016,1,0.990318129312202,0,10,adenylate cyclase activity,MF,
1768,GO:0004017,1,0.953748603151111,0,7,adenylate kinase activity,MF,
1769,GO:0004018,1,0.98799447644581,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1770,GO:0004019,1,0.981420734163361,0,2,adenylosuccinate synthase activity,MF,
1771,GO:0004020,1,0.989203708821213,0,2,adenylylsulfate kinase activity,MF,
1772,GO:0004021,1,0.986876387876045,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1773,GO:0004022,1,0.911068860437771,0,9,alcohol dehydrogenase (NAD) activity,MF,
1774,GO:0004024,1,0.938996853283328,0,6,alcohol dehydrogenase activity, zinc-dependent,MF,
1775,GO:0004027,1,0.975059027298357,0,2,alcohol sulfotransferase activity,MF,
1776,GO:0004028,1,0.960423279656235,0,5,3-chloroallyl aldehyde dehydrogenase activity,MF,
1777,GO:0004029,1,0.918146139003766,0,14,aldehyde dehydrogenase (NAD) activity,MF,
1778,GO:0004030,1,0.948136681167976,0,7,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1780,GO:0004032,1,0.919313747659645,0,7,alditol:NADP+ 1-oxidoreductase activity,MF,
1782,GO:0004034,1,0.991317921526807,0,1,aldose 1-epimerase activity,MF,
1783,GO:0004035,1,0.968271724020965,0,4,alkaline phosphatase activity,MF,
1784,GO:0004037,1,0.987936528897544,0,1,allantoicase activity,MF,
1785,GO:0004040,1,0.976166626963029,0,3,amidase activity,MF,
1786,GO:0004042,1,0.989655340272943,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1787,GO:0004043,1,0.996403026181617,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1788,GO:0004044,1,0.997173348733304,0,1,amidophosphoribosyltransferase activity,MF,
1789,GO:0004045,1,0.966518535443858,0,3,aminoacyl-tRNA hydrolase activity,MF,
1790,GO:0004046,1,0.945844601996497,0,5,aminoacylase activity,MF,
1791,GO:0004047,1,0.977818680108824,0,2,aminomethyltransferase activity,MF,
1792,GO:0004051,1,0.9916530783066,0,1,arachidonate 5-lipoxygenase activity,MF,
1793,GO:0004052,1,0.974701883929001,0,3,arachidonate 12-lipoxygenase activity,MF,
1794,GO:0004053,1,0.977398806347877,0,2,arginase activity,MF,
1795,GO:0004055,1,0.988840631351649,0,1,argininosuccinate synthase activity,MF,
1796,GO:0004056,1,0.989373672139854,0,1,argininosuccinate lyase activity,MF,
1797,GO:0004057,1,0.990191907385196,0,1,arginyltransferase activity,MF,
1798,GO:0004058,1,0.989468721778578,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1799,GO:0004059,1,0.987973602728523,0,1,aralkylamine N-acetyltransferase activity,MF,
1800,GO:0004060,1,0.965544198191092,0,3,arylamine N-acetyltransferase activity,MF,
1801,GO:0004061,1,0.98848070233315,0,1,arylformamidase activity,MF,
1802,GO:0004062,1,0.883408824882085,0,11,aryl sulfotransferase activity,MF,
1803,GO:0004063,1,0.976328067718811,0,2,aryldialkylphosphatase activity,MF,
1805,GO:0004065,1,0.935432358566454,0,12,arylsulfatase activity,MF,
1806,GO:0004066,1,0.981990754448995,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1807,GO:0004067,1,0.979896325152343,0,2,asparaginase activity,MF,
1808,GO:0004068,1,0.996833139940667,0,1,aspartate 1-decarboxylase activity,MF,
1809,GO:0004069,1,0.969178286418094,0,3,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1810,GO:0004070,1,0.999999996379559,0,1,aspartate carbamoyltransferase activity,MF,
1811,GO:0004074,1,0.974864135012106,0,2,biliverdin reductase activity,MF,
1812,GO:0004075,1,0.981101238439836,0,5,biotin carboxylase activity,MF,
1813,GO:0004077,1,0.999999996372699,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1814,GO:0004078,1,0.999999996372699,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1815,GO:0004079,1,0.999999996372699,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1816,GO:0004080,1,0.999999996372699,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1817,GO:0004081,1,0.980031737806338,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1818,GO:0004082,1,0.954226911717594,0,4,bisphosphoglycerate mutase activity,MF,
1819,GO:0004084,1,0.988292552479546,0,2,branched-chain-amino-acid transaminase activity,MF,
1820,GO:0004085,1,0.989133993605324,0,1,butyryl-CoA dehydrogenase activity,MF,
1821,GO:0004087,1,0.999999934383817,0,1,carbamoyl-phosphate synthase (ammonia) activity,MF,
1822,GO:0004088,1,0.999999930763347,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1823,GO:0004089,1,0.884870639690817,0,13,carbonate dehydratase activity,MF,
1824,GO:0004090,1,0.952069117299057,0,4,carbonyl reductase (NADPH) activity,MF,
1825,GO:0004092,1,0.992887415922428,0,1,carnitine O-acetyltransferase activity,MF,
1827,GO:0004096,1,0.967734449789724,0,3,catalase activity,MF,
1828,GO:0004098,1,0.989079402357716,0,1,cerebroside-sulfatase activity,MF,
1829,GO:0004102,1,0.991247490428139,0,1,choline O-acetyltransferase activity,MF,
1830,GO:0004103,1,0.980693505991758,0,2,choline kinase activity,MF,
1831,GO:0004104,1,0.975369012132369,0,3,cholinesterase activity,MF,
1832,GO:0004105,1,0.988196855022503,0,2,choline-phosphate cytidylyltransferase activity,MF,
1833,GO:0004108,1,0.993657777065081,0,1,citrate (Si)-synthase activity,MF,
1834,GO:0004109,1,0.983812694622059,0,2,coproporphyrinogen oxidase activity,MF,
1835,GO:0004111,1,0.942840858566188,0,6,creatine kinase activity,MF,
1836,GO:0004112,1,0.904922266821233,0,25,cyclic-nucleotide phosphodiesterase activity,MF,
1837,GO:0004113,1,0.999933177243888,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1838,GO:0004114,1,0.904982806453671,0,24,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1839,GO:0004115,1,0.96851691919963,0,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1840,GO:0004117,1,0.977983262955395,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1841,GO:0004118,1,0.998655774713448,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1842,GO:0004119,1,0.998472447717766,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1843,GO:0004122,1,0.991848723520862,0,1,cystathionine beta-synthase activity,MF,
1844,GO:0004123,1,0.988606833667475,0,1,cystathionine gamma-lyase activity,MF,
1845,GO:0004126,1,0.915611855009229,0,8,cytidine deaminase activity,MF,
1846,GO:0004127,1,0.970827802142136,0,4,cytidylate kinase activity,MF,
1847,GO:0004128,1,0.940723779426085,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1849,GO:0004131,1,0.987291077611859,0,1,cytosine deaminase activity,MF,
1850,GO:0004132,1,0.989503751525506,0,1,dCMP deaminase activity,MF,
1851,GO:0004133,1,0.999999996379923,0,1,glycogen debranching enzyme activity,MF,
1852,GO:0004134,1,0.999999996379923,0,1,4-alpha-glucanotransferase activity,MF,
1853,GO:0004135,1,0.999999996379923,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1854,GO:0004137,1,0.991721728933499,0,2,deoxycytidine kinase activity,MF,
1855,GO:0004138,1,0.9873751125871,0,1,deoxyguanosine kinase activity,MF,
1857,GO:0004140,1,0.980171384294694,0,2,dephospho-CoA kinase activity,MF,
1858,GO:0004142,1,0.977922659749486,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1859,GO:0004143,1,0.978339503647802,0,11,diacylglycerol kinase activity,MF,
1860,GO:0004144,1,0.952937537212143,0,5,diacylglycerol O-acyltransferase activity,MF,
1861,GO:0004145,1,0.965163858013226,0,3,diamine N-acetyltransferase activity,MF,
1862,GO:0004146,1,0.997800620129705,0,1,dihydrofolate reductase activity,MF,
1863,GO:0004148,1,0.996502821220058,0,1,dihydrolipoyl dehydrogenase activity,MF,
1864,GO:0004149,1,0.993026991574692,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1865,GO:0004151,1,0.999999996379559,0,1,dihydroorotase activity,MF,
1866,GO:0004152,1,0.989640888480121,0,1,dihydroorotate dehydrogenase activity,MF,
1867,GO:0004155,1,0.988365318180984,0,1,6,7-dihydropteridine reductase activity,MF,
1868,GO:0004157,1,0.989207986830672,0,2,dihydropyrimidinase activity,MF,
1869,GO:0004161,1,0.980923081420185,0,2,dimethylallyltranstransferase activity,MF,
1870,GO:0004163,1,0.988762903547959,0,1,diphosphomevalonate decarboxylase activity,MF,
1871,GO:0004164,1,0.98873984146559,0,1,diphthine synthase activity,MF,
1873,GO:0004167,1,0.965489622199779,0,3,dopachrome isomerase activity,MF,
1874,GO:0004168,1,0.990129252018048,0,1,dolichol kinase activity,MF,
1875,GO:0004169,1,0.956764540726881,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1876,GO:0004170,1,0.988981881900696,0,1,dUTP diphosphatase activity,MF,
1879,GO:0004176,1,0.982137367687026,0,4,ATP-dependent peptidase activity,MF,
1883,GO:0004185,1,0.958844867878208,0,5,serine-type carboxypeptidase activity,MF,
1884,GO:0004190,1,0.811799612530703,0,24,aspartic-type endopeptidase activity,MF,
1886,GO:0004198,1,0.873172610592063,0,19,calcium-dependent cysteine-type endopeptidase activity,MF,
1887,GO:0004222,1,0.551862463040371,0,112,metalloendopeptidase activity,MF,
1891,GO:0004301,1,0.94835164054216,0,5,epoxide hydrolase activity,MF,
1893,GO:0004304,1,0.978187083796274,0,2,estrone sulfotransferase activity,MF,
1894,GO:0004305,1,0.970882685522011,0,4,ethanolamine kinase activity,MF,
1895,GO:0004306,1,0.98893565016618,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1896,GO:0004307,1,0.97783241680222,0,2,ethanolaminephosphotransferase activity,MF,
1897,GO:0004308,1,0.943509091490088,0,6,exo-alpha-sialidase activity,MF,
1898,GO:0004310,1,0.989783393189947,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1899,GO:0004311,1,0.969601207791409,0,4,farnesyltranstransferase activity,MF,
1901,GO:0004313,1,0.999999996387332,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1902,GO:0004314,1,0.989223933345086,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1903,GO:0004315,1,0.987660695366218,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1904,GO:0004316,1,0.999999996387332,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1905,GO:0004317,1,0.999999996387332,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1906,GO:0004319,1,0.999999996387332,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1907,GO:0004320,1,0.98864394026523,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1909,GO:0004322,1,0.973767604195594,0,6,ferroxidase activity,MF,
1910,GO:0004324,1,0.989060321771781,0,1,ferredoxin-NADP+ reductase activity,MF,
1911,GO:0004325,1,0.999999996380312,0,1,ferrochelatase activity,MF,
1912,GO:0004326,1,0.991348857151105,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1913,GO:0004329,1,0.992647685874096,0,2,formate-tetrahydrofolate ligase activity,MF,
1914,GO:0004331,1,0.983769792415193,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1915,GO:0004332,1,0.967906793122762,0,3,fructose-bisphosphate aldolase activity,MF,
1916,GO:0004333,1,0.98873984146559,0,1,fumarate hydratase activity,MF,
1917,GO:0004334,1,0.987949376598353,0,1,fumarylacetoacetase activity,MF,
1918,GO:0004335,1,0.9824255434986,0,2,galactokinase activity,MF,
1919,GO:0004336,1,0.993307601763826,0,1,galactosylceramidase activity,MF,
1920,GO:0004337,1,0.980923081420185,0,2,geranyltranstransferase activity,MF,
1921,GO:0004339,1,0.999999996375827,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1922,GO:0004340,1,0.98041469725555,0,5,glucokinase activity,MF,
1924,GO:0004342,1,0.979742832495169,0,2,glucosamine-6-phosphate deaminase activity,MF,
1925,GO:0004343,1,0.997835061490837,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1926,GO:0004345,1,0.99070106113271,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1927,GO:0004346,1,0.97656827037701,0,3,glucose-6-phosphatase activity,MF,
1928,GO:0004347,1,0.98970987048019,0,1,glucose-6-phosphate isomerase activity,MF,
1929,GO:0004348,1,0.976242626825506,0,3,glucosylceramidase activity,MF,
1930,GO:0004349,1,0.99599416017826,0,1,glutamate 5-kinase activity,MF,
1931,GO:0004350,1,0.99599416017826,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1932,GO:0004351,1,0.981924371781555,0,3,glutamate decarboxylase activity,MF,
1933,GO:0004352,1,0.986738117156834,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1934,GO:0004353,1,0.986738117156834,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1935,GO:0004356,1,0.998999378314394,0,2,glutamate-ammonia ligase activity,MF,
1936,GO:0004357,1,0.991218873510729,0,2,glutamate-cysteine ligase activity,MF,
1937,GO:0004359,1,0.982219957264685,0,3,glutaminase activity,MF,
1938,GO:0004360,1,0.99386736918844,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1939,GO:0004361,1,0.988519776894314,0,1,glutaryl-CoA dehydrogenase activity,MF,
1940,GO:0004362,1,0.990411274272043,0,1,glutathione-disulfide reductase activity,MF,
1941,GO:0004363,1,0.989088979351481,0,1,glutathione synthase activity,MF,
1943,GO:0004365,1,0.975889975415075,0,2,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1944,GO:0004366,1,0.992969163751469,0,2,glycerol-3-phosphate O-acyltransferase activity,MF,
1945,GO:0004367,1,0.990946080483294,0,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1946,GO:0004368,1,0.993147726902887,0,2,glycerol-3-phosphate dehydrogenase activity,MF,
1947,GO:0004370,1,0.985759168550894,0,3,glycerol kinase activity,MF,
1948,GO:0004372,1,0.981587552150228,0,2,glycine hydroxymethyltransferase activity,MF,
1949,GO:0004373,1,0.990326323027533,0,2,glycogen (starch) synthase activity,MF,
1950,GO:0004375,1,0.997473039359802,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1951,GO:0004376,1,0.966204211381606,0,4,glycolipid mannosyltransferase activity,MF,
1952,GO:0004377,1,0.991544958006887,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1953,GO:0004378,1,0.993288197418697,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1954,GO:0004379,1,0.999578904349101,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1955,GO:0004380,1,0.988202697554432,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1956,GO:0004381,1,0.988202697554432,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1957,GO:0004382,1,0.98566455207802,0,2,guanosine-diphosphatase activity,MF,
1958,GO:0004383,1,0.96470105615016,0,17,guanylate cyclase activity,MF,
1959,GO:0004385,1,0.96505838549269,0,13,guanylate kinase activity,MF,
1960,GO:0004386,1,0.54873419505434,0,147,helicase activity,MF,
1961,GO:0004392,1,0.976869765911452,0,2,heme oxygenase (decyclizing) activity,MF,
1962,GO:0004394,1,0.998560823350876,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1963,GO:0004395,1,0.987647083299915,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1964,GO:0004396,1,0.98041469725555,0,5,hexokinase activity,MF,
1965,GO:0004397,1,0.994499905927764,0,1,histidine ammonia-lyase activity,MF,
1966,GO:0004398,1,0.990999848970619,0,1,histidine decarboxylase activity,MF,
1967,GO:0004402,1,0.723672672718151,0,54,histone acetyltransferase activity,MF,
1968,GO:0004407,1,0.814551633103008,0,40,histone deacetylase activity,MF,
1969,GO:0004408,1,0.990484368788493,0,1,holocytochrome-c synthase activity,MF,
1970,GO:0004411,1,0.98915669815631,0,1,homogentisate 1,2-dioxygenase activity,MF,
1971,GO:0004415,1,0.950764779080336,0,6,hyalurononglucosaminidase activity,MF,
1972,GO:0004416,1,0.981937353467284,0,2,hydroxyacylglutathione hydrolase activity,MF,
1973,GO:0004418,1,0.987973602728523,0,1,hydroxymethylbilane synthase activity,MF,
1974,GO:0004419,1,0.979612531138712,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1975,GO:0004420,1,0.999293189791113,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1976,GO:0004421,1,0.987068656117021,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1977,GO:0004422,1,0.987879530616557,0,1,hypoxanthine phosphoribosyltransferase activity,MF,
1978,GO:0004423,1,0.99999999637142,0,1,iduronate-2-sulfatase activity,MF,
1979,GO:0004427,1,0.964688933002601,0,3,inorganic diphosphatase activity,MF,
1980,GO:0004430,1,0.991010524575826,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1981,GO:0004435,1,0.897905526484614,0,27,phosphatidylinositol phospholipase C activity,MF,
1982,GO:0004438,1,0.962745688216792,0,14,phosphatidylinositol-3-phosphatase activity,MF,
1983,GO:0004439,1,0.971875934844669,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1984,GO:0004441,1,0.989722670023768,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1985,GO:0004445,1,0.974122362343922,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1986,GO:0004446,1,0.993002887673498,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1987,GO:0004447,1,0.993545760983938,0,2,iodide peroxidase activity,MF,
1989,GO:0004449,1,0.968818518455054,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1991,GO:0004452,1,0.977786295009183,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
1992,GO:0004454,1,0.991029978048249,0,1,ketohexokinase activity,MF,
1995,GO:0004459,1,0.945358192589723,0,5,L-lactate dehydrogenase activity,MF,
1996,GO:0004461,1,0.975781200098986,0,3,lactose synthase activity,MF,
1997,GO:0004462,1,0.989554979947929,0,1,lactoylglutathione lyase activity,MF,
1998,GO:0004463,1,0.989658959139861,0,1,leukotriene-A4 hydrolase activity,MF,
2000,GO:0004465,1,0.934120476868106,0,8,lipoprotein lipase activity,MF,
2002,GO:0004467,1,0.928412597459959,0,13,long-chain fatty acid-CoA ligase activity,MF,
2003,GO:0004468,1,0.962053420646703,0,6,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
2005,GO:0004471,1,0.985214295882842,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
2006,GO:0004473,1,0.985214295882842,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
2007,GO:0004474,1,0.999999977716115,0,1,malate synthase activity,MF,
2008,GO:0004475,1,0.988256714907937,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
2009,GO:0004476,1,0.988688643487989,0,1,mannose-6-phosphate isomerase activity,MF,
2010,GO:0004477,1,0.973937800199878,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
2011,GO:0004478,1,0.98860525182163,0,2,methionine adenosyltransferase activity,MF,
2012,GO:0004479,1,0.992534180667998,0,1,methionyl-tRNA formyltransferase activity,MF,
2013,GO:0004482,1,0.9999999963739,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2014,GO:0004484,1,0.999224023743137,0,1,mRNA guanylyltransferase activity,MF,
2015,GO:0004485,1,0.98853215831179,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2016,GO:0004486,1,0.995998681516664,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2017,GO:0004487,1,0.977226133667614,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2018,GO:0004488,1,0.973937800199878,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2019,GO:0004489,1,0.99999999637961,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2020,GO:0004490,1,0.988224987373363,0,1,methylglutaconyl-CoA hydratase activity,MF,
2021,GO:0004491,1,0.990074869994379,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2022,GO:0004492,1,0.989813059982135,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2023,GO:0004493,1,0.987277716208903,0,1,methylmalonyl-CoA epimerase activity,MF,
2024,GO:0004494,1,0.993565238364922,0,1,methylmalonyl-CoA mutase activity,MF,
2025,GO:0004496,1,0.989657149410863,0,1,mevalonate kinase activity,MF,
2027,GO:0004498,1,0.991348857151105,0,1,calcidiol 1-monooxygenase activity,MF,
2028,GO:0004499,1,0.961337171109922,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2029,GO:0004500,1,0.986633464855788,0,2,dopamine beta-monooxygenase activity,MF,
2030,GO:0004502,1,0.999841537032463,0,1,kynurenine 3-monooxygenase activity,MF,
2031,GO:0004503,1,0.989622877163354,0,1,monophenol monooxygenase activity,MF,
2032,GO:0004504,1,0.997095912840533,0,1,peptidylglycine monooxygenase activity,MF,
2034,GO:0004506,1,0.993711379022639,0,1,squalene monooxygenase activity,MF,
2035,GO:0004507,1,0.989322135366931,0,2,steroid 11-beta-monooxygenase activity,MF,
2037,GO:0004509,1,0.989494971003938,0,1,steroid 21-monooxygenase activity,MF,
2038,GO:0004510,1,0.979731461594817,0,2,tryptophan 5-monooxygenase activity,MF,
2039,GO:0004511,1,0.989085784307189,0,1,tyrosine 3-monooxygenase activity,MF,
2040,GO:0004512,1,0.990383019076429,0,1,inositol-3-phosphate synthase activity,MF,
2041,GO:0004513,1,0.990574549295068,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2042,GO:0004514,1,0.98753992461402,0,2,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2043,GO:0004515,1,0.986243490688892,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2044,GO:0004517,1,0.989955753794311,0,3,nitric-oxide synthase activity,MF,
2047,GO:0004520,1,0.666172879787176,0,50,endodeoxyribonuclease activity,MF,
2049,GO:0004522,1,0.950751969831532,0,4,ribonuclease A activity,MF,
2050,GO:0004523,1,0.938657776199041,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2051,GO:0004525,1,0.979554003964193,0,4,ribonuclease III activity,MF,
2052,GO:0004526,1,0.909399793866615,0,10,ribonuclease P activity,MF,
2053,GO:0004527,1,0.641600806477378,0,73,exonuclease activity,MF,
2054,GO:0004528,1,0.969441695095946,0,5,phosphodiesterase I activity,MF,
2055,GO:0004529,1,0.86999983936392,0,19,exodeoxyribonuclease activity,MF,
2056,GO:0004530,1,0.994237656652596,0,1,deoxyribonuclease I activity,MF,
2057,GO:0004531,1,0.977048997799485,0,2,deoxyribonuclease II activity,MF,
2058,GO:0004532,1,0.82351374261701,0,32,exoribonuclease activity,MF,
2059,GO:0004534,1,0.995939777103856,0,2,5'-3' exoribonuclease activity,MF,
2060,GO:0004535,1,0.950148526205932,0,12,poly(A)-specific ribonuclease activity,MF,
2061,GO:0004536,1,0.573513598633026,0,69,deoxyribonuclease activity,MF,
2063,GO:0004549,1,0.87018096259686,0,15,tRNA-specific ribonuclease activity,MF,
2064,GO:0004550,1,0.85571125687962,0,16,nucleoside diphosphate kinase activity,MF,
2065,GO:0004551,1,0.901633170982172,0,14,nucleotide diphosphatase activity,MF,
2067,GO:0004555,1,0.988950990789635,0,1,alpha,alpha-trehalase activity,MF,
2068,GO:0004556,1,0.946264633845306,0,5,alpha-amylase activity,MF,
2070,GO:0004558,1,0.996011052820118,0,4,alpha-1,4-glucosidase activity,MF,
2071,GO:0004559,1,0.963409218030797,0,13,alpha-mannosidase activity,MF,
2072,GO:0004560,1,0.979663299275961,0,2,alpha-L-fucosidase activity,MF,
2073,GO:0004561,1,0.992686359848639,0,1,alpha-N-acetylglucosaminidase activity,MF,
2075,GO:0004564,1,0.999999996372909,0,1,beta-fructofuranosidase activity,MF,
2076,GO:0004565,1,0.953273322152732,0,6,beta-galactosidase activity,MF,
2077,GO:0004566,1,0.979148781847677,0,3,beta-glucuronidase activity,MF,
2078,GO:0004567,1,0.995300013377687,0,1,beta-mannosidase activity,MF,
2079,GO:0004568,1,0.973100772493214,0,3,chitinase activity,MF,
2080,GO:0004569,1,0.999385324562941,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2081,GO:0004571,1,0.975015833502893,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2082,GO:0004572,1,0.999903917793256,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2083,GO:0004573,1,0.992446643006449,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2084,GO:0004574,1,0.996580183377494,0,2,oligo-1,6-glucosidase activity,MF,
2085,GO:0004575,1,0.999999996372909,0,1,sucrose alpha-glucosidase activity,MF,
2087,GO:0004577,1,0.981468007100871,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2088,GO:0004578,1,0.997875966464858,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2089,GO:0004579,1,0.920015959485369,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2092,GO:0004583,1,0.978580896214707,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2093,GO:0004584,1,0.990795480804676,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2094,GO:0004585,1,0.988365318180984,0,1,ornithine carbamoyltransferase activity,MF,
2095,GO:0004586,1,0.989640888480121,0,1,ornithine decarboxylase activity,MF,
2096,GO:0004587,1,0.989337883172791,0,1,ornithine-oxo-acid transaminase activity,MF,
2097,GO:0004588,1,0.992102348416464,0,1,orotate phosphoribosyltransferase activity,MF,
2098,GO:0004590,1,0.992102348416464,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2099,GO:0004591,1,0.995416876669916,0,3,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2100,GO:0004594,1,0.968917819440771,0,4,pantothenate kinase activity,MF,
2101,GO:0004595,1,0.990525246171653,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2102,GO:0004596,1,0.928774336373072,0,11,peptide alpha-N-acetyltransferase activity,MF,
2103,GO:0004597,1,0.996697090969176,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2104,GO:0004598,1,0.997095912840533,0,1,peptidylamidoglycolate lyase activity,MF,
2107,GO:0004603,1,0.987511578056136,0,1,phenylethanolamine N-methyltransferase activity,MF,
2108,GO:0004605,1,0.983422475858392,0,3,phosphatidate cytidylyltransferase activity,MF,
2109,GO:0004607,1,0.987776983228391,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2110,GO:0004608,1,0.987360893008489,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2111,GO:0004609,1,0.982166993981258,0,2,phosphatidylserine decarboxylase activity,MF,
2112,GO:0004610,1,0.989397686662513,0,1,phosphoacetylglucosamine mutase activity,MF,
2113,GO:0004611,1,0.981597996686832,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2114,GO:0004613,1,0.981597996686832,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2115,GO:0004614,1,0.975811830798967,0,3,phosphoglucomutase activity,MF,
2116,GO:0004615,1,0.978425623531679,0,2,phosphomannomutase activity,MF,
2117,GO:0004616,1,0.975855504090661,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2118,GO:0004617,1,0.989470467406246,0,1,phosphoglycerate dehydrogenase activity,MF,
2119,GO:0004618,1,0.979506150361221,0,2,phosphoglycerate kinase activity,MF,
2120,GO:0004619,1,0.954226911717594,0,4,phosphoglycerate mutase activity,MF,
2122,GO:0004621,1,0.990490488218666,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2125,GO:0004629,1,0.877594495278154,0,30,phospholipase C activity,MF,
2126,GO:0004630,1,0.95522828263711,0,6,phospholipase D activity,MF,
2127,GO:0004631,1,0.98769151788437,0,1,phosphomevalonate kinase activity,MF,
2128,GO:0004632,1,0.987643716410788,0,1,phosphopantothenate--cysteine ligase activity,MF,
2129,GO:0004633,1,0.99020765436424,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2130,GO:0004634,1,0.960203706306877,0,4,phosphopyruvate hydratase activity,MF,
2131,GO:0004637,1,0.99587834037342,0,1,phosphoribosylamine-glycine ligase activity,MF,
2132,GO:0004638,1,0.995403588576857,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2133,GO:0004639,1,0.995403588576857,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2134,GO:0004641,1,0.99587834037342,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2135,GO:0004642,1,0.999978512729599,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2136,GO:0004643,1,0.989746516163076,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2137,GO:0004644,1,0.99587834037342,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2138,GO:0004645,1,0.967637692153814,0,6,phosphorylase activity,MF,
2139,GO:0004647,1,0.967920656464723,0,3,phosphoserine phosphatase activity,MF,
2140,GO:0004648,1,0.989829811634005,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2141,GO:0004649,1,0.987277437413742,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2142,GO:0004651,1,0.987576533629277,0,2,polynucleotide 5'-phosphatase activity,MF,
2143,GO:0004652,1,0.982672339707981,0,8,polynucleotide adenylyltransferase activity,MF,
2144,GO:0004653,1,0.908470821464311,0,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,
2145,GO:0004654,1,0.999426095987091,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2146,GO:0004655,1,0.994664375544848,0,1,porphobilinogen synthase activity,MF,
2147,GO:0004656,1,0.965982322857432,0,4,procollagen-proline 4-dioxygenase activity,MF,
2148,GO:0004657,1,0.978764791050234,0,2,proline dehydrogenase activity,MF,
2149,GO:0004658,1,0.980188530323587,0,2,propionyl-CoA carboxylase activity,MF,
2150,GO:0004659,1,0.89907302875779,0,15,prenyltransferase activity,MF,
2151,GO:0004660,1,0.981231958043615,0,2,protein farnesyltransferase activity,MF,
2152,GO:0004661,1,0.957611807300664,0,5,protein geranylgeranyltransferase activity,MF,
2153,GO:0004662,1,0.980784493598837,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2154,GO:0004663,1,0.964904410993449,0,4,Rab geranylgeranyltransferase activity,MF,
2155,GO:0004666,1,0.999116477719425,0,2,prostaglandin-endoperoxide synthase activity,MF,
2156,GO:0004667,1,0.975679364058054,0,2,prostaglandin-D synthase activity,MF,
2157,GO:0004668,1,0.972803310963447,0,5,protein-arginine deiminase activity,MF,
2158,GO:0004671,1,0.9996770429036,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2160,GO:0004673,1,0.971774403090671,0,7,protein histidine kinase activity,MF,
2161,GO:0004674,1,0.128437635727166,0,431,protein serine/threonine kinase activity,MF,
2162,GO:0004675,1,0.955232024835293,0,16,transmembrane receptor protein serine/threonine kinase activity,MF,
2163,GO:0004676,1,0.999999996378986,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2164,GO:0004677,1,0.992913833623497,0,3,DNA-dependent protein kinase activity,MF,
2165,GO:0004679,1,0.964866679059683,0,7,AMP-activated protein kinase activity,MF,
2166,GO:0004683,1,0.86705302481998,0,28,calmodulin-dependent protein kinase activity,MF,
2167,GO:0004686,1,0.999999996381175,0,1,elongation factor-2 kinase activity,MF,
2168,GO:0004687,1,0.99278188342101,0,4,myosin light chain kinase activity,MF,
2169,GO:0004689,1,0.985758881832119,0,5,phosphorylase kinase activity,MF,
2170,GO:0004690,1,0.961043154255742,0,9,cyclic nucleotide-dependent protein kinase activity,MF,
2171,GO:0004691,1,0.967964208409687,0,7,cAMP-dependent protein kinase activity,MF,
2172,GO:0004692,1,0.992851737258069,0,2,cGMP-dependent protein kinase activity,MF,
2173,GO:0004693,1,0.796828994017577,0,27,cyclin-dependent protein serine/threonine kinase activity,MF,
2174,GO:0004694,1,0.991066519882296,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2175,GO:0004697,1,0.938408276414737,0,16,protein kinase C activity,MF,
2176,GO:0004698,1,0.981714794465439,0,4,calcium-dependent protein kinase C activity,MF,
2177,GO:0004699,1,0.98892579661001,0,3,calcium-independent protein kinase C activity,MF,
2178,GO:0004702,1,0.690550341430136,0,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,
2179,GO:0004703,1,0.95466681733641,0,5,G-protein coupled receptor kinase activity,MF,
2180,GO:0004704,1,0.967665611317716,0,6,NF-kappaB-inducing kinase activity,MF,
2181,GO:0004705,1,0.984847732640816,0,3,JUN kinase activity,MF,
2182,GO:0004706,1,0.992319997070485,0,3,JUN kinase kinase kinase activity,MF,
2183,GO:0004707,1,0.918365766316936,0,14,MAP kinase activity,MF,
2184,GO:0004708,1,0.923658223276735,0,13,MAP kinase kinase activity,MF,
2185,GO:0004709,1,0.930053339137272,0,20,MAP kinase kinase kinase activity,MF,
2186,GO:0004711,1,0.983151072678015,0,3,ribosomal protein S6 kinase activity,MF,
2187,GO:0004712,1,0.787151181772809,0,40,protein serine/threonine/tyrosine kinase activity,MF,
2189,GO:0004714,1,0.824647374217591,0,64,transmembrane receptor protein tyrosine kinase activity,MF,
2190,GO:0004715,1,0.74657826566012,0,50,non-membrane spanning protein tyrosine kinase activity,MF,
2191,GO:0004716,1,0.983139138765381,0,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,
2192,GO:0004719,1,0.98487342647514,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2193,GO:0004720,1,0.989612979437703,0,3,protein-lysine 6-oxidase activity,MF,
2195,GO:0004722,1,0.674149480347281,0,67,protein serine/threonine phosphatase activity,MF,
2196,GO:0004723,1,0.984815093367712,0,6,calcium-dependent protein serine/threonine phosphatase activity,MF,
2198,GO:0004726,1,0.95337050847785,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2199,GO:0004727,1,0.977403613574593,0,2,prenylated protein tyrosine phosphatase activity,MF,
2200,GO:0004728,1,0.991798445845593,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2201,GO:0004729,1,0.988609563752324,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2204,GO:0004733,1,0.995966998989074,0,1,pyridoxamine-phosphate oxidase activity,MF,
2205,GO:0004735,1,0.969476146011268,0,3,pyrroline-5-carboxylate reductase activity,MF,
2206,GO:0004736,1,0.998139497300553,0,1,pyruvate carboxylase activity,MF,
2207,GO:0004738,1,0.959782258336153,0,6,pyruvate dehydrogenase activity,MF,
2208,GO:0004739,1,0.971766623881109,0,3,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2210,GO:0004741,1,0.99619377244029,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2211,GO:0004742,1,0.998993929979302,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2212,GO:0004743,1,0.985638587542364,0,2,pyruvate kinase activity,MF,
2213,GO:0004744,1,0.991917529713633,0,1,retinal isomerase activity,MF,
2214,GO:0004745,1,0.828917441471132,0,18,retinol dehydrogenase activity,MF,
2215,GO:0004747,1,0.987561936682946,0,1,ribokinase activity,MF,
2216,GO:0004748,1,0.989994992422479,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2217,GO:0004749,1,0.949840968345655,0,5,ribose phosphate diphosphokinase activity,MF,
2218,GO:0004750,1,0.990529344379638,0,1,ribulose-phosphate 3-epimerase activity,MF,
2219,GO:0004751,1,0.988871990256435,0,1,ribose-5-phosphate isomerase activity,MF,
2220,GO:0004753,1,0.999999996371891,0,1,saccharopine dehydrogenase activity,MF,
2221,GO:0004756,1,0.982300988070447,0,2,selenide, water dikinase activity,MF,
2222,GO:0004757,1,0.987951223214789,0,1,sepiapterin reductase activity,MF,
2223,GO:0004758,1,0.970199421241041,0,5,serine C-palmitoyltransferase activity,MF,
2224,GO:0004760,1,0.988252144942411,0,1,serine-pyruvate transaminase activity,MF,
2225,GO:0004766,1,0.987660701412748,0,1,spermidine synthase activity,MF,
2226,GO:0004767,1,0.95682919493184,0,6,sphingomyelin phosphodiesterase activity,MF,
2227,GO:0004768,1,0.986332656106821,0,3,stearoyl-CoA 9-desaturase activity,MF,
2229,GO:0004771,1,0.971532416032742,0,4,sterol esterase activity,MF,
2230,GO:0004772,1,0.98541076145282,0,2,sterol O-acyltransferase activity,MF,
2231,GO:0004773,1,0.999999996374941,0,1,steryl-sulfatase activity,MF,
2232,GO:0004774,1,0.969057920866668,0,3,succinate-CoA ligase activity,MF,
2233,GO:0004775,1,0.978091181754988,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2234,GO:0004776,1,0.9788349672781,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2235,GO:0004777,1,0.999908180509053,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2236,GO:0004778,1,0.988310174662441,0,1,succinyl-CoA hydrolase activity,MF,
2237,GO:0004779,1,0.989203708821213,0,2,sulfate adenylyltransferase activity,MF,
2238,GO:0004781,1,0.989203708821213,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2239,GO:0004782,1,0.989188473792192,0,2,sulfinoalanine decarboxylase activity,MF,
2240,GO:0004784,1,0.94287197946958,0,5,superoxide dismutase activity,MF,
2241,GO:0004788,1,0.990782840187539,0,1,thiamine diphosphokinase activity,MF,
2242,GO:0004790,1,0.991644038120897,0,1,thioether S-methyltransferase activity,MF,
2243,GO:0004791,1,0.903974261562301,0,10,thioredoxin-disulfide reductase activity,MF,
2244,GO:0004792,1,0.967012378359652,0,3,thiosulfate sulfurtransferase activity,MF,
2245,GO:0004793,1,0.981587552150228,0,2,threonine aldolase activity,MF,
2246,GO:0004794,1,0.976250928575506,0,2,L-threonine ammonia-lyase activity,MF,
2247,GO:0004796,1,0.989800062774136,0,1,thromboxane-A synthase activity,MF,
2248,GO:0004797,1,0.98809828617148,0,2,thymidine kinase activity,MF,
2249,GO:0004798,1,0.981252736973267,0,2,thymidylate kinase activity,MF,
2250,GO:0004799,1,0.98821157638415,0,1,thymidylate synthase activity,MF,
2251,GO:0004800,1,0.978325322364769,0,3,thyroxine 5'-deiodinase activity,MF,
2252,GO:0004801,1,0.987619265051838,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2253,GO:0004802,1,0.974787796013609,0,3,transketolase activity,MF,
2254,GO:0004803,1,0.989151771634233,0,3,transposase activity,MF,
2255,GO:0004806,1,0.829266929776536,0,21,triglyceride lipase activity,MF,
2256,GO:0004807,1,0.987956779957383,0,1,triose-phosphate isomerase activity,MF,
2257,GO:0004809,1,0.971272090731116,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2258,GO:0004810,1,0.990435569307827,0,1,tRNA adenylyltransferase activity,MF,
2259,GO:0004812,1,0.724855149671407,0,44,aminoacyl-tRNA ligase activity,MF,
2260,GO:0004813,1,0.984257965063475,0,3,alanine-tRNA ligase activity,MF,
2261,GO:0004814,1,0.957122704990437,0,4,arginine-tRNA ligase activity,MF,
2262,GO:0004815,1,0.986190225246914,0,2,aspartate-tRNA ligase activity,MF,
2263,GO:0004816,1,0.98363999741755,0,2,asparagine-tRNA ligase activity,MF,
2264,GO:0004817,1,0.981139948497666,0,2,cysteine-tRNA ligase activity,MF,
2265,GO:0004818,1,0.997656554510238,0,2,glutamate-tRNA ligase activity,MF,
2266,GO:0004819,1,0.991160007999267,0,1,glutamine-tRNA ligase activity,MF,
2267,GO:0004820,1,0.980902224801451,0,2,glycine-tRNA ligase activity,MF,
2268,GO:0004821,1,0.980766007846572,0,2,histidine-tRNA ligase activity,MF,
2269,GO:0004822,1,0.995634688452539,0,2,isoleucine-tRNA ligase activity,MF,
2270,GO:0004823,1,0.998427786672869,0,2,leucine-tRNA ligase activity,MF,
2271,GO:0004824,1,0.989792648350572,0,1,lysine-tRNA ligase activity,MF,
2272,GO:0004825,1,0.986726384179517,0,2,methionine-tRNA ligase activity,MF,
2273,GO:0004826,1,0.954954839480194,0,5,phenylalanine-tRNA ligase activity,MF,
2274,GO:0004827,1,0.990560848093226,0,2,proline-tRNA ligase activity,MF,
2275,GO:0004828,1,0.978839162468726,0,2,serine-tRNA ligase activity,MF,
2276,GO:0004829,1,0.979327005929857,0,3,threonine-tRNA ligase activity,MF,
2277,GO:0004830,1,0.985188568108852,0,2,tryptophan-tRNA ligase activity,MF,
2278,GO:0004831,1,0.984385481349749,0,2,tyrosine-tRNA ligase activity,MF,
2279,GO:0004832,1,0.995338918902082,0,3,valine-tRNA ligase activity,MF,
2280,GO:0004833,1,0.967557628163473,0,3,tryptophan 2,3-dioxygenase activity,MF,
2281,GO:0004835,1,0.999910674503412,0,1,tubulin-tyrosine ligase activity,MF,
2282,GO:0004838,1,0.992605397731212,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2283,GO:0004839,1,0.987559121054003,0,4,ubiquitin activating enzyme activity,MF,
2284,GO:0004842,1,0.0980338576036896,0,423,ubiquitin-protein transferase activity,MF,
2285,GO:0004843,1,0.7336988757546,0,73,thiol-dependent ubiquitin-specific protease activity,MF,
2286,GO:0004844,1,0.949637078726927,0,5,uracil DNA N-glycosylase activity,MF,
2287,GO:0004849,1,0.951924069988414,0,5,uridine kinase activity,MF,
2288,GO:0004850,1,0.979901203473699,0,2,uridine phosphorylase activity,MF,
2289,GO:0004852,1,0.987781711445888,0,1,uroporphyrinogen-III synthase activity,MF,
2290,GO:0004853,1,0.987830290763824,0,1,uroporphyrinogen decarboxylase activity,MF,
2292,GO:0004855,1,0.999999912924884,0,1,xanthine oxidase activity,MF,
2293,GO:0004856,1,0.996964750000636,0,1,xylulokinase activity,MF,
2296,GO:0004860,1,0.523045553182324,0,92,protein kinase inhibitor activity,MF,
2297,GO:0004861,1,0.902288097004131,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2298,GO:0004862,1,0.927718458231656,0,9,cAMP-dependent protein kinase inhibitor activity,MF,
2299,GO:0004864,1,0.779669159911168,0,33,protein phosphatase inhibitor activity,MF,
2300,GO:0004865,1,0.92515333040987,0,8,protein serine/threonine phosphatase inhibitor activity,MF,
2306,GO:0004873,1,0.976077109022679,0,2,asialoglycoprotein receptor activity,MF,
2307,GO:0004874,1,0.999659261596307,0,2,aryl hydrocarbon receptor activity,MF,
2308,GO:0004875,1,0.920341716946446,0,10,complement receptor activity,MF,
2309,GO:0004876,1,0.989235529949153,0,1,complement component C3a receptor activity,MF,
2310,GO:0004877,1,0.999999996391921,0,1,complement component C3b receptor activity,MF,
2311,GO:0004878,1,0.9824252849457,0,2,complement component C5a receptor activity,MF,
2312,GO:0004879,1,0.778296959478964,0,46,RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding,MF,
2313,GO:0004882,1,0.976818475183816,0,3,androgen receptor activity,MF,
2314,GO:0004883,1,0.999999996376377,0,1,glucocorticoid receptor activity,MF,
2315,GO:0004886,1,0.980838056732838,0,3,9-cis retinoic acid receptor activity,MF,
2316,GO:0004887,1,0.953108536304454,0,7,thyroid hormone receptor activity,MF,
2318,GO:0004890,1,0.890256497344687,0,19,GABA-A receptor activity,MF,
2320,GO:0004897,1,0.982604606347826,0,4,ciliary neurotrophic factor receptor activity,MF,
2321,GO:0004900,1,0.988914291456888,0,1,erythropoietin receptor activity,MF,
2322,GO:0004904,1,0.96127118940035,0,5,interferon receptor activity,MF,
2323,GO:0004905,1,0.987874325322212,0,2,type I interferon receptor activity,MF,
2324,GO:0004906,1,0.980153527317038,0,2,interferon-gamma receptor activity,MF,
2325,GO:0004908,1,0.955580310356883,0,7,interleukin-1 receptor activity,MF,
2326,GO:0004909,1,0.989062026676775,0,2,interleukin-1, Type I, activating receptor activity,MF,
2327,GO:0004910,1,0.981683103154614,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2328,GO:0004911,1,0.981230785598278,0,3,interleukin-2 receptor activity,MF,
2329,GO:0004912,1,0.988247876757445,0,2,interleukin-3 receptor activity,MF,
2330,GO:0004913,1,0.979121244750161,0,2,interleukin-4 receptor activity,MF,
2331,GO:0004914,1,0.989191254529807,0,2,interleukin-5 receptor activity,MF,
2332,GO:0004915,1,0.993179381441076,0,2,interleukin-6 receptor activity,MF,
2333,GO:0004917,1,0.977018078721888,0,2,interleukin-7 receptor activity,MF,
2334,GO:0004918,1,0.983971519495844,0,2,interleukin-8 receptor activity,MF,
2335,GO:0004919,1,0.989974988047088,0,1,interleukin-9 receptor activity,MF,
2336,GO:0004920,1,0.966420789500485,0,5,interleukin-10 receptor activity,MF,
2337,GO:0004921,1,0.994702982197217,0,1,interleukin-11 receptor activity,MF,
2338,GO:0004923,1,0.99470297754503,0,2,leukemia inhibitory factor receptor activity,MF,
2339,GO:0004924,1,0.991473922341472,0,3,oncostatin-M receptor activity,MF,
2340,GO:0004925,1,0.999999996404567,0,1,prolactin receptor activity,MF,
2342,GO:0004931,1,0.937187594830973,0,7,extracellular ATP-gated cation channel activity,MF,
2343,GO:0004935,1,0.92003458695649,0,10,adrenergic receptor activity,MF,
2344,GO:0004936,1,0.955212284452436,0,6,alpha-adrenergic receptor activity,MF,
2345,GO:0004937,1,0.972777808286834,0,3,alpha1-adrenergic receptor activity,MF,
2346,GO:0004938,1,0.981946841642472,0,3,alpha2-adrenergic receptor activity,MF,
2347,GO:0004939,1,0.97481065368062,0,3,beta-adrenergic receptor activity,MF,
2348,GO:0004940,1,0.99304628573826,0,1,beta1-adrenergic receptor activity,MF,
2349,GO:0004941,1,0.989526652572035,0,1,beta2-adrenergic receptor activity,MF,
2350,GO:0004945,1,0.959513415570357,0,4,angiotensin type II receptor activity,MF,
2351,GO:0004946,1,0.975787063626225,0,2,bombesin receptor activity,MF,
2352,GO:0004947,1,0.986320453814601,0,2,bradykinin receptor activity,MF,
2353,GO:0004948,1,0.983809534422532,0,3,calcitonin receptor activity,MF,
2354,GO:0004949,1,0.986170524805816,0,3,cannabinoid receptor activity,MF,
2355,GO:0004950,1,0.812347585185795,0,23,chemokine receptor activity,MF,
2356,GO:0004951,1,0.978383245479173,0,2,cholecystokinin receptor activity,MF,
2357,GO:0004952,1,0.874468797832455,0,12,dopamine neurotransmitter receptor activity,MF,
2358,GO:0004953,1,0.881711440798934,0,15,icosanoid receptor activity,MF,
2359,GO:0004954,1,0.914391362000257,0,11,prostanoid receptor activity,MF,
2360,GO:0004955,1,0.923251614381568,0,10,prostaglandin receptor activity,MF,
2361,GO:0004956,1,0.985155467972267,0,2,prostaglandin D receptor activity,MF,
2362,GO:0004957,1,0.951278257388207,0,6,prostaglandin E receptor activity,MF,
2363,GO:0004958,1,0.991634000263269,0,2,prostaglandin F receptor activity,MF,
2364,GO:0004960,1,0.990409252857432,0,1,thromboxane receptor activity,MF,
2365,GO:0004961,1,0.990409252857432,0,1,thromboxane A2 receptor activity,MF,
2366,GO:0004962,1,0.996311370511169,0,2,endothelin receptor activity,MF,
2367,GO:0004963,1,0.986721478213753,0,2,follicle-stimulating hormone receptor activity,MF,
2368,GO:0004964,1,0.994188989899865,0,1,luteinizing hormone receptor activity,MF,
2369,GO:0004965,1,0.997644300052296,0,3,G-protein coupled GABA receptor activity,MF,
2370,GO:0004966,1,0.922227752186685,0,7,galanin receptor activity,MF,
2371,GO:0004967,1,0.972640687234948,0,3,glucagon receptor activity,MF,
2372,GO:0004968,1,0.998755989722122,0,2,gonadotropin-releasing hormone receptor activity,MF,
2373,GO:0004969,1,0.963560893111336,0,6,histamine receptor activity,MF,
2376,GO:0004972,1,0.996522603261482,0,7,NMDA glutamate receptor activity,MF,
2377,GO:0004974,1,0.964285358228262,0,4,leukotriene receptor activity,MF,
2378,GO:0004977,1,0.943922478761757,0,6,melanocortin receptor activity,MF,
2379,GO:0004978,1,0.996766454489474,0,1,corticotropin receptor activity,MF,
2380,GO:0004979,1,0.988957146665087,0,1,beta-endorphin receptor activity,MF,
2381,GO:0004980,1,0.969840010357497,0,3,melanocyte-stimulating hormone receptor activity,MF,
2382,GO:0004982,1,0.956554126458034,0,4,N-formyl peptide receptor activity,MF,
2383,GO:0004983,1,0.93394712465771,0,8,neuropeptide Y receptor activity,MF,
2384,GO:0004984,1,0.00810450382976944,0,376,olfactory receptor activity,MF,
2385,GO:0004985,1,0.928786039134776,0,8,opioid receptor activity,MF,
2386,GO:0004990,1,0.999002180190209,0,1,oxytocin receptor activity,MF,
2387,GO:0004991,1,0.982333278288977,0,2,parathyroid hormone receptor activity,MF,
2388,GO:0004992,1,0.986547121731056,0,3,platelet activating factor receptor activity,MF,
2389,GO:0004993,1,0.764350761155957,0,26,G-protein coupled serotonin receptor activity,MF,
2390,GO:0004994,1,0.95949162022289,0,5,somatostatin receptor activity,MF,
2391,GO:0004995,1,0.974830513721015,0,3,tachykinin receptor activity,MF,
2392,GO:0004996,1,0.985284163686486,0,2,thyroid-stimulating hormone receptor activity,MF,
2393,GO:0004997,1,0.987747577746719,0,1,thyrotropin-releasing hormone receptor activity,MF,
2394,GO:0004998,1,0.993177452718331,0,2,transferrin receptor activity,MF,
2395,GO:0004999,1,0.979175567236031,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2396,GO:0005000,1,0.950543013872822,0,7,vasopressin receptor activity,MF,
2397,GO:0005001,1,0.974724746406756,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2398,GO:0005003,1,0.931026214687844,0,19,ephrin receptor activity,MF,
2399,GO:0005004,1,0.979888600035022,0,7,GPI-linked ephrin receptor activity,MF,
2400,GO:0005005,1,0.966179394315473,0,8,transmembrane-ephrin receptor activity,MF,
2401,GO:0005006,1,0.984168716878987,0,2,epidermal growth factor-activated receptor activity,MF,
2402,GO:0005007,1,0.985465650421207,0,5,fibroblast growth factor-activated receptor activity,MF,
2403,GO:0005008,1,0.999999996376662,0,1,hepatocyte growth factor-activated receptor activity,MF,
2404,GO:0005009,1,0.99999999639046,0,1,insulin-activated receptor activity,MF,
2405,GO:0005010,1,0.99999669299238,0,3,insulin-like growth factor-activated receptor activity,MF,
2406,GO:0005011,1,0.997737977582485,0,2,macrophage colony-stimulating factor receptor activity,MF,
2407,GO:0005017,1,0.988039064747767,0,3,platelet-derived growth factor-activated receptor activity,MF,
2408,GO:0005018,1,0.99999999637622,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2409,GO:0005019,1,0.98803907073138,0,2,platelet-derived growth factor beta-receptor activity,MF,
2410,GO:0005020,1,0.999919816307882,0,1,stem cell factor receptor activity,MF,
2411,GO:0005021,1,0.988448073339938,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2412,GO:0005024,1,0.980547180491312,0,9,transforming growth factor beta-activated receptor activity,MF,
2413,GO:0005025,1,0.992194726461824,0,4,transforming growth factor beta receptor activity, type I,MF,
2414,GO:0005026,1,0.988474921812007,0,2,transforming growth factor beta receptor activity, type II,MF,
2415,GO:0005030,1,0.985247899593251,0,4,neurotrophin receptor activity,MF,
2416,GO:0005031,1,0.81763654156487,0,24,tumor necrosis factor-activated receptor activity,MF,
2417,GO:0005034,1,0.994512019025568,0,1,osmosensor activity,MF,
2418,GO:0005035,1,0.81763654156487,0,24,death receptor activity,MF,
2419,GO:0005041,1,0.958954189868683,0,13,low-density lipoprotein receptor activity,MF,
2420,GO:0005042,1,0.99679986482134,0,2,netrin receptor activity,MF,
2421,GO:0005044,1,0.797558038487469,0,41,scavenger receptor activity,MF,
2422,GO:0005046,1,0.980692901425701,0,2,KDEL sequence binding,MF,
2423,GO:0005047,1,0.970567168351628,0,4,signal recognition particle binding,MF,
2424,GO:0005048,1,0.779656157152107,0,43,signal sequence binding,MF,
2425,GO:0005049,1,0.983940528170006,0,7,nuclear export signal receptor activity,MF,
2426,GO:0005052,1,0.991147198609111,0,2,peroxisome matrix targeting signal-1 binding,MF,
2427,GO:0005053,1,0.988006007972467,0,1,peroxisome matrix targeting signal-2 binding,MF,
2428,GO:0005055,1,0.978714296991664,0,2,laminin receptor activity,MF,
2430,GO:0005068,1,0.938207035643875,0,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2431,GO:0005070,1,0.70022684469404,0,57,SH3/SH2 adaptor activity,MF,
2432,GO:0005072,1,0.966720890544545,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2433,GO:0005078,1,0.988334084548321,0,7,MAP-kinase scaffold activity,MF,
2434,GO:0005080,1,0.790684074633896,0,42,protein kinase C binding,MF,
2436,GO:0005086,1,0.942740814899605,0,19,ARF guanyl-nucleotide exchange factor activity,MF,
2437,GO:0005087,1,0.961825587811438,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2439,GO:0005089,1,0.836154050445796,0,78,Rho guanyl-nucleotide exchange factor activity,MF,
2440,GO:0005090,1,0.990009397148328,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2441,GO:0005092,1,0.897048849428644,0,14,GDP-dissociation inhibitor activity,MF,
2442,GO:0005093,1,0.982138717273653,0,2,Rab GDP-dissociation inhibitor activity,MF,
2443,GO:0005094,1,0.964285753343029,0,3,Rho GDP-dissociation inhibitor activity,MF,
2444,GO:0005095,1,0.926835708744602,0,14,GTPase inhibitor activity,MF,
2449,GO:0005109,1,0.773094647974706,0,36,frizzled binding,MF,
2450,GO:0005110,1,0.993409571458814,0,2,frizzled-2 binding,MF,
2452,GO:0005112,1,0.916254310145221,0,20,Notch binding,MF,
2453,GO:0005113,1,0.943004761215229,0,8,patched binding,MF,
2454,GO:0005114,1,0.968037165582056,0,7,type II transforming growth factor beta receptor binding,MF,
2455,GO:0005115,1,0.999999996371578,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2456,GO:0005119,1,0.993826290737801,0,3,smoothened binding,MF,
2458,GO:0005124,1,0.989798208311358,0,1,scavenger receptor binding,MF,
2459,GO:0005125,1,0.104345720231579,0,218,cytokine activity,MF,
2461,GO:0005127,1,0.961809850114783,0,5,ciliary neurotrophic factor receptor binding,MF,
2462,GO:0005128,1,0.982848910784648,0,2,erythropoietin receptor binding,MF,
2463,GO:0005129,1,0.98723350921926,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
2464,GO:0005130,1,0.988067247534859,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2465,GO:0005131,1,0.976155660692299,0,5,growth hormone receptor binding,MF,
2466,GO:0005132,1,0.805864620735236,0,17,type I interferon receptor binding,MF,
2467,GO:0005133,1,0.987573985404204,0,1,interferon-gamma receptor binding,MF,
2468,GO:0005134,1,0.950480146986697,0,5,interleukin-2 receptor binding,MF,
2469,GO:0005135,1,0.982427250910607,0,2,interleukin-3 receptor binding,MF,
2470,GO:0005136,1,0.970569926721248,0,3,interleukin-4 receptor binding,MF,
2471,GO:0005137,1,0.977382004425231,0,2,interleukin-5 receptor binding,MF,
2473,GO:0005139,1,0.989673458219995,0,1,interleukin-7 receptor binding,MF,
2474,GO:0005140,1,0.987173722599235,0,1,interleukin-9 receptor binding,MF,
2475,GO:0005141,1,0.988312537004459,0,1,interleukin-10 receptor binding,MF,
2476,GO:0005142,1,0.990757606749609,0,1,interleukin-11 receptor binding,MF,
2477,GO:0005143,1,0.96139100664834,0,5,interleukin-12 receptor binding,MF,
2478,GO:0005144,1,0.987667601272536,0,1,interleukin-13 receptor binding,MF,
2479,GO:0005146,1,0.986208667484483,0,2,leukemia inhibitory factor receptor binding,MF,
2480,GO:0005147,1,0.988941777993996,0,1,oncostatin-M receptor binding,MF,
2481,GO:0005148,1,0.974914429908382,0,2,prolactin receptor binding,MF,
2482,GO:0005149,1,0.880884134471493,0,17,interleukin-1 receptor binding,MF,
2483,GO:0005150,1,0.985325534581095,0,2,interleukin-1, Type I receptor binding,MF,
2484,GO:0005151,1,0.988679212994751,0,2,interleukin-1, Type II receptor binding,MF,
2485,GO:0005152,1,0.980462308601563,0,3,interleukin-1 receptor antagonist activity,MF,
2486,GO:0005153,1,0.9943543411653,0,1,interleukin-8 receptor binding,MF,
2488,GO:0005157,1,0.968180973752349,0,3,macrophage colony-stimulating factor receptor binding,MF,
2490,GO:0005159,1,0.896088802379282,0,16,insulin-like growth factor receptor binding,MF,
2491,GO:0005160,1,0.711086669417489,0,49,transforming growth factor beta receptor binding,MF,
2492,GO:0005161,1,0.964876006555897,0,14,platelet-derived growth factor receptor binding,MF,
2493,GO:0005163,1,0.987405369214795,0,1,nerve growth factor receptor binding,MF,
2495,GO:0005165,1,0.944051071202228,0,11,neurotrophin receptor binding,MF,
2496,GO:0005166,1,0.967393921080761,0,3,neurotrophin p75 receptor binding,MF,
2497,GO:0005167,1,0.988325429292073,0,7,neurotrophin TRK receptor binding,MF,
2498,GO:0005168,1,0.990180172586706,0,6,neurotrophin TRKA receptor binding,MF,
2499,GO:0005169,1,0.998091738029771,0,2,neurotrophin TRKB receptor binding,MF,
2500,GO:0005170,1,0.999964660140604,0,1,neurotrophin TRKC receptor binding,MF,
2501,GO:0005171,1,0.979094905146605,0,2,hepatocyte growth factor receptor binding,MF,
2502,GO:0005172,1,0.946800589217188,0,10,vascular endothelial growth factor receptor binding,MF,
2503,GO:0005173,1,0.998778389919627,0,3,stem cell factor receptor binding,MF,
2504,GO:0005174,1,0.979422423897305,0,2,CD40 receptor binding,MF,
2505,GO:0005175,1,0.987194196303093,0,1,CD27 receptor binding,MF,
2506,GO:0005176,1,0.977629741643923,0,3,ErbB-2 class receptor binding,MF,
2507,GO:0005178,1,0.584396824405429,0,100,integrin binding,MF,
2508,GO:0005179,1,0.298391643035323,0,111,hormone activity,MF,
2509,GO:0005183,1,0.988519776894314,0,1,gonadotropin hormone-releasing hormone activity,MF,
2510,GO:0005184,1,0.72169304900177,0,27,neuropeptide hormone activity,MF,
2511,GO:0005185,1,0.974501991626575,0,2,neurohypophyseal hormone activity,MF,
2513,GO:0005199,1,0.995520622140357,0,1,structural constituent of cell wall,MF,
2514,GO:0005200,1,0.493818957468539,0,104,structural constituent of cytoskeleton,MF,
2515,GO:0005201,1,0.757409998894595,0,75,extracellular matrix structural constituent,MF,
2516,GO:0005212,1,0.784726783982974,0,20,structural constituent of eye lens,MF,
2519,GO:0005217,1,0.922778842246631,0,28,intracellular ligand-gated ion channel activity,MF,
2520,GO:0005219,1,0.987343927381686,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2521,GO:0005220,1,0.999999989195344,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2522,GO:0005221,1,0.964148551949009,0,9,intracellular cyclic nucleotide activated cation channel activity,MF,
2523,GO:0005222,1,0.992490146079511,0,4,intracellular cAMP activated cation channel activity,MF,
2524,GO:0005223,1,0.98585457973018,0,4,intracellular cGMP activated cation channel activity,MF,
2525,GO:0005225,1,0.969582665481682,0,8,volume-sensitive anion channel activity,MF,
2526,GO:0005227,1,0.821984318632083,0,30,calcium activated cation channel activity,MF,
2527,GO:0005229,1,0.940306663589733,0,16,intracellular calcium activated chloride channel activity,MF,
2531,GO:0005237,1,0.963834418918504,0,6,inhibitory extracellular ligand-gated ion channel activity,MF,
2532,GO:0005242,1,0.88024978849052,0,22,inward rectifier potassium channel activity,MF,
2533,GO:0005243,1,0.891258513055464,0,14,gap junction channel activity,MF,
2534,GO:0005244,1,0.379378240232913,0,192,voltage-gated ion channel activity,MF,
2535,GO:0005245,1,0.829951673593081,0,41,voltage-gated calcium channel activity,MF,
2536,GO:0005246,1,0.788839908590008,0,33,calcium channel regulator activity,MF,
2537,GO:0005247,1,0.94320931644513,0,12,voltage-gated chloride channel activity,MF,
2538,GO:0005248,1,0.968719610716689,0,23,voltage-gated sodium channel activity,MF,
2539,GO:0005249,1,0.640170337249017,0,88,voltage-gated potassium channel activity,MF,
2540,GO:0005250,1,0.982795995056921,0,4,A-type (transient outward) potassium channel activity,MF,
2541,GO:0005251,1,0.897418415550669,0,20,delayed rectifier potassium channel activity,MF,
2542,GO:0005252,1,0.997992570586687,0,1,open rectifier potassium channel activity,MF,
2545,GO:0005260,1,0.999999996373532,0,1,intracellular ATPase-gated chloride channel activity,MF,
2547,GO:0005262,1,0.623208720697178,0,114,calcium channel activity,MF,
2548,GO:0005267,1,0.473168401959266,0,124,potassium channel activity,MF,
2549,GO:0005272,1,0.869649650162349,0,45,sodium channel activity,MF,
2550,GO:0005275,1,0.975073640372723,0,3,amine transmembrane transporter activity,MF,
2551,GO:0005276,1,0.991711970667283,0,1,vesicular hydrogen:amino acid antiporter activity,MF,
2552,GO:0005277,1,0.971660905364249,0,3,acetylcholine transmembrane transporter activity,MF,
2553,GO:0005280,1,0.963711402010204,0,6,hydrogen:amino acid symporter activity,MF,
2554,GO:0005283,1,0.955845695126034,0,11,sodium:amino acid symporter activity,MF,
2555,GO:0005287,1,0.999999996382036,0,1,high-affinity basic amino acid transmembrane transporter activity,MF,
2556,GO:0005289,1,0.999999996382036,0,1,high-affinity arginine transmembrane transporter activity,MF,
2557,GO:0005290,1,0.983970861356623,0,2,L-histidine transmembrane transporter activity,MF,
2558,GO:0005292,1,0.999999996382036,0,1,high-affinity lysine transmembrane transporter activity,MF,
2559,GO:0005294,1,0.987972684577021,0,3,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2560,GO:0005298,1,0.996170436728225,0,2,proline:sodium symporter activity,MF,
2561,GO:0005302,1,0.994499905927764,0,1,L-tyrosine transmembrane transporter activity,MF,
2562,GO:0005307,1,0.999903921437995,0,1,choline:sodium symporter activity,MF,
2563,GO:0005308,1,0.995771212335886,0,2,creatine transmembrane transporter activity,MF,
2564,GO:0005309,1,0.996311024055997,0,1,creatine:sodium symporter activity,MF,
2568,GO:0005315,1,0.985675007059022,0,4,inorganic phosphate transmembrane transporter activity,MF,
2569,GO:0005316,1,0.995138955563757,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2572,GO:0005325,1,0.996849720927078,0,1,peroxisomal fatty-acyl-CoA transporter activity,MF,
2573,GO:0005326,1,0.877193627456828,0,25,neurotransmitter transporter activity,MF,
2574,GO:0005328,1,0.931638495666565,0,19,neurotransmitter:sodium symporter activity,MF,
2575,GO:0005329,1,0.977747331128222,0,5,dopamine transmembrane transporter activity,MF,
2576,GO:0005330,1,0.997225738426409,0,2,dopamine:sodium symporter activity,MF,
2577,GO:0005332,1,0.974036391328335,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2578,GO:0005333,1,0.976035967224529,0,3,norepinephrine transmembrane transporter activity,MF,
2579,GO:0005334,1,0.995478574863344,0,1,norepinephrine:sodium symporter activity,MF,
2580,GO:0005335,1,0.999334848714627,0,1,serotonin:sodium symporter activity,MF,
2581,GO:0005337,1,0.92410280674054,0,9,nucleoside transmembrane transporter activity,MF,
2582,GO:0005338,1,0.931657559097148,0,9,nucleotide-sugar transmembrane transporter activity,MF,
2584,GO:0005343,1,0.874416179543342,0,25,organic acid:sodium symporter activity,MF,
2585,GO:0005344,1,0.849141925146921,0,14,oxygen transporter activity,MF,
2586,GO:0005345,1,0.949549180671677,0,6,purine nucleobase transmembrane transporter activity,MF,
2587,GO:0005346,1,0.9169529516056,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2588,GO:0005347,1,0.936365694043194,0,9,ATP transmembrane transporter activity,MF,
2589,GO:0005350,1,0.973846464305785,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2590,GO:0005351,1,0.902817889346633,0,15,sugar:proton symporter activity,MF,
2591,GO:0005353,1,0.990619980762556,0,1,fructose transmembrane transporter activity,MF,
2592,GO:0005355,1,0.883785321758361,0,19,glucose transmembrane transporter activity,MF,
2593,GO:0005362,1,0.985450419823311,0,2,low-affinity glucose:sodium symporter activity,MF,
2594,GO:0005365,1,0.999999992782202,0,2,myo-inositol transmembrane transporter activity,MF,
2595,GO:0005366,1,0.999999996378723,0,1,myo-inositol:proton symporter activity,MF,
2596,GO:0005367,1,0.999999996403497,0,1,myo-inositol:sodium symporter activity,MF,
2597,GO:0005368,1,0.999999996375723,0,1,taurine transmembrane transporter activity,MF,
2598,GO:0005369,1,0.999999996375723,0,1,taurine:sodium symporter activity,MF,
2599,GO:0005372,1,0.910255531883867,0,12,water transmembrane transporter activity,MF,
2601,GO:0005381,1,0.943932900851352,0,9,iron ion transmembrane transporter activity,MF,
2602,GO:0005384,1,0.981771407389186,0,4,manganese ion transmembrane transporter activity,MF,
2603,GO:0005385,1,0.855863454886364,0,22,zinc ion transmembrane transporter activity,MF,
2604,GO:0005388,1,0.979460783326211,0,14,calcium-transporting ATPase activity,MF,
2605,GO:0005391,1,0.939458447822769,0,10,sodium:potassium-exchanging ATPase activity,MF,
2606,GO:0005395,1,0.999999996380863,0,1,eye pigment precursor transporter activity,MF,
2607,GO:0005402,1,0.902817889346633,0,15,cation:sugar symporter activity,MF,
2608,GO:0005412,1,0.956077613802538,0,6,glucose:sodium symporter activity,MF,
2609,GO:0005415,1,0.971327705738323,0,3,nucleoside:sodium symporter activity,MF,
2610,GO:0005416,1,0.92114714815766,0,17,cation:amino acid symporter activity,MF,
2611,GO:0005427,1,0.991481724112405,0,2,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2612,GO:0005432,1,0.980250410752897,0,5,calcium:sodium antiporter activity,MF,
2613,GO:0005436,1,0.930908092536549,0,10,sodium:phosphate symporter activity,MF,
2614,GO:0005451,1,0.937636474198439,0,14,monovalent cation:proton antiporter activity,MF,
2615,GO:0005452,1,0.867703020133067,0,24,inorganic anion exchanger activity,MF,
2616,GO:0005456,1,0.988803713154355,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2617,GO:0005457,1,0.986471326193314,0,3,GDP-fucose transmembrane transporter activity,MF,
2618,GO:0005459,1,0.976244231753256,0,2,UDP-galactose transmembrane transporter activity,MF,
2619,GO:0005461,1,0.999999996375464,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2620,GO:0005462,1,0.989948342177731,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2621,GO:0005464,1,0.9999999963776,0,1,UDP-xylose transmembrane transporter activity,MF,
2622,GO:0005471,1,0.975055366127299,0,3,ATP:ADP antiporter activity,MF,
2623,GO:0005476,1,0.988975681364968,0,1,carnitine:acyl carnitine antiporter activity,MF,
2624,GO:0005477,1,0.996297813953236,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2625,GO:0005483,1,0.983672620394004,0,3,soluble NSF attachment protein activity,MF,
2626,GO:0005484,1,0.746176200891345,0,38,SNAP receptor activity,MF,
2627,GO:0005487,1,0.876042207381627,0,28,nucleocytoplasmic transporter activity,MF,
2630,GO:0005497,1,0.95912950669106,0,4,androgen binding,MF,
2631,GO:0005499,1,0.957137274691151,0,6,vitamin D binding,MF,
2633,GO:0005502,1,0.97563369466463,0,3,11-cis retinal binding,MF,
2634,GO:0005503,1,0.989332793388196,0,1,all-trans retinal binding,MF,
2639,GO:0005513,1,0.917222393773138,0,13,detection of calcium ion,BP,
2641,GO:0005516,1,0.431588425506871,0,189,calmodulin binding,MF,
2642,GO:0005518,1,0.726262639625161,0,61,collagen binding,MF,
2643,GO:0005519,1,0.998002374568097,0,1,cytoskeletal regulatory protein binding,MF,
2644,GO:0005520,1,0.817576972200169,0,28,insulin-like growth factor binding,MF,
2646,GO:0005522,1,0.965304036235505,0,9,profilin binding,MF,
2650,GO:0005527,1,0.886777075650779,0,14,macrolide binding,MF,
2651,GO:0005528,1,0.886777075650779,0,14,FK506 binding,MF,
2652,GO:0005534,1,0.965467200785244,0,4,galactose binding,MF,
2653,GO:0005536,1,0.938973525315902,0,11,glucose binding,MF,
2654,GO:0005537,1,0.880306684001753,0,17,mannose binding,MF,
2656,GO:0005540,1,0.899767752897122,0,20,hyaluronic acid binding,MF,
2657,GO:0005542,1,0.908739921126005,0,10,folic acid binding,MF,
2660,GO:0005545,1,0.948212865439764,0,18,1-phosphatidylinositol binding,MF,
2662,GO:0005547,1,0.865542558371503,0,35,phosphatidylinositol-3,4,5-trisphosphate binding,MF,
2664,GO:0005549,1,0.343308769907507,0,84,odorant binding,MF,
2665,GO:0005550,1,0.987161500251914,0,1,pheromone binding,MF,
2668,GO:0005577,1,0.941397076486917,0,9,fibrinogen complex,CC,
2670,GO:0005579,1,0.955741313401359,0,7,membrane attack complex,CC,
2671,GO:0005581,1,0.643315383231543,0,88,collagen trimer,CC,
2672,GO:0005582,1,0.999959061008756,0,1,collagen type XV trimer,CC,
2673,GO:0005583,1,0.984077443032716,0,12,fibrillar collagen trimer,CC,
2674,GO:0005584,1,0.999985652099063,0,2,collagen type I trimer,CC,
2675,GO:0005585,1,0.999845724317784,0,1,collagen type II trimer,CC,
2676,GO:0005586,1,0.999993206350177,0,1,collagen type III trimer,CC,
2677,GO:0005587,1,0.999999978283793,0,6,collagen type IV trimer,CC,
2678,GO:0005588,1,0.999999989139943,0,3,collagen type V trimer,CC,
2679,GO:0005589,1,0.986814388203457,0,3,collagen type VI trimer,CC,
2680,GO:0005590,1,0.999999996391682,0,1,collagen type VII trimer,CC,
2681,GO:0005591,1,0.991961250736736,0,1,collagen type VIII trimer,CC,
2682,GO:0005592,1,0.999999992754009,0,2,collagen type XI trimer,CC,
2683,GO:0005593,1,0.980485976014696,0,6,FACIT collagen trimer,CC,
2684,GO:0005594,1,0.980487340738819,0,3,collagen type IX trimer,CC,
2685,GO:0005595,1,0.999999996394895,0,1,collagen type XII trimer,CC,
2686,GO:0005596,1,0.999999996375647,0,1,collagen type XIV trimer,CC,
2687,GO:0005597,1,0.999998627511705,0,1,collagen type XVI trimer,CC,
2688,GO:0005598,1,0.991961250736736,0,1,short-chain collagen trimer,CC,
2689,GO:0005600,1,0.994037991498953,0,1,collagen type XIII trimer,CC,
2690,GO:0005602,1,0.975006680001392,0,2,complement component C1 complex,CC,
2693,GO:0005606,1,0.999999989149044,0,3,laminin-1 complex,CC,
2694,GO:0005607,1,0.999876084536183,0,2,laminin-2 complex,CC,
2695,GO:0005608,1,0.99999999276478,0,2,laminin-3 complex,CC,
2696,GO:0005610,1,0.998308503262001,0,3,laminin-5 complex,CC,
2697,GO:0005614,1,0.94122840329291,0,13,interstitial matrix,CC,
2704,GO:0005638,1,0.975777852175574,0,4,lamin filament,CC,
2705,GO:0005639,1,0.913275294237971,0,14,integral component of nuclear inner membrane,CC,
2707,GO:0005641,1,0.953328657470283,0,8,nuclear envelope lumen,CC,
2708,GO:0005642,1,0.982759189863744,0,5,annulate lamellae,CC,
2709,GO:0005643,1,0.696327939972771,0,72,nuclear pore,CC,
2710,GO:0005652,1,0.957089643944095,0,8,nuclear lamina,CC,
2712,GO:0005655,1,0.9375393838136,0,7,nucleolar ribonuclease P complex,CC,
2713,GO:0005656,1,0.980887951317669,0,2,nuclear pre-replicative complex,CC,
2714,GO:0005657,1,0.641366353208506,0,65,replication fork,CC,
2715,GO:0005658,1,0.960298711051392,0,6,alpha DNA polymerase:primase complex,CC,
2716,GO:0005662,1,0.890817059563546,0,15,DNA replication factor A complex,CC,
2717,GO:0005663,1,0.944331250055467,0,6,DNA replication factor C complex,CC,
2718,GO:0005664,1,0.932130807115734,0,9,nuclear origin of replication recognition complex,CC,
2719,GO:0005665,1,0.853445413745385,0,18,DNA-directed RNA polymerase II, core complex,CC,
2720,GO:0005666,1,0.862284920237605,0,17,DNA-directed RNA polymerase III complex,CC,
2721,GO:0005667,1,0.122686073195614,0,304,transcription factor complex,CC,
2722,GO:0005668,1,0.978331668080217,0,2,RNA polymerase transcription factor SL1 complex,CC,
2723,GO:0005669,1,0.762593491954089,0,35,transcription factor TFIID complex,CC,
2724,GO:0005671,1,0.93155645318804,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2725,GO:0005672,1,0.942583233025103,0,5,transcription factor TFIIA complex,CC,
2726,GO:0005673,1,0.98811033555713,0,1,transcription factor TFIIE complex,CC,
2727,GO:0005674,1,0.979698597571216,0,2,transcription factor TFIIF complex,CC,
2728,GO:0005675,1,0.898109286517546,0,12,holo TFIIH complex,CC,
2729,GO:0005677,1,0.965013758701235,0,9,chromatin silencing complex,CC,
2730,GO:0005680,1,0.84522307401837,0,21,anaphase-promoting complex,CC,
2731,GO:0005681,1,0.257787104347665,0,174,spliceosomal complex,CC,
2732,GO:0005682,1,0.867482317915164,0,20,U5 snRNP,CC,
2733,GO:0005683,1,0.919603384581149,0,7,U7 snRNP,CC,
2734,GO:0005684,1,0.741784935400053,0,33,U2-type spliceosomal complex,CC,
2735,GO:0005685,1,0.826074446664396,0,19,U1 snRNP,CC,
2736,GO:0005686,1,0.838737192266712,0,17,U2 snRNP,CC,
2737,GO:0005687,1,0.889227306546544,0,10,U4 snRNP,CC,
2738,GO:0005688,1,0.933385380506057,0,6,U6 snRNP,CC,
2739,GO:0005689,1,0.775098029233794,0,25,U12-type spliceosomal complex,CC,
2740,GO:0005690,1,0.990102009116146,0,1,U4atac snRNP,CC,
2741,GO:0005691,1,0.999056693482752,0,1,U6atac snRNP,CC,
2742,GO:0005694,1,0.00220936676034315,0,897,chromosome,CC,
2743,GO:0005697,1,0.87295063787911,0,21,telomerase holoenzyme complex,CC,
2744,GO:0005712,1,0.991251875543847,0,2,chiasma,CC,
2745,GO:0005713,1,0.986101111526699,0,2,recombination nodule,CC,
2746,GO:0005715,1,0.991251880888793,0,1,late recombination nodule,CC,
2747,GO:0005719,1,0.820597404062495,0,24,nuclear euchromatin,CC,
2748,GO:0005720,1,0.817107578140405,0,33,nuclear heterochromatin,CC,
2749,GO:0005721,1,0.922271716559339,0,18,pericentric heterochromatin,CC,
2750,GO:0005724,1,0.98833394167051,0,1,nuclear telomeric heterochromatin,CC,
2751,GO:0005726,1,0.992745291621225,0,3,perichromatin fibrils,CC,
2753,GO:0005731,1,0.98853560337144,0,1,nucleolus organizer region,CC,
2754,GO:0005732,1,0.842389456134572,0,16,small nucleolar ribonucleoprotein complex,CC,
2755,GO:0005736,1,0.9176039749865,0,11,DNA-directed RNA polymerase I complex,CC,
2760,GO:0005742,1,0.908993269219184,0,9,mitochondrial outer membrane translocase complex,CC,
2762,GO:0005744,1,0.904270052764655,0,10,mitochondrial inner membrane presequence translocase complex,CC,
2763,GO:0005745,1,0.985973109725749,0,2,m-AAA complex,CC,
2764,GO:0005746,1,0.411821143558223,0,77,mitochondrial respiratory chain,CC,
2765,GO:0005747,1,0.606954573631056,0,42,mitochondrial respiratory chain complex I,CC,
2766,GO:0005749,1,0.959247947479429,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2767,GO:0005750,1,0.892376938539296,0,11,mitochondrial respiratory chain complex III,CC,
2768,GO:0005751,1,0.85693388044307,0,12,mitochondrial respiratory chain complex IV,CC,
2769,GO:0005753,1,0.784817196867901,0,20,mitochondrial proton-transporting ATP synthase complex,CC,
2770,GO:0005754,1,0.988899119991551,0,1,mitochondrial proton-transporting ATP synthase, catalytic core,CC,
2771,GO:0005757,1,0.987247606983837,0,1,mitochondrial permeability transition pore complex,CC,
2774,GO:0005760,1,0.9983451027731,0,2,gamma DNA polymerase complex,CC,
2777,GO:0005763,1,0.729749128312265,0,26,mitochondrial small ribosomal subunit,CC,
2779,GO:0005765,1,0.129913901537142,0,322,lysosomal membrane,CC,
2781,GO:0005767,1,0.891668767344215,0,14,secondary lysosome,CC,
2785,GO:0005771,1,0.739213386896375,0,38,multivesicular body,CC,
2787,GO:0005774,1,0.0923613165251935,0,367,vacuolar membrane,CC,
2792,GO:0005779,1,0.88791337790776,0,14,integral component of peroxisomal membrane,CC,
2795,GO:0005784,1,0.95365688769471,0,4,Sec61 translocon complex,CC,
2796,GO:0005785,1,0.945867879964008,0,6,signal recognition particle receptor complex,CC,
2797,GO:0005786,1,0.943736010858634,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2798,GO:0005787,1,0.955019702074277,0,5,signal peptidase complex,CC,
2799,GO:0005788,1,0.317986386982758,0,196,endoplasmic reticulum lumen,CC,
2802,GO:0005791,1,0.619884334802061,0,68,rough endoplasmic reticulum,CC,
2805,GO:0005795,1,0.524747308476504,0,120,Golgi stack,CC,
2806,GO:0005796,1,0.497434929150944,0,97,Golgi lumen,CC,
2807,GO:0005797,1,0.973020793596625,0,4,Golgi medial cisterna,CC,
2808,GO:0005798,1,0.594907785225105,0,83,Golgi-associated vesicle,CC,
2809,GO:0005801,1,0.790541735258005,0,40,cis-Golgi network,CC,
2810,GO:0005802,1,0.332140047560461,0,183,trans-Golgi network,CC,
2812,GO:0005813,1,0.0738118860797046,0,467,centrosome,CC,
2813,GO:0005814,1,0.572366227474947,0,105,centriole,CC,
2815,GO:0005818,1,0.983924608888949,0,5,aster,CC,
2817,GO:0005826,1,0.989519980128482,0,4,actomyosin contractile ring,CC,
2818,GO:0005827,1,0.978100264818583,0,5,polar microtubule,CC,
2819,GO:0005828,1,0.980274964544428,0,6,kinetochore microtubule,CC,
2821,GO:0005832,1,0.90399386255193,0,11,chaperonin-containing T-complex,CC,
2822,GO:0005833,1,0.862172667806721,0,12,hemoglobin complex,CC,
2823,GO:0005834,1,0.764727579483593,0,35,heterotrimeric G-protein complex,CC,
2824,GO:0005838,1,0.7973556625555,0,21,proteasome regulatory particle,CC,
2827,GO:0005844,1,0.758331500496038,0,44,polysome,CC,
2828,GO:0005845,1,0.92857311530716,0,13,mRNA cap binding complex,CC,
2829,GO:0005846,1,0.989692300487505,0,2,nuclear cap binding complex,CC,
2830,GO:0005847,1,0.911515830163657,0,14,mRNA cleavage and polyadenylation specificity factor complex,CC,
2831,GO:0005849,1,0.897281591928473,0,19,mRNA cleavage factor complex,CC,
2832,GO:0005850,1,0.984128448597593,0,4,eukaryotic translation initiation factor 2 complex,CC,
2833,GO:0005851,1,0.947480256679001,0,6,eukaryotic translation initiation factor 2B complex,CC,
2834,GO:0005852,1,0.862283767470561,0,17,eukaryotic translation initiation factor 3 complex,CC,
2835,GO:0005853,1,0.960816757499704,0,4,eukaryotic translation elongation factor 1 complex,CC,
2837,GO:0005858,1,0.968823468673712,0,12,axonemal dynein complex,CC,
2838,GO:0005859,1,0.89465466133603,0,27,muscle myosin complex,CC,
2839,GO:0005861,1,0.91457914166939,0,8,troponin complex,CC,
2840,GO:0005862,1,0.967991683610539,0,4,muscle thin filament tropomyosin,CC,
2841,GO:0005863,1,0.995792854370594,0,3,striated muscle myosin thick filament,CC,
2843,GO:0005868,1,0.861332058502197,0,22,cytoplasmic dynein complex,CC,
2844,GO:0005869,1,0.936387061323145,0,8,dynactin complex,CC,
2845,GO:0005871,1,0.836624070918632,0,52,kinesin complex,CC,
2846,GO:0005873,1,0.99972490251317,0,2,plus-end kinesin complex,CC,
2848,GO:0005875,1,0.515494986046371,0,141,microtubule associated complex,CC,
2849,GO:0005876,1,0.761824178208464,0,52,spindle microtubule,CC,
2850,GO:0005879,1,0.987807313348594,0,3,axonemal microtubule,CC,
2851,GO:0005881,1,0.752843412924641,0,47,cytoplasmic microtubule,CC,
2853,GO:0005883,1,0.966810024837448,0,8,neurofilament,CC,
2854,GO:0005884,1,0.665811071308673,0,81,actin filament,CC,
2855,GO:0005885,1,0.889799426940413,0,11,Arp2/3 protein complex,CC,
2858,GO:0005889,1,0.992966086894887,0,2,hydrogen:potassium-exchanging ATPase complex,CC,
2860,GO:0005891,1,0.843002163650326,0,38,voltage-gated calcium channel complex,CC,
2861,GO:0005892,1,0.877814474077158,0,17,acetylcholine-gated channel complex,CC,
2862,GO:0005895,1,0.990005565215556,0,1,interleukin-5 receptor complex,CC,
2863,GO:0005896,1,0.98080565472726,0,3,interleukin-6 receptor complex,CC,
2864,GO:0005898,1,0.998108181229332,0,1,interleukin-13 receptor complex,CC,
2865,GO:0005899,1,0.999999989151575,0,3,insulin receptor complex,CC,
2866,GO:0005900,1,0.991473927630322,0,2,oncostatin-M receptor complex,CC,
2867,GO:0005901,1,0.743565706041441,0,69,caveola,CC,
2868,GO:0005902,1,0.640865832851156,0,78,microvillus,CC,
2869,GO:0005903,1,0.604851492539638,0,98,brush border,CC,
2870,GO:0005905,1,0.749710859074646,0,67,clathrin-coated pit,CC,
2871,GO:0005911,1,0.139868172775411,0,394,cell-cell junction,CC,
2873,GO:0005913,1,0.667548171344049,0,81,cell-cell adherens junction,CC,
2874,GO:0005914,1,0.995398892184177,0,1,spot adherens junction,CC,
2875,GO:0005915,1,0.979838928255002,0,7,zonula adherens,CC,
2876,GO:0005916,1,0.967416177781046,0,10,fascia adherens,CC,
2877,GO:0005921,1,0.779324500381277,0,30,gap junction,CC,
2878,GO:0005922,1,0.837875013838835,0,20,connexin complex,CC,
2879,GO:0005923,1,0.598646816058422,0,109,bicellular tight junction,CC,
2882,GO:0005927,1,0.975558090364812,0,3,muscle tendon junction,CC,
2883,GO:0005929,1,0.0484001296951836,0,479,cilium,CC,
2884,GO:0005930,1,0.655374866636294,0,84,axoneme,CC,
2886,GO:0005940,1,0.993747934067793,0,1,septin ring,CC,
2887,GO:0005942,1,0.943121868446073,0,19,phosphatidylinositol 3-kinase complex,CC,
2888,GO:0005943,1,0.997069883745063,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2889,GO:0005944,1,0.993217712543953,0,3,phosphatidylinositol 3-kinase complex, class IB,CC,
2890,GO:0005945,1,0.989402378904789,0,2,6-phosphofructokinase complex,CC,
2891,GO:0005947,1,0.95894299926834,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2892,GO:0005952,1,0.960603664422303,0,7,cAMP-dependent protein kinase complex,CC,
2893,GO:0005953,1,0.980784493598837,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2894,GO:0005954,1,0.991287059867833,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2895,GO:0005955,1,0.987840478593121,0,4,calcineurin complex,CC,
2896,GO:0005956,1,0.98000895941407,0,2,protein kinase CK2 complex,CC,
2897,GO:0005958,1,0.986646066749015,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2898,GO:0005960,1,0.985547214960035,0,2,glycine cleavage complex,CC,
2899,GO:0005964,1,0.985758881832119,0,5,phosphorylase kinase complex,CC,
2900,GO:0005965,1,0.981231958043615,0,2,protein farnesyltransferase complex,CC,
2901,GO:0005967,1,0.988916877866566,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2902,GO:0005968,1,0.976376897111657,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2903,GO:0005969,1,0.999999996384669,0,1,serine-pyruvate aminotransferase complex,CC,
2904,GO:0005971,1,0.990224951024038,0,2,ribonucleoside-diphosphate reductase complex,CC,
2906,GO:0005976,1,0.579464284875973,0,99,polysaccharide metabolic process,BP,
2907,GO:0005977,1,0.682634825360931,0,72,glycogen metabolic process,BP,
2908,GO:0005978,1,0.781046923168385,0,46,glycogen biosynthetic process,BP,
2909,GO:0005979,1,0.904157635355769,0,26,regulation of glycogen biosynthetic process,BP,
2910,GO:0005980,1,0.875724035316205,0,26,glycogen catabolic process,BP,
2911,GO:0005981,1,0.968964578410505,0,6,regulation of glycogen catabolic process,BP,
2912,GO:0005982,1,0.999999996375827,0,1,starch metabolic process,BP,
2913,GO:0005983,1,0.999999996375827,0,1,starch catabolic process,BP,
2915,GO:0005985,1,0.972621439686509,0,3,sucrose metabolic process,BP,
2916,GO:0005986,1,0.975959683743276,0,2,sucrose biosynthetic process,BP,
2917,GO:0005988,1,0.982791142759917,0,3,lactose metabolic process,BP,
2918,GO:0005989,1,0.982791142759917,0,3,lactose biosynthetic process,BP,
2919,GO:0005991,1,0.988950990789635,0,1,trehalose metabolic process,BP,
2920,GO:0005993,1,0.988950990789635,0,1,trehalose catabolic process,BP,
2922,GO:0005997,1,0.96214734129549,0,4,xylulose metabolic process,BP,
2923,GO:0005998,1,0.996964750000636,0,1,xylulose catabolic process,BP,
2924,GO:0005999,1,0.9775354693246,0,2,xylulose biosynthetic process,BP,
2925,GO:0006000,1,0.888241766252974,0,14,fructose metabolic process,BP,
2926,GO:0006001,1,0.967178116637843,0,4,fructose catabolic process,BP,
2927,GO:0006002,1,0.92956736044786,0,9,fructose 6-phosphate metabolic process,BP,
2928,GO:0006003,1,0.983769792415193,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2929,GO:0006004,1,0.918603368625914,0,15,fucose metabolic process,BP,
2931,GO:0006007,1,0.787297985647019,0,30,glucose catabolic process,BP,
2934,GO:0006013,1,0.95642836241337,0,8,mannose metabolic process,BP,
2935,GO:0006014,1,0.964432916984494,0,3,D-ribose metabolic process,BP,
2936,GO:0006015,1,0.962309935168614,0,4,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2937,GO:0006020,1,0.950737730025574,0,11,inositol metabolic process,BP,
2938,GO:0006021,1,0.974293382320366,0,4,inositol biosynthetic process,BP,
2945,GO:0006030,1,0.973100772493214,0,3,chitin metabolic process,BP,
2946,GO:0006032,1,0.973100772493214,0,3,chitin catabolic process,BP,
2947,GO:0006037,1,0.988033318391619,0,1,cell wall chitin metabolic process,BP,
2948,GO:0006040,1,0.79123902580472,0,34,amino sugar metabolic process,BP,
2949,GO:0006041,1,0.977888440970888,0,3,glucosamine metabolic process,BP,
2950,GO:0006043,1,0.99051296294005,0,1,glucosamine catabolic process,BP,
2951,GO:0006044,1,0.90636600043618,0,15,N-acetylglucosamine metabolic process,BP,
2952,GO:0006045,1,0.997305198173563,0,2,N-acetylglucosamine biosynthetic process,BP,
2953,GO:0006047,1,0.899231488713757,0,14,UDP-N-acetylglucosamine metabolic process,BP,
2954,GO:0006048,1,0.934235127487772,0,9,UDP-N-acetylglucosamine biosynthetic process,BP,
2955,GO:0006049,1,0.993360996682053,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2956,GO:0006050,1,0.976321433828117,0,2,mannosamine metabolic process,BP,
2957,GO:0006051,1,0.976321433828117,0,2,N-acetylmannosamine metabolic process,BP,
2958,GO:0006054,1,0.93949746845776,0,9,N-acetylneuraminate metabolic process,BP,
2959,GO:0006055,1,0.987612795703566,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2960,GO:0006056,1,0.988688643487989,0,1,mannoprotein metabolic process,BP,
2961,GO:0006057,1,0.988688643487989,0,1,mannoprotein biosynthetic process,BP,
2962,GO:0006059,1,0.967514032135605,0,3,hexitol metabolic process,BP,
2963,GO:0006060,1,0.979475731205501,0,2,sorbitol metabolic process,BP,
2964,GO:0006061,1,0.987855476448624,0,1,sorbitol biosynthetic process,BP,
2965,GO:0006062,1,0.991518053072052,0,1,sorbitol catabolic process,BP,
2966,GO:0006063,1,0.820989249370366,0,22,uronic acid metabolic process,BP,
2967,GO:0006064,1,0.952643268976188,0,5,glucuronate catabolic process,BP,
2968,GO:0006065,1,0.984669217604691,0,3,UDP-glucuronate biosynthetic process,BP,
2970,GO:0006067,1,0.816908503759034,0,21,ethanol metabolic process,BP,
2971,GO:0006068,1,0.883581977474011,0,12,ethanol catabolic process,BP,
2972,GO:0006069,1,0.901619579095856,0,12,ethanol oxidation,BP,
2973,GO:0006071,1,0.873614898312347,0,16,glycerol metabolic process,BP,
2974,GO:0006072,1,0.969963934647699,0,7,glycerol-3-phosphate metabolic process,BP,
2975,GO:0006073,1,0.68263476986183,0,73,cellular glucan metabolic process,BP,
2978,GO:0006083,1,0.992856233286193,0,3,acetate metabolic process,BP,
2982,GO:0006089,1,0.912940589707563,0,12,lactate metabolic process,BP,
2986,GO:0006096,1,0.635359166866094,0,67,glycolytic process,BP,
2993,GO:0006104,1,0.968332067967209,0,4,succinyl-CoA metabolic process,BP,
2995,GO:0006106,1,0.970082139428772,0,3,fumarate metabolic process,BP,
2999,GO:0006110,1,0.832331372981995,0,32,regulation of glycolytic process,BP,
3000,GO:0006111,1,0.82273405318836,0,33,regulation of gluconeogenesis,BP,
3001,GO:0006112,1,0.620207977611248,0,85,energy reserve metabolic process,BP,
3002,GO:0006113,1,0.993128389988697,0,1,fermentation,BP,
3003,GO:0006114,1,0.972541628159009,0,4,glycerol biosynthetic process,BP,
3004,GO:0006116,1,0.973744400399167,0,3,NADH oxidation,BP,
3005,GO:0006117,1,0.991741501148104,0,1,acetaldehyde metabolic process,BP,
3006,GO:0006119,1,0.352945794258662,0,99,oxidative phosphorylation,BP,
3007,GO:0006120,1,0.590053884262017,0,46,mitochondrial electron transport, NADH to ubiquinone,BP,
3008,GO:0006121,1,0.966670561449265,0,3,mitochondrial electron transport, succinate to ubiquinone,BP,
3009,GO:0006122,1,0.891992463758737,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
3010,GO:0006123,1,0.829635837560235,0,17,mitochondrial electron transport, cytochrome c to oxygen,BP,
3011,GO:0006127,1,0.993147731886099,0,1,glycerophosphate shuttle,BP,
3016,GO:0006147,1,0.999983082155749,0,1,guanine catabolic process,BP,
3019,GO:0006154,1,0.98811033555713,0,1,adenosine catabolic process,BP,
3020,GO:0006157,1,0.98811033555713,0,1,deoxyadenosine catabolic process,BP,
3023,GO:0006165,1,0.543378596413846,0,83,nucleoside diphosphate phosphorylation,BP,
3024,GO:0006166,1,0.954416813278456,0,5,purine ribonucleoside salvage,BP,
3025,GO:0006167,1,0.929840823982636,0,7,AMP biosynthetic process,BP,
3026,GO:0006168,1,0.975250119192283,0,2,adenine salvage,BP,
3027,GO:0006169,1,0.98959060716668,0,1,adenosine salvage,BP,
3029,GO:0006172,1,0.987052804188521,0,2,ADP biosynthetic process,BP,
3030,GO:0006173,1,0.996548031549379,0,1,dADP biosynthetic process,BP,
3031,GO:0006175,1,0.98959060716668,0,1,dATP biosynthetic process,BP,
3032,GO:0006177,1,0.971428002863391,0,3,GMP biosynthetic process,BP,
3033,GO:0006178,1,0.987879530616557,0,1,guanine salvage,BP,
3034,GO:0006182,1,0.772663204458967,0,41,cGMP biosynthetic process,BP,
3035,GO:0006183,1,0.882602810859803,0,11,GTP biosynthetic process,BP,
3036,GO:0006185,1,0.987358580697023,0,1,dGDP biosynthetic process,BP,
3037,GO:0006188,1,0.94260897393878,0,10,IMP biosynthetic process,BP,
3038,GO:0006189,1,0.966593429168869,0,6,'de novo' IMP biosynthetic process,BP,
3039,GO:0006193,1,0.987454994210949,0,1,ITP catabolic process,BP,
3041,GO:0006196,1,0.997232325559828,0,2,AMP catabolic process,BP,
3042,GO:0006198,1,0.961967777093249,0,18,cAMP catabolic process,BP,
3043,GO:0006203,1,0.971647436000304,0,3,dGTP catabolic process,BP,
3044,GO:0006206,1,0.871046331088856,0,19,pyrimidine nucleobase metabolic process,BP,
3045,GO:0006207,1,0.974996004789396,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3046,GO:0006208,1,0.974499838833233,0,3,pyrimidine nucleobase catabolic process,BP,
3047,GO:0006210,1,0.974499838833233,0,3,thymine catabolic process,BP,
3048,GO:0006211,1,0.999999996392571,0,1,5-methylcytosine catabolic process,BP,
3049,GO:0006212,1,0.984270068861863,0,2,uracil catabolic process,BP,
3050,GO:0006213,1,0.629642620305992,0,47,pyrimidine nucleoside metabolic process,BP,
3051,GO:0006214,1,0.994359198959087,0,1,thymidine catabolic process,BP,
3052,GO:0006216,1,0.90412250534368,0,9,cytidine catabolic process,BP,
3053,GO:0006218,1,0.988794920138329,0,1,uridine catabolic process,BP,
3054,GO:0006220,1,0.64097379240593,0,45,pyrimidine nucleotide metabolic process,BP,
3055,GO:0006221,1,0.746185917048207,0,30,pyrimidine nucleotide biosynthetic process,BP,
3056,GO:0006222,1,0.915820960575477,0,10,UMP biosynthetic process,BP,
3057,GO:0006226,1,0.988981881900696,0,1,dUMP biosynthetic process,BP,
3058,GO:0006227,1,0.981252736973267,0,2,dUDP biosynthetic process,BP,
3059,GO:0006228,1,0.900611872370803,0,10,UTP biosynthetic process,BP,
3060,GO:0006231,1,0.979522453151024,0,2,dTMP biosynthetic process,BP,
3061,GO:0006233,1,0.981252736973267,0,2,dTDP biosynthetic process,BP,
3062,GO:0006235,1,0.957774979381295,0,4,dTTP biosynthetic process,BP,
3063,GO:0006238,1,0.987620565988309,0,1,CMP salvage,BP,
3064,GO:0006241,1,0.861549256956612,0,14,CTP biosynthetic process,BP,
3065,GO:0006244,1,0.882599294479851,0,12,pyrimidine nucleotide catabolic process,BP,
3066,GO:0006253,1,0.987470452549771,0,1,dCTP catabolic process,BP,
3067,GO:0006256,1,0.993414436255799,0,1,UDP catabolic process,BP,
3071,GO:0006261,1,0.413486083520797,0,132,DNA-dependent DNA replication,BP,
3072,GO:0006264,1,0.946525184980812,0,10,mitochondrial DNA replication,BP,
3073,GO:0006265,1,0.956122870696415,0,9,DNA topological change,BP,
3074,GO:0006266,1,0.822999704026024,0,24,DNA ligation,BP,
3075,GO:0006267,1,0.980887951317669,0,2,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3076,GO:0006268,1,0.954588959786912,0,7,DNA unwinding involved in DNA replication,BP,
3077,GO:0006269,1,0.974200271283276,0,4,DNA replication, synthesis of RNA primer,BP,
3078,GO:0006270,1,0.749406726039504,0,39,DNA replication initiation,BP,
3079,GO:0006271,1,0.891748511676935,0,16,DNA strand elongation involved in DNA replication,BP,
3080,GO:0006272,1,0.99998694925149,0,2,leading strand elongation,BP,
3081,GO:0006273,1,0.950892644998476,0,8,lagging strand elongation,BP,
3082,GO:0006274,1,0.991657600429728,0,1,DNA replication termination,BP,
3083,GO:0006275,1,0.49827075912845,0,111,regulation of DNA replication,BP,
3084,GO:0006278,1,0.670420807986205,0,62,RNA-dependent DNA biosynthetic process,BP,
3085,GO:0006281,1,0.0330293034302988,0,493,DNA repair,BP,
3086,GO:0006282,1,0.612127879145408,0,77,regulation of DNA repair,BP,
3087,GO:0006283,1,0.546147698544433,0,73,transcription-coupled nucleotide-excision repair,BP,
3088,GO:0006284,1,0.729239963270947,0,41,base-excision repair,BP,
3089,GO:0006285,1,0.900464184863076,0,10,base-excision repair, AP site formation,BP,
3090,GO:0006286,1,0.975812335914195,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3091,GO:0006287,1,0.974850418680996,0,5,base-excision repair, gap-filling,BP,
3092,GO:0006288,1,0.973314281336078,0,3,base-excision repair, DNA ligation,BP,
3093,GO:0006289,1,0.402474110592813,0,114,nucleotide-excision repair,BP,
3094,GO:0006290,1,0.957743405131876,0,7,pyrimidine dimer repair,BP,
3095,GO:0006293,1,0.874049922753803,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3096,GO:0006294,1,0.798307689906032,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3097,GO:0006295,1,0.874049922753803,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3098,GO:0006296,1,0.756369010261013,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3099,GO:0006297,1,0.836673764254685,0,23,nucleotide-excision repair, DNA gap filling,BP,
3100,GO:0006298,1,0.828614974529344,0,31,mismatch repair,BP,
3101,GO:0006301,1,0.72388055108028,0,50,postreplication repair,BP,
3102,GO:0006302,1,0.263249118549949,0,199,double-strand break repair,BP,
3103,GO:0006303,1,0.605599095187076,0,67,double-strand break repair via nonhomologous end joining,BP,
3104,GO:0006304,1,0.520077072635815,0,95,DNA modification,BP,
3105,GO:0006305,1,0.72834990786969,0,59,DNA alkylation,BP,
3106,GO:0006306,1,0.72834990786969,0,59,DNA methylation,BP,
3107,GO:0006307,1,0.922206855776105,0,10,DNA dealkylation involved in DNA repair,BP,
3109,GO:0006309,1,0.861464873186262,0,19,apoptotic DNA fragmentation,BP,
3110,GO:0006310,1,0.183880618114009,0,250,DNA recombination,BP,
3111,GO:0006311,1,0.983114002804989,0,3,meiotic gene conversion,BP,
3112,GO:0006312,1,0.72870906895929,0,47,mitotic recombination,BP,
3113,GO:0006313,1,0.989864503252414,0,2,transposition, DNA-mediated,BP,
3114,GO:0006323,1,0.196520425260557,0,185,DNA packaging,BP,
3115,GO:0006325,1,0.0100049614607037,0,709,chromatin organization,BP,
3116,GO:0006333,1,0.214899577756265,0,174,chromatin assembly or disassembly,BP,
3117,GO:0006334,1,0.269109215101442,0,132,nucleosome assembly,BP,
3118,GO:0006335,1,0.693996377094724,0,32,DNA replication-dependent nucleosome assembly,BP,
3119,GO:0006336,1,0.637853803182601,0,48,DNA replication-independent nucleosome assembly,BP,
3120,GO:0006337,1,0.885492304775593,0,18,nucleosome disassembly,BP,
3121,GO:0006338,1,0.362606380038492,0,149,chromatin remodeling,BP,
3122,GO:0006342,1,0.359438891896104,0,114,chromatin silencing,BP,
3123,GO:0006343,1,0.997534268301677,0,1,establishment of chromatin silencing,BP,
3124,GO:0006344,1,0.989535869058644,0,4,maintenance of chromatin silencing,BP,
3125,GO:0006346,1,0.87154350712298,0,20,methylation-dependent chromatin silencing,BP,
3126,GO:0006348,1,0.921152691959906,0,9,chromatin silencing at telomere,BP,
3127,GO:0006349,1,0.932225386888307,0,16,regulation of gene expression by genetic imprinting,BP,
3130,GO:0006353,1,0.444912984457866,0,104,DNA-templated transcription, termination,BP,
3133,GO:0006356,1,0.847157405427401,0,31,regulation of transcription from RNA polymerase I promoter,BP,
3135,GO:0006359,1,0.863424013090793,0,25,regulation of transcription from RNA polymerase III promoter,BP,
3136,GO:0006360,1,0.66615523209088,0,59,transcription from RNA polymerase I promoter,BP,
3137,GO:0006361,1,0.76213311183556,0,32,transcription initiation from RNA polymerase I promoter,BP,
3138,GO:0006362,1,0.775114310789095,0,31,transcription elongation from RNA polymerase I promoter,BP,
3139,GO:0006363,1,0.772791522345526,0,30,termination of RNA polymerase I transcription,BP,
3143,GO:0006368,1,0.497876602205284,0,97,transcription elongation from RNA polymerase II promoter,BP,
3144,GO:0006369,1,0.59806168537099,0,69,termination of RNA polymerase II transcription,BP,
3145,GO:0006370,1,0.773085198325781,0,30,7-methylguanosine mRNA capping,BP,
3147,GO:0006378,1,0.812972549716567,0,39,mRNA polyadenylation,BP,
3148,GO:0006379,1,0.827563912700589,0,25,mRNA cleavage,BP,
3149,GO:0006382,1,0.989053295798443,0,4,adenosine to inosine editing,BP,
3150,GO:0006383,1,0.699443800123778,0,51,transcription from RNA polymerase III promoter,BP,
3151,GO:0006384,1,0.964458396976029,0,8,transcription initiation from RNA polymerase III promoter,BP,
3152,GO:0006388,1,0.863629896073745,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3153,GO:0006390,1,0.943643886426773,0,7,transcription from mitochondrial promoter,BP,
3154,GO:0006391,1,0.975511889806191,0,3,transcription initiation from mitochondrial promoter,BP,
3157,GO:0006398,1,0.969918163239865,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3160,GO:0006401,1,0.132594823894622,0,246,RNA catabolic process,BP,
3161,GO:0006402,1,0.162781841241328,0,217,mRNA catabolic process,BP,
3162,GO:0006403,1,0.244933914162431,0,218,RNA localization,BP,
3163,GO:0006404,1,0.985491896002952,0,3,RNA import into nucleus,BP,
3164,GO:0006405,1,0.40954343951649,0,137,RNA export from nucleus,BP,
3165,GO:0006406,1,0.509384386308655,0,108,mRNA export from nucleus,BP,
3166,GO:0006407,1,0.98747451658825,0,2,rRNA export from nucleus,BP,
3167,GO:0006408,1,0.978456061436435,0,2,snRNA export from nucleus,BP,
3168,GO:0006409,1,0.865269491425255,0,31,tRNA export from nucleus,BP,
3170,GO:0006413,1,0.174470279310864,0,188,translational initiation,BP,
3174,GO:0006418,1,0.689527062492504,0,48,tRNA aminoacylation for protein translation,BP,
3175,GO:0006419,1,0.984257965063475,0,3,alanyl-tRNA aminoacylation,BP,
3176,GO:0006420,1,0.957122704990437,0,4,arginyl-tRNA aminoacylation,BP,
3177,GO:0006421,1,0.979191960905421,0,3,asparaginyl-tRNA aminoacylation,BP,
3178,GO:0006422,1,0.990669797487169,0,1,aspartyl-tRNA aminoacylation,BP,
3179,GO:0006423,1,0.981139948497666,0,2,cysteinyl-tRNA aminoacylation,BP,
3180,GO:0006424,1,0.997656554510238,0,2,glutamyl-tRNA aminoacylation,BP,
3181,GO:0006425,1,0.991160007999267,0,1,glutaminyl-tRNA aminoacylation,BP,
3182,GO:0006426,1,0.980902224801451,0,2,glycyl-tRNA aminoacylation,BP,
3183,GO:0006427,1,0.980766007846572,0,2,histidyl-tRNA aminoacylation,BP,
3184,GO:0006428,1,0.995634688452539,0,2,isoleucyl-tRNA aminoacylation,BP,
3185,GO:0006429,1,0.998427786672869,0,2,leucyl-tRNA aminoacylation,BP,
3186,GO:0006430,1,0.989792648350572,0,1,lysyl-tRNA aminoacylation,BP,
3187,GO:0006431,1,0.986726384179517,0,2,methionyl-tRNA aminoacylation,BP,
3188,GO:0006432,1,0.962590607568876,0,4,phenylalanyl-tRNA aminoacylation,BP,
3189,GO:0006433,1,0.990560848093226,0,2,prolyl-tRNA aminoacylation,BP,
3190,GO:0006434,1,0.978839162468726,0,2,seryl-tRNA aminoacylation,BP,
3191,GO:0006435,1,0.979327005929857,0,3,threonyl-tRNA aminoacylation,BP,
3192,GO:0006436,1,0.985188568108852,0,2,tryptophanyl-tRNA aminoacylation,BP,
3193,GO:0006437,1,0.984385481349749,0,2,tyrosyl-tRNA aminoacylation,BP,
3194,GO:0006438,1,0.995338918902082,0,3,valyl-tRNA aminoacylation,BP,
3195,GO:0006446,1,0.618003464603842,0,70,regulation of translational initiation,BP,
3196,GO:0006447,1,0.987623451190444,0,3,regulation of translational initiation by iron,BP,
3197,GO:0006448,1,0.833523530682601,0,26,regulation of translational elongation,BP,
3198,GO:0006449,1,0.959498155232029,0,8,regulation of translational termination,BP,
3199,GO:0006450,1,0.890307531796311,0,16,regulation of translational fidelity,BP,
3200,GO:0006451,1,0.941149899153102,0,9,translational readthrough,BP,
3201,GO:0006452,1,0.985218494977132,0,3,translational frameshifting,BP,
3202,GO:0006457,1,0.157434037791076,0,221,protein folding,BP,
3203,GO:0006458,1,0.758885935115348,0,32,'de novo' protein folding,BP,
3205,GO:0006463,1,0.997153585625323,0,1,steroid hormone receptor complex assembly,BP,
3207,GO:0006465,1,0.845232776515492,0,19,signal peptide processing,BP,
3211,GO:0006471,1,0.848468705970685,0,22,protein ADP-ribosylation,BP,
3212,GO:0006473,1,0.319050490711292,0,173,protein acetylation,BP,
3213,GO:0006474,1,0.917073611308772,0,16,N-terminal protein amino acid acetylation,BP,
3214,GO:0006475,1,0.38478460566911,0,148,internal protein amino acid acetylation,BP,
3215,GO:0006476,1,0.603324051182656,0,92,protein deacetylation,BP,
3216,GO:0006477,1,0.95600950536823,0,7,protein sulfation,BP,
3217,GO:0006478,1,0.978910076381212,0,2,peptidyl-tyrosine sulfation,BP,
3219,GO:0006480,1,0.979082915952268,0,2,N-terminal protein amino acid methylation,BP,
3220,GO:0006481,1,0.9873646893368,0,2,C-terminal protein methylation,BP,
3221,GO:0006482,1,0.937397988323769,0,28,protein demethylation,BP,
3224,GO:0006488,1,0.862185332549175,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3225,GO:0006489,1,0.946793882229948,0,7,dolichyl diphosphate biosynthetic process,BP,
3226,GO:0006490,1,0.854886977014819,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3227,GO:0006491,1,0.940046565892273,0,18,N-glycan processing,BP,
3230,GO:0006498,1,0.970504964993164,0,6,N-terminal protein lipidation,BP,
3231,GO:0006499,1,0.991522789946058,0,4,N-terminal protein myristoylation,BP,
3232,GO:0006500,1,0.978803906494838,0,2,N-terminal protein palmitoylation,BP,
3233,GO:0006501,1,0.571878206978289,0,69,C-terminal protein lipidation,BP,
3236,GO:0006507,1,0.990490488218666,0,1,GPI anchor release,BP,
3238,GO:0006509,1,0.803382496108755,0,39,membrane protein ectodomain proteolysis,BP,
3240,GO:0006513,1,0.755124135488413,0,57,protein monoubiquitination,BP,
3241,GO:0006515,1,0.869196880898581,0,23,misfolded or incompletely synthesized protein catabolic process,BP,
3242,GO:0006516,1,0.88987789356382,0,17,glycoprotein catabolic process,BP,
3243,GO:0006517,1,0.845581969300372,0,34,protein deglycosylation,BP,
3247,GO:0006522,1,0.95449914178738,0,5,alanine metabolic process,BP,
3248,GO:0006524,1,0.95449914178738,0,5,alanine catabolic process,BP,
3249,GO:0006525,1,0.86513839529293,0,17,arginine metabolic process,BP,
3250,GO:0006526,1,0.956942023772668,0,4,arginine biosynthetic process,BP,
3251,GO:0006527,1,0.943432925594036,0,9,arginine catabolic process,BP,
3252,GO:0006528,1,0.950367955608256,0,5,asparagine metabolic process,BP,
3253,GO:0006529,1,0.981990754448995,0,2,asparagine biosynthetic process,BP,
3254,GO:0006530,1,0.979896325152343,0,2,asparagine catabolic process,BP,
3255,GO:0006531,1,0.905567136799082,0,11,aspartate metabolic process,BP,
3256,GO:0006532,1,0.969178286418094,0,3,aspartate biosynthetic process,BP,
3257,GO:0006533,1,0.969184745864032,0,3,aspartate catabolic process,BP,
3258,GO:0006534,1,0.910466593797092,0,13,cysteine metabolic process,BP,
3259,GO:0006535,1,0.991848723520862,0,1,cysteine biosynthetic process from serine,BP,
3262,GO:0006538,1,0.950614088886874,0,7,glutamate catabolic process,BP,
3263,GO:0006540,1,0.982889168043128,0,2,glutamate decarboxylation to succinate,BP,
3264,GO:0006541,1,0.878386711557776,0,24,glutamine metabolic process,BP,
3265,GO:0006542,1,0.998999378314394,0,2,glutamine biosynthetic process,BP,
3266,GO:0006543,1,0.988196857435896,0,3,glutamine catabolic process,BP,
3267,GO:0006544,1,0.885211648370338,0,15,glycine metabolic process,BP,
3268,GO:0006545,1,0.958562737784324,0,5,glycine biosynthetic process,BP,
3269,GO:0006546,1,0.975347329122971,0,3,glycine catabolic process,BP,
3270,GO:0006547,1,0.933960769599116,0,9,histidine metabolic process,BP,
3271,GO:0006548,1,0.946442079488147,0,7,histidine catabolic process,BP,
3274,GO:0006551,1,0.95338726634143,0,7,leucine metabolic process,BP,
3275,GO:0006552,1,0.96468446596913,0,5,leucine catabolic process,BP,
3276,GO:0006553,1,0.930742862069714,0,11,lysine metabolic process,BP,
3277,GO:0006554,1,0.93723632392387,0,10,lysine catabolic process,BP,
3279,GO:0006556,1,0.978422433490221,0,3,S-adenosylmethionine biosynthetic process,BP,
3280,GO:0006557,1,0.995026999315685,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3283,GO:0006560,1,0.919348453363943,0,9,proline metabolic process,BP,
3284,GO:0006561,1,0.950479468601218,0,6,proline biosynthetic process,BP,
3285,GO:0006562,1,0.962386114096556,0,4,proline catabolic process,BP,
3286,GO:0006563,1,0.905473259879351,0,10,L-serine metabolic process,BP,
3287,GO:0006564,1,0.940154329320047,0,6,L-serine biosynthetic process,BP,
3288,GO:0006565,1,0.971583425120492,0,3,L-serine catabolic process,BP,
3289,GO:0006566,1,0.977802997550381,0,2,threonine metabolic process,BP,
3290,GO:0006567,1,0.988209352047045,0,1,threonine catabolic process,BP,
3291,GO:0006568,1,0.892828458542569,0,13,tryptophan metabolic process,BP,
3292,GO:0006569,1,0.903205801819689,0,11,tryptophan catabolic process,BP,
3293,GO:0006570,1,0.918359354251159,0,9,tyrosine metabolic process,BP,
3294,GO:0006572,1,0.947014589065536,0,5,tyrosine catabolic process,BP,
3296,GO:0006574,1,0.959344646164101,0,4,valine catabolic process,BP,
3300,GO:0006578,1,0.950808090339638,0,7,amino-acid betaine biosynthetic process,BP,
3301,GO:0006579,1,0.977131009360405,0,3,amino-acid betaine catabolic process,BP,
3302,GO:0006580,1,0.99227728643266,0,1,ethanolamine metabolic process,BP,
3303,GO:0006581,1,0.985620123294072,0,2,acetylcholine catabolic process,BP,
3304,GO:0006582,1,0.893102539717346,0,19,melanin metabolic process,BP,
3305,GO:0006583,1,0.980456952427101,0,2,melanin biosynthetic process from tyrosine,BP,
3306,GO:0006584,1,0.700608791385406,0,49,catecholamine metabolic process,BP,
3307,GO:0006585,1,0.989085784307189,0,1,dopamine biosynthetic process from tyrosine,BP,
3308,GO:0006586,1,0.844586781650004,0,18,indolalkylamine metabolic process,BP,
3309,GO:0006589,1,0.986633464855788,0,2,octopamine biosynthetic process,BP,
3310,GO:0006590,1,0.917297489417646,0,16,thyroid hormone generation,BP,
3311,GO:0006591,1,0.939708723478645,0,7,ornithine metabolic process,BP,
3312,GO:0006592,1,0.99599416017826,0,1,ornithine biosynthetic process,BP,
3313,GO:0006593,1,0.988365318180984,0,1,ornithine catabolic process,BP,
3314,GO:0006595,1,0.854808304830395,0,15,polyamine metabolic process,BP,
3315,GO:0006596,1,0.885624399544321,0,12,polyamine biosynthetic process,BP,
3316,GO:0006597,1,0.983554286325374,0,2,spermine biosynthetic process,BP,
3317,GO:0006598,1,0.932409218326195,0,6,polyamine catabolic process,BP,
3318,GO:0006599,1,0.988154741572323,0,1,phosphagen metabolic process,BP,
3320,GO:0006601,1,0.979258799691701,0,2,creatine biosynthetic process,BP,
3321,GO:0006603,1,0.988154741572323,0,1,phosphocreatine metabolic process,BP,
3324,GO:0006607,1,0.928682205933909,0,22,NLS-bearing protein import into nucleus,BP,
3325,GO:0006610,1,0.978039886242079,0,8,ribosomal protein import into nucleus,BP,
3327,GO:0006612,1,0.191256050052749,0,178,protein targeting to membrane,BP,
3328,GO:0006613,1,0.329476108956054,0,96,cotranslational protein targeting to membrane,BP,
3329,GO:0006614,1,0.338922853256363,0,91,SRP-dependent cotranslational protein targeting to membrane,BP,
3330,GO:0006616,1,0.939797465113301,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3331,GO:0006617,1,0.97771461593603,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3332,GO:0006620,1,0.960854890891843,0,6,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3333,GO:0006621,1,0.931578847703283,0,9,protein retention in ER lumen,BP,
3334,GO:0006622,1,0.939494965126167,0,17,protein targeting to lysosome,BP,
3335,GO:0006623,1,0.875567635057463,0,28,protein targeting to vacuole,BP,
3336,GO:0006624,1,0.97707174747921,0,2,vacuolar protein processing,BP,
3337,GO:0006625,1,0.905185639113945,0,17,protein targeting to peroxisome,BP,
3338,GO:0006626,1,0.315035131843268,0,141,protein targeting to mitochondrion,BP,
3339,GO:0006627,1,0.933879206906803,0,7,protein processing involved in protein targeting to mitochondrion,BP,
3349,GO:0006642,1,0.98835393814384,0,4,triglyceride mobilization,BP,
3352,GO:0006646,1,0.929450724663221,0,12,phosphatidylethanolamine biosynthetic process,BP,
3353,GO:0006649,1,0.994441719442918,0,2,phospholipid transfer to membrane,BP,
3356,GO:0006654,1,0.817644226410672,0,35,phosphatidic acid biosynthetic process,BP,
3357,GO:0006655,1,0.943813536203053,0,9,phosphatidylglycerol biosynthetic process,BP,
3359,GO:0006657,1,0.947715677855423,0,7,CDP-choline pathway,BP,
3361,GO:0006659,1,0.969499460598003,0,4,phosphatidylserine biosynthetic process,BP,
3362,GO:0006660,1,0.988711279405679,0,1,phosphatidylserine catabolic process,BP,
3365,GO:0006663,1,0.970896080911441,0,4,platelet activating factor biosynthetic process,BP,
3368,GO:0006666,1,0.999926518949191,0,1,3-keto-sphinganine metabolic process,BP,
3369,GO:0006667,1,0.976990097814518,0,3,sphinganine metabolic process,BP,
3370,GO:0006668,1,0.988815521393712,0,2,sphinganine-1-phosphate metabolic process,BP,
3371,GO:0006669,1,0.9935701070472,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3372,GO:0006670,1,0.927213418288059,0,10,sphingosine metabolic process,BP,
3373,GO:0006671,1,0.999074413660751,0,1,phytosphingosine metabolic process,BP,
3376,GO:0006678,1,0.958243104690215,0,7,glucosylceramide metabolic process,BP,
3377,GO:0006679,1,0.988211767037098,0,2,glucosylceramide biosynthetic process,BP,
3378,GO:0006680,1,0.98047318611607,0,3,glucosylceramide catabolic process,BP,
3379,GO:0006681,1,0.964764854508954,0,5,galactosylceramide metabolic process,BP,
3380,GO:0006682,1,0.982080539609819,0,2,galactosylceramide biosynthetic process,BP,
3381,GO:0006683,1,0.993307601763826,0,1,galactosylceramide catabolic process,BP,
3382,GO:0006684,1,0.903895874402174,0,14,sphingomyelin metabolic process,BP,
3383,GO:0006685,1,0.960977521715239,0,6,sphingomyelin catabolic process,BP,
3384,GO:0006686,1,0.962125214534195,0,6,sphingomyelin biosynthetic process,BP,
3386,GO:0006688,1,0.907005496452108,0,15,glycosphingolipid biosynthetic process,BP,
3390,GO:0006692,1,0.76243502834684,0,33,prostanoid metabolic process,BP,
3391,GO:0006693,1,0.76243502834684,0,33,prostaglandin metabolic process,BP,
3394,GO:0006696,1,0.97799784882027,0,2,ergosterol biosynthetic process,BP,
3397,GO:0006701,1,0.952021911098734,0,7,progesterone biosynthetic process,BP,
3403,GO:0006707,1,0.912327013918818,0,11,cholesterol catabolic process,BP,
3405,GO:0006711,1,0.978590841155819,0,2,estrogen catabolic process,BP,
3406,GO:0006713,1,0.988731241787655,0,1,glucocorticoid catabolic process,BP,
3407,GO:0006714,1,0.975984983276443,0,2,sesquiterpenoid metabolic process,BP,
3410,GO:0006722,1,0.990980523232525,0,1,triterpenoid metabolic process,BP,
3412,GO:0006726,1,0.972544786434269,0,4,eye pigment biosynthetic process,BP,
3414,GO:0006730,1,0.775597258056524,0,33,one-carbon metabolic process,BP,
3418,GO:0006735,1,0.809390843729419,0,26,NADH regeneration,BP,
3422,GO:0006741,1,0.979100261229074,0,3,NADP biosynthetic process,BP,
3423,GO:0006742,1,0.983446718798996,0,2,NADP catabolic process,BP,
3424,GO:0006743,1,0.874099379145929,0,14,ubiquinone metabolic process,BP,
3425,GO:0006744,1,0.874718316519291,0,13,ubiquinone biosynthetic process,BP,
3426,GO:0006747,1,0.989304060135563,0,1,FAD biosynthetic process,BP,
3429,GO:0006751,1,0.919278044976278,0,8,glutathione catabolic process,BP,
3431,GO:0006754,1,0.672544539042331,0,42,ATP biosynthetic process,BP,
3432,GO:0006757,1,0.635359166866094,0,67,ATP generation from ADP,BP,
3433,GO:0006760,1,0.83273658049899,0,25,folic acid-containing compound metabolic process,BP,
3436,GO:0006768,1,0.940727730703193,0,11,biotin metabolic process,BP,
3438,GO:0006772,1,0.963572133744989,0,4,thiamine metabolic process,BP,
3440,GO:0006776,1,0.943015483108197,0,8,vitamin A metabolic process,BP,
3441,GO:0006777,1,0.960387457232681,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3443,GO:0006779,1,0.832898335766732,0,24,porphyrin-containing compound biosynthetic process,BP,
3444,GO:0006780,1,0.977916008559409,0,2,uroporphyrinogen III biosynthetic process,BP,
3445,GO:0006781,1,0.990013231248957,0,1,succinyl-CoA pathway,BP,
3446,GO:0006782,1,0.922139303665959,0,8,protoporphyrinogen IX biosynthetic process,BP,
3447,GO:0006783,1,0.854024153114787,0,20,heme biosynthetic process,BP,
3448,GO:0006784,1,0.993745492035209,0,2,heme a biosynthetic process,BP,
3449,GO:0006787,1,0.923567299805573,0,7,porphyrin-containing compound catabolic process,BP,
3450,GO:0006788,1,0.976869765911452,0,2,heme oxidation,BP,
3451,GO:0006789,1,0.981696043477737,0,2,bilirubin conjugation,BP,
3455,GO:0006797,1,0.993002887673498,0,1,polyphosphate metabolic process,BP,
3459,GO:0006808,1,0.974912463374933,0,3,regulation of nitrogen utilization,BP,
3464,GO:0006813,1,0.276736925343226,0,224,potassium ion transport,BP,
3467,GO:0006817,1,0.868192196343009,0,24,phosphate ion transport,BP,
3471,GO:0006824,1,0.954821456211803,0,5,cobalt ion transport,BP,
3473,GO:0006826,1,0.661358724587494,0,57,iron ion transport,BP,
3474,GO:0006828,1,0.955987951199694,0,11,manganese ion transport,BP,
3475,GO:0006829,1,0.840678474754147,0,26,zinc II ion transport,BP,
3476,GO:0006833,1,0.86126465761807,0,19,water transport,BP,
3479,GO:0006837,1,0.879362563279796,0,16,serotonin transport,BP,
3481,GO:0006842,1,0.979948865884354,0,4,tricarboxylic acid transport,BP,
3482,GO:0006843,1,0.988252144942411,0,1,mitochondrial citrate transport,BP,
3483,GO:0006844,1,0.979888534283067,0,2,acyl carnitine transport,BP,
3484,GO:0006848,1,0.971568363154374,0,4,pyruvate transport,BP,
3485,GO:0006850,1,0.975179379573793,0,3,mitochondrial pyruvate transport,BP,
3486,GO:0006851,1,0.938164861905652,0,8,mitochondrial calcium ion transport,BP,
3489,GO:0006857,1,0.951391837888944,0,9,oligopeptide transport,BP,
3490,GO:0006858,1,0.989153440864698,0,2,extracellular transport,BP,
3491,GO:0006860,1,0.989153446632419,0,1,extracellular amino acid transport,BP,
3492,GO:0006862,1,0.86345367537636,0,20,nucleotide transport,BP,
3493,GO:0006863,1,0.938064784869137,0,7,purine nucleobase transport,BP,
3494,GO:0006864,1,0.987473057819827,0,2,pyrimidine nucleotide transport,BP,
3496,GO:0006867,1,0.983970861356623,0,2,asparagine transport,BP,
3497,GO:0006868,1,0.968112723478329,0,5,glutamine transport,BP,
3502,GO:0006876,1,0.997598341365831,0,1,cellular cadmium ion homeostasis,BP,
3504,GO:0006879,1,0.738162292282544,0,46,cellular iron ion homeostasis,BP,
3505,GO:0006880,1,0.940276125545846,0,5,intracellular sequestering of iron ion,BP,
3506,GO:0006882,1,0.844988896579474,0,25,cellular zinc ion homeostasis,BP,
3507,GO:0006883,1,0.940861935033866,0,13,cellular sodium ion homeostasis,BP,
3508,GO:0006884,1,0.923971267412369,0,17,cell volume homeostasis,BP,
3514,GO:0006891,1,0.826500706673105,0,47,intra-Golgi vesicle-mediated transport,BP,
3515,GO:0006892,1,0.645763105058287,0,87,post-Golgi vesicle-mediated transport,BP,
3516,GO:0006893,1,0.775188449675945,0,45,Golgi to plasma membrane transport,BP,
3517,GO:0006895,1,0.952028103933171,0,18,Golgi to endosome transport,BP,
3518,GO:0006896,1,0.957848480608204,0,10,Golgi to vacuole transport,BP,
3521,GO:0006900,1,0.50161983628882,0,109,membrane budding,BP,
3522,GO:0006901,1,0.685968023358803,0,64,vesicle coating,BP,
3523,GO:0006903,1,0.638140212225584,0,80,vesicle targeting,BP,
3524,GO:0006904,1,0.764382122400959,0,43,vesicle docking involved in exocytosis,BP,
3528,GO:0006910,1,0.889842698510736,0,15,phagocytosis, recognition,BP,
3529,GO:0006911,1,0.805463014701993,0,31,phagocytosis, engulfment,BP,
3534,GO:0006921,1,0.804496151931961,0,30,cellular component disassembly involved in execution phase of apoptosis,BP,
3536,GO:0006925,1,0.878017500912857,0,17,inflammatory cell apoptotic process,BP,
3538,GO:0006929,1,0.882854703797786,0,27,substrate-dependent cell migration,BP,
3539,GO:0006930,1,0.96243796998129,0,8,substrate-dependent cell migration, cell extension,BP,
3540,GO:0006931,1,0.977957172455373,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3541,GO:0006933,1,0.967743081918103,0,4,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3544,GO:0006937,1,0.400028440658608,0,146,regulation of muscle contraction,BP,
3545,GO:0006939,1,0.566577806766006,0,94,smooth muscle contraction,BP,
3546,GO:0006940,1,0.693273685862716,0,54,regulation of smooth muscle contraction,BP,
3547,GO:0006941,1,0.393351894011559,0,163,striated muscle contraction,BP,
3548,GO:0006942,1,0.62926058085114,0,84,regulation of striated muscle contraction,BP,
3549,GO:0006948,1,0.994271707701199,0,1,induction by virus of host cell-cell fusion,BP,
3550,GO:0006949,1,0.726645315738958,0,49,syncytium formation,BP,
3553,GO:0006953,1,0.669648611104238,0,46,acute-phase response,BP,
3558,GO:0006958,1,0.789208684043191,0,32,complement activation, classical pathway,BP,
3560,GO:0006963,1,0.974457752067809,0,2,positive regulation of antibacterial peptide biosynthetic process,BP,
3561,GO:0006965,1,0.974457752067809,0,2,positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria,BP,
3562,GO:0006968,1,0.582744797183999,0,59,cellular defense response,BP,
3563,GO:0006970,1,0.655012503539732,0,68,response to osmotic stress,BP,
3564,GO:0006971,1,0.973914875914203,0,8,hypotonic response,BP,
3565,GO:0006972,1,0.861802238561371,0,21,hyperosmotic response,BP,
3567,GO:0006975,1,0.944163574144536,0,8,DNA damage induced protein phosphorylation,BP,
3568,GO:0006977,1,0.639900025853249,0,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3569,GO:0006978,1,0.897018665275517,0,17,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3571,GO:0006982,1,0.964337147606492,0,3,response to lipid hydroperoxide,BP,
3572,GO:0006983,1,0.959626122778601,0,10,ER overload response,BP,
3573,GO:0006984,1,0.759347695308403,0,42,ER-nucleus signaling pathway,BP,
3575,GO:0006987,1,0.957157552276354,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3576,GO:0006990,1,0.969397981654619,0,4,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3577,GO:0006991,1,0.951241312710781,0,9,response to sterol depletion,BP,
3578,GO:0006995,1,0.976707427267321,0,4,cellular response to nitrogen starvation,BP,
3580,GO:0006997,1,0.434921910128601,0,136,nucleus organization,BP,
3581,GO:0006998,1,0.618555057725821,0,81,nuclear envelope organization,BP,
3582,GO:0006999,1,0.937246864812162,0,14,nuclear pore organization,BP,
3583,GO:0007000,1,0.964800700095549,0,6,nucleolus organization,BP,
3584,GO:0007004,1,0.676917926885158,0,60,telomere maintenance via telomerase,BP,
3587,GO:0007007,1,0.842972028099539,0,18,inner mitochondrial membrane organization,BP,
3588,GO:0007008,1,0.928227282144997,0,8,outer mitochondrial membrane organization,BP,
3589,GO:0007009,1,0.229812403963824,0,275,plasma membrane organization,BP,
3591,GO:0007014,1,0.997035697400361,0,1,actin ubiquitination,BP,
3593,GO:0007016,1,0.989179519972842,0,10,cytoskeletal anchoring at plasma membrane,BP,
3594,GO:0007017,1,0.0341655249690199,0,608,microtubule-based process,BP,
3595,GO:0007018,1,0.293294766657934,0,237,microtubule-based movement,BP,
3596,GO:0007019,1,0.826880104689884,0,29,microtubule depolymerization,BP,
3597,GO:0007020,1,0.90809462218308,0,23,microtubule nucleation,BP,
3598,GO:0007021,1,0.942781455620778,0,6,tubulin complex assembly,BP,
3599,GO:0007023,1,0.964407096496441,0,4,post-chaperonin tubulin folding pathway,BP,
3600,GO:0007026,1,0.895084273914707,0,17,negative regulation of microtubule depolymerization,BP,
3601,GO:0007028,1,0.964814649017678,0,10,cytoplasm organization,BP,
3602,GO:0007029,1,0.793996572199995,0,40,endoplasmic reticulum organization,BP,
3603,GO:0007030,1,0.643610772448,0,98,Golgi organization,BP,
3605,GO:0007032,1,0.64092154005228,0,69,endosome organization,BP,
3608,GO:0007035,1,0.882334447363791,0,18,vacuolar acidification,BP,
3609,GO:0007037,1,0.999998413985746,0,1,vacuolar phosphate transport,BP,
3610,GO:0007039,1,0.94400698696626,0,8,protein catabolic process in the vacuole,BP,
3613,GO:0007042,1,0.939309300349728,0,6,lysosomal lumen acidification,BP,
3614,GO:0007043,1,0.647856274067663,0,90,cell-cell junction assembly,BP,
3615,GO:0007044,1,0.755656165029954,0,85,cell-substrate junction assembly,BP,
3616,GO:0007045,1,0.783784493064519,0,69,cell-substrate adherens junction assembly,BP,
3618,GO:0007050,1,0.206402330021153,0,233,cell cycle arrest,BP,
3619,GO:0007051,1,0.457832044912975,0,139,spindle organization,BP,
3620,GO:0007052,1,0.597087648574143,0,87,mitotic spindle organization,BP,
3621,GO:0007056,1,0.968764755430163,0,3,spindle assembly involved in female meiosis,BP,
3622,GO:0007057,1,0.980392137433963,0,2,spindle assembly involved in female meiosis I,BP,
3623,GO:0007059,1,0.14212823628339,0,308,chromosome segregation,BP,
3624,GO:0007060,1,0.977328796455418,0,3,male meiosis chromosome segregation,BP,
3625,GO:0007062,1,0.488187203337463,0,115,sister chromatid cohesion,BP,
3626,GO:0007063,1,0.927151069259205,0,17,regulation of sister chromatid cohesion,BP,
3627,GO:0007064,1,0.922256797947314,0,19,mitotic sister chromatid cohesion,BP,
3628,GO:0007066,1,0.974841131636773,0,2,female meiosis sister chromatid cohesion,BP,
3629,GO:0007067,1,0.0638337650210517,0,438,mitotic nuclear division,BP,
3630,GO:0007068,1,0.999624137301413,0,2,negative regulation of transcription during mitotic cell cycle,BP,
3631,GO:0007070,1,0.999624137301413,0,2,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
3632,GO:0007072,1,0.98853560337144,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3633,GO:0007076,1,0.953428956182917,0,14,mitotic chromosome condensation,BP,
3634,GO:0007077,1,0.796346537427882,0,42,mitotic nuclear envelope disassembly,BP,
3635,GO:0007079,1,0.992690065866187,0,3,mitotic chromosome movement towards spindle pole,BP,
3636,GO:0007080,1,0.727069167485748,0,40,mitotic metaphase plate congression,BP,
3637,GO:0007084,1,0.913553170667169,0,10,mitotic nuclear envelope reassembly,BP,
3638,GO:0007088,1,0.376495399541755,0,148,regulation of mitotic nuclear division,BP,
3639,GO:0007089,1,0.976916976497337,0,4,traversing start control point of mitotic cell cycle,BP,
3640,GO:0007091,1,0.741152780390072,0,46,metaphase/anaphase transition of mitotic cell cycle,BP,
3641,GO:0007093,1,0.352741268030461,0,147,mitotic cell cycle checkpoint,BP,
3642,GO:0007094,1,0.830961401851152,0,27,mitotic spindle assembly checkpoint,BP,
3643,GO:0007095,1,0.937904783904571,0,14,mitotic G2 DNA damage checkpoint,BP,
3644,GO:0007096,1,0.867336475457837,0,18,regulation of exit from mitosis,BP,
3645,GO:0007097,1,0.978184017279615,0,9,nuclear migration,BP,
3646,GO:0007098,1,0.675188385216065,0,80,centrosome cycle,BP,
3647,GO:0007099,1,0.891227741494464,0,27,centriole replication,BP,
3648,GO:0007100,1,0.927241137729504,0,13,mitotic centrosome separation,BP,
3649,GO:0007113,1,0.968286200666525,0,3,endomitotic cell cycle,BP,
3650,GO:0007126,1,0.346430565423469,0,163,meiotic nuclear division,BP,
3651,GO:0007127,1,0.515738292870098,0,93,meiosis I,BP,
3652,GO:0007129,1,0.74704608183592,0,37,synapsis,BP,
3653,GO:0007130,1,0.861639487080655,0,19,synaptonemal complex assembly,BP,
3654,GO:0007131,1,0.745001894291713,0,43,reciprocal meiotic recombination,BP,
3655,GO:0007135,1,0.93553738240608,0,8,meiosis II,BP,
3656,GO:0007140,1,0.763805829242973,0,40,male meiosis,BP,
3657,GO:0007141,1,0.868517971820644,0,17,male meiosis I,BP,
3658,GO:0007143,1,0.858865220170364,0,24,female meiotic division,BP,
3659,GO:0007144,1,0.958569245695597,0,6,female meiosis I,BP,
3660,GO:0007146,1,0.991657600429728,0,1,meiotic recombination nodule assembly,BP,
3661,GO:0007147,1,0.996686529706208,0,1,female meiosis II,BP,
3664,GO:0007156,1,0.617771215744554,0,152,homophilic cell adhesion via plasma membrane adhesion molecules,BP,
3665,GO:0007157,1,0.80532615266473,0,39,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
3666,GO:0007158,1,0.972743675842443,0,15,neuron cell-cell adhesion,BP,
3668,GO:0007160,1,0.427904105145675,0,193,cell-matrix adhesion,BP,
3669,GO:0007161,1,0.990770486256614,0,4,calcium-independent cell-matrix adhesion,BP,
3670,GO:0007162,1,0.2510013269313,0,223,negative regulation of cell adhesion,BP,
3671,GO:0007163,1,0.478476429826424,0,161,establishment or maintenance of cell polarity,BP,
3676,GO:0007168,1,0.930544026110938,0,10,receptor guanylyl cyclase signaling pathway,BP,
3678,GO:0007171,1,0.944056991076093,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3679,GO:0007172,1,0.957249994386601,0,8,signal complex assembly,BP,
3681,GO:0007174,1,0.990263027701851,0,1,epidermal growth factor catabolic process,BP,
3682,GO:0007175,1,0.950141538005214,0,11,negative regulation of epidermal growth factor-activated receptor activity,BP,
3683,GO:0007176,1,0.879725726348784,0,25,regulation of epidermal growth factor-activated receptor activity,BP,
3684,GO:0007178,1,0.161556768695536,0,309,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
3685,GO:0007179,1,0.390774254480211,0,167,transforming growth factor beta receptor signaling pathway,BP,
3686,GO:0007181,1,0.98156615886467,0,3,transforming growth factor beta receptor complex assembly,BP,
3687,GO:0007182,1,0.972029716130047,0,6,common-partner SMAD protein phosphorylation,BP,
3688,GO:0007183,1,0.93135529507404,0,14,SMAD protein complex assembly,BP,
3689,GO:0007184,1,0.881541727339419,0,23,SMAD protein import into nucleus,BP,
3690,GO:0007185,1,0.988053112352181,0,7,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3692,GO:0007187,1,0.258484063987429,0,176,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,
3693,GO:0007188,1,0.338253513585051,0,149,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,
3694,GO:0007189,1,0.639868537638211,0,62,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
3695,GO:0007190,1,0.790697425435009,0,38,activation of adenylate cyclase activity,BP,
3696,GO:0007191,1,0.931149042999007,0,10,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3697,GO:0007193,1,0.627782104634992,0,74,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,
3698,GO:0007194,1,0.803639383373605,0,28,negative regulation of adenylate cyclase activity,BP,
3699,GO:0007195,1,0.898556121917791,0,11,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3700,GO:0007196,1,0.983934124435457,0,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3701,GO:0007197,1,0.959319879203053,0,5,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3702,GO:0007198,1,0.96160682021658,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3703,GO:0007199,1,0.985034060552955,0,2,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3704,GO:0007200,1,0.390362349865263,0,109,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
3707,GO:0007205,1,0.849946220383294,0,28,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,
3708,GO:0007206,1,0.998685655247448,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3709,GO:0007207,1,0.949608710009465,0,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3710,GO:0007208,1,0.994297488143672,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3711,GO:0007210,1,0.764350761155957,0,26,serotonin receptor signaling pathway,BP,
3712,GO:0007212,1,0.699100487783294,0,45,dopamine receptor signaling pathway,BP,
3713,GO:0007213,1,0.889296802354504,0,15,G-protein coupled acetylcholine receptor signaling pathway,BP,
3714,GO:0007214,1,0.886359625874692,0,23,gamma-aminobutyric acid signaling pathway,BP,
3716,GO:0007216,1,0.960366687536966,0,14,G-protein coupled glutamate receptor signaling pathway,BP,
3717,GO:0007217,1,0.930374825720382,0,7,tachykinin receptor signaling pathway,BP,
3718,GO:0007218,1,0.389349977667976,0,98,neuropeptide signaling pathway,BP,
3719,GO:0007219,1,0.350241566047091,0,159,Notch signaling pathway,BP,
3720,GO:0007220,1,0.933705855686178,0,16,Notch receptor processing,BP,
3721,GO:0007221,1,0.986594929379633,0,7,positive regulation of transcription of Notch receptor target,BP,
3722,GO:0007223,1,0.848754176816407,0,39,Wnt signaling pathway, calcium modulating pathway,BP,
3723,GO:0007224,1,0.54587037774408,0,119,smoothened signaling pathway,BP,
3724,GO:0007225,1,0.999607592814813,0,1,patched ligand maturation,BP,
3725,GO:0007227,1,0.983097402671942,0,4,signal transduction downstream of smoothened,BP,
3726,GO:0007228,1,0.985156926928889,0,3,positive regulation of hh target transcription factor activity,BP,
3727,GO:0007229,1,0.680440276787235,0,89,integrin-mediated signaling pathway,BP,
3728,GO:0007231,1,0.972163214289755,0,3,osmosensory signaling pathway,BP,
3730,GO:0007250,1,0.886855773117337,0,18,activation of NF-kappaB-inducing kinase activity,BP,
3731,GO:0007252,1,0.929429614026109,0,15,I-kappaB phosphorylation,BP,
3732,GO:0007253,1,0.903502663641394,0,11,cytoplasmic sequestering of NF-kappaB,BP,
3734,GO:0007256,1,0.992319028464371,0,6,activation of JNKK activity,BP,
3735,GO:0007257,1,0.867030717548629,0,34,activation of JUN kinase activity,BP,
3736,GO:0007258,1,0.978956149756623,0,4,JUN phosphorylation,BP,
3739,GO:0007262,1,0.968684675500645,0,8,STAT protein import into nucleus,BP,
3740,GO:0007263,1,0.859800347725536,0,23,nitric oxide mediated signal transduction,BP,
3743,GO:0007266,1,0.467928934424264,0,165,Rho protein signal transduction,BP,
3746,GO:0007269,1,0.498405172897571,0,135,neurotransmitter secretion,BP,
3747,GO:0007270,1,0.509376565749643,0,132,neuron-neuron synaptic transmission,BP,
3748,GO:0007271,1,0.764077248361284,0,35,synaptic transmission, cholinergic,BP,
3755,GO:0007284,1,0.999391263498651,0,1,spermatogonial cell division,BP,
3756,GO:0007286,1,0.379413297126397,0,125,spermatid development,BP,
3757,GO:0007288,1,0.936902422819569,0,8,sperm axoneme assembly,BP,
3758,GO:0007289,1,0.885359121717795,0,17,spermatid nucleus differentiation,BP,
3759,GO:0007290,1,0.963748251954765,0,4,spermatid nucleus elongation,BP,
3760,GO:0007291,1,0.987350241308514,0,1,sperm individualization,BP,
3762,GO:0007296,1,0.988404666315456,0,4,vitellogenesis,BP,
3763,GO:0007308,1,0.987987657630493,0,2,oocyte construction,BP,
3764,GO:0007309,1,0.987987657630493,0,2,oocyte axis specification,BP,
3765,GO:0007314,1,0.987987657630493,0,2,oocyte anterior/posterior axis specification,BP,
3766,GO:0007315,1,0.987987657630493,0,2,pole plasm assembly,BP,
3767,GO:0007320,1,0.905535821355586,0,13,insemination,BP,
3768,GO:0007321,1,0.987281694667972,0,1,sperm displacement,BP,
3770,GO:0007339,1,0.734923486700041,0,34,binding of sperm to zona pellucida,BP,
3771,GO:0007340,1,0.74594549191617,0,35,acrosome reaction,BP,
3773,GO:0007342,1,0.882361841387349,0,12,fusion of sperm to egg plasma membrane,BP,
3774,GO:0007343,1,0.959074528307116,0,5,egg activation,BP,
3775,GO:0007344,1,0.988613664589566,0,1,pronuclear fusion,BP,
3777,GO:0007349,1,0.987350241308514,0,1,cellularization,BP,
3778,GO:0007350,1,0.903125116859802,0,17,blastoderm segmentation,BP,
3779,GO:0007351,1,0.914469961625598,0,14,tripartite regional subdivision,BP,
3780,GO:0007352,1,0.980443842511334,0,3,zygotic specification of dorsal/ventral axis,BP,
3781,GO:0007354,1,0.954541604043315,0,5,zygotic determination of anterior/posterior axis, embryo,BP,
3782,GO:0007356,1,0.959137245137294,0,4,thorax and anterior abdomen determination,BP,
3784,GO:0007369,1,0.373882979524354,0,176,gastrulation,BP,
3785,GO:0007371,1,0.997145662464174,0,1,ventral midline determination,BP,
3786,GO:0007379,1,0.875269430263905,0,17,segment specification,BP,
3787,GO:0007386,1,0.968199118436798,0,5,compartment pattern specification,BP,
3788,GO:0007387,1,0.992357093654399,0,1,anterior compartment pattern formation,BP,
3789,GO:0007388,1,0.992357093654399,0,1,posterior compartment specification,BP,
3791,GO:0007398,1,0.897117737040068,0,21,ectoderm development,BP,
3793,GO:0007400,1,0.991273856262465,0,1,neuroblast fate determination,BP,
3794,GO:0007402,1,0.977917168724821,0,2,ganglion mother cell fate determination,BP,
3795,GO:0007403,1,0.995784523078276,0,1,glial cell fate determination,BP,
3796,GO:0007405,1,0.785105044653912,0,53,neuroblast proliferation,BP,
3797,GO:0007406,1,0.976441933933109,0,5,negative regulation of neuroblast proliferation,BP,
3800,GO:0007412,1,0.973436368126721,0,3,axon target recognition,BP,
3801,GO:0007413,1,0.925802427117679,0,21,axonal fasciculation,BP,
3802,GO:0007416,1,0.600204570508989,0,136,synapse assembly,BP,
3804,GO:0007418,1,0.981467627987306,0,4,ventral midline development,BP,
3806,GO:0007422,1,0.689292883885031,0,69,peripheral nervous system development,BP,
3808,GO:0007424,1,0.991648557536278,0,1,open tracheal system development,BP,
3809,GO:0007431,1,0.807529418291948,0,38,salivary gland development,BP,
3810,GO:0007435,1,0.831735912631175,0,34,salivary gland morphogenesis,BP,
3811,GO:0007439,1,0.985276769014505,0,2,ectodermal digestive tract development,BP,
3812,GO:0007440,1,0.962601267104245,0,10,foregut morphogenesis,BP,
3813,GO:0007442,1,0.969503646594128,0,7,hindgut morphogenesis,BP,
3814,GO:0007468,1,0.971072054139403,0,3,regulation of rhodopsin gene expression,BP,
3815,GO:0007492,1,0.65005411520262,0,77,endoderm development,BP,
3816,GO:0007493,1,0.986862158441821,0,2,endodermal cell fate determination,BP,
3817,GO:0007494,1,0.950032076242268,0,11,midgut development,BP,
3818,GO:0007495,1,0.994645058213303,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3819,GO:0007497,1,0.998601630561229,0,2,posterior midgut development,BP,
3820,GO:0007498,1,0.453250493608931,0,124,mesoderm development,BP,
3821,GO:0007499,1,0.999476483762563,0,1,ectoderm and mesoderm interaction,BP,
3822,GO:0007500,1,0.97257811328191,0,3,mesodermal cell fate determination,BP,
3823,GO:0007501,1,0.899099909668524,0,14,mesodermal cell fate specification,BP,
3824,GO:0007506,1,0.932212912224223,0,7,gonadal mesoderm development,BP,
3826,GO:0007509,1,0.991486723112723,0,2,mesoderm migration involved in gastrulation,BP,
3827,GO:0007512,1,0.932850849500385,0,12,adult heart development,BP,
3829,GO:0007518,1,0.97969675945492,0,2,myoblast fate determination,BP,
3831,GO:0007520,1,0.76591705004966,0,38,myoblast fusion,BP,
3832,GO:0007521,1,0.995571874494119,0,2,muscle cell fate determination,BP,
3833,GO:0007522,1,0.99999999637244,0,1,visceral muscle development,BP,
3834,GO:0007525,1,0.991798440676823,0,2,somatic muscle development,BP,
3835,GO:0007528,1,0.844349131528726,0,41,neuromuscular junction development,BP,
3836,GO:0007529,1,0.997393990321769,0,1,establishment of synaptic specificity at neuromuscular junction,BP,
3837,GO:0007530,1,0.857992271131194,0,23,sex determination,BP,
3838,GO:0007538,1,0.992034054834,0,3,primary sex determination,BP,
3839,GO:0007542,1,0.997803263224464,0,2,primary sex determination, germ-line,BP,
3841,GO:0007549,1,0.95076501168882,0,9,dosage compensation,BP,
3842,GO:0007565,1,0.266339883951608,0,182,female pregnancy,BP,
3843,GO:0007566,1,0.711637636974681,0,48,embryo implantation,BP,
3844,GO:0007567,1,0.878458710085238,0,18,parturition,BP,
3846,GO:0007569,1,0.569281529093101,0,93,cell aging,BP,
3847,GO:0007571,1,0.987384919683888,0,2,age-dependent general metabolic decline,BP,
3848,GO:0007576,1,0.991594414574029,0,1,nucleolar fragmentation,BP,
3850,GO:0007585,1,0.692355539996774,0,64,respiratory gaseous exchange,BP,
3852,GO:0007588,1,0.594437809797997,0,66,excretion,BP,
3853,GO:0007589,1,0.55422416702372,0,87,body fluid secretion,BP,
3854,GO:0007595,1,0.82435352104516,0,40,lactation,BP,
3856,GO:0007597,1,0.850826919372565,0,19,blood coagulation, intrinsic pathway,BP,
3861,GO:0007602,1,0.628272454375679,0,59,phototransduction,BP,
3862,GO:0007603,1,0.76261066112373,0,38,phototransduction, visible light,BP,
3864,GO:0007606,1,0.00330668934511834,0,473,sensory perception of chemical stimulus,BP,
3865,GO:0007608,1,0.00686840362725157,0,402,sensory perception of smell,BP,
3868,GO:0007612,1,0.537818462981897,0,128,learning,BP,
3870,GO:0007614,1,0.942109956176127,0,9,short-term memory,BP,
3871,GO:0007616,1,0.889898605608178,0,30,long-term memory,BP,
3875,GO:0007620,1,0.865705000521975,0,20,copulation,BP,
3876,GO:0007621,1,0.974291650908032,0,4,negative regulation of female receptivity,BP,
3879,GO:0007624,1,0.998502298805978,0,1,ultradian rhythm,BP,
3880,GO:0007625,1,0.871418292021714,0,18,grooming behavior,BP,
3882,GO:0007628,1,0.872317922286723,0,28,adult walking behavior,BP,
3883,GO:0007631,1,0.428806205019118,0,107,feeding behavior,BP,
3884,GO:0007632,1,0.780217957327347,0,50,visual behavior,BP,
3885,GO:0007634,1,0.991129538042713,0,1,optokinetic behavior,BP,
3886,GO:0007635,1,0.919697432579638,0,17,chemosensory behavior,BP,
3888,GO:0008009,1,0.57165397999299,0,47,chemokine activity,MF,
3889,GO:0008013,1,0.763359170118376,0,78,beta-catenin binding,MF,
3892,GO:0008017,1,0.393426388439652,0,208,microtubule binding,MF,
3893,GO:0008020,1,0.965151740849495,0,4,G-protein coupled photoreceptor activity,MF,
3894,GO:0008021,1,0.375694439106991,0,145,synaptic vesicle,CC,
3895,GO:0008022,1,0.356343512322607,0,176,protein C-terminus binding,MF,
3896,GO:0008023,1,0.781824734623938,0,45,transcription elongation factor complex,CC,
3897,GO:0008024,1,0.96288042954644,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3898,GO:0008026,1,0.646220124158101,0,99,ATP-dependent helicase activity,MF,
3899,GO:0008028,1,0.775936929562553,0,37,monocarboxylic acid transmembrane transporter activity,MF,
3901,GO:0008035,1,0.91890729437632,0,9,high-density lipoprotein particle binding,MF,
3902,GO:0008037,1,0.416263786457452,0,131,cell recognition,BP,
3903,GO:0008038,1,0.883783077829604,0,34,neuron recognition,BP,
3904,GO:0008039,1,0.988073323030041,0,1,synaptic target recognition,BP,
3905,GO:0008043,1,0.975029852781935,0,2,intracellular ferritin complex,CC,
3906,GO:0008045,1,0.878692995474208,0,25,motor neuron axon guidance,BP,
3907,GO:0008046,1,0.9871805959864,0,7,axon guidance receptor activity,MF,
3909,GO:0008048,1,0.942836389143859,0,5,calcium sensitive guanylate cyclase activator activity,MF,
3911,GO:0008050,1,0.99104075264228,0,2,female courtship behavior,BP,
3912,GO:0008052,1,0.987361667413007,0,1,sensory organ boundary specification,BP,
3913,GO:0008053,1,0.867101879721404,0,19,mitochondrial fusion,BP,
3914,GO:0008057,1,0.999999996381332,0,1,eye pigment granule organization,BP,
3915,GO:0008061,1,0.932454010853677,0,8,chitin binding,MF,
3916,GO:0008063,1,0.96668478095125,0,6,Toll signaling pathway,BP,
3918,GO:0008065,1,0.982860070689053,0,3,establishment of blood-nerve barrier,BP,
3920,GO:0008068,1,0.993657777065081,0,1,extracellular-glutamate-gated chloride channel activity,MF,
3921,GO:0008073,1,0.96432497651812,0,3,ornithine decarboxylase inhibitor activity,MF,
3922,GO:0008074,1,0.96470105615016,0,17,guanylate cyclase complex, soluble,CC,
3923,GO:0008076,1,0.618764117343365,0,87,voltage-gated potassium channel complex,CC,
3924,GO:0008078,1,0.966770296408253,0,4,mesodermal cell migration,BP,
3925,GO:0008079,1,0.966088416646759,0,6,translation termination factor activity,MF,
3926,GO:0008080,1,0.571684151587314,0,83,N-acetyltransferase activity,MF,
3927,GO:0008081,1,0.634053574294535,0,90,phosphoric diester hydrolase activity,MF,
3929,GO:0008088,1,0.799473863357284,0,45,axo-dendritic transport,BP,
3930,GO:0008089,1,0.837595034771151,0,30,anterograde axonal transport,BP,
3931,GO:0008090,1,0.949849901107093,0,9,retrograde axonal transport,BP,
3932,GO:0008091,1,0.995980525803397,0,8,spectrin,CC,
3934,GO:0008093,1,0.942175110543027,0,11,cytoskeletal adaptor activity,MF,
3935,GO:0008094,1,0.697301243563223,0,74,DNA-dependent ATPase activity,MF,
3936,GO:0008097,1,0.933491162525793,0,6,5S rRNA binding,MF,
3938,GO:0008105,1,0.944278045796033,0,17,asymmetric protein localization,BP,
3939,GO:0008106,1,0.83849062212273,0,16,alcohol dehydrogenase (NADP+) activity,MF,
3940,GO:0008107,1,0.99294020796979,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3942,GO:0008109,1,0.985366842029959,0,3,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3943,GO:0008111,1,0.989310804215667,0,1,alpha-methylacyl-CoA racemase activity,MF,
3946,GO:0008115,1,0.991017055661357,0,1,sarcosine oxidase activity,MF,
3947,GO:0008116,1,0.999997177314998,0,1,prostaglandin-I synthase activity,MF,
3948,GO:0008117,1,0.999999982935418,0,1,sphinganine-1-phosphate aldolase activity,MF,
3949,GO:0008118,1,0.990229360297411,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3950,GO:0008119,1,0.99495768371548,0,1,thiopurine S-methyltransferase activity,MF,
3951,GO:0008120,1,0.988322018244957,0,1,ceramide glucosyltransferase activity,MF,
3952,GO:0008121,1,0.915792845222807,0,8,ubiquinol-cytochrome-c reductase activity,MF,
3953,GO:0008123,1,0.99313805987487,0,1,cholesterol 7-alpha-monooxygenase activity,MF,
3955,GO:0008126,1,0.992983615869936,0,1,acetylesterase activity,MF,
3956,GO:0008127,1,0.987692946890955,0,1,quercetin 2,3-dioxygenase activity,MF,
3957,GO:0008131,1,0.974088942041524,0,5,primary amine oxidase activity,MF,
3960,GO:0008137,1,0.635349816884007,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3961,GO:0008138,1,0.723095487659776,0,44,protein tyrosine/serine/threonine phosphatase activity,MF,
3962,GO:0008139,1,0.903322380096004,0,26,nuclear localization sequence binding,MF,
3963,GO:0008140,1,0.94861898763391,0,8,cAMP response element binding protein binding,MF,
3964,GO:0008142,1,0.979697658027984,0,5,oxysterol binding,MF,
3965,GO:0008143,1,0.937481477975891,0,12,poly(A) binding,MF,
3967,GO:0008146,1,0.681738147661285,0,52,sulfotransferase activity,MF,
3968,GO:0008147,1,0.974516904627323,0,2,structural constituent of bone,MF,
3972,GO:0008156,1,0.82186898836772,0,34,negative regulation of DNA replication,BP,
3973,GO:0008157,1,0.898327223945523,0,18,protein phosphatase 1 binding,MF,
3974,GO:0008158,1,0.985574581571534,0,3,hedgehog receptor activity,MF,
3975,GO:0008160,1,0.991912933935171,0,1,protein tyrosine phosphatase activator activity,MF,
3977,GO:0008169,1,0.979246819070901,0,3,C-methyltransferase activity,MF,
3979,GO:0008171,1,0.890280928056093,0,15,O-methyltransferase activity,MF,
3980,GO:0008172,1,0.944091228482695,0,7,S-methyltransferase activity,MF,
3981,GO:0008173,1,0.70542905609138,0,45,RNA methyltransferase activity,MF,
3982,GO:0008174,1,0.979165363410958,0,3,mRNA methyltransferase activity,MF,
3983,GO:0008175,1,0.826996638715972,0,25,tRNA methyltransferase activity,MF,
3984,GO:0008176,1,0.976559708547558,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3985,GO:0008177,1,0.96660345368014,0,3,succinate dehydrogenase (ubiquinone) activity,MF,
3986,GO:0008179,1,0.940401901001149,0,12,adenylate cyclase binding,MF,
3987,GO:0008180,1,0.801460604067069,0,32,COP9 signalosome,CC,
3988,GO:0008184,1,0.987468342737693,0,3,glycogen phosphorylase activity,MF,
3989,GO:0008186,1,0.726974714058982,0,68,RNA-dependent ATPase activity,MF,
3990,GO:0008187,1,0.873846213767519,0,21,poly-pyrimidine tract binding,MF,
3991,GO:0008188,1,0.669805193177864,0,44,neuropeptide receptor activity,MF,
3992,GO:0008190,1,0.952193753400444,0,9,eukaryotic initiation factor 4E binding,MF,
3993,GO:0008191,1,0.901241021438474,0,15,metalloendopeptidase inhibitor activity,MF,
3994,GO:0008192,1,0.985369989779318,0,3,RNA guanylyltransferase activity,MF,
3995,GO:0008193,1,0.986135294605547,0,2,tRNA guanylyltransferase activity,MF,
3997,GO:0008195,1,0.999014651940054,0,3,phosphatidate phosphatase activity,MF,
4000,GO:0008200,1,0.804149301692387,0,31,ion channel inhibitor activity,MF,
4004,GO:0008204,1,0.97799784882027,0,2,ergosterol metabolic process,BP,
4012,GO:0008214,1,0.937397988323769,0,28,protein dealkylation,BP,
4013,GO:0008215,1,0.928636981497676,0,7,spermine metabolic process,BP,
4014,GO:0008216,1,0.916748764560685,0,8,spermidine metabolic process,BP,
4015,GO:0008217,1,0.313485507765468,0,165,regulation of blood pressure,BP,
4016,GO:0008218,1,0.976882186327717,0,3,bioluminescence,BP,
4018,GO:0008227,1,0.608532597476789,0,52,G-protein coupled amine receptor activity,MF,
4019,GO:0008228,1,0.911270134654936,0,12,opsonization,BP,
4026,GO:0008239,1,0.931934399525297,0,9,dipeptidyl-peptidase activity,MF,
4027,GO:0008240,1,0.991408921785258,0,3,tripeptidyl-peptidase activity,MF,
4028,GO:0008241,1,0.983745963440501,0,2,peptidyl-dipeptidase activity,MF,
4029,GO:0008242,1,0.904023258206487,0,12,omega peptidase activity,MF,
4030,GO:0008250,1,0.889039830134376,0,12,oligosaccharyltransferase complex,CC,
4031,GO:0008251,1,0.992458447719158,0,2,tRNA-specific adenosine deaminase activity,MF,
4032,GO:0008252,1,0.915270578485241,0,13,nucleotidase activity,MF,
4033,GO:0008253,1,0.923377821939775,0,11,5'-nucleotidase activity,MF,
4034,GO:0008254,1,0.99999999638,0,1,3'-nucleotidase activity,MF,
4035,GO:0008260,1,0.985285836001561,0,2,3-oxoacid CoA-transferase activity,MF,
4036,GO:0008263,1,0.9862613254974,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
4037,GO:0008265,1,0.992472632785116,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
4038,GO:0008266,1,0.889270390503561,0,18,poly(U) RNA binding,MF,
4039,GO:0008267,1,0.999999996384669,0,1,poly-glutamine tract binding,MF,
4040,GO:0008269,1,0.979322095683213,0,2,JAK pathway signal transduction adaptor activity,MF,
4042,GO:0008271,1,0.941404654084462,0,13,secondary active sulfate transmembrane transporter activity,MF,
4043,GO:0008272,1,0.926729480358481,0,15,sulfate transport,BP,
4044,GO:0008273,1,0.975587153596174,0,5,calcium, potassium:sodium antiporter activity,MF,
4045,GO:0008274,1,0.966374216210094,0,7,gamma-tubulin ring complex,CC,
4046,GO:0008275,1,0.992464452155035,0,3,gamma-tubulin small complex,CC,
4047,GO:0008276,1,0.672415081633337,0,67,protein methyltransferase activity,MF,
4049,GO:0008278,1,0.954100194774644,0,9,cohesin complex,CC,
4050,GO:0008281,1,0.999391790936399,0,2,sulfonylurea receptor activity,MF,
4051,GO:0008282,1,0.984438697828074,0,4,ATP-sensitive potassium channel complex,CC,
4056,GO:0008287,1,0.77573426713144,0,45,protein serine/threonine phosphatase complex,CC,
4058,GO:0008290,1,0.941687967660281,0,8,F-actin capping protein complex,CC,
4059,GO:0008291,1,0.977695461909994,0,4,acetylcholine metabolic process,BP,
4060,GO:0008292,1,0.991960643412997,0,2,acetylcholine biosynthetic process,BP,
4061,GO:0008294,1,0.998411570893729,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
4062,GO:0008295,1,0.961831771458049,0,4,spermidine biosynthetic process,BP,
4063,GO:0008296,1,0.916129140333448,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4064,GO:0008297,1,0.950972785975627,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4065,GO:0008298,1,0.90570883374671,0,12,intracellular mRNA localization,BP,
4066,GO:0008299,1,0.820150910364229,0,25,isoprenoid biosynthetic process,BP,
4067,GO:0008300,1,0.928097712969946,0,8,isoprenoid catabolic process,BP,
4068,GO:0008301,1,0.880623112514267,0,19,DNA binding, bending,MF,
4069,GO:0008305,1,0.919721580151828,0,32,integrin complex,CC,
4070,GO:0008306,1,0.675998721064329,0,72,associative learning,BP,
4071,GO:0008307,1,0.766914906306311,0,46,structural constituent of muscle,MF,
4072,GO:0008308,1,0.881172856080106,0,18,voltage-gated anion channel activity,MF,
4073,GO:0008309,1,0.962871561042795,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4074,GO:0008310,1,0.964065141966795,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4075,GO:0008311,1,0.977461944974819,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4076,GO:0008312,1,0.934412696871434,0,7,7S RNA binding,MF,
4077,GO:0008318,1,0.950807571097743,0,7,protein prenyltransferase activity,MF,
4078,GO:0008320,1,0.840568190268894,0,17,protein transmembrane transporter activity,MF,
4079,GO:0008321,1,0.991581087112491,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4081,GO:0008327,1,0.851337784638426,0,21,methyl-CpG binding,MF,
4083,GO:0008329,1,0.870283792819465,0,17,signaling pattern recognition receptor activity,MF,
4084,GO:0008330,1,0.971647876542297,0,3,protein tyrosine/threonine phosphatase activity,MF,
4085,GO:0008331,1,0.972072529797866,0,12,high voltage-gated calcium channel activity,MF,
4086,GO:0008332,1,0.999999989162607,0,3,low voltage-gated calcium channel activity,MF,
4087,GO:0008333,1,0.789714150081071,0,42,endosome to lysosome transport,BP,
4088,GO:0008334,1,0.847137489871842,0,24,histone mRNA metabolic process,BP,
4089,GO:0008336,1,0.989035033890079,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4090,GO:0008340,1,0.954284830052612,0,12,determination of adult lifespan,BP,
4091,GO:0008343,1,0.904453444902821,0,10,adult feeding behavior,BP,
4092,GO:0008344,1,0.656143206163777,0,78,adult locomotory behavior,BP,
4094,GO:0008348,1,0.996841434995585,0,1,negative regulation of antimicrobial humoral response,BP,
4095,GO:0008349,1,0.983884442392154,0,4,MAP kinase kinase kinase kinase activity,MF,
4096,GO:0008352,1,0.992120933506873,0,1,katanin complex,CC,
4097,GO:0008353,1,0.872098929006487,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
4098,GO:0008354,1,0.965103658266255,0,7,germ cell migration,BP,
4099,GO:0008355,1,0.997939027469477,0,2,olfactory learning,BP,
4100,GO:0008356,1,0.902850151315736,0,17,asymmetric cell division,BP,
4101,GO:0008358,1,0.987987657630493,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4105,GO:0008373,1,0.872061543288862,0,21,sialyltransferase activity,MF,
4108,GO:0008376,1,0.839999516733981,0,34,acetylgalactosaminyltransferase activity,MF,
4109,GO:0008378,1,0.799626617780445,0,31,galactosyltransferase activity,MF,
4110,GO:0008379,1,0.939073789299348,0,5,thioredoxin peroxidase activity,MF,
4112,GO:0008381,1,0.952741334411772,0,8,mechanically-gated ion channel activity,MF,
4113,GO:0008384,1,0.989282779481416,0,3,IkappaB kinase activity,MF,
4116,GO:0008387,1,0.990447743086166,0,1,steroid 7-alpha-hydroxylase activity,MF,
4117,GO:0008389,1,0.977418797070105,0,2,coumarin 7-hydroxylase activity,MF,
4118,GO:0008391,1,0.850093923533169,0,16,arachidonic acid monooxygenase activity,MF,
4119,GO:0008392,1,0.850093923533169,0,16,arachidonic acid epoxygenase activity,MF,
4121,GO:0008396,1,0.981469210994371,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4122,GO:0008397,1,0.997892872106596,0,1,sterol 12-alpha-hydroxylase activity,MF,
4123,GO:0008398,1,0.99411107638574,0,1,sterol 14-demethylase activity,MF,
4124,GO:0008401,1,0.969822247256897,0,4,retinoic acid 4-hydroxylase activity,MF,
4125,GO:0008403,1,0.994589471351123,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4126,GO:0008404,1,0.988941777993996,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4127,GO:0008405,1,0.988941777993996,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4129,GO:0008408,1,0.745401290865678,0,48,3'-5' exonuclease activity,MF,
4130,GO:0008409,1,0.933127658071963,0,12,5'-3' exonuclease activity,MF,
4131,GO:0008410,1,0.974284994521036,0,3,CoA-transferase activity,MF,
4132,GO:0008413,1,0.976808434010159,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4133,GO:0008417,1,0.930452598577279,0,13,fucosyltransferase activity,MF,
4134,GO:0008418,1,0.987468429989096,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4135,GO:0008419,1,0.992079142895533,0,1,RNA lariat debranching enzyme activity,MF,
4136,GO:0008420,1,0.957123283344674,0,6,CTD phosphatase activity,MF,
4137,GO:0008422,1,0.974999500750314,0,5,beta-glucosidase activity,MF,
4138,GO:0008424,1,0.995148460683886,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4139,GO:0008425,1,0.987647083299915,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4140,GO:0008426,1,0.972381857698309,0,3,protein kinase C inhibitor activity,MF,
4141,GO:0008427,1,0.966238640917896,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4142,GO:0008428,1,0.981904258853428,0,3,ribonuclease inhibitor activity,MF,
4143,GO:0008429,1,0.934280606299421,0,8,phosphatidylethanolamine binding,MF,
4144,GO:0008430,1,0.965460686784685,0,5,selenium binding,MF,
4145,GO:0008431,1,0.97559593234612,0,3,vitamin E binding,MF,
4146,GO:0008432,1,0.96839882913292,0,7,JUN kinase binding,MF,
4147,GO:0008434,1,0.999575264954682,0,1,calcitriol receptor activity,MF,
4148,GO:0008437,1,0.989414915447417,0,1,thyrotropin-releasing hormone activity,MF,
4149,GO:0008440,1,0.931138514310186,0,10,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4150,GO:0008441,1,0.991225555956231,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4151,GO:0008442,1,0.989326015957914,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4152,GO:0008443,1,0.965541379120529,0,7,phosphofructokinase activity,MF,
4153,GO:0008444,1,0.990109782243798,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4154,GO:0008445,1,0.988289056556148,0,1,D-aspartate oxidase activity,MF,
4155,GO:0008446,1,0.988429705368738,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4156,GO:0008448,1,0.988867491081249,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4157,GO:0008449,1,0.998649531234254,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4158,GO:0008453,1,0.978699607330727,0,2,alanine-glyoxylate transaminase activity,MF,
4159,GO:0008454,1,0.981517942241787,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4160,GO:0008455,1,0.992331240483365,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4161,GO:0008456,1,0.997093914670211,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4162,GO:0008457,1,0.998428334772665,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4163,GO:0008458,1,0.99496725467276,0,1,carnitine O-octanoyltransferase activity,MF,
4164,GO:0008459,1,0.990562192611352,0,2,chondroitin 6-sulfotransferase activity,MF,
4165,GO:0008460,1,0.989092177106063,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4166,GO:0008465,1,0.987611508885694,0,1,glycerate dehydrogenase activity,MF,
4167,GO:0008466,1,0.98428898696534,0,2,glycogenin glucosyltransferase activity,MF,
4168,GO:0008467,1,0.935898322426003,0,7,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4169,GO:0008469,1,0.938136158029043,0,7,histone-arginine N-methyltransferase activity,MF,
4170,GO:0008470,1,0.999460257696104,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4172,GO:0008475,1,0.985790013588227,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4173,GO:0008476,1,0.978910076381212,0,2,protein-tyrosine sulfotransferase activity,MF,
4174,GO:0008478,1,0.999999996380967,0,1,pyridoxal kinase activity,MF,
4175,GO:0008479,1,0.932545228823193,0,6,queuine tRNA-ribosyltransferase activity,MF,
4177,GO:0008481,1,0.982597699920338,0,2,sphinganine kinase activity,MF,
4178,GO:0008482,1,0.990673960789241,0,1,sulfite oxidase activity,MF,
4179,GO:0008483,1,0.875594027955071,0,17,transaminase activity,MF,
4180,GO:0008484,1,0.919920942577733,0,17,sulfuric ester hydrolase activity,MF,
4181,GO:0008486,1,0.968037406610311,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4182,GO:0008488,1,0.994577377896742,0,1,gamma-glutamyl carboxylase activity,MF,
4183,GO:0008489,1,0.993271224147252,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
4184,GO:0008493,1,0.988952528708528,0,1,tetracycline transporter activity,MF,
4185,GO:0008494,1,0.958901131216886,0,7,translation activator activity,MF,
4186,GO:0008495,1,0.993745496893616,0,1,protoheme IX farnesyltransferase activity,MF,
4187,GO:0008496,1,0.998779699154118,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4188,GO:0008499,1,0.904574338230367,0,14,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4189,GO:0008502,1,0.96569366364197,0,3,melatonin receptor activity,MF,
4190,GO:0008503,1,0.961788068484605,0,6,benzodiazepine receptor activity,MF,
4191,GO:0008504,1,0.949505747256231,0,9,monoamine transmembrane transporter activity,MF,
4192,GO:0008506,1,0.981529972959541,0,3,sucrose:proton symporter activity,MF,
4193,GO:0008507,1,0.996494184663377,0,1,sodium:iodide symporter activity,MF,
4194,GO:0008508,1,0.941629307454646,0,6,bile acid:sodium symporter activity,MF,
4196,GO:0008510,1,0.994911325890348,0,4,sodium:bicarbonate symporter activity,MF,
4197,GO:0008511,1,0.999588511222874,0,2,sodium:potassium:chloride symporter activity,MF,
4198,GO:0008513,1,0.970775028231089,0,3,secondary active organic cation transmembrane transporter activity,MF,
4200,GO:0008515,1,0.981529972959541,0,3,sucrose transmembrane transporter activity,MF,
4201,GO:0008517,1,0.959067193315115,0,6,folic acid transporter activity,MF,
4202,GO:0008518,1,0.992964354370504,0,1,reduced folate carrier activity,MF,
4203,GO:0008519,1,0.821894754950414,0,27,ammonium transmembrane transporter activity,MF,
4204,GO:0008520,1,0.990778624738743,0,2,L-ascorbate:sodium symporter activity,MF,
4205,GO:0008521,1,0.992116285519845,0,1,acetyl-CoA transporter activity,MF,
4206,GO:0008523,1,0.995217254339197,0,2,sodium-dependent multivitamin transmembrane transporter activity,MF,
4207,GO:0008525,1,0.984577267598619,0,6,phosphatidylcholine transporter activity,MF,
4208,GO:0008526,1,0.971169045445082,0,7,phosphatidylinositol transporter activity,MF,
4209,GO:0008527,1,0.754454149765102,0,25,taste receptor activity,MF,
4210,GO:0008528,1,0.344352105305687,0,123,G-protein coupled peptide receptor activity,MF,
4211,GO:0008531,1,0.992331240483365,0,1,riboflavin kinase activity,MF,
4212,GO:0008532,1,0.969902122903058,0,4,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4213,GO:0008534,1,0.976673040190944,0,2,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4214,GO:0008535,1,0.844023653293366,0,20,respiratory chain complex IV assembly,BP,
4215,GO:0008536,1,0.89768883798942,0,32,Ran GTPase binding,MF,
4216,GO:0008537,1,0.969692894647635,0,3,proteasome activator complex,CC,
4217,GO:0008540,1,0.895652657665054,0,10,proteasome regulatory particle, base subcomplex,CC,
4218,GO:0008541,1,0.922714800979757,0,7,proteasome regulatory particle, lid subcomplex,CC,
4219,GO:0008542,1,0.803849231767015,0,45,visual learning,BP,
4222,GO:0008545,1,0.997169401245435,0,1,JUN kinase kinase activity,MF,
4223,GO:0008553,1,0.937194464418665,0,7,hydrogen-exporting ATPase activity, phosphorylative mechanism,MF,
4224,GO:0008554,1,0.999662272398562,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4225,GO:0008555,1,0.999973370837893,0,1,chloride-transporting ATPase activity,MF,
4226,GO:0008556,1,0.928185042860631,0,11,potassium-transporting ATPase activity,MF,
4227,GO:0008559,1,0.988581205985082,0,7,xenobiotic-transporting ATPase activity,MF,
4229,GO:0008568,1,0.968341344264862,0,8,microtubule-severing ATPase activity,MF,
4230,GO:0008569,1,0.983468121433107,0,4,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4231,GO:0008574,1,0.985182506336296,0,16,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4232,GO:0008579,1,0.999952630314292,0,1,JUN kinase phosphatase activity,MF,
4233,GO:0008582,1,0.977619667431465,0,5,regulation of synaptic growth at neuromuscular junction,BP,
4236,GO:0008588,1,0.964671125980193,0,4,release of cytoplasmic sequestered NF-kappaB,BP,
4237,GO:0008589,1,0.761571076952587,0,66,regulation of smoothened signaling pathway,BP,
4238,GO:0008592,1,0.994904987350892,0,1,regulation of Toll signaling pathway,BP,
4239,GO:0008593,1,0.663045729761548,0,64,regulation of Notch signaling pathway,BP,
4240,GO:0008594,1,0.99813326189769,0,1,photoreceptor cell morphogenesis,BP,
4241,GO:0008595,1,0.914469961625598,0,14,anterior/posterior axis specification, embryo,BP,
4242,GO:0008597,1,0.974921716645459,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4243,GO:0008603,1,0.947635638325847,0,7,cAMP-dependent protein kinase regulator activity,MF,
4244,GO:0008607,1,0.977640426774373,0,4,phosphorylase kinase regulator activity,MF,
4245,GO:0008608,1,0.835338615126263,0,26,attachment of spindle microtubules to kinetochore,BP,
4246,GO:0008609,1,0.999999996382688,0,1,alkylglycerone-phosphate synthase activity,MF,
4248,GO:0008611,1,0.980306577289443,0,4,ether lipid biosynthetic process,BP,
4249,GO:0008612,1,0.964695167936578,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4250,GO:0008613,1,0.98720169877262,0,1,diuretic hormone activity,MF,
4251,GO:0008614,1,0.985837503226054,0,2,pyridoxine metabolic process,BP,
4252,GO:0008615,1,0.985837503226054,0,2,pyridoxine biosynthetic process,BP,
4253,GO:0008616,1,0.932545228823193,0,6,queuosine biosynthetic process,BP,
4254,GO:0008617,1,0.9873751125871,0,1,guanosine metabolic process,BP,
4255,GO:0008622,1,0.958097206815805,0,5,epsilon DNA polymerase complex,CC,
4256,GO:0008623,1,0.991068828541605,0,2,CHRAC,CC,
4258,GO:0008626,1,0.967662592652225,0,4,granzyme-mediated apoptotic signaling pathway,BP,
4259,GO:0008627,1,0.963975286905157,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4260,GO:0008628,1,0.952766368497991,0,4,hormone-mediated apoptotic signaling pathway,BP,
4263,GO:0008635,1,0.933538161747137,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4265,GO:0008641,1,0.939971110184883,0,10,small protein activating enzyme activity,MF,
4268,GO:0008649,1,0.896978872789809,0,13,rRNA methyltransferase activity,MF,
4270,GO:0008653,1,0.997875966464858,0,1,lipopolysaccharide metabolic process,BP,
4272,GO:0008655,1,0.898348324013781,0,11,pyrimidine-containing compound salvage,BP,
4274,GO:0008665,1,0.987371501774334,0,1,2'-phosphotransferase activity,MF,
4276,GO:0008689,1,0.987647083299915,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4277,GO:0008700,1,0.991657600429728,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4278,GO:0008705,1,0.999999996398545,0,1,methionine synthase activity,MF,
4280,GO:0008721,1,0.991300277190173,0,1,D-serine ammonia-lyase activity,MF,
4281,GO:0008725,1,0.987440978919977,0,1,DNA-3-methyladenine glycosylase activity,MF,
4282,GO:0008732,1,0.981587552150228,0,2,L-allo-threonine aldolase activity,MF,
4283,GO:0008745,1,0.953556495740692,0,4,N-acetylmuramoyl-L-alanine amidase activity,MF,
4284,GO:0008746,1,0.986970375668874,0,2,NAD(P)+ transhydrogenase activity,MF,
4285,GO:0008747,1,0.988154741572323,0,1,N-acetylneuraminate lyase activity,MF,
4286,GO:0008750,1,0.999526342462488,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4287,GO:0008753,1,0.995907957674375,0,1,NADPH dehydrogenase (quinone) activity,MF,
4289,GO:0008761,1,0.999956817826212,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4290,GO:0008768,1,0.987275476973223,0,1,UDP-sugar diphosphatase activity,MF,
4291,GO:0008775,1,0.988836177349058,0,1,acetate CoA-transferase activity,MF,
4292,GO:0008781,1,0.976355615990633,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4293,GO:0008783,1,0.990125353848087,0,1,agmatinase activity,MF,
4294,GO:0008785,1,0.98816767388073,0,1,alkyl hydroperoxide reductase activity,MF,
4295,GO:0008794,1,0.987302752639619,0,1,arsenate reductase (glutaredoxin) activity,MF,
4296,GO:0008796,1,0.980031737806338,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4297,GO:0008798,1,0.99086936746001,0,2,beta-aspartyl-peptidase activity,MF,
4298,GO:0008802,1,0.996403026181617,0,1,betaine-aldehyde dehydrogenase activity,MF,
4299,GO:0008803,1,0.987357048219781,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4300,GO:0008808,1,0.997376890728512,0,1,cardiolipin synthase activity,MF,
4301,GO:0008811,1,0.987259972058179,0,1,chloramphenicol O-acetyltransferase activity,MF,
4302,GO:0008812,1,0.996749693893663,0,1,choline dehydrogenase activity,MF,
4303,GO:0008817,1,0.998486067143848,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4304,GO:0008821,1,0.926068443600293,0,9,crossover junction endodeoxyribonuclease activity,MF,
4305,GO:0008823,1,0.997042029686486,0,3,cupric reductase activity,MF,
4306,GO:0008829,1,0.988824331714101,0,1,dCTP deaminase activity,MF,
4307,GO:0008832,1,0.994717449770596,0,1,dGTPase activity,MF,
4308,GO:0008843,1,0.990586917343966,0,1,endochitinase activity,MF,
4309,GO:0008852,1,0.992935481934735,0,1,exodeoxyribonuclease I activity,MF,
4310,GO:0008853,1,0.965676785080169,0,4,exodeoxyribonuclease III activity,MF,
4311,GO:0008859,1,0.987332793548753,0,1,exoribonuclease II activity,MF,
4312,GO:0008865,1,0.988645220732919,0,4,fructokinase activity,MF,
4313,GO:0008887,1,0.994900192164014,0,1,glycerate kinase activity,MF,
4314,GO:0008889,1,0.968193494806411,0,6,glycerophosphodiester phosphodiesterase activity,MF,
4315,GO:0008890,1,0.988209352047045,0,1,glycine C-acetyltransferase activity,MF,
4316,GO:0008891,1,0.988619143020241,0,1,glycolate oxidase activity,MF,
4317,GO:0008892,1,0.999983082155749,0,1,guanine deaminase activity,MF,
4318,GO:0008893,1,0.987401019283895,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4319,GO:0008894,1,0.992477361402284,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4320,GO:0008897,1,0.9930752448595,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4321,GO:0008898,1,0.999999996398545,0,1,S-adenosylmethionine-homocysteine S-methyltransferase activity,MF,
4322,GO:0008900,1,0.981038724589915,0,3,hydrogen:potassium-exchanging ATPase activity,MF,
4323,GO:0008903,1,0.987463409907391,0,1,hydroxypyruvate isomerase activity,MF,
4324,GO:0008905,1,0.988256714907937,0,1,mannose-phosphate guanylyltransferase activity,MF,
4325,GO:0008934,1,0.97830098581565,0,4,inositol monophosphate 1-phosphatase activity,MF,
4326,GO:0008940,1,0.982211607259258,0,3,nitrate reductase activity,MF,
4327,GO:0008941,1,0.980749240685432,0,2,nitric oxide dioxygenase activity,MF,
4328,GO:0008948,1,0.973821193570733,0,4,oxaloacetate decarboxylase activity,MF,
4329,GO:0008955,1,0.997926437271025,0,1,peptidoglycan glycosyltransferase activity,MF,
4330,GO:0008962,1,0.991777922394465,0,1,phosphatidylglycerophosphatase activity,MF,
4331,GO:0008963,1,0.989921815379994,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4332,GO:0008967,1,0.983922233104836,0,2,phosphoglycolate phosphatase activity,MF,
4333,GO:0008969,1,0.969237696528519,0,3,phosphohistidine phosphatase activity,MF,
4335,GO:0008973,1,0.994943321324012,0,1,phosphopentomutase activity,MF,
4336,GO:0008988,1,0.983384249277821,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4337,GO:0008995,1,0.991798445845593,0,1,ribonuclease E activity,MF,
4338,GO:0009000,1,0.991238714137615,0,1,selenocysteine lyase activity,MF,
4339,GO:0009007,1,0.996882772847312,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4340,GO:0009008,1,0.981376290839031,0,5,DNA-methyltransferase activity,MF,
4341,GO:0009013,1,0.999908180509053,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4342,GO:0009019,1,0.975131574306466,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4343,GO:0009020,1,0.989258807756115,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4344,GO:0009032,1,0.988389825126606,0,1,thymidine phosphorylase activity,MF,
4345,GO:0009041,1,0.97442836519675,0,3,uridylate kinase activity,MF,
4346,GO:0009048,1,0.970859095250189,0,7,dosage compensation by inactivation of X chromosome,BP,
4347,GO:0009051,1,0.967652236533924,0,3,pentose-phosphate shunt, oxidative branch,BP,
4355,GO:0009061,1,0.990939835818504,0,1,anaerobic respiration,BP,
4359,GO:0009065,1,0.835692437171409,0,25,glutamine family amino acid catabolic process,BP,
4362,GO:0009068,1,0.875773101282767,0,17,aspartate family amino acid catabolic process,BP,
4363,GO:0009069,1,0.734311008094989,0,38,serine family amino acid metabolic process,BP,
4364,GO:0009070,1,0.864474250415387,0,16,serine family amino acid biosynthetic process,BP,
4365,GO:0009071,1,0.9052899487512,0,10,serine family amino acid catabolic process,BP,
4368,GO:0009078,1,0.95449914178738,0,5,pyruvate family amino acid metabolic process,BP,
4369,GO:0009080,1,0.95449914178738,0,5,pyruvate family amino acid catabolic process,BP,
4371,GO:0009082,1,0.988292552479546,0,2,branched-chain amino acid biosynthetic process,BP,
4374,GO:0009085,1,0.9930752448595,0,1,lysine biosynthetic process,BP,
4376,GO:0009087,1,0.995697036542217,0,1,methionine catabolic process,BP,
4377,GO:0009092,1,0.964886303300215,0,4,homoserine metabolic process,BP,
4378,GO:0009093,1,0.968699122708754,0,3,cysteine catabolic process,BP,
4379,GO:0009098,1,0.988292552479546,0,2,leucine biosynthetic process,BP,
4380,GO:0009099,1,0.988292552479546,0,2,valine biosynthetic process,BP,
4383,GO:0009103,1,0.997875966464858,0,1,lipopolysaccharide biosynthetic process,BP,
4384,GO:0009106,1,0.972491314004957,0,3,lipoate metabolic process,BP,
4385,GO:0009107,1,0.975904888924577,0,2,lipoate biosynthetic process,BP,
4389,GO:0009111,1,0.91049998973767,0,11,vitamin catabolic process,BP,
4391,GO:0009113,1,0.919696733675784,0,11,purine nucleobase biosynthetic process,BP,
4397,GO:0009123,1,0.0869151916062127,0,291,nucleoside monophosphate metabolic process,BP,
4398,GO:0009124,1,0.464533806258464,0,85,nucleoside monophosphate biosynthetic process,BP,
4399,GO:0009125,1,0.911835002967183,0,11,nucleoside monophosphate catabolic process,BP,
4400,GO:0009126,1,0.108274495223794,0,268,purine nucleoside monophosphate metabolic process,BP,
4401,GO:0009127,1,0.55830595844509,0,65,purine nucleoside monophosphate biosynthetic process,BP,
4402,GO:0009128,1,0.930484108512034,0,9,purine nucleoside monophosphate catabolic process,BP,
4403,GO:0009129,1,0.876695820933922,0,14,pyrimidine nucleoside monophosphate metabolic process,BP,
4404,GO:0009130,1,0.887161946131683,0,13,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4405,GO:0009131,1,0.988213803811303,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4407,GO:0009133,1,0.946749452462606,0,6,nucleoside diphosphate biosynthetic process,BP,
4408,GO:0009134,1,0.941046027530903,0,7,nucleoside diphosphate catabolic process,BP,
4409,GO:0009135,1,0.57661664707548,0,88,purine nucleoside diphosphate metabolic process,BP,
4410,GO:0009136,1,0.974573774874868,0,3,purine nucleoside diphosphate biosynthetic process,BP,
4411,GO:0009137,1,0.966201248081336,0,4,purine nucleoside diphosphate catabolic process,BP,
4412,GO:0009138,1,0.97478966755863,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4413,GO:0009139,1,0.981252736973267,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4414,GO:0009140,1,0.993414436255799,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4415,GO:0009141,1,0.0938535237018083,0,275,nucleoside triphosphate metabolic process,BP,
4416,GO:0009142,1,0.514129636092884,0,70,nucleoside triphosphate biosynthetic process,BP,
4417,GO:0009143,1,0.915257411673628,0,11,nucleoside triphosphate catabolic process,BP,
4418,GO:0009144,1,0.110144697461373,0,255,purine nucleoside triphosphate metabolic process,BP,
4419,GO:0009145,1,0.587154459884809,0,54,purine nucleoside triphosphate biosynthetic process,BP,
4420,GO:0009146,1,0.948044022396977,0,6,purine nucleoside triphosphate catabolic process,BP,
4421,GO:0009147,1,0.799351585131872,0,22,pyrimidine nucleoside triphosphate metabolic process,BP,
4422,GO:0009148,1,0.825128249899,0,19,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4423,GO:0009149,1,0.987470452549771,0,1,pyrimidine nucleoside triphosphate catabolic process,BP,
4425,GO:0009151,1,0.91201378329631,0,10,purine deoxyribonucleotide metabolic process,BP,
4427,GO:0009153,1,0.973706278043607,0,3,purine deoxyribonucleotide biosynthetic process,BP,
4429,GO:0009155,1,0.948635916117341,0,6,purine deoxyribonucleotide catabolic process,BP,
4430,GO:0009156,1,0.500753787024942,0,77,ribonucleoside monophosphate biosynthetic process,BP,
4431,GO:0009157,1,0.93741286225641,0,7,deoxyribonucleoside monophosphate biosynthetic process,BP,
4432,GO:0009158,1,0.942303855393466,0,8,ribonucleoside monophosphate catabolic process,BP,
4433,GO:0009159,1,0.979968958318379,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4434,GO:0009161,1,0.0982291883197804,0,279,ribonucleoside monophosphate metabolic process,BP,
4435,GO:0009162,1,0.907005492178568,0,10,deoxyribonucleoside monophosphate metabolic process,BP,
4436,GO:0009163,1,0.632061832732813,0,47,nucleoside biosynthetic process,BP,
4440,GO:0009167,1,0.109673668455406,0,267,purine ribonucleoside monophosphate metabolic process,BP,
4441,GO:0009168,1,0.55830595844509,0,65,purine ribonucleoside monophosphate biosynthetic process,BP,
4442,GO:0009169,1,0.942303855393466,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4443,GO:0009170,1,0.987358580697023,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4444,GO:0009173,1,0.915820960575477,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4445,GO:0009174,1,0.915820960575477,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4446,GO:0009176,1,0.957307724808733,0,4,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4447,GO:0009177,1,0.968728200578917,0,3,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4448,GO:0009178,1,0.988213803811303,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4449,GO:0009179,1,0.57661664707548,0,88,purine ribonucleoside diphosphate metabolic process,BP,
4450,GO:0009180,1,0.974573774874868,0,3,purine ribonucleoside diphosphate biosynthetic process,BP,
4451,GO:0009181,1,0.966201248081336,0,4,purine ribonucleoside diphosphate catabolic process,BP,
4452,GO:0009182,1,0.972211161811306,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4453,GO:0009183,1,0.983949905688299,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4454,GO:0009184,1,0.988071294918011,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4455,GO:0009185,1,0.565653039669026,0,90,ribonucleoside diphosphate metabolic process,BP,
4456,GO:0009186,1,0.953980831359327,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4458,GO:0009188,1,0.974573774874868,0,3,ribonucleoside diphosphate biosynthetic process,BP,
4459,GO:0009189,1,0.965501194191453,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4461,GO:0009191,1,0.947904578959747,0,6,ribonucleoside diphosphate catabolic process,BP,
4462,GO:0009192,1,0.988071294918011,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
4463,GO:0009193,1,0.993414436255799,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4464,GO:0009195,1,0.993414436255799,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4465,GO:0009196,1,0.981252736973267,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4466,GO:0009197,1,0.981252736973267,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4467,GO:0009199,1,0.112362266424518,0,254,ribonucleoside triphosphate metabolic process,BP,
4468,GO:0009200,1,0.866108762690156,0,15,deoxyribonucleoside triphosphate metabolic process,BP,
4469,GO:0009201,1,0.567537043256268,0,59,ribonucleoside triphosphate biosynthetic process,BP,
4470,GO:0009202,1,0.947801734640205,0,5,deoxyribonucleoside triphosphate biosynthetic process,BP,
4471,GO:0009203,1,0.987454994210949,0,1,ribonucleoside triphosphate catabolic process,BP,
4472,GO:0009204,1,0.948058868547067,0,6,deoxyribonucleoside triphosphate catabolic process,BP,
4473,GO:0009205,1,0.117541619873775,0,248,purine ribonucleoside triphosphate metabolic process,BP,
4474,GO:0009206,1,0.593356392481147,0,53,purine ribonucleoside triphosphate biosynthetic process,BP,
4475,GO:0009207,1,0.987454994210949,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4476,GO:0009208,1,0.854677029246553,0,16,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4477,GO:0009209,1,0.861549227864142,0,15,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4478,GO:0009211,1,0.935345233939043,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4479,GO:0009212,1,0.957774979381295,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4480,GO:0009213,1,0.987470452549771,0,1,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4481,GO:0009214,1,0.951137450711292,0,21,cyclic nucleotide catabolic process,BP,
4482,GO:0009215,1,0.926230562360141,0,8,purine deoxyribonucleoside triphosphate metabolic process,BP,
4483,GO:0009216,1,0.98959060716668,0,1,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4484,GO:0009217,1,0.960092246907224,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4485,GO:0009218,1,0.801495948789773,0,24,pyrimidine ribonucleotide metabolic process,BP,
4486,GO:0009219,1,0.834110303242292,0,17,pyrimidine deoxyribonucleotide metabolic process,BP,
4487,GO:0009220,1,0.813308685922083,0,22,pyrimidine ribonucleotide biosynthetic process,BP,
4488,GO:0009221,1,0.938887052151309,0,6,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4489,GO:0009222,1,0.993414436255799,0,1,pyrimidine ribonucleotide catabolic process,BP,
4490,GO:0009223,1,0.888455748254401,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4491,GO:0009224,1,0.987620565988309,0,1,CMP biosynthetic process,BP,
4493,GO:0009226,1,0.837390415946692,0,21,nucleotide-sugar biosynthetic process,BP,
4495,GO:0009229,1,0.990782840187539,0,1,thiamine diphosphate biosynthetic process,BP,
4496,GO:0009231,1,0.992331240483365,0,1,riboflavin biosynthetic process,BP,
4497,GO:0009233,1,0.982358492798099,0,3,menaquinone metabolic process,BP,
4498,GO:0009234,1,0.996770639106046,0,1,menaquinone biosynthetic process,BP,
4499,GO:0009235,1,0.84337627165541,0,21,cobalamin metabolic process,BP,
4500,GO:0009236,1,0.991499457834322,0,3,cobalamin biosynthetic process,BP,
4502,GO:0009240,1,0.945013993823353,0,5,isopentenyl diphosphate biosynthetic process,BP,
4503,GO:0009245,1,0.987192131992394,0,1,lipid A biosynthetic process,BP,
4505,GO:0009249,1,0.951139952017887,0,4,protein lipoylation,BP,
4506,GO:0009250,1,0.781046923168385,0,46,glucan biosynthetic process,BP,
4507,GO:0009251,1,0.87572400859914,0,27,glucan catabolic process,BP,
4508,GO:0009253,1,0.917658940793934,0,7,peptidoglycan catabolic process,BP,
4509,GO:0009256,1,0.978030477517604,0,5,10-formyltetrahydrofolate metabolic process,BP,
4510,GO:0009257,1,0.992647685874096,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4511,GO:0009258,1,0.994441719443852,0,2,10-formyltetrahydrofolate catabolic process,BP,
4516,GO:0009263,1,0.905035082828708,0,12,deoxyribonucleotide biosynthetic process,BP,
4518,GO:0009265,1,0.914188043560132,0,9,2'-deoxyribonucleotide biosynthetic process,BP,
4521,GO:0009268,1,0.748044047488012,0,40,response to pH,BP,
4523,GO:0009298,1,0.955993492938678,0,4,GDP-mannose biosynthetic process,BP,
4524,GO:0009299,1,0.883383803924884,0,23,mRNA transcription,BP,
4525,GO:0009301,1,0.622346592898549,0,65,snRNA transcription,BP,
4527,GO:0009304,1,0.964404972406341,0,7,tRNA transcription,BP,
4528,GO:0009305,1,0.999999996372699,0,1,protein biotinylation,BP,
4531,GO:0009309,1,0.798583076376054,0,22,amine biosynthetic process,BP,
4534,GO:0009312,1,0.873340503591552,0,16,oligosaccharide biosynthetic process,BP,
4537,GO:0009328,1,0.973407410317746,0,3,phenylalanine-tRNA ligase complex,CC,
4538,GO:0009330,1,0.997165236925449,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4539,GO:0009331,1,0.990946075066454,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4540,GO:0009346,1,0.999007313619746,0,1,citrate lyase complex,CC,
4541,GO:0009353,1,0.987732472422601,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4542,GO:0009360,1,0.992303073096104,0,1,DNA polymerase III complex,CC,
4543,GO:0009368,1,0.978401217766626,0,2,endopeptidase Clp complex,CC,
4544,GO:0009372,1,0.995105658528154,0,1,quorum sensing,BP,
4545,GO:0009374,1,0.981101238418572,0,5,biotin binding,MF,
4546,GO:0009378,1,0.990768310686342,0,5,four-way junction helicase activity,MF,
4547,GO:0009383,1,0.99149550635737,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4548,GO:0009384,1,0.988151189294135,0,2,N-acylmannosamine kinase activity,MF,
4549,GO:0009386,1,0.978892642859612,0,2,translational attenuation,BP,
4550,GO:0009394,1,0.760619325464231,0,27,2'-deoxyribonucleotide metabolic process,BP,
4552,GO:0009396,1,0.927403610342103,0,10,folic acid-containing compound biosynthetic process,BP,
4553,GO:0009397,1,0.981797580659946,0,3,folic acid-containing compound catabolic process,BP,
4554,GO:0009398,1,0.992331240483365,0,1,FMN biosynthetic process,BP,
4555,GO:0009399,1,0.987478111458317,0,1,nitrogen fixation,BP,
4556,GO:0009400,1,0.992998068768905,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4557,GO:0009403,1,0.99437377019296,0,1,toxin biosynthetic process,BP,
4559,GO:0009405,1,0.999978667998077,0,2,pathogenesis,BP,
4560,GO:0009408,1,0.368621867530104,0,157,response to heat,BP,
4563,GO:0009411,1,0.470757105266705,0,123,response to UV,BP,
4564,GO:0009414,1,0.945801794036273,0,8,response to water deprivation,BP,
4565,GO:0009415,1,0.918712473991673,0,14,response to water,BP,
4568,GO:0009436,1,0.970533517013261,0,3,glyoxylate catabolic process,BP,
4570,GO:0009438,1,0.949478487473193,0,5,methylglyoxal metabolic process,BP,
4571,GO:0009439,1,0.975612922357931,0,2,cyanate metabolic process,BP,
4572,GO:0009440,1,0.975612922357931,0,2,cyanate catabolic process,BP,
4573,GO:0009441,1,0.976080021291857,0,3,glycolate metabolic process,BP,
4574,GO:0009443,1,0.999999996380967,0,1,pyridoxal 5'-phosphate salvage,BP,
4575,GO:0009444,1,0.999959183298652,0,1,pyruvate oxidation,BP,
4576,GO:0009445,1,0.943231394514451,0,6,putrescine metabolic process,BP,
4577,GO:0009446,1,0.967453435132472,0,4,putrescine biosynthetic process,BP,
4578,GO:0009447,1,0.963736367664033,0,3,putrescine catabolic process,BP,
4581,GO:0009450,1,0.999676770659601,0,2,gamma-aminobutyric acid catabolic process,BP,
4583,GO:0009452,1,0.742956564692936,0,34,7-methylguanosine RNA capping,BP,
4585,GO:0009581,1,0.430528621034836,0,130,detection of external stimulus,BP,
4586,GO:0009582,1,0.422031934227893,0,133,detection of abiotic stimulus,BP,
4587,GO:0009583,1,0.586254417107792,0,73,detection of light stimulus,BP,
4588,GO:0009584,1,0.697319938355088,0,54,detection of visible light,BP,
4589,GO:0009590,1,0.98957989367694,0,1,detection of gravity,BP,
4591,GO:0009595,1,0.882086411098963,0,21,detection of biotic stimulus,BP,
4592,GO:0009597,1,0.96892668475071,0,5,detection of virus,BP,
4595,GO:0009608,1,0.985906586185441,0,2,response to symbiont,BP,
4596,GO:0009609,1,0.985906586185441,0,2,response to symbiotic bacterium,BP,
4601,GO:0009620,1,0.625707503230963,0,46,response to fungus,BP,
4602,GO:0009624,1,0.967378088056958,0,3,response to nematode,BP,
4604,GO:0009629,1,0.921998676098459,0,9,response to gravity,BP,
4605,GO:0009631,1,0.999888458788254,0,1,cold acclimation,BP,
4608,GO:0009637,1,0.993524268698247,0,2,response to blue light,BP,
4609,GO:0009642,1,0.935766304849172,0,12,response to light intensity,BP,
4610,GO:0009644,1,0.989651842117289,0,2,response to high light intensity,BP,
4611,GO:0009645,1,0.996052812655762,0,1,response to low light intensity stimulus,BP,
4612,GO:0009646,1,0.995162711325382,0,1,response to absence of light,BP,
4613,GO:0009648,1,0.851645793760056,0,23,photoperiodism,BP,
4614,GO:0009649,1,0.83484619493987,0,25,entrainment of circadian clock,BP,
4615,GO:0009650,1,0.902156831595833,0,13,UV protection,BP,
4616,GO:0009651,1,0.860814000108576,0,20,response to salt stress,BP,
4618,GO:0009673,1,0.996833139940667,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4619,GO:0009692,1,0.991880798145084,0,1,ethylene metabolic process,BP,
4620,GO:0009698,1,0.92879119565321,0,7,phenylpropanoid metabolic process,BP,
4621,GO:0009712,1,0.700608791385406,0,49,catechol-containing compound metabolic process,BP,
4622,GO:0009713,1,0.859218591984338,0,20,catechol-containing compound biosynthetic process,BP,
4627,GO:0009730,1,0.962387460971173,0,4,detection of carbohydrate stimulus,BP,
4628,GO:0009732,1,0.962387460971173,0,4,detection of hexose stimulus,BP,
4629,GO:0009737,1,0.99899806074031,0,1,response to abscisic acid,BP,
4630,GO:0009738,1,0.99899806074031,0,1,abscisic acid-activated signaling pathway,BP,
4632,GO:0009744,1,0.972197343899827,0,6,response to sucrose,BP,
4635,GO:0009750,1,0.945427717466357,0,8,response to fructose,BP,
4636,GO:0009751,1,0.991455473843153,0,1,response to salicylic acid,BP,
4637,GO:0009753,1,0.951881567758867,0,4,response to jasmonic acid,BP,
4638,GO:0009755,1,0.266746110468032,0,218,hormone-mediated signaling pathway,BP,
4639,GO:0009756,1,0.945530944092313,0,7,carbohydrate mediated signaling,BP,
4640,GO:0009757,1,0.959425200422839,0,5,hexose mediated signaling,BP,
4641,GO:0009758,1,0.999999996388895,0,1,carbohydrate utilization,BP,
4642,GO:0009785,1,0.993524268698247,0,2,blue light signaling pathway,BP,
4643,GO:0009786,1,0.975957853896031,0,3,regulation of asymmetric cell division,BP,
4644,GO:0009787,1,0.99899806074031,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4645,GO:0009789,1,0.99899806074031,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4649,GO:0009794,1,0.973499393682828,0,4,regulation of mitotic cell cycle, embryonic,BP,
4650,GO:0009798,1,0.552170450976138,0,88,axis specification,BP,
4652,GO:0009804,1,0.92879119565321,0,7,coumarin metabolic process,BP,
4653,GO:0009810,1,0.990164429951147,0,1,stilbene metabolic process,BP,
4654,GO:0009812,1,0.896660800266113,0,12,flavonoid metabolic process,BP,
4655,GO:0009814,1,0.990137054666132,0,1,defense response, incompatible interaction,BP,
4656,GO:0009817,1,0.990137054666132,0,1,defense response to fungus, incompatible interaction,BP,
4657,GO:0009820,1,0.935307733736249,0,7,alkaloid metabolic process,BP,
4658,GO:0009822,1,0.969701735852102,0,3,alkaloid catabolic process,BP,
4659,GO:0009826,1,0.976675385294916,0,3,unidimensional cell growth,BP,
4660,GO:0009838,1,0.949516238922364,0,6,abscission,BP,
4661,GO:0009841,1,0.990778630182022,0,1,mitochondrial endopeptidase Clp complex,CC,
4663,GO:0009880,1,0.678093509136564,0,62,embryonic pattern specification,BP,
4664,GO:0009881,1,0.881837310076648,0,14,photoreceptor activity,MF,
4665,GO:0009882,1,0.993524268698247,0,2,blue light photoreceptor activity,MF,
4666,GO:0009886,1,0.920688708858634,0,13,post-embryonic animal morphogenesis,BP,
4678,GO:0009898,1,0.39547066486413,0,164,cytoplasmic side of plasma membrane,CC,
4679,GO:0009912,1,0.954475872934377,0,6,auditory receptor cell fate commitment,BP,
4682,GO:0009917,1,0.99114693989692,0,1,sterol 5-alpha reductase activity,MF,
4685,GO:0009925,1,0.873347914615045,0,29,basal plasma membrane,CC,
4686,GO:0009931,1,0.934327851143661,0,11,calcium-dependent protein serine/threonine kinase activity,MF,
4687,GO:0009946,1,0.968675786593104,0,3,proximal/distal axis specification,BP,
4688,GO:0009948,1,0.681410736175888,0,50,anterior/posterior axis specification,BP,
4689,GO:0009949,1,0.988187278153849,0,1,polarity specification of anterior/posterior axis,BP,
4690,GO:0009950,1,0.923393216636271,0,16,dorsal/ventral axis specification,BP,
4691,GO:0009952,1,0.248086317717206,0,200,anterior/posterior pattern specification,BP,
4692,GO:0009953,1,0.532282360365482,0,94,dorsal/ventral pattern formation,BP,
4693,GO:0009954,1,0.818811858503553,0,31,proximal/distal pattern formation,BP,
4694,GO:0009955,1,0.990148774377315,0,1,adaxial/abaxial pattern specification,BP,
4695,GO:0009956,1,0.997778062551676,0,1,radial pattern formation,BP,
4696,GO:0009957,1,0.989030034982647,0,3,epidermal cell fate specification,BP,
4700,GO:0009972,1,0.90412250534368,0,9,cytidine deamination,BP,
4701,GO:0009975,1,0.945103684455402,0,20,cyclase activity,MF,
4705,GO:0009988,1,0.589322228212374,0,64,cell-cell recognition,BP,
4707,GO:0009992,1,0.990053619668509,0,1,cellular water homeostasis,BP,
4709,GO:0009996,1,0.94842410631847,0,6,negative regulation of cell fate specification,BP,
4710,GO:0009997,1,0.993409576390941,0,1,negative regulation of cardioblast cell fate specification,BP,
4712,GO:0010002,1,0.915914105342078,0,19,cardioblast differentiation,BP,
4714,GO:0010009,1,0.983544921410211,0,2,cytoplasmic side of endosome membrane,CC,
4715,GO:0010015,1,0.987233076566383,0,1,root morphogenesis,BP,
4716,GO:0010021,1,0.994495059883519,0,1,amylopectin biosynthetic process,BP,
4717,GO:0010025,1,0.96776249642477,0,4,wax biosynthetic process,BP,
4718,GO:0010032,1,0.986284507382147,0,6,meiotic chromosome condensation,BP,
4720,GO:0010034,1,0.996293406926107,0,1,response to acetate,BP,
4722,GO:0010037,1,0.994206026079447,0,1,response to carbon dioxide,BP,
4724,GO:0010039,1,0.811444156555842,0,32,response to iron ion,BP,
4725,GO:0010040,1,0.960537052693289,0,5,response to iron(II) ion,BP,
4726,GO:0010041,1,0.960253605495539,0,5,response to iron(III) ion,BP,
4727,GO:0010042,1,0.924780163712375,0,15,response to manganese ion,BP,
4728,GO:0010043,1,0.63821962339598,0,52,response to zinc ion,BP,
4729,GO:0010044,1,0.959814661780378,0,5,response to aluminum ion,BP,
4730,GO:0010045,1,0.999999996382089,0,1,response to nickel cation,BP,
4731,GO:0010046,1,0.967430280093459,0,4,response to mycotoxin,BP,
4732,GO:0010053,1,0.987233076566383,0,1,root epidermal cell differentiation,BP,
4733,GO:0010054,1,0.987233076566383,0,1,trichoblast differentiation,BP,
4734,GO:0010070,1,0.991017055661357,0,1,zygote asymmetric cell division,BP,
4735,GO:0010085,1,0.989695277448999,0,1,polarity specification of proximal/distal axis,BP,
4736,GO:0010092,1,0.821973800820965,0,29,specification of animal organ identity,BP,
4737,GO:0010106,1,0.989215679571707,0,1,cellular response to iron ion starvation,BP,
4738,GO:0010107,1,0.856330851274775,0,28,potassium ion import,BP,
4739,GO:0010124,1,0.987554816056891,0,1,phenylacetate catabolic process,BP,
4740,GO:0010133,1,0.973833395508872,0,3,proline catabolic process to glutamate,BP,
4741,GO:0010138,1,0.947304380237318,0,5,pyrimidine ribonucleotide salvage,BP,
4742,GO:0010155,1,0.842012129398263,0,17,regulation of proton transport,BP,
4743,GO:0010157,1,0.991702890350533,0,2,response to chlorate,BP,
4744,GO:0010159,1,0.983371338647751,0,3,specification of animal organ position,BP,
4745,GO:0010160,1,0.987361667413007,0,1,formation of animal organ boundary,BP,
4746,GO:0010164,1,0.98828207420764,0,1,response to cesium ion,BP,
4747,GO:0010165,1,0.839882398154502,0,34,response to X-ray,BP,
4748,GO:0010166,1,0.96776249642477,0,4,wax metabolic process,BP,
4749,GO:0010171,1,0.803750920997321,0,46,body morphogenesis,BP,
4750,GO:0010172,1,0.973893445680721,0,11,embryonic body morphogenesis,BP,
4751,GO:0010181,1,0.90330310463162,0,16,FMN binding,MF,
4752,GO:0010182,1,0.959425200422839,0,5,sugar mediated signaling pathway,BP,
4753,GO:0010189,1,0.988430964820817,0,1,vitamin E biosynthetic process,BP,
4754,GO:0010193,1,0.951780090514171,0,5,response to ozone,BP,
4756,GO:0010216,1,0.986413579302771,0,6,maintenance of DNA methylation,BP,
4757,GO:0010224,1,0.874435631891532,0,17,response to UV-B,BP,
4758,GO:0010225,1,0.948351967621638,0,12,response to UV-C,BP,
4759,GO:0010226,1,0.851937649928069,0,23,response to lithium ion,BP,
4760,GO:0010232,1,0.994359198959087,0,1,vascular transport,BP,
4762,GO:0010248,1,0.908109101245493,0,13,establishment or maintenance of transmembrane electrochemical gradient,BP,
4763,GO:0010255,1,0.959425200422839,0,5,glucose mediated signaling pathway,BP,
4764,GO:0010256,1,0.0481505094668471,0,553,endomembrane system organization,BP,
4765,GO:0010257,1,0.534149508417167,0,55,NADH dehydrogenase complex assembly,BP,
4766,GO:0010259,1,0.867611620481951,0,27,multicellular organism aging,BP,
4767,GO:0010260,1,0.991702895606922,0,1,animal organ senescence,BP,
4768,GO:0010265,1,0.971531226449529,0,6,SCF complex assembly,BP,
4769,GO:0010266,1,0.981956702595146,0,3,response to vitamin B1,BP,
4770,GO:0010269,1,0.950063837509289,0,6,response to selenium ion,BP,
4771,GO:0010273,1,0.987317673364274,0,2,detoxification of copper ion,BP,
4772,GO:0010286,1,0.972254367095284,0,3,heat acclimation,BP,
4774,GO:0010309,1,0.988422165401928,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4775,GO:0010310,1,0.889227200158227,0,13,regulation of hydrogen peroxide metabolic process,BP,
4776,GO:0010314,1,0.944076489470107,0,11,phosphatidylinositol-5-phosphate binding,MF,
4777,GO:0010324,1,0.727622822620099,0,48,membrane invagination,BP,
4778,GO:0010332,1,0.734755661650529,0,52,response to gamma radiation,BP,
4779,GO:0010335,1,0.999263353510476,0,1,response to non-ionic osmotic stress,BP,
4780,GO:0010340,1,0.972427745919432,0,5,carboxyl-O-methyltransferase activity,MF,
4781,GO:0010348,1,0.991657600429728,0,1,lithium:proton antiporter activity,MF,
4782,GO:0010359,1,0.990895991663559,0,5,regulation of anion channel activity,BP,
4783,GO:0010360,1,0.992641600283129,0,2,negative regulation of anion channel activity,BP,
4784,GO:0010369,1,0.931888121802008,0,14,chromocenter,CC,
4785,GO:0010370,1,0.986973218432882,0,2,perinucleolar chromocenter,CC,
4786,GO:0010383,1,0.988033318391619,0,1,cell wall polysaccharide metabolic process,BP,
4787,GO:0010385,1,0.971826253151203,0,5,double-stranded methylated DNA binding,MF,
4788,GO:0010387,1,0.975762646879077,0,3,COP9 signalosome assembly,BP,
4790,GO:0010390,1,0.90086725104373,0,23,histone monoubiquitination,BP,
4791,GO:0010420,1,0.987647083299915,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4792,GO:0010421,1,0.912642577230098,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4793,GO:0010428,1,0.99999999637197,0,1,methyl-CpNpG binding,MF,
4794,GO:0010430,1,0.989696849563654,0,2,fatty acid omega-oxidation,BP,
4795,GO:0010446,1,0.974960049141297,0,3,response to alkaline pH,BP,
4796,GO:0010447,1,0.859209615288085,0,22,response to acidic pH,BP,
4797,GO:0010452,1,0.95992515506793,0,9,histone H3-K36 methylation,BP,
4798,GO:0010453,1,0.799328520683626,0,28,regulation of cell fate commitment,BP,
4799,GO:0010454,1,0.89915333290841,0,11,negative regulation of cell fate commitment,BP,
4800,GO:0010455,1,0.923614013951267,0,9,positive regulation of cell fate commitment,BP,
4801,GO:0010457,1,0.984552888233326,0,9,centriole-centriole cohesion,BP,
4802,GO:0010458,1,0.799157607406068,0,30,exit from mitosis,BP,
4803,GO:0010459,1,0.913801690514522,0,9,negative regulation of heart rate,BP,
4804,GO:0010460,1,0.852007443390682,0,22,positive regulation of heart rate,BP,
4805,GO:0010463,1,0.785731782095415,0,47,mesenchymal cell proliferation,BP,
4806,GO:0010464,1,0.845283483909418,0,35,regulation of mesenchymal cell proliferation,BP,
4807,GO:0010465,1,0.992060594125086,0,2,nerve growth factor receptor activity,MF,
4811,GO:0010469,1,0.505170065894126,0,124,regulation of receptor activity,BP,
4812,GO:0010470,1,0.794645776372068,0,36,regulation of gastrulation,BP,
4813,GO:0010477,1,0.994948109577164,0,1,response to sulfur dioxide,BP,
4814,GO:0010481,1,0.987193153264559,0,2,epidermal cell division,BP,
4815,GO:0010482,1,0.987193153264559,0,2,regulation of epidermal cell division,BP,
4816,GO:0010484,1,0.989230591329402,0,3,H3 histone acetyltransferase activity,MF,
4817,GO:0010485,1,0.914319235059586,0,17,H4 histone acetyltransferase activity,MF,
4818,GO:0010494,1,0.84620340356444,0,39,cytoplasmic stress granule,CC,
4819,GO:0010496,1,0.989404570639733,0,1,intercellular transport,BP,
4821,GO:0010499,1,0.98428145252546,0,4,proteasomal ubiquitin-independent protein catabolic process,BP,
4822,GO:0010501,1,0.755766188627486,0,45,RNA secondary structure unwinding,BP,
4826,GO:0010509,1,0.999993206350177,0,1,polyamine homeostasis,BP,
4828,GO:0010511,1,0.958853837913585,0,6,regulation of phosphatidylinositol biosynthetic process,BP,
4829,GO:0010512,1,0.985848411404307,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4830,GO:0010513,1,0.972620981842067,0,4,positive regulation of phosphatidylinositol biosynthetic process,BP,
4833,GO:0010519,1,0.951680816338045,0,7,negative regulation of phospholipase activity,BP,
4834,GO:0010520,1,0.988962802343659,0,2,regulation of reciprocal meiotic recombination,BP,
4835,GO:0010521,1,0.978033970051759,0,3,telomerase inhibitor activity,MF,
4836,GO:0010522,1,0.577229623835569,0,85,regulation of calcium ion transport into cytosol,BP,
4837,GO:0010523,1,0.886541470100458,0,17,negative regulation of calcium ion transport into cytosol,BP,
4838,GO:0010524,1,0.714676416623411,0,45,positive regulation of calcium ion transport into cytosol,BP,
4839,GO:0010528,1,0.905942191114477,0,13,regulation of transposition,BP,
4840,GO:0010529,1,0.905942191114477,0,13,negative regulation of transposition,BP,
4841,GO:0010531,1,0.994349483019485,0,1,activation of JAK1 kinase activity,BP,
4842,GO:0010533,1,0.917271142883019,0,8,regulation of activation of Janus kinase activity,BP,
4843,GO:0010534,1,0.917271142883019,0,8,regulation of activation of JAK2 kinase activity,BP,
4844,GO:0010535,1,0.939120251747959,0,6,positive regulation of activation of JAK2 kinase activity,BP,
4845,GO:0010536,1,0.939120251747959,0,6,positive regulation of activation of Janus kinase activity,BP,
4846,GO:0010543,1,0.847567376498812,0,29,regulation of platelet activation,BP,
4847,GO:0010544,1,0.90459665057604,0,17,negative regulation of platelet activation,BP,
4851,GO:0010559,1,0.783432510566252,0,36,regulation of glycoprotein biosynthetic process,BP,
4852,GO:0010560,1,0.899921857585877,0,17,positive regulation of glycoprotein biosynthetic process,BP,
4853,GO:0010561,1,0.923842226834176,0,10,negative regulation of glycoprotein biosynthetic process,BP,
4858,GO:0010566,1,0.931578364895086,0,12,regulation of ketone biosynthetic process,BP,
4859,GO:0010569,1,0.890436080817571,0,20,regulation of double-strand break repair via homologous recombination,BP,
4860,GO:0010571,1,0.986288699249429,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4861,GO:0010572,1,0.987702859903746,0,3,positive regulation of platelet activation,BP,
4862,GO:0010573,1,0.823307670538413,0,33,vascular endothelial growth factor production,BP,
4863,GO:0010574,1,0.823307705968641,0,32,regulation of vascular endothelial growth factor production,BP,
4864,GO:0010575,1,0.871895180593769,0,27,positive regulation of vascular endothelial growth factor production,BP,
4865,GO:0010578,1,0.953380516962884,0,6,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4866,GO:0010579,1,0.953380516962884,0,6,positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4867,GO:0010586,1,0.910803157166883,0,17,miRNA metabolic process,BP,
4868,GO:0010587,1,0.979778234375798,0,6,miRNA catabolic process,BP,
4869,GO:0010591,1,0.832327271092575,0,28,regulation of lamellipodium assembly,BP,
4870,GO:0010592,1,0.891974449433586,0,17,positive regulation of lamellipodium assembly,BP,
4871,GO:0010593,1,0.9768209950531,0,4,negative regulation of lamellipodium assembly,BP,
4874,GO:0010596,1,0.801350545006534,0,38,negative regulation of endothelial cell migration,BP,
4875,GO:0010603,1,0.981477694487079,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4878,GO:0010606,1,0.995146976396884,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4879,GO:0010607,1,0.989265482009668,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4881,GO:0010609,1,0.98331670528875,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4882,GO:0010610,1,0.999999996387745,0,1,regulation of mRNA stability involved in response to stress,BP,
4883,GO:0010611,1,0.803355163138366,0,41,regulation of cardiac muscle hypertrophy,BP,
4884,GO:0010612,1,0.9780852246648,0,6,regulation of cardiac muscle adaptation,BP,
4885,GO:0010613,1,0.890276734485516,0,24,positive regulation of cardiac muscle hypertrophy,BP,
4886,GO:0010614,1,0.902108233858907,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4887,GO:0010615,1,0.995372793616996,0,2,positive regulation of cardiac muscle adaptation,BP,
4888,GO:0010616,1,0.994364046927429,0,3,negative regulation of cardiac muscle adaptation,BP,
4889,GO:0010621,1,0.968585547564054,0,3,negative regulation of transcription by transcription factor localization,BP,
4890,GO:0010623,1,0.913323464714783,0,13,programmed cell death involved in cell development,BP,
4891,GO:0010624,1,0.978278979202233,0,5,regulation of Schwann cell proliferation,BP,
4892,GO:0010626,1,0.978278979202233,0,5,negative regulation of Schwann cell proliferation,BP,
4897,GO:0010633,1,0.727651424089591,0,54,negative regulation of epithelial cell migration,BP,
4899,GO:0010635,1,0.945667523097883,0,8,regulation of mitochondrial fusion,BP,
4900,GO:0010636,1,0.991711965404114,0,2,positive regulation of mitochondrial fusion,BP,
4901,GO:0010637,1,0.960908897609463,0,5,negative regulation of mitochondrial fusion,BP,
4904,GO:0010640,1,0.907155040508386,0,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,
4905,GO:0010641,1,0.982559912193251,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4906,GO:0010642,1,0.924968959144295,0,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,
4907,GO:0010643,1,0.982790811116509,0,3,cell communication by chemical coupling,BP,
4908,GO:0010644,1,0.884765749374397,0,27,cell communication by electrical coupling,BP,
4909,GO:0010645,1,0.988930826552537,0,2,regulation of cell communication by chemical coupling,BP,
4913,GO:0010649,1,0.940894145268115,0,12,regulation of cell communication by electrical coupling,BP,
4914,GO:0010650,1,0.999286626689344,0,2,positive regulation of cell communication by electrical coupling,BP,
4915,GO:0010652,1,0.988930826552537,0,2,positive regulation of cell communication by chemical coupling,BP,
4921,GO:0010661,1,0.902273527712393,0,16,positive regulation of muscle cell apoptotic process,BP,
4923,GO:0010663,1,0.968707172479728,0,8,positive regulation of striated muscle cell apoptotic process,BP,
4926,GO:0010666,1,0.968707172479728,0,8,positive regulation of cardiac muscle cell apoptotic process,BP,
4928,GO:0010668,1,0.974258205870021,0,7,ectodermal cell differentiation,BP,
4932,GO:0010677,1,0.807539953692564,0,34,negative regulation of cellular carbohydrate metabolic process,BP,
4933,GO:0010692,1,0.977679467058513,0,9,regulation of alkaline phosphatase activity,BP,
4934,GO:0010693,1,0.987650901890963,0,3,negative regulation of alkaline phosphatase activity,BP,
4935,GO:0010694,1,0.989904891876623,0,6,positive regulation of alkaline phosphatase activity,BP,
4936,GO:0010698,1,0.983791039670407,0,2,acetyltransferase activator activity,MF,
4937,GO:0010700,1,0.94622663403068,0,7,negative regulation of norepinephrine secretion,BP,
4938,GO:0010701,1,0.97334980509803,0,4,positive regulation of norepinephrine secretion,BP,
4939,GO:0010705,1,0.992053451948791,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4940,GO:0010710,1,0.977390304380926,0,3,regulation of collagen catabolic process,BP,
4941,GO:0010711,1,0.987230933638233,0,1,negative regulation of collagen catabolic process,BP,
4942,GO:0010712,1,0.761327215633541,0,34,regulation of collagen metabolic process,BP,
4943,GO:0010713,1,0.933860493639471,0,8,negative regulation of collagen metabolic process,BP,
4944,GO:0010714,1,0.832902360948587,0,23,positive regulation of collagen metabolic process,BP,
4945,GO:0010715,1,0.947802530337834,0,13,regulation of extracellular matrix disassembly,BP,
4946,GO:0010716,1,0.968299878356204,0,4,negative regulation of extracellular matrix disassembly,BP,
4947,GO:0010717,1,0.669587459089499,0,73,regulation of epithelial to mesenchymal transition,BP,
4948,GO:0010718,1,0.836561704354795,0,39,positive regulation of epithelial to mesenchymal transition,BP,
4949,GO:0010719,1,0.815893775367198,0,26,negative regulation of epithelial to mesenchymal transition,BP,
4952,GO:0010722,1,0.999999996379689,0,1,regulation of ferrochelatase activity,BP,
4953,GO:0010724,1,0.974391924749227,0,4,regulation of definitive erythrocyte differentiation,BP,
4954,GO:0010725,1,0.977851932493688,0,3,regulation of primitive erythrocyte differentiation,BP,
4955,GO:0010726,1,0.984109919054011,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4956,GO:0010727,1,0.953306700405014,0,6,negative regulation of hydrogen peroxide metabolic process,BP,
4957,GO:0010728,1,0.97981570382851,0,3,regulation of hydrogen peroxide biosynthetic process,BP,
4958,GO:0010729,1,0.989487957650253,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4959,GO:0010730,1,0.990225807084485,0,2,negative regulation of hydrogen peroxide biosynthetic process,BP,
4960,GO:0010731,1,0.990701066579052,0,1,protein glutathionylation,BP,
4961,GO:0010732,1,0.990701066579052,0,1,regulation of protein glutathionylation,BP,
4962,GO:0010734,1,0.990701066579052,0,1,negative regulation of protein glutathionylation,BP,
4963,GO:0010735,1,0.985200082193327,0,4,positive regulation of transcription via serum response element binding,BP,
4964,GO:0010736,1,0.988067574926649,0,2,serum response element binding,MF,
4965,GO:0010737,1,0.867599263085329,0,29,protein kinase A signaling,BP,
4966,GO:0010738,1,0.9267285576322,0,19,regulation of protein kinase A signaling,BP,
4967,GO:0010739,1,0.969901378954882,0,6,positive regulation of protein kinase A signaling,BP,
4970,GO:0010744,1,0.885257105609184,0,16,positive regulation of macrophage derived foam cell differentiation,BP,
4972,GO:0010746,1,0.993038823473926,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4973,GO:0010748,1,0.993038823473926,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4974,GO:0010749,1,0.986376203232965,0,4,regulation of nitric oxide mediated signal transduction,BP,
4975,GO:0010750,1,0.999215292729516,0,1,positive regulation of nitric oxide mediated signal transduction,BP,
4976,GO:0010751,1,0.987150909691243,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4977,GO:0010752,1,0.998987708709351,0,2,regulation of cGMP-mediated signaling,BP,
4978,GO:0010754,1,0.99999999631441,0,1,negative regulation of cGMP-mediated signaling,BP,
4979,GO:0010755,1,0.903269619462052,0,11,regulation of plasminogen activation,BP,
4980,GO:0010756,1,0.948127935039169,0,5,positive regulation of plasminogen activation,BP,
4981,GO:0010757,1,0.95270697643136,0,6,negative regulation of plasminogen activation,BP,
4982,GO:0010758,1,0.85471248156013,0,20,regulation of macrophage chemotaxis,BP,
4983,GO:0010759,1,0.87662588458902,0,15,positive regulation of macrophage chemotaxis,BP,
4984,GO:0010760,1,0.97601656876541,0,4,negative regulation of macrophage chemotaxis,BP,
4985,GO:0010761,1,0.821154161884014,0,38,fibroblast migration,BP,
4986,GO:0010762,1,0.847306864979502,0,29,regulation of fibroblast migration,BP,
4987,GO:0010763,1,0.943463943914317,0,11,positive regulation of fibroblast migration,BP,
4988,GO:0010764,1,0.942115243673186,0,8,negative regulation of fibroblast migration,BP,
4990,GO:0010766,1,0.935064907457721,0,13,negative regulation of sodium ion transport,BP,
4991,GO:0010767,1,0.992232811905918,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4992,GO:0010768,1,0.999999996375045,0,1,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4994,GO:0010770,1,0.551641684087736,0,130,positive regulation of cell morphogenesis involved in differentiation,BP,
4996,GO:0010792,1,0.957791806156973,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4997,GO:0010793,1,0.978889997196034,0,5,regulation of mRNA export from nucleus,BP,
4998,GO:0010795,1,0.987647083299915,0,1,regulation of ubiquinone biosynthetic process,BP,
4999,GO:0010796,1,0.967589300744603,0,3,regulation of multivesicular body size,BP,
5000,GO:0010797,1,0.987580095176834,0,1,regulation of multivesicular body size involved in endosome transport,BP,
5001,GO:0010799,1,0.833191071175139,0,38,regulation of peptidyl-threonine phosphorylation,BP,
5002,GO:0010800,1,0.877085827583495,0,27,positive regulation of peptidyl-threonine phosphorylation,BP,
5003,GO:0010801,1,0.928107031105151,0,14,negative regulation of peptidyl-threonine phosphorylation,BP,
5006,GO:0010805,1,0.991743775026976,0,1,regulation of lysine import,BP,
5007,GO:0010807,1,0.976008397013135,0,5,regulation of synaptic vesicle priming,BP,
5008,GO:0010808,1,0.999999996375074,0,1,positive regulation of synaptic vesicle priming,BP,
5009,GO:0010810,1,0.421326271248851,0,174,regulation of cell-substrate adhesion,BP,
5010,GO:0010811,1,0.560846819006848,0,104,positive regulation of cell-substrate adhesion,BP,
5011,GO:0010812,1,0.83239597583488,0,48,negative regulation of cell-substrate adhesion,BP,
5012,GO:0010813,1,0.987882507560377,0,2,neuropeptide catabolic process,BP,
5013,GO:0010814,1,0.999897289031873,0,1,substance P catabolic process,BP,
5014,GO:0010815,1,0.968107928967524,0,5,bradykinin catabolic process,BP,
5015,GO:0010816,1,0.999897289031873,0,1,calcitonin catabolic process,BP,
5017,GO:0010818,1,0.839063103647272,0,20,T cell chemotaxis,BP,
5018,GO:0010819,1,0.909191235553163,0,11,regulation of T cell chemotaxis,BP,
5019,GO:0010820,1,0.920679088600915,0,10,positive regulation of T cell chemotaxis,BP,
5023,GO:0010824,1,0.828006212145707,0,36,regulation of centrosome duplication,BP,
5024,GO:0010825,1,0.978163416486691,0,6,positive regulation of centrosome duplication,BP,
5025,GO:0010826,1,0.952297612883267,0,10,negative regulation of centrosome duplication,BP,
5028,GO:0010829,1,0.902477828871012,0,15,negative regulation of glucose transport,BP,
5029,GO:0010830,1,0.688265606352318,0,52,regulation of myotube differentiation,BP,
5030,GO:0010831,1,0.792007168736148,0,30,positive regulation of myotube differentiation,BP,
5031,GO:0010832,1,0.907537951726867,0,15,negative regulation of myotube differentiation,BP,
5032,GO:0010833,1,0.635582737334013,0,71,telomere maintenance via telomere lengthening,BP,
5033,GO:0010835,1,0.968770558997942,0,5,regulation of protein ADP-ribosylation,BP,
5034,GO:0010836,1,0.989446085008349,0,1,negative regulation of protein ADP-ribosylation,BP,
5035,GO:0010837,1,0.871106852279739,0,28,regulation of keratinocyte proliferation,BP,
5036,GO:0010838,1,0.946847170463498,0,9,positive regulation of keratinocyte proliferation,BP,
5037,GO:0010839,1,0.958633923083366,0,12,negative regulation of keratinocyte proliferation,BP,
5038,GO:0010840,1,0.939587243275856,0,6,regulation of circadian sleep/wake cycle, wakefulness,BP,
5039,GO:0010841,1,0.950224925661765,0,5,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
5040,GO:0010842,1,0.915249080286652,0,22,retina layer formation,BP,
5041,GO:0010845,1,0.988962802343659,0,2,positive regulation of reciprocal meiotic recombination,BP,
5042,GO:0010847,1,0.984600147112909,0,4,regulation of chromatin assembly,BP,
5043,GO:0010848,1,0.994130804892777,0,2,regulation of chromatin disassembly,BP,
5044,GO:0010849,1,0.990117563826666,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
5045,GO:0010851,1,0.910457793802519,0,9,cyclase regulator activity,MF,
5046,GO:0010852,1,0.990504783633364,0,1,cyclase inhibitor activity,MF,
5047,GO:0010853,1,0.920444696320378,0,7,cyclase activator activity,MF,
5048,GO:0010854,1,0.998639412133424,0,1,adenylate cyclase regulator activity,MF,
5049,GO:0010855,1,0.998639412133424,0,1,adenylate cyclase inhibitor activity,MF,
5050,GO:0010857,1,0.926966610803351,0,12,calcium-dependent protein kinase activity,MF,
5051,GO:0010858,1,0.966238640917896,0,3,calcium-dependent protein kinase regulator activity,MF,
5052,GO:0010859,1,0.999044755382564,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5053,GO:0010861,1,0.992772859486738,0,4,thyroid hormone receptor activator activity,MF,
5054,GO:0010862,1,0.720151073833753,0,48,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
5058,GO:0010868,1,0.996707781614054,0,2,negative regulation of triglyceride biosynthetic process,BP,
5059,GO:0010869,1,0.90292500974075,0,20,regulation of receptor biosynthetic process,BP,
5060,GO:0010870,1,0.921883941938897,0,11,positive regulation of receptor biosynthetic process,BP,
5061,GO:0010871,1,0.980802019964132,0,6,negative regulation of receptor biosynthetic process,BP,
5067,GO:0010877,1,0.978047264237329,0,2,lipid transport involved in lipid storage,BP,
5069,GO:0010879,1,0.990391082169678,0,1,cholesterol transport involved in cholesterol storage,BP,
5070,GO:0010880,1,0.867441939239313,0,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5071,GO:0010881,1,0.898255503520065,0,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
5072,GO:0010882,1,0.876508533777986,0,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,
5074,GO:0010884,1,0.86210634041546,0,22,positive regulation of lipid storage,BP,
5076,GO:0010886,1,0.97068988022218,0,7,positive regulation of cholesterol storage,BP,
5079,GO:0010889,1,0.918743061040584,0,12,regulation of sequestering of triglyceride,BP,
5080,GO:0010890,1,0.938764335188309,0,7,positive regulation of sequestering of triglyceride,BP,
5081,GO:0010891,1,0.978683333313,0,5,negative regulation of sequestering of triglyceride,BP,
5083,GO:0010894,1,0.85544370453117,0,21,negative regulation of steroid biosynthetic process,BP,
5084,GO:0010896,1,0.891194946130058,0,12,regulation of triglyceride catabolic process,BP,
5085,GO:0010897,1,0.969077991053963,0,4,negative regulation of triglyceride catabolic process,BP,
5086,GO:0010898,1,0.919650993170147,0,8,positive regulation of triglyceride catabolic process,BP,
5089,GO:0010901,1,0.939453500260628,0,5,regulation of very-low-density lipoprotein particle remodeling,BP,
5090,GO:0010902,1,0.976472198364282,0,2,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5091,GO:0010903,1,0.962096353129721,0,3,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5092,GO:0010904,1,0.990074869994379,0,1,regulation of UDP-glucose catabolic process,BP,
5093,GO:0010905,1,0.990074869994379,0,1,negative regulation of UDP-glucose catabolic process,BP,
5096,GO:0010908,1,0.993814685798652,0,2,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5097,GO:0010909,1,0.993814685798652,0,2,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5098,GO:0010911,1,0.976895847385263,0,5,regulation of isomerase activity,BP,
5099,GO:0010912,1,0.976895847385263,0,5,positive regulation of isomerase activity,BP,
5102,GO:0010917,1,0.926447203299212,0,9,negative regulation of mitochondrial membrane potential,BP,
5103,GO:0010918,1,0.963352906848734,0,4,positive regulation of mitochondrial membrane potential,BP,
5104,GO:0010919,1,0.907213799878864,0,14,regulation of inositol phosphate biosynthetic process,BP,
5105,GO:0010920,1,0.99304146129124,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5109,GO:0010924,1,0.99304146129124,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5110,GO:0010925,1,0.99304146129124,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5111,GO:0010927,1,0.637450913416028,0,94,cellular component assembly involved in morphogenesis,BP,
5112,GO:0010931,1,0.999999996385948,0,1,macrophage tolerance induction,BP,
5113,GO:0010932,1,0.999999996385948,0,1,regulation of macrophage tolerance induction,BP,
5114,GO:0010933,1,0.999999996385948,0,1,positive regulation of macrophage tolerance induction,BP,
5115,GO:0010934,1,0.91882132386496,0,14,macrophage cytokine production,BP,
5116,GO:0010935,1,0.929070191451171,0,12,regulation of macrophage cytokine production,BP,
5117,GO:0010936,1,0.972511689674625,0,5,negative regulation of macrophage cytokine production,BP,
5119,GO:0010940,1,0.938517523389624,0,6,positive regulation of necrotic cell death,BP,
5122,GO:0010944,1,0.9401765133704,0,9,negative regulation of transcription by competitive promoter binding,BP,
5124,GO:0010949,1,0.984754892204901,0,2,negative regulation of intestinal phytosterol absorption,BP,
5128,GO:0010954,1,0.890240836377733,0,18,positive regulation of protein processing,BP,
5130,GO:0010956,1,0.982132584137878,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5131,GO:0010957,1,0.960831311533258,0,5,negative regulation of vitamin D biosynthetic process,BP,
5132,GO:0010958,1,0.979768579142122,0,4,regulation of amino acid import,BP,
5134,GO:0010960,1,0.972711555734606,0,11,magnesium ion homeostasis,BP,
5135,GO:0010961,1,0.983145547842831,0,5,cellular magnesium ion homeostasis,BP,
5136,GO:0010962,1,0.904157635355769,0,26,regulation of glucan biosynthetic process,BP,
5137,GO:0010963,1,0.979780933688144,0,2,regulation of L-arginine import,BP,
5138,GO:0010965,1,0.741152780390072,0,46,regulation of mitotic sister chromatid separation,BP,
5139,GO:0010966,1,0.976469786654019,0,5,regulation of phosphate transport,BP,
5140,GO:0010967,1,0.98848070233315,0,1,regulation of polyamine biosynthetic process,BP,
5141,GO:0010968,1,0.972064844332069,0,5,regulation of microtubule nucleation,BP,
5142,GO:0010970,1,0.542483648526999,0,121,transport along microtubule,BP,
5143,GO:0010971,1,0.885023508065236,0,20,positive regulation of G2/M transition of mitotic cell cycle,BP,
5146,GO:0010976,1,0.345185349114295,0,227,positive regulation of neuron projection development,BP,
5148,GO:0010979,1,0.984806853333641,0,3,regulation of vitamin D 24-hydroxylase activity,BP,
5149,GO:0010980,1,0.984806853333641,0,3,positive regulation of vitamin D 24-hydroxylase activity,BP,
5150,GO:0010982,1,0.976304270178794,0,3,regulation of high-density lipoprotein particle clearance,BP,
5151,GO:0010983,1,0.989001568914398,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5154,GO:0010986,1,0.968122985345216,0,4,positive regulation of lipoprotein particle clearance,BP,
5155,GO:0010987,1,0.987162616910712,0,1,negative regulation of high-density lipoprotein particle clearance,BP,
5156,GO:0010988,1,0.918989844175273,0,9,regulation of low-density lipoprotein particle clearance,BP,
5157,GO:0010989,1,0.969659038804424,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5158,GO:0010990,1,0.970763717492759,0,6,regulation of SMAD protein complex assembly,BP,
5159,GO:0010991,1,0.972631879169431,0,5,negative regulation of SMAD protein complex assembly,BP,
5160,GO:0010992,1,0.983621130997769,0,4,ubiquitin homeostasis,BP,
5161,GO:0010993,1,0.962579294630481,0,5,regulation of ubiquitin homeostasis,BP,
5162,GO:0010994,1,0.962579294630481,0,5,free ubiquitin chain polymerization,BP,
5164,GO:0010997,1,0.967487312641949,0,6,anaphase-promoting complex binding,MF,
5165,GO:0010998,1,0.947683065449744,0,11,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5166,GO:0010999,1,0.999219666370847,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5168,GO:0012502,1,0.987221357721054,0,2,induction of programmed cell death,BP,
5171,GO:0012507,1,0.669365310925849,0,56,ER to Golgi transport vesicle membrane,CC,
5172,GO:0012510,1,0.911437489419677,0,14,trans-Golgi network transport vesicle membrane,CC,
5173,GO:0014002,1,0.878367455314464,0,24,astrocyte development,BP,
5174,GO:0014003,1,0.753801705083966,0,37,oligodendrocyte development,BP,
5175,GO:0014004,1,0.994780077103792,0,1,microglia differentiation,BP,
5176,GO:0014005,1,0.994780077103792,0,1,microglia development,BP,
5177,GO:0014009,1,0.834663785632553,0,33,glial cell proliferation,BP,
5178,GO:0014010,1,0.978278971309501,0,6,Schwann cell proliferation,BP,
5179,GO:0014011,1,0.991657600429728,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5180,GO:0014012,1,0.951104071354165,0,6,peripheral nervous system axon regeneration,BP,
5181,GO:0014013,1,0.523392339152484,0,92,regulation of gliogenesis,BP,
5182,GO:0014014,1,0.739940808026237,0,38,negative regulation of gliogenesis,BP,
5183,GO:0014015,1,0.720858570500396,0,46,positive regulation of gliogenesis,BP,
5184,GO:0014016,1,0.974114559559914,0,3,neuroblast differentiation,BP,
5185,GO:0014017,1,0.991273856262465,0,1,neuroblast fate commitment,BP,
5186,GO:0014020,1,0.647609349170264,0,91,primary neural tube formation,BP,
5187,GO:0014022,1,0.987299633608275,0,3,neural plate elongation,BP,
5188,GO:0014028,1,0.977658749215988,0,4,notochord formation,BP,
5189,GO:0014029,1,0.927689312938307,0,12,neural crest formation,BP,
5190,GO:0014031,1,0.693546403733566,0,62,mesenchymal cell development,BP,
5191,GO:0014032,1,0.701880311682212,0,58,neural crest cell development,BP,
5192,GO:0014033,1,0.670841427672929,0,66,neural crest cell differentiation,BP,
5193,GO:0014034,1,0.974953169895313,0,3,neural crest cell fate commitment,BP,
5194,GO:0014036,1,0.987546610861854,0,1,neural crest cell fate specification,BP,
5195,GO:0014037,1,0.853926167550318,0,33,Schwann cell differentiation,BP,
5196,GO:0014038,1,0.980448454642598,0,3,regulation of Schwann cell differentiation,BP,
5197,GO:0014040,1,0.991741495912551,0,2,positive regulation of Schwann cell differentiation,BP,
5198,GO:0014041,1,0.961654637849996,0,11,regulation of neuron maturation,BP,
5199,GO:0014042,1,0.997300610857436,0,4,positive regulation of neuron maturation,BP,
5200,GO:0014043,1,0.985592452230658,0,4,negative regulation of neuron maturation,BP,
5201,GO:0014044,1,0.891566049884949,0,25,Schwann cell development,BP,
5202,GO:0014045,1,0.976674858172031,0,4,establishment of endothelial blood-brain barrier,BP,
5203,GO:0014046,1,0.81609301826231,0,27,dopamine secretion,BP,
5205,GO:0014048,1,0.915869448009562,0,14,regulation of glutamate secretion,BP,
5206,GO:0014049,1,0.956628501655059,0,8,positive regulation of glutamate secretion,BP,
5207,GO:0014050,1,0.962640963361533,0,5,negative regulation of glutamate secretion,BP,
5208,GO:0014051,1,0.975812031673328,0,8,gamma-aminobutyric acid secretion,BP,
5209,GO:0014052,1,0.981458841073679,0,5,regulation of gamma-aminobutyric acid secretion,BP,
5210,GO:0014053,1,0.999768569133436,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5211,GO:0014054,1,0.981686070472662,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5212,GO:0014055,1,0.975079582818004,0,3,acetylcholine secretion, neurotransmission,BP,
5213,GO:0014056,1,0.975079582818004,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5214,GO:0014057,1,0.982766730198524,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5215,GO:0014059,1,0.81609301826231,0,27,regulation of dopamine secretion,BP,
5216,GO:0014060,1,0.957513283573652,0,5,regulation of epinephrine secretion,BP,
5217,GO:0014061,1,0.888276739497502,0,15,regulation of norepinephrine secretion,BP,
5218,GO:0014062,1,0.940802033109559,0,7,regulation of serotonin secretion,BP,
5219,GO:0014063,1,0.965122741072861,0,4,negative regulation of serotonin secretion,BP,
5220,GO:0014064,1,0.999334848714627,0,1,positive regulation of serotonin secretion,BP,
5223,GO:0014067,1,0.930997878032922,0,11,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5224,GO:0014068,1,0.716091638915925,0,63,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
5225,GO:0014069,1,0.487972878454477,0,190,postsynaptic density,CC,
5229,GO:0014075,1,0.787056445660306,0,38,response to amine,BP,
5230,GO:0014701,1,0.984289892356872,0,9,junctional sarcoplasmic reticulum membrane,CC,
5231,GO:0014704,1,0.83654008708099,0,46,intercalated disc,CC,
5232,GO:0014705,1,0.998753644800957,0,1,C zone,CC,
5234,GO:0014707,1,0.971011035674913,0,3,branchiomeric skeletal muscle development,BP,
5235,GO:0014717,1,0.971225161723394,0,3,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5236,GO:0014718,1,0.982830166826993,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5237,GO:0014719,1,0.96007526033479,0,5,skeletal muscle satellite cell activation,BP,
5238,GO:0014721,1,0.971393643262605,0,5,twitch skeletal muscle contraction,BP,
5239,GO:0014722,1,0.958023650108667,0,5,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5240,GO:0014724,1,0.996264712586476,0,2,regulation of twitch skeletal muscle contraction,BP,
5241,GO:0014728,1,0.993128385002531,0,2,regulation of the force of skeletal muscle contraction,BP,
5242,GO:0014731,1,0.988926444718966,0,7,spectrin-associated cytoskeleton,CC,
5243,GO:0014732,1,0.942395539399253,0,8,skeletal muscle atrophy,BP,
5244,GO:0014733,1,0.957686835941137,0,13,regulation of skeletal muscle adaptation,BP,
5245,GO:0014734,1,0.989540785437488,0,3,skeletal muscle hypertrophy,BP,
5248,GO:0014737,1,0.98859458603141,0,1,positive regulation of muscle atrophy,BP,
5249,GO:0014738,1,0.972080679796504,0,3,regulation of muscle hyperplasia,BP,
5250,GO:0014739,1,0.987184937064024,0,1,positive regulation of muscle hyperplasia,BP,
5251,GO:0014740,1,0.984701219361983,0,2,negative regulation of muscle hyperplasia,BP,
5252,GO:0014741,1,0.895656319136548,0,18,negative regulation of muscle hypertrophy,BP,
5253,GO:0014742,1,0.890276734485516,0,24,positive regulation of muscle hypertrophy,BP,
5254,GO:0014743,1,0.79760423491114,0,43,regulation of muscle hypertrophy,BP,
5255,GO:0014744,1,0.971407851301756,0,5,positive regulation of muscle adaptation,BP,
5257,GO:0014801,1,0.987355522973505,0,1,longitudinal sarcoplasmic reticulum,CC,
5258,GO:0014802,1,0.966920271523801,0,4,terminal cisterna,CC,
5259,GO:0014804,1,0.989268823034668,0,1,terminal cisterna lumen,CC,
5260,GO:0014805,1,0.955359169694995,0,4,smooth muscle adaptation,BP,
5261,GO:0014806,1,0.979473060714386,0,2,smooth muscle hyperplasia,BP,
5262,GO:0014807,1,0.928400943889379,0,9,regulation of somitogenesis,BP,
5264,GO:0014809,1,0.964680089390463,0,4,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5265,GO:0014810,1,0.987234815350784,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5266,GO:0014812,1,0.690893008120101,0,74,muscle cell migration,BP,
5267,GO:0014813,1,0.990378990484081,0,1,skeletal muscle satellite cell commitment,BP,
5268,GO:0014816,1,0.976202507460245,0,6,skeletal muscle satellite cell differentiation,BP,
5269,GO:0014819,1,0.936237538621631,0,11,regulation of skeletal muscle contraction,BP,
5270,GO:0014820,1,0.947176863006757,0,8,tonic smooth muscle contraction,BP,
5271,GO:0014821,1,0.861789546975667,0,17,phasic smooth muscle contraction,BP,
5272,GO:0014822,1,0.991648557536278,0,1,detection of wounding,BP,
5274,GO:0014824,1,0.94717687682793,0,7,artery smooth muscle contraction,BP,
5275,GO:0014826,1,0.968371301725309,0,4,vein smooth muscle contraction,BP,
5276,GO:0014827,1,0.964067629747539,0,4,intestine smooth muscle contraction,BP,
5277,GO:0014829,1,0.897116854953275,0,19,vascular smooth muscle contraction,BP,
5278,GO:0014831,1,0.961407828194256,0,7,gastro-intestinal system smooth muscle contraction,BP,
5279,GO:0014832,1,0.959544590391,0,7,urinary bladder smooth muscle contraction,BP,
5280,GO:0014834,1,0.9782014561913,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
5281,GO:0014835,1,0.989343489624792,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5282,GO:0014839,1,0.976904084779416,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
5283,GO:0014841,1,0.946330632264486,0,10,skeletal muscle satellite cell proliferation,BP,
5284,GO:0014842,1,0.946330646246007,0,9,regulation of skeletal muscle satellite cell proliferation,BP,
5285,GO:0014843,1,0.999999996377315,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5286,GO:0014846,1,0.998749874254994,0,2,esophagus smooth muscle contraction,BP,
5287,GO:0014848,1,0.959544590391,0,7,urinary tract smooth muscle contraction,BP,
5288,GO:0014850,1,0.900335987910835,0,16,response to muscle activity,BP,
5289,GO:0014852,1,0.993101808989047,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5290,GO:0014853,1,0.993101808989047,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5291,GO:0014854,1,0.920265119743495,0,13,response to inactivity,BP,
5293,GO:0014856,1,0.935147027031765,0,11,skeletal muscle cell proliferation,BP,
5294,GO:0014857,1,0.935147043097463,0,10,regulation of skeletal muscle cell proliferation,BP,
5295,GO:0014858,1,0.988187278153849,0,1,positive regulation of skeletal muscle cell proliferation,BP,
5296,GO:0014859,1,0.988215246065856,0,2,negative regulation of skeletal muscle cell proliferation,BP,
5297,GO:0014861,1,0.9999740992563,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5298,GO:0014862,1,0.993128385002531,0,2,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5299,GO:0014866,1,0.956393615141801,0,7,skeletal myofibril assembly,BP,
5300,GO:0014870,1,0.947516574242891,0,10,response to muscle inactivity,BP,
5301,GO:0014873,1,0.980431788010464,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5304,GO:0014877,1,0.947516574242891,0,10,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5305,GO:0014878,1,0.977358244816467,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5306,GO:0014883,1,0.967548590637112,0,7,transition between fast and slow fiber,BP,
5307,GO:0014886,1,0.994284891712381,0,2,transition between slow and fast fiber,BP,
5308,GO:0014887,1,0.920503695138459,0,19,cardiac muscle adaptation,BP,
5309,GO:0014888,1,0.802871329659491,0,40,striated muscle adaptation,BP,
5311,GO:0014891,1,0.935296225749058,0,9,striated muscle atrophy,BP,
5312,GO:0014894,1,0.947516574242891,0,10,response to denervation involved in regulation of muscle adaptation,BP,
5313,GO:0014895,1,0.987199441584784,0,1,smooth muscle hypertrophy,BP,
5314,GO:0014896,1,0.703985657704953,0,70,muscle hypertrophy,BP,
5315,GO:0014897,1,0.71828507408728,0,68,striated muscle hypertrophy,BP,
5316,GO:0014898,1,0.920503695138459,0,19,cardiac muscle hypertrophy in response to stress,BP,
5317,GO:0014900,1,0.96054490396607,0,4,muscle hyperplasia,BP,
5318,GO:0014901,1,0.971225161723394,0,3,satellite cell activation involved in skeletal muscle regeneration,BP,
5319,GO:0014902,1,0.559098629360357,0,98,myotube differentiation,BP,
5320,GO:0014904,1,0.820628158571716,0,32,myotube cell development,BP,
5321,GO:0014905,1,0.987251465172202,0,1,myoblast fusion involved in skeletal muscle regeneration,BP,
5322,GO:0014908,1,0.97616508345144,0,3,myotube differentiation involved in skeletal muscle regeneration,BP,
5323,GO:0014909,1,0.738704831946291,0,64,smooth muscle cell migration,BP,
5324,GO:0014910,1,0.772319288654424,0,56,regulation of smooth muscle cell migration,BP,
5325,GO:0014911,1,0.871490411764032,0,32,positive regulation of smooth muscle cell migration,BP,
5326,GO:0014912,1,0.897555044451666,0,20,negative regulation of smooth muscle cell migration,BP,
5327,GO:0014916,1,0.989240495810276,0,3,regulation of lung blood pressure,BP,
5330,GO:0015014,1,0.990531216723694,0,3,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5331,GO:0015015,1,0.979302846444847,0,5,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5332,GO:0015016,1,0.993523407970865,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5333,GO:0015018,1,0.973785112690222,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5334,GO:0015019,1,0.999934859928253,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5335,GO:0015020,1,0.782501621886184,0,31,glucuronosyltransferase activity,MF,
5336,GO:0015026,1,0.81187088604335,0,36,coreceptor activity,MF,
5337,GO:0015030,1,0.707496065071142,0,49,Cajal body,CC,
5339,GO:0015035,1,0.823141432241106,0,21,protein disulfide oxidoreductase activity,MF,
5340,GO:0015036,1,0.690355153701864,0,39,disulfide oxidoreductase activity,MF,
5341,GO:0015037,1,0.871686263628897,0,13,peptide disulfide oxidoreductase activity,MF,
5342,GO:0015038,1,0.942130708365158,0,5,glutathione disulfide oxidoreductase activity,MF,
5343,GO:0015039,1,0.989060321771781,0,1,NADPH-adrenodoxin reductase activity,MF,
5344,GO:0015052,1,0.992028193048787,0,1,beta3-adrenergic receptor activity,MF,
5345,GO:0015054,1,0.989824222640719,0,1,gastrin receptor activity,MF,
5346,GO:0015055,1,0.98884806907306,0,1,secretin receptor activity,MF,
5347,GO:0015056,1,0.980254761288119,0,2,corticotrophin-releasing factor receptor activity,MF,
5348,GO:0015057,1,0.970386734722142,0,5,thrombin-activated receptor activity,MF,
5350,GO:0015067,1,0.991784760639737,0,1,amidinotransferase activity,MF,
5351,GO:0015068,1,0.991784760639737,0,1,glycine amidinotransferase activity,MF,
5352,GO:0015074,1,0.943772009242622,0,10,DNA integration,BP,
5356,GO:0015079,1,0.406409755848187,0,157,potassium ion transmembrane transporter activity,MF,
5358,GO:0015085,1,0.598258590076458,0,133,calcium ion transmembrane transporter activity,MF,
5359,GO:0015086,1,0.998573908503945,0,1,cadmium ion transmembrane transporter activity,MF,
5360,GO:0015087,1,0.998573908503945,0,1,cobalt ion transmembrane transporter activity,MF,
5361,GO:0015088,1,0.999640847183594,0,1,copper uptake transmembrane transporter activity,MF,
5362,GO:0015091,1,0.992700256397007,0,2,ferric iron transmembrane transporter activity,MF,
5363,GO:0015093,1,0.99359017362349,0,3,ferrous iron transmembrane transporter activity,MF,
5364,GO:0015094,1,0.998573908503945,0,1,lead ion transmembrane transporter activity,MF,
5365,GO:0015095,1,0.920000000797776,0,17,magnesium ion transmembrane transporter activity,MF,
5366,GO:0015098,1,0.989061908074489,0,1,molybdate ion transmembrane transporter activity,MF,
5367,GO:0015101,1,0.890504665474473,0,14,organic cation transmembrane transporter activity,MF,
5369,GO:0015105,1,0.987670378251574,0,1,arsenite transmembrane transporter activity,MF,
5370,GO:0015106,1,0.932915458709536,0,19,bicarbonate transmembrane transporter activity,MF,
5372,GO:0015111,1,0.994977067882809,0,3,iodide transmembrane transporter activity,MF,
5373,GO:0015112,1,0.992083781691505,0,1,nitrate transmembrane transporter activity,MF,
5374,GO:0015114,1,0.901376680073164,0,17,phosphate ion transmembrane transporter activity,MF,
5375,GO:0015116,1,0.931077259607733,0,14,sulfate transmembrane transporter activity,MF,
5376,GO:0015117,1,0.989035033890079,0,1,thiosulfate transmembrane transporter activity,MF,
5377,GO:0015119,1,0.982728582242917,0,3,hexose phosphate transmembrane transporter activity,MF,
5378,GO:0015125,1,0.90878826912741,0,13,bile acid transmembrane transporter activity,MF,
5379,GO:0015126,1,0.999662272398562,0,1,canalicular bile acid transmembrane transporter activity,MF,
5380,GO:0015127,1,0.999871944703624,0,1,bilirubin transmembrane transporter activity,MF,
5381,GO:0015129,1,0.973584390472183,0,5,lactate transmembrane transporter activity,MF,
5382,GO:0015130,1,0.998490135981731,0,1,mevalonate transmembrane transporter activity,MF,
5383,GO:0015131,1,0.989035033890079,0,1,oxaloacetate transmembrane transporter activity,MF,
5384,GO:0015132,1,0.998717522938239,0,1,prostaglandin transmembrane transporter activity,MF,
5385,GO:0015136,1,0.995285849228816,0,1,sialic acid transmembrane transporter activity,MF,
5386,GO:0015137,1,0.979948865884354,0,4,citrate transmembrane transporter activity,MF,
5387,GO:0015139,1,0.993084902554068,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5388,GO:0015140,1,0.977863509603099,0,2,malate transmembrane transporter activity,MF,
5389,GO:0015141,1,0.982191181084,0,3,succinate transmembrane transporter activity,MF,
5390,GO:0015142,1,0.979948865884354,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5391,GO:0015143,1,0.906458067953575,0,10,urate transmembrane transporter activity,MF,
5392,GO:0015144,1,0.742961387222609,0,41,carbohydrate transmembrane transporter activity,MF,
5393,GO:0015145,1,0.867905738423806,0,22,monosaccharide transmembrane transporter activity,MF,
5394,GO:0015149,1,0.875992062464392,0,20,hexose transmembrane transporter activity,MF,
5395,GO:0015152,1,0.989779695136045,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5396,GO:0015154,1,0.981529972959541,0,3,disaccharide transmembrane transporter activity,MF,
5397,GO:0015157,1,0.981529972959541,0,3,oligosaccharide transmembrane transporter activity,MF,
5398,GO:0015165,1,0.955606150309433,0,6,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5399,GO:0015166,1,0.942388191824276,0,9,polyol transmembrane transporter activity,MF,
5400,GO:0015168,1,0.951158667017775,0,6,glycerol transmembrane transporter activity,MF,
5403,GO:0015173,1,0.979105827445571,0,3,aromatic amino acid transmembrane transporter activity,MF,
5404,GO:0015174,1,0.936619186008158,0,9,basic amino acid transmembrane transporter activity,MF,
5405,GO:0015175,1,0.822080267874082,0,31,neutral amino acid transmembrane transporter activity,MF,
5407,GO:0015180,1,0.963752643577068,0,7,L-alanine transmembrane transporter activity,MF,
5408,GO:0015181,1,0.979429216045202,0,4,arginine transmembrane transporter activity,MF,
5409,GO:0015182,1,0.983970861356623,0,2,L-asparagine transmembrane transporter activity,MF,
5410,GO:0015183,1,0.974282191320734,0,4,L-aspartate transmembrane transporter activity,MF,
5411,GO:0015184,1,0.977005663452024,0,4,L-cystine transmembrane transporter activity,MF,
5412,GO:0015185,1,0.96596187073384,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5413,GO:0015186,1,0.972216461930064,0,4,L-glutamine transmembrane transporter activity,MF,
5414,GO:0015187,1,0.94918375479885,0,8,glycine transmembrane transporter activity,MF,
5415,GO:0015189,1,0.979429223705299,0,3,L-lysine transmembrane transporter activity,MF,
5416,GO:0015190,1,0.99268159030409,0,1,L-leucine transmembrane transporter activity,MF,
5417,GO:0015191,1,0.99268159030409,0,1,L-methionine transmembrane transporter activity,MF,
5418,GO:0015193,1,0.975703526410553,0,7,L-proline transmembrane transporter activity,MF,
5419,GO:0015194,1,0.923631969941499,0,9,L-serine transmembrane transporter activity,MF,
5420,GO:0015195,1,0.998890254767214,0,1,L-threonine transmembrane transporter activity,MF,
5421,GO:0015196,1,0.991251880888793,0,1,L-tryptophan transmembrane transporter activity,MF,
5423,GO:0015198,1,0.987782959249493,0,5,oligopeptide transporter activity,MF,
5424,GO:0015199,1,0.963981508457039,0,4,amino-acid betaine transmembrane transporter activity,MF,
5425,GO:0015203,1,0.987277997855441,0,1,polyamine transmembrane transporter activity,MF,
5426,GO:0015204,1,0.979644893605569,0,4,urea transmembrane transporter activity,MF,
5427,GO:0015205,1,0.940789444769608,0,8,nucleobase transmembrane transporter activity,MF,
5428,GO:0015207,1,0.975055366127299,0,3,adenine transmembrane transporter activity,MF,
5429,GO:0015211,1,0.966714767123328,0,4,purine nucleoside transmembrane transporter activity,MF,
5430,GO:0015215,1,0.888895029496009,0,16,nucleotide transmembrane transporter activity,MF,
5431,GO:0015216,1,0.916425025076767,0,12,purine nucleotide transmembrane transporter activity,MF,
5432,GO:0015217,1,0.936365694043194,0,9,ADP transmembrane transporter activity,MF,
5433,GO:0015218,1,0.987473057819827,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5434,GO:0015220,1,0.97300833040602,0,6,choline transmembrane transporter activity,MF,
5435,GO:0015222,1,0.981531714559186,0,3,serotonin transmembrane transporter activity,MF,
5436,GO:0015226,1,0.963981508457039,0,4,carnitine transmembrane transporter activity,MF,
5437,GO:0015227,1,0.979888534283067,0,2,acyl carnitine transmembrane transporter activity,MF,
5438,GO:0015228,1,0.984847343245695,0,2,coenzyme A transmembrane transporter activity,MF,
5439,GO:0015229,1,0.990778624738743,0,2,L-ascorbic acid transporter activity,MF,
5440,GO:0015230,1,0.984316920206231,0,2,FAD transmembrane transporter activity,MF,
5441,GO:0015232,1,0.959305847536635,0,8,heme transporter activity,MF,
5442,GO:0015234,1,0.972088531149684,0,4,thiamine transmembrane transporter activity,MF,
5443,GO:0015235,1,0.978271955291518,0,3,cobalamin transporter activity,MF,
5446,GO:0015247,1,0.999999992775708,0,2,aminophospholipid transporter activity,MF,
5448,GO:0015250,1,0.911742243228851,0,11,water channel activity,MF,
5449,GO:0015252,1,0.952932424966444,0,6,hydrogen ion channel activity,MF,
5450,GO:0015254,1,0.959658879082249,0,4,glycerol channel activity,MF,
5451,GO:0015265,1,0.981057025257673,0,3,urea channel activity,MF,
5452,GO:0015266,1,0.89328373407563,0,11,protein channel activity,MF,
5454,GO:0015269,1,0.864342520767785,0,19,calcium-activated potassium channel activity,MF,
5455,GO:0015271,1,0.937069977504476,0,12,outward rectifier potassium channel activity,MF,
5456,GO:0015272,1,0.975909931237104,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5457,GO:0015275,1,0.990240787119037,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5459,GO:0015277,1,0.984618264930315,0,5,kainate selective glutamate receptor activity,MF,
5460,GO:0015278,1,0.957104274787281,0,18,calcium-release channel activity,MF,
5461,GO:0015279,1,0.947472411164145,0,11,store-operated calcium channel activity,MF,
5462,GO:0015280,1,0.94328923485387,0,9,ligand-gated sodium channel activity,MF,
5463,GO:0015288,1,0.940800686882981,0,6,porin activity,MF,
5465,GO:0015292,1,0.991657600429728,0,1,uniporter activity,MF,
5468,GO:0015295,1,0.831786474307451,0,28,solute:proton symporter activity,MF,
5469,GO:0015296,1,0.791804389487545,0,49,anion:cation symporter activity,MF,
5470,GO:0015297,1,0.655626624787906,0,79,antiporter activity,MF,
5471,GO:0015298,1,0.850256946361816,0,32,solute:cation antiporter activity,MF,
5472,GO:0015299,1,0.902692072795825,0,19,solute:proton antiporter activity,MF,
5473,GO:0015301,1,0.854323211957948,0,31,anion:anion antiporter activity,MF,
5474,GO:0015307,1,0.974074842046145,0,3,drug:proton antiporter activity,MF,
5475,GO:0015315,1,0.982728582242917,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5476,GO:0015319,1,0.993657777065081,0,1,sodium:inorganic phosphate symporter activity,MF,
5477,GO:0015320,1,0.988444871320663,0,1,phosphate ion carrier activity,MF,
5478,GO:0015321,1,0.954156092658041,0,7,sodium-dependent phosphate transmembrane transporter activity,MF,
5479,GO:0015322,1,0.991481724112405,0,2,secondary active oligopeptide transmembrane transporter activity,MF,
5480,GO:0015327,1,0.999999996393668,0,1,cystine:glutamate antiporter activity,MF,
5481,GO:0015328,1,0.999999996393668,0,1,cystine secondary active transmembrane transporter activity,MF,
5482,GO:0015333,1,0.976859386159931,0,4,peptide:proton symporter activity,MF,
5483,GO:0015347,1,0.883333357960802,0,16,sodium-independent organic anion transmembrane transporter activity,MF,
5484,GO:0015349,1,0.973133913879168,0,5,thyroid hormone transmembrane transporter activity,MF,
5485,GO:0015350,1,0.992964349354596,0,2,methotrexate transporter activity,MF,
5486,GO:0015361,1,0.991094811231428,0,1,low-affinity sodium:dicarboxylate symporter activity,MF,
5487,GO:0015362,1,0.998270227682962,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5488,GO:0015367,1,0.988705602565549,0,1,oxoglutarate:malate antiporter activity,MF,
5489,GO:0015368,1,0.956315948898794,0,10,calcium:cation antiporter activity,MF,
5491,GO:0015373,1,0.996494184663377,0,1,monovalent anion:sodium symporter activity,MF,
5492,GO:0015375,1,0.987972690556412,0,2,glycine:sodium symporter activity,MF,
5493,GO:0015377,1,0.990513793599716,0,9,cation:chloride symporter activity,MF,
5494,GO:0015378,1,0.999996121450449,0,1,sodium:chloride symporter activity,MF,
5495,GO:0015379,1,0.990925425698999,0,6,potassium:chloride symporter activity,MF,
5496,GO:0015382,1,0.99066568622804,0,2,sodium:sulfate symporter activity,MF,
5497,GO:0015385,1,0.942205304649193,0,13,sodium:proton antiporter activity,MF,
5498,GO:0015386,1,0.958130739746225,0,11,potassium:proton antiporter activity,MF,
5499,GO:0015389,1,0.979870947081302,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5500,GO:0015390,1,0.990223434331869,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5502,GO:0015403,1,0.983550005576148,0,3,thiamine uptake transmembrane transporter activity,MF,
5504,GO:0015410,1,0.997677595472862,0,1,manganese-transporting ATPase activity,MF,
5505,GO:0015420,1,0.999999996375099,0,1,cobalamin-transporting ATPase activity,MF,
5506,GO:0015421,1,0.996280174916049,0,1,oligopeptide-transporting ATPase activity,MF,
5507,GO:0015431,1,0.999999996375099,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5508,GO:0015432,1,0.995963528125476,0,2,bile acid-exporting ATPase activity,MF,
5509,GO:0015433,1,0.994306293861836,0,2,peptide antigen-transporting ATPase activity,MF,
5510,GO:0015439,1,0.99367726678093,0,1,heme-transporting ATPase activity,MF,
5511,GO:0015440,1,0.984203743198372,0,4,peptide-transporting ATPase activity,MF,
5512,GO:0015450,1,0.922919225236672,0,8,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5513,GO:0015459,1,0.736338938868518,0,44,potassium channel regulator activity,MF,
5514,GO:0015464,1,0.832675383961908,0,22,acetylcholine receptor activity,MF,
5515,GO:0015467,1,0.952162267420569,0,10,G-protein activated inward rectifier potassium channel activity,MF,
5517,GO:0015489,1,0.987277997855441,0,1,putrescine transmembrane transporter activity,MF,
5518,GO:0015491,1,0.881064252917155,0,28,cation:cation antiporter activity,MF,
5519,GO:0015495,1,0.991711970667283,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5520,GO:0015499,1,0.992095383735228,0,1,formate transmembrane transporter activity,MF,
5521,GO:0015501,1,0.997093910499742,0,2,glutamate:sodium symporter activity,MF,
5522,GO:0015526,1,0.982728582242917,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5523,GO:0015538,1,0.995285849228816,0,1,sialic acid:proton symporter activity,MF,
5524,GO:0015556,1,0.946116140167718,0,8,C4-dicarboxylate transmembrane transporter activity,MF,
5525,GO:0015562,1,0.969862078959422,0,5,efflux transmembrane transporter activity,MF,
5526,GO:0015563,1,0.975774399977337,0,4,uptake transmembrane transporter activity,MF,
5527,GO:0015578,1,0.99119055560299,0,1,mannose transmembrane transporter activity,MF,
5528,GO:0015605,1,0.873528308164497,0,19,organophosphate ester transmembrane transporter activity,MF,
5529,GO:0015607,1,0.996849720927078,0,1,fatty-acyl-CoA transporter activity,MF,
5530,GO:0015616,1,0.990722802504539,0,3,DNA translocase activity,MF,
5534,GO:0015633,1,0.989735498072516,0,1,zinc-transporting ATPase activity,MF,
5535,GO:0015635,1,0.990578670108462,0,1,short-chain fatty acid transporter activity,MF,
5536,GO:0015636,1,0.990578670108462,0,1,short-chain fatty acid uptake transporter activity,MF,
5537,GO:0015639,1,0.998573908503945,0,1,ferrous iron uptake transmembrane transporter activity,MF,
5538,GO:0015643,1,0.918409939254246,0,11,toxic substance binding,MF,
5540,GO:0015651,1,0.936459896762891,0,8,quaternary ammonium group transmembrane transporter activity,MF,
5541,GO:0015658,1,0.99268159030409,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5542,GO:0015659,1,0.992095383735228,0,1,formate uptake transmembrane transporter activity,MF,
5543,GO:0015660,1,0.992095383735228,0,1,formate efflux transmembrane transporter activity,MF,
5544,GO:0015662,1,0.850997098265745,0,37,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5545,GO:0015665,1,0.942388191824276,0,9,alcohol transmembrane transporter activity,MF,
5546,GO:0015669,1,0.807246154870389,0,19,gas transport,BP,
5547,GO:0015670,1,0.959562536550573,0,4,carbon dioxide transport,BP,
5548,GO:0015671,1,0.841312315979103,0,15,oxygen transport,BP,
5550,GO:0015677,1,0.996683921509076,0,6,copper ion import,BP,
5551,GO:0015679,1,0.999999996387381,0,1,plasma membrane copper ion transport,BP,
5552,GO:0015680,1,0.974710912763302,0,3,intracellular copper ion transport,BP,
5553,GO:0015682,1,0.753629281351064,0,38,ferric iron transport,BP,
5554,GO:0015684,1,0.956950596099658,0,7,ferrous iron transport,BP,
5555,GO:0015688,1,0.969270656555269,0,3,iron chelate transport,BP,
5556,GO:0015689,1,0.989061908074489,0,1,molybdate ion transport,BP,
5557,GO:0015691,1,0.980621405857163,0,4,cadmium ion transport,BP,
5558,GO:0015692,1,0.998573908503945,0,1,lead ion transport,BP,
5559,GO:0015693,1,0.919976140844481,0,18,magnesium ion transport,BP,
5560,GO:0015694,1,0.999871944703624,0,1,mercury ion transport,BP,
5561,GO:0015695,1,0.835976077817347,0,21,organic cation transport,BP,
5562,GO:0015696,1,0.500627413819799,0,90,ammonium transport,BP,
5563,GO:0015697,1,0.926668964796184,0,10,quaternary ammonium group transport,BP,
5565,GO:0015701,1,0.755646031473178,0,44,bicarbonate transport,BP,
5566,GO:0015705,1,0.994977058669398,0,5,iodide transport,BP,
5567,GO:0015706,1,0.992083781691505,0,1,nitrate transport,BP,
5568,GO:0015707,1,0.997598341365831,0,1,nitrite transport,BP,
5569,GO:0015709,1,0.989035033890079,0,1,thiosulfate transport,BP,
5571,GO:0015712,1,0.954510636139606,0,6,hexose phosphate transport,BP,
5573,GO:0015721,1,0.811659913860745,0,30,bile acid and bile salt transport,BP,
5574,GO:0015722,1,0.993389845491873,0,3,canalicular bile acid transport,BP,
5575,GO:0015723,1,0.999871944703624,0,1,bilirubin transport,BP,
5576,GO:0015724,1,0.992095383735228,0,1,formate transport,BP,
5577,GO:0015727,1,0.972517640214661,0,6,lactate transport,BP,
5578,GO:0015728,1,0.998490135981731,0,1,mevalonate transport,BP,
5579,GO:0015729,1,0.989035033890079,0,1,oxaloacetate transport,BP,
5580,GO:0015732,1,0.894842160233824,0,15,prostaglandin transport,BP,
5581,GO:0015734,1,0.999999996375723,0,1,taurine transport,BP,
5582,GO:0015739,1,0.995285849228816,0,1,sialic acid transport,BP,
5584,GO:0015742,1,0.971858847057966,0,3,alpha-ketoglutarate transport,BP,
5585,GO:0015743,1,0.989035033890079,0,1,malate transport,BP,
5586,GO:0015744,1,0.982191181084,0,3,succinate transport,BP,
5587,GO:0015746,1,0.979948865884354,0,4,citrate transport,BP,
5588,GO:0015747,1,0.908947201073023,0,10,urate transport,BP,
5591,GO:0015755,1,0.98215497289393,0,2,fructose transport,BP,
5593,GO:0015760,1,0.954510636139606,0,6,glucose-6-phosphate transport,BP,
5594,GO:0015761,1,0.99119055560299,0,1,mannose transport,BP,
5595,GO:0015766,1,0.981529972959541,0,3,disaccharide transport,BP,
5596,GO:0015770,1,0.981529972959541,0,3,sucrose transport,BP,
5597,GO:0015772,1,0.981529972959541,0,3,oligosaccharide transport,BP,
5598,GO:0015780,1,0.942673443813227,0,8,nucleotide-sugar transport,BP,
5599,GO:0015781,1,0.955606150309433,0,6,pyrimidine nucleotide-sugar transport,BP,
5600,GO:0015782,1,0.988803713154355,0,1,CMP-N-acetylneuraminate transport,BP,
5601,GO:0015783,1,0.986471326193314,0,3,GDP-fucose transport,BP,
5602,GO:0015785,1,0.976244231753256,0,2,UDP-galactose transport,BP,
5603,GO:0015787,1,0.999999996375464,0,1,UDP-glucuronic acid transport,BP,
5604,GO:0015788,1,0.989948342177731,0,2,UDP-N-acetylglucosamine transport,BP,
5605,GO:0015790,1,0.9999999963776,0,1,UDP-xylose transport,BP,
5606,GO:0015791,1,0.934935463674334,0,11,polyol transport,BP,
5607,GO:0015793,1,0.951158667017775,0,6,glycerol transport,BP,
5608,GO:0015797,1,0.992095383735228,0,1,mannitol transport,BP,
5609,GO:0015798,1,0.999999989183528,0,3,myo-inositol transport,BP,
5611,GO:0015801,1,0.966019789729124,0,5,aromatic amino acid transport,BP,
5612,GO:0015802,1,0.905463497778885,0,13,basic amino acid transport,BP,
5613,GO:0015803,1,0.982157301034451,0,4,branched-chain amino acid transport,BP,
5614,GO:0015804,1,0.811622633342713,0,35,neutral amino acid transport,BP,
5615,GO:0015805,1,0.990243205478651,0,1,S-adenosyl-L-methionine transport,BP,
5617,GO:0015808,1,0.963752643577068,0,7,L-alanine transport,BP,
5618,GO:0015809,1,0.946860842966036,0,8,arginine transport,BP,
5620,GO:0015811,1,0.977005663452024,0,4,L-cystine transport,BP,
5621,GO:0015812,1,0.943274990262674,0,12,gamma-aminobutyric acid transport,BP,
5623,GO:0015816,1,0.949159136620923,0,10,glycine transport,BP,
5624,GO:0015817,1,0.983970861356623,0,2,histidine transport,BP,
5625,GO:0015819,1,0.97134150757555,0,4,lysine transport,BP,
5626,GO:0015820,1,0.989398738784981,0,3,leucine transport,BP,
5627,GO:0015821,1,0.99268159030409,0,1,methionine transport,BP,
5628,GO:0015822,1,0.986035831611698,0,3,ornithine transport,BP,
5629,GO:0015824,1,0.975678236780772,0,9,proline transport,BP,
5630,GO:0015825,1,0.923631969941499,0,9,L-serine transport,BP,
5631,GO:0015826,1,0.998890254767214,0,1,threonine transport,BP,
5632,GO:0015827,1,0.978004796283741,0,3,tryptophan transport,BP,
5633,GO:0015828,1,0.994499905927764,0,1,tyrosine transport,BP,
5635,GO:0015837,1,0.540168680109745,0,79,amine transport,BP,
5636,GO:0015838,1,0.953905138401813,0,6,amino-acid betaine transport,BP,
5637,GO:0015840,1,0.956365390776629,0,6,urea transport,BP,
5638,GO:0015842,1,0.961230724694934,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5639,GO:0015844,1,0.584212753136631,0,72,monoamine transport,BP,
5640,GO:0015846,1,0.95222077522383,0,6,polyamine transport,BP,
5641,GO:0015847,1,0.987277997855441,0,1,putrescine transport,BP,
5644,GO:0015851,1,0.929410161927264,0,9,nucleobase transport,BP,
5645,GO:0015853,1,0.963264944257021,0,4,adenine transport,BP,
5646,GO:0015855,1,0.973846464305785,0,3,pyrimidine nucleobase transport,BP,
5647,GO:0015858,1,0.931727547667274,0,8,nucleoside transport,BP,
5648,GO:0015860,1,0.981590648034268,0,2,purine nucleoside transmembrane transport,BP,
5649,GO:0015862,1,0.990661476358324,0,1,uridine transport,BP,
5650,GO:0015864,1,0.98097549295122,0,2,pyrimidine nucleoside transport,BP,
5651,GO:0015865,1,0.895182017080217,0,15,purine nucleotide transport,BP,
5652,GO:0015866,1,0.936365694043194,0,9,ADP transport,BP,
5653,GO:0015867,1,0.925495053660324,0,11,ATP transport,BP,
5654,GO:0015868,1,0.895697806019756,0,14,purine ribonucleotide transport,BP,
5655,GO:0015870,1,0.958640206562775,0,5,acetylcholine transport,BP,
5656,GO:0015871,1,0.972998853517875,0,8,choline transport,BP,
5657,GO:0015872,1,0.744722473245262,0,39,dopamine transport,BP,
5658,GO:0015874,1,0.862204633417744,0,20,norepinephrine transport,BP,
5659,GO:0015876,1,0.992116285519845,0,1,acetyl-CoA transport,BP,
5660,GO:0015878,1,0.995217258907765,0,1,biotin transport,BP,
5661,GO:0015879,1,0.954144326154792,0,5,carnitine transport,BP,
5662,GO:0015880,1,0.984847343245695,0,2,coenzyme A transport,BP,
5663,GO:0015881,1,0.995771212335886,0,2,creatine transport,BP,
5664,GO:0015882,1,0.990778624738743,0,2,L-ascorbic acid transport,BP,
5665,GO:0015883,1,0.984316920206231,0,2,FAD transport,BP,
5666,GO:0015884,1,0.946849620410715,0,7,folic acid transport,BP,
5667,GO:0015886,1,0.948979224354315,0,9,heme transport,BP,
5668,GO:0015887,1,0.995217258907765,0,1,pantothenate transmembrane transport,BP,
5669,GO:0015888,1,0.965506042761259,0,5,thiamine transport,BP,
5670,GO:0015889,1,0.933794916015959,0,8,cobalamin transport,BP,
5671,GO:0015891,1,0.969270656555269,0,3,siderophore transport,BP,
5673,GO:0015904,1,0.988952528708528,0,1,tetracycline transport,BP,
5676,GO:0015910,1,0.987418886112779,0,2,peroxisomal long-chain fatty acid import,BP,
5677,GO:0015911,1,0.983927221173116,0,5,plasma membrane long-chain fatty acid transport,BP,
5678,GO:0015912,1,0.990578670108462,0,1,short-chain fatty acid transport,BP,
5679,GO:0015913,1,0.990578670108462,0,1,short-chain fatty acid import,BP,
5681,GO:0015916,1,0.992116285519845,0,1,fatty-acyl-CoA transport,BP,
5682,GO:0015917,1,0.999999989156398,0,3,aminophospholipid transport,BP,
5684,GO:0015919,1,0.961911568985817,0,7,peroxisomal membrane transport,BP,
5685,GO:0015920,1,0.981174052987902,0,2,lipopolysaccharide transport,BP,
5686,GO:0015922,1,0.988289056556148,0,1,aspartate oxidase activity,MF,
5687,GO:0015923,1,0.958879861301229,0,14,mannosidase activity,MF,
5688,GO:0015924,1,0.974922123041822,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5690,GO:0015926,1,0.961612048280755,0,12,glucosidase activity,MF,
5691,GO:0015927,1,0.988950990789635,0,1,trehalase activity,MF,
5692,GO:0015928,1,0.979663299275961,0,2,fucosidase activity,MF,
5694,GO:0015931,1,0.241724109454439,0,224,nucleobase-containing compound transport,BP,
5695,GO:0015932,1,0.773370388283043,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5697,GO:0015935,1,0.457191248800691,0,68,small ribosomal subunit,CC,
5701,GO:0015939,1,0.952360168435854,0,7,pantothenate metabolic process,BP,
5702,GO:0015942,1,0.953782594433755,0,6,formate metabolic process,BP,
5703,GO:0015949,1,0.829947767539137,0,22,nucleobase-containing small molecule interconversion,BP,
5704,GO:0015959,1,0.948198145209297,0,7,diadenosine polyphosphate metabolic process,BP,
5705,GO:0015960,1,0.979510914750354,0,3,diadenosine polyphosphate biosynthetic process,BP,
5706,GO:0015961,1,0.968037406610311,0,4,diadenosine polyphosphate catabolic process,BP,
5707,GO:0015965,1,0.979510914750354,0,3,diadenosine tetraphosphate metabolic process,BP,
5708,GO:0015966,1,0.979510914750354,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5710,GO:0015985,1,0.765133249790639,0,25,energy coupled proton transport, down electrochemical gradient,BP,
5711,GO:0015986,1,0.765133249790639,0,25,ATP synthesis coupled proton transport,BP,
5712,GO:0015988,1,0.801591468239513,0,27,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5713,GO:0015991,1,0.801591468239513,0,27,ATP hydrolysis coupled proton transport,BP,
5715,GO:0015993,1,0.989073025495939,0,2,molecular hydrogen transport,BP,
5716,GO:0016004,1,0.914627724803658,0,11,phospholipase activator activity,MF,
5717,GO:0016005,1,0.991596596588463,0,2,phospholipase A2 activator activity,MF,
5718,GO:0016010,1,0.880987269762062,0,21,dystrophin-associated glycoprotein complex,CC,
5719,GO:0016011,1,0.954235297243562,0,7,dystroglycan complex,CC,
5720,GO:0016012,1,0.954235740116948,0,6,sarcoglycan complex,CC,
5721,GO:0016013,1,0.969163901621541,0,4,syntrophin complex,CC,
5722,GO:0016015,1,0.934327459153715,0,7,morphogen activity,MF,
5723,GO:0016018,1,0.920479617071535,0,10,cyclosporin A binding,MF,
5724,GO:0016019,1,0.942319877877624,0,5,peptidoglycan receptor activity,MF,
5727,GO:0016024,1,0.954777611963616,0,11,CDP-diacylglycerol biosynthetic process,BP,
5728,GO:0016028,1,0.996728693625204,0,1,rhabdomere,CC,
5729,GO:0016031,1,0.982819973334789,0,2,tRNA import into mitochondrion,BP,
5731,GO:0016034,1,0.987750629389171,0,1,maleylacetoacetate isomerase activity,MF,
5732,GO:0016035,1,0.987493772074108,0,3,zeta DNA polymerase complex,CC,
5733,GO:0016036,1,0.990409252857432,0,1,cellular response to phosphate starvation,BP,
5734,GO:0016037,1,0.992619666292586,0,1,light absorption,BP,
5735,GO:0016038,1,0.992619666292586,0,1,absorption of visible light,BP,
5738,GO:0016045,1,0.934414703969448,0,12,detection of bacterium,BP,
5739,GO:0016046,1,0.999998549851777,0,1,detection of fungus,BP,
5740,GO:0016048,1,0.901316400103206,0,18,detection of temperature stimulus,BP,
5741,GO:0016049,1,0.0528414343353196,0,473,cell growth,BP,
5748,GO:0016056,1,0.790257111973197,0,32,rhodopsin mediated signaling pathway,BP,
5749,GO:0016062,1,0.985602727873324,0,2,adaptation of rhodopsin mediated signaling,BP,
5750,GO:0016064,1,0.472473336043146,0,98,immunoglobulin mediated immune response,BP,
5751,GO:0016068,1,0.967010229741479,0,3,type I hypersensitivity,BP,
5755,GO:0016073,1,0.546763269373238,0,77,snRNA metabolic process,BP,
5756,GO:0016074,1,0.867559280187957,0,13,snoRNA metabolic process,BP,
5757,GO:0016075,1,0.888818082506662,0,15,rRNA catabolic process,BP,
5758,GO:0016077,1,0.999999996372751,0,1,snoRNA catabolic process,BP,
5759,GO:0016078,1,0.977305432464614,0,3,tRNA catabolic process,BP,
5760,GO:0016079,1,0.687866864942993,0,80,synaptic vesicle exocytosis,BP,
5761,GO:0016080,1,0.995963823635454,0,4,synaptic vesicle targeting,BP,
5762,GO:0016081,1,0.964168538445941,0,8,synaptic vesicle docking,BP,
5763,GO:0016082,1,0.946467671755424,0,13,synaptic vesicle priming,BP,
5764,GO:0016093,1,0.930405582361047,0,8,polyprenol metabolic process,BP,
5765,GO:0016094,1,0.994864354752132,0,2,polyprenol biosynthetic process,BP,
5766,GO:0016095,1,0.96828912024329,0,3,polyprenol catabolic process,BP,
5767,GO:0016098,1,0.942025444737299,0,6,monoterpenoid metabolic process,BP,
5769,GO:0016102,1,0.936101341631608,0,8,diterpenoid biosynthetic process,BP,
5770,GO:0016103,1,0.965207058916833,0,4,diterpenoid catabolic process,BP,
5771,GO:0016107,1,0.975984983276443,0,2,sesquiterpenoid catabolic process,BP,
5772,GO:0016108,1,0.993055936423407,0,1,tetraterpenoid metabolic process,BP,
5773,GO:0016114,1,0.918234153392137,0,10,terpenoid biosynthetic process,BP,
5774,GO:0016115,1,0.942021171665993,0,6,terpenoid catabolic process,BP,
5775,GO:0016116,1,0.993055936423407,0,1,carotenoid metabolic process,BP,
5776,GO:0016119,1,0.993055936423407,0,1,carotene metabolic process,BP,
5777,GO:0016121,1,0.993055936423407,0,1,carotene catabolic process,BP,
5778,GO:0016122,1,0.993055936423407,0,1,xanthophyll metabolic process,BP,
5781,GO:0016127,1,0.912327013918818,0,11,sterol catabolic process,BP,
5788,GO:0016149,1,0.984460811137354,0,3,translation release factor activity, codon specific,MF,
5789,GO:0016151,1,0.978970131301934,0,2,nickel cation binding,MF,
5790,GO:0016153,1,0.995527620496782,0,1,urocanate hydratase activity,MF,
5791,GO:0016154,1,0.988389825126606,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5792,GO:0016155,1,0.994441719443852,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5793,GO:0016160,1,0.94626461984961,0,6,amylase activity,MF,
5794,GO:0016165,1,0.982844981502259,0,2,linoleate 13S-lipoxygenase activity,MF,
5795,GO:0016167,1,0.981885107460038,0,3,glial cell-derived neurotrophic factor receptor activity,MF,
5796,GO:0016174,1,0.979547827316047,0,6,NAD(P)H oxidase activity,MF,
5797,GO:0016175,1,0.936514901189293,0,9,superoxide-generating NADPH oxidase activity,MF,
5798,GO:0016176,1,0.946118790256647,0,7,superoxide-generating NADPH oxidase activator activity,MF,
5799,GO:0016180,1,0.884548997522952,0,18,snRNA processing,BP,
5800,GO:0016182,1,0.99969043436888,0,1,synaptic vesicle budding from endosome,BP,
5801,GO:0016185,1,0.994957679099695,0,2,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5802,GO:0016188,1,0.953958187720458,0,9,synaptic vesicle maturation,BP,
5803,GO:0016189,1,0.999999996384669,0,1,synaptic vesicle to endosome fusion,BP,
5804,GO:0016191,1,0.983030168214314,0,5,synaptic vesicle uncoating,BP,
5807,GO:0016198,1,0.971331170268661,0,7,axon choice point recognition,BP,
5808,GO:0016199,1,0.987190363163088,0,5,axon midline choice point recognition,BP,
5810,GO:0016203,1,0.999999996380967,0,1,muscle attachment,BP,
5811,GO:0016206,1,0.98447983782341,0,2,catechol O-methyltransferase activity,MF,
5812,GO:0016208,1,0.910318252639027,0,11,AMP binding,MF,
5814,GO:0016211,1,0.998999378314394,0,2,ammonia ligase activity,MF,
5815,GO:0016212,1,0.981492339803558,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5816,GO:0016213,1,0.994504751513727,0,1,linoleoyl-CoA desaturase activity,MF,
5817,GO:0016215,1,0.986332656106821,0,3,acyl-CoA desaturase activity,MF,
5818,GO:0016222,1,0.984860050450808,0,2,procollagen-proline 4-dioxygenase complex,CC,
5819,GO:0016226,1,0.83548653192018,0,18,iron-sulfur cluster assembly,BP,
5821,GO:0016230,1,0.984277407258126,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5822,GO:0016231,1,0.999898639174517,0,1,beta-N-acetylglucosaminidase activity,MF,
5823,GO:0016232,1,0.99285381201371,0,1,HNK-1 sulfotransferase activity,MF,
5824,GO:0016233,1,0.67189385077944,0,53,telomere capping,BP,
5825,GO:0016234,1,0.672869739109004,0,75,inclusion body,CC,
5826,GO:0016235,1,0.811062911978812,0,38,aggresome,CC,
5828,GO:0016237,1,0.996601222492386,0,2,lysosomal microautophagy,BP,
5829,GO:0016239,1,0.763497897912987,0,55,positive regulation of macroautophagy,BP,
5830,GO:0016240,1,0.97779267719824,0,4,autophagosome docking,BP,
5832,GO:0016242,1,0.880317526523588,0,24,negative regulation of macroautophagy,BP,
5833,GO:0016243,1,0.998089224294264,0,1,regulation of autophagosome size,BP,
5834,GO:0016246,1,0.947490085238238,0,10,RNA interference,BP,
5836,GO:0016248,1,0.802171932292228,0,32,channel inhibitor activity,MF,
5837,GO:0016250,1,0.992629183230314,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5838,GO:0016254,1,0.880560428606362,0,15,preassembly of GPI anchor in ER membrane,BP,
5839,GO:0016255,1,0.950351222636286,0,7,attachment of GPI anchor to protein,BP,
5840,GO:0016256,1,0.987623868547276,0,2,N-glycan processing to lysosome,BP,
5841,GO:0016259,1,0.979551826336777,0,3,selenocysteine metabolic process,BP,
5842,GO:0016260,1,0.990378990484081,0,1,selenocysteine biosynthetic process,BP,
5843,GO:0016262,1,0.980713335946499,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5844,GO:0016263,1,0.9780875192962,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5845,GO:0016264,1,0.939623275672669,0,12,gap junction assembly,BP,
5846,GO:0016266,1,0.742410697740433,0,55,O-glycan processing,BP,
5847,GO:0016267,1,0.9780875192962,0,2,O-glycan processing, core 1,BP,
5848,GO:0016269,1,0.991357709386186,0,1,O-glycan processing, core 3,BP,
5849,GO:0016272,1,0.91628250581631,0,7,prefoldin complex,CC,
5850,GO:0016273,1,0.906865970562224,0,11,arginine N-methyltransferase activity,MF,
5851,GO:0016274,1,0.906865970562224,0,11,protein-arginine N-methyltransferase activity,MF,
5852,GO:0016277,1,0.990969801322254,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5853,GO:0016278,1,0.805500892396946,0,43,lysine N-methyltransferase activity,MF,
5854,GO:0016279,1,0.812288483486637,0,42,protein-lysine N-methyltransferase activity,MF,
5855,GO:0016281,1,0.953079917129144,0,9,eukaryotic translation initiation factor 4F complex,CC,
5856,GO:0016282,1,0.999258300656869,0,1,eukaryotic 43S preinitiation complex,CC,
5857,GO:0016286,1,0.963702637057576,0,4,small conductance calcium-activated potassium channel activity,MF,
5858,GO:0016287,1,0.992256212297251,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5860,GO:0016290,1,0.901833405686348,0,10,palmitoyl-CoA hydrolase activity,MF,
5861,GO:0016295,1,0.98864394026523,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5862,GO:0016296,1,0.98864394026523,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5863,GO:0016297,1,0.98864394026523,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5865,GO:0016300,1,0.976344505072597,0,4,tRNA (uracil) methyltransferase activity,MF,
5869,GO:0016308,1,0.974576639043665,0,7,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5870,GO:0016309,1,0.991871113493999,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5873,GO:0016312,1,0.982969298327448,0,4,inositol bisphosphate phosphatase activity,MF,
5874,GO:0016314,1,0.988573390227408,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5875,GO:0016316,1,0.998354845830292,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5876,GO:0016320,1,0.987653175528754,0,2,endoplasmic reticulum membrane fusion,BP,
5877,GO:0016321,1,0.975382657199539,0,3,female meiosis chromosome segregation,BP,
5878,GO:0016322,1,0.947767855428647,0,10,neuron remodeling,BP,
5879,GO:0016323,1,0.355452038071197,0,201,basolateral plasma membrane,CC,
5880,GO:0016324,1,0.234906826434328,0,274,apical plasma membrane,CC,
5881,GO:0016327,1,0.870493120488396,0,18,apicolateral plasma membrane,CC,
5882,GO:0016328,1,0.763349872554175,0,52,lateral plasma membrane,CC,
5883,GO:0016331,1,0.467821413477259,0,145,morphogenesis of embryonic epithelium,BP,
5884,GO:0016332,1,0.997776321818463,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5885,GO:0016333,1,0.993455758084661,0,1,morphogenesis of follicular epithelium,BP,
5886,GO:0016334,1,0.993455758084661,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5888,GO:0016338,1,0.809748914033974,0,23,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,
5889,GO:0016339,1,0.890733543220639,0,28,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5890,GO:0016340,1,0.999999541905886,0,2,calcium-dependent cell-matrix adhesion,BP,
5891,GO:0016342,1,0.971624842286896,0,9,catenin complex,CC,
5892,GO:0016344,1,0.990247193766058,0,3,meiotic chromosome movement towards spindle pole,BP,
5893,GO:0016358,1,0.478899336588507,0,194,dendrite development,BP,
5894,GO:0016361,1,0.981007027367178,0,4,activin receptor activity, type I,MF,
5895,GO:0016362,1,0.999999992808467,0,2,activin receptor activity, type II,MF,
5897,GO:0016401,1,0.980293990284556,0,2,palmitoyl-CoA oxidase activity,MF,
5898,GO:0016402,1,0.974737373599874,0,3,pristanoyl-CoA oxidase activity,MF,
5899,GO:0016403,1,0.985846127200513,0,2,dimethylargininase activity,MF,
5900,GO:0016404,1,0.991810504892804,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5906,GO:0016410,1,0.498501705469278,0,100,N-acyltransferase activity,MF,
5907,GO:0016411,1,0.848712563823807,0,26,acylglycerol O-acyltransferase activity,MF,
5908,GO:0016412,1,0.988387359903205,0,1,serine O-acyltransferase activity,MF,
5909,GO:0016413,1,0.95162883733141,0,7,O-acetyltransferase activity,MF,
5910,GO:0016414,1,0.99496725467276,0,1,O-octanoyltransferase activity,MF,
5911,GO:0016415,1,0.98236400084332,0,2,octanoyltransferase activity,MF,
5913,GO:0016417,1,0.81929815153137,0,30,S-acyltransferase activity,MF,
5914,GO:0016418,1,0.998993926167025,0,2,S-acetyltransferase activity,MF,
5915,GO:0016419,1,0.989223933345086,0,2,S-malonyltransferase activity,MF,
5916,GO:0016420,1,0.989223933345086,0,2,malonyltransferase activity,MF,
5917,GO:0016421,1,0.96894608923341,0,6,CoA carboxylase activity,MF,
5918,GO:0016422,1,0.979165371128543,0,2,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5919,GO:0016423,1,0.914877383502689,0,11,tRNA (guanine) methyltransferase activity,MF,
5920,GO:0016426,1,0.975637760022813,0,3,tRNA (adenine) methyltransferase activity,MF,
5921,GO:0016427,1,0.945174954051202,0,7,tRNA (cytosine) methyltransferase activity,MF,
5922,GO:0016428,1,0.973305310208166,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5923,GO:0016429,1,0.975637760022813,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5924,GO:0016433,1,0.941703005361982,0,6,rRNA (adenine) methyltransferase activity,MF,
5925,GO:0016434,1,0.99149550635737,0,2,rRNA (cytosine) methyltransferase activity,MF,
5926,GO:0016435,1,0.988765795927979,0,2,rRNA (guanine) methyltransferase activity,MF,
5927,GO:0016441,1,0.716984830826407,0,65,posttranscriptional gene silencing,BP,
5928,GO:0016442,1,0.951407640929898,0,10,RISC complex,CC,
5929,GO:0016444,1,0.728154208419538,0,52,somatic cell DNA recombination,BP,
5930,GO:0016445,1,0.731669327384321,0,48,somatic diversification of immunoglobulins,BP,
5931,GO:0016446,1,0.928495725033243,0,11,somatic hypermutation of immunoglobulin genes,BP,
5932,GO:0016447,1,0.757286868464966,0,43,somatic recombination of immunoglobulin gene segments,BP,
5934,GO:0016454,1,0.970199421241041,0,5,C-palmitoyltransferase activity,MF,
5935,GO:0016458,1,0.169971024247078,0,248,gene silencing,BP,
5936,GO:0016459,1,0.786066226525228,0,70,myosin complex,CC,
5937,GO:0016460,1,0.880636593868052,0,33,myosin II complex,CC,
5938,GO:0016461,1,0.960304675392701,0,10,unconventional myosin complex,CC,
5940,GO:0016469,1,0.619798031182556,0,46,proton-transporting two-sector ATPase complex,CC,
5941,GO:0016471,1,0.871169273723117,0,16,vacuolar proton-transporting V-type ATPase complex,CC,
5942,GO:0016476,1,0.983225428185324,0,3,regulation of embryonic cell shape,BP,
5944,GO:0016479,1,0.976766211139001,0,4,negative regulation of transcription from RNA polymerase I promoter,BP,
5945,GO:0016480,1,0.9686059986045,0,3,negative regulation of transcription from RNA polymerase III promoter,BP,
5948,GO:0016486,1,0.783620453758035,0,32,peptide hormone processing,BP,
5949,GO:0016487,1,0.975984983276443,0,2,farnesol metabolic process,BP,
5950,GO:0016488,1,0.975984983276443,0,2,farnesol catabolic process,BP,
5952,GO:0016492,1,0.986735710908828,0,2,G-protein coupled neurotensin receptor activity,MF,
5953,GO:0016493,1,0.903558714643886,0,11,C-C chemokine receptor activity,MF,
5954,GO:0016494,1,0.934312804219035,0,7,C-X-C chemokine receptor activity,MF,
5955,GO:0016495,1,0.994620898870946,0,1,C-X3-C chemokine receptor activity,MF,
5956,GO:0016496,1,0.994976822420577,0,1,substance P receptor activity,MF,
5957,GO:0016497,1,0.991021361472952,0,1,substance K receptor activity,MF,
5958,GO:0016499,1,0.978342028919127,0,2,orexin receptor activity,MF,
5959,GO:0016500,1,0.933206262440317,0,11,protein-hormone receptor activity,MF,
5960,GO:0016501,1,0.989691635042332,0,1,prostacyclin receptor activity,MF,
5962,GO:0016503,1,0.951051662473761,0,4,pheromone receptor activity,MF,
5965,GO:0016507,1,0.993994126631451,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5966,GO:0016508,1,0.984109392752023,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5967,GO:0016509,1,0.975886961703444,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5968,GO:0016514,1,0.922879896990498,0,15,SWI/SNF complex,CC,
5969,GO:0016517,1,0.989351484000675,0,1,interleukin-12 receptor activity,MF,
5970,GO:0016519,1,0.98951254738286,0,1,gastric inhibitory peptide receptor activity,MF,
5971,GO:0016520,1,0.962656600147288,0,4,growth hormone-releasing hormone receptor activity,MF,
5972,GO:0016521,1,0.994574958817842,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5973,GO:0016525,1,0.670642015674606,0,70,negative regulation of angiogenesis,BP,
5976,GO:0016530,1,0.96210805157519,0,5,metallochaperone activity,MF,
5977,GO:0016531,1,0.962108062571485,0,4,copper chaperone activity,MF,
5978,GO:0016532,1,0.987317673364274,0,2,superoxide dismutase copper chaperone activity,MF,
5979,GO:0016533,1,0.976501264546531,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5980,GO:0016534,1,0.988857555805227,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5981,GO:0016538,1,0.773573906171976,0,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5982,GO:0016539,1,0.977949577856796,0,2,intein-mediated protein splicing,BP,
5983,GO:0016540,1,0.934142434987001,0,11,protein autoprocessing,BP,
5984,GO:0016553,1,0.937284405732182,0,10,base conversion or substitution editing,BP,
5985,GO:0016554,1,0.965601432983185,0,4,cytidine to uridine editing,BP,
5987,GO:0016557,1,0.969385749837484,0,3,peroxisome membrane biogenesis,BP,
5988,GO:0016558,1,0.926854239465706,0,12,protein import into peroxisome matrix,BP,
5989,GO:0016559,1,0.924125888243127,0,9,peroxisome fission,BP,
5990,GO:0016560,1,0.990443348642908,0,3,protein import into peroxisome matrix, docking,BP,
5991,GO:0016561,1,0.985353954023169,0,2,protein import into peroxisome matrix, translocation,BP,
5993,GO:0016569,1,0.0608222587612203,0,516,covalent chromatin modification,BP,
5994,GO:0016570,1,0.10601542894445,0,410,histone modification,BP,
5995,GO:0016571,1,0.536129930973101,0,121,histone methylation,BP,
5996,GO:0016572,1,0.794025675618911,0,34,histone phosphorylation,BP,
5997,GO:0016573,1,0.42472236273859,0,138,histone acetylation,BP,
5998,GO:0016574,1,0.834010965751981,0,39,histone ubiquitination,BP,
5999,GO:0016575,1,0.647801448694421,0,80,histone deacetylation,BP,
6000,GO:0016576,1,0.969127826605468,0,6,histone dephosphorylation,BP,
6001,GO:0016577,1,0.955656003616804,0,26,histone demethylation,BP,
6002,GO:0016578,1,0.897792397436994,0,21,histone deubiquitination,BP,
6004,GO:0016580,1,0.943093629721796,0,13,Sin3 complex,CC,
6005,GO:0016581,1,0.932712581085614,0,17,NuRD complex,CC,
6006,GO:0016584,1,0.935639644809945,0,8,nucleosome positioning,BP,
6007,GO:0016586,1,0.999248125788628,0,1,RSC complex,CC,
6008,GO:0016589,1,0.970887898451875,0,7,NURF complex,CC,
6009,GO:0016590,1,0.999999996372516,0,1,ACF complex,CC,
6010,GO:0016591,1,0.488132365908338,0,100,DNA-directed RNA polymerase II, holoenzyme,CC,
6011,GO:0016592,1,0.783180106905927,0,35,mediator complex,CC,
6012,GO:0016593,1,0.965623324761454,0,7,Cdc73/Paf1 complex,CC,
6013,GO:0016594,1,0.907660875145067,0,15,glycine binding,MF,
6015,GO:0016596,1,0.991657600429728,0,1,thienylcyclohexylpiperidine binding,MF,
6017,GO:0016598,1,0.979163282480674,0,2,protein arginylation,BP,
6018,GO:0016600,1,0.969310134170989,0,9,flotillin complex,CC,
6019,GO:0016601,1,0.892518230494806,0,30,Rac protein signal transduction,BP,
6020,GO:0016602,1,0.973461318437917,0,4,CCAAT-binding factor complex,CC,
6021,GO:0016603,1,0.978605219953114,0,2,glutaminyl-peptide cyclotransferase activity,MF,
6023,GO:0016605,1,0.602548464167974,0,95,PML body,CC,
6025,GO:0016608,1,0.97452274509185,0,2,growth hormone-releasing hormone activity,MF,
6029,GO:0016618,1,0.987611508885694,0,1,hydroxypyruvate reductase activity,MF,
6030,GO:0016620,1,0.780030410874217,0,35,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
6032,GO:0016624,1,0.948724889266586,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
6035,GO:0016634,1,0.929339579549451,0,9,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
6036,GO:0016635,1,0.956587621395279,0,4,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
6037,GO:0016638,1,0.879702199817214,0,19,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
6038,GO:0016639,1,0.97470507487792,0,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
6039,GO:0016641,1,0.916461563044976,0,14,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
6040,GO:0016642,1,0.997473039359802,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
6042,GO:0016646,1,0.898478997269095,0,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
6043,GO:0016647,1,0.96946691785433,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
6046,GO:0016652,1,0.986970375668874,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
6047,GO:0016653,1,0.926493450336927,0,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,
6048,GO:0016655,1,0.549768183190583,0,51,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
6049,GO:0016657,1,0.977207284934417,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
6050,GO:0016661,1,0.9620206666359,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
6051,GO:0016662,1,0.991848723520862,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
6053,GO:0016668,1,0.864670262760157,0,15,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
6054,GO:0016670,1,0.966150517987033,0,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
6056,GO:0016672,1,0.975410002324126,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
6059,GO:0016679,1,0.90835217502796,0,9,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
6060,GO:0016681,1,0.915792845222807,0,8,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
6062,GO:0016701,1,0.796365088188117,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
6063,GO:0016702,1,0.806116426268504,0,24,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
6066,GO:0016708,1,0.980749240685432,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6067,GO:0016709,1,0.774982442430132,0,35,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,
6068,GO:0016711,1,0.991880798145084,0,1,flavonoid 3'-monooxygenase activity,MF,
6069,GO:0016712,1,0.802809735566492,0,25,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6072,GO:0016715,1,0.981997946494906,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
6073,GO:0016716,1,0.982845943893475,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen,MF,
6075,GO:0016721,1,0.94287197946958,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6077,GO:0016723,1,0.970272507637727,0,8,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
6078,GO:0016724,1,0.973767604195594,0,6,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
6081,GO:0016727,1,0.999999912924884,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6082,GO:0016728,1,0.989994992422479,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
6083,GO:0016730,1,0.989060321771781,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6084,GO:0016731,1,0.989060321771781,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6087,GO:0016742,1,0.944504082297377,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6088,GO:0016743,1,0.9883653122649,0,2,carboxyl- or carbamoyltransferase activity,MF,
6089,GO:0016744,1,0.962716780689046,0,4,transferase activity, transferring aldehyde or ketonic groups,MF,
6092,GO:0016748,1,0.97345013694169,0,3,succinyltransferase activity,MF,
6093,GO:0016749,1,0.980286760280229,0,2,N-succinyltransferase activity,MF,
6094,GO:0016751,1,0.993026991574692,0,1,S-succinyltransferase activity,MF,
6095,GO:0016755,1,0.816498845593985,0,22,transferase activity, transferring amino-acyl groups,MF,
6100,GO:0016768,1,0.988470401723811,0,1,spermine synthase activity,MF,
6101,GO:0016769,1,0.857712912664085,0,19,transferase activity, transferring nitrogenous groups,MF,
6104,GO:0016774,1,0.975581760926898,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6105,GO:0016775,1,0.916216333112431,0,13,phosphotransferase activity, nitrogenous group as acceptor,MF,
6106,GO:0016776,1,0.774884742270556,0,39,phosphotransferase activity, phosphate group as acceptor,MF,
6107,GO:0016778,1,0.941082579066607,0,6,diphosphotransferase activity,MF,
6109,GO:0016780,1,0.884920634405738,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6110,GO:0016781,1,0.982300988070447,0,2,phosphotransferase activity, paired acceptors,MF,
6111,GO:0016782,1,0.572368889772808,0,69,transferase activity, transferring sulfur-containing groups,MF,
6112,GO:0016783,1,0.886798695843775,0,11,sulfurtransferase activity,MF,
6113,GO:0016784,1,0.987983996453764,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6114,GO:0016785,1,0.999998627511705,0,1,transferase activity, transferring selenium-containing groups,MF,
6119,GO:0016793,1,0.994717449770596,0,1,triphosphoric monoester hydrolase activity,MF,
6120,GO:0016794,1,0.987401019283895,0,1,diphosphoric monoester hydrolase activity,MF,
6121,GO:0016796,1,0.74001263659201,0,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6123,GO:0016799,1,0.809812586588905,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6124,GO:0016801,1,0.9129529671942,0,9,hydrolase activity, acting on ether bonds,MF,
6125,GO:0016802,1,0.990500696840587,0,1,trialkylsulfonium hydrolase activity,MF,
6126,GO:0016803,1,0.921714239065089,0,8,ether hydrolase activity,MF,
6130,GO:0016812,1,0.97385749656546,0,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6131,GO:0016813,1,0.916885750511071,0,11,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6132,GO:0016814,1,0.769601675013043,0,33,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6133,GO:0016815,1,0.987791238169804,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6137,GO:0016822,1,0.964811221211259,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6138,GO:0016823,1,0.964811221211259,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6139,GO:0016826,1,0.992629183230314,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6142,GO:0016831,1,0.774196872889923,0,32,carboxy-lyase activity,MF,
6144,GO:0016833,1,0.959929314035058,0,4,oxo-acid-lyase activity,MF,
6148,GO:0016840,1,0.920024024458323,0,9,carbon-nitrogen lyase activity,MF,
6149,GO:0016841,1,0.951903257030602,0,5,ammonia-lyase activity,MF,
6150,GO:0016842,1,0.974655480701728,0,3,amidine-lyase activity,MF,
6151,GO:0016843,1,0.991657600429728,0,1,amine-lyase activity,MF,
6152,GO:0016844,1,0.991657600429728,0,1,strictosidine synthase activity,MF,
6154,GO:0016849,1,0.95169586149969,0,20,phosphorus-oxygen lyase activity,MF,
6156,GO:0016854,1,0.908399524262218,0,13,racemase and epimerase activity,MF,
6157,GO:0016855,1,0.991300277190173,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6158,GO:0016857,1,0.948802306967898,0,9,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6159,GO:0016859,1,0.675131980344885,0,40,cis-trans isomerase activity,MF,
6162,GO:0016862,1,0.987167312885023,0,1,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6164,GO:0016864,1,0.897312160791585,0,18,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6166,GO:0016868,1,0.911037483961761,0,10,intramolecular transferase activity, phosphotransferases,MF,
6167,GO:0016872,1,0.990383019076429,0,1,intramolecular lyase activity,MF,
6169,GO:0016875,1,0.724855149671407,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6170,GO:0016876,1,0.724855149671407,0,44,ligase activity, forming aminoacyl-tRNA and related compounds,MF,
6173,GO:0016879,1,0.765110095057196,0,47,ligase activity, forming carbon-nitrogen bonds,MF,
6174,GO:0016880,1,0.998999378314394,0,2,acid-ammonia (or amide) ligase activity,MF,
6175,GO:0016881,1,0.89724348114049,0,17,acid-amino acid ligase activity,MF,
6176,GO:0016882,1,0.98321608118766,0,2,cyclo-ligase activity,MF,
6177,GO:0016884,1,0.95084596272387,0,9,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6179,GO:0016886,1,0.948608103681761,0,8,ligase activity, forming phosphoric ester bonds,MF,
6181,GO:0016888,1,0.931277215989299,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6182,GO:0016889,1,0.894539800777569,0,12,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6183,GO:0016890,1,0.987172628206875,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6184,GO:0016891,1,0.803683055816118,0,26,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6185,GO:0016892,1,0.900803146524943,0,9,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6186,GO:0016893,1,0.76207482142761,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6187,GO:0016894,1,0.805729910717847,0,21,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6188,GO:0016895,1,0.86999983936392,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6189,GO:0016896,1,0.839951441389103,0,30,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6191,GO:0016899,1,0.97428259300115,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6192,GO:0016900,1,0.974977891951901,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6193,GO:0016901,1,0.974448727434071,0,5,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6195,GO:0016907,1,0.959319879203053,0,5,G-protein coupled acetylcholine receptor activity,MF,
6196,GO:0016909,1,0.984847732640816,0,3,SAP kinase activity,MF,
6197,GO:0016913,1,0.989124303259853,0,1,follicle-stimulating hormone activity,MF,
6198,GO:0016917,1,0.888157329690283,0,22,GABA receptor activity,MF,
6200,GO:0016920,1,0.999999996379168,0,1,pyroglutamyl-peptidase activity,MF,
6201,GO:0016922,1,0.910977080741522,0,21,ligand-dependent nuclear receptor binding,MF,
6202,GO:0016925,1,0.617804302303403,0,88,protein sumoylation,BP,
6203,GO:0016926,1,0.97214002674105,0,7,protein desumoylation,BP,
6204,GO:0016929,1,0.97214002674105,0,7,SUMO-specific protease activity,MF,
6205,GO:0016933,1,0.963834429584998,0,5,extracellular-glycine-gated ion channel activity,MF,
6206,GO:0016934,1,0.963834429584998,0,5,extracellular-glycine-gated chloride channel activity,MF,
6207,GO:0016935,1,0.990629756715121,0,2,glycine-gated chloride channel complex,CC,
6209,GO:0016938,1,0.993514131208701,0,1,kinesin I complex,CC,
6210,GO:0016939,1,0.993794234363604,0,3,kinesin II complex,CC,
6211,GO:0016941,1,0.986617208194041,0,3,natriuretic peptide receptor activity,MF,
6212,GO:0016942,1,0.969250103730787,0,5,insulin-like growth factor binding protein complex,CC,
6213,GO:0016964,1,0.999999996418861,0,1,alpha-2 macroglobulin receptor activity,MF,
6214,GO:0016971,1,0.983892512166828,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6215,GO:0016972,1,0.983515002724089,0,4,thiol oxidase activity,MF,
6216,GO:0016973,1,0.910770955851436,0,14,poly(A)+ mRNA export from nucleus,BP,
6217,GO:0016979,1,0.976437801029822,0,2,lipoate-protein ligase activity,MF,
6218,GO:0016990,1,0.990435569307827,0,1,arginine deiminase activity,MF,
6219,GO:0016992,1,0.988425931795391,0,1,lipoate synthase activity,MF,
6220,GO:0016997,1,0.943509091490088,0,6,alpha-sialidase activity,MF,
6221,GO:0016998,1,0.962367930711644,0,3,cell wall macromolecule catabolic process,BP,
6222,GO:0016999,1,0.988354108247528,0,2,antibiotic metabolic process,BP,
6223,GO:0017002,1,0.980950334472955,0,7,activin-activated receptor activity,MF,
6224,GO:0017003,1,0.990484368788493,0,1,protein-heme linkage,BP,
6225,GO:0017004,1,0.798384944664535,0,26,cytochrome complex assembly,BP,
6226,GO:0017005,1,0.996749693893663,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6227,GO:0017006,1,0.990484368788493,0,1,protein-tetrapyrrole linkage,BP,
6228,GO:0017014,1,0.939085960926164,0,12,protein nitrosylation,BP,
6229,GO:0017015,1,0.58530690296446,0,97,regulation of transforming growth factor beta receptor signaling pathway,BP,
6231,GO:0017017,1,0.897905485523006,0,13,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6232,GO:0017018,1,0.999742798060919,0,4,myosin phosphatase activity,MF,
6233,GO:0017020,1,0.993101808989047,0,1,myosin phosphatase regulator activity,MF,
6236,GO:0017025,1,0.845851311407394,0,23,TBP-class protein binding,MF,
6237,GO:0017034,1,0.988946358008886,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6240,GO:0017042,1,0.98844867478336,0,2,glycosylceramidase activity,MF,
6241,GO:0017045,1,0.987660701412748,0,1,corticotropin-releasing hormone activity,MF,
6243,GO:0017048,1,0.709048398197012,0,83,Rho GTPase binding,MF,
6244,GO:0017049,1,0.903444176494195,0,16,GTP-Rho binding,MF,
6245,GO:0017050,1,0.982597699920338,0,2,D-erythro-sphingosine kinase activity,MF,
6246,GO:0017053,1,0.667342419529981,0,85,transcriptional repressor complex,CC,
6247,GO:0017055,1,0.986853646557491,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6248,GO:0017056,1,0.9261960298941,0,19,structural constituent of nuclear pore,MF,
6249,GO:0017057,1,0.987392457309959,0,2,6-phosphogluconolactonase activity,MF,
6250,GO:0017059,1,0.938878111621206,0,8,serine C-palmitoyltransferase complex,CC,
6251,GO:0017060,1,0.973839424695995,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6252,GO:0017061,1,0.999771662688709,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6253,GO:0017062,1,0.956018062314132,0,5,respiratory chain complex III assembly,BP,
6254,GO:0017064,1,0.979332370597168,0,2,fatty acid amide hydrolase activity,MF,
6255,GO:0017065,1,0.988176356328653,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6256,GO:0017069,1,0.757434594014344,0,33,snRNA binding,MF,
6257,GO:0017070,1,0.926035921180715,0,9,U6 snRNA binding,MF,
6258,GO:0017071,1,0.996797784838846,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6259,GO:0017075,1,0.92070502602857,0,19,syntaxin-1 binding,MF,
6261,GO:0017077,1,0.966759004002607,0,3,oxidative phosphorylation uncoupler activity,MF,
6263,GO:0017081,1,0.891987560024212,0,17,chloride channel regulator activity,MF,
6264,GO:0017084,1,0.99599416017826,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6266,GO:0017089,1,0.967827735967848,0,3,glycolipid transporter activity,MF,
6267,GO:0017090,1,0.993443602256647,0,1,meprin A complex,CC,
6268,GO:0017091,1,0.869354725248856,0,23,AU-rich element binding,MF,
6269,GO:0017095,1,0.997184500034296,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6270,GO:0017096,1,0.987750629389171,0,1,acetylserotonin O-methyltransferase activity,MF,
6271,GO:0017098,1,0.982525105460383,0,2,sulfonylurea receptor binding,MF,
6272,GO:0017099,1,0.983997311025264,0,2,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6273,GO:0017101,1,0.929183867295102,0,11,aminoacyl-tRNA synthetase multienzyme complex,CC,
6274,GO:0017102,1,0.986166989768344,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6275,GO:0017108,1,0.956844994061457,0,6,5'-flap endonuclease activity,MF,
6276,GO:0017109,1,0.991218873510729,0,2,glutamate-cysteine ligase complex,CC,
6277,GO:0017110,1,0.896713604468375,0,13,nucleoside-diphosphatase activity,MF,
6279,GO:0017112,1,0.783725522112241,0,49,Rab guanyl-nucleotide exchange factor activity,MF,
6280,GO:0017113,1,0.994359198959087,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6281,GO:0017116,1,0.987713594040574,0,2,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6282,GO:0017119,1,0.922344180352599,0,13,Golgi transport complex,CC,
6283,GO:0017121,1,0.921297817567423,0,12,phospholipid scrambling,BP,
6284,GO:0017124,1,0.550123075332408,0,118,SH3 domain binding,MF,
6285,GO:0017125,1,0.999611445974899,0,1,deoxycytidyl transferase activity,MF,
6286,GO:0017126,1,0.999964771003143,0,1,nucleologenesis,BP,
6288,GO:0017128,1,0.935847901439085,0,10,phospholipid scramblase activity,MF,
6289,GO:0017129,1,0.985775450082407,0,2,triglyceride binding,MF,
6291,GO:0017134,1,0.89544841229389,0,23,fibroblast growth factor binding,MF,
6292,GO:0017136,1,0.916198056172603,0,15,NAD-dependent histone deacetylase activity,MF,
6295,GO:0017144,1,0.766669610215489,0,32,drug metabolic process,BP,
6296,GO:0017145,1,0.850027517558356,0,34,stem cell division,BP,
6297,GO:0017146,1,0.989803933031678,0,10,NMDA selective glutamate receptor complex,CC,
6298,GO:0017147,1,0.848236971082455,0,30,Wnt-protein binding,MF,
6300,GO:0017150,1,0.968282936754602,0,3,tRNA dihydrouridine synthase activity,MF,
6301,GO:0017151,1,0.956342851355156,0,8,DEAD/H-box RNA helicase binding,MF,
6302,GO:0017153,1,0.984236818201139,0,3,sodium:dicarboxylate symporter activity,MF,
6303,GO:0017154,1,0.986935600806151,0,11,semaphorin receptor activity,MF,
6307,GO:0017159,1,0.986883426684474,0,2,pantetheine hydrolase activity,MF,
6308,GO:0017160,1,0.945133683963438,0,13,Ral GTPase binding,MF,
6309,GO:0017161,1,0.998354845830292,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6310,GO:0017162,1,0.96063925466572,0,9,aryl hydrocarbon receptor binding,MF,
6311,GO:0017166,1,0.983591350660952,0,9,vinculin binding,MF,
6312,GO:0017168,1,0.998176618874935,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6313,GO:0017169,1,0.937196241411734,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6315,GO:0017172,1,0.988272808597456,0,1,cysteine dioxygenase activity,MF,
6316,GO:0017174,1,0.987424170039788,0,1,glycine N-methyltransferase activity,MF,
6317,GO:0017176,1,0.952433641807129,0,5,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6318,GO:0017177,1,0.997758871194876,0,1,glucosidase II complex,CC,
6319,GO:0017182,1,0.956081216918755,0,6,peptidyl-diphthamide metabolic process,BP,
6320,GO:0017183,1,0.956081216918755,0,6,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6321,GO:0017185,1,0.982494030164694,0,4,peptidyl-lysine hydroxylation,BP,
6322,GO:0017186,1,0.978605219953114,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6323,GO:0017187,1,0.899209622099602,0,11,peptidyl-glutamic acid carboxylation,BP,
6324,GO:0017188,1,0.999999996371761,0,1,aspartate N-acetyltransferase activity,MF,
6325,GO:0017196,1,0.967514705627952,0,6,N-terminal peptidyl-methionine acetylation,BP,
6326,GO:0017198,1,0.975495328343631,0,2,N-terminal peptidyl-serine acetylation,BP,
6327,GO:0018002,1,0.975495328343631,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6328,GO:0018003,1,0.974841409688905,0,2,peptidyl-lysine N6-acetylation,BP,
6329,GO:0018008,1,0.999578904349101,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6330,GO:0018009,1,0.989887861919443,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6331,GO:0018011,1,0.991657600429728,0,1,N-terminal peptidyl-alanine methylation,BP,
6332,GO:0018012,1,0.991657600429728,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6333,GO:0018013,1,0.991657600429728,0,1,N-terminal peptidyl-glycine methylation,BP,
6334,GO:0018016,1,0.991657600429728,0,1,N-terminal peptidyl-proline dimethylation,BP,
6335,GO:0018022,1,0.611266414418839,0,102,peptidyl-lysine methylation,BP,
6336,GO:0018023,1,0.851938327455966,0,32,peptidyl-lysine trimethylation,BP,
6337,GO:0018024,1,0.854477653412959,0,35,histone-lysine N-methyltransferase activity,MF,
6338,GO:0018025,1,0.991657600429728,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6339,GO:0018026,1,0.959962714226731,0,6,peptidyl-lysine monomethylation,BP,
6340,GO:0018027,1,0.910183770177763,0,15,peptidyl-lysine dimethylation,BP,
6341,GO:0018032,1,0.997095912840533,0,1,protein amidation,BP,
6342,GO:0018057,1,0.994378626543239,0,1,peptidyl-lysine oxidation,BP,
6343,GO:0018063,1,0.990484368788493,0,1,cytochrome c-heme linkage,BP,
6344,GO:0018065,1,0.90900851891886,0,8,protein-cofactor linkage,BP,
6345,GO:0018076,1,0.99942895401949,0,4,N-terminal peptidyl-lysine acetylation,BP,
6346,GO:0018094,1,0.995706269082892,0,1,protein polyglycylation,BP,
6347,GO:0018095,1,0.95506879942623,0,8,protein polyglutamylation,BP,
6348,GO:0018101,1,0.972803310963447,0,5,protein citrullination,BP,
6350,GO:0018105,1,0.202755885743655,0,272,peptidyl-serine phosphorylation,BP,
6351,GO:0018106,1,0.9872138675537,0,1,peptidyl-histidine phosphorylation,BP,
6352,GO:0018107,1,0.596081658016802,0,108,peptidyl-threonine phosphorylation,BP,
6354,GO:0018114,1,0.991300277190173,0,1,threonine racemase activity,MF,
6355,GO:0018117,1,0.988360455585529,0,1,protein adenylylation,BP,
6356,GO:0018119,1,0.939085960926164,0,12,peptidyl-cysteine S-nitrosylation,BP,
6357,GO:0018125,1,0.973036812153488,0,3,peptidyl-cysteine methylation,BP,
6358,GO:0018126,1,0.903675237322138,0,17,protein hydroxylation,BP,
6360,GO:0018146,1,0.838016272632835,0,28,keratan sulfate biosynthetic process,BP,
6362,GO:0018153,1,0.983217534687078,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6363,GO:0018158,1,0.917717049989907,0,9,protein oxidation,BP,
6364,GO:0018160,1,0.987973602728523,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6365,GO:0018169,1,0.988081464998003,0,1,ribosomal S6-glutamic acid ligase activity,MF,
6366,GO:0018171,1,0.97525987446115,0,3,peptidyl-cysteine oxidation,BP,
6367,GO:0018175,1,0.988360455585529,0,1,protein nucleotidylation,BP,
6368,GO:0018190,1,0.988387359903205,0,1,protein octanoylation,BP,
6369,GO:0018191,1,0.988387359903205,0,1,peptidyl-serine octanoylation,BP,
6370,GO:0018192,1,0.991186186932819,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6372,GO:0018194,1,0.991657600429728,0,1,peptidyl-alanine modification,BP,
6373,GO:0018195,1,0.827585858687552,0,23,peptidyl-arginine modification,BP,
6375,GO:0018197,1,0.994792571075334,0,3,peptidyl-aspartic acid modification,BP,
6376,GO:0018198,1,0.830332583232824,0,27,peptidyl-cysteine modification,BP,
6377,GO:0018199,1,0.962179021056301,0,4,peptidyl-glutamine modification,BP,
6378,GO:0018200,1,0.797382579733732,0,30,peptidyl-glutamic acid modification,BP,
6379,GO:0018201,1,0.991239986724273,0,3,peptidyl-glycine modification,BP,
6380,GO:0018202,1,0.943852298418624,0,8,peptidyl-histidine modification,BP,
6381,GO:0018205,1,0.132804491183781,0,342,peptidyl-lysine modification,BP,
6382,GO:0018206,1,0.913079658692993,0,12,peptidyl-methionine modification,BP,
6383,GO:0018208,1,0.630468208740929,0,50,peptidyl-proline modification,BP,
6384,GO:0018209,1,0.179881023311552,0,288,peptidyl-serine modification,BP,
6385,GO:0018210,1,0.586706119033168,0,112,peptidyl-threonine modification,BP,
6388,GO:0018214,1,0.899209622099602,0,11,protein carboxylation,BP,
6389,GO:0018216,1,0.880260603917273,0,15,peptidyl-arginine methylation,BP,
6390,GO:0018217,1,0.998089224294264,0,1,peptidyl-aspartic acid phosphorylation,BP,
6391,GO:0018230,1,0.961297137951942,0,6,peptidyl-L-cysteine S-palmitoylation,BP,
6392,GO:0018231,1,0.961297137951942,0,6,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6393,GO:0018242,1,0.983560009033186,0,4,protein O-linked glycosylation via serine,BP,
6394,GO:0018243,1,0.984335634035931,0,4,protein O-linked glycosylation via threonine,BP,
6395,GO:0018262,1,0.983217534687078,0,2,isopeptide cross-linking,BP,
6396,GO:0018271,1,0.999999996372699,0,1,biotin-protein ligase activity,MF,
6397,GO:0018272,1,0.988606833667475,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6398,GO:0018277,1,0.988261901363836,0,2,protein deamination,BP,
6400,GO:0018282,1,0.990863158439841,0,2,metal incorporation into metallo-sulfur cluster,BP,
6401,GO:0018283,1,0.990863158439841,0,2,iron incorporation into metallo-sulfur cluster,BP,
6402,GO:0018293,1,0.987570346932512,0,1,protein-FAD linkage,BP,
6403,GO:0018298,1,0.887262695715599,0,13,protein-chromophore linkage,BP,
6404,GO:0018307,1,0.97861477030014,0,2,enzyme active site formation,BP,
6405,GO:0018312,1,0.987096535645984,0,2,peptidyl-serine ADP-ribosylation,BP,
6406,GO:0018315,1,0.998807705642567,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6408,GO:0018323,1,0.98731767947796,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6409,GO:0018342,1,0.935776752093799,0,10,protein prenylation,BP,
6410,GO:0018343,1,0.974096670547764,0,3,protein farnesylation,BP,
6411,GO:0018344,1,0.949379745726575,0,7,protein geranylgeranylation,BP,
6412,GO:0018345,1,0.862050968863586,0,24,protein palmitoylation,BP,
6413,GO:0018350,1,0.990909953174646,0,1,protein esterification,BP,
6414,GO:0018352,1,0.979535583284151,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6415,GO:0018364,1,0.974855594862687,0,2,peptidyl-glutamine methylation,BP,
6416,GO:0018377,1,0.987869199326985,0,5,protein myristoylation,BP,
6417,GO:0018393,1,0.403525118098383,0,143,internal peptidyl-lysine acetylation,BP,
6418,GO:0018394,1,0.389694381599871,0,148,peptidyl-lysine acetylation,BP,
6419,GO:0018395,1,0.996656886905039,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6420,GO:0018400,1,0.999999996376584,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6421,GO:0018401,1,0.967416769247293,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6423,GO:0018410,1,0.547927809844577,0,76,C-terminal protein amino acid modification,BP,
6424,GO:0018423,1,0.987683702481799,0,1,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6425,GO:0018444,1,0.99296916375608,0,2,translation release factor complex,CC,
6426,GO:0018455,1,0.987664834036443,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6427,GO:0018467,1,0.992046703873699,0,1,formaldehyde dehydrogenase activity,MF,
6428,GO:0018478,1,0.990074869994379,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6429,GO:0018479,1,0.978590841155819,0,2,benzaldehyde dehydrogenase (NAD+) activity,MF,
6430,GO:0018585,1,0.989988348401563,0,1,fluorene oxygenase activity,MF,
6431,GO:0018636,1,0.96387724550145,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6432,GO:0018675,1,0.977072571603811,0,2,(S)-limonene 6-monooxygenase activity,MF,
6433,GO:0018676,1,0.977072571603811,0,2,(S)-limonene 7-monooxygenase activity,MF,
6434,GO:0018685,1,0.96072238611255,0,4,alkane 1-monooxygenase activity,MF,
6435,GO:0018733,1,0.987554816056891,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6436,GO:0018738,1,0.987558366229859,0,1,S-formylglutathione hydrolase activity,MF,
6437,GO:0018773,1,0.988437274027011,0,1,acetylpyruvate hydrolase activity,MF,
6438,GO:0018872,1,0.991256272890253,0,1,arsonoacetate metabolic process,BP,
6439,GO:0018874,1,0.989604925449343,0,1,benzoate metabolic process,BP,
6441,GO:0018885,1,0.988414654182688,0,1,carbon tetrachloride metabolic process,BP,
6444,GO:0018910,1,0.988414654182688,0,1,benzene metabolic process,BP,
6445,GO:0018916,1,0.973788276380485,0,3,nitrobenzene metabolic process,BP,
6446,GO:0018917,1,0.989988348401563,0,1,fluorene metabolic process,BP,
6447,GO:0018931,1,0.976843812127721,0,2,naphthalene metabolic process,BP,
6450,GO:0018964,1,0.99883071476294,0,1,propylene metabolic process,BP,
6451,GO:0018969,1,0.993244562670755,0,1,thiocyanate metabolic process,BP,
6452,GO:0018979,1,0.988854032176888,0,1,trichloroethylene metabolic process,BP,
6453,GO:0018992,1,0.997803263224464,0,2,germ-line sex determination,BP,
6454,GO:0018993,1,0.987310091667007,0,2,somatic sex determination,BP,
6455,GO:0018995,1,0.929827396868119,0,14,host,CC,
6457,GO:0019002,1,0.98827818414799,0,2,GMP binding,MF,
6458,GO:0019003,1,0.642883630711298,0,57,GDP binding,MF,
6459,GO:0019005,1,0.717166048844559,0,50,SCF ubiquitin ligase complex,CC,
6460,GO:0019008,1,0.986459468945386,0,2,molybdopterin synthase complex,CC,
6461,GO:0019012,1,0.967042428965429,0,4,virion,CC,
6462,GO:0019028,1,0.991657600429728,0,1,viral capsid,CC,
6463,GO:0019031,1,0.975179379573793,0,3,viral envelope,CC,
6464,GO:0019034,1,0.998802850344494,0,2,viral replication complex,CC,
6465,GO:0019035,1,0.999999785707766,0,1,viral integration complex,CC,
6466,GO:0019042,1,0.926936286520474,0,11,viral latency,BP,
6467,GO:0019043,1,0.926936321677083,0,9,establishment of viral latency,BP,
6468,GO:0019045,1,0.999999992762435,0,2,latent virus replication,BP,
6469,GO:0019046,1,0.999999992762435,0,2,release from viral latency,BP,
6470,GO:0019048,1,0.824921379392359,0,35,modulation by virus of host morphology or physiology,BP,
6471,GO:0019049,1,0.982552635856931,0,3,evasion or tolerance of host defenses by virus,BP,
6472,GO:0019050,1,0.971520329920131,0,3,suppression by virus of host apoptotic process,BP,
6473,GO:0019054,1,0.873262177960285,0,22,modulation by virus of host process,BP,
6474,GO:0019056,1,0.993133224664389,0,1,modulation by virus of host transcription,BP,
6476,GO:0019060,1,0.962747994408797,0,5,intracellular transport of viral protein in host cell,BP,
6477,GO:0019061,1,0.990431515265201,0,1,uncoating of virus,BP,
6478,GO:0019062,1,0.950782098636875,0,8,virion attachment to host cell,BP,
6479,GO:0019064,1,0.952220543243637,0,6,fusion of virus membrane with host plasma membrane,BP,
6480,GO:0019065,1,0.986613154868855,0,3,receptor-mediated endocytosis of virus by host cell,BP,
6481,GO:0019068,1,0.746135123020973,0,37,virion assembly,BP,
6482,GO:0019072,1,0.998139493305638,0,2,viral genome packaging,BP,
6483,GO:0019074,1,0.998139493305638,0,2,viral RNA genome packaging,BP,
6484,GO:0019075,1,0.983384249277821,0,2,virus maturation,BP,
6485,GO:0019076,1,0.801666730291599,0,35,viral release from host cell,BP,
6487,GO:0019080,1,0.183474566581132,0,185,viral gene expression,BP,
6488,GO:0019081,1,0.92774655692835,0,10,viral translation,BP,
6489,GO:0019082,1,0.99862035898038,0,1,viral protein processing,BP,
6490,GO:0019083,1,0.198232602457539,0,174,viral transcription,BP,
6491,GO:0019085,1,0.994592246786332,0,2,early viral transcription,BP,
6492,GO:0019086,1,0.971845338044307,0,4,late viral transcription,BP,
6493,GO:0019087,1,0.978492972585626,0,3,transformation of host cell by virus,BP,
6494,GO:0019088,1,0.98821157638415,0,1,immortalization of host cell by virus,BP,
6495,GO:0019089,1,0.999999996375045,0,1,transmission of virus,BP,
6497,GO:0019100,1,0.997803263224464,0,2,male germ-line sex determination,BP,
6498,GO:0019101,1,0.993317306397642,0,1,female somatic sex determination,BP,
6499,GO:0019102,1,0.993952691954143,0,1,male somatic sex determination,BP,
6500,GO:0019103,1,0.956997967796153,0,5,pyrimidine nucleotide binding,MF,
6501,GO:0019104,1,0.860273727873203,0,14,DNA N-glycosylase activity,MF,
6502,GO:0019107,1,0.999578904349101,0,2,myristoyltransferase activity,MF,
6503,GO:0019113,1,0.977072571603811,0,2,limonene monooxygenase activity,MF,
6504,GO:0019115,1,0.989332793388196,0,1,benzaldehyde dehydrogenase activity,MF,
6505,GO:0019118,1,0.987791238169804,0,1,phenanthrene-epoxide hydrolase activity,MF,
6506,GO:0019119,1,0.987791238169804,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6507,GO:0019135,1,0.989024025633896,0,1,deoxyhypusine monooxygenase activity,MF,
6508,GO:0019136,1,0.967681767274403,0,4,deoxynucleoside kinase activity,MF,
6509,GO:0019144,1,0.975822523696297,0,2,ADP-sugar diphosphatase activity,MF,
6510,GO:0019145,1,0.991415393511459,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6511,GO:0019153,1,0.988240774746811,0,1,protein-disulfide reductase (glutathione) activity,MF,
6512,GO:0019158,1,0.988645220732919,0,4,mannokinase activity,MF,
6514,GO:0019171,1,0.999999996387332,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6516,GO:0019185,1,0.9916337984204,0,2,snRNA-activating protein complex,CC,
6517,GO:0019187,1,0.997875966464858,0,1,beta-1,4-mannosyltransferase activity,MF,
6518,GO:0019198,1,0.974724746406756,0,16,transmembrane receptor protein phosphatase activity,MF,
6519,GO:0019199,1,0.78767375405505,0,80,transmembrane receptor protein kinase activity,MF,
6520,GO:0019200,1,0.896640095610638,0,19,carbohydrate kinase activity,MF,
6521,GO:0019201,1,0.886589680210555,0,24,nucleotide kinase activity,MF,
6522,GO:0019202,1,0.99599416017826,0,1,amino acid kinase activity,MF,
6523,GO:0019203,1,0.93761224199469,0,9,carbohydrate phosphatase activity,MF,
6524,GO:0019205,1,0.718588101921253,0,47,nucleobase-containing compound kinase activity,MF,
6525,GO:0019206,1,0.893716483965722,0,13,nucleoside kinase activity,MF,
6526,GO:0019207,1,0.256514943683107,0,196,kinase regulator activity,MF,
6527,GO:0019208,1,0.586654745087986,0,81,phosphatase regulator activity,MF,
6528,GO:0019209,1,0.634473632057596,0,72,kinase activator activity,MF,
6529,GO:0019210,1,0.507343523407197,0,96,kinase inhibitor activity,MF,
6530,GO:0019211,1,0.935474155645264,0,10,phosphatase activator activity,MF,
6531,GO:0019212,1,0.766215826225251,0,35,phosphatase inhibitor activity,MF,
6532,GO:0019213,1,0.745276629932594,0,52,deacetylase activity,MF,
6533,GO:0019215,1,0.951574550932401,0,13,intermediate filament binding,MF,
6541,GO:0019226,1,0.681514862614756,0,68,transmission of nerve impulse,BP,
6542,GO:0019227,1,0.964595314711036,0,7,neuronal action potential propagation,BP,
6543,GO:0019228,1,0.86884360039207,0,33,neuronal action potential,BP,
6544,GO:0019229,1,0.686571703360549,0,58,regulation of vasoconstriction,BP,
6545,GO:0019230,1,0.985160477548707,0,4,proprioception,BP,
6546,GO:0019233,1,0.572358637306493,0,88,sensory perception of pain,BP,
6547,GO:0019236,1,0.926209751960327,0,7,response to pheromone,BP,
6548,GO:0019237,1,0.974151873075166,0,5,centromeric DNA binding,MF,
6549,GO:0019238,1,0.953574853876408,0,6,cyclohydrolase activity,MF,
6550,GO:0019239,1,0.804867765114299,0,27,deaminase activity,MF,
6551,GO:0019240,1,0.984405636388551,0,5,citrulline biosynthetic process,BP,
6552,GO:0019242,1,0.98970987048019,0,1,methylglyoxal biosynthetic process,BP,
6553,GO:0019243,1,0.981937353467284,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6554,GO:0019244,1,0.987637693758964,0,1,lactate biosynthetic process from pyruvate,BP,
6555,GO:0019249,1,0.975110922390686,0,3,lactate biosynthetic process,BP,
6556,GO:0019254,1,0.976340284398531,0,3,carnitine metabolic process, CoA-linked,BP,
6557,GO:0019255,1,0.979421774916615,0,2,glucose 1-phosphate metabolic process,BP,
6558,GO:0019262,1,0.954011302078302,0,4,N-acetylneuraminate catabolic process,BP,
6559,GO:0019264,1,0.981587552150228,0,2,glycine biosynthetic process from serine,BP,
6560,GO:0019265,1,0.978699607330727,0,2,glycine biosynthetic process, by transamination of glyoxylate,BP,
6561,GO:0019276,1,0.979984980390478,0,3,UDP-N-acetylgalactosamine metabolic process,BP,
6562,GO:0019285,1,0.993164318148533,0,2,glycine betaine biosynthetic process from choline,BP,
6563,GO:0019287,1,0.966489025140862,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6565,GO:0019303,1,0.975288069721652,0,2,D-ribose catabolic process,BP,
6566,GO:0019310,1,0.987923818244243,0,1,inositol catabolic process,BP,
6567,GO:0019317,1,0.959518021845812,0,9,fucose catabolic process,BP,
6571,GO:0019321,1,0.881986486251226,0,12,pentose metabolic process,BP,
6572,GO:0019322,1,0.957990768695539,0,4,pentose biosynthetic process,BP,
6573,GO:0019323,1,0.951014501707943,0,5,pentose catabolic process,BP,
6574,GO:0019336,1,0.938558345056718,0,9,phenol-containing compound catabolic process,BP,
6575,GO:0019341,1,0.991880798145084,0,1,dibenzo-p-dioxin catabolic process,BP,
6576,GO:0019343,1,0.980547697425261,0,2,cysteine biosynthetic process via cystathionine,BP,
6577,GO:0019344,1,0.971531171412621,0,3,cysteine biosynthetic process,BP,
6578,GO:0019346,1,0.964886303300215,0,4,transsulfuration,BP,
6579,GO:0019348,1,0.957913581668343,0,5,dolichol metabolic process,BP,
6580,GO:0019355,1,0.986245185383385,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6584,GO:0019364,1,0.983446718798996,0,2,pyridine nucleotide catabolic process,BP,
6586,GO:0019368,1,0.965614615829925,0,5,fatty acid elongation, unsaturated fatty acid,BP,
6587,GO:0019369,1,0.646324433764024,0,51,arachidonic acid metabolic process,BP,
6589,GO:0019371,1,0.909490241458061,0,11,cyclooxygenase pathway,BP,
6591,GO:0019373,1,0.83009693795038,0,20,epoxygenase P450 pathway,BP,
6592,GO:0019374,1,0.953199552148299,0,6,galactolipid metabolic process,BP,
6593,GO:0019375,1,0.982080539609819,0,2,galactolipid biosynthetic process,BP,
6594,GO:0019376,1,0.981402872279555,0,2,galactolipid catabolic process,BP,
6597,GO:0019389,1,0.992032818988262,0,1,glucuronoside metabolic process,BP,
6598,GO:0019391,1,0.992032818988262,0,1,glucuronoside catabolic process,BP,
6600,GO:0019400,1,0.845204772770332,0,19,alditol metabolic process,BP,
6601,GO:0019401,1,0.960727982571901,0,5,alditol biosynthetic process,BP,
6602,GO:0019402,1,0.987789643859906,0,1,galactitol metabolic process,BP,
6603,GO:0019405,1,0.965623922352919,0,6,alditol catabolic process,BP,
6604,GO:0019406,1,0.987855476448624,0,1,hexitol biosynthetic process,BP,
6605,GO:0019407,1,0.991518053072052,0,1,hexitol catabolic process,BP,
6606,GO:0019408,1,0.999669220090892,0,1,dolichol biosynthetic process,BP,
6607,GO:0019413,1,0.992947411753955,0,2,acetate biosynthetic process,BP,
6608,GO:0019417,1,0.994100963140045,0,2,sulfur oxidation,BP,
6609,GO:0019418,1,0.9674032953472,0,3,sulfide oxidation,BP,
6610,GO:0019427,1,0.992947411753955,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6616,GO:0019441,1,0.935549783402997,0,7,tryptophan catabolic process to kynurenine,BP,
6617,GO:0019442,1,0.976632412739056,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6618,GO:0019448,1,0.968699122708754,0,3,L-cysteine catabolic process,BP,
6619,GO:0019464,1,0.975347329122971,0,3,glycine decarboxylation via glycine cleavage system,BP,
6620,GO:0019470,1,0.968377804592788,0,4,4-hydroxyproline catabolic process,BP,
6621,GO:0019471,1,0.924923096440605,0,10,4-hydroxyproline metabolic process,BP,
6622,GO:0019474,1,0.974489621694919,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6623,GO:0019477,1,0.974489621694919,0,4,L-lysine catabolic process,BP,
6624,GO:0019478,1,0.976673199303574,0,2,D-amino acid catabolic process,BP,
6625,GO:0019481,1,0.990334806597043,0,1,L-alanine catabolic process, by transamination,BP,
6626,GO:0019482,1,0.970596490746127,0,4,beta-alanine metabolic process,BP,
6627,GO:0019483,1,0.984065241864597,0,2,beta-alanine biosynthetic process,BP,
6629,GO:0019510,1,0.990500696840587,0,1,S-adenosylhomocysteine catabolic process,BP,
6630,GO:0019511,1,0.922837650530917,0,11,peptidyl-proline hydroxylation,BP,
6631,GO:0019516,1,0.979536734824884,0,2,lactate oxidation,BP,
6632,GO:0019518,1,0.988209352047045,0,1,L-threonine catabolic process to glycine,BP,
6633,GO:0019519,1,0.991518053072052,0,1,pentitol metabolic process,BP,
6634,GO:0019520,1,0.980955999894265,0,2,aldonic acid metabolic process,BP,
6635,GO:0019521,1,0.980955999894265,0,2,D-gluconate metabolic process,BP,
6636,GO:0019527,1,0.991518053072052,0,1,pentitol catabolic process,BP,
6638,GO:0019531,1,0.950278439262583,0,11,oxalate transmembrane transporter activity,MF,
6639,GO:0019532,1,0.93911021029182,0,12,oxalate transport,BP,
6642,GO:0019541,1,0.992947411753955,0,2,propionate metabolic process,BP,
6643,GO:0019542,1,0.992947411753955,0,2,propionate biosynthetic process,BP,
6644,GO:0019546,1,0.990435569307827,0,1,arginine deiminase pathway,BP,
6645,GO:0019547,1,0.987938355875487,0,1,arginine catabolic process to ornithine,BP,
6646,GO:0019550,1,0.981131492924872,0,2,glutamate catabolic process to aspartate,BP,
6647,GO:0019551,1,0.981131492924872,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6648,GO:0019556,1,0.969330750169307,0,4,histidine catabolic process to glutamate and formamide,BP,
6649,GO:0019557,1,0.969330750169307,0,4,histidine catabolic process to glutamate and formate,BP,
6650,GO:0019563,1,0.973886101406198,0,5,glycerol catabolic process,BP,
6651,GO:0019566,1,0.991657600429728,0,1,arabinose metabolic process,BP,
6652,GO:0019585,1,0.820989249370366,0,22,glucuronate metabolic process,BP,
6653,GO:0019605,1,0.989604925449343,0,1,butyrate metabolic process,BP,
6654,GO:0019614,1,0.948285650966606,0,8,catechol-containing compound catabolic process,BP,
6655,GO:0019626,1,0.96148768016258,0,5,short-chain fatty acid catabolic process,BP,
6656,GO:0019627,1,0.884480766959149,0,13,urea metabolic process,BP,
6658,GO:0019640,1,0.952643268976188,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6659,GO:0019659,1,0.993128389988697,0,1,glucose catabolic process to lactate,BP,
6660,GO:0019660,1,0.993128389988697,0,1,glycolytic fermentation,BP,
6661,GO:0019661,1,0.993128389988697,0,1,glucose catabolic process to lactate via pyruvate,BP,
6662,GO:0019673,1,0.921581166920778,0,7,GDP-mannose metabolic process,BP,
6664,GO:0019676,1,0.988965305490211,0,2,ammonia assimilation cycle,BP,
6665,GO:0019677,1,0.996070804472539,0,1,NAD catabolic process,BP,
6671,GO:0019706,1,0.834902057957336,0,26,protein-cysteine S-palmitoyltransferase activity,MF,
6672,GO:0019707,1,0.834902057957336,0,26,protein-cysteine S-acyltransferase activity,MF,
6673,GO:0019720,1,0.960387457232681,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6675,GO:0019724,1,0.464436360300352,0,100,B cell mediated immunity,BP,
6677,GO:0019730,1,0.408203810864814,0,79,antimicrobial humoral response,BP,
6678,GO:0019731,1,0.641758176573826,0,39,antibacterial humoral response,BP,
6679,GO:0019732,1,0.982566967774119,0,2,antifungal humoral response,BP,
6680,GO:0019740,1,0.973955433764689,0,4,nitrogen utilization,BP,
6681,GO:0019742,1,0.990980523232525,0,1,pentacyclic triterpenoid metabolic process,BP,
6682,GO:0019747,1,0.970726987586494,0,3,regulation of isoprenoid metabolic process,BP,
6684,GO:0019751,1,0.526251662135957,0,105,polyol metabolic process,BP,
6686,GO:0019755,1,0.917678998969561,0,10,one-carbon compound transport,BP,
6687,GO:0019763,1,0.950490517074301,0,5,immunoglobulin receptor activity,MF,
6688,GO:0019767,1,0.974855158789802,0,2,IgE receptor activity,MF,
6689,GO:0019770,1,0.988656439486428,0,1,IgG receptor activity,MF,
6690,GO:0019773,1,0.9054230168447,0,8,proteasome core complex, alpha-subunit complex,CC,
6691,GO:0019774,1,0.98722309555945,0,1,proteasome core complex, beta-subunit complex,CC,
6692,GO:0019776,1,0.981804081532364,0,3,Atg8 ligase activity,MF,
6693,GO:0019777,1,0.978506731025907,0,2,Atg12 transferase activity,MF,
6694,GO:0019778,1,0.999810766637014,0,1,Atg12 activating enzyme activity,MF,
6695,GO:0019780,1,0.999999996375515,0,1,FAT10 activating enzyme activity,MF,
6696,GO:0019781,1,0.978744103244375,0,2,NEDD8 activating enzyme activity,MF,
6697,GO:0019782,1,0.995342448684563,0,1,ISG15 activating enzyme activity,MF,
6698,GO:0019783,1,0.548436652067944,0,119,ubiquitin-like protein-specific protease activity,MF,
6699,GO:0019784,1,0.944679804534104,0,6,NEDD8-specific protease activity,MF,
6700,GO:0019785,1,0.98785689916779,0,2,ISG15-specific protease activity,MF,
6701,GO:0019787,1,0.082576186078085,0,443,ubiquitin-like protein transferase activity,MF,
6702,GO:0019788,1,0.952118286065636,0,5,NEDD8 transferase activity,MF,
6703,GO:0019789,1,0.895574372948956,0,16,SUMO transferase activity,MF,
6704,GO:0019798,1,0.965982322857432,0,4,procollagen-proline dioxygenase activity,MF,
6705,GO:0019799,1,0.991657600429728,0,1,tubulin N-acetyltransferase activity,MF,
6706,GO:0019800,1,0.957218107804569,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6707,GO:0019805,1,0.975676299635383,0,3,quinolinate biosynthetic process,BP,
6708,GO:0019807,1,0.987825325831458,0,1,aspartoacylase activity,MF,
6709,GO:0019808,1,0.972680327902762,0,3,polyamine binding,MF,
6710,GO:0019809,1,0.977542521994382,0,2,spermidine binding,MF,
6711,GO:0019810,1,0.995026999315685,0,1,putrescine binding,MF,
6712,GO:0019811,1,0.999334848714627,0,1,cocaine binding,MF,
6713,GO:0019814,1,0.954749122503829,0,5,immunoglobulin complex,CC,
6714,GO:0019815,1,0.975208838867476,0,3,B cell receptor complex,CC,
6716,GO:0019826,1,0.988888866325849,0,3,oxygen sensor activity,MF,
6717,GO:0019827,1,0.458397337825971,0,148,stem cell population maintenance,BP,
6718,GO:0019828,1,0.987166869671588,0,2,aspartic-type endopeptidase inhibitor activity,MF,
6719,GO:0019829,1,0.649980666424633,0,63,cation-transporting ATPase activity,MF,
6720,GO:0019834,1,0.952505496415863,0,4,phospholipase A2 inhibitor activity,MF,
6721,GO:0019835,1,0.746511056871539,0,31,cytolysis,BP,
6722,GO:0019836,1,0.98271366919633,0,2,hemolysis by symbiont of host erythrocytes,BP,
6723,GO:0019838,1,0.522309565168507,0,127,growth factor binding,MF,
6730,GO:0019855,1,0.921005358641768,0,8,calcium channel inhibitor activity,MF,
6731,GO:0019856,1,0.974996004789396,0,6,pyrimidine nucleobase biosynthetic process,BP,
6732,GO:0019857,1,0.999999996392571,0,1,5-methylcytosine metabolic process,BP,
6733,GO:0019858,1,0.984380506488929,0,3,cytosine metabolic process,BP,
6734,GO:0019859,1,0.974499838833233,0,3,thymine metabolic process,BP,
6735,GO:0019860,1,0.972665627306212,0,3,uracil metabolic process,BP,
6736,GO:0019862,1,0.976229033603631,0,2,IgA binding,MF,
6737,GO:0019863,1,0.943189138001388,0,5,IgE binding,MF,
6738,GO:0019864,1,0.885187495995535,0,11,IgG binding,MF,
6739,GO:0019865,1,0.802050876891616,0,21,immunoglobulin binding,MF,
6742,GO:0019869,1,0.950478528577055,0,9,chloride channel inhibitor activity,MF,
6743,GO:0019870,1,0.959495446059786,0,7,potassium channel inhibitor activity,MF,
6744,GO:0019871,1,0.982956762922999,0,5,sodium channel inhibitor activity,MF,
6745,GO:0019878,1,0.9930752448595,0,1,lysine biosynthetic process via aminoadipic acid,BP,
6747,GO:0019883,1,0.934637995311618,0,11,antigen processing and presentation of endogenous antigen,BP,
6749,GO:0019885,1,0.964821743316783,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6751,GO:0019887,1,0.290928827782276,0,176,protein kinase regulator activity,MF,
6752,GO:0019888,1,0.60853080394168,0,69,protein phosphatase regulator activity,MF,
6753,GO:0019894,1,0.855961695881465,0,35,kinesin binding,MF,
6754,GO:0019896,1,0.973606436345059,0,8,axonal transport of mitochondrion,BP,
6755,GO:0019897,1,0.39768936213664,0,147,extrinsic component of plasma membrane,CC,
6756,GO:0019898,1,0.222258619477289,0,254,extrinsic component of membrane,CC,
6760,GO:0019902,1,0.479988746553126,0,153,phosphatase binding,MF,
6761,GO:0019903,1,0.580895735496047,0,109,protein phosphatase binding,MF,
6763,GO:0019905,1,0.663838999270378,0,81,syntaxin binding,MF,
6764,GO:0019907,1,0.936359227284763,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6765,GO:0019908,1,0.890694106282474,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6766,GO:0019911,1,0.916886672964459,0,10,structural constituent of myelin sheath,MF,
6767,GO:0019912,1,0.980891599727264,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6769,GO:0019918,1,0.973977513751546,0,3,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6770,GO:0019919,1,0.964726042431534,0,4,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6772,GO:0019933,1,0.760428839205915,0,48,cAMP-mediated signaling,BP,
6773,GO:0019934,1,0.940851342552394,0,12,cGMP-mediated signaling,BP,
6774,GO:0019935,1,0.717184836132208,0,59,cyclic-nucleotide-mediated signaling,BP,
6776,GO:0019948,1,0.983488681572139,0,2,SUMO activating enzyme activity,MF,
6778,GO:0019955,1,0.554440060905636,0,91,cytokine binding,MF,
6779,GO:0019956,1,0.882753385038621,0,19,chemokine binding,MF,
6780,GO:0019957,1,0.941356896359594,0,7,C-C chemokine binding,MF,
6781,GO:0019958,1,0.968807898237178,0,5,C-X-C chemokine binding,MF,
6782,GO:0019959,1,0.983513963453668,0,3,interleukin-8 binding,MF,
6783,GO:0019960,1,0.991630472818562,0,5,C-X3-C chemokine binding,MF,
6784,GO:0019961,1,0.995980582244765,0,2,interferon binding,MF,
6785,GO:0019962,1,0.999999996373196,0,1,type I interferon binding,MF,
6786,GO:0019964,1,0.995980586667751,0,1,interferon-gamma binding,MF,
6787,GO:0019966,1,0.949353590757274,0,8,interleukin-1 binding,MF,
6788,GO:0019969,1,0.997063867291121,0,1,interleukin-10 binding,MF,
6789,GO:0019970,1,0.994702982197217,0,1,interleukin-11 binding,MF,
6790,GO:0019972,1,0.97876844197789,0,2,interleukin-12 binding,MF,
6791,GO:0019975,1,0.9879166162612,0,1,interleukin-17 binding,MF,
6792,GO:0019976,1,0.981230785598278,0,3,interleukin-2 binding,MF,
6793,GO:0019981,1,0.993179381441076,0,2,interleukin-6 binding,MF,
6794,GO:0019983,1,0.989974988047088,0,1,interleukin-9 binding,MF,
6795,GO:0019985,1,0.787211516972478,0,38,translesion synthesis,BP,
6796,GO:0019988,1,0.992534180667998,0,1,charged-tRNA amino acid modification,BP,
6797,GO:0019992,1,0.961473759319377,0,11,diacylglycerol binding,MF,
6798,GO:0020003,1,0.992553151165099,0,1,symbiont-containing vacuole,CC,
6799,GO:0020005,1,0.992553151165099,0,1,symbiont-containing vacuole membrane,CC,
6800,GO:0020012,1,0.992340637996542,0,1,evasion or tolerance of host immune response,BP,
6801,GO:0020016,1,0.992488410414542,0,3,ciliary pocket,CC,
6802,GO:0020018,1,0.992488410414542,0,3,ciliary pocket membrane,CC,
6803,GO:0020021,1,0.98821157638415,0,1,immortalization of host cell,BP,
6804,GO:0020027,1,0.88580957834924,0,15,hemoglobin metabolic process,BP,
6806,GO:0021501,1,0.989702569287809,0,1,prechordal plate formation,BP,
6807,GO:0021502,1,0.986323313706448,0,3,neural fold elevation formation,BP,
6808,GO:0021503,1,0.999999996387096,0,1,neural fold bending,BP,
6809,GO:0021508,1,0.99999999637734,0,1,floor plate formation,BP,
6810,GO:0021509,1,0.989366833601249,0,1,roof plate formation,BP,
6811,GO:0021510,1,0.531747236744754,0,98,spinal cord development,BP,
6812,GO:0021511,1,0.871216238921095,0,23,spinal cord patterning,BP,
6813,GO:0021512,1,0.998782049583193,0,1,spinal cord anterior/posterior patterning,BP,
6814,GO:0021513,1,0.872279832465029,0,21,spinal cord dorsal/ventral patterning,BP,
6815,GO:0021514,1,0.902437801922367,0,16,ventral spinal cord interneuron differentiation,BP,
6816,GO:0021515,1,0.689634052178699,0,52,cell differentiation in spinal cord,BP,
6817,GO:0021516,1,0.839598880394729,0,21,dorsal spinal cord development,BP,
6818,GO:0021517,1,0.739136445261258,0,44,ventral spinal cord development,BP,
6819,GO:0021519,1,0.987667601272536,0,1,spinal cord association neuron specification,BP,
6820,GO:0021520,1,0.907747239684544,0,12,spinal cord motor neuron cell fate specification,BP,
6821,GO:0021521,1,0.932355527073915,0,10,ventral spinal cord interneuron specification,BP,
6822,GO:0021522,1,0.799795685011701,0,32,spinal cord motor neuron differentiation,BP,
6823,GO:0021523,1,0.958385600820104,0,5,somatic motor neuron differentiation,BP,
6824,GO:0021524,1,0.969668070781588,0,3,visceral motor neuron differentiation,BP,
6825,GO:0021526,1,0.979957689666053,0,2,medial motor column neuron differentiation,BP,
6826,GO:0021527,1,0.893695409081505,0,14,spinal cord association neuron differentiation,BP,
6827,GO:0021528,1,0.991657600429728,0,1,commissural neuron differentiation in spinal cord,BP,
6828,GO:0021529,1,0.972504519049614,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6829,GO:0021530,1,0.972504519049614,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6830,GO:0021532,1,0.784629750117084,0,38,neural tube patterning,BP,
6831,GO:0021533,1,0.905065557864137,0,19,cell differentiation in hindbrain,BP,
6832,GO:0021534,1,0.925525692086826,0,11,cell proliferation in hindbrain,BP,
6833,GO:0021535,1,0.937862630686914,0,14,cell migration in hindbrain,BP,
6834,GO:0021536,1,0.610833587380802,0,76,diencephalon development,BP,
6835,GO:0021537,1,0.294631663383512,0,235,telencephalon development,BP,
6836,GO:0021538,1,0.993677485690367,0,2,epithalamus development,BP,
6837,GO:0021539,1,0.978591936067044,0,2,subthalamus development,BP,
6838,GO:0021540,1,0.98405001917546,0,4,corpus callosum morphogenesis,BP,
6839,GO:0021541,1,0.9987065520523,0,1,ammon gyrus development,BP,
6840,GO:0021542,1,0.908991193541666,0,17,dentate gyrus development,BP,
6841,GO:0021543,1,0.444381734128382,0,161,pallium development,BP,
6842,GO:0021544,1,0.876794036440358,0,22,subpallium development,BP,
6844,GO:0021546,1,0.938794050664902,0,7,rhombomere development,BP,
6845,GO:0021547,1,0.989702569287809,0,1,midbrain-hindbrain boundary initiation,BP,
6846,GO:0021548,1,0.941390456523661,0,10,pons development,BP,
6847,GO:0021549,1,0.657841013933791,0,89,cerebellum development,BP,
6848,GO:0021550,1,0.985203989419791,0,2,medulla oblongata development,BP,
6849,GO:0021551,1,0.99045992881711,0,2,central nervous system morphogenesis,BP,
6850,GO:0021553,1,0.99198551658901,0,3,olfactory nerve development,BP,
6851,GO:0021554,1,0.935699303267366,0,12,optic nerve development,BP,
6852,GO:0021555,1,0.963292426855044,0,4,midbrain-hindbrain boundary morphogenesis,BP,
6853,GO:0021557,1,0.959429518231461,0,4,oculomotor nerve development,BP,
6854,GO:0021558,1,0.964057689696663,0,3,trochlear nerve development,BP,
6855,GO:0021559,1,0.933480563281548,0,11,trigeminal nerve development,BP,
6856,GO:0021560,1,0.986620065527455,0,2,abducens nerve development,BP,
6857,GO:0021561,1,0.945243552263429,0,10,facial nerve development,BP,
6858,GO:0021562,1,0.952764962563098,0,8,vestibulocochlear nerve development,BP,
6859,GO:0021563,1,0.977993649712589,0,5,glossopharyngeal nerve development,BP,
6860,GO:0021564,1,0.983856050313342,0,3,vagus nerve development,BP,
6861,GO:0021566,1,0.999788917175458,0,1,hypoglossal nerve development,BP,
6862,GO:0021568,1,0.976567724229782,0,2,rhombomere 2 development,BP,
6863,GO:0021569,1,0.970280221005771,0,3,rhombomere 3 development,BP,
6864,GO:0021570,1,0.975760949370152,0,2,rhombomere 4 development,BP,
6865,GO:0021571,1,0.976063573084503,0,3,rhombomere 5 development,BP,
6866,GO:0021572,1,0.995450489808144,0,1,rhombomere 6 development,BP,
6867,GO:0021575,1,0.818131707048021,0,38,hindbrain morphogenesis,BP,
6868,GO:0021576,1,0.990459934296563,0,1,hindbrain formation,BP,
6869,GO:0021577,1,0.98978909736774,0,2,hindbrain structural organization,BP,
6870,GO:0021578,1,0.973930496110075,0,6,hindbrain maturation,BP,
6871,GO:0021586,1,0.987701194520422,0,3,pons maturation,BP,
6872,GO:0021587,1,0.849451997569893,0,34,cerebellum morphogenesis,BP,
6873,GO:0021588,1,0.990459934296563,0,1,cerebellum formation,BP,
6874,GO:0021589,1,0.98978909736774,0,2,cerebellum structural organization,BP,
6875,GO:0021590,1,0.986059195434274,0,3,cerebellum maturation,BP,
6876,GO:0021591,1,0.889726951681115,0,26,ventricular system development,BP,
6877,GO:0021592,1,0.999951539130649,0,2,fourth ventricle development,BP,
6878,GO:0021593,1,0.981829668016865,0,2,rhombomere morphogenesis,BP,
6879,GO:0021594,1,0.993063175990633,0,1,rhombomere formation,BP,
6880,GO:0021598,1,0.986620065527455,0,2,abducens nerve morphogenesis,BP,
6881,GO:0021599,1,0.986620065527455,0,2,abducens nerve formation,BP,
6882,GO:0021602,1,0.858283781039924,0,27,cranial nerve morphogenesis,BP,
6883,GO:0021603,1,0.945927066088601,0,8,cranial nerve formation,BP,
6884,GO:0021604,1,0.94166182076978,0,10,cranial nerve structural organization,BP,
6885,GO:0021610,1,0.945243552263429,0,10,facial nerve morphogenesis,BP,
6886,GO:0021612,1,0.952855958338313,0,8,facial nerve structural organization,BP,
6887,GO:0021615,1,0.977993657633128,0,4,glossopharyngeal nerve morphogenesis,BP,
6888,GO:0021618,1,0.999788917175458,0,1,hypoglossal nerve morphogenesis,BP,
6889,GO:0021622,1,0.983733655322404,0,2,oculomotor nerve morphogenesis,BP,
6890,GO:0021623,1,0.983733655322404,0,2,oculomotor nerve formation,BP,
6891,GO:0021626,1,0.973930496110075,0,6,central nervous system maturation,BP,
6892,GO:0021631,1,0.987535538605583,0,6,optic nerve morphogenesis,BP,
6893,GO:0021633,1,0.98825649675123,0,2,optic nerve structural organization,BP,
6894,GO:0021634,1,0.998408769958625,0,1,optic nerve formation,BP,
6895,GO:0021636,1,0.983352800530488,0,5,trigeminal nerve morphogenesis,BP,
6896,GO:0021637,1,0.983352800530488,0,5,trigeminal nerve structural organization,BP,
6897,GO:0021639,1,0.988478122456043,0,1,trochlear nerve morphogenesis,BP,
6898,GO:0021642,1,0.988478122456043,0,1,trochlear nerve formation,BP,
6899,GO:0021644,1,0.983856057091943,0,2,vagus nerve morphogenesis,BP,
6900,GO:0021648,1,0.966157007847337,0,5,vestibulocochlear nerve morphogenesis,BP,
6901,GO:0021649,1,0.991322336389918,0,1,vestibulocochlear nerve structural organization,BP,
6902,GO:0021650,1,0.974616116827885,0,4,vestibulocochlear nerve formation,BP,
6903,GO:0021658,1,0.981829668016865,0,2,rhombomere 3 morphogenesis,BP,
6904,GO:0021660,1,0.993063175990633,0,1,rhombomere 3 formation,BP,
6905,GO:0021664,1,0.993063175990633,0,1,rhombomere 5 morphogenesis,BP,
6906,GO:0021666,1,0.993063175990633,0,1,rhombomere 5 formation,BP,
6907,GO:0021670,1,0.951170019310513,0,12,lateral ventricle development,BP,
6909,GO:0021678,1,0.987194598272239,0,3,third ventricle development,BP,
6910,GO:0021679,1,0.995262221554035,0,1,cerebellar molecular layer development,BP,
6911,GO:0021680,1,0.91114984297667,0,24,cerebellar Purkinje cell layer development,BP,
6912,GO:0021681,1,0.932511541875212,0,12,cerebellar granular layer development,BP,
6913,GO:0021682,1,0.999999545525632,0,1,nerve maturation,BP,
6914,GO:0021683,1,0.956073834846157,0,9,cerebellar granular layer morphogenesis,BP,
6915,GO:0021684,1,0.96536617617484,0,7,cerebellar granular layer formation,BP,
6916,GO:0021685,1,0.999999996380471,0,1,cerebellar granular layer structural organization,BP,
6917,GO:0021686,1,0.988345945209257,0,1,cerebellar granular layer maturation,BP,
6918,GO:0021687,1,0.995262221554035,0,1,cerebellar molecular layer morphogenesis,BP,
6919,GO:0021688,1,0.995262221554035,0,1,cerebellar molecular layer formation,BP,
6920,GO:0021691,1,0.997686504744307,0,2,cerebellar Purkinje cell layer maturation,BP,
6921,GO:0021692,1,0.953525349821821,0,13,cerebellar Purkinje cell layer morphogenesis,BP,
6922,GO:0021693,1,0.995262216996355,0,2,cerebellar Purkinje cell layer structural organization,BP,
6923,GO:0021694,1,0.958066026006189,0,10,cerebellar Purkinje cell layer formation,BP,
6924,GO:0021695,1,0.796619252918322,0,45,cerebellar cortex development,BP,
6925,GO:0021696,1,0.873272974034349,0,28,cerebellar cortex morphogenesis,BP,
6926,GO:0021697,1,0.901519662808213,0,20,cerebellar cortex formation,BP,
6927,GO:0021698,1,0.995262216996355,0,2,cerebellar cortex structural organization,BP,
6928,GO:0021699,1,0.986059195434274,0,3,cerebellar cortex maturation,BP,
6930,GO:0021702,1,0.958066026006189,0,10,cerebellar Purkinje cell differentiation,BP,
6931,GO:0021703,1,0.988478122456043,0,1,locus ceruleus development,BP,
6932,GO:0021707,1,0.96536617617484,0,7,cerebellar granule cell differentiation,BP,
6933,GO:0021718,1,0.988857555805227,0,2,superior olivary nucleus development,BP,
6934,GO:0021722,1,0.988857555805227,0,2,superior olivary nucleus maturation,BP,
6935,GO:0021723,1,0.993877124963719,0,1,medullary reticular formation development,BP,
6936,GO:0021730,1,0.994550756351644,0,2,trigeminal sensory nucleus development,BP,
6937,GO:0021732,1,0.990459934296563,0,1,midbrain-hindbrain boundary maturation,BP,
6938,GO:0021740,1,0.994550756351644,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6939,GO:0021747,1,0.99691577421356,0,3,cochlear nucleus development,BP,
6940,GO:0021750,1,0.991273856262465,0,1,vestibular nucleus development,BP,
6941,GO:0021754,1,0.9873751125871,0,1,facial nucleus development,BP,
6942,GO:0021756,1,0.924609059532611,0,16,striatum development,BP,
6943,GO:0021757,1,0.996749693893663,0,1,caudate nucleus development,BP,
6944,GO:0021758,1,0.996749693893663,0,1,putamen development,BP,
6945,GO:0021759,1,0.978818768404425,0,4,globus pallidus development,BP,
6946,GO:0021761,1,0.564871106337665,0,102,limbic system development,BP,
6947,GO:0021762,1,0.745555306849195,0,42,substantia nigra development,BP,
6948,GO:0021763,1,0.990270970834262,0,1,subthalamic nucleus development,BP,
6949,GO:0021764,1,0.989691450857527,0,4,amygdala development,BP,
6950,GO:0021766,1,0.665512874275423,0,76,hippocampus development,BP,
6951,GO:0021767,1,0.987949370612106,0,2,mammillary body development,BP,
6952,GO:0021768,1,0.996124621040254,0,1,nucleus accumbens development,BP,
6953,GO:0021769,1,0.979912865790506,0,4,orbitofrontal cortex development,BP,
6954,GO:0021771,1,0.999999721765981,0,1,lateral geniculate nucleus development,BP,
6955,GO:0021772,1,0.864095786878427,0,32,olfactory bulb development,BP,
6956,GO:0021773,1,0.990020894766442,0,3,striatal medium spiny neuron differentiation,BP,
6957,GO:0021775,1,0.999758315039978,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6958,GO:0021776,1,0.999758315039978,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6959,GO:0021778,1,0.97250451005781,0,4,oligodendrocyte cell fate specification,BP,
6960,GO:0021779,1,0.97250451005781,0,4,oligodendrocyte cell fate commitment,BP,
6961,GO:0021780,1,0.97250451005781,0,4,glial cell fate specification,BP,
6962,GO:0021781,1,0.924809104944824,0,12,glial cell fate commitment,BP,
6963,GO:0021782,1,0.585690012601042,0,83,glial cell development,BP,
6964,GO:0021783,1,0.896085082788017,0,16,preganglionic parasympathetic fiber development,BP,
6965,GO:0021784,1,0.982948012433398,0,2,postganglionic parasympathetic fiber development,BP,
6966,GO:0021785,1,0.983352786767969,0,7,branchiomotor neuron axon guidance,BP,
6967,GO:0021793,1,0.995697036542217,0,1,chemorepulsion of branchiomotor axon,BP,
6968,GO:0021794,1,0.908338616898489,0,15,thalamus development,BP,
6969,GO:0021795,1,0.814254143932274,0,42,cerebral cortex cell migration,BP,
6970,GO:0021796,1,0.968773139413797,0,5,cerebral cortex regionalization,BP,
6971,GO:0021797,1,0.957517119513812,0,5,forebrain anterior/posterior pattern specification,BP,
6972,GO:0021798,1,0.957259925155849,0,6,forebrain dorsal/ventral pattern formation,BP,
6973,GO:0021799,1,0.860457540546491,0,30,cerebral cortex radially oriented cell migration,BP,
6974,GO:0021800,1,0.979641154748661,0,8,cerebral cortex tangential migration,BP,
6975,GO:0021801,1,0.896090602187883,0,22,cerebral cortex radial glia guided migration,BP,
6976,GO:0021812,1,0.991803004907154,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6977,GO:0021813,1,0.991803010155503,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6978,GO:0021814,1,0.975911203148539,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6979,GO:0021815,1,0.986610915159375,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6980,GO:0021816,1,0.99165759515344,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
6981,GO:0021817,1,0.99491120658196,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6982,GO:0021819,1,0.938985243202185,0,12,layer formation in cerebral cortex,BP,
6983,GO:0021822,1,0.989904816120801,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6984,GO:0021823,1,0.999814809684911,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6985,GO:0021824,1,0.991321317877953,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6986,GO:0021825,1,0.991137718594995,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6987,GO:0021826,1,0.941334965836433,0,10,substrate-independent telencephalic tangential migration,BP,
6988,GO:0021827,1,0.999814809684911,0,2,postnatal olfactory bulb interneuron migration,BP,
6989,GO:0021828,1,0.991321317877953,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6990,GO:0021830,1,0.950055216635031,0,9,interneuron migration from the subpallium to the cortex,BP,
6991,GO:0021831,1,0.984011187706557,0,2,embryonic olfactory bulb interneuron precursor migration,BP,
6992,GO:0021836,1,0.999814809684911,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6993,GO:0021840,1,0.987847720770734,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6994,GO:0021842,1,0.987847720770734,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6995,GO:0021843,1,0.941334965836433,0,10,substrate-independent telencephalic tangential interneuron migration,BP,
6996,GO:0021846,1,0.874968348869233,0,27,cell proliferation in forebrain,BP,
6997,GO:0021847,1,0.989121291123338,0,3,ventricular zone neuroblast division,BP,
6998,GO:0021849,1,0.992803671823023,0,2,neuroblast division in subventricular zone,BP,
6999,GO:0021852,1,0.984012301405286,0,2,pyramidal neuron migration,BP,
7000,GO:0021853,1,0.966147455457638,0,6,cerebral cortex GABAergic interneuron migration,BP,
7001,GO:0021854,1,0.845508568516185,0,22,hypothalamus development,BP,
7002,GO:0021855,1,0.96984452593609,0,4,hypothalamus cell migration,BP,
7003,GO:0021856,1,0.991321317877953,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
7004,GO:0021858,1,0.987352494105513,0,1,GABAergic neuron differentiation in basal ganglia,BP,
7005,GO:0021859,1,0.966479369915304,0,10,pyramidal neuron differentiation,BP,
7006,GO:0021860,1,0.966479380079014,0,9,pyramidal neuron development,BP,
7007,GO:0021861,1,0.972014314126102,0,4,forebrain radial glial cell differentiation,BP,
7008,GO:0021869,1,0.975639904504366,0,6,forebrain ventricular zone progenitor cell division,BP,
7009,GO:0021870,1,0.999999996373144,0,1,Cajal-Retzius cell differentiation,BP,
7010,GO:0021871,1,0.84391552926112,0,23,forebrain regionalization,BP,
7011,GO:0021872,1,0.705577005606141,0,63,forebrain generation of neurons,BP,
7012,GO:0021873,1,0.971757308519548,0,8,forebrain neuroblast division,BP,
7013,GO:0021874,1,0.993409576390941,0,1,Wnt signaling pathway involved in forebrain neuroblast division,BP,
7014,GO:0021877,1,0.939747361243817,0,10,forebrain neuron fate commitment,BP,
7015,GO:0021879,1,0.725769948506212,0,55,forebrain neuron differentiation,BP,
7016,GO:0021881,1,0.995662366531996,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
7017,GO:0021882,1,0.981068936115031,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
7018,GO:0021884,1,0.856131376146333,0,31,forebrain neuron development,BP,
7019,GO:0021885,1,0.755662752915558,0,58,forebrain cell migration,BP,
7020,GO:0021886,1,0.991321317877953,0,2,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
7021,GO:0021888,1,0.991321317877953,0,2,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
7022,GO:0021889,1,0.938966604547558,0,13,olfactory bulb interneuron differentiation,BP,
7023,GO:0021891,1,0.97398925866223,0,8,olfactory bulb interneuron development,BP,
7024,GO:0021892,1,0.910352607988556,0,12,cerebral cortex GABAergic interneuron differentiation,BP,
7025,GO:0021893,1,0.981068936115031,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
7026,GO:0021894,1,0.94523097922713,0,8,cerebral cortex GABAergic interneuron development,BP,
7027,GO:0021895,1,0.865727184730776,0,22,cerebral cortex neuron differentiation,BP,
7028,GO:0021896,1,0.999970019653211,0,2,forebrain astrocyte differentiation,BP,
7029,GO:0021897,1,0.999970019653211,0,2,forebrain astrocyte development,BP,
7030,GO:0021898,1,0.976812773583224,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
7031,GO:0021902,1,0.971441310774665,0,6,commitment of neuronal cell to specific neuron type in forebrain,BP,
7032,GO:0021903,1,0.908132553914391,0,11,rostrocaudal neural tube patterning,BP,
7033,GO:0021904,1,0.878064267328163,0,23,dorsal/ventral neural tube patterning,BP,
7034,GO:0021910,1,0.982124757454906,0,7,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
7035,GO:0021912,1,0.975005328458827,0,2,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,
7036,GO:0021913,1,0.964209414118461,0,3,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,
7037,GO:0021914,1,0.981531186814122,0,4,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
7038,GO:0021915,1,0.45049834786974,0,155,neural tube development,BP,
7039,GO:0021919,1,0.996302219152977,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
7040,GO:0021920,1,0.987667601272536,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
7041,GO:0021924,1,0.93422743148344,0,10,cell proliferation in external granule layer,BP,
7042,GO:0021930,1,0.93422743148344,0,10,cerebellar granule cell precursor proliferation,BP,
7043,GO:0021932,1,0.949528261156305,0,10,hindbrain radial glia guided cell migration,BP,
7044,GO:0021933,1,0.988345945209257,0,1,radial glia guided migration of cerebellar granule cell,BP,
7045,GO:0021934,1,0.993877120154987,0,2,hindbrain tangential cell migration,BP,
7046,GO:0021935,1,0.999999996402979,0,1,cerebellar granule cell precursor tangential migration,BP,
7047,GO:0021936,1,0.941629249087289,0,10,regulation of cerebellar granule cell precursor proliferation,BP,
7048,GO:0021937,1,0.962087440064704,0,6,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
7049,GO:0021938,1,0.981467627987306,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
7050,GO:0021940,1,0.953371121803109,0,8,positive regulation of cerebellar granule cell precursor proliferation,BP,
7051,GO:0021941,1,0.98768848245067,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
7052,GO:0021942,1,0.971557673218055,0,5,radial glia guided migration of Purkinje cell,BP,
7053,GO:0021943,1,0.988856030943946,0,4,formation of radial glial scaffolds,BP,
7054,GO:0021952,1,0.953907708501542,0,22,central nervous system projection neuron axonogenesis,BP,
7055,GO:0021953,1,0.376894460566085,0,172,central nervous system neuron differentiation,BP,
7056,GO:0021954,1,0.730277383113639,0,70,central nervous system neuron development,BP,
7057,GO:0021955,1,0.920979276599811,0,28,central nervous system neuron axonogenesis,BP,
7058,GO:0021956,1,0.989390812753677,0,1,central nervous system interneuron axonogenesis,BP,
7059,GO:0021957,1,0.984308964483203,0,6,corticospinal tract morphogenesis,BP,
7060,GO:0021960,1,0.983130207045709,0,5,anterior commissure morphogenesis,BP,
7061,GO:0021965,1,0.999788909865739,0,3,spinal cord ventral commissure morphogenesis,BP,
7062,GO:0021966,1,0.98748191128279,0,2,corticospinal neuron axon guidance,BP,
7063,GO:0021972,1,0.999814813340433,0,1,corticospinal neuron axon guidance through spinal cord,BP,
7064,GO:0021978,1,0.913364981078486,0,11,telencephalon regionalization,BP,
7065,GO:0021979,1,0.967865302904753,0,6,hypothalamus cell differentiation,BP,
7066,GO:0021983,1,0.740262823960671,0,42,pituitary gland development,BP,
7067,GO:0021984,1,0.883676405450508,0,14,adenohypophysis development,BP,
7068,GO:0021985,1,0.990522206602202,0,2,neurohypophysis development,BP,
7069,GO:0021986,1,0.993677485690367,0,2,habenula development,BP,
7070,GO:0021987,1,0.599856045141534,0,107,cerebral cortex development,BP,
7071,GO:0021988,1,0.860107240734487,0,33,olfactory lobe development,BP,
7072,GO:0021993,1,0.999951542757745,0,1,initiation of neural tube closure,BP,
7073,GO:0021997,1,0.999999992758052,0,2,neural plate axis specification,BP,
7074,GO:0021998,1,0.996656886905039,0,1,neural plate mediolateral regionalization,BP,
7075,GO:0021999,1,0.96164292267542,0,6,neural plate anterior/posterior regionalization,BP,
7076,GO:0022004,1,0.990459934296563,0,1,midbrain-hindbrain boundary maturation during brain development,BP,
7077,GO:0022007,1,0.987299633608275,0,3,convergent extension involved in neural plate elongation,BP,
7079,GO:0022009,1,0.976674858172031,0,4,central nervous system vasculogenesis,BP,
7080,GO:0022010,1,0.895898993547735,0,15,central nervous system myelination,BP,
7081,GO:0022011,1,0.902855856108513,0,22,myelination in peripheral nervous system,BP,
7082,GO:0022012,1,0.999999996385791,0,1,subpallium cell proliferation in forebrain,BP,
7083,GO:0022013,1,0.999999996387745,0,1,pallium cell proliferation in forebrain,BP,
7084,GO:0022018,1,0.999999996385791,0,1,lateral ganglionic eminence cell proliferation,BP,
7085,GO:0022027,1,0.988179908978782,0,5,interkinetic nuclear migration,BP,
7086,GO:0022028,1,0.981682815787816,0,7,tangential migration from the subventricular zone to the olfactory bulb,BP,
7087,GO:0022029,1,0.763044942603773,0,55,telencephalon cell migration,BP,
7088,GO:0022030,1,0.896090602187883,0,22,telencephalon glial cell migration,BP,
7089,GO:0022037,1,0.623747426952495,0,98,metencephalon development,BP,
7090,GO:0022038,1,0.931187982100645,0,14,corpus callosum development,BP,
7091,GO:0022400,1,0.813748177825425,0,28,regulation of rhodopsin mediated signaling pathway,BP,
7092,GO:0022401,1,0.878550100943338,0,14,negative adaptation of signaling pathway,BP,
7096,GO:0022406,1,0.376161354988435,0,169,membrane docking,BP,
7098,GO:0022408,1,0.374258423592243,0,137,negative regulation of cell-cell adhesion,BP,
7104,GO:0022417,1,0.926202785029515,0,7,protein maturation by protein folding,BP,
7106,GO:0022601,1,0.992530815292856,0,2,menstrual cycle phase,BP,
7110,GO:0022605,1,0.955905017549245,0,6,oogenesis stage,BP,
7113,GO:0022612,1,0.527200622959505,0,120,gland morphogenesis,BP,
7115,GO:0022614,1,0.981078500265913,0,5,membrane to membrane docking,BP,
7116,GO:0022615,1,0.949923828563883,0,7,protein to membrane docking,BP,
7117,GO:0022616,1,0.88523366006503,0,22,DNA strand elongation,BP,
7118,GO:0022617,1,0.598332261150047,0,85,extracellular matrix disassembly,BP,
7120,GO:0022622,1,0.987233076566383,0,1,root system development,BP,
7121,GO:0022624,1,0.773147407862234,0,24,proteasome accessory complex,CC,
7122,GO:0022625,1,0.497662370220051,0,59,cytosolic large ribosomal subunit,CC,
7123,GO:0022626,1,0.285837037798561,0,111,cytosolic ribosome,CC,
7124,GO:0022627,1,0.611528565501544,0,44,cytosolic small ribosomal subunit,CC,
7127,GO:0022820,1,0.990925425698999,0,6,potassium ion symporter activity,MF,
7128,GO:0022821,1,0.934732160638245,0,16,potassium ion antiporter activity,MF,
7130,GO:0022829,1,0.831287021268863,0,21,wide pore channel activity,MF,
7131,GO:0022832,1,0.379378240232913,0,192,voltage-gated channel activity,MF,
7132,GO:0022833,1,0.952741334411772,0,8,mechanically gated channel activity,MF,
7137,GO:0022839,1,0.767008614949454,0,45,ion gated channel activity,MF,
7138,GO:0022840,1,0.954927613974519,0,7,leak channel activity,MF,
7139,GO:0022841,1,0.972576430952686,0,4,potassium ion leak channel activity,MF,
7140,GO:0022842,1,0.954927613974519,0,7,narrow pore channel activity,MF,
7141,GO:0022843,1,0.520291858398638,0,130,voltage-gated cation channel activity,MF,
7142,GO:0022848,1,0.87781450040849,0,16,acetylcholine-gated cation-selective channel activity,MF,
7143,GO:0022850,1,0.946168439684218,0,5,serotonin-gated cation-selective channel activity,MF,
7144,GO:0022851,1,0.97543152083821,0,5,GABA-gated chloride ion channel activity,MF,
7145,GO:0022852,1,0.991934402687944,0,2,glycine-gated chloride ion channel activity,MF,
7146,GO:0022853,1,0.506669995231621,0,124,active ion transmembrane transporter activity,MF,
7148,GO:0022858,1,0.963752643577068,0,7,alanine transmembrane transporter activity,MF,
7149,GO:0022865,1,0.993682139567738,0,1,transmembrane electron transfer carrier,MF,
7150,GO:0022884,1,0.838645627346267,0,20,macromolecule transmembrane transporter activity,MF,
7151,GO:0022889,1,0.923631969941499,0,9,serine transmembrane transporter activity,MF,
7155,GO:0022897,1,0.976859386159931,0,4,proton-dependent peptide secondary active transmembrane transporter activity,MF,
7160,GO:0023016,1,0.984220594825495,0,3,signal transduction by trans-phosphorylation,BP,
7161,GO:0023019,1,0.859664051106922,0,18,signal transduction involved in regulation of gene expression,BP,
7162,GO:0023021,1,0.974558081635831,0,3,termination of signal transduction,BP,
7163,GO:0023023,1,0.822094164977384,0,20,MHC protein complex binding,MF,
7164,GO:0023024,1,0.970565413459613,0,3,MHC class I protein complex binding,MF,
7165,GO:0023025,1,0.984898750958645,0,2,MHC class Ib protein complex binding,MF,
7166,GO:0023026,1,0.855497396820069,0,16,MHC class II protein complex binding,MF,
7167,GO:0023029,1,0.970296100351423,0,5,MHC class Ib protein binding,MF,
7168,GO:0023030,1,0.984898750958645,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7169,GO:0023035,1,0.947605659005994,0,8,CD40 signaling pathway,BP,
7170,GO:0023041,1,0.961235596843372,0,6,neuronal signal transduction,BP,
7175,GO:0023058,1,0.865888475281648,0,16,adaptation of signaling pathway,BP,
7178,GO:0030002,1,0.931565826291151,0,13,cellular anion homeostasis,BP,
7180,GO:0030004,1,0.524799158737409,0,106,cellular monovalent inorganic cation homeostasis,BP,
7181,GO:0030007,1,0.967268141891442,0,8,cellular potassium ion homeostasis,BP,
7182,GO:0030008,1,0.926188046076986,0,8,TRAPP complex,CC,
7183,GO:0030010,1,0.658406236652995,0,101,establishment of cell polarity,BP,
7184,GO:0030011,1,0.9123212881549,0,16,maintenance of cell polarity,BP,
7185,GO:0030014,1,0.926750440612195,0,15,CCR4-NOT complex,CC,
7186,GO:0030015,1,0.988285870181638,0,3,CCR4-NOT core complex,CC,
7189,GO:0030018,1,0.548327616920104,0,117,Z disc,CC,
7190,GO:0030020,1,0.980336032938106,0,6,extracellular matrix structural constituent conferring tensile strength,MF,
7191,GO:0030021,1,0.946291841753839,0,6,extracellular matrix structural constituent conferring compression resistance,MF,
7192,GO:0030023,1,0.995961216357289,0,5,extracellular matrix constituent conferring elasticity,MF,
7193,GO:0030027,1,0.466289109831895,0,172,lamellipodium,CC,
7197,GO:0030032,1,0.749966467095311,0,55,lamellipodium assembly,BP,
7198,GO:0030033,1,0.950669722694269,0,15,microvillus assembly,BP,
7199,GO:0030035,1,0.991843124874224,0,4,microspike assembly,BP,
7201,GO:0030037,1,0.999810086508596,0,1,actin filament reorganization involved in cell cycle,BP,
7202,GO:0030038,1,0.670698583033991,0,81,contractile actin filament bundle assembly,BP,
7205,GO:0030043,1,0.976410166350928,0,3,actin filament fragmentation,BP,
7206,GO:0030046,1,0.983912068833389,0,5,parallel actin filament bundle assembly,BP,
7207,GO:0030047,1,0.990640222703284,0,3,actin modification,BP,
7208,GO:0030048,1,0.595046815680371,0,119,actin filament-based movement,BP,
7209,GO:0030049,1,0.761023573591256,0,39,muscle filament sliding,BP,
7210,GO:0030050,1,0.995611876898987,0,4,vesicle transport along actin filament,BP,
7213,GO:0030056,1,0.999998684548847,0,6,hemidesmosome,CC,
7214,GO:0030057,1,0.946401225555365,0,25,desmosome,CC,
7217,GO:0030062,1,0.950085200628322,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7218,GO:0030070,1,0.979454697875975,0,3,insulin processing,BP,
7219,GO:0030071,1,0.746599132262877,0,44,regulation of mitotic metaphase/anaphase transition,BP,
7228,GO:0030103,1,0.981755365064236,0,2,vasopressin secretion,BP,
7229,GO:0030104,1,0.701674444688401,0,66,water homeostasis,BP,
7230,GO:0030107,1,0.993084902554068,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7231,GO:0030108,1,0.987983996453764,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7232,GO:0030109,1,0.982239228535834,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7233,GO:0030110,1,0.988254428359639,0,1,HLA-C specific inhibitory MHC class I receptor activity,MF,
7235,GO:0030117,1,0.621368330197572,0,91,membrane coat,CC,
7236,GO:0030118,1,0.801455343697427,0,48,clathrin coat,CC,
7237,GO:0030119,1,0.811154039342421,0,43,AP-type membrane coat adaptor complex,CC,
7238,GO:0030120,1,0.778892853161498,0,49,vesicle coat,CC,
7239,GO:0030121,1,0.963972173521886,0,6,AP-1 adaptor complex,CC,
7240,GO:0030122,1,0.945955107386533,0,13,AP-2 adaptor complex,CC,
7241,GO:0030123,1,0.964193319420886,0,10,AP-3 adaptor complex,CC,
7242,GO:0030125,1,0.89044155606876,0,24,clathrin vesicle coat,CC,
7243,GO:0030126,1,0.911562438481054,0,13,COPI vesicle coat,CC,
7244,GO:0030127,1,0.958577981769973,0,12,COPII vesicle coat,CC,
7245,GO:0030128,1,0.945496091358232,0,14,clathrin coat of endocytic vesicle,CC,
7246,GO:0030130,1,0.93341890957402,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7247,GO:0030131,1,0.874174298631968,0,30,clathrin adaptor complex,CC,
7248,GO:0030132,1,0.915767443198349,0,18,clathrin coat of coated pit,CC,
7250,GO:0030134,1,0.612241657539055,0,75,ER to Golgi transport vesicle,CC,
7252,GO:0030136,1,0.348048858020917,0,176,clathrin-coated vesicle,CC,
7253,GO:0030137,1,0.849850215507911,0,23,COPI-coated vesicle,CC,
7255,GO:0030140,1,0.8522543324035,0,29,trans-Golgi network transport vesicle,CC,
7257,GO:0030144,1,0.9809922693929,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
7259,GO:0030148,1,0.601445328936304,0,76,sphingolipid biosynthetic process,BP,
7261,GO:0030150,1,0.851221841309107,0,16,protein import into mitochondrial matrix,BP,
7262,GO:0030151,1,0.966877191906208,0,4,molybdenum ion binding,MF,
7265,GO:0030156,1,0.987216483009426,0,1,benzodiazepine receptor binding,MF,
7266,GO:0030157,1,0.913672364391619,0,13,pancreatic juice secretion,BP,
7267,GO:0030158,1,0.988124930638479,0,3,protein xylosyltransferase activity,MF,
7268,GO:0030159,1,0.891438285494668,0,24,receptor signaling complex scaffold activity,MF,
7269,GO:0030160,1,0.989019300774919,0,4,GKAP/Homer scaffold activity,MF,
7272,GO:0030165,1,0.686954768036967,0,84,PDZ domain binding,MF,
7274,GO:0030167,1,0.978177077312075,0,4,proteoglycan catabolic process,BP,
7275,GO:0030168,1,0.389629146438497,0,157,platelet activation,BP,
7276,GO:0030169,1,0.941849310302176,0,14,low-density lipoprotein particle binding,MF,
7278,GO:0030171,1,0.979879053217417,0,2,voltage-gated proton channel activity,MF,
7279,GO:0030172,1,0.962783647731415,0,3,troponin C binding,MF,
7280,GO:0030173,1,0.717289636148751,0,53,integral component of Golgi membrane,CC,
7281,GO:0030174,1,0.96598408831874,0,5,regulation of DNA-dependent DNA replication initiation,BP,
7282,GO:0030175,1,0.673786475285453,0,92,filopodium,CC,
7287,GO:0030183,1,0.468850112742402,0,113,B cell differentiation,BP,
7288,GO:0030184,1,0.992553151165099,0,1,nitric oxide transmembrane transporter activity,MF,
7289,GO:0030185,1,0.969779145559141,0,3,nitric oxide transport,BP,
7290,GO:0030186,1,0.975870396220124,0,2,melatonin metabolic process,BP,
7291,GO:0030187,1,0.975870396220124,0,2,melatonin biosynthetic process,BP,
7293,GO:0030194,1,0.838263375627702,0,24,positive regulation of blood coagulation,BP,
7294,GO:0030195,1,0.681950300353687,0,48,negative regulation of blood coagulation,BP,
7295,GO:0030197,1,0.986304316868613,0,3,extracellular matrix constituent, lubricant activity,MF,
7296,GO:0030198,1,0.2211794007766,0,306,extracellular matrix organization,BP,
7297,GO:0030199,1,0.866824802273126,0,37,collagen fibril organization,BP,
7298,GO:0030200,1,0.97836425418267,0,3,heparan sulfate proteoglycan catabolic process,BP,
7300,GO:0030202,1,0.98676707624582,0,8,heparin metabolic process,BP,
7304,GO:0030206,1,0.89688467161602,0,25,chondroitin sulfate biosynthetic process,BP,
7306,GO:0030208,1,0.942087322169462,0,12,dermatan sulfate biosynthetic process,BP,
7308,GO:0030210,1,0.98676707624582,0,8,heparin biosynthetic process,BP,
7310,GO:0030213,1,0.931785262250656,0,12,hyaluronan biosynthetic process,BP,
7312,GO:0030215,1,0.971475118135813,0,10,semaphorin receptor binding,MF,
7315,GO:0030218,1,0.558560735023974,0,94,erythrocyte differentiation,BP,
7316,GO:0030219,1,0.688258433630565,0,47,megakaryocyte differentiation,BP,
7317,GO:0030220,1,0.904640394600272,0,18,platelet formation,BP,
7318,GO:0030221,1,0.987819958112975,0,2,basophil differentiation,BP,
7319,GO:0030222,1,0.955821123530679,0,5,eosinophil differentiation,BP,
7320,GO:0030223,1,0.968469897065629,0,5,neutrophil differentiation,BP,
7321,GO:0030224,1,0.805687099593838,0,33,monocyte differentiation,BP,
7323,GO:0030226,1,0.999999992775708,0,2,apolipoprotein receptor activity,MF,
7324,GO:0030228,1,0.93611577836241,0,16,lipoprotein particle receptor activity,MF,
7325,GO:0030229,1,0.986948814485499,0,4,very-low-density lipoprotein particle receptor activity,MF,
7326,GO:0030233,1,0.988348355554348,0,1,deoxynucleotide transmembrane transporter activity,MF,
7328,GO:0030235,1,0.950859460419501,0,9,nitric-oxide synthase regulator activity,MF,
7329,GO:0030237,1,0.991080596716397,0,2,female sex determination,BP,
7330,GO:0030238,1,0.922841249646775,0,14,male sex determination,BP,
7331,GO:0030239,1,0.742221572417887,0,59,myofibril assembly,BP,
7332,GO:0030240,1,0.966777511825332,0,5,skeletal muscle thin filament assembly,BP,
7333,GO:0030241,1,0.98733561897938,0,3,skeletal muscle myosin thick filament assembly,BP,
7334,GO:0030242,1,0.989157295872914,0,4,pexophagy,BP,
7336,GO:0030247,1,0.84909796503167,0,21,polysaccharide binding,MF,
7337,GO:0030249,1,0.911699163007686,0,8,guanylate cyclase regulator activity,MF,
7338,GO:0030250,1,0.920444696320378,0,7,guanylate cyclase activator activity,MF,
7339,GO:0030251,1,0.990504783633364,0,1,guanylate cyclase inhibitor activity,MF,
7340,GO:0030252,1,0.907830815688391,0,15,growth hormone secretion,BP,
7342,GO:0030259,1,0.944251693104125,0,6,lipid glycosylation,BP,
7343,GO:0030260,1,0.480082825379397,0,124,entry into host cell,BP,
7344,GO:0030261,1,0.823555545614259,0,31,chromosome condensation,BP,
7345,GO:0030262,1,0.820515142827649,0,28,apoptotic nuclear changes,BP,
7346,GO:0030263,1,0.990308515666972,0,4,apoptotic chromosome condensation,BP,
7347,GO:0030264,1,0.998685659124255,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7348,GO:0030267,1,0.987611508885694,0,1,glyoxylate reductase (NADP) activity,MF,
7349,GO:0030272,1,0.987285749860684,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7350,GO:0030273,1,0.991034288807779,0,1,melanin-concentrating hormone receptor activity,MF,
7352,GO:0030275,1,0.894937985342747,0,17,LRR domain binding,MF,
7353,GO:0030276,1,0.766762895859913,0,58,clathrin binding,MF,
7355,GO:0030278,1,0.322052314171988,0,179,regulation of ossification,BP,
7356,GO:0030279,1,0.654819058524153,0,68,negative regulation of ossification,BP,
7358,GO:0030282,1,0.543994806487507,0,96,bone mineralization,BP,
7360,GO:0030284,1,0.982519146262744,0,4,estrogen receptor activity,MF,
7361,GO:0030285,1,0.917755932711157,0,15,integral component of synaptic vesicle membrane,CC,
7362,GO:0030286,1,0.78141984333377,0,47,dynein complex,CC,
7363,GO:0030289,1,0.973827604953798,0,3,protein phosphatase 4 complex,CC,
7364,GO:0030290,1,0.996472558544577,0,1,sphingolipid activator protein activity,MF,
7365,GO:0030291,1,0.772644117231643,0,33,protein serine/threonine kinase inhibitor activity,MF,
7366,GO:0030292,1,0.979220607299935,0,3,protein tyrosine kinase inhibitor activity,MF,
7367,GO:0030294,1,0.990166389245851,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7368,GO:0030295,1,0.66288961469426,0,65,protein kinase activator activity,MF,
7369,GO:0030296,1,0.923254771600653,0,17,protein tyrosine kinase activator activity,MF,
7370,GO:0030297,1,0.974845327850301,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7371,GO:0030298,1,0.987593738746098,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7372,GO:0030299,1,0.88443102956795,0,14,intestinal cholesterol absorption,BP,
7373,GO:0030300,1,0.93390716117899,0,7,regulation of intestinal cholesterol absorption,BP,
7375,GO:0030302,1,0.988348355554348,0,1,deoxynucleotide transport,BP,
7376,GO:0030305,1,0.987483375161367,0,2,heparanase activity,MF,
7377,GO:0030306,1,0.967283621483536,0,8,ADP-ribosylation factor binding,MF,
7378,GO:0030307,1,0.397544602964454,0,151,positive regulation of cell growth,BP,
7379,GO:0030308,1,0.340317045651878,0,155,negative regulation of cell growth,BP,
7380,GO:0030309,1,0.95789026654055,0,5,poly-N-acetyllactosamine metabolic process,BP,
7381,GO:0030311,1,0.962437816241179,0,4,poly-N-acetyllactosamine biosynthetic process,BP,
7382,GO:0030312,1,0.990318799438873,0,1,external encapsulating structure,CC,
7383,GO:0030314,1,0.984289905726474,0,7,junctional membrane complex,CC,
7384,GO:0030315,1,0.838864862189792,0,44,T-tubule,CC,
7385,GO:0030316,1,0.580109210479904,0,86,osteoclast differentiation,BP,
7387,GO:0030318,1,0.904008871032489,0,24,melanocyte differentiation,BP,
7388,GO:0030320,1,0.931565826291151,0,13,cellular monovalent inorganic anion homeostasis,BP,
7389,GO:0030321,1,0.962201721238709,0,5,transepithelial chloride transport,BP,
7390,GO:0030322,1,0.990298835585748,0,1,stabilization of membrane potential,BP,
7393,GO:0030325,1,0.860821546948863,0,20,adrenal gland development,BP,
7394,GO:0030326,1,0.521980879034007,0,122,embryonic limb morphogenesis,BP,
7395,GO:0030327,1,0.986155234391634,0,3,prenylated protein catabolic process,BP,
7396,GO:0030328,1,0.991595051950065,0,2,prenylcysteine catabolic process,BP,
7397,GO:0030329,1,0.991595051950065,0,2,prenylcysteine metabolic process,BP,
7398,GO:0030330,1,0.495835295744308,0,104,DNA damage response, signal transduction by p53 class mediator,BP,
7399,GO:0030331,1,0.831222014584892,0,38,estrogen receptor binding,MF,
7400,GO:0030332,1,0.8649225017708,0,24,cyclin binding,MF,
7403,GO:0030336,1,0.301768151601488,0,210,negative regulation of cell migration,BP,
7404,GO:0030337,1,0.979508860286396,0,2,DNA polymerase processivity factor activity,MF,
7405,GO:0030342,1,0.994589471351123,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7406,GO:0030343,1,0.981029900141319,0,2,vitamin D3 25-hydroxylase activity,MF,
7407,GO:0030345,1,0.946291841753839,0,6,structural constituent of tooth enamel,MF,
7408,GO:0030346,1,0.961033504048292,0,6,protein phosphatase 2B binding,MF,
7409,GO:0030348,1,0.987117587888555,0,3,syntaxin-3 binding,MF,
7410,GO:0030350,1,0.996394295562623,0,2,iron-responsive element binding,MF,
7411,GO:0030351,1,0.993002887673498,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7412,GO:0030354,1,0.987222696230163,0,1,melanin-concentrating hormone activity,MF,
7413,GO:0030366,1,0.976395647579627,0,2,molybdopterin synthase activity,MF,
7414,GO:0030368,1,0.956133449870195,0,8,interleukin-17 receptor activity,MF,
7415,GO:0030369,1,0.982302498005623,0,3,ICAM-3 receptor activity,MF,
7416,GO:0030371,1,0.904364097370266,0,24,translation repressor activity,MF,
7417,GO:0030372,1,0.999665261768254,0,1,high molecular weight B cell growth factor receptor binding,MF,
7418,GO:0030374,1,0.793154440571051,0,50,ligand-dependent nuclear receptor transcription coactivator activity,MF,
7419,GO:0030375,1,0.992772859486738,0,4,thyroid hormone receptor coactivator activity,MF,
7420,GO:0030377,1,0.987918412591761,0,1,urokinase plasminogen activator receptor activity,MF,
7421,GO:0030378,1,0.991300277190173,0,1,serine racemase activity,MF,
7422,GO:0030379,1,0.99999999637888,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7423,GO:0030380,1,0.987601932369141,0,1,interleukin-17E receptor binding,MF,
7424,GO:0030382,1,0.988602744255345,0,1,sperm mitochondrion organization,BP,
7425,GO:0030387,1,0.987909458649506,0,1,fructosamine-3-kinase activity,MF,
7426,GO:0030388,1,0.927843116894706,0,7,fructose 1,6-bisphosphate metabolic process,BP,
7427,GO:0030389,1,0.987909458649506,0,1,fructosamine metabolic process,BP,
7428,GO:0030393,1,0.987909458649506,0,1,fructoselysine metabolic process,BP,
7429,GO:0030395,1,0.967763422000998,0,3,lactose binding,MF,
7430,GO:0030397,1,0.780194219724707,0,46,membrane disassembly,BP,
7431,GO:0030407,1,0.989063495059152,0,1,formimidoyltransferase activity,MF,
7432,GO:0030409,1,0.989063495059152,0,1,glutamate formimidoyltransferase activity,MF,
7433,GO:0030412,1,0.989063495059152,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7435,GO:0030421,1,0.987294093381271,0,1,defecation,BP,
7436,GO:0030422,1,0.975051207687972,0,4,production of siRNA involved in RNA interference,BP,
7437,GO:0030423,1,0.976686469578521,0,3,targeting of mRNA for destruction involved in RNA interference,BP,
7442,GO:0030429,1,0.988006973601008,0,1,kynureninase activity,MF,
7443,GO:0030430,1,0.976904609063082,0,4,host cell cytoplasm,CC,
7445,GO:0030432,1,0.923155355322412,0,9,peristalsis,BP,
7446,GO:0030433,1,0.639518898291614,0,71,ubiquitin-dependent ERAD pathway,BP,
7448,GO:0030450,1,0.977747519437203,0,3,regulation of complement activation, classical pathway,BP,
7449,GO:0030451,1,0.999999996391921,0,1,regulation of complement activation, alternative pathway,BP,
7450,GO:0030473,1,0.99491120658196,0,3,nuclear migration along microtubule,BP,
7451,GO:0030478,1,0.988700817449621,0,4,actin cap,CC,
7452,GO:0030485,1,0.975947626424011,0,3,smooth muscle contractile fiber,CC,
7454,GO:0030490,1,0.668051246002554,0,48,maturation of SSU-rRNA,BP,
7455,GO:0030492,1,0.938522716271339,0,5,hemoglobin binding,MF,
7456,GO:0030496,1,0.429690279100268,0,142,midbody,CC,
7458,GO:0030500,1,0.663009198344072,0,65,regulation of bone mineralization,BP,
7459,GO:0030501,1,0.819758424216672,0,35,positive regulation of bone mineralization,BP,
7460,GO:0030502,1,0.887764028982186,0,16,negative regulation of bone mineralization,BP,
7461,GO:0030504,1,0.999999996385739,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7462,GO:0030505,1,0.999999992767128,0,2,inorganic diphosphate transport,BP,
7463,GO:0030506,1,0.942606993180176,0,19,ankyrin binding,MF,
7464,GO:0030507,1,0.903579649509074,0,25,spectrin binding,MF,
7465,GO:0030509,1,0.434681261069275,0,146,BMP signaling pathway,BP,
7466,GO:0030510,1,0.640686259512955,0,81,regulation of BMP signaling pathway,BP,
7467,GO:0030511,1,0.86677427911879,0,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7468,GO:0030512,1,0.707736921657242,0,64,negative regulation of transforming growth factor beta receptor signaling pathway,BP,
7469,GO:0030513,1,0.839828047177846,0,32,positive regulation of BMP signaling pathway,BP,
7470,GO:0030514,1,0.769807491142599,0,45,negative regulation of BMP signaling pathway,BP,
7472,GO:0030516,1,0.707070231932363,0,75,regulation of axon extension,BP,
7473,GO:0030517,1,0.880425224844864,0,24,negative regulation of axon extension,BP,
7474,GO:0030518,1,0.496920968608717,0,124,intracellular steroid hormone receptor signaling pathway,BP,
7475,GO:0030520,1,0.766560472303118,0,48,intracellular estrogen receptor signaling pathway,BP,
7476,GO:0030521,1,0.706414214213133,0,65,androgen receptor signaling pathway,BP,
7477,GO:0030522,1,0.223477801651405,0,262,intracellular receptor signaling pathway,BP,
7478,GO:0030523,1,0.998993929979302,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7479,GO:0030526,1,0.999714312598298,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7481,GO:0030532,1,0.595561350186574,0,65,small nuclear ribonucleoprotein complex,CC,
7483,GO:0030538,1,0.978637661562993,0,3,embryonic genitalia morphogenesis,BP,
7486,GO:0030544,1,0.791716825976512,0,33,Hsp70 protein binding,MF,
7487,GO:0030545,1,0.691907016357143,0,53,receptor regulator activity,MF,
7488,GO:0030546,1,0.792244016471904,0,37,receptor activator activity,MF,
7489,GO:0030547,1,0.883964193104398,0,15,receptor inhibitor activity,MF,
7490,GO:0030548,1,0.950002461700489,0,6,acetylcholine receptor regulator activity,MF,
7491,GO:0030549,1,0.987505581743228,0,1,acetylcholine receptor activator activity,MF,
7492,GO:0030550,1,0.973464627582493,0,4,acetylcholine receptor inhibitor activity,MF,
7493,GO:0030551,1,0.851442669569317,0,37,cyclic nucleotide binding,MF,
7494,GO:0030552,1,0.926210406850568,0,24,cAMP binding,MF,
7495,GO:0030553,1,0.937768881635976,0,14,cGMP binding,MF,
7497,GO:0030572,1,0.997376890728512,0,1,phosphatidyltransferase activity,MF,
7498,GO:0030573,1,0.972343358404532,0,3,bile acid catabolic process,BP,
7500,GO:0030575,1,0.959969005926049,0,10,nuclear body organization,BP,
7501,GO:0030576,1,0.98752044925201,0,2,Cajal body organization,BP,
7502,GO:0030578,1,0.981330764441621,0,4,PML body organization,BP,
7503,GO:0030579,1,0.965582872612715,0,6,ubiquitin-dependent SMAD protein catabolic process,BP,
7504,GO:0030580,1,0.987647083299915,0,1,quinone cofactor methyltransferase activity,MF,
7505,GO:0030581,1,0.962747994408797,0,5,symbiont intracellular protein transport in host,BP,
7506,GO:0030586,1,0.995162711325382,0,1,[methionine synthase] reductase activity,MF,
7507,GO:0030593,1,0.43665502202483,0,86,neutrophil chemotaxis,BP,
7509,GO:0030595,1,0.196499202863655,0,187,leukocyte chemotaxis,BP,
7510,GO:0030611,1,0.987302752639619,0,1,arsenate reductase activity,MF,
7511,GO:0030613,1,0.963022555677172,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7512,GO:0030614,1,0.963022555677172,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7513,GO:0030616,1,0.999999996388895,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7514,GO:0030617,1,0.987337597276773,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7515,GO:0030618,1,0.993568282812275,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7516,GO:0030619,1,0.947181786502703,0,6,U1 snRNA binding,MF,
7517,GO:0030620,1,0.942211336314414,0,5,U2 snRNA binding,MF,
7518,GO:0030621,1,0.973540255998843,0,5,U4 snRNA binding,MF,
7519,GO:0030622,1,0.990083732090337,0,2,U4atac snRNA binding,MF,
7520,GO:0030623,1,0.999999996380654,0,1,U5 snRNA binding,MF,
7521,GO:0030624,1,0.999056693482752,0,1,U6atac snRNA binding,MF,
7522,GO:0030626,1,0.986556069544739,0,2,U12 snRNA binding,MF,
7523,GO:0030627,1,0.9807799521271,0,2,pre-mRNA 5'-splice site binding,MF,
7524,GO:0030628,1,0.947826459627293,0,6,pre-mRNA 3'-splice site binding,MF,
7525,GO:0030638,1,0.914148142160058,0,8,polyketide metabolic process,BP,
7526,GO:0030641,1,0.557617149275142,0,92,regulation of cellular pH,BP,
7527,GO:0030643,1,0.953654356887663,0,9,cellular phosphate ion homeostasis,BP,
7528,GO:0030644,1,0.976846650755698,0,4,cellular chloride ion homeostasis,BP,
7529,GO:0030647,1,0.905322979599565,0,9,aminoglycoside antibiotic metabolic process,BP,
7530,GO:0030653,1,0.999871944703624,0,1,beta-lactam antibiotic metabolic process,BP,
7531,GO:0030656,1,0.899357100005035,0,12,regulation of vitamin metabolic process,BP,
7534,GO:0030660,1,0.717271831836481,0,50,Golgi-associated vesicle membrane,CC,
7535,GO:0030662,1,0.34407193928895,0,163,coated vesicle membrane,CC,
7536,GO:0030663,1,0.880810949320061,0,16,COPI-coated vesicle membrane,CC,
7537,GO:0030665,1,0.498125383440452,0,105,clathrin-coated vesicle membrane,CC,
7540,GO:0030669,1,0.706308818930812,0,50,clathrin-coated endocytic vesicle membrane,CC,
7541,GO:0030670,1,0.609980645981199,0,69,phagocytic vesicle membrane,CC,
7542,GO:0030672,1,0.61985004008758,0,74,synaptic vesicle membrane,CC,
7543,GO:0030673,1,0.955735584910255,0,16,axolemma,CC,
7544,GO:0030674,1,0.404838491200106,0,161,protein binding, bridging,MF,
7545,GO:0030676,1,0.964514075167891,0,15,Rac guanyl-nucleotide exchange factor activity,MF,
7548,GO:0030681,1,0.9375393838136,0,7,multimeric ribonuclease P complex,CC,
7549,GO:0030682,1,0.992340637996542,0,1,evasion or tolerance of host defense response,BP,
7550,GO:0030683,1,0.992340637996542,0,1,evasion or tolerance by virus of host immune response,BP,
7551,GO:0030684,1,0.600141668154136,0,67,preribosome,CC,
7552,GO:0030686,1,0.824204682831294,0,29,90S preribosome,CC,
7553,GO:0030687,1,0.82784562100378,0,22,preribosome, large subunit precursor,CC,
7554,GO:0030688,1,0.931912152411657,0,11,preribosome, small subunit precursor,CC,
7555,GO:0030689,1,0.974797846994225,0,3,Noc complex,CC,
7556,GO:0030690,1,0.99283942135449,0,1,Noc1p-Noc2p complex,CC,
7557,GO:0030691,1,0.99283942135449,0,1,Noc2p-Noc3p complex,CC,
7558,GO:0030692,1,0.981829331977735,0,2,Noc4p-Nop14p complex,CC,
7560,GO:0030696,1,0.994536236406517,0,1,tRNA (m5U54) methyltransferase activity,MF,
7561,GO:0030697,1,0.994536236406517,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7562,GO:0030705,1,0.512544717737318,0,138,cytoskeleton-dependent intracellular transport,BP,
7563,GO:0030718,1,0.975987080634533,0,3,germ-line stem cell population maintenance,BP,
7564,GO:0030719,1,0.987987657630493,0,2,P granule organization,BP,
7565,GO:0030728,1,0.871920432934213,0,20,ovulation,BP,
7566,GO:0030729,1,0.995361280816281,0,1,acetoacetate-CoA ligase activity,MF,
7567,GO:0030730,1,0.897205553552383,0,15,sequestering of triglyceride,BP,
7568,GO:0030731,1,0.987371102885666,0,1,guanidinoacetate N-methyltransferase activity,MF,
7569,GO:0030742,1,0.84244615386291,0,24,GTP-dependent protein binding,MF,
7570,GO:0030748,1,0.991644038120897,0,1,amine N-methyltransferase activity,MF,
7572,GO:0030791,1,0.991256272890253,0,1,arsenite methyltransferase activity,MF,
7573,GO:0030792,1,0.991256272890253,0,1,methylarsonite methyltransferase activity,MF,
7575,GO:0030800,1,0.71770046067431,0,46,negative regulation of cyclic nucleotide metabolic process,BP,
7578,GO:0030803,1,0.739430485015773,0,42,negative regulation of cyclic nucleotide biosynthetic process,BP,
7580,GO:0030805,1,0.993239706664181,0,3,regulation of cyclic nucleotide catabolic process,BP,
7581,GO:0030806,1,0.993239711628937,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7582,GO:0030807,1,0.999999996372621,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7584,GO:0030809,1,0.726773029042058,0,45,negative regulation of nucleotide biosynthetic process,BP,
7586,GO:0030811,1,0.993239706664181,0,3,regulation of nucleotide catabolic process,BP,
7587,GO:0030812,1,0.993239711628937,0,2,negative regulation of nucleotide catabolic process,BP,
7588,GO:0030813,1,0.999999996372621,0,1,positive regulation of nucleotide catabolic process,BP,
7590,GO:0030815,1,0.733527050550226,0,44,negative regulation of cAMP metabolic process,BP,
7593,GO:0030818,1,0.755732364843477,0,40,negative regulation of cAMP biosynthetic process,BP,
7595,GO:0030820,1,0.993239706664181,0,3,regulation of cAMP catabolic process,BP,
7596,GO:0030821,1,0.993239711628937,0,2,negative regulation of cAMP catabolic process,BP,
7597,GO:0030822,1,0.999999996372621,0,1,positive regulation of cAMP catabolic process,BP,
7598,GO:0030823,1,0.811549240328722,0,28,regulation of cGMP metabolic process,BP,
7599,GO:0030824,1,0.978476356249677,0,2,negative regulation of cGMP metabolic process,BP,
7600,GO:0030825,1,0.839544036231343,0,21,positive regulation of cGMP metabolic process,BP,
7601,GO:0030826,1,0.829483315425461,0,22,regulation of cGMP biosynthetic process,BP,
7602,GO:0030827,1,0.978476356249677,0,2,negative regulation of cGMP biosynthetic process,BP,
7603,GO:0030828,1,0.848613884763968,0,19,positive regulation of cGMP biosynthetic process,BP,
7608,GO:0030836,1,0.945040223127322,0,9,positive regulation of actin filament depolymerization,BP,
7611,GO:0030842,1,0.999994516078798,0,1,regulation of intermediate filament depolymerization,BP,
7612,GO:0030844,1,0.999994516078798,0,1,positive regulation of intermediate filament depolymerization,BP,
7613,GO:0030845,1,0.99304146129124,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7614,GO:0030846,1,0.999999996400838,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7615,GO:0030849,1,0.988493741264294,0,2,autosome,CC,
7616,GO:0030850,1,0.794320283525938,0,45,prostate gland development,BP,
7617,GO:0030851,1,0.823821828253275,0,29,granulocyte differentiation,BP,
7618,GO:0030852,1,0.921478931369848,0,14,regulation of granulocyte differentiation,BP,
7619,GO:0030853,1,0.971207890772291,0,8,negative regulation of granulocyte differentiation,BP,
7620,GO:0030854,1,0.945655197207716,0,7,positive regulation of granulocyte differentiation,BP,
7622,GO:0030856,1,0.463441695371604,0,121,regulation of epithelial cell differentiation,BP,
7623,GO:0030857,1,0.795248597455461,0,37,negative regulation of epithelial cell differentiation,BP,
7624,GO:0030858,1,0.706679026833901,0,54,positive regulation of epithelial cell differentiation,BP,
7625,GO:0030859,1,0.950934644041646,0,12,polarized epithelial cell differentiation,BP,
7626,GO:0030860,1,0.996390855977535,0,2,regulation of polarized epithelial cell differentiation,BP,
7627,GO:0030862,1,0.996390855977535,0,2,positive regulation of polarized epithelial cell differentiation,BP,
7628,GO:0030863,1,0.718219912194827,0,79,cortical cytoskeleton,CC,
7629,GO:0030864,1,0.814420364650757,0,55,cortical actin cytoskeleton,CC,
7630,GO:0030865,1,0.877898131472006,0,33,cortical cytoskeleton organization,BP,
7631,GO:0030866,1,0.898773691492157,0,28,cortical actin cytoskeleton organization,BP,
7632,GO:0030867,1,0.858494065710019,0,21,rough endoplasmic reticulum membrane,CC,
7634,GO:0030870,1,0.98201303569202,0,5,Mre11 complex,CC,
7635,GO:0030874,1,0.98853560337144,0,1,nucleolar chromatin,CC,
7636,GO:0030877,1,0.950342669347472,0,11,beta-catenin destruction complex,CC,
7637,GO:0030878,1,0.843740412252953,0,24,thyroid gland development,BP,
7638,GO:0030879,1,0.509466126447468,0,129,mammary gland development,BP,
7639,GO:0030880,1,0.409925546071929,0,127,RNA polymerase complex,CC,
7640,GO:0030881,1,0.913665561850013,0,9,beta-2-microglobulin binding,MF,
7641,GO:0030882,1,0.956522345001257,0,5,lipid antigen binding,MF,
7642,GO:0030883,1,0.956522345001257,0,5,endogenous lipid antigen binding,MF,
7643,GO:0030884,1,0.956522345001257,0,5,exogenous lipid antigen binding,MF,
7644,GO:0030885,1,0.943553280092014,0,5,regulation of myeloid dendritic cell activation,BP,
7645,GO:0030886,1,0.967117390102863,0,3,negative regulation of myeloid dendritic cell activation,BP,
7646,GO:0030887,1,0.988093766746822,0,1,positive regulation of myeloid dendritic cell activation,BP,
7648,GO:0030889,1,0.904157450370749,0,15,negative regulation of B cell proliferation,BP,
7650,GO:0030891,1,0.96051675293585,0,5,VCB complex,CC,
7651,GO:0030893,1,0.975522592409101,0,6,meiotic cohesin complex,CC,
7652,GO:0030894,1,0.787017838855028,0,30,replisome,CC,
7653,GO:0030895,1,0.971527344649779,0,3,apolipoprotein B mRNA editing enzyme complex,CC,
7654,GO:0030896,1,0.948224247723698,0,6,checkpoint clamp complex,CC,
7655,GO:0030897,1,0.942687685111157,0,14,HOPS complex,CC,
7656,GO:0030898,1,0.986571644460881,0,12,actin-dependent ATPase activity,MF,
7657,GO:0030899,1,0.987560142853803,0,2,calcium-dependent ATPase activity,MF,
7658,GO:0030900,1,0.152237435150112,0,360,forebrain development,BP,
7659,GO:0030901,1,0.526096623866909,0,92,midbrain development,BP,
7660,GO:0030902,1,0.484669007011006,0,141,hindbrain development,BP,
7661,GO:0030903,1,0.906473629368044,0,19,notochord development,BP,
7662,GO:0030904,1,0.889713951585577,0,20,retromer complex,CC,
7663,GO:0030905,1,0.973611407769831,0,4,retromer, tubulation complex,CC,
7664,GO:0030906,1,0.971724727405911,0,4,retromer, cargo-selective complex,CC,
7665,GO:0030908,1,0.977949577856796,0,2,protein splicing,BP,
7666,GO:0030910,1,0.98207207702506,0,4,olfactory placode formation,BP,
7667,GO:0030911,1,0.972871912365948,0,6,TPR domain binding,MF,
7668,GO:0030913,1,0.972576668414504,0,7,paranodal junction assembly,BP,
7669,GO:0030914,1,0.912583052122215,0,13,STAGA complex,CC,
7670,GO:0030915,1,0.951594124218559,0,6,Smc5-Smc6 complex,CC,
7671,GO:0030916,1,0.941166283952207,0,8,otic vesicle formation,BP,
7672,GO:0030917,1,0.92634561752352,0,9,midbrain-hindbrain boundary development,BP,
7673,GO:0030920,1,0.975495328343631,0,2,peptidyl-serine acetylation,BP,
7674,GO:0030934,1,0.999999989162218,0,3,anchoring collagen complex,CC,
7675,GO:0030935,1,0.991961250736736,0,1,sheet-forming collagen trimer,CC,
7676,GO:0030936,1,0.994037991498953,0,1,transmembrane collagen trimer,CC,
7677,GO:0030942,1,0.969596789567583,0,3,endoplasmic reticulum signal peptide binding,MF,
7678,GO:0030943,1,0.971429655296154,0,3,mitochondrion targeting sequence binding,MF,
7680,GO:0030948,1,0.967238830996685,0,7,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7682,GO:0030950,1,0.978908170586419,0,4,establishment or maintenance of actin cytoskeleton polarity,BP,
7683,GO:0030951,1,0.987699438337614,0,3,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7684,GO:0030952,1,0.966865017595286,0,7,establishment or maintenance of cytoskeleton polarity,BP,
7685,GO:0030953,1,0.98348650638386,0,6,astral microtubule organization,BP,
7686,GO:0030955,1,0.939541309884211,0,14,potassium ion binding,MF,
7687,GO:0030956,1,0.985604879410826,0,2,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7688,GO:0030957,1,0.933191078423597,0,10,Tat protein binding,MF,
7689,GO:0030961,1,0.991657600429728,0,1,peptidyl-arginine hydroxylation,BP,
7690,GO:0030964,1,0.606954573631056,0,42,NADH dehydrogenase complex,CC,
7692,GO:0030969,1,0.983379940335693,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7693,GO:0030970,1,0.849773099189809,0,26,retrograde protein transport, ER to cytosol,BP,
7694,GO:0030971,1,0.749050110890919,0,52,receptor tyrosine kinase binding,MF,
7695,GO:0030974,1,0.988348355554348,0,1,thiamine pyrophosphate transport,BP,
7696,GO:0030975,1,0.990782840187539,0,1,thiamine binding,MF,
7698,GO:0030977,1,0.988797848236797,0,1,taurine binding,MF,
7699,GO:0030981,1,0.991949729321825,0,2,cortical microtubule cytoskeleton,CC,
7700,GO:0030983,1,0.940535035889864,0,12,mismatched DNA binding,MF,
7701,GO:0030984,1,0.987521531662503,0,1,kininogen binding,MF,
7702,GO:0030990,1,0.853173177755514,0,28,intraciliary transport particle,CC,
7703,GO:0030991,1,0.980420238746017,0,7,intraciliary transport particle A,CC,
7704,GO:0030992,1,0.886449507169272,0,18,intraciliary transport particle B,CC,
7705,GO:0030997,1,0.985703439157853,0,3,regulation of centriole-centriole cohesion,BP,
7706,GO:0031000,1,0.938235433355764,0,15,response to caffeine,BP,
7707,GO:0031001,1,0.991657600429728,0,1,response to brefeldin A,BP,
7708,GO:0031002,1,0.987631058642231,0,1,actin rod,CC,
7709,GO:0031005,1,0.952164519389658,0,11,filamin binding,MF,
7710,GO:0031010,1,0.962120444689721,0,11,ISWI-type complex,CC,
7711,GO:0031011,1,0.87954370084562,0,14,Ino80 complex,CC,
7713,GO:0031013,1,0.946398877974071,0,5,troponin I binding,MF,
7714,GO:0031014,1,0.950010984783425,0,4,troponin T binding,MF,
7715,GO:0031016,1,0.631875314220027,0,72,pancreas development,BP,
7716,GO:0031017,1,0.94771466760469,0,6,exocrine pancreas development,BP,
7717,GO:0031018,1,0.745835897424801,0,44,endocrine pancreas development,BP,
7718,GO:0031021,1,0.976350757310113,0,3,interphase microtubule organizing center,CC,
7719,GO:0031022,1,0.997810982052534,0,2,nuclear migration along microfilament,BP,
7720,GO:0031023,1,0.576710331496693,0,115,microtubule organizing center organization,BP,
7721,GO:0031032,1,0.463101348979728,0,164,actomyosin structure organization,BP,
7722,GO:0031033,1,0.943964325132597,0,15,myosin filament organization,BP,
7723,GO:0031034,1,0.953711680028298,0,14,myosin filament assembly,BP,
7724,GO:0031038,1,0.989783393189947,0,1,myosin II filament organization,BP,
7725,GO:0031045,1,0.946803398116101,0,12,dense core granule,CC,
7726,GO:0031047,1,0.335052343211577,0,158,gene silencing by RNA,BP,
7727,GO:0031048,1,0.991657600429728,0,1,chromatin silencing by small RNA,BP,
7728,GO:0031049,1,0.992913843613084,0,1,programmed DNA elimination,BP,
7729,GO:0031050,1,0.830820718231574,0,35,dsRNA fragmentation,BP,
7730,GO:0031052,1,0.992913843613084,0,1,chromosome breakage,BP,
7731,GO:0031053,1,0.964917222860346,0,9,primary miRNA processing,BP,
7732,GO:0031054,1,0.924290168484447,0,13,pre-miRNA processing,BP,
7733,GO:0031055,1,0.653335461277599,0,41,chromatin remodeling at centromere,BP,
7734,GO:0031056,1,0.486598022370173,0,128,regulation of histone modification,BP,
7735,GO:0031057,1,0.824828320215965,0,39,negative regulation of histone modification,BP,
7736,GO:0031058,1,0.623400647320024,0,81,positive regulation of histone modification,BP,
7737,GO:0031060,1,0.756519756535459,0,58,regulation of histone methylation,BP,
7738,GO:0031061,1,0.934354106346828,0,19,negative regulation of histone methylation,BP,
7739,GO:0031062,1,0.850482210405789,0,33,positive regulation of histone methylation,BP,
7740,GO:0031063,1,0.855934810061061,0,25,regulation of histone deacetylation,BP,
7741,GO:0031064,1,0.966452727124108,0,5,negative regulation of histone deacetylation,BP,
7742,GO:0031065,1,0.917555703948396,0,16,positive regulation of histone deacetylation,BP,
7743,GO:0031069,1,0.843400346535532,0,26,hair follicle morphogenesis,BP,
7744,GO:0031071,1,0.990863163865291,0,1,cysteine desulfurase activity,MF,
7745,GO:0031072,1,0.53857260089397,0,94,heat shock protein binding,MF,
7746,GO:0031074,1,0.981764608853263,0,4,nucleocytoplasmic shuttling complex,CC,
7747,GO:0031076,1,0.872238148845254,0,35,embryonic camera-type eye development,BP,
7748,GO:0031077,1,0.955447516258519,0,7,post-embryonic camera-type eye development,BP,
7749,GO:0031078,1,0.950344641090883,0,11,histone deacetylase activity (H3-K14 specific),MF,
7750,GO:0031080,1,0.950041619179578,0,10,nuclear pore outer ring,CC,
7751,GO:0031081,1,0.998617805219,0,1,nuclear pore distribution,BP,
7752,GO:0031082,1,0.86261730357662,0,19,BLOC complex,CC,
7753,GO:0031083,1,0.878418178284026,0,14,BLOC-1 complex,CC,
7754,GO:0031084,1,0.990848226322029,0,3,BLOC-2 complex,CC,
7755,GO:0031085,1,0.991101488420203,0,2,BLOC-3 complex,CC,
7756,GO:0031086,1,0.9512155310603,0,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7757,GO:0031087,1,0.957115206743806,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7758,GO:0031088,1,0.967638057874092,0,6,platelet dense granule membrane,CC,
7759,GO:0031089,1,0.881043678899456,0,13,platelet dense granule lumen,CC,
7761,GO:0031091,1,0.536229796595083,0,90,platelet alpha granule,CC,
7762,GO:0031092,1,0.915940992699348,0,17,platelet alpha granule membrane,CC,
7763,GO:0031093,1,0.617795158940868,0,66,platelet alpha granule lumen,CC,
7764,GO:0031094,1,0.979977664472704,0,10,platelet dense tubular network,CC,
7765,GO:0031095,1,0.991875755040787,0,8,platelet dense tubular network membrane,CC,
7769,GO:0031102,1,0.748361438170563,0,49,neuron projection regeneration,BP,
7770,GO:0031103,1,0.803544651485634,0,40,axon regeneration,BP,
7771,GO:0031104,1,0.998350541879693,0,1,dendrite regeneration,BP,
7772,GO:0031105,1,0.956072403156718,0,6,septin complex,CC,
7773,GO:0031106,1,0.999651159210314,0,1,septin ring organization,BP,
7774,GO:0031109,1,0.59933773557799,0,83,microtubule polymerization or depolymerization,BP,
7775,GO:0031110,1,0.699226426829638,0,53,regulation of microtubule polymerization or depolymerization,BP,
7776,GO:0031111,1,0.84180568705538,0,26,negative regulation of microtubule polymerization or depolymerization,BP,
7777,GO:0031112,1,0.862418728279451,0,22,positive regulation of microtubule polymerization or depolymerization,BP,
7778,GO:0031113,1,0.815934567306224,0,31,regulation of microtubule polymerization,BP,
7779,GO:0031114,1,0.890167751077211,0,18,regulation of microtubule depolymerization,BP,
7780,GO:0031115,1,0.928487730341115,0,10,negative regulation of microtubule polymerization,BP,
7781,GO:0031116,1,0.885416888001722,0,19,positive regulation of microtubule polymerization,BP,
7782,GO:0031117,1,0.974050358515839,0,3,positive regulation of microtubule depolymerization,BP,
7783,GO:0031118,1,0.932093549158096,0,6,rRNA pseudouridine synthesis,BP,
7785,GO:0031120,1,0.954713000140383,0,4,snRNA pseudouridine synthesis,BP,
7786,GO:0031122,1,0.832100178383824,0,44,cytoplasmic microtubule organization,BP,
7787,GO:0031123,1,0.460162654292217,0,114,RNA 3'-end processing,BP,
7788,GO:0031124,1,0.56023314146134,0,89,mRNA 3'-end processing,BP,
7789,GO:0031125,1,0.899551993041339,0,10,rRNA 3'-end processing,BP,
7790,GO:0031126,1,0.92268304586475,0,7,snoRNA 3'-end processing,BP,
7791,GO:0031127,1,0.99294020796979,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
7792,GO:0031128,1,0.81766739587379,0,30,developmental induction,BP,
7793,GO:0031129,1,0.999924327998121,0,1,inductive cell-cell signaling,BP,
7794,GO:0031133,1,0.97671448947468,0,5,regulation of axon diameter,BP,
7795,GO:0031134,1,0.991316684351222,0,2,sister chromatid biorientation,BP,
7796,GO:0031143,1,0.90463000563139,0,17,pseudopodium,CC,
7799,GO:0031151,1,0.999999996381384,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7800,GO:0031161,1,0.994456275455832,0,1,phosphatidylinositol catabolic process,BP,
7801,GO:0031163,1,0.83548653192018,0,18,metallo-sulfur cluster assembly,BP,
7802,GO:0031166,1,0.989838890236781,0,3,integral component of vacuolar membrane,CC,
7803,GO:0031167,1,0.866745968700329,0,16,rRNA methylation,BP,
7805,GO:0031177,1,0.987192125854061,0,2,phosphopantetheine binding,MF,
7806,GO:0031179,1,0.986128153621074,0,2,peptide modification,BP,
7807,GO:0031201,1,0.682844117860807,0,51,SNARE complex,CC,
7808,GO:0031204,1,0.987167492865009,0,2,posttranslational protein targeting to membrane, translocation,BP,
7809,GO:0031205,1,0.987163858441165,0,3,endoplasmic reticulum Sec complex,CC,
7810,GO:0031208,1,0.991689287730223,0,2,POZ domain binding,MF,
7811,GO:0031209,1,0.976455424353191,0,8,SCAR complex,CC,
7813,GO:0031211,1,0.938878111621206,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7814,GO:0031213,1,0.9975310447542,0,2,RSF complex,CC,
7815,GO:0031214,1,0.438346751021354,0,126,biomineral tissue development,BP,
7821,GO:0031228,1,0.689826193230082,0,58,intrinsic component of Golgi membrane,CC,
7822,GO:0031229,1,0.913275294237971,0,14,intrinsic component of nuclear inner membrane,CC,
7823,GO:0031231,1,0.88791337790776,0,14,intrinsic component of peroxisomal membrane,CC,
7824,GO:0031232,1,0.947425829105567,0,7,extrinsic component of external side of plasma membrane,CC,
7825,GO:0031233,1,0.806786950579815,0,25,intrinsic component of external side of plasma membrane,CC,
7826,GO:0031234,1,0.527367143497883,0,105,extrinsic component of cytoplasmic side of plasma membrane,CC,
7827,GO:0031235,1,0.958986574782468,0,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7828,GO:0031247,1,0.982224511256563,0,2,actin rod assembly,BP,
7829,GO:0031248,1,0.56499801149402,0,88,protein acetyltransferase complex,CC,
7830,GO:0031249,1,0.991051548276411,0,1,denatured protein binding,MF,
7831,GO:0031251,1,0.999959748501983,0,2,PAN complex,CC,
7833,GO:0031253,1,0.197656449081222,0,295,cell projection membrane,CC,
7834,GO:0031254,1,0.91628230353734,0,13,cell trailing edge,CC,
7835,GO:0031256,1,0.527050680411889,0,134,leading edge membrane,CC,
7836,GO:0031257,1,0.991657600429728,0,1,cell trailing edge membrane,CC,
7837,GO:0031258,1,0.900188975058909,0,19,lamellipodium membrane,CC,
7838,GO:0031259,1,0.991657600429728,0,1,uropod membrane,CC,
7839,GO:0031260,1,0.987438132381701,0,1,pseudopodium membrane,CC,
7840,GO:0031261,1,0.961583772502838,0,5,DNA replication preinitiation complex,CC,
7841,GO:0031262,1,0.954941062915472,0,4,Ndc80 complex,CC,
7845,GO:0031268,1,0.88744092584738,0,16,pseudopodium organization,BP,
7846,GO:0031269,1,0.898740278040615,0,15,pseudopodium assembly,BP,
7847,GO:0031271,1,0.991657600429728,0,1,lateral pseudopodium assembly,BP,
7848,GO:0031272,1,0.906306952375985,0,13,regulation of pseudopodium assembly,BP,
7849,GO:0031274,1,0.913936799706134,0,12,positive regulation of pseudopodium assembly,BP,
7850,GO:0031275,1,0.991657600429728,0,1,regulation of lateral pseudopodium assembly,BP,
7851,GO:0031279,1,0.52292167862961,0,89,regulation of cyclase activity,BP,
7852,GO:0031280,1,0.78631246763037,0,30,negative regulation of cyclase activity,BP,
7853,GO:0031281,1,0.665294243497988,0,59,positive regulation of cyclase activity,BP,
7854,GO:0031282,1,0.881759701387045,0,13,regulation of guanylate cyclase activity,BP,
7855,GO:0031283,1,0.978476356249677,0,2,negative regulation of guanylate cyclase activity,BP,
7856,GO:0031284,1,0.901172027313126,0,11,positive regulation of guanylate cyclase activity,BP,
7857,GO:0031289,1,0.993974628638275,0,1,actin phosphorylation,BP,
7858,GO:0031290,1,0.934091864648082,0,21,retinal ganglion cell axon guidance,BP,
7859,GO:0031291,1,0.998688128692813,0,1,Ran protein signal transduction,BP,
7860,GO:0031293,1,0.911679199411214,0,16,membrane protein intracellular domain proteolysis,BP,
7861,GO:0031294,1,0.526071273206938,0,79,lymphocyte costimulation,BP,
7862,GO:0031295,1,0.546468070431074,0,76,T cell costimulation,BP,
7863,GO:0031296,1,0.950626953687105,0,4,B cell costimulation,BP,
7864,GO:0031297,1,0.873426995984017,0,24,replication fork processing,BP,
7865,GO:0031298,1,0.959002231987129,0,6,replication fork protection complex,CC,
7868,GO:0031302,1,0.999897289031873,0,1,intrinsic component of endosome membrane,CC,
7871,GO:0031306,1,0.837805768060017,0,24,intrinsic component of mitochondrial outer membrane,CC,
7872,GO:0031307,1,0.838269859503225,0,23,integral component of mitochondrial outer membrane,CC,
7873,GO:0031308,1,0.991657600429728,0,1,intrinsic component of nuclear outer membrane,CC,
7874,GO:0031309,1,0.991657600429728,0,1,integral component of nuclear outer membrane,CC,
7875,GO:0031310,1,0.989838890236781,0,3,intrinsic component of vacuolar membrane,CC,
7876,GO:0031312,1,0.826758300604282,0,28,extrinsic component of organelle membrane,CC,
7877,GO:0031313,1,0.963264572921111,0,6,extrinsic component of endosome membrane,CC,
7878,GO:0031314,1,0.954742825668263,0,6,extrinsic component of mitochondrial inner membrane,CC,
7879,GO:0031315,1,0.993070411884165,0,2,extrinsic component of mitochondrial outer membrane,CC,
7880,GO:0031320,1,0.991518053072052,0,1,hexitol dehydrogenase activity,MF,
7890,GO:0031332,1,0.951407627915116,0,11,RNAi effector complex,CC,
7893,GO:0031335,1,0.98188872622716,0,2,regulation of sulfur amino acid metabolic process,BP,
7894,GO:0031337,1,0.990409252857432,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7896,GO:0031339,1,0.985403544829798,0,5,negative regulation of vesicle fusion,BP,
7897,GO:0031340,1,0.94437700926639,0,8,positive regulation of vesicle fusion,BP,
7899,GO:0031342,1,0.869295929126911,0,16,negative regulation of cell killing,BP,
7903,GO:0031346,1,0.226694104009972,0,305,positive regulation of cell projection organization,BP,
7907,GO:0031362,1,0.839204534833748,0,20,anchored component of external side of plasma membrane,CC,
7908,GO:0031365,1,0.843758600232313,0,28,N-terminal protein amino acid modification,BP,
7909,GO:0031369,1,0.82456416093511,0,29,translation initiation factor binding,MF,
7910,GO:0031370,1,0.999613089580403,0,1,eukaryotic initiation factor 4G binding,MF,
7911,GO:0031371,1,0.925914281572228,0,9,ubiquitin conjugating enzyme complex,CC,
7912,GO:0031372,1,0.979782573683925,0,2,UBC13-MMS2 complex,CC,
7913,GO:0031379,1,0.99326425766263,0,2,RNA-directed RNA polymerase complex,CC,
7914,GO:0031380,1,0.995162711325382,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7915,GO:0031386,1,0.921081470377235,0,8,protein tag,MF,
7916,GO:0031389,1,0.993249409208299,0,1,Rad17 RFC-like complex,CC,
7917,GO:0031390,1,0.933288324112578,0,8,Ctf18 RFC-like complex,CC,
7918,GO:0031392,1,0.965145276386986,0,6,regulation of prostaglandin biosynthetic process,BP,
7919,GO:0031393,1,0.991897572999957,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7920,GO:0031394,1,0.973030897055912,0,4,positive regulation of prostaglandin biosynthetic process,BP,
7927,GO:0031402,1,0.951033178499181,0,13,sodium ion binding,MF,
7928,GO:0031403,1,0.995664675726682,0,2,lithium ion binding,MF,
7929,GO:0031404,1,0.93705913176951,0,9,chloride ion binding,MF,
7931,GO:0031407,1,0.990808137278926,0,1,oxylipin metabolic process,BP,
7933,GO:0031414,1,0.940949842852134,0,10,N-terminal protein acetyltransferase complex,CC,
7934,GO:0031415,1,0.961195558301441,0,5,NatA complex,CC,
7935,GO:0031416,1,0.987421425127496,0,2,NatB complex,CC,
7936,GO:0031417,1,0.991414943644946,0,3,NatC complex,CC,
7938,GO:0031419,1,0.932329006016882,0,9,cobalamin binding,MF,
7939,GO:0031420,1,0.924659168497296,0,19,alkali metal ion binding,MF,
7941,GO:0031427,1,0.978268800201049,0,4,response to methotrexate,BP,
7942,GO:0031428,1,0.955249913063466,0,4,box C/D snoRNP complex,CC,
7943,GO:0031429,1,0.942767788778549,0,5,box H/ACA snoRNP complex,CC,
7944,GO:0031430,1,0.858045203567744,0,29,M band,CC,
7945,GO:0031432,1,0.914397903604472,0,14,titin binding,MF,
7946,GO:0031433,1,0.94866217452501,0,7,telethonin binding,MF,
7947,GO:0031434,1,0.929026996340288,0,14,mitogen-activated protein kinase kinase binding,MF,
7948,GO:0031435,1,0.931680250774944,0,16,mitogen-activated protein kinase kinase kinase binding,MF,
7949,GO:0031436,1,0.991839565443874,0,2,BRCA1-BARD1 complex,CC,
7950,GO:0031437,1,0.985210078261493,0,2,regulation of mRNA cleavage,BP,
7951,GO:0031438,1,0.994106205153046,0,1,negative regulation of mRNA cleavage,BP,
7952,GO:0031439,1,0.991051548276411,0,1,positive regulation of mRNA cleavage,BP,
7953,GO:0031440,1,0.893567669681761,0,20,regulation of mRNA 3'-end processing,BP,
7954,GO:0031441,1,0.959870153755937,0,8,negative regulation of mRNA 3'-end processing,BP,
7955,GO:0031442,1,0.950248124753538,0,8,positive regulation of mRNA 3'-end processing,BP,
7956,GO:0031443,1,0.996264712591441,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7957,GO:0031444,1,0.975036420932386,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7958,GO:0031445,1,0.988333935762767,0,2,regulation of heterochromatin assembly,BP,
7959,GO:0031446,1,0.996264716953498,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7960,GO:0031448,1,0.996264716953498,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7961,GO:0031449,1,0.999999996372987,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7962,GO:0031453,1,0.988333935762767,0,2,positive regulation of heterochromatin assembly,BP,
7963,GO:0031455,1,0.993164318148533,0,2,glycine betaine metabolic process,BP,
7964,GO:0031456,1,0.993164318148533,0,2,glycine betaine biosynthetic process,BP,
7965,GO:0031460,1,0.99974941944399,0,1,glycine betaine transport,BP,
7966,GO:0031461,1,0.374297551100078,0,171,cullin-RING ubiquitin ligase complex,CC,
7967,GO:0031462,1,0.94391523515881,0,9,Cul2-RING ubiquitin ligase complex,CC,
7968,GO:0031463,1,0.708472237587853,0,70,Cul3-RING ubiquitin ligase complex,CC,
7969,GO:0031464,1,0.940524045297565,0,10,Cul4A-RING E3 ubiquitin ligase complex,CC,
7970,GO:0031465,1,0.974353719537519,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7971,GO:0031466,1,0.954795321526792,0,6,Cul5-RING ubiquitin ligase complex,CC,
7972,GO:0031467,1,0.977663568872605,0,4,Cul7-RING ubiquitin ligase complex,CC,
7973,GO:0031468,1,0.874498839682363,0,17,nuclear envelope reassembly,BP,
7974,GO:0031475,1,0.988073323030041,0,1,myosin V complex,CC,
7975,GO:0031477,1,0.99999999638094,0,1,myosin VII complex,CC,
7976,GO:0031489,1,0.884122350390711,0,17,myosin V binding,MF,
7977,GO:0031490,1,0.564623490074444,0,87,chromatin DNA binding,MF,
7978,GO:0031491,1,0.730904233915879,0,49,nucleosome binding,MF,
7979,GO:0031492,1,0.791867575632979,0,30,nucleosomal DNA binding,MF,
7980,GO:0031493,1,0.978354707199475,0,3,nucleosomal histone binding,MF,
7981,GO:0031494,1,0.991657600429728,0,1,regulation of mating type switching,BP,
7982,GO:0031497,1,0.242770305407726,0,149,chromatin assembly,BP,
7983,GO:0031498,1,0.880290147128669,0,20,chromatin disassembly,BP,
7986,GO:0031506,1,0.988688643487989,0,1,cell wall glycoprotein biosynthetic process,BP,
7987,GO:0031507,1,0.921714092666508,0,12,heterochromatin assembly,BP,
7988,GO:0031508,1,0.962073150477445,0,4,pericentric heterochromatin assembly,BP,
7989,GO:0031509,1,0.968381488752787,0,3,telomeric heterochromatin assembly,BP,
7990,GO:0031510,1,0.971626435771999,0,3,SUMO activating enzyme complex,CC,
7991,GO:0031514,1,0.353203980820655,0,128,motile cilium,CC,
7992,GO:0031515,1,0.97460048996346,0,3,tRNA (m1A) methyltransferase complex,CC,
7993,GO:0031519,1,0.796407263002652,0,44,PcG protein complex,CC,
7994,GO:0031523,1,0.992406531131302,0,2,Myb complex,CC,
7995,GO:0031526,1,0.745853292891913,0,52,brush border membrane,CC,
7996,GO:0031527,1,0.924269449096182,0,17,filopodium membrane,CC,
7997,GO:0031528,1,0.882883825753171,0,22,microvillus membrane,CC,
7998,GO:0031529,1,0.756779143630721,0,41,ruffle organization,BP,
7999,GO:0031531,1,0.962571466992483,0,3,thyrotropin-releasing hormone receptor binding,MF,
8000,GO:0031532,1,0.615230370474734,0,85,actin cytoskeleton reorganization,BP,
8001,GO:0031536,1,0.946555285122748,0,5,positive regulation of exit from mitosis,BP,
8002,GO:0031543,1,0.922837668863502,0,10,peptidyl-proline dioxygenase activity,MF,
8003,GO:0031544,1,0.993877124963719,0,1,peptidyl-proline 3-dioxygenase activity,MF,
8004,GO:0031545,1,0.928526256372025,0,9,peptidyl-proline 4-dioxygenase activity,MF,
8005,GO:0031547,1,0.99764410043147,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
8006,GO:0031548,1,0.998103261002969,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8007,GO:0031549,1,0.99997620456382,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8008,GO:0031550,1,0.998127012604431,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
8009,GO:0031554,1,0.999999996400838,0,1,regulation of DNA-templated transcription, termination,BP,
8010,GO:0031559,1,0.998785569571622,0,1,oxidosqualene cyclase activity,MF,
8011,GO:0031570,1,0.361236901845392,0,155,DNA integrity checkpoint,BP,
8012,GO:0031571,1,0.616394421732884,0,68,mitotic G1 DNA damage checkpoint,BP,
8013,GO:0031572,1,0.843825183139982,0,34,G2 DNA damage checkpoint,BP,
8014,GO:0031573,1,0.87522877914312,0,15,intra-S DNA damage checkpoint,BP,
8015,GO:0031577,1,0.780631749739238,0,35,spindle checkpoint,BP,
8016,GO:0031579,1,0.838235829333156,0,23,membrane raft organization,BP,
8017,GO:0031580,1,0.927514881613663,0,9,membrane raft distribution,BP,
8018,GO:0031581,1,0.965556150316923,0,11,hemidesmosome assembly,BP,
8019,GO:0031583,1,0.989744678367247,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
8020,GO:0031584,1,0.949575841299853,0,6,activation of phospholipase D activity,BP,
8021,GO:0031585,1,0.997560719291906,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
8022,GO:0031587,1,0.997560723369056,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
8023,GO:0031588,1,0.949246615433227,0,10,nucleotide-activated protein kinase complex,CC,
8024,GO:0031589,1,0.242872661415916,0,298,cell-substrate adhesion,BP,
8025,GO:0031590,1,0.985030217485169,0,2,wybutosine metabolic process,BP,
8026,GO:0031591,1,0.985030217485169,0,2,wybutosine biosynthetic process,BP,
8027,GO:0031592,1,0.999999996384226,0,1,centrosomal corona,CC,
8028,GO:0031593,1,0.812289390772228,0,39,polyubiquitin binding,MF,
8029,GO:0031594,1,0.750131314913569,0,55,neuromuscular junction,CC,
8030,GO:0031595,1,0.916386169896075,0,8,nuclear proteasome complex,CC,
8031,GO:0031597,1,0.905658569666868,0,10,cytosolic proteasome complex,CC,
8032,GO:0031616,1,0.921199712113215,0,9,spindle pole centrosome,CC,
8033,GO:0031618,1,0.965537854562686,0,8,nuclear pericentric heterochromatin,CC,
8034,GO:0031620,1,0.949796089659282,0,8,regulation of fever generation,BP,
8035,GO:0031622,1,0.950893254367498,0,7,positive regulation of fever generation,BP,
8036,GO:0031623,1,0.623216970550227,0,79,receptor internalization,BP,
8037,GO:0031624,1,0.871953474534319,0,33,ubiquitin conjugating enzyme binding,MF,
8038,GO:0031625,1,0.163437246593053,0,286,ubiquitin protein ligase binding,MF,
8039,GO:0031626,1,0.999926879944743,0,1,beta-endorphin binding,MF,
8040,GO:0031627,1,0.983529745545574,0,3,telomeric loop formation,BP,
8041,GO:0031628,1,0.925834880416846,0,9,opioid receptor binding,MF,
8042,GO:0031629,1,0.897609059298169,0,15,synaptic vesicle fusion to presynaptic active zone membrane,BP,
8043,GO:0031630,1,0.982222147351193,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
8044,GO:0031635,1,0.9887576283292,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
8046,GO:0031639,1,0.822672719136638,0,22,plasminogen activation,BP,
8047,GO:0031640,1,0.725987573736209,0,30,killing of cells of other organism,BP,
8048,GO:0031641,1,0.853519714796174,0,30,regulation of myelination,BP,
8049,GO:0031642,1,0.965387640124676,0,7,negative regulation of myelination,BP,
8050,GO:0031643,1,0.943307954867806,0,11,positive regulation of myelination,BP,
8051,GO:0031644,1,0.659585962464306,0,65,regulation of neurological system process,BP,
8052,GO:0031645,1,0.885971169215471,0,16,negative regulation of neurological system process,BP,
8053,GO:0031646,1,0.875124109869825,0,22,positive regulation of neurological system process,BP,
8055,GO:0031648,1,0.794801438156934,0,37,protein destabilization,BP,
8056,GO:0031649,1,0.908721945080161,0,17,heat generation,BP,
8057,GO:0031650,1,0.939843556170248,0,12,regulation of heat generation,BP,
8058,GO:0031651,1,0.998550297867607,0,1,negative regulation of heat generation,BP,
8059,GO:0031652,1,0.942296019305993,0,10,positive regulation of heat generation,BP,
8060,GO:0031657,1,0.960476203245192,0,8,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
8061,GO:0031658,1,0.999994189436789,0,1,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
8062,GO:0031659,1,0.960481793797175,0,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
8063,GO:0031660,1,0.989720839770265,0,1,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,BP,
8064,GO:0031662,1,0.989720839770265,0,1,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle,BP,
8066,GO:0031664,1,0.866228784997537,0,19,regulation of lipopolysaccharide-mediated signaling pathway,BP,
8067,GO:0031665,1,0.930819078137423,0,9,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
8068,GO:0031666,1,0.941229784594183,0,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
8072,GO:0031670,1,0.776362149526009,0,39,cellular response to nutrient,BP,
8073,GO:0031672,1,0.79941346852174,0,41,A band,CC,
8074,GO:0031673,1,0.9999999964295,0,1,H zone,CC,
8075,GO:0031674,1,0.494767739815332,0,131,I band,CC,
8076,GO:0031681,1,0.937529458273158,0,9,G-protein beta-subunit binding,MF,
8077,GO:0031682,1,0.993933191648242,0,1,G-protein gamma-subunit binding,MF,
8078,GO:0031683,1,0.869199540405937,0,20,G-protein beta/gamma-subunit complex binding,MF,
8079,GO:0031685,1,0.992528522088956,0,2,adenosine receptor binding,MF,
8080,GO:0031686,1,0.994242521917544,0,1,A1 adenosine receptor binding,MF,
8081,GO:0031690,1,0.89719421859141,0,17,adrenergic receptor binding,MF,
8082,GO:0031691,1,0.979332274588069,0,2,alpha-1A adrenergic receptor binding,MF,
8083,GO:0031692,1,0.977001174002034,0,3,alpha-1B adrenergic receptor binding,MF,
8084,GO:0031694,1,0.961528336431508,0,4,alpha-2A adrenergic receptor binding,MF,
8085,GO:0031695,1,0.991210234017725,0,1,alpha-2B adrenergic receptor binding,MF,
8086,GO:0031696,1,0.988851087125427,0,2,alpha-2C adrenergic receptor binding,MF,
8087,GO:0031697,1,0.997729017305247,0,3,beta-1 adrenergic receptor binding,MF,
8088,GO:0031698,1,0.978569477240547,0,4,beta-2 adrenergic receptor binding,MF,
8089,GO:0031699,1,0.990589955126607,0,2,beta-3 adrenergic receptor binding,MF,
8090,GO:0031700,1,0.987934704716481,0,1,adrenomedullin receptor binding,MF,
8091,GO:0031701,1,0.949768292536297,0,11,angiotensin receptor binding,MF,
8092,GO:0031702,1,0.959226587195658,0,10,type 1 angiotensin receptor binding,MF,
8093,GO:0031703,1,0.991743775026976,0,1,type 2 angiotensin receptor binding,MF,
8094,GO:0031704,1,0.994813753533921,0,1,apelin receptor binding,MF,
8095,GO:0031705,1,0.957256984093052,0,4,bombesin receptor binding,MF,
8096,GO:0031707,1,0.989744678367247,0,1,endothelin A receptor binding,MF,
8097,GO:0031708,1,0.969489748224956,0,3,endothelin B receptor binding,MF,
8098,GO:0031710,1,0.987385340533252,0,1,neuromedin B receptor binding,MF,
8099,GO:0031711,1,0.986177475167814,0,2,bradykinin receptor binding,MF,
8100,GO:0031714,1,0.999899977433943,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8101,GO:0031715,1,0.999899977433943,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8102,GO:0031716,1,0.974701926727928,0,2,calcitonin receptor binding,MF,
8103,GO:0031720,1,0.962015169596325,0,3,haptoglobin binding,MF,
8104,GO:0031721,1,0.987249524593575,0,1,hemoglobin alpha binding,MF,
8105,GO:0031724,1,0.987564328280312,0,1,CXCR5 chemokine receptor binding,MF,
8106,GO:0031726,1,0.938027726022118,0,5,CCR1 chemokine receptor binding,MF,
8107,GO:0031727,1,0.978716713543473,0,2,CCR2 chemokine receptor binding,MF,
8108,GO:0031728,1,0.962108783152392,0,3,CCR3 chemokine receptor binding,MF,
8109,GO:0031729,1,0.974930489623701,0,2,CCR4 chemokine receptor binding,MF,
8111,GO:0031731,1,0.96204584667281,0,3,CCR6 chemokine receptor binding,MF,
8112,GO:0031732,1,0.974640493683239,0,2,CCR7 chemokine receptor binding,MF,
8113,GO:0031735,1,0.962526302191938,0,3,CCR10 chemokine receptor binding,MF,
8114,GO:0031737,1,0.99504847536143,0,1,CX3C chemokine receptor binding,MF,
8115,GO:0031739,1,0.989824222640719,0,1,cholecystokinin receptor binding,MF,
8116,GO:0031741,1,0.989824222640719,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8117,GO:0031748,1,0.945346950198437,0,8,D1 dopamine receptor binding,MF,
8118,GO:0031749,1,0.980221861148988,0,3,D2 dopamine receptor binding,MF,
8119,GO:0031750,1,0.981328031634191,0,2,D3 dopamine receptor binding,MF,
8120,GO:0031751,1,0.988413405111657,0,1,D4 dopamine receptor binding,MF,
8121,GO:0031752,1,0.987475046028339,0,3,D5 dopamine receptor binding,MF,
8122,GO:0031753,1,0.992738880974434,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8123,GO:0031755,1,0.992738880974434,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8124,GO:0031762,1,0.979332274588069,0,2,follicle-stimulating hormone receptor binding,MF,
8125,GO:0031763,1,0.987233076566383,0,1,galanin receptor binding,MF,
8126,GO:0031764,1,0.987233076566383,0,1,type 1 galanin receptor binding,MF,
8127,GO:0031765,1,0.987233076566383,0,1,type 2 galanin receptor binding,MF,
8128,GO:0031766,1,0.987233076566383,0,1,type 3 galanin receptor binding,MF,
8129,GO:0031768,1,0.987207770502897,0,1,ghrelin receptor binding,MF,
8130,GO:0031770,1,0.987151902518417,0,1,growth hormone-releasing hormone receptor binding,MF,
8131,GO:0031771,1,0.987170199616193,0,1,type 1 hypocretin receptor binding,MF,
8132,GO:0031772,1,0.987170199616193,0,1,type 2 hypocretin receptor binding,MF,
8133,GO:0031773,1,0.987207076579492,0,1,kisspeptin receptor binding,MF,
8134,GO:0031775,1,0.99999999638592,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8140,GO:0031798,1,0.999999996382531,0,1,type 1 metabotropic glutamate receptor binding,MF,
8141,GO:0031800,1,0.976959122277376,0,3,type 3 metabotropic glutamate receptor binding,MF,
8142,GO:0031802,1,0.991671169631541,0,2,type 5 metabotropic glutamate receptor binding,MF,
8143,GO:0031811,1,0.997729025450055,0,1,G-protein coupled nucleotide receptor binding,MF,
8144,GO:0031812,1,0.997729025450055,0,1,P2Y1 nucleotide receptor binding,MF,
8145,GO:0031821,1,0.95731235195805,0,7,G-protein coupled serotonin receptor binding,MF,
8146,GO:0031826,1,0.967663440779598,0,3,type 2A serotonin receptor binding,MF,
8147,GO:0031834,1,0.987492724524205,0,1,neurokinin receptor binding,MF,
8148,GO:0031835,1,0.987492724524205,0,1,substance P receptor binding,MF,
8149,GO:0031838,1,0.950238600217686,0,4,haptoglobin-hemoglobin complex,CC,
8150,GO:0031848,1,0.945463847882789,0,10,protection from non-homologous end joining at telomere,BP,
8151,GO:0031849,1,0.950725042672079,0,5,olfactory receptor binding,MF,
8152,GO:0031851,1,0.987239710208756,0,1,kappa-type opioid receptor binding,MF,
8153,GO:0031852,1,0.979834434147502,0,4,mu-type opioid receptor binding,MF,
8154,GO:0031854,1,0.987148051755264,0,1,orexigenic neuropeptide QRFP receptor binding,MF,
8155,GO:0031855,1,0.987159241441705,0,1,oxytocin receptor binding,MF,
8156,GO:0031856,1,0.987248084240437,0,1,parathyroid hormone receptor binding,MF,
8157,GO:0031857,1,0.987248084240437,0,1,type 1 parathyroid hormone receptor binding,MF,
8158,GO:0031858,1,0.994574958817842,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8159,GO:0031859,1,0.98908259197523,0,1,platelet activating factor receptor binding,MF,
8160,GO:0031860,1,0.996231707909974,0,3,telomeric 3' overhang formation,BP,
8161,GO:0031861,1,0.987142087287163,0,1,prolactin-releasing peptide receptor binding,MF,
8162,GO:0031862,1,0.99751394183338,0,2,prostanoid receptor binding,MF,
8163,GO:0031867,1,0.997513945953153,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8164,GO:0031870,1,0.999999996373065,0,1,thromboxane A2 receptor binding,MF,
8165,GO:0031871,1,0.984739718376863,0,3,proteinase activated receptor binding,MF,
8166,GO:0031877,1,0.999999996376636,0,1,somatostatin receptor binding,MF,
8167,GO:0031883,1,0.989757555074622,0,1,taste receptor binding,MF,
8168,GO:0031893,1,0.975996650841317,0,3,vasopressin receptor binding,MF,
8169,GO:0031894,1,0.985714023662804,0,2,V1A vasopressin receptor binding,MF,
8170,GO:0031895,1,0.987179409917434,0,1,V1B vasopressin receptor binding,MF,
8171,GO:0031896,1,0.990142912163584,0,1,V2 vasopressin receptor binding,MF,
8173,GO:0031902,1,0.437089224862776,0,109,late endosome membrane,CC,
8175,GO:0031904,1,0.777570711102839,0,29,endosome lumen,CC,
8176,GO:0031905,1,0.98641347204496,0,2,early endosome lumen,CC,
8177,GO:0031906,1,0.924204699838677,0,7,late endosome lumen,CC,
8179,GO:0031914,1,0.971049769163625,0,5,negative regulation of synaptic plasticity,BP,
8180,GO:0031915,1,0.943226836902709,0,9,positive regulation of synaptic plasticity,BP,
8182,GO:0031930,1,0.987960498551718,0,1,mitochondria-nucleus signaling pathway,BP,
8183,GO:0031931,1,0.965298198984224,0,7,TORC1 complex,CC,
8184,GO:0031932,1,0.923756919539291,0,12,TORC2 complex,CC,
8185,GO:0031933,1,0.978604466039109,0,3,telomeric heterochromatin,CC,
8186,GO:0031935,1,0.922798526179062,0,21,regulation of chromatin silencing,BP,
8187,GO:0031936,1,0.96129697481515,0,9,negative regulation of chromatin silencing,BP,
8188,GO:0031937,1,0.9774188446484,0,8,positive regulation of chromatin silencing,BP,
8189,GO:0031938,1,0.977600105227395,0,2,regulation of chromatin silencing at telomere,BP,
8190,GO:0031940,1,0.98833394167051,0,1,positive regulation of chromatin silencing at telomere,BP,
8191,GO:0031941,1,0.875607328134445,0,27,filamentous actin,CC,
8192,GO:0031943,1,0.94505767614025,0,9,regulation of glucocorticoid metabolic process,BP,
8193,GO:0031944,1,0.971342593579756,0,5,negative regulation of glucocorticoid metabolic process,BP,
8194,GO:0031945,1,0.99774836316084,0,1,positive regulation of glucocorticoid metabolic process,BP,
8195,GO:0031946,1,0.968666056013423,0,7,regulation of glucocorticoid biosynthetic process,BP,
8196,GO:0031947,1,0.971342593579756,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8197,GO:0031948,1,0.99774836316084,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8198,GO:0031952,1,0.835732880900949,0,40,regulation of protein autophosphorylation,BP,
8199,GO:0031953,1,0.94737767925759,0,11,negative regulation of protein autophosphorylation,BP,
8200,GO:0031954,1,0.896464403770241,0,25,positive regulation of protein autophosphorylation,BP,
8201,GO:0031957,1,0.932631305754002,0,10,very long-chain fatty acid-CoA ligase activity,MF,
8202,GO:0031958,1,0.940245957225465,0,16,corticosteroid receptor signaling pathway,BP,
8203,GO:0031959,1,0.999957574426284,0,1,mineralocorticoid receptor signaling pathway,BP,
8205,GO:0031962,1,0.999999996372022,0,1,mineralocorticoid receptor binding,MF,
8216,GO:0031984,1,0.16944735798345,0,300,organelle subcompartment,CC,
8217,GO:0031985,1,0.611040297876295,0,90,Golgi cisterna,CC,
8218,GO:0031987,1,0.953294464957065,0,9,locomotion involved in locomotory behavior,BP,
8219,GO:0031989,1,0.975787063626225,0,2,bombesin receptor signaling pathway,BP,
8220,GO:0031990,1,0.990628259695777,0,2,mRNA export from nucleus in response to heat stress,BP,
8221,GO:0031994,1,0.946690206394386,0,12,insulin-like growth factor I binding,MF,
8222,GO:0031995,1,0.946920858941153,0,8,insulin-like growth factor II binding,MF,
8223,GO:0031996,1,0.90983609067815,0,14,thioesterase binding,MF,
8224,GO:0031997,1,0.976959122277376,0,3,N-terminal myristoylation domain binding,MF,
8225,GO:0031998,1,0.954188413323283,0,15,regulation of fatty acid beta-oxidation,BP,
8226,GO:0031999,1,0.984284389999836,0,4,negative regulation of fatty acid beta-oxidation,BP,
8227,GO:0032000,1,0.9649596937985,0,9,positive regulation of fatty acid beta-oxidation,BP,
8228,GO:0032002,1,0.97274860808042,0,3,interleukin-28 receptor complex,CC,
8229,GO:0032003,1,0.991657600429728,0,1,interleukin-28 receptor binding,MF,
8232,GO:0032008,1,0.807231420661223,0,32,positive regulation of TOR signaling,BP,
8233,GO:0032009,1,0.975226654099261,0,8,early phagosome,CC,
8234,GO:0032010,1,0.953542307677062,0,5,phagolysosome,CC,
8235,GO:0032011,1,0.977678488330632,0,15,ARF protein signal transduction,BP,
8236,GO:0032012,1,0.977678488330632,0,15,regulation of ARF protein signal transduction,BP,
8237,GO:0032020,1,0.944247995425112,0,6,ISG15-protein conjugation,BP,
8238,GO:0032021,1,0.967042428965429,0,4,NELF complex,CC,
8239,GO:0032023,1,0.990447743086166,0,1,trypsinogen activation,BP,
8241,GO:0032025,1,0.929122848068648,0,9,response to cobalt ion,BP,
8242,GO:0032026,1,0.920112828466388,0,18,response to magnesium ion,BP,
8243,GO:0032027,1,0.964744279779175,0,6,myosin light chain binding,MF,
8244,GO:0032028,1,0.989779695136045,0,1,myosin head/neck binding,MF,
8245,GO:0032029,1,0.999999996404516,0,1,myosin tail binding,MF,
8246,GO:0032036,1,0.897797549220725,0,12,myosin heavy chain binding,MF,
8247,GO:0032038,1,0.974762677843786,0,2,myosin II heavy chain binding,MF,
8248,GO:0032039,1,0.953566529669021,0,11,integrator complex,CC,
8249,GO:0032040,1,0.800197176164342,0,30,small-subunit processome,CC,
8250,GO:0032041,1,0.950344641090883,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8251,GO:0032042,1,0.919363048477745,0,16,mitochondrial DNA metabolic process,BP,
8252,GO:0032044,1,0.985138315402617,0,2,DSIF complex,CC,
8253,GO:0032045,1,0.950011108472734,0,12,guanyl-nucleotide exchange factor complex,CC,
8254,GO:0032048,1,0.907326225719914,0,14,cardiolipin metabolic process,BP,
8255,GO:0032049,1,0.951719574571494,0,7,cardiolipin biosynthetic process,BP,
8256,GO:0032050,1,0.972570998860553,0,5,clathrin heavy chain binding,MF,
8257,GO:0032051,1,0.969273628102699,0,6,clathrin light chain binding,MF,
8258,GO:0032052,1,0.911027737446551,0,9,bile acid binding,MF,
8259,GO:0032053,1,0.982638556623737,0,3,ciliary basal body organization,BP,
8260,GO:0032055,1,0.943067848703203,0,9,negative regulation of translation in response to stress,BP,
8261,GO:0032056,1,0.968091163414231,0,6,positive regulation of translation in response to stress,BP,
8262,GO:0032057,1,0.957957456667433,0,7,negative regulation of translational initiation in response to stress,BP,
8263,GO:0032058,1,0.988107337162673,0,4,positive regulation of translational initiation in response to stress,BP,
8264,GO:0032059,1,0.961697426253792,0,7,bleb,CC,
8265,GO:0032060,1,0.946898341992199,0,10,bleb assembly,BP,
8266,GO:0032066,1,0.992721384059112,0,3,nucleolus to nucleoplasm transport,BP,
8267,GO:0032069,1,0.837327026046411,0,26,regulation of nuclease activity,BP,
8268,GO:0032070,1,0.922248114603614,0,10,regulation of deoxyribonuclease activity,BP,
8269,GO:0032071,1,0.94087556667412,0,8,regulation of endodeoxyribonuclease activity,BP,
8270,GO:0032072,1,0.995775337703485,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8271,GO:0032074,1,0.949245205435993,0,7,negative regulation of nuclease activity,BP,
8272,GO:0032075,1,0.899064331868629,0,15,positive regulation of nuclease activity,BP,
8273,GO:0032076,1,0.979758547272982,0,2,negative regulation of deoxyribonuclease activity,BP,
8274,GO:0032077,1,0.959356993476409,0,5,positive regulation of deoxyribonuclease activity,BP,
8275,GO:0032078,1,0.987293487014129,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8276,GO:0032079,1,0.971257764866128,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8278,GO:0032089,1,0.993217368677326,0,2,NACHT domain binding,MF,
8280,GO:0032091,1,0.577102606582236,0,81,negative regulation of protein binding,BP,
8282,GO:0032093,1,0.991657600429728,0,1,SAM domain binding,MF,
8283,GO:0032094,1,0.743548127888911,0,36,response to food,BP,
8284,GO:0032095,1,0.851822294563262,0,17,regulation of response to food,BP,
8285,GO:0032096,1,0.911928453493302,0,10,negative regulation of response to food,BP,
8286,GO:0032097,1,0.951580856854299,0,4,positive regulation of response to food,BP,
8287,GO:0032098,1,0.814607125532532,0,21,regulation of appetite,BP,
8288,GO:0032099,1,0.911928453493302,0,10,negative regulation of appetite,BP,
8289,GO:0032100,1,0.951580856854299,0,4,positive regulation of appetite,BP,
8291,GO:0032102,1,0.180357515672742,0,246,negative regulation of response to external stimulus,BP,
8293,GO:0032104,1,0.825498088299547,0,23,regulation of response to extracellular stimulus,BP,
8294,GO:0032105,1,0.902452096793197,0,12,negative regulation of response to extracellular stimulus,BP,
8295,GO:0032106,1,0.93378756285831,0,6,positive regulation of response to extracellular stimulus,BP,
8296,GO:0032107,1,0.825498088299547,0,23,regulation of response to nutrient levels,BP,
8297,GO:0032108,1,0.902452096793197,0,12,negative regulation of response to nutrient levels,BP,
8298,GO:0032109,1,0.93378756285831,0,6,positive regulation of response to nutrient levels,BP,
8299,GO:0032113,1,0.987573985404204,0,1,regulation of carbohydrate phosphatase activity,BP,
8300,GO:0032116,1,0.991657595177054,0,2,SMC loading complex,CC,
8301,GO:0032119,1,0.920001218991694,0,12,sequestering of zinc ion,BP,
8302,GO:0032127,1,0.992839536520183,0,2,dense core granule membrane,CC,
8303,GO:0032129,1,0.985896747429166,0,2,histone deacetylase activity (H3-K9 specific),MF,
8304,GO:0032133,1,0.948950046037006,0,5,chromosome passenger complex,CC,
8305,GO:0032135,1,0.97059857154695,0,6,DNA insertion or deletion binding,MF,
8306,GO:0032137,1,0.984754227781379,0,3,guanine/thymine mispair binding,MF,
8307,GO:0032138,1,0.985955155346662,0,4,single base insertion or deletion binding,MF,
8308,GO:0032139,1,0.981806410243129,0,3,dinucleotide insertion or deletion binding,MF,
8309,GO:0032142,1,0.992924681760931,0,3,single guanine insertion binding,MF,
8310,GO:0032143,1,0.993445460219143,0,2,single thymine insertion binding,MF,
8311,GO:0032144,1,0.999768569133436,0,1,4-aminobutyrate transaminase complex,CC,
8312,GO:0032145,1,0.999768569133436,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8315,GO:0032153,1,0.726293881950492,0,57,cell division site,CC,
8316,GO:0032154,1,0.752577183306027,0,48,cleavage furrow,CC,
8317,GO:0032155,1,0.726293881950492,0,57,cell division site part,CC,
8318,GO:0032156,1,0.954834156018488,0,7,septin cytoskeleton,CC,
8319,GO:0032173,1,0.993747934067793,0,1,septin collar,CC,
8320,GO:0032181,1,0.993983422456252,0,2,dinucleotide repeat insertion binding,MF,
8321,GO:0032182,1,0.5138846231169,0,121,ubiquitin-like protein binding,MF,
8322,GO:0032183,1,0.932977614651451,0,16,SUMO binding,MF,
8323,GO:0032184,1,0.98519273123149,0,5,SUMO polymer binding,MF,
8324,GO:0032185,1,0.9913116452277,0,2,septin cytoskeleton organization,BP,
8325,GO:0032190,1,0.946308336043468,0,5,acrosin binding,MF,
8326,GO:0032194,1,0.996770639106046,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8327,GO:0032196,1,0.894818954028291,0,16,transposition,BP,
8328,GO:0032197,1,0.997845331374933,0,1,transposition, RNA-mediated,BP,
8329,GO:0032200,1,0.303093433960421,0,160,telomere organization,BP,
8330,GO:0032201,1,0.973183595204109,0,6,telomere maintenance via semi-conservative replication,BP,
8331,GO:0032202,1,0.966748928937587,0,4,telomere assembly,BP,
8332,GO:0032203,1,0.988934119966093,0,1,telomere formation via telomerase,BP,
8333,GO:0032204,1,0.648351523631228,0,71,regulation of telomere maintenance,BP,
8334,GO:0032205,1,0.859660515230669,0,31,negative regulation of telomere maintenance,BP,
8335,GO:0032206,1,0.726669891423906,0,48,positive regulation of telomere maintenance,BP,
8336,GO:0032207,1,0.993254256196027,0,1,regulation of telomere maintenance via recombination,BP,
8337,GO:0032208,1,0.993254256196027,0,1,negative regulation of telomere maintenance via recombination,BP,
8338,GO:0032210,1,0.73683262326731,0,47,regulation of telomere maintenance via telomerase,BP,
8339,GO:0032211,1,0.910661197774293,0,15,negative regulation of telomere maintenance via telomerase,BP,
8340,GO:0032212,1,0.791118401239173,0,33,positive regulation of telomere maintenance via telomerase,BP,
8341,GO:0032213,1,0.986724836327325,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8342,GO:0032214,1,0.986724836327325,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8343,GO:0032217,1,0.975179379573793,0,3,riboflavin transporter activity,MF,
8344,GO:0032218,1,0.975179379573793,0,3,riboflavin transport,BP,
8345,GO:0032222,1,0.926282691102405,0,9,regulation of synaptic transmission, cholinergic,BP,
8346,GO:0032223,1,0.991746049233625,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8347,GO:0032224,1,0.941361789635034,0,7,positive regulation of synaptic transmission, cholinergic,BP,
8348,GO:0032225,1,0.890904033128145,0,16,regulation of synaptic transmission, dopaminergic,BP,
8349,GO:0032226,1,0.939645866217739,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8350,GO:0032227,1,0.993171522746219,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8351,GO:0032228,1,0.866972478719511,0,31,regulation of synaptic transmission, GABAergic,BP,
8352,GO:0032229,1,0.955897982890947,0,6,negative regulation of synaptic transmission, GABAergic,BP,
8353,GO:0032230,1,0.926433339842198,0,13,positive regulation of synaptic transmission, GABAergic,BP,
8354,GO:0032231,1,0.669083050676639,0,82,regulation of actin filament bundle assembly,BP,
8355,GO:0032232,1,0.901429662009971,0,23,negative regulation of actin filament bundle assembly,BP,
8356,GO:0032233,1,0.742913944990422,0,51,positive regulation of actin filament bundle assembly,BP,
8357,GO:0032237,1,0.985180133731779,0,4,activation of store-operated calcium channel activity,BP,
8358,GO:0032239,1,0.946465718626629,0,13,regulation of nucleobase-containing compound transport,BP,
8359,GO:0032240,1,0.999999588680931,0,2,negative regulation of nucleobase-containing compound transport,BP,
8360,GO:0032241,1,0.969506083393882,0,4,positive regulation of nucleobase-containing compound transport,BP,
8361,GO:0032242,1,0.992969168767015,0,1,regulation of nucleoside transport,BP,
8362,GO:0032244,1,0.992969168767015,0,1,positive regulation of nucleoside transport,BP,
8363,GO:0032252,1,0.999789037500953,0,3,secretory granule localization,BP,
8365,GO:0032261,1,0.941368741719541,0,7,purine nucleotide salvage,BP,
8366,GO:0032262,1,0.947304380237318,0,5,pyrimidine nucleotide salvage,BP,
8367,GO:0032264,1,0.975193231541015,0,4,IMP salvage,BP,
8375,GO:0032274,1,0.915482461893116,0,14,gonadotropin secretion,BP,
8376,GO:0032275,1,0.955199381722644,0,9,luteinizing hormone secretion,BP,
8377,GO:0032276,1,0.918033898805043,0,11,regulation of gonadotropin secretion,BP,
8378,GO:0032277,1,0.94016642814941,0,7,negative regulation of gonadotropin secretion,BP,
8379,GO:0032278,1,0.949962245031757,0,7,positive regulation of gonadotropin secretion,BP,
8380,GO:0032279,1,0.479445584523189,0,194,asymmetric synapse,CC,
8381,GO:0032280,1,0.977638387316046,0,4,symmetric synapse,CC,
8383,GO:0032286,1,0.975912235349256,0,4,central nervous system myelin maintenance,BP,
8384,GO:0032287,1,0.966965900129641,0,7,peripheral nervous system myelin maintenance,BP,
8385,GO:0032288,1,0.923612236237935,0,18,myelin assembly,BP,
8386,GO:0032289,1,0.977464881263847,0,3,central nervous system myelin formation,BP,
8387,GO:0032290,1,0.991657595177675,0,2,peripheral nervous system myelin formation,BP,
8388,GO:0032291,1,0.895898993547735,0,15,axon ensheathment in central nervous system,BP,
8389,GO:0032292,1,0.902855856108513,0,22,peripheral nervous system axon ensheathment,BP,
8390,GO:0032296,1,0.979554003964193,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8391,GO:0032298,1,0.990300829709693,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8392,GO:0032299,1,0.968703024218898,0,3,ribonuclease H2 complex,CC,
8393,GO:0032300,1,0.973136259441409,0,8,mismatch repair complex,CC,
8394,GO:0032301,1,0.993445460219143,0,2,MutSalpha complex,CC,
8395,GO:0032302,1,0.993983422456252,0,2,MutSbeta complex,CC,
8396,GO:0032303,1,0.873547164487984,0,17,regulation of icosanoid secretion,BP,
8397,GO:0032304,1,0.983967006326232,0,3,negative regulation of icosanoid secretion,BP,
8398,GO:0032305,1,0.879637209832462,0,15,positive regulation of icosanoid secretion,BP,
8399,GO:0032306,1,0.901772282839577,0,10,regulation of prostaglandin secretion,BP,
8400,GO:0032308,1,0.901772282839577,0,10,positive regulation of prostaglandin secretion,BP,
8401,GO:0032309,1,0.702855437216204,0,43,icosanoid secretion,BP,
8402,GO:0032310,1,0.896107137824466,0,13,prostaglandin secretion,BP,
8404,GO:0032324,1,0.949208925648098,0,7,molybdopterin cofactor biosynthetic process,BP,
8405,GO:0032328,1,0.953136323325195,0,10,alanine transport,BP,
8406,GO:0032329,1,0.916014087969741,0,10,serine transport,BP,
8408,GO:0032331,1,0.890640055689601,0,18,negative regulation of chondrocyte differentiation,BP,
8410,GO:0032341,1,0.955973481459533,0,9,aldosterone metabolic process,BP,
8411,GO:0032342,1,0.955973481459533,0,9,aldosterone biosynthetic process,BP,
8412,GO:0032344,1,0.966294251862107,0,6,regulation of aldosterone metabolic process,BP,
8413,GO:0032345,1,0.974065838060062,0,4,negative regulation of aldosterone metabolic process,BP,
8414,GO:0032346,1,0.992023160320756,0,2,positive regulation of aldosterone metabolic process,BP,
8415,GO:0032347,1,0.966294251862107,0,6,regulation of aldosterone biosynthetic process,BP,
8416,GO:0032348,1,0.974065838060062,0,4,negative regulation of aldosterone biosynthetic process,BP,
8417,GO:0032349,1,0.992023160320756,0,2,positive regulation of aldosterone biosynthetic process,BP,
8418,GO:0032350,1,0.858368706980979,0,26,regulation of hormone metabolic process,BP,
8419,GO:0032351,1,0.959290320006224,0,6,negative regulation of hormone metabolic process,BP,
8420,GO:0032352,1,0.952150331957995,0,11,positive regulation of hormone metabolic process,BP,
8421,GO:0032353,1,0.971342593579756,0,5,negative regulation of hormone biosynthetic process,BP,
8424,GO:0032356,1,0.965454406552731,0,8,oxidized DNA binding,MF,
8425,GO:0032357,1,0.965454406552731,0,8,oxidized purine DNA binding,MF,
8426,GO:0032358,1,0.987262555038096,0,1,oxidized pyrimidine DNA binding,MF,
8427,GO:0032361,1,0.989404570639733,0,1,pyridoxal phosphate catabolic process,BP,
8428,GO:0032364,1,0.962986065270585,0,6,oxygen homeostasis,BP,
8441,GO:0032377,1,0.954789290938072,0,7,regulation of intracellular lipid transport,BP,
8442,GO:0032378,1,0.996741300368013,0,1,negative regulation of intracellular lipid transport,BP,
8443,GO:0032379,1,0.969952113813531,0,3,positive regulation of intracellular lipid transport,BP,
8444,GO:0032380,1,0.954789290938072,0,7,regulation of intracellular sterol transport,BP,
8445,GO:0032381,1,0.996741300368013,0,1,negative regulation of intracellular sterol transport,BP,
8446,GO:0032382,1,0.969952113813531,0,3,positive regulation of intracellular sterol transport,BP,
8447,GO:0032383,1,0.954789290938072,0,7,regulation of intracellular cholesterol transport,BP,
8448,GO:0032384,1,0.996741300368013,0,1,negative regulation of intracellular cholesterol transport,BP,
8449,GO:0032385,1,0.969952113813531,0,3,positive regulation of intracellular cholesterol transport,BP,
8451,GO:0032387,1,0.446440255319265,0,118,negative regulation of intracellular transport,BP,
8452,GO:0032388,1,0.172507487571243,0,278,positive regulation of intracellular transport,BP,
8453,GO:0032389,1,0.980071701137061,0,4,MutLalpha complex,CC,
8454,GO:0032391,1,0.846859550173887,0,34,photoreceptor connecting cilium,CC,
8455,GO:0032392,1,0.659569614464289,0,80,DNA geometric change,BP,
8456,GO:0032393,1,0.907797148334305,0,9,MHC class I receptor activity,MF,
8457,GO:0032394,1,0.979951372086824,0,2,MHC class Ib receptor activity,MF,
8458,GO:0032395,1,0.891953327406846,0,10,MHC class II receptor activity,MF,
8459,GO:0032396,1,0.964304166177294,0,4,inhibitory MHC class I receptor activity,MF,
8460,GO:0032397,1,0.987983996453764,0,1,activating MHC class I receptor activity,MF,
8461,GO:0032398,1,0.98843474795644,0,1,MHC class Ib protein complex,CC,
8462,GO:0032399,1,0.963169032008754,0,3,HECT domain binding,MF,
8463,GO:0032400,1,0.825523679689728,0,25,melanosome localization,BP,
8464,GO:0032401,1,0.838925768623518,0,23,establishment of melanosome localization,BP,
8465,GO:0032402,1,0.838925801490639,0,22,melanosome transport,BP,
8467,GO:0032404,1,0.944013160617491,0,8,mismatch repair complex binding,MF,
8468,GO:0032405,1,0.969857648558072,0,5,MutLalpha complex binding,MF,
8469,GO:0032407,1,0.962032720317916,0,5,MutSalpha complex binding,MF,
8471,GO:0032410,1,0.646150057852703,0,63,negative regulation of transporter activity,BP,
8474,GO:0032413,1,0.677430247451305,0,55,negative regulation of ion transmembrane transporter activity,BP,
8476,GO:0032415,1,0.943558919445327,0,6,regulation of sodium:proton antiporter activity,BP,
8477,GO:0032416,1,0.977764604049474,0,2,negative regulation of sodium:proton antiporter activity,BP,
8478,GO:0032417,1,0.965022563131037,0,4,positive regulation of sodium:proton antiporter activity,BP,
8479,GO:0032418,1,0.653552132372493,0,60,lysosome localization,BP,
8480,GO:0032419,1,0.990263027701851,0,1,extrinsic component of lysosome membrane,CC,
8481,GO:0032420,1,0.805753528769254,0,36,stereocilium,CC,
8482,GO:0032421,1,0.760317170339884,0,44,stereocilium bundle,CC,
8483,GO:0032422,1,0.981906350016111,0,2,purine-rich negative regulatory element binding,MF,
8484,GO:0032423,1,0.9889750368899,0,3,regulation of mismatch repair,BP,
8485,GO:0032425,1,0.990230695321066,0,2,positive regulation of mismatch repair,BP,
8486,GO:0032426,1,0.943913614353773,0,8,stereocilium tip,CC,
8487,GO:0032427,1,0.989349281281055,0,2,GBD domain binding,MF,
8488,GO:0032428,1,0.996472558544577,0,1,beta-N-acetylgalactosaminidase activity,MF,
8492,GO:0032432,1,0.769177611567032,0,55,actin filament bundle,CC,
8493,GO:0032433,1,0.959774324430676,0,13,filopodium tip,CC,
8494,GO:0032434,1,0.510763918891653,0,106,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8495,GO:0032435,1,0.849217535983282,0,23,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8496,GO:0032436,1,0.626770079019411,0,75,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8497,GO:0032437,1,0.979148294848553,0,4,cuticular plate,CC,
8498,GO:0032438,1,0.835652471752868,0,25,melanosome organization,BP,
8499,GO:0032439,1,0.986918757058575,0,4,endosome localization,BP,
8500,GO:0032440,1,0.987628421255001,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8501,GO:0032444,1,0.99005167988846,0,3,activin responsive factor complex,CC,
8502,GO:0032445,1,0.990619980762556,0,1,fructose import,BP,
8504,GO:0032448,1,0.988202697554432,0,1,DNA hairpin binding,MF,
8505,GO:0032449,1,0.991876396144332,0,3,CBM complex,CC,
8506,GO:0032450,1,0.996011057237555,0,3,maltose alpha-glucosidase activity,MF,
8507,GO:0032451,1,0.900845001016748,0,34,demethylase activity,MF,
8508,GO:0032452,1,0.971449215008328,0,24,histone demethylase activity,MF,
8509,GO:0032453,1,0.991864366949543,0,6,histone demethylase activity (H3-K4 specific),MF,
8510,GO:0032454,1,0.986131208140755,0,9,histone demethylase activity (H3-K9 specific),MF,
8511,GO:0032455,1,0.976909338193122,0,4,nerve growth factor processing,BP,
8512,GO:0032456,1,0.86419093342693,0,32,endocytic recycling,BP,
8513,GO:0032458,1,0.997648944792807,0,1,slow endocytic recycling,BP,
8514,GO:0032459,1,0.775361990901073,0,34,regulation of protein oligomerization,BP,
8515,GO:0032460,1,0.894048465304835,0,15,negative regulation of protein oligomerization,BP,
8516,GO:0032461,1,0.861842563582102,0,19,positive regulation of protein oligomerization,BP,
8517,GO:0032462,1,0.888012046473959,0,16,regulation of protein homooligomerization,BP,
8518,GO:0032463,1,0.928788895237521,0,10,negative regulation of protein homooligomerization,BP,
8519,GO:0032464,1,0.94942483480702,0,7,positive regulation of protein homooligomerization,BP,
8520,GO:0032465,1,0.654947338931451,0,66,regulation of cytokinesis,BP,
8521,GO:0032466,1,0.954635293756006,0,7,negative regulation of cytokinesis,BP,
8522,GO:0032467,1,0.781801836588791,0,37,positive regulation of cytokinesis,BP,
8523,GO:0032468,1,0.99612014552695,0,1,Golgi calcium ion homeostasis,BP,
8524,GO:0032469,1,0.888374662164011,0,20,endoplasmic reticulum calcium ion homeostasis,BP,
8525,GO:0032470,1,0.996264712599364,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8526,GO:0032471,1,0.940663494431049,0,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8527,GO:0032472,1,0.985443613826789,0,2,Golgi calcium ion transport,BP,
8528,GO:0032473,1,0.999999996391606,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8529,GO:0032474,1,0.997216103842226,0,2,otolith morphogenesis,BP,
8533,GO:0032482,1,0.970869373141208,0,6,Rab protein signal transduction,BP,
8534,GO:0032483,1,0.990367203379625,0,4,regulation of Rab protein signal transduction,BP,
8535,GO:0032484,1,0.995036537141876,0,3,Ral protein signal transduction,BP,
8536,GO:0032485,1,0.995036537141876,0,3,regulation of Ral protein signal transduction,BP,
8537,GO:0032486,1,0.958822474040123,0,13,Rap protein signal transduction,BP,
8538,GO:0032487,1,0.996040526941837,0,3,regulation of Rap protein signal transduction,BP,
8539,GO:0032488,1,0.930404398881685,0,8,Cdc42 protein signal transduction,BP,
8540,GO:0032489,1,0.950383984352715,0,5,regulation of Cdc42 protein signal transduction,BP,
8541,GO:0032490,1,0.944632925361373,0,11,detection of molecule of bacterial origin,BP,
8542,GO:0032493,1,0.955799142314788,0,7,response to bacterial lipoprotein,BP,
8543,GO:0032494,1,0.940472367023259,0,8,response to peptidoglycan,BP,
8544,GO:0032495,1,0.944335103181989,0,14,response to muramyl dipeptide,BP,
8546,GO:0032497,1,0.96716413512813,0,4,detection of lipopolysaccharide,BP,
8547,GO:0032498,1,0.9992549192931,0,1,detection of muramyl dipeptide,BP,
8548,GO:0032499,1,0.986673108539212,0,2,detection of peptidoglycan,BP,
8549,GO:0032500,1,0.9992549192931,0,1,muramyl dipeptide binding,MF,
8553,GO:0032506,1,0.911967225410448,0,19,cytokinetic process,BP,
8554,GO:0032507,1,0.5876679908507,0,85,maintenance of protein location in cell,BP,
8555,GO:0032508,1,0.692292536406828,0,71,DNA duplex unwinding,BP,
8556,GO:0032509,1,0.920512467393407,0,12,endosome transport via multivesicular body sorting pathway,BP,
8557,GO:0032510,1,0.979344910905953,0,4,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8558,GO:0032511,1,0.950645094217894,0,6,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8560,GO:0032516,1,0.932678169011839,0,15,positive regulation of phosphoprotein phosphatase activity,BP,
8561,GO:0032525,1,0.925674256813337,0,10,somite rostral/caudal axis specification,BP,
8563,GO:0032527,1,0.803858783645966,0,37,protein exit from endoplasmic reticulum,BP,
8564,GO:0032528,1,0.917995562571775,0,23,microvillus organization,BP,
8565,GO:0032530,1,0.944634338816731,0,13,regulation of microvillus organization,BP,
8566,GO:0032532,1,0.960377871800141,0,7,regulation of microvillus length,BP,
8567,GO:0032534,1,0.983612189327532,0,6,regulation of microvillus assembly,BP,
8569,GO:0032536,1,0.935920974736719,0,13,regulation of cell projection size,BP,
8570,GO:0032541,1,0.978693399385052,0,4,cortical endoplasmic reticulum,CC,
8571,GO:0032542,1,0.987760924633936,0,2,sulfiredoxin activity,MF,
8573,GO:0032545,1,0.986219223613473,0,2,CURI complex,CC,
8576,GO:0032551,1,0.991587748442403,0,2,pyrimidine ribonucleoside binding,MF,
8577,GO:0032552,1,0.949375887355864,0,6,deoxyribonucleotide binding,MF,
8579,GO:0032554,1,0.961425849258032,0,5,purine deoxyribonucleotide binding,MF,
8581,GO:0032556,1,0.987470452549771,0,1,pyrimidine deoxyribonucleotide binding,MF,
8582,GO:0032557,1,0.98158992646798,0,3,pyrimidine ribonucleotide binding,MF,
8583,GO:0032558,1,0.966532985187255,0,4,adenyl deoxyribonucleotide binding,MF,
8585,GO:0032560,1,0.994717449770596,0,1,guanyl deoxyribonucleotide binding,MF,
8587,GO:0032564,1,0.966532985187255,0,4,dATP binding,MF,
8588,GO:0032567,1,0.994717449770596,0,1,dGTP binding,MF,
8589,GO:0032570,1,0.736774819381811,0,41,response to progesterone,BP,
8590,GO:0032571,1,0.968005736727236,0,5,response to vitamin K,BP,
8591,GO:0032574,1,0.997956362893216,0,1,5'-3' RNA helicase activity,MF,
8592,GO:0032575,1,0.997956362893216,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8593,GO:0032580,1,0.669427864369098,0,73,Golgi cisterna membrane,CC,
8594,GO:0032581,1,0.988897606741538,0,1,ER-dependent peroxisome organization,BP,
8595,GO:0032584,1,0.960141433306174,0,6,growth cone membrane,CC,
8596,GO:0032585,1,0.931045407067223,0,9,multivesicular body membrane,CC,
8597,GO:0032587,1,0.692744810953681,0,80,ruffle membrane,CC,
8598,GO:0032588,1,0.585468271710095,0,80,trans-Golgi network membrane,CC,
8599,GO:0032589,1,0.843036653086057,0,36,neuron projection membrane,CC,
8600,GO:0032590,1,0.87644633729139,0,21,dendrite membrane,CC,
8601,GO:0032591,1,0.977492733822695,0,9,dendritic spine membrane,CC,
8603,GO:0032593,1,0.95644861310886,0,7,insulin-responsive compartment,CC,
8604,GO:0032594,1,0.926965064310672,0,9,protein transport within lipid bilayer,BP,
8605,GO:0032595,1,0.990040130479495,0,1,B cell receptor transport within lipid bilayer,BP,
8606,GO:0032596,1,0.957604818831203,0,6,protein transport into membrane raft,BP,
8607,GO:0032597,1,0.990040130479495,0,1,B cell receptor transport into membrane raft,BP,
8608,GO:0032599,1,0.990040130479495,0,1,protein transport out of membrane raft,BP,
8609,GO:0032600,1,0.990040130479495,0,1,chemokine receptor transport out of membrane raft,BP,
8610,GO:0032601,1,0.975116864899638,0,2,connective tissue growth factor production,BP,
8612,GO:0032603,1,0.987304015793293,0,1,fractalkine production,BP,
8613,GO:0032604,1,0.891164845706418,0,15,granulocyte macrophage colony-stimulating factor production,BP,
8614,GO:0032605,1,0.994717449770596,0,1,hepatocyte growth factor production,BP,
8619,GO:0032610,1,0.931257783445335,0,7,interleukin-1 alpha production,BP,
8623,GO:0032615,1,0.697411578489443,0,51,interleukin-12 production,BP,
8624,GO:0032616,1,0.846655044157718,0,21,interleukin-13 production,BP,
8625,GO:0032618,1,0.977283683815976,0,2,interleukin-15 production,BP,
8626,GO:0032620,1,0.804557057955367,0,25,interleukin-17 production,BP,
8627,GO:0032621,1,0.968833081175108,0,7,interleukin-18 production,BP,
8629,GO:0032625,1,0.996405206557,0,1,interleukin-21 production,BP,
8630,GO:0032627,1,0.934672620603251,0,8,interleukin-23 production,BP,
8631,GO:0032632,1,0.975764398211121,0,4,interleukin-3 production,BP,
8632,GO:0032633,1,0.793017550614155,0,32,interleukin-4 production,BP,
8633,GO:0032634,1,0.859815438869828,0,20,interleukin-5 production,BP,
8636,GO:0032639,1,0.982379719108469,0,2,TRAIL production,BP,
8638,GO:0032641,1,0.974071717589364,0,3,lymphotoxin A production,BP,
8640,GO:0032643,1,0.987667601272536,0,1,regulation of connective tissue growth factor production,BP,
8641,GO:0032644,1,0.987304015793293,0,1,regulation of fractalkine production,BP,
8642,GO:0032645,1,0.891164845706418,0,15,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8643,GO:0032646,1,0.994717449770596,0,1,regulation of hepatocyte growth factor production,BP,
8647,GO:0032650,1,0.943359980361391,0,6,regulation of interleukin-1 alpha production,BP,
8651,GO:0032655,1,0.705517649749558,0,49,regulation of interleukin-12 production,BP,
8652,GO:0032656,1,0.868159274833801,0,19,regulation of interleukin-13 production,BP,
8653,GO:0032658,1,0.98871696812522,0,1,regulation of interleukin-15 production,BP,
8654,GO:0032660,1,0.828095411561687,0,22,regulation of interleukin-17 production,BP,
8655,GO:0032661,1,0.971815815682193,0,5,regulation of interleukin-18 production,BP,
8656,GO:0032663,1,0.707774165403104,0,50,regulation of interleukin-2 production,BP,
8657,GO:0032667,1,0.934672620603251,0,8,regulation of interleukin-23 production,BP,
8658,GO:0032672,1,0.978113908898198,0,3,regulation of interleukin-3 production,BP,
8659,GO:0032673,1,0.809867487701425,0,27,regulation of interleukin-4 production,BP,
8660,GO:0032674,1,0.870621243535016,0,19,regulation of interleukin-5 production,BP,
8663,GO:0032679,1,0.982379719108469,0,2,regulation of TRAIL production,BP,
8665,GO:0032681,1,0.992375915620732,0,1,regulation of lymphotoxin A production,BP,
8666,GO:0032682,1,0.871655100504508,0,16,negative regulation of chemokine production,BP,
8667,GO:0032685,1,0.995034159918739,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8668,GO:0032686,1,0.994717449770596,0,1,negative regulation of hepatocyte growth factor production,BP,
8671,GO:0032689,1,0.764901864903961,0,31,negative regulation of interferon-gamma production,BP,
8672,GO:0032690,1,0.987905896439868,0,1,negative regulation of interleukin-1 alpha production,BP,
8673,GO:0032691,1,0.904036620873528,0,12,negative regulation of interleukin-1 beta production,BP,
8674,GO:0032692,1,0.85838017951471,0,18,negative regulation of interleukin-1 production,BP,
8675,GO:0032693,1,0.874956179215053,0,16,negative regulation of interleukin-10 production,BP,
8676,GO:0032695,1,0.920424033925551,0,15,negative regulation of interleukin-12 production,BP,
8677,GO:0032696,1,0.959754319563215,0,5,negative regulation of interleukin-13 production,BP,
8678,GO:0032700,1,0.916686202381796,0,11,negative regulation of interleukin-17 production,BP,
8679,GO:0032701,1,0.983404278104139,0,2,negative regulation of interleukin-18 production,BP,
8680,GO:0032703,1,0.861425739933342,0,18,negative regulation of interleukin-2 production,BP,
8681,GO:0032707,1,0.990823598353837,0,2,negative regulation of interleukin-23 production,BP,
8682,GO:0032712,1,0.990624122034123,0,1,negative regulation of interleukin-3 production,BP,
8683,GO:0032713,1,0.957450702604922,0,6,negative regulation of interleukin-4 production,BP,
8684,GO:0032714,1,0.943590901345785,0,7,negative regulation of interleukin-5 production,BP,
8685,GO:0032715,1,0.780298626321055,0,36,negative regulation of interleukin-6 production,BP,
8686,GO:0032717,1,0.882458771636364,0,16,negative regulation of interleukin-8 production,BP,
8687,GO:0032720,1,0.710109853035857,0,42,negative regulation of tumor necrosis factor production,BP,
8689,GO:0032723,1,0.987667601272536,0,1,positive regulation of connective tissue growth factor production,BP,
8690,GO:0032724,1,0.987304015793293,0,1,positive regulation of fractalkine production,BP,
8691,GO:0032725,1,0.907195731646009,0,13,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8692,GO:0032727,1,0.920425025061659,0,16,positive regulation of interferon-alpha production,BP,
8695,GO:0032730,1,0.954912991422591,0,5,positive regulation of interleukin-1 alpha production,BP,
8699,GO:0032735,1,0.769419810351061,0,32,positive regulation of interleukin-12 production,BP,
8700,GO:0032736,1,0.904593644969523,0,14,positive regulation of interleukin-13 production,BP,
8701,GO:0032738,1,0.98871696812522,0,1,positive regulation of interleukin-15 production,BP,
8702,GO:0032740,1,0.886213702016884,0,13,positive regulation of interleukin-17 production,BP,
8703,GO:0032741,1,0.99327857124828,0,2,positive regulation of interleukin-18 production,BP,
8704,GO:0032743,1,0.841456049555956,0,30,positive regulation of interleukin-2 production,BP,
8705,GO:0032747,1,0.952733362057874,0,5,positive regulation of interleukin-23 production,BP,
8706,GO:0032752,1,0.987372320298239,0,2,positive regulation of interleukin-3 production,BP,
8707,GO:0032753,1,0.838011171034323,0,22,positive regulation of interleukin-4 production,BP,
8708,GO:0032754,1,0.932523528258241,0,11,positive regulation of interleukin-5 production,BP,
8711,GO:0032759,1,0.982379719108469,0,2,positive regulation of TRAIL production,BP,
8713,GO:0032761,1,0.992375915620732,0,1,positive regulation of lymphotoxin A production,BP,
8714,GO:0032762,1,0.956007034319113,0,7,mast cell cytokine production,BP,
8715,GO:0032763,1,0.966181688840264,0,5,regulation of mast cell cytokine production,BP,
8716,GO:0032764,1,0.984450781692326,0,2,negative regulation of mast cell cytokine production,BP,
8717,GO:0032765,1,0.981444637328757,0,3,positive regulation of mast cell cytokine production,BP,
8718,GO:0032767,1,0.984345967863924,0,3,copper-dependent protein binding,MF,
8721,GO:0032770,1,0.820540540524524,0,27,positive regulation of monooxygenase activity,BP,
8722,GO:0032771,1,0.998851168465918,0,1,regulation of monophenol monooxygenase activity,BP,
8723,GO:0032773,1,0.998851168465918,0,1,positive regulation of monophenol monooxygenase activity,BP,
8725,GO:0032775,1,0.996882772847312,0,1,DNA methylation on adenine,BP,
8726,GO:0032776,1,0.985312721254903,0,4,DNA methylation on cytosine,BP,
8727,GO:0032777,1,0.969219476717401,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8730,GO:0032782,1,0.970506474703362,0,6,bile acid secretion,BP,
8731,GO:0032783,1,0.9866399828787,0,2,ELL-EAF complex,CC,
8733,GO:0032785,1,0.919969180835556,0,12,negative regulation of DNA-templated transcription, elongation,BP,
8734,GO:0032786,1,0.867429707616413,0,22,positive regulation of DNA-templated transcription, elongation,BP,
8736,GO:0032788,1,0.988310174662441,0,1,saturated monocarboxylic acid metabolic process,BP,
8737,GO:0032789,1,0.988310174662441,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8738,GO:0032790,1,0.942877672660638,0,8,ribosome disassembly,BP,
8739,GO:0032792,1,0.968036353660856,0,5,negative regulation of CREB transcription factor activity,BP,
8740,GO:0032793,1,0.934811172260104,0,14,positive regulation of CREB transcription factor activity,BP,
8741,GO:0032794,1,0.949696526105973,0,14,GTPase activating protein binding,MF,
8742,GO:0032795,1,0.965935459709679,0,4,heterotrimeric G-protein binding,MF,
8743,GO:0032796,1,0.988303100799201,0,2,uropod organization,BP,
8744,GO:0032797,1,0.92210141516358,0,11,SMN complex,CC,
8745,GO:0032798,1,0.983384249277821,0,2,Swi5-Sfr1 complex,CC,
8746,GO:0032799,1,0.923269568259281,0,14,low-density lipoprotein receptor particle metabolic process,BP,
8747,GO:0032800,1,0.871402179539287,0,24,receptor biosynthetic process,BP,
8748,GO:0032801,1,0.909162679264997,0,22,receptor catabolic process,BP,
8749,GO:0032802,1,0.965749491419401,0,5,low-density lipoprotein particle receptor catabolic process,BP,
8750,GO:0032803,1,0.965749491419401,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8751,GO:0032804,1,0.986969072693564,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8752,GO:0032805,1,0.98431895904025,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8753,GO:0032806,1,0.837952251015412,0,24,carboxy-terminal domain protein kinase complex,CC,
8754,GO:0032807,1,0.976539332996206,0,3,DNA ligase IV complex,CC,
8755,GO:0032808,1,0.97256677587345,0,6,lacrimal gland development,BP,
8756,GO:0032809,1,0.901682754295979,0,19,neuronal cell body membrane,CC,
8757,GO:0032810,1,0.987964796823442,0,2,sterol response element binding,MF,
8758,GO:0032811,1,0.969828566593226,0,4,negative regulation of epinephrine secretion,BP,
8759,GO:0032812,1,0.987304649836741,0,1,positive regulation of epinephrine secretion,BP,
8762,GO:0032815,1,0.927551197724928,0,7,negative regulation of natural killer cell activation,BP,
8764,GO:0032817,1,0.930098456883816,0,9,regulation of natural killer cell proliferation,BP,
8765,GO:0032819,1,0.939889360169762,0,7,positive regulation of natural killer cell proliferation,BP,
8766,GO:0032823,1,0.919546864411947,0,12,regulation of natural killer cell differentiation,BP,
8767,GO:0032824,1,0.964293124336486,0,3,negative regulation of natural killer cell differentiation,BP,
8768,GO:0032825,1,0.965058135709555,0,7,positive regulation of natural killer cell differentiation,BP,
8769,GO:0032826,1,0.953074196401118,0,4,regulation of natural killer cell differentiation involved in immune response,BP,
8770,GO:0032827,1,0.964293124336486,0,3,negative regulation of natural killer cell differentiation involved in immune response,BP,
8771,GO:0032829,1,0.967032813027015,0,3,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8772,GO:0032831,1,0.967032813027015,0,3,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8773,GO:0032832,1,0.97613394331001,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8774,GO:0032834,1,0.97613394331001,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8775,GO:0032835,1,0.76063227181378,0,63,glomerulus development,BP,
8776,GO:0032836,1,0.97945060003144,0,10,glomerular basement membrane development,BP,
8777,GO:0032838,1,0.726122401933849,0,62,cell projection cytoplasm,CC,
8778,GO:0032839,1,0.89646558751111,0,22,dendrite cytoplasm,CC,
8779,GO:0032841,1,0.996635649694438,0,1,calcitonin binding,MF,
8782,GO:0032846,1,0.246258480969473,0,203,positive regulation of homeostatic process,BP,
8783,GO:0032847,1,0.960525053831622,0,5,regulation of cellular pH reduction,BP,
8784,GO:0032848,1,0.997545316127058,0,1,negative regulation of cellular pH reduction,BP,
8785,GO:0032849,1,0.962889355656723,0,4,positive regulation of cellular pH reduction,BP,
8790,GO:0032873,1,0.792329765857107,0,41,negative regulation of stress-activated MAPK cascade,BP,
8792,GO:0032875,1,0.987461259377015,0,7,regulation of DNA endoreduplication,BP,
8793,GO:0032876,1,0.995611783694267,0,4,negative regulation of DNA endoreduplication,BP,
8794,GO:0032877,1,0.997061771750318,0,2,positive regulation of DNA endoreduplication,BP,
8795,GO:0032878,1,0.933012716572576,0,20,regulation of establishment or maintenance of cell polarity,BP,
8798,GO:0032881,1,0.857504687215822,0,36,regulation of polysaccharide metabolic process,BP,
8799,GO:0032885,1,0.879558999277735,0,33,regulation of polysaccharide biosynthetic process,BP,
8800,GO:0032886,1,0.420501707500609,0,152,regulation of microtubule-based process,BP,
8801,GO:0032889,1,0.991504619685906,0,1,regulation of vacuole fusion, non-autophagic,BP,
8802,GO:0032890,1,0.732528680138192,0,48,regulation of organic acid transport,BP,
8803,GO:0032891,1,0.912266614618037,0,17,negative regulation of organic acid transport,BP,
8804,GO:0032892,1,0.805889541186365,0,28,positive regulation of organic acid transport,BP,
8805,GO:0032897,1,0.840765303969495,0,24,negative regulation of viral transcription,BP,
8806,GO:0032898,1,0.984574690725167,0,4,neurotrophin production,BP,
8807,GO:0032899,1,0.990680646055738,0,2,regulation of neurotrophin production,BP,
8808,GO:0032900,1,0.992969168767015,0,1,negative regulation of neurotrophin production,BP,
8809,GO:0032901,1,0.99769540302298,0,1,positive regulation of neurotrophin production,BP,
8810,GO:0032902,1,0.993837065402253,0,2,nerve growth factor production,BP,
8811,GO:0032905,1,0.950569953454426,0,9,transforming growth factor beta1 production,BP,
8812,GO:0032906,1,0.972207927288342,0,8,transforming growth factor beta2 production,BP,
8813,GO:0032907,1,0.990040119311677,0,3,transforming growth factor beta3 production,BP,
8814,GO:0032908,1,0.950569953454426,0,9,regulation of transforming growth factor beta1 production,BP,
8815,GO:0032909,1,0.972207927288342,0,8,regulation of transforming growth factor beta2 production,BP,
8816,GO:0032910,1,0.990040119311677,0,3,regulation of transforming growth factor beta3 production,BP,
8817,GO:0032911,1,0.994708538403336,0,3,negative regulation of transforming growth factor beta1 production,BP,
8818,GO:0032912,1,0.994957836798479,0,2,negative regulation of transforming growth factor beta2 production,BP,
8819,GO:0032913,1,0.990040130479495,0,1,negative regulation of transforming growth factor beta3 production,BP,
8820,GO:0032914,1,0.955628461127181,0,6,positive regulation of transforming growth factor beta1 production,BP,
8821,GO:0032915,1,0.979080277402079,0,2,positive regulation of transforming growth factor beta2 production,BP,
8822,GO:0032916,1,0.999999992766268,0,2,positive regulation of transforming growth factor beta3 production,BP,
8823,GO:0032917,1,0.965163858013226,0,3,polyamine acetylation,BP,
8824,GO:0032918,1,0.965163858013226,0,3,spermidine acetylation,BP,
8825,GO:0032919,1,0.987339217613658,0,1,spermine acetylation,BP,
8826,GO:0032920,1,0.987339217613658,0,1,putrescine acetylation,BP,
8827,GO:0032922,1,0.793541467130358,0,51,circadian regulation of gene expression,BP,
8828,GO:0032924,1,0.76958804529148,0,39,activin receptor signaling pathway,BP,
8829,GO:0032925,1,0.853184972281915,0,23,regulation of activin receptor signaling pathway,BP,
8830,GO:0032926,1,0.943203562809571,0,9,negative regulation of activin receptor signaling pathway,BP,
8831,GO:0032927,1,0.960849895146207,0,8,positive regulation of activin receptor signaling pathway,BP,
8832,GO:0032928,1,0.893538759822318,0,13,regulation of superoxide anion generation,BP,
8833,GO:0032929,1,0.977608550675324,0,2,negative regulation of superoxide anion generation,BP,
8834,GO:0032930,1,0.91415865783436,0,10,positive regulation of superoxide anion generation,BP,
8835,GO:0032933,1,0.956927522641092,0,8,SREBP signaling pathway,BP,
8837,GO:0032937,1,0.983129936200343,0,3,SREBP-SCAP-Insig complex,CC,
8839,GO:0032941,1,0.735678042308973,0,38,secretion by tissue,BP,
8842,GO:0032945,1,0.617827489828666,0,64,negative regulation of mononuclear cell proliferation,BP,
8844,GO:0032947,1,0.726093269996921,0,68,protein complex scaffold,MF,
8845,GO:0032954,1,0.995283483065169,0,2,regulation of cytokinetic process,BP,
8847,GO:0032957,1,0.966850221010458,0,9,inositol trisphosphate metabolic process,BP,
8848,GO:0032958,1,0.889237921207419,0,20,inositol phosphate biosynthetic process,BP,
8849,GO:0032959,1,0.971723186256894,0,7,inositol trisphosphate biosynthetic process,BP,
8850,GO:0032960,1,0.974354858548454,0,5,regulation of inositol trisphosphate biosynthetic process,BP,
8851,GO:0032962,1,0.975342385245015,0,4,positive regulation of inositol trisphosphate biosynthetic process,BP,
8853,GO:0032964,1,0.780654288500309,0,35,collagen biosynthetic process,BP,
8854,GO:0032965,1,0.798085666422242,0,29,regulation of collagen biosynthetic process,BP,
8855,GO:0032966,1,0.945944607521527,0,7,negative regulation of collagen biosynthetic process,BP,
8856,GO:0032967,1,0.843754994595751,0,22,positive regulation of collagen biosynthetic process,BP,
8857,GO:0032968,1,0.93303612729481,0,13,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8859,GO:0032971,1,0.966608510710069,0,4,regulation of muscle filament sliding,BP,
8860,GO:0032972,1,0.974853045397302,0,2,regulation of muscle filament sliding speed,BP,
8861,GO:0032976,1,0.987247606983837,0,1,release of matrix enzymes from mitochondria,BP,
8862,GO:0032980,1,0.991025668935949,0,1,keratinocyte activation,BP,
8863,GO:0032981,1,0.534149508417167,0,55,mitochondrial respiratory chain complex I assembly,BP,
8864,GO:0032982,1,0.966941142061453,0,22,myosin filament,CC,
8865,GO:0032983,1,0.989518028808284,0,2,kainate selective glutamate receptor complex,CC,
8867,GO:0032986,1,0.866063159313939,0,20,protein-DNA complex disassembly,BP,
8868,GO:0032988,1,0.907968452417871,0,13,ribonucleoprotein complex disassembly,BP,
8872,GO:0032993,1,0.163275535198432,0,188,protein-DNA complex,CC,
8874,GO:0032996,1,0.988963313730548,0,1,Bcl3-Bcl10 complex,CC,
8875,GO:0032997,1,0.978305093559789,0,2,Fc receptor complex,CC,
8876,GO:0032998,1,0.978305093559789,0,2,Fc-epsilon receptor I complex,CC,
8878,GO:0033003,1,0.755718239075863,0,37,regulation of mast cell activation,BP,
8879,GO:0033004,1,0.904386144082474,0,12,negative regulation of mast cell activation,BP,
8880,GO:0033005,1,0.885108362568252,0,15,positive regulation of mast cell activation,BP,
8881,GO:0033006,1,0.793887081029253,0,29,regulation of mast cell activation involved in immune response,BP,
8882,GO:0033007,1,0.933044853850356,0,8,negative regulation of mast cell activation involved in immune response,BP,
8883,GO:0033008,1,0.892280556105397,0,13,positive regulation of mast cell activation involved in immune response,BP,
8884,GO:0033010,1,0.964361402210164,0,5,paranodal junction,CC,
8885,GO:0033011,1,0.959862507894279,0,4,perinuclear theca,CC,
8887,GO:0033014,1,0.825807956989017,0,27,tetrapyrrole biosynthetic process,BP,
8888,GO:0033015,1,0.923567299805573,0,7,tetrapyrrole catabolic process,BP,
8889,GO:0033017,1,0.830623458951885,0,37,sarcoplasmic reticulum membrane,CC,
8890,GO:0033018,1,0.956052380146985,0,7,sarcoplasmic reticulum lumen,CC,
8891,GO:0033023,1,0.98360366401754,0,3,mast cell homeostasis,BP,
8892,GO:0033024,1,0.98360366401754,0,3,mast cell apoptotic process,BP,
8893,GO:0033025,1,0.98360366401754,0,3,regulation of mast cell apoptotic process,BP,
8894,GO:0033026,1,0.987150479003609,0,2,negative regulation of mast cell apoptotic process,BP,
8895,GO:0033028,1,0.824239388236114,0,28,myeloid cell apoptotic process,BP,
8896,GO:0033029,1,0.974558921249012,0,5,regulation of neutrophil apoptotic process,BP,
8897,GO:0033030,1,0.999999996373612,0,1,negative regulation of neutrophil apoptotic process,BP,
8898,GO:0033031,1,0.974558929860521,0,4,positive regulation of neutrophil apoptotic process,BP,
8899,GO:0033032,1,0.857039087830845,0,24,regulation of myeloid cell apoptotic process,BP,
8900,GO:0033033,1,0.91286290009626,0,12,negative regulation of myeloid cell apoptotic process,BP,
8901,GO:0033034,1,0.959423873444636,0,8,positive regulation of myeloid cell apoptotic process,BP,
8903,GO:0033037,1,0.999999918690941,0,1,polysaccharide localization,BP,
8904,GO:0033038,1,0.796489697704546,0,18,bitter taste receptor activity,MF,
8905,GO:0033040,1,0.993980631566827,0,2,sour taste receptor activity,MF,
8906,GO:0033041,1,0.983210307698125,0,2,sweet taste receptor activity,MF,
8908,GO:0033044,1,0.194619164410932,0,281,regulation of chromosome organization,BP,
8909,GO:0033045,1,0.678995317544972,0,61,regulation of sister chromatid segregation,BP,
8910,GO:0033046,1,0.812793994926031,0,33,negative regulation of sister chromatid segregation,BP,
8911,GO:0033047,1,0.72569026683185,0,51,regulation of mitotic sister chromatid segregation,BP,
8912,GO:0033048,1,0.81279403201521,0,32,negative regulation of mitotic sister chromatid segregation,BP,
8913,GO:0033058,1,0.998816941308122,0,2,directional locomotion,BP,
8914,GO:0033059,1,0.704412702399798,0,50,cellular pigmentation,BP,
8915,GO:0033061,1,0.941383379935082,0,7,DNA recombinase mediator complex,CC,
8916,GO:0033063,1,0.957295013823753,0,5,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8917,GO:0033065,1,0.979289056133504,0,2,Rad51C-XRCC3 complex,CC,
8918,GO:0033076,1,0.967129629154907,0,3,isoquinoline alkaloid metabolic process,BP,
8920,GO:0033078,1,0.976787674358587,0,3,extrathymic T cell differentiation,BP,
8921,GO:0033079,1,0.936496745629797,0,9,immature T cell proliferation,BP,
8922,GO:0033080,1,0.955218963261122,0,7,immature T cell proliferation in thymus,BP,
8923,GO:0033081,1,0.846544812059756,0,24,regulation of T cell differentiation in thymus,BP,
8924,GO:0033082,1,0.988140594788359,0,2,regulation of extrathymic T cell differentiation,BP,
8925,GO:0033083,1,0.938611226838394,0,8,regulation of immature T cell proliferation,BP,
8926,GO:0033084,1,0.957375375195811,0,6,regulation of immature T cell proliferation in thymus,BP,
8927,GO:0033085,1,0.93716284086926,0,8,negative regulation of T cell differentiation in thymus,BP,
8928,GO:0033087,1,0.966711559669742,0,5,negative regulation of immature T cell proliferation,BP,
8929,GO:0033088,1,0.977940510647844,0,4,negative regulation of immature T cell proliferation in thymus,BP,
8930,GO:0033089,1,0.930024442622145,0,11,positive regulation of T cell differentiation in thymus,BP,
8931,GO:0033091,1,0.970939729935456,0,3,positive regulation of immature T cell proliferation,BP,
8932,GO:0033092,1,0.97897465793832,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8933,GO:0033093,1,0.981640187065419,0,5,Weibel-Palade body,CC,
8934,GO:0033106,1,0.991834996155373,0,1,cis-Golgi network membrane,CC,
8935,GO:0033108,1,0.434301565032032,0,77,mitochondrial respiratory chain complex assembly,BP,
8936,GO:0033116,1,0.621268926076343,0,66,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8937,GO:0033119,1,0.82561113718549,0,25,negative regulation of RNA splicing,BP,
8938,GO:0033120,1,0.85777231250982,0,25,positive regulation of RNA splicing,BP,
8939,GO:0033121,1,0.993239706664181,0,3,regulation of purine nucleotide catabolic process,BP,
8940,GO:0033122,1,0.993239711628937,0,2,negative regulation of purine nucleotide catabolic process,BP,
8941,GO:0033123,1,0.999999996372621,0,1,positive regulation of purine nucleotide catabolic process,BP,
8942,GO:0033127,1,0.905567239213953,0,13,regulation of histone phosphorylation,BP,
8943,GO:0033128,1,0.969811971192026,0,3,negative regulation of histone phosphorylation,BP,
8944,GO:0033129,1,0.946892974656205,0,8,positive regulation of histone phosphorylation,BP,
8945,GO:0033130,1,0.960406644840849,0,8,acetylcholine receptor binding,MF,
8946,GO:0033131,1,0.931625784976737,0,8,regulation of glucokinase activity,BP,
8947,GO:0033132,1,0.966357738816644,0,4,negative regulation of glucokinase activity,BP,
8948,GO:0033133,1,0.964068477724072,0,4,positive regulation of glucokinase activity,BP,
8949,GO:0033135,1,0.422651846286267,0,121,regulation of peptidyl-serine phosphorylation,BP,
8950,GO:0033136,1,0.946601527653696,0,8,serine phosphorylation of STAT3 protein,BP,
8951,GO:0033137,1,0.864106429317669,0,23,negative regulation of peptidyl-serine phosphorylation,BP,
8952,GO:0033138,1,0.491096465974077,0,92,positive regulation of peptidyl-serine phosphorylation,BP,
8953,GO:0033139,1,0.774541436583716,0,23,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8954,GO:0033140,1,0.981736401997741,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8955,GO:0033141,1,0.788977838055067,0,21,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8956,GO:0033142,1,0.990098120150865,0,2,progesterone receptor binding,MF,
8957,GO:0033143,1,0.69658227189867,0,64,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8958,GO:0033144,1,0.85320136245576,0,31,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8959,GO:0033145,1,0.910145559427899,0,15,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8960,GO:0033146,1,0.855170854745321,0,30,regulation of intracellular estrogen receptor signaling pathway,BP,
8961,GO:0033147,1,0.940928085567993,0,13,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8962,GO:0033148,1,0.958652240323511,0,9,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8963,GO:0033149,1,0.996870391411366,0,2,FFAT motif binding,MF,
8964,GO:0033150,1,0.968977842158483,0,3,cytoskeletal calyx,CC,
8965,GO:0033151,1,0.946945953995294,0,13,V(D)J recombination,BP,
8966,GO:0033152,1,0.984751571132618,0,4,immunoglobulin V(D)J recombination,BP,
8967,GO:0033153,1,0.987396812007754,0,5,T cell receptor V(D)J recombination,BP,
8969,GO:0033158,1,0.89617911193595,0,19,regulation of protein import into nucleus, translocation,BP,
8970,GO:0033159,1,0.986346861656672,0,3,negative regulation of protein import into nucleus, translocation,BP,
8971,GO:0033160,1,0.942149954245777,0,12,positive regulation of protein import into nucleus, translocation,BP,
8972,GO:0033162,1,0.88834313233644,0,12,melanosome membrane,CC,
8973,GO:0033165,1,0.985605189366848,0,3,interphotoreceptor matrix,CC,
8974,GO:0033167,1,0.999999996396927,0,1,ARC complex,CC,
8975,GO:0033168,1,0.999999996396927,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8976,GO:0033169,1,0.977943787051647,0,10,histone H3-K9 demethylation,BP,
8977,GO:0033170,1,0.935085780865754,0,8,protein-DNA loading ATPase activity,MF,
8978,GO:0033173,1,0.875931737612619,0,24,calcineurin-NFAT signaling cascade,BP,
8979,GO:0033176,1,0.818531503975793,0,23,proton-transporting V-type ATPase complex,CC,
8980,GO:0033177,1,0.80644573677757,0,21,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8981,GO:0033178,1,0.858285238058218,0,16,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8982,GO:0033179,1,0.920799791621567,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8983,GO:0033180,1,0.933086068640818,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8984,GO:0033182,1,0.964138400466942,0,9,regulation of histone ubiquitination,BP,
8985,GO:0033183,1,0.990950517501128,0,3,negative regulation of histone ubiquitination,BP,
8986,GO:0033184,1,0.981180342317097,0,5,positive regulation of histone ubiquitination,BP,
8988,GO:0033186,1,0.985964460752126,0,3,CAF-1 complex,CC,
8989,GO:0033188,1,0.985281119118618,0,3,sphingomyelin synthase activity,MF,
8990,GO:0033189,1,0.875083754856402,0,17,response to vitamin A,BP,
8991,GO:0033192,1,0.993907910170584,0,4,calmodulin-dependent protein phosphatase activity,MF,
8992,GO:0033193,1,0.999827246618124,0,1,Lsd1/2 complex,CC,
8993,GO:0033194,1,0.890613670638056,0,16,response to hydroperoxide,BP,
8994,GO:0033197,1,0.921034504753784,0,12,response to vitamin E,BP,
8995,GO:0033198,1,0.792472031140922,0,31,response to ATP,BP,
8996,GO:0033202,1,0.87954370084562,0,14,DNA helicase complex,CC,
8997,GO:0033204,1,0.991315714661173,0,1,ribonuclease P RNA binding,MF,
8998,GO:0033206,1,0.985252216992781,0,5,meiotic cytokinesis,BP,
9000,GO:0033210,1,0.946335341536425,0,9,leptin-mediated signaling pathway,BP,
9001,GO:0033211,1,0.968870293682491,0,6,adiponectin-activated signaling pathway,BP,
9002,GO:0033212,1,0.9908334975736,0,1,iron assimilation,BP,
9003,GO:0033214,1,0.9908334975736,0,1,iron assimilation by chelation and transport,BP,
9004,GO:0033216,1,0.97993618790222,0,5,ferric iron import,BP,
9006,GO:0033227,1,0.974888534297965,0,5,dsRNA transport,BP,
9007,GO:0033229,1,0.997093914670211,0,1,cysteine transmembrane transporter activity,MF,
9008,GO:0033231,1,0.998041284082169,0,1,carbohydrate export,BP,
9009,GO:0033233,1,0.858335385172675,0,21,regulation of protein sumoylation,BP,
9010,GO:0033234,1,0.931046560775498,0,10,negative regulation of protein sumoylation,BP,
9011,GO:0033235,1,0.920943729397293,0,11,positive regulation of protein sumoylation,BP,
9013,GO:0033239,1,0.984880587509847,0,4,negative regulation of cellular amine metabolic process,BP,
9014,GO:0033240,1,0.9267550811583,0,9,positive regulation of cellular amine metabolic process,BP,
9015,GO:0033241,1,0.999999996389206,0,1,regulation of cellular amine catabolic process,BP,
9016,GO:0033242,1,0.999999996389206,0,1,negative regulation of cellular amine catabolic process,BP,
9017,GO:0033256,1,0.944875070472888,0,7,I-kappaB/NF-kappaB complex,CC,
9018,GO:0033257,1,0.983095506256508,0,2,Bcl3/NF-kappaB2 complex,CC,
9019,GO:0033260,1,0.832923023335224,0,29,nuclear DNA replication,BP,
9020,GO:0033262,1,0.939334813411254,0,13,regulation of nuclear cell cycle DNA replication,BP,
9021,GO:0033263,1,0.990949297006013,0,4,CORVET complex,CC,
9022,GO:0033265,1,0.973002969648638,0,4,choline binding,MF,
9023,GO:0033267,1,0.432409698916208,0,174,axon part,CC,
9024,GO:0033268,1,0.956963935194282,0,15,node of Ranvier,CC,
9025,GO:0033269,1,0.977683052106044,0,4,internode region of axon,CC,
9026,GO:0033270,1,0.968552129386465,0,11,paranode region of axon,CC,
9027,GO:0033273,1,0.537337269227573,0,90,response to vitamin,BP,
9028,GO:0033274,1,0.99999999637961,0,1,response to vitamin B2,BP,
9029,GO:0033275,1,0.761023573591256,0,39,actin-myosin filament sliding,BP,
9030,GO:0033276,1,0.906116976421456,0,14,transcription factor TFTC complex,CC,
9031,GO:0033277,1,0.990358871618429,0,2,abortive mitotic cell cycle,BP,
9032,GO:0033278,1,0.954213419533072,0,8,cell proliferation in midbrain,BP,
9033,GO:0033280,1,0.808391421594767,0,35,response to vitamin D,BP,
9034,GO:0033290,1,0.998558196765875,0,1,eukaryotic 48S preinitiation complex,CC,
9035,GO:0033291,1,0.987145861542642,0,1,eukaryotic 80S initiation complex,CC,
9036,GO:0033292,1,0.987800041615563,0,3,T-tubule organization,BP,
9038,GO:0033299,1,0.959768396443515,0,5,secretion of lysosomal enzymes,BP,
9039,GO:0033300,1,0.98152087602726,0,4,dehydroascorbic acid transporter activity,MF,
9040,GO:0033301,1,0.99706185916452,0,1,cell cycle comprising mitosis without cytokinesis,BP,
9042,GO:0033313,1,0.934485248032784,0,8,meiotic cell cycle checkpoint,BP,
9043,GO:0033314,1,0.932024319279215,0,9,mitotic DNA replication checkpoint,BP,
9044,GO:0033315,1,0.987362443638139,0,1,meiotic DNA replication checkpoint,BP,
9045,GO:0033316,1,0.993899064481029,0,1,meiotic spindle assembly checkpoint,BP,
9046,GO:0033319,1,0.989728164273725,0,1,UDP-D-xylose metabolic process,BP,
9047,GO:0033320,1,0.989728164273725,0,1,UDP-D-xylose biosynthetic process,BP,
9048,GO:0033326,1,0.983301046186337,0,3,cerebrospinal fluid secretion,BP,
9049,GO:0033327,1,0.940132666221121,0,10,Leydig cell differentiation,BP,
9050,GO:0033328,1,0.996629268245158,0,1,peroxisome membrane targeting sequence binding,MF,
9051,GO:0033341,1,0.991500139435368,0,2,regulation of collagen binding,BP,
9052,GO:0033342,1,0.99150014473131,0,1,negative regulation of collagen binding,BP,
9053,GO:0033343,1,0.999999996383913,0,1,positive regulation of collagen binding,BP,
9055,GO:0033345,1,0.990869531971653,0,1,asparagine catabolic process via L-aspartate,BP,
9056,GO:0033353,1,0.983777295184984,0,4,S-adenosylmethionine cycle,BP,
9057,GO:0033363,1,0.832702202383944,0,29,secretory granule organization,BP,
9058,GO:0033364,1,0.98762578733333,0,2,mast cell secretory granule organization,BP,
9060,GO:0033366,1,0.987625793361721,0,1,protein localization to secretory granule,BP,
9061,GO:0033367,1,0.987625793361721,0,1,protein localization to mast cell secretory granule,BP,
9062,GO:0033368,1,0.987625793361721,0,1,protease localization to mast cell secretory granule,BP,
9063,GO:0033370,1,0.987625793361721,0,1,maintenance of protein location in mast cell secretory granule,BP,
9064,GO:0033371,1,0.987625793361721,0,1,T cell secretory granule organization,BP,
9065,GO:0033373,1,0.987625793361721,0,1,maintenance of protease location in mast cell secretory granule,BP,
9066,GO:0033374,1,0.987625793361721,0,1,protein localization to T cell secretory granule,BP,
9067,GO:0033375,1,0.987625793361721,0,1,protease localization to T cell secretory granule,BP,
9068,GO:0033377,1,0.987625793361721,0,1,maintenance of protein location in T cell secretory granule,BP,
9069,GO:0033379,1,0.987625793361721,0,1,maintenance of protease location in T cell secretory granule,BP,
9070,GO:0033380,1,0.987625793361721,0,1,granzyme B localization to T cell secretory granule,BP,
9071,GO:0033382,1,0.987625793361721,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
9072,GO:0033383,1,0.980923081420185,0,2,geranyl diphosphate metabolic process,BP,
9073,GO:0033384,1,0.980923081420185,0,2,geranyl diphosphate biosynthetic process,BP,
9074,GO:0033385,1,0.992829831324053,0,1,geranylgeranyl diphosphate metabolic process,BP,
9075,GO:0033386,1,0.992829831324053,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
9076,GO:0033387,1,0.988491519521746,0,2,putrescine biosynthetic process from ornithine,BP,
9077,GO:0033388,1,0.990125353848087,0,1,putrescine biosynthetic process from arginine,BP,
9078,GO:0033391,1,0.95105636223074,0,12,chromatoid body,CC,
9079,GO:0033477,1,0.989377095207634,0,1,S-methylmethionine metabolic process,BP,
9080,GO:0033483,1,0.942827672871118,0,9,gas homeostasis,BP,
9081,GO:0033484,1,0.979072990145939,0,3,nitric oxide homeostasis,BP,
9082,GO:0033488,1,0.99411107638574,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
9085,GO:0033499,1,0.991317921526807,0,1,galactose catabolic process via UDP-galactose,BP,
9087,GO:0033503,1,0.965336230961347,0,5,HULC complex,CC,
9088,GO:0033504,1,0.961477705443111,0,7,floor plate development,BP,
9089,GO:0033505,1,0.989695271791727,0,2,floor plate morphogenesis,BP,
9090,GO:0033512,1,0.983323939954961,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
9091,GO:0033514,1,0.991017055661357,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9092,GO:0033522,1,0.914014499568458,0,19,histone H2A ubiquitination,BP,
9093,GO:0033523,1,0.951410327737734,0,10,histone H2B ubiquitination,BP,
9095,GO:0033540,1,0.903114475939888,0,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9096,GO:0033549,1,0.896493058308053,0,14,MAP kinase phosphatase activity,MF,
9097,GO:0033552,1,0.987218774368248,0,1,response to vitamin B3,BP,
9098,GO:0033553,1,0.978524782121416,0,4,rDNA heterochromatin,CC,
9100,GO:0033555,1,0.681247807274336,0,66,multicellular organismal response to stress,BP,
9101,GO:0033557,1,0.975179379573793,0,3,Slx1-Slx4 complex,CC,
9102,GO:0033558,1,0.814551633103008,0,40,protein deacetylase activity,MF,
9104,GO:0033560,1,0.997800620129705,0,1,folate reductase activity,MF,
9105,GO:0033561,1,0.891461571672353,0,21,regulation of water loss via skin,BP,
9106,GO:0033563,1,0.987403176034187,0,3,dorsal/ventral axon guidance,BP,
9107,GO:0033564,1,0.993784568248734,0,5,anterior/posterior axon guidance,BP,
9108,GO:0033565,1,0.98704562393381,0,3,ESCRT-0 complex,CC,
9109,GO:0033566,1,0.98276609699347,0,2,gamma-tubulin complex localization,BP,
9110,GO:0033567,1,0.972296799033222,0,4,DNA replication, Okazaki fragment processing,BP,
9111,GO:0033570,1,0.999912920620146,0,1,transferrin transmembrane transporter activity,MF,
9112,GO:0033572,1,0.763931411049282,0,35,transferrin transport,BP,
9113,GO:0033574,1,0.70557576615731,0,43,response to testosterone,BP,
9114,GO:0033577,1,0.984889457146717,0,2,protein glycosylation in endoplasmic reticulum,BP,
9115,GO:0033578,1,0.968905633022859,0,5,protein glycosylation in Golgi,BP,
9116,GO:0033588,1,0.958469581115769,0,6,Elongator holoenzyme complex,CC,
9117,GO:0033590,1,0.971888953104966,0,3,response to cobalamin,BP,
9118,GO:0033591,1,0.968436293144585,0,5,response to L-ascorbic acid,BP,
9119,GO:0033592,1,0.981405156491077,0,5,RNA strand annealing activity,MF,
9120,GO:0033593,1,0.99999999640269,0,1,BRCA2-MAGE-D1 complex,CC,
9121,GO:0033594,1,0.963975710127406,0,4,response to hydroxyisoflavone,BP,
9122,GO:0033595,1,0.984720799945092,0,2,response to genistein,BP,
9123,GO:0033596,1,0.9964953451906,0,3,TSC1-TSC2 complex,CC,
9124,GO:0033598,1,0.859758499975798,0,27,mammary gland epithelial cell proliferation,BP,
9125,GO:0033599,1,0.906213810828256,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9126,GO:0033600,1,0.972886300127213,0,5,negative regulation of mammary gland epithelial cell proliferation,BP,
9127,GO:0033601,1,0.980121606054695,0,7,positive regulation of mammary gland epithelial cell proliferation,BP,
9128,GO:0033602,1,0.991872724094513,0,3,negative regulation of dopamine secretion,BP,
9129,GO:0033603,1,0.965363415252635,0,6,positive regulation of dopamine secretion,BP,
9130,GO:0033604,1,0.92719297925227,0,12,negative regulation of catecholamine secretion,BP,
9131,GO:0033605,1,0.927694407355713,0,11,positive regulation of catecholamine secretion,BP,
9132,GO:0033606,1,0.990040130479495,0,1,chemokine receptor transport within lipid bilayer,BP,
9133,GO:0033609,1,0.991657600429728,0,1,oxalate metabolic process,BP,
9136,GO:0033615,1,0.976586164919495,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9137,GO:0033617,1,0.879093293509607,0,14,mitochondrial respiratory chain complex IV assembly,BP,
9138,GO:0033619,1,0.731246094528216,0,55,membrane protein proteolysis,BP,
9139,GO:0033622,1,0.914805989743247,0,18,integrin activation,BP,
9140,GO:0033623,1,0.949787641965843,0,10,regulation of integrin activation,BP,
9141,GO:0033624,1,0.995720103213825,0,2,negative regulation of integrin activation,BP,
9142,GO:0033625,1,0.96791163110693,0,5,positive regulation of integrin activation,BP,
9143,GO:0033626,1,0.997023587758964,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9144,GO:0033627,1,0.738587150743799,0,55,cell adhesion mediated by integrin,BP,
9145,GO:0033628,1,0.773817009949197,0,39,regulation of cell adhesion mediated by integrin,BP,
9146,GO:0033629,1,0.954357603980044,0,9,negative regulation of cell adhesion mediated by integrin,BP,
9147,GO:0033630,1,0.888265682151007,0,17,positive regulation of cell adhesion mediated by integrin,BP,
9148,GO:0033631,1,0.939190294370934,0,12,cell-cell adhesion mediated by integrin,BP,
9149,GO:0033632,1,0.945324938327056,0,8,regulation of cell-cell adhesion mediated by integrin,BP,
9150,GO:0033633,1,0.999713417726914,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9151,GO:0033634,1,0.967173091757803,0,4,positive regulation of cell-cell adhesion mediated by integrin,BP,
9152,GO:0033643,1,0.965815745447764,0,9,host cell part,CC,
9153,GO:0033644,1,0.998615248312486,0,1,host cell membrane,CC,
9154,GO:0033646,1,0.967544855722345,0,7,host intracellular part,CC,
9155,GO:0033647,1,0.975095675058071,0,5,host intracellular organelle,CC,
9156,GO:0033648,1,0.975095675058071,0,5,host intracellular membrane-bounded organelle,CC,
9157,GO:0033650,1,0.988630136325738,0,1,host cell mitochondrion,CC,
9158,GO:0033655,1,0.976904609063082,0,4,host cell cytoplasm part,CC,
9159,GO:0033668,1,0.970062324161412,0,4,negative regulation by symbiont of host apoptotic process,BP,
9162,GO:0033676,1,0.987862294851839,0,1,double-stranded DNA-dependent ATPase activity,MF,
9163,GO:0033677,1,0.984619391434994,0,2,DNA/RNA helicase activity,MF,
9164,GO:0033678,1,0.992134884296411,0,1,5'-3' DNA/RNA helicase activity,MF,
9165,GO:0033680,1,0.992134884296411,0,1,ATP-dependent DNA/RNA helicase activity,MF,
9166,GO:0033682,1,0.992134884296411,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9167,GO:0033683,1,0.74186089275682,0,39,nucleotide-excision repair, DNA incision,BP,
9168,GO:0033684,1,0.955564566827719,0,7,regulation of luteinizing hormone secretion,BP,
9169,GO:0033685,1,0.978594499233137,0,3,negative regulation of luteinizing hormone secretion,BP,
9170,GO:0033686,1,0.976470313700956,0,4,positive regulation of luteinizing hormone secretion,BP,
9171,GO:0033687,1,0.862914332209156,0,26,osteoblast proliferation,BP,
9172,GO:0033688,1,0.885904481828601,0,23,regulation of osteoblast proliferation,BP,
9173,GO:0033689,1,0.97397718225173,0,9,negative regulation of osteoblast proliferation,BP,
9174,GO:0033690,1,0.928489256069597,0,11,positive regulation of osteoblast proliferation,BP,
9175,GO:0033691,1,0.969017895311453,0,9,sialic acid binding,MF,
9176,GO:0033692,1,0.723815177337135,0,58,cellular polysaccharide biosynthetic process,BP,
9177,GO:0033693,1,0.986802208350707,0,3,neurofilament bundle assembly,BP,
9178,GO:0033695,1,0.965582815908718,0,4,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9179,GO:0033699,1,0.989470467406246,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9181,GO:0033735,1,0.987326510191226,0,1,aspartate dehydrogenase activity,MF,
9182,GO:0033737,1,0.991415393511459,0,1,1-pyrroline dehydrogenase activity,MF,
9183,GO:0033743,1,0.967403256931117,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9184,GO:0033746,1,0.996656886905039,0,1,histone demethylase activity (H3-R2 specific),MF,
9185,GO:0033749,1,0.996656886905039,0,1,histone demethylase activity (H4-R3 specific),MF,
9186,GO:0033750,1,0.900988018659642,0,12,ribosome localization,BP,
9187,GO:0033753,1,0.900988018659642,0,12,establishment of ribosome localization,BP,
9188,GO:0033754,1,0.978827335505285,0,2,indoleamine 2,3-dioxygenase activity,MF,
9189,GO:0033762,1,0.735817759404711,0,48,response to glucagon,BP,
9191,GO:0033765,1,0.973870566324442,0,3,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9192,GO:0033768,1,0.994057483978035,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9193,GO:0033778,1,0.997892872106596,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9194,GO:0033780,1,0.992662520819034,0,1,taurochenodeoxycholate 6alpha-hydroxylase activity,MF,
9195,GO:0033781,1,0.989702569287809,0,1,cholesterol 24-hydroxylase activity,MF,
9196,GO:0033787,1,0.993002887673498,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9197,GO:0033791,1,0.990607568052662,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9198,GO:0033798,1,0.989746516163076,0,1,thyroxine 5-deiodinase activity,MF,
9199,GO:0033814,1,0.987886501186532,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9200,GO:0033819,1,0.987333500356701,0,1,lipoyl(octanoyl) transferase activity,MF,
9201,GO:0033823,1,0.993696758730521,0,1,procollagen glucosyltransferase activity,MF,
9202,GO:0033829,1,0.968866615098572,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9203,GO:0033842,1,0.99190035195877,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9204,GO:0033857,1,0.999955540382241,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9205,GO:0033858,1,0.994570120275529,0,1,N-acetylgalactosamine kinase activity,MF,
9206,GO:0033860,1,0.91794654408378,0,8,regulation of NAD(P)H oxidase activity,BP,
9207,GO:0033861,1,0.966035020058617,0,3,negative regulation of NAD(P)H oxidase activity,BP,
9208,GO:0033862,1,0.993682139567738,0,1,UMP kinase activity,MF,
9209,GO:0033864,1,0.950234048950177,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9212,GO:0033867,1,0.988350769116958,0,1,Fas-activated serine/threonine kinase activity,MF,
9214,GO:0033871,1,0.989218981406881,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9215,GO:0033872,1,0.981082760028184,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9217,GO:0033878,1,0.997409142745385,0,1,hormone-sensitive lipase activity,MF,
9218,GO:0033882,1,0.987514876358812,0,1,choloyl-CoA hydrolase activity,MF,
9219,GO:0033883,1,0.977012793804975,0,2,pyridoxal phosphatase activity,MF,
9220,GO:0033885,1,0.990164429951147,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9221,GO:0033897,1,0.987625793361721,0,1,ribonuclease T2 activity,MF,
9222,GO:0033906,1,0.979470977399191,0,2,hyaluronoglucuronidase activity,MF,
9223,GO:0033919,1,0.997758871194876,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9224,GO:0033925,1,0.999263353510476,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9225,GO:0033961,1,0.98861777227253,0,1,cis-stilbene-oxide hydrolase activity,MF,
9226,GO:0033962,1,0.941321915071188,0,18,cytoplasmic mRNA processing body assembly,BP,
9227,GO:0033967,1,0.987526012197698,0,1,box C/D snoRNA metabolic process,BP,
9228,GO:0033979,1,0.991741501148104,0,1,box H/ACA snoRNA metabolic process,BP,
9229,GO:0033981,1,0.987186263926252,0,1,D-dopachrome decarboxylase activity,MF,
9230,GO:0033989,1,0.992260893557381,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9232,GO:0034014,1,0.990490488218666,0,1,response to triglyceride,BP,
9233,GO:0034021,1,0.974545602088016,0,2,response to silicon dioxide,BP,
9239,GO:0034035,1,0.846751072761193,0,19,purine ribonucleoside bisphosphate metabolic process,BP,
9240,GO:0034036,1,0.964503642550005,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9241,GO:0034038,1,0.987547776319727,0,1,deoxyhypusine synthase activity,MF,
9242,GO:0034039,1,0.989113028430245,0,1,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9245,GO:0034045,1,0.941800410598491,0,14,pre-autophagosomal structure membrane,CC,
9246,GO:0034046,1,0.985906452861342,0,5,poly(G) binding,MF,
9247,GO:0034056,1,0.983593675992291,0,4,estrogen response element binding,MF,
9248,GO:0034057,1,0.989670842107673,0,2,RNA strand-exchange activity,MF,
9249,GO:0034058,1,0.977807206306131,0,9,endosomal vesicle fusion,BP,
9250,GO:0034059,1,0.989714531134548,0,3,response to anoxia,BP,
9251,GO:0034061,1,0.823857616362116,0,33,DNA polymerase activity,MF,
9252,GO:0034062,1,0.719137152898073,0,42,5'-3' RNA polymerase activity,MF,
9253,GO:0034063,1,0.970183470013128,0,10,stress granule assembly,BP,
9254,GO:0034066,1,0.987694378371925,0,1,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9255,GO:0034067,1,0.914272048694161,0,32,protein localization to Golgi apparatus,BP,
9256,GO:0034080,1,0.679171851402199,0,37,CENP-A containing nucleosome assembly,BP,
9257,GO:0034085,1,0.980495949860255,0,3,establishment of sister chromatid cohesion,BP,
9258,GO:0034086,1,0.959088525474063,0,9,maintenance of sister chromatid cohesion,BP,
9259,GO:0034088,1,0.959088525474063,0,9,maintenance of mitotic sister chromatid cohesion,BP,
9260,GO:0034091,1,0.976852374484189,0,5,regulation of maintenance of sister chromatid cohesion,BP,
9261,GO:0034092,1,0.999999992794904,0,2,negative regulation of maintenance of sister chromatid cohesion,BP,
9262,GO:0034093,1,0.976852390772264,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9264,GO:0034098,1,0.962244457368067,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9265,GO:0034101,1,0.518703096600243,0,102,erythrocyte homeostasis,BP,
9267,GO:0034104,1,0.881481578687036,0,19,negative regulation of tissue remodeling,BP,
9268,GO:0034105,1,0.821330276923395,0,26,positive regulation of tissue remodeling,BP,
9269,GO:0034109,1,0.656391929170496,0,71,homotypic cell-cell adhesion,BP,
9270,GO:0034110,1,0.882166685404032,0,22,regulation of homotypic cell-cell adhesion,BP,
9271,GO:0034111,1,0.931132199785373,0,13,negative regulation of homotypic cell-cell adhesion,BP,
9272,GO:0034112,1,0.965605722584582,0,4,positive regulation of homotypic cell-cell adhesion,BP,
9273,GO:0034113,1,0.757577596003188,0,49,heterotypic cell-cell adhesion,BP,
9274,GO:0034114,1,0.853752139669613,0,20,regulation of heterotypic cell-cell adhesion,BP,
9275,GO:0034115,1,0.92814234739962,0,9,negative regulation of heterotypic cell-cell adhesion,BP,
9276,GO:0034116,1,0.909137562333809,0,12,positive regulation of heterotypic cell-cell adhesion,BP,
9277,GO:0034117,1,0.987166577231582,0,1,erythrocyte aggregation,BP,
9278,GO:0034118,1,0.987166577231582,0,1,regulation of erythrocyte aggregation,BP,
9279,GO:0034120,1,0.987166577231582,0,1,positive regulation of erythrocyte aggregation,BP,
9282,GO:0034123,1,0.886467707887894,0,18,positive regulation of toll-like receptor signaling pathway,BP,
9283,GO:0034124,1,0.963857752332353,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9284,GO:0034125,1,0.977804895516539,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9287,GO:0034130,1,0.993007707207986,0,1,toll-like receptor 1 signaling pathway,BP,
9288,GO:0034134,1,0.93616069275961,0,10,toll-like receptor 2 signaling pathway,BP,
9289,GO:0034135,1,0.962799407648717,0,5,regulation of toll-like receptor 2 signaling pathway,BP,
9290,GO:0034136,1,0.993213577354532,0,2,negative regulation of toll-like receptor 2 signaling pathway,BP,
9291,GO:0034137,1,0.969379650686478,0,3,positive regulation of toll-like receptor 2 signaling pathway,BP,
9292,GO:0034138,1,0.900427735353205,0,16,toll-like receptor 3 signaling pathway,BP,
9293,GO:0034139,1,0.951967634097274,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9294,GO:0034140,1,0.990783697130676,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9295,GO:0034141,1,0.95424908528633,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9296,GO:0034142,1,0.837016413130824,0,28,toll-like receptor 4 signaling pathway,BP,
9297,GO:0034143,1,0.914107307796674,0,14,regulation of toll-like receptor 4 signaling pathway,BP,
9298,GO:0034144,1,0.976927362726343,0,5,negative regulation of toll-like receptor 4 signaling pathway,BP,
9299,GO:0034145,1,0.93570783321816,0,9,positive regulation of toll-like receptor 4 signaling pathway,BP,
9300,GO:0034146,1,0.997957353217746,0,2,toll-like receptor 5 signaling pathway,BP,
9301,GO:0034147,1,0.999148640907736,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9302,GO:0034148,1,0.999148640907736,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9303,GO:0034150,1,0.999999996371812,0,1,toll-like receptor 6 signaling pathway,BP,
9304,GO:0034154,1,0.977095617051065,0,5,toll-like receptor 7 signaling pathway,BP,
9305,GO:0034155,1,0.996178194492557,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
9306,GO:0034157,1,0.996178194492557,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
9307,GO:0034158,1,0.99867077668669,0,1,toll-like receptor 8 signaling pathway,BP,
9308,GO:0034162,1,0.919494120879348,0,18,toll-like receptor 9 signaling pathway,BP,
9309,GO:0034163,1,0.991969544482513,0,3,regulation of toll-like receptor 9 signaling pathway,BP,
9310,GO:0034164,1,0.999999996376584,0,1,negative regulation of toll-like receptor 9 signaling pathway,BP,
9311,GO:0034165,1,0.99196954969355,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9312,GO:0034166,1,0.995243300986144,0,1,toll-like receptor 10 signaling pathway,BP,
9313,GO:0034182,1,0.976852374484189,0,5,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9314,GO:0034183,1,0.999999992794904,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9315,GO:0034184,1,0.976852390772264,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9316,GO:0034185,1,0.940269771202396,0,16,apolipoprotein binding,MF,
9317,GO:0034186,1,0.970884293254811,0,4,apolipoprotein A-I binding,MF,
9318,GO:0034188,1,0.999999992775708,0,2,apolipoprotein A-I receptor activity,MF,
9319,GO:0034189,1,0.993343201794822,0,2,very-low-density lipoprotein particle binding,MF,
9320,GO:0034190,1,0.951767531956726,0,6,apolipoprotein receptor binding,MF,
9321,GO:0034191,1,0.967309364736544,0,4,apolipoprotein A-I receptor binding,MF,
9322,GO:0034196,1,0.956707203766448,0,5,acylglycerol transport,BP,
9323,GO:0034197,1,0.956707203766448,0,5,triglyceride transport,BP,
9324,GO:0034198,1,0.791694038261951,0,36,cellular response to amino acid starvation,BP,
9325,GO:0034199,1,0.934574213438836,0,17,activation of protein kinase A activity,BP,
9326,GO:0034201,1,0.971724229258665,0,5,response to oleic acid,BP,
9327,GO:0034203,1,0.999885082203742,0,1,glycolipid translocation,BP,
9328,GO:0034204,1,0.977563218792069,0,23,lipid translocation,BP,
9329,GO:0034205,1,0.928913070248286,0,14,beta-amyloid formation,BP,
9330,GO:0034211,1,0.999999996391606,0,1,GTP-dependent protein kinase activity,MF,
9331,GO:0034212,1,0.677545192683584,0,63,peptide N-acetyltransferase activity,MF,
9332,GO:0034213,1,0.988131315677453,0,1,quinolinate catabolic process,BP,
9333,GO:0034214,1,0.955269067392233,0,7,protein hexamerization,BP,
9334,GO:0034219,1,0.829901239745821,0,26,carbohydrate transmembrane transport,BP,
9336,GO:0034224,1,0.979771761015405,0,2,cellular response to zinc ion starvation,BP,
9337,GO:0034226,1,0.991743769777111,0,2,lysine import,BP,
9338,GO:0034227,1,0.947974306568827,0,5,tRNA thio-modification,BP,
9339,GO:0034230,1,0.999610897074206,0,1,enkephalin processing,BP,
9340,GO:0034231,1,0.999610897074206,0,1,islet amyloid polypeptide processing,BP,
9341,GO:0034235,1,0.947935934247945,0,7,GPI anchor binding,MF,
9342,GO:0034236,1,0.923779307642911,0,14,protein kinase A catalytic subunit binding,MF,
9343,GO:0034237,1,0.950578752608635,0,16,protein kinase A regulatory subunit binding,MF,
9344,GO:0034238,1,0.981451476329986,0,3,macrophage fusion,BP,
9345,GO:0034239,1,0.981451476329986,0,3,regulation of macrophage fusion,BP,
9346,GO:0034241,1,0.981451476329986,0,3,positive regulation of macrophage fusion,BP,
9347,GO:0034242,1,0.976925511090345,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9348,GO:0034243,1,0.872807192087999,0,23,regulation of transcription elongation from RNA polymerase II promoter,BP,
9349,GO:0034244,1,0.925055736619702,0,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9350,GO:0034245,1,0.997431787541536,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9351,GO:0034247,1,0.975637929761927,0,2,snoRNA splicing,BP,
9355,GO:0034255,1,0.989936963505739,0,1,regulation of urea metabolic process,BP,
9357,GO:0034271,1,0.989800570219606,0,2,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9358,GO:0034272,1,0.989800570219606,0,2,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9359,GO:0034274,1,0.993612337861676,0,3,Atg12-Atg5-Atg16 complex,CC,
9360,GO:0034275,1,0.988182900239937,0,1,kynurenic acid metabolic process,BP,
9361,GO:0034276,1,0.988182900239937,0,1,kynurenic acid biosynthetic process,BP,
9363,GO:0034285,1,0.972197343899827,0,6,response to disaccharide,BP,
9364,GO:0034287,1,0.962387460971173,0,4,detection of monosaccharide stimulus,BP,
9366,GO:0034309,1,0.98731767947796,0,1,primary alcohol biosynthetic process,BP,
9367,GO:0034310,1,0.852516548444733,0,15,primary alcohol catabolic process,BP,
9368,GO:0034311,1,0.915946149219264,0,11,diol metabolic process,BP,
9369,GO:0034312,1,0.943413707129138,0,8,diol biosynthetic process,BP,
9370,GO:0034314,1,0.799893923486539,0,32,Arp2/3 complex-mediated actin nucleation,BP,
9371,GO:0034315,1,0.906962355659784,0,16,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9372,GO:0034316,1,0.964284072844069,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9373,GO:0034329,1,0.432675697371352,0,191,cell junction assembly,BP,
9375,GO:0034331,1,0.971447205372927,0,8,cell junction maintenance,BP,
9377,GO:0034333,1,0.754196194495651,0,79,adherens junction assembly,BP,
9378,GO:0034334,1,0.999043426118772,0,2,adherens junction maintenance,BP,
9379,GO:0034337,1,0.99760379122383,0,1,RNA folding,BP,
9380,GO:0034338,1,0.992983615869936,0,1,short-chain carboxylesterase activity,MF,
9383,GO:0034342,1,0.981591956277685,0,2,response to type III interferon,BP,
9384,GO:0034343,1,0.989403448632776,0,3,type III interferon production,BP,
9385,GO:0034344,1,0.989403448632776,0,3,regulation of type III interferon production,BP,
9386,GO:0034346,1,0.993935629231289,0,1,positive regulation of type III interferon production,BP,
9387,GO:0034349,1,0.915143212718388,0,15,glial cell apoptotic process,BP,
9388,GO:0034350,1,0.95389711018159,0,8,regulation of glial cell apoptotic process,BP,
9389,GO:0034351,1,0.95389711018159,0,8,negative regulation of glial cell apoptotic process,BP,
9390,GO:0034354,1,0.987629738760797,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9393,GO:0034359,1,0.999999996415366,0,1,mature chylomicron,CC,
9394,GO:0034360,1,0.999999996415366,0,1,chylomicron remnant,CC,
9396,GO:0034362,1,0.908740540613029,0,12,low-density lipoprotein particle,CC,
9397,GO:0034363,1,0.962387656504186,0,4,intermediate-density lipoprotein particle,CC,
9399,GO:0034365,1,0.974681059274754,0,2,discoidal high-density lipoprotein particle,CC,
9400,GO:0034366,1,0.909082817715504,0,8,spherical high-density lipoprotein particle,CC,
9404,GO:0034370,1,0.881972012733808,0,11,triglyceride-rich lipoprotein particle remodeling,BP,
9405,GO:0034371,1,0.972566099789206,0,3,chylomicron remodeling,BP,
9406,GO:0034372,1,0.881972012733808,0,11,very-low-density lipoprotein particle remodeling,BP,
9407,GO:0034373,1,0.988261297406379,0,1,intermediate-density lipoprotein particle remodeling,BP,
9411,GO:0034378,1,0.987951812109276,0,2,chylomicron assembly,BP,
9413,GO:0034380,1,0.907641683000164,0,10,high-density lipoprotein particle assembly,BP,
9416,GO:0034383,1,0.873855216804232,0,18,low-density lipoprotein particle clearance,BP,
9417,GO:0034384,1,0.908645792749255,0,9,high-density lipoprotein particle clearance,BP,
9419,GO:0034388,1,0.963914117228989,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9420,GO:0034389,1,0.906232205862509,0,15,lipid particle organization,BP,
9421,GO:0034390,1,0.889436201425915,0,15,smooth muscle cell apoptotic process,BP,
9422,GO:0034391,1,0.889436201425915,0,15,regulation of smooth muscle cell apoptotic process,BP,
9423,GO:0034392,1,0.966764890319451,0,5,negative regulation of smooth muscle cell apoptotic process,BP,
9424,GO:0034393,1,0.931437038644454,0,8,positive regulation of smooth muscle cell apoptotic process,BP,
9426,GO:0034395,1,0.983648845972371,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9427,GO:0034397,1,0.928996000249455,0,13,telomere localization,BP,
9428,GO:0034398,1,0.972676208744773,0,6,telomere tethering at nuclear periphery,BP,
9430,GO:0034402,1,0.990628259674076,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9431,GO:0034405,1,0.826396250904268,0,34,response to fluid shear stress,BP,
9432,GO:0034414,1,0.987722884113335,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9433,GO:0034416,1,0.993002887673498,0,1,bisphosphoglycerate phosphatase activity,MF,
9434,GO:0034417,1,0.993002887673498,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9436,GO:0034421,1,0.985238610029587,0,3,post-translational protein acetylation,BP,
9437,GO:0034423,1,0.991995844666959,0,1,autophagosome lumen,CC,
9438,GO:0034427,1,0.937252217914842,0,7,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9439,GO:0034431,1,0.968037406610311,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9440,GO:0034432,1,0.968037406610311,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9446,GO:0034439,1,0.983317174449214,0,2,lipoprotein lipid oxidation,BP,
9448,GO:0034441,1,0.964368223586648,0,3,plasma lipoprotein oxidation,BP,
9449,GO:0034442,1,0.959057205036586,0,4,regulation of lipoprotein oxidation,BP,
9450,GO:0034443,1,0.963122860713618,0,3,negative regulation of lipoprotein oxidation,BP,
9451,GO:0034444,1,0.975331685915573,0,2,regulation of plasma lipoprotein oxidation,BP,
9452,GO:0034445,1,0.975331685915573,0,2,negative regulation of plasma lipoprotein oxidation,BP,
9453,GO:0034446,1,0.679332177385468,0,78,substrate adhesion-dependent cell spreading,BP,
9455,GO:0034448,1,0.988815477813736,0,1,EGO complex,CC,
9456,GO:0034450,1,0.940507280261502,0,13,ubiquitin-ubiquitin ligase activity,MF,
9457,GO:0034451,1,0.891779328581235,0,25,centriolar satellite,CC,
9458,GO:0034452,1,0.971257626118252,0,9,dynactin binding,MF,
9459,GO:0034453,1,0.943503813943869,0,18,microtubule anchoring,BP,
9460,GO:0034454,1,0.990313656124099,0,6,microtubule anchoring at centrosome,BP,
9461,GO:0034455,1,0.991243096157674,0,2,t-UTP complex,CC,
9462,GO:0034456,1,0.986219223613473,0,2,UTP-C complex,CC,
9463,GO:0034457,1,0.966725194377654,0,3,Mpp10 complex,CC,
9464,GO:0034458,1,0.991317921526807,0,1,3'-5' RNA helicase activity,MF,
9465,GO:0034462,1,0.990330801809516,0,1,small-subunit processome assembly,BP,
9466,GO:0034463,1,0.987145861542642,0,1,90S preribosome assembly,BP,
9467,GO:0034464,1,0.938204167581799,0,9,BBSome,CC,
9468,GO:0034465,1,0.972615348333352,0,4,response to carbon monoxide,BP,
9469,GO:0034466,1,0.992624424307463,0,1,chromaffin granule lumen,CC,
9471,GO:0034471,1,0.983803594165371,0,3,ncRNA 5'-end processing,BP,
9472,GO:0034472,1,0.930541753750781,0,8,snRNA 3'-end processing,BP,
9473,GO:0034474,1,0.999999996378776,0,1,U2 snRNA 3'-end processing,BP,
9474,GO:0034475,1,0.942128498710658,0,5,U4 snRNA 3'-end processing,BP,
9475,GO:0034477,1,0.991657600429728,0,1,U6 snRNA 3'-end processing,BP,
9476,GO:0034481,1,0.959697229178975,0,6,chondroitin sulfotransferase activity,MF,
9477,GO:0034483,1,0.925878947595093,0,15,heparan sulfate sulfotransferase activity,MF,
9478,GO:0034485,1,0.984482191801791,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9479,GO:0034486,1,0.98951607001257,0,1,vacuolar transmembrane transport,BP,
9480,GO:0034497,1,0.981971345404132,0,7,protein localization to pre-autophagosomal structure,BP,
9481,GO:0034498,1,0.960490967268822,0,7,early endosome to Golgi transport,BP,
9482,GO:0034499,1,0.999679940678326,0,2,late endosome to Golgi transport,BP,
9483,GO:0034501,1,0.888298134897656,0,15,protein localization to kinetochore,BP,
9484,GO:0034502,1,0.635120630542167,0,63,protein localization to chromosome,BP,
9486,GO:0034505,1,0.883380790215771,0,21,tooth mineralization,BP,
9487,GO:0034506,1,0.998161212044196,0,1,chromosome, centromeric core domain,CC,
9488,GO:0034508,1,0.637842114342452,0,49,centromere complex assembly,BP,
9489,GO:0034511,1,0.967229338858195,0,5,U3 snoRNA binding,MF,
9490,GO:0034513,1,0.942767788778549,0,5,box H/ACA snoRNA binding,MF,
9491,GO:0034516,1,0.988006973601008,0,1,response to vitamin B6,BP,
9492,GO:0034518,1,0.92857311530716,0,13,RNA cap binding complex,CC,
9493,GO:0034545,1,0.988437274027011,0,1,fumarylpyruvate hydrolase activity,MF,
9494,GO:0034551,1,0.956018062314132,0,5,mitochondrial respiratory chain complex III assembly,BP,
9495,GO:0034552,1,0.975207479437647,0,2,respiratory chain complex II assembly,BP,
9496,GO:0034553,1,0.975207479437647,0,2,mitochondrial respiratory chain complex II assembly,BP,
9497,GO:0034584,1,0.988087937376909,0,3,piRNA binding,MF,
9498,GO:0034587,1,0.899991115790651,0,16,piRNA metabolic process,BP,
9499,GO:0034589,1,0.998890254767214,0,1,hydroxyproline transport,BP,
9500,GO:0034590,1,0.998890254767214,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9501,GO:0034593,1,0.90483017571672,0,26,phosphatidylinositol bisphosphate phosphatase activity,MF,
9502,GO:0034594,1,0.973510993106964,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9503,GO:0034595,1,0.960355779921736,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9504,GO:0034596,1,0.964110401287314,0,10,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9505,GO:0034597,1,0.977959514399621,0,4,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9507,GO:0034602,1,0.998895765158013,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9508,GO:0034603,1,0.959782258336153,0,6,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9509,GO:0034604,1,0.959782258336153,0,6,pyruvate dehydrogenase (NAD+) activity,MF,
9510,GO:0034605,1,0.543354393985555,0,110,cellular response to heat,BP,
9514,GO:0034616,1,0.91914648207741,0,14,response to laminar fluid shear stress,BP,
9515,GO:0034617,1,0.979150299784392,0,4,tetrahydrobiopterin binding,MF,
9516,GO:0034618,1,0.960564313145761,0,6,arginine binding,MF,
9519,GO:0034625,1,0.969599470846233,0,3,fatty acid elongation, monounsaturated fatty acid,BP,
9520,GO:0034626,1,0.977340838387403,0,4,fatty acid elongation, polyunsaturated fatty acid,BP,
9521,GO:0034627,1,0.974043741298602,0,4,'de novo' NAD biosynthetic process,BP,
9522,GO:0034628,1,0.986245185383385,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9523,GO:0034629,1,0.82960917092517,0,27,cellular protein complex localization,BP,
9526,GO:0034634,1,0.999999996375099,0,1,glutathione transmembrane transporter activity,MF,
9527,GO:0034635,1,0.989411458953521,0,2,glutathione transport,BP,
9528,GO:0034637,1,0.64964485502125,0,72,cellular carbohydrate biosynthetic process,BP,
9531,GO:0034643,1,0.931344812358566,0,17,establishment of mitochondrion localization, microtubule-mediated,BP,
9532,GO:0034644,1,0.674082244486258,0,69,cellular response to UV,BP,
9534,GO:0034647,1,0.999999992775266,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9535,GO:0034648,1,0.991873381155051,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9536,GO:0034649,1,0.99769540302298,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9537,GO:0034650,1,0.961007177491956,0,9,cortisol metabolic process,BP,
9538,GO:0034651,1,0.961007177491956,0,9,cortisol biosynthetic process,BP,
9539,GO:0034653,1,0.965207058916833,0,4,retinoic acid catabolic process,BP,
9542,GO:0034656,1,0.933952047344168,0,7,nucleobase-containing small molecule catabolic process,BP,
9543,GO:0034657,1,0.978778709458078,0,3,GID complex,CC,
9545,GO:0034661,1,0.870434261133153,0,23,ncRNA catabolic process,BP,
9546,GO:0034663,1,0.93045951516568,0,10,endoplasmic reticulum chaperone complex,CC,
9547,GO:0034665,1,0.996919853533986,0,2,integrin alpha1-beta1 complex,CC,
9548,GO:0034666,1,0.991312357989722,0,3,integrin alpha2-beta1 complex,CC,
9549,GO:0034667,1,0.997047102049757,0,2,integrin alpha3-beta1 complex,CC,
9550,GO:0034668,1,0.997852161842949,0,1,integrin alpha4-beta1 complex,CC,
9551,GO:0034669,1,0.992686354775588,0,2,integrin alpha4-beta7 complex,CC,
9552,GO:0034670,1,0.999999996394242,0,1,chemotaxis to arachidonic acid,BP,
9553,GO:0034673,1,0.987827677416781,0,3,inhibin-betaglycan-ActRII complex,CC,
9554,GO:0034676,1,0.999999964592311,0,1,integrin alpha6-beta4 complex,CC,
9555,GO:0034677,1,0.997236156041462,0,1,integrin alpha7-beta1 complex,CC,
9556,GO:0034678,1,0.991792275719903,0,3,integrin alpha8-beta1 complex,CC,
9557,GO:0034679,1,0.998018646612852,0,1,integrin alpha9-beta1 complex,CC,
9558,GO:0034680,1,0.997159953116027,0,2,integrin alpha10-beta1 complex,CC,
9559,GO:0034681,1,0.997079327702942,0,2,integrin alpha11-beta1 complex,CC,
9560,GO:0034683,1,0.999756715934497,0,2,integrin alphav-beta3 complex,CC,
9561,GO:0034684,1,0.995576526740419,0,2,integrin alphav-beta5 complex,CC,
9562,GO:0034685,1,0.99098266346577,0,2,integrin alphav-beta6 complex,CC,
9563,GO:0034686,1,0.999999992767284,0,2,integrin alphav-beta8 complex,CC,
9564,GO:0034687,1,0.993372209230166,0,2,integrin alphaL-beta2 complex,CC,
9565,GO:0034693,1,0.991225561310078,0,1,U11/U12 snRNP,CC,
9566,GO:0034694,1,0.831300258285675,0,30,response to prostaglandin,BP,
9567,GO:0034695,1,0.860833639662742,0,24,response to prostaglandin E,BP,
9568,GO:0034696,1,0.989744678367247,0,1,response to prostaglandin F,BP,
9573,GO:0034704,1,0.771791055982712,0,55,calcium channel complex,CC,
9574,GO:0034705,1,0.605366605161279,0,90,potassium channel complex,CC,
9575,GO:0034706,1,0.958472744864766,0,20,sodium channel complex,CC,
9577,GO:0034708,1,0.564668114594834,0,83,methyltransferase complex,CC,
9578,GO:0034709,1,0.867125859547883,0,12,methylosome,CC,
9579,GO:0034711,1,0.966332295654186,0,5,inhibin binding,MF,
9580,GO:0034713,1,0.94954753956727,0,9,type I transforming growth factor beta receptor binding,MF,
9581,GO:0034714,1,0.984760519303431,0,3,type III transforming growth factor beta receptor binding,MF,
9582,GO:0034715,1,0.928682322995704,0,6,pICln-Sm protein complex,CC,
9583,GO:0034718,1,0.999981543720513,0,1,SMN-Gemin2 complex,CC,
9584,GO:0034719,1,0.845795985041561,0,17,SMN-Sm protein complex,CC,
9585,GO:0034720,1,0.991864366949543,0,6,histone H3-K4 demethylation,BP,
9586,GO:0034721,1,0.999999992775266,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9587,GO:0034722,1,0.988017643055512,0,1,gamma-glutamyl-peptidase activity,MF,
9588,GO:0034723,1,0.693996377094724,0,32,DNA replication-dependent nucleosome organization,BP,
9589,GO:0034724,1,0.637572438649178,0,49,DNA replication-independent nucleosome organization,BP,
9590,GO:0034727,1,0.996601222492386,0,2,piecemeal microautophagy of nucleus,BP,
9591,GO:0034728,1,0.230555397546627,0,159,nucleosome organization,BP,
9592,GO:0034729,1,0.986514614623194,0,3,histone H3-K79 methylation,BP,
9593,GO:0034736,1,0.98541076145282,0,2,cholesterol O-acyltransferase activity,MF,
9594,GO:0034739,1,0.97787721501775,0,2,histone deacetylase activity (H4-K16 specific),MF,
9595,GO:0034750,1,0.995714890507083,0,2,Scrib-APC-beta-catenin complex,CC,
9596,GO:0034751,1,0.979297176694655,0,3,aryl hydrocarbon receptor complex,CC,
9597,GO:0034752,1,0.999999996374159,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
9598,GO:0034753,1,0.999999996374159,0,1,nuclear aryl hydrocarbon receptor complex,CC,
9600,GO:0034755,1,0.931264737015951,0,11,iron ion transmembrane transport,BP,
9601,GO:0034756,1,0.96415207267213,0,4,regulation of iron ion transport,BP,
9602,GO:0034757,1,0.987149310021002,0,2,negative regulation of iron ion transport,BP,
9603,GO:0034758,1,0.976705746146419,0,2,positive regulation of iron ion transport,BP,
9604,GO:0034759,1,0.987149310021002,0,2,regulation of iron ion transmembrane transport,BP,
9605,GO:0034760,1,0.987149310021002,0,2,negative regulation of iron ion transmembrane transport,BP,
9607,GO:0034763,1,0.576225060560389,0,79,negative regulation of transmembrane transport,BP,
9610,GO:0034766,1,0.610738682525028,0,73,negative regulation of ion transmembrane transport,BP,
9612,GO:0034769,1,0.988077657919572,0,2,basement membrane disassembly,BP,
9613,GO:0034770,1,0.988948910715427,0,6,histone H4-K20 methylation,BP,
9614,GO:0034773,1,0.988948922291893,0,4,histone H4-K20 trimethylation,BP,
9616,GO:0034775,1,0.999999996375099,0,1,glutathione transmembrane transport,BP,
9617,GO:0034776,1,0.954788709104623,0,10,response to histamine,BP,
9618,GO:0034875,1,0.965582815908718,0,4,caffeine oxidase activity,MF,
9619,GO:0034899,1,0.989682539287995,0,1,trimethylamine monooxygenase activity,MF,
9620,GO:0034959,1,0.999897289031873,0,1,endothelin maturation,BP,
9621,GO:0034963,1,0.987526012197698,0,1,box C/D snoRNA processing,BP,
9622,GO:0034964,1,0.991741501148104,0,1,box H/ACA snoRNA processing,BP,
9623,GO:0034968,1,0.638880855433937,0,96,histone lysine methylation,BP,
9624,GO:0034969,1,0.910620686176517,0,11,histone arginine methylation,BP,
9625,GO:0034970,1,0.985698422320196,0,2,histone H3-R2 methylation,BP,
9626,GO:0034971,1,0.983638767798457,0,2,histone H3-R17 methylation,BP,
9627,GO:0034972,1,0.990164429951147,0,1,histone H3-R26 methylation,BP,
9628,GO:0034975,1,0.922021074557101,0,12,protein folding in endoplasmic reticulum,BP,
9630,GO:0034979,1,0.916198056172603,0,15,NAD-dependent protein deacetylase activity,MF,
9631,GO:0034982,1,0.906475407400656,0,10,mitochondrial protein processing,BP,
9632,GO:0034983,1,0.964855983193296,0,7,peptidyl-lysine deacetylation,BP,
9633,GO:0034986,1,0.999999996379689,0,1,iron chaperone activity,MF,
9634,GO:0034987,1,0.951612650352434,0,6,immunoglobulin receptor binding,MF,
9635,GO:0034988,1,0.991160002640048,0,2,Fc-gamma receptor I complex binding,MF,
9636,GO:0034991,1,0.976766042307178,0,4,nuclear meiotic cohesin complex,CC,
9637,GO:0034992,1,0.96562118552358,0,7,microtubule organizing center attachment site,CC,
9638,GO:0034993,1,0.96562118552358,0,7,LINC complex,CC,
9639,GO:0034998,1,0.991657600429728,0,1,oligosaccharyltransferase I complex,CC,
9640,GO:0035003,1,0.990504783633364,0,1,subapical complex,CC,
9642,GO:0035005,1,0.99162419671134,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9643,GO:0035014,1,0.974593489635969,0,7,phosphatidylinositol 3-kinase regulator activity,MF,
9644,GO:0035019,1,0.645849269614126,0,72,somatic stem cell population maintenance,BP,
9645,GO:0035020,1,0.96726359566998,0,12,regulation of Rac protein signal transduction,BP,
9646,GO:0035021,1,0.982042824509963,0,4,negative regulation of Rac protein signal transduction,BP,
9647,GO:0035022,1,0.999738210579354,0,2,positive regulation of Rac protein signal transduction,BP,
9648,GO:0035023,1,0.605821869924931,0,123,regulation of Rho protein signal transduction,BP,
9649,GO:0035024,1,0.925267104029306,0,17,negative regulation of Rho protein signal transduction,BP,
9650,GO:0035025,1,0.842805379302321,0,25,positive regulation of Rho protein signal transduction,BP,
9651,GO:0035026,1,0.994716959855508,0,2,leading edge cell differentiation,BP,
9652,GO:0035032,1,0.959589808602576,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9653,GO:0035033,1,0.975216113465322,0,3,histone deacetylase regulator activity,MF,
9654,GO:0035034,1,0.984367698726097,0,2,histone acetyltransferase regulator activity,MF,
9655,GO:0035035,1,0.877875754379177,0,26,histone acetyltransferase binding,MF,
9656,GO:0035036,1,0.666875881633027,0,45,sperm-egg recognition,BP,
9657,GO:0035037,1,0.999302953292599,0,1,sperm entry,BP,
9658,GO:0035038,1,0.984727412674292,0,2,female pronucleus assembly,BP,
9659,GO:0035039,1,0.977862438067465,0,2,male pronucleus assembly,BP,
9660,GO:0035041,1,0.987147335349958,0,1,sperm chromatin decondensation,BP,
9661,GO:0035042,1,0.987147335349958,0,1,fertilization, exchange of chromosomal proteins,BP,
9662,GO:0035048,1,0.99692387904039,0,1,splicing factor protein import into nucleus,BP,
9663,GO:0035050,1,0.665212392263434,0,74,embryonic heart tube development,BP,
9664,GO:0035051,1,0.527067948910688,0,120,cardiocyte differentiation,BP,
9665,GO:0035054,1,0.980348819298208,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9666,GO:0035061,1,0.998624197090629,0,3,interchromatin granule,CC,
9667,GO:0035063,1,0.996946383215042,0,2,nuclear speck organization,BP,
9668,GO:0035064,1,0.75784407077786,0,53,methylated histone binding,MF,
9669,GO:0035065,1,0.725543608460156,0,50,regulation of histone acetylation,BP,
9670,GO:0035066,1,0.818501385690969,0,29,positive regulation of histone acetylation,BP,
9671,GO:0035067,1,0.906997986735194,0,16,negative regulation of histone acetylation,BP,
9672,GO:0035068,1,0.955373449751009,0,6,micro-ribonucleoprotein complex,CC,
9673,GO:0035082,1,0.744813547439817,0,42,axoneme assembly,BP,
9674,GO:0035087,1,0.968537042789435,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9675,GO:0035088,1,0.818857476157415,0,36,establishment or maintenance of apical/basal cell polarity,BP,
9676,GO:0035089,1,0.94252405516736,0,11,establishment of apical/basal cell polarity,BP,
9677,GO:0035090,1,0.924764935255306,0,12,maintenance of apical/basal cell polarity,BP,
9679,GO:0035092,1,0.9465988963004,0,8,sperm chromatin condensation,BP,
9680,GO:0035093,1,0.974789451129494,0,4,spermatogenesis, exchange of chromosomal proteins,BP,
9682,GO:0035095,1,0.965974048053508,0,7,behavioral response to nicotine,BP,
9683,GO:0035097,1,0.701375616580431,0,63,histone methyltransferase complex,CC,
9684,GO:0035098,1,0.917737375450045,0,17,ESC/E(Z) complex,CC,
9685,GO:0035101,1,0.982952034272302,0,3,FACT complex,CC,
9686,GO:0035102,1,0.930286149902968,0,12,PRC1 complex,CC,
9687,GO:0035105,1,0.994432021214985,0,1,sterol regulatory element binding protein import into nucleus,BP,
9688,GO:0035106,1,0.981625577873146,0,3,operant conditioning,BP,
9689,GO:0035107,1,0.48770212488999,0,142,appendage morphogenesis,BP,
9690,GO:0035108,1,0.48770212488999,0,142,limb morphogenesis,BP,
9692,GO:0035113,1,0.521980879034007,0,122,embryonic appendage morphogenesis,BP,
9693,GO:0035115,1,0.819257562384282,0,30,embryonic forelimb morphogenesis,BP,
9694,GO:0035116,1,0.809123298488107,0,28,embryonic hindlimb morphogenesis,BP,
9695,GO:0035120,1,0.999999996401411,0,1,post-embryonic appendage morphogenesis,BP,
9696,GO:0035127,1,0.999999996401411,0,1,post-embryonic limb morphogenesis,BP,
9697,GO:0035128,1,0.999999996401411,0,1,post-embryonic forelimb morphogenesis,BP,
9698,GO:0035136,1,0.794775725395617,0,38,forelimb morphogenesis,BP,
9699,GO:0035137,1,0.781053507522472,0,36,hindlimb morphogenesis,BP,
9700,GO:0035145,1,0.876155823774827,0,20,exon-exon junction complex,CC,
9701,GO:0035148,1,0.470141889290109,0,142,tube formation,BP,
9702,GO:0035150,1,0.389050929474612,0,132,regulation of tube size,BP,
9703,GO:0035162,1,0.91639704017238,0,21,embryonic hemopoiesis,BP,
9704,GO:0035166,1,0.988304851240791,0,3,post-embryonic hemopoiesis,BP,
9705,GO:0035173,1,0.905406302986676,0,16,histone kinase activity,MF,
9706,GO:0035174,1,0.954547213756918,0,6,histone serine kinase activity,MF,
9707,GO:0035175,1,0.988514526301702,0,1,histone kinase activity (H3-S10 specific),MF,
9708,GO:0035176,1,0.810538340429328,0,47,social behavior,BP,
9709,GO:0035184,1,0.967725575056917,0,6,histone threonine kinase activity,MF,
9710,GO:0035188,1,0.99496246959351,0,1,hatching,BP,
9711,GO:0035189,1,0.982143671700129,0,3,Rb-E2F complex,CC,
9712,GO:0035194,1,0.716984881915972,0,64,posttranscriptional gene silencing by RNA,BP,
9713,GO:0035195,1,0.733101396444127,0,60,gene silencing by miRNA,BP,
9714,GO:0035196,1,0.832410968163303,0,34,production of miRNAs involved in gene silencing by miRNA,BP,
9715,GO:0035197,1,0.965788579183025,0,8,siRNA binding,MF,
9716,GO:0035198,1,0.911739857847305,0,14,miRNA binding,MF,
9717,GO:0035226,1,0.994115947443441,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9718,GO:0035227,1,0.994115947443441,0,1,regulation of glutamate-cysteine ligase activity,BP,
9719,GO:0035229,1,0.994115947443441,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9720,GO:0035234,1,0.955090961161672,0,8,ectopic germ cell programmed cell death,BP,
9722,GO:0035239,1,0.163235541288379,0,346,tube morphogenesis,BP,
9723,GO:0035240,1,0.87456465446859,0,13,dopamine binding,MF,
9724,GO:0035241,1,0.973927023828719,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
9725,GO:0035242,1,0.964726042431534,0,4,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9726,GO:0035243,1,0.973977513751546,0,3,protein-arginine omega-N symmetric methyltransferase activity,MF,
9727,GO:0035246,1,0.906865970562224,0,11,peptidyl-arginine N-methylation,BP,
9728,GO:0035247,1,0.939614419081855,0,7,peptidyl-arginine omega-N-methylation,BP,
9729,GO:0035248,1,0.993109056704184,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9730,GO:0035249,1,0.723419916696676,0,74,synaptic transmission, glutamatergic,BP,
9731,GO:0035250,1,0.824259001865816,0,27,UDP-galactosyltransferase activity,MF,
9733,GO:0035252,1,0.968240786665168,0,6,UDP-xylosyltransferase activity,MF,
9734,GO:0035253,1,0.971599885093291,0,8,ciliary rootlet,CC,
9735,GO:0035254,1,0.86290373546853,0,33,glutamate receptor binding,MF,
9736,GO:0035255,1,0.908460483192562,0,22,ionotropic glutamate receptor binding,MF,
9737,GO:0035256,1,0.958179722925942,0,6,G-protein coupled glutamate receptor binding,MF,
9738,GO:0035257,1,0.481056280891379,0,133,nuclear hormone receptor binding,MF,
9739,GO:0035258,1,0.639559913791302,0,84,steroid hormone receptor binding,MF,
9740,GO:0035259,1,0.953803683143151,0,13,glucocorticoid receptor binding,MF,
9741,GO:0035261,1,0.999999992792348,0,2,external genitalia morphogenesis,BP,
9742,GO:0035262,1,0.990521144377465,0,2,gonad morphogenesis,BP,
9745,GO:0035267,1,0.855472021539292,0,18,NuA4 histone acetyltransferase complex,CC,
9748,GO:0035270,1,0.424013024105137,0,124,endocrine system development,BP,
9749,GO:0035272,1,0.754757261999061,0,48,exocrine system development,BP,
9750,GO:0035276,1,0.97955740477948,0,3,ethanol binding,MF,
9751,GO:0035278,1,0.927537999061352,0,13,miRNA mediated inhibition of translation,BP,
9752,GO:0035279,1,0.988217147268132,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9753,GO:0035280,1,0.955373437479161,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9754,GO:0035281,1,0.987402916756448,0,2,pre-miRNA export from nucleus,BP,
9755,GO:0035282,1,0.542044632678593,0,95,segmentation,BP,
9756,GO:0035283,1,0.977362174456406,0,3,central nervous system segmentation,BP,
9757,GO:0035284,1,0.977362174456406,0,3,brain segmentation,BP,
9758,GO:0035290,1,0.987602848322345,0,3,trunk segmentation,BP,
9760,GO:0035296,1,0.424282101763435,0,123,regulation of tube diameter,BP,
9761,GO:0035299,1,0.999105366192616,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9766,GO:0035307,1,0.827796867832442,0,33,positive regulation of protein dephosphorylation,BP,
9768,GO:0035312,1,0.969371994479372,0,6,5'-3' exodeoxyribonuclease activity,MF,
9769,GO:0035313,1,0.938128450564815,0,16,wound healing, spreading of epidermal cells,BP,
9770,GO:0035315,1,0.796029256473117,0,38,hair cell differentiation,BP,
9771,GO:0035325,1,0.940272797918936,0,9,Toll-like receptor binding,MF,
9772,GO:0035326,1,0.567459707400825,0,96,enhancer binding,MF,
9773,GO:0035327,1,0.86253916418806,0,21,transcriptionally active chromatin,CC,
9774,GO:0035329,1,0.889823104232981,0,35,hippo signaling,BP,
9775,GO:0035330,1,0.975114221728094,0,9,regulation of hippo signaling,BP,
9776,GO:0035331,1,0.981895642397886,0,6,negative regulation of hippo signaling,BP,
9777,GO:0035332,1,0.999999996388555,0,1,positive regulation of hippo signaling,BP,
9782,GO:0035339,1,0.957078573951655,0,4,SPOTS complex,CC,
9783,GO:0035349,1,0.984847343245695,0,2,coenzyme A transmembrane transport,BP,
9784,GO:0035350,1,0.984316920206231,0,2,FAD transmembrane transport,BP,
9785,GO:0035354,1,0.988693268972617,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9786,GO:0035355,1,0.999999996371812,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9787,GO:0035356,1,0.946372891721146,0,7,cellular triglyceride homeostasis,BP,
9788,GO:0035357,1,0.899252520678534,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9789,GO:0035358,1,0.931974956687481,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9790,GO:0035359,1,0.977907671048879,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9791,GO:0035360,1,0.962870868971258,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9792,GO:0035363,1,0.986458403296789,0,2,histone locus body,CC,
9793,GO:0035368,1,0.962490957112019,0,5,selenocysteine insertion sequence binding,MF,
9794,GO:0035370,1,0.982293702615674,0,2,UBC13-UEV1A complex,CC,
9795,GO:0035371,1,0.949792588097017,0,17,microtubule plus-end,CC,
9796,GO:0035372,1,0.966566990900729,0,9,protein localization to microtubule,BP,
9797,GO:0035373,1,0.988124978233941,0,3,chondroitin sulfate proteoglycan binding,MF,
9798,GO:0035374,1,0.971872625609237,0,6,chondroitin sulfate binding,MF,
9799,GO:0035375,1,0.999999996382818,0,1,zymogen binding,MF,
9800,GO:0035376,1,0.916385943894527,0,9,sterol import,BP,
9801,GO:0035377,1,0.992553146066119,0,2,transepithelial water transport,BP,
9802,GO:0035378,1,0.981796426509688,0,2,carbon dioxide transmembrane transport,BP,
9803,GO:0035379,1,0.981796426509688,0,2,carbon dioxide transmembrane transporter activity,MF,
9804,GO:0035381,1,0.9371875791388,0,8,ATP-gated ion channel activity,MF,
9807,GO:0035385,1,0.988320022886668,0,7,Roundabout signaling pathway,BP,
9808,GO:0035397,1,0.983788148224098,0,2,helper T cell enhancement of adaptive immune response,BP,
9809,GO:0035400,1,0.999957574426284,0,1,histone tyrosine kinase activity,MF,
9810,GO:0035401,1,0.999957574426284,0,1,histone kinase activity (H3-Y41 specific),MF,
9811,GO:0035402,1,0.986169224411662,0,2,histone kinase activity (H3-T11 specific),MF,
9812,GO:0035403,1,0.999972531569295,0,2,histone kinase activity (H3-T6 specific),MF,
9813,GO:0035404,1,0.927394113341668,0,10,histone-serine phosphorylation,BP,
9814,GO:0035405,1,0.967725575056917,0,6,histone-threonine phosphorylation,BP,
9815,GO:0035406,1,0.999957574426284,0,1,histone-tyrosine phosphorylation,BP,
9816,GO:0035407,1,0.986169224411662,0,2,histone H3-T11 phosphorylation,BP,
9817,GO:0035408,1,0.999972531569295,0,2,histone H3-T6 phosphorylation,BP,
9818,GO:0035409,1,0.999957574426284,0,1,histone H3-Y41 phosphorylation,BP,
9819,GO:0035410,1,0.987594992920963,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9820,GO:0035411,1,0.885828338394734,0,26,catenin import into nucleus,BP,
9821,GO:0035412,1,0.896994002188379,0,24,regulation of catenin import into nucleus,BP,
9822,GO:0035413,1,0.959427375784655,0,11,positive regulation of catenin import into nucleus,BP,
9823,GO:0035414,1,0.946731566744537,0,11,negative regulation of catenin import into nucleus,BP,
9824,GO:0035418,1,0.861719001631544,0,31,protein localization to synapse,BP,
9825,GO:0035419,1,0.993734672961793,0,2,activation of MAPK activity involved in innate immune response,BP,
9826,GO:0035425,1,0.979448194252873,0,3,autocrine signaling,BP,
9827,GO:0035426,1,0.979641250298931,0,5,extracellular matrix-cell signaling,BP,
9828,GO:0035428,1,0.883785321758361,0,19,hexose transmembrane transport,BP,
9830,GO:0035435,1,0.891485016822287,0,18,phosphate ion transmembrane transport,BP,
9831,GO:0035437,1,0.929686275616449,0,10,maintenance of protein localization in endoplasmic reticulum,BP,
9832,GO:0035438,1,0.988462709383963,0,1,cyclic-di-GMP binding,MF,
9833,GO:0035441,1,0.996770461288131,0,3,cell migration involved in vasculogenesis,BP,
9834,GO:0035442,1,0.980593473355691,0,2,dipeptide transmembrane transport,BP,
9835,GO:0035443,1,0.999999996375099,0,1,tripeptide transmembrane transport,BP,
9836,GO:0035445,1,0.994310605605121,0,1,borate transmembrane transport,BP,
9838,GO:0035456,1,0.828638894977594,0,22,response to interferon-beta,BP,
9840,GO:0035458,1,0.899388749798714,0,14,cellular response to interferon-beta,BP,
9841,GO:0035459,1,0.959331639500464,0,10,cargo loading into vesicle,BP,
9842,GO:0035461,1,0.951062844267387,0,9,vitamin transmembrane transport,BP,
9843,GO:0035469,1,0.986068853247988,0,5,determination of pancreatic left/right asymmetry,BP,
9844,GO:0035470,1,0.977335293583228,0,2,positive regulation of vascular wound healing,BP,
9845,GO:0035472,1,0.994188989899865,0,1,choriogonadotropin hormone receptor activity,MF,
9846,GO:0035473,1,0.958842387529291,0,6,lipase binding,MF,
9847,GO:0035478,1,0.990447743086166,0,1,chylomicron binding,MF,
9848,GO:0035480,1,0.98751377475558,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9849,GO:0035481,1,0.98751377475558,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9850,GO:0035482,1,0.964229076654156,0,3,gastric motility,BP,
9851,GO:0035483,1,0.975557677379275,0,2,gastric emptying,BP,
9852,GO:0035490,1,0.994533815206607,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9853,GO:0035491,1,0.994533815206607,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9854,GO:0035493,1,0.904014411091582,0,16,SNARE complex assembly,BP,
9855,GO:0035494,1,0.979414373770054,0,3,SNARE complex disassembly,BP,
9856,GO:0035497,1,0.917404111238926,0,13,cAMP response element binding,MF,
9857,GO:0035498,1,0.997936442410314,0,1,carnosine metabolic process,BP,
9858,GO:0035499,1,0.997936442410314,0,1,carnosine biosynthetic process,BP,
9859,GO:0035500,1,0.990177178116761,0,2,MH2 domain binding,MF,
9860,GO:0035501,1,0.992913843613084,0,1,MH1 domain binding,MF,
9861,GO:0035502,1,0.957116497045287,0,6,metanephric part of ureteric bud development,BP,
9862,GO:0035504,1,0.988033318391619,0,1,regulation of myosin light chain kinase activity,BP,
9863,GO:0035505,1,0.988033318391619,0,1,positive regulation of myosin light chain kinase activity,BP,
9864,GO:0035507,1,0.984106665223094,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9865,GO:0035508,1,0.999997009557058,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9866,GO:0035509,1,0.984109618461221,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9867,GO:0035510,1,0.829150070748391,0,24,DNA dealkylation,BP,
9868,GO:0035511,1,0.961655836450103,0,5,oxidative DNA demethylation,BP,
9869,GO:0035513,1,0.974841358474797,0,4,oxidative RNA demethylation,BP,
9870,GO:0035514,1,0.986207814260222,0,2,DNA demethylase activity,MF,
9871,GO:0035515,1,0.974841358474797,0,4,oxidative RNA demethylase activity,MF,
9872,GO:0035516,1,0.998869148299007,0,1,oxidative DNA demethylase activity,MF,
9873,GO:0035517,1,0.994785401531654,0,2,PR-DUB complex,CC,
9874,GO:0035518,1,0.940458495414356,0,12,histone H2A monoubiquitination,BP,
9875,GO:0035519,1,0.963161884694053,0,4,protein K29-linked ubiquitination,BP,
9876,GO:0035520,1,0.976137079028532,0,9,monoubiquitinated protein deubiquitination,BP,
9877,GO:0035521,1,0.980436575828918,0,4,monoubiquitinated histone deubiquitination,BP,
9878,GO:0035522,1,0.980436575828918,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9879,GO:0035523,1,0.988241273912208,0,4,protein K29-linked deubiquitination,BP,
9880,GO:0035524,1,0.975703526410553,0,7,proline transmembrane transport,BP,
9881,GO:0035525,1,0.991741501148104,0,1,NF-kappaB p50/p65 complex,CC,
9882,GO:0035526,1,0.998644690689917,0,2,retrograde transport, plasma membrane to Golgi,BP,
9883,GO:0035529,1,0.967996000593395,0,5,NADH pyrophosphatase activity,MF,
9884,GO:0035538,1,0.994998337971573,0,1,carbohydrate response element binding,MF,
9885,GO:0035539,1,0.976808434010159,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9886,GO:0035542,1,0.958480755596789,0,9,regulation of SNARE complex assembly,BP,
9887,GO:0035543,1,0.988198276636717,0,1,positive regulation of SNARE complex assembly,BP,
9888,GO:0035544,1,0.998709451430415,0,2,negative regulation of SNARE complex assembly,BP,
9889,GO:0035545,1,0.997858979380413,0,1,determination of left/right asymmetry in nervous system,BP,
9890,GO:0035546,1,0.993084902554068,0,1,interferon-beta secretion,BP,
9891,GO:0035547,1,0.993084902554068,0,1,regulation of interferon-beta secretion,BP,
9892,GO:0035548,1,0.993084902554068,0,1,negative regulation of interferon-beta secretion,BP,
9893,GO:0035552,1,0.978950829867547,0,3,oxidative single-stranded DNA demethylation,BP,
9894,GO:0035553,1,0.982926396334683,0,3,oxidative single-stranded RNA demethylation,BP,
9896,GO:0035561,1,0.899492611087049,0,20,regulation of chromatin binding,BP,
9897,GO:0035562,1,0.97767025463992,0,8,negative regulation of chromatin binding,BP,
9898,GO:0035563,1,0.923947949673616,0,11,positive regulation of chromatin binding,BP,
9899,GO:0035564,1,0.984491257768883,0,4,regulation of kidney size,BP,
9900,GO:0035565,1,0.992777141015238,0,1,regulation of pronephros size,BP,
9901,GO:0035566,1,0.9916543196391,0,2,regulation of metanephros size,BP,
9903,GO:0035568,1,0.991657600429728,0,1,N-terminal peptidyl-proline methylation,BP,
9904,GO:0035570,1,0.991657600429728,0,1,N-terminal peptidyl-serine methylation,BP,
9905,GO:0035572,1,0.991657600429728,0,1,N-terminal peptidyl-serine dimethylation,BP,
9906,GO:0035573,1,0.991657600429728,0,1,N-terminal peptidyl-serine trimethylation,BP,
9907,GO:0035574,1,0.999999996373038,0,1,histone H4-K20 demethylation,BP,
9908,GO:0035575,1,0.999999996373038,0,1,histone demethylase activity (H4-K20 specific),MF,
9909,GO:0035577,1,0.683518287776706,0,57,azurophil granule membrane,CC,
9911,GO:0035579,1,0.567906532725748,0,89,specific granule membrane,CC,
9912,GO:0035580,1,0.593946754759235,0,60,specific granule lumen,CC,
9913,GO:0035581,1,0.959701719648839,0,8,sequestering of extracellular ligand from receptor,BP,
9914,GO:0035582,1,0.966040670420134,0,4,sequestering of BMP in extracellular matrix,BP,
9915,GO:0035583,1,0.999921332350412,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9916,GO:0035584,1,0.877378176858326,0,16,calcium-mediated signaling using intracellular calcium source,BP,
9917,GO:0035585,1,0.999999996412836,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9923,GO:0035591,1,0.66202688827641,0,78,signaling adaptor activity,MF,
9924,GO:0035594,1,0.968877709414019,0,4,ganglioside binding,MF,
9925,GO:0035596,1,0.984636463620673,0,2,methylthiotransferase activity,MF,
9926,GO:0035597,1,0.989484454666992,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9927,GO:0035598,1,0.995100898158996,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9928,GO:0035600,1,0.984636463620673,0,2,tRNA methylthiolation,BP,
9930,GO:0035602,1,0.99836915535236,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9931,GO:0035603,1,0.99836915535236,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9932,GO:0035604,1,0.99836915535236,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9933,GO:0035605,1,0.987714680118774,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9934,GO:0035606,1,0.975041266390848,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9935,GO:0035607,1,0.998367571574677,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9936,GO:0035608,1,0.956038397864998,0,8,protein deglutamylation,BP,
9937,GO:0035609,1,0.970567562787573,0,5,C-terminal protein deglutamylation,BP,
9938,GO:0035610,1,0.981176946527955,0,5,protein side chain deglutamylation,BP,
9939,GO:0035611,1,0.992986024286482,0,1,protein branching point deglutamylation,BP,
9940,GO:0035612,1,0.973448543032393,0,7,AP-2 adaptor complex binding,MF,
9941,GO:0035613,1,0.941168288612835,0,11,RNA stem-loop binding,MF,
9942,GO:0035614,1,0.96987797604864,0,3,snRNA stem-loop binding,MF,
9943,GO:0035615,1,0.952558119517561,0,11,clathrin adaptor activity,MF,
9944,GO:0035616,1,0.994058232917123,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9945,GO:0035617,1,0.981752263716998,0,3,stress granule disassembly,BP,
9946,GO:0035620,1,0.99972957212704,0,2,ceramide transporter activity,MF,
9947,GO:0035621,1,0.989314923861365,0,2,ER to Golgi ceramide transport,BP,
9948,GO:0035622,1,0.997821323322562,0,1,intrahepatic bile duct development,BP,
9950,GO:0035624,1,0.978418566943316,0,5,receptor transactivation,BP,
9951,GO:0035625,1,0.978418574796447,0,4,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9952,GO:0035627,1,0.982094981845041,0,5,ceramide transport,BP,
9953,GO:0035630,1,0.956965626693933,0,8,bone mineralization involved in bone maturation,BP,
9954,GO:0035631,1,0.930499226848195,0,11,CD40 receptor complex,CC,
9955,GO:0035633,1,0.987550374946588,0,4,maintenance of permeability of blood-brain barrier,BP,
9956,GO:0035634,1,0.953201304867913,0,5,response to stilbenoid,BP,
9957,GO:0035635,1,0.929594740895339,0,17,entry of bacterium into host cell,BP,
9959,GO:0035638,1,0.999607592814813,0,1,signal maturation,BP,
9961,GO:0035640,1,0.898081199333605,0,22,exploration behavior,BP,
9962,GO:0035641,1,0.949675485242401,0,12,locomotory exploration behavior,BP,
9963,GO:0035642,1,0.993638289809075,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9964,GO:0035643,1,0.988485871524491,0,1,L-DOPA receptor activity,MF,
9965,GO:0035644,1,0.993782056625461,0,1,phosphoanandamide dephosphorylation,BP,
9966,GO:0035645,1,0.998846643958965,0,1,enteric smooth muscle cell differentiation,BP,
9967,GO:0035646,1,0.929910760811144,0,10,endosome to melanosome transport,BP,
9968,GO:0035650,1,0.968813049825171,0,3,AP-1 adaptor complex binding,MF,
9969,GO:0035651,1,0.974223499066418,0,3,AP-3 adaptor complex binding,MF,
9970,GO:0035655,1,0.964151648616037,0,5,interleukin-18-mediated signaling pathway,BP,
9971,GO:0035659,1,0.988522406864506,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9972,GO:0035662,1,0.963484432499709,0,3,Toll-like receptor 4 binding,MF,
9973,GO:0035663,1,0.981802942688023,0,3,Toll-like receptor 2 binding,MF,
9974,GO:0035664,1,0.98871696812522,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9975,GO:0035665,1,0.98871696812522,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9977,GO:0035668,1,0.993669987169482,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9978,GO:0035669,1,0.993669987169482,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9979,GO:0035671,1,0.954364047897098,0,5,enone reductase activity,MF,
9980,GO:0035672,1,0.96862183302515,0,6,oligopeptide transmembrane transport,BP,
9981,GO:0035673,1,0.987793328118469,0,4,oligopeptide transmembrane transporter activity,MF,
9982,GO:0035674,1,0.983114462951156,0,2,tricarboxylic acid transmembrane transport,BP,
9983,GO:0035684,1,0.987218774368248,0,1,helper T cell extravasation,BP,
9984,GO:0035686,1,0.939550738206989,0,7,sperm fibrous sheath,CC,
9985,GO:0035690,1,0.640136155367752,0,65,cellular response to drug,BP,
9986,GO:0035691,1,0.986694687764837,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9987,GO:0035692,1,0.987534873234057,0,2,macrophage migration inhibitory factor receptor complex,CC,
9988,GO:0035693,1,0.987713213770888,0,1,NOS2-CD74 complex,CC,
9989,GO:0035694,1,0.981145185528421,0,4,mitochondrial protein catabolic process,BP,
9990,GO:0035695,1,0.998895765158013,0,1,mitophagy by induced vacuole formation,BP,
9991,GO:0035696,1,0.989430735597602,0,3,monocyte extravasation,BP,
9994,GO:0035700,1,0.980193650515495,0,2,astrocyte chemotaxis,BP,
9995,GO:0035701,1,0.965524411928118,0,6,hematopoietic stem cell migration,BP,
9996,GO:0035704,1,0.991388739056542,0,1,helper T cell chemotaxis,BP,
9997,GO:0035705,1,0.991388739056542,0,1,T-helper 17 cell chemotaxis,BP,
9998,GO:0035708,1,0.996075298321824,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9999,GO:0035709,1,0.986262430477005,0,2,memory T cell activation,BP,
10000,GO:0035710,1,0.613553282468566,0,70,CD4-positive, alpha-beta T cell activation,BP,
10001,GO:0035711,1,0.983414865743895,0,2,T-helper 1 cell activation,BP,
10002,GO:0035712,1,0.991162053583301,0,2,T-helper 2 cell activation,BP,
10003,GO:0035713,1,0.996075298321824,0,1,response to nitrogen dioxide,BP,
10004,GO:0035714,1,0.996075298321824,0,1,cellular response to nitrogen dioxide,BP,
10005,GO:0035717,1,0.992176797630768,0,1,chemokine (C-C motif) ligand 7 binding,MF,
10006,GO:0035718,1,0.987713213770888,0,1,macrophage migration inhibitory factor binding,MF,
10007,GO:0035720,1,0.986378522822995,0,3,intraciliary anterograde transport,BP,
10008,GO:0035721,1,0.976027546976902,0,9,intraciliary retrograde transport,BP,
10009,GO:0035722,1,0.98930949877334,0,3,interleukin-12-mediated signaling pathway,BP,
10010,GO:0035723,1,0.982848895976951,0,3,interleukin-15-mediated signaling pathway,BP,
10011,GO:0035724,1,0.999999996377419,0,1,CD24 biosynthetic process,BP,
10013,GO:0035726,1,0.958064627217345,0,7,common myeloid progenitor cell proliferation,BP,
10014,GO:0035727,1,0.968255620587477,0,4,lysophosphatidic acid binding,MF,
10015,GO:0035728,1,0.900746243556719,0,17,response to hepatocyte growth factor,BP,
10016,GO:0035729,1,0.909331050547755,0,15,cellular response to hepatocyte growth factor stimulus,BP,
10017,GO:0035730,1,0.987335631224693,0,1,S-nitrosoglutathione binding,MF,
10018,GO:0035731,1,0.987335631224693,0,1,dinitrosyl-iron complex binding,MF,
10019,GO:0035732,1,0.987335631224693,0,1,nitric oxide storage,BP,
10020,GO:0035733,1,0.96653974429722,0,7,hepatic stellate cell activation,BP,
10021,GO:0035735,1,0.808773217254441,0,38,intraciliary transport involved in cilium assembly,BP,
10022,GO:0035739,1,0.966180664465728,0,5,CD4-positive, alpha-beta T cell proliferation,BP,
10023,GO:0035740,1,0.964310286731756,0,4,CD8-positive, alpha-beta T cell proliferation,BP,
10024,GO:0035743,1,0.887255034227553,0,13,CD4-positive, alpha-beta T cell cytokine production,BP,
10025,GO:0035744,1,0.977122559847126,0,2,T-helper 1 cell cytokine production,BP,
10026,GO:0035745,1,0.903038435991233,0,11,T-helper 2 cell cytokine production,BP,
10027,GO:0035746,1,0.98758750256206,0,1,granzyme A production,BP,
10028,GO:0035747,1,0.898069463016048,0,11,natural killer cell chemotaxis,BP,
10029,GO:0035748,1,0.980179882942891,0,6,myelin sheath abaxonal region,CC,
10030,GO:0035749,1,0.967413778648765,0,6,myelin sheath adaxonal region,CC,
10031,GO:0035750,1,0.999971297537525,0,1,protein localization to myelin sheath abaxonal region,BP,
10032,GO:0035751,1,0.911260928632847,0,10,regulation of lysosomal lumen pH,BP,
10033,GO:0035752,1,0.989080996827037,0,1,lysosomal lumen pH elevation,BP,
10034,GO:0035754,1,0.936121556912541,0,8,B cell chemotaxis,BP,
10035,GO:0035755,1,0.991711970667283,0,1,cardiolipin hydrolase activity,MF,
10036,GO:0035757,1,0.990013231248957,0,1,chemokine (C-C motif) ligand 19 binding,MF,
10037,GO:0035758,1,0.990013231248957,0,1,chemokine (C-C motif) ligand 21 binding,MF,
10038,GO:0035759,1,0.979758463936729,0,2,mesangial cell-matrix adhesion,BP,
10042,GO:0035769,1,0.987564328280312,0,1,B cell chemotaxis across high endothelial venule,BP,
10044,GO:0035771,1,0.954986565323773,0,6,interleukin-4-mediated signaling pathway,BP,
10045,GO:0035772,1,0.988649491188727,0,1,interleukin-13-mediated signaling pathway,BP,
10046,GO:0035773,1,0.708009438126942,0,55,insulin secretion involved in cellular response to glucose stimulus,BP,
10047,GO:0035774,1,0.827329707259879,0,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
10048,GO:0035782,1,0.98758750256206,0,1,mature natural killer cell chemotaxis,BP,
10049,GO:0035783,1,0.996075298321824,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
10050,GO:0035786,1,0.991657600429728,0,1,protein complex oligomerization,BP,
10051,GO:0035787,1,0.985210337229421,0,5,cell migration involved in kidney development,BP,
10052,GO:0035788,1,0.985242189585903,0,4,cell migration involved in metanephros development,BP,
10053,GO:0035789,1,0.985242189585903,0,4,metanephric mesenchymal cell migration,BP,
10054,GO:0035790,1,0.996926615535285,0,3,platelet-derived growth factor receptor-alpha signaling pathway,BP,
10055,GO:0035791,1,0.952175442084221,0,13,platelet-derived growth factor receptor-beta signaling pathway,BP,
10056,GO:0035793,1,0.985848237531077,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
10057,GO:0035794,1,0.642882039975509,0,56,positive regulation of mitochondrial membrane permeability,BP,
10059,GO:0035799,1,0.987364129098393,0,4,ureter maturation,BP,
10060,GO:0035800,1,0.985481875743497,0,2,deubiquitinase activator activity,MF,
10061,GO:0035801,1,0.98256353502005,0,2,adrenal cortex development,BP,
10062,GO:0035802,1,0.98256353502005,0,2,adrenal cortex formation,BP,
10063,GO:0035803,1,0.975895965846683,0,2,egg coat formation,BP,
10064,GO:0035805,1,0.990318799438873,0,1,egg coat,CC,
10065,GO:0035809,1,0.853505468670397,0,20,regulation of urine volume,BP,
10066,GO:0035810,1,0.916409171516973,0,13,positive regulation of urine volume,BP,
10067,GO:0035811,1,0.951070268975792,0,5,negative regulation of urine volume,BP,
10068,GO:0035812,1,0.837363799212325,0,21,renal sodium excretion,BP,
10069,GO:0035813,1,0.837363799212325,0,21,regulation of renal sodium excretion,BP,
10070,GO:0035814,1,0.947491080191407,0,5,negative regulation of renal sodium excretion,BP,
10071,GO:0035815,1,0.903953173130838,0,13,positive regulation of renal sodium excretion,BP,
10072,GO:0035821,1,0.426724797093285,0,113,modification of morphology or physiology of other organism,BP,
10073,GO:0035822,1,0.983113995857039,0,4,gene conversion,BP,
10074,GO:0035825,1,0.745001894291713,0,43,reciprocal DNA recombination,BP,
10075,GO:0035826,1,0.979443343505506,0,5,rubidium ion transport,BP,
10076,GO:0035838,1,0.998597801161477,0,3,growing cell tip,CC,
10077,GO:0035841,1,0.999982529409928,0,2,new growing cell tip,CC,
10078,GO:0035844,1,0.977468201047052,0,4,cloaca development,BP,
10079,GO:0035845,1,0.974051315058854,0,9,photoreceptor cell outer segment organization,BP,
10080,GO:0035846,1,0.99046400189741,0,1,oviduct epithelium development,BP,
10081,GO:0035847,1,0.99046400189741,0,1,uterine epithelium development,BP,
10082,GO:0035849,1,0.99046400189741,0,1,nephric duct elongation,BP,
10083,GO:0035850,1,0.802842295372258,0,46,epithelial cell differentiation involved in kidney development,BP,
10084,GO:0035851,1,0.993604193709798,0,1,Krueppel-associated box domain binding,MF,
10085,GO:0035852,1,0.99046400189741,0,1,horizontal cell localization,BP,
10086,GO:0035853,1,0.999243003669656,0,1,chromosome passenger complex localization to spindle midzone,BP,
10087,GO:0035854,1,0.983592291840724,0,2,eosinophil fate commitment,BP,
10088,GO:0035855,1,0.953129864823914,0,15,megakaryocyte development,BP,
10089,GO:0035859,1,0.919587351079828,0,12,Seh1-associated complex,CC,
10090,GO:0035860,1,0.974845693069663,0,6,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
10091,GO:0035861,1,0.846288129268241,0,29,site of double-strand break,CC,
10092,GO:0035862,1,0.999999996372751,0,1,dITP metabolic process,BP,
10093,GO:0035863,1,0.999999996372751,0,1,dITP catabolic process,BP,
10094,GO:0035864,1,0.927580822463462,0,12,response to potassium ion,BP,
10095,GO:0035865,1,0.956242728077832,0,7,cellular response to potassium ion,BP,
10096,GO:0035867,1,0.999756708620081,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10097,GO:0035869,1,0.732781888100456,0,56,ciliary transition zone,CC,
10098,GO:0035870,1,0.987454988109708,0,2,dITP diphosphatase activity,MF,
10099,GO:0035871,1,0.976577158682117,0,10,protein K11-linked deubiquitination,BP,
10100,GO:0035872,1,0.821288751922268,0,34,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
10101,GO:0035873,1,0.972517640214661,0,6,lactate transmembrane transport,BP,
10103,GO:0035878,1,0.934245681196349,0,10,nail development,BP,
10104,GO:0035879,1,0.986939468642538,0,3,plasma membrane lactate transport,BP,
10105,GO:0035880,1,0.976728399186812,0,3,embryonic nail plate morphogenesis,BP,
10106,GO:0035881,1,0.946303087037723,0,8,amacrine cell differentiation,BP,
10107,GO:0035883,1,0.854996615858496,0,26,enteroendocrine cell differentiation,BP,
10108,GO:0035886,1,0.89463453437464,0,18,vascular smooth muscle cell differentiation,BP,
10109,GO:0035887,1,0.988606833667475,0,1,aortic smooth muscle cell differentiation,BP,
10110,GO:0035890,1,0.801666730291599,0,35,exit from host,BP,
10111,GO:0035891,1,0.801666730291599,0,35,exit from host cell,BP,
10112,GO:0035897,1,0.953074719242795,0,6,proteolysis in other organism,BP,
10113,GO:0035898,1,0.983180307794764,0,3,parathyroid hormone secretion,BP,
10114,GO:0035900,1,0.956913616299849,0,6,response to isolation stress,BP,
10115,GO:0035902,1,0.827154539255013,0,24,response to immobilization stress,BP,
10116,GO:0035904,1,0.842134704954502,0,48,aorta development,BP,
10117,GO:0035905,1,0.979865812027164,0,4,ascending aorta development,BP,
10118,GO:0035907,1,0.953730405221665,0,9,dorsal aorta development,BP,
10119,GO:0035909,1,0.886940351733818,0,29,aorta morphogenesis,BP,
10120,GO:0035910,1,0.979865812027164,0,4,ascending aorta morphogenesis,BP,
10121,GO:0035912,1,0.958441186353754,0,8,dorsal aorta morphogenesis,BP,
10123,GO:0035915,1,0.989549656717848,0,1,pore formation in membrane of other organism,BP,
10124,GO:0035921,1,0.989739168452463,0,1,desmosome disassembly,BP,
10125,GO:0035922,1,0.982848925348778,0,2,foramen ovale closure,BP,
10126,GO:0035924,1,0.840878764672291,0,37,cellular response to vascular endothelial growth factor stimulus,BP,
10127,GO:0035925,1,0.951477929346173,0,11,mRNA 3'-UTR AU-rich region binding,MF,
10128,GO:0035926,1,0.975018673298654,0,4,chemokine (C-C motif) ligand 2 secretion,BP,
10129,GO:0035927,1,0.957680387959393,0,5,RNA import into mitochondrion,BP,
10130,GO:0035928,1,0.974424434665534,0,3,rRNA import into mitochondrion,BP,
10131,GO:0035929,1,0.852156498441418,0,19,steroid hormone secretion,BP,
10132,GO:0035930,1,0.885625402294667,0,14,corticosteroid hormone secretion,BP,
10133,GO:0035931,1,0.951227054810453,0,6,mineralocorticoid secretion,BP,
10134,GO:0035932,1,0.951227054810453,0,6,aldosterone secretion,BP,
10135,GO:0035933,1,0.931061080496352,0,8,glucocorticoid secretion,BP,
10136,GO:0035934,1,0.967181790984056,0,3,corticosterone secretion,BP,
10137,GO:0035935,1,0.995086611654992,0,1,androgen secretion,BP,
10138,GO:0035936,1,0.995292927925586,0,2,testosterone secretion,BP,
10139,GO:0035938,1,0.987422903090434,0,3,estradiol secretion,BP,
10140,GO:0035939,1,0.981205081285419,0,3,microsatellite binding,MF,
10141,GO:0035945,1,0.991317921526807,0,1,mitochondrial ncRNA surveillance,BP,
10142,GO:0035946,1,0.991317921526807,0,1,mitochondrial mRNA surveillance,BP,
10143,GO:0035947,1,0.969039227409179,0,6,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10144,GO:0035948,1,0.976236413100013,0,4,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10147,GO:0035964,1,0.976308669229636,0,4,COPI-coated vesicle budding,BP,
10148,GO:0035965,1,0.954618645739863,0,6,cardiolipin acyl-chain remodeling,BP,
10151,GO:0035970,1,0.942366600886688,0,11,peptidyl-threonine dephosphorylation,BP,
10152,GO:0035971,1,0.98758750256206,0,1,peptidyl-histidine dephosphorylation,BP,
10153,GO:0035973,1,0.992905727489893,0,4,aggrephagy,BP,
10154,GO:0035976,1,0.95125024987153,0,5,transcription factor AP-1 complex,CC,
10155,GO:0035977,1,0.981695383124525,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10156,GO:0035978,1,0.992913843613084,0,1,histone H2A-S139 phosphorylation,BP,
10157,GO:0035981,1,0.987432154699133,0,2,tongue muscle cell differentiation,BP,
10158,GO:0035983,1,0.989849187017806,0,3,response to trichostatin A,BP,
10159,GO:0035984,1,0.989849187017806,0,3,cellular response to trichostatin A,BP,
10160,GO:0035985,1,0.959221968163754,0,4,senescence-associated heterochromatin focus,CC,
10161,GO:0035986,1,0.970039481326283,0,3,senescence-associated heterochromatin focus assembly,BP,
10162,GO:0035987,1,0.795485748700475,0,45,endodermal cell differentiation,BP,
10163,GO:0035988,1,0.920577720439609,0,14,chondrocyte proliferation,BP,
10164,GO:0035989,1,0.966230666660138,0,5,tendon development,BP,
10165,GO:0035990,1,0.96623068706789,0,3,tendon cell differentiation,BP,
10166,GO:0035992,1,0.96623068706789,0,3,tendon formation,BP,
10167,GO:0035993,1,0.979094033350668,0,2,deltoid tuberosity development,BP,
10168,GO:0035994,1,0.882629100137131,0,19,response to muscle stretch,BP,
10169,GO:0035995,1,0.963302731579021,0,4,detection of muscle stretch,BP,
10170,GO:0035998,1,0.989240507280597,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10171,GO:0035999,1,0.931563670483073,0,9,tetrahydrofolate interconversion,BP,
10172,GO:0036002,1,0.81924693621049,0,27,pre-mRNA binding,MF,
10173,GO:0036003,1,0.843172873027036,0,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10174,GO:0036004,1,0.987603837160757,0,1,GAF domain binding,MF,
10175,GO:0036005,1,0.933728133248379,0,10,response to macrophage colony-stimulating factor,BP,
10176,GO:0036006,1,0.933728133248379,0,10,cellular response to macrophage colony-stimulating factor stimulus,BP,
10177,GO:0036009,1,0.987526012197698,0,1,protein-glutamine N-methyltransferase activity,MF,
10178,GO:0036010,1,0.958014142505672,0,13,protein localization to endosome,BP,
10179,GO:0036015,1,0.965862219801555,0,5,response to interleukin-3,BP,
10180,GO:0036016,1,0.965862219801555,0,5,cellular response to interleukin-3,BP,
10181,GO:0036017,1,0.939982009998487,0,6,response to erythropoietin,BP,
10182,GO:0036018,1,0.952223445351715,0,5,cellular response to erythropoietin,BP,
10183,GO:0036019,1,0.913210940709064,0,19,endolysosome,CC,
10184,GO:0036020,1,0.947387116933508,0,14,endolysosome membrane,CC,
10185,GO:0036021,1,0.974429218856249,0,4,endolysosome lumen,CC,
10186,GO:0036022,1,0.973878185090849,0,3,limb joint morphogenesis,BP,
10187,GO:0036023,1,0.973878185090849,0,3,embryonic skeletal limb joint morphogenesis,BP,
10188,GO:0036024,1,0.990586917343966,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10189,GO:0036025,1,0.990586917343966,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10190,GO:0036026,1,0.990586917343966,0,1,protein C inhibitor-PLAT complex,CC,
10191,GO:0036027,1,0.990586917343966,0,1,protein C inhibitor-PLAU complex,CC,
10192,GO:0036028,1,0.990586917343966,0,1,protein C inhibitor-thrombin complex,CC,
10193,GO:0036029,1,0.990586917343966,0,1,protein C inhibitor-KLK3 complex,CC,
10194,GO:0036030,1,0.990586917343966,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10195,GO:0036031,1,0.987500724142209,0,1,recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex,BP,
10196,GO:0036033,1,0.998469707069205,0,4,mediator complex binding,MF,
10197,GO:0036034,1,0.983000591562766,0,2,mediator complex assembly,BP,
10198,GO:0036035,1,0.899027367801907,0,17,osteoclast development,BP,
10199,GO:0036037,1,0.88381801807525,0,16,CD8-positive, alpha-beta T cell activation,BP,
10200,GO:0036038,1,0.910435109873057,0,12,MKS complex,CC,
10202,GO:0036042,1,0.963643710277503,0,3,long-chain fatty acyl-CoA binding,MF,
10203,GO:0036046,1,0.994480519036392,0,1,protein demalonylation,BP,
10204,GO:0036047,1,0.994480519036392,0,1,peptidyl-lysine demalonylation,BP,
10205,GO:0036048,1,0.994480519036392,0,1,protein desuccinylation,BP,
10206,GO:0036049,1,0.994480519036392,0,1,peptidyl-lysine desuccinylation,BP,
10207,GO:0036053,1,0.992380623680821,0,1,glomerular endothelium fenestra,CC,
10208,GO:0036054,1,0.994480519036392,0,1,protein-malonyllysine demalonylase activity,MF,
10209,GO:0036055,1,0.994480519036392,0,1,protein-succinyllysine desuccinylase activity,MF,
10210,GO:0036056,1,0.980542354275286,0,8,filtration diaphragm,CC,
10211,GO:0036057,1,0.980542354275286,0,8,slit diaphragm,CC,
10212,GO:0036058,1,0.998168926242794,0,1,filtration diaphragm assembly,BP,
10213,GO:0036060,1,0.998168926242794,0,1,slit diaphragm assembly,BP,
10214,GO:0036064,1,0.609585211119092,0,92,ciliary basal body,CC,
10215,GO:0036065,1,0.899285647669963,0,23,fucosylation,BP,
10216,GO:0036066,1,0.964564684696703,0,11,protein O-linked fucosylation,BP,
10217,GO:0036071,1,0.995148460683886,0,1,N-glycan fucosylation,BP,
10220,GO:0036079,1,0.986471326193314,0,3,purine nucleotide-sugar transport,BP,
10221,GO:0036080,1,0.986471326193314,0,3,purine nucleotide-sugar transmembrane transporter activity,MF,
10222,GO:0036085,1,0.991657600429728,0,1,GDP-fucose import into Golgi lumen,BP,
10223,GO:0036088,1,0.988247587492541,0,1,D-serine catabolic process,BP,
10224,GO:0036089,1,0.965592771670858,0,7,cleavage furrow formation,BP,
10225,GO:0036090,1,0.979027050399201,0,2,cleavage furrow ingression,BP,
10226,GO:0036091,1,0.964711794276483,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10228,GO:0036093,1,0.938250797111336,0,6,germ cell proliferation,BP,
10230,GO:0036100,1,0.965210221960794,0,4,leukotriene catabolic process,BP,
10231,GO:0036101,1,0.965210221960794,0,4,leukotriene B4 catabolic process,BP,
10232,GO:0036102,1,0.965210221960794,0,4,leukotriene B4 metabolic process,BP,
10233,GO:0036105,1,0.996629268245158,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10235,GO:0036111,1,0.992260893557381,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10236,GO:0036112,1,0.974180149963017,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10237,GO:0036114,1,0.988094796714652,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10238,GO:0036115,1,0.988094796714652,0,1,fatty-acyl-CoA catabolic process,BP,
10239,GO:0036116,1,0.988094796714652,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10240,GO:0036117,1,0.981673305733943,0,2,hyaluranon cable,CC,
10241,GO:0036118,1,0.979883076088498,0,3,hyaluranon cable assembly,BP,
10242,GO:0036119,1,0.901538588598329,0,20,response to platelet-derived growth factor,BP,
10243,GO:0036120,1,0.907372974784228,0,19,cellular response to platelet-derived growth factor stimulus,BP,
10244,GO:0036122,1,0.937125328188304,0,9,BMP binding,MF,
10245,GO:0036123,1,0.943799829879609,0,7,histone H3-K9 dimethylation,BP,
10246,GO:0036124,1,0.934188604113827,0,16,histone H3-K9 trimethylation,BP,
10247,GO:0036125,1,0.993994126631451,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10248,GO:0036126,1,0.544677111947384,0,71,sperm flagellum,CC,
10249,GO:0036128,1,0.936647515854257,0,8,CatSper complex,CC,
10250,GO:0036130,1,0.987594992920963,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10251,GO:0036131,1,0.987594992920963,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10252,GO:0036132,1,0.979355624086171,0,3,13-prostaglandin reductase activity,MF,
10253,GO:0036134,1,0.989800062774136,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10254,GO:0036135,1,0.991657595160864,0,2,Schwann cell migration,BP,
10255,GO:0036137,1,0.981492339803558,0,2,kynurenine aminotransferase activity,MF,
10256,GO:0036138,1,0.999999996378177,0,1,peptidyl-histidine hydroxylation,BP,
10257,GO:0036139,1,0.999999996378177,0,1,peptidyl-histidine dioxygenase activity,MF,
10258,GO:0036140,1,0.999999996378177,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10259,GO:0036143,1,0.987267298523712,0,1,kringle domain binding,MF,
10260,GO:0036145,1,0.988708439499656,0,1,dendritic cell homeostasis,BP,
10261,GO:0036146,1,0.989715094729133,0,2,cellular response to mycotoxin,BP,
10262,GO:0036148,1,0.88362841064979,0,17,phosphatidylglycerol acyl-chain remodeling,BP,
10267,GO:0036153,1,0.992820244320386,0,1,triglyceride acyl-chain remodeling,BP,
10268,GO:0036155,1,0.949265898912529,0,7,acylglycerol acyl-chain remodeling,BP,
10269,GO:0036156,1,0.999999992818796,0,2,inner dynein arm,CC,
10270,GO:0036157,1,0.968823536454623,0,5,outer dynein arm,CC,
10271,GO:0036158,1,0.900731119307645,0,12,outer dynein arm assembly,BP,
10272,GO:0036159,1,0.942194725811383,0,9,inner dynein arm assembly,BP,
10273,GO:0036164,1,0.987453524490379,0,1,cell-abiotic substrate adhesion,BP,
10274,GO:0036166,1,0.993154977323939,0,3,phenotypic switching,BP,
10275,GO:0036179,1,0.99256738898565,0,1,osteoclast maturation,BP,
10276,GO:0036194,1,0.976310692215903,0,2,muscle cell projection,CC,
10277,GO:0036195,1,0.976310692215903,0,2,muscle cell projection membrane,CC,
10279,GO:0036215,1,0.990917403512956,0,3,response to stem cell factor,BP,
10280,GO:0036216,1,0.990917403512956,0,3,cellular response to stem cell factor stimulus,BP,
10281,GO:0036219,1,0.987207770502897,0,1,GTP diphosphatase activity,MF,
10282,GO:0036220,1,0.987454994210949,0,1,ITP diphosphatase activity,MF,
10283,GO:0036222,1,0.987454994210949,0,1,XTP diphosphatase activity,MF,
10284,GO:0036228,1,0.989689791218446,0,2,protein targeting to nuclear inner membrane,BP,
10286,GO:0036233,1,0.983043148822174,0,2,glycine import,BP,
10287,GO:0036245,1,0.987705392191189,0,2,cellular response to menadione,BP,
10288,GO:0036250,1,0.98915669815631,0,1,peroxisome transport along microtubule,BP,
10289,GO:0036257,1,0.777479766787392,0,31,multivesicular body organization,BP,
10290,GO:0036258,1,0.7831378110974,0,30,multivesicular body assembly,BP,
10291,GO:0036260,1,0.742956564692936,0,34,RNA capping,BP,
10292,GO:0036261,1,0.996968824021239,0,1,7-methylguanosine cap hypermethylation,BP,
10293,GO:0036265,1,0.964028883073395,0,4,RNA (guanine-N7)-methylation,BP,
10294,GO:0036266,1,0.991614695091367,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10295,GO:0036269,1,0.988182894282693,0,2,swimming behavior,BP,
10296,GO:0036284,1,0.988039244544445,0,1,tubulobulbar complex,CC,
10297,GO:0036289,1,0.972126676473302,0,6,peptidyl-serine autophosphorylation,BP,
10298,GO:0036290,1,0.998142609797833,0,1,protein trans-autophosphorylation,BP,
10299,GO:0036292,1,0.984911737438401,0,2,DNA rewinding,BP,
10302,GO:0036295,1,0.963253631834008,0,7,cellular response to increased oxygen levels,BP,
10303,GO:0036296,1,0.885439395795906,0,19,response to increased oxygen levels,BP,
10304,GO:0036297,1,0.754463365849868,0,43,interstrand cross-link repair,BP,
10305,GO:0036301,1,0.972055728329399,0,4,macrophage colony-stimulating factor production,BP,
10306,GO:0036302,1,0.977070823631246,0,7,atrioventricular canal development,BP,
10307,GO:0036303,1,0.925779101156483,0,18,lymph vessel morphogenesis,BP,
10308,GO:0036304,1,0.982766349889207,0,2,umbilical cord morphogenesis,BP,
10309,GO:0036305,1,0.999999222881736,0,1,ameloblast differentiation,BP,
10310,GO:0036306,1,0.988244177608165,0,1,embryonic heart tube elongation,BP,
10311,GO:0036309,1,0.999999992828916,0,2,protein localization to M-band,BP,
10312,GO:0036310,1,0.965193238999241,0,8,annealing helicase activity,MF,
10313,GO:0036312,1,0.975020062872674,0,10,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10314,GO:0036313,1,0.985686518629748,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10315,GO:0036314,1,0.900651260798308,0,24,response to sterol,BP,
10316,GO:0036315,1,0.942294028443963,0,16,cellular response to sterol,BP,
10317,GO:0036317,1,0.991657600429728,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10318,GO:0036323,1,0.999603714274603,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10319,GO:0036324,1,0.98674437971862,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10320,GO:0036326,1,0.999603714274603,0,1,VEGF-A-activated receptor activity,MF,
10321,GO:0036327,1,0.999603714274603,0,1,VEGF-B-activated receptor activity,MF,
10322,GO:0036332,1,0.999603714274603,0,1,placental growth factor-activated receptor activity,MF,
10323,GO:0036333,1,0.991993536302241,0,1,hepatocyte homeostasis,BP,
10324,GO:0036335,1,0.999944964882879,0,1,intestinal stem cell homeostasis,BP,
10325,GO:0036336,1,0.798304789760207,0,30,dendritic cell migration,BP,
10326,GO:0036337,1,0.982007233206155,0,4,Fas signaling pathway,BP,
10327,GO:0036338,1,0.975179379573793,0,3,viral membrane,CC,
10328,GO:0036342,1,0.911890012919143,0,18,post-anal tail morphogenesis,BP,
10329,GO:0036343,1,0.997804078630032,0,1,psychomotor behavior,BP,
10330,GO:0036344,1,0.894489192412378,0,19,platelet morphogenesis,BP,
10331,GO:0036345,1,0.98177122245661,0,2,platelet maturation,BP,
10332,GO:0036351,1,0.990599302187582,0,1,histone H2A-K13 ubiquitination,BP,
10333,GO:0036352,1,0.990599302187582,0,1,histone H2A-K15 ubiquitination,BP,
10334,GO:0036353,1,0.99469275713988,0,2,histone H2A-K119 monoubiquitination,BP,
10335,GO:0036361,1,0.991300277190173,0,1,racemase activity, acting on amino acids and derivatives,MF,
10336,GO:0036363,1,0.990992103978477,0,2,transforming growth factor beta activation,BP,
10337,GO:0036367,1,0.985602727873324,0,2,light adaption,BP,
10338,GO:0036369,1,0.999999992763609,0,2,transcription factor catabolic process,BP,
10339,GO:0036371,1,0.999999996385216,0,1,protein localization to T-tubule,BP,
10340,GO:0036372,1,0.987347262608021,0,1,opsin transport,BP,
10341,GO:0036374,1,0.942068790793815,0,6,glutathione hydrolase activity,MF,
10343,GO:0036378,1,0.972541587680194,0,3,calcitriol biosynthetic process from calciol,BP,
10345,GO:0036387,1,0.980887951317669,0,2,pre-replicative complex,CC,
10346,GO:0036388,1,0.980887951317669,0,2,pre-replicative complex assembly,BP,
10347,GO:0036392,1,0.997035697400361,0,1,chemokine (C-C motif) ligand 20 production,BP,
10348,GO:0036393,1,0.993244562670755,0,1,thiocyanate peroxidase activity,MF,
10349,GO:0036396,1,0.967540196664327,0,4,MIS complex,CC,
10350,GO:0036398,1,0.986265297797483,0,2,TCR signalosome,CC,
10351,GO:0036399,1,0.995105658528154,0,1,TCR signalosome assembly,BP,
10352,GO:0036402,1,0.930445433104674,0,6,proteasome-activating ATPase activity,MF,
10353,GO:0036403,1,0.991963554888094,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10354,GO:0036404,1,0.999999996396927,0,1,conversion of ds siRNA to ss siRNA,BP,
10355,GO:0036413,1,0.989479457514541,0,2,histone H3-R26 citrullination,BP,
10356,GO:0036414,1,0.972803310963447,0,5,histone citrullination,BP,
10357,GO:0036435,1,0.980517167609165,0,3,K48-linked polyubiquitin binding,MF,
10358,GO:0036438,1,0.978786809773349,0,4,maintenance of lens transparency,BP,
10359,GO:0036440,1,0.993657777065081,0,1,citrate synthase activity,MF,
10360,GO:0036442,1,0.826336591412635,0,22,hydrogen-exporting ATPase activity,MF,
10361,GO:0036444,1,0.973167189771876,0,4,mitochondrial calcium uptake,BP,
10362,GO:0036445,1,0.952651755177035,0,13,neuronal stem cell division,BP,
10363,GO:0036446,1,0.994726232061823,0,3,myofibroblast differentiation,BP,
10364,GO:0036449,1,0.99372111189555,0,4,microtubule minus-end,CC,
10365,GO:0036452,1,0.795008941532908,0,27,ESCRT complex,CC,
10366,GO:0036454,1,0.969250103730787,0,5,growth factor complex,CC,
10367,GO:0036455,1,0.987478111458317,0,1,iron-sulfur transferase activity,MF,
10368,GO:0036457,1,0.987310418408726,0,3,keratohyalin granule,CC,
10369,GO:0036458,1,0.990109782243798,0,1,hepatocyte growth factor binding,MF,
10370,GO:0036459,1,0.58345335091937,0,109,thiol-dependent ubiquitinyl hydrolase activity,MF,
10371,GO:0036461,1,0.975574696281312,0,2,BLOC-2 complex binding,MF,
10374,GO:0036465,1,0.840777923754537,0,41,synaptic vesicle recycling,BP,
10375,GO:0036466,1,0.999036413127059,0,2,synaptic vesicle recycling via endosome,BP,
10376,GO:0036468,1,0.989468721778578,0,1,L-dopa decarboxylase activity,MF,
10377,GO:0036470,1,0.98731767947796,0,1,tyrosine 3-monooxygenase activator activity,MF,
10378,GO:0036471,1,0.98731767947796,0,1,cellular response to glyoxal,BP,
10380,GO:0036474,1,0.854113763409994,0,23,cell death in response to hydrogen peroxide,BP,
10381,GO:0036475,1,0.9172785683677,0,17,neuron death in response to oxidative stress,BP,
10382,GO:0036476,1,0.979502352672235,0,3,neuron death in response to hydrogen peroxide,BP,
10384,GO:0036478,1,0.98731767947796,0,1,L-dopa decarboxylase activator activity,MF,
10385,GO:0036479,1,0.999999996391606,0,1,peroxidase inhibitor activity,MF,
10386,GO:0036480,1,0.965001164707756,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10387,GO:0036481,1,0.945733081269453,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10388,GO:0036482,1,0.979542344980115,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10389,GO:0036483,1,0.999365756635023,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10390,GO:0036484,1,0.987602848322345,0,3,trunk neural crest cell migration,BP,
10391,GO:0036486,1,0.987602848322345,0,3,ventral trunk neural crest cell migration,BP,
10392,GO:0036487,1,0.999999996389206,0,1,nitric-oxide synthase inhibitor activity,MF,
10393,GO:0036488,1,0.976301857777709,0,2,CHOP-C/EBP complex,CC,
10394,GO:0036490,1,0.966439611545301,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
10395,GO:0036491,1,0.9702528415079,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10396,GO:0036492,1,0.9702528415079,0,7,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10397,GO:0036493,1,0.979741218105435,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10398,GO:0036494,1,0.999996321319508,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10399,GO:0036496,1,0.978955590481097,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10400,GO:0036497,1,0.99086740883784,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10402,GO:0036499,1,0.854444718192892,0,20,PERK-mediated unfolded protein response,BP,
10403,GO:0036500,1,0.936101418972578,0,10,ATF6-mediated unfolded protein response,BP,
10404,GO:0036501,1,0.999070495174642,0,1,UFD1-NPL4 complex,CC,
10405,GO:0036502,1,0.994398048211695,0,1,Derlin-1-VIMP complex,CC,
10406,GO:0036503,1,0.579051487436026,0,87,ERAD pathway,BP,
10407,GO:0036505,1,0.984763785622376,0,2,prosaposin receptor activity,MF,
10408,GO:0036506,1,0.981467143376554,0,3,maintenance of unfolded protein,BP,
10409,GO:0036507,1,0.883464464065924,0,24,protein demannosylation,BP,
10410,GO:0036508,1,0.883464464065924,0,24,protein alpha-1,2-demannosylation,BP,
10411,GO:0036509,1,0.981695397573715,0,2,trimming of terminal mannose on B branch,BP,
10412,GO:0036510,1,0.981695390347879,0,3,trimming of terminal mannose on C branch,BP,
10413,GO:0036511,1,0.981695397573715,0,2,trimming of first mannose on A branch,BP,
10414,GO:0036512,1,0.981695397573715,0,2,trimming of second mannose on A branch,BP,
10415,GO:0036513,1,0.937816847273454,0,11,Derlin-1 retrotranslocation complex,CC,
10416,GO:0036514,1,0.991245637641152,0,5,dopaminergic neuron axon guidance,BP,
10417,GO:0036515,1,0.997751019883391,0,4,serotonergic neuron axon guidance,BP,
10418,GO:0036517,1,0.999999996371578,0,1,chemoattraction of serotonergic neuron axon,BP,
10419,GO:0036518,1,0.993480070397012,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10420,GO:0036520,1,0.990459934296563,0,1,astrocyte-dopaminergic neuron signaling,BP,
10421,GO:0036524,1,0.98731767947796,0,1,protein deglycase activity,MF,
10422,GO:0036525,1,0.98731767947796,0,1,protein deglycation,BP,
10423,GO:0036526,1,0.98731767947796,0,1,peptidyl-cysteine deglycation,BP,
10424,GO:0036527,1,0.98731767947796,0,1,peptidyl-arginine deglycation,BP,
10425,GO:0036528,1,0.98731767947796,0,1,peptidyl-lysine deglycation,BP,
10426,GO:0036529,1,0.98731767947796,0,1,protein deglycation, glyoxal removal,BP,
10427,GO:0036530,1,0.98731767947796,0,1,protein deglycation, methylglyoxal removal,BP,
10428,GO:0036531,1,0.98731767947796,0,1,glutathione deglycation,BP,
10429,GO:0038001,1,0.965140774564942,0,4,paracrine signaling,BP,
10430,GO:0038002,1,0.999970023251624,0,1,endocrine signaling,BP,
10431,GO:0038003,1,0.918891898285213,0,10,opioid receptor signaling pathway,BP,
10432,GO:0038007,1,0.99317844958223,0,4,netrin-activated signaling pathway,BP,
10433,GO:0038009,1,0.987800053657777,0,1,regulation of signal transduction by receptor internalization,BP,
10434,GO:0038016,1,0.986643534816754,0,2,insulin receptor internalization,BP,
10435,GO:0038018,1,0.999364230703177,0,2,Wnt receptor catabolic process,BP,
10436,GO:0038021,1,0.998796088880202,0,1,leptin receptor activity,MF,
10438,GO:0038024,1,0.712969607815827,0,61,cargo receptor activity,MF,
10439,GO:0038025,1,0.995301806682074,0,2,reelin receptor activity,MF,
10440,GO:0038026,1,0.994549184299473,0,4,reelin-mediated signaling pathway,BP,
10441,GO:0038027,1,0.988886854964423,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10442,GO:0038028,1,0.982301006516674,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10443,GO:0038030,1,0.971752862565981,0,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,
10444,GO:0038031,1,0.973946299516886,0,6,non-canonical Wnt signaling pathway via JNK cascade,BP,
10445,GO:0038033,1,0.975665056667911,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10447,GO:0038036,1,0.940546007030284,0,8,sphingosine-1-phosphate receptor activity,MF,
10448,GO:0038037,1,0.999022600167925,0,3,G-protein coupled receptor dimeric complex,CC,
10449,GO:0038038,1,0.999999996378098,0,1,G-protein coupled receptor homodimeric complex,CC,
10450,GO:0038039,1,0.99902260398378,0,2,G-protein coupled receptor heterodimeric complex,CC,
10451,GO:0038042,1,0.999999996378098,0,1,dimeric G-protein coupled receptor signaling pathway,BP,
10452,GO:0038043,1,0.989191254529807,0,2,interleukin-5-mediated signaling pathway,BP,
10453,GO:0038044,1,0.984041094813323,0,5,transforming growth factor-beta secretion,BP,
10454,GO:0038046,1,0.988683014331792,0,1,enkephalin receptor activity,MF,
10455,GO:0038047,1,0.988957146665087,0,1,morphine receptor activity,MF,
10456,GO:0038048,1,0.999798273745579,0,1,dynorphin receptor activity,MF,
10457,GO:0038049,1,0.999999992779282,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10458,GO:0038051,1,0.999999996376377,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10459,GO:0038052,1,0.991203665661933,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10460,GO:0038060,1,0.990417596707535,0,2,nitric oxide-cGMP-mediated signaling pathway,BP,
10462,GO:0038062,1,0.992273105938019,0,2,protein tyrosine kinase collagen receptor activity,MF,
10463,GO:0038063,1,0.992122030125476,0,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,
10464,GO:0038064,1,0.992117045761903,0,4,collagen receptor activity,MF,
10465,GO:0038065,1,0.991965993238226,0,11,collagen-activated signaling pathway,BP,
10466,GO:0038066,1,0.834136723952653,0,34,p38MAPK cascade,BP,
10467,GO:0038083,1,0.768644834600578,0,52,peptidyl-tyrosine autophosphorylation,BP,
10468,GO:0038084,1,0.910033145862515,0,23,vascular endothelial growth factor signaling pathway,BP,
10469,GO:0038085,1,0.97954938434992,0,4,vascular endothelial growth factor binding,MF,
10470,GO:0038086,1,0.996211373749792,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10471,GO:0038089,1,0.975298060580561,0,6,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10472,GO:0038091,1,0.996211373749792,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10473,GO:0038092,1,0.893656859594958,0,14,nodal signaling pathway,BP,
10475,GO:0038094,1,0.647571824046679,0,75,Fc-gamma receptor signaling pathway,BP,
10477,GO:0038096,1,0.677666392038834,0,71,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10478,GO:0038097,1,0.999959183298652,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10479,GO:0038098,1,0.988126485391925,0,2,sequestering of BMP from receptor via BMP binding,BP,
10480,GO:0038100,1,0.987374300839911,0,2,nodal binding,MF,
10481,GO:0038101,1,0.988564908365588,0,1,sequestering of nodal from receptor via nodal binding,BP,
10482,GO:0038106,1,0.994188989899865,0,1,choriogonadotropin hormone binding,MF,
10483,GO:0038107,1,0.934631460971058,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10484,GO:0038108,1,0.972200794252824,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10485,GO:0038109,1,0.990917403512956,0,3,Kit signaling pathway,BP,
10486,GO:0038110,1,0.969817016829381,0,5,interleukin-2-mediated signaling pathway,BP,
10487,GO:0038111,1,0.977018078721888,0,2,interleukin-7-mediated signaling pathway,BP,
10488,GO:0038112,1,0.983971519495844,0,2,interleukin-8-mediated signaling pathway,BP,
10489,GO:0038113,1,0.989974988047088,0,1,interleukin-9-mediated signaling pathway,BP,
10490,GO:0038114,1,0.995038932589787,0,1,interleukin-21-mediated signaling pathway,BP,
10491,GO:0038115,1,0.990013231248957,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10492,GO:0038116,1,0.990013231248957,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10493,GO:0038117,1,0.990013231248957,0,1,C-C motif chemokine 19 receptor activity,MF,
10494,GO:0038118,1,0.987408883959657,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10495,GO:0038121,1,0.990013231248957,0,1,C-C motif chemokine 21 receptor activity,MF,
10496,GO:0038123,1,0.977045916779772,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10497,GO:0038124,1,0.973743446964741,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10499,GO:0038128,1,0.808727214381956,0,38,ERBB2 signaling pathway,BP,
10500,GO:0038129,1,0.971816805778829,0,3,ERBB3 signaling pathway,BP,
10501,GO:0038131,1,0.989111420432912,0,1,neuregulin receptor activity,MF,
10502,GO:0038132,1,0.994906195936559,0,5,neuregulin binding,MF,
10503,GO:0038133,1,0.989540796804739,0,1,ERBB2-ERBB3 signaling pathway,BP,
10504,GO:0038145,1,0.965793849751785,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10505,GO:0038154,1,0.994702982197217,0,1,interleukin-11-mediated signaling pathway,BP,
10506,GO:0038155,1,0.982290290482399,0,2,interleukin-23-mediated signaling pathway,BP,
10507,GO:0038156,1,0.988247876757445,0,2,interleukin-3-mediated signaling pathway,BP,
10508,GO:0038158,1,0.984415042806236,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10509,GO:0038161,1,0.979070804143762,0,5,prolactin signaling pathway,BP,
10510,GO:0038162,1,0.98883498744853,0,2,erythropoietin-mediated signaling pathway,BP,
10511,GO:0038163,1,0.973121393882794,0,3,thrombopoietin-mediated signaling pathway,BP,
10512,GO:0038164,1,0.996774821502488,0,1,thrombopoietin receptor activity,MF,
10513,GO:0038165,1,0.980509239544811,0,4,oncostatin-M-mediated signaling pathway,BP,
10514,GO:0038166,1,0.936742157124366,0,10,angiotensin-activated signaling pathway,BP,
10515,GO:0038167,1,0.999970221701697,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10516,GO:0038168,1,0.999970221701697,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10517,GO:0038169,1,0.95949162022289,0,5,somatostatin receptor signaling pathway,BP,
10518,GO:0038170,1,0.95949162022289,0,5,somatostatin signaling pathway,BP,
10519,GO:0038171,1,0.976339574991476,0,6,cannabinoid signaling pathway,BP,
10520,GO:0038172,1,0.987907964333115,0,2,interleukin-33-mediated signaling pathway,BP,
10521,GO:0038178,1,0.9824252849457,0,2,complement component C5a signaling pathway,BP,
10522,GO:0038179,1,0.834047601024881,0,34,neurotrophin signaling pathway,BP,
10523,GO:0038180,1,0.969616526158452,0,8,nerve growth factor signaling pathway,BP,
10524,GO:0038181,1,0.977658741773712,0,3,bile acid receptor activity,MF,
10525,GO:0038182,1,0.988017643055512,0,1,G-protein coupled bile acid receptor activity,MF,
10526,GO:0038183,1,0.977658741773712,0,3,bile acid signaling pathway,BP,
10527,GO:0038184,1,0.988017643055512,0,1,cell surface bile acid receptor signaling pathway,BP,
10528,GO:0038185,1,0.989936963505739,0,1,intracellular bile acid receptor signaling pathway,BP,
10529,GO:0038186,1,0.999575264954682,0,1,lithocholic acid receptor activity,MF,
10530,GO:0038187,1,0.870283792819465,0,17,pattern recognition receptor activity,MF,
10531,GO:0038188,1,0.978383245479173,0,2,cholecystokinin signaling pathway,BP,
10532,GO:0038189,1,0.987566503022702,0,2,neuropilin signaling pathway,BP,
10533,GO:0038190,1,0.987566503022702,0,2,VEGF-activated neuropilin signaling pathway,BP,
10534,GO:0038191,1,0.999998974404281,0,1,neuropilin binding,MF,
10535,GO:0038192,1,0.98951254738286,0,1,gastric inhibitory peptide signaling pathway,BP,
10536,GO:0038193,1,0.990409252857432,0,1,thromboxane A2 signaling pathway,BP,
10537,GO:0038194,1,0.985284163686486,0,2,thyroid-stimulating hormone signaling pathway,BP,
10538,GO:0038195,1,0.987918412591761,0,1,urokinase plasminogen activator signaling pathway,BP,
10539,GO:0038201,1,0.914007954620384,0,15,TOR complex,CC,
10540,GO:0038202,1,0.838406242795217,0,27,TORC1 signaling,BP,
10541,GO:0038203,1,0.958375821502108,0,6,TORC2 signaling,BP,
10542,GO:0039003,1,0.996047050278914,0,2,pronephric field specification,BP,
10543,GO:0039007,1,0.999994354333577,0,1,pronephric nephron morphogenesis,BP,
10544,GO:0039008,1,0.999994354333577,0,1,pronephric nephron tubule morphogenesis,BP,
10545,GO:0039017,1,0.996047050278914,0,2,pattern specification involved in pronephros development,BP,
10546,GO:0039019,1,0.989532032770536,0,3,pronephric nephron development,BP,
10547,GO:0039020,1,0.992771534351039,0,2,pronephric nephron tubule development,BP,
10548,GO:0039022,1,0.999994354333577,0,1,pronephric duct development,BP,
10549,GO:0039023,1,0.999994354333577,0,1,pronephric duct morphogenesis,BP,
10550,GO:0039506,1,0.992510394896914,0,2,modulation by virus of host molecular function,BP,
10551,GO:0039507,1,0.992510394896914,0,2,suppression by virus of host molecular function,BP,
10552,GO:0039513,1,0.992591137466873,0,1,suppression by virus of host catalytic activity,BP,
10553,GO:0039516,1,0.992591137466873,0,1,modulation by virus of host catalytic activity,BP,
10554,GO:0039519,1,0.99980468670998,0,2,modulation by virus of host autophagy,BP,
10555,GO:0039520,1,0.99999391897077,0,1,induction by virus of host autophagy,BP,
10556,GO:0039521,1,0.999810766637014,0,1,suppression by virus of host autophagy,BP,
10557,GO:0039526,1,0.971520329920131,0,3,modulation by virus of host apoptotic process,BP,
10558,GO:0039528,1,0.909581882478657,0,22,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10559,GO:0039529,1,0.945716030775364,0,17,RIG-I signaling pathway,BP,
10560,GO:0039530,1,0.940799220184781,0,9,MDA-5 signaling pathway,BP,
10561,GO:0039531,1,0.937233934996808,0,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10562,GO:0039532,1,0.962569420219325,0,8,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10563,GO:0039533,1,0.966291407755228,0,6,regulation of MDA-5 signaling pathway,BP,
10564,GO:0039534,1,0.977811591393301,0,3,negative regulation of MDA-5 signaling pathway,BP,
10565,GO:0039535,1,0.948751598457763,0,14,regulation of RIG-I signaling pathway,BP,
10566,GO:0039536,1,0.974395900412213,0,6,negative regulation of RIG-I signaling pathway,BP,
10567,GO:0039552,1,0.99999027702207,0,1,RIG-I binding,MF,
10568,GO:0039650,1,0.992591137466873,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10569,GO:0039656,1,0.976168808439701,0,3,modulation by virus of host gene expression,BP,
10570,GO:0039663,1,0.952220543243637,0,6,membrane fusion involved in viral entry into host cell,BP,
10571,GO:0039689,1,0.980622381005592,0,3,negative stranded viral RNA replication,BP,
10572,GO:0039692,1,0.929312859880506,0,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10573,GO:0039694,1,0.878197566189191,0,22,viral RNA genome replication,BP,
10574,GO:0039702,1,0.83256062993847,0,21,viral budding via host ESCRT complex,BP,
10575,GO:0039703,1,0.878197566189191,0,22,RNA replication,BP,
10576,GO:0039706,1,0.934419796746004,0,10,co-receptor binding,MF,
10577,GO:0039713,1,0.995850945276373,0,1,viral factory,CC,
10578,GO:0039714,1,0.995850945276373,0,1,cytoplasmic viral factory,CC,
10579,GO:0040001,1,0.89944105745083,0,20,establishment of mitotic spindle localization,BP,
10582,GO:0040009,1,0.990496590698677,0,2,regulation of growth rate,BP,
10587,GO:0040015,1,0.946230161905457,0,10,negative regulation of multicellular organism growth,BP,
10588,GO:0040016,1,0.949265478318217,0,8,embryonic cleavage,BP,
10591,GO:0040019,1,0.842119477838047,0,33,positive regulation of embryonic development,BP,
10592,GO:0040020,1,0.822358301488514,0,28,regulation of meiotic nuclear division,BP,
10593,GO:0040023,1,0.967072594337965,0,13,establishment of nucleus localization,BP,
10594,GO:0040029,1,0.15824458146184,0,262,regulation of gene expression, epigenetic,BP,
10595,GO:0040030,1,0.984550059328779,0,2,regulation of molecular function, epigenetic,BP,
10596,GO:0040031,1,0.947564573518429,0,5,snRNA modification,BP,
10597,GO:0040032,1,0.989042917527244,0,1,post-embryonic body morphogenesis,BP,
10598,GO:0040033,1,0.927537999061352,0,13,negative regulation of translation, ncRNA-mediated,BP,
10599,GO:0040034,1,0.912753141246145,0,12,regulation of development, heterochronic,BP,
10600,GO:0040036,1,0.864473675063,0,26,regulation of fibroblast growth factor receptor signaling pathway,BP,
10601,GO:0040037,1,0.941541067935802,0,12,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
10602,GO:0040038,1,0.994956219342252,0,3,polar body extrusion after meiotic divisions,BP,
10603,GO:0040040,1,0.999999996373038,0,1,thermosensory behavior,BP,
10604,GO:0042000,1,0.991019208360606,0,1,translocation of peptides or proteins into host,BP,
10605,GO:0042007,1,0.9878830104369,0,1,interleukin-18 binding,MF,
10606,GO:0042008,1,0.996227084658062,0,1,interleukin-18 receptor activity,MF,
10607,GO:0042011,1,0.994271707701199,0,1,interleukin-16 binding,MF,
10608,GO:0042012,1,0.994271707701199,0,1,interleukin-16 receptor activity,MF,
10609,GO:0042015,1,0.979357881332078,0,3,interleukin-20 binding,MF,
10610,GO:0042017,1,0.992781927136656,0,1,interleukin-22 binding,MF,
10611,GO:0042018,1,0.992781927136656,0,1,interleukin-22 receptor activity,MF,
10612,GO:0042019,1,0.982290290482399,0,2,interleukin-23 binding,MF,
10613,GO:0042020,1,0.982290290482399,0,2,interleukin-23 receptor activity,MF,
10614,GO:0042022,1,0.989351484000675,0,1,interleukin-12 receptor complex,CC,
10615,GO:0042023,1,0.987461259377015,0,7,DNA endoreduplication,BP,
10616,GO:0042025,1,0.990420746327027,0,3,host cell nucleus,CC,
10617,GO:0042026,1,0.825985079081568,0,24,protein refolding,BP,
10618,GO:0042030,1,0.975836128069057,0,4,ATPase inhibitor activity,MF,
10622,GO:0042040,1,0.998807705642567,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10623,GO:0042043,1,0.964099235432614,0,12,neurexin family protein binding,MF,
10624,GO:0042044,1,0.827634898812574,0,26,fluid transport,BP,
10625,GO:0042045,1,0.959299382936592,0,8,epithelial fluid transport,BP,
10626,GO:0042048,1,0.981851875235312,0,8,olfactory behavior,BP,
10627,GO:0042053,1,0.889233007851517,0,17,regulation of dopamine metabolic process,BP,
10628,GO:0042054,1,0.772488676504778,0,47,histone methyltransferase activity,MF,
10629,GO:0042056,1,0.779618312035934,0,26,chemoattractant activity,MF,
10631,GO:0042059,1,0.790082555908865,0,40,negative regulation of epidermal growth factor receptor signaling pathway,BP,
10634,GO:0042069,1,0.889233007851517,0,17,regulation of catecholamine metabolic process,BP,
10635,GO:0042073,1,0.78840396913097,0,45,intraciliary transport,BP,
10636,GO:0042074,1,0.918466451145498,0,14,cell migration involved in gastrulation,BP,
10637,GO:0042078,1,0.964317854368054,0,4,germ-line stem cell division,BP,
10638,GO:0042083,1,0.98821157638415,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10639,GO:0042084,1,0.999999996398545,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10640,GO:0042088,1,0.737250793652447,0,38,T-helper 1 type immune response,BP,
10642,GO:0042090,1,0.953734219681905,0,8,interleukin-12 biosynthetic process,BP,
10643,GO:0042091,1,0.985599211494005,0,3,interleukin-10 biosynthetic process,BP,
10644,GO:0042092,1,0.757909846009868,0,34,type 2 immune response,BP,
10645,GO:0042093,1,0.70893727255969,0,50,T-helper cell differentiation,BP,
10646,GO:0042094,1,0.848522987786874,0,21,interleukin-2 biosynthetic process,BP,
10647,GO:0042095,1,0.873487141128637,0,17,interferon-gamma biosynthetic process,BP,
10648,GO:0042097,1,0.987309219770311,0,3,interleukin-4 biosynthetic process,BP,
10651,GO:0042101,1,0.856582071996456,0,19,T cell receptor complex,CC,
10654,GO:0042105,1,0.943101008467939,0,5,alpha-beta T cell receptor complex,CC,
10657,GO:0042109,1,0.974071717589364,0,3,lymphotoxin A biosynthetic process,BP,
10661,GO:0042117,1,0.936970264255322,0,8,monocyte activation,BP,
10662,GO:0042118,1,0.939810132845655,0,10,endothelial cell activation,BP,
10664,GO:0042126,1,0.965860011261865,0,4,nitrate metabolic process,BP,
10666,GO:0042128,1,0.990673960789241,0,1,nitrate assimilation,BP,
10668,GO:0042130,1,0.679109034036035,0,51,negative regulation of T cell proliferation,BP,
10669,GO:0042131,1,0.991511334782995,0,1,thiamine phosphate phosphatase activity,MF,
10670,GO:0042132,1,0.975959683743276,0,2,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10671,GO:0042133,1,0.835680270355441,0,29,neurotransmitter metabolic process,BP,
10672,GO:0042134,1,0.976866653522862,0,2,rRNA primary transcript binding,MF,
10673,GO:0042135,1,0.940236315331108,0,11,neurotransmitter catabolic process,BP,
10674,GO:0042136,1,0.902805282902622,0,17,neurotransmitter biosynthetic process,BP,
10675,GO:0042137,1,0.982809065281138,0,2,sequestering of neurotransmitter,BP,
10676,GO:0042138,1,0.949775316410689,0,5,meiotic DNA double-strand break formation,BP,
10677,GO:0042140,1,0.991657600429728,0,1,late meiotic recombination nodule assembly,BP,
10678,GO:0042144,1,0.991243765826517,0,2,vacuole fusion, non-autophagic,BP,
10680,GO:0042148,1,0.938935987626546,0,8,strand invasion,BP,
10681,GO:0042149,1,0.80592282566269,0,34,cellular response to glucose starvation,BP,
10685,GO:0042160,1,0.94827525099008,0,5,lipoprotein modification,BP,
10686,GO:0042161,1,0.94827525099008,0,5,lipoprotein oxidation,BP,
10687,GO:0042162,1,0.836076985633116,0,32,telomeric DNA binding,MF,
10688,GO:0042163,1,0.9879166162612,0,1,interleukin-12 beta subunit binding,MF,
10689,GO:0042164,1,0.990740820043039,0,1,interleukin-12 alpha subunit binding,MF,
10690,GO:0042165,1,0.851545776267918,0,22,neurotransmitter binding,MF,
10691,GO:0042166,1,0.875212359266344,0,17,acetylcholine binding,MF,
10692,GO:0042167,1,0.923567299805573,0,7,heme catabolic process,BP,
10694,GO:0042169,1,0.871532130991544,0,30,SH2 domain binding,MF,
10695,GO:0042171,1,0.927507555954099,0,17,lysophosphatidic acid acyltransferase activity,MF,
10698,GO:0042177,1,0.51110227112076,0,99,negative regulation of protein catabolic process,BP,
10699,GO:0042178,1,0.910221348398963,0,10,xenobiotic catabolic process,BP,
10702,GO:0042182,1,0.940760104538069,0,7,ketone catabolic process,BP,
10703,GO:0042196,1,0.977396805656654,0,2,chlorinated hydrocarbon metabolic process,BP,
10704,GO:0042197,1,0.977396805656654,0,2,halogenated hydrocarbon metabolic process,BP,
10705,GO:0042214,1,0.982216914243226,0,2,terpene metabolic process,BP,
10709,GO:0042222,1,0.95688557634781,0,4,interleukin-1 biosynthetic process,BP,
10710,GO:0042223,1,0.987372320298239,0,2,interleukin-3 biosynthetic process,BP,
10711,GO:0042225,1,0.987173722599235,0,1,interleukin-5 biosynthetic process,BP,
10712,GO:0042226,1,0.864764001072844,0,18,interleukin-6 biosynthetic process,BP,
10713,GO:0042228,1,0.90664336940075,0,13,interleukin-8 biosynthetic process,BP,
10714,GO:0042231,1,0.987463035004913,0,2,interleukin-13 biosynthetic process,BP,
10715,GO:0042241,1,0.994904987350892,0,1,interleukin-18 biosynthetic process,BP,
10716,GO:0042245,1,0.990654017624388,0,2,RNA repair,BP,
10717,GO:0042246,1,0.656739700137959,0,53,tissue regeneration,BP,
10718,GO:0042247,1,0.993455758084661,0,1,establishment of planar polarity of follicular epithelium,BP,
10719,GO:0042249,1,0.933800152225586,0,17,establishment of planar polarity of embryonic epithelium,BP,
10720,GO:0042253,1,0.955440252332128,0,5,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10722,GO:0042255,1,0.621990345092264,0,48,ribosome assembly,BP,
10723,GO:0042256,1,0.962832003330563,0,5,mature ribosome assembly,BP,
10724,GO:0042262,1,0.944550797980386,0,5,DNA protection,BP,
10725,GO:0042264,1,0.996697086692843,0,2,peptidyl-aspartic acid hydroxylation,BP,
10726,GO:0042265,1,0.999999996378177,0,1,peptidyl-asparagine hydroxylation,BP,
10727,GO:0042267,1,0.642897370051992,0,53,natural killer cell mediated cytotoxicity,BP,
10728,GO:0042268,1,0.918497969598463,0,9,regulation of cytolysis,BP,
10729,GO:0042269,1,0.786359842320435,0,31,regulation of natural killer cell mediated cytotoxicity,BP,
10730,GO:0042270,1,0.975640819519998,0,3,protection from natural killer cell mediated cytotoxicity,BP,
10731,GO:0042271,1,0.986234331827751,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10732,GO:0042272,1,0.9814898376406,0,4,nuclear RNA export factor complex,CC,
10733,GO:0042273,1,0.571104305797005,0,58,ribosomal large subunit biogenesis,BP,
10734,GO:0042274,1,0.576187919958811,0,61,ribosomal small subunit biogenesis,BP,
10735,GO:0042275,1,0.988075354091876,0,1,error-free postreplication DNA repair,BP,
10736,GO:0042276,1,0.862310799156528,0,20,error-prone translesion synthesis,BP,
10739,GO:0042281,1,0.984147331031094,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10740,GO:0042282,1,0.999293189791113,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10741,GO:0042284,1,0.976909360287658,0,2,sphingolipid delta-4 desaturase activity,MF,
10742,GO:0042285,1,0.968240786665168,0,6,xylosyltransferase activity,MF,
10743,GO:0042287,1,0.795116042550677,0,29,MHC protein binding,MF,
10744,GO:0042288,1,0.850196611874569,0,19,MHC class I protein binding,MF,
10745,GO:0042289,1,0.959995797201428,0,5,MHC class II protein binding,MF,
10746,GO:0042292,1,0.991186186932819,0,1,URM1 activating enzyme activity,MF,
10747,GO:0042296,1,0.96098167758958,0,4,ISG15 transferase activity,MF,
10748,GO:0042297,1,0.98977991981689,0,7,vocal learning,BP,
10753,GO:0042307,1,0.591901729201663,0,94,positive regulation of protein import into nucleus,BP,
10754,GO:0042308,1,0.66175873426457,0,64,negative regulation of protein import into nucleus,BP,
10755,GO:0042309,1,0.980151673110448,0,2,homoiothermy,BP,
10756,GO:0042310,1,0.6215593980443,0,74,vasoconstriction,BP,
10757,GO:0042311,1,0.803165955067044,0,30,vasodilation,BP,
10758,GO:0042313,1,0.989744678367247,0,1,protein kinase C deactivation,BP,
10759,GO:0042316,1,0.999871944703624,0,1,penicillin metabolic process,BP,
10760,GO:0042320,1,0.938288068259449,0,6,regulation of circadian sleep/wake cycle, REM sleep,BP,
10761,GO:0042321,1,0.949096384919045,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10762,GO:0042322,1,0.975025085734553,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10763,GO:0042323,1,0.98116244223155,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10764,GO:0042324,1,0.987170199616193,0,1,hypocretin receptor binding,MF,
10768,GO:0042328,1,0.992589536227975,0,2,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10770,GO:0042335,1,0.990183387379717,0,3,cuticle development,BP,
10774,GO:0042346,1,0.835077833944209,0,24,positive regulation of NF-kappaB import into nucleus,BP,
10775,GO:0042347,1,0.857566111653486,0,22,negative regulation of NF-kappaB import into nucleus,BP,
10777,GO:0042350,1,0.974236875141637,0,3,GDP-L-fucose biosynthetic process,BP,
10778,GO:0042351,1,0.976361097790459,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10779,GO:0042352,1,0.997824762674209,0,1,GDP-L-fucose salvage,BP,
10780,GO:0042354,1,0.959518021845812,0,9,L-fucose metabolic process,BP,
10781,GO:0042355,1,0.959518021845812,0,9,L-fucose catabolic process,BP,
10782,GO:0042356,1,0.987791238169804,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10783,GO:0042357,1,0.979634202047428,0,2,thiamine diphosphate metabolic process,BP,
10785,GO:0042360,1,0.960402414059009,0,4,vitamin E metabolic process,BP,
10786,GO:0042361,1,0.985541530953315,0,2,menaquinone catabolic process,BP,
10787,GO:0042362,1,0.895250800061927,0,13,fat-soluble vitamin biosynthetic process,BP,
10788,GO:0042363,1,0.932114593190962,0,9,fat-soluble vitamin catabolic process,BP,
10790,GO:0042365,1,0.976823979539064,0,2,water-soluble vitamin catabolic process,BP,
10791,GO:0042368,1,0.908674155923505,0,11,vitamin D biosynthetic process,BP,
10792,GO:0042369,1,0.979894146512388,0,3,vitamin D catabolic process,BP,
10793,GO:0042371,1,0.996770639106046,0,1,vitamin K biosynthetic process,BP,
10794,GO:0042373,1,0.945909921854139,0,6,vitamin K metabolic process,BP,
10795,GO:0042374,1,0.973183800234778,0,3,phylloquinone metabolic process,BP,
10796,GO:0042376,1,0.973183800234778,0,3,phylloquinone catabolic process,BP,
10797,GO:0042377,1,0.985541530953315,0,2,vitamin K catabolic process,BP,
10799,GO:0042382,1,0.968024599998812,0,6,paraspeckles,CC,
10802,GO:0042392,1,0.982835875706459,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10803,GO:0042393,1,0.329111887931741,0,180,histone binding,MF,
10804,GO:0042396,1,0.988154741572323,0,1,phosphagen biosynthetic process,BP,
10806,GO:0042401,1,0.808668212088304,0,21,cellular biogenic amine biosynthetic process,BP,
10808,GO:0042403,1,0.891203587304408,0,20,thyroid hormone metabolic process,BP,
10809,GO:0042404,1,0.989746516163076,0,1,thyroid hormone catabolic process,BP,
10810,GO:0042405,1,0.97696339499618,0,11,nuclear inclusion body,CC,
10811,GO:0042406,1,0.953152042916263,0,5,extrinsic component of endoplasmic reticulum membrane,CC,
10812,GO:0042407,1,0.895984771386158,0,12,cristae formation,BP,
10813,GO:0042412,1,0.980693276367181,0,2,taurine biosynthetic process,BP,
10814,GO:0042413,1,0.991362137740827,0,1,carnitine catabolic process,BP,
10815,GO:0042414,1,0.976732589276565,0,3,epinephrine metabolic process,BP,
10816,GO:0042415,1,0.937653397867533,0,10,norepinephrine metabolic process,BP,
10817,GO:0042416,1,0.91713088634688,0,12,dopamine biosynthetic process,BP,
10818,GO:0042417,1,0.792369576074916,0,34,dopamine metabolic process,BP,
10819,GO:0042418,1,0.976732597452881,0,2,epinephrine biosynthetic process,BP,
10820,GO:0042420,1,0.953998777652464,0,7,dopamine catabolic process,BP,
10821,GO:0042421,1,0.954314277399019,0,6,norepinephrine biosynthetic process,BP,
10822,GO:0042423,1,0.859218591984338,0,20,catecholamine biosynthetic process,BP,
10823,GO:0042424,1,0.948285650966606,0,8,catecholamine catabolic process,BP,
10825,GO:0042427,1,0.969411972538941,0,3,serotonin biosynthetic process,BP,
10826,GO:0042428,1,0.938754731479529,0,11,serotonin metabolic process,BP,
10827,GO:0042430,1,0.809945863376359,0,26,indole-containing compound metabolic process,BP,
10828,GO:0042431,1,0.990352852801268,0,1,indole metabolic process,BP,
10829,GO:0042435,1,0.946014761980756,0,5,indole-containing compound biosynthetic process,BP,
10830,GO:0042436,1,0.903205801819689,0,11,indole-containing compound catabolic process,BP,
10831,GO:0042438,1,0.895302165262793,0,18,melanin biosynthetic process,BP,
10832,GO:0042439,1,0.979013166564743,0,3,ethanolamine-containing compound metabolic process,BP,
10834,GO:0042441,1,0.972544786434269,0,4,eye pigment metabolic process,BP,
10839,GO:0042450,1,0.989373672139854,0,1,arginine biosynthetic process via ornithine,BP,
10840,GO:0042451,1,0.809078529415893,0,21,purine nucleoside biosynthetic process,BP,
10842,GO:0042455,1,0.683551838582572,0,39,ribonucleoside biosynthetic process,BP,
10843,GO:0042461,1,0.827400992272931,0,40,photoreceptor cell development,BP,
10844,GO:0042462,1,0.849769540726509,0,31,eye photoreceptor cell development,BP,
10845,GO:0042470,1,0.480417897617677,0,104,melanosome,CC,
10846,GO:0042471,1,0.492004009749447,0,115,ear morphogenesis,BP,
10847,GO:0042472,1,0.581845616214997,0,95,inner ear morphogenesis,BP,
10848,GO:0042473,1,0.941695093386433,0,9,outer ear morphogenesis,BP,
10849,GO:0042474,1,0.84388114868767,0,20,middle ear morphogenesis,BP,
10850,GO:0042475,1,0.606555443431027,0,81,odontogenesis of dentin-containing tooth,BP,
10851,GO:0042476,1,0.484981386494036,0,115,odontogenesis,BP,
10852,GO:0042481,1,0.817697355048513,0,25,regulation of odontogenesis,BP,
10853,GO:0042482,1,0.919105278243551,0,10,positive regulation of odontogenesis,BP,
10854,GO:0042483,1,0.97663023278831,0,4,negative regulation of odontogenesis,BP,
10855,GO:0042487,1,0.901166707341492,0,13,regulation of odontogenesis of dentin-containing tooth,BP,
10856,GO:0042488,1,0.978554914651129,0,3,positive regulation of odontogenesis of dentin-containing tooth,BP,
10857,GO:0042489,1,0.985241606953659,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10858,GO:0042490,1,0.714190540652498,0,56,mechanoreceptor differentiation,BP,
10859,GO:0042491,1,0.834723702100394,0,31,auditory receptor cell differentiation,BP,
10860,GO:0042492,1,0.974420444330326,0,8,gamma-delta T cell differentiation,BP,
10862,GO:0042494,1,0.988464426061889,0,4,detection of bacterial lipoprotein,BP,
10863,GO:0042495,1,0.988693268972617,0,2,detection of triacyl bacterial lipopeptide,BP,
10864,GO:0042496,1,0.995655419037998,0,2,detection of diacyl bacterial lipopeptide,BP,
10865,GO:0042497,1,0.995655423526606,0,1,triacyl lipopeptide binding,MF,
10866,GO:0042500,1,0.971452870569774,0,5,aspartic endopeptidase activity, intramembrane cleaving,MF,
10867,GO:0042501,1,0.749981631341685,0,28,serine phosphorylation of STAT protein,BP,
10868,GO:0042502,1,0.991657600429728,0,1,tyrosine phosphorylation of Stat2 protein,BP,
10870,GO:0042504,1,0.954110650190667,0,5,tyrosine phosphorylation of Stat4 protein,BP,
10871,GO:0042505,1,0.970789491542691,0,3,tyrosine phosphorylation of Stat6 protein,BP,
10873,GO:0042508,1,0.840747354291188,0,20,tyrosine phosphorylation of Stat1 protein,BP,
10875,GO:0042510,1,0.857357911277159,0,17,regulation of tyrosine phosphorylation of Stat1 protein,BP,
10876,GO:0042511,1,0.911146805357663,0,11,positive regulation of tyrosine phosphorylation of Stat1 protein,BP,
10877,GO:0042512,1,0.968846628913059,0,3,negative regulation of tyrosine phosphorylation of Stat1 protein,BP,
10880,GO:0042518,1,0.951083965064811,0,7,negative regulation of tyrosine phosphorylation of Stat3 protein,BP,
10881,GO:0042519,1,0.954110650190667,0,5,regulation of tyrosine phosphorylation of Stat4 protein,BP,
10882,GO:0042520,1,0.95953428750149,0,4,positive regulation of tyrosine phosphorylation of Stat4 protein,BP,
10883,GO:0042521,1,0.994349483019485,0,1,negative regulation of tyrosine phosphorylation of Stat4 protein,BP,
10886,GO:0042524,1,0.980757997358251,0,3,negative regulation of tyrosine phosphorylation of Stat5 protein,BP,
10887,GO:0042525,1,0.970789491542691,0,3,regulation of tyrosine phosphorylation of Stat6 protein,BP,
10888,GO:0042526,1,0.982086220914244,0,2,positive regulation of tyrosine phosphorylation of Stat6 protein,BP,
10889,GO:0042527,1,0.988498849455759,0,1,negative regulation of tyrosine phosphorylation of Stat6 protein,BP,
10891,GO:0042532,1,0.927502430504743,0,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10892,GO:0042533,1,0.871778190657267,0,19,tumor necrosis factor biosynthetic process,BP,
10893,GO:0042534,1,0.871778190657267,0,19,regulation of tumor necrosis factor biosynthetic process,BP,
10894,GO:0042535,1,0.937675578893703,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10895,GO:0042536,1,0.940766078199199,0,6,negative regulation of tumor necrosis factor biosynthetic process,BP,
10897,GO:0042538,1,0.938674022131154,0,8,hyperosmotic salinity response,BP,
10898,GO:0042539,1,0.994512014320901,0,2,hypotonic salinity response,BP,
10899,GO:0042541,1,0.926332105426178,0,9,hemoglobin biosynthetic process,BP,
10901,GO:0042543,1,0.987164973405019,0,1,protein N-linked glycosylation via arginine,BP,
10902,GO:0042546,1,0.988688643487989,0,1,cell wall biogenesis,BP,
10903,GO:0042551,1,0.813183824911853,0,42,neuron maturation,BP,
10905,GO:0042554,1,0.821919572107849,0,24,superoxide anion generation,BP,
10906,GO:0042555,1,0.933491961282583,0,11,MCM complex,CC,
10909,GO:0042560,1,0.981797580659946,0,3,pteridine-containing compound catabolic process,BP,
10911,GO:0042564,1,0.999002180190209,0,1,NLS-dependent protein nuclear import complex,CC,
10912,GO:0042565,1,0.987402916756448,0,2,RNA nuclear export complex,CC,
10913,GO:0042567,1,0.981680044982762,0,4,insulin-like growth factor ternary complex,CC,
10914,GO:0042568,1,0.987339940152064,0,1,insulin-like growth factor binary complex,CC,
10915,GO:0042571,1,0.979024298138835,0,2,immunoglobulin complex, circulating,CC,
10917,GO:0042573,1,0.828156848862638,0,22,retinoic acid metabolic process,BP,
10918,GO:0042574,1,0.92704029680947,0,11,retinal metabolic process,BP,
10919,GO:0042575,1,0.905501824686372,0,17,DNA polymerase complex,CC,
10920,GO:0042577,1,0.98502879120666,0,2,lipid phosphatase activity,MF,
10923,GO:0042581,1,0.316597411337731,0,156,specific granule,CC,
10925,GO:0042583,1,0.955135621160418,0,8,chromaffin granule,CC,
10926,GO:0042584,1,0.972031273465344,0,6,chromaffin granule membrane,CC,
10927,GO:0042585,1,0.989134957651915,0,2,germinal vesicle,CC,
10928,GO:0042586,1,0.987511578056136,0,1,peptide deformylase activity,MF,
10929,GO:0042587,1,0.972084196043912,0,6,glycogen granule,CC,
10930,GO:0042588,1,0.892925219085469,0,15,zymogen granule,CC,
10931,GO:0042589,1,0.923243443154442,0,11,zymogen granule membrane,CC,
10936,GO:0042595,1,0.984870607751904,0,2,behavioral response to starvation,BP,
10937,GO:0042596,1,0.828958444349973,0,32,fear response,BP,
10938,GO:0042599,1,0.868111394292038,0,17,lamellar body,CC,
10939,GO:0042602,1,0.987271072403462,0,1,riboflavin reductase (NADPH) activity,MF,
10940,GO:0042605,1,0.810288365902252,0,23,peptide antigen binding,MF,
10941,GO:0042608,1,0.93640408607844,0,7,T cell receptor binding,MF,
10942,GO:0042609,1,0.94273920540875,0,7,CD4 receptor binding,MF,
10943,GO:0042610,1,0.979585458426155,0,2,CD8 receptor binding,MF,
10944,GO:0042611,1,0.750824965855716,0,24,MHC protein complex,CC,
10945,GO:0042612,1,0.907629007167161,0,8,MHC class I protein complex,CC,
10946,GO:0042613,1,0.827358131314817,0,16,MHC class II protein complex,CC,
10947,GO:0042622,1,0.890809852827452,0,16,photoreceptor outer segment membrane,CC,
10949,GO:0042624,1,0.987199441584784,0,1,ATPase activity, uncoupled,MF,
10950,GO:0042625,1,0.640424196394655,0,75,ATPase coupled ion transmembrane transporter activity,MF,
10953,GO:0042628,1,0.990376976927382,0,1,mating plug formation,BP,
10954,GO:0042629,1,0.856956679475244,0,22,mast cell granule,CC,
10955,GO:0042631,1,0.993567129142752,0,3,cellular response to water deprivation,BP,
10960,GO:0042636,1,0.979099212760893,0,5,negative regulation of hair cycle,BP,
10961,GO:0042637,1,0.97631007498797,0,4,catagen,BP,
10962,GO:0042640,1,0.983032219895802,0,5,anagen,BP,
10963,GO:0042641,1,0.774381267907084,0,61,actomyosin,CC,
10964,GO:0042643,1,0.990432111538609,0,2,actomyosin, actin portion,CC,
10966,GO:0042658,1,0.987713213770888,0,1,MHC class II protein binding, via antigen binding groove,MF,
10967,GO:0042659,1,0.925090974000375,0,13,regulation of cell fate specification,BP,
10968,GO:0042660,1,0.993409571464487,0,2,positive regulation of cell fate specification,BP,
10969,GO:0042661,1,0.947575827139454,0,7,regulation of mesodermal cell fate specification,BP,
10970,GO:0042662,1,0.957066768601283,0,4,negative regulation of mesodermal cell fate specification,BP,
10971,GO:0042663,1,0.961442632524529,0,4,regulation of endodermal cell fate specification,BP,
10972,GO:0042664,1,0.98751377475558,0,1,negative regulation of endodermal cell fate specification,BP,
10973,GO:0042665,1,0.997547154876351,0,1,regulation of ectodermal cell fate specification,BP,
10974,GO:0042666,1,0.997547154876351,0,1,negative regulation of ectodermal cell fate specification,BP,
10975,GO:0042667,1,0.987417807105176,0,1,auditory receptor cell fate specification,BP,
10976,GO:0042668,1,0.963507957697228,0,3,auditory receptor cell fate determination,BP,
10977,GO:0042670,1,0.956122309423585,0,9,retinal cone cell differentiation,BP,
10978,GO:0042684,1,0.993409576390941,0,1,cardioblast cell fate commitment,BP,
10979,GO:0042685,1,0.993409576390941,0,1,cardioblast cell fate specification,BP,
10980,GO:0042686,1,0.993409576390941,0,1,regulation of cardioblast cell fate specification,BP,
10981,GO:0042692,1,0.128630672941381,0,357,muscle cell differentiation,BP,
10982,GO:0042693,1,0.858459864872212,0,17,muscle cell fate commitment,BP,
10983,GO:0042694,1,0.987256921313791,0,1,muscle cell fate specification,BP,
10984,GO:0042695,1,0.966038339507345,0,5,thelarche,BP,
10986,GO:0042699,1,0.95581374419939,0,5,follicle-stimulating hormone signaling pathway,BP,
10987,GO:0042700,1,0.993654392658642,0,2,luteinizing hormone signaling pathway,BP,
10988,GO:0042701,1,0.96699692190241,0,4,progesterone secretion,BP,
10989,GO:0042703,1,0.993317306397642,0,1,menstruation,BP,
10990,GO:0042704,1,0.994570335984399,0,2,uterine wall breakdown,BP,
10991,GO:0042709,1,0.990766010795186,0,1,succinate-CoA ligase complex,CC,
10992,GO:0042710,1,0.982566967774119,0,2,biofilm formation,BP,
10993,GO:0042711,1,0.923001655101366,0,13,maternal behavior,BP,
10994,GO:0042713,1,0.979054875360441,0,6,sperm ejaculation,BP,
10995,GO:0042719,1,0.944144319027683,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10996,GO:0042720,1,0.975465831595922,0,2,mitochondrial inner membrane peptidase complex,CC,
10997,GO:0042721,1,0.988412156840981,0,1,mitochondrial inner membrane protein insertion complex,CC,
10998,GO:0042723,1,0.946587849601401,0,7,thiamine-containing compound metabolic process,BP,
11000,GO:0042727,1,0.981716681075591,0,2,flavin-containing compound biosynthetic process,BP,
11001,GO:0042728,1,0.99763454673982,0,1,flavin-containing compound catabolic process,BP,
11002,GO:0042730,1,0.794158935578695,0,27,fibrinolysis,BP,
11003,GO:0042731,1,0.977136289915891,0,4,PH domain binding,MF,
11004,GO:0042732,1,0.971895350953843,0,3,D-xylose metabolic process,BP,
11005,GO:0042733,1,0.729455575089563,0,58,embryonic digit morphogenesis,BP,
11006,GO:0042734,1,0.814035075192421,0,66,presynaptic membrane,CC,
11007,GO:0042737,1,0.887061393744649,0,14,drug catabolic process,BP,
11008,GO:0042738,1,0.917338747285689,0,11,exogenous drug catabolic process,BP,
11010,GO:0042743,1,0.689894283391835,0,42,hydrogen peroxide metabolic process,BP,
11011,GO:0042744,1,0.826560630128379,0,22,hydrogen peroxide catabolic process,BP,
11013,GO:0042746,1,0.939587243275856,0,6,circadian sleep/wake cycle, wakefulness,BP,
11015,GO:0042748,1,0.932119247204096,0,9,circadian sleep/wake cycle, non-REM sleep,BP,
11016,GO:0042749,1,0.810476436665989,0,22,regulation of circadian sleep/wake cycle,BP,
11017,GO:0042752,1,0.540553058991913,0,96,regulation of circadian rhythm,BP,
11018,GO:0042753,1,0.872677148243457,0,18,positive regulation of circadian rhythm,BP,
11019,GO:0042754,1,0.920193687928074,0,13,negative regulation of circadian rhythm,BP,
11020,GO:0042755,1,0.776091734402345,0,32,eating behavior,BP,
11021,GO:0042756,1,0.915453067048223,0,10,drinking behavior,BP,
11022,GO:0042758,1,0.951382838740989,0,7,long-chain fatty acid catabolic process,BP,
11024,GO:0042760,1,0.971766380362921,0,5,very long-chain fatty acid catabolic process,BP,
11027,GO:0042765,1,0.961976993531414,0,5,GPI-anchor transamidase complex,CC,
11028,GO:0042766,1,0.999999996386078,0,1,nucleosome mobilization,BP,
11029,GO:0042769,1,0.748206325073803,0,36,DNA damage response, detection of DNA damage,BP,
11030,GO:0042770,1,0.456208861547777,0,118,signal transduction in response to DNA damage,BP,
11032,GO:0042772,1,0.885790746858234,0,18,DNA damage response, signal transduction resulting in transcription,BP,
11033,GO:0042773,1,0.40217505961187,0,83,ATP synthesis coupled electron transport,BP,
11034,GO:0042774,1,0.991657600429728,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
11035,GO:0042775,1,0.405582769355353,0,82,mitochondrial ATP synthesis coupled electron transport,BP,
11036,GO:0042776,1,0.793807654689776,0,19,mitochondrial ATP synthesis coupled proton transport,BP,
11037,GO:0042779,1,0.987722884113335,0,2,tRNA 3'-trailer cleavage,BP,
11038,GO:0042780,1,0.961183813455505,0,5,tRNA 3'-end processing,BP,
11039,GO:0042781,1,0.987722884113335,0,2,3'-tRNA processing endoribonuclease activity,MF,
11041,GO:0042788,1,0.968842509176747,0,7,polysomal ribosome,CC,
11042,GO:0042789,1,0.89908979177986,0,18,mRNA transcription from RNA polymerase II promoter,BP,
11043,GO:0042790,1,0.910157915776701,0,13,transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
11044,GO:0042791,1,0.967630460004686,0,6,5S class rRNA transcription from RNA polymerase III type 1 promoter,BP,
11045,GO:0042795,1,0.622346592898549,0,65,snRNA transcription from RNA polymerase II promoter,BP,
11046,GO:0042796,1,0.978204601689422,0,4,snRNA transcription from RNA polymerase III promoter,BP,
11047,GO:0042797,1,0.967630460004686,0,6,tRNA transcription from RNA polymerase III promoter,BP,
11048,GO:0042799,1,0.999999996408454,0,1,histone methyltransferase activity (H4-K20 specific),MF,
11049,GO:0042800,1,0.921798872272627,0,13,histone methyltransferase activity (H3-K4 specific),MF,
11050,GO:0042801,1,0.999999996372804,0,1,polo kinase kinase activity,MF,
11053,GO:0042805,1,0.87003940738152,0,40,actinin binding,MF,
11054,GO:0042806,1,0.963970758564871,0,4,fucose binding,MF,
11055,GO:0042809,1,0.93248115543109,0,15,vitamin D receptor binding,MF,
11056,GO:0042813,1,0.955154510387292,0,15,Wnt-activated receptor activity,MF,
11058,GO:0042819,1,0.985837496815951,0,3,vitamin B6 biosynthetic process,BP,
11059,GO:0042820,1,0.989404570639733,0,1,vitamin B6 catabolic process,BP,
11060,GO:0042822,1,0.985413957304132,0,3,pyridoxal phosphate metabolic process,BP,
11061,GO:0042823,1,0.995966994571126,0,2,pyridoxal phosphate biosynthetic process,BP,
11062,GO:0042824,1,0.977124380445729,0,4,MHC class I peptide loading complex,CC,
11063,GO:0042825,1,0.987878836833456,0,3,TAP complex,CC,
11064,GO:0042826,1,0.564467082441619,0,102,histone deacetylase binding,MF,
11065,GO:0042827,1,0.851568096945565,0,20,platelet dense granule,CC,
11066,GO:0042832,1,0.843220419971937,0,19,defense response to protozoan,BP,
11067,GO:0042834,1,0.923791223469919,0,10,peptidoglycan binding,MF,
11068,GO:0042835,1,0.997816916385387,0,2,BRE binding,MF,
11069,GO:0042839,1,0.987983996453764,0,1,D-glucuronate metabolic process,BP,
11070,GO:0042840,1,0.987983996453764,0,1,D-glucuronate catabolic process,BP,
11071,GO:0042843,1,0.987438132381701,0,1,D-xylose catabolic process,BP,
11072,GO:0042851,1,0.965853354624629,0,4,L-alanine metabolic process,BP,
11073,GO:0042853,1,0.965853354624629,0,4,L-alanine catabolic process,BP,
11074,GO:0042866,1,0.954242310105376,0,5,pyruvate biosynthetic process,BP,
11075,GO:0042883,1,0.997093914670211,0,1,cysteine transport,BP,
11077,GO:0042887,1,0.776588120024911,0,33,amide transmembrane transporter activity,MF,
11078,GO:0042891,1,0.988952528708528,0,1,antibiotic transport,BP,
11079,GO:0042895,1,0.988952528708528,0,1,antibiotic transporter activity,MF,
11080,GO:0042903,1,0.987675114002303,0,2,tubulin deacetylase activity,MF,
11081,GO:0042904,1,0.967427872336713,0,4,9-cis-retinoic acid biosynthetic process,BP,
11082,GO:0042905,1,0.967427872336713,0,4,9-cis-retinoic acid metabolic process,BP,
11083,GO:0042908,1,0.984407114620504,0,10,xenobiotic transport,BP,
11084,GO:0042910,1,0.985491126508285,0,9,xenobiotic transporter activity,MF,
11085,GO:0042918,1,0.999999996375723,0,1,alkanesulfonate transport,BP,
11086,GO:0042921,1,0.940285880589309,0,15,glucocorticoid receptor signaling pathway,BP,
11087,GO:0042922,1,0.987249524593575,0,1,neuromedin U receptor binding,MF,
11088,GO:0042923,1,0.819515548327381,0,21,neuropeptide binding,MF,
11089,GO:0042924,1,0.989619282044019,0,1,neuromedin U binding,MF,
11090,GO:0042927,1,0.991657600429728,0,1,siderophore transporter activity,MF,
11091,GO:0042930,1,0.991657600429728,0,1,enterobactin transport,BP,
11092,GO:0042931,1,0.991657600429728,0,1,enterobactin transporter activity,MF,
11093,GO:0042936,1,0.994441724162223,0,1,dipeptide transporter activity,MF,
11094,GO:0042937,1,0.999999996375099,0,1,tripeptide transporter activity,MF,
11095,GO:0042938,1,0.975142218840751,0,3,dipeptide transport,BP,
11096,GO:0042939,1,0.989411458953521,0,2,tripeptide transport,BP,
11098,GO:0042941,1,0.989235529949153,0,1,D-alanine transport,BP,
11099,GO:0042942,1,0.9810809857018,0,2,D-serine transport,BP,
11100,GO:0042946,1,0.991657600429728,0,1,glucoside transport,BP,
11101,GO:0042947,1,0.991657600429728,0,1,glucoside transmembrane transporter activity,MF,
11102,GO:0042953,1,0.938500101473324,0,14,lipoprotein transport,BP,
11103,GO:0042954,1,0.999999989226456,0,3,lipoprotein transporter activity,MF,
11104,GO:0042959,1,0.999999996375723,0,1,alkanesulfonate transporter activity,MF,
11105,GO:0042974,1,0.879087932350292,0,24,retinoic acid receptor binding,MF,
11106,GO:0042975,1,0.955749286999202,0,10,peroxisome proliferator activated receptor binding,MF,
11109,GO:0042978,1,0.998838693722063,0,2,ornithine decarboxylase activator activity,MF,
11110,GO:0042979,1,0.96320476460629,0,5,ornithine decarboxylase regulator activity,MF,
11113,GO:0042983,1,0.947431420905878,0,7,amyloid precursor protein biosynthetic process,BP,
11114,GO:0042984,1,0.947431420905878,0,7,regulation of amyloid precursor protein biosynthetic process,BP,
11115,GO:0042985,1,0.972234440255956,0,4,negative regulation of amyloid precursor protein biosynthetic process,BP,
11116,GO:0042986,1,0.984956935684117,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
11118,GO:0042988,1,0.999921905791882,0,1,X11-like protein binding,MF,
11119,GO:0042989,1,0.932860860357777,0,7,sequestering of actin monomers,BP,
11122,GO:0042992,1,0.768191557273246,0,41,negative regulation of transcription factor import into nucleus,BP,
11123,GO:0042993,1,0.742061492228929,0,47,positive regulation of transcription factor import into nucleus,BP,
11124,GO:0042994,1,0.839094443775049,0,22,cytoplasmic sequestering of transcription factor,BP,
11126,GO:0042996,1,0.970831835543205,0,6,regulation of Golgi to plasma membrane protein transport,BP,
11127,GO:0042997,1,0.974110036554534,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
11128,GO:0042998,1,0.996635378414875,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
11129,GO:0042999,1,0.999412471524228,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
11130,GO:0043000,1,0.987349661317846,0,2,Golgi to plasma membrane CFTR protein transport,BP,
11131,GO:0043001,1,0.828738225184231,0,30,Golgi to plasma membrane protein transport,BP,
11132,GO:0043002,1,0.999412471524228,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
11133,GO:0043004,1,0.999412471524228,0,1,cytoplasmic sequestering of CFTR protein,BP,
11135,GO:0043006,1,0.981371757861318,0,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,
11136,GO:0043008,1,0.94043688424668,0,8,ATP-dependent protein binding,MF,
11139,GO:0043011,1,0.841678551054411,0,19,myeloid dendritic cell differentiation,BP,
11140,GO:0043012,1,0.991812142624782,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11142,GO:0043015,1,0.879412222501018,0,24,gamma-tubulin binding,MF,
11143,GO:0043016,1,0.992375915620732,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11144,GO:0043017,1,0.992375915620732,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11145,GO:0043020,1,0.912031345877864,0,10,NADPH oxidase complex,CC,
11147,GO:0043022,1,0.767468721954625,0,45,ribosome binding,MF,
11148,GO:0043023,1,0.937136065598697,0,7,ribosomal large subunit binding,MF,
11149,GO:0043024,1,0.926226344369281,0,13,ribosomal small subunit binding,MF,
11155,GO:0043031,1,0.927811039825937,0,7,negative regulation of macrophage activation,BP,
11156,GO:0043032,1,0.869427693967962,0,15,positive regulation of macrophage activation,BP,
11157,GO:0043033,1,0.999999996379923,0,1,isoamylase complex,CC,
11158,GO:0043034,1,0.933324678312872,0,19,costamere,CC,
11159,GO:0043035,1,0.99734443916887,0,1,chromatin insulator sequence binding,MF,
11160,GO:0043038,1,0.677135056506966,0,51,amino acid activation,BP,
11161,GO:0043039,1,0.679572128655995,0,50,tRNA aminoacylation,BP,
11162,GO:0043041,1,0.996424808340183,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11164,GO:0043044,1,0.574933201371778,0,69,ATP-dependent chromatin remodeling,BP,
11165,GO:0043045,1,0.958363345161811,0,7,DNA methylation involved in embryo development,BP,
11166,GO:0043046,1,0.882625172458109,0,20,DNA methylation involved in gamete generation,BP,
11167,GO:0043047,1,0.945315649764552,0,9,single-stranded telomeric DNA binding,MF,
11168,GO:0043048,1,0.990129252018048,0,1,dolichyl monophosphate biosynthetic process,BP,
11169,GO:0043049,1,0.994081846487967,0,1,otic placode formation,BP,
11170,GO:0043060,1,0.991251880888793,0,1,meiotic metaphase I plate congression,BP,
11171,GO:0043062,1,0.221123333464566,0,307,extracellular structure organization,BP,
11172,GO:0043063,1,0.999749828787896,0,1,intercellular bridge organization,BP,
11178,GO:0043073,1,0.873788215027273,0,17,germ cell nucleus,CC,
11179,GO:0043083,1,0.961905599700465,0,9,synaptic cleft,CC,
11180,GO:0043084,1,0.953834837110887,0,9,penile erection,BP,
11185,GO:0043091,1,0.977427442977545,0,4,L-arginine import,BP,
11188,GO:0043095,1,0.987207076579492,0,1,regulation of GTP cyclohydrolase I activity,BP,
11189,GO:0043096,1,0.975250119192283,0,2,purine nucleobase salvage,BP,
11190,GO:0043097,1,0.898348324013781,0,11,pyrimidine nucleoside salvage,BP,
11193,GO:0043103,1,0.987879530616557,0,1,hypoxanthine salvage,BP,
11194,GO:0043105,1,0.987207076579492,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11195,GO:0043111,1,0.987670378251574,0,1,replication fork arrest,BP,
11196,GO:0043112,1,0.421552761410879,0,149,receptor metabolic process,BP,
11197,GO:0043113,1,0.800918222521731,0,47,receptor clustering,BP,
11198,GO:0043114,1,0.859472125990437,0,29,regulation of vascular permeability,BP,
11199,GO:0043116,1,0.951378748939987,0,10,negative regulation of vascular permeability,BP,
11200,GO:0043117,1,0.936101724997431,0,9,positive regulation of vascular permeability,BP,
11201,GO:0043120,1,0.981545640893005,0,3,tumor necrosis factor binding,MF,
11202,GO:0043121,1,0.966717788752821,0,10,neurotrophin binding,MF,
11206,GO:0043125,1,0.978102556630981,0,4,ErbB-3 class receptor binding,MF,
11207,GO:0043126,1,0.988033318391619,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11208,GO:0043128,1,0.988033318391619,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11209,GO:0043129,1,0.958205968676915,0,7,surfactant homeostasis,BP,
11210,GO:0043130,1,0.561672155507908,0,101,ubiquitin binding,MF,
11211,GO:0043132,1,0.984885794614446,0,2,NAD transport,BP,
11212,GO:0043133,1,0.974672498708384,0,2,hindgut contraction,BP,
11213,GO:0043134,1,0.974672498708384,0,2,regulation of hindgut contraction,BP,
11214,GO:0043136,1,0.994393193361575,0,1,glycerol-3-phosphatase activity,MF,
11215,GO:0043137,1,0.977909053321277,0,3,DNA replication, removal of RNA primer,BP,
11216,GO:0043138,1,0.950456135328512,0,12,3'-5' DNA helicase activity,MF,
11217,GO:0043139,1,0.952418431926782,0,7,5'-3' DNA helicase activity,MF,
11218,GO:0043140,1,0.990762418502208,0,6,ATP-dependent 3'-5' DNA helicase activity,MF,
11219,GO:0043141,1,0.962873043208923,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11220,GO:0043142,1,0.920277794599916,0,12,single-stranded DNA-dependent ATPase activity,MF,
11221,GO:0043143,1,0.990774421946724,0,1,regulation of translation by machinery localization,BP,
11222,GO:0043144,1,0.900190431407672,0,9,snoRNA processing,BP,
11223,GO:0043149,1,0.670698583033991,0,81,stress fiber assembly,BP,
11224,GO:0043152,1,0.971732278559702,0,4,induction of bacterial agglutination,BP,
11225,GO:0043153,1,0.884478846082482,0,19,entrainment of circadian clock by photoperiod,BP,
11227,GO:0043159,1,0.973944171588457,0,3,acrosomal matrix,CC,
11228,GO:0043160,1,0.991657600429728,0,1,acrosomal lumen,CC,
11230,GO:0043162,1,0.875979459445977,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11231,GO:0043163,1,0.984989833294214,0,3,cell envelope organization,BP,
11236,GO:0043171,1,0.838619522442692,0,29,peptide catabolic process,BP,
11237,GO:0043173,1,0.889798093581813,0,13,nucleotide salvage,BP,
11238,GO:0043174,1,0.857364751980674,0,16,nucleoside salvage,BP,
11239,GO:0043175,1,0.836434577810005,0,30,RNA polymerase core enzyme binding,MF,
11240,GO:0043176,1,0.916219374204267,0,11,amine binding,MF,
11243,GO:0043179,1,0.989744678367247,0,1,rhythmic excitation,BP,
11244,GO:0043181,1,0.996580187682197,0,1,vacuolar sequestering,BP,
11245,GO:0043183,1,0.9837321355168,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11246,GO:0043184,1,0.967758060157714,0,7,vascular endothelial growth factor receptor 2 binding,MF,
11247,GO:0043185,1,0.98968435726498,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11248,GO:0043186,1,0.913995305964054,0,16,P granule,CC,
11249,GO:0043189,1,0.855472021539292,0,18,H4/H2A histone acetyltransferase complex,CC,
11250,GO:0043190,1,0.965954793594847,0,8,ATP-binding cassette (ABC) transporter complex,CC,
11251,GO:0043194,1,0.961983246076166,0,12,axon initial segment,CC,
11252,GO:0043195,1,0.720713333782123,0,61,terminal bouton,CC,
11253,GO:0043196,1,0.932937434291515,0,8,varicosity,CC,
11254,GO:0043197,1,0.575148534572147,0,120,dendritic spine,CC,
11255,GO:0043198,1,0.876125814399457,0,33,dendritic shaft,CC,
11256,GO:0043199,1,0.97205497468383,0,4,sulfate binding,MF,
11257,GO:0043200,1,0.516531973280754,0,106,response to amino acid,BP,
11258,GO:0043201,1,0.981477215756242,0,11,response to leucine,BP,
11260,GO:0043203,1,0.94474988861597,0,7,axon hillock,CC,
11261,GO:0043204,1,0.535522892412479,0,104,perikaryon,CC,
11263,GO:0043208,1,0.936864470695244,0,8,glycosphingolipid binding,MF,
11265,GO:0043210,1,0.988797848236797,0,1,alkanesulfonate binding,MF,
11266,GO:0043215,1,0.998041284082169,0,1,daunorubicin transport,BP,
11267,GO:0043217,1,0.9406692421208,0,12,myelin maintenance,BP,
11268,GO:0043218,1,0.914741211641351,0,14,compact myelin,CC,
11269,GO:0043219,1,0.976999673403747,0,4,lateral loop,CC,
11270,GO:0043220,1,0.936369192282203,0,11,Schmidt-Lanterman incisure,CC,
11271,GO:0043221,1,0.99761648146168,0,1,SMC family protein binding,MF,
11272,GO:0043225,1,0.98501516203938,0,13,ATPase-coupled anion transmembrane transporter activity,MF,
11283,GO:0043236,1,0.872837295247821,0,28,laminin binding,MF,
11284,GO:0043237,1,0.972037778822772,0,6,laminin-1 binding,MF,
11285,GO:0043240,1,0.957626013742057,0,8,Fanconi anaemia nuclear complex,CC,
11288,GO:0043243,1,0.866444539129103,0,21,positive regulation of protein complex disassembly,BP,
11290,GO:0043247,1,0.94488872871718,0,12,telomere maintenance in response to DNA damage,BP,
11291,GO:0043248,1,0.872847076687186,0,13,proteasome assembly,BP,
11292,GO:0043249,1,0.91450787852856,0,11,erythrocyte maturation,BP,
11293,GO:0043250,1,0.988039244544445,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11294,GO:0043251,1,0.988039244544445,0,1,sodium-dependent organic anion transport,BP,
11295,GO:0043252,1,0.835364407156126,0,25,sodium-independent organic anion transport,BP,
11297,GO:0043255,1,0.679054613615477,0,77,regulation of carbohydrate biosynthetic process,BP,
11298,GO:0043256,1,0.998184783060569,0,8,laminin complex,CC,
11299,GO:0043257,1,0.999999996371812,0,1,laminin-8 complex,CC,
11300,GO:0043259,1,0.999999989158955,0,3,laminin-10 complex,CC,
11301,GO:0043260,1,0.999999989158695,0,3,laminin-11 complex,CC,
11302,GO:0043262,1,0.978666524243399,0,3,adenosine-diphosphatase activity,MF,
11303,GO:0043265,1,0.994432021214985,0,1,ectoplasm,CC,
11304,GO:0043266,1,0.617644161880906,0,81,regulation of potassium ion transport,BP,
11305,GO:0043267,1,0.858383588753912,0,25,negative regulation of potassium ion transport,BP,
11306,GO:0043268,1,0.860603025774057,0,33,positive regulation of potassium ion transport,BP,
11309,GO:0043271,1,0.447929576130675,0,120,negative regulation of ion transport,BP,
11310,GO:0043273,1,0.999978353041879,0,1,CTPase activity,MF,
11311,GO:0043274,1,0.926468681035691,0,15,phospholipase binding,MF,
11313,GO:0043277,1,0.81073865960736,0,35,apoptotic cell clearance,BP,
11318,GO:0043291,1,0.999999992800511,0,2,RAVE complex,CC,
11320,GO:0043293,1,0.988660611639608,0,2,apoptosome,CC,
11321,GO:0043295,1,0.899171427669158,0,11,glutathione binding,MF,
11322,GO:0043296,1,0.572954732685555,0,123,apical junction complex,CC,
11323,GO:0043297,1,0.770817093590701,0,54,apical junction assembly,BP,
11325,GO:0043300,1,0.753716180749819,0,39,regulation of leukocyte degranulation,BP,
11326,GO:0043301,1,0.927215104360204,0,11,negative regulation of leukocyte degranulation,BP,
11327,GO:0043302,1,0.866693484036023,0,18,positive regulation of leukocyte degranulation,BP,
11328,GO:0043303,1,0.724544348557597,0,45,mast cell degranulation,BP,
11329,GO:0043304,1,0.793887081029253,0,29,regulation of mast cell degranulation,BP,
11330,GO:0043305,1,0.939081474877174,0,7,negative regulation of mast cell degranulation,BP,
11331,GO:0043306,1,0.892280556105397,0,13,positive regulation of mast cell degranulation,BP,
11332,GO:0043307,1,0.932440451976974,0,7,eosinophil activation,BP,
11333,GO:0043308,1,0.942785834476994,0,6,eosinophil degranulation,BP,
11334,GO:0043309,1,0.972625701468698,0,3,regulation of eosinophil degranulation,BP,
11335,GO:0043310,1,0.991388739056542,0,1,negative regulation of eosinophil degranulation,BP,
11336,GO:0043311,1,0.981075270396992,0,2,positive regulation of eosinophil degranulation,BP,
11338,GO:0043313,1,0.988308680546624,0,5,regulation of neutrophil degranulation,BP,
11339,GO:0043314,1,0.999947889827562,0,2,negative regulation of neutrophil degranulation,BP,
11340,GO:0043315,1,0.998490135981731,0,1,positive regulation of neutrophil degranulation,BP,
11341,GO:0043316,1,0.988816414046613,0,2,cytotoxic T cell degranulation,BP,
11342,GO:0043317,1,0.995998681516664,0,1,regulation of cytotoxic T cell degranulation,BP,
11343,GO:0043318,1,0.995998681516664,0,1,negative regulation of cytotoxic T cell degranulation,BP,
11344,GO:0043320,1,0.956059115155579,0,7,natural killer cell degranulation,BP,
11345,GO:0043321,1,0.991585404684219,0,2,regulation of natural killer cell degranulation,BP,
11346,GO:0043323,1,0.991585404684219,0,2,positive regulation of natural killer cell degranulation,BP,
11347,GO:0043324,1,0.972544786434269,0,4,pigment metabolic process involved in developmental pigmentation,BP,
11348,GO:0043325,1,0.889851500903803,0,21,phosphatidylinositol-3,4-bisphosphate binding,MF,
11349,GO:0043328,1,0.962049750944615,0,4,protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11352,GO:0043335,1,0.984572682869327,0,2,protein unfolding,BP,
11353,GO:0043337,1,0.997376890728512,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11354,GO:0043353,1,0.962429471801214,0,7,enucleate erythrocyte differentiation,BP,
11355,GO:0043366,1,0.989055207774806,0,2,beta selection,BP,
11356,GO:0043367,1,0.646702627074398,0,63,CD4-positive, alpha-beta T cell differentiation,BP,
11357,GO:0043368,1,0.805494452128348,0,31,positive T cell selection,BP,
11358,GO:0043369,1,0.858619345435688,0,20,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11359,GO:0043370,1,0.748051953016994,0,38,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11360,GO:0043371,1,0.902066160009459,0,15,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11361,GO:0043372,1,0.810496820946293,0,25,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11362,GO:0043373,1,0.876708142972452,0,16,CD4-positive, alpha-beta T cell lineage commitment,BP,
11363,GO:0043374,1,0.929627053197181,0,11,CD8-positive, alpha-beta T cell differentiation,BP,
11364,GO:0043375,1,0.997545316127058,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11365,GO:0043376,1,0.994426619499361,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11366,GO:0043378,1,0.997800620129705,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11367,GO:0043379,1,0.940825385400572,0,9,memory T cell differentiation,BP,
11368,GO:0043380,1,0.940825400404459,0,8,regulation of memory T cell differentiation,BP,
11369,GO:0043381,1,0.991657600429728,0,1,negative regulation of memory T cell differentiation,BP,
11370,GO:0043382,1,0.952295649090109,0,6,positive regulation of memory T cell differentiation,BP,
11371,GO:0043383,1,0.917806772458443,0,13,negative T cell selection,BP,
11372,GO:0043385,1,0.990566313287312,0,1,mycotoxin metabolic process,BP,
11373,GO:0043388,1,0.703760493238015,0,49,positive regulation of DNA binding,BP,
11374,GO:0043390,1,0.990566313287312,0,1,aflatoxin B1 metabolic process,BP,
11375,GO:0043392,1,0.697717788389746,0,51,negative regulation of DNA binding,BP,
11377,GO:0043394,1,0.834553810913099,0,34,proteoglycan binding,MF,
11378,GO:0043395,1,0.897843792131803,0,18,heparan sulfate proteoglycan binding,MF,
11379,GO:0043396,1,0.984932468662005,0,3,corticotropin-releasing hormone secretion,BP,
11380,GO:0043397,1,0.984932468662005,0,3,regulation of corticotropin-releasing hormone secretion,BP,
11381,GO:0043398,1,0.984996021669631,0,3,HLH domain binding,MF,
11382,GO:0043400,1,0.955532483416471,0,5,cortisol secretion,BP,
11383,GO:0043401,1,0.374657279997989,0,178,steroid hormone mediated signaling pathway,BP,
11384,GO:0043402,1,0.991657589919695,0,3,glucocorticoid mediated signaling pathway,BP,
11385,GO:0043403,1,0.807237683988201,0,28,skeletal muscle tissue regeneration,BP,
11388,GO:0043407,1,0.602206975054238,0,71,negative regulation of MAP kinase activity,BP,
11390,GO:0043409,1,0.401053099514351,0,145,negative regulation of MAPK cascade,BP,
11395,GO:0043415,1,0.967619050151327,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11396,GO:0043416,1,0.956192247923039,0,6,regulation of skeletal muscle tissue regeneration,BP,
11397,GO:0043418,1,0.978221333522305,0,3,homocysteine catabolic process,BP,
11398,GO:0043420,1,0.988006973601008,0,1,anthranilate metabolic process,BP,
11399,GO:0043422,1,0.923555293456427,0,12,protein kinase B binding,MF,
11400,GO:0043423,1,0.998987712595692,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11401,GO:0043425,1,0.86355297080035,0,26,bHLH transcription factor binding,MF,
11402,GO:0043426,1,0.974778857044037,0,5,MRF binding,MF,
11405,GO:0043435,1,0.968559948245675,0,5,response to corticotropin-releasing hormone,BP,
11407,GO:0043438,1,0.993152568679764,0,1,acetoacetic acid metabolic process,BP,
11408,GO:0043449,1,0.990720930238193,0,2,cellular alkene metabolic process,BP,
11409,GO:0043455,1,0.923505829627045,0,11,regulation of secondary metabolic process,BP,
11410,GO:0043456,1,0.954226911717594,0,4,regulation of pentose-phosphate shunt,BP,
11411,GO:0043457,1,0.873462845900015,0,23,regulation of cellular respiration,BP,
11412,GO:0043461,1,0.965007728710786,0,4,proton-transporting ATP synthase complex assembly,BP,
11414,GO:0043465,1,0.993128389988697,0,1,regulation of fermentation,BP,
11415,GO:0043467,1,0.638378325770336,0,80,regulation of generation of precursor metabolites and energy,BP,
11416,GO:0043470,1,0.780736652058962,0,41,regulation of carbohydrate catabolic process,BP,
11417,GO:0043471,1,0.915418771925688,0,11,regulation of cellular carbohydrate catabolic process,BP,
11418,GO:0043473,1,0.55158777642922,0,95,pigmentation,BP,
11419,GO:0043474,1,0.972544786434269,0,4,pigment metabolic process involved in pigmentation,BP,
11420,GO:0043476,1,0.929910726761668,0,12,pigment accumulation,BP,
11421,GO:0043482,1,0.929910726761668,0,12,cellular pigment accumulation,BP,
11422,GO:0043484,1,0.515216763612113,0,103,regulation of RNA splicing,BP,
11423,GO:0043485,1,0.929910760811144,0,10,endosome to pigment granule transport,BP,
11424,GO:0043486,1,0.631103631317248,0,48,histone exchange,BP,
11427,GO:0043489,1,0.846742027200859,0,31,RNA stabilization,BP,
11428,GO:0043490,1,0.992835755338341,0,2,malate-aspartate shuttle,BP,
11431,GO:0043495,1,0.963296707761349,0,7,protein anchor,MF,
11433,GO:0043497,1,0.946212081504578,0,8,regulation of protein heterodimerization activity,BP,
11435,GO:0043501,1,0.87846939950807,0,23,skeletal muscle adaptation,BP,
11437,GO:0043503,1,0.976922733413026,0,2,skeletal muscle fiber adaptation,BP,
11438,GO:0043504,1,0.988908652206184,0,3,mitochondrial DNA repair,BP,
11439,GO:0043506,1,0.692897707812911,0,80,regulation of JUN kinase activity,BP,
11440,GO:0043507,1,0.776133798777009,0,63,positive regulation of JUN kinase activity,BP,
11441,GO:0043508,1,0.907683713330588,0,14,negative regulation of JUN kinase activity,BP,
11442,GO:0043509,1,0.990020905945555,0,1,activin A complex,CC,
11443,GO:0043511,1,0.978025612920791,0,2,inhibin complex,CC,
11444,GO:0043512,1,0.978025612920791,0,2,inhibin A complex,CC,
11445,GO:0043513,1,0.987884754444476,0,1,inhibin B complex,CC,
11446,GO:0043514,1,0.97876844197789,0,2,interleukin-12 complex,CC,
11447,GO:0043515,1,0.97959520669642,0,4,kinetochore binding,MF,
11448,GO:0043516,1,0.82581757479331,0,28,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11449,GO:0043517,1,0.925435402642763,0,13,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11450,GO:0043518,1,0.902838337960292,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11451,GO:0043519,1,0.989783393189947,0,1,regulation of myosin II filament organization,BP,
11452,GO:0043522,1,0.916942602872919,0,11,leucine zipper domain binding,MF,
11455,GO:0043525,1,0.72770811314196,0,48,positive regulation of neuron apoptotic process,BP,
11456,GO:0043527,1,0.951750969134248,0,5,tRNA methyltransferase complex,CC,
11458,GO:0043532,1,0.965618909788662,0,4,angiostatin binding,MF,
11459,GO:0043533,1,0.982803772753769,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11460,GO:0043534,1,0.642476654047572,0,76,blood vessel endothelial cell migration,BP,
11461,GO:0043535,1,0.71349278247919,0,54,regulation of blood vessel endothelial cell migration,BP,
11462,GO:0043536,1,0.850004357717354,0,27,positive regulation of blood vessel endothelial cell migration,BP,
11463,GO:0043537,1,0.857282082674815,0,25,negative regulation of blood vessel endothelial cell migration,BP,
11464,GO:0043538,1,0.993974628638275,0,1,regulation of actin phosphorylation,BP,
11465,GO:0043539,1,0.836348942399832,0,25,protein serine/threonine kinase activator activity,MF,
11466,GO:0043540,1,0.988600021793749,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11467,GO:0043541,1,0.984798382990735,0,3,UDP-N-acetylglucosamine transferase complex,CC,
11469,GO:0043543,1,0.265061081576492,0,204,protein acylation,BP,
11470,GO:0043544,1,0.996502821220058,0,1,lipoamide binding,MF,
11471,GO:0043545,1,0.949208925648098,0,7,molybdopterin cofactor metabolic process,BP,
11474,GO:0043548,1,0.872144518387577,0,32,phosphatidylinositol 3-kinase binding,MF,
11476,GO:0043550,1,0.803768109047571,0,48,regulation of lipid kinase activity,BP,
11477,GO:0043551,1,0.853113253960434,0,39,regulation of phosphatidylinositol 3-kinase activity,BP,
11478,GO:0043552,1,0.883919159218607,0,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,
11479,GO:0043553,1,0.990345349027025,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11480,GO:0043555,1,0.878609336046448,0,21,regulation of translation in response to stress,BP,
11481,GO:0043558,1,0.897354978739776,0,17,regulation of translational initiation in response to stress,BP,
11482,GO:0043559,1,0.986010807114703,0,6,insulin binding,MF,
11483,GO:0043560,1,0.968310911055159,0,11,insulin receptor substrate binding,MF,
11484,GO:0043562,1,0.976707427267321,0,4,cellular response to nitrogen levels,BP,
11485,GO:0043564,1,0.973243522970994,0,3,Ku70:Ku80 complex,CC,
11487,GO:0043567,1,0.845885339159546,0,23,regulation of insulin-like growth factor receptor signaling pathway,BP,
11488,GO:0043568,1,0.916766609084489,0,13,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11489,GO:0043569,1,0.969101915102901,0,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11490,GO:0043570,1,0.990759213550039,0,4,maintenance of DNA repeat elements,BP,
11491,GO:0043574,1,0.902331787933367,0,18,peroxisomal transport,BP,
11492,GO:0043576,1,0.906886766644882,0,22,regulation of respiratory gaseous exchange,BP,
11493,GO:0043578,1,0.994911206609413,0,3,nuclear matrix organization,BP,
11494,GO:0043583,1,0.300848708245404,0,201,ear development,BP,
11495,GO:0043584,1,0.923844051556397,0,15,nose development,BP,
11496,GO:0043585,1,0.993007339027104,0,3,nose morphogenesis,BP,
11497,GO:0043586,1,0.874168317800902,0,20,tongue development,BP,
11498,GO:0043587,1,0.945844254946154,0,9,tongue morphogenesis,BP,
11500,GO:0043589,1,0.975508711979163,0,9,skin morphogenesis,BP,
11501,GO:0043596,1,0.740550120288544,0,43,nuclear replication fork,CC,
11502,GO:0043601,1,0.796796173274059,0,29,nuclear replisome,CC,
11503,GO:0043602,1,0.991428740525173,0,1,nitrate catabolic process,BP,
11506,GO:0043605,1,0.966883573612622,0,3,cellular amide catabolic process,BP,
11507,GO:0043606,1,0.969330750169307,0,4,formamide metabolic process,BP,
11508,GO:0043610,1,0.999999996388895,0,1,regulation of carbohydrate utilization,BP,
11509,GO:0043614,1,0.998519946706454,0,2,multi-eIF complex,CC,
11511,GO:0043616,1,0.827563980345996,0,38,keratinocyte proliferation,BP,
11513,GO:0043619,1,0.93948291264341,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11515,GO:0043621,1,0.734754548165147,0,53,protein self-association,MF,
11516,GO:0043622,1,0.988806291092713,0,4,cortical microtubule organization,BP,
11519,GO:0043625,1,0.96796857017796,0,4,delta DNA polymerase complex,CC,
11520,GO:0043626,1,0.987749865519914,0,1,PCNA complex,CC,
11522,GO:0043628,1,0.836326159676264,0,20,ncRNA 3'-end processing,BP,
11523,GO:0043631,1,0.809033495483845,0,40,RNA polyadenylation,BP,
11525,GO:0043633,1,0.958716134475172,0,5,polyadenylation-dependent RNA catabolic process,BP,
11526,GO:0043634,1,0.959266850462091,0,4,polyadenylation-dependent ncRNA catabolic process,BP,
11527,GO:0043647,1,0.715141744147231,0,67,inositol phosphate metabolic process,BP,
11529,GO:0043649,1,0.880614244522317,0,15,dicarboxylic acid catabolic process,BP,
11532,GO:0043652,1,0.963472281816152,0,7,engulfment of apoptotic cell,BP,
11533,GO:0043653,1,0.935909601049997,0,8,mitochondrial fragmentation involved in apoptotic process,BP,
11534,GO:0043654,1,0.95195432352446,0,7,recognition of apoptotic cell,BP,
11535,GO:0043656,1,0.967544855722345,0,7,intracellular region of host,CC,
11536,GO:0043657,1,0.929827396868119,0,14,host cell,CC,
11538,GO:0043679,1,0.520570477365777,0,109,axon terminus,CC,
11539,GO:0043682,1,0.999999992762095,0,2,copper-transporting ATPase activity,MF,
11540,GO:0043686,1,0.971966228136883,0,3,co-translational protein modification,BP,
11541,GO:0043687,1,0.475501565705371,0,98,post-translational protein modification,BP,
11543,GO:0043696,1,0.983194263728726,0,3,dedifferentiation,BP,
11544,GO:0043697,1,0.983194263728726,0,3,cell dedifferentiation,BP,
11545,GO:0043733,1,0.987440978919977,0,1,DNA-3-methylbase glycosylase activity,MF,
11546,GO:0043734,1,0.966540007593814,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11547,GO:0043739,1,0.994948109577164,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11548,GO:0043754,1,0.999999996399743,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11550,GO:0043795,1,0.987855476448624,0,1,glyceraldehyde oxidoreductase activity,MF,
11551,GO:0043812,1,0.991426955660852,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11552,GO:0043813,1,0.994254756985373,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11553,GO:0043843,1,0.9916530783066,0,1,ADP-specific glucokinase activity,MF,
11554,GO:0043849,1,0.993348857383483,0,1,Ras palmitoyltransferase activity,MF,
11555,GO:0043855,1,0.964148551949009,0,9,cyclic nucleotide-gated ion channel activity,MF,
11556,GO:0043865,1,0.99268159030409,0,1,methionine transmembrane transporter activity,MF,
11557,GO:0043874,1,0.989446085008349,0,1,acireductone synthase activity,MF,
11558,GO:0043890,1,0.990829266487804,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11559,GO:0043891,1,0.975889975415075,0,2,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11562,GO:0043902,1,0.322948634673687,0,159,positive regulation of multi-organism process,BP,
11564,GO:0043914,1,0.997828198821841,0,1,NADPH:sulfur oxidoreductase activity,MF,
11565,GO:0043916,1,0.987440978919977,0,1,DNA-7-methylguanine glycosylase activity,MF,
11566,GO:0043921,1,0.848540406773284,0,25,modulation by host of viral transcription,BP,
11567,GO:0043922,1,0.911336311978992,0,12,negative regulation by host of viral transcription,BP,
11568,GO:0043923,1,0.922591823536767,0,15,positive regulation by host of viral transcription,BP,
11569,GO:0043924,1,0.999999996424833,0,1,suramin binding,MF,
11570,GO:0043928,1,0.769151382545858,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11571,GO:0043931,1,0.94074050854364,0,15,ossification involved in bone maturation,BP,
11572,GO:0043932,1,0.963720775919995,0,4,ossification involved in bone remodeling,BP,
11574,GO:0043946,1,0.988612296882815,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11575,GO:0043947,1,0.988612296882815,0,1,positive regulation by host of symbiont catalytic activity,BP,
11576,GO:0043949,1,0.868652483675304,0,21,regulation of cAMP-mediated signaling,BP,
11577,GO:0043950,1,0.92120834758804,0,9,positive regulation of cAMP-mediated signaling,BP,
11578,GO:0043951,1,0.967857086977668,0,6,negative regulation of cAMP-mediated signaling,BP,
11579,GO:0043954,1,0.871418387748362,0,26,cellular component maintenance,BP,
11580,GO:0043966,1,0.708187720805096,0,54,histone H3 acetylation,BP,
11581,GO:0043967,1,0.690203819565145,0,58,histone H4 acetylation,BP,
11582,GO:0043968,1,0.879856585882533,0,15,histone H2A acetylation,BP,
11583,GO:0043969,1,0.999999996388947,0,1,histone H2B acetylation,BP,
11584,GO:0043970,1,0.944169154592766,0,11,histone H3-K9 acetylation,BP,
11585,GO:0043973,1,0.99015072949539,0,1,histone H3-K4 acetylation,BP,
11586,GO:0043974,1,0.997797154390557,0,2,histone H3-K27 acetylation,BP,
11587,GO:0043981,1,0.922182752859387,0,12,histone H4-K5 acetylation,BP,
11588,GO:0043982,1,0.922182752859387,0,12,histone H4-K8 acetylation,BP,
11589,GO:0043983,1,0.964343896789294,0,4,histone H4-K12 acetylation,BP,
11590,GO:0043984,1,0.91990695898056,0,17,histone H4-K16 acetylation,BP,
11591,GO:0043985,1,0.953181513321623,0,6,histone H4-R3 methylation,BP,
11592,GO:0043987,1,0.967258832906763,0,4,histone H3-S10 phosphorylation,BP,
11593,GO:0043988,1,0.976413682677605,0,3,histone H3-S28 phosphorylation,BP,
11594,GO:0043990,1,0.994208459578895,0,1,histone H2A-S1 phosphorylation,BP,
11595,GO:0043995,1,0.950891478793419,0,9,histone acetyltransferase activity (H4-K5 specific),MF,
11596,GO:0043996,1,0.950891478793419,0,9,histone acetyltransferase activity (H4-K8 specific),MF,
11597,GO:0043997,1,0.9943543411653,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11598,GO:0043998,1,0.995370690312859,0,1,H2A histone acetyltransferase activity,MF,
11599,GO:0044003,1,0.777615443626313,0,43,modification by symbiont of host morphology or physiology,BP,
11600,GO:0044004,1,0.970154196178863,0,4,disruption by symbiont of host cell,BP,
11601,GO:0044007,1,0.999999996375045,0,1,dissemination or transmission of symbiont from host,BP,
11602,GO:0044010,1,0.982566967774119,0,2,single-species biofilm formation,BP,
11603,GO:0044020,1,0.962526196925096,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11604,GO:0044026,1,0.985218901933076,0,3,DNA hypermethylation,BP,
11605,GO:0044027,1,0.98786143417095,0,2,hypermethylation of CpG island,BP,
11606,GO:0044028,1,0.994680644085951,0,2,DNA hypomethylation,BP,
11607,GO:0044029,1,0.994680644085951,0,2,hypomethylation of CpG island,BP,
11608,GO:0044030,1,0.891614044749079,0,20,regulation of DNA methylation,BP,
11609,GO:0044033,1,0.156417168866831,0,209,multi-organism metabolic process,BP,
11610,GO:0044034,1,0.980622381005592,0,3,multi-organism biosynthetic process,BP,
11611,GO:0044035,1,0.988332745727326,0,1,multi-organism catabolic process,BP,
11612,GO:0044036,1,0.940088456358574,0,5,cell wall macromolecule metabolic process,BP,
11613,GO:0044038,1,0.988688643487989,0,1,cell wall macromolecule biosynthetic process,BP,
11614,GO:0044042,1,0.68263476986183,0,73,glucan metabolic process,BP,
11615,GO:0044053,1,0.991019208360606,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11617,GO:0044058,1,0.732468002879336,0,38,regulation of digestive system process,BP,
11618,GO:0044060,1,0.730746148154034,0,43,regulation of endocrine process,BP,
11619,GO:0044062,1,0.826417594494611,0,24,regulation of excretion,BP,
11620,GO:0044065,1,0.928844100157515,0,15,regulation of respiratory system process,BP,
11621,GO:0044068,1,0.867669901972707,0,25,modulation by symbiont of host cellular process,BP,
11622,GO:0044070,1,0.543402335169796,0,101,regulation of anion transport,BP,
11627,GO:0044090,1,0.940828614331135,0,17,positive regulation of vacuole organization,BP,
11628,GO:0044091,1,0.860543919672339,0,32,membrane biogenesis,BP,
11631,GO:0044094,1,0.998802850344494,0,2,host cell nuclear part,CC,
11633,GO:0044107,1,0.951138913438231,0,5,cellular alcohol metabolic process,BP,
11634,GO:0044108,1,0.951138913438231,0,5,cellular alcohol biosynthetic process,BP,
11635,GO:0044110,1,0.827933324872197,0,19,growth involved in symbiotic interaction,BP,
11636,GO:0044111,1,0.988332739800411,0,2,development involved in symbiotic interaction,BP,
11637,GO:0044115,1,0.988332745727326,0,1,development of symbiont involved in interaction with host,BP,
11638,GO:0044116,1,0.827933324872197,0,19,growth of symbiont involved in interaction with host,BP,
11639,GO:0044117,1,0.838676727270405,0,18,growth of symbiont in host,BP,
11640,GO:0044126,1,0.869767109818978,0,15,regulation of growth of symbiont in host,BP,
11641,GO:0044128,1,0.999879136456154,0,1,positive regulation of growth of symbiont in host,BP,
11642,GO:0044130,1,0.869872386057888,0,14,negative regulation of growth of symbiont in host,BP,
11643,GO:0044133,1,0.987207770502897,0,1,growth of symbiont on or near host,BP,
11644,GO:0044139,1,0.987207770502897,0,1,modulation of growth of symbiont on or near host,BP,
11645,GO:0044140,1,0.987207770502897,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11646,GO:0044144,1,0.858628629398666,0,16,modulation of growth of symbiont involved in interaction with host,BP,
11647,GO:0044145,1,0.988332745727326,0,1,modulation of development of symbiont involved in interaction with host,BP,
11648,GO:0044146,1,0.858732570256584,0,15,negative regulation of growth of symbiont involved in interaction with host,BP,
11649,GO:0044147,1,0.988332745727326,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11650,GO:0044148,1,0.999879136456154,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11651,GO:0044154,1,0.954977619912334,0,7,histone H3-K14 acetylation,BP,
11652,GO:0044179,1,0.98271366919633,0,2,hemolysis in other organism,BP,
11653,GO:0044183,1,0.781538776611488,0,27,protein binding involved in protein folding,MF,
11654,GO:0044190,1,0.988630136325738,0,1,host cell mitochondrial envelope,CC,
11655,GO:0044194,1,0.964351709540878,0,4,cytolytic granule,CC,
11656,GO:0044205,1,0.98182439986268,0,3,'de novo' UMP biosynthetic process,BP,
11657,GO:0044206,1,0.947304380237318,0,5,UMP salvage,BP,
11658,GO:0044207,1,0.998558196765875,0,1,translation initiation ternary complex,CC,
11659,GO:0044208,1,0.969636525028647,0,3,'de novo' AMP biosynthetic process,BP,
11660,GO:0044209,1,0.976939492486784,0,2,AMP salvage,BP,
11661,GO:0044210,1,0.989577931615604,0,2,'de novo' CTP biosynthetic process,BP,
11662,GO:0044211,1,0.9667398400897,0,3,CTP salvage,BP,
11664,GO:0044213,1,0.921047649656132,0,11,intronic transcription regulatory region DNA binding,MF,
11665,GO:0044214,1,0.994774233046254,0,3,spanning component of plasma membrane,CC,
11666,GO:0044215,1,0.893824559751082,0,19,other organism,CC,
11667,GO:0044216,1,0.893824559751082,0,19,other organism cell,CC,
11668,GO:0044217,1,0.893824559751082,0,19,other organism part,CC,
11669,GO:0044218,1,0.981835159769721,0,3,other organism cell membrane,CC,
11670,GO:0044220,1,0.999702533148587,0,1,host cell perinuclear region of cytoplasm,CC,
11671,GO:0044221,1,0.998615248312486,0,1,host cell synapse,CC,
11672,GO:0044224,1,0.968423481666709,0,10,juxtaparanode region of axon,CC,
11673,GO:0044228,1,0.999597567947608,0,1,host cell surface,CC,
11674,GO:0044231,1,0.998615248312486,0,1,host cell presynaptic membrane,CC,
11675,GO:0044232,1,0.940190905763149,0,14,organelle membrane contact site,CC,
11676,GO:0044233,1,0.942357611619896,0,10,ER-mitochondrion membrane contact site,CC,
11680,GO:0044240,1,0.95402269339986,0,4,multicellular organismal lipid catabolic process,BP,
11681,GO:0044241,1,0.771263046585388,0,27,lipid digestion,BP,
11684,GO:0044245,1,0.988314884737489,0,4,polysaccharide digestion,BP,
11685,GO:0044246,1,0.760221095816497,0,35,regulation of multicellular organismal metabolic process,BP,
11686,GO:0044247,1,0.87572400859914,0,27,cellular polysaccharide catabolic process,BP,
11689,GO:0044252,1,0.932505929314683,0,9,negative regulation of multicellular organismal metabolic process,BP,
11690,GO:0044253,1,0.832902360948587,0,23,positive regulation of multicellular organismal metabolic process,BP,
11691,GO:0044254,1,0.986046966057704,0,4,multicellular organismal protein catabolic process,BP,
11693,GO:0044256,1,0.986046966057704,0,4,protein digestion,BP,
11695,GO:0044258,1,0.990909953174646,0,1,intestinal lipid catabolic process,BP,
11699,GO:0044264,1,0.629563778946973,0,86,cellular polysaccharide metabolic process,BP,
11701,GO:0044266,1,0.986046966057704,0,4,multicellular organismal macromolecule catabolic process,BP,
11703,GO:0044268,1,0.986046959701195,0,5,multicellular organismal protein metabolic process,BP,
11708,GO:0044275,1,0.741013710156436,0,45,cellular carbohydrate catabolic process,BP,
11709,GO:0044279,1,0.981835159769721,0,3,other organism membrane,CC,
11713,GO:0044284,1,0.987295922156678,0,1,mitochondrial crista junction,CC,
11714,GO:0044291,1,0.793849070895166,0,60,cell-cell contact zone,CC,
11715,GO:0044292,1,0.950853342499159,0,9,dendrite terminus,CC,
11716,GO:0044294,1,0.987625901747005,0,5,dendritic growth cone,CC,
11717,GO:0044295,1,0.949803859790407,0,16,axonal growth cone,CC,
11719,GO:0044298,1,0.901682754295979,0,19,cell body membrane,CC,
11720,GO:0044299,1,0.987218774368248,0,1,C-fiber,CC,
11721,GO:0044300,1,0.984228087706129,0,5,cerebellar mossy fiber,CC,
11722,GO:0044301,1,0.987278297494192,0,2,climbing fiber,CC,
11723,GO:0044302,1,0.990305379464683,0,2,dentate gyrus mossy fiber,CC,
11724,GO:0044304,1,0.770760339886192,0,61,main axon,CC,
11725,GO:0044305,1,0.995660039104295,0,4,calyx of Held,CC,
11726,GO:0044306,1,0.478473073154814,0,124,neuron projection terminus,CC,
11727,GO:0044307,1,0.999999996407907,0,1,dendritic branch,CC,
11728,GO:0044308,1,0.9995398560739,0,3,axonal spine,CC,
11729,GO:0044309,1,0.574882662116572,0,122,neuron spine,CC,
11730,GO:0044313,1,0.997181227625885,0,3,protein K6-linked deubiquitination,BP,
11731,GO:0044314,1,0.959002859541343,0,4,protein K27-linked ubiquitination,BP,
11732,GO:0044316,1,0.988794003087771,0,2,cone cell pedicle,CC,
11733,GO:0044317,1,0.987804086934893,0,1,rod spherule,CC,
11734,GO:0044319,1,0.864519828614373,0,26,wound healing, spreading of cells,BP,
11735,GO:0044320,1,0.904105170131093,0,16,cellular response to leptin stimulus,BP,
11737,GO:0044322,1,0.873518537868689,0,25,endoplasmic reticulum quality control compartment,CC,
11738,GO:0044323,1,0.989744206775069,0,4,retinoic acid-responsive element binding,MF,
11739,GO:0044324,1,0.975483640956879,0,2,regulation of transcription involved in anterior/posterior axis specification,BP,
11741,GO:0044326,1,0.985865207993217,0,3,dendritic spine neck,CC,
11742,GO:0044327,1,0.971987053722812,0,6,dendritic spine head,CC,
11743,GO:0044331,1,0.902975687694733,0,15,cell-cell adhesion mediated by cadherin,BP,
11744,GO:0044332,1,0.989393248206482,0,7,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11745,GO:0044333,1,0.989000550182656,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11746,GO:0044334,1,0.993814685798652,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11747,GO:0044335,1,0.988031342858396,0,2,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11748,GO:0044336,1,0.97935394888053,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11749,GO:0044337,1,0.999999996379296,0,1,canonical Wnt signaling pathway involved in positive regulation of apoptotic process,BP,
11750,GO:0044338,1,0.987014899009894,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11751,GO:0044339,1,0.986461753693117,0,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11752,GO:0044340,1,0.970615700947764,0,6,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11753,GO:0044341,1,0.946625896939349,0,9,sodium-dependent phosphate transport,BP,
11754,GO:0044342,1,0.894376606672159,0,17,type B pancreatic cell proliferation,BP,
11755,GO:0044343,1,0.992623012822554,0,2,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11757,GO:0044345,1,0.99920826098847,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11758,GO:0044346,1,0.924869581947374,0,18,fibroblast apoptotic process,BP,
11759,GO:0044349,1,0.988559552384467,0,1,DNA excision,BP,
11761,GO:0044352,1,0.984474235168748,0,4,pinosome,CC,
11762,GO:0044354,1,0.984474235168748,0,4,macropinosome,CC,
11763,GO:0044355,1,0.9879274359181,0,1,clearance of foreign intracellular DNA,BP,
11764,GO:0044356,1,0.9879274359181,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11765,GO:0044359,1,0.935180732903378,0,7,modulation of molecular function in other organism,BP,
11766,GO:0044362,1,0.935180732903378,0,7,negative regulation of molecular function in other organism,BP,
11767,GO:0044364,1,0.725987573736209,0,30,disruption of cells of other organism,BP,
11768,GO:0044374,1,0.997105894292183,0,1,sequence-specific DNA binding, bending,MF,
11769,GO:0044375,1,0.963643214642559,0,3,regulation of peroxisome size,BP,
11770,GO:0044376,1,0.965107265277663,0,3,RNA polymerase II complex import to nucleus,BP,
11771,GO:0044377,1,0.997105894292183,0,1,RNA polymerase II core promoter proximal region sequence-specific DNA binding, bending,MF,
11772,GO:0044378,1,0.987969838511052,0,2,non-sequence-specific DNA binding, bending,MF,
11773,GO:0044380,1,0.859519610539348,0,36,protein localization to cytoskeleton,BP,
11775,GO:0044387,1,0.953468463740604,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11776,GO:0044388,1,0.94736771284794,0,5,small protein activating enzyme binding,MF,
11777,GO:0044389,1,0.155596747111237,0,291,ubiquitin-like protein ligase binding,MF,
11778,GO:0044390,1,0.827882387885102,0,38,ubiquitin-like protein conjugating enzyme binding,MF,
11780,GO:0044393,1,0.98468084779206,0,3,microspike,CC,
11781,GO:0044395,1,0.991816710779969,0,1,protein targeting to vacuolar membrane,BP,
11783,GO:0044406,1,0.926936125857984,0,11,adhesion of symbiont to host,BP,
11784,GO:0044407,1,0.982566967774119,0,2,single-species biofilm formation in or on host organism,BP,
11785,GO:0044409,1,0.480082825379397,0,124,entry into host,BP,
11786,GO:0044413,1,0.982552635856931,0,3,avoidance of host defenses,BP,
11787,GO:0044415,1,0.982552635856931,0,3,evasion or tolerance of host defenses,BP,
11788,GO:0044416,1,0.978254710179525,0,2,induction by symbiont of host defense response,BP,
11789,GO:0044417,1,0.991019208360606,0,1,translocation of molecules into host,BP,
11794,GO:0044423,1,0.967042428965429,0,4,virion part,CC,
11797,GO:0044427,1,0.00398084393204455,0,793,chromosomal part,CC,
11808,GO:0044441,1,0.109759833256221,0,364,ciliary part,CC,
11812,GO:0044447,1,0.920916643629111,0,22,axoneme part,CC,
11813,GO:0044448,1,0.575006582171815,0,119,cell cortex part,CC,
11815,GO:0044450,1,0.459662794311677,0,147,microtubule organizing center part,CC,
11818,GO:0044453,1,0.905650922848156,0,15,nuclear membrane part,CC,
11819,GO:0044454,1,0.03421057475594,0,476,nuclear chromosome part,CC,
11822,GO:0044458,1,0.856463568886637,0,20,motile cilium assembly,BP,
11826,GO:0044467,1,0.984542673639574,0,2,glial cell-derived neurotrophic factor secretion,BP,
11827,GO:0044501,1,0.995096136888045,0,1,modulation of signal transduction in other organism,BP,
11828,GO:0044524,1,0.988606833667475,0,1,protein sulfhydration,BP,
11829,GO:0044530,1,0.989611895705824,0,3,supraspliceosomal complex,CC,
11830,GO:0044531,1,0.969838514825233,0,5,modulation of programmed cell death in other organism,BP,
11831,GO:0044532,1,0.969838514825233,0,5,modulation of apoptotic process in other organism,BP,
11832,GO:0044533,1,0.987221357721054,0,2,positive regulation of apoptotic process in other organism,BP,
11833,GO:0044537,1,0.988714122281553,0,1,regulation of circulating fibrinogen levels,BP,
11835,GO:0044540,1,0.988606833667475,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11836,GO:0044546,1,0.94440163263609,0,11,NLRP3 inflammasome complex assembly,BP,
11837,GO:0044547,1,0.972095866877068,0,5,DNA topoisomerase binding,MF,
11839,GO:0044549,1,0.987207076579492,0,1,GTP cyclohydrolase binding,MF,
11841,GO:0044557,1,0.954569889392653,0,8,relaxation of smooth muscle,BP,
11842,GO:0044558,1,0.999833560951617,0,1,uterine smooth muscle relaxation,BP,
11843,GO:0044565,1,0.981743629307036,0,2,dendritic cell proliferation,BP,
11844,GO:0044571,1,0.954039170320516,0,4,[2Fe-2S] cluster assembly,BP,
11845,GO:0044594,1,0.992260893557381,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11846,GO:0044595,1,0.987647083299915,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11847,GO:0044596,1,0.987647083299915,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11848,GO:0044597,1,0.914148142160058,0,8,daunorubicin metabolic process,BP,
11849,GO:0044598,1,0.914148142160058,0,8,doxorubicin metabolic process,BP,
11850,GO:0044599,1,0.991657600429728,0,1,AP-5 adaptor complex,CC,
11851,GO:0044609,1,0.989887861919443,0,1,DBIRD complex,CC,
11852,GO:0044610,1,0.990391082169678,0,1,FMN transmembrane transporter activity,MF,
11853,GO:0044611,1,0.99889666804059,0,3,nuclear pore inner ring,CC,
11854,GO:0044613,1,0.951295896359898,0,6,nuclear pore central transport channel,CC,
11855,GO:0044614,1,0.986695947341963,0,4,nuclear pore cytoplasmic filaments,CC,
11856,GO:0044615,1,0.988269016368383,0,6,nuclear pore nuclear basket,CC,
11857,GO:0044620,1,0.987192131992394,0,1,ACP phosphopantetheine attachment site binding,MF,
11858,GO:0044650,1,0.950782098636875,0,8,adhesion of symbiont to host cell,BP,
11859,GO:0044665,1,0.833796405500196,0,27,MLL1/2 complex,CC,
11860,GO:0044666,1,0.959865148315197,0,7,MLL3/4 complex,CC,
11861,GO:0044691,1,0.998052531735884,0,3,tooth eruption,BP,
11866,GO:0044704,1,0.990376976927382,0,1,single-organism reproductive behavior,BP,
11873,GO:0044713,1,0.987207770502897,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11874,GO:0044714,1,0.987207770502897,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11875,GO:0044715,1,0.975791147113131,0,2,8-oxo-dGDP phosphatase activity,MF,
11876,GO:0044716,1,0.988071294918011,0,1,8-oxo-GDP phosphatase activity,MF,
11877,GO:0044717,1,0.988071294918011,0,1,8-hydroxy-dADP phosphatase activity,MF,
11878,GO:0044721,1,0.98915669815631,0,1,protein import into peroxisome matrix, substrate release,BP,
11879,GO:0044722,1,0.997652536752675,0,1,renal phosphate excretion,BP,
11882,GO:0044725,1,0.987394153211597,0,2,chromatin reprogramming in the zygote,BP,
11883,GO:0044726,1,0.987394159297292,0,1,protection of DNA demethylation of female pronucleus,BP,
11884,GO:0044727,1,0.999999996400579,0,1,DNA demethylation of male pronucleus,BP,
11885,GO:0044728,1,0.644990644557019,0,74,DNA methylation or demethylation,BP,
11886,GO:0044729,1,0.986262627989872,0,3,hemi-methylated DNA-binding,MF,
11887,GO:0044736,1,0.967042428965429,0,4,acid-sensing ion channel activity,MF,
11888,GO:0044743,1,0.695723277890779,0,42,protein transmembrane import into intracellular organelle,BP,
11890,GO:0044745,1,0.999999996382036,0,1,amino acid transmembrane import,BP,
11891,GO:0044752,1,0.98194523127592,0,3,response to human chorionic gonadotropin,BP,
11892,GO:0044753,1,0.993273643639067,0,2,amphisome,CC,
11893,GO:0044754,1,0.93769697780201,0,9,autolysosome,CC,
11897,GO:0044766,1,0.63742549932548,0,71,multi-organism transport,BP,
11899,GO:0044769,1,0.741936465487516,0,31,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11901,GO:0044771,1,0.9548231473692,0,5,meiotic cell cycle phase transition,BP,
11903,GO:0044773,1,0.515780210081639,0,94,mitotic DNA damage checkpoint,BP,
11904,GO:0044774,1,0.496721217329739,0,101,mitotic DNA integrity checkpoint,BP,
11905,GO:0044778,1,0.956875031314438,0,4,meiotic DNA integrity checkpoint,BP,
11906,GO:0044779,1,0.993899064481029,0,1,meiotic spindle checkpoint,BP,
11907,GO:0044782,1,0.171871475991727,0,309,cilium organization,BP,
11908,GO:0044783,1,0.613780340082198,0,69,G1 DNA damage checkpoint,BP,
11909,GO:0044784,1,0.731789120255649,0,47,metaphase/anaphase transition of cell cycle,BP,
11910,GO:0044785,1,0.981371220263603,0,2,metaphase/anaphase transition of meiotic cell cycle,BP,
11911,GO:0044786,1,0.822463981296402,0,36,cell cycle DNA replication,BP,
11912,GO:0044788,1,0.885864492323113,0,20,modulation by host of viral process,BP,
11913,GO:0044789,1,0.98621508700853,0,5,modulation by host of viral release from host cell,BP,
11914,GO:0044791,1,0.98621508700853,0,5,positive regulation by host of viral release from host cell,BP,
11915,GO:0044793,1,0.951090517609802,0,7,negative regulation by host of viral process,BP,
11916,GO:0044794,1,0.932342827142823,0,13,positive regulation by host of viral process,BP,
11917,GO:0044795,1,0.987512675322051,0,1,trans-Golgi network to recycling endosome transport,BP,
11918,GO:0044796,1,0.987749865519914,0,1,DNA polymerase processivity factor complex,CC,
11919,GO:0044798,1,0.365067523932715,0,140,nuclear transcription factor complex,CC,
11920,GO:0044800,1,0.952220543243637,0,6,multi-organism membrane fusion,BP,
11923,GO:0044803,1,0.774734839277818,0,31,multi-organism membrane organization,BP,
11924,GO:0044804,1,0.923676477551569,0,13,nucleophagy,BP,
11925,GO:0044805,1,0.996601222492386,0,2,late nucleophagy,BP,
11926,GO:0044806,1,0.985510092532941,0,6,G-quadruplex DNA unwinding,BP,
11927,GO:0044815,1,0.301489565515027,0,108,DNA packaging complex,CC,
11928,GO:0044818,1,0.874143492591732,0,22,mitotic G2/M transition checkpoint,BP,
11929,GO:0044819,1,0.616394421732884,0,68,mitotic G1/S transition checkpoint,BP,
11930,GO:0044821,1,0.972735000192708,0,5,meiotic telomere tethering at nuclear periphery,BP,
11931,GO:0044827,1,0.95177877677942,0,11,modulation by host of viral genome replication,BP,
11932,GO:0044828,1,0.982865457591702,0,4,negative regulation by host of viral genome replication,BP,
11933,GO:0044829,1,0.969307639646648,0,7,positive regulation by host of viral genome replication,BP,
11934,GO:0044830,1,0.999038748781858,0,1,modulation by host of viral RNA genome replication,BP,
11935,GO:0044837,1,0.991354731435087,0,3,actomyosin contractile ring organization,BP,
11937,GO:0044843,1,0.194780374271358,0,249,cell cycle G1/S phase transition,BP,
11938,GO:0044848,1,0.952570294751351,0,11,biological phase,BP,
11939,GO:0044849,1,0.905341957059849,0,15,estrous cycle,BP,
11940,GO:0044851,1,0.959741120249491,0,9,hair cycle phase,BP,
11941,GO:0044853,1,0.706632601025139,0,82,plasma membrane raft,CC,
11942,GO:0044854,1,0.954214989359603,0,5,plasma membrane raft assembly,BP,
11943,GO:0044855,1,0.992470268844801,0,1,plasma membrane raft distribution,BP,
11944,GO:0044856,1,0.992470268844801,0,1,plasma membrane raft localization,BP,
11945,GO:0044857,1,0.954214989359603,0,5,plasma membrane raft organization,BP,
11946,GO:0044858,1,0.992470268844801,0,1,plasma membrane raft polarization,BP,
11947,GO:0044860,1,0.973415636045191,0,4,protein localization to plasma membrane raft,BP,
11948,GO:0044861,1,0.989002104578712,0,2,protein transport into plasma membrane raft,BP,
11949,GO:0044866,1,0.976629431674011,0,2,modulation by host of viral exo-alpha-sialidase activity,BP,
11950,GO:0044867,1,0.976629431674011,0,2,modulation by host of viral catalytic activity,BP,
11951,GO:0044868,1,0.97662942346599,0,3,modulation by host of viral molecular function,BP,
11952,GO:0044869,1,0.976629431674011,0,2,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11953,GO:0044870,1,0.976629431674011,0,2,modulation by host of viral glycoprotein metabolic process,BP,
11954,GO:0044871,1,0.976629431674011,0,2,negative regulation by host of viral glycoprotein metabolic process,BP,
11955,GO:0044872,1,0.938500101473324,0,14,lipoprotein localization,BP,
11957,GO:0045002,1,0.94736080819998,0,7,double-strand break repair via single-strand annealing,BP,
11958,GO:0045003,1,0.916129410636124,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11959,GO:0045004,1,0.995976054597742,0,2,DNA replication proofreading,BP,
11960,GO:0045005,1,0.849162971555876,0,28,DNA-dependent DNA replication maintenance of fidelity,BP,
11961,GO:0045006,1,0.891620125565444,0,10,DNA deamination,BP,
11962,GO:0045007,1,0.965838155214318,0,3,depurination,BP,
11963,GO:0045008,1,0.922175856137852,0,8,depyrimidination,BP,
11964,GO:0045009,1,0.88834313233644,0,12,chitosome,CC,
11965,GO:0045010,1,0.75181122578752,0,42,actin nucleation,BP,
11966,GO:0045013,1,0.981804895209383,0,2,carbon catabolite repression of transcription,BP,
11967,GO:0045014,1,0.981804895209383,0,2,negative regulation of transcription by glucose,BP,
11968,GO:0045016,1,0.995417670965192,0,1,mitochondrial magnesium ion transport,BP,
11971,GO:0045022,1,0.834838384237376,0,34,early endosome to late endosome transport,BP,
11972,GO:0045023,1,0.935160130531054,0,10,G0 to G1 transition,BP,
11973,GO:0045025,1,0.990748959249134,0,2,mitochondrial degradosome,CC,
11974,GO:0045026,1,0.770763137521692,0,32,plasma membrane fusion,BP,
11975,GO:0045027,1,0.989757555074622,0,1,DNA end binding,MF,
11978,GO:0045030,1,0.988326778018912,0,1,UTP-activated nucleotide receptor activity,MF,
11979,GO:0045031,1,0.9836026566511,0,2,ATP-activated adenosine receptor activity,MF,
11980,GO:0045032,1,0.994242521917544,0,1,ADP-activated adenosine receptor activity,MF,
11981,GO:0045039,1,0.940882920375584,0,5,protein import into mitochondrial inner membrane,BP,
11982,GO:0045040,1,0.944460423592975,0,6,protein import into mitochondrial outer membrane,BP,
11983,GO:0045041,1,0.978776846492711,0,2,protein import into mitochondrial intermembrane space,BP,
11984,GO:0045046,1,0.964952302052659,0,6,protein import into peroxisome membrane,BP,
11985,GO:0045047,1,0.312832037651233,0,100,protein targeting to ER,BP,
11986,GO:0045048,1,0.960579318193888,0,5,protein insertion into ER membrane,BP,
11987,GO:0045053,1,0.99218611887207,0,2,protein retention in Golgi apparatus,BP,
11988,GO:0045054,1,0.96710107607905,0,4,constitutive secretory pathway,BP,
11990,GO:0045056,1,0.929494545243918,0,12,transcytosis,BP,
11991,GO:0045058,1,0.746861232174312,0,46,T cell selection,BP,
11992,GO:0045059,1,0.929328159046754,0,10,positive thymic T cell selection,BP,
11993,GO:0045060,1,0.920001072440054,0,12,negative thymic T cell selection,BP,
11994,GO:0045061,1,0.879313646428045,0,21,thymic T cell selection,BP,
11995,GO:0045062,1,0.988511905683435,0,1,extrathymic T cell selection,BP,
11996,GO:0045063,1,0.888356660750738,0,17,T-helper 1 cell differentiation,BP,
11997,GO:0045064,1,0.877270780197943,0,16,T-helper 2 cell differentiation,BP,
11998,GO:0045065,1,0.978205912698034,0,3,cytotoxic T cell differentiation,BP,
11999,GO:0045066,1,0.846625019028718,0,21,regulatory T cell differentiation,BP,
12001,GO:0045070,1,0.849502203161961,0,32,positive regulation of viral genome replication,BP,
12003,GO:0045072,1,0.88455314613299,0,16,regulation of interferon-gamma biosynthetic process,BP,
12005,GO:0045074,1,0.985599211494005,0,3,regulation of interleukin-10 biosynthetic process,BP,
12006,GO:0045075,1,0.953734219681905,0,8,regulation of interleukin-12 biosynthetic process,BP,
12007,GO:0045076,1,0.870899434473304,0,18,regulation of interleukin-2 biosynthetic process,BP,
12008,GO:0045077,1,0.962205225644872,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
12009,GO:0045078,1,0.919321437105316,0,12,positive regulation of interferon-gamma biosynthetic process,BP,
12010,GO:0045079,1,0.963720957777639,0,3,negative regulation of chemokine biosynthetic process,BP,
12012,GO:0045081,1,0.996637775791884,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
12013,GO:0045082,1,0.988924492260778,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
12014,GO:0045083,1,0.998379119831484,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
12015,GO:0045084,1,0.955283235998635,0,6,positive regulation of interleukin-12 biosynthetic process,BP,
12016,GO:0045085,1,0.957025921160195,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
12017,GO:0045086,1,0.931759473358469,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
12021,GO:0045091,1,0.942902319950992,0,8,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12022,GO:0045092,1,0.996575906857934,0,1,interleukin-18 receptor complex,CC,
12023,GO:0045095,1,0.366681400983311,0,92,keratin filament,CC,
12024,GO:0045098,1,0.979974612446565,0,2,type III intermediate filament,CC,
12025,GO:0045103,1,0.770529371942363,0,44,intermediate filament-based process,BP,
12026,GO:0045104,1,0.773703626504775,0,43,intermediate filament cytoskeleton organization,BP,
12027,GO:0045105,1,0.996493038359684,0,2,intermediate filament polymerization or depolymerization,BP,
12028,GO:0045106,1,0.999994516078798,0,1,intermediate filament depolymerization,BP,
12029,GO:0045108,1,0.999994516078798,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
12030,GO:0045109,1,0.873061450910106,0,22,intermediate filament organization,BP,
12031,GO:0045110,1,0.974338505017327,0,6,intermediate filament bundle assembly,BP,
12033,GO:0045112,1,0.961615089875922,0,6,integrin biosynthetic process,BP,
12034,GO:0045113,1,0.961615100959675,0,5,regulation of integrin biosynthetic process,BP,
12035,GO:0045116,1,0.869384336925967,0,15,protein neddylation,BP,
12036,GO:0045117,1,0.864749882838077,0,18,azole transport,BP,
12037,GO:0045118,1,0.956503317380505,0,6,azole transporter activity,MF,
12038,GO:0045120,1,0.908506437943994,0,14,pronucleus,CC,
12042,GO:0045125,1,0.876535343845387,0,15,bioactive lipid receptor activity,MF,
12043,GO:0045127,1,0.988193868027381,0,1,N-acetylglucosamine kinase activity,MF,
12044,GO:0045130,1,0.992382978094713,0,1,keratan sulfotransferase activity,MF,
12045,GO:0045131,1,0.99366264927225,0,1,pre-mRNA branch point binding,MF,
12046,GO:0045132,1,0.627162951246507,0,70,meiotic chromosome segregation,BP,
12047,GO:0045134,1,0.971805465857362,0,4,uridine-diphosphatase activity,MF,
12048,GO:0045136,1,0.944365432666959,0,9,development of secondary sexual characteristics,BP,
12050,GO:0045141,1,0.937711453703882,0,11,meiotic telomere clustering,BP,
12051,GO:0045142,1,0.997889497515149,0,1,triplex DNA binding,MF,
12052,GO:0045143,1,0.705052318085616,0,48,homologous chromosome segregation,BP,
12053,GO:0045144,1,0.938649134368355,0,7,meiotic sister chromatid segregation,BP,
12054,GO:0045145,1,0.986423553083486,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
12055,GO:0045153,1,0.987576422454554,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
12056,GO:0045155,1,0.987567092306823,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
12057,GO:0045159,1,0.958973242211403,0,5,myosin II binding,MF,
12058,GO:0045160,1,0.999623928692521,0,1,myosin I complex,CC,
12059,GO:0045161,1,0.954210080617286,0,12,neuronal ion channel clustering,BP,
12060,GO:0045162,1,0.983557619064501,0,7,clustering of voltage-gated sodium channels,BP,
12061,GO:0045163,1,0.991025658166789,0,3,clustering of voltage-gated potassium channels,BP,
12062,GO:0045165,1,0.196162991587902,0,240,cell fate commitment,BP,
12063,GO:0045168,1,0.983260918055296,0,2,cell-cell signaling involved in cell fate commitment,BP,
12064,GO:0045171,1,0.75260100596621,0,43,intercellular bridge,CC,
12065,GO:0045174,1,0.975410002324126,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12066,GO:0045176,1,0.963869433270945,0,11,apical protein localization,BP,
12067,GO:0045177,1,0.163105956095922,0,339,apical part of cell,CC,
12068,GO:0045178,1,0.794003088959336,0,47,basal part of cell,CC,
12069,GO:0045179,1,0.95357712897214,0,7,apical cortex,CC,
12070,GO:0045180,1,0.999854214124048,0,5,basal cortex,CC,
12071,GO:0045182,1,0.83246556200842,0,37,translation regulator activity,MF,
12073,GO:0045185,1,0.560189353170266,0,93,maintenance of protein location,BP,
12074,GO:0045186,1,0.999999996381643,0,1,zonula adherens assembly,BP,
12075,GO:0045187,1,0.821237739017188,0,20,regulation of circadian sleep/wake cycle, sleep,BP,
12076,GO:0045188,1,0.932119263820819,0,8,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12077,GO:0045189,1,0.987293789996454,0,1,connective tissue growth factor biosynthetic process,BP,
12078,GO:0045190,1,0.767684100171198,0,40,isotype switching,BP,
12079,GO:0045191,1,0.821287057293873,0,28,regulation of isotype switching,BP,
12080,GO:0045196,1,0.98758094324463,0,3,establishment or maintenance of neuroblast polarity,BP,
12081,GO:0045197,1,0.853456260729443,0,30,establishment or maintenance of epithelial cell apical/basal polarity,BP,
12082,GO:0045198,1,0.95745341403584,0,7,establishment of epithelial cell apical/basal polarity,BP,
12083,GO:0045199,1,0.924764935255306,0,12,maintenance of epithelial cell apical/basal polarity,BP,
12084,GO:0045200,1,0.98758094324463,0,3,establishment of neuroblast polarity,BP,
12086,GO:0045204,1,0.99574389840138,0,3,MAPK export from nucleus,BP,
12087,GO:0045208,1,0.996420455755939,0,1,MAPK phosphatase export from nucleus,BP,
12088,GO:0045209,1,0.996420455755939,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
12089,GO:0045210,1,0.999984783455344,0,2,FasL biosynthetic process,BP,
12091,GO:0045212,1,0.991746049233625,0,1,neurotransmitter receptor biosynthetic process,BP,
12092,GO:0045213,1,0.971146341863596,0,3,neurotransmitter receptor metabolic process,BP,
12093,GO:0045214,1,0.80360861178842,0,43,sarcomere organization,BP,
12095,GO:0045217,1,0.972377573733609,0,6,cell-cell junction maintenance,BP,
12096,GO:0045218,1,0.986945622231489,0,3,zonula adherens maintenance,BP,
12097,GO:0045219,1,0.999984787086356,0,1,regulation of FasL biosynthetic process,BP,
12098,GO:0045221,1,0.999984787086356,0,1,negative regulation of FasL biosynthetic process,BP,
12099,GO:0045222,1,0.987514876358812,0,1,CD4 biosynthetic process,BP,
12100,GO:0045223,1,0.987514876358812,0,1,regulation of CD4 biosynthetic process,BP,
12101,GO:0045225,1,0.987514876358812,0,1,negative regulation of CD4 biosynthetic process,BP,
12102,GO:0045226,1,0.977185504257318,0,3,extracellular polysaccharide biosynthetic process,BP,
12103,GO:0045229,1,0.984989833294214,0,3,external encapsulating structure organization,BP,
12104,GO:0045234,1,0.988722668707618,0,1,protein palmitoleylation,BP,
12105,GO:0045236,1,0.85285575325523,0,15,CXCR chemokine receptor binding,MF,
12106,GO:0045239,1,0.925302331033868,0,12,tricarboxylic acid cycle enzyme complex,CC,
12107,GO:0045240,1,0.944571708688238,0,10,dihydrolipoyl dehydrogenase complex,CC,
12108,GO:0045244,1,0.990766010795186,0,1,succinate-CoA ligase complex (GDP-forming),CC,
12110,GO:0045252,1,0.972933190931772,0,6,oxoglutarate dehydrogenase complex,CC,
12111,GO:0045254,1,0.950097677060177,0,8,pyruvate dehydrogenase complex,CC,
12112,GO:0045257,1,0.959247947479429,0,4,succinate dehydrogenase complex (ubiquinone),CC,
12113,GO:0045259,1,0.775255844592797,0,21,proton-transporting ATP synthase complex,CC,
12114,GO:0045261,1,0.94135422990225,0,5,proton-transporting ATP synthase complex, catalytic core F(1),CC,
12115,GO:0045263,1,0.875886005410454,0,11,proton-transporting ATP synthase complex, coupling factor F(o),CC,
12116,GO:0045265,1,0.987172763503919,0,1,proton-transporting ATP synthase, stator stalk,CC,
12117,GO:0045267,1,0.988899119991551,0,1,proton-transporting ATP synthase, catalytic core,CC,
12118,GO:0045271,1,0.606954573631056,0,42,respiratory chain complex I,CC,
12119,GO:0045273,1,0.959247947479429,0,4,respiratory chain complex II,CC,
12120,GO:0045275,1,0.892376938539296,0,11,respiratory chain complex III,CC,
12121,GO:0045277,1,0.835038296030145,0,14,respiratory chain complex IV,CC,
12122,GO:0045281,1,0.959247947479429,0,4,succinate dehydrogenase complex,CC,
12123,GO:0045283,1,0.959247947479429,0,4,fumarate reductase complex,CC,
12124,GO:0045292,1,0.877289586712935,0,17,mRNA cis splicing, via spliceosome,BP,
12125,GO:0045293,1,0.967540196664327,0,4,mRNA editing complex,CC,
12126,GO:0045294,1,0.960771456663575,0,10,alpha-catenin binding,MF,
12127,GO:0045295,1,0.990168933380471,0,10,gamma-catenin binding,MF,
12129,GO:0045297,1,0.990376976927382,0,1,post-mating behavior,BP,
12130,GO:0045298,1,0.983160790207659,0,3,tubulin complex,CC,
12131,GO:0045299,1,0.999999996389624,0,1,otolith mineralization,BP,
12132,GO:0045309,1,0.807719119878651,0,44,protein phosphorylated amino acid binding,MF,
12134,GO:0045322,1,0.993589583913992,0,1,unmethylated CpG binding,MF,
12135,GO:0045323,1,0.981369229665749,0,3,interleukin-1 receptor complex,CC,
12136,GO:0045324,1,0.910308428477211,0,15,late endosome to vacuole transport,BP,
12137,GO:0045329,1,0.957354524841437,0,5,carnitine biosynthetic process,BP,
12138,GO:0045332,1,0.977675596077229,0,22,phospholipid translocation,BP,
12140,GO:0045334,1,0.629112847831528,0,65,clathrin-coated endocytic vesicle,CC,
12141,GO:0045335,1,0.504724977827805,0,102,phagocytic vesicle,CC,
12142,GO:0045337,1,0.980923081420185,0,2,farnesyl diphosphate biosynthetic process,BP,
12143,GO:0045338,1,0.97089985468717,0,3,farnesyl diphosphate metabolic process,BP,
12144,GO:0045340,1,0.98731767947796,0,1,mercury ion binding,MF,
12145,GO:0045341,1,0.964127629770772,0,7,MHC class I biosynthetic process,BP,
12146,GO:0045342,1,0.909115862024312,0,13,MHC class II biosynthetic process,BP,
12147,GO:0045343,1,0.964127629770772,0,7,regulation of MHC class I biosynthetic process,BP,
12148,GO:0045345,1,0.976571507435616,0,6,positive regulation of MHC class I biosynthetic process,BP,
12149,GO:0045346,1,0.91130613114992,0,12,regulation of MHC class II biosynthetic process,BP,
12150,GO:0045347,1,0.960265548584249,0,5,negative regulation of MHC class II biosynthetic process,BP,
12151,GO:0045348,1,0.937934349725223,0,8,positive regulation of MHC class II biosynthetic process,BP,
12155,GO:0045352,1,0.988711279405679,0,1,interleukin-1 Type I receptor antagonist activity,MF,
12156,GO:0045353,1,0.988711279405679,0,1,interleukin-1 Type II receptor antagonist activity,MF,
12159,GO:0045356,1,0.990065957640234,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
12163,GO:0045360,1,0.969260554093875,0,3,regulation of interleukin-1 biosynthetic process,BP,
12164,GO:0045362,1,0.969260554093875,0,3,positive regulation of interleukin-1 biosynthetic process,BP,
12165,GO:0045366,1,0.999960750971415,0,1,regulation of interleukin-13 biosynthetic process,BP,
12166,GO:0045368,1,0.999960750971415,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
12167,GO:0045381,1,0.994904987350892,0,1,regulation of interleukin-18 biosynthetic process,BP,
12168,GO:0045399,1,0.987372320298239,0,2,regulation of interleukin-3 biosynthetic process,BP,
12169,GO:0045401,1,0.987372320298239,0,2,positive regulation of interleukin-3 biosynthetic process,BP,
12170,GO:0045402,1,0.987309219770311,0,3,regulation of interleukin-4 biosynthetic process,BP,
12171,GO:0045403,1,0.994933742467394,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12172,GO:0045404,1,0.992336961938344,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12173,GO:0045405,1,0.987173722599235,0,1,regulation of interleukin-5 biosynthetic process,BP,
12174,GO:0045407,1,0.987173722599235,0,1,positive regulation of interleukin-5 biosynthetic process,BP,
12175,GO:0045408,1,0.880441131220447,0,16,regulation of interleukin-6 biosynthetic process,BP,
12176,GO:0045409,1,0.961722006405774,0,5,negative regulation of interleukin-6 biosynthetic process,BP,
12177,GO:0045410,1,0.947926458233007,0,8,positive regulation of interleukin-6 biosynthetic process,BP,
12178,GO:0045414,1,0.90730163756749,0,12,regulation of interleukin-8 biosynthetic process,BP,
12179,GO:0045415,1,0.961052336609415,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12180,GO:0045416,1,0.944150023633473,0,8,positive regulation of interleukin-8 biosynthetic process,BP,
12181,GO:0045423,1,0.967535850814252,0,4,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12182,GO:0045425,1,0.980037516544196,0,3,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12186,GO:0045445,1,0.604833458019546,0,79,myoblast differentiation,BP,
12187,GO:0045446,1,0.630713943673375,0,91,endothelial cell differentiation,BP,
12188,GO:0045448,1,0.973499393682828,0,4,mitotic cell cycle, embryonic,BP,
12190,GO:0045454,1,0.559346913381532,0,68,cell redox homeostasis,BP,
12192,GO:0045472,1,0.922500977996964,0,12,response to ether,BP,
12193,GO:0045475,1,0.940189856600702,0,11,locomotor rhythm,BP,
12195,GO:0045494,1,0.8453535433827,0,34,photoreceptor cell maintenance,BP,
12196,GO:0045495,1,0.913995305964054,0,16,pole plasm,CC,
12197,GO:0045499,1,0.969307257316027,0,9,chemorepellent activity,MF,
12198,GO:0045503,1,0.979091564848298,0,4,dynein light chain binding,MF,
12199,GO:0045504,1,0.97053317846144,0,4,dynein heavy chain binding,MF,
12200,GO:0045505,1,0.937785062213638,0,8,dynein intermediate chain binding,MF,
12201,GO:0045509,1,0.989763237975997,0,2,interleukin-27 receptor activity,MF,
12202,GO:0045513,1,0.9879166162612,0,1,interleukin-27 binding,MF,
12203,GO:0045517,1,0.987603837160757,0,1,interleukin-20 receptor binding,MF,
12204,GO:0045518,1,0.97526042061615,0,2,interleukin-22 receptor binding,MF,
12205,GO:0045519,1,0.978255871287409,0,2,interleukin-23 receptor binding,MF,
12206,GO:0045523,1,0.975043165449496,0,2,interleukin-27 receptor binding,MF,
12208,GO:0045541,1,0.958278788647594,0,5,negative regulation of cholesterol biosynthetic process,BP,
12210,GO:0045545,1,0.967898108539672,0,6,syndecan binding,MF,
12211,GO:0045550,1,0.975984983276443,0,2,geranylgeranyl reductase activity,MF,
12212,GO:0045553,1,0.993874687227096,0,1,TRAIL biosynthetic process,BP,
12213,GO:0045554,1,0.993874687227096,0,1,regulation of TRAIL biosynthetic process,BP,
12214,GO:0045556,1,0.993874687227096,0,1,positive regulation of TRAIL biosynthetic process,BP,
12215,GO:0045569,1,0.971295970710466,0,4,TRAIL binding,MF,
12216,GO:0045575,1,0.977199767129275,0,2,basophil activation,BP,
12217,GO:0045576,1,0.669935830069116,0,55,mast cell activation,BP,
12218,GO:0045577,1,0.870634532394386,0,24,regulation of B cell differentiation,BP,
12219,GO:0045578,1,0.965311725124885,0,4,negative regulation of B cell differentiation,BP,
12220,GO:0045579,1,0.928886116927035,0,13,positive regulation of B cell differentiation,BP,
12222,GO:0045581,1,0.775916171344333,0,34,negative regulation of T cell differentiation,BP,
12224,GO:0045583,1,0.985056530012587,0,2,regulation of cytotoxic T cell differentiation,BP,
12225,GO:0045585,1,0.985056530012587,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12226,GO:0045586,1,0.994808985663346,0,5,regulation of gamma-delta T cell differentiation,BP,
12227,GO:0045588,1,0.997535543494382,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12228,GO:0045589,1,0.861281222496299,0,19,regulation of regulatory T cell differentiation,BP,
12229,GO:0045590,1,0.981684143197593,0,3,negative regulation of regulatory T cell differentiation,BP,
12230,GO:0045591,1,0.890285124713815,0,12,positive regulation of regulatory T cell differentiation,BP,
12234,GO:0045598,1,0.5056618690527,0,110,regulation of fat cell differentiation,BP,
12235,GO:0045599,1,0.787308985171634,0,42,negative regulation of fat cell differentiation,BP,
12236,GO:0045600,1,0.69420152584749,0,54,positive regulation of fat cell differentiation,BP,
12237,GO:0045601,1,0.861380387291059,0,30,regulation of endothelial cell differentiation,BP,
12238,GO:0045602,1,0.984775384076128,0,7,negative regulation of endothelial cell differentiation,BP,
12239,GO:0045603,1,0.909391906370119,0,16,positive regulation of endothelial cell differentiation,BP,
12240,GO:0045604,1,0.710320797409899,0,48,regulation of epidermal cell differentiation,BP,
12241,GO:0045605,1,0.90392198720327,0,13,negative regulation of epidermal cell differentiation,BP,
12242,GO:0045606,1,0.873978652640061,0,20,positive regulation of epidermal cell differentiation,BP,
12243,GO:0045607,1,0.943669887461684,0,7,regulation of auditory receptor cell differentiation,BP,
12244,GO:0045608,1,0.983260911152592,0,3,negative regulation of auditory receptor cell differentiation,BP,
12245,GO:0045609,1,0.987417807105176,0,1,positive regulation of auditory receptor cell differentiation,BP,
12246,GO:0045616,1,0.807471466552311,0,32,regulation of keratinocyte differentiation,BP,
12247,GO:0045617,1,0.938398892051124,0,8,negative regulation of keratinocyte differentiation,BP,
12248,GO:0045618,1,0.91382805158753,0,14,positive regulation of keratinocyte differentiation,BP,
12250,GO:0045620,1,0.71436707836322,0,42,negative regulation of lymphocyte differentiation,BP,
12252,GO:0045622,1,0.791578888144087,0,30,regulation of T-helper cell differentiation,BP,
12253,GO:0045623,1,0.905896270125882,0,14,negative regulation of T-helper cell differentiation,BP,
12254,GO:0045624,1,0.854028876004795,0,19,positive regulation of T-helper cell differentiation,BP,
12255,GO:0045625,1,0.92590195660238,0,10,regulation of T-helper 1 cell differentiation,BP,
12256,GO:0045626,1,0.987001380197763,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12257,GO:0045627,1,0.950076137574132,0,6,positive regulation of T-helper 1 cell differentiation,BP,
12258,GO:0045628,1,0.91547616860225,0,12,regulation of T-helper 2 cell differentiation,BP,
12259,GO:0045629,1,0.973983172362726,0,4,negative regulation of T-helper 2 cell differentiation,BP,
12260,GO:0045630,1,0.939942354601645,0,8,positive regulation of T-helper 2 cell differentiation,BP,
12261,GO:0045631,1,0.943669887461684,0,7,regulation of mechanoreceptor differentiation,BP,
12262,GO:0045632,1,0.971163901777346,0,4,negative regulation of mechanoreceptor differentiation,BP,
12263,GO:0045633,1,0.987417807105176,0,1,positive regulation of mechanoreceptor differentiation,BP,
12264,GO:0045634,1,0.975921299146398,0,7,regulation of melanocyte differentiation,BP,
12265,GO:0045636,1,0.997521789355309,0,5,positive regulation of melanocyte differentiation,BP,
12267,GO:0045638,1,0.528084206238582,0,85,negative regulation of myeloid cell differentiation,BP,
12269,GO:0045643,1,0.983970098865962,0,2,regulation of eosinophil differentiation,BP,
12270,GO:0045645,1,0.983970098865962,0,2,positive regulation of eosinophil differentiation,BP,
12271,GO:0045646,1,0.794972839217111,0,38,regulation of erythrocyte differentiation,BP,
12272,GO:0045647,1,0.949785606989312,0,8,negative regulation of erythrocyte differentiation,BP,
12273,GO:0045648,1,0.884081498517174,0,23,positive regulation of erythrocyte differentiation,BP,
12275,GO:0045650,1,0.948974358259494,0,7,negative regulation of macrophage differentiation,BP,
12277,GO:0045652,1,0.739466372117124,0,28,regulation of megakaryocyte differentiation,BP,
12278,GO:0045653,1,0.803142056186408,0,18,negative regulation of megakaryocyte differentiation,BP,
12279,GO:0045654,1,0.940416517508974,0,7,positive regulation of megakaryocyte differentiation,BP,
12280,GO:0045655,1,0.887014583397151,0,18,regulation of monocyte differentiation,BP,
12281,GO:0045656,1,0.959737410466461,0,7,negative regulation of monocyte differentiation,BP,
12282,GO:0045657,1,0.937606004718011,0,9,positive regulation of monocyte differentiation,BP,
12283,GO:0045658,1,0.996391985882257,0,2,regulation of neutrophil differentiation,BP,
12284,GO:0045659,1,0.996391985882257,0,2,negative regulation of neutrophil differentiation,BP,
12285,GO:0045661,1,0.723693195470494,0,48,regulation of myoblast differentiation,BP,
12286,GO:0045662,1,0.847339632063572,0,21,negative regulation of myoblast differentiation,BP,
12287,GO:0045663,1,0.88755335743892,0,21,positive regulation of myoblast differentiation,BP,
12290,GO:0045666,1,0.208704624911969,0,305,positive regulation of neuron differentiation,BP,
12291,GO:0045667,1,0.534576127669168,0,107,regulation of osteoblast differentiation,BP,
12292,GO:0045668,1,0.807194544876659,0,39,negative regulation of osteoblast differentiation,BP,
12293,GO:0045669,1,0.70448909246251,0,57,positive regulation of osteoblast differentiation,BP,
12294,GO:0045670,1,0.648015943171875,0,63,regulation of osteoclast differentiation,BP,
12295,GO:0045671,1,0.875383758614664,0,25,negative regulation of osteoclast differentiation,BP,
12296,GO:0045672,1,0.824135252116363,0,24,positive regulation of osteoclast differentiation,BP,
12298,GO:0045683,1,0.888735676263336,0,17,negative regulation of epidermis development,BP,
12300,GO:0045685,1,0.66154164257455,0,56,regulation of glial cell differentiation,BP,
12301,GO:0045686,1,0.826844925407085,0,23,negative regulation of glial cell differentiation,BP,
12302,GO:0045687,1,0.78134756293842,0,32,positive regulation of glial cell differentiation,BP,
12303,GO:0045703,1,0.987594992920963,0,1,ketoreductase activity,MF,
12304,GO:0045713,1,0.954705982273752,0,10,low-density lipoprotein particle receptor biosynthetic process,BP,
12305,GO:0045714,1,0.965391868097164,0,9,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12306,GO:0045715,1,0.999142188562807,0,3,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12307,GO:0045716,1,0.967556193670704,0,4,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12309,GO:0045719,1,0.984287551294366,0,5,negative regulation of glycogen biosynthetic process,BP,
12310,GO:0045720,1,0.982817750359682,0,2,negative regulation of integrin biosynthetic process,BP,
12311,GO:0045721,1,0.910844540113411,0,13,negative regulation of gluconeogenesis,BP,
12312,GO:0045722,1,0.956416824663536,0,10,positive regulation of gluconeogenesis,BP,
12314,GO:0045724,1,0.909495836877794,0,20,positive regulation of cilium assembly,BP,
12315,GO:0045725,1,0.940000538842574,0,15,positive regulation of glycogen biosynthetic process,BP,
12316,GO:0045726,1,0.985152519966305,0,3,positive regulation of integrin biosynthetic process,BP,
12318,GO:0045728,1,0.989974988047088,0,1,respiratory burst after phagocytosis,BP,
12319,GO:0045730,1,0.813277951974321,0,25,respiratory burst,BP,
12321,GO:0045736,1,0.856559281384968,0,24,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12322,GO:0045737,1,0.778879199408108,0,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12323,GO:0045738,1,0.909858217817747,0,17,negative regulation of DNA repair,BP,
12324,GO:0045739,1,0.767909379344229,0,38,positive regulation of DNA repair,BP,
12325,GO:0045740,1,0.681552654038604,0,54,positive regulation of DNA replication,BP,
12326,GO:0045741,1,0.942910685965845,0,11,positive regulation of epidermal growth factor-activated receptor activity,BP,
12328,GO:0045743,1,0.961047248703314,0,6,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12330,GO:0045745,1,0.836131097863546,0,24,positive regulation of G-protein coupled receptor protein signaling pathway,BP,
12331,GO:0045746,1,0.832781932790756,0,27,negative regulation of Notch signaling pathway,BP,
12332,GO:0045747,1,0.80734146508167,0,33,positive regulation of Notch signaling pathway,BP,
12333,GO:0045751,1,0.994904987350892,0,1,negative regulation of Toll signaling pathway,BP,
12334,GO:0045759,1,0.948534169734523,0,7,negative regulation of action potential,BP,
12335,GO:0045760,1,0.946738760636652,0,11,positive regulation of action potential,BP,
12336,GO:0045761,1,0.594798335175698,0,74,regulation of adenylate cyclase activity,BP,
12337,GO:0045762,1,0.748333087447607,0,46,positive regulation of adenylate cyclase activity,BP,
12338,GO:0045763,1,0.999852150610843,0,2,negative regulation of cellular amino acid metabolic process,BP,
12339,GO:0045764,1,0.96800575990033,0,3,positive regulation of cellular amino acid metabolic process,BP,
12340,GO:0045765,1,0.280959791321193,0,207,regulation of angiogenesis,BP,
12341,GO:0045766,1,0.482407475608712,0,119,positive regulation of angiogenesis,BP,
12342,GO:0045769,1,0.999999996400187,0,1,negative regulation of asymmetric cell division,BP,
12343,GO:0045773,1,0.853571797292211,0,39,positive regulation of axon extension,BP,
12344,GO:0045776,1,0.716884049769351,0,43,negative regulation of blood pressure,BP,
12345,GO:0045777,1,0.764973971039122,0,34,positive regulation of blood pressure,BP,
12346,GO:0045778,1,0.595381656282479,0,82,positive regulation of ossification,BP,
12347,GO:0045779,1,0.913679089981194,0,12,negative regulation of bone resorption,BP,
12348,GO:0045780,1,0.914427773148315,0,13,positive regulation of bone resorption,BP,
12351,GO:0045787,1,0.111740085573788,0,334,positive regulation of cell cycle,BP,
12353,GO:0045793,1,0.933835209509963,0,11,positive regulation of cell size,BP,
12354,GO:0045794,1,0.992242628225381,0,5,negative regulation of cell volume,BP,
12355,GO:0045795,1,0.999999996377969,0,1,positive regulation of cell volume,BP,
12356,GO:0045796,1,0.984754892204901,0,2,negative regulation of intestinal cholesterol absorption,BP,
12357,GO:0045799,1,0.988163179532704,0,3,positive regulation of chromatin assembly or disassembly,BP,
12360,GO:0045814,1,0.332000898247491,0,130,negative regulation of gene expression, epigenetic,BP,
12361,GO:0045815,1,0.507487990992661,0,79,positive regulation of gene expression, epigenetic,BP,
12362,GO:0045818,1,0.987153275782085,0,1,negative regulation of glycogen catabolic process,BP,
12363,GO:0045819,1,0.997855572229775,0,1,positive regulation of glycogen catabolic process,BP,
12364,GO:0045820,1,0.93874315309459,0,11,negative regulation of glycolytic process,BP,
12365,GO:0045821,1,0.941196195821847,0,13,positive regulation of glycolytic process,BP,
12366,GO:0045822,1,0.881124275681731,0,20,negative regulation of heart contraction,BP,
12367,GO:0045823,1,0.790024984987354,0,33,positive regulation of heart contraction,BP,
12369,GO:0045827,1,0.987594992920963,0,1,negative regulation of isoprenoid metabolic process,BP,
12370,GO:0045829,1,0.97362389858507,0,4,negative regulation of isotype switching,BP,
12371,GO:0045830,1,0.859912919252795,0,20,positive regulation of isotype switching,BP,
12374,GO:0045835,1,0.919508451671223,0,11,negative regulation of meiotic nuclear division,BP,
12375,GO:0045836,1,0.93243211663918,0,11,positive regulation of meiotic nuclear division,BP,
12376,GO:0045837,1,0.904026515377532,0,11,negative regulation of membrane potential,BP,
12377,GO:0045838,1,0.92411014787323,0,9,positive regulation of membrane potential,BP,
12378,GO:0045839,1,0.757833842201908,0,41,negative regulation of mitotic nuclear division,BP,
12379,GO:0045840,1,0.750246915629077,0,45,positive regulation of mitotic nuclear division,BP,
12380,GO:0045841,1,0.812794106147916,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
12381,GO:0045842,1,0.973661253766844,0,6,positive regulation of mitotic metaphase/anaphase transition,BP,
12383,GO:0045844,1,0.718709045639742,0,63,positive regulation of striated muscle tissue development,BP,
12384,GO:0045848,1,0.989936963505739,0,1,positive regulation of nitrogen utilization,BP,
12385,GO:0045851,1,0.665427812278549,0,49,pH reduction,BP,
12386,GO:0045852,1,0.963763420865065,0,6,pH elevation,BP,
12391,GO:0045869,1,0.942902533309642,0,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12392,GO:0045870,1,0.999999785707766,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12393,GO:0045872,1,0.978986005825994,0,2,positive regulation of rhodopsin gene expression,BP,
12394,GO:0045875,1,0.999999989171474,0,3,negative regulation of sister chromatid cohesion,BP,
12395,GO:0045876,1,0.956974558728544,0,7,positive regulation of sister chromatid cohesion,BP,
12396,GO:0045879,1,0.903598946009919,0,25,negative regulation of smoothened signaling pathway,BP,
12397,GO:0045880,1,0.900849447496599,0,27,positive regulation of smoothened signaling pathway,BP,
12398,GO:0045887,1,0.999999996380758,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12401,GO:0045896,1,0.999623619591033,0,3,regulation of transcription during mitotic cell cycle,BP,
12402,GO:0045897,1,0.999999482172686,0,1,positive regulation of transcription during mitotic cell cycle,BP,
12403,GO:0045898,1,0.908956995878918,0,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12404,GO:0045899,1,0.921518521479334,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12405,GO:0045900,1,0.976868162037449,0,4,negative regulation of translational elongation,BP,
12406,GO:0045901,1,0.966405110789549,0,5,positive regulation of translational elongation,BP,
12407,GO:0045903,1,0.976825003378986,0,2,positive regulation of translational fidelity,BP,
12408,GO:0045905,1,0.985218494977132,0,3,positive regulation of translational termination,BP,
12409,GO:0045906,1,0.970496628275667,0,7,negative regulation of vasoconstriction,BP,
12410,GO:0045907,1,0.800419458611792,0,31,positive regulation of vasoconstriction,BP,
12411,GO:0045910,1,0.906622320733368,0,21,negative regulation of DNA recombination,BP,
12412,GO:0045911,1,0.850410523391326,0,23,positive regulation of DNA recombination,BP,
12413,GO:0045912,1,0.796391087501853,0,37,negative regulation of carbohydrate metabolic process,BP,
12415,GO:0045914,1,0.985026246417987,0,2,negative regulation of catecholamine metabolic process,BP,
12416,GO:0045915,1,0.95626992828815,0,6,positive regulation of catecholamine metabolic process,BP,
12417,GO:0045916,1,0.954997384592953,0,8,negative regulation of complement activation,BP,
12418,GO:0045917,1,0.985538375697657,0,3,positive regulation of complement activation,BP,
12419,GO:0045918,1,0.96078508245292,0,4,negative regulation of cytolysis,BP,
12420,GO:0045919,1,0.956000556423905,0,5,positive regulation of cytolysis,BP,
12421,GO:0045920,1,0.840517914190974,0,28,negative regulation of exocytosis,BP,
12422,GO:0045921,1,0.613186724109843,0,77,positive regulation of exocytosis,BP,
12425,GO:0045924,1,0.944414492576396,0,8,regulation of female receptivity,BP,
12426,GO:0045925,1,0.978314133976373,0,3,positive regulation of female receptivity,BP,
12430,GO:0045931,1,0.474190677511965,0,126,positive regulation of mitotic cell cycle,BP,
12431,GO:0045932,1,0.89029699826349,0,20,negative regulation of muscle contraction,BP,
12432,GO:0045933,1,0.768716501267205,0,39,positive regulation of muscle contraction,BP,
12437,GO:0045938,1,0.927482404936869,0,7,positive regulation of circadian sleep/wake cycle, sleep,BP,
12438,GO:0045939,1,0.83984591026001,0,23,negative regulation of steroid metabolic process,BP,
12440,GO:0045943,1,0.904389032881594,0,21,positive regulation of transcription from RNA polymerase I promoter,BP,
12442,GO:0045945,1,0.968797162071971,0,9,positive regulation of transcription from RNA polymerase III promoter,BP,
12443,GO:0045947,1,0.871869256098137,0,21,negative regulation of translational initiation,BP,
12444,GO:0045948,1,0.859833699665674,0,23,positive regulation of translational initiation,BP,
12445,GO:0045950,1,0.969970839488499,0,4,negative regulation of mitotic recombination,BP,
12446,GO:0045953,1,0.914446270259313,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12447,GO:0045954,1,0.879925995130134,0,18,positive regulation of natural killer cell mediated cytotoxicity,BP,
12448,GO:0045955,1,0.955819101941962,0,10,negative regulation of calcium ion-dependent exocytosis,BP,
12449,GO:0045956,1,0.905712567787291,0,21,positive regulation of calcium ion-dependent exocytosis,BP,
12450,GO:0045957,1,0.999999996391921,0,1,negative regulation of complement activation, alternative pathway,BP,
12451,GO:0045959,1,0.977747519437203,0,3,negative regulation of complement activation, classical pathway,BP,
12452,GO:0045963,1,0.985026246417987,0,2,negative regulation of dopamine metabolic process,BP,
12453,GO:0045964,1,0.95626992828815,0,6,positive regulation of dopamine metabolic process,BP,
12454,GO:0045974,1,0.927537999061352,0,13,regulation of translation, ncRNA-mediated,BP,
12455,GO:0045976,1,0.993577072931075,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12456,GO:0045977,1,0.987942018230641,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12457,GO:0045980,1,0.627560129155325,0,66,negative regulation of nucleotide metabolic process,BP,
12459,GO:0045986,1,0.914089575276725,0,14,negative regulation of smooth muscle contraction,BP,
12460,GO:0045987,1,0.851733594602064,0,25,positive regulation of smooth muscle contraction,BP,
12461,GO:0045988,1,0.979510854804201,0,6,negative regulation of striated muscle contraction,BP,
12462,GO:0045989,1,0.903788477362578,0,14,positive regulation of striated muscle contraction,BP,
12463,GO:0045990,1,0.958313599090605,0,6,carbon catabolite regulation of transcription,BP,
12464,GO:0045991,1,0.96729867723708,0,5,carbon catabolite activation of transcription,BP,
12465,GO:0045992,1,0.864990553181284,0,26,negative regulation of embryonic development,BP,
12466,GO:0045993,1,0.999219666370847,0,1,negative regulation of translational initiation by iron,BP,
12467,GO:0045994,1,0.988394802457583,0,2,positive regulation of translational initiation by iron,BP,
12468,GO:0045995,1,0.532312264683051,0,117,regulation of embryonic development,BP,
12469,GO:0046005,1,0.962329653627025,0,3,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12471,GO:0046007,1,0.935511519767905,0,10,negative regulation of activated T cell proliferation,BP,
12472,GO:0046010,1,0.971896038723339,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12473,GO:0046013,1,0.969990011578541,0,3,regulation of T cell homeostatic proliferation,BP,
12474,GO:0046015,1,0.94721469300979,0,6,regulation of transcription by glucose,BP,
12475,GO:0046016,1,0.967298687242177,0,4,positive regulation of transcription by glucose,BP,
12476,GO:0046021,1,0.999623619591033,0,3,regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
12477,GO:0046022,1,0.999999482172686,0,1,positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,BP,
12478,GO:0046030,1,0.961686577060726,0,11,inositol trisphosphate phosphatase activity,MF,
12479,GO:0046031,1,0.611179901006101,0,72,ADP metabolic process,BP,
12480,GO:0046032,1,0.988103063232136,0,1,ADP catabolic process,BP,
12481,GO:0046033,1,0.909599932084451,0,12,AMP metabolic process,BP,
12482,GO:0046034,1,0.144387214146117,0,224,ATP metabolic process,BP,
12483,GO:0046035,1,0.987620565988309,0,1,CMP metabolic process,BP,
12484,GO:0046036,1,0.861549256956612,0,14,CTP metabolic process,BP,
12485,GO:0046037,1,0.912017397260797,0,20,GMP metabolic process,BP,
12486,GO:0046038,1,0.987879530616557,0,1,GMP catabolic process,BP,
12487,GO:0046039,1,0.816934383470432,0,26,GTP metabolic process,BP,
12488,GO:0046040,1,0.925053346377029,0,13,IMP metabolic process,BP,
12489,GO:0046041,1,0.979586977862979,0,2,ITP metabolic process,BP,
12490,GO:0046048,1,0.993414436255799,0,1,UDP metabolic process,BP,
12491,GO:0046049,1,0.915820960575477,0,10,UMP metabolic process,BP,
12492,GO:0046051,1,0.893430603281106,0,11,UTP metabolic process,BP,
12493,GO:0046054,1,0.987358580697023,0,1,dGMP metabolic process,BP,
12494,GO:0046056,1,0.984660178900247,0,2,dADP metabolic process,BP,
12495,GO:0046057,1,0.988071294918011,0,1,dADP catabolic process,BP,
12497,GO:0046060,1,0.948069924071763,0,5,dATP metabolic process,BP,
12498,GO:0046061,1,0.970315035648327,0,3,dATP catabolic process,BP,
12499,GO:0046065,1,0.987470452549771,0,1,dCTP metabolic process,BP,
12500,GO:0046066,1,0.975579492707392,0,2,dGDP metabolic process,BP,
12501,GO:0046067,1,0.988071294918011,0,1,dGDP catabolic process,BP,
12502,GO:0046068,1,0.735646712250313,0,55,cGMP metabolic process,BP,
12503,GO:0046069,1,0.973203324947563,0,7,cGMP catabolic process,BP,
12504,GO:0046070,1,0.959377720405572,0,4,dGTP metabolic process,BP,
12505,GO:0046072,1,0.981252736973267,0,2,dTDP metabolic process,BP,
12506,GO:0046073,1,0.979522453151024,0,2,dTMP metabolic process,BP,
12507,GO:0046075,1,0.957774979381295,0,4,dTTP metabolic process,BP,
12508,GO:0046077,1,0.981252736973267,0,2,dUDP metabolic process,BP,
12509,GO:0046078,1,0.965801336123889,0,3,dUMP metabolic process,BP,
12510,GO:0046079,1,0.988213803811303,0,1,dUMP catabolic process,BP,
12511,GO:0046080,1,0.988981881900696,0,1,dUTP metabolic process,BP,
12512,GO:0046083,1,0.975250119192283,0,2,adenine metabolic process,BP,
12513,GO:0046084,1,0.975250119192283,0,2,adenine biosynthetic process,BP,
12514,GO:0046085,1,0.949389033060872,0,7,adenosine metabolic process,BP,
12515,GO:0046086,1,0.987863974327786,0,2,adenosine biosynthetic process,BP,
12516,GO:0046087,1,0.90412250534368,0,9,cytidine metabolic process,BP,
12517,GO:0046090,1,0.98811033555713,0,1,deoxyadenosine metabolic process,BP,
12518,GO:0046092,1,0.999858122876777,0,1,deoxycytidine metabolic process,BP,
12519,GO:0046098,1,0.982097728280196,0,3,guanine metabolic process,BP,
12520,GO:0046099,1,0.987879530616557,0,1,guanine biosynthetic process,BP,
12521,GO:0046100,1,0.966337799926222,0,3,hypoxanthine metabolic process,BP,
12522,GO:0046101,1,0.966337799926222,0,3,hypoxanthine biosynthetic process,BP,
12524,GO:0046103,1,0.98811033555713,0,1,inosine biosynthetic process,BP,
12525,GO:0046104,1,0.982524091280281,0,3,thymidine metabolic process,BP,
12526,GO:0046108,1,0.979901203473699,0,2,uridine metabolic process,BP,
12528,GO:0046111,1,0.98811033555713,0,1,xanthine biosynthetic process,BP,
12529,GO:0046112,1,0.896685514672678,0,17,nucleobase biosynthetic process,BP,
12531,GO:0046116,1,0.932545228823193,0,6,queuosine metabolic process,BP,
12533,GO:0046122,1,0.975634380498651,0,2,purine deoxyribonucleoside metabolic process,BP,
12534,GO:0046124,1,0.98811033555713,0,1,purine deoxyribonucleoside catabolic process,BP,
12535,GO:0046125,1,0.982524091280281,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12536,GO:0046127,1,0.994359198959087,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12538,GO:0046129,1,0.809078529415893,0,21,purine ribonucleoside biosynthetic process,BP,
12540,GO:0046131,1,0.727038450501324,0,32,pyrimidine ribonucleoside metabolic process,BP,
12541,GO:0046132,1,0.816130494612408,0,21,pyrimidine ribonucleoside biosynthetic process,BP,
12542,GO:0046133,1,0.888091096238874,0,11,pyrimidine ribonucleoside catabolic process,BP,
12543,GO:0046134,1,0.754736681456339,0,29,pyrimidine nucleoside biosynthetic process,BP,
12544,GO:0046135,1,0.814860666822575,0,20,pyrimidine nucleoside catabolic process,BP,
12545,GO:0046136,1,0.96443604395261,0,3,positive regulation of vitamin metabolic process,BP,
12546,GO:0046137,1,0.948908442393744,0,6,negative regulation of vitamin metabolic process,BP,
12547,GO:0046144,1,0.988247587492541,0,1,D-alanine family amino acid metabolic process,BP,
12549,GO:0046148,1,0.694653356351255,0,51,pigment biosynthetic process,BP,
12550,GO:0046149,1,0.923567299805573,0,7,pigment catabolic process,BP,
12551,GO:0046160,1,0.993745492035209,0,2,heme a metabolic process,BP,
12552,GO:0046164,1,0.694658185349711,0,46,alcohol catabolic process,BP,
12554,GO:0046166,1,0.977869565223486,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12555,GO:0046167,1,0.985759168550894,0,3,glycerol-3-phosphate biosynthetic process,BP,
12556,GO:0046168,1,0.990946080483294,0,2,glycerol-3-phosphate catabolic process,BP,
12557,GO:0046173,1,0.763533345176566,0,40,polyol biosynthetic process,BP,
12558,GO:0046174,1,0.910264040842833,0,18,polyol catabolic process,BP,
12559,GO:0046176,1,0.991657600429728,0,1,aldonic acid catabolic process,BP,
12560,GO:0046177,1,0.991657600429728,0,1,D-gluconate catabolic process,BP,
12561,GO:0046184,1,0.921119246829512,0,15,aldehyde biosynthetic process,BP,
12562,GO:0046185,1,0.896795137924741,0,11,aldehyde catabolic process,BP,
12563,GO:0046189,1,0.753535824771339,0,40,phenol-containing compound biosynthetic process,BP,
12564,GO:0046203,1,0.976170797884531,0,2,spermidine catabolic process,BP,
12565,GO:0046204,1,0.987339217613658,0,1,nor-spermidine metabolic process,BP,
12566,GO:0046208,1,0.956283116396937,0,4,spermine catabolic process,BP,
12568,GO:0046210,1,0.991428740525173,0,1,nitric oxide catabolic process,BP,
12569,GO:0046218,1,0.903205801819689,0,11,indolalkylamine catabolic process,BP,
12570,GO:0046219,1,0.946014761980756,0,5,indolalkylamine biosynthetic process,BP,
12571,GO:0046222,1,0.990566313287312,0,1,aflatoxin metabolic process,BP,
12572,GO:0046226,1,0.976363723494764,0,2,coumarin catabolic process,BP,
12573,GO:0046247,1,0.993055936423407,0,1,terpene catabolic process,BP,
12574,GO:0046271,1,0.976363723494764,0,2,phenylpropanoid catabolic process,BP,
12575,GO:0046272,1,0.990164429951147,0,1,stilbene catabolic process,BP,
12576,GO:0046292,1,0.979349789340234,0,3,formaldehyde metabolic process,BP,
12577,GO:0046293,1,0.999639283075737,0,1,formaldehyde biosynthetic process,BP,
12578,GO:0046294,1,0.979703246181876,0,2,formaldehyde catabolic process,BP,
12579,GO:0046295,1,0.98731767947796,0,1,glycolate biosynthetic process,BP,
12580,GO:0046296,1,0.988619143020241,0,1,glycolate catabolic process,BP,
12581,GO:0046305,1,0.980693276367181,0,2,alkanesulfonate biosynthetic process,BP,
12582,GO:0046314,1,0.988154741572323,0,1,phosphocreatine biosynthetic process,BP,
12583,GO:0046316,1,0.991657600429728,0,1,gluconokinase activity,MF,
12584,GO:0046317,1,0.999888458788254,0,1,regulation of glucosylceramide biosynthetic process,BP,
12585,GO:0046318,1,0.999888458788254,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12587,GO:0046321,1,0.936174465981533,0,14,positive regulation of fatty acid oxidation,BP,
12591,GO:0046325,1,0.918206583974186,0,12,negative regulation of glucose import,BP,
12593,GO:0046327,1,0.99222814746323,0,1,glycerol biosynthetic process from pyruvate,BP,
12595,GO:0046329,1,0.836059409944876,0,32,negative regulation of JNK cascade,BP,
12597,GO:0046331,1,0.983260918055296,0,2,lateral inhibition,BP,
12598,GO:0046332,1,0.734650785978042,0,73,SMAD binding,MF,
12599,GO:0046333,1,0.986633464855788,0,2,octopamine metabolic process,BP,
12600,GO:0046337,1,0.91358462977248,0,15,phosphatidylethanolamine metabolic process,BP,
12601,GO:0046338,1,0.988719113159625,0,2,phosphatidylethanolamine catabolic process,BP,
12603,GO:0046340,1,0.984596417941942,0,3,diacylglycerol catabolic process,BP,
12604,GO:0046341,1,0.944256876589488,0,12,CDP-diacylglycerol metabolic process,BP,
12605,GO:0046348,1,0.913418542674271,0,9,amino sugar catabolic process,BP,
12606,GO:0046349,1,0.931716170608456,0,11,amino sugar biosynthetic process,BP,
12607,GO:0046351,1,0.959161318771301,0,5,disaccharide biosynthetic process,BP,
12608,GO:0046352,1,0.988950990789635,0,1,disaccharide catabolic process,BP,
12610,GO:0046360,1,0.989809343645212,0,1,2-oxobutyrate biosynthetic process,BP,
12611,GO:0046361,1,0.989809343645212,0,1,2-oxobutyrate metabolic process,BP,
12614,GO:0046368,1,0.969509348759005,0,4,GDP-L-fucose metabolic process,BP,
12615,GO:0046370,1,0.979475731205501,0,2,fructose biosynthetic process,BP,
12616,GO:0046373,1,0.991657600429728,0,1,L-arabinose metabolic process,BP,
12617,GO:0046379,1,0.977185504257318,0,3,extracellular polysaccharide metabolic process,BP,
12618,GO:0046380,1,0.997348267284739,0,1,N-acetylneuraminate biosynthetic process,BP,
12619,GO:0046381,1,0.987612795703566,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12620,GO:0046385,1,0.914188043560132,0,9,deoxyribose phosphate biosynthetic process,BP,
12623,GO:0046391,1,0.962309935168614,0,4,5-phosphoribose 1-diphosphate metabolic process,BP,
12626,GO:0046398,1,0.982627191575188,0,4,UDP-glucuronate metabolic process,BP,
12627,GO:0046403,1,0.988559552384467,0,1,polynucleotide 3'-phosphatase activity,MF,
12628,GO:0046404,1,0.977302454265726,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12630,GO:0046416,1,0.968174831474462,0,3,D-amino acid metabolic process,BP,
12632,GO:0046426,1,0.727983539861066,0,49,negative regulation of JAK-STAT cascade,BP,
12635,GO:0046436,1,0.988247587492541,0,1,D-alanine metabolic process,BP,
12636,GO:0046437,1,0.991300277190173,0,1,D-amino acid biosynthetic process,BP,
12637,GO:0046439,1,0.952980262071205,0,7,L-cysteine metabolic process,BP,
12638,GO:0046440,1,0.974489621694919,0,4,L-lysine metabolic process,BP,
12639,GO:0046443,1,0.989304060135563,0,1,FAD metabolic process,BP,
12640,GO:0046444,1,0.992331240483365,0,1,FMN metabolic process,BP,
12641,GO:0046448,1,0.991142587041807,0,1,tropane alkaloid metabolic process,BP,
12643,GO:0046452,1,0.987569508494488,0,2,dihydrofolate metabolic process,BP,
12645,GO:0046457,1,0.823748117229772,0,23,prostanoid biosynthetic process,BP,
12646,GO:0046459,1,0.906457786604118,0,13,short-chain fatty acid metabolic process,BP,
12649,GO:0046462,1,0.980462316063355,0,2,monoacylglycerol metabolic process,BP,
12652,GO:0046465,1,0.946793882229948,0,7,dolichyl diphosphate metabolic process,BP,
12655,GO:0046469,1,0.959979846227912,0,6,platelet activating factor metabolic process,BP,
12657,GO:0046471,1,0.802378098776437,0,31,phosphatidylglycerol metabolic process,BP,
12658,GO:0046473,1,0.817644226410672,0,35,phosphatidic acid metabolic process,BP,
12661,GO:0046476,1,0.970501893651592,0,4,glycosylceramide biosynthetic process,BP,
12669,GO:0046490,1,0.945013993823353,0,5,isopentenyl diphosphate metabolic process,BP,
12670,GO:0046491,1,0.987277716208903,0,1,L-methylmalonyl-CoA metabolic process,BP,
12671,GO:0046493,1,0.987192131992394,0,1,lipid A metabolic process,BP,
12674,GO:0046498,1,0.959071838145851,0,6,S-adenosylhomocysteine metabolic process,BP,
12675,GO:0046499,1,0.995026999315685,0,1,S-adenosylmethioninamine metabolic process,BP,
12676,GO:0046500,1,0.912153199145191,0,13,S-adenosylmethionine metabolic process,BP,
12677,GO:0046501,1,0.921419232901948,0,10,protoporphyrinogen IX metabolic process,BP,
12678,GO:0046502,1,0.977916008559409,0,2,uroporphyrinogen III metabolic process,BP,
12680,GO:0046504,1,0.980306577289443,0,4,glycerol ether biosynthetic process,BP,
12681,GO:0046511,1,0.989002104587068,0,2,sphinganine biosynthetic process,BP,
12682,GO:0046512,1,0.943413707129138,0,8,sphingosine biosynthetic process,BP,
12683,GO:0046513,1,0.712133520992245,0,47,ceramide biosynthetic process,BP,
12685,GO:0046519,1,0.913647512306208,0,13,sphingoid metabolic process,BP,
12686,GO:0046520,1,0.941115900405398,0,9,sphingoid biosynthetic process,BP,
12687,GO:0046521,1,0.988957146665087,0,1,sphingoid catabolic process,BP,
12689,GO:0046525,1,0.988556879018992,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12690,GO:0046526,1,0.991518053072052,0,1,D-xylulose reductase activity,MF,
12692,GO:0046530,1,0.768572412176976,0,55,photoreceptor cell differentiation,BP,
12693,GO:0046532,1,0.961583773221861,0,7,regulation of photoreceptor cell differentiation,BP,
12694,GO:0046533,1,0.962349341114228,0,6,negative regulation of photoreceptor cell differentiation,BP,
12695,GO:0046534,1,0.999204729432052,0,1,positive regulation of photoreceptor cell differentiation,BP,
12696,GO:0046538,1,0.954226911717594,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12697,GO:0046539,1,0.987299002490663,0,1,histamine N-methyltransferase activity,MF,
12698,GO:0046540,1,0.846523804042834,0,19,U4/U6 x U5 tri-snRNP complex,CC,
12699,GO:0046541,1,0.883508105888254,0,13,saliva secretion,BP,
12700,GO:0046543,1,0.957868321751175,0,7,development of secondary female sexual characteristics,BP,
12701,GO:0046544,1,0.999886537532904,0,1,development of secondary male sexual characteristics,BP,
12704,GO:0046548,1,0.96336177217801,0,9,retinal rod cell development,BP,
12705,GO:0046549,1,0.956122309423585,0,9,retinal cone cell development,BP,
12706,GO:0046554,1,0.987704468201962,0,1,malate dehydrogenase (NADP+) activity,MF,
12707,GO:0046556,1,0.991657600429728,0,1,alpha-L-arabinofuranosidase activity,MF,
12708,GO:0046570,1,0.987639027939274,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12710,GO:0046577,1,0.997245909208112,0,1,long-chain-alcohol oxidase activity,MF,
12711,GO:0046578,1,0.457247903154723,0,199,regulation of Ras protein signal transduction,BP,
12712,GO:0046579,1,0.762545418940738,0,45,positive regulation of Ras protein signal transduction,BP,
12713,GO:0046580,1,0.823144898845797,0,43,negative regulation of Ras protein signal transduction,BP,
12714,GO:0046581,1,0.98479450530781,0,6,intercellular canaliculus,CC,
12715,GO:0046586,1,0.981172682667415,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12716,GO:0046587,1,0.993794244072025,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12717,GO:0046588,1,0.98730024600544,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12718,GO:0046592,1,0.978256061103247,0,2,polyamine oxidase activity,MF,
12719,GO:0046596,1,0.784028251778569,0,29,regulation of viral entry into host cell,BP,
12720,GO:0046597,1,0.851098272548626,0,19,negative regulation of viral entry into host cell,BP,
12721,GO:0046598,1,0.923364117421961,0,9,positive regulation of viral entry into host cell,BP,
12722,GO:0046599,1,0.933032654844243,0,15,regulation of centriole replication,BP,
12723,GO:0046600,1,0.977720935824955,0,6,negative regulation of centriole replication,BP,
12724,GO:0046601,1,0.988366408694953,0,3,positive regulation of centriole replication,BP,
12725,GO:0046602,1,0.949437473329719,0,9,regulation of mitotic centrosome separation,BP,
12726,GO:0046604,1,0.974911933851755,0,5,positive regulation of mitotic centrosome separation,BP,
12727,GO:0046605,1,0.770903057113098,0,47,regulation of centrosome cycle,BP,
12728,GO:0046606,1,0.952297612883267,0,10,negative regulation of centrosome cycle,BP,
12729,GO:0046607,1,0.953618920967065,0,11,positive regulation of centrosome cycle,BP,
12730,GO:0046618,1,0.97109703381796,0,5,drug export,BP,
12731,GO:0046619,1,0.994081841694676,0,2,optic placode formation involved in camera-type eye formation,BP,
12734,GO:0046622,1,0.789735828946196,0,44,positive regulation of organ growth,BP,
12735,GO:0046623,1,0.999751054145043,0,1,sphingolipid-translocating ATPase activity,MF,
12736,GO:0046624,1,0.97755055107044,0,5,sphingolipid transporter activity,MF,
12737,GO:0046625,1,0.897123039381392,0,14,sphingolipid binding,MF,
12738,GO:0046626,1,0.752795067357586,0,48,regulation of insulin receptor signaling pathway,BP,
12739,GO:0046627,1,0.828403020696538,0,30,negative regulation of insulin receptor signaling pathway,BP,
12740,GO:0046628,1,0.939463439492407,0,12,positive regulation of insulin receptor signaling pathway,BP,
12741,GO:0046629,1,0.938573555973703,0,13,gamma-delta T cell activation,BP,
12744,GO:0046633,1,0.827894291736466,0,26,alpha-beta T cell proliferation,BP,
12747,GO:0046636,1,0.81778184535035,0,27,negative regulation of alpha-beta T cell activation,BP,
12750,GO:0046639,1,0.882159114833124,0,18,negative regulation of alpha-beta T cell differentiation,BP,
12751,GO:0046640,1,0.838801077536964,0,23,regulation of alpha-beta T cell proliferation,BP,
12752,GO:0046641,1,0.854049414706474,0,19,positive regulation of alpha-beta T cell proliferation,BP,
12753,GO:0046642,1,0.962220507234832,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12754,GO:0046643,1,0.987193334508691,0,7,regulation of gamma-delta T cell activation,BP,
12755,GO:0046645,1,0.989899187724533,0,5,positive regulation of gamma-delta T cell activation,BP,
12758,GO:0046653,1,0.884485712661583,0,17,tetrahydrofolate metabolic process,BP,
12759,GO:0046654,1,0.965760603943597,0,6,tetrahydrofolate biosynthetic process,BP,
12760,GO:0046655,1,0.889015910727472,0,18,folic acid metabolic process,BP,
12761,GO:0046657,1,0.987285749860684,0,1,folic acid catabolic process,BP,
12762,GO:0046658,1,0.667296376268473,0,44,anchored component of plasma membrane,CC,
12765,GO:0046666,1,0.963232846374,0,4,retinal cell programmed cell death,BP,
12766,GO:0046668,1,0.986600772943992,0,2,regulation of retinal cell programmed cell death,BP,
12767,GO:0046671,1,0.997545316127058,0,1,negative regulation of retinal cell programmed cell death,BP,
12768,GO:0046676,1,0.793493131557045,0,36,negative regulation of insulin secretion,BP,
12770,GO:0046680,1,0.989720839770265,0,1,response to DDT,BP,
12772,GO:0046684,1,0.966372938891233,0,4,response to pyrethroid,BP,
12773,GO:0046685,1,0.800962304212751,0,29,response to arsenic-containing substance,BP,
12775,GO:0046687,1,0.98744914291305,0,1,response to chromate,BP,
12776,GO:0046688,1,0.816713651304783,0,25,response to copper ion,BP,
12777,GO:0046689,1,0.916010846184497,0,11,response to mercury ion,BP,
12778,GO:0046690,1,0.996052812655762,0,1,response to tellurium ion,BP,
12779,GO:0046691,1,0.993065589473214,0,1,intracellular canaliculus,CC,
12780,GO:0046692,1,0.987281694667972,0,1,sperm competition,BP,
12781,GO:0046696,1,0.960662147977261,0,6,lipopolysaccharide receptor complex,CC,
12782,GO:0046697,1,0.880248835964897,0,20,decidualization,BP,
12784,GO:0046703,1,0.903296954786187,0,9,natural killer cell lectin-like receptor binding,MF,
12785,GO:0046707,1,0.98810305725792,0,2,IDP metabolic process,BP,
12786,GO:0046709,1,0.98810305725792,0,2,IDP catabolic process,BP,
12787,GO:0046710,1,0.953543243956255,0,14,GDP metabolic process,BP,
12788,GO:0046711,1,0.987358580697023,0,1,GDP biosynthetic process,BP,
12789,GO:0046712,1,0.988071294918011,0,1,GDP catabolic process,BP,
12790,GO:0046713,1,0.994310605605121,0,1,borate transport,BP,
12791,GO:0046715,1,0.994310605605121,0,1,borate transmembrane transporter activity,MF,
12792,GO:0046716,1,0.897171661454993,0,17,muscle cell cellular homeostasis,BP,
12794,GO:0046718,1,0.512575303323164,0,109,viral entry into host cell,BP,
12795,GO:0046719,1,0.953981355011016,0,9,regulation by virus of viral protein levels in host cell,BP,
12796,GO:0046724,1,0.980439662421522,0,2,oxalic acid secretion,BP,
12797,GO:0046725,1,0.996437854493469,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12798,GO:0046726,1,0.994439396803401,0,3,positive regulation by virus of viral protein levels in host cell,BP,
12799,GO:0046730,1,0.978254710179525,0,2,induction of host immune response by virus,BP,
12800,GO:0046732,1,0.978254710179525,0,2,active induction of host immune response by virus,BP,
12801,GO:0046745,1,0.991657600429728,0,1,viral capsid secondary envelopment,BP,
12802,GO:0046755,1,0.813866333269997,0,24,viral budding,BP,
12803,GO:0046777,1,0.355251908711651,0,230,protein autophosphorylation,BP,
12804,GO:0046778,1,0.982919213225903,0,2,modification by virus of host mRNA processing,BP,
12805,GO:0046782,1,0.615098071851457,0,64,regulation of viral transcription,BP,
12806,GO:0046784,1,0.930993755063276,0,8,viral mRNA export from host cell nucleus,BP,
12807,GO:0046785,1,0.718448561198012,0,56,microtubule polymerization,BP,
12808,GO:0046786,1,0.999763876618055,0,1,viral replication complex formation and maintenance,BP,
12809,GO:0046789,1,0.994717449770596,0,1,host cell surface receptor binding,MF,
12810,GO:0046790,1,0.937045413683603,0,8,virion binding,MF,
12811,GO:0046794,1,0.657053185565396,0,68,transport of virus,BP,
12812,GO:0046811,1,0.987178096050506,0,2,histone deacetylase inhibitor activity,MF,
12813,GO:0046812,1,0.994717449770596,0,1,host cell surface binding,MF,
12814,GO:0046813,1,0.970914773938455,0,5,receptor-mediated virion attachment to host cell,BP,
12815,GO:0046817,1,0.987593738746098,0,1,chemokine receptor antagonist activity,MF,
12817,GO:0046823,1,0.627201483173966,0,73,negative regulation of nucleocytoplasmic transport,BP,
12818,GO:0046824,1,0.52640885682633,0,114,positive regulation of nucleocytoplasmic transport,BP,
12820,GO:0046826,1,0.947946619599749,0,7,negative regulation of protein export from nucleus,BP,
12821,GO:0046827,1,0.887768923421071,0,20,positive regulation of protein export from nucleus,BP,
12822,GO:0046831,1,0.955444536479742,0,11,regulation of RNA export from nucleus,BP,
12823,GO:0046832,1,0.999999588680931,0,2,negative regulation of RNA export from nucleus,BP,
12824,GO:0046833,1,0.976372088696866,0,3,positive regulation of RNA export from nucleus,BP,
12826,GO:0046835,1,0.894793532997118,0,21,carbohydrate phosphorylation,BP,
12827,GO:0046836,1,0.948679385546526,0,6,glycolipid transport,BP,
12828,GO:0046838,1,0.961923813085178,0,10,phosphorylated carbohydrate dephosphorylation,BP,
12829,GO:0046839,1,0.911470989661847,0,25,phospholipid dephosphorylation,BP,
12830,GO:0046847,1,0.819168102622874,0,51,filopodium assembly,BP,
12831,GO:0046848,1,0.962061303888868,0,3,hydroxyapatite binding,MF,
12834,GO:0046851,1,0.911549552698883,0,14,negative regulation of bone remodeling,BP,
12835,GO:0046852,1,0.914427773148315,0,13,positive regulation of bone remodeling,BP,
12837,GO:0046855,1,0.967524028011593,0,9,inositol phosphate dephosphorylation,BP,
12838,GO:0046856,1,0.92053087541018,0,24,phosphatidylinositol dephosphorylation,BP,
12841,GO:0046870,1,0.955187163460604,0,6,cadmium ion binding,MF,
12844,GO:0046874,1,0.95216453208209,0,5,quinolinate metabolic process,BP,
12845,GO:0046875,1,0.873577960728168,0,25,ephrin receptor binding,MF,
12846,GO:0046877,1,0.927522608800948,0,8,regulation of saliva secretion,BP,
12847,GO:0046878,1,0.962710466467282,0,4,positive regulation of saliva secretion,BP,
12849,GO:0046880,1,0.962276301353736,0,6,regulation of follicle-stimulating hormone secretion,BP,
12850,GO:0046881,1,0.962276301353736,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12851,GO:0046882,1,0.97285823472827,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12853,GO:0046884,1,0.961908585361097,0,7,follicle-stimulating hormone secretion,BP,
12854,GO:0046885,1,0.930867455399064,0,17,regulation of hormone biosynthetic process,BP,
12855,GO:0046886,1,0.970107578427581,0,8,positive regulation of hormone biosynthetic process,BP,
12857,GO:0046888,1,0.645247844138654,0,63,negative regulation of hormone secretion,BP,
12860,GO:0046898,1,0.973209443754466,0,4,response to cycloheximide,BP,
12861,GO:0046899,1,0.983756362051903,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12862,GO:0046900,1,0.991348857151105,0,1,tetrahydrofolylpolyglutamate metabolic process,BP,
12863,GO:0046901,1,0.991348857151105,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12866,GO:0046904,1,0.987913031917531,0,1,calcium oxalate binding,MF,
12869,GO:0046909,1,0.991986613004594,0,1,intermembrane transport,BP,
12870,GO:0046911,1,0.987537367367283,0,1,metal chelating activity,MF,
12871,GO:0046912,1,0.979833987987455,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12875,GO:0046920,1,0.951494546499842,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12876,GO:0046921,1,0.995148460683886,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12877,GO:0046922,1,0.989649407380356,0,2,peptide-O-fucosyltransferase activity,MF,
12878,GO:0046923,1,0.959948533953252,0,4,ER retention sequence binding,MF,
12879,GO:0046928,1,0.76033127699072,0,51,regulation of neurotransmitter secretion,BP,
12880,GO:0046929,1,0.945679829557088,0,11,negative regulation of neurotransmitter secretion,BP,
12881,GO:0046930,1,0.871282879831886,0,17,pore complex,CC,
12882,GO:0046931,1,0.918485236416913,0,15,pore complex assembly,BP,
12883,GO:0046933,1,0.826166709892656,0,16,proton-transporting ATP synthase activity, rotational mechanism,MF,
12885,GO:0046935,1,0.981060073817215,0,6,1-phosphatidylinositol-3-kinase regulator activity,MF,
12886,GO:0046939,1,0.518627726179772,0,88,nucleotide phosphorylation,BP,
12887,GO:0046940,1,0.972442747291369,0,3,nucleoside monophosphate phosphorylation,BP,
12890,GO:0046946,1,0.985790013588227,0,3,hydroxylysine metabolic process,BP,
12891,GO:0046947,1,0.985790013588227,0,3,hydroxylysine biosynthetic process,BP,
12896,GO:0046958,1,0.9811841405027,0,6,nonassociative learning,BP,
12897,GO:0046959,1,0.995194237229234,0,4,habituation,BP,
12898,GO:0046960,1,0.986390643561007,0,2,sensitization,BP,
12899,GO:0046961,1,0.856966101105366,0,19,proton-transporting ATPase activity, rotational mechanism,MF,
12900,GO:0046963,1,0.979278681465154,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12901,GO:0046964,1,0.979278681465154,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12902,GO:0046965,1,0.921071003098966,0,15,retinoid X receptor binding,MF,
12903,GO:0046966,1,0.856289065462279,0,27,thyroid hormone receptor binding,MF,
12904,GO:0046967,1,0.991709033999871,0,2,cytosol to ER transport,BP,
12905,GO:0046968,1,0.98575932438297,0,3,peptide antigen transport,BP,
12906,GO:0046969,1,0.985896747429166,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12907,GO:0046970,1,0.989218981406881,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12908,GO:0046972,1,0.950891478793419,0,9,histone acetyltransferase activity (H4-K16 specific),MF,
12909,GO:0046974,1,0.982159359090493,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12910,GO:0046975,1,0.968749557353007,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12911,GO:0046976,1,0.987538715296345,0,3,histone methyltransferase activity (H3-K27 specific),MF,
12912,GO:0046977,1,0.975700244535819,0,4,TAP binding,MF,
12913,GO:0046978,1,0.975700244535819,0,4,TAP1 binding,MF,
12914,GO:0046979,1,0.97749798372373,0,3,TAP2 binding,MF,
12915,GO:0046980,1,0.998161212044196,0,1,tapasin binding,MF,
12918,GO:0046984,1,0.970957346369716,0,4,regulation of hemoglobin biosynthetic process,BP,
12919,GO:0046985,1,0.971715786359929,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12920,GO:0046986,1,0.999219666370847,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12922,GO:0047006,1,0.975874189429574,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12923,GO:0047012,1,0.988245313455576,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12925,GO:0047016,1,0.990082613397751,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12926,GO:0047017,1,0.979355269651954,0,2,prostaglandin-F synthase activity,MF,
12927,GO:0047020,1,0.987594992920963,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12928,GO:0047021,1,0.987616670252174,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12929,GO:0047023,1,0.963425297652054,0,3,androsterone dehydrogenase activity,MF,
12930,GO:0047025,1,0.983320162930448,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12932,GO:0047042,1,0.98782038483178,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12934,GO:0047057,1,0.974977891951901,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12935,GO:0047066,1,0.987322398686695,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12936,GO:0047086,1,0.96387724550145,0,3,ketosteroid monooxygenase activity,MF,
12937,GO:0047105,1,0.991415393511459,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12938,GO:0047115,1,0.951765643835436,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12939,GO:0047117,1,0.999999996387332,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12940,GO:0047127,1,0.987806514792733,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12941,GO:0047130,1,0.999999996371891,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12942,GO:0047131,1,0.999999996371891,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12943,GO:0047134,1,0.928037155087892,0,7,protein-disulfide reductase activity,MF,
12944,GO:0047144,1,0.959250324413398,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12945,GO:0047150,1,0.991397617992745,0,1,betaine-homocysteine S-methyltransferase activity,MF,
12946,GO:0047159,1,0.997919750615008,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12947,GO:0047166,1,0.989117856463236,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12948,GO:0047173,1,0.999742809095682,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12949,GO:0047179,1,0.975140406915434,0,2,platelet-activating factor acetyltransferase activity,MF,
12950,GO:0047184,1,0.966906852796804,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12951,GO:0047191,1,0.997919750615008,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12952,GO:0047192,1,0.987037073617774,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12953,GO:0047196,1,0.977826784221326,0,2,long-chain-alcohol O-fatty-acyltransferase activity,MF,
12954,GO:0047198,1,0.987426005800229,0,1,cysteine-S-conjugate N-acetyltransferase activity,MF,
12955,GO:0047220,1,0.992710220435024,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12956,GO:0047223,1,0.976952034522147,0,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12957,GO:0047224,1,0.991357709386186,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12958,GO:0047225,1,0.99020765436424,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
12959,GO:0047237,1,0.988149548962127,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12960,GO:0047238,1,0.984198309497732,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12961,GO:0047256,1,0.998428334772665,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12962,GO:0047263,1,0.993271224147252,0,1,N-acylsphingosine galactosyltransferase activity,MF,
12963,GO:0047273,1,0.99527167571663,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12964,GO:0047275,1,0.98634989390901,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12965,GO:0047277,1,0.989225592956745,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12966,GO:0047280,1,0.999401564418406,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12967,GO:0047288,1,0.976973897868318,0,2,monosialoganglioside sialyltransferase activity,MF,
12968,GO:0047290,1,0.988355605903273,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12969,GO:0047291,1,0.990574549295068,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12970,GO:0047293,1,0.988341134162893,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12971,GO:0047298,1,0.999768569133436,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12972,GO:0047305,1,0.990334806597043,0,1,(R)-3-amino-2-methylpropionate-pyruvate transaminase activity,MF,
12973,GO:0047322,1,0.999888455158162,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12974,GO:0047323,1,0.98987282949776,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12975,GO:0047325,1,0.994986386930573,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12976,GO:0047326,1,0.988745589333162,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12977,GO:0047341,1,0.995779931099641,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12978,GO:0047372,1,0.933472915855404,0,10,acylglycerol lipase activity,MF,
12979,GO:0047374,1,0.974995477703112,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12980,GO:0047389,1,0.994632528469244,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12981,GO:0047390,1,0.997869181379137,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12982,GO:0047391,1,0.989216707424037,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
12983,GO:0047394,1,0.990284890830125,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12984,GO:0047395,1,0.993433878982438,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12985,GO:0047408,1,0.988616402284682,0,1,alkenylglycerophosphocholine hydrolase activity,MF,
12986,GO:0047409,1,0.988616402284682,0,1,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12987,GO:0047429,1,0.927281554355131,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12989,GO:0047444,1,0.987612795703566,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12990,GO:0047451,1,0.999999996387332,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12991,GO:0047464,1,0.999852729768039,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12992,GO:0047484,1,0.952568208808535,0,9,regulation of response to osmotic stress,BP,
12993,GO:0047485,1,0.478567650028633,0,106,protein N-terminus binding,MF,
12994,GO:0047493,1,0.985281119118618,0,3,ceramide cholinephosphotransferase activity,MF,
12995,GO:0047496,1,0.826740237198546,0,36,vesicle transport along microtubule,BP,
12996,GO:0047497,1,0.931344812358566,0,17,mitochondrion transport along microtubule,BP,
12997,GO:0047498,1,0.938769399386386,0,8,calcium-dependent phospholipase A2 activity,MF,
12998,GO:0047499,1,0.952825453722455,0,6,calcium-independent phospholipase A2 activity,MF,
12999,GO:0047522,1,0.979355624086171,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
13000,GO:0047536,1,0.990229360297411,0,1,2-aminoadipate transaminase activity,MF,
13001,GO:0047545,1,0.999999996373196,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
13002,GO:0047555,1,0.937101568604639,0,14,3',5'-cyclic-GMP phosphodiesterase activity,MF,
13003,GO:0047560,1,0.999926518949191,0,1,3-dehydrosphinganine reductase activity,MF,
13005,GO:0047617,1,0.850276654262681,0,17,acyl-CoA hydrolase activity,MF,
13006,GO:0047620,1,0.993433878982438,0,1,acylglycerol kinase activity,MF,
13007,GO:0047621,1,0.988437274027011,0,1,acylpyruvate hydrolase activity,MF,
13008,GO:0047623,1,0.987159286436432,0,3,adenosine-phosphate deaminase activity,MF,
13009,GO:0047631,1,0.955363799160078,0,4,ADP-ribose diphosphatase activity,MF,
13010,GO:0047635,1,0.986876387876045,0,2,alanine-oxo-acid transaminase activity,MF,
13011,GO:0047638,1,0.992662520819034,0,1,albendazole monooxygenase activity,MF,
13012,GO:0047658,1,0.98848070233315,0,1,alpha-amino-acid esterase activity,MF,
13013,GO:0047661,1,0.991300277190173,0,1,amino-acid racemase activity,MF,
13014,GO:0047676,1,0.999922281754478,0,1,arachidonate-CoA ligase activity,MF,
13015,GO:0047685,1,0.988046191531106,0,1,amine sulfotransferase activity,MF,
13016,GO:0047693,1,0.987207770502897,0,1,ATP diphosphatase activity,MF,
13017,GO:0047696,1,0.985292779427642,0,2,beta-adrenergic receptor kinase activity,MF,
13018,GO:0047704,1,0.989356594816964,0,1,bile-salt sulfotransferase activity,MF,
13019,GO:0047708,1,0.977274883855407,0,2,biotinidase activity,MF,
13020,GO:0047710,1,0.986975885679985,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
13021,GO:0047714,1,0.988015696663845,0,1,galactolipase activity,MF,
13022,GO:0047718,1,0.964095588859087,0,3,indanol dehydrogenase activity,MF,
13023,GO:0047726,1,0.991428740525173,0,1,iron-cytochrome-c reductase activity,MF,
13024,GO:0047730,1,0.997936442410314,0,1,carnosine synthase activity,MF,
13025,GO:0047734,1,0.991657600429728,0,1,CDP-glycerol diphosphatase activity,MF,
13026,GO:0047743,1,0.987558366229859,0,1,chlordecone reductase activity,MF,
13027,GO:0047747,1,0.990825037147251,0,1,cholate-CoA ligase activity,MF,
13029,GO:0047751,1,0.973870566324442,0,3,cholestenone 5-alpha-reductase activity,MF,
13030,GO:0047756,1,0.968843275302818,0,4,chondroitin 4-sulfotransferase activity,MF,
13031,GO:0047757,1,0.998139493323211,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
13033,GO:0047783,1,0.989322135366931,0,2,corticosterone 18-monooxygenase activity,MF,
13034,GO:0047787,1,0.97997427129794,0,2,delta4-3-oxosteroid 5beta-reductase activity,MF,
13035,GO:0047800,1,0.99705382047779,0,1,cysteamine dioxygenase activity,MF,
13036,GO:0047801,1,0.989865326735127,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
13037,GO:0047837,1,0.987438132381701,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
13038,GO:0047840,1,0.987470452549771,0,1,dCTP diphosphatase activity,MF,
13039,GO:0047844,1,0.965270688273355,0,3,deoxycytidine deaminase activity,MF,
13040,GO:0047856,1,0.987554816056891,0,1,dihydrocoumarin hydrolase activity,MF,
13042,GO:0047865,1,0.994198725216833,0,1,dimethylglycine dehydrogenase activity,MF,
13043,GO:0047874,1,0.989801917807757,0,1,dolichyldiphosphatase activity,MF,
13044,GO:0047888,1,0.989228902667284,0,1,fatty acid peroxidase activity,MF,
13045,GO:0047894,1,0.964323537548561,0,3,flavonol 3-sulfotransferase activity,MF,
13046,GO:0047915,1,0.988442335711196,0,1,ganglioside galactosyltransferase activity,MF,
13047,GO:0047933,1,0.999999996387406,0,1,glucose-1,6-bisphosphate synthase activity,MF,
13048,GO:0047936,1,0.999999996390747,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
13049,GO:0047939,1,0.987983996453764,0,1,L-glucuronate reductase activity,MF,
13050,GO:0047946,1,0.98964449787295,0,1,glutamine N-acyltransferase activity,MF,
13051,GO:0047961,1,0.956292851447335,0,4,glycine N-acyltransferase activity,MF,
13052,GO:0047962,1,0.988243042541061,0,1,glycine N-benzoyltransferase activity,MF,
13053,GO:0047963,1,0.995782227266356,0,1,glycine N-choloyltransferase activity,MF,
13054,GO:0047969,1,0.988619143020241,0,1,glyoxylate oxidase activity,MF,
13055,GO:0047977,1,0.983116426281465,0,2,hepoxilin-epoxide hydrolase activity,MF,
13056,GO:0047982,1,0.988606833667475,0,1,homocysteine desulfhydrase activity,MF,
13057,GO:0047988,1,0.989073031274248,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
13059,GO:0048003,1,0.954404395342335,0,7,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
13060,GO:0048006,1,0.997306008372406,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
13061,GO:0048007,1,0.954404395342335,0,7,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
13062,GO:0048008,1,0.840568305337704,0,47,platelet-derived growth factor receptor signaling pathway,BP,
13065,GO:0048011,1,0.859284686829194,0,26,neurotrophin TRK receptor signaling pathway,BP,
13066,GO:0048012,1,0.898156962139407,0,16,hepatocyte growth factor receptor signaling pathway,BP,
13067,GO:0048013,1,0.621363547403515,0,87,ephrin receptor signaling pathway,BP,
13068,GO:0048014,1,0.998556468822646,0,3,Tie signaling pathway,BP,
13070,GO:0048016,1,0.82992608026945,0,35,inositol phosphate-mediated signaling,BP,
13072,GO:0048018,1,0.837617867845716,0,21,receptor agonist activity,MF,
13073,GO:0048019,1,0.911049628209908,0,10,receptor antagonist activity,MF,
13075,GO:0048021,1,0.967817048026787,0,7,regulation of melanin biosynthetic process,BP,
13076,GO:0048022,1,0.988291378458569,0,3,negative regulation of melanin biosynthetic process,BP,
13077,GO:0048023,1,0.979285027777385,0,4,positive regulation of melanin biosynthetic process,BP,
13078,GO:0048024,1,0.632126019962368,0,68,regulation of mRNA splicing, via spliceosome,BP,
13079,GO:0048025,1,0.862826760860789,0,20,negative regulation of mRNA splicing, via spliceosome,BP,
13080,GO:0048026,1,0.895081840162093,0,15,positive regulation of mRNA splicing, via spliceosome,BP,
13081,GO:0048027,1,0.862779974496155,0,21,mRNA 5'-UTR binding,MF,
13083,GO:0048030,1,0.956551076815032,0,4,disaccharide binding,MF,
13084,GO:0048033,1,0.993745496893616,0,1,heme o metabolic process,BP,
13085,GO:0048034,1,0.993745496893616,0,1,heme O biosynthetic process,BP,
13089,GO:0048040,1,0.989728164273725,0,1,UDP-glucuronate decarboxylase activity,MF,
13090,GO:0048041,1,0.783784493064519,0,69,focal adhesion assembly,BP,
13091,GO:0048048,1,0.87392412960148,0,32,embryonic eye morphogenesis,BP,
13092,GO:0048050,1,0.946114425743934,0,6,post-embryonic eye morphogenesis,BP,
13093,GO:0048058,1,0.995278763637129,0,1,compound eye corneal lens development,BP,
13094,GO:0048066,1,0.771155300995576,0,45,developmental pigmentation,BP,
13095,GO:0048069,1,0.95663181027706,0,8,eye pigmentation,BP,
13096,GO:0048070,1,0.929835947809974,0,16,regulation of developmental pigmentation,BP,
13097,GO:0048073,1,0.997907808063972,0,2,regulation of eye pigmentation,BP,
13098,GO:0048075,1,0.99890454383289,0,1,positive regulation of eye pigmentation,BP,
13099,GO:0048087,1,0.967374396404011,0,9,positive regulation of developmental pigmentation,BP,
13100,GO:0048096,1,0.960491276687364,0,9,chromatin-mediated maintenance of transcription,BP,
13101,GO:0048101,1,0.985542017710592,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
13102,GO:0048102,1,0.958973518359497,0,6,autophagic cell death,BP,
13103,GO:0048103,1,0.920417737069656,0,22,somatic stem cell division,BP,
13104,GO:0048104,1,0.996745761718799,0,4,establishment of body hair or bristle planar orientation,BP,
13105,GO:0048105,1,0.996745761718799,0,4,establishment of body hair planar orientation,BP,
13106,GO:0048133,1,0.964317854368054,0,4,male germ-line stem cell asymmetric division,BP,
13107,GO:0048137,1,0.991657600429728,0,1,spermatocyte division,BP,
13108,GO:0048143,1,0.969839226496858,0,5,astrocyte activation,BP,
13111,GO:0048146,1,0.695645004955336,0,51,positive regulation of fibroblast proliferation,BP,
13114,GO:0048149,1,0.883810920234637,0,14,behavioral response to ethanol,BP,
13116,GO:0048160,1,0.999462304024685,0,1,primary follicle stage,BP,
13117,GO:0048162,1,0.968772216289383,0,3,multi-layer follicle stage,BP,
13118,GO:0048165,1,0.999457075097585,0,2,fused antrum stage,BP,
13121,GO:0048169,1,0.904890078386022,0,22,regulation of long-term neuronal synaptic plasticity,BP,
13122,GO:0048170,1,0.990096352618581,0,4,positive regulation of long-term neuronal synaptic plasticity,BP,
13123,GO:0048172,1,0.956452161082959,0,14,regulation of short-term neuronal synaptic plasticity,BP,
13124,GO:0048174,1,0.99835484977967,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
13125,GO:0048175,1,0.994717449770596,0,1,hepatocyte growth factor biosynthetic process,BP,
13126,GO:0048176,1,0.994717449770596,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
13127,GO:0048178,1,0.994717449770596,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
13128,GO:0048179,1,0.982345028503736,0,3,activin receptor complex,CC,
13129,GO:0048180,1,0.990020905945555,0,1,activin complex,CC,
13130,GO:0048185,1,0.937803111776011,0,12,activin binding,MF,
13131,GO:0048188,1,0.929958036910107,0,13,Set1C/COMPASS complex,CC,
13133,GO:0048194,1,0.963185210089982,0,9,Golgi vesicle budding,BP,
13134,GO:0048199,1,0.673752241861421,0,67,vesicle targeting, to, from or within Golgi,BP,
13135,GO:0048200,1,0.976308669229636,0,4,Golgi transport vesicle coating,BP,
13136,GO:0048203,1,0.982311367547995,0,2,vesicle targeting, trans-Golgi to endosome,BP,
13137,GO:0048205,1,0.976308669229636,0,4,COPI coating of Golgi vesicle,BP,
13138,GO:0048207,1,0.694440065454838,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
13139,GO:0048208,1,0.694440065454838,0,62,COPII vesicle coating,BP,
13140,GO:0048209,1,0.989942221493366,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
13141,GO:0048210,1,0.97893030698552,0,2,Golgi vesicle fusion to target membrane,BP,
13142,GO:0048211,1,0.99754347664701,0,1,Golgi vesicle docking,BP,
13143,GO:0048213,1,0.981664414261262,0,2,Golgi vesicle prefusion complex stabilization,BP,
13144,GO:0048227,1,0.949275842847705,0,8,plasma membrane to endosome transport,BP,
13146,GO:0048237,1,0.966734144547506,0,3,rough endoplasmic reticulum lumen,CC,
13147,GO:0048239,1,0.983128113663102,0,2,negative regulation of DNA recombination at telomere,BP,
13148,GO:0048240,1,0.829976424059436,0,21,sperm capacitation,BP,
13149,GO:0048241,1,0.946900770994448,0,6,epinephrine transport,BP,
13150,GO:0048242,1,0.957513283573652,0,5,epinephrine secretion,BP,
13151,GO:0048243,1,0.888226717734043,0,16,norepinephrine secretion,BP,
13153,GO:0048245,1,0.887329695099643,0,11,eosinophil chemotaxis,BP,
13154,GO:0048246,1,0.773968420714656,0,29,macrophage chemotaxis,BP,
13155,GO:0048247,1,0.563088263890018,0,56,lymphocyte chemotaxis,BP,
13156,GO:0048248,1,0.943152383479863,0,5,CXCR3 chemokine receptor binding,MF,
13157,GO:0048250,1,0.97722197275327,0,2,mitochondrial iron ion transport,BP,
13158,GO:0048251,1,0.973213904714631,0,7,elastic fiber assembly,BP,
13159,GO:0048254,1,0.964872731286807,0,4,snoRNA localization,BP,
13160,GO:0048255,1,0.866538432281663,0,28,mRNA stabilization,BP,
13161,GO:0048256,1,0.943215452000247,0,8,flap endonuclease activity,MF,
13162,GO:0048257,1,0.982723419973354,0,2,3'-flap endonuclease activity,MF,
13164,GO:0048260,1,0.773046589300279,0,45,positive regulation of receptor-mediated endocytosis,BP,
13166,GO:0048262,1,0.935763803594303,0,9,determination of dorsal/ventral asymmetry,BP,
13167,GO:0048263,1,0.941614609676453,0,8,determination of dorsal identity,BP,
13168,GO:0048264,1,0.993789369049204,0,1,determination of ventral identity,BP,
13169,GO:0048265,1,0.831158100691192,0,30,response to pain,BP,
13170,GO:0048266,1,0.930144295360371,0,14,behavioral response to pain,BP,
13171,GO:0048268,1,0.932505831629701,0,16,clathrin coat assembly,BP,
13172,GO:0048269,1,0.982651333356102,0,2,methionine adenosyltransferase complex,CC,
13173,GO:0048270,1,0.989700745450554,0,1,methionine adenosyltransferase regulator activity,MF,
13174,GO:0048273,1,0.977746974370975,0,5,mitogen-activated protein kinase p38 binding,MF,
13175,GO:0048278,1,0.693277327564906,0,62,vesicle docking,BP,
13176,GO:0048280,1,0.924269365374207,0,10,vesicle fusion with Golgi apparatus,BP,
13178,GO:0048285,1,0.0212066525932676,0,599,organelle fission,BP,
13179,GO:0048286,1,0.841244781787025,0,36,lung alveolus development,BP,
13180,GO:0048289,1,0.954520481406018,0,7,isotype switching to IgE isotypes,BP,
13181,GO:0048290,1,0.952369728232767,0,6,isotype switching to IgA isotypes,BP,
13182,GO:0048291,1,0.899950296200167,0,14,isotype switching to IgG isotypes,BP,
13183,GO:0048293,1,0.954520481406018,0,7,regulation of isotype switching to IgE isotypes,BP,
13184,GO:0048294,1,0.983578680710566,0,3,negative regulation of isotype switching to IgE isotypes,BP,
13185,GO:0048295,1,0.970460488139224,0,4,positive regulation of isotype switching to IgE isotypes,BP,
13186,GO:0048296,1,0.95677123091632,0,5,regulation of isotype switching to IgA isotypes,BP,
13187,GO:0048297,1,0.989880341231416,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13188,GO:0048298,1,0.966555061857177,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13189,GO:0048302,1,0.90849727495435,0,13,regulation of isotype switching to IgG isotypes,BP,
13190,GO:0048304,1,0.924823857009008,0,10,positive regulation of isotype switching to IgG isotypes,BP,
13193,GO:0048308,1,0.898287299038862,0,14,organelle inheritance,BP,
13194,GO:0048311,1,0.959840696480097,0,13,mitochondrion distribution,BP,
13195,GO:0048312,1,0.972802631340156,0,8,intracellular distribution of mitochondria,BP,
13196,GO:0048313,1,0.898287299038862,0,14,Golgi inheritance,BP,
13197,GO:0048318,1,0.942586722180541,0,8,axial mesoderm development,BP,
13198,GO:0048319,1,0.983368309687846,0,4,axial mesoderm morphogenesis,BP,
13199,GO:0048320,1,0.98336831658557,0,3,axial mesoderm formation,BP,
13200,GO:0048321,1,0.989695277448999,0,1,axial mesodermal cell differentiation,BP,
13201,GO:0048322,1,0.989695277448999,0,1,axial mesodermal cell fate commitment,BP,
13202,GO:0048327,1,0.989695277448999,0,1,axial mesodermal cell fate specification,BP,
13203,GO:0048332,1,0.671729248215306,0,70,mesoderm morphogenesis,BP,
13204,GO:0048333,1,0.828813424066433,0,32,mesodermal cell differentiation,BP,
13205,GO:0048337,1,0.993409576390941,0,1,positive regulation of mesodermal cell fate specification,BP,
13206,GO:0048338,1,0.996656886905039,0,1,mesoderm structural organization,BP,
13207,GO:0048339,1,0.914401089685023,0,18,paraxial mesoderm development,BP,
13208,GO:0048340,1,0.95382289274243,0,10,paraxial mesoderm morphogenesis,BP,
13209,GO:0048341,1,0.95702347443361,0,7,paraxial mesoderm formation,BP,
13210,GO:0048342,1,0.981909938868129,0,2,paraxial mesodermal cell differentiation,BP,
13211,GO:0048343,1,0.981909938868129,0,2,paraxial mesodermal cell fate commitment,BP,
13212,GO:0048352,1,0.996656886905039,0,1,paraxial mesoderm structural organization,BP,
13213,GO:0048364,1,0.987233076566383,0,1,root development,BP,
13214,GO:0048365,1,0.836380835281932,0,44,Rac GTPase binding,MF,
13215,GO:0048368,1,0.889838278050484,0,15,lateral mesoderm development,BP,
13216,GO:0048369,1,0.976711845056481,0,4,lateral mesoderm morphogenesis,BP,
13217,GO:0048370,1,0.976711845056481,0,4,lateral mesoderm formation,BP,
13218,GO:0048371,1,0.988331573178994,0,3,lateral mesodermal cell differentiation,BP,
13219,GO:0048372,1,0.996655305476511,0,2,lateral mesodermal cell fate commitment,BP,
13220,GO:0048377,1,0.996655305476511,0,2,lateral mesodermal cell fate specification,BP,
13221,GO:0048378,1,0.996655305476511,0,2,regulation of lateral mesodermal cell fate specification,BP,
13222,GO:0048382,1,0.967957003011069,0,4,mesendoderm development,BP,
13223,GO:0048384,1,0.803665514832659,0,30,retinoic acid receptor signaling pathway,BP,
13224,GO:0048385,1,0.885729680432216,0,16,regulation of retinoic acid receptor signaling pathway,BP,
13225,GO:0048386,1,0.977401892205885,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13226,GO:0048387,1,0.937256675350709,0,10,negative regulation of retinoic acid receptor signaling pathway,BP,
13227,GO:0048388,1,0.975164667668063,0,3,endosomal lumen acidification,BP,
13228,GO:0048389,1,0.977875052733733,0,2,intermediate mesoderm development,BP,
13229,GO:0048390,1,0.988714122281553,0,1,intermediate mesoderm morphogenesis,BP,
13230,GO:0048391,1,0.988714122281553,0,1,intermediate mesoderm formation,BP,
13231,GO:0048392,1,0.988714122281553,0,1,intermediate mesodermal cell differentiation,BP,
13232,GO:0048403,1,0.997671657441792,0,3,brain-derived neurotrophic factor binding,MF,
13233,GO:0048406,1,0.975675528028617,0,6,nerve growth factor binding,MF,
13234,GO:0048407,1,0.984469973384913,0,11,platelet-derived growth factor binding,MF,
13235,GO:0048408,1,0.974375401625616,0,3,epidermal growth factor binding,MF,
13239,GO:0048475,1,0.621368330197572,0,91,coated membrane,CC,
13240,GO:0048476,1,0.949448268715441,0,5,Holliday junction resolvase complex,CC,
13242,GO:0048478,1,0.969420857297878,0,6,replication fork protection,BP,
13243,GO:0048483,1,0.779244342958117,0,43,autonomic nervous system development,BP,
13244,GO:0048484,1,0.944556478682636,0,11,enteric nervous system development,BP,
13245,GO:0048485,1,0.900634761907308,0,21,sympathetic nervous system development,BP,
13246,GO:0048486,1,0.879180407427963,0,18,parasympathetic nervous system development,BP,
13247,GO:0048487,1,0.78839454628876,0,34,beta-tubulin binding,MF,
13248,GO:0048488,1,0.887414780614433,0,31,synaptic vesicle endocytosis,BP,
13249,GO:0048489,1,0.538382642188012,0,125,synaptic vesicle transport,BP,
13250,GO:0048490,1,0.886389675539106,0,17,anterograde synaptic vesicle transport,BP,
13251,GO:0048495,1,0.98858515415542,0,5,Roundabout binding,MF,
13252,GO:0048496,1,0.989998061737356,0,4,maintenance of animal organ identity,BP,
13253,GO:0048499,1,0.990796648250764,0,2,synaptic vesicle membrane organization,BP,
13254,GO:0048500,1,0.921344593876348,0,9,signal recognition particle,CC,
13255,GO:0048505,1,0.92413357192253,0,11,regulation of timing of cell differentiation,BP,
13260,GO:0048515,1,0.368640391642465,0,130,spermatid differentiation,BP,
13263,GO:0048520,1,0.833099873794154,0,23,positive regulation of behavior,BP,
13264,GO:0048521,1,0.888044955848482,0,13,negative regulation of behavior,BP,
13267,GO:0048524,1,0.481512582285092,0,106,positive regulation of viral process,BP,
13269,GO:0048531,1,0.8847372795768,0,16,beta-1,3-galactosyltransferase activity,MF,
13270,GO:0048532,1,0.911633614770153,0,17,anatomical structure arrangement,BP,
13274,GO:0048537,1,0.949669517157714,0,7,mucosal-associated lymphoid tissue development,BP,
13276,GO:0048539,1,0.958385287578548,0,7,bone marrow development,BP,
13277,GO:0048541,1,0.949669517157714,0,7,Peyer's patch development,BP,
13279,GO:0048546,1,0.759423317251566,0,49,digestive tract morphogenesis,BP,
13280,GO:0048548,1,0.955555462351676,0,9,regulation of pinocytosis,BP,
13281,GO:0048549,1,0.987932571982888,0,4,positive regulation of pinocytosis,BP,
13282,GO:0048550,1,0.967230531147718,0,5,negative regulation of pinocytosis,BP,
13283,GO:0048557,1,0.879081048882099,0,18,embryonic digestive tract morphogenesis,BP,
13284,GO:0048560,1,0.980371449469979,0,2,establishment of anatomical structure orientation,BP,
13285,GO:0048561,1,0.990215540232811,0,1,establishment of animal organ orientation,BP,
13287,GO:0048563,1,0.945896079655051,0,8,post-embryonic animal organ morphogenesis,BP,
13288,GO:0048565,1,0.500404419333071,0,125,digestive tract development,BP,
13289,GO:0048566,1,0.796529986619146,0,33,embryonic digestive tract development,BP,
13290,GO:0048567,1,0.991648557536278,0,1,ectodermal digestive tract morphogenesis,BP,
13292,GO:0048569,1,0.921700298928489,0,15,post-embryonic animal organ development,BP,
13293,GO:0048570,1,0.952651669864912,0,10,notochord morphogenesis,BP,
13294,GO:0048571,1,0.987226748607661,0,1,long-day photoperiodism,BP,
13298,GO:0048588,1,0.436552466540128,0,182,developmental cell growth,BP,
13302,GO:0048596,1,0.925817422012914,0,23,embryonic camera-type eye morphogenesis,BP,
13303,GO:0048597,1,0.965446649818419,0,3,post-embryonic camera-type eye morphogenesis,BP,
13308,GO:0048611,1,0.985276769014505,0,2,embryonic ectodermal digestive tract development,BP,
13309,GO:0048613,1,0.991648557536278,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13310,GO:0048617,1,0.962601277998898,0,9,embryonic foregut morphogenesis,BP,
13311,GO:0048619,1,0.981094819215498,0,3,embryonic hindgut morphogenesis,BP,
13312,GO:0048621,1,0.989720839770265,0,1,post-embryonic digestive tract morphogenesis,BP,
13313,GO:0048625,1,0.968747101730193,0,5,myoblast fate commitment,BP,
13314,GO:0048627,1,0.982841995396683,0,2,myoblast development,BP,
13315,GO:0048630,1,0.955967374122024,0,8,skeletal muscle tissue growth,BP,
13316,GO:0048631,1,0.977265852983088,0,6,regulation of skeletal muscle tissue growth,BP,
13317,GO:0048632,1,0.992853806977732,0,2,negative regulation of skeletal muscle tissue growth,BP,
13318,GO:0048633,1,0.984300742033065,0,4,positive regulation of skeletal muscle tissue growth,BP,
13321,GO:0048636,1,0.718709045639742,0,63,positive regulation of muscle organ development,BP,
13327,GO:0048643,1,0.868981829737561,0,24,positive regulation of skeletal muscle tissue development,BP,
13328,GO:0048644,1,0.636073522063619,0,78,muscle organ morphogenesis,BP,
13329,GO:0048645,1,0.677522322510737,0,58,animal organ formation,BP,
13333,GO:0048661,1,0.649363386581314,0,72,positive regulation of smooth muscle cell proliferation,BP,
13335,GO:0048663,1,0.615665010052194,0,66,neuron fate commitment,BP,
13336,GO:0048664,1,0.904746234765796,0,10,neuron fate determination,BP,
13337,GO:0048665,1,0.780415928945792,0,30,neuron fate specification,BP,
13340,GO:0048668,1,0.905989022549709,0,24,collateral sprouting,BP,
13341,GO:0048669,1,0.977374304182762,0,5,collateral sprouting in absence of injury,BP,
13342,GO:0048670,1,0.917118737838002,0,18,regulation of collateral sprouting,BP,
13343,GO:0048671,1,0.969373025945042,0,9,negative regulation of collateral sprouting,BP,
13344,GO:0048672,1,0.946107758203404,0,9,positive regulation of collateral sprouting,BP,
13345,GO:0048673,1,0.988207130797825,0,1,collateral sprouting of intact axon in response to injury,BP,
13346,GO:0048675,1,0.671649847800963,0,99,axon extension,BP,
13347,GO:0048677,1,0.993062371443925,0,3,axon extension involved in regeneration,BP,
13348,GO:0048678,1,0.660179959263969,0,62,response to axon injury,BP,
13349,GO:0048679,1,0.879195773288124,0,22,regulation of axon regeneration,BP,
13350,GO:0048680,1,0.95067219360273,0,6,positive regulation of axon regeneration,BP,
13351,GO:0048681,1,0.939244461270046,0,12,negative regulation of axon regeneration,BP,
13352,GO:0048682,1,0.993062371443925,0,3,sprouting of injured axon,BP,
13353,GO:0048683,1,0.988207130797825,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13354,GO:0048685,1,0.988207130797825,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13355,GO:0048686,1,0.993062376444676,0,2,regulation of sprouting of injured axon,BP,
13356,GO:0048687,1,0.993133224664389,0,1,positive regulation of sprouting of injured axon,BP,
13357,GO:0048688,1,0.999928667197683,0,1,negative regulation of sprouting of injured axon,BP,
13358,GO:0048690,1,0.993062376444676,0,2,regulation of axon extension involved in regeneration,BP,
13359,GO:0048691,1,0.993133224664389,0,1,positive regulation of axon extension involved in regeneration,BP,
13360,GO:0048692,1,0.999928667197683,0,1,negative regulation of axon extension involved in regeneration,BP,
13361,GO:0048696,1,0.981326563155287,0,3,regulation of collateral sprouting in absence of injury,BP,
13362,GO:0048697,1,0.981513331388985,0,2,positive regulation of collateral sprouting in absence of injury,BP,
13363,GO:0048698,1,0.999809745834246,0,1,negative regulation of collateral sprouting in absence of injury,BP,
13365,GO:0048701,1,0.796504702013375,0,45,embryonic cranial skeleton morphogenesis,BP,
13366,GO:0048702,1,0.970407767401676,0,7,embryonic neurocranium morphogenesis,BP,
13367,GO:0048703,1,0.945816721516834,0,11,embryonic viscerocranium morphogenesis,BP,
13368,GO:0048704,1,0.55565225753089,0,93,embryonic skeletal system morphogenesis,BP,
13372,GO:0048709,1,0.566462640881011,0,82,oligodendrocyte differentiation,BP,
13373,GO:0048710,1,0.840867485586999,0,25,regulation of astrocyte differentiation,BP,
13374,GO:0048711,1,0.917348929600342,0,11,positive regulation of astrocyte differentiation,BP,
13375,GO:0048712,1,0.91668243774508,0,12,negative regulation of astrocyte differentiation,BP,
13376,GO:0048713,1,0.796850817369206,0,30,regulation of oligodendrocyte differentiation,BP,
13377,GO:0048714,1,0.885515677551985,0,16,positive regulation of oligodendrocyte differentiation,BP,
13378,GO:0048715,1,0.912932201801702,0,11,negative regulation of oligodendrocyte differentiation,BP,
13380,GO:0048730,1,0.822115878426436,0,29,epidermis morphogenesis,BP,
13383,GO:0048733,1,0.959599345405196,0,7,sebaceous gland development,BP,
13384,GO:0048736,1,0.431777655120627,0,164,appendage development,BP,
13386,GO:0048739,1,0.959356691668767,0,9,cardiac muscle fiber development,BP,
13387,GO:0048741,1,0.835023806940839,0,29,skeletal muscle fiber development,BP,
13388,GO:0048742,1,0.934032049691435,0,10,regulation of skeletal muscle fiber development,BP,
13389,GO:0048743,1,0.94405955927513,0,7,positive regulation of skeletal muscle fiber development,BP,
13390,GO:0048745,1,0.927394926067209,0,19,smooth muscle tissue development,BP,
13391,GO:0048747,1,0.746971802250404,0,50,muscle fiber development,BP,
13392,GO:0048749,1,0.993443970371584,0,2,compound eye development,BP,
13393,GO:0048752,1,0.96466040712618,0,7,semicircular canal morphogenesis,BP,
13394,GO:0048753,1,0.833598267749074,0,26,pigment granule organization,BP,
13395,GO:0048754,1,0.45636715838796,0,148,branching morphogenesis of an epithelial tube,BP,
13396,GO:0048755,1,0.965043004733132,0,9,branching morphogenesis of a nerve,BP,
13397,GO:0048757,1,0.929910760811144,0,10,pigment granule maturation,BP,
13398,GO:0048762,1,0.340384620592744,0,180,mesenchymal cell differentiation,BP,
13399,GO:0048763,1,0.999865005461802,0,4,calcium-induced calcium release activity,MF,
13400,GO:0048764,1,0.987233076566383,0,1,trichoblast maturation,BP,
13401,GO:0048765,1,0.987233076566383,0,1,root hair cell differentiation,BP,
13402,GO:0048767,1,0.987233076566383,0,1,root hair elongation,BP,
13403,GO:0048769,1,0.987335618985509,0,3,sarcomerogenesis,BP,
13404,GO:0048770,1,0.480417897617677,0,104,pigment granule,CC,
13406,GO:0048786,1,0.92455092083265,0,31,presynaptic active zone,CC,
13407,GO:0048787,1,0.986902358165275,0,4,presynaptic active zone membrane,CC,
13408,GO:0048788,1,0.999999992855778,0,2,cytoskeleton of presynaptic active zone,CC,
13409,GO:0048789,1,0.999770119379547,0,1,cytoskeletal matrix organization at active zone,BP,
13410,GO:0048790,1,0.988035290866311,0,1,maintenance of presynaptic active zone structure,BP,
13411,GO:0048791,1,0.896093854826691,0,30,calcium ion-regulated exocytosis of neurotransmitter,BP,
13412,GO:0048792,1,0.995821207450251,0,1,spontaneous exocytosis of neurotransmitter,BP,
13413,GO:0048793,1,0.965516989035943,0,8,pronephros development,BP,
13414,GO:0048799,1,0.915927146630126,0,21,animal organ maturation,BP,
13417,GO:0048808,1,0.970822253797106,0,4,male genitalia morphogenesis,BP,
13419,GO:0048813,1,0.66645774550983,0,118,dendrite morphogenesis,BP,
13420,GO:0048814,1,0.76909257860471,0,74,regulation of dendrite morphogenesis,BP,
13421,GO:0048817,1,0.998761532511519,0,2,negative regulation of hair follicle maturation,BP,
13422,GO:0048818,1,0.968059151489559,0,5,positive regulation of hair follicle maturation,BP,
13423,GO:0048819,1,0.96278305296297,0,8,regulation of hair follicle maturation,BP,
13424,GO:0048820,1,0.930672368814171,0,16,hair follicle maturation,BP,
13425,GO:0048821,1,0.863085179599524,0,23,erythrocyte development,BP,
13426,GO:0048822,1,0.989865321119265,0,2,enucleate erythrocyte development,BP,
13427,GO:0048839,1,0.359886189958008,0,175,inner ear development,BP,
13428,GO:0048840,1,0.981824731675408,0,5,otolith development,BP,
13429,GO:0048841,1,0.951090894808429,0,16,regulation of axon extension involved in axon guidance,BP,
13430,GO:0048842,1,0.976863362591742,0,7,positive regulation of axon extension involved in axon guidance,BP,
13431,GO:0048843,1,0.969343538791754,0,8,negative regulation of axon extension involved in axon guidance,BP,
13432,GO:0048844,1,0.762060907241701,0,57,artery morphogenesis,BP,
13433,GO:0048845,1,0.9519627664099,0,10,venous blood vessel morphogenesis,BP,
13434,GO:0048846,1,0.950501621395086,0,21,axon extension involved in axon guidance,BP,
13435,GO:0048850,1,0.987960486548036,0,3,hypophysis morphogenesis,BP,
13436,GO:0048852,1,0.978077867831571,0,4,diencephalon morphogenesis,BP,
13437,GO:0048853,1,0.908039179737827,0,14,forebrain morphogenesis,BP,
13438,GO:0048854,1,0.861053155468776,0,33,brain morphogenesis,BP,
13439,GO:0048855,1,0.999999996374891,0,1,adenohypophysis morphogenesis,BP,
13441,GO:0048857,1,0.668287373972778,0,62,neural nucleus development,BP,
13443,GO:0048859,1,0.953651512383088,0,5,formation of anatomical boundary,BP,
13444,GO:0048861,1,0.98098412020665,0,4,leukemia inhibitory factor signaling pathway,BP,
13445,GO:0048863,1,0.391207028797482,0,162,stem cell differentiation,BP,
13446,GO:0048864,1,0.686024082400629,0,62,stem cell development,BP,
13447,GO:0048865,1,0.925541663476593,0,8,stem cell fate commitment,BP,
13448,GO:0048866,1,0.967120627141314,0,3,stem cell fate specification,BP,
13449,GO:0048867,1,0.969382219925728,0,3,stem cell fate determination,BP,
13454,GO:0048873,1,0.80706323343896,0,30,homeostasis of number of cells within a tissue,BP,
13455,GO:0048874,1,0.995105658528154,0,1,homeostasis of number of cells in a free-living population,BP,
13456,GO:0048875,1,0.946434554814006,0,9,chemical homeostasis within a tissue,BP,
13458,GO:0048880,1,0.98372263903083,0,4,sensory system development,BP,
13459,GO:0048892,1,0.993877124963719,0,1,lateral line nerve development,BP,
13460,GO:0048894,1,0.993877124963719,0,1,efferent axon development in a lateral line nerve,BP,
13461,GO:0048925,1,0.993877124963719,0,1,lateral line system development,BP,
13462,GO:0048934,1,0.934170123165383,0,13,peripheral nervous system neuron differentiation,BP,
13463,GO:0048935,1,0.934170123165383,0,13,peripheral nervous system neuron development,BP,
13464,GO:0048936,1,0.978752455924485,0,3,peripheral nervous system neuron axonogenesis,BP,
13465,GO:0050000,1,0.625623458149058,0,65,chromosome localization,BP,
13466,GO:0050023,1,0.988947917053333,0,1,L-fuconate dehydratase activity,MF,
13467,GO:0050031,1,0.991017055661357,0,1,L-pipecolate oxidase activity,MF,
13468,GO:0050038,1,0.987257932335274,0,1,L-xylulose reductase (NADP+) activity,MF,
13469,GO:0050051,1,0.965210221960794,0,4,leukotriene-B4 20-monooxygenase activity,MF,
13470,GO:0050062,1,0.989709316516677,0,2,long-chain-fatty-acyl-CoA reductase activity,MF,
13471,GO:0050072,1,0.956410762124477,0,7,m7G(5')pppN diphosphatase activity,MF,
13472,GO:0050080,1,0.990105894622013,0,1,malonyl-CoA decarboxylase activity,MF,
13473,GO:0050104,1,0.988035290866311,0,1,L-gulonate 3-dehydrogenase activity,MF,
13474,GO:0050113,1,0.987923818244243,0,1,inositol oxygenase activity,MF,
13475,GO:0050115,1,0.999742809095682,0,1,myosin-light-chain-phosphatase activity,MF,
13476,GO:0050119,1,0.998092388524174,0,2,N-acetylglucosamine deacetylase activity,MF,
13477,GO:0050121,1,0.987986846062943,0,1,N-acylglucosamine 2-epimerase activity,MF,
13478,GO:0050124,1,0.997348267284739,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13479,GO:0050129,1,0.99472227106412,0,1,N-formylglutamate deformylase activity,MF,
13480,GO:0050135,1,0.976164388566155,0,2,NAD(P)+ nucleosidase activity,MF,
13481,GO:0050136,1,0.635349816884007,0,38,NADH dehydrogenase (quinone) activity,MF,
13482,GO:0050144,1,0.991657600429728,0,1,nucleoside deoxyribosyltransferase activity,MF,
13483,GO:0050145,1,0.972442747291369,0,3,nucleoside phosphate kinase activity,MF,
13484,GO:0050146,1,0.99996273972874,0,1,nucleoside phosphotransferase activity,MF,
13485,GO:0050152,1,0.987659328724384,0,1,omega-amidase activity,MF,
13486,GO:0050178,1,0.987167312885023,0,1,phenylpyruvate tautomerase activity,MF,
13487,GO:0050197,1,0.990595172043783,0,1,phytanate-CoA ligase activity,MF,
13488,GO:0050201,1,0.997824762674209,0,1,fucokinase activity,MF,
13489,GO:0050211,1,0.993696758730521,0,1,procollagen galactosyltransferase activity,MF,
13490,GO:0050220,1,0.966435751299699,0,3,prostaglandin-E synthase activity,MF,
13491,GO:0050221,1,0.987616670252174,0,1,prostaglandin-E2 9-reductase activity,MF,
13492,GO:0050252,1,0.978234392427371,0,3,retinol O-fatty-acyltransferase activity,MF,
13493,GO:0050253,1,0.992477156267405,0,2,retinyl-palmitate esterase activity,MF,
13494,GO:0050254,1,0.968920485237507,0,3,rhodopsin kinase activity,MF,
13495,GO:0050262,1,0.983384249277821,0,2,ribosylnicotinamide kinase activity,MF,
13496,GO:0050265,1,0.992920070960865,0,3,RNA uridylyltransferase activity,MF,
13498,GO:0050290,1,0.999609797723028,0,1,sphingomyelin phosphodiesterase D activity,MF,
13499,GO:0050291,1,0.94062349863914,0,7,sphingosine N-acyltransferase activity,MF,
13500,GO:0050294,1,0.954102063634995,0,4,steroid sulfotransferase activity,MF,
13501,GO:0050308,1,0.93761224199469,0,9,sugar-phosphatase activity,MF,
13502,GO:0050309,1,0.97656827037701,0,3,sugar-terminal-phosphatase activity,MF,
13503,GO:0050313,1,0.987339217613658,0,1,sulfur dioxygenase activity,MF,
13504,GO:0050321,1,0.943491548490006,0,12,tau-protein kinase activity,MF,
13505,GO:0050333,1,0.988748467685398,0,1,thiamin-triphosphatase activity,MF,
13506,GO:0050346,1,0.991657600429728,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13507,GO:0050347,1,0.984704323424068,0,2,trans-octaprenyltranstransferase activity,MF,
13508,GO:0050353,1,0.993055936423407,0,1,trimethyllysine dioxygenase activity,MF,
13509,GO:0050355,1,0.999224023743137,0,1,triphosphatase activity,MF,
13510,GO:0050379,1,0.999852729768039,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13511,GO:0050405,1,0.999888455158162,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13512,GO:0050421,1,0.991848723520862,0,1,nitrite reductase (NO-forming) activity,MF,
13513,GO:0050427,1,0.846751072761193,0,19,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13514,GO:0050428,1,0.964503642550005,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13515,GO:0050429,1,0.999999996375437,0,1,calcium-dependent phospholipase C activity,MF,
13516,GO:0050431,1,0.95080457504945,0,17,transforming growth factor beta binding,MF,
13517,GO:0050432,1,0.707999328061576,0,47,catecholamine secretion,BP,
13518,GO:0050433,1,0.708056913074075,0,44,regulation of catecholamine secretion,BP,
13519,GO:0050434,1,0.734049863778258,0,41,positive regulation of viral transcription,BP,
13520,GO:0050435,1,0.860725641721609,0,26,beta-amyloid metabolic process,BP,
13521,GO:0050436,1,0.997694350909954,0,2,microfibril binding,MF,
13522,GO:0050444,1,0.995162711325382,0,1,aquacobalamin reductase (NADPH) activity,MF,
13523,GO:0050462,1,0.987612795703566,0,1,N-acetylneuraminate synthase activity,MF,
13524,GO:0050473,1,0.983537797095508,0,3,arachidonate 15-lipoxygenase activity,MF,
13525,GO:0050479,1,0.991657600429728,0,1,glyceryl-ether monooxygenase activity,MF,
13526,GO:0050480,1,0.989899159704561,0,1,imidazolonepropionase activity,MF,
13527,GO:0050482,1,0.783543454914486,0,29,arachidonic acid secretion,BP,
13528,GO:0050497,1,0.984636463620673,0,2,transferase activity, transferring alkylthio groups,MF,
13529,GO:0050501,1,0.9667780354528,0,4,hyaluronan synthase activity,MF,
13531,GO:0050509,1,0.992589536227975,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13532,GO:0050510,1,0.987132859945599,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13533,GO:0050512,1,0.989713524578748,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13534,GO:0050528,1,0.990918482576119,0,1,acyloxyacyl hydrolase activity,MF,
13535,GO:0050542,1,0.934485374110175,0,6,icosanoid binding,MF,
13537,GO:0050544,1,0.94522679839916,0,5,arachidonic acid binding,MF,
13538,GO:0050560,1,0.995478574863344,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13539,GO:0050561,1,0.997804078630032,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13540,GO:0050567,1,0.985604879410826,0,2,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13541,GO:0050571,1,0.988268194691096,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13542,GO:0050577,1,0.987791238169804,0,1,GDP-L-fucose synthase activity,MF,
13543,GO:0050591,1,0.992662520819034,0,1,quinine 3-monooxygenase activity,MF,
13544,GO:0050610,1,0.975410002324126,0,2,methylarsonate reductase activity,MF,
13545,GO:0050613,1,0.985592531139687,0,2,delta14-sterol reductase activity,MF,
13546,GO:0050614,1,0.998857933040789,0,1,delta24-sterol reductase activity,MF,
13547,GO:0050632,1,0.987886501186532,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13548,GO:0050646,1,0.988641178112612,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13549,GO:0050647,1,0.988641178112612,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13550,GO:0050648,1,0.988641178112612,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13551,GO:0050649,1,0.992662520819034,0,1,testosterone 6-beta-hydroxylase activity,MF,
13552,GO:0050650,1,0.862305379554796,0,29,chondroitin sulfate proteoglycan biosynthetic process,BP,
13553,GO:0050651,1,0.926053181035738,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13554,GO:0050652,1,0.997073898631566,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13555,GO:0050653,1,0.995006354656759,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13558,GO:0050656,1,0.968842431173479,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13559,GO:0050657,1,0.324188936242316,0,186,nucleic acid transport,BP,
13560,GO:0050658,1,0.324188936242316,0,186,RNA transport,BP,
13561,GO:0050659,1,0.999530007467227,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13566,GO:0050664,1,0.918212534360994,0,14,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13567,GO:0050665,1,0.940906582827267,0,9,hydrogen peroxide biosynthetic process,BP,
13568,GO:0050666,1,0.98188872622716,0,2,regulation of homocysteine metabolic process,BP,
13569,GO:0050667,1,0.908092508972662,0,14,homocysteine metabolic process,BP,
13570,GO:0050668,1,0.990409252857432,0,1,positive regulation of homocysteine metabolic process,BP,
13573,GO:0050672,1,0.617827489828666,0,64,negative regulation of lymphocyte proliferation,BP,
13575,GO:0050674,1,0.98718161050591,0,1,urothelial cell proliferation,BP,
13576,GO:0050675,1,0.98718161050591,0,1,regulation of urothelial cell proliferation,BP,
13577,GO:0050677,1,0.98718161050591,0,1,positive regulation of urothelial cell proliferation,BP,
13581,GO:0050681,1,0.794155381658898,0,42,androgen receptor binding,MF,
13582,GO:0050682,1,0.999960269357063,0,2,AF-2 domain binding,MF,
13583,GO:0050683,1,0.998411574800839,0,1,AF-1 domain binding,MF,
13584,GO:0050684,1,0.51653609012309,0,100,regulation of mRNA processing,BP,
13585,GO:0050685,1,0.842910806699023,0,23,positive regulation of mRNA processing,BP,
13586,GO:0050686,1,0.823273542578599,0,29,negative regulation of mRNA processing,BP,
13587,GO:0050687,1,0.884847184275047,0,20,negative regulation of defense response to virus,BP,
13588,GO:0050688,1,0.560621297022747,0,86,regulation of defense response to virus,BP,
13589,GO:0050689,1,0.959960345679254,0,4,negative regulation of defense response to virus by host,BP,
13590,GO:0050690,1,0.819467789785959,0,28,regulation of defense response to virus by virus,BP,
13591,GO:0050691,1,0.776429563331859,0,31,regulation of defense response to virus by host,BP,
13592,GO:0050692,1,0.983073582299756,0,3,DBD domain binding,MF,
13593,GO:0050693,1,0.959653042864765,0,6,LBD domain binding,MF,
13594,GO:0050694,1,0.963980159331197,0,4,galactose 3-O-sulfotransferase activity,MF,
13595,GO:0050698,1,0.986874390490554,0,2,proteoglycan sulfotransferase activity,MF,
13597,GO:0050700,1,0.971703600039671,0,7,CARD domain binding,MF,
13600,GO:0050703,1,0.950544100538593,0,5,interleukin-1 alpha secretion,BP,
13602,GO:0050705,1,0.962894916520231,0,4,regulation of interleukin-1 alpha secretion,BP,
13606,GO:0050709,1,0.487485206587315,0,105,negative regulation of protein secretion,BP,
13607,GO:0050710,1,0.711495034956441,0,48,negative regulation of cytokine secretion,BP,
13608,GO:0050711,1,0.935140462255178,0,8,negative regulation of interleukin-1 secretion,BP,
13609,GO:0050712,1,0.987905896439868,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13610,GO:0050713,1,0.959680022559659,0,5,negative regulation of interleukin-1 beta secretion,BP,
13614,GO:0050717,1,0.974685240529314,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13616,GO:0050719,1,0.987262295066964,0,1,interleukin-1 alpha biosynthetic process,BP,
13617,GO:0050720,1,0.969234433229351,0,3,interleukin-1 beta biosynthetic process,BP,
13618,GO:0050721,1,0.987262295066964,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
13619,GO:0050722,1,0.981767833592938,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13620,GO:0050725,1,0.981767833592938,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13621,GO:0050726,1,0.987262295066964,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
13623,GO:0050728,1,0.468766932228829,0,99,negative regulation of inflammatory response,BP,
13624,GO:0050729,1,0.458685479319504,0,100,positive regulation of inflammatory response,BP,
13627,GO:0050732,1,0.761726636975285,0,41,negative regulation of peptidyl-tyrosine phosphorylation,BP,
13628,GO:0050733,1,0.943976831922037,0,7,RS domain binding,MF,
13629,GO:0050746,1,0.906704683138948,0,14,regulation of lipoprotein metabolic process,BP,
13630,GO:0050747,1,0.966327182584306,0,5,positive regulation of lipoprotein metabolic process,BP,
13631,GO:0050748,1,0.952104475227559,0,6,negative regulation of lipoprotein metabolic process,BP,
13632,GO:0050750,1,0.886482065780777,0,16,low-density lipoprotein particle receptor binding,MF,
13633,GO:0050751,1,0.987304015793293,0,1,fractalkine biosynthetic process,BP,
13634,GO:0050752,1,0.987304015793293,0,1,regulation of fractalkine biosynthetic process,BP,
13635,GO:0050754,1,0.987304015793293,0,1,positive regulation of fractalkine biosynthetic process,BP,
13637,GO:0050756,1,0.987304015793293,0,1,fractalkine metabolic process,BP,
13638,GO:0050757,1,0.979595947666692,0,2,thymidylate synthase biosynthetic process,BP,
13639,GO:0050758,1,0.979595947666692,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13640,GO:0050760,1,0.992021256355255,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13642,GO:0050765,1,0.919243570619,0,11,negative regulation of phagocytosis,BP,
13649,GO:0050772,1,0.727506635957431,0,73,positive regulation of axonogenesis,BP,
13650,GO:0050773,1,0.628841863022323,0,122,regulation of dendrite development,BP,
13651,GO:0050774,1,0.938834642643187,0,15,negative regulation of dendrite morphogenesis,BP,
13652,GO:0050775,1,0.900219242555692,0,33,positive regulation of dendrite morphogenesis,BP,
13656,GO:0050779,1,0.914898458900416,0,20,RNA destabilization,BP,
13657,GO:0050780,1,0.915766543531331,0,15,dopamine receptor binding,MF,
13658,GO:0050783,1,0.991142587041807,0,1,cocaine metabolic process,BP,
13660,GO:0050787,1,0.987191232932125,0,2,detoxification of mercury ion,BP,
13666,GO:0050795,1,0.632743386533842,0,62,regulation of behavior,BP,
13671,GO:0050803,1,0.60034171457487,0,117,regulation of synapse structure or activity,BP,
13673,GO:0050805,1,0.717780476786984,0,66,negative regulation of synaptic transmission,BP,
13675,GO:0050807,1,0.608804510312715,0,113,regulation of synapse organization,BP,
13676,GO:0050808,1,0.366045801068528,0,238,synapse organization,BP,
13678,GO:0050811,1,0.921123163769564,0,14,GABA receptor binding,MF,
13680,GO:0050815,1,0.960655495684579,0,6,phosphoserine binding,MF,
13681,GO:0050816,1,0.984536828077423,0,3,phosphothreonine binding,MF,
13684,GO:0050819,1,0.660748063254539,0,51,negative regulation of coagulation,BP,
13685,GO:0050820,1,0.838263342638874,0,25,positive regulation of coagulation,BP,
13687,GO:0050822,1,0.996138037436052,0,1,peptide stabilization,BP,
13688,GO:0050823,1,0.996138037436052,0,1,peptide antigen stabilization,BP,
13689,GO:0050828,1,0.991657600429728,0,1,regulation of liquid surface tension,BP,
13691,GO:0050830,1,0.509354082333332,0,65,defense response to Gram-positive bacterium,BP,
13692,GO:0050832,1,0.701505704459946,0,31,defense response to fungus,BP,
13693,GO:0050833,1,0.971568363154374,0,4,pyruvate transmembrane transporter activity,MF,
13695,GO:0050840,1,0.786541917414471,0,48,extracellular matrix binding,MF,
13696,GO:0050847,1,0.987109388761072,0,4,progesterone receptor signaling pathway,BP,
13698,GO:0050849,1,0.880836697375934,0,18,negative regulation of calcium-mediated signaling,BP,
13699,GO:0050850,1,0.74295647113151,0,38,positive regulation of calcium-mediated signaling,BP,
13702,GO:0050853,1,0.758069781678353,0,44,B cell receptor signaling pathway,BP,
13703,GO:0050854,1,0.732807943662246,0,45,regulation of antigen receptor-mediated signaling pathway,BP,
13704,GO:0050855,1,0.914919878120319,0,14,regulation of B cell receptor signaling pathway,BP,
13705,GO:0050856,1,0.779851750408225,0,33,regulation of T cell receptor signaling pathway,BP,
13706,GO:0050857,1,0.886372838362785,0,18,positive regulation of antigen receptor-mediated signaling pathway,BP,
13707,GO:0050858,1,0.845905277564257,0,21,negative regulation of antigen receptor-mediated signaling pathway,BP,
13708,GO:0050859,1,0.967032060655105,0,4,negative regulation of B cell receptor signaling pathway,BP,
13709,GO:0050860,1,0.866332191932154,0,18,negative regulation of T cell receptor signaling pathway,BP,
13710,GO:0050861,1,0.968137690826526,0,7,positive regulation of B cell receptor signaling pathway,BP,
13711,GO:0050862,1,0.915700218165292,0,10,positive regulation of T cell receptor signaling pathway,BP,
13715,GO:0050866,1,0.298949256810846,0,161,negative regulation of cell activation,BP,
13717,GO:0050868,1,0.502091130847208,0,91,negative regulation of T cell activation,BP,
13718,GO:0050869,1,0.805241691405372,0,30,negative regulation of B cell activation,BP,
13721,GO:0050872,1,0.915129385345147,0,13,white fat cell differentiation,BP,
13725,GO:0050879,1,0.752837238484123,0,47,multicellular organismal movement,BP,
13726,GO:0050880,1,0.393826600019318,0,131,regulation of blood vessel size,BP,
13727,GO:0050881,1,0.752837238484123,0,47,musculoskeletal movement,BP,
13728,GO:0050882,1,0.994249090250401,0,5,voluntary musculoskeletal movement,BP,
13729,GO:0050883,1,0.979605244771691,0,2,musculoskeletal movement, spinal reflex action,BP,
13730,GO:0050884,1,0.922247016563182,0,16,neuromuscular process controlling posture,BP,
13732,GO:0050886,1,0.577381363312283,0,79,endocrine process,BP,
13734,GO:0050891,1,0.721967604115965,0,62,multicellular organismal water homeostasis,BP,
13735,GO:0050892,1,0.800312619560939,0,33,intestinal absorption,BP,
13736,GO:0050893,1,0.971704189594963,0,4,sensory processing,BP,
13737,GO:0050894,1,0.999999996376636,0,1,determination of affect,BP,
13739,GO:0050897,1,0.999999996372751,0,1,cobalt ion binding,MF,
13741,GO:0050901,1,0.864868253690327,0,21,leukocyte tethering or rolling,BP,
13742,GO:0050902,1,0.986612654183366,0,2,leukocyte adhesive activation,BP,
13743,GO:0050904,1,0.981403682395283,0,3,diapedesis,BP,
13745,GO:0050906,1,0.00376402893397568,0,468,detection of stimulus involved in sensory perception,BP,
13746,GO:0050907,1,0.00505049065156221,0,419,detection of chemical stimulus involved in sensory perception,BP,
13747,GO:0050908,1,0.91619214996612,0,17,detection of light stimulus involved in visual perception,BP,
13748,GO:0050909,1,0.539302064006326,0,62,sensory perception of taste,BP,
13749,GO:0050910,1,0.930711127301144,0,12,detection of mechanical stimulus involved in sensory perception of sound,BP,
13750,GO:0050911,1,0.00810450382976944,0,376,detection of chemical stimulus involved in sensory perception of smell,BP,
13751,GO:0050912,1,0.640688631269419,0,40,detection of chemical stimulus involved in sensory perception of taste,BP,
13752,GO:0050913,1,0.656707041769611,0,38,sensory perception of bitter taste,BP,
13753,GO:0050915,1,0.969308242968235,0,5,sensory perception of sour taste,BP,
13754,GO:0050916,1,0.955132576926361,0,6,sensory perception of sweet taste,BP,
13755,GO:0050917,1,0.957653727330635,0,6,sensory perception of umami taste,BP,
13756,GO:0050918,1,0.683484311493014,0,52,positive chemotaxis,BP,
13757,GO:0050919,1,0.941009119535453,0,22,negative chemotaxis,BP,
13760,GO:0050922,1,0.805292296141947,0,35,negative regulation of chemotaxis,BP,
13761,GO:0050923,1,0.995512630539552,0,4,regulation of negative chemotaxis,BP,
13762,GO:0050924,1,0.999814813340433,0,1,positive regulation of negative chemotaxis,BP,
13763,GO:0050925,1,0.999999992753254,0,2,negative regulation of negative chemotaxis,BP,
13764,GO:0050926,1,0.844520600404952,0,23,regulation of positive chemotaxis,BP,
13765,GO:0050927,1,0.84456518359957,0,22,positive regulation of positive chemotaxis,BP,
13766,GO:0050928,1,0.999947316269307,0,1,negative regulation of positive chemotaxis,BP,
13767,GO:0050929,1,0.999814813340433,0,1,induction of negative chemotaxis,BP,
13768,GO:0050930,1,0.887124020612502,0,12,induction of positive chemotaxis,BP,
13769,GO:0050931,1,0.840598497918976,0,34,pigment cell differentiation,BP,
13770,GO:0050932,1,0.959702512947569,0,9,regulation of pigment cell differentiation,BP,
13771,GO:0050942,1,0.980946876968289,0,7,positive regulation of pigment cell differentiation,BP,
13772,GO:0050951,1,0.902485587975112,0,20,sensory perception of temperature stimulus,BP,
13775,GO:0050955,1,0.998407488740522,0,3,thermoception,BP,
13776,GO:0050957,1,0.973669354054073,0,7,equilibrioception,BP,
13777,GO:0050960,1,0.998479269538922,0,1,detection of temperature stimulus involved in thermoception,BP,
13778,GO:0050961,1,0.912970126539396,0,14,detection of temperature stimulus involved in sensory perception,BP,
13779,GO:0050962,1,0.91619214996612,0,17,detection of light stimulus involved in sensory perception,BP,
13780,GO:0050965,1,0.912970126539396,0,14,detection of temperature stimulus involved in sensory perception of pain,BP,
13781,GO:0050966,1,0.968372320158035,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13782,GO:0050968,1,0.990079865292367,0,3,detection of chemical stimulus involved in sensory perception of pain,BP,
13783,GO:0050974,1,0.86788901881408,0,24,detection of mechanical stimulus involved in sensory perception,BP,
13784,GO:0050975,1,0.976963219486985,0,3,sensory perception of touch,BP,
13785,GO:0050976,1,0.988794914311295,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13786,GO:0050982,1,0.806880198466035,0,42,detection of mechanical stimulus,BP,
13787,GO:0050992,1,0.977786295009183,0,2,dimethylallyl diphosphate biosynthetic process,BP,
13788,GO:0050993,1,0.977786295009183,0,2,dimethylallyl diphosphate metabolic process,BP,
13791,GO:0050996,1,0.829010864329129,0,27,positive regulation of lipid catabolic process,BP,
13793,GO:0050998,1,0.91739967867417,0,16,nitric-oxide synthase binding,MF,
13795,GO:0051000,1,0.881537712682627,0,20,positive regulation of nitric-oxide synthase activity,BP,
13799,GO:0051006,1,0.903612591665391,0,10,positive regulation of lipoprotein lipase activity,BP,
13800,GO:0051010,1,0.979538575592642,0,11,microtubule plus-end binding,MF,
13801,GO:0051011,1,0.967238612499231,0,7,microtubule minus-end binding,MF,
13802,GO:0051012,1,0.988441596339708,0,2,microtubule sliding,BP,
13803,GO:0051013,1,0.966304494500523,0,6,microtubule severing,BP,
13804,GO:0051014,1,0.951561871373107,0,9,actin filament severing,BP,
13806,GO:0051016,1,0.897478744561502,0,16,barbed-end actin filament capping,BP,
13807,GO:0051017,1,0.537982234027332,0,126,actin filament bundle assembly,BP,
13808,GO:0051018,1,0.839480234554388,0,42,protein kinase A binding,MF,
13809,GO:0051019,1,0.904894479378208,0,23,mitogen-activated protein kinase binding,MF,
13811,GO:0051021,1,0.980925371063715,0,3,GDP-dissociation inhibitor binding,MF,
13812,GO:0051022,1,0.980925371063715,0,3,Rho GDP-dissociation inhibitor binding,MF,
13815,GO:0051025,1,0.986204018073961,0,2,negative regulation of immunoglobulin secretion,BP,
13816,GO:0051026,1,0.962344785439141,0,6,chiasma assembly,BP,
13817,GO:0051028,1,0.443118677909433,0,143,mRNA transport,BP,
13818,GO:0051029,1,0.962216803616913,0,5,rRNA transport,BP,
13819,GO:0051030,1,0.967190595190877,0,3,snRNA transport,BP,
13820,GO:0051031,1,0.850387180006749,0,33,tRNA transport,BP,
13821,GO:0051032,1,0.997716019220917,0,3,nucleic acid transmembrane transporter activity,MF,
13822,GO:0051033,1,0.997716019220917,0,3,RNA transmembrane transporter activity,MF,
13823,GO:0051036,1,0.959148975325542,0,5,regulation of endosome size,BP,
13824,GO:0051037,1,0.994331607551733,0,2,regulation of transcription involved in meiotic cell cycle,BP,
13825,GO:0051038,1,0.999339547477948,0,1,negative regulation of transcription involved in meiotic cell cycle,BP,
13826,GO:0051039,1,0.994988777548835,0,1,positive regulation of transcription involved in meiotic cell cycle,BP,
13827,GO:0051040,1,0.989541634508758,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13828,GO:0051041,1,0.99504847536143,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13829,GO:0051042,1,0.994465974192092,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13830,GO:0051043,1,0.876089713364644,0,21,regulation of membrane protein ectodomain proteolysis,BP,
13831,GO:0051044,1,0.913514247914774,0,14,positive regulation of membrane protein ectodomain proteolysis,BP,
13832,GO:0051045,1,0.959061174087945,0,7,negative regulation of membrane protein ectodomain proteolysis,BP,
13835,GO:0051048,1,0.258181230678497,0,191,negative regulation of secretion,BP,
13841,GO:0051054,1,0.248799289443168,0,202,positive regulation of DNA metabolic process,BP,
13843,GO:0051056,1,0.306797575469876,0,295,regulation of small GTPase mediated signal transduction,BP,
13844,GO:0051057,1,0.74834914060208,0,52,positive regulation of small GTPase mediated signal transduction,BP,
13845,GO:0051058,1,0.822992195622885,0,44,negative regulation of small GTPase mediated signal transduction,BP,
13846,GO:0051059,1,0.803600909150012,0,28,NF-kappaB binding,MF,
13847,GO:0051066,1,0.977730028790833,0,2,dihydrobiopterin metabolic process,BP,
13848,GO:0051068,1,0.996502821220058,0,1,dihydrolipoamide metabolic process,BP,
13849,GO:0051081,1,0.780194219724707,0,46,nuclear envelope disassembly,BP,
13850,GO:0051082,1,0.404575312652272,0,104,unfolded protein binding,MF,
13851,GO:0051083,1,0.978825233606324,0,2,'de novo' cotranslational protein folding,BP,
13852,GO:0051084,1,0.877403601223815,0,16,'de novo' posttranslational protein folding,BP,
13853,GO:0051085,1,0.907085778374942,0,12,chaperone mediated protein folding requiring cofactor,BP,
13854,GO:0051086,1,0.989278861677529,0,1,chaperone mediated protein folding independent of cofactor,BP,
13855,GO:0051087,1,0.537801945237558,0,86,chaperone binding,MF,
13856,GO:0051088,1,0.992330137559035,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13857,GO:0051089,1,0.997869181379137,0,1,constitutive protein ectodomain proteolysis,BP,
13863,GO:0051095,1,0.949446591259841,0,9,regulation of helicase activity,BP,
13864,GO:0051096,1,0.97042511721406,0,6,positive regulation of helicase activity,BP,
13865,GO:0051097,1,0.9783872300794,0,3,negative regulation of helicase activity,BP,
13868,GO:0051100,1,0.390275887926439,0,137,negative regulation of binding,BP,
13869,GO:0051101,1,0.460173399971792,0,108,regulation of DNA binding,BP,
13870,GO:0051102,1,0.998243388728328,0,1,DNA ligation involved in DNA recombination,BP,
13871,GO:0051103,1,0.912168698497947,0,11,DNA ligation involved in DNA repair,BP,
13872,GO:0051105,1,0.968068757049073,0,5,regulation of DNA ligation,BP,
13873,GO:0051106,1,0.974649554646207,0,4,positive regulation of DNA ligation,BP,
13874,GO:0051107,1,0.993249409208299,0,1,negative regulation of DNA ligation,BP,
13875,GO:0051117,1,0.595690241583561,0,74,ATPase binding,MF,
13876,GO:0051119,1,0.784873511813385,0,34,sugar transmembrane transporter activity,MF,
13877,GO:0051120,1,0.978509085974935,0,3,hepoxilin A3 synthase activity,MF,
13878,GO:0051121,1,0.962335372989635,0,5,hepoxilin metabolic process,BP,
13879,GO:0051122,1,0.962335372989635,0,5,hepoxilin biosynthetic process,BP,
13880,GO:0051123,1,0.804941564864938,0,30,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13881,GO:0051124,1,0.973720439711276,0,7,synaptic growth at neuromuscular junction,BP,
13882,GO:0051125,1,0.869405048358024,0,24,regulation of actin nucleation,BP,
13883,GO:0051126,1,0.953001712434866,0,6,negative regulation of actin nucleation,BP,
13884,GO:0051127,1,0.949330494436944,0,13,positive regulation of actin nucleation,BP,
13888,GO:0051131,1,0.856320217567857,0,18,chaperone-mediated protein complex assembly,BP,
13889,GO:0051132,1,0.91766524465014,0,10,NK T cell activation,BP,
13890,GO:0051133,1,0.929744702831873,0,8,regulation of NK T cell activation,BP,
13891,GO:0051134,1,0.989031885238146,0,1,negative regulation of NK T cell activation,BP,
13892,GO:0051135,1,0.940060415411681,0,7,positive regulation of NK T cell activation,BP,
13893,GO:0051136,1,0.976254176272157,0,6,regulation of NK T cell differentiation,BP,
13894,GO:0051138,1,0.987972062214637,0,4,positive regulation of NK T cell differentiation,BP,
13895,GO:0051139,1,0.997598341365831,0,1,metal ion:proton antiporter activity,MF,
13896,GO:0051140,1,0.961398927694515,0,4,regulation of NK T cell proliferation,BP,
13897,GO:0051142,1,0.961398927694515,0,4,positive regulation of NK T cell proliferation,BP,
13898,GO:0051145,1,0.748413308635092,0,50,smooth muscle cell differentiation,BP,
13899,GO:0051146,1,0.261598731128061,0,238,striated muscle cell differentiation,BP,
13900,GO:0051147,1,0.356568088041347,0,163,regulation of muscle cell differentiation,BP,
13901,GO:0051148,1,0.672237152162847,0,59,negative regulation of muscle cell differentiation,BP,
13902,GO:0051149,1,0.562087127719556,0,89,positive regulation of muscle cell differentiation,BP,
13903,GO:0051150,1,0.861510801891926,0,25,regulation of smooth muscle cell differentiation,BP,
13904,GO:0051151,1,0.937310539770381,0,11,negative regulation of smooth muscle cell differentiation,BP,
13905,GO:0051152,1,0.928938331587634,0,10,positive regulation of smooth muscle cell differentiation,BP,
13906,GO:0051153,1,0.538962279739563,0,90,regulation of striated muscle cell differentiation,BP,
13907,GO:0051154,1,0.830228486190962,0,29,negative regulation of striated muscle cell differentiation,BP,
13908,GO:0051155,1,0.669975939451525,0,55,positive regulation of striated muscle cell differentiation,BP,
13910,GO:0051160,1,0.991518053072052,0,1,L-xylitol catabolic process,BP,
13911,GO:0051164,1,0.991518053072052,0,1,L-xylitol metabolic process,BP,
13912,GO:0051167,1,0.952643268976188,0,5,xylulose 5-phosphate metabolic process,BP,
13920,GO:0051176,1,0.976886763792796,0,5,positive regulation of sulfur metabolic process,BP,
13921,GO:0051177,1,0.938649134368355,0,7,meiotic sister chromatid cohesion,BP,
13923,GO:0051180,1,0.770004214721375,0,34,vitamin transport,BP,
13924,GO:0051181,1,0.825481181852715,0,25,cofactor transport,BP,
13925,GO:0051182,1,0.957011494060007,0,6,coenzyme transport,BP,
13927,GO:0051184,1,0.886381489616271,0,19,cofactor transporter activity,MF,
13928,GO:0051185,1,0.967547217800252,0,4,coenzyme transporter activity,MF,
13932,GO:0051189,1,0.949208925648098,0,7,prosthetic group metabolic process,BP,
13933,GO:0051192,1,0.987192131992394,0,1,prosthetic group binding,MF,
13935,GO:0051194,1,0.934725555360609,0,14,positive regulation of cofactor metabolic process,BP,
13936,GO:0051195,1,0.93874315309459,0,11,negative regulation of cofactor metabolic process,BP,
13938,GO:0051197,1,0.934725555360609,0,14,positive regulation of coenzyme metabolic process,BP,
13939,GO:0051198,1,0.93874315309459,0,11,negative regulation of coenzyme metabolic process,BP,
13940,GO:0051204,1,0.787684867553266,0,32,protein insertion into mitochondrial membrane,BP,
13941,GO:0051205,1,0.701481675491383,0,45,protein insertion into membrane,BP,
13946,GO:0051219,1,0.68668102429198,0,77,phosphoprotein binding,MF,
13947,GO:0051220,1,0.743754150684874,0,43,cytoplasmic sequestering of protein,BP,
13950,GO:0051224,1,0.275694007369953,0,193,negative regulation of protein transport,BP,
13951,GO:0051225,1,0.613869528512221,0,84,spindle assembly,BP,
13952,GO:0051228,1,0.999916514328924,0,1,mitotic spindle disassembly,BP,
13953,GO:0051230,1,0.999916514328924,0,1,spindle disassembly,BP,
13954,GO:0051231,1,0.934956508736943,0,11,spindle elongation,BP,
13955,GO:0051232,1,0.990846201281476,0,1,meiotic spindle elongation,BP,
13956,GO:0051233,1,0.844445864069565,0,28,spindle midzone,CC,
13959,GO:0051236,1,0.322038663646197,0,189,establishment of RNA localization,BP,
13968,GO:0051250,1,0.392840563987825,0,123,negative regulation of lymphocyte activation,BP,
13973,GO:0051255,1,0.940887557967335,0,10,spindle midzone assembly,BP,
13974,GO:0051256,1,0.949194648451995,0,9,mitotic spindle midzone assembly,BP,
13975,GO:0051257,1,0.991251880888793,0,1,meiotic spindle midzone assembly,BP,
13981,GO:0051264,1,0.992820244320386,0,1,mono-olein transacylation activity,MF,
13982,GO:0051265,1,0.992820244320386,0,1,diolein transacylation activity,MF,
13983,GO:0051267,1,0.994933742467394,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13987,GO:0051276,1,0.000689405043462308,0,1106,chromosome organization,BP,
13988,GO:0051279,1,0.669538371218514,0,68,regulation of release of sequestered calcium ion into cytosol,BP,
13989,GO:0051280,1,0.905108252677026,0,13,negative regulation of release of sequestered calcium ion into cytosol,BP,
13990,GO:0051281,1,0.792001145266945,0,34,positive regulation of release of sequestered calcium ion into cytosol,BP,
13993,GO:0051284,1,0.905108231184209,0,14,positive regulation of sequestering of calcium ion,BP,
13994,GO:0051286,1,0.983812609848322,0,7,cell tip,CC,
13997,GO:0051290,1,0.634311958584083,0,43,protein heterotetramerization,BP,
13999,GO:0051292,1,0.965924472958089,0,9,nuclear pore complex assembly,BP,
14000,GO:0051293,1,0.881290366842502,0,28,establishment of spindle localization,BP,
14001,GO:0051294,1,0.894946322078811,0,20,establishment of spindle orientation,BP,
14002,GO:0051295,1,0.982415142453227,0,5,establishment of meiotic spindle localization,BP,
14003,GO:0051296,1,0.987395862813797,0,1,establishment of meiotic spindle orientation,BP,
14004,GO:0051297,1,0.584033645625795,0,109,centrosome organization,BP,
14005,GO:0051298,1,0.769707503919564,0,61,centrosome duplication,BP,
14006,GO:0051299,1,0.924625888631714,0,14,centrosome separation,BP,
14007,GO:0051301,1,0.0317145864458166,0,547,cell division,BP,
14008,GO:0051302,1,0.40361245465747,0,131,regulation of cell division,BP,
14009,GO:0051303,1,0.625661460982461,0,64,establishment of chromosome localization,BP,
14010,GO:0051304,1,0.670558174326104,0,66,chromosome separation,BP,
14011,GO:0051305,1,0.983007984750831,0,6,chromosome movement towards spindle pole,BP,
14012,GO:0051306,1,0.731552006277364,0,48,mitotic sister chromatid separation,BP,
14013,GO:0051307,1,0.914379257206958,0,16,meiotic chromosome separation,BP,
14014,GO:0051308,1,0.991657600429728,0,1,male meiosis chromosome separation,BP,
14015,GO:0051310,1,0.680778964961238,0,48,metaphase plate congression,BP,
14016,GO:0051311,1,0.991251880888793,0,1,meiotic metaphase plate congression,BP,
14017,GO:0051315,1,0.935038366598495,0,9,attachment of mitotic spindle microtubules to kinetochore,BP,
14018,GO:0051321,1,0.261437867379381,0,211,meiotic cell cycle,BP,
14021,GO:0051339,1,0.513950480897598,0,90,regulation of lyase activity,BP,
14025,GO:0051343,1,0.971019095368175,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
14031,GO:0051349,1,0.664468463730044,0,59,positive regulation of lyase activity,BP,
14032,GO:0051350,1,0.772770019549653,0,32,negative regulation of lyase activity,BP,
14033,GO:0051351,1,0.939933527844486,0,6,positive regulation of ligase activity,BP,
14037,GO:0051355,1,0.997405358818918,0,1,proprioception involved in equilibrioception,BP,
14038,GO:0051365,1,0.978879641049408,0,3,cellular response to potassium ion starvation,BP,
14039,GO:0051371,1,0.958960059875624,0,18,muscle alpha-actinin binding,MF,
14040,GO:0051373,1,0.963859203418761,0,5,FATZ binding,MF,
14041,GO:0051377,1,0.989685280262336,0,3,mannose-ethanolamine phosphotransferase activity,MF,
14042,GO:0051378,1,0.916219374204267,0,11,serotonin binding,MF,
14043,GO:0051379,1,0.957208710761072,0,6,epinephrine binding,MF,
14044,GO:0051380,1,0.97249022999397,0,4,norepinephrine binding,MF,
14045,GO:0051382,1,0.936371631392695,0,11,kinetochore assembly,BP,
14046,GO:0051383,1,0.919772464326681,0,15,kinetochore organization,BP,
14049,GO:0051386,1,0.937611106393878,0,11,regulation of neurotrophin TRK receptor signaling pathway,BP,
14050,GO:0051387,1,0.966187997003653,0,4,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
14051,GO:0051388,1,0.981810828597297,0,5,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
14052,GO:0051389,1,0.999999996401934,0,1,inactivation of MAPKK activity,BP,
14053,GO:0051391,1,0.997928106866493,0,1,tRNA acetylation,BP,
14054,GO:0051392,1,0.997928106866493,0,1,tRNA N-acetyltransferase activity,MF,
14055,GO:0051393,1,0.897215577497874,0,32,alpha-actinin binding,MF,
14056,GO:0051394,1,0.987800053657777,0,1,regulation of nerve growth factor receptor activity,BP,
14057,GO:0051400,1,0.92825551229286,0,10,BH domain binding,MF,
14060,GO:0051409,1,0.929281767589761,0,10,response to nitrosative stress,BP,
14061,GO:0051410,1,0.957604674186216,0,5,detoxification of nitrogen compound,BP,
14063,GO:0051414,1,0.987186571753855,0,5,response to cortisol,BP,
14064,GO:0051415,1,0.975377205700545,0,6,interphase microtubule nucleation by interphase microtubule organizing center,BP,
14065,GO:0051418,1,0.975377197249193,0,7,microtubule nucleation by microtubule organizing center,BP,
14066,GO:0051424,1,0.988877999150257,0,1,corticotropin-releasing hormone binding,MF,
14067,GO:0051425,1,0.991029818454508,0,4,PTB domain binding,MF,
14068,GO:0051427,1,0.391155820998282,0,156,hormone receptor binding,MF,
14069,GO:0051428,1,0.833973791953954,0,19,peptide hormone receptor binding,MF,
14070,GO:0051429,1,0.940199093244307,0,6,corticotropin-releasing hormone receptor binding,MF,
14071,GO:0051430,1,0.963961426613677,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
14072,GO:0051431,1,0.95096392874178,0,4,corticotropin-releasing hormone receptor 2 binding,MF,
14073,GO:0051433,1,0.999345778023363,0,1,BH2 domain binding,MF,
14074,GO:0051434,1,0.973859580664347,0,4,BH3 domain binding,MF,
14079,GO:0051440,1,0.996686529706208,0,1,regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle,BP,
14080,GO:0051441,1,0.996686529706208,0,1,positive regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle,BP,
14083,GO:0051445,1,0.761705768709389,0,39,regulation of meiotic cell cycle,BP,
14084,GO:0051446,1,0.918817171452142,0,14,positive regulation of meiotic cell cycle,BP,
14085,GO:0051447,1,0.876861319310359,0,17,negative regulation of meiotic cell cycle,BP,
14086,GO:0051450,1,0.892925946633045,0,14,myoblast proliferation,BP,
14087,GO:0051451,1,0.935426759444873,0,10,myoblast migration,BP,
14088,GO:0051452,1,0.672328225570969,0,48,intracellular pH reduction,BP,
14089,GO:0051453,1,0.562881494577295,0,90,regulation of intracellular pH,BP,
14090,GO:0051454,1,0.963763420865065,0,6,intracellular pH elevation,BP,
14091,GO:0051457,1,0.921389379633438,0,15,maintenance of protein location in nucleus,BP,
14092,GO:0051458,1,0.938735331600302,0,7,corticotropin secretion,BP,
14093,GO:0051459,1,0.946623003639825,0,6,regulation of corticotropin secretion,BP,
14094,GO:0051460,1,0.988877999150257,0,1,negative regulation of corticotropin secretion,BP,
14095,GO:0051461,1,0.957273462823644,0,5,positive regulation of corticotropin secretion,BP,
14096,GO:0051462,1,0.955532483416471,0,5,regulation of cortisol secretion,BP,
14097,GO:0051463,1,0.999999996374395,0,1,negative regulation of cortisol secretion,BP,
14098,GO:0051464,1,0.955532495667156,0,4,positive regulation of cortisol secretion,BP,
14099,GO:0051466,1,0.985312666713422,0,2,positive regulation of corticotropin-releasing hormone secretion,BP,
14101,GO:0051481,1,0.913587833021029,0,14,negative regulation of cytosolic calcium ion concentration,BP,
14102,GO:0051482,1,0.803257547613825,0,28,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,
14103,GO:0051489,1,0.848347031314333,0,37,regulation of filopodium assembly,BP,
14104,GO:0051490,1,0.973151557935856,0,3,negative regulation of filopodium assembly,BP,
14105,GO:0051491,1,0.900663726323591,0,26,positive regulation of filopodium assembly,BP,
14106,GO:0051492,1,0.706526495480958,0,70,regulation of stress fiber assembly,BP,
14110,GO:0051496,1,0.774160036479243,0,43,positive regulation of stress fiber assembly,BP,
14111,GO:0051497,1,0.91272731585995,0,20,negative regulation of stress fiber assembly,BP,
14112,GO:0051499,1,0.97955306047789,0,2,D-aminoacyl-tRNA deacylase activity,MF,
14113,GO:0051500,1,0.97955306047789,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
14114,GO:0051503,1,0.906305922084773,0,13,adenine nucleotide transport,BP,
14115,GO:0051510,1,0.987631058642231,0,1,regulation of unidimensional cell growth,BP,
14116,GO:0051511,1,0.987631058642231,0,1,negative regulation of unidimensional cell growth,BP,
14117,GO:0051525,1,0.973402836480754,0,5,NFAT protein binding,MF,
14118,GO:0051531,1,0.929068416320571,0,16,NFAT protein import into nucleus,BP,
14119,GO:0051532,1,0.929068433526739,0,15,regulation of NFAT protein import into nucleus,BP,
14120,GO:0051533,1,0.946270954252406,0,10,positive regulation of NFAT protein import into nucleus,BP,
14121,GO:0051534,1,0.981828653375604,0,5,negative regulation of NFAT protein import into nucleus,BP,
14124,GO:0051538,1,0.976612613025372,0,3,3 iron, 4 sulfur cluster binding,MF,
14127,GO:0051541,1,0.963884184524523,0,5,elastin metabolic process,BP,
14128,GO:0051542,1,0.99077441651146,0,2,elastin biosynthetic process,BP,
14129,GO:0051543,1,0.990774421946724,0,1,regulation of elastin biosynthetic process,BP,
14130,GO:0051545,1,0.990774421946724,0,1,negative regulation of elastin biosynthetic process,BP,
14131,GO:0051546,1,0.925407242452203,0,15,keratinocyte migration,BP,
14132,GO:0051547,1,0.95981197742019,0,10,regulation of keratinocyte migration,BP,
14133,GO:0051548,1,0.999994185817382,0,2,negative regulation of keratinocyte migration,BP,
14134,GO:0051549,1,0.959817575708838,0,8,positive regulation of keratinocyte migration,BP,
14135,GO:0051552,1,0.954926329856858,0,6,flavone metabolic process,BP,
14136,GO:0051560,1,0.892178170340642,0,16,mitochondrial calcium ion homeostasis,BP,
14137,GO:0051561,1,0.935085807064099,0,8,positive regulation of mitochondrial calcium ion concentration,BP,
14138,GO:0051562,1,0.981059171157194,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
14139,GO:0051563,1,0.996012231569907,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
14140,GO:0051567,1,0.888549616945016,0,32,histone H3-K9 methylation,BP,
14141,GO:0051568,1,0.784592499005339,0,47,histone H3-K4 methylation,BP,
14142,GO:0051569,1,0.884764901472806,0,24,regulation of histone H3-K4 methylation,BP,
14143,GO:0051570,1,0.912609723569141,0,23,regulation of histone H3-K9 methylation,BP,
14144,GO:0051571,1,0.94389484038109,0,14,positive regulation of histone H3-K4 methylation,BP,
14145,GO:0051572,1,0.983364752303497,0,4,negative regulation of histone H3-K4 methylation,BP,
14146,GO:0051573,1,0.955488575889634,0,12,negative regulation of histone H3-K9 methylation,BP,
14147,GO:0051574,1,0.959975681757572,0,10,positive regulation of histone H3-K9 methylation,BP,
14148,GO:0051575,1,0.970826140196694,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
14149,GO:0051580,1,0.915147477104067,0,12,regulation of neurotransmitter uptake,BP,
14150,GO:0051581,1,0.983171926866068,0,3,negative regulation of neurotransmitter uptake,BP,
14151,GO:0051582,1,0.968346357403003,0,3,positive regulation of neurotransmitter uptake,BP,
14152,GO:0051583,1,0.91148470225882,0,11,dopamine uptake involved in synaptic transmission,BP,
14153,GO:0051584,1,0.925770313450932,0,8,regulation of dopamine uptake involved in synaptic transmission,BP,
14154,GO:0051585,1,0.994565281223551,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
14155,GO:0051586,1,0.968346357403003,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
14156,GO:0051588,1,0.699493091906115,0,62,regulation of neurotransmitter transport,BP,
14157,GO:0051589,1,0.929758846903288,0,14,negative regulation of neurotransmitter transport,BP,
14158,GO:0051590,1,0.923866304642536,0,14,positive regulation of neurotransmitter transport,BP,
14160,GO:0051592,1,0.484430582194705,0,113,response to calcium ion,BP,
14161,GO:0051593,1,0.905137804729601,0,11,response to folic acid,BP,
14162,GO:0051594,1,0.962387460971173,0,4,detection of glucose,BP,
14163,GO:0051595,1,0.987855470429914,0,2,response to methylglyoxal,BP,
14164,GO:0051596,1,0.981937353467284,0,2,methylglyoxal catabolic process,BP,
14166,GO:0051598,1,0.988464927681145,0,2,meiotic recombination checkpoint,BP,
14167,GO:0051599,1,0.971370858912573,0,6,response to hydrostatic pressure,BP,
14168,GO:0051601,1,0.94000924501226,0,9,exocyst localization,BP,
14169,GO:0051602,1,0.749737859793724,0,40,response to electrical stimulus,BP,
14174,GO:0051608,1,0.910273382646703,0,11,histamine transport,BP,
14175,GO:0051610,1,0.982517877593495,0,4,serotonin uptake,BP,
14176,GO:0051611,1,0.983171926866068,0,3,regulation of serotonin uptake,BP,
14177,GO:0051612,1,0.983171926866068,0,3,negative regulation of serotonin uptake,BP,
14178,GO:0051615,1,0.999998021508324,0,1,histamine uptake,BP,
14179,GO:0051620,1,0.994565281223551,0,1,norepinephrine uptake,BP,
14180,GO:0051621,1,0.994565281223551,0,1,regulation of norepinephrine uptake,BP,
14181,GO:0051622,1,0.994565281223551,0,1,negative regulation of norepinephrine uptake,BP,
14182,GO:0051639,1,0.976040879246654,0,8,actin filament network formation,BP,
14183,GO:0051640,1,0.0670319186361117,0,482,organelle localization,BP,
14185,GO:0051642,1,0.931198776608031,0,21,centrosome localization,BP,
14186,GO:0051643,1,0.991657595187268,0,2,endoplasmic reticulum localization,BP,
14187,GO:0051645,1,0.925100891230036,0,12,Golgi localization,BP,
14188,GO:0051646,1,0.843736120419803,0,38,mitochondrion localization,BP,
14189,GO:0051647,1,0.925666663125821,0,21,nucleus localization,BP,
14190,GO:0051648,1,0.273145802107397,0,255,vesicle localization,BP,
14192,GO:0051650,1,0.288163335300017,0,239,establishment of vesicle localization,BP,
14193,GO:0051651,1,0.524006708335124,0,102,maintenance of location in cell,BP,
14194,GO:0051653,1,0.863873414757661,0,33,spindle localization,BP,
14195,GO:0051654,1,0.920622408465876,0,18,establishment of mitochondrion localization,BP,
14196,GO:0051656,1,0.0902049082189884,0,416,establishment of organelle localization,BP,
14197,GO:0051657,1,0.965809608281594,0,10,maintenance of organelle location,BP,
14198,GO:0051659,1,0.986651320143623,0,2,maintenance of mitochondrion location,BP,
14199,GO:0051660,1,0.991903871040941,0,4,establishment of centrosome localization,BP,
14200,GO:0051661,1,0.987196940630324,0,5,maintenance of centrosome location,BP,
14201,GO:0051664,1,0.998617805219,0,1,nuclear pore localization,BP,
14202,GO:0051665,1,0.920776079259102,0,10,membrane raft localization,BP,
14203,GO:0051668,1,0.630103744181498,0,80,localization within membrane,BP,
14204,GO:0051673,1,0.977693468367651,0,2,membrane disruption in other organism,BP,
14206,GO:0051683,1,0.943832610984625,0,7,establishment of Golgi localization,BP,
14207,GO:0051684,1,0.993125103191586,0,3,maintenance of Golgi location,BP,
14208,GO:0051685,1,0.991657600429728,0,1,maintenance of ER location,BP,
14209,GO:0051691,1,0.976086323172871,0,2,cellular oligosaccharide metabolic process,BP,
14210,GO:0051692,1,0.976086323172871,0,2,cellular oligosaccharide catabolic process,BP,
14213,GO:0051695,1,0.999339547477948,0,1,actin filament uncapping,BP,
14214,GO:0051697,1,0.961634491446106,0,4,protein delipidation,BP,
14215,GO:0051701,1,0.318115601904536,0,190,interaction with host,BP,
14216,GO:0051702,1,0.6343192654092,0,62,interaction with symbiont,BP,
14217,GO:0051703,1,0.810538340429328,0,47,intraspecies interaction between organisms,BP,
14219,GO:0051705,1,0.735183313776784,0,63,multi-organism behavior,BP,
14221,GO:0051708,1,0.962747994408797,0,5,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14222,GO:0051709,1,0.95039382978221,0,7,regulation of killing of cells of other organism,BP,
14223,GO:0051712,1,0.955707824106828,0,6,positive regulation of killing of cells of other organism,BP,
14224,GO:0051715,1,0.98271366919633,0,2,cytolysis in other organism,BP,
14226,GO:0051717,1,0.992997116037983,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14227,GO:0051721,1,0.908461606371487,0,25,protein phosphatase 2A binding,MF,
14228,GO:0051722,1,0.991216800521576,0,1,protein C-terminal methylesterase activity,MF,
14229,GO:0051723,1,0.991216800521576,0,1,protein methylesterase activity,MF,
14230,GO:0051724,1,0.990391082169678,0,1,NAD transporter activity,MF,
14231,GO:0051725,1,0.97195652777572,0,4,protein de-ADP-ribosylation,BP,
14233,GO:0051728,1,0.993696758730521,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14234,GO:0051729,1,0.993696758730521,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14235,GO:0051731,1,0.977302446189162,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14236,GO:0051732,1,0.988613664589566,0,1,polyribonucleotide kinase activity,MF,
14237,GO:0051733,1,0.977302454265726,0,3,polydeoxyribonucleotide kinase activity,MF,
14238,GO:0051734,1,0.977302454265726,0,3,ATP-dependent polynucleotide kinase activity,MF,
14239,GO:0051736,1,0.988613664589566,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14240,GO:0051747,1,0.987324446737428,0,1,cytosine C-5 DNA demethylase activity,MF,
14241,GO:0051748,1,0.989918033882649,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14242,GO:0051754,1,0.984334466438852,0,3,meiotic sister chromatid cohesion, centromeric,BP,
14243,GO:0051758,1,0.999999996375281,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14244,GO:0051764,1,0.954254056466841,0,12,actin crosslink formation,BP,
14245,GO:0051765,1,0.983787957227653,0,2,inositol tetrakisphosphate kinase activity,MF,
14246,GO:0051766,1,0.926467504420588,0,11,inositol trisphosphate kinase activity,MF,
14247,GO:0051767,1,0.902203685759448,0,17,nitric-oxide synthase biosynthetic process,BP,
14248,GO:0051769,1,0.902203685759448,0,17,regulation of nitric-oxide synthase biosynthetic process,BP,
14249,GO:0051770,1,0.930291746443,0,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,
14250,GO:0051771,1,0.969824309317699,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
14251,GO:0051775,1,0.918502242297209,0,11,response to redox state,BP,
14252,GO:0051780,1,0.998490135981731,0,1,behavioral response to nutrient,BP,
14253,GO:0051781,1,0.561406701439672,0,82,positive regulation of cell division,BP,
14254,GO:0051782,1,0.90974898699076,0,16,negative regulation of cell division,BP,
14255,GO:0051783,1,0.326649578768837,0,170,regulation of nuclear division,BP,
14256,GO:0051784,1,0.700994529984417,0,51,negative regulation of nuclear division,BP,
14257,GO:0051785,1,0.706375747702008,0,55,positive regulation of nuclear division,BP,
14258,GO:0051786,1,0.99527167571663,0,1,all-trans-retinol 13,14-reductase activity,MF,
14259,GO:0051787,1,0.919079313475045,0,13,misfolded protein binding,MF,
14260,GO:0051788,1,0.867950893524104,0,22,response to misfolded protein,BP,
14261,GO:0051790,1,0.970698994096517,0,4,short-chain fatty acid biosynthetic process,BP,
14262,GO:0051791,1,0.952964584967011,0,5,medium-chain fatty acid metabolic process,BP,
14263,GO:0051792,1,0.975901251501289,0,2,medium-chain fatty acid biosynthetic process,BP,
14264,GO:0051793,1,0.991903746081278,0,1,medium-chain fatty acid catabolic process,BP,
14265,GO:0051794,1,0.97631007498797,0,4,regulation of timing of catagen,BP,
14266,GO:0051795,1,0.97743318811877,0,3,positive regulation of timing of catagen,BP,
14267,GO:0051796,1,0.998851168465918,0,1,negative regulation of timing of catagen,BP,
14270,GO:0051799,1,0.983212913467065,0,4,negative regulation of hair follicle development,BP,
14271,GO:0051800,1,0.988857249741018,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14272,GO:0051801,1,0.98271366919633,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14273,GO:0051805,1,0.992340637996542,0,1,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14274,GO:0051806,1,0.480082825379397,0,124,entry into cell of other organism involved in symbiotic interaction,BP,
14275,GO:0051807,1,0.992340637996542,0,1,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14276,GO:0051808,1,0.991019208360606,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14277,GO:0051817,1,0.535657122926043,0,93,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,
14278,GO:0051818,1,0.890120500718686,0,12,disruption of cells of other organism involved in symbiotic interaction,BP,
14279,GO:0051821,1,0.999999996375045,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14280,GO:0051823,1,0.960162980150414,0,9,regulation of synapse structural plasticity,BP,
14281,GO:0051828,1,0.480082825379397,0,124,entry into other organism involved in symbiotic interaction,BP,
14282,GO:0051832,1,0.982552635856931,0,3,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14283,GO:0051834,1,0.982552635856931,0,3,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14284,GO:0051835,1,0.978138106696017,0,4,positive regulation of synapse structural plasticity,BP,
14285,GO:0051836,1,0.991019208360606,0,1,translocation of molecules into other organism involved in symbiotic interaction,BP,
14286,GO:0051851,1,0.649209127741842,0,58,modification by host of symbiont morphology or physiology,BP,
14287,GO:0051852,1,0.917523124583442,0,8,disruption by host of symbiont cells,BP,
14288,GO:0051861,1,0.852412014234083,0,19,glycolipid binding,MF,
14289,GO:0051864,1,0.99092469079139,0,5,histone demethylase activity (H3-K36 specific),MF,
14290,GO:0051865,1,0.740812637728535,0,53,protein autoubiquitination,BP,
14291,GO:0051866,1,0.983957414809097,0,2,general adaptation syndrome,BP,
14292,GO:0051867,1,0.987649110641854,0,1,general adaptation syndrome, behavioral process,BP,
14293,GO:0051870,1,0.972891651629516,0,3,methotrexate binding,MF,
14294,GO:0051873,1,0.917523124583442,0,8,killing by host of symbiont cells,BP,
14295,GO:0051875,1,0.825523644646852,0,26,pigment granule localization,BP,
14296,GO:0051877,1,0.986429899290701,0,2,pigment granule aggregation in cell center,BP,
14297,GO:0051878,1,0.996187099332432,0,1,lateral element assembly,BP,
14298,GO:0051879,1,0.842606350701081,0,31,Hsp90 protein binding,MF,
14299,GO:0051880,1,0.988214686271468,0,7,G-quadruplex DNA binding,MF,
14300,GO:0051881,1,0.603736015167173,0,60,regulation of mitochondrial membrane potential,BP,
14301,GO:0051882,1,0.848451194605911,0,22,mitochondrial depolarization,BP,
14302,GO:0051883,1,0.890120500718686,0,12,killing of cells in other organism involved in symbiotic interaction,BP,
14303,GO:0051884,1,0.986147377652695,0,4,regulation of timing of anagen,BP,
14304,GO:0051885,1,0.990411268749751,0,2,positive regulation of timing of anagen,BP,
14305,GO:0051886,1,0.999910262013799,0,1,negative regulation of timing of anagen,BP,
14306,GO:0051890,1,0.970177534822771,0,7,regulation of cardioblast differentiation,BP,
14307,GO:0051891,1,0.977809639366355,0,5,positive regulation of cardioblast differentiation,BP,
14308,GO:0051892,1,0.99219608449043,0,2,negative regulation of cardioblast differentiation,BP,
14309,GO:0051893,1,0.827227430167752,0,50,regulation of focal adhesion assembly,BP,
14310,GO:0051894,1,0.901768110720745,0,23,positive regulation of focal adhesion assembly,BP,
14311,GO:0051895,1,0.960313086667373,0,14,negative regulation of focal adhesion assembly,BP,
14314,GO:0051898,1,0.822632685923636,0,34,negative regulation of protein kinase B signaling,BP,
14315,GO:0051899,1,0.645974673716607,0,95,membrane depolarization,BP,
14316,GO:0051900,1,0.870444481317719,0,19,regulation of mitochondrial depolarization,BP,
14317,GO:0051901,1,0.927860828290793,0,9,positive regulation of mitochondrial depolarization,BP,
14318,GO:0051902,1,0.957112896788451,0,6,negative regulation of mitochondrial depolarization,BP,
14319,GO:0051903,1,0.992046703873699,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14320,GO:0051904,1,0.838925768623191,0,23,pigment granule transport,BP,
14321,GO:0051905,1,0.838925735752693,0,24,establishment of pigment granule localization,BP,
14322,GO:0051908,1,0.99472227106412,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14323,GO:0051916,1,0.99358714912321,0,1,granulocyte colony-stimulating factor binding,MF,
14324,GO:0051917,1,0.891041756887194,0,14,regulation of fibrinolysis,BP,
14325,GO:0051918,1,0.920284263240129,0,10,negative regulation of fibrinolysis,BP,
14326,GO:0051919,1,0.966353215946618,0,4,positive regulation of fibrinolysis,BP,
14327,GO:0051920,1,0.909618243548389,0,8,peroxiredoxin activity,MF,
14328,GO:0051923,1,0.87286868006888,0,16,sulfation,BP,
14330,GO:0051926,1,0.672487618227682,0,53,negative regulation of calcium ion transport,BP,
14332,GO:0051930,1,0.82693423985358,0,30,regulation of sensory perception of pain,BP,
14333,GO:0051931,1,0.82693423985358,0,30,regulation of sensory perception,BP,
14334,GO:0051932,1,0.839491386862477,0,38,synaptic transmission, GABAergic,BP,
14335,GO:0051933,1,0.9991452672785,0,4,amino acid neurotransmitter reuptake,BP,
14336,GO:0051934,1,0.91148470225882,0,11,catecholamine uptake involved in synaptic transmission,BP,
14337,GO:0051935,1,0.9991452672785,0,4,glutamate reuptake,BP,
14338,GO:0051937,1,0.643084225253401,0,60,catecholamine transport,BP,
14340,GO:0051939,1,0.999275054209641,0,1,gamma-aminobutyric acid import,BP,
14341,GO:0051940,1,0.925770313450932,0,8,regulation of catecholamine uptake involved in synaptic transmission,BP,
14342,GO:0051941,1,0.999987400791499,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14343,GO:0051944,1,0.968346357403003,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14344,GO:0051945,1,0.994565281223551,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14345,GO:0051946,1,0.999987400791499,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14346,GO:0051952,1,0.582806676015841,0,71,regulation of amine transport,BP,
14347,GO:0051953,1,0.861121375605493,0,22,negative regulation of amine transport,BP,
14348,GO:0051954,1,0.809817164245748,0,30,positive regulation of amine transport,BP,
14349,GO:0051955,1,0.843630671054808,0,27,regulation of amino acid transport,BP,
14350,GO:0051956,1,0.933643151097571,0,10,negative regulation of amino acid transport,BP,
14351,GO:0051957,1,0.90974126936861,0,15,positive regulation of amino acid transport,BP,
14352,GO:0051958,1,0.992964349354596,0,2,methotrexate transport,BP,
14353,GO:0051959,1,0.958148810396305,0,12,dynein light intermediate chain binding,MF,
14357,GO:0051963,1,0.759141656333493,0,75,regulation of synapse assembly,BP,
14358,GO:0051964,1,0.999223138456536,0,5,negative regulation of synapse assembly,BP,
14359,GO:0051965,1,0.801137527963029,0,57,positive regulation of synapse assembly,BP,
14360,GO:0051966,1,0.78942727046623,0,58,regulation of synaptic transmission, glutamatergic,BP,
14361,GO:0051967,1,0.894163643123568,0,14,negative regulation of synaptic transmission, glutamatergic,BP,
14362,GO:0051968,1,0.945161429116534,0,20,positive regulation of synaptic transmission, glutamatergic,BP,
14363,GO:0051969,1,0.876914784985693,0,16,regulation of transmission of nerve impulse,BP,
14364,GO:0051970,1,0.951552880992742,0,5,negative regulation of transmission of nerve impulse,BP,
14365,GO:0051971,1,0.945299798880903,0,7,positive regulation of transmission of nerve impulse,BP,
14366,GO:0051972,1,0.739297356285272,0,44,regulation of telomerase activity,BP,
14367,GO:0051973,1,0.788304605706209,0,35,positive regulation of telomerase activity,BP,
14368,GO:0051974,1,0.936407223292916,0,9,negative regulation of telomerase activity,BP,
14369,GO:0051977,1,0.977578208623933,0,2,lysophospholipid transport,BP,
14370,GO:0051978,1,0.990092304622051,0,1,lysophospholipid transporter activity,MF,
14371,GO:0051983,1,0.609552290271326,0,80,regulation of chromosome segregation,BP,
14372,GO:0051984,1,0.907225451700751,0,19,positive regulation of chromosome segregation,BP,
14373,GO:0051985,1,0.802532684563527,0,34,negative regulation of chromosome segregation,BP,
14374,GO:0051987,1,0.967417030171227,0,4,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14375,GO:0051988,1,0.931356854613741,0,11,regulation of attachment of spindle microtubules to kinetochore,BP,
14377,GO:0051996,1,0.989783393189947,0,1,squalene synthase activity,MF,
14378,GO:0051998,1,0.972427745919432,0,5,protein carboxyl O-methyltransferase activity,MF,
14379,GO:0052026,1,0.993133224664389,0,1,modulation by symbiont of host transcription,BP,
14380,GO:0052027,1,0.995096136888045,0,1,modulation by symbiont of host signal transduction pathway,BP,
14381,GO:0052031,1,0.978254710179525,0,2,modulation by symbiont of host defense response,BP,
14382,GO:0052040,1,0.969838514825233,0,5,modulation by symbiont of host programmed cell death,BP,
14383,GO:0052041,1,0.970062324161412,0,4,negative regulation by symbiont of host programmed cell death,BP,
14384,GO:0052042,1,0.987221357721054,0,2,positive regulation by symbiont of host programmed cell death,BP,
14385,GO:0052047,1,0.990837724979115,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14386,GO:0052053,1,0.992591137466873,0,1,negative regulation by symbiont of host catalytic activity,BP,
14387,GO:0052055,1,0.958272527397581,0,5,modulation by symbiont of host molecular function,BP,
14388,GO:0052056,1,0.992510394896914,0,2,negative regulation by symbiont of host molecular function,BP,
14389,GO:0052066,1,0.999999996378359,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14390,GO:0052097,1,0.995105658528154,0,1,interspecies quorum sensing,BP,
14391,GO:0052106,1,0.995105658528154,0,1,quorum sensing involved in interaction with host,BP,
14392,GO:0052126,1,0.801666730291599,0,35,movement in host environment,BP,
14393,GO:0052148,1,0.992591137466873,0,1,modulation by symbiont of host catalytic activity,BP,
14394,GO:0052150,1,0.969838514825233,0,5,modulation by symbiont of host apoptotic process,BP,
14395,GO:0052151,1,0.987221357721054,0,2,positive regulation by symbiont of host apoptotic process,BP,
14396,GO:0052173,1,0.958946182442131,0,6,response to defenses of other organism involved in symbiotic interaction,BP,
14397,GO:0052182,1,0.990837730402527,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14398,GO:0052190,1,0.999999996378359,0,1,modulation by symbiont of host phagocytosis,BP,
14399,GO:0052191,1,0.999999996378359,0,1,positive regulation by symbiont of host phagocytosis,BP,
14400,GO:0052192,1,0.801666730291599,0,35,movement in environment of other organism involved in symbiotic interaction,BP,
14401,GO:0052199,1,0.969392367389715,0,3,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14402,GO:0052200,1,0.958946182442131,0,6,response to host defenses,BP,
14403,GO:0052203,1,0.958350513070103,0,4,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14404,GO:0052204,1,0.935180732903378,0,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14405,GO:0052205,1,0.935180732903378,0,7,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14406,GO:0052212,1,0.990837730402527,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14407,GO:0052213,1,0.990837730402527,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14408,GO:0052214,1,0.988332745727326,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14409,GO:0052227,1,0.988332745727326,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14410,GO:0052229,1,0.988332745727326,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14411,GO:0052231,1,0.999999996378359,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14412,GO:0052248,1,0.969838514825233,0,5,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14413,GO:0052250,1,0.995096136888045,0,1,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14414,GO:0052251,1,0.978254710179525,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14415,GO:0052255,1,0.978254710179525,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14416,GO:0052312,1,0.84270609287499,0,26,modulation of transcription in other organism involved in symbiotic interaction,BP,
14417,GO:0052314,1,0.978668546357074,0,2,phytoalexin metabolic process,BP,
14418,GO:0052330,1,0.987221357721054,0,2,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14419,GO:0052331,1,0.98271366919633,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14420,GO:0052360,1,0.988332745727326,0,1,catabolism by host of symbiont macromolecule,BP,
14421,GO:0052361,1,0.988332745727326,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14422,GO:0052362,1,0.988332745727326,0,1,catabolism by host of symbiont protein,BP,
14423,GO:0052363,1,0.988332745727326,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14424,GO:0052364,1,0.988332745727326,0,1,catabolism by host of substance in symbiont,BP,
14425,GO:0052370,1,0.999999996378359,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14426,GO:0052381,1,0.98987282949776,0,1,tRNA dimethylallyltransferase activity,MF,
14427,GO:0052403,1,0.976629431674011,0,2,negative regulation by host of symbiont catalytic activity,BP,
14428,GO:0052405,1,0.942241072992161,0,5,negative regulation by host of symbiont molecular function,BP,
14429,GO:0052416,1,0.988332745727326,0,1,metabolism by host of symbiont macromolecule,BP,
14430,GO:0052417,1,0.988332745727326,0,1,metabolism by host of symbiont protein,BP,
14431,GO:0052418,1,0.988332745727326,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14432,GO:0052419,1,0.988332745727326,0,1,metabolism by host of substance in symbiont,BP,
14433,GO:0052422,1,0.958350513070103,0,4,modulation by host of symbiont catalytic activity,BP,
14434,GO:0052428,1,0.935256858603531,0,6,modification by host of symbiont molecular function,BP,
14435,GO:0052433,1,0.969838514825233,0,5,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14436,GO:0052472,1,0.848540406773284,0,25,modulation by host of symbiont transcription,BP,
14437,GO:0052490,1,0.970062324161412,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14438,GO:0052501,1,0.987221357721054,0,2,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14439,GO:0052509,1,0.978254710179525,0,2,positive regulation by symbiont of host defense response,BP,
14440,GO:0052510,1,0.978254710179525,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14441,GO:0052522,1,0.999999996378359,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14444,GO:0052550,1,0.988437274027011,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14445,GO:0052551,1,0.999388298832925,0,1,response to defense-related nitric oxide production by other organism involved in symbiotic interaction,BP,
14446,GO:0052552,1,0.978254710179525,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14447,GO:0052553,1,0.978254710179525,0,2,modulation by symbiont of host immune response,BP,
14448,GO:0052564,1,0.958946194048586,0,5,response to immune response of other organism involved in symbiotic interaction,BP,
14449,GO:0052565,1,0.999388298832925,0,1,response to defense-related host nitric oxide production,BP,
14450,GO:0052567,1,0.988437274027011,0,1,response to defense-related host reactive oxygen species production,BP,
14451,GO:0052572,1,0.958946194048586,0,5,response to host immune response,BP,
14452,GO:0052590,1,0.999999996372127,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14453,GO:0052591,1,0.999999996372127,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14454,GO:0052593,1,0.990095690178371,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14455,GO:0052594,1,0.990095690178371,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14456,GO:0052595,1,0.990095690178371,0,2,aliphatic-amine oxidase activity,MF,
14457,GO:0052596,1,0.990095690178371,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14458,GO:0052629,1,0.971078331060798,0,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14459,GO:0052642,1,0.980406434725514,0,2,lysophosphatidic acid phosphatase activity,MF,
14460,GO:0052646,1,0.95909847694682,0,8,alditol phosphate metabolic process,BP,
14461,GO:0052650,1,0.91110861222279,0,9,NADP-retinol dehydrogenase activity,MF,
14462,GO:0052651,1,0.980462316063355,0,2,monoacylglycerol catabolic process,BP,
14464,GO:0052654,1,0.988292552479546,0,2,L-leucine transaminase activity,MF,
14465,GO:0052655,1,0.988292552479546,0,2,L-valine transaminase activity,MF,
14466,GO:0052656,1,0.988292552479546,0,2,L-isoleucine transaminase activity,MF,
14467,GO:0052657,1,0.987879530616557,0,1,guanine phosphoribosyltransferase activity,MF,
14468,GO:0052658,1,0.977900819535381,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14469,GO:0052659,1,0.972325147722993,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14470,GO:0052666,1,0.989258807756115,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14473,GO:0052695,1,0.86185064028539,0,17,cellular glucuronidation,BP,
14474,GO:0052696,1,0.954771835543807,0,5,flavonoid glucuronidation,BP,
14475,GO:0052697,1,0.919124562396012,0,9,xenobiotic glucuronidation,BP,
14476,GO:0052723,1,0.979263481030559,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14477,GO:0052724,1,0.979263481030559,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14478,GO:0052725,1,0.994986386930573,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14479,GO:0052726,1,0.994986386930573,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14480,GO:0052731,1,0.98978154387629,0,1,phosphocholine phosphatase activity,MF,
14481,GO:0052732,1,0.98978154387629,0,1,phosphoethanolamine phosphatase activity,MF,
14484,GO:0052741,1,0.977072571603811,0,2,(R)-limonene 6-monooxygenase activity,MF,
14486,GO:0052743,1,0.965514543435692,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14487,GO:0052744,1,0.962745688216792,0,14,phosphatidylinositol monophosphate phosphatase activity,MF,
14488,GO:0052745,1,0.92915918682188,0,19,inositol phosphate phosphatase activity,MF,
14489,GO:0052746,1,0.999105366192616,0,1,inositol phosphorylation,BP,
14490,GO:0052794,1,0.960963087142419,0,4,exo-alpha-(2->3)-sialidase activity,MF,
14491,GO:0052795,1,0.960963087142419,0,4,exo-alpha-(2->6)-sialidase activity,MF,
14492,GO:0052796,1,0.960963087142419,0,4,exo-alpha-(2->8)-sialidase activity,MF,
14493,GO:0052798,1,0.989746516163076,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14494,GO:0052803,1,0.912306327826365,0,11,imidazole-containing compound metabolic process,BP,
14495,GO:0052805,1,0.946442079488147,0,7,imidazole-containing compound catabolic process,BP,
14496,GO:0052810,1,0.989279173753813,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14497,GO:0052811,1,0.986679835978567,0,5,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14498,GO:0052812,1,0.989142922739844,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14500,GO:0052815,1,0.983349348182706,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14501,GO:0052816,1,0.995782227266356,0,1,long-chain acyl-CoA hydrolase activity,MF,
14502,GO:0052817,1,0.995782227266356,0,1,very long chain acyl-CoA hydrolase activity,MF,
14503,GO:0052821,1,0.987440978919977,0,1,DNA-7-methyladenine glycosylase activity,MF,
14504,GO:0052822,1,0.987440978919977,0,1,DNA-3-methylguanine glycosylase activity,MF,
14505,GO:0052825,1,0.994986386930573,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14506,GO:0052826,1,0.993002887673498,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14507,GO:0052827,1,0.988024078217789,0,2,inositol pentakisphosphate phosphatase activity,MF,
14508,GO:0052828,1,0.998354845830292,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14509,GO:0052829,1,0.989722670023768,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14510,GO:0052830,1,0.994986386930573,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14511,GO:0052831,1,0.994986386930573,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14512,GO:0052832,1,0.97830098581565,0,4,inositol monophosphate 3-phosphatase activity,MF,
14513,GO:0052833,1,0.97830098581565,0,4,inositol monophosphate 4-phosphatase activity,MF,
14514,GO:0052834,1,0.97830098581565,0,4,inositol monophosphate phosphatase activity,MF,
14515,GO:0052835,1,0.994986386930573,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14516,GO:0052836,1,0.979307036126013,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14517,GO:0052839,1,0.979307036126013,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14518,GO:0052840,1,0.968037406610311,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14519,GO:0052841,1,0.968037406610311,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14520,GO:0052842,1,0.968037406610311,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14521,GO:0052843,1,0.968037406610311,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14522,GO:0052844,1,0.968037406610311,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14523,GO:0052845,1,0.968037406610311,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14524,GO:0052846,1,0.968037406610311,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14525,GO:0052847,1,0.968037406610311,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14526,GO:0052848,1,0.968037406610311,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14527,GO:0052851,1,0.997042029686486,0,3,ferric-chelate reductase (NADPH) activity,MF,
14528,GO:0052852,1,0.976973766431063,0,2,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14529,GO:0052853,1,0.976973766431063,0,2,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14530,GO:0052854,1,0.976973766431063,0,2,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14531,GO:0052858,1,0.996455222165833,0,1,peptidyl-lysine acetyltransferase activity,MF,
14532,GO:0052866,1,0.899188205764937,0,29,phosphatidylinositol phosphate phosphatase activity,MF,
14533,GO:0052869,1,0.990816583710127,0,1,arachidonic acid omega-hydroxylase activity,MF,
14534,GO:0052870,1,0.98459491770097,0,2,tocopherol omega-hydroxylase activity,MF,
14535,GO:0052871,1,0.98459491770097,0,2,alpha-tocopherol omega-hydroxylase activity,MF,
14536,GO:0052872,1,0.990816583710127,0,1,tocotrienol omega-hydroxylase activity,MF,
14537,GO:0052884,1,0.991917529713633,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14538,GO:0052885,1,0.991917529713633,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14539,GO:0052890,1,0.989133993605324,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14540,GO:0052894,1,0.989657149410863,0,1,norspermine:oxygen oxidoreductase activity,MF,
14541,GO:0052895,1,0.989657149410863,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14542,GO:0052899,1,0.98848070233315,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14543,GO:0052901,1,0.978256061103247,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14544,GO:0052902,1,0.98848070233315,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14545,GO:0052903,1,0.98848070233315,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14546,GO:0052904,1,0.98848070233315,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14547,GO:0052906,1,0.999950992792092,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14548,GO:0052907,1,0.991657600429728,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14549,GO:0052909,1,0.991657600429728,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14550,GO:0052917,1,0.990850439327305,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14551,GO:0052918,1,0.999999996374419,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14552,GO:0052925,1,0.988070281967543,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14553,GO:0052926,1,0.999999996374419,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14554,GO:0052927,1,0.990435569307827,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14555,GO:0052928,1,0.990435569307827,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14556,GO:0052929,1,0.990435569307827,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14557,GO:0055001,1,0.434537077926056,0,149,muscle cell development,BP,
14558,GO:0055002,1,0.473925726190294,0,134,striated muscle cell development,BP,
14559,GO:0055003,1,0.942569782280796,0,17,cardiac myofibril assembly,BP,
14560,GO:0055005,1,0.983266806875762,0,3,ventricular cardiac myofibril assembly,BP,
14561,GO:0055006,1,0.729162189629365,0,64,cardiac cell development,BP,
14562,GO:0055007,1,0.611297537630334,0,97,cardiac muscle cell differentiation,BP,
14563,GO:0055008,1,0.70834017666573,0,62,cardiac muscle tissue morphogenesis,BP,
14564,GO:0055009,1,0.950159011652873,0,7,atrial cardiac muscle tissue morphogenesis,BP,
14565,GO:0055010,1,0.775740919287088,0,47,ventricular cardiac muscle tissue morphogenesis,BP,
14566,GO:0055011,1,0.965234258878799,0,3,atrial cardiac muscle cell differentiation,BP,
14567,GO:0055012,1,0.891579938275813,0,18,ventricular cardiac muscle cell differentiation,BP,
14568,GO:0055013,1,0.738281067335663,0,59,cardiac muscle cell development,BP,
14569,GO:0055014,1,0.965234258878799,0,3,atrial cardiac muscle cell development,BP,
14570,GO:0055015,1,0.901836293452471,0,13,ventricular cardiac muscle cell development,BP,
14572,GO:0055018,1,0.988714122281553,0,1,regulation of cardiac muscle fiber development,BP,
14573,GO:0055020,1,0.988714122281553,0,1,positive regulation of cardiac muscle fiber development,BP,
14576,GO:0055023,1,0.868754045355579,0,29,positive regulation of cardiac muscle tissue growth,BP,
14578,GO:0055025,1,0.821785689716522,0,40,positive regulation of cardiac muscle tissue development,BP,
14580,GO:0055029,1,0.413795385580425,0,124,nuclear DNA-directed RNA polymerase complex,CC,
14582,GO:0055038,1,0.708816982454233,0,56,recycling endosome membrane,CC,
14583,GO:0055048,1,0.999999996379897,0,1,anastral spindle assembly,BP,
14584,GO:0055056,1,0.955823355314372,0,9,D-glucose transmembrane transporter activity,MF,
14585,GO:0055057,1,0.952651755177035,0,13,neuroblast division,BP,
14586,GO:0055059,1,0.980343626403362,0,5,asymmetric neuroblast division,BP,
14587,GO:0055062,1,0.941799246016758,0,12,phosphate ion homeostasis,BP,
14588,GO:0055064,1,0.974846720625242,0,5,chloride ion homeostasis,BP,
14591,GO:0055069,1,0.844265384059512,0,26,zinc ion homeostasis,BP,
14594,GO:0055073,1,0.984800115383681,0,2,cadmium ion homeostasis,BP,
14596,GO:0055075,1,0.933024049195594,0,15,potassium ion homeostasis,BP,
14598,GO:0055077,1,0.969559569629254,0,4,gap junction hemi-channel activity,MF,
14599,GO:0055078,1,0.739780297195547,0,43,sodium ion homeostasis,BP,
14603,GO:0055083,1,0.91809873864941,0,17,monovalent inorganic anion homeostasis,BP,
14606,GO:0055087,1,0.986121950612179,0,3,Ski complex,CC,
14608,GO:0055089,1,0.922646420090658,0,13,fatty acid homeostasis,BP,
14609,GO:0055090,1,0.746990595595873,0,32,acylglycerol homeostasis,BP,
14612,GO:0055093,1,0.885439395795906,0,19,response to hyperoxia,BP,
14614,GO:0055095,1,0.984389938098579,0,3,lipoprotein particle mediated signaling,BP,
14615,GO:0055096,1,0.984389938098579,0,3,low-density lipoprotein particle mediated signaling,BP,
14616,GO:0055098,1,0.915035824786723,0,16,response to low-density lipoprotein particle,BP,
14618,GO:0055100,1,0.985386969189725,0,3,adiponectin binding,MF,
14620,GO:0055103,1,0.994933742467394,0,1,ligase regulator activity,MF,
14621,GO:0055105,1,0.939987199120024,0,5,ubiquitin-protein transferase inhibitor activity,MF,
14622,GO:0055106,1,0.865449441876836,0,16,ubiquitin-protein transferase regulator activity,MF,
14623,GO:0055108,1,0.98932263108283,0,1,Golgi to transport vesicle transport,BP,
14624,GO:0055111,1,0.999998601942145,0,1,ingression involved in gastrulation with mouth forming second,BP,
14625,GO:0055113,1,0.999999996400657,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14627,GO:0055117,1,0.681184531690542,0,72,regulation of cardiac muscle contraction,BP,
14628,GO:0055118,1,0.979523198588877,0,5,negative regulation of cardiac muscle contraction,BP,
14629,GO:0055119,1,0.91761253653272,0,17,relaxation of cardiac muscle,BP,
14630,GO:0055120,1,0.987404495369061,0,1,striated muscle dense body,CC,
14631,GO:0055123,1,0.456410248752178,0,136,digestive system development,BP,
14632,GO:0055129,1,0.963332406677927,0,4,L-proline biosynthetic process,BP,
14633,GO:0055130,1,0.988247587492541,0,1,D-alanine catabolic process,BP,
14634,GO:0055131,1,0.948097380897843,0,6,C3HC4-type RING finger domain binding,MF,
14635,GO:0060001,1,0.999999996388424,0,1,minus-end directed microfilament motor activity,MF,
14636,GO:0060002,1,0.997439305094312,0,3,plus-end directed microfilament motor activity,MF,
14637,GO:0060003,1,0.999999992762095,0,2,copper ion export,BP,
14638,GO:0060004,1,0.918574276196902,0,18,reflex,BP,
14639,GO:0060005,1,0.98804288012125,0,4,vestibular reflex,BP,
14640,GO:0060007,1,0.998586914213064,0,1,linear vestibuloocular reflex,BP,
14641,GO:0060008,1,0.904456833442561,0,18,Sertoli cell differentiation,BP,
14642,GO:0060009,1,0.932976863452884,0,14,Sertoli cell development,BP,
14643,GO:0060010,1,0.995288210573114,0,1,Sertoli cell fate commitment,BP,
14644,GO:0060011,1,0.97292736751595,0,4,Sertoli cell proliferation,BP,
14645,GO:0060012,1,0.952238723568711,0,7,synaptic transmission, glycinergic,BP,
14646,GO:0060013,1,0.96961905168312,0,8,righting reflex,BP,
14647,GO:0060014,1,0.981035642055432,0,2,granulosa cell differentiation,BP,
14648,GO:0060016,1,0.987636361967201,0,1,granulosa cell development,BP,
14649,GO:0060017,1,0.961460941368289,0,7,parathyroid gland development,BP,
14650,GO:0060018,1,0.98429482553141,0,4,astrocyte fate commitment,BP,
14651,GO:0060019,1,0.937076651029664,0,9,radial glial cell differentiation,BP,
14652,GO:0060020,1,0.9566418452777,0,7,Bergmann glial cell differentiation,BP,
14653,GO:0060021,1,0.63489469568922,0,87,palate development,BP,
14654,GO:0060022,1,0.98049704320034,0,6,hard palate development,BP,
14655,GO:0060023,1,0.983837888349143,0,5,soft palate development,BP,
14656,GO:0060024,1,0.987558793589034,0,4,rhythmic synaptic transmission,BP,
14657,GO:0060025,1,0.999347325761764,0,2,regulation of synaptic activity,BP,
14658,GO:0060026,1,0.920580095938625,0,15,convergent extension,BP,
14659,GO:0060027,1,0.967820913986679,0,8,convergent extension involved in gastrulation,BP,
14660,GO:0060028,1,0.9635896463639,0,7,convergent extension involved in axis elongation,BP,
14661,GO:0060029,1,0.964754041563254,0,6,convergent extension involved in organogenesis,BP,
14662,GO:0060031,1,0.989150192007311,0,2,mediolateral intercalation,BP,
14663,GO:0060032,1,0.996043802539177,0,2,notochord regression,BP,
14664,GO:0060033,1,0.936104210685233,0,11,anatomical structure regression,BP,
14665,GO:0060034,1,0.997936442410314,0,1,notochord cell differentiation,BP,
14666,GO:0060035,1,0.997936442410314,0,1,notochord cell development,BP,
14667,GO:0060037,1,0.864100708121418,0,24,pharyngeal system development,BP,
14669,GO:0060039,1,0.924207963610839,0,20,pericardium development,BP,
14670,GO:0060040,1,0.964213287561016,0,4,retinal bipolar neuron differentiation,BP,
14675,GO:0060045,1,0.908174747679528,0,22,positive regulation of cardiac muscle cell proliferation,BP,
14676,GO:0060046,1,0.837509865719649,0,19,regulation of acrosome reaction,BP,
14678,GO:0060048,1,0.506251858383356,0,122,cardiac muscle contraction,BP,
14679,GO:0060049,1,0.894416391668066,0,17,regulation of protein glycosylation,BP,
14680,GO:0060050,1,0.952818276994341,0,8,positive regulation of protein glycosylation,BP,
14681,GO:0060051,1,0.971230997887253,0,3,negative regulation of protein glycosylation,BP,
14682,GO:0060052,1,0.958442660625065,0,9,neurofilament cytoskeleton organization,BP,
14683,GO:0060053,1,0.990897166449356,0,2,neurofilament cytoskeleton,CC,
14684,GO:0060054,1,0.937399354951168,0,7,positive regulation of epithelial cell proliferation involved in wound healing,BP,
14685,GO:0060055,1,0.900298375277767,0,18,angiogenesis involved in wound healing,BP,
14686,GO:0060056,1,0.942678789723482,0,9,mammary gland involution,BP,
14687,GO:0060057,1,0.985489173324558,0,3,apoptotic process involved in mammary gland involution,BP,
14688,GO:0060058,1,0.985489173324558,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
14690,GO:0060060,1,0.994368908741436,0,2,post-embryonic retina morphogenesis in camera-type eye,BP,
14691,GO:0060061,1,0.978598727057313,0,3,Spemann organizer formation,BP,
14692,GO:0060064,1,0.988025457538679,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14694,GO:0060066,1,0.974966957446866,0,3,oviduct development,BP,
14695,GO:0060067,1,0.990463996385486,0,2,cervix development,BP,
14699,GO:0060072,1,0.997224426362812,0,2,large conductance calcium-activated potassium channel activity,MF,
14700,GO:0060073,1,0.96727509362966,0,7,micturition,BP,
14701,GO:0060074,1,0.95107149303144,0,17,synapse maturation,BP,
14702,GO:0060075,1,0.981257334214457,0,6,regulation of resting membrane potential,BP,
14703,GO:0060076,1,0.92509858299369,0,25,excitatory synapse,CC,
14704,GO:0060077,1,0.933423368109878,0,12,inhibitory synapse,CC,
14707,GO:0060080,1,0.959575707236966,0,14,inhibitory postsynaptic potential,BP,
14708,GO:0060081,1,0.931989702782123,0,12,membrane hyperpolarization,BP,
14709,GO:0060083,1,0.993463664622966,0,3,smooth muscle contraction involved in micturition,BP,
14710,GO:0060084,1,0.983411778022771,0,3,synaptic transmission involved in micturition,BP,
14711,GO:0060086,1,0.987044096049705,0,2,circadian temperature homeostasis,BP,
14712,GO:0060087,1,0.954728873145533,0,6,relaxation of vascular smooth muscle,BP,
14713,GO:0060088,1,0.945800603299336,0,10,auditory receptor cell stereocilium organization,BP,
14716,GO:0060091,1,0.932896804785273,0,9,kinocilium,CC,
14717,GO:0060099,1,0.935895048664618,0,11,regulation of phagocytosis, engulfment,BP,
14718,GO:0060100,1,0.953684217626157,0,9,positive regulation of phagocytosis, engulfment,BP,
14719,GO:0060101,1,0.989031885238146,0,1,negative regulation of phagocytosis, engulfment,BP,
14720,GO:0060112,1,0.976229216524845,0,2,generation of ovulation cycle rhythm,BP,
14721,GO:0060113,1,0.734213558484785,0,52,inner ear receptor cell differentiation,BP,
14722,GO:0060114,1,0.987357048219781,0,1,vestibular receptor cell differentiation,BP,
14723,GO:0060117,1,0.917634130803255,0,18,auditory receptor cell development,BP,
14724,GO:0060118,1,0.987357048219781,0,1,vestibular receptor cell development,BP,
14725,GO:0060119,1,0.808626173873806,0,38,inner ear receptor cell development,BP,
14726,GO:0060120,1,0.954475872934377,0,6,inner ear receptor cell fate commitment,BP,
14727,GO:0060122,1,0.854725412386329,0,24,inner ear receptor stereocilium organization,BP,
14728,GO:0060123,1,0.932570078028574,0,11,regulation of growth hormone secretion,BP,
14729,GO:0060124,1,0.932570127651874,0,8,positive regulation of growth hormone secretion,BP,
14730,GO:0060125,1,0.999999992747961,0,2,negative regulation of growth hormone secretion,BP,
14731,GO:0060126,1,0.952369451824604,0,5,somatotropin secreting cell differentiation,BP,
14732,GO:0060127,1,0.990270970834262,0,1,prolactin secreting cell differentiation,BP,
14733,GO:0060128,1,0.981938325492828,0,2,corticotropin hormone secreting cell differentiation,BP,
14734,GO:0060129,1,0.979727035254492,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14735,GO:0060133,1,0.975648610579817,0,2,somatotropin secreting cell development,BP,
14736,GO:0060134,1,0.939643368017813,0,13,prepulse inhibition,BP,
14737,GO:0060135,1,0.695405522193541,0,59,maternal process involved in female pregnancy,BP,
14738,GO:0060136,1,0.968717234358444,0,5,embryonic process involved in female pregnancy,BP,
14739,GO:0060137,1,0.938291347729727,0,9,maternal process involved in parturition,BP,
14740,GO:0060139,1,0.987221357721054,0,2,positive regulation of apoptotic process by virus,BP,
14741,GO:0060142,1,0.791249145405644,0,26,regulation of syncytium formation by plasma membrane fusion,BP,
14742,GO:0060143,1,0.809969638300704,0,24,positive regulation of syncytium formation by plasma membrane fusion,BP,
14743,GO:0060147,1,0.851832201913773,0,32,regulation of posttranscriptional gene silencing,BP,
14744,GO:0060148,1,0.885919012610568,0,21,positive regulation of posttranscriptional gene silencing,BP,
14745,GO:0060149,1,0.952073443949527,0,12,negative regulation of posttranscriptional gene silencing,BP,
14746,GO:0060151,1,0.998378598996213,0,2,peroxisome localization,BP,
14747,GO:0060152,1,0.998378598996213,0,2,microtubule-based peroxisome localization,BP,
14748,GO:0060154,1,0.978547353129366,0,3,cellular process regulating host cell cycle in response to virus,BP,
14749,GO:0060155,1,0.935748534187233,0,8,platelet dense granule organization,BP,
14751,GO:0060158,1,0.872299102506125,0,13,phospholipase C-activating dopamine receptor signaling pathway,BP,
14752,GO:0060159,1,0.931480521193189,0,10,regulation of dopamine receptor signaling pathway,BP,
14753,GO:0060160,1,0.973395507753989,0,3,negative regulation of dopamine receptor signaling pathway,BP,
14754,GO:0060161,1,0.969593131583521,0,5,positive regulation of dopamine receptor signaling pathway,BP,
14755,GO:0060163,1,0.978955423168576,0,2,subpallium neuron fate commitment,BP,
14756,GO:0060164,1,0.961959621331342,0,4,regulation of timing of neuron differentiation,BP,
14757,GO:0060165,1,0.991273856262465,0,1,regulation of timing of subpallium neuron differentiation,BP,
14758,GO:0060166,1,0.975467853141203,0,3,olfactory pit development,BP,
14759,GO:0060167,1,0.979721798788203,0,3,regulation of adenosine receptor signaling pathway,BP,
14760,GO:0060168,1,0.991511329487869,0,2,positive regulation of adenosine receptor signaling pathway,BP,
14761,GO:0060169,1,0.98811033555713,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14762,GO:0060170,1,0.603076889721074,0,81,ciliary membrane,CC,
14763,GO:0060171,1,0.99962392502647,0,2,stereocilium membrane,CC,
14764,GO:0060173,1,0.431777655120627,0,164,limb development,BP,
14765,GO:0060174,1,0.959683181527798,0,10,limb bud formation,BP,
14766,GO:0060175,1,0.999999996379375,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14767,GO:0060177,1,0.908556803577309,0,13,regulation of angiotensin metabolic process,BP,
14768,GO:0060178,1,0.990362895858321,0,1,regulation of exocyst localization,BP,
14770,GO:0060180,1,0.936532249276644,0,9,female mating behavior,BP,
14771,GO:0060184,1,0.993696758730521,0,1,cell cycle switching,BP,
14772,GO:0060187,1,0.99949653460272,0,2,cell pole,CC,
14776,GO:0060197,1,0.977473725033133,0,3,cloacal septation,BP,
14777,GO:0060198,1,0.907495252490529,0,12,clathrin-sculpted vesicle,CC,
14778,GO:0060199,1,0.97159764782435,0,4,clathrin-sculpted glutamate transport vesicle,CC,
14779,GO:0060200,1,0.978844595632201,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14780,GO:0060201,1,0.978844595632201,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14781,GO:0060203,1,0.97159764782435,0,4,clathrin-sculpted glutamate transport vesicle membrane,CC,
14783,GO:0060211,1,0.934208221986716,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14784,GO:0060212,1,0.988824331714101,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14785,GO:0060213,1,0.934208221986716,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14786,GO:0060214,1,0.961977285217953,0,4,endocardium formation,BP,
14787,GO:0060215,1,0.954191561999567,0,9,primitive hemopoiesis,BP,
14788,GO:0060216,1,0.925045907121733,0,19,definitive hemopoiesis,BP,
14789,GO:0060217,1,0.999827246618124,0,1,hemangioblast cell differentiation,BP,
14790,GO:0060218,1,0.909539016484594,0,17,hematopoietic stem cell differentiation,BP,
14791,GO:0060219,1,0.924686779315122,0,16,camera-type eye photoreceptor cell differentiation,BP,
14792,GO:0060221,1,0.980025661200165,0,3,retinal rod cell differentiation,BP,
14794,GO:0060229,1,0.893416588766421,0,13,lipase activator activity,MF,
14795,GO:0060230,1,0.964329181381501,0,3,lipoprotein lipase activator activity,MF,
14796,GO:0060231,1,0.882366974659776,0,20,mesenchymal to epithelial transition,BP,
14797,GO:0060232,1,0.98613876821367,0,2,delamination,BP,
14798,GO:0060235,1,0.980282908518484,0,4,lens induction in camera-type eye,BP,
14799,GO:0060236,1,0.846078365561955,0,23,regulation of mitotic spindle organization,BP,
14800,GO:0060242,1,0.960853653816362,0,9,contact inhibition,BP,
14801,GO:0060243,1,0.998734465325686,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14802,GO:0060244,1,0.977365211194067,0,4,negative regulation of cell proliferation involved in contact inhibition,BP,
14803,GO:0060245,1,0.997145662464174,0,1,detection of cell density,BP,
14804,GO:0060246,1,0.997145662464174,0,1,detection of cell density by contact stimulus,BP,
14805,GO:0060248,1,0.997145662464174,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14807,GO:0060251,1,0.880542761485812,0,24,regulation of glial cell proliferation,BP,
14808,GO:0060252,1,0.951428128945893,0,10,positive regulation of glial cell proliferation,BP,
14809,GO:0060253,1,0.925196735470035,0,13,negative regulation of glial cell proliferation,BP,
14810,GO:0060254,1,0.988803713154355,0,1,regulation of N-terminal protein palmitoylation,BP,
14812,GO:0060259,1,0.867383790434066,0,20,regulation of feeding behavior,BP,
14815,GO:0060262,1,0.988803713154355,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14816,GO:0060263,1,0.902068971054082,0,11,regulation of respiratory burst,BP,
14817,GO:0060264,1,0.954371342512747,0,4,regulation of respiratory burst involved in inflammatory response,BP,
14818,GO:0060265,1,0.976267511083389,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14819,GO:0060266,1,0.965125842355629,0,3,negative regulation of respiratory burst involved in inflammatory response,BP,
14820,GO:0060267,1,0.953451520835888,0,5,positive regulation of respiratory burst,BP,
14821,GO:0060268,1,0.965125831934908,0,4,negative regulation of respiratory burst,BP,
14822,GO:0060271,1,0.17401192015368,0,305,cilium assembly,BP,
14823,GO:0060272,1,0.913965524803969,0,12,embryonic skeletal joint morphogenesis,BP,
14824,GO:0060278,1,0.975552182963878,0,3,regulation of ovulation,BP,
14825,GO:0060279,1,0.984790655476666,0,2,positive regulation of ovulation,BP,
14826,GO:0060280,1,0.990619980762556,0,1,negative regulation of ovulation,BP,
14827,GO:0060281,1,0.947094113005668,0,9,regulation of oocyte development,BP,
14828,GO:0060282,1,0.978101312237717,0,4,positive regulation of oocyte development,BP,
14829,GO:0060283,1,0.977251259074416,0,4,negative regulation of oocyte development,BP,
14831,GO:0060285,1,0.854650262410855,0,23,cilium-dependent cell motility,BP,
14832,GO:0060287,1,0.955995461858546,0,8,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14833,GO:0060290,1,0.958970898226977,0,8,transdifferentiation,BP,
14835,GO:0060292,1,0.914905272556946,0,23,long term synaptic depression,BP,
14836,GO:0060293,1,0.913995305964054,0,16,germ plasm,CC,
14837,GO:0060294,1,0.868806045385283,0,14,cilium movement involved in cell motility,BP,
14838,GO:0060295,1,0.960383716109568,0,5,regulation of cilium movement involved in cell motility,BP,
14839,GO:0060296,1,0.960383716109568,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14840,GO:0060297,1,0.960413646606122,0,7,regulation of sarcomere organization,BP,
14841,GO:0060298,1,0.972278036234989,0,4,positive regulation of sarcomere organization,BP,
14842,GO:0060299,1,0.987800053657777,0,1,negative regulation of sarcomere organization,BP,
14843,GO:0060300,1,0.967615226018577,0,4,regulation of cytokine activity,BP,
14844,GO:0060301,1,0.991322336389918,0,1,positive regulation of cytokine activity,BP,
14845,GO:0060302,1,0.977468498965358,0,2,negative regulation of cytokine activity,BP,
14846,GO:0060304,1,0.993925878831934,0,1,regulation of phosphatidylinositol dephosphorylation,BP,
14847,GO:0060305,1,0.99304146129124,0,1,regulation of cell diameter,BP,
14848,GO:0060306,1,0.868174682868284,0,29,regulation of membrane repolarization,BP,
14849,GO:0060307,1,0.916606139603406,0,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,
14850,GO:0060309,1,0.974724212041274,0,2,elastin catabolic process,BP,
14851,GO:0060310,1,0.987230933638233,0,1,regulation of elastin catabolic process,BP,
14852,GO:0060311,1,0.987230933638233,0,1,negative regulation of elastin catabolic process,BP,
14853,GO:0060312,1,0.953915884563044,0,9,regulation of blood vessel remodeling,BP,
14854,GO:0060313,1,0.98717947851599,0,3,negative regulation of blood vessel remodeling,BP,
14855,GO:0060314,1,0.859634829317537,0,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,
14856,GO:0060315,1,0.915542737304992,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14857,GO:0060316,1,0.948696318265518,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14858,GO:0060317,1,0.815278892071277,0,31,cardiac epithelial to mesenchymal transition,BP,
14859,GO:0060318,1,0.974391916107012,0,5,definitive erythrocyte differentiation,BP,
14860,GO:0060319,1,0.969210428157103,0,5,primitive erythrocyte differentiation,BP,
14862,GO:0060323,1,0.842490312982555,0,33,head morphogenesis,BP,
14863,GO:0060324,1,0.807407720484658,0,46,face development,BP,
14864,GO:0060325,1,0.880067190004031,0,28,face morphogenesis,BP,
14866,GO:0060327,1,0.992543664014755,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14867,GO:0060330,1,0.846378950162328,0,21,regulation of response to interferon-gamma,BP,
14868,GO:0060331,1,0.955977389870069,0,4,negative regulation of response to interferon-gamma,BP,
14869,GO:0060332,1,0.981752956103682,0,4,positive regulation of response to interferon-gamma,BP,
14871,GO:0060334,1,0.850708670344226,0,20,regulation of interferon-gamma-mediated signaling pathway,BP,
14872,GO:0060335,1,0.981752956103682,0,4,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14873,GO:0060336,1,0.955977389870069,0,4,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14876,GO:0060339,1,0.960928171504251,0,6,negative regulation of type I interferon-mediated signaling pathway,BP,
14879,GO:0060342,1,0.98170695775104,0,2,photoreceptor inner segment membrane,CC,
14881,GO:0060345,1,0.995459856190394,0,1,spleen trabecula formation,BP,
14882,GO:0060346,1,0.95789135314943,0,10,bone trabecula formation,BP,
14887,GO:0060351,1,0.884081410946215,0,23,cartilage development involved in endochondral bone morphogenesis,BP,
14888,GO:0060352,1,0.944275373902232,0,7,cell adhesion molecule production,BP,
14889,GO:0060353,1,0.951718102680125,0,5,regulation of cell adhesion molecule production,BP,
14890,GO:0060354,1,0.987294093381271,0,1,negative regulation of cell adhesion molecule production,BP,
14891,GO:0060355,1,0.963969749009078,0,4,positive regulation of cell adhesion molecule production,BP,
14892,GO:0060356,1,0.990387049638992,0,1,leucine import,BP,
14894,GO:0060363,1,0.926209416181035,0,9,cranial suture morphogenesis,BP,
14895,GO:0060364,1,0.975131507248257,0,4,frontal suture morphogenesis,BP,
14896,GO:0060366,1,0.999999996385791,0,1,lambdoid suture morphogenesis,BP,
14897,GO:0060367,1,0.999999996385791,0,1,sagittal suture morphogenesis,BP,
14898,GO:0060368,1,0.95479137578594,0,7,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14899,GO:0060369,1,0.975215342199701,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14900,GO:0060370,1,0.987410593284206,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14901,GO:0060371,1,0.982047609088621,0,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,
14902,GO:0060372,1,0.974954039483479,0,6,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14903,GO:0060373,1,0.97450349813116,0,6,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
14904,GO:0060374,1,0.988769915897326,0,5,mast cell differentiation,BP,
14905,GO:0060375,1,0.994761856363989,0,2,regulation of mast cell differentiation,BP,
14906,GO:0060377,1,0.994933742467394,0,1,negative regulation of mast cell differentiation,BP,
14907,GO:0060378,1,0.999999996383287,0,1,regulation of brood size,BP,
14908,GO:0060379,1,0.954917489282585,0,11,cardiac muscle cell myoblast differentiation,BP,
14909,GO:0060380,1,0.989619282044019,0,1,regulation of single-stranded telomeric DNA binding,BP,
14910,GO:0060381,1,0.989619282044019,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14911,GO:0060382,1,0.998360578038849,0,2,regulation of DNA strand elongation,BP,
14912,GO:0060383,1,0.998360581988621,0,1,positive regulation of DNA strand elongation,BP,
14913,GO:0060384,1,0.927468065871759,0,25,innervation,BP,
14914,GO:0060385,1,0.975709100159157,0,5,axonogenesis involved in innervation,BP,
14915,GO:0060386,1,0.999999813571415,0,1,synapse assembly involved in innervation,BP,
14916,GO:0060389,1,0.657434347669491,0,63,pathway-restricted SMAD protein phosphorylation,BP,
14917,GO:0060390,1,0.910435420087559,0,16,regulation of SMAD protein import into nucleus,BP,
14918,GO:0060391,1,0.93953871254086,0,12,positive regulation of SMAD protein import into nucleus,BP,
14919,GO:0060392,1,0.969187374522273,0,3,negative regulation of SMAD protein import into nucleus,BP,
14920,GO:0060393,1,0.658112217880557,0,60,regulation of pathway-restricted SMAD protein phosphorylation,BP,
14921,GO:0060394,1,0.929772016852308,0,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14922,GO:0060395,1,0.70584092354312,0,56,SMAD protein signal transduction,BP,
14925,GO:0060398,1,0.986652318291745,0,4,regulation of growth hormone receptor signaling pathway,BP,
14926,GO:0060399,1,0.987165874662523,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14927,GO:0060400,1,0.999479822754856,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14930,GO:0060404,1,0.996799869058843,0,1,axonemal microtubule depolymerization,BP,
14931,GO:0060405,1,0.967718346784261,0,6,regulation of penile erection,BP,
14932,GO:0060406,1,0.97936458860005,0,4,positive regulation of penile erection,BP,
14933,GO:0060407,1,0.98811033555713,0,1,negative regulation of penile erection,BP,
14934,GO:0060411,1,0.726510231732084,0,62,cardiac septum morphogenesis,BP,
14935,GO:0060412,1,0.844373072078339,0,36,ventricular septum morphogenesis,BP,
14936,GO:0060413,1,0.927177977788957,0,15,atrial septum morphogenesis,BP,
14937,GO:0060414,1,0.994075086743753,0,3,aorta smooth muscle tissue morphogenesis,BP,
14938,GO:0060415,1,0.664586754237096,0,73,muscle tissue morphogenesis,BP,
14942,GO:0060421,1,0.848523835638608,0,33,positive regulation of heart growth,BP,
14943,GO:0060422,1,0.99051296294005,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14944,GO:0060423,1,0.979344127328616,0,3,foregut regionalization,BP,
14945,GO:0060424,1,0.979344127328616,0,3,lung field specification,BP,
14946,GO:0060425,1,0.735954709669203,0,52,lung morphogenesis,BP,
14947,GO:0060426,1,0.955357487409023,0,6,lung vasculature development,BP,
14948,GO:0060428,1,0.780623591941912,0,40,lung epithelium development,BP,
14950,GO:0060430,1,0.959787458003552,0,7,lung saccule development,BP,
14951,GO:0060431,1,0.964587200277772,0,5,primary lung bud formation,BP,
14952,GO:0060432,1,0.98718161050591,0,1,lung pattern specification process,BP,
14953,GO:0060433,1,0.9264134036317,0,11,bronchus development,BP,
14954,GO:0060434,1,0.991174069743851,0,2,bronchus morphogenesis,BP,
14955,GO:0060435,1,0.965586136322741,0,3,bronchiole development,BP,
14956,GO:0060436,1,0.98718161050591,0,1,bronchiole morphogenesis,BP,
14957,GO:0060437,1,0.969596180486957,0,5,lung growth,BP,
14958,GO:0060438,1,0.895608278173807,0,19,trachea development,BP,
14959,GO:0060439,1,0.93205591495136,0,11,trachea morphogenesis,BP,
14960,GO:0060440,1,0.962368928439255,0,6,trachea formation,BP,
14961,GO:0060441,1,0.836432002949281,0,29,epithelial tube branching involved in lung morphogenesis,BP,
14962,GO:0060442,1,0.945198776043525,0,12,branching involved in prostate gland morphogenesis,BP,
14963,GO:0060443,1,0.803095116784529,0,45,mammary gland morphogenesis,BP,
14964,GO:0060444,1,0.894364641452012,0,23,branching involved in mammary gland duct morphogenesis,BP,
14965,GO:0060445,1,0.890130647343979,0,23,branching involved in salivary gland morphogenesis,BP,
14966,GO:0060446,1,0.991648557536278,0,1,branching involved in open tracheal system development,BP,
14967,GO:0060447,1,0.975519116807593,0,3,bud outgrowth involved in lung branching,BP,
14968,GO:0060448,1,0.987952050756203,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14969,GO:0060449,1,0.952177691088702,0,7,bud elongation involved in lung branching,BP,
14970,GO:0060450,1,0.987159241441705,0,1,positive regulation of hindgut contraction,BP,
14971,GO:0060452,1,0.921495049240953,0,11,positive regulation of cardiac muscle contraction,BP,
14972,GO:0060453,1,0.930872404104596,0,10,regulation of gastric acid secretion,BP,
14973,GO:0060454,1,0.993578049024889,0,2,positive regulation of gastric acid secretion,BP,
14974,GO:0060455,1,0.950826523202093,0,5,negative regulation of gastric acid secretion,BP,
14975,GO:0060456,1,0.906603008378088,0,11,positive regulation of digestive system process,BP,
14976,GO:0060457,1,0.882045424674332,0,16,negative regulation of digestive system process,BP,
14977,GO:0060458,1,0.979933715323337,0,2,right lung development,BP,
14978,GO:0060459,1,0.96848663845074,0,3,left lung development,BP,
14979,GO:0060460,1,0.980065717074346,0,2,left lung morphogenesis,BP,
14980,GO:0060461,1,0.991648557536278,0,1,right lung morphogenesis,BP,
14981,GO:0060462,1,0.975096412431741,0,7,lung lobe development,BP,
14982,GO:0060463,1,0.975096412431741,0,7,lung lobe morphogenesis,BP,
14983,GO:0060465,1,0.991466054788005,0,2,pharynx development,BP,
14984,GO:0060466,1,0.999999996377419,0,1,activation of meiosis involved in egg activation,BP,
14985,GO:0060467,1,0.937945525059324,0,6,negative regulation of fertilization,BP,
14986,GO:0060468,1,0.978261341630054,0,2,prevention of polyspermy,BP,
14987,GO:0060473,1,0.987692946890955,0,1,cortical granule,CC,
14988,GO:0060474,1,0.957908426403787,0,4,positive regulation of flagellated sperm motility involved in capacitation,BP,
14989,GO:0060478,1,0.967234023339823,0,4,acrosomal vesicle exocytosis,BP,
14990,GO:0060479,1,0.842977055531402,0,27,lung cell differentiation,BP,
14991,GO:0060480,1,0.952665837267176,0,4,lung goblet cell differentiation,BP,
14992,GO:0060481,1,0.950543275060194,0,5,lobar bronchus epithelium development,BP,
14993,GO:0060482,1,0.948428716789428,0,6,lobar bronchus development,BP,
14994,GO:0060484,1,0.939252436374759,0,10,lung-associated mesenchyme development,BP,
14995,GO:0060485,1,0.229074491709137,0,234,mesenchyme development,BP,
14996,GO:0060486,1,0.977386571008016,0,4,Clara cell differentiation,BP,
14997,GO:0060487,1,0.846550394200845,0,26,lung epithelial cell differentiation,BP,
14998,GO:0060488,1,0.999967673746301,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14999,GO:0060489,1,0.999967673746301,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
15000,GO:0060490,1,0.999967673746301,0,2,lateral sprouting involved in lung morphogenesis,BP,
15002,GO:0060492,1,0.979344127328616,0,3,lung induction,BP,
15003,GO:0060495,1,0.98718161050591,0,1,cell-cell signaling involved in lung development,BP,
15004,GO:0060496,1,0.98718161050591,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
15005,GO:0060501,1,0.96816169685235,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
15006,GO:0060502,1,0.947309583689176,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
15007,GO:0060503,1,0.988714122281553,0,1,bud dilation involved in lung branching,BP,
15008,GO:0060509,1,0.979495054379172,0,5,Type I pneumocyte differentiation,BP,
15009,GO:0060510,1,0.961745930904247,0,5,Type II pneumocyte differentiation,BP,
15010,GO:0060512,1,0.868156251211102,0,28,prostate gland morphogenesis,BP,
15011,GO:0060513,1,0.945925078133591,0,10,prostatic bud formation,BP,
15012,GO:0060514,1,0.993952691954143,0,1,prostate induction,BP,
15013,GO:0060515,1,0.993952691954143,0,1,prostate field specification,BP,
15014,GO:0060516,1,0.986034133382028,0,2,primary prostatic bud elongation,BP,
15015,GO:0060517,1,0.997821323322562,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
15016,GO:0060520,1,0.993952691954143,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
15017,GO:0060523,1,0.986575538460181,0,3,prostate epithelial cord elongation,BP,
15018,GO:0060525,1,0.967259313510274,0,11,prostate glandular acinus development,BP,
15019,GO:0060526,1,0.982201467177681,0,6,prostate glandular acinus morphogenesis,BP,
15020,GO:0060527,1,0.982201467177681,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
15021,GO:0060528,1,0.98530513804002,0,4,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
15022,GO:0060529,1,0.997846485733158,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
15023,GO:0060532,1,0.996745614389641,0,2,bronchus cartilage development,BP,
15024,GO:0060534,1,0.965430916781732,0,8,trachea cartilage development,BP,
15025,GO:0060535,1,0.980090488439342,0,4,trachea cartilage morphogenesis,BP,
15029,GO:0060539,1,0.947893053622642,0,8,diaphragm development,BP,
15031,GO:0060542,1,0.999999980468215,0,1,regulation of strand invasion,BP,
15033,GO:0060545,1,0.986792676423968,0,2,positive regulation of necroptotic process,BP,
15037,GO:0060549,1,0.987573985404204,0,1,regulation of fructose 1,6-bisphosphate 1-phosphatase activity,BP,
15038,GO:0060550,1,0.987573985404204,0,1,positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity,BP,
15039,GO:0060551,1,0.987573985404204,0,1,regulation of fructose 1,6-bisphosphate metabolic process,BP,
15040,GO:0060552,1,0.987573985404204,0,1,positive regulation of fructose 1,6-bisphosphate metabolic process,BP,
15041,GO:0060556,1,0.926255892151575,0,9,regulation of vitamin D biosynthetic process,BP,
15042,GO:0060557,1,0.96443604395261,0,3,positive regulation of vitamin D biosynthetic process,BP,
15043,GO:0060558,1,0.946796667340952,0,7,regulation of calcidiol 1-monooxygenase activity,BP,
15044,GO:0060559,1,0.96443604395261,0,3,positive regulation of calcidiol 1-monooxygenase activity,BP,
15045,GO:0060560,1,0.400969915433734,0,202,developmental growth involved in morphogenesis,BP,
15046,GO:0060561,1,0.891666406489465,0,24,apoptotic process involved in morphogenesis,BP,
15047,GO:0060562,1,0.197615871561841,0,309,epithelial tube morphogenesis,BP,
15048,GO:0060563,1,0.745138437490797,0,48,neuroepithelial cell differentiation,BP,
15049,GO:0060566,1,0.999999996400838,0,1,positive regulation of DNA-templated transcription, termination,BP,
15050,GO:0060571,1,0.846049168371852,0,25,morphogenesis of an epithelial fold,BP,
15051,GO:0060572,1,0.90085417971514,0,17,morphogenesis of an epithelial bud,BP,
15052,GO:0060573,1,0.932355527073915,0,10,cell fate specification involved in pattern specification,BP,
15053,GO:0060574,1,0.964621517541779,0,4,intestinal epithelial cell maturation,BP,
15054,GO:0060575,1,0.881127759669237,0,17,intestinal epithelial cell differentiation,BP,
15055,GO:0060576,1,0.918480447518947,0,10,intestinal epithelial cell development,BP,
15056,GO:0060577,1,0.978628625248386,0,2,pulmonary vein morphogenesis,BP,
15057,GO:0060578,1,0.990270970834262,0,1,superior vena cava morphogenesis,BP,
15058,GO:0060579,1,0.906496279666999,0,14,ventral spinal cord interneuron fate commitment,BP,
15059,GO:0060580,1,0.989655340272943,0,1,ventral spinal cord interneuron fate determination,BP,
15060,GO:0060581,1,0.906496279666999,0,14,cell fate commitment involved in pattern specification,BP,
15061,GO:0060582,1,0.989655340272943,0,1,cell fate determination involved in pattern specification,BP,
15062,GO:0060584,1,0.976755074973599,0,3,regulation of prostaglandin-endoperoxide synthase activity,BP,
15063,GO:0060585,1,0.976755074973599,0,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
15064,GO:0060586,1,0.942986589600091,0,9,multicellular organismal iron ion homeostasis,BP,
15065,GO:0060587,1,0.983317174449214,0,2,regulation of lipoprotein lipid oxidation,BP,
15066,GO:0060588,1,0.98748484460217,0,1,negative regulation of lipoprotein lipid oxidation,BP,
15068,GO:0060590,1,0.749285027581604,0,38,ATPase regulator activity,MF,
15069,GO:0060591,1,0.964695548444468,0,5,chondroblast differentiation,BP,
15070,GO:0060592,1,0.966800615823939,0,7,mammary gland formation,BP,
15071,GO:0060594,1,0.985571497759453,0,3,mammary gland specification,BP,
15072,GO:0060595,1,0.985571504216835,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
15073,GO:0060596,1,0.992154534917002,0,3,mammary placode formation,BP,
15074,GO:0060598,1,0.987607662497046,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
15075,GO:0060599,1,0.993952687129123,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
15076,GO:0060600,1,0.957853940310594,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
15077,GO:0060601,1,0.944351168126582,0,13,lateral sprouting from an epithelium,BP,
15078,GO:0060602,1,0.893578247883523,0,20,branch elongation of an epithelium,BP,
15079,GO:0060603,1,0.869974325410087,0,31,mammary gland duct morphogenesis,BP,
15080,GO:0060605,1,0.968044374808422,0,5,tube lumen cavitation,BP,
15081,GO:0060606,1,0.662830632645316,0,86,tube closure,BP,
15082,GO:0060611,1,0.991077486541396,0,1,mammary gland fat development,BP,
15084,GO:0060613,1,0.981238583591998,0,4,fat pad development,BP,
15085,GO:0060615,1,0.985571504216835,0,2,mammary gland bud formation,BP,
15086,GO:0060620,1,0.966349364652607,0,3,regulation of cholesterol import,BP,
15087,GO:0060621,1,0.974480528254625,0,2,negative regulation of cholesterol import,BP,
15088,GO:0060623,1,0.969740607310597,0,3,regulation of chromosome condensation,BP,
15090,GO:0060628,1,0.929582194985157,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
15091,GO:0060629,1,0.982120449881947,0,2,regulation of homologous chromosome segregation,BP,
15092,GO:0060631,1,0.953681137183754,0,7,regulation of meiosis I,BP,
15093,GO:0060632,1,0.903591085379904,0,17,regulation of microtubule-based movement,BP,
15094,GO:0060633,1,0.972815627176893,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
15095,GO:0060638,1,0.953353587434631,0,8,mesenchymal-epithelial cell signaling,BP,
15096,GO:0060644,1,0.889786191583262,0,17,mammary gland epithelial cell differentiation,BP,
15097,GO:0060648,1,0.97468370047897,0,3,mammary gland bud morphogenesis,BP,
15098,GO:0060661,1,0.977318068831769,0,2,submandibular salivary gland formation,BP,
15099,GO:0060662,1,0.968044374808422,0,5,salivary gland cavitation,BP,
15100,GO:0060664,1,0.945961341791746,0,6,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
15101,GO:0060665,1,0.974648297212138,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
15102,GO:0060666,1,0.991242569634384,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
15103,GO:0060667,1,0.985571504216835,0,2,branch elongation involved in salivary gland morphogenesis,BP,
15104,GO:0060668,1,0.996639901362461,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
15105,GO:0060669,1,0.87272882983512,0,22,embryonic placenta morphogenesis,BP,
15106,GO:0060670,1,0.93039308486565,0,11,branching involved in labyrinthine layer morphogenesis,BP,
15107,GO:0060671,1,0.983784165605512,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
15108,GO:0060672,1,0.983784165605512,0,3,epithelial cell morphogenesis involved in placental branching,BP,
15109,GO:0060674,1,0.847069183797743,0,29,placenta blood vessel development,BP,
15110,GO:0060675,1,0.69071835985397,0,64,ureteric bud morphogenesis,BP,
15111,GO:0060676,1,0.961546342389981,0,6,ureteric bud formation,BP,
15112,GO:0060677,1,0.971367929235499,0,8,ureteric bud elongation,BP,
15113,GO:0060678,1,0.990378990484081,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15114,GO:0060681,1,0.971441481124982,0,5,branch elongation involved in ureteric bud branching,BP,
15115,GO:0060683,1,0.992643465411783,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
15116,GO:0060684,1,0.940946728828239,0,7,epithelial-mesenchymal cell signaling,BP,
15117,GO:0060685,1,0.96935166147245,0,6,regulation of prostatic bud formation,BP,
15118,GO:0060686,1,0.986909779798185,0,4,negative regulation of prostatic bud formation,BP,
15119,GO:0060687,1,0.975290249263486,0,7,regulation of branching involved in prostate gland morphogenesis,BP,
15120,GO:0060688,1,0.717378139269365,0,54,regulation of morphogenesis of a branching structure,BP,
15121,GO:0060689,1,0.983498371212342,0,3,cell differentiation involved in salivary gland development,BP,
15122,GO:0060690,1,0.988781779731915,0,1,epithelial cell differentiation involved in salivary gland development,BP,
15123,GO:0060691,1,0.988781779731915,0,1,epithelial cell maturation involved in salivary gland development,BP,
15124,GO:0060693,1,0.943247808067703,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
15125,GO:0060694,1,0.976229451496723,0,2,regulation of cholesterol transporter activity,BP,
15126,GO:0060695,1,0.987154294092386,0,1,negative regulation of cholesterol transporter activity,BP,
15128,GO:0060697,1,0.980033827641441,0,2,positive regulation of phospholipid catabolic process,BP,
15129,GO:0060698,1,0.992768599268963,0,2,endoribonuclease inhibitor activity,MF,
15130,GO:0060699,1,0.971873943181419,0,4,regulation of endoribonuclease activity,BP,
15131,GO:0060700,1,0.971873934054439,0,5,regulation of ribonuclease activity,BP,
15132,GO:0060701,1,0.992768599268963,0,2,negative regulation of ribonuclease activity,BP,
15133,GO:0060702,1,0.992768599268963,0,2,negative regulation of endoribonuclease activity,BP,
15134,GO:0060703,1,0.992368855453696,0,1,deoxyribonuclease inhibitor activity,MF,
15135,GO:0060706,1,0.84617593360398,0,26,cell differentiation involved in embryonic placenta development,BP,
15136,GO:0060707,1,0.932097198071933,0,12,trophoblast giant cell differentiation,BP,
15137,GO:0060708,1,0.96718462860568,0,4,spongiotrophoblast differentiation,BP,
15138,GO:0060709,1,0.993089732258129,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
15139,GO:0060710,1,0.966869732604519,0,6,chorio-allantoic fusion,BP,
15140,GO:0060711,1,0.742443045852346,0,47,labyrinthine layer development,BP,
15141,GO:0060712,1,0.902123693431189,0,15,spongiotrophoblast layer development,BP,
15142,GO:0060713,1,0.888446126772255,0,19,labyrinthine layer morphogenesis,BP,
15143,GO:0060715,1,0.992591132377875,0,2,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
15144,GO:0060716,1,0.876441297412554,0,20,labyrinthine layer blood vessel development,BP,
15145,GO:0060717,1,0.984040115793393,0,6,chorion development,BP,
15146,GO:0060718,1,0.986916376853038,0,5,chorionic trophoblast cell differentiation,BP,
15147,GO:0060720,1,0.987307196386563,0,2,spongiotrophoblast cell proliferation,BP,
15148,GO:0060721,1,0.987307196386563,0,2,regulation of spongiotrophoblast cell proliferation,BP,
15149,GO:0060722,1,0.987307196386563,0,2,cell proliferation involved in embryonic placenta development,BP,
15150,GO:0060723,1,0.987307196386563,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
15151,GO:0060729,1,0.973490445988936,0,5,intestinal epithelial structure maintenance,BP,
15152,GO:0060730,1,0.987103650349476,0,2,regulation of intestinal epithelial structure maintenance,BP,
15153,GO:0060731,1,0.995105658528154,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
15154,GO:0060732,1,0.914501907018724,0,12,positive regulation of inositol phosphate biosynthetic process,BP,
15155,GO:0060733,1,0.997218365693604,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
15156,GO:0060734,1,0.990374070211253,0,2,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
15157,GO:0060735,1,0.987794434633824,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
15158,GO:0060736,1,0.969656811775651,0,11,prostate gland growth,BP,
15159,GO:0060737,1,0.984425876666733,0,4,prostate gland morphogenetic growth,BP,
15160,GO:0060738,1,0.982511699894829,0,2,epithelial-mesenchymal signaling involved in prostate gland development,BP,
15161,GO:0060739,1,0.999999996382348,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
15162,GO:0060740,1,0.886567516820556,0,26,prostate gland epithelium morphogenesis,BP,
15163,GO:0060741,1,0.972359127977406,0,3,prostate gland stromal morphogenesis,BP,
15164,GO:0060742,1,0.951865680166506,0,12,epithelial cell differentiation involved in prostate gland development,BP,
15165,GO:0060743,1,0.979921546771548,0,3,epithelial cell maturation involved in prostate gland development,BP,
15166,GO:0060744,1,0.966038339507345,0,5,mammary gland branching involved in thelarche,BP,
15167,GO:0060745,1,0.99129330687229,0,5,mammary gland branching involved in pregnancy,BP,
15168,GO:0060746,1,0.923001655101366,0,13,parental behavior,BP,
15169,GO:0060748,1,0.991714562932234,0,2,tertiary branching involved in mammary gland duct morphogenesis,BP,
15170,GO:0060749,1,0.894072149018929,0,17,mammary gland alveolus development,BP,
15171,GO:0060750,1,0.987607644295506,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
15172,GO:0060751,1,0.977865961278349,0,5,branch elongation involved in mammary gland duct branching,BP,
15173,GO:0060752,1,0.984754892204901,0,2,intestinal phytosterol absorption,BP,
15174,GO:0060753,1,0.950597520696264,0,6,regulation of mast cell chemotaxis,BP,
15175,GO:0060754,1,0.962174336013858,0,5,positive regulation of mast cell chemotaxis,BP,
15179,GO:0060762,1,0.955672581804429,0,6,regulation of branching involved in mammary gland duct morphogenesis,BP,
15180,GO:0060763,1,0.978500890077835,0,3,mammary duct terminal end bud growth,BP,
15181,GO:0060764,1,0.987640778202108,0,2,cell-cell signaling involved in mammary gland development,BP,
15182,GO:0060765,1,0.856909489968356,0,26,regulation of androgen receptor signaling pathway,BP,
15183,GO:0060766,1,0.931583021429925,0,12,negative regulation of androgen receptor signaling pathway,BP,
15184,GO:0060767,1,0.925954523820968,0,11,epithelial cell proliferation involved in prostate gland development,BP,
15185,GO:0060768,1,0.927977494757607,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
15186,GO:0060769,1,0.978069766964776,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
15187,GO:0060770,1,0.948793351945152,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
15188,GO:0060775,1,0.989150192007311,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
15189,GO:0060781,1,0.988187278153849,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
15190,GO:0060782,1,0.988187278153849,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
15191,GO:0060783,1,0.988187278153849,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
15192,GO:0060784,1,0.997821323322562,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
15193,GO:0060788,1,0.916731553294884,0,15,ectodermal placode formation,BP,
15194,GO:0060789,1,0.940861011727236,0,7,hair follicle placode formation,BP,
15195,GO:0060795,1,0.777993801355044,0,35,cell fate commitment involved in formation of primary germ layer,BP,
15196,GO:0060796,1,0.978846204920975,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15197,GO:0060800,1,0.981464464215536,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15198,GO:0060802,1,0.989695277448999,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15199,GO:0060803,1,0.988011812540354,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15200,GO:0060804,1,0.994465974192092,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
15201,GO:0060806,1,0.988457596958614,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15202,GO:0060807,1,0.990724061960345,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15203,GO:0060809,1,0.992467900032637,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
15204,GO:0060816,1,0.999999996398594,0,1,random inactivation of X chromosome,BP,
15205,GO:0060817,1,0.990164429951147,0,1,inactivation of paternal X chromosome,BP,
15206,GO:0060821,1,0.999999996388555,0,1,inactivation of X chromosome by DNA methylation,BP,
15207,GO:0060823,1,0.993966487488128,0,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15208,GO:0060825,1,0.977549832052526,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15209,GO:0060827,1,0.998296792324339,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15211,GO:0060829,1,0.998296792324339,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15212,GO:0060830,1,0.984617629749213,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15213,GO:0060831,1,0.953834452461254,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
15214,GO:0060836,1,0.968052821233942,0,7,lymphatic endothelial cell differentiation,BP,
15215,GO:0060837,1,0.939896526016177,0,8,blood vessel endothelial cell differentiation,BP,
15216,GO:0060838,1,0.991872953967338,0,2,lymphatic endothelial cell fate commitment,BP,
15217,GO:0060839,1,0.963326113443673,0,6,endothelial cell fate commitment,BP,
15218,GO:0060840,1,0.715212092071406,0,78,artery development,BP,
15219,GO:0060841,1,0.93240065494922,0,16,venous blood vessel development,BP,
15220,GO:0060842,1,0.95880932103661,0,6,arterial endothelial cell differentiation,BP,
15221,GO:0060843,1,0.999999996391896,0,1,venous endothelial cell differentiation,BP,
15222,GO:0060844,1,0.98608210141495,0,2,arterial endothelial cell fate commitment,BP,
15223,GO:0060846,1,0.977524265391042,0,3,blood vessel endothelial cell fate commitment,BP,
15224,GO:0060847,1,0.977524265391042,0,3,endothelial cell fate specification,BP,
15225,GO:0060849,1,0.991872953967338,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15226,GO:0060850,1,0.88170858953256,0,15,regulation of transcription involved in cell fate commitment,BP,
15227,GO:0060853,1,0.995262221554035,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
15228,GO:0060856,1,0.937507322243336,0,10,establishment of blood-brain barrier,BP,
15229,GO:0060857,1,0.99043962529358,0,1,establishment of glial blood-brain barrier,BP,
15230,GO:0060872,1,0.960365077503928,0,9,semicircular canal development,BP,
15231,GO:0060873,1,0.999999996385791,0,1,anterior semicircular canal development,BP,
15232,GO:0060875,1,0.999999996385791,0,1,lateral semicircular canal development,BP,
15233,GO:0060876,1,0.97842396290941,0,2,semicircular canal formation,BP,
15234,GO:0060879,1,0.98718161050591,0,1,semicircular canal fusion,BP,
15235,GO:0060896,1,0.958427017390859,0,9,neural plate pattern specification,BP,
15236,GO:0060897,1,0.958427040792278,0,7,neural plate regionalization,BP,
15237,GO:0060900,1,0.959607365048979,0,12,embryonic camera-type eye formation,BP,
15238,GO:0060901,1,0.998851168465918,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15239,GO:0060903,1,0.976833921566303,0,4,positive regulation of meiosis I,BP,
15240,GO:0060904,1,0.997969576389408,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15241,GO:0060907,1,0.955340287363763,0,7,positive regulation of macrophage cytokine production,BP,
15242,GO:0060911,1,0.903741704610091,0,12,cardiac cell fate commitment,BP,
15243,GO:0060912,1,0.975982714548849,0,3,cardiac cell fate specification,BP,
15244,GO:0060913,1,0.970876301835338,0,3,cardiac cell fate determination,BP,
15245,GO:0060914,1,0.83999584989795,0,22,heart formation,BP,
15246,GO:0060915,1,0.985571504216835,0,2,mesenchymal cell differentiation involved in lung development,BP,
15247,GO:0060916,1,0.979998917097905,0,5,mesenchymal cell proliferation involved in lung development,BP,
15248,GO:0060920,1,0.976396511832844,0,5,cardiac pacemaker cell differentiation,BP,
15249,GO:0060921,1,0.98712394936143,0,3,sinoatrial node cell differentiation,BP,
15250,GO:0060922,1,0.989133749208618,0,2,atrioventricular node cell differentiation,BP,
15251,GO:0060923,1,0.938702113301428,0,8,cardiac muscle cell fate commitment,BP,
15252,GO:0060926,1,0.988743289940428,0,4,cardiac pacemaker cell development,BP,
15253,GO:0060927,1,0.989133993605324,0,1,cardiac pacemaker cell fate commitment,BP,
15254,GO:0060928,1,0.989133749208618,0,2,atrioventricular node cell development,BP,
15255,GO:0060929,1,0.989133993605324,0,1,atrioventricular node cell fate commitment,BP,
15256,GO:0060931,1,0.999605289845655,0,2,sinoatrial node cell development,BP,
15257,GO:0060932,1,0.988756102298382,0,2,His-Purkinje system cell differentiation,BP,
15258,GO:0060935,1,0.987678280333477,0,3,cardiac fibroblast cell differentiation,BP,
15259,GO:0060936,1,0.987678280333477,0,3,cardiac fibroblast cell development,BP,
15260,GO:0060938,1,0.987678280333477,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15261,GO:0060939,1,0.987678280333477,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15262,GO:0060940,1,0.987678286388811,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15263,GO:0060947,1,0.971212233918923,0,7,cardiac vascular smooth muscle cell differentiation,BP,
15264,GO:0060948,1,0.988408459816817,0,3,cardiac vascular smooth muscle cell development,BP,
15265,GO:0060956,1,0.964119970232521,0,6,endocardial cell differentiation,BP,
15266,GO:0060957,1,0.993553067633092,0,1,endocardial cell fate commitment,BP,
15267,GO:0060964,1,0.853483175495683,0,29,regulation of gene silencing by miRNA,BP,
15268,GO:0060965,1,0.953893800912742,0,10,negative regulation of gene silencing by miRNA,BP,
15269,GO:0060966,1,0.851832201913773,0,32,regulation of gene silencing by RNA,BP,
15270,GO:0060967,1,0.952073443949527,0,12,negative regulation of gene silencing by RNA,BP,
15271,GO:0060968,1,0.683812606204257,0,64,regulation of gene silencing,BP,
15272,GO:0060969,1,0.91521116577778,0,21,negative regulation of gene silencing,BP,
15273,GO:0060971,1,0.975942061628999,0,4,embryonic heart tube left/right pattern formation,BP,
15274,GO:0060972,1,0.890514807734165,0,21,left/right pattern formation,BP,
15275,GO:0060973,1,0.921440030551427,0,14,cell migration involved in heart development,BP,
15276,GO:0060974,1,0.975074311579823,0,2,cell migration involved in heart formation,BP,
15277,GO:0060975,1,0.98751377475558,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15278,GO:0060976,1,0.8545943315562,0,42,coronary vasculature development,BP,
15279,GO:0060977,1,0.955635235884634,0,13,coronary vasculature morphogenesis,BP,
15280,GO:0060978,1,0.991322157328103,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15281,GO:0060979,1,0.996770630593124,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
15282,GO:0060980,1,0.996770639106046,0,1,cell migration involved in coronary vasculogenesis,BP,
15283,GO:0060981,1,0.999999826530918,0,1,cell migration involved in coronary angiogenesis,BP,
15284,GO:0060982,1,0.966303217860959,0,8,coronary artery morphogenesis,BP,
15285,GO:0060986,1,0.740747262900286,0,44,endocrine hormone secretion,BP,
15286,GO:0060987,1,0.990619980762556,0,1,lipid tube,CC,
15287,GO:0060988,1,0.985662559852004,0,3,lipid tube assembly,BP,
15288,GO:0060989,1,0.996315423752187,0,1,lipid tube assembly involved in organelle fusion,BP,
15290,GO:0060993,1,0.613381143035796,0,92,kidney morphogenesis,BP,
15291,GO:0060994,1,0.985749027042252,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15292,GO:0060995,1,0.994019825342913,0,2,cell-cell signaling involved in kidney development,BP,
15293,GO:0060996,1,0.761471610073447,0,81,dendritic spine development,BP,
15294,GO:0060997,1,0.881636849538132,0,46,dendritic spine morphogenesis,BP,
15295,GO:0060998,1,0.811762486899634,0,60,regulation of dendritic spine development,BP,
15296,GO:0060999,1,0.870232538549628,0,37,positive regulation of dendritic spine development,BP,
15297,GO:0061000,1,0.964329115130125,0,12,negative regulation of dendritic spine development,BP,
15298,GO:0061001,1,0.912991371304261,0,34,regulation of dendritic spine morphogenesis,BP,
15299,GO:0061002,1,0.979580623717965,0,6,negative regulation of dendritic spine morphogenesis,BP,
15300,GO:0061003,1,0.966058526436423,0,17,positive regulation of dendritic spine morphogenesis,BP,
15301,GO:0061004,1,0.926032202864454,0,9,pattern specification involved in kidney development,BP,
15302,GO:0061005,1,0.756361092083187,0,56,cell differentiation involved in kidney development,BP,
15304,GO:0061009,1,0.956830682197957,0,5,common bile duct development,BP,
15305,GO:0061010,1,0.979467030745555,0,3,gall bladder development,BP,
15306,GO:0061011,1,0.988638413128034,0,1,hepatic duct development,BP,
15307,GO:0061013,1,0.861942560706013,0,32,regulation of mRNA catabolic process,BP,
15308,GO:0061014,1,0.873302795548451,0,26,positive regulation of mRNA catabolic process,BP,
15309,GO:0061015,1,0.988488460834563,0,1,snRNA import into nucleus,BP,
15310,GO:0061017,1,0.98149697287594,0,2,hepatoblast differentiation,BP,
15313,GO:0061026,1,0.999999996405192,0,1,cardiac muscle tissue regeneration,BP,
15314,GO:0061027,1,0.982766349889207,0,2,umbilical cord development,BP,
15315,GO:0061028,1,0.845712096960541,0,38,establishment of endothelial barrier,BP,
15316,GO:0061029,1,0.925953081660035,0,13,eyelid development in camera-type eye,BP,
15317,GO:0061030,1,0.965879126666283,0,4,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15318,GO:0061031,1,0.969098700205594,0,3,endodermal digestive tract morphogenesis,BP,
15319,GO:0061032,1,0.984623382671055,0,2,visceral serous pericardium development,BP,
15320,GO:0061033,1,0.985064452852175,0,2,secretion by lung epithelial cell involved in lung growth,BP,
15321,GO:0061034,1,0.998820175819425,0,2,olfactory bulb mitral cell layer development,BP,
15324,GO:0061037,1,0.85439764849895,0,24,negative regulation of cartilage development,BP,
15325,GO:0061038,1,0.969791720837698,0,6,uterus morphogenesis,BP,
15326,GO:0061040,1,0.999999996388895,0,1,female gonad morphogenesis,BP,
15328,GO:0061042,1,0.938614412680458,0,9,vascular wound healing,BP,
15329,GO:0061043,1,0.971164323503411,0,4,regulation of vascular wound healing,BP,
15330,GO:0061044,1,0.994533815206607,0,1,negative regulation of vascular wound healing,BP,
15331,GO:0061045,1,0.645046877895364,0,64,negative regulation of wound healing,BP,
15332,GO:0061046,1,0.954970822674232,0,6,regulation of branching involved in lung morphogenesis,BP,
15333,GO:0061047,1,0.968289550667015,0,4,positive regulation of branching involved in lung morphogenesis,BP,
15334,GO:0061048,1,0.988402199519739,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15335,GO:0061049,1,0.888349403332804,0,19,cell growth involved in cardiac muscle cell development,BP,
15336,GO:0061050,1,0.920231929794436,0,12,regulation of cell growth involved in cardiac muscle cell development,BP,
15337,GO:0061051,1,0.956626016722848,0,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,
15338,GO:0061052,1,0.961968917158001,0,5,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15339,GO:0061053,1,0.609409661655398,0,84,somite development,BP,
15340,GO:0061054,1,0.971265821077589,0,4,dermatome development,BP,
15341,GO:0061055,1,0.981966701169117,0,4,myotome development,BP,
15342,GO:0061056,1,0.961046053139299,0,4,sclerotome development,BP,
15344,GO:0061072,1,0.949754254876423,0,9,iris morphogenesis,BP,
15345,GO:0061073,1,0.981728392888949,0,3,ciliary body morphogenesis,BP,
15346,GO:0061074,1,0.951208002133523,0,6,regulation of neural retina development,BP,
15347,GO:0061075,1,0.981068936115031,0,2,positive regulation of neural retina development,BP,
15348,GO:0061076,1,0.99441261044449,0,1,negative regulation of neural retina development,BP,
15349,GO:0061077,1,0.605930869292807,0,62,chaperone-mediated protein folding,BP,
15350,GO:0061078,1,0.987167312885023,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15351,GO:0061081,1,0.925569099726352,0,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
15352,GO:0061082,1,0.867089644654249,0,22,myeloid leukocyte cytokine production,BP,
15353,GO:0061083,1,0.976256632695817,0,4,regulation of protein refolding,BP,
15354,GO:0061084,1,0.976256632695817,0,4,negative regulation of protein refolding,BP,
15355,GO:0061085,1,0.953984238261231,0,9,regulation of histone H3-K27 methylation,BP,
15356,GO:0061086,1,0.977888995016535,0,4,negative regulation of histone H3-K27 methylation,BP,
15357,GO:0061087,1,0.970214342388697,0,6,positive regulation of histone H3-K27 methylation,BP,
15358,GO:0061088,1,0.944103924607332,0,10,regulation of sequestering of zinc ion,BP,
15359,GO:0061090,1,0.990961231336358,0,1,positive regulation of sequestering of zinc ion,BP,
15360,GO:0061091,1,0.997890826736301,0,3,regulation of phospholipid translocation,BP,
15361,GO:0061092,1,0.997890826736301,0,3,positive regulation of phospholipid translocation,BP,
15362,GO:0061097,1,0.70119162868877,0,64,regulation of protein tyrosine kinase activity,BP,
15363,GO:0061098,1,0.820596204262591,0,37,positive regulation of protein tyrosine kinase activity,BP,
15364,GO:0061099,1,0.872278892383372,0,23,negative regulation of protein tyrosine kinase activity,BP,
15365,GO:0061100,1,0.991273856262465,0,1,lung neuroendocrine cell differentiation,BP,
15366,GO:0061101,1,0.930914569183068,0,8,neuroendocrine cell differentiation,BP,
15367,GO:0061102,1,0.979320269449252,0,2,stomach neuroendocrine cell differentiation,BP,
15368,GO:0061103,1,0.991273856262465,0,1,carotid body glomus cell differentiation,BP,
15369,GO:0061104,1,0.984218088064683,0,2,adrenal chromaffin cell differentiation,BP,
15370,GO:0061105,1,0.987942018230641,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15371,GO:0061106,1,0.987942018230641,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15372,GO:0061107,1,0.97193168480232,0,3,seminal vesicle development,BP,
15373,GO:0061108,1,0.990376976927382,0,1,seminal vesicle epithelium development,BP,
15374,GO:0061110,1,0.986400946519652,0,3,dense core granule biogenesis,BP,
15375,GO:0061113,1,0.978501531072082,0,4,pancreas morphogenesis,BP,
15376,GO:0061114,1,0.994081846487967,0,1,branching involved in pancreas morphogenesis,BP,
15377,GO:0061115,1,0.98718161050591,0,1,lung proximal/distal axis specification,BP,
15379,GO:0061133,1,0.936860008553612,0,6,endopeptidase activator activity,MF,
15382,GO:0061136,1,0.387673064107269,0,143,regulation of proteasomal protein catabolic process,BP,
15383,GO:0061138,1,0.387738633787869,0,180,morphogenesis of a branching epithelium,BP,
15384,GO:0061140,1,0.908208267083477,0,10,lung secretory cell differentiation,BP,
15385,GO:0061141,1,0.979770498165103,0,3,lung ciliated cell differentiation,BP,
15386,GO:0061143,1,0.993007707207986,0,1,alveolar primary septum development,BP,
15387,GO:0061144,1,0.994257116074789,0,1,alveolar secondary septum development,BP,
15388,GO:0061145,1,0.996745614389641,0,2,lung smooth muscle development,BP,
15389,GO:0061146,1,0.983206311086868,0,3,Peyer's patch morphogenesis,BP,
15390,GO:0061149,1,0.988714122281553,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15391,GO:0061150,1,0.988714122281553,0,1,renal system segmentation,BP,
15392,GO:0061151,1,0.988714122281553,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15393,GO:0061152,1,0.983725055695271,0,2,trachea submucosa development,BP,
15394,GO:0061153,1,0.983725055695271,0,2,trachea gland development,BP,
15395,GO:0061154,1,0.90620391606433,0,15,endothelial tube morphogenesis,BP,
15396,GO:0061155,1,0.988714122281553,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15397,GO:0061156,1,0.973562245149478,0,5,pulmonary artery morphogenesis,BP,
15398,GO:0061157,1,0.917753697721547,0,19,mRNA destabilization,BP,
15399,GO:0061158,1,0.951864819364298,0,12,3'-UTR-mediated mRNA destabilization,BP,
15400,GO:0061162,1,0.942524025788095,0,13,establishment of monopolar cell polarity,BP,
15401,GO:0061168,1,0.987250492003227,0,1,regulation of hair follicle placode formation,BP,
15402,GO:0061170,1,0.987250492003227,0,1,negative regulation of hair follicle placode formation,BP,
15403,GO:0061178,1,0.723270037801444,0,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15404,GO:0061179,1,0.928470203837953,0,8,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15405,GO:0061180,1,0.699336399873658,0,66,mammary gland epithelium development,BP,
15406,GO:0061181,1,0.998732054164559,0,1,regulation of chondrocyte development,BP,
15407,GO:0061183,1,0.971265821077589,0,4,regulation of dermatome development,BP,
15408,GO:0061184,1,0.981716145161743,0,3,positive regulation of dermatome development,BP,
15409,GO:0061185,1,0.989356594816964,0,1,negative regulation of dermatome development,BP,
15410,GO:0061187,1,0.999970905743859,0,2,regulation of chromatin silencing at rDNA,BP,
15411,GO:0061188,1,0.999970905743859,0,2,negative regulation of chromatin silencing at rDNA,BP,
15412,GO:0061189,1,0.988187278153849,0,1,positive regulation of sclerotome development,BP,
15413,GO:0061190,1,0.988187278153849,0,1,regulation of sclerotome development,BP,
15414,GO:0061193,1,0.987361667413007,0,1,taste bud development,BP,
15415,GO:0061196,1,0.968537329532656,0,6,fungiform papilla development,BP,
15416,GO:0061197,1,0.977915953593137,0,5,fungiform papilla morphogenesis,BP,
15417,GO:0061198,1,0.985581241242471,0,3,fungiform papilla formation,BP,
15418,GO:0061200,1,0.9382995771168,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15419,GO:0061202,1,0.9382995771168,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15420,GO:0061205,1,0.98132299952995,0,3,paramesonephric duct development,BP,
15421,GO:0061206,1,0.992777141015238,0,1,mesonephros morphogenesis,BP,
15422,GO:0061209,1,0.968140673688679,0,4,cell proliferation involved in mesonephros development,BP,
15423,GO:0061213,1,0.86945847476959,0,22,positive regulation of mesonephros development,BP,
15424,GO:0061215,1,0.992777141015238,0,1,mesonephric nephron development,BP,
15425,GO:0061216,1,0.988714122281553,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
15426,GO:0061217,1,0.836050683520611,0,26,regulation of mesonephros development,BP,
15427,GO:0061218,1,0.956648615364608,0,6,negative regulation of mesonephros development,BP,
15428,GO:0061227,1,0.977875052733733,0,2,pattern specification involved in mesonephros development,BP,
15429,GO:0061228,1,0.992777141015238,0,1,mesonephric nephron morphogenesis,BP,
15430,GO:0061235,1,0.992777141015238,0,1,mesenchymal stem cell maintenance involved in mesonephric nephron morphogenesis,BP,
15431,GO:0061245,1,0.818857476157415,0,36,establishment or maintenance of bipolar cell polarity,BP,
15432,GO:0061289,1,0.994019825342913,0,2,Wnt signaling pathway involved in kidney development,BP,
15433,GO:0061290,1,0.994019825342913,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15434,GO:0061295,1,0.992777141015238,0,1,regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
15435,GO:0061296,1,0.992777141015238,0,1,negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
15436,GO:0061298,1,0.953925471143164,0,16,retina vasculature development in camera-type eye,BP,
15437,GO:0061299,1,0.967718608114346,0,9,retina vasculature morphogenesis in camera-type eye,BP,
15438,GO:0061300,1,0.988073317058041,0,2,cerebellum vasculature development,BP,
15439,GO:0061301,1,0.999999996380915,0,1,cerebellum vasculature morphogenesis,BP,
15440,GO:0061302,1,0.960062122063631,0,5,smooth muscle cell-matrix adhesion,BP,
15441,GO:0061303,1,0.936888235136974,0,8,cornea development in camera-type eye,BP,
15442,GO:0061304,1,0.9998091125105,0,4,retinal blood vessel morphogenesis,BP,
15443,GO:0061307,1,0.932793164818967,0,8,cardiac neural crest cell differentiation involved in heart development,BP,
15444,GO:0061308,1,0.932793164818967,0,8,cardiac neural crest cell development involved in heart development,BP,
15445,GO:0061309,1,0.946002660148828,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15446,GO:0061311,1,0.831814924563651,0,26,cell surface receptor signaling pathway involved in heart development,BP,
15447,GO:0061312,1,0.948382919247536,0,6,BMP signaling pathway involved in heart development,BP,
15448,GO:0061314,1,0.950989298920897,0,9,Notch signaling involved in heart development,BP,
15449,GO:0061316,1,0.957488585810006,0,5,canonical Wnt signaling pathway involved in heart development,BP,
15450,GO:0061317,1,0.961543210048604,0,4,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15451,GO:0061318,1,0.917835069003089,0,19,renal filtration cell differentiation,BP,
15452,GO:0061323,1,0.894510349315155,0,16,cell proliferation involved in heart morphogenesis,BP,
15453,GO:0061324,1,0.995784523078276,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15454,GO:0061325,1,0.965998331377951,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15456,GO:0061333,1,0.650227606892767,0,77,renal tubule morphogenesis,BP,
15458,GO:0061339,1,0.942524025788095,0,13,establishment or maintenance of monopolar cell polarity,BP,
15459,GO:0061341,1,0.999967673715137,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15460,GO:0061343,1,0.992994010319735,0,4,cell adhesion involved in heart morphogenesis,BP,
15461,GO:0061346,1,0.999967673715137,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15462,GO:0061347,1,0.999999996371578,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15463,GO:0061348,1,0.999999996371578,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15464,GO:0061349,1,0.999999996371578,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15465,GO:0061350,1,0.999999996371578,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15466,GO:0061351,1,0.509146549244247,0,127,neural precursor cell proliferation,BP,
15467,GO:0061354,1,0.999999996371578,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15468,GO:0061355,1,0.975372105665167,0,3,Wnt protein secretion,BP,
15469,GO:0061356,1,0.975372105665167,0,3,regulation of Wnt protein secretion,BP,
15470,GO:0061357,1,0.986264467179793,0,2,positive regulation of Wnt protein secretion,BP,
15471,GO:0061358,1,0.988957146665087,0,1,negative regulation of Wnt protein secretion,BP,
15472,GO:0061360,1,0.998408769958625,0,1,optic chiasma development,BP,
15473,GO:0061364,1,0.999793800566698,0,3,apoptotic process involved in luteolysis,BP,
15474,GO:0061365,1,0.892799664236689,0,11,positive regulation of triglyceride lipase activity,BP,
15475,GO:0061366,1,0.979933857328477,0,3,behavioral response to chemical pain,BP,
15476,GO:0061368,1,0.979933857328477,0,3,behavioral response to formalin induced pain,BP,
15477,GO:0061369,1,0.99774836316084,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15479,GO:0061371,1,0.699467605630705,0,63,determination of heart left/right asymmetry,BP,
15480,GO:0061373,1,0.987949370612106,0,2,mammillary axonal complex development,BP,
15481,GO:0061374,1,0.987949376598353,0,1,mammillothalamic axonal tract development,BP,
15482,GO:0061377,1,0.894072149018929,0,17,mammary gland lobule development,BP,
15483,GO:0061378,1,0.97761872652567,0,2,corpora quadrigemina development,BP,
15484,GO:0061379,1,0.97761872652567,0,2,inferior colliculus development,BP,
15485,GO:0061381,1,0.987949376598353,0,1,cell migration in diencephalon,BP,
15488,GO:0061386,1,0.999999992762435,0,2,closure of optic fissure,BP,
15489,GO:0061387,1,0.666701828487414,0,89,regulation of extent of cell growth,BP,
15490,GO:0061394,1,0.978208082032976,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15491,GO:0061395,1,0.988534280225861,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15492,GO:0061402,1,0.983521366151414,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15493,GO:0061408,1,0.989974988047088,0,1,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15495,GO:0061419,1,0.985136561090406,0,4,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15496,GO:0061428,1,0.971410176127638,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15497,GO:0061430,1,0.957234983075492,0,12,bone trabecula morphogenesis,BP,
15498,GO:0061433,1,0.989218981406881,0,1,cellular response to caloric restriction,BP,
15499,GO:0061436,1,0.900563528831483,0,19,establishment of skin barrier,BP,
15500,GO:0061437,1,0.851848366249481,0,26,renal system vasculature development,BP,
15501,GO:0061438,1,0.970465124064447,0,7,renal system vasculature morphogenesis,BP,
15502,GO:0061439,1,0.970465124064447,0,7,kidney vasculature morphogenesis,BP,
15503,GO:0061440,1,0.851848366249481,0,26,kidney vasculature development,BP,
15504,GO:0061441,1,0.991188513045359,0,2,renal artery morphogenesis,BP,
15505,GO:0061443,1,0.993553062730305,0,2,endocardial cushion cell differentiation,BP,
15506,GO:0061444,1,0.999999996372647,0,1,endocardial cushion cell development,BP,
15507,GO:0061445,1,0.993553067633092,0,1,endocardial cushion cell fate commitment,BP,
15509,GO:0061450,1,0.929761976783777,0,8,trophoblast cell migration,BP,
15510,GO:0061451,1,0.993877124963719,0,1,retrotrapezoid nucleus development,BP,
15511,GO:0061452,1,0.993877124963719,0,1,retrotrapezoid nucleus neuron differentiation,BP,
15513,GO:0061459,1,0.999999996382036,0,1,L-arginine transmembrane transporter activity,MF,
15514,GO:0061461,1,0.991743769777111,0,2,L-lysine import,BP,
15515,GO:0061462,1,0.870032316236287,0,27,protein localization to lysosome,BP,
15516,GO:0061467,1,0.997313716211327,0,1,basolateral protein localization,BP,
15517,GO:0061469,1,0.951676476607301,0,9,regulation of type B pancreatic cell proliferation,BP,
15518,GO:0061470,1,0.982533686808701,0,4,T follicular helper cell differentiation,BP,
15519,GO:0061474,1,0.991585409969415,0,1,phagolysosome membrane,CC,
15520,GO:0061476,1,0.994206026079447,0,1,response to anticoagulant,BP,
15521,GO:0061481,1,0.987262555038096,0,1,response to TNF agonist,BP,
15522,GO:0061484,1,0.973224906129393,0,6,hematopoietic stem cell homeostasis,BP,
15523,GO:0061485,1,0.999999996381591,0,1,memory T cell proliferation,BP,
15524,GO:0061501,1,0.991657600429728,0,1,cyclic-GMP-AMP synthase activity,MF,
15525,GO:0061502,1,0.988229386753159,0,4,early endosome to recycling endosome transport,BP,
15526,GO:0061505,1,0.988600971852888,0,3,DNA topoisomerase II activity,MF,
15527,GO:0061507,1,0.988462709383963,0,1,cyclic-GMP-AMP binding,MF,
15528,GO:0061511,1,0.982856652252844,0,4,centriole elongation,BP,
15529,GO:0061512,1,0.830205478694496,0,31,protein localization to cilium,BP,
15530,GO:0061513,1,0.982728582242917,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15531,GO:0061515,1,0.736459310226998,0,53,myeloid cell development,BP,
15532,GO:0061517,1,0.985104620984343,0,2,macrophage proliferation,BP,
15533,GO:0061518,1,0.985104620984343,0,2,microglial cell proliferation,BP,
15534,GO:0061519,1,0.996532986134879,0,1,macrophage homeostasis,BP,
15535,GO:0061523,1,0.996799869058843,0,1,cilium disassembly,BP,
15536,GO:0061525,1,0.969482021468981,0,8,hindgut development,BP,
15537,GO:0061526,1,0.967331973682429,0,4,acetylcholine secretion,BP,
15538,GO:0061528,1,0.999768569133436,0,1,aspartate secretion,BP,
15539,GO:0061534,1,0.999999996407541,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15540,GO:0061535,1,0.999788913541107,0,2,glutamate secretion, neurotransmission,BP,
15541,GO:0061536,1,0.994813753533921,0,1,glycine secretion,BP,
15542,GO:0061537,1,0.994813753533921,0,1,glycine secretion, neurotransmission,BP,
15543,GO:0061542,1,0.987647083299915,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15544,GO:0061547,1,0.990326323027533,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15545,GO:0061548,1,0.93913644559212,0,13,ganglion development,BP,
15546,GO:0061549,1,0.959830311142259,0,9,sympathetic ganglion development,BP,
15547,GO:0061550,1,0.979464804466446,0,5,cranial ganglion development,BP,
15548,GO:0061551,1,0.983611742498423,0,4,trigeminal ganglion development,BP,
15549,GO:0061552,1,0.991322336389918,0,1,ganglion morphogenesis,BP,
15551,GO:0061572,1,0.537982234027332,0,126,actin filament bundle organization,BP,
15552,GO:0061574,1,0.979651491232302,0,3,ASAP complex,CC,
15553,GO:0061575,1,0.952830815416858,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15554,GO:0061577,1,0.964690487923411,0,10,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15555,GO:0061578,1,0.956096705189646,0,9,Lys63-specific deubiquitinase activity,MF,
15556,GO:0061580,1,0.998439442435801,0,1,colon epithelial cell migration,BP,
15557,GO:0061582,1,0.998439438500699,0,2,intestinal epithelial cell migration,BP,
15558,GO:0061588,1,0.982928269024604,0,5,calcium activated phospholipid scrambling,BP,
15559,GO:0061589,1,0.982928276012211,0,4,calcium activated phosphatidylserine scrambling,BP,
15560,GO:0061590,1,0.982928269024604,0,5,calcium activated phosphatidylcholine scrambling,BP,
15561,GO:0061591,1,0.982928269024604,0,5,calcium activated galactosylceramide scrambling,BP,
15562,GO:0061598,1,0.998807705642567,0,1,molybdopterin adenylyltransferase activity,MF,
15563,GO:0061599,1,0.998807705642567,0,1,molybdopterin molybdotransferase activity,MF,
15564,GO:0061604,1,0.991186186932819,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15565,GO:0061605,1,0.991186186932819,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15566,GO:0061609,1,0.991081815282712,0,1,fructose-1-phosphate aldolase activity,MF,
15567,GO:0061611,1,0.988688643487989,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15568,GO:0061614,1,0.880450806796351,0,30,pri-miRNA transcription from RNA polymerase II promoter,BP,
15569,GO:0061615,1,0.799491424631833,0,27,glycolytic process through fructose-6-phosphate,BP,
15570,GO:0061617,1,0.939861925239525,0,6,MICOS complex,CC,
15571,GO:0061618,1,0.999999996403007,0,1,sublamina densa,CC,
15572,GO:0061620,1,0.799491424631833,0,27,glycolytic process through glucose-6-phosphate,BP,
15573,GO:0061621,1,0.809390843729419,0,26,canonical glycolysis,BP,
15574,GO:0061622,1,0.982632956693116,0,2,glycolytic process through glucose-1-phosphate,BP,
15575,GO:0061623,1,0.987789643859906,0,1,glycolytic process from galactose,BP,
15576,GO:0061624,1,0.967178116637843,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15577,GO:0061626,1,0.950639410407936,0,7,pharyngeal arch artery morphogenesis,BP,
15578,GO:0061627,1,0.989377095207634,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15579,GO:0061628,1,0.99049251800679,0,3,H3K27me3 modified histone binding,MF,
15580,GO:0061629,1,0.987855476448624,0,1,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15581,GO:0061630,1,0.339874289727218,0,195,ubiquitin protein ligase activity,MF,
15582,GO:0061631,1,0.798758383390068,0,29,ubiquitin conjugating enzyme activity,MF,
15583,GO:0061635,1,0.94845147588756,0,6,regulation of protein complex stability,BP,
15584,GO:0061640,1,0.811042565661748,0,44,cytoskeleton-dependent cytokinesis,BP,
15585,GO:0061641,1,0.679171851402199,0,37,CENP-A containing chromatin organization,BP,
15586,GO:0061642,1,0.999999996371578,0,1,chemoattraction of axon,BP,
15587,GO:0061643,1,0.989204939035615,0,3,chemorepulsion of axon,BP,
15588,GO:0061646,1,0.999788917175458,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15589,GO:0061647,1,0.849303888813366,0,41,histone H3-K9 modification,BP,
15590,GO:0061649,1,0.99946094038114,0,1,ubiquitinated histone binding,MF,
15591,GO:0061650,1,0.788807698143313,0,30,ubiquitin-like protein conjugating enzyme activity,MF,
15592,GO:0061656,1,0.987564328280312,0,1,SUMO conjugating enzyme activity,MF,
15593,GO:0061659,1,0.327071181849295,0,200,ubiquitin-like protein ligase activity,MF,
15594,GO:0061663,1,0.999999996380863,0,1,NEDD8 ligase activity,MF,
15595,GO:0061665,1,0.962645383150732,0,5,SUMO ligase activity,MF,
15596,GO:0061668,1,0.97812023940074,0,4,mitochondrial ribosome assembly,BP,
15597,GO:0061669,1,0.999328078817532,0,3,spontaneous neurotransmitter secretion,BP,
15598,GO:0061670,1,0.988035290866311,0,1,evoked neurotransmitter secretion,BP,
15599,GO:0061673,1,0.991657595160759,0,2,mitotic spindle astral microtubule,CC,
15600,GO:0061676,1,0.982855779460606,0,4,importin-alpha family protein binding,MF,
15601,GO:0061682,1,0.99070315481249,0,1,seminal vesicle morphogenesis,BP,
15602,GO:0061684,1,0.926213961215284,0,11,chaperone-mediated autophagy,BP,
15603,GO:0061687,1,0.976774864353236,0,4,detoxification of inorganic compound,BP,
15604,GO:0061689,1,0.972569817381772,0,4,tricellular tight junction,CC,
15605,GO:0061690,1,0.987527137809405,0,1,lipoamidase activity,MF,
15607,GO:0061697,1,0.994480519036392,0,1,protein-glutaryllysine deglutarylase activity,MF,
15608,GO:0061698,1,0.994480519036392,0,1,protein deglutarylation,BP,
15609,GO:0061699,1,0.994480519036392,0,1,peptidyl-lysine deglutarylation,BP,
15610,GO:0061700,1,0.946331113737901,0,8,GATOR2 complex,CC,
15612,GO:0061709,1,0.999999996376768,0,1,reticulophagy,BP,
15613,GO:0061711,1,0.978866059285561,0,2,N(6)-L-threonylcarbamoyladenine synthase,MF,
15614,GO:0061712,1,0.995100898158996,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15615,GO:0061713,1,0.987404495369061,0,1,anterior neural tube closure,BP,
15616,GO:0061714,1,0.97503656003243,0,2,folic acid receptor activity,MF,
15617,GO:0061718,1,0.809390843729419,0,26,glucose catabolic process to pyruvate,BP,
15618,GO:0061723,1,0.991164361836331,0,2,glycophagy,BP,
15619,GO:0061724,1,0.96530360275896,0,6,lipophagy,BP,
15620,GO:0061726,1,0.627092629647215,0,77,mitochondrion disassembly,BP,
15621,GO:0061727,1,0.981937353467284,0,2,methylglyoxal catabolic process to lactate,BP,
15622,GO:0061731,1,0.989994992422479,0,3,ribonucleoside-diphosphate reductase activity,MF,
15623,GO:0061732,1,0.956433638084849,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15624,GO:0061733,1,0.717620051538207,0,55,peptide-lysine-N-acetyltransferase activity,MF,
15625,GO:0061734,1,0.994304231228639,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15626,GO:0061736,1,0.999999671031117,0,1,engulfment of target by autophagosome,BP,
15627,GO:0061737,1,0.952571219253449,0,5,leukotriene signaling pathway,BP,
15628,GO:0061738,1,0.975349151167954,0,3,late endosomal microautophagy,BP,
15629,GO:0061739,1,0.994933742467394,0,1,protein lipidation involved in autophagosome assembly,BP,
15630,GO:0061740,1,0.987842173270143,0,2,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15631,GO:0061741,1,0.98951607001257,0,1,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15632,GO:0061743,1,0.966681752786216,0,4,motor learning,BP,
15633,GO:0061744,1,0.997593455192777,0,2,motor behavior,BP,
15634,GO:0061749,1,0.999337964036349,0,2,forked DNA-dependent helicase activity,MF,
15635,GO:0061750,1,0.990640705572929,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15636,GO:0061752,1,0.983141607706447,0,2,telomeric repeat-containing RNA binding,MF,
15637,GO:0061753,1,0.999999671031117,0,1,substrate localization to autophagosome,BP,
15638,GO:0061756,1,0.854735080487341,0,24,leukocyte adhesion to vascular endothelial cell,BP,
15639,GO:0061757,1,0.981887609827104,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15640,GO:0061762,1,0.999871809314247,0,3,CAMKK-AMPK signaling cascade,BP,
15641,GO:0061763,1,0.983692242327334,0,2,multivesicular body-lysosome fusion,BP,
15642,GO:0061767,1,0.999999996372022,0,1,negative regulation of lung blood pressure,BP,
15643,GO:0061768,1,0.999720524606248,0,1,magnesium:sodium antiporter activity,MF,
15644,GO:0061769,1,0.983384249277821,0,2,ribosylnicotinate kinase activity,MF,
15645,GO:0061770,1,0.989974988047088,0,1,translation elongation factor binding,MF,
15646,GO:0061771,1,0.989218981406881,0,1,response to caloric restriction,BP,
15647,GO:0061772,1,0.995747747758561,0,1,drug transport across blood-nerve barrier,BP,
15648,GO:0061778,1,0.940306663589733,0,16,intracellular chloride channel activity,MF,
15649,GO:0061782,1,0.99835484977967,0,1,vesicle fusion with vesicle,BP,
15650,GO:0061783,1,0.829321197153825,0,15,peptidoglycan muralytic activity,MF,
15651,GO:0061792,1,0.99512239654367,0,3,secretory granule maturation,BP,
15652,GO:0061798,1,0.998550297867607,0,1,GTP 3',8'-cyclase activity,MF,
15653,GO:0061799,1,0.998550297867607,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15654,GO:0061809,1,0.976164388566155,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15655,GO:0061811,1,0.988000229293676,0,1,ADP-ribosyl cyclase activity,MF,
15656,GO:0061812,1,0.988000229293676,0,1,cyclic ADP-ribose hydrolase,MF,
15657,GO:0061819,1,0.985115762489917,0,3,telomeric DNA-containing double minutes formation,BP,
15658,GO:0061820,1,0.957611710742216,0,9,telomeric D-loop disassembly,BP,
15659,GO:0061821,1,0.995200731455886,0,4,telomeric D-loop binding,MF,
15660,GO:0061825,1,0.997838488005057,0,1,podosome core,CC,
15661,GO:0061827,1,0.99158991158068,0,1,sperm head,CC,
15662,GO:0061833,1,0.98920025736586,0,2,protein localization to tricellular tight junction,BP,
15663,GO:0061842,1,0.921256721453305,0,22,microtubule organizing center localization,BP,
15664,GO:0061844,1,0.92599516373701,0,7,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
15665,GO:0061845,1,0.994986386930573,0,1,neuron projection branch point,CC,
15666,GO:0061846,1,0.994986386930573,0,1,dendritic spine cytoplasm,CC,
15667,GO:0061847,1,0.990566313287312,0,1,response to cholecystokinin,BP,
15668,GO:0061849,1,0.999337964036349,0,2,telomeric G-quadruplex DNA binding,MF,
15669,GO:0061850,1,0.987287511472091,0,1,growth cone leading edge,CC,
15670,GO:0065001,1,0.977997794545171,0,4,specification of axis polarity,BP,
15671,GO:0065002,1,0.641478699093111,0,53,intracellular protein transmembrane transport,BP,
15673,GO:0065004,1,0.134203257280937,0,227,protein-DNA complex assembly,BP,
15675,GO:0065006,1,0.975273646830553,0,2,protein-carbohydrate complex assembly,BP,
15679,GO:0065010,1,0.974315941524524,0,3,extracellular membrane-bounded organelle,CC,
15680,GO:0070001,1,0.801792341621158,0,25,aspartic-type peptidase activity,MF,
15681,GO:0070002,1,0.987692946890955,0,1,glutamic-type peptidase activity,MF,
15683,GO:0070006,1,0.926773264504402,0,18,metalloaminopeptidase activity,MF,
15684,GO:0070008,1,0.937776894010495,0,9,serine-type exopeptidase activity,MF,
15685,GO:0070009,1,0.995138955563757,0,1,serine-type aminopeptidase activity,MF,
15687,GO:0070012,1,0.990897171869812,0,1,oligopeptidase activity,MF,
15689,GO:0070016,1,0.966691084215719,0,10,armadillo repeat domain binding,MF,
15690,GO:0070022,1,0.993361913197128,0,4,transforming growth factor beta receptor complex,CC,
15691,GO:0070025,1,0.991848723520862,0,1,carbon monoxide binding,MF,
15692,GO:0070026,1,0.979286776309338,0,2,nitric oxide binding,MF,
15693,GO:0070032,1,0.959843323300992,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
15694,GO:0070033,1,0.979405312015883,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15695,GO:0070034,1,0.888793181217837,0,17,telomerase RNA binding,MF,
15696,GO:0070035,1,0.646220124158101,0,99,purine NTP-dependent helicase activity,MF,
15697,GO:0070037,1,0.987408002364872,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15698,GO:0070039,1,0.988765795927979,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15699,GO:0070044,1,0.968968351164819,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15700,GO:0070050,1,0.938869357027965,0,8,neuron cellular homeostasis,BP,
15701,GO:0070051,1,0.987275126824064,0,3,fibrinogen binding,MF,
15702,GO:0070052,1,0.982116248665634,0,3,collagen V binding,MF,
15703,GO:0070053,1,0.971234727951729,0,4,thrombospondin receptor activity,MF,
15704,GO:0070054,1,0.983379940335693,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15705,GO:0070055,1,0.983379940335693,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15707,GO:0070060,1,0.999999996390852,0,1,'de novo' actin filament nucleation,BP,
15708,GO:0070061,1,0.959824666317675,0,5,fructose binding,MF,
15710,GO:0070063,1,0.763799418970367,0,44,RNA polymerase binding,MF,
15712,GO:0070069,1,0.733527171825868,0,28,cytochrome complex,CC,
15713,GO:0070070,1,0.97353086870043,0,9,proton-transporting V-type ATPase complex assembly,BP,
15714,GO:0070071,1,0.939457655652615,0,13,proton-transporting two-sector ATPase complex assembly,BP,
15715,GO:0070072,1,0.97353086870043,0,9,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15716,GO:0070075,1,0.97450388017936,0,2,tear secretion,BP,
15717,GO:0070076,1,0.958864919943071,0,23,histone lysine demethylation,BP,
15718,GO:0070077,1,0.996656886905039,0,1,histone arginine demethylation,BP,
15719,GO:0070078,1,0.996656886905039,0,1,histone H3-R2 demethylation,BP,
15720,GO:0070079,1,0.996656886905039,0,1,histone H4-R3 demethylation,BP,
15721,GO:0070080,1,0.986683474769862,0,2,titin Z domain binding,MF,
15722,GO:0070081,1,0.960377702659552,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15723,GO:0070083,1,0.960377702659552,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15725,GO:0070086,1,0.970181986671686,0,4,ubiquitin-dependent endocytosis,BP,
15726,GO:0070087,1,0.985847759981225,0,6,chromo shadow domain binding,MF,
15727,GO:0070091,1,0.945365898545236,0,7,glucagon secretion,BP,
15728,GO:0070092,1,0.957296019245759,0,6,regulation of glucagon secretion,BP,
15729,GO:0070093,1,0.97100488008608,0,3,negative regulation of glucagon secretion,BP,
15730,GO:0070094,1,0.987207422932434,0,1,positive regulation of glucagon secretion,BP,
15731,GO:0070095,1,0.973552545559874,0,3,fructose-6-phosphate binding,MF,
15732,GO:0070096,1,0.982819973334789,0,2,mitochondrial outer membrane translocase complex assembly,BP,
15733,GO:0070097,1,0.983523086147738,0,6,delta-catenin binding,MF,
15734,GO:0070098,1,0.46489671781303,0,76,chemokine-mediated signaling pathway,BP,
15735,GO:0070099,1,0.962181695675612,0,8,regulation of chemokine-mediated signaling pathway,BP,
15736,GO:0070100,1,0.986436873789406,0,5,negative regulation of chemokine-mediated signaling pathway,BP,
15737,GO:0070101,1,0.975413968502989,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15738,GO:0070102,1,0.954690313825449,0,10,interleukin-6-mediated signaling pathway,BP,
15739,GO:0070103,1,0.980899029136806,0,2,regulation of interleukin-6-mediated signaling pathway,BP,
15740,GO:0070104,1,0.988498849455759,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15741,GO:0070105,1,0.992312458016392,0,1,positive regulation of interleukin-6-mediated signaling pathway,BP,
15742,GO:0070106,1,0.989763237975997,0,2,interleukin-27-mediated signaling pathway,BP,
15743,GO:0070110,1,0.982604613374386,0,3,ciliary neurotrophic factor receptor complex,CC,
15744,GO:0070119,1,0.998468351162688,0,1,ciliary neurotrophic factor binding,MF,
15745,GO:0070120,1,0.971822700239329,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15746,GO:0070121,1,0.999994354333577,0,1,Kupffer's vesicle development,BP,
15747,GO:0070122,1,0.997765860877206,0,1,isopeptidase activity,MF,
15748,GO:0070123,1,0.99999999637523,0,1,transforming growth factor beta receptor activity, type III,MF,
15749,GO:0070124,1,0.980033405137109,0,2,mitochondrial translational initiation,BP,
15752,GO:0070127,1,0.974041165818754,0,5,tRNA aminoacylation for mitochondrial protein translation,BP,
15754,GO:0070130,1,0.991657600429728,0,1,negative regulation of mitochondrial translation,BP,
15755,GO:0070131,1,0.938032197568325,0,7,positive regulation of mitochondrial translation,BP,
15756,GO:0070137,1,0.994337511071762,0,3,ubiquitin-like protein-specific endopeptidase activity,MF,
15757,GO:0070138,1,0.997765860877206,0,1,ubiquitin-like protein-specific isopeptidase activity,MF,
15758,GO:0070139,1,0.994337511071762,0,3,SUMO-specific endopeptidase activity,MF,
15759,GO:0070140,1,0.997765860877206,0,1,SUMO-specific isopeptidase activity,MF,
15760,GO:0070141,1,0.964621684090371,0,6,response to UV-A,BP,
15761,GO:0070142,1,0.984028965553204,0,4,synaptic vesicle budding,BP,
15762,GO:0070143,1,0.999663270823557,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15763,GO:0070145,1,0.995478574863344,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15764,GO:0070159,1,0.990884405971751,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15765,GO:0070160,1,0.588077633144098,0,112,occluding junction,CC,
15767,GO:0070162,1,0.97286049497025,0,6,adiponectin secretion,BP,
15768,GO:0070163,1,0.97286049497025,0,6,regulation of adiponectin secretion,BP,
15769,GO:0070164,1,0.984173368753239,0,4,negative regulation of adiponectin secretion,BP,
15770,GO:0070165,1,0.988506654600595,0,2,positive regulation of adiponectin secretion,BP,
15771,GO:0070166,1,0.925256987308105,0,14,enamel mineralization,BP,
15772,GO:0070167,1,0.616026323334117,0,73,regulation of biomineral tissue development,BP,
15773,GO:0070168,1,0.872440115783563,0,18,negative regulation of biomineral tissue development,BP,
15774,GO:0070169,1,0.789823231491147,0,39,positive regulation of biomineral tissue development,BP,
15775,GO:0070170,1,0.93290528016863,0,9,regulation of tooth mineralization,BP,
15776,GO:0070171,1,0.991260661078413,0,2,negative regulation of tooth mineralization,BP,
15777,GO:0070172,1,0.958913713508128,0,5,positive regulation of tooth mineralization,BP,
15778,GO:0070173,1,0.969062653366676,0,4,regulation of enamel mineralization,BP,
15779,GO:0070175,1,0.987365582233255,0,2,positive regulation of enamel mineralization,BP,
15780,GO:0070176,1,0.988760010502162,0,1,DRM complex,CC,
15781,GO:0070178,1,0.979649305836638,0,2,D-serine metabolic process,BP,
15782,GO:0070179,1,0.991300277190173,0,1,D-serine biosynthetic process,BP,
15783,GO:0070180,1,0.974548522922427,0,2,large ribosomal subunit rRNA binding,MF,
15784,GO:0070181,1,0.928951434108596,0,8,small ribosomal subunit rRNA binding,MF,
15785,GO:0070182,1,0.92293176021288,0,15,DNA polymerase binding,MF,
15786,GO:0070184,1,0.989974988047088,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15787,GO:0070187,1,0.954752643173812,0,6,shelterin complex,CC,
15788,GO:0070189,1,0.927291513291223,0,8,kynurenine metabolic process,BP,
15789,GO:0070191,1,0.991657600429728,0,1,methionine-R-sulfoxide reductase activity,MF,
15790,GO:0070192,1,0.69480845864398,0,56,chromosome organization involved in meiotic cell cycle,BP,
15791,GO:0070193,1,0.846192669809251,0,21,synaptonemal complex organization,BP,
15792,GO:0070194,1,0.990032434197631,0,1,synaptonemal complex disassembly,BP,
15794,GO:0070197,1,0.972735000192708,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15795,GO:0070198,1,0.836838258837553,0,27,protein localization to chromosome, telomeric region,BP,
15796,GO:0070199,1,0.834915988131356,0,21,establishment of protein localization to chromosome,BP,
15797,GO:0070200,1,0.893859062397887,0,15,establishment of protein localization to telomere,BP,
15799,GO:0070202,1,0.91408896960975,0,10,regulation of establishment of protein localization to chromosome,BP,
15800,GO:0070203,1,0.91408896960975,0,10,regulation of establishment of protein localization to telomere,BP,
15801,GO:0070206,1,0.737033966589693,0,46,protein trimerization,BP,
15802,GO:0070207,1,0.815810719067315,0,26,protein homotrimerization,BP,
15803,GO:0070208,1,0.948070197997163,0,12,protein heterotrimerization,BP,
15804,GO:0070212,1,0.99430953834696,0,3,protein poly-ADP-ribosylation,BP,
15805,GO:0070213,1,0.987794809046318,0,4,protein auto-ADP-ribosylation,BP,
15806,GO:0070217,1,0.988699937621508,0,1,transcription factor TFIIIB complex assembly,BP,
15807,GO:0070221,1,0.9674032953472,0,3,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15811,GO:0070230,1,0.835085725125681,0,20,positive regulation of lymphocyte apoptotic process,BP,
15815,GO:0070234,1,0.867853654698046,0,15,positive regulation of T cell apoptotic process,BP,
15818,GO:0070237,1,0.999924879762242,0,1,positive regulation of activation-induced cell death of T cells,BP,
15819,GO:0070238,1,0.988417154724802,0,1,activated T cell autonomous cell death,BP,
15820,GO:0070239,1,0.988417154724802,0,1,regulation of activated T cell autonomous cell death,BP,
15821,GO:0070241,1,0.988417154724802,0,1,positive regulation of activated T cell autonomous cell death,BP,
15822,GO:0070242,1,0.900602137093313,0,16,thymocyte apoptotic process,BP,
15823,GO:0070243,1,0.928669534941234,0,11,regulation of thymocyte apoptotic process,BP,
15824,GO:0070244,1,0.963464862266727,0,6,negative regulation of thymocyte apoptotic process,BP,
15825,GO:0070245,1,0.963895691920302,0,5,positive regulation of thymocyte apoptotic process,BP,
15826,GO:0070246,1,0.987688667285741,0,1,natural killer cell apoptotic process,BP,
15827,GO:0070247,1,0.987688667285741,0,1,regulation of natural killer cell apoptotic process,BP,
15828,GO:0070251,1,0.990595172043783,0,1,pristanate-CoA ligase activity,MF,
15829,GO:0070252,1,0.607189620370942,0,102,actin-mediated cell contraction,BP,
15830,GO:0070253,1,0.956901359077863,0,4,somatostatin secretion,BP,
15831,GO:0070254,1,0.914842354045493,0,11,mucus secretion,BP,
15832,GO:0070255,1,0.938570257638908,0,9,regulation of mucus secretion,BP,
15833,GO:0070256,1,0.98116244223155,0,2,negative regulation of mucus secretion,BP,
15834,GO:0070257,1,0.964105051346077,0,6,positive regulation of mucus secretion,BP,
15835,GO:0070259,1,0.988434194908752,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15836,GO:0070260,1,0.991657600429728,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15837,GO:0070262,1,0.918976969059355,0,12,peptidyl-serine dephosphorylation,BP,
15840,GO:0070267,1,0.996507136507488,0,1,oncosis,BP,
15842,GO:0070269,1,0.937383546585669,0,6,pyroptosis,BP,
15844,GO:0070272,1,0.965007728710786,0,4,proton-transporting ATP synthase complex biogenesis,BP,
15845,GO:0070273,1,0.906126320647751,0,20,phosphatidylinositol-4-phosphate binding,MF,
15846,GO:0070274,1,0.977639899772855,0,2,RES complex,CC,
15847,GO:0070278,1,0.950214269197252,0,6,extracellular matrix constituent secretion,BP,
15849,GO:0070283,1,0.988425931795391,0,1,radical SAM enzyme activity,MF,
15850,GO:0070286,1,0.862603475420015,0,21,axonemal dynein complex assembly,BP,
15851,GO:0070287,1,0.996686529706208,0,1,ferritin receptor activity,MF,
15852,GO:0070288,1,0.975029852781935,0,2,ferritin complex,CC,
15853,GO:0070290,1,0.975915706245155,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15854,GO:0070292,1,0.994154909179538,0,1,N-acylphosphatidylethanolamine metabolic process,BP,
15856,GO:0070294,1,0.979960671514473,0,4,renal sodium ion absorption,BP,
15857,GO:0070295,1,0.974274256639103,0,3,renal water absorption,BP,
15859,GO:0070300,1,0.925397162727683,0,15,phosphatidic acid binding,MF,
15860,GO:0070301,1,0.58507776474961,0,80,cellular response to hydrogen peroxide,BP,
15862,GO:0070303,1,0.792329765857107,0,41,negative regulation of stress-activated protein kinase signaling cascade,BP,
15864,GO:0070305,1,0.980256987403389,0,7,response to cGMP,BP,
15865,GO:0070306,1,0.82933075455737,0,30,lens fiber cell differentiation,BP,
15866,GO:0070307,1,0.910603455238465,0,13,lens fiber cell development,BP,
15867,GO:0070309,1,0.96746421491322,0,5,lens fiber cell morphogenesis,BP,
15868,GO:0070314,1,0.940464446768833,0,8,G1 to G0 transition,BP,
15869,GO:0070315,1,0.979017457917943,0,3,G1 to G0 transition involved in cell differentiation,BP,
15870,GO:0070316,1,0.946343902917,0,8,regulation of G0 to G1 transition,BP,
15871,GO:0070317,1,0.975130603646508,0,4,negative regulation of G0 to G1 transition,BP,
15872,GO:0070318,1,0.970484947694277,0,4,positive regulation of G0 to G1 transition,BP,
15873,GO:0070320,1,0.992169805765653,0,1,inward rectifier potassium channel inhibitor activity,MF,
15874,GO:0070324,1,0.951213969668942,0,6,thyroid hormone binding,MF,
15875,GO:0070325,1,0.852849621252809,0,21,lipoprotein particle receptor binding,MF,
15876,GO:0070326,1,0.97268786008869,0,4,very-low-density lipoprotein particle receptor binding,MF,
15877,GO:0070327,1,0.937694720111535,0,9,thyroid hormone transport,BP,
15878,GO:0070328,1,0.746990595595873,0,32,triglyceride homeostasis,BP,
15879,GO:0070330,1,0.826509926895318,0,22,aromatase activity,MF,
15880,GO:0070335,1,0.999999996379559,0,1,aspartate binding,MF,
15881,GO:0070336,1,0.991657579380805,0,2,flap-structured DNA binding,MF,
15882,GO:0070337,1,0.999999980468215,0,1,3'-flap-structured DNA binding,MF,
15883,GO:0070339,1,0.956020482343427,0,6,response to bacterial lipopeptide,BP,
15884,GO:0070340,1,0.988693263112958,0,3,detection of bacterial lipopeptide,BP,
15885,GO:0070341,1,0.922487292207662,0,11,fat cell proliferation,BP,
15886,GO:0070342,1,0.987144524307364,0,1,brown fat cell proliferation,BP,
15887,GO:0070343,1,0.961531468939503,0,4,white fat cell proliferation,BP,
15888,GO:0070344,1,0.922487292207662,0,11,regulation of fat cell proliferation,BP,
15889,GO:0070345,1,0.966932006051381,0,6,negative regulation of fat cell proliferation,BP,
15890,GO:0070346,1,0.955127818171496,0,4,positive regulation of fat cell proliferation,BP,
15891,GO:0070347,1,0.987144524307364,0,1,regulation of brown fat cell proliferation,BP,
15892,GO:0070349,1,0.987144524307364,0,1,positive regulation of brown fat cell proliferation,BP,
15893,GO:0070350,1,0.961531468939503,0,4,regulation of white fat cell proliferation,BP,
15894,GO:0070351,1,0.987293789996454,0,1,negative regulation of white fat cell proliferation,BP,
15895,GO:0070352,1,0.975011551085679,0,2,positive regulation of white fat cell proliferation,BP,
15896,GO:0070358,1,0.996170480742251,0,3,actin polymerization-dependent cell motility,BP,
15897,GO:0070361,1,0.994344624525173,0,1,mitochondrial light strand promoter anti-sense binding,MF,
15898,GO:0070362,1,0.994344624525173,0,1,mitochondrial heavy strand promoter anti-sense binding,MF,
15899,GO:0070363,1,0.989186081621465,0,1,mitochondrial light strand promoter sense binding,MF,
15900,GO:0070365,1,0.910748955921287,0,13,hepatocyte differentiation,BP,
15901,GO:0070366,1,0.977166690353135,0,2,regulation of hepatocyte differentiation,BP,
15902,GO:0070367,1,0.989523122609231,0,1,negative regulation of hepatocyte differentiation,BP,
15903,GO:0070368,1,0.98751377475558,0,1,positive regulation of hepatocyte differentiation,BP,
15904,GO:0070369,1,0.993814685798652,0,2,beta-catenin-TCF7L2 complex,CC,
15905,GO:0070370,1,0.972254367095284,0,3,cellular heat acclimation,BP,
15908,GO:0070373,1,0.717040357848733,0,54,negative regulation of ERK1 and ERK2 cascade,BP,
15910,GO:0070375,1,0.984090372193179,0,3,ERK5 cascade,BP,
15911,GO:0070376,1,0.993239716586919,0,1,regulation of ERK5 cascade,BP,
15912,GO:0070377,1,0.993239716586919,0,1,negative regulation of ERK5 cascade,BP,
15913,GO:0070381,1,0.99568317758955,0,1,endosome to plasma membrane transport vesicle,CC,
15914,GO:0070382,1,0.350412704629192,0,159,exocytic vesicle,CC,
15915,GO:0070383,1,0.93706413217597,0,6,DNA cytosine deamination,BP,
15916,GO:0070384,1,0.974284699837631,0,4,Harderian gland development,BP,
15917,GO:0070389,1,0.952008053092808,0,7,chaperone cofactor-dependent protein refolding,BP,
15918,GO:0070390,1,0.988522406864506,0,1,transcription export complex 2,CC,
15919,GO:0070391,1,0.920433111880578,0,9,response to lipoteichoic acid,BP,
15920,GO:0070392,1,0.987408883959657,0,1,detection of lipoteichoic acid,BP,
15921,GO:0070401,1,0.978769276044698,0,2,NADP+ binding,MF,
15923,GO:0070403,1,0.895470211844494,0,13,NAD+ binding,MF,
15924,GO:0070404,1,0.975872113536096,0,2,NADH binding,MF,
15926,GO:0070407,1,0.994344624525173,0,1,oxidation-dependent protein catabolic process,BP,
15927,GO:0070408,1,0.999999934383817,0,1,carbamoyl phosphate metabolic process,BP,
15928,GO:0070409,1,0.999999934383817,0,1,carbamoyl phosphate biosynthetic process,BP,
15929,GO:0070410,1,0.948850160269634,0,11,co-SMAD binding,MF,
15930,GO:0070411,1,0.960492772834921,0,11,I-SMAD binding,MF,
15931,GO:0070412,1,0.914313900200176,0,23,R-SMAD binding,MF,
15932,GO:0070417,1,0.977347690802992,0,6,cellular response to cold,BP,
15933,GO:0070418,1,0.999916317321682,0,1,DNA-dependent protein kinase complex,CC,
15934,GO:0070419,1,0.947721911383179,0,8,nonhomologous end joining complex,CC,
15935,GO:0070423,1,0.829975045113889,0,33,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15936,GO:0070424,1,0.970829274649339,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15937,GO:0070425,1,0.992935948244614,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15938,GO:0070426,1,0.98259029649952,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15939,GO:0070427,1,0.979226246492534,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15940,GO:0070428,1,0.999147191812089,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15941,GO:0070429,1,0.999148640907736,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15942,GO:0070430,1,0.999998549851777,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15943,GO:0070431,1,0.947585831410068,0,9,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15944,GO:0070432,1,0.975648259336692,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15945,GO:0070433,1,0.992935948244614,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15946,GO:0070434,1,0.98259029649952,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15947,GO:0070435,1,0.987042932140639,0,2,Shc-EGFR complex,CC,
15948,GO:0070436,1,0.993928270504011,0,2,Grb2-EGFR complex,CC,
15949,GO:0070442,1,0.987818743140242,0,1,integrin alphaIIb-beta3 complex,CC,
15950,GO:0070444,1,0.967377073841367,0,6,oligodendrocyte progenitor proliferation,BP,
15951,GO:0070445,1,0.967377073841367,0,6,regulation of oligodendrocyte progenitor proliferation,BP,
15952,GO:0070446,1,0.989218981406881,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15953,GO:0070447,1,0.994059920389444,0,1,positive regulation of oligodendrocyte progenitor proliferation,BP,
15954,GO:0070449,1,0.988978780241368,0,1,elongin complex,CC,
15955,GO:0070458,1,0.973788276380485,0,3,cellular detoxification of nitrogen compound,BP,
15956,GO:0070459,1,0.954232019866061,0,6,prolactin secretion,BP,
15957,GO:0070460,1,0.99763454673982,0,1,thyroid-stimulating hormone secretion,BP,
15958,GO:0070461,1,0.838303532213042,0,28,SAGA-type complex,CC,
15959,GO:0070462,1,0.996799869058843,0,1,plus-end specific microtubule depolymerization,BP,
15960,GO:0070463,1,0.99600771942443,0,1,tubulin-dependent ATPase activity,MF,
15961,GO:0070469,1,0.395188718242336,0,82,respiratory chain,CC,
15962,GO:0070471,1,0.942925133868304,0,8,uterine smooth muscle contraction,BP,
15963,GO:0070472,1,0.950778102515321,0,7,regulation of uterine smooth muscle contraction,BP,
15964,GO:0070473,1,0.989235529949153,0,1,negative regulation of uterine smooth muscle contraction,BP,
15965,GO:0070474,1,0.961127364992506,0,6,positive regulation of uterine smooth muscle contraction,BP,
15966,GO:0070475,1,0.950422240224301,0,5,rRNA base methylation,BP,
15967,GO:0070476,1,0.987170801643876,0,1,rRNA (guanine-N7)-methylation,BP,
15968,GO:0070478,1,0.998625457075454,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15969,GO:0070481,1,0.993336720446648,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15971,GO:0070483,1,0.994645058213303,0,1,detection of hypoxia,BP,
15972,GO:0070486,1,0.93376714848951,0,11,leukocyte aggregation,BP,
15973,GO:0070487,1,0.981153948032651,0,5,monocyte aggregation,BP,
15974,GO:0070488,1,0.974481778241221,0,2,neutrophil aggregation,BP,
15975,GO:0070489,1,0.989205789850076,0,1,T cell aggregation,BP,
15976,GO:0070491,1,0.711972679596763,0,58,repressing transcription factor binding,MF,
15977,GO:0070492,1,0.915373512780684,0,11,oligosaccharide binding,MF,
15978,GO:0070493,1,0.939660492733868,0,12,thrombin-activated receptor signaling pathway,BP,
15979,GO:0070494,1,0.982915157747071,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15980,GO:0070495,1,0.982915157747071,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15981,GO:0070498,1,0.874913337122059,0,20,interleukin-1-mediated signaling pathway,BP,
15982,GO:0070506,1,0.984405221848937,0,2,high-density lipoprotein particle receptor activity,MF,
15983,GO:0070507,1,0.474437487254686,0,130,regulation of microtubule cytoskeleton organization,BP,
15984,GO:0070508,1,0.916385943894527,0,9,cholesterol import,BP,
15986,GO:0070510,1,0.999999996379454,0,1,regulation of histone H4-K20 methylation,BP,
15987,GO:0070512,1,0.999999996379454,0,1,positive regulation of histone H4-K20 methylation,BP,
15989,GO:0070522,1,0.976896558063006,0,4,ERCC4-ERCC1 complex,CC,
15990,GO:0070524,1,0.987868296472864,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15992,GO:0070527,1,0.70911879002612,0,53,platelet aggregation,BP,
15993,GO:0070528,1,0.854781795140942,0,26,protein kinase C signaling,BP,
15994,GO:0070530,1,0.929810597623856,0,17,K63-linked polyubiquitin binding,MF,
15995,GO:0070531,1,0.951429862331884,0,7,BRCA1-A complex,CC,
15996,GO:0070534,1,0.7619299990925,0,41,protein K63-linked ubiquitination,BP,
15997,GO:0070535,1,0.981627101005212,0,5,histone H2A K63-linked ubiquitination,BP,
15998,GO:0070536,1,0.881882955295232,0,27,protein K63-linked deubiquitination,BP,
15999,GO:0070537,1,0.978891456254148,0,3,histone H2A K63-linked deubiquitination,BP,
16001,GO:0070539,1,0.996191549146816,0,1,linoleic acid binding,MF,
16002,GO:0070541,1,0.994664370868918,0,2,response to platinum ion,BP,
16004,GO:0070543,1,0.989043357112638,0,2,response to linoleic acid,BP,
16005,GO:0070544,1,0.99092469079139,0,5,histone H3-K36 demethylation,BP,
16006,GO:0070545,1,0.971521027748628,0,4,PeBoW complex,CC,
16007,GO:0070546,1,0.97387532397188,0,3,L-phenylalanine aminotransferase activity,MF,
16008,GO:0070547,1,0.992605397731212,0,1,L-tyrosine aminotransferase activity,MF,
16009,GO:0070548,1,0.99386736918844,0,2,L-glutamine aminotransferase activity,MF,
16010,GO:0070551,1,0.991657600429728,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
16011,GO:0070552,1,0.958489903402089,0,5,BRISC complex,CC,
16012,GO:0070553,1,0.991657600429728,0,1,nicotinic acid receptor activity,MF,
16013,GO:0070554,1,0.98945501099779,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
16015,GO:0070557,1,0.978012582852139,0,2,PCNA-p21 complex,CC,
16016,GO:0070560,1,0.99304146129124,0,1,protein secretion by platelet,BP,
16017,GO:0070561,1,0.956099131296359,0,9,vitamin D receptor signaling pathway,BP,
16018,GO:0070562,1,0.969135318713204,0,6,regulation of vitamin D receptor signaling pathway,BP,
16019,GO:0070563,1,0.989616008272866,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
16020,GO:0070564,1,0.981308610548799,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
16021,GO:0070566,1,0.896317086618063,0,23,adenylyltransferase activity,MF,
16022,GO:0070567,1,0.938313845745302,0,9,cytidylyltransferase activity,MF,
16023,GO:0070568,1,0.969686805296807,0,5,guanylyltransferase activity,MF,
16025,GO:0070570,1,0.860422338244972,0,25,regulation of neuron projection regeneration,BP,
16026,GO:0070571,1,0.930722503564455,0,13,negative regulation of neuron projection regeneration,BP,
16027,GO:0070572,1,0.940618386541776,0,7,positive regulation of neuron projection regeneration,BP,
16028,GO:0070573,1,0.975816935415935,0,3,metallodipeptidase activity,MF,
16029,GO:0070574,1,0.980621405857163,0,4,cadmium ion transmembrane transport,BP,
16030,GO:0070576,1,0.979274549955928,0,3,vitamin D 24-hydroxylase activity,MF,
16031,GO:0070577,1,0.96833355617838,0,17,lysine-acetylated histone binding,MF,
16032,GO:0070578,1,0.933937983395584,0,8,RISC-loading complex,CC,
16033,GO:0070579,1,0.991775627935355,0,4,methylcytosine dioxygenase activity,MF,
16034,GO:0070584,1,0.870851166953424,0,20,mitochondrion morphogenesis,BP,
16035,GO:0070585,1,0.232660183283765,0,185,protein localization to mitochondrion,BP,
16036,GO:0070586,1,0.921003009342433,0,10,cell-cell adhesion involved in gastrulation,BP,
16037,GO:0070587,1,0.92814234739962,0,9,regulation of cell-cell adhesion involved in gastrulation,BP,
16039,GO:0070589,1,0.988688643487989,0,1,cellular component macromolecule biosynthetic process,BP,
16040,GO:0070593,1,0.99999999637948,0,1,dendrite self-avoidance,BP,
16041,GO:0070601,1,0.972879829483377,0,7,centromeric sister chromatid cohesion,BP,
16042,GO:0070602,1,0.991880749441519,0,3,regulation of centromeric sister chromatid cohesion,BP,
16043,GO:0070603,1,0.667249580981109,0,73,SWI/SNF superfamily-type complex,CC,
16044,GO:0070611,1,0.992009701125171,0,1,histone methyltransferase activity (H3-R2 specific),MF,
16045,GO:0070612,1,0.992009701125171,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
16047,GO:0070615,1,0.998333235201131,0,1,nucleosome-dependent ATPase activity,MF,
16048,GO:0070618,1,0.992246853015286,0,1,Grb2-Sos complex,CC,
16049,GO:0070625,1,0.98968435726498,0,1,zymogen granule exocytosis,BP,
16050,GO:0070626,1,0.98799447644581,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
16051,GO:0070627,1,0.961751994464414,0,5,ferrous iron import,BP,
16052,GO:0070628,1,0.917292471997821,0,12,proteasome binding,MF,
16053,GO:0070633,1,0.885349987621166,0,18,transepithelial transport,BP,
16054,GO:0070634,1,0.978250855351288,0,3,transepithelial ammonium transport,BP,
16057,GO:0070640,1,0.972540039403167,0,4,vitamin D3 metabolic process,BP,
16058,GO:0070643,1,0.981029900141319,0,2,vitamin D 25-hydroxylase activity,MF,
16059,GO:0070644,1,0.998388690071315,0,3,vitamin D response element binding,MF,
16062,GO:0070649,1,0.994956219342252,0,3,formin-nucleated actin cable assembly,BP,
16063,GO:0070651,1,0.993336720446648,0,1,nonfunctional rRNA decay,BP,
16064,GO:0070652,1,0.950422126778009,0,8,HAUS complex,CC,
16065,GO:0070653,1,0.962096353129721,0,3,high-density lipoprotein particle receptor binding,MF,
16067,GO:0070662,1,0.993956806823822,0,3,mast cell proliferation,BP,
16069,GO:0070664,1,0.608510596234196,0,67,negative regulation of leukocyte proliferation,BP,
16071,GO:0070666,1,0.994036517332445,0,2,regulation of mast cell proliferation,BP,
16072,GO:0070667,1,0.994059920389444,0,1,negative regulation of mast cell proliferation,BP,
16073,GO:0070668,1,0.994036517332445,0,2,positive regulation of mast cell proliferation,BP,
16074,GO:0070669,1,0.951436838097914,0,9,response to interleukin-2,BP,
16076,GO:0070671,1,0.97498567780533,0,5,response to interleukin-12,BP,
16077,GO:0070672,1,0.982646015497727,0,6,response to interleukin-15,BP,
16078,GO:0070673,1,0.932833771536006,0,9,response to interleukin-18,BP,
16079,GO:0070676,1,0.967236448105073,0,3,intralumenal vesicle formation,BP,
16080,GO:0070679,1,0.986791788934146,0,9,inositol 1,4,5 trisphosphate binding,MF,
16081,GO:0070681,1,0.985604879410826,0,2,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
16082,GO:0070682,1,0.974573534849687,0,3,proteasome regulatory particle assembly,BP,
16083,GO:0070684,1,0.987490084628611,0,1,seminal clot liquefaction,BP,
16084,GO:0070685,1,0.989796354419671,0,1,macropinocytic cup,CC,
16085,GO:0070694,1,0.991657600429728,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
16086,GO:0070695,1,0.978295663211198,0,5,FHF complex,CC,
16088,GO:0070697,1,0.973093662883397,0,4,activin receptor binding,MF,
16089,GO:0070698,1,0.982903491827921,0,2,type I activin receptor binding,MF,
16090,GO:0070699,1,0.990020900352972,0,2,type II activin receptor binding,MF,
16092,GO:0070701,1,0.99999999281864,0,2,mucus layer,CC,
16093,GO:0070702,1,0.999999996388294,0,1,inner mucus layer,CC,
16094,GO:0070703,1,0.999999996388294,0,1,outer mucus layer,CC,
16096,GO:0070715,1,0.995105658528154,0,1,sodium-dependent organic cation transport,BP,
16097,GO:0070717,1,0.923206027645999,0,18,poly-purine tract binding,MF,
16098,GO:0070722,1,0.996111189449722,0,1,Tle3-Aes complex,CC,
16099,GO:0070723,1,0.913705385674808,0,21,response to cholesterol,BP,
16100,GO:0070724,1,0.983193012202408,0,2,BMP receptor complex,CC,
16102,GO:0070728,1,0.975541974892614,0,6,leucine binding,MF,
16103,GO:0070733,1,0.988360455585529,0,1,protein adenylyltransferase activity,MF,
16104,GO:0070734,1,0.905979305335246,0,18,histone H3-K27 methylation,BP,
16105,GO:0070735,1,0.995706269082892,0,1,protein-glycine ligase activity,MF,
16106,GO:0070736,1,0.995706269082892,0,1,protein-glycine ligase activity, initiating,MF,
16107,GO:0070739,1,0.959646829396463,0,6,protein-glutamic acid ligase activity,MF,
16108,GO:0070740,1,0.977481325976607,0,3,tubulin-glutamic acid ligase activity,MF,
16109,GO:0070741,1,0.812840216657929,0,31,response to interleukin-6,BP,
16111,GO:0070743,1,0.978255871287409,0,2,interleukin-23 complex,CC,
16112,GO:0070761,1,0.95104897745783,0,6,pre-snoRNP complex,CC,
16113,GO:0070765,1,0.967480519259315,0,6,gamma-secretase complex,CC,
16114,GO:0070772,1,0.994271707701199,0,1,PAS complex,CC,
16115,GO:0070773,1,0.987767596792157,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
16116,GO:0070774,1,0.999074413660751,0,1,phytoceramidase activity,MF,
16117,GO:0070775,1,0.972470720329661,0,7,H3 histone acetyltransferase complex,CC,
16118,GO:0070776,1,0.972470720329661,0,7,MOZ/MORF histone acetyltransferase complex,CC,
16120,GO:0070778,1,0.974282191320734,0,4,L-aspartate transport,BP,
16122,GO:0070780,1,0.982835875706459,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
16123,GO:0070781,1,0.988365312258148,0,2,response to biotin,BP,
16124,GO:0070782,1,0.989963557630705,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
16125,GO:0070813,1,0.956495232024136,0,5,hydrogen sulfide metabolic process,BP,
16126,GO:0070814,1,0.96876360142373,0,4,hydrogen sulfide biosynthetic process,BP,
16127,GO:0070815,1,0.982494030164694,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
16128,GO:0070816,1,0.897510735053523,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
16129,GO:0070818,1,0.988609563752324,0,1,protoporphyrinogen oxidase activity,MF,
16131,GO:0070821,1,0.648264536352091,0,71,tertiary granule membrane,CC,
16132,GO:0070822,1,0.922564051059715,0,16,Sin3-type complex,CC,
16133,GO:0070826,1,0.998573908503945,0,1,paraferritin complex,CC,
16134,GO:0070827,1,0.991317910846921,0,3,chromatin maintenance,BP,
16135,GO:0070828,1,0.919720459923957,0,15,heterochromatin organization,BP,
16136,GO:0070829,1,0.99999999637961,0,1,heterochromatin maintenance,BP,
16137,GO:0070830,1,0.802385939414393,0,45,bicellular tight junction assembly,BP,
16138,GO:0070831,1,0.980878752147028,0,9,basement membrane assembly,BP,
16139,GO:0070836,1,0.964958975582506,0,4,caveola assembly,BP,
16140,GO:0070837,1,0.98152087602726,0,4,dehydroascorbic acid transport,BP,
16142,GO:0070839,1,0.993069014407711,0,2,divalent metal ion export,BP,
16143,GO:0070840,1,0.949156242357414,0,19,dynein complex binding,MF,
16144,GO:0070841,1,0.875949994166004,0,21,inclusion body assembly,BP,
16145,GO:0070842,1,0.9818414993439,0,4,aggresome assembly,BP,
16146,GO:0070843,1,0.998439442435801,0,1,misfolded protein transport,BP,
16147,GO:0070844,1,0.998439442435801,0,1,polyubiquitinated protein transport,BP,
16148,GO:0070845,1,0.998439442435801,0,1,polyubiquitinated misfolded protein transport,BP,
16149,GO:0070846,1,0.998439442435801,0,1,Hsp90 deacetylation,BP,
16150,GO:0070847,1,0.943202974913503,0,6,core mediator complex,CC,
16152,GO:0070849,1,0.806494112939818,0,41,response to epidermal growth factor,BP,
16154,GO:0070852,1,0.958656414620576,0,7,cell body fiber,CC,
16155,GO:0070853,1,0.999999992762981,0,2,myosin VI binding,MF,
16156,GO:0070856,1,0.999999996373118,0,1,myosin VI light chain binding,MF,
16158,GO:0070858,1,0.974118102875242,0,3,negative regulation of bile acid biosynthetic process,BP,
16160,GO:0070860,1,0.99056219809714,0,1,RNA polymerase I core factor complex,CC,
16161,GO:0070861,1,0.896625993659259,0,21,regulation of protein exit from endoplasmic reticulum,BP,
16162,GO:0070862,1,0.942373366034868,0,9,negative regulation of protein exit from endoplasmic reticulum,BP,
16163,GO:0070863,1,0.955120643866281,0,10,positive regulation of protein exit from endoplasmic reticulum,BP,
16164,GO:0070873,1,0.881491442046583,0,29,regulation of glycogen metabolic process,BP,
16165,GO:0070874,1,0.971641096691499,0,6,negative regulation of glycogen metabolic process,BP,
16166,GO:0070875,1,0.937983775684534,0,16,positive regulation of glycogen metabolic process,BP,
16167,GO:0070876,1,0.974480359476835,0,4,SOSS complex,CC,
16168,GO:0070877,1,0.990842310723319,0,2,microprocessor complex,CC,
16169,GO:0070878,1,0.972850334336667,0,8,primary miRNA binding,MF,
16170,GO:0070883,1,0.975490211670782,0,4,pre-miRNA binding,MF,
16171,GO:0070884,1,0.904222273870443,0,17,regulation of calcineurin-NFAT signaling cascade,BP,
16172,GO:0070885,1,0.977405414932607,0,4,negative regulation of calcineurin-NFAT signaling cascade,BP,
16173,GO:0070886,1,0.948945904909149,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
16175,GO:0070888,1,0.796463798534071,0,35,E-box binding,MF,
16176,GO:0070889,1,0.982870064607813,0,2,platelet alpha granule organization,BP,
16177,GO:0070890,1,0.990778624738743,0,2,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16178,GO:0070891,1,0.960240045304298,0,4,lipoteichoic acid binding,MF,
16179,GO:0070892,1,0.989651723771441,0,1,lipoteichoic acid receptor activity,MF,
16180,GO:0070893,1,0.9927202039203,0,2,transposon integration,BP,
16181,GO:0070894,1,0.9927202039203,0,2,regulation of transposon integration,BP,
16182,GO:0070895,1,0.9927202039203,0,2,negative regulation of transposon integration,BP,
16183,GO:0070897,1,0.770523244681506,0,36,DNA-templated transcriptional preinitiation complex assembly,BP,
16184,GO:0070898,1,0.991103477923515,0,2,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16185,GO:0070899,1,0.99376986957673,0,1,mitochondrial tRNA wobble uridine modification,BP,
16189,GO:0070903,1,0.989292282782248,0,1,mitochondrial tRNA thio-modification,BP,
16190,GO:0070904,1,0.990778624738743,0,2,transepithelial L-ascorbic acid transport,BP,
16191,GO:0070905,1,0.979771196088176,0,3,serine binding,MF,
16192,GO:0070911,1,0.789297343042202,0,32,global genome nucleotide-excision repair,BP,
16193,GO:0070914,1,0.939781269210064,0,11,UV-damage excision repair,BP,
16194,GO:0070915,1,0.95578700355377,0,5,lysophosphatidic acid receptor activity,MF,
16195,GO:0070918,1,0.830820718231574,0,35,production of small RNA involved in gene silencing by RNA,BP,
16196,GO:0070920,1,0.919561599613998,0,15,regulation of production of small RNA involved in gene silencing by RNA,BP,
16197,GO:0070922,1,0.944491319084656,0,8,small RNA loading onto RISC,BP,
16199,GO:0070926,1,0.997620100517047,0,1,regulation of ATP:ADP antiporter activity,BP,
16200,GO:0070931,1,0.999999835837954,0,1,Golgi-associated vesicle lumen,CC,
16201,GO:0070932,1,0.904645611064925,0,20,histone H3 deacetylation,BP,
16202,GO:0070933,1,0.96345634032144,0,9,histone H4 deacetylation,BP,
16203,GO:0070934,1,0.987593015555312,0,5,CRD-mediated mRNA stabilization,BP,
16204,GO:0070935,1,0.951462833136754,0,10,3'-UTR-mediated mRNA stabilization,BP,
16206,GO:0070937,1,0.986070738978659,0,6,CRD-mediated mRNA stability complex,CC,
16207,GO:0070938,1,0.954156412701736,0,11,contractile ring,CC,
16208,GO:0070939,1,0.986944939076383,0,3,Dsl1/NZR complex,CC,
16209,GO:0070940,1,0.975550860686012,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16210,GO:0070942,1,0.932764095959947,0,6,neutrophil mediated cytotoxicity,BP,
16211,GO:0070943,1,0.932764095959947,0,6,neutrophil mediated killing of symbiont cell,BP,
16212,GO:0070944,1,0.944758027001439,0,5,neutrophil mediated killing of bacterium,BP,
16213,GO:0070945,1,0.969212448192549,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16214,GO:0070946,1,0.987311081224204,0,1,neutrophil mediated killing of gram-positive bacterium,BP,
16215,GO:0070947,1,0.987310430611764,0,1,neutrophil mediated killing of fungus,BP,
16216,GO:0070948,1,0.993157405994137,0,1,regulation of neutrophil mediated cytotoxicity,BP,
16217,GO:0070949,1,0.993157405994137,0,1,regulation of neutrophil mediated killing of symbiont cell,BP,
16218,GO:0070950,1,0.993157405994137,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16219,GO:0070951,1,0.993157405994137,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16220,GO:0070960,1,0.993157405994137,0,1,positive regulation of neutrophil mediated cytotoxicity,BP,
16221,GO:0070961,1,0.993157405994137,0,1,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16222,GO:0070962,1,0.993157405994137,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16223,GO:0070963,1,0.993157405994137,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16224,GO:0070966,1,0.991805657586334,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16226,GO:0070971,1,0.94522906318235,0,11,endoplasmic reticulum exit site,CC,
16227,GO:0070972,1,0.269231278328262,0,126,protein localization to endoplasmic reticulum,BP,
16228,GO:0070973,1,0.978660389633903,0,4,protein localization to endoplasmic reticulum exit site,BP,
16229,GO:0070974,1,0.993952691954143,0,1,POU domain binding,MF,
16230,GO:0070975,1,0.999999996380915,0,1,FHA domain binding,MF,
16231,GO:0070976,1,0.992354742068774,0,1,TIR domain binding,MF,
16232,GO:0070977,1,0.927655877046247,0,17,bone maturation,BP,
16233,GO:0070979,1,0.796004997521622,0,26,protein K11-linked ubiquitination,BP,
16234,GO:0070980,1,0.990770215483747,0,1,biphenyl catabolic process,BP,
16235,GO:0070981,1,0.990649008384682,0,1,L-asparagine biosynthetic process,BP,
16236,GO:0070982,1,0.990649008384682,0,1,L-asparagine metabolic process,BP,
16237,GO:0070984,1,0.998566066960732,0,1,SET domain binding,MF,
16238,GO:0070985,1,0.976042240451908,0,2,TFIIK complex,CC,
16239,GO:0070986,1,0.944794435967417,0,13,left/right axis specification,BP,
16240,GO:0070987,1,0.873145433365695,0,18,error-free translesion synthesis,BP,
16241,GO:0070988,1,0.742615687962337,0,57,demethylation,BP,
16242,GO:0070989,1,0.903249256915558,0,12,oxidative demethylation,BP,
16243,GO:0070990,1,0.909732745763092,0,8,snRNP binding,MF,
16244,GO:0070991,1,0.988357270967317,0,2,medium-chain-acyl-CoA dehydrogenase activity,MF,
16245,GO:0070992,1,0.98127432060903,0,2,translation initiation complex,CC,
16246,GO:0070993,1,0.997817557948904,0,2,translation preinitiation complex,CC,
16247,GO:0070994,1,0.999385324562941,0,1,detection of oxidative stress,BP,
16248,GO:0070995,1,0.984361262678679,0,3,NADPH oxidation,BP,
16251,GO:0071000,1,0.979967187132488,0,2,response to magnetism,BP,
16252,GO:0071001,1,0.978916250701561,0,3,U4/U6 snRNP,CC,
16253,GO:0071004,1,0.8761997058046,0,16,U2-type prespliceosome,CC,
16254,GO:0071006,1,0.976826674874628,0,3,U2-type catalytic step 1 spliceosome,CC,
16255,GO:0071007,1,0.99074501404141,0,1,U2-type catalytic step 2 spliceosome,CC,
16256,GO:0071008,1,0.966734328217135,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16257,GO:0071010,1,0.84467640752924,0,19,prespliceosome,CC,
16258,GO:0071011,1,0.812022483389748,0,23,precatalytic spliceosome,CC,
16259,GO:0071012,1,0.96574801718439,0,4,catalytic step 1 spliceosome,CC,
16260,GO:0071013,1,0.494128756729059,0,95,catalytic step 2 spliceosome,CC,
16261,GO:0071014,1,0.935229245759649,0,7,post-mRNA release spliceosomal complex,CC,
16262,GO:0071020,1,0.977301771646501,0,2,post-spliceosomal complex,CC,
16263,GO:0071021,1,0.988511905683435,0,1,U2-type post-spliceosomal complex,CC,
16264,GO:0071025,1,0.889377670116861,0,12,RNA surveillance,BP,
16265,GO:0071026,1,0.991317921526807,0,1,cytoplasmic RNA surveillance,BP,
16266,GO:0071027,1,0.903196771043361,0,10,nuclear RNA surveillance,BP,
16267,GO:0071028,1,0.903196771043361,0,10,nuclear mRNA surveillance,BP,
16268,GO:0071029,1,0.959266850462091,0,4,nuclear ncRNA surveillance,BP,
16269,GO:0071030,1,0.981309934516843,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16270,GO:0071031,1,0.977746943887965,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16271,GO:0071033,1,0.948453574100701,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16272,GO:0071034,1,0.970622777269697,0,4,CUT catabolic process,BP,
16273,GO:0071035,1,0.959266850462091,0,4,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16274,GO:0071038,1,0.977746943887965,0,2,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16275,GO:0071042,1,0.999426095987091,0,1,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16276,GO:0071043,1,0.970622777269697,0,4,CUT metabolic process,BP,
16277,GO:0071044,1,0.951720099512448,0,11,histone mRNA catabolic process,BP,
16278,GO:0071045,1,0.988348355554348,0,1,nuclear histone mRNA catabolic process,BP,
16279,GO:0071046,1,0.959266850462091,0,4,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16280,GO:0071047,1,0.999426095987091,0,1,polyadenylation-dependent mRNA catabolic process,BP,
16281,GO:0071048,1,0.981309934516843,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16282,GO:0071049,1,0.977746943887965,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16283,GO:0071051,1,0.942128498710658,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16284,GO:0071062,1,0.987024812629875,0,3,alphav-beta3 integrin-vitronectin complex,CC,
16285,GO:0071065,1,0.98808828184056,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16287,GO:0071072,1,0.980215208882853,0,4,negative regulation of phospholipid biosynthetic process,BP,
16289,GO:0071074,1,0.989104980212887,0,2,eukaryotic initiation factor eIF2 binding,MF,
16290,GO:0071077,1,0.984847343245695,0,2,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16291,GO:0071103,1,0.130780022297735,0,265,DNA conformation change,BP,
16292,GO:0071104,1,0.977392612874094,0,3,response to interleukin-9,BP,
16293,GO:0071105,1,0.98695825090398,0,2,response to interleukin-11,BP,
16294,GO:0071106,1,0.984847343245695,0,2,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16295,GO:0071107,1,0.926945835958695,0,11,response to parathyroid hormone,BP,
16296,GO:0071108,1,0.920957636141469,0,25,protein K48-linked deubiquitination,BP,
16297,GO:0071109,1,0.999999992774327,0,2,superior temporal gyrus development,BP,
16298,GO:0071110,1,0.999999996372699,0,1,histone biotinylation,BP,
16299,GO:0071133,1,0.994475671194365,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16300,GO:0071139,1,0.991867039112905,0,2,resolution of recombination intermediates,BP,
16301,GO:0071140,1,0.991867039112905,0,2,resolution of mitotic recombination intermediates,BP,
16302,GO:0071141,1,0.973843638376801,0,9,SMAD protein complex,CC,
16303,GO:0071144,1,0.999999992769868,0,2,SMAD2-SMAD3 protein complex,CC,
16304,GO:0071146,1,0.98987282949776,0,1,SMAD3-SMAD4 protein complex,CC,
16305,GO:0071148,1,0.999955533311466,0,2,TEAD-1-YAP complex,CC,
16306,GO:0071149,1,0.989957711429321,0,2,TEAD-2-YAP complex,CC,
16307,GO:0071156,1,0.456893843321594,0,105,regulation of cell cycle arrest,BP,
16308,GO:0071157,1,0.849864800207857,0,20,negative regulation of cell cycle arrest,BP,
16309,GO:0071158,1,0.550091813145901,0,83,positive regulation of cell cycle arrest,BP,
16310,GO:0071159,1,0.97910842389578,0,2,NF-kappaB complex,CC,
16311,GO:0071163,1,0.969239395312281,0,3,DNA replication preinitiation complex assembly,BP,
16312,GO:0071164,1,0.996968824021239,0,1,RNA trimethylguanosine synthase activity,MF,
16313,GO:0071166,1,0.439190010505802,0,127,ribonucleoprotein complex localization,BP,
16314,GO:0071167,1,0.996968824021239,0,1,ribonucleoprotein complex import into nucleus,BP,
16315,GO:0071168,1,0.8872355795327,0,15,protein localization to chromatin,BP,
16316,GO:0071169,1,0.934114406791942,0,6,establishment of protein localization to chromatin,BP,
16317,GO:0071170,1,0.991657600429728,0,1,site-specific DNA replication termination,BP,
16318,GO:0071171,1,0.991657600429728,0,1,site-specific DNA replication termination at RTS1 barrier,BP,
16319,GO:0071173,1,0.822601397887615,0,28,spindle assembly checkpoint,BP,
16320,GO:0071174,1,0.815072881004196,0,29,mitotic spindle checkpoint,BP,
16321,GO:0071203,1,0.981125464016087,0,4,WASH complex,CC,
16322,GO:0071204,1,0.955972204794455,0,6,histone pre-mRNA 3'end processing complex,CC,
16323,GO:0071205,1,0.999206485219934,0,4,protein localization to juxtaparanode region of axon,BP,
16324,GO:0071206,1,0.999999996382531,0,1,establishment of protein localization to juxtaparanode region of axon,BP,
16325,GO:0071207,1,0.988015676956031,0,2,histone pre-mRNA stem-loop binding,MF,
16326,GO:0071208,1,0.951971806579303,0,4,histone pre-mRNA DCP binding,MF,
16327,GO:0071209,1,0.96710626704043,0,3,U7 snRNA binding,MF,
16328,GO:0071211,1,0.987841845827215,0,3,protein targeting to vacuole involved in autophagy,BP,
16330,GO:0071215,1,0.99899806074031,0,1,cellular response to abscisic acid stimulus,BP,
16332,GO:0071217,1,0.998041284082169,0,1,cellular response to external biotic stimulus,BP,
16333,GO:0071218,1,0.891661318064941,0,19,cellular response to misfolded protein,BP,
16335,GO:0071220,1,0.956020482343427,0,6,cellular response to bacterial lipoprotein,BP,
16336,GO:0071221,1,0.956020482343427,0,6,cellular response to bacterial lipopeptide,BP,
16338,GO:0071223,1,0.920433111880578,0,9,cellular response to lipoteichoic acid,BP,
16339,GO:0071224,1,0.979305281014976,0,2,cellular response to peptidoglycan,BP,
16340,GO:0071225,1,0.982832556607489,0,5,cellular response to muramyl dipeptide,BP,
16341,GO:0071226,1,0.982931944710535,0,3,cellular response to molecule of fungal origin,BP,
16342,GO:0071228,1,0.99339499881309,0,1,cellular response to tumor cell,BP,
16344,GO:0071230,1,0.727373019673948,0,62,cellular response to amino acid stimulus,BP,
16345,GO:0071231,1,0.97503656003243,0,2,cellular response to folic acid,BP,
16346,GO:0071233,1,0.995540624624395,0,7,cellular response to leucine,BP,
16349,GO:0071242,1,0.708773275149247,0,55,cellular response to ammonium ion,BP,
16350,GO:0071243,1,0.870688458010287,0,15,cellular response to arsenic-containing substance,BP,
16351,GO:0071245,1,0.996739200613543,0,1,cellular response to carbon monoxide,BP,
16352,GO:0071247,1,0.98744914291305,0,1,cellular response to chromate,BP,
16354,GO:0071250,1,0.999999996374604,0,1,cellular response to nitrite,BP,
16355,GO:0071253,1,0.964419311507412,0,6,connexin binding,MF,
16356,GO:0071256,1,0.95365688769471,0,4,translocon complex,CC,
16357,GO:0071257,1,0.931730288636429,0,12,cellular response to electrical stimulus,BP,
16358,GO:0071258,1,0.998490135981731,0,1,cellular response to gravity,BP,
16359,GO:0071259,1,0.979967187132488,0,2,cellular response to magnetism,BP,
16361,GO:0071262,1,0.997218365693604,0,2,regulation of translational initiation in response to starvation,BP,
16362,GO:0071264,1,0.997218365693604,0,2,positive regulation of translational initiation in response to starvation,BP,
16364,GO:0071266,1,0.988606833667475,0,1,'de novo' L-methionine biosynthetic process,BP,
16366,GO:0071268,1,0.990500696840587,0,1,homocysteine biosynthetic process,BP,
16367,GO:0071275,1,0.989940756060877,0,1,cellular response to aluminum ion,BP,
16369,GO:0071277,1,0.750793798295718,0,51,cellular response to calcium ion,BP,
16370,GO:0071279,1,0.976367163265381,0,3,cellular response to cobalt ion,BP,
16371,GO:0071280,1,0.914021292043438,0,12,cellular response to copper ion,BP,
16373,GO:0071283,1,0.977204568067923,0,2,cellular response to iron(III) ion,BP,
16374,GO:0071284,1,0.990434626360689,0,3,cellular response to lead ion,BP,
16375,GO:0071285,1,0.897570386429681,0,13,cellular response to lithium ion,BP,
16376,GO:0071286,1,0.981087831583573,0,6,cellular response to magnesium ion,BP,
16377,GO:0071287,1,0.958628589745711,0,9,cellular response to manganese ion,BP,
16378,GO:0071288,1,0.978550764805638,0,3,cellular response to mercury ion,BP,
16379,GO:0071294,1,0.848264681354886,0,18,cellular response to zinc ion,BP,
16380,GO:0071295,1,0.847600812291151,0,28,cellular response to vitamin,BP,
16381,GO:0071298,1,0.995779931099641,0,1,cellular response to L-ascorbic acid,BP,
16382,GO:0071300,1,0.659453382558634,0,66,cellular response to retinoic acid,BP,
16383,GO:0071301,1,0.999999996380863,0,1,cellular response to vitamin B1,BP,
16384,GO:0071305,1,0.895601443234733,0,19,cellular response to vitamin D,BP,
16385,GO:0071306,1,0.988934114154519,0,2,cellular response to vitamin E,BP,
16386,GO:0071307,1,0.986311098672952,0,2,cellular response to vitamin K,BP,
16389,GO:0071313,1,0.980171841094317,0,7,cellular response to caffeine,BP,
16390,GO:0071314,1,0.969619165042326,0,3,cellular response to cocaine,BP,
16391,GO:0071315,1,0.974373956374388,0,4,cellular response to morphine,BP,
16392,GO:0071316,1,0.932436968360777,0,8,cellular response to nicotine,BP,
16393,GO:0071317,1,0.974373956374388,0,4,cellular response to isoquinoline alkaloid,BP,
16394,GO:0071318,1,0.904808812676623,0,13,cellular response to ATP,BP,
16396,GO:0071321,1,0.992188318475342,0,6,cellular response to cGMP,BP,
16398,GO:0071324,1,0.99982915738731,0,1,cellular response to disaccharide stimulus,BP,
16400,GO:0071329,1,0.99982915738731,0,1,cellular response to sucrose stimulus,BP,
16402,GO:0071332,1,0.964208164555929,0,5,cellular response to fructose stimulus,BP,
16404,GO:0071335,1,0.977318068831769,0,2,hair follicle cell proliferation,BP,
16405,GO:0071336,1,0.977318068831769,0,2,regulation of hair follicle cell proliferation,BP,
16406,GO:0071338,1,0.977318068831769,0,2,positive regulation of hair follicle cell proliferation,BP,
16407,GO:0071339,1,0.833796405500196,0,27,MLL1 complex,CC,
16408,GO:0071340,1,0.921493343331991,0,11,skeletal muscle acetylcholine-gated channel clustering,BP,
16409,GO:0071344,1,0.976074537983701,0,2,diphosphate metabolic process,BP,
16413,GO:0071348,1,0.999647572763174,0,1,cellular response to interleukin-11,BP,
16414,GO:0071349,1,0.98930949877334,0,3,cellular response to interleukin-12,BP,
16415,GO:0071350,1,0.982848895976951,0,3,cellular response to interleukin-15,BP,
16416,GO:0071351,1,0.952167641391792,0,6,cellular response to interleukin-18,BP,
16417,GO:0071352,1,0.963797107886152,0,6,cellular response to interleukin-2,BP,
16419,GO:0071354,1,0.846726667366372,0,27,cellular response to interleukin-6,BP,
16420,GO:0071355,1,0.989974988047088,0,1,cellular response to interleukin-9,BP,
16423,GO:0071359,1,0.732022142079152,0,52,cellular response to dsRNA,BP,
16424,GO:0071360,1,0.910902955628301,0,12,cellular response to exogenous dsRNA,BP,
16425,GO:0071361,1,0.948621457718223,0,12,cellular response to ethanol,BP,
16426,GO:0071362,1,0.968222804117614,0,6,cellular response to ether,BP,
16428,GO:0071364,1,0.825139652106178,0,37,cellular response to epidermal growth factor stimulus,BP,
16432,GO:0071374,1,0.95100144857793,0,8,cellular response to parathyroid hormone stimulus,BP,
16434,GO:0071376,1,0.968559948245675,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16435,GO:0071377,1,0.781364435319817,0,39,cellular response to glucagon stimulus,BP,
16437,GO:0071379,1,0.902963026645394,0,22,cellular response to prostaglandin stimulus,BP,
16438,GO:0071380,1,0.92542690897569,0,17,cellular response to prostaglandin E stimulus,BP,
16442,GO:0071386,1,0.995219618479641,0,3,cellular response to corticosterone stimulus,BP,
16443,GO:0071387,1,0.999926879944743,0,1,cellular response to cortisol stimulus,BP,
16444,GO:0071389,1,0.963069820970261,0,6,cellular response to mineralocorticoid stimulus,BP,
16445,GO:0071391,1,0.947085663907761,0,12,cellular response to estrogen stimulus,BP,
16446,GO:0071392,1,0.775016704189954,0,35,cellular response to estradiol stimulus,BP,
16447,GO:0071393,1,0.99824488700157,0,1,cellular response to progesterone stimulus,BP,
16448,GO:0071394,1,0.945346988241404,0,9,cellular response to testosterone stimulus,BP,
16449,GO:0071395,1,0.951881567758867,0,4,cellular response to jasmonic acid stimulus,BP,
16451,GO:0071397,1,0.955946780582379,0,13,cellular response to cholesterol,BP,
16453,GO:0071400,1,0.991190488787934,0,2,cellular response to oleic acid,BP,
16454,GO:0071401,1,0.990490488218666,0,1,cellular response to triglyceride,BP,
16455,GO:0071402,1,0.89222763304531,0,16,cellular response to lipoprotein particle stimulus,BP,
16456,GO:0071403,1,0.987218774368248,0,1,cellular response to high density lipoprotein particle stimulus,BP,
16457,GO:0071404,1,0.926282367316914,0,13,cellular response to low-density lipoprotein particle stimulus,BP,
16459,GO:0071409,1,0.981836508554717,0,3,cellular response to cycloheximide,BP,
16460,GO:0071412,1,0.990459934296563,0,1,cellular response to genistein,BP,
16461,GO:0071413,1,0.990459934296563,0,1,cellular response to hydroxyisoflavone,BP,
16462,GO:0071415,1,0.980171833568178,0,8,cellular response to purine-containing compound,BP,
16464,GO:0071418,1,0.987781711445888,0,1,cellular response to amine stimulus,BP,
16465,GO:0071420,1,0.985902697155648,0,7,cellular response to histamine,BP,
16466,GO:0071421,1,0.974924508874748,0,5,manganese ion transmembrane transport,BP,
16467,GO:0071422,1,0.982191181084,0,3,succinate transmembrane transport,BP,
16468,GO:0071423,1,0.989035033890079,0,1,malate transmembrane transport,BP,
16469,GO:0071425,1,0.891390397042278,0,20,hematopoietic stem cell proliferation,BP,
16470,GO:0071426,1,0.444966609110623,0,125,ribonucleoprotein complex export from nucleus,BP,
16471,GO:0071427,1,0.509384386308655,0,108,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16472,GO:0071428,1,0.889693425398935,0,14,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16473,GO:0071431,1,0.865269491425255,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16474,GO:0071435,1,0.91892709232794,0,12,potassium ion export,BP,
16476,GO:0071437,1,0.951596219323017,0,12,invadopodium,CC,
16477,GO:0071438,1,0.967170297251611,0,6,invadopodium membrane,CC,
16478,GO:0071439,1,0.956046302346058,0,8,clathrin complex,CC,
16479,GO:0071440,1,0.970162894016084,0,5,regulation of histone H3-K14 acetylation,BP,
16480,GO:0071441,1,0.997534268301677,0,1,negative regulation of histone H3-K14 acetylation,BP,
16481,GO:0071442,1,0.972561502305366,0,4,positive regulation of histone H3-K14 acetylation,BP,
16482,GO:0071444,1,0.98714160951474,0,1,cellular response to pheromone,BP,
16483,GO:0071447,1,0.953921876025036,0,8,cellular response to hydroperoxide,BP,
16484,GO:0071449,1,0.98730592286762,0,1,cellular response to lipid hydroperoxide,BP,
16488,GO:0071454,1,0.999999996381175,0,1,cellular response to anoxia,BP,
16489,GO:0071455,1,0.963253631834008,0,7,cellular response to hyperoxia,BP,
16491,GO:0071458,1,0.963216695562583,0,6,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16492,GO:0071459,1,0.874842443418297,0,18,protein localization to chromosome, centromeric region,BP,
16493,GO:0071460,1,0.975563836811072,0,2,cellular response to cell-matrix adhesion,BP,
16494,GO:0071461,1,0.980464090190429,0,2,cellular response to redox state,BP,
16495,GO:0071462,1,0.983906747732351,0,5,cellular response to water stimulus,BP,
16496,GO:0071464,1,0.990277572763476,0,2,cellular response to hydrostatic pressure,BP,
16498,GO:0071467,1,0.867540353071694,0,20,cellular response to pH,BP,
16499,GO:0071468,1,0.944060966799801,0,11,cellular response to acidic pH,BP,
16500,GO:0071469,1,0.987358722285078,0,2,cellular response to alkaline pH,BP,
16501,GO:0071470,1,0.852228260886065,0,29,cellular response to osmotic stress,BP,
16502,GO:0071471,1,0.999263353510476,0,1,cellular response to non-ionic osmotic stress,BP,
16503,GO:0071472,1,0.960318599220827,0,8,cellular response to salt stress,BP,
16504,GO:0071474,1,0.95179735484312,0,8,cellular hyperosmotic response,BP,
16505,GO:0071475,1,0.98388386959333,0,3,cellular hyperosmotic salinity response,BP,
16506,GO:0071476,1,0.973914884641922,0,7,cellular hypotonic response,BP,
16507,GO:0071477,1,0.994512014320901,0,2,cellular hypotonic salinity response,BP,
16508,GO:0071478,1,0.366011804653424,0,164,cellular response to radiation,BP,
16509,GO:0071479,1,0.675250238872919,0,64,cellular response to ionizing radiation,BP,
16510,GO:0071480,1,0.848094351569965,0,26,cellular response to gamma radiation,BP,
16511,GO:0071481,1,0.946444068842884,0,13,cellular response to X-ray,BP,
16512,GO:0071482,1,0.526232554363986,0,107,cellular response to light stimulus,BP,
16513,GO:0071483,1,0.993524268698247,0,2,cellular response to blue light,BP,
16514,GO:0071484,1,0.995111707613031,0,2,cellular response to light intensity,BP,
16515,GO:0071485,1,0.995162711325382,0,1,cellular response to absence of light,BP,
16516,GO:0071486,1,0.999948751317214,0,1,cellular response to high light intensity,BP,
16517,GO:0071492,1,0.980623801872995,0,3,cellular response to UV-A,BP,
16518,GO:0071493,1,0.931954680116425,0,8,cellular response to UV-B,BP,
16519,GO:0071494,1,0.997224422206024,0,3,cellular response to UV-C,BP,
16522,GO:0071498,1,0.905924969157516,0,18,cellular response to fluid shear stress,BP,
16523,GO:0071499,1,0.947235091513968,0,7,cellular response to laminar fluid shear stress,BP,
16524,GO:0071500,1,0.952831704769665,0,6,cellular response to nitrosative stress,BP,
16525,GO:0071501,1,0.956927522641092,0,8,cellular response to sterol depletion,BP,
16526,GO:0071502,1,0.965464821469188,0,5,cellular response to temperature stimulus,BP,
16527,GO:0071503,1,0.981787977356844,0,5,response to heparin,BP,
16528,GO:0071504,1,0.991257384026569,0,4,cellular response to heparin,BP,
16529,GO:0071505,1,0.987586256242482,0,2,response to mycophenolic acid,BP,
16530,GO:0071506,1,0.987586256242482,0,2,cellular response to mycophenolic acid,BP,
16531,GO:0071514,1,0.862345278516968,0,25,genetic imprinting,BP,
16532,GO:0071515,1,0.991657600429728,0,1,genetic imprinting at mating-type locus,BP,
16533,GO:0071516,1,0.991657600429728,0,1,establishment of imprinting at mating-type locus,BP,
16534,GO:0071526,1,0.94386840361142,0,23,semaphorin-plexin signaling pathway,BP,
16535,GO:0071527,1,0.990803916695749,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16536,GO:0071528,1,0.997684727678706,0,1,tRNA re-export from nucleus,BP,
16537,GO:0071529,1,0.991761977835266,0,1,cementum mineralization,BP,
16538,GO:0071532,1,0.985221927813956,0,5,ankyrin repeat binding,MF,
16539,GO:0071535,1,0.975961016504976,0,4,RING-like zinc finger domain binding,MF,
16540,GO:0071538,1,0.990566313287312,0,1,SH2 domain-mediated complex assembly,BP,
16541,GO:0071539,1,0.908337807644854,0,23,protein localization to centrosome,BP,
16542,GO:0071540,1,0.9999616954467,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16543,GO:0071541,1,0.935861371162257,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16544,GO:0071542,1,0.771022575929319,0,37,dopaminergic neuron differentiation,BP,
16545,GO:0071543,1,0.968037406610311,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16546,GO:0071544,1,0.987767596792157,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16547,GO:0071545,1,0.954212311916649,0,11,inositol phosphate catabolic process,BP,
16548,GO:0071546,1,0.966786930791096,0,7,pi-body,CC,
16549,GO:0071547,1,0.967997409172161,0,5,piP-body,CC,
16554,GO:0071554,1,0.940088456358574,0,5,cell wall organization or biogenesis,BP,
16555,GO:0071556,1,0.752185302440934,0,28,integral component of lumenal side of endoplasmic reticulum membrane,CC,
16556,GO:0071557,1,0.999785967667601,0,4,histone H3-K27 demethylation,BP,
16557,GO:0071558,1,0.999785967667601,0,4,histone demethylase activity (H3-K27 specific),MF,
16560,GO:0071561,1,0.999858403017933,0,1,nucleus-vacuole junction,CC,
16561,GO:0071564,1,0.9381572102427,0,12,npBAF complex,CC,
16562,GO:0071565,1,0.933888640476556,0,14,nBAF complex,CC,
16563,GO:0071566,1,0.993492236607567,0,1,UFM1 activating enzyme activity,MF,
16564,GO:0071567,1,0.978313318539271,0,2,UFM1 hydrolase activity,MF,
16565,GO:0071568,1,0.979237827245462,0,2,UFM1 transferase activity,MF,
16566,GO:0071569,1,0.942539404790315,0,6,protein ufmylation,BP,
16567,GO:0071573,1,0.993426587355053,0,1,shelterin complex assembly,BP,
16568,GO:0071575,1,0.996575906857934,0,1,integral component of external side of plasma membrane,CC,
16569,GO:0071577,1,0.855863424809142,0,23,zinc II ion transmembrane transport,BP,
16570,GO:0071578,1,0.949249256247203,0,8,zinc II ion transmembrane import,BP,
16571,GO:0071579,1,0.98254954245567,0,2,regulation of zinc ion transport,BP,
16572,GO:0071580,1,0.989449560760648,0,1,regulation of zinc ion transmembrane transport,BP,
16573,GO:0071581,1,0.989449560760648,0,1,regulation of zinc ion transmembrane import,BP,
16574,GO:0071582,1,0.989449560760648,0,1,negative regulation of zinc ion transport,BP,
16575,GO:0071583,1,0.989449560760648,0,1,negative regulation of zinc ion transmembrane transport,BP,
16576,GO:0071584,1,0.989449560760648,0,1,negative regulation of zinc ion transmembrane import,BP,
16577,GO:0071585,1,0.989449560760648,0,1,detoxification of cadmium ion,BP,
16578,GO:0071586,1,0.970983470358153,0,3,CAAX-box protein processing,BP,
16579,GO:0071593,1,0.97730632366418,0,3,lymphocyte aggregation,BP,
16580,GO:0071595,1,0.983384249277821,0,2,Nem1-Spo7 phosphatase complex,CC,
16581,GO:0071596,1,0.999958562157716,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16582,GO:0071598,1,0.979764711098913,0,3,neuronal ribonucleoprotein granule,CC,
16583,GO:0071599,1,0.918675330192446,0,15,otic vesicle development,BP,
16584,GO:0071600,1,0.933761006058063,0,10,otic vesicle morphogenesis,BP,
16585,GO:0071602,1,0.999074413660751,0,1,phytosphingosine biosynthetic process,BP,
16586,GO:0071603,1,0.982258867307989,0,4,endothelial cell-cell adhesion,BP,
16587,GO:0071604,1,0.853418857727195,0,28,transforming growth factor beta production,BP,
16588,GO:0071605,1,0.904931458550823,0,12,monocyte chemotactic protein-1 production,BP,
16589,GO:0071608,1,0.99067108272214,0,2,macrophage inflammatory protein-1 alpha production,BP,
16590,GO:0071609,1,0.951657389340963,0,8,chemokine (C-C motif) ligand 5 production,BP,
16591,GO:0071611,1,0.97556336665476,0,3,granulocyte colony-stimulating factor production,BP,
16592,GO:0071612,1,0.999999996404413,0,1,IP-10 production,BP,
16593,GO:0071613,1,0.979139396994151,0,2,granzyme B production,BP,
16594,GO:0071614,1,0.988941777993996,0,1,linoleic acid epoxygenase activity,MF,
16595,GO:0071615,1,0.99437377019296,0,1,oxidative deethylation,BP,
16597,GO:0071617,1,0.927507555954099,0,17,lysophospholipid acyltransferase activity,MF,
16598,GO:0071619,1,0.990425437849209,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16599,GO:0071621,1,0.371816549416338,0,105,granulocyte chemotaxis,BP,
16600,GO:0071622,1,0.626126453574629,0,47,regulation of granulocyte chemotaxis,BP,
16601,GO:0071623,1,0.991473944833211,0,2,negative regulation of granulocyte chemotaxis,BP,
16602,GO:0071624,1,0.724722226237729,0,29,positive regulation of granulocyte chemotaxis,BP,
16603,GO:0071625,1,0.958724693433477,0,17,vocalization behavior,BP,
16604,GO:0071626,1,0.976169736435076,0,2,mastication,BP,
16605,GO:0071629,1,0.988348355554348,0,1,ubiquitin-dependent catabolism of misfolded proteins by cytoplasm-associated proteasome,BP,
16606,GO:0071630,1,0.991614684528349,0,3,ubiquitin-dependent catabolism of misfolded proteins by nucleus-associated proteasome,BP,
16607,GO:0071633,1,0.980562464785819,0,2,dihydroceramidase activity,MF,
16608,GO:0071634,1,0.85393431085495,0,27,regulation of transforming growth factor beta production,BP,
16609,GO:0071635,1,0.96336427949938,0,7,negative regulation of transforming growth factor beta production,BP,
16610,GO:0071636,1,0.888205735760453,0,17,positive regulation of transforming growth factor beta production,BP,
16611,GO:0071637,1,0.904931458550823,0,12,regulation of monocyte chemotactic protein-1 production,BP,
16612,GO:0071638,1,0.961330042012692,0,5,negative regulation of monocyte chemotactic protein-1 production,BP,
16613,GO:0071639,1,0.941350555047159,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16614,GO:0071640,1,0.99067108272214,0,2,regulation of macrophage inflammatory protein 1 alpha production,BP,
16615,GO:0071641,1,0.996138037436052,0,1,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16616,GO:0071642,1,0.994512019025568,0,1,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16617,GO:0071649,1,0.962793234243444,0,7,regulation of chemokine (C-C motif) ligand 5 production,BP,
16618,GO:0071650,1,0.979605245499592,0,2,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16619,GO:0071651,1,0.982840763378424,0,5,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16620,GO:0071655,1,0.97556336665476,0,3,regulation of granulocyte colony-stimulating factor production,BP,
16621,GO:0071656,1,0.990624122034123,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16622,GO:0071657,1,0.98479782711203,0,2,positive regulation of granulocyte colony-stimulating factor production,BP,
16623,GO:0071658,1,0.999999996404413,0,1,regulation of IP-10 production,BP,
16624,GO:0071660,1,0.999999996404413,0,1,positive regulation of IP-10 production,BP,
16625,GO:0071661,1,0.979139396994151,0,2,regulation of granzyme B production,BP,
16626,GO:0071663,1,0.979139396994151,0,2,positive regulation of granzyme B production,BP,
16627,GO:0071664,1,0.989362794087556,0,3,catenin-TCF7L2 complex,CC,
16628,GO:0071665,1,0.995520622140357,0,1,gamma-catenin-TCF7L2 complex,CC,
16629,GO:0071670,1,0.951101442424153,0,8,smooth muscle cell chemotaxis,BP,
16630,GO:0071671,1,0.956555054471324,0,6,regulation of smooth muscle cell chemotaxis,BP,
16631,GO:0071672,1,0.963884830922241,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16632,GO:0071673,1,0.9796793985228,0,3,positive regulation of smooth muscle cell chemotaxis,BP,
16633,GO:0071674,1,0.472053827547493,0,77,mononuclear cell migration,BP,
16634,GO:0071675,1,0.711107497429988,0,40,regulation of mononuclear cell migration,BP,
16635,GO:0071676,1,0.969979609724525,0,6,negative regulation of mononuclear cell migration,BP,
16636,GO:0071677,1,0.79959530286164,0,22,positive regulation of mononuclear cell migration,BP,
16637,GO:0071678,1,0.999999996382818,0,1,olfactory bulb axon guidance,BP,
16638,GO:0071679,1,0.978692509303489,0,7,commissural neuron axon guidance,BP,
16639,GO:0071680,1,0.988307696093293,0,5,response to indole-3-methanol,BP,
16640,GO:0071681,1,0.988307696093293,0,5,cellular response to indole-3-methanol,BP,
16641,GO:0071682,1,0.835484822833654,0,19,endocytic vesicle lumen,CC,
16642,GO:0071684,1,0.99496246959351,0,1,organism emergence from protective structure,BP,
16643,GO:0071688,1,0.956629983937298,0,13,striated muscle myosin thick filament assembly,BP,
16644,GO:0071691,1,0.999999996378305,0,1,cardiac muscle thin filament assembly,BP,
16645,GO:0071692,1,0.965964643514496,0,6,protein localization to extracellular region,BP,
16646,GO:0071694,1,0.965964643514496,0,6,maintenance of protein location in extracellular region,BP,
16647,GO:0071695,1,0.790928362735906,0,53,anatomical structure maturation,BP,
16648,GO:0071696,1,0.90877099684723,0,16,ectodermal placode development,BP,
16649,GO:0071697,1,0.916731553294884,0,15,ectodermal placode morphogenesis,BP,
16650,GO:0071698,1,0.98207207702506,0,4,olfactory placode development,BP,
16651,GO:0071699,1,0.98207207702506,0,4,olfactory placode morphogenesis,BP,
16652,GO:0071701,1,0.99971609675009,0,1,regulation of MAPK export from nucleus,BP,
16657,GO:0071707,1,0.987649787625518,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16658,GO:0071709,1,0.891791161851923,0,28,membrane assembly,BP,
16659,GO:0071711,1,0.938735726582826,0,20,basement membrane organization,BP,
16660,GO:0071712,1,0.926294775559404,0,10,ER-associated misfolded protein catabolic process,BP,
16661,GO:0071714,1,0.998717522938239,0,1,icosanoid transmembrane transporter activity,MF,
16662,GO:0071715,1,0.701861285934986,0,45,icosanoid transport,BP,
16663,GO:0071723,1,0.924142053275566,0,10,lipopeptide binding,MF,
16664,GO:0071724,1,0.973743446964741,0,4,response to diacyl bacterial lipopeptide,BP,
16665,GO:0071725,1,0.977045916779772,0,3,response to triacyl bacterial lipopeptide,BP,
16666,GO:0071726,1,0.973743446964741,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16667,GO:0071727,1,0.977045916779772,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16668,GO:0071731,1,0.864262640089413,0,19,response to nitric oxide,BP,
16669,GO:0071732,1,0.88432310181603,0,16,cellular response to nitric oxide,BP,
16670,GO:0071733,1,0.971216236684961,0,3,transcriptional activation by promoter-enhancer looping,BP,
16671,GO:0071763,1,0.974177322147601,0,5,nuclear membrane organization,BP,
16672,GO:0071765,1,0.998685659124255,0,1,nuclear inner membrane organization,BP,
16673,GO:0071772,1,0.409824852491951,0,156,response to BMP,BP,
16674,GO:0071773,1,0.409824852491951,0,156,cellular response to BMP stimulus,BP,
16676,GO:0071782,1,0.915323349944281,0,16,endoplasmic reticulum tubular network,CC,
16677,GO:0071786,1,0.932729864177495,0,12,endoplasmic reticulum tubular network organization,BP,
16678,GO:0071787,1,0.966893049172303,0,4,endoplasmic reticulum tubular network formation,BP,
16679,GO:0071791,1,0.988479272441409,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16680,GO:0071796,1,0.987681583940641,0,1,K6-linked polyubiquitin binding,MF,
16681,GO:0071797,1,0.977680524577563,0,3,LUBAC complex,CC,
16682,GO:0071798,1,0.969342143795677,0,5,response to prostaglandin D,BP,
16683,GO:0071799,1,0.969342143795677,0,5,cellular response to prostaglandin D stimulus,BP,
16684,GO:0071800,1,0.89626893514913,0,20,podosome assembly,BP,
16685,GO:0071801,1,0.927146754013223,0,14,regulation of podosome assembly,BP,
16686,GO:0071802,1,0.998633080677521,0,1,negative regulation of podosome assembly,BP,
16687,GO:0071803,1,0.949181602087642,0,10,positive regulation of podosome assembly,BP,
16688,GO:0071804,1,0.351380791510309,0,189,cellular potassium ion transport,BP,
16689,GO:0071805,1,0.351380791510309,0,189,potassium ion transmembrane transport,BP,
16690,GO:0071806,1,0.595963787102682,0,60,protein transmembrane transport,BP,
16691,GO:0071812,1,0.984876852448774,0,2,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16692,GO:0071813,1,0.867387626720057,0,24,lipoprotein particle binding,MF,
16693,GO:0071814,1,0.867387626720057,0,24,protein-lipid complex binding,MF,
16694,GO:0071816,1,0.960579329482048,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16695,GO:0071817,1,0.960743073327808,0,5,MMXD complex,CC,
16696,GO:0071818,1,0.972182721667564,0,3,BAT3 complex,CC,
16697,GO:0071819,1,0.987169020415316,0,1,DUBm complex,CC,
16698,GO:0071820,1,0.987942018230641,0,1,N-box binding,MF,
16699,GO:0071821,1,0.999999996379531,0,1,FANCM-MHF complex,CC,
16701,GO:0071823,1,0.975273646830553,0,2,protein-carbohydrate complex subunit organization,BP,
16702,GO:0071824,1,0.112316867076812,0,256,protein-DNA complex subunit organization,BP,
16707,GO:0071837,1,0.896793213775731,0,17,HMG box domain binding,MF,
16708,GO:0071838,1,0.954614661002298,0,6,cell proliferation in bone marrow,BP,
16709,GO:0071839,1,0.95345233237754,0,5,apoptotic process in bone marrow,BP,
16711,GO:0071846,1,0.987190406094336,0,1,actin filament debranching,BP,
16712,GO:0071847,1,0.979675586692106,0,4,TNFSF11-mediated signaling pathway,BP,
16713,GO:0071848,1,0.984876852448774,0,2,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16714,GO:0071850,1,0.908558421204031,0,14,mitotic cell cycle arrest,BP,
16716,GO:0071863,1,0.957371762661704,0,6,regulation of cell proliferation in bone marrow,BP,
16717,GO:0071864,1,0.957371762661704,0,6,positive regulation of cell proliferation in bone marrow,BP,
16718,GO:0071865,1,0.960336429801661,0,5,regulation of apoptotic process in bone marrow,BP,
16719,GO:0071866,1,0.960336429801661,0,5,negative regulation of apoptotic process in bone marrow,BP,
16726,GO:0071873,1,0.987257238360772,0,3,response to norepinephrine,BP,
16727,GO:0071874,1,0.987257244499219,0,2,cellular response to norepinephrine stimulus,BP,
16728,GO:0071875,1,0.87882491693103,0,21,adrenergic receptor signaling pathway,BP,
16729,GO:0071877,1,0.974220379321886,0,6,regulation of adrenergic receptor signaling pathway,BP,
16730,GO:0071878,1,0.997620092342079,0,3,negative regulation of adrenergic receptor signaling pathway,BP,
16731,GO:0071879,1,0.988639435456567,0,3,positive regulation of adrenergic receptor signaling pathway,BP,
16732,GO:0071880,1,0.910415162520484,0,14,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16733,GO:0071881,1,0.997620100517047,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16734,GO:0071882,1,0.997620100517047,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16735,GO:0071883,1,0.981946834502666,0,4,activation of MAPK activity by adrenergic receptor signaling pathway,BP,
16736,GO:0071884,1,0.999999996373404,0,1,vitamin D receptor activator activity,MF,
16737,GO:0071885,1,0.979082915952268,0,2,N-terminal protein N-methyltransferase activity,MF,
16738,GO:0071886,1,0.994297488143672,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16740,GO:0071888,1,0.941933016628633,0,8,macrophage apoptotic process,BP,
16741,GO:0071889,1,0.890779370918016,0,23,14-3-3 protein binding,MF,
16742,GO:0071890,1,0.999932837267119,0,1,bicarbonate binding,MF,
16743,GO:0071893,1,0.988714122281553,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16744,GO:0071894,1,0.995775337703485,0,1,histone H2B conserved C-terminal lysine ubiquitination,BP,
16745,GO:0071895,1,0.980628648893742,0,3,odontoblast differentiation,BP,
16746,GO:0071896,1,0.999862910462342,0,4,protein localization to adherens junction,BP,
16748,GO:0071898,1,0.979372457143114,0,3,regulation of estrogen receptor binding,BP,
16749,GO:0071899,1,0.979372457143114,0,3,negative regulation of estrogen receptor binding,BP,
16753,GO:0071907,1,0.973869559936852,0,7,determination of digestive tract left/right asymmetry,BP,
16754,GO:0071908,1,0.999976033648353,0,1,determination of intestine left/right asymmetry,BP,
16755,GO:0071909,1,0.999976033648353,0,1,determination of stomach left/right asymmetry,BP,
16756,GO:0071910,1,0.98593573235536,0,6,determination of liver left/right asymmetry,BP,
16757,GO:0071914,1,0.99752134605304,0,1,prominosome,CC,
16758,GO:0071918,1,0.979644893605569,0,4,urea transmembrane transport,BP,
16759,GO:0071920,1,0.981981935091842,0,2,cleavage body,CC,
16760,GO:0071921,1,0.980495949860255,0,3,cohesin loading,BP,
16761,GO:0071922,1,0.980495949860255,0,3,regulation of cohesin loading,BP,
16762,GO:0071926,1,0.990032289585523,0,3,endocannabinoid signaling pathway,BP,
16763,GO:0071929,1,0.986058668573938,0,2,alpha-tubulin acetylation,BP,
16764,GO:0071930,1,0.991966539328458,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16765,GO:0071931,1,0.987784876593026,0,1,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16766,GO:0071933,1,0.962553679470937,0,8,Arp2/3 complex binding,MF,
16767,GO:0071934,1,0.972088531149684,0,4,thiamine transmembrane transport,BP,
16768,GO:0071936,1,0.980306126394867,0,8,coreceptor activity involved in Wnt signaling pathway,MF,
16769,GO:0071941,1,0.865240682155022,0,15,nitrogen cycle metabolic process,BP,
16770,GO:0071942,1,0.982604862360636,0,3,XPC complex,CC,
16772,GO:0071947,1,0.992918707408818,0,4,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16773,GO:0071949,1,0.896324612018635,0,17,FAD binding,MF,
16774,GO:0071951,1,0.992534180667998,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16775,GO:0071953,1,0.968781850524974,0,4,elastic fiber,CC,
16776,GO:0071954,1,0.996075298321824,0,1,chemokine (C-C motif) ligand 11 production,BP,
16778,GO:0071962,1,0.996455222165833,0,1,mitotic sister chromatid cohesion, centromeric,BP,
16779,GO:0071963,1,0.976381757615197,0,2,establishment or maintenance of cell polarity regulating cell shape,BP,
16780,GO:0071964,1,0.987631058642231,0,1,establishment of cell polarity regulating cell shape,BP,
16781,GO:0071971,1,0.951916440959692,0,7,extracellular exosome assembly,BP,
16782,GO:0071976,1,0.995176953435096,0,1,cell gliding,BP,
16783,GO:0071985,1,0.941776146019222,0,9,multivesicular body sorting pathway,BP,
16784,GO:0071986,1,0.95090080706869,0,6,Ragulator complex,CC,
16785,GO:0071987,1,0.985706801485351,0,3,WD40-repeat domain binding,MF,
16786,GO:0071997,1,0.999999996375099,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16788,GO:0072003,1,0.984056618945709,0,3,kidney rudiment formation,BP,
16789,GO:0072004,1,0.996047050278914,0,2,kidney field specification,BP,
16791,GO:0072007,1,0.94636529953448,0,7,mesangial cell differentiation,BP,
16792,GO:0072008,1,0.956857844843656,0,6,glomerular mesangial cell differentiation,BP,
16794,GO:0072010,1,0.888776692318994,0,23,glomerular epithelium development,BP,
16795,GO:0072011,1,0.968875660055891,0,3,glomerular endothelium development,BP,
16796,GO:0072012,1,0.859430319830852,0,24,glomerulus vasculature development,BP,
16798,GO:0072015,1,0.966646913369081,0,12,glomerular visceral epithelial cell development,BP,
16799,GO:0072016,1,0.992005081113284,0,1,glomerular parietal epithelial cell development,BP,
16800,GO:0072017,1,0.96505098222678,0,12,distal tubule development,BP,
16802,GO:0072021,1,0.978496648153688,0,4,ascending thin limb development,BP,
16803,GO:0072023,1,0.978628781733002,0,2,thick ascending limb development,BP,
16804,GO:0072024,1,0.988029382160309,0,1,macula densa development,BP,
16805,GO:0072025,1,0.966525099824798,0,5,distal convoluted tubule development,BP,
16806,GO:0072027,1,0.991553937564633,0,1,connecting tubule development,BP,
16807,GO:0072028,1,0.649821107094059,0,77,nephron morphogenesis,BP,
16808,GO:0072033,1,0.982511545172969,0,8,renal vesicle formation,BP,
16809,GO:0072034,1,0.989570780576434,0,3,renal vesicle induction,BP,
16810,GO:0072036,1,0.997145662464174,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16811,GO:0072038,1,0.965354945460837,0,6,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16812,GO:0072039,1,0.987049297979811,0,4,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16813,GO:0072040,1,0.987049297979811,0,4,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16814,GO:0072044,1,0.943317638412744,0,13,collecting duct development,BP,
16815,GO:0072046,1,0.987962362085118,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16816,GO:0072047,1,0.949465546530237,0,5,proximal/distal pattern formation involved in nephron development,BP,
16817,GO:0072048,1,0.926032202864454,0,9,renal system pattern specification,BP,
16818,GO:0072049,1,0.953309101916012,0,6,comma-shaped body morphogenesis,BP,
16819,GO:0072050,1,0.947232697617846,0,8,S-shaped body morphogenesis,BP,
16820,GO:0072051,1,0.988029382160309,0,1,juxtaglomerular apparatus development,BP,
16821,GO:0072053,1,0.993570143834057,0,2,renal inner medulla development,BP,
16822,GO:0072054,1,0.993570143834057,0,2,renal outer medulla development,BP,
16823,GO:0072055,1,0.999865016274797,0,1,renal cortex development,BP,
16824,GO:0072059,1,0.999865016274797,0,1,cortical collecting duct development,BP,
16825,GO:0072060,1,0.997776321818463,0,1,outer medullary collecting duct development,BP,
16826,GO:0072061,1,0.979200274055812,0,3,inner medullary collecting duct development,BP,
16827,GO:0072069,1,0.984123376179126,0,3,DCT cell differentiation,BP,
16828,GO:0072070,1,0.932809883447717,0,11,loop of Henle development,BP,
16829,GO:0072071,1,0.977111346635191,0,2,kidney interstitial fibroblast differentiation,BP,
16831,GO:0072074,1,0.89889148900596,0,18,kidney mesenchyme development,BP,
16832,GO:0072075,1,0.926135419829909,0,15,metanephric mesenchyme development,BP,
16833,GO:0072076,1,0.998176614902213,0,2,nephrogenic mesenchyme development,BP,
16834,GO:0072077,1,0.906862060686864,0,19,renal vesicle morphogenesis,BP,
16835,GO:0072078,1,0.654794932652497,0,73,nephron tubule morphogenesis,BP,
16836,GO:0072079,1,0.87067923000913,0,19,nephron tubule formation,BP,
16838,GO:0072081,1,0.949465546530237,0,5,specification of nephron tubule identity,BP,
16839,GO:0072086,1,0.95999218720585,0,4,specification of loop of Henle identity,BP,
16840,GO:0072087,1,0.8969135314918,0,20,renal vesicle development,BP,
16841,GO:0072088,1,0.651012413907386,0,75,nephron epithelium morphogenesis,BP,
16842,GO:0072089,1,0.58832040707141,0,106,stem cell proliferation,BP,
16843,GO:0072091,1,0.720270477685423,0,58,regulation of stem cell proliferation,BP,
16844,GO:0072092,1,0.999924320755828,0,3,ureteric bud invasion,BP,
16845,GO:0072093,1,0.997070195791036,0,4,metanephric renal vesicle formation,BP,
16846,GO:0072095,1,0.973937787976924,0,4,regulation of branch elongation involved in ureteric bud branching,BP,
16847,GO:0072096,1,0.988714122281553,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16848,GO:0072097,1,0.988714122281553,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16849,GO:0072098,1,0.977875052733733,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16850,GO:0072099,1,0.988714122281553,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16851,GO:0072100,1,0.988714122281553,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16852,GO:0072101,1,0.988714122281553,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16853,GO:0072102,1,0.973598530523462,0,8,glomerulus morphogenesis,BP,
16854,GO:0072103,1,0.979093843848065,0,5,glomerulus vasculature morphogenesis,BP,
16855,GO:0072104,1,0.979093843848065,0,5,glomerular capillary formation,BP,
16856,GO:0072106,1,0.973713518315914,0,4,regulation of ureteric bud formation,BP,
16857,GO:0072107,1,0.973713518315914,0,4,positive regulation of ureteric bud formation,BP,
16858,GO:0072108,1,0.981127245286731,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16859,GO:0072109,1,0.900558521474042,0,15,glomerular mesangium development,BP,
16860,GO:0072110,1,0.93473677538511,0,10,glomerular mesangial cell proliferation,BP,
16861,GO:0072111,1,0.869082945656761,0,20,cell proliferation involved in kidney development,BP,
16862,GO:0072112,1,0.917835069003089,0,19,glomerular visceral epithelial cell differentiation,BP,
16863,GO:0072114,1,0.992771534351039,0,2,pronephros morphogenesis,BP,
16864,GO:0072124,1,0.934736950376805,0,9,regulation of glomerular mesangial cell proliferation,BP,
16865,GO:0072125,1,0.968565973763122,0,4,negative regulation of glomerular mesangial cell proliferation,BP,
16866,GO:0072126,1,0.965081777185069,0,5,positive regulation of glomerular mesangial cell proliferation,BP,
16867,GO:0072127,1,0.990378990484081,0,1,renal capsule development,BP,
16868,GO:0072128,1,0.990378990484081,0,1,renal capsule morphogenesis,BP,
16869,GO:0072129,1,0.990378990484081,0,1,renal capsule formation,BP,
16870,GO:0072130,1,0.990378990484081,0,1,renal capsule specification,BP,
16871,GO:0072131,1,0.978142520714833,0,4,kidney mesenchyme morphogenesis,BP,
16872,GO:0072132,1,0.754128408276065,0,46,mesenchyme morphogenesis,BP,
16873,GO:0072133,1,0.978142520714833,0,4,metanephric mesenchyme morphogenesis,BP,
16874,GO:0072134,1,0.998176614902213,0,2,nephrogenic mesenchyme morphogenesis,BP,
16875,GO:0072135,1,0.982871233925445,0,3,kidney mesenchymal cell proliferation,BP,
16876,GO:0072136,1,0.982871233925445,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16877,GO:0072137,1,0.989808177258454,0,4,condensed mesenchymal cell proliferation,BP,
16878,GO:0072138,1,0.973912763971462,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16879,GO:0072139,1,0.98000103533179,0,3,glomerular parietal epithelial cell differentiation,BP,
16880,GO:0072141,1,0.977111346635191,0,2,renal interstitial fibroblast development,BP,
16881,GO:0072143,1,0.953634123192183,0,6,mesangial cell development,BP,
16882,GO:0072144,1,0.96420661481762,0,5,glomerular mesangial cell development,BP,
16883,GO:0072148,1,0.900492044572217,0,15,epithelial cell fate commitment,BP,
16884,GO:0072156,1,0.998610117297987,0,3,distal tubule morphogenesis,BP,
16885,GO:0072160,1,0.948332259965296,0,15,nephron tubule epithelial cell differentiation,BP,
16886,GO:0072161,1,0.943590460418465,0,8,mesenchymal cell differentiation involved in kidney development,BP,
16887,GO:0072162,1,0.972177959275894,0,5,metanephric mesenchymal cell differentiation,BP,
16888,GO:0072163,1,0.579349126569976,0,98,mesonephric epithelium development,BP,
16889,GO:0072164,1,0.579349126569976,0,98,mesonephric tubule development,BP,
16890,GO:0072165,1,0.98903818528758,0,1,anterior mesonephric tubule development,BP,
16891,GO:0072166,1,0.982868578911448,0,2,posterior mesonephric tubule development,BP,
16892,GO:0072167,1,0.98903818528758,0,1,specification of mesonephric tubule identity,BP,
16893,GO:0072168,1,0.98903818528758,0,1,specification of anterior mesonephric tubule identity,BP,
16894,GO:0072169,1,0.98903818528758,0,1,specification of posterior mesonephric tubule identity,BP,
16896,GO:0072171,1,0.683124695534951,0,65,mesonephric tubule morphogenesis,BP,
16897,GO:0072172,1,0.932760844708759,0,9,mesonephric tubule formation,BP,
16898,GO:0072173,1,0.950157533071524,0,10,metanephric tubule morphogenesis,BP,
16899,GO:0072174,1,0.973792367737177,0,6,metanephric tubule formation,BP,
16900,GO:0072175,1,0.503861906323402,0,128,epithelial tube formation,BP,
16901,GO:0072176,1,0.922620613321376,0,15,nephric duct development,BP,
16902,GO:0072177,1,0.941244510088604,0,8,mesonephric duct development,BP,
16903,GO:0072178,1,0.93287231277772,0,12,nephric duct morphogenesis,BP,
16904,GO:0072179,1,0.962472551329143,0,5,nephric duct formation,BP,
16905,GO:0072180,1,0.960867178326728,0,4,mesonephric duct morphogenesis,BP,
16906,GO:0072181,1,0.980825766828209,0,2,mesonephric duct formation,BP,
16907,GO:0072182,1,0.948487275013508,0,13,regulation of nephron tubule epithelial cell differentiation,BP,
16908,GO:0072183,1,0.985514778973593,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16909,GO:0072184,1,0.98903818528758,0,1,renal vesicle progenitor cell differentiation,BP,
16910,GO:0072185,1,0.97992960372287,0,2,metanephric cap development,BP,
16911,GO:0072186,1,0.97992960372287,0,2,metanephric cap morphogenesis,BP,
16912,GO:0072189,1,0.931055696194633,0,13,ureter development,BP,
16913,GO:0072190,1,0.975744198648883,0,3,ureter urothelium development,BP,
16914,GO:0072191,1,0.967321745324785,0,4,ureter smooth muscle development,BP,
16915,GO:0072192,1,0.988714122281553,0,1,ureter epithelial cell differentiation,BP,
16916,GO:0072193,1,0.967321745324785,0,4,ureter smooth muscle cell differentiation,BP,
16917,GO:0072194,1,0.977221983664692,0,3,kidney smooth muscle tissue development,BP,
16918,GO:0072195,1,0.988187278153849,0,1,kidney smooth muscle cell differentiation,BP,
16919,GO:0072197,1,0.98061000257588,0,3,ureter morphogenesis,BP,
16920,GO:0072198,1,0.969434352850656,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16921,GO:0072199,1,0.969434352850656,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16922,GO:0072200,1,0.988714122281553,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16923,GO:0072201,1,0.952524812272541,0,8,negative regulation of mesenchymal cell proliferation,BP,
16924,GO:0072202,1,0.869964486120918,0,26,cell differentiation involved in metanephros development,BP,
16925,GO:0072203,1,0.942731156031329,0,10,cell proliferation involved in metanephros development,BP,
16926,GO:0072204,1,0.994019825342913,0,2,cell-cell signaling involved in metanephros development,BP,
16927,GO:0072205,1,0.972932732520752,0,8,metanephric collecting duct development,BP,
16928,GO:0072206,1,0.988029382160309,0,1,metanephric juxtaglomerular apparatus development,BP,
16930,GO:0072208,1,0.988904667403653,0,2,metanephric smooth muscle tissue development,BP,
16931,GO:0072209,1,0.985587354752329,0,2,metanephric mesangial cell differentiation,BP,
16932,GO:0072210,1,0.812623338220853,0,40,metanephric nephron development,BP,
16933,GO:0072213,1,0.990378990484081,0,1,metanephric capsule development,BP,
16934,GO:0072214,1,0.999865016274797,0,1,metanephric cortex development,BP,
16935,GO:0072215,1,0.882533655671177,0,23,regulation of metanephros development,BP,
16936,GO:0072216,1,0.929187691926289,0,14,positive regulation of metanephros development,BP,
16937,GO:0072217,1,0.951221927542009,0,9,negative regulation of metanephros development,BP,
16938,GO:0072218,1,0.978496648153688,0,4,metanephric ascending thin limb development,BP,
16939,GO:0072219,1,0.999865016274797,0,1,metanephric cortical collecting duct development,BP,
16940,GO:0072221,1,0.966525099824798,0,5,metanephric distal convoluted tubule development,BP,
16941,GO:0072223,1,0.973946500008306,0,5,metanephric glomerular mesangium development,BP,
16942,GO:0072224,1,0.925723128949945,0,16,metanephric glomerulus development,BP,
16943,GO:0072227,1,0.988029382160309,0,1,metanephric macula densa development,BP,
16945,GO:0072233,1,0.978628781733002,0,2,metanephric thick ascending limb development,BP,
16947,GO:0072235,1,0.966394582732322,0,7,metanephric distal tubule development,BP,
16948,GO:0072236,1,0.97632040811726,0,5,metanephric loop of Henle development,BP,
16950,GO:0072239,1,0.953893609167665,0,8,metanephric glomerulus vasculature development,BP,
16951,GO:0072240,1,0.984123376179126,0,3,metanephric DCT cell differentiation,BP,
16953,GO:0072244,1,0.98836772095539,0,3,metanephric glomerular epithelium development,BP,
16954,GO:0072248,1,0.98836772095539,0,3,metanephric glomerular visceral epithelial cell differentiation,BP,
16955,GO:0072249,1,0.98836772095539,0,3,metanephric glomerular visceral epithelial cell development,BP,
16956,GO:0072254,1,0.985587354752329,0,2,metanephric glomerular mesangial cell differentiation,BP,
16957,GO:0072255,1,0.993154987272083,0,1,metanephric glomerular mesangial cell development,BP,
16958,GO:0072257,1,0.990116762624955,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16959,GO:0072258,1,0.98903818528758,0,1,metanephric interstitial fibroblast differentiation,BP,
16960,GO:0072259,1,0.98903818528758,0,1,metanephric interstitial fibroblast development,BP,
16961,GO:0072262,1,0.988190272908991,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16962,GO:0072265,1,0.990378990484081,0,1,metanephric capsule morphogenesis,BP,
16963,GO:0072266,1,0.990378990484081,0,1,metanephric capsule formation,BP,
16964,GO:0072267,1,0.990378990484081,0,1,metanephric capsule specification,BP,
16965,GO:0072268,1,0.961116566150951,0,4,pattern specification involved in metanephros development,BP,
16966,GO:0072272,1,0.981213017926808,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
16967,GO:0072273,1,0.879195871861625,0,26,metanephric nephron morphogenesis,BP,
16968,GO:0072274,1,0.999999996371549,0,1,metanephric glomerular basement membrane development,BP,
16969,GO:0072275,1,0.990270791537594,0,3,metanephric glomerulus morphogenesis,BP,
16970,GO:0072276,1,0.990270791537594,0,3,metanephric glomerulus vasculature morphogenesis,BP,
16971,GO:0072277,1,0.990270791537594,0,3,metanephric glomerular capillary formation,BP,
16972,GO:0072278,1,0.976967889304688,0,4,metanephric comma-shaped body morphogenesis,BP,
16973,GO:0072282,1,0.963909167620314,0,8,metanephric nephron tubule morphogenesis,BP,
16974,GO:0072283,1,0.916426291551868,0,16,metanephric renal vesicle morphogenesis,BP,
16975,GO:0072284,1,0.97074189476297,0,6,metanephric S-shaped body morphogenesis,BP,
16976,GO:0072285,1,0.997145662464174,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16977,GO:0072286,1,0.991553937564633,0,1,metanephric connecting tubule development,BP,
16978,GO:0072287,1,0.999999996415495,0,1,metanephric distal tubule morphogenesis,BP,
16979,GO:0072289,1,0.987883300052521,0,4,metanephric nephron tubule formation,BP,
16980,GO:0072298,1,0.979099830994142,0,6,regulation of metanephric glomerulus development,BP,
16981,GO:0072299,1,0.993762557561425,0,1,negative regulation of metanephric glomerulus development,BP,
16982,GO:0072300,1,0.985245972795452,0,5,positive regulation of metanephric glomerulus development,BP,
16983,GO:0072301,1,0.988190446718195,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16984,GO:0072302,1,0.993762557561425,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16985,GO:0072303,1,0.994393193361575,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16986,GO:0072304,1,0.996047050278914,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16987,GO:0072305,1,0.996047050278914,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16988,GO:0072307,1,0.990116762624955,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16989,GO:0072308,1,0.996437854493469,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16990,GO:0072309,1,0.996047050278914,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16991,GO:0072310,1,0.958916566542021,0,13,glomerular epithelial cell development,BP,
16992,GO:0072311,1,0.910492068490967,0,20,glomerular epithelial cell differentiation,BP,
16993,GO:0072312,1,0.98836772095539,0,3,metanephric glomerular epithelial cell differentiation,BP,
16994,GO:0072313,1,0.98836772095539,0,3,metanephric glomerular epithelial cell development,BP,
16995,GO:0072318,1,0.972722752190122,0,6,clathrin coat disassembly,BP,
16996,GO:0072319,1,0.963051198789045,0,7,vesicle uncoating,BP,
16997,GO:0072320,1,0.987598321050482,0,2,volume-sensitive chloride channel activity,MF,
16998,GO:0072321,1,0.913407367548389,0,9,chaperone-mediated protein transport,BP,
17003,GO:0072334,1,0.976244231753256,0,2,UDP-galactose transmembrane transport,BP,
17004,GO:0072337,1,0.850262876631792,0,26,modified amino acid transport,BP,
17006,GO:0072340,1,0.98848070233315,0,1,cellular lactam catabolic process,BP,
17007,GO:0072341,1,0.634598693164052,0,67,modified amino acid binding,MF,
17008,GO:0072343,1,0.976737122536016,0,2,pancreatic stellate cell proliferation,BP,
17009,GO:0072344,1,0.994736731202169,0,1,rescue of stalled ribosome,BP,
17010,GO:0072345,1,0.977609719520526,0,4,NAADP-sensitive calcium-release channel activity,MF,
17011,GO:0072348,1,0.819601658373426,0,34,sulfur compound transport,BP,
17012,GO:0072349,1,0.903705356367459,0,18,modified amino acid transmembrane transporter activity,MF,
17014,GO:0072354,1,0.981326701928885,0,2,histone kinase activity (H3-T3 specific),MF,
17015,GO:0072355,1,0.981326701928885,0,2,histone H3-T3 phosphorylation,BP,
17016,GO:0072356,1,0.990903798700068,0,2,chromosome passenger complex localization to kinetochore,BP,
17017,GO:0072357,1,0.976708392230057,0,7,PTW/PP1 phosphatase complex,CC,
17020,GO:0072361,1,0.999999992779829,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
17021,GO:0072362,1,0.999999996384281,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
17022,GO:0072363,1,0.999999996395571,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
17023,GO:0072364,1,0.999999992783796,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17024,GO:0072365,1,0.999999996388243,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
17025,GO:0072366,1,0.999999996395571,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
17026,GO:0072367,1,0.992448156560484,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
17027,GO:0072368,1,0.99891979062571,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
17028,GO:0072369,1,0.993521425699261,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
17030,GO:0072377,1,0.993419296450914,0,1,blood coagulation, common pathway,BP,
17032,GO:0072379,1,0.972182721667564,0,3,ER membrane insertion complex,CC,
17033,GO:0072383,1,0.989824263561641,0,8,plus-end-directed vesicle transport along microtubule,BP,
17034,GO:0072384,1,0.72908398528367,0,66,organelle transport along microtubule,BP,
17035,GO:0072385,1,0.991544154497436,0,3,minus-end-directed organelle transport along microtubule,BP,
17036,GO:0072386,1,0.98982423038316,0,9,plus-end-directed organelle transport along microtubule,BP,
17037,GO:0072387,1,0.986963706924538,0,2,flavin adenine dinucleotide metabolic process,BP,
17038,GO:0072388,1,0.989304060135563,0,1,flavin adenine dinucleotide biosynthetic process,BP,
17039,GO:0072389,1,0.99763454673982,0,1,flavin adenine dinucleotide catabolic process,BP,
17040,GO:0072393,1,0.986196772591902,0,8,microtubule anchoring at microtubule organizing center,BP,
17041,GO:0072395,1,0.626007708103733,0,64,signal transduction involved in cell cycle checkpoint,BP,
17042,GO:0072396,1,0.970375770836686,0,6,response to cell cycle checkpoint signaling,BP,
17043,GO:0072401,1,0.626007769938484,0,63,signal transduction involved in DNA integrity checkpoint,BP,
17044,GO:0072402,1,0.970375770836686,0,6,response to DNA integrity checkpoint signaling,BP,
17045,GO:0072413,1,0.635839728222156,0,61,signal transduction involved in mitotic cell cycle checkpoint,BP,
17046,GO:0072414,1,0.999999996379141,0,1,response to mitotic cell cycle checkpoint signaling,BP,
17047,GO:0072422,1,0.626007769938484,0,63,signal transduction involved in DNA damage checkpoint,BP,
17048,GO:0072423,1,0.970375770836686,0,6,response to DNA damage checkpoint signaling,BP,
17049,GO:0072425,1,0.993677261930994,0,2,signal transduction involved in G2 DNA damage checkpoint,BP,
17050,GO:0072428,1,0.988966401454329,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
17051,GO:0072429,1,0.970375789648707,0,4,response to intra-S DNA damage checkpoint signaling,BP,
17052,GO:0072431,1,0.639899965536829,0,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
17053,GO:0072432,1,0.999999996379141,0,1,response to G1 DNA damage checkpoint signaling,BP,
17054,GO:0072434,1,0.993677261930994,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
17055,GO:0072487,1,0.978739148787717,0,4,MSL complex,CC,
17056,GO:0072488,1,0.871160577852303,0,18,ammonium transmembrane transport,BP,
17057,GO:0072492,1,0.988630136325738,0,1,host cell mitochondrial intermembrane space,CC,
17058,GO:0072497,1,0.980091519798464,0,8,mesenchymal stem cell differentiation,BP,
17059,GO:0072498,1,0.898588317572571,0,14,embryonic skeletal joint development,BP,
17060,GO:0072501,1,0.953654356887663,0,9,cellular divalent inorganic anion homeostasis,BP,
17061,GO:0072502,1,0.953654356887663,0,9,cellular trivalent inorganic anion homeostasis,BP,
17063,GO:0072505,1,0.941799246016758,0,12,divalent inorganic anion homeostasis,BP,
17064,GO:0072506,1,0.941799246016758,0,12,trivalent inorganic anion homeostasis,BP,
17066,GO:0072509,1,0.467733389837632,0,174,divalent inorganic cation transmembrane transporter activity,MF,
17067,GO:0072510,1,0.992700256397007,0,2,trivalent inorganic cation transmembrane transporter activity,MF,
17069,GO:0072512,1,0.753629281351064,0,38,trivalent inorganic cation transport,BP,
17070,GO:0072513,1,0.97429520136552,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
17071,GO:0072517,1,0.995850945276373,0,1,host cell viral assembly compartment,CC,
17072,GO:0072518,1,0.99999999637523,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
17073,GO:0072520,1,0.95322658276741,0,10,seminiferous tubule development,BP,
17080,GO:0072527,1,0.504603363282556,0,75,pyrimidine-containing compound metabolic process,BP,
17081,GO:0072528,1,0.699545122412092,0,39,pyrimidine-containing compound biosynthetic process,BP,
17082,GO:0072529,1,0.73452983362414,0,31,pyrimidine-containing compound catabolic process,BP,
17083,GO:0072530,1,0.923244236672983,0,9,purine-containing compound transmembrane transport,BP,
17084,GO:0072531,1,0.903397388445242,0,14,pyrimidine-containing compound transmembrane transport,BP,
17085,GO:0072534,1,0.999928663569088,0,2,perineuronal net,CC,
17086,GO:0072535,1,0.973113895942955,0,3,tumor necrosis factor (ligand) superfamily member 11 production,BP,
17087,GO:0072536,1,0.982290290482399,0,2,interleukin-23 receptor complex,CC,
17088,GO:0072537,1,0.943835029027997,0,10,fibroblast activation,BP,
17089,GO:0072538,1,0.847061224884528,0,21,T-helper 17 type immune response,BP,
17090,GO:0072539,1,0.860347228135904,0,19,T-helper 17 cell differentiation,BP,
17091,GO:0072540,1,0.902696745599678,0,12,T-helper 17 cell lineage commitment,BP,
17092,GO:0072542,1,0.948603675792371,0,7,protein phosphatase activator activity,MF,
17093,GO:0072544,1,0.988485871524491,0,1,L-DOPA binding,MF,
17094,GO:0072545,1,0.97857538469116,0,2,tyrosine binding,MF,
17095,GO:0072546,1,0.852061626871118,0,18,ER membrane protein complex,CC,
17096,GO:0072553,1,0.979756630439707,0,6,terminal button organization,BP,
17097,GO:0072554,1,0.986430366839686,0,2,blood vessel lumenization,BP,
17098,GO:0072556,1,0.998615248312486,0,1,other organism presynaptic membrane,CC,
17102,GO:0072560,1,0.981902558453956,0,2,type B pancreatic cell maturation,BP,
17104,GO:0072563,1,0.982734302065725,0,2,endothelial microparticle,CC,
17105,GO:0072564,1,0.978173000722563,0,2,blood microparticle formation,BP,
17106,GO:0072566,1,0.98329042098342,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
17107,GO:0072567,1,0.914416269626987,0,10,chemokine (C-X-C motif) ligand 2 production,BP,
17108,GO:0072572,1,0.989902930092111,0,1,poly-ADP-D-ribose binding,MF,
17109,GO:0072573,1,0.999148640907736,0,1,tolerance induction to lipopolysaccharide,BP,
17110,GO:0072574,1,0.886130789553727,0,17,hepatocyte proliferation,BP,
17111,GO:0072575,1,0.886130789553727,0,17,epithelial cell proliferation involved in liver morphogenesis,BP,
17112,GO:0072576,1,0.886130739782401,0,19,liver morphogenesis,BP,
17113,GO:0072577,1,0.759899923616848,0,46,endothelial cell apoptotic process,BP,
17114,GO:0072578,1,0.969304203078638,0,8,neurotransmitter-gated ion channel clustering,BP,
17115,GO:0072579,1,0.998807705642567,0,1,glycine receptor clustering,BP,
17116,GO:0072583,1,0.787778530266728,0,59,clathrin-dependent endocytosis,BP,
17117,GO:0072584,1,0.938584467575605,0,10,caveolin-mediated endocytosis,BP,
17118,GO:0072586,1,0.999281684395039,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
17119,GO:0072587,1,0.999281684395039,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
17120,GO:0072588,1,0.942767788778549,0,5,box H/ACA RNP complex,CC,
17121,GO:0072589,1,0.954425946106461,0,4,box H/ACA scaRNP complex,CC,
17122,GO:0072590,1,0.999999992769997,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
17123,GO:0072591,1,0.999999996371552,0,1,citrate-L-glutamate ligase activity,MF,
17124,GO:0072592,1,0.958824021087883,0,5,oxygen metabolic process,BP,
17127,GO:0072595,1,0.831034314346186,0,30,maintenance of protein localization in organelle,BP,
17128,GO:0072599,1,0.311917183585202,0,104,establishment of protein localization to endoplasmic reticulum,BP,
17129,GO:0072600,1,0.97782292284455,0,22,establishment of protein localization to Golgi,BP,
17130,GO:0072602,1,0.974356309538692,0,5,interleukin-4 secretion,BP,
17131,GO:0072603,1,0.954267796546741,0,6,interleukin-5 secretion,BP,
17135,GO:0072610,1,0.93455004326794,0,9,interleukin-12 secretion,BP,
17136,GO:0072611,1,0.931184933415483,0,8,interleukin-13 secretion,BP,
17137,GO:0072615,1,0.989936963505739,0,1,interleukin-17 secretion,BP,
17138,GO:0072616,1,0.998078108047528,0,1,interleukin-18 secretion,BP,
17139,GO:0072619,1,0.996405206557,0,1,interleukin-21 secretion,BP,
17140,GO:0072641,1,0.978523014301519,0,3,type I interferon secretion,BP,
17141,GO:0072642,1,0.985337515325025,0,2,interferon-alpha secretion,BP,
17142,GO:0072643,1,0.890552073999571,0,17,interferon-gamma secretion,BP,
17143,GO:0072655,1,0.233326184425676,0,183,establishment of protein localization to mitochondrion,BP,
17144,GO:0072656,1,0.970233134211552,0,5,maintenance of protein location in mitochondrion,BP,
17145,GO:0072657,1,0.0279884806788356,0,493,protein localization to membrane,BP,
17146,GO:0072658,1,0.999999996395232,0,1,maintenance of protein location in membrane,BP,
17147,GO:0072659,1,0.314807077362579,0,212,protein localization to plasma membrane,BP,
17148,GO:0072660,1,0.999999996395232,0,1,maintenance of protein location in plasma membrane,BP,
17149,GO:0072661,1,0.903704435467965,0,24,protein targeting to plasma membrane,BP,
17150,GO:0072662,1,0.905185639113945,0,17,protein localization to peroxisome,BP,
17151,GO:0072663,1,0.905185639113945,0,17,establishment of protein localization to peroxisome,BP,
17152,GO:0072665,1,0.810105169800767,0,40,protein localization to vacuole,BP,
17153,GO:0072666,1,0.86415767785341,0,31,establishment of protein localization to vacuole,BP,
17154,GO:0072669,1,0.924759752596726,0,7,tRNA-splicing ligase complex,CC,
17155,GO:0072671,1,0.991614695091367,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
17156,GO:0072672,1,0.975098524891822,0,6,neutrophil extravasation,BP,
17157,GO:0072673,1,0.941035746025309,0,14,lamellipodium morphogenesis,BP,
17158,GO:0072674,1,0.983384235530633,0,4,multinuclear osteoclast differentiation,BP,
17159,GO:0072675,1,0.991657589925955,0,3,osteoclast fusion,BP,
17161,GO:0072677,1,0.862398046742408,0,15,eosinophil migration,BP,
17163,GO:0072679,1,0.955319047921798,0,5,thymocyte migration,BP,
17164,GO:0072680,1,0.994475671194365,0,1,extracellular matrix-dependent thymocyte migration,BP,
17165,GO:0072681,1,0.994475671194365,0,1,fibronectin-dependent thymocyte migration,BP,
17166,GO:0072682,1,0.995720107681049,0,1,eosinophil extravasation,BP,
17168,GO:0072684,1,0.997443072002597,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17169,GO:0072686,1,0.723149075795649,0,65,mitotic spindle,CC,
17170,GO:0072687,1,0.932475867123553,0,8,meiotic spindle,CC,
17171,GO:0072695,1,0.983128113663102,0,2,regulation of DNA recombination at telomere,BP,
17172,GO:0072697,1,0.98210350047034,0,2,protein localization to cell cortex,BP,
17173,GO:0072698,1,0.864779227515873,0,33,protein localization to microtubule cytoskeleton,BP,
17174,GO:0072702,1,0.999998101517059,0,1,response to methyl methanesulfonate,BP,
17175,GO:0072703,1,0.999998101517059,0,1,cellular response to methyl methanesulfonate,BP,
17176,GO:0072706,1,0.991700627672326,0,1,response to sodium dodecyl sulfate,BP,
17177,GO:0072707,1,0.991700627672326,0,1,cellular response to sodium dodecyl sulfate,BP,
17178,GO:0072708,1,0.970314301501559,0,4,response to sorbitol,BP,
17179,GO:0072709,1,0.986166787199246,0,2,cellular response to sorbitol,BP,
17180,GO:0072710,1,0.978280526704305,0,7,response to hydroxyurea,BP,
17181,GO:0072711,1,0.986511287798265,0,6,cellular response to hydroxyurea,BP,
17182,GO:0072714,1,0.98859458603141,0,1,response to selenite ion,BP,
17183,GO:0072715,1,0.98859458603141,0,1,cellular response to selenite ion,BP,
17184,GO:0072716,1,0.970895512216136,0,4,response to actinomycin D,BP,
17185,GO:0072717,1,0.979064625847303,0,3,cellular response to actinomycin D,BP,
17186,GO:0072718,1,0.955713124758831,0,9,response to cisplatin,BP,
17187,GO:0072719,1,0.967895434837994,0,6,cellular response to cisplatin,BP,
17188,GO:0072720,1,0.983384249277821,0,2,response to dithiothreitol,BP,
17189,GO:0072721,1,0.991657600429728,0,1,cellular response to dithiothreitol,BP,
17190,GO:0072733,1,0.962721335124538,0,4,response to staurosporine,BP,
17191,GO:0072734,1,0.962721335124538,0,4,cellular response to staurosporine,BP,
17192,GO:0072737,1,0.981812143039508,0,2,response to diamide,BP,
17193,GO:0072738,1,0.981812143039508,0,2,cellular response to diamide,BP,
17194,GO:0072739,1,0.991657600429728,0,1,response to anisomycin,BP,
17195,GO:0072750,1,0.98767316499071,0,1,cellular response to leptomycin B,BP,
17196,GO:0072752,1,0.999999996376298,0,1,cellular response to rapamycin,BP,
17197,GO:0072755,1,0.997224430538685,0,1,cellular response to benomyl,BP,
17198,GO:0072757,1,0.986637200032601,0,3,cellular response to camptothecin,BP,
17199,GO:0075136,1,0.958946182442131,0,6,response to host,BP,
17200,GO:0075509,1,0.986613154868855,0,3,endocytosis involved in viral entry into host cell,BP,
17201,GO:0075519,1,0.98720169877262,0,1,microtubule-dependent intracellular transport of viral material,BP,
17202,GO:0075521,1,0.98720169877262,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17203,GO:0075522,1,0.949729059829872,0,7,IRES-dependent viral translational initiation,BP,
17204,GO:0075525,1,0.960550210839007,0,5,viral translational termination-reinitiation,BP,
17205,GO:0075528,1,0.978254710179525,0,2,modulation by virus of host immune response,BP,
17206,GO:0075606,1,0.98720169877262,0,1,transport of viral material towards nucleus,BP,
17207,GO:0075713,1,0.936948776613609,0,8,establishment of integrated proviral latency,BP,
17208,GO:0075732,1,0.999244306056699,0,2,viral penetration into host nucleus,BP,
17209,GO:0075733,1,0.665997481751224,0,65,intracellular transport of virus,BP,
17210,GO:0080008,1,0.884179722308446,0,26,Cul4-RING E3 ubiquitin ligase complex,CC,
17211,GO:0080009,1,0.967540196664327,0,4,mRNA methylation,BP,
17212,GO:0080019,1,0.989709316516677,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17213,GO:0080025,1,0.909003816205542,0,20,phosphatidylinositol-3,5-bisphosphate binding,MF,
17214,GO:0080033,1,0.999999996374604,0,1,response to nitrite,BP,
17215,GO:0080048,1,0.991657600429728,0,1,GDP-D-glucose phosphorylase activity,MF,
17216,GO:0080058,1,0.987784876593026,0,1,protein deglutathionylation,BP,
17217,GO:0080084,1,0.979903141116661,0,5,5S rDNA binding,MF,
17219,GO:0080101,1,0.987360893008489,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17220,GO:0080111,1,0.869044150962858,0,18,DNA demethylation,BP,
17221,GO:0080120,1,0.970983470358153,0,3,CAAX-box protein maturation,BP,
17222,GO:0080121,1,0.984847343245695,0,2,AMP transport,BP,
17223,GO:0080122,1,0.984847343245695,0,2,AMP transmembrane transporter activity,MF,
17224,GO:0080129,1,0.987446726529102,0,1,proteasome core complex assembly,BP,
17225,GO:0080130,1,0.97387532397188,0,3,L-phenylalanine:2-oxoglutarate aminotransferase activity,MF,
17226,GO:0080132,1,0.991068833933716,0,1,fatty acid alpha-hydroxylase activity,MF,
17229,GO:0080144,1,0.989028739333893,0,1,amino acid homeostasis,BP,
17230,GO:0080146,1,0.988606833667475,0,1,L-cysteine desulfhydrase activity,MF,
17231,GO:0080147,1,0.987233076566383,0,1,root hair cell development,BP,
17232,GO:0080154,1,0.785377708068602,0,25,regulation of fertilization,BP,
17233,GO:0080163,1,0.990924884094402,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17235,GO:0080182,1,0.947216162495015,0,13,histone H3-K4 trimethylation,BP,
17236,GO:0080184,1,0.954875265581348,0,5,response to phenylpropanoid,BP,
17237,GO:0085018,1,0.992553151165099,0,1,maintenance of symbiont-containing vacuole by host,BP,
17238,GO:0085020,1,0.944977287343259,0,7,protein K6-linked ubiquitination,BP,
17239,GO:0085029,1,0.870074650385308,0,29,extracellular matrix assembly,BP,
17240,GO:0085032,1,0.995096136888045,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17241,GO:0086001,1,0.789083053580517,0,64,cardiac muscle cell action potential,BP,
17242,GO:0086002,1,0.845819335475191,0,47,cardiac muscle cell action potential involved in contraction,BP,
17243,GO:0086003,1,0.809117299189654,0,57,cardiac muscle cell contraction,BP,
17244,GO:0086004,1,0.890387955907318,0,35,regulation of cardiac muscle cell contraction,BP,
17245,GO:0086005,1,0.888691720623965,0,30,ventricular cardiac muscle cell action potential,BP,
17246,GO:0086006,1,0.986605052218928,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17247,GO:0086007,1,0.996216475497257,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17248,GO:0086008,1,0.927263119967815,0,11,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
17249,GO:0086009,1,0.801292362588268,0,40,membrane repolarization,BP,
17250,GO:0086010,1,0.891277439928593,0,48,membrane depolarization during action potential,BP,
17251,GO:0086011,1,0.87093583537419,0,23,membrane repolarization during action potential,BP,
17252,GO:0086012,1,0.946721052087149,0,22,membrane depolarization during cardiac muscle cell action potential,BP,
17253,GO:0086013,1,0.886754711372449,0,20,membrane repolarization during cardiac muscle cell action potential,BP,
17254,GO:0086014,1,0.947254833214683,0,18,atrial cardiac muscle cell action potential,BP,
17255,GO:0086015,1,0.987644181019969,0,9,SA node cell action potential,BP,
17256,GO:0086016,1,0.981999043469945,0,10,AV node cell action potential,BP,
17257,GO:0086017,1,0.980599457992799,0,4,Purkinje myocyte action potential,BP,
17258,GO:0086018,1,0.987644181019969,0,9,SA node cell to atrial cardiac muscle cell signalling,BP,
17259,GO:0086019,1,0.904699952347564,0,29,cell-cell signaling involved in cardiac conduction,BP,
17260,GO:0086020,1,0.99454107374412,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17261,GO:0086021,1,0.99454107374412,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17262,GO:0086023,1,0.978184992293892,0,6,adrenergic receptor signaling pathway involved in heart process,BP,
17263,GO:0086024,1,0.999999996385271,0,1,adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17264,GO:0086026,1,0.947254833214683,0,18,atrial cardiac muscle cell to AV node cell signaling,BP,
17265,GO:0086027,1,0.981999043469945,0,10,AV node cell to bundle of His cell signaling,BP,
17266,GO:0086028,1,0.971039784727156,0,7,bundle of His cell to Purkinje myocyte signaling,BP,
17267,GO:0086029,1,0.973069088682277,0,6,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
17268,GO:0086030,1,0.989551430521535,0,1,adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
17270,GO:0086037,1,0.996416101244376,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17271,GO:0086039,1,0.99999999638592,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17272,GO:0086040,1,0.999391263498651,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17273,GO:0086041,1,0.999999996380052,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17274,GO:0086042,1,0.980726838252969,0,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,
17275,GO:0086043,1,0.971039784727156,0,7,bundle of His cell action potential,BP,
17276,GO:0086044,1,0.994541078442231,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
17277,GO:0086045,1,0.996932169569788,0,5,membrane depolarization during AV node cell action potential,BP,
17278,GO:0086046,1,0.999999981917747,0,5,membrane depolarization during SA node cell action potential,BP,
17279,GO:0086047,1,0.985982462121183,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17280,GO:0086048,1,0.995881003099162,0,3,membrane depolarization during bundle of His cell action potential,BP,
17281,GO:0086050,1,0.993065589473214,0,1,membrane repolarization during bundle of His cell action potential,BP,
17282,GO:0086052,1,0.993065589473214,0,1,membrane repolarization during SA node cell action potential,BP,
17283,GO:0086053,1,0.99454107374412,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
17284,GO:0086054,1,0.994541078442231,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
17285,GO:0086055,1,0.994541078442231,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
17286,GO:0086056,1,0.998633072930066,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17287,GO:0086057,1,0.997580126899744,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17288,GO:0086059,1,0.999999992765173,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17289,GO:0086060,1,0.999999996387329,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17290,GO:0086061,1,0.999999996387329,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17291,GO:0086062,1,0.987664827990719,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17292,GO:0086063,1,0.999999996387329,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17293,GO:0086064,1,0.897192740911417,0,23,cell communication by electrical coupling involved in cardiac conduction,BP,
17294,GO:0086065,1,0.809053829478635,0,52,cell communication involved in cardiac conduction,BP,
17295,GO:0086066,1,0.947254833214683,0,18,atrial cardiac muscle cell to AV node cell communication,BP,
17296,GO:0086067,1,0.981999036308662,0,11,AV node cell to bundle of His cell communication,BP,
17297,GO:0086068,1,0.973069088682277,0,6,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
17298,GO:0086069,1,0.955433821826052,0,14,bundle of His cell to Purkinje myocyte communication,BP,
17299,GO:0086070,1,0.98764417496311,0,10,SA node cell to atrial cardiac muscle cell communication,BP,
17300,GO:0086072,1,0.991265061507268,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17301,GO:0086073,1,0.989369658601849,0,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
17302,GO:0086075,1,0.988930820749992,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
17303,GO:0086076,1,0.994541078442231,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
17304,GO:0086077,1,0.99454107374412,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17305,GO:0086078,1,0.994541078442231,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
17306,GO:0086079,1,0.994541078442231,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
17307,GO:0086080,1,0.96913115046383,0,11,protein binding involved in heterotypic cell-cell adhesion,MF,
17308,GO:0086082,1,0.991265061507268,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17309,GO:0086083,1,0.989369658601849,0,6,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
17310,GO:0086087,1,0.993065589473214,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17311,GO:0086089,1,0.974177429619481,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17312,GO:0086090,1,0.993065589473214,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17313,GO:0086091,1,0.887815300937906,0,34,regulation of heart rate by cardiac conduction,BP,
17314,GO:0086092,1,0.987912724236117,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17315,GO:0086097,1,0.989986383939616,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
17316,GO:0086098,1,0.990428325937521,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17317,GO:0086100,1,0.996311370511169,0,2,endothelin receptor signaling pathway,BP,
17318,GO:0086103,1,0.956956017999933,0,9,G-protein coupled receptor signaling pathway involved in heart process,BP,
17319,GO:0089700,1,0.988223708989707,0,4,protein kinase D signaling,BP,
17320,GO:0089701,1,0.951224480360653,0,5,U2AF,CC,
17321,GO:0089709,1,0.983970861356623,0,2,L-histidine transmembrane transport,BP,
17323,GO:0089712,1,0.974282191320734,0,4,L-aspartate transmembrane transport,BP,
17324,GO:0089717,1,0.994774233046254,0,3,spanning component of membrane,CC,
17325,GO:0089718,1,0.999999996382036,0,1,amino acid import across plasma membrane,BP,
17327,GO:0090002,1,0.486622522276128,0,136,establishment of protein localization to plasma membrane,BP,
17328,GO:0090003,1,0.791653467098926,0,44,regulation of establishment of protein localization to plasma membrane,BP,
17329,GO:0090004,1,0.860342083279057,0,29,positive regulation of establishment of protein localization to plasma membrane,BP,
17330,GO:0090005,1,0.931973582178672,0,12,negative regulation of establishment of protein localization to plasma membrane,BP,
17331,GO:0090009,1,0.926946031420165,0,11,primitive streak formation,BP,
17332,GO:0090010,1,0.989695277448999,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17333,GO:0090022,1,0.727672317309038,0,31,regulation of neutrophil chemotaxis,BP,
17334,GO:0090023,1,0.753162118901369,0,26,positive regulation of neutrophil chemotaxis,BP,
17335,GO:0090024,1,0.991473944833211,0,2,negative regulation of neutrophil chemotaxis,BP,
17336,GO:0090025,1,0.817535992622687,0,22,regulation of monocyte chemotaxis,BP,
17337,GO:0090026,1,0.839440750960122,0,17,positive regulation of monocyte chemotaxis,BP,
17338,GO:0090027,1,0.979762098102743,0,4,negative regulation of monocyte chemotaxis,BP,
17339,GO:0090030,1,0.95484893549954,0,9,regulation of steroid hormone biosynthetic process,BP,
17340,GO:0090031,1,0.983519733041514,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17341,GO:0090032,1,0.971342593579756,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17342,GO:0090034,1,0.986709774402346,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17343,GO:0090035,1,0.986709774402346,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17344,GO:0090036,1,0.939468493145674,0,15,regulation of protein kinase C signaling,BP,
17345,GO:0090037,1,0.953176096040895,0,8,positive regulation of protein kinase C signaling,BP,
17346,GO:0090038,1,0.992072437074127,0,2,negative regulation of protein kinase C signaling,BP,
17347,GO:0090042,1,0.958388183986037,0,7,tubulin deacetylation,BP,
17348,GO:0090043,1,0.970350486204932,0,5,regulation of tubulin deacetylation,BP,
17349,GO:0090044,1,0.988252144942411,0,1,positive regulation of tubulin deacetylation,BP,
17350,GO:0090045,1,0.95717892100887,0,7,positive regulation of deacetylase activity,BP,
17351,GO:0090049,1,0.89423397228305,0,19,regulation of cell migration involved in sprouting angiogenesis,BP,
17352,GO:0090050,1,0.959511292794671,0,7,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17353,GO:0090051,1,0.936665857426369,0,11,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17354,GO:0090063,1,0.981517328456417,0,4,positive regulation of microtubule nucleation,BP,
17355,GO:0090065,1,0.998092392517714,0,1,regulation of production of siRNA involved in RNA interference,BP,
17357,GO:0090068,1,0.201422117583684,0,246,positive regulation of cell cycle process,BP,
17358,GO:0090069,1,0.954937428943177,0,10,regulation of ribosome biogenesis,BP,
17359,GO:0090070,1,0.969742622715377,0,6,positive regulation of ribosome biogenesis,BP,
17360,GO:0090071,1,0.984736573353714,0,4,negative regulation of ribosome biogenesis,BP,
17361,GO:0090073,1,0.940315681306103,0,8,positive regulation of protein homodimerization activity,BP,
17362,GO:0090074,1,0.977918113013111,0,5,negative regulation of protein homodimerization activity,BP,
17363,GO:0090075,1,0.837441883389852,0,29,relaxation of muscle,BP,
17364,GO:0090076,1,0.99623891143681,0,2,relaxation of skeletal muscle,BP,
17366,GO:0090079,1,0.91294664231407,0,20,translation regulator activity, nucleic acid binding,MF,
17367,GO:0090080,1,0.981019137015757,0,5,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17368,GO:0090081,1,0.976424478857125,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17369,GO:0090082,1,0.976424478857125,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17370,GO:0090083,1,0.892164997879679,0,16,regulation of inclusion body assembly,BP,
17371,GO:0090084,1,0.9243048981406,0,11,negative regulation of inclusion body assembly,BP,
17372,GO:0090085,1,0.942437110481861,0,8,regulation of protein deubiquitination,BP,
17373,GO:0090086,1,0.964587811915849,0,3,negative regulation of protein deubiquitination,BP,
17375,GO:0090088,1,0.980593473355691,0,2,regulation of oligopeptide transport,BP,
17376,GO:0090089,1,0.980593473355691,0,2,regulation of dipeptide transport,BP,
17378,GO:0090091,1,0.987380106459454,0,5,positive regulation of extracellular matrix disassembly,BP,
17379,GO:0090092,1,0.28274811132757,0,206,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17380,GO:0090094,1,0.97992960372287,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17381,GO:0090095,1,0.990791265500965,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17382,GO:0090096,1,0.990791265500965,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17383,GO:0090100,1,0.543430569141753,0,99,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17384,GO:0090101,1,0.555585073304764,0,102,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17385,GO:0090102,1,0.785095588904148,0,45,cochlea development,BP,
17386,GO:0090103,1,0.863854160637497,0,23,cochlea morphogenesis,BP,
17387,GO:0090104,1,0.99613356699837,0,1,pancreatic epsilon cell differentiation,BP,
17388,GO:0090107,1,0.977550625792501,0,3,regulation of high-density lipoprotein particle assembly,BP,
17389,GO:0090108,1,0.989648109637414,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17390,GO:0090109,1,0.827227430167752,0,50,regulation of cell-substrate junction assembly,BP,
17391,GO:0090110,1,0.982601763141334,0,5,cargo loading into COPII-coated vesicle,BP,
17392,GO:0090113,1,0.990009397148328,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17393,GO:0090114,1,0.686962177602737,0,66,COPII-coated vesicle budding,BP,
17394,GO:0090116,1,0.99675997309335,0,3,C-5 methylation of cytosine,BP,
17395,GO:0090118,1,0.978598354835433,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
17396,GO:0090119,1,0.988782339264777,0,2,vesicle-mediated cholesterol transport,BP,
17397,GO:0090122,1,0.989453038998871,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17398,GO:0090128,1,0.96331561574866,0,11,regulation of synapse maturation,BP,
17399,GO:0090129,1,0.972313401603469,0,8,positive regulation of synapse maturation,BP,
17401,GO:0090131,1,0.953425734424971,0,5,mesenchyme migration,BP,
17403,GO:0090133,1,0.987403188222156,0,1,mesendoderm migration,BP,
17404,GO:0090134,1,0.987403188222156,0,1,cell migration involved in mesendoderm migration,BP,
17405,GO:0090135,1,0.979223882304402,0,3,actin filament branching,BP,
17406,GO:0090136,1,0.947507194184491,0,15,epithelial cell-cell adhesion,BP,
17407,GO:0090138,1,0.996849720927078,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17408,GO:0090140,1,0.919317361323988,0,19,regulation of mitochondrial fission,BP,
17409,GO:0090141,1,0.929984995972699,0,12,positive regulation of mitochondrial fission,BP,
17410,GO:0090148,1,0.958929048561932,0,11,membrane fission,BP,
17411,GO:0090149,1,0.989996704423924,0,2,mitochondrial membrane fission,BP,
17412,GO:0090150,1,0.0598207014979709,0,359,establishment of protein localization to membrane,BP,
17413,GO:0090151,1,0.861156816466835,0,15,establishment of protein localization to mitochondrial membrane,BP,
17414,GO:0090152,1,0.992000462293178,0,1,establishment of protein localization to mitochondrial membrane involved in mitochondrial fission,BP,
17415,GO:0090153,1,0.901059928907708,0,13,regulation of sphingolipid biosynthetic process,BP,
17416,GO:0090154,1,0.942511920613888,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17417,GO:0090155,1,0.967616272488737,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17418,GO:0090156,1,0.967724248014014,0,3,cellular sphingolipid homeostasis,BP,
17419,GO:0090158,1,0.979769652829227,0,3,endoplasmic reticulum membrane organization,BP,
17420,GO:0090160,1,0.988514591351469,0,5,Golgi to lysosome transport,BP,
17421,GO:0090161,1,0.967005204614912,0,11,Golgi ribbon formation,BP,
17422,GO:0090162,1,0.92043544324727,0,21,establishment of epithelial cell polarity,BP,
17423,GO:0090164,1,0.992186118853931,0,2,asymmetric Golgi ribbon formation,BP,
17424,GO:0090166,1,0.956275933190702,0,6,Golgi disassembly,BP,
17425,GO:0090168,1,0.971674531184531,0,4,Golgi reassembly,BP,
17426,GO:0090169,1,0.887884323730046,0,16,regulation of spindle assembly,BP,
17427,GO:0090170,1,0.966772295092353,0,4,regulation of Golgi inheritance,BP,
17428,GO:0090171,1,0.997487954678594,0,1,chondrocyte morphogenesis,BP,
17431,GO:0090176,1,0.999997678958524,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17432,GO:0090177,1,0.943175102544408,0,15,establishment of planar polarity involved in neural tube closure,BP,
17433,GO:0090178,1,0.955037363538075,0,14,regulation of establishment of planar polarity involved in neural tube closure,BP,
17434,GO:0090179,1,0.955573826470604,0,13,planar cell polarity pathway involved in neural tube closure,BP,
17436,GO:0090182,1,0.977926637719533,0,2,regulation of secretion of lysosomal enzymes,BP,
17437,GO:0090183,1,0.708313273181077,0,55,regulation of kidney development,BP,
17438,GO:0090184,1,0.778023570529932,0,40,positive regulation of kidney development,BP,
17439,GO:0090185,1,0.886350802696616,0,18,negative regulation of kidney development,BP,
17440,GO:0090186,1,0.959328697608131,0,7,regulation of pancreatic juice secretion,BP,
17441,GO:0090187,1,0.976939670074246,0,2,positive regulation of pancreatic juice secretion,BP,
17442,GO:0090188,1,0.981976640907082,0,5,negative regulation of pancreatic juice secretion,BP,
17443,GO:0090189,1,0.855992118394842,0,23,regulation of branching involved in ureteric bud morphogenesis,BP,
17444,GO:0090190,1,0.890190235120113,0,19,positive regulation of branching involved in ureteric bud morphogenesis,BP,
17445,GO:0090191,1,0.969355976956404,0,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,
17446,GO:0090192,1,0.915967247809068,0,14,regulation of glomerulus development,BP,
17447,GO:0090193,1,0.945707619766431,0,10,positive regulation of glomerulus development,BP,
17448,GO:0090194,1,0.968565973763122,0,4,negative regulation of glomerulus development,BP,
17452,GO:0090198,1,0.993157405994137,0,1,negative regulation of chemokine secretion,BP,
17456,GO:0090202,1,0.971216236684961,0,3,gene looping,BP,
17457,GO:0090204,1,0.975379800769665,0,3,protein localization to nuclear pore,BP,
17459,GO:0090206,1,0.958278788647594,0,5,negative regulation of cholesterol metabolic process,BP,
17462,GO:0090209,1,0.941719118974502,0,8,negative regulation of triglyceride metabolic process,BP,
17463,GO:0090210,1,0.990477971255821,0,2,regulation of establishment of blood-brain barrier,BP,
17464,GO:0090212,1,0.990477971255821,0,2,negative regulation of establishment of blood-brain barrier,BP,
17465,GO:0090214,1,0.974943509757803,0,3,spongiotrophoblast layer developmental growth,BP,
17466,GO:0090218,1,0.854512972194244,0,33,positive regulation of lipid kinase activity,BP,
17467,GO:0090219,1,0.984801862957364,0,3,negative regulation of lipid kinase activity,BP,
17468,GO:0090220,1,0.929052180586045,0,12,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17469,GO:0090222,1,0.999999996376716,0,1,centrosome-templated microtubule nucleation,BP,
17470,GO:0090224,1,0.840560846386239,0,25,regulation of spindle organization,BP,
17471,GO:0090230,1,0.964977270607396,0,6,regulation of centromere complex assembly,BP,
17472,GO:0090231,1,0.889913291358228,0,16,regulation of spindle checkpoint,BP,
17473,GO:0090232,1,0.946090030271851,0,8,positive regulation of spindle checkpoint,BP,
17474,GO:0090233,1,0.992204790093199,0,1,negative regulation of spindle checkpoint,BP,
17475,GO:0090234,1,0.985198868770272,0,3,regulation of kinetochore assembly,BP,
17476,GO:0090235,1,0.982390431481427,0,2,regulation of metaphase plate congression,BP,
17477,GO:0090237,1,0.967535475721695,0,6,regulation of arachidonic acid secretion,BP,
17478,GO:0090238,1,0.967682811414334,0,5,positive regulation of arachidonic acid secretion,BP,
17479,GO:0090239,1,0.913742546517737,0,12,regulation of histone H4 acetylation,BP,
17480,GO:0090240,1,0.946423607466187,0,7,positive regulation of histone H4 acetylation,BP,
17481,GO:0090241,1,0.959494323711431,0,5,negative regulation of histone H4 acetylation,BP,
17482,GO:0090244,1,0.977472104628153,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17483,GO:0090245,1,0.984481470254299,0,5,axis elongation involved in somitogenesis,BP,
17484,GO:0090246,1,0.99920826098847,0,1,convergent extension involved in somitogenesis,BP,
17485,GO:0090247,1,0.991798445845593,0,1,cell motility involved in somitogenic axis elongation,BP,
17486,GO:0090249,1,0.991798445845593,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17487,GO:0090251,1,0.999999996402744,0,1,protein localization involved in establishment of planar polarity,BP,
17489,GO:0090258,1,0.992125544663325,0,3,negative regulation of mitochondrial fission,BP,
17490,GO:0090259,1,0.980068011688509,0,5,regulation of retinal ganglion cell axon guidance,BP,
17491,GO:0090260,1,0.997984075597232,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17492,GO:0090261,1,0.959256618139312,0,4,positive regulation of inclusion body assembly,BP,
17494,GO:0090264,1,0.978716713543473,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17495,GO:0090265,1,0.978716713543473,0,2,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17496,GO:0090266,1,0.900808437720853,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17497,GO:0090267,1,0.950701988455433,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17498,GO:0090269,1,0.97199505133853,0,6,fibroblast growth factor production,BP,
17499,GO:0090270,1,0.97199505133853,0,6,regulation of fibroblast growth factor production,BP,
17500,GO:0090271,1,0.990927043904425,0,3,positive regulation of fibroblast growth factor production,BP,
17501,GO:0090272,1,0.980896041527833,0,3,negative regulation of fibroblast growth factor production,BP,
17502,GO:0090273,1,0.981803749326923,0,2,regulation of somatostatin secretion,BP,
17503,GO:0090274,1,0.981803749326923,0,2,positive regulation of somatostatin secretion,BP,
17506,GO:0090278,1,0.761857503154897,0,41,negative regulation of peptide hormone secretion,BP,
17507,GO:0090279,1,0.537692531382111,0,96,regulation of calcium ion import,BP,
17508,GO:0090280,1,0.70259290224653,0,49,positive regulation of calcium ion import,BP,
17509,GO:0090281,1,0.832445236497557,0,21,negative regulation of calcium ion import,BP,
17510,GO:0090283,1,0.981592147498224,0,3,regulation of protein glycosylation in Golgi,BP,
17511,GO:0090284,1,0.999999996380131,0,1,positive regulation of protein glycosylation in Golgi,BP,
17512,GO:0090285,1,0.981592154737729,0,2,negative regulation of protein glycosylation in Golgi,BP,
17513,GO:0090286,1,0.950969868832697,0,8,cytoskeletal anchoring at nuclear membrane,BP,
17515,GO:0090288,1,0.497614695933111,0,124,negative regulation of cellular response to growth factor stimulus,BP,
17516,GO:0090289,1,0.964362513447402,0,5,regulation of osteoclast proliferation,BP,
17517,GO:0090290,1,0.966672097791376,0,3,positive regulation of osteoclast proliferation,BP,
17518,GO:0090291,1,0.997611440682214,0,2,negative regulation of osteoclast proliferation,BP,
17519,GO:0090292,1,0.994911206609413,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17520,GO:0090293,1,0.989936963505739,0,1,nitrogen catabolite regulation of transcription,BP,
17521,GO:0090294,1,0.989936963505739,0,1,nitrogen catabolite activation of transcription,BP,
17522,GO:0090296,1,0.975663936587884,0,4,regulation of mitochondrial DNA replication,BP,
17523,GO:0090297,1,0.987663454066629,0,1,positive regulation of mitochondrial DNA replication,BP,
17524,GO:0090298,1,0.987851791964428,0,3,negative regulation of mitochondrial DNA replication,BP,
17525,GO:0090299,1,0.988394765234882,0,1,regulation of neural crest formation,BP,
17526,GO:0090301,1,0.988394765234882,0,1,negative regulation of neural crest formation,BP,
17527,GO:0090303,1,0.717422797859359,0,46,positive regulation of wound healing,BP,
17530,GO:0090306,1,0.967636117692778,0,5,spindle assembly involved in meiosis,BP,
17531,GO:0090307,1,0.729875478878247,0,52,mitotic spindle assembly,BP,
17532,GO:0090308,1,0.967083164163195,0,9,regulation of methylation-dependent chromatin silencing,BP,
17533,GO:0090309,1,0.991905348786278,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17534,GO:0090310,1,0.980130947707051,0,3,negative regulation of methylation-dependent chromatin silencing,BP,
17535,GO:0090311,1,0.807717324207887,0,35,regulation of protein deacetylation,BP,
17536,GO:0090312,1,0.874935309713607,0,21,positive regulation of protein deacetylation,BP,
17537,GO:0090313,1,0.818138855162278,0,27,regulation of protein targeting to membrane,BP,
17538,GO:0090314,1,0.850760655513544,0,22,positive regulation of protein targeting to membrane,BP,
17539,GO:0090315,1,0.95887568586124,0,5,negative regulation of protein targeting to membrane,BP,
17540,GO:0090316,1,0.218547356662917,0,241,positive regulation of intracellular protein transport,BP,
17541,GO:0090317,1,0.552411446462034,0,90,negative regulation of intracellular protein transport,BP,
17542,GO:0090320,1,0.990447743086166,0,1,regulation of chylomicron remnant clearance,BP,
17543,GO:0090321,1,0.990447743086166,0,1,positive regulation of chylomicron remnant clearance,BP,
17545,GO:0090323,1,0.987167312885023,0,1,prostaglandin secretion involved in immune response,BP,
17546,GO:0090324,1,0.965930146206521,0,5,negative regulation of oxidative phosphorylation,BP,
17547,GO:0090325,1,0.974275295399533,0,4,regulation of locomotion involved in locomotory behavior,BP,
17548,GO:0090326,1,0.995172207019078,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17549,GO:0090327,1,0.998550297867607,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17550,GO:0090329,1,0.782549404698082,0,43,regulation of DNA-dependent DNA replication,BP,
17551,GO:0090330,1,0.931280936510094,0,15,regulation of platelet aggregation,BP,
17552,GO:0090331,1,0.94913734902255,0,10,negative regulation of platelet aggregation,BP,
17553,GO:0090335,1,0.932244251853648,0,13,regulation of brown fat cell differentiation,BP,
17554,GO:0090336,1,0.954021233937573,0,7,positive regulation of brown fat cell differentiation,BP,
17555,GO:0090340,1,0.989648109637414,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17556,GO:0090341,1,0.988156889359619,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17557,GO:0090342,1,0.817177153206303,0,35,regulation of cell aging,BP,
17558,GO:0090343,1,0.928119810083722,0,9,positive regulation of cell aging,BP,
17559,GO:0090344,1,0.916814595019257,0,17,negative regulation of cell aging,BP,
17560,GO:0090345,1,0.97974056631997,0,2,cellular organohalogen metabolic process,BP,
17561,GO:0090346,1,0.97974056631997,0,2,cellular organofluorine metabolic process,BP,
17562,GO:0090347,1,0.98821157638415,0,1,regulation of cellular organohalogen metabolic process,BP,
17563,GO:0090348,1,0.98821157638415,0,1,regulation of cellular organofluorine metabolic process,BP,
17564,GO:0090349,1,0.98821157638415,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17565,GO:0090350,1,0.98821157638415,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17566,GO:0090357,1,0.987629738760797,0,1,regulation of tryptophan metabolic process,BP,
17567,GO:0090360,1,0.978791416676666,0,3,platelet-derived growth factor production,BP,
17568,GO:0090361,1,0.978791416676666,0,3,regulation of platelet-derived growth factor production,BP,
17569,GO:0090362,1,0.989048669377155,0,2,positive regulation of platelet-derived growth factor production,BP,
17570,GO:0090365,1,0.977479645164094,0,2,regulation of mRNA modification,BP,
17571,GO:0090366,1,0.987291077611859,0,1,positive regulation of mRNA modification,BP,
17572,GO:0090367,1,0.99006327088848,0,1,negative regulation of mRNA modification,BP,
17573,GO:0090370,1,0.974399425206892,0,4,negative regulation of cholesterol efflux,BP,
17574,GO:0090381,1,0.96998821468567,0,3,regulation of heart induction,BP,
17575,GO:0090382,1,0.731933701568821,0,41,phagosome maturation,BP,
17576,GO:0090383,1,0.784549766035786,0,27,phagosome acidification,BP,
17577,GO:0090385,1,0.94690963365279,0,7,phagosome-lysosome fusion,BP,
17578,GO:0090386,1,0.999999996382506,0,1,phagosome maturation involved in apoptotic cell clearance,BP,
17579,GO:0090387,1,0.999999996382506,0,1,phagolysosome assembly involved in apoptotic cell clearance,BP,
17580,GO:0090389,1,0.999999996382506,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17581,GO:0090394,1,0.977559223442529,0,9,negative regulation of excitatory postsynaptic potential,BP,
17582,GO:0090398,1,0.705931969860688,0,54,cellular senescence,BP,
17583,GO:0090399,1,0.935786906858547,0,12,replicative senescence,BP,
17584,GO:0090400,1,0.955177775167426,0,8,stress-induced premature senescence,BP,
17585,GO:0090402,1,0.982306504850696,0,2,oncogene-induced cell senescence,BP,
17586,GO:0090403,1,0.978325110442481,0,4,oxidative stress-induced premature senescence,BP,
17588,GO:0090409,1,0.990488447929504,0,1,malonyl-CoA synthetase activity,MF,
17589,GO:0090410,1,0.990488447929504,0,1,malonate catabolic process,BP,
17590,GO:0090416,1,0.991680231264716,0,1,nicotinate transporter activity,MF,
17591,GO:0090420,1,0.976843812127721,0,2,naphthalene-containing compound metabolic process,BP,
17592,GO:0090422,1,0.988348355554348,0,1,thiamine pyrophosphate transporter activity,MF,
17593,GO:0090425,1,0.994081846487967,0,1,acinar cell differentiation,BP,
17594,GO:0090427,1,0.979424352808186,0,3,activation of meiosis,BP,
17595,GO:0090435,1,0.948807546393075,0,7,protein localization to nuclear envelope,BP,
17596,GO:0090467,1,0.977427442977545,0,4,arginine import,BP,
17597,GO:0090472,1,0.99862035898038,0,1,dibasic protein processing,BP,
17598,GO:0090480,1,0.991657600429728,0,1,purine nucleotide-sugar transmembrane transport,BP,
17599,GO:0090481,1,0.966429485264303,0,5,pyrimidine nucleotide-sugar transmembrane transport,BP,
17600,GO:0090482,1,0.958514777976122,0,8,vitamin transmembrane transporter activity,MF,
17602,GO:0090493,1,0.91148470225882,0,11,catecholamine uptake,BP,
17603,GO:0090494,1,0.91148470225882,0,11,dopamine uptake,BP,
17604,GO:0090498,1,0.982068425848236,0,3,extrinsic component of Golgi membrane,CC,
17605,GO:0090500,1,0.964022081454953,0,5,endocardial cushion to mesenchymal transition,BP,
17608,GO:0090503,1,0.807082037004138,0,34,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17609,GO:0090504,1,0.864519800006686,0,27,epiboly,BP,
17610,GO:0090505,1,0.864519828614373,0,26,epiboly involved in wound healing,BP,
17611,GO:0090520,1,0.914539191622461,0,12,sphingolipid mediated signaling pathway,BP,
17612,GO:0090521,1,0.983928793489036,0,4,glomerular visceral epithelial cell migration,BP,
17613,GO:0090526,1,0.99605944033802,0,2,regulation of gluconeogenesis involved in cellular glucose homeostasis,BP,
17614,GO:0090527,1,0.981460150542046,0,6,actin filament reorganization,BP,
17615,GO:0090529,1,0.988908214376503,0,1,cell septum assembly,BP,
17617,GO:0090534,1,0.988514526301702,0,1,calcium ion-transporting ATPase complex,CC,
17618,GO:0090537,1,0.998331839118341,0,2,CERF complex,CC,
17619,GO:0090541,1,0.990720133428302,0,2,MIT domain binding,MF,
17620,GO:0090543,1,0.938364415768291,0,7,Flemming body,CC,
17621,GO:0090544,1,0.881729818611491,0,23,BAF-type complex,CC,
17622,GO:0090545,1,0.932712581085614,0,17,CHD-type complex,CC,
17623,GO:0090554,1,0.997792813457867,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17624,GO:0090555,1,0.999751050476503,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17625,GO:0090556,1,0.999999992775708,0,2,phosphatidylserine-translocating ATPase activity,MF,
17626,GO:0090557,1,0.987554657570029,0,8,establishment of endothelial intestinal barrier,BP,
17627,GO:0090558,1,0.987233076566383,0,1,plant epidermis development,BP,
17629,GO:0090560,1,0.989965461331077,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17630,GO:0090568,1,0.868558441153807,0,31,nuclear transcriptional repressor complex,CC,
17631,GO:0090571,1,0.969876419267176,0,4,RNA polymerase II transcription repressor complex,CC,
17632,GO:0090575,1,0.429422150587051,0,115,RNA polymerase II transcription factor complex,CC,
17633,GO:0090576,1,0.964404961866993,0,8,RNA polymerase III transcription factor complex,CC,
17634,GO:0090579,1,0.971216236684961,0,3,dsDNA loop formation,BP,
17635,GO:0090594,1,0.955693453739424,0,6,inflammatory response to wounding,BP,
17637,GO:0090598,1,0.970822253797106,0,4,male anatomical structure morphogenesis,BP,
17638,GO:0090599,1,0.993778786073361,0,6,alpha-glucosidase activity,MF,
17639,GO:0090600,1,0.997758871194876,0,1,alpha-1,3-glucosidase activity,MF,
17640,GO:0090611,1,0.963377380818401,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17641,GO:0090615,1,0.999426095987091,0,1,mitochondrial mRNA processing,BP,
17642,GO:0090616,1,0.999426095987091,0,1,mitochondrial mRNA 3'-end processing,BP,
17643,GO:0090619,1,0.990770215483747,0,1,meiotic spindle pole,CC,
17644,GO:0090624,1,0.991657600429728,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17645,GO:0090625,1,0.991657600429728,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17646,GO:0090627,1,0.987233076566383,0,1,plant epidermal cell differentiation,BP,
17648,GO:0090631,1,0.987402916756448,0,2,pre-miRNA transporter activity,MF,
17649,GO:0090634,1,0.988065228259427,0,1,microglial cell mediated cytotoxicity,BP,
17651,GO:0090648,1,0.999999996374081,0,1,response to environmental enrichment,BP,
17652,GO:0090649,1,0.978468770982746,0,5,response to oxygen-glucose deprivation,BP,
17653,GO:0090650,1,0.978468770982746,0,5,cellular response to oxygen-glucose deprivation,BP,
17654,GO:0090651,1,0.999999996377211,0,1,apical cytoplasm,CC,
17655,GO:0090656,1,0.933440962166203,0,15,t-circle formation,BP,
17656,GO:0090657,1,0.949243093459112,0,11,telomeric loop disassembly,BP,
17657,GO:0090659,1,0.87231789498559,0,29,walking behavior,BP,
17658,GO:0090661,1,0.954425946106461,0,4,box H/ACA telomerase RNP complex,CC,
17659,GO:0090662,1,0.651261058693914,0,74,ATP hydrolysis coupled transmembrane transport,BP,
17660,GO:0090665,1,0.880987269762062,0,21,glycoprotein complex,CC,
17661,GO:0090666,1,0.96053115125471,0,4,scaRNA localization to Cajal body,BP,
17662,GO:0090669,1,0.977180306391843,0,3,telomerase RNA stabilization,BP,
17663,GO:0090670,1,0.851163012116392,0,16,RNA localization to Cajal body,BP,
17664,GO:0090671,1,0.851163012116392,0,16,telomerase RNA localization to Cajal body,BP,
17665,GO:0090672,1,0.851163012116392,0,16,telomerase RNA localization,BP,
17666,GO:0090675,1,0.99477423767509,0,2,intermicrovillar adhesion,BP,
17667,GO:0090676,1,0.993409576390941,0,1,calcium ion transmembrane transport via low voltage-gated calcium channel,BP,
17668,GO:0090677,1,0.993154987272083,0,1,reversible differentiation,BP,
17669,GO:0090678,1,0.993154987272083,0,1,cell dedifferentiation involved in phenotypic switching,BP,
17670,GO:0090713,1,0.940825385400572,0,9,immunological memory process,BP,
17671,GO:0090715,1,0.940825385400572,0,9,immunological memory formation process,BP,
17672,GO:0090722,1,0.975175108387383,0,4,receptor-receptor interaction,MF,
17673,GO:0090723,1,0.907662017091403,0,16,growth cone part,CC,
17674,GO:0090724,1,0.970037776142063,0,5,central region of growth cone,CC,
17675,GO:0090725,1,0.985050394483061,0,2,peripheral region of growth cone,CC,
17676,GO:0090731,1,0.987537367367283,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17677,GO:0090732,1,0.987631058642231,0,1,cofilin-actin rod,CC,
17678,GO:0090734,1,0.846288129268241,0,29,site of DNA damage,CC,
17679,GO:0090735,1,0.916129410636124,0,10,DNA repair complex assembly,BP,
17680,GO:0090737,1,0.933440962166203,0,15,telomere maintenance via telomere trimming,BP,
17681,GO:0093001,1,0.994780077103792,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17682,GO:0095500,1,0.854155225968502,0,21,acetylcholine receptor signaling pathway,BP,
17683,GO:0097001,1,0.947639238557371,0,7,ceramide binding,MF,
17684,GO:0097003,1,0.987861412939906,0,2,adipokinetic hormone receptor activity,MF,
17686,GO:0097009,1,0.875867782311543,0,33,energy homeostasis,BP,
17687,GO:0097010,1,0.98960897365854,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17688,GO:0097011,1,0.938482139531961,0,9,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17689,GO:0097012,1,0.938482139531961,0,9,response to granulocyte macrophage colony-stimulating factor,BP,
17690,GO:0097013,1,0.965828567079413,0,3,phagocytic vesicle lumen,CC,
17691,GO:0097014,1,0.655374866636294,0,84,ciliary plasm,CC,
17692,GO:0097016,1,0.98715463175264,0,3,L27 domain binding,MF,
17693,GO:0097017,1,0.983349314918944,0,3,renal protein absorption,BP,
17694,GO:0097018,1,0.990810396412569,0,2,renal albumin absorption,BP,
17695,GO:0097020,1,0.995506617216838,0,1,COPII adaptor activity,MF,
17696,GO:0097021,1,0.978627333430906,0,3,lymphocyte migration into lymphoid organs,BP,
17697,GO:0097022,1,0.990013231248957,0,1,lymphocyte migration into lymph node,BP,
17698,GO:0097025,1,0.999480642399153,0,3,MPP7-DLG1-LIN7 complex,CC,
17699,GO:0097026,1,0.964905004468921,0,4,dendritic cell dendrite assembly,BP,
17700,GO:0097027,1,0.935197367087249,0,8,ubiquitin-protein transferase activator activity,MF,
17702,GO:0097029,1,0.958383654088013,0,4,mature conventional dendritic cell differentiation,BP,
17703,GO:0097031,1,0.534149508417167,0,55,mitochondrial respiratory chain complex I biogenesis,BP,
17704,GO:0097032,1,0.975207479437647,0,2,mitochondrial respiratory chain complex II biogenesis,BP,
17705,GO:0097033,1,0.956018062314132,0,5,mitochondrial respiratory chain complex III biogenesis,BP,
17706,GO:0097034,1,0.879093293509607,0,14,mitochondrial respiratory chain complex IV biogenesis,BP,
17707,GO:0097035,1,0.876786255356129,0,37,regulation of membrane lipid distribution,BP,
17708,GO:0097037,1,0.995830364118973,0,1,heme export,BP,
17709,GO:0097038,1,0.956932938228509,0,11,perinuclear endoplasmic reticulum,CC,
17710,GO:0097039,1,0.977680516583966,0,4,protein linear polyubiquitination,BP,
17711,GO:0097045,1,0.999650137005206,0,1,phosphatidylserine exposure on blood platelet,BP,
17712,GO:0097048,1,0.966986860060114,0,6,dendritic cell apoptotic process,BP,
17714,GO:0097050,1,0.939171036306014,0,11,type B pancreatic cell apoptotic process,BP,
17715,GO:0097051,1,0.997103191175319,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17716,GO:0097052,1,0.969719545279152,0,3,L-kynurenine metabolic process,BP,
17717,GO:0097053,1,0.988006973601008,0,1,L-kynurenine catabolic process,BP,
17718,GO:0097055,1,0.990125353848087,0,1,agmatine biosynthetic process,BP,
17719,GO:0097056,1,0.967580706021101,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17720,GO:0097057,1,0.977915438443916,0,2,TRAF2-GSTP1 complex,CC,
17721,GO:0097058,1,0.96693308634688,0,3,CRLF-CLCF1 complex,CC,
17722,GO:0097059,1,0.978227642136823,0,2,CNTFR-CLCF1 complex,CC,
17724,GO:0097061,1,0.819679425732796,0,58,dendritic spine organization,BP,
17725,GO:0097062,1,0.926989232885323,0,12,dendritic spine maintenance,BP,
17726,GO:0097065,1,0.98026399733337,0,2,anterior head development,BP,
17727,GO:0097066,1,0.872658385871994,0,24,response to thyroid hormone,BP,
17728,GO:0097067,1,0.937920658404752,0,15,cellular response to thyroid hormone stimulus,BP,
17729,GO:0097068,1,0.980964594406335,0,5,response to thyroxine,BP,
17730,GO:0097069,1,0.991218873510729,0,2,cellular response to thyroxine stimulus,BP,
17731,GO:0097070,1,0.977408304833812,0,5,ductus arteriosus closure,BP,
17732,GO:0097084,1,0.945957913159536,0,8,vascular smooth muscle cell development,BP,
17733,GO:0097086,1,0.99681652257502,0,1,amniotic stem cell differentiation,BP,
17735,GO:0097090,1,0.976998401177662,0,10,presynaptic membrane organization,BP,
17736,GO:0097091,1,0.982583620597668,0,9,synaptic vesicle clustering,BP,
17737,GO:0097094,1,0.892718826402854,0,17,craniofacial suture morphogenesis,BP,
17738,GO:0097100,1,0.964232972072145,0,5,supercoiled DNA binding,MF,
17739,GO:0097101,1,0.977524265391042,0,3,blood vessel endothelial cell fate specification,BP,
17740,GO:0097102,1,0.98662534628896,0,2,endothelial tip cell fate specification,BP,
17741,GO:0097104,1,0.996127922890168,0,8,postsynaptic membrane assembly,BP,
17742,GO:0097105,1,0.989329112449849,0,8,presynaptic membrane assembly,BP,
17743,GO:0097106,1,0.969099770027489,0,13,postsynaptic density organization,BP,
17744,GO:0097107,1,0.99947799192028,0,5,postsynaptic density assembly,BP,
17745,GO:0097108,1,0.994532869053275,0,3,hedgehog family protein binding,MF,
17746,GO:0097109,1,0.986493040579909,0,5,neuroligin family protein binding,MF,
17747,GO:0097110,1,0.780828619120062,0,50,scaffold protein binding,MF,
17748,GO:0097111,1,0.999999992753254,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17749,GO:0097112,1,0.992784591505476,0,2,gamma-aminobutyric acid receptor clustering,BP,
17750,GO:0097113,1,0.976350319557437,0,5,AMPA glutamate receptor clustering,BP,
17751,GO:0097114,1,0.987310314460618,0,4,NMDA glutamate receptor clustering,BP,
17752,GO:0097115,1,0.999770119379547,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17753,GO:0097116,1,0.999483803339536,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17754,GO:0097117,1,0.999999996379636,0,1,guanylate kinase-associated protein clustering,BP,
17755,GO:0097118,1,0.999044743959169,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17756,GO:0097119,1,0.983872367711709,0,9,postsynaptic density protein 95 clustering,BP,
17757,GO:0097120,1,0.941134325880531,0,14,receptor localization to synapse,BP,
17758,GO:0097123,1,0.979491643104821,0,2,cyclin A1-CDK2 complex,CC,
17759,GO:0097124,1,0.983147475674808,0,2,cyclin A2-CDK2 complex,CC,
17760,GO:0097125,1,0.978450629630668,0,2,cyclin B1-CDK1 complex,CC,
17761,GO:0097129,1,0.98792742991245,0,2,cyclin D2-CDK4 complex,CC,
17762,GO:0097134,1,0.979381066272621,0,2,cyclin E1-CDK2 complex,CC,
17763,GO:0097135,1,0.982817819705667,0,2,cyclin E2-CDK2 complex,CC,
17764,GO:0097136,1,0.972506997942019,0,5,Bcl-2 family protein complex,CC,
17765,GO:0097144,1,0.987247606983837,0,1,BAX complex,CC,
17766,GO:0097149,1,0.989214002016213,0,3,centralspindlin complex,CC,
17767,GO:0097150,1,0.939875075151399,0,20,neuronal stem cell population maintenance,BP,
17768,GO:0097151,1,0.997645504416811,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17769,GO:0097152,1,0.920355204566691,0,13,mesenchymal cell apoptotic process,BP,
17771,GO:0097154,1,0.885888579333188,0,15,GABAergic neuron differentiation,BP,
17772,GO:0097155,1,0.998771441158293,0,3,fasciculation of sensory neuron axon,BP,
17773,GO:0097156,1,0.998771445001401,0,2,fasciculation of motor neuron axon,BP,
17774,GO:0097157,1,0.959679675766908,0,7,pre-mRNA intronic binding,MF,
17775,GO:0097158,1,0.988345945209257,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17777,GO:0097160,1,0.98714931616766,0,1,polychlorinated biphenyl binding,MF,
17778,GO:0097161,1,0.999999996374813,0,1,DH domain binding,MF,
17779,GO:0097162,1,0.995086611654992,0,1,MADS box domain binding,MF,
17781,GO:0097165,1,0.975696736228442,0,5,nuclear stress granule,CC,
17782,GO:0097166,1,0.989315863302456,0,2,lens epithelial cell proliferation,BP,
17783,GO:0097167,1,0.978027033640505,0,4,circadian regulation of translation,BP,
17784,GO:0097168,1,0.989343934539299,0,2,mesenchymal stem cell proliferation,BP,
17786,GO:0097176,1,0.990808137278926,0,1,epoxide metabolic process,BP,
17787,GO:0097177,1,0.976214815310522,0,2,mitochondrial ribosome binding,MF,
17788,GO:0097178,1,0.811929758455879,0,30,ruffle assembly,BP,
17789,GO:0097179,1,0.990586917343966,0,1,protease inhibitor complex,CC,
17790,GO:0097180,1,0.990586917343966,0,1,serine protease inhibitor complex,CC,
17791,GO:0097181,1,0.990586917343966,0,1,protein C inhibitor-coagulation factor V complex,CC,
17792,GO:0097182,1,0.990586917343966,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17793,GO:0097183,1,0.990586917343966,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17794,GO:0097186,1,0.897034162268294,0,21,amelogenesis,BP,
17795,GO:0097187,1,0.973005662395479,0,3,dentinogenesis,BP,
17801,GO:0097195,1,0.979273704348653,0,3,pilomotor reflex,BP,
17802,GO:0097196,1,0.980944577968552,0,2,Shu complex,CC,
17803,GO:0097197,1,0.960612489281557,0,7,tetraspanin-enriched microdomain,CC,
17804,GO:0097198,1,0.993789364207364,0,2,histone H3-K36 trimethylation,BP,
17805,GO:0097199,1,0.992591122213135,0,2,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17807,GO:0097201,1,0.90553553329077,0,13,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17809,GO:0097205,1,0.913344016740848,0,18,renal filtration,BP,
17810,GO:0097208,1,0.958479032108879,0,6,alveolar lamellar body,CC,
17811,GO:0097209,1,0.974095411490307,0,4,epidermal lamellar body,CC,
17812,GO:0097210,1,0.979286915584913,0,5,response to gonadotropin-releasing hormone,BP,
17813,GO:0097211,1,0.979286915584913,0,5,cellular response to gonadotropin-releasing hormone,BP,
17814,GO:0097212,1,0.976629744995235,0,2,lysosomal membrane organization,BP,
17815,GO:0097213,1,0.987171207637524,0,1,regulation of lysosomal membrane permeability,BP,
17816,GO:0097214,1,0.987171207637524,0,1,positive regulation of lysosomal membrane permeability,BP,
17817,GO:0097222,1,0.999426095987091,0,1,mitochondrial mRNA polyadenylation,BP,
17819,GO:0097224,1,0.988613664589566,0,1,sperm connecting piece,CC,
17820,GO:0097225,1,0.877446093316636,0,15,sperm midpiece,CC,
17821,GO:0097226,1,0.990472142882743,0,1,sperm mitochondrial sheath,CC,
17822,GO:0097227,1,0.958098389642794,0,6,sperm annulus,CC,
17823,GO:0097228,1,0.872629674137678,0,20,sperm principal piece,CC,
17824,GO:0097229,1,0.987738484043392,0,1,sperm end piece,CC,
17825,GO:0097231,1,0.988530315445819,0,1,cell motility in response to calcium ion,BP,
17826,GO:0097232,1,0.99538949148883,0,2,lamellar body membrane,CC,
17827,GO:0097233,1,0.99538949148883,0,2,alveolar lamellar body membrane,CC,
17828,GO:0097237,1,0.952596062271834,0,8,cellular response to toxic substance,BP,
17829,GO:0097238,1,0.987855476448624,0,1,cellular response to methylglyoxal,BP,
17830,GO:0097240,1,0.972735000192708,0,5,chromosome attachment to the nuclear envelope,BP,
17831,GO:0097241,1,0.981991281597411,0,2,hematopoietic stem cell migration to bone marrow,BP,
17832,GO:0097242,1,0.967989314513998,0,7,beta-amyloid clearance,BP,
17833,GO:0097252,1,0.98003716567197,0,3,oligodendrocyte apoptotic process,BP,
17834,GO:0097254,1,0.989807486330914,0,1,renal tubular secretion,BP,
17835,GO:0097255,1,0.95185424517587,0,5,R2TP complex,CC,
17836,GO:0097258,1,0.98459491770097,0,2,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17837,GO:0097259,1,0.98459491770097,0,2,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17838,GO:0097260,1,0.992237498065028,0,1,eoxin A4 synthase activity,MF,
17839,GO:0097264,1,0.946512508774848,0,8,self proteolysis,BP,
17840,GO:0097267,1,0.936124501787938,0,9,omega-hydroxylase P450 pathway,BP,
17841,GO:0097272,1,0.988365290799547,0,2,ammonia homeostasis,BP,
17842,GO:0097273,1,0.999999974663504,0,1,creatinine homeostasis,BP,
17843,GO:0097274,1,0.995962440581707,0,2,urea homeostasis,BP,
17844,GO:0097275,1,0.999999974663504,0,1,cellular ammonia homeostasis,BP,
17845,GO:0097276,1,0.999999974663504,0,1,cellular creatinine homeostasis,BP,
17846,GO:0097277,1,0.999999974663504,0,1,cellular urea homeostasis,BP,
17847,GO:0097278,1,0.95994024734131,0,4,complement-dependent cytotoxicity,BP,
17848,GO:0097283,1,0.952685070955317,0,6,keratinocyte apoptotic process,BP,
17849,GO:0097284,1,0.915251297544992,0,14,hepatocyte apoptotic process,BP,
17851,GO:0097291,1,0.989411464668733,0,1,renal phosphate ion absorption,BP,
17853,GO:0097298,1,0.997838488005057,0,1,regulation of nucleus size,BP,
17856,GO:0097306,1,0.795912701774238,0,54,cellular response to alcohol,BP,
17857,GO:0097319,1,0.990619980762556,0,1,carbohydrate import into cell,BP,
17858,GO:0097320,1,0.936564682910064,0,17,plasma membrane tubulation,BP,
17859,GO:0097322,1,0.968576712345002,0,7,7SK snRNA binding,MF,
17860,GO:0097324,1,0.999919812683061,0,2,melanocyte migration,BP,
17861,GO:0097325,1,0.99277713595847,0,2,melanocyte proliferation,BP,
17862,GO:0097326,1,0.999919816307882,0,1,melanocyte adhesion,BP,
17863,GO:0097327,1,0.962174238771958,0,5,response to antineoplastic agent,BP,
17864,GO:0097332,1,0.984215513878574,0,2,response to antipsychotic drug,BP,
17865,GO:0097338,1,0.996084371399737,0,2,response to clozapine,BP,
17869,GO:0097343,1,0.984039558086247,0,4,ripoptosome assembly,BP,
17870,GO:0097344,1,0.994098897983534,0,1,Rix1 complex,CC,
17871,GO:0097345,1,0.658055546356928,0,53,mitochondrial outer membrane permeabilization,BP,
17872,GO:0097346,1,0.841907337605719,0,21,INO80-type complex,CC,
17873,GO:0097350,1,0.980075500701946,0,4,neutrophil clearance,BP,
17874,GO:0097352,1,0.793841852585088,0,34,autophagosome maturation,BP,
17875,GO:0097354,1,0.935776752093799,0,10,prenylation,BP,
17876,GO:0097356,1,0.999999996381749,0,1,perinucleolar compartment,CC,
17877,GO:0097359,1,0.999800389308592,0,2,UDP-glucosylation,BP,
17878,GO:0097360,1,0.981613736613632,0,4,chorionic trophoblast cell proliferation,BP,
17879,GO:0097361,1,0.972394639202519,0,4,CIA complex,CC,
17880,GO:0097362,1,0.988278152166982,0,2,MCM8-MCM9 complex,CC,
17881,GO:0097363,1,0.999988592189262,0,1,protein O-GlcNAc transferase activity,MF,
17883,GO:0097368,1,0.982521321228046,0,4,establishment of Sertoli cell barrier,BP,
17884,GO:0097369,1,0.952389868372688,0,14,sodium ion import,BP,
17885,GO:0097371,1,0.975898156699768,0,6,MDM2/MDM4 family protein binding,MF,
17886,GO:0097372,1,0.98853560337144,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17887,GO:0097374,1,0.979151563463293,0,2,sensory neuron axon guidance,BP,
17888,GO:0097376,1,0.987884754444476,0,1,interneuron axon guidance,BP,
17889,GO:0097381,1,0.871836131003687,0,19,photoreceptor disc membrane,CC,
17890,GO:0097382,1,0.999999996372751,0,1,deoxynucleoside-diphosphatase activity,MF,
17891,GO:0097383,1,0.999999996372751,0,1,dIDP diphosphatase activity,MF,
17892,GO:0097384,1,0.958734355121176,0,6,cellular lipid biosynthetic process,BP,
17893,GO:0097386,1,0.928225153430501,0,15,glial cell projection,CC,
17894,GO:0097393,1,0.999999996401411,0,1,telomeric repeat-containing RNA transcription,BP,
17895,GO:0097394,1,0.999999996401411,0,1,telomeric repeat-containing RNA transcription from RNA pol II promoter,BP,
17896,GO:0097396,1,0.997035697400361,0,1,response to interleukin-17,BP,
17897,GO:0097398,1,0.997035697400361,0,1,cellular response to interleukin-17,BP,
17898,GO:0097400,1,0.997035697400361,0,1,interleukin-17-mediated signaling pathway,BP,
17899,GO:0097401,1,0.993657777065081,0,1,synaptic vesicle lumen acidification,BP,
17900,GO:0097402,1,0.991473324978239,0,1,neuroblast migration,BP,
17901,GO:0097403,1,0.993838121320329,0,1,cellular response to raffinose,BP,
17902,GO:0097409,1,0.989257140818515,0,1,glial cytoplasmic inclusion,CC,
17903,GO:0097411,1,0.984003578593125,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17904,GO:0097413,1,0.948385293540004,0,6,Lewy body,CC,
17905,GO:0097414,1,0.989257140818515,0,1,classical Lewy body,CC,
17906,GO:0097418,1,0.980750170413978,0,5,neurofibrillary tangle,CC,
17908,GO:0097422,1,0.970428900146914,0,5,tubular endosome,CC,
17910,GO:0097427,1,0.990985418566405,0,2,microtubule bundle,CC,
17911,GO:0097428,1,0.917175300676231,0,7,protein maturation by iron-sulfur cluster transfer,BP,
17912,GO:0097431,1,0.944814063669844,0,13,mitotic spindle pole,CC,
17913,GO:0097433,1,0.959726966574884,0,6,dense body,CC,
17915,GO:0097440,1,0.971946154962788,0,12,apical dendrite,CC,
17916,GO:0097441,1,0.990417630694894,0,3,basilar dendrite,CC,
17917,GO:0097442,1,0.999996700200902,0,1,CA3 pyramidal cell dendrite,CC,
17918,GO:0097443,1,0.982077205943097,0,6,sorting endosome,CC,
17919,GO:0097444,1,0.999900199325551,0,1,spine apparatus,CC,
17920,GO:0097447,1,0.981116150213026,0,2,dendritic tree,CC,
17921,GO:0097449,1,0.951736091087095,0,9,astrocyte projection,CC,
17922,GO:0097450,1,0.983564089022681,0,3,astrocyte end-foot,CC,
17923,GO:0097451,1,0.996346382068437,0,2,glial limiting end-foot,CC,
17924,GO:0097452,1,0.975204752149419,0,4,GAIT complex,CC,
17925,GO:0097453,1,0.990991255587827,0,1,mesaxon,CC,
17926,GO:0097454,1,0.982347388747256,0,3,Schwann cell microvillus,CC,
17927,GO:0097457,1,0.996264716953498,0,1,hippocampal mossy fiber,CC,
17929,GO:0097459,1,0.953374186171469,0,9,iron ion import into cell,BP,
17930,GO:0097460,1,0.96312591497646,0,4,ferrous iron import into cell,BP,
17931,GO:0097461,1,0.992487176114317,0,4,ferric iron import into cell,BP,
17932,GO:0097462,1,0.989257140818515,0,1,Lewy neurite,CC,
17933,GO:0097466,1,0.981695383124525,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17934,GO:0097468,1,0.912642577230098,0,12,programmed cell death in response to reactive oxygen species,BP,
17935,GO:0097470,1,0.989225365264472,0,5,ribbon synapse,CC,
17936,GO:0097472,1,0.791063270261888,0,28,cyclin-dependent protein kinase activity,MF,
17937,GO:0097473,1,0.999948751317214,0,1,retinal rod cell apoptotic process,BP,
17938,GO:0097475,1,0.960524223805052,0,7,motor neuron migration,BP,
17939,GO:0097476,1,0.972619952315184,0,4,spinal cord motor neuron migration,BP,
17940,GO:0097477,1,0.982344557384771,0,3,lateral motor column neuron migration,BP,
17941,GO:0097479,1,0.531911095201556,0,132,synaptic vesicle localization,BP,
17942,GO:0097480,1,0.538382642188012,0,125,establishment of synaptic vesicle localization,BP,
17943,GO:0097484,1,0.884890905195695,0,27,dendrite extension,BP,
17945,GO:0097486,1,0.924204699838677,0,7,multivesicular body lumen,CC,
17946,GO:0097487,1,0.979150159225442,0,3,multivesicular body, internal vesicle,CC,
17947,GO:0097489,1,0.991666648726133,0,1,multivesicular body, internal vesicle lumen,CC,
17948,GO:0097490,1,0.987576905587238,0,4,sympathetic neuron projection extension,BP,
17949,GO:0097491,1,0.987576905587238,0,4,sympathetic neuron projection guidance,BP,
17950,GO:0097493,1,0.964989403260504,0,17,structural molecule activity conferring elasticity,MF,
17951,GO:0097494,1,0.988129198201233,0,2,regulation of vesicle size,BP,
17952,GO:0097497,1,0.994512019025568,0,1,blood vessel endothelial cell delamination,BP,
17953,GO:0097498,1,0.98912752491613,0,2,endothelial tube lumen extension,BP,
17954,GO:0097499,1,0.932200218698341,0,9,protein localization to non-motile cilium,BP,
17955,GO:0097500,1,0.962286016532045,0,5,receptor localization to non-motile cilium,BP,
17956,GO:0097501,1,0.97491609772499,0,4,stress response to metal ion,BP,
17958,GO:0097503,1,0.872061543288862,0,21,sialylation,BP,
17959,GO:0097504,1,0.933188710030106,0,10,Gemini of coiled bodies,CC,
17960,GO:0097505,1,0.999999900550709,0,1,Rad6-Rad18 complex,CC,
17961,GO:0097506,1,0.949637078726927,0,5,deaminated base DNA N-glycosylase activity,MF,
17962,GO:0097510,1,0.989578110201723,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17963,GO:0097512,1,0.939799784659082,0,7,cardiac myofibril,CC,
17964,GO:0097513,1,0.99999998914216,0,3,myosin II filament,CC,
17965,GO:0097517,1,0.801853306464666,0,49,contractile actin filament bundle,CC,
17966,GO:0097524,1,0.954585499690871,0,6,sperm plasma membrane,CC,
17967,GO:0097525,1,0.6221622749558,0,57,spliceosomal snRNP complex,CC,
17968,GO:0097526,1,0.795168615587926,0,24,spliceosomal tri-snRNP complex,CC,
17970,GO:0097529,1,0.255838211982068,0,162,myeloid leukocyte migration,BP,
17971,GO:0097530,1,0.348407812173804,0,115,granulocyte migration,BP,
17972,GO:0097531,1,0.91945820389727,0,13,mast cell migration,BP,
17973,GO:0097534,1,0.992293692406992,0,1,lymphoid lineage cell migration,BP,
17974,GO:0097535,1,0.992293692406992,0,1,lymphoid lineage cell migration into thymus,BP,
17975,GO:0097536,1,0.982179108354525,0,2,thymus epithelium morphogenesis,BP,
17976,GO:0097539,1,0.971925075769083,0,9,ciliary transition fiber,CC,
17977,GO:0097541,1,0.991657600429728,0,1,axonemal basal plate,CC,
17978,GO:0097542,1,0.79634156624438,0,44,ciliary tip,CC,
17979,GO:0097543,1,0.993070758980114,0,2,ciliary inversin compartment,CC,
17980,GO:0097546,1,0.862478789906228,0,27,ciliary base,CC,
17981,GO:0097550,1,0.948124960901646,0,6,transcriptional preinitiation complex,CC,
17983,GO:0097573,1,0.987784876593026,0,1,glutathione oxidoreductase activity,MF,
17984,GO:0097576,1,0.793403990880932,0,36,vacuole fusion,BP,
17985,GO:0097577,1,0.940276125545846,0,5,sequestering of iron ion,BP,
17986,GO:0097581,1,0.695180612615045,0,70,lamellipodium organization,BP,
17987,GO:0097598,1,0.991635489647505,0,2,sperm cytoplasmic droplet,CC,
17988,GO:0097602,1,0.902595391687954,0,14,cullin family protein binding,MF,
17989,GO:0097603,1,0.987221702583832,0,3,temperature-gated ion channel activity,MF,
17990,GO:0097604,1,0.988725424574335,0,2,temperature-gated cation channel activity,MF,
17991,GO:0097610,1,0.752577183306027,0,48,cell surface furrow,CC,
17992,GO:0097617,1,0.947240594451115,0,13,annealing activity,MF,
17993,GO:0097623,1,0.954325888251712,0,7,potassium ion export across plasma membrane,BP,
17994,GO:0097625,1,0.999999996382036,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17995,GO:0097626,1,0.999999996382036,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17996,GO:0097627,1,0.999999996382036,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17997,GO:0097629,1,0.987841899987309,0,3,extrinsic component of omegasome membrane,CC,
17998,GO:0097630,1,0.991657600429728,0,1,intrinsic component of omegasome membrane,CC,
17999,GO:0097631,1,0.991657600429728,0,1,integral component of omegasome membrane,CC,
18000,GO:0097632,1,0.99159877315691,0,2,extrinsic component of pre-autophagosomal structure membrane,CC,
18001,GO:0097635,1,0.999441569574237,0,2,extrinsic component of autophagosome membrane,CC,
18002,GO:0097636,1,0.991733997725666,0,2,intrinsic component of autophagosome membrane,CC,
18003,GO:0097637,1,0.991733997725666,0,2,integral component of autophagosome membrane,CC,
18004,GO:0097638,1,0.999999996382036,0,1,L-arginine import across plasma membrane,BP,
18005,GO:0097639,1,0.999999996382036,0,1,L-lysine import across plasma membrane,BP,
18006,GO:0097640,1,0.999999996382036,0,1,L-ornithine import across plasma membrane,BP,
18007,GO:0097642,1,0.976236246212449,0,4,calcitonin family receptor activity,MF,
18008,GO:0097644,1,0.996635649694438,0,1,calcitonin family binding,MF,
18009,GO:0097648,1,0.999022600167925,0,3,G-protein coupled receptor complex,CC,
18010,GO:0097651,1,0.990307308846478,0,5,phosphatidylinositol 3-kinase complex, class I,CC,
18012,GO:0097676,1,0.989957838644831,0,3,histone H3-K36 dimethylation,BP,
18013,GO:0097677,1,0.970423065180189,0,3,STAT family protein binding,MF,
18014,GO:0097680,1,0.988084977479999,0,3,double-strand break repair via classical nonhomologous end joining,BP,
18015,GO:0097681,1,0.999999992801767,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
18016,GO:0097688,1,0.976350319557437,0,5,glutamate receptor clustering,BP,
18017,GO:0097689,1,0.995459856190394,0,1,iron channel activity,MF,
18018,GO:0097692,1,0.999999996374159,0,1,histone H3-K4 monomethylation,BP,
18019,GO:0097694,1,0.993426577541301,0,3,establishment of RNA localization to telomere,BP,
18020,GO:0097695,1,0.993426577541301,0,3,establishment of macromolecular complex localization to telomere,BP,
18022,GO:0097699,1,0.99920295972563,0,1,vascular endothelial cell response to fluid shear stress,BP,
18024,GO:0097709,1,0.966684768038047,0,6,connective tissue replacement,BP,
18025,GO:0097711,1,0.590626035405759,0,93,ciliary basal body docking,BP,
18026,GO:0097718,1,0.851597168705598,0,31,disordered domain specific binding,MF,
18027,GO:0097720,1,0.865450073112613,0,25,calcineurin-mediated signaling,BP,
18029,GO:0097724,1,0.988849558772555,0,1,sperm flagellum movement,BP,
18030,GO:0097726,1,0.987475033784534,0,1,LEM domain binding,MF,
18031,GO:0097729,1,0.544677111947384,0,71,9+2 motile cilium,CC,
18032,GO:0097730,1,0.471719360336228,0,126,non-motile cilium,CC,
18033,GO:0097731,1,0.550670972761228,0,100,9+0 non-motile cilium,CC,
18034,GO:0097732,1,0.932896804785273,0,9,9+2 non-motile cilium,CC,
18035,GO:0097733,1,0.550670972761228,0,100,photoreceptor cell cilium,CC,
18036,GO:0097734,1,0.862116209545685,0,19,extracellular exosome biogenesis,BP,
18037,GO:0097742,1,0.985630687063608,0,4,de novo centriole assembly,BP,
18038,GO:0097746,1,0.424282101763435,0,123,regulation of blood vessel diameter,BP,
18039,GO:0097747,1,0.719137152898073,0,42,RNA polymerase activity,MF,
18040,GO:0097755,1,0.671802545264808,0,55,positive regulation of blood vessel diameter,BP,
18041,GO:0097756,1,0.596006329924686,0,80,negative regulation of blood vessel diameter,BP,
18042,GO:0098501,1,0.952658802340839,0,5,polynucleotide dephosphorylation,BP,
18043,GO:0098502,1,0.964646454814429,0,3,DNA dephosphorylation,BP,
18044,GO:0098503,1,0.988559552384467,0,1,DNA 3' dephosphorylation,BP,
18045,GO:0098504,1,0.988559552384467,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
18046,GO:0098505,1,0.945315663945528,0,8,G-rich strand telomeric DNA binding,MF,
18047,GO:0098506,1,0.988559552384467,0,1,polynucleotide 3' dephosphorylation,BP,
18048,GO:0098507,1,0.987576533629277,0,2,polynucleotide 5' dephosphorylation,BP,
18049,GO:0098518,1,0.976277102287905,0,3,polynucleotide phosphatase activity,MF,
18050,GO:0098519,1,0.964273100449916,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
18051,GO:0098528,1,0.972511383395604,0,5,skeletal muscle fiber differentiation,BP,
18052,GO:0098530,1,0.999999980468215,0,1,positive regulation of strand invasion,BP,
18053,GO:0098531,1,0.778296959478964,0,46,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,
18054,GO:0098532,1,0.953606282753403,0,7,histone H3-K27 trimethylation,BP,
18056,GO:0098534,1,0.871760468930685,0,29,centriole assembly,BP,
18057,GO:0098535,1,0.985630687063608,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
18058,GO:0098536,1,0.98346367756989,0,4,deuterosome,CC,
18060,GO:0098543,1,0.934413335379509,0,13,detection of other organism,BP,
18061,GO:0098547,1,0.990330801809516,0,1,lumenal side of Golgi membrane,CC,
18063,GO:0098553,1,0.752185302440934,0,28,lumenal side of endoplasmic reticulum membrane,CC,
18064,GO:0098554,1,0.93640086215103,0,9,cytoplasmic side of endoplasmic reticulum membrane,CC,
18065,GO:0098556,1,0.988519776894314,0,1,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
18066,GO:0098559,1,0.983544921410211,0,2,cytoplasmic side of early endosome membrane,CC,
18067,GO:0098562,1,0.361467316374548,0,177,cytoplasmic side of membrane,CC,
18068,GO:0098563,1,0.891408644630273,0,18,intrinsic component of synaptic vesicle membrane,CC,
18070,GO:0098574,1,0.985119405063688,0,2,cytoplasmic side of lysosomal membrane,CC,
18071,GO:0098575,1,0.979939527853908,0,2,lumenal side of lysosomal membrane,CC,
18072,GO:0098576,1,0.966232044660717,0,4,lumenal side of membrane,CC,
18073,GO:0098581,1,0.893628278388616,0,18,detection of external biotic stimulus,BP,
18074,GO:0098582,1,0.996749689621851,0,2,innate vocalization behavior,BP,
18075,GO:0098583,1,0.976169736435076,0,2,learned vocalization behavior,BP,
18076,GO:0098586,1,0.795593351543645,0,40,cellular response to virus,BP,
18080,GO:0098592,1,0.985781370805425,0,3,cytoplasmic side of apical plasma membrane,CC,
18081,GO:0098594,1,0.98721724168907,0,1,mucin granule,CC,
18082,GO:0098595,1,0.990318799438873,0,1,perivitelline space,CC,
18083,GO:0098596,1,0.98977991981689,0,7,imitative learning,BP,
18084,GO:0098597,1,0.989779914204736,0,8,observational learning,BP,
18085,GO:0098598,1,0.966191279793282,0,9,learned vocalization behavior or vocal learning,BP,
18087,GO:0098601,1,0.995697036542217,0,1,selenomethionine adenosyltransferase activity,MF,
18090,GO:0098619,1,0.989069849812446,0,1,selenocysteine-tRNA ligase activity,MF,
18091,GO:0098621,1,0.999998627511705,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
18092,GO:0098625,1,0.997378793451102,0,1,methylselenol reductase activity,MF,
18093,GO:0098626,1,0.997378793451102,0,1,methylseleninic acid reductase activity,MF,
18094,GO:0098631,1,0.81149099197638,0,38,protein binding involved in cell adhesion,MF,
18095,GO:0098632,1,0.825992013082448,0,31,protein binding involved in cell-cell adhesion,MF,
18096,GO:0098633,1,0.99153598406105,0,1,collagen fibril binding,MF,
18097,GO:0098634,1,0.982470685634554,0,7,protein binding involved in cell-matrix adhesion,MF,
18098,GO:0098636,1,0.900598926112309,0,35,protein complex involved in cell adhesion,CC,
18099,GO:0098637,1,0.997852161842949,0,1,protein complex involved in cell-matrix adhesion,CC,
18100,GO:0098639,1,0.996686902991109,0,5,collagen binding involved in cell-matrix adhesion,MF,
18101,GO:0098640,1,0.98573691235555,0,2,integrin binding involved in cell-matrix adhesion,MF,
18102,GO:0098641,1,0.85388676127332,0,18,cadherin binding involved in cell-cell adhesion,MF,
18103,GO:0098642,1,0.991961219483212,0,7,network-forming collagen trimer,CC,
18104,GO:0098643,1,0.984077443032716,0,12,banded collagen fibril,CC,
18105,GO:0098644,1,0.976165614204844,0,20,complex of collagen trimers,CC,
18106,GO:0098645,1,0.991961219483212,0,7,collagen network,CC,
18107,GO:0098646,1,0.991961250736736,0,1,collagen sheet,CC,
18108,GO:0098647,1,0.986814388203457,0,3,collagen beaded filament,CC,
18109,GO:0098648,1,0.999999996391682,0,1,collagen anchoring fibril,CC,
18110,GO:0098651,1,0.991920605332148,0,8,basement membrane collagen trimer,CC,
18111,GO:0098652,1,0.999999996391682,0,1,collagen type VII anchoring fibril,CC,
18115,GO:0098659,1,0.870556142541746,0,34,inorganic cation import into cell,BP,
18119,GO:0098664,1,0.764350761155957,0,26,G-protein coupled serotonin receptor signaling pathway,BP,
18120,GO:0098665,1,0.979215987329314,0,2,serotonin receptor complex,CC,
18121,GO:0098668,1,0.954325888251712,0,7,potassium ion export from cell,BP,
18122,GO:0098679,1,0.999999992779829,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18123,GO:0098680,1,0.998092392517714,0,1,template-free RNA nucleotidyltransferase,MF,
18124,GO:0098687,1,0.110104045645329,0,331,chromosomal region,CC,
18125,GO:0098700,1,0.945158646311838,0,7,neurotransmitter loading into synaptic vesicle,BP,
18126,GO:0098703,1,0.975610448225357,0,7,calcium ion import across plasma membrane,BP,
18127,GO:0098704,1,0.990619980762556,0,1,carbohydrate import across plasma membrane,BP,
18128,GO:0098706,1,0.995431743094256,0,1,ferric iron import across plasma membrane,BP,
18129,GO:0098711,1,0.995431743094256,0,1,iron ion import across plasma membrane,BP,
18130,GO:0098719,1,0.95238988122834,0,13,sodium ion import across plasma membrane,BP,
18131,GO:0098722,1,0.945357437772038,0,9,asymmetric stem cell division,BP,
18132,GO:0098727,1,0.454704400390406,0,150,maintenance of cell number,BP,
18133,GO:0098728,1,0.964317854368054,0,4,germline stem cell asymmetric division,BP,
18136,GO:0098735,1,0.986655859872764,0,5,positive regulation of the force of heart contraction,BP,
18137,GO:0098736,1,0.999999996389206,0,1,negative regulation of the force of heart contraction,BP,
18138,GO:0098739,1,0.871872485478054,0,30,import across plasma membrane,BP,
18139,GO:0098742,1,0.376262924981463,0,222,cell-cell adhesion via plasma-membrane adhesion molecules,BP,
18140,GO:0098743,1,0.853929372900908,0,22,cell aggregation,BP,
18141,GO:0098745,1,0.988600021793749,0,1,Dcp1-Dcp2 complex,CC,
18142,GO:0098746,1,0.99967897914886,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18143,GO:0098748,1,0.952558119517561,0,11,endocytic adaptor activity,MF,
18144,GO:0098749,1,0.999455462763884,0,1,cerebellar neuron development,BP,
18145,GO:0098751,1,0.856854892041162,0,32,bone cell development,BP,
18147,GO:0098756,1,0.995038932589787,0,1,response to interleukin-21,BP,
18148,GO:0098757,1,0.995038932589787,0,1,cellular response to interleukin-21,BP,
18149,GO:0098758,1,0.978453875469138,0,3,response to interleukin-8,BP,
18150,GO:0098759,1,0.978453875469138,0,3,cellular response to interleukin-8,BP,
18151,GO:0098760,1,0.969155881253163,0,3,response to interleukin-7,BP,
18152,GO:0098761,1,0.969155881253163,0,3,cellular response to interleukin-7,BP,
18153,GO:0098770,1,0.997137724943713,0,2,FBXO family protein binding,MF,
18157,GO:0098779,1,0.953895476104615,0,9,positive regulation of macromitophagy in response to mitochondrial depolarization,BP,
18158,GO:0098780,1,0.894194908898249,0,18,response to mitochondrial depolarisation,BP,
18160,GO:0098782,1,0.988794920138329,0,1,mechanically-gated potassium channel activity,MF,
18161,GO:0098787,1,0.922918068036675,0,12,mRNA cleavage involved in mRNA processing,BP,
18162,GO:0098789,1,0.938524195785383,0,9,pre-mRNA cleavage required for polyadenylation,BP,
18163,GO:0098791,1,0.189713389767652,0,282,Golgi subcompartment,CC,
18164,GO:0098792,1,0.953852403934938,0,8,xenophagy,BP,
18165,GO:0098793,1,0.143555061865238,0,337,presynapse,CC,
18167,GO:0098795,1,0.988217147268132,0,2,mRNA cleavage involved in gene silencing,BP,
18171,GO:0098799,1,0.887773305359756,0,12,outer mitochondrial membrane protein complex,CC,
18172,GO:0098800,1,0.284586765060905,0,109,inner mitochondrial membrane protein complex,CC,
18173,GO:0098801,1,0.783490708679648,0,34,regulation of renal system process,BP,
18175,GO:0098803,1,0.438791489601001,0,70,respiratory chain complex,CC,
18177,GO:0098808,1,0.981002006638196,0,2,mRNA cap binding,MF,
18178,GO:0098809,1,0.991848723520862,0,1,nitrite reductase activity,MF,
18179,GO:0098810,1,0.900265039796078,0,17,neurotransmitter reuptake,BP,
18180,GO:0098811,1,0.738625381176679,0,55,transcriptional repressor activity, RNA polymerase II activating transcription factor binding,MF,
18181,GO:0098813,1,0.17647474586104,0,265,nuclear chromosome segregation,BP,
18182,GO:0098814,1,0.999328078817532,0,3,spontaneous synaptic transmission,BP,
18183,GO:0098815,1,0.895073022379635,0,33,modulation of excitatory postsynaptic potential,BP,
18184,GO:0098821,1,0.983960354331342,0,5,BMP receptor activity,MF,
18185,GO:0098822,1,0.991186186932819,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18186,GO:0098827,1,0.88502377475342,0,20,endoplasmic reticulum subcompartment,CC,
18187,GO:0098828,1,0.997645504416811,0,7,modulation of inhibitory postsynaptic potential,BP,
18188,GO:0098829,1,0.999999996375592,0,1,intestinal folate absorption,BP,
18189,GO:0098830,1,0.99969043436888,0,1,presynaptic endosome,CC,
18190,GO:0098831,1,0.999999992855778,0,2,presynaptic active zone cytoplasmic component,CC,
18191,GO:0098833,1,0.999793270733588,0,1,presynaptic endocytic zone,CC,
18192,GO:0098835,1,0.999793270733588,0,1,presynaptic endocytic zone membrane,CC,
18193,GO:0098837,1,0.983454195776622,0,2,postsynaptic recycling endosome,CC,
18194,GO:0098838,1,0.992964354370504,0,1,reduced folate transmembrane transport,BP,
18195,GO:0098839,1,0.986864520349859,0,7,postsynaptic density membrane,CC,
18196,GO:0098840,1,0.778366831331351,0,46,protein transport along microtubule,BP,
18197,GO:0098843,1,0.999999996382531,0,1,postsynaptic endocytic zone,CC,
18198,GO:0098844,1,0.999999996382531,0,1,postsynaptic endocytic zone membrane,CC,
18199,GO:0098845,1,0.973912916106209,0,4,postsynaptic endosome,CC,
18200,GO:0098847,1,0.925165669347997,0,11,sequence-specific single stranded DNA binding,MF,
18201,GO:0098850,1,0.989218981406881,0,1,extrinsic component of synaptic vesicle membrane,CC,
18202,GO:0098852,1,0.129913901537142,0,322,lytic vacuole membrane,CC,
18203,GO:0098855,1,0.995678634736312,0,3,HCN channel complex,CC,
18204,GO:0098856,1,0.88443102956795,0,14,intestinal lipid absorption,BP,
18206,GO:0098858,1,0.406467739962799,0,178,actin-based cell projection,CC,
18207,GO:0098862,1,0.470514674851456,0,136,cluster of actin-based cell projections,CC,
18208,GO:0098868,1,0.87735346354731,0,23,bone growth,BP,
18210,GO:0098870,1,0.964595314711036,0,7,action potential propagation,BP,
18211,GO:0098871,1,0.988472972149306,0,1,postsynaptic actin cytoskeleton,CC,
18212,GO:0098875,1,0.999602044253052,0,1,epididymosome,CC,
18213,GO:0098876,1,0.672817697547771,0,68,vesicle-mediated transport to the plasma membrane,BP,
18214,GO:0098877,1,0.92940301656667,0,11,neurotransmitter receptor transport to plasma membrane,BP,
18216,GO:0098881,1,0.973469315473867,0,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
18217,GO:0098883,1,0.988771600271842,0,1,synapse disassembly,BP,
18218,GO:0098884,1,0.999999996382531,0,1,postsynaptic neurotransmitter receptor internalization,BP,
18219,GO:0098885,1,0.999999992762512,0,2,modification of postsynaptic actin cytoskeleton,BP,
18220,GO:0098886,1,0.991558624100425,0,2,modification of dendritic spine,BP,
18221,GO:0098887,1,0.969021621446651,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18222,GO:0098888,1,0.999999996380262,0,1,extrinsic component of presynaptic membrane,CC,
18223,GO:0098890,1,0.999999996380262,0,1,extrinsic component of postsynaptic membrane,CC,
18224,GO:0098895,1,0.99863054261301,0,1,postsynaptic endosome membrane,CC,
18225,GO:0098900,1,0.819974495828455,0,48,regulation of action potential,BP,
18226,GO:0098901,1,0.922479238054837,0,27,regulation of cardiac muscle cell action potential,BP,
18227,GO:0098902,1,0.969067285689347,0,6,regulation of membrane depolarization during action potential,BP,
18228,GO:0098903,1,0.973471937252097,0,8,regulation of membrane repolarization during action potential,BP,
18229,GO:0098904,1,0.985853440986683,0,3,regulation of AV node cell action potential,BP,
18230,GO:0098905,1,0.98186651579622,0,2,regulation of bundle of His cell action potential,BP,
18231,GO:0098906,1,0.994541078442231,0,1,regulation of Purkinje myocyte action potential,BP,
18232,GO:0098907,1,0.999999992810032,0,2,regulation of SA node cell action potential,BP,
18233,GO:0098908,1,0.962239005918736,0,5,regulation of neuronal action potential,BP,
18234,GO:0098909,1,0.956678569566127,0,8,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18235,GO:0098910,1,0.990857140601525,0,6,regulation of atrial cardiac muscle cell action potential,BP,
18236,GO:0098911,1,0.971263580679444,0,14,regulation of ventricular cardiac muscle cell action potential,BP,
18237,GO:0098912,1,0.998633072935329,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18238,GO:0098914,1,0.963803393418754,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18239,GO:0098915,1,0.933871110372473,0,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
18241,GO:0098917,1,0.998125305299758,0,4,retrograde trans-synaptic signaling,BP,
18242,GO:0098918,1,0.988789072672353,0,1,structural constituent of synapse,MF,
18243,GO:0098920,1,0.999999965615178,0,1,retrograde trans-synaptic signaling by lipid,BP,
18244,GO:0098921,1,0.999999965615178,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
18245,GO:0098923,1,0.999999996379559,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18246,GO:0098924,1,0.999999996379559,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18247,GO:0098927,1,0.824997765496064,0,37,vesicle-mediated transport between endosomal compartments,BP,
18248,GO:0098928,1,0.999999992855778,0,2,presynaptic signal transduction,BP,
18249,GO:0098930,1,0.815796120371614,0,38,axonal transport,BP,
18250,GO:0098935,1,0.995128609042536,0,3,dendritic transport,BP,
18251,GO:0098936,1,0.996672951968262,0,6,intrinsic component of postsynaptic membrane,CC,
18252,GO:0098937,1,0.995128609042536,0,3,anterograde dendritic transport,BP,
18253,GO:0098939,1,0.99999999637588,0,1,dendritic transport of mitochondrion,BP,
18254,GO:0098942,1,0.999770119379547,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18255,GO:0098943,1,0.987823282086371,0,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,
18256,GO:0098948,1,0.999591351050541,0,3,intrinsic component of postsynaptic specialization membrane,CC,
18257,GO:0098953,1,0.988129204155051,0,1,receptor diffusion trapping,BP,
18258,GO:0098957,1,0.999732249396606,0,1,anterograde axonal transport of mitochondrion,BP,
18259,GO:0098960,1,0.875652638749981,0,20,postsynaptic neurotransmitter receptor activity,MF,
18260,GO:0098967,1,0.973469315473867,0,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
18261,GO:0098968,1,0.999930075847107,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18262,GO:0098969,1,0.933914206975339,0,10,neurotransmitter receptor transport to postsynaptic membrane,BP,
18263,GO:0098970,1,0.988129204155051,0,1,postsynaptic neurotransmitter receptor diffusion trapping,BP,
18264,GO:0098971,1,0.995128613631285,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18265,GO:0098972,1,0.99999999637588,0,1,anterograde dendritic transport of mitochondrion,BP,
18266,GO:0098973,1,0.988789072672353,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18267,GO:0098974,1,0.988789072672353,0,1,postsynaptic actin cytoskeleton organization,BP,
18268,GO:0098976,1,0.991151294342921,0,1,excitatory chemical synaptic transmission,BP,
18269,GO:0098982,1,0.993969753941198,0,1,GABA-ergic synapse,CC,
18270,GO:0098984,1,0.472755337130859,0,196,neuron to neuron synapse,CC,
18271,GO:0098988,1,0.989478632853433,0,5,G-protein coupled glutamate receptor activity,MF,
18272,GO:0098989,1,0.988046185552893,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18273,GO:0098992,1,0.991260666430442,0,1,neuronal dense core vesicle,CC,
18274,GO:0098993,1,0.971310884253117,0,3,anchored component of synaptic vesicle membrane,CC,
18275,GO:0098999,1,0.99863054261301,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18276,GO:0099003,1,0.538382642188012,0,125,vesicle-mediated transport in synapse,BP,
18277,GO:0099004,1,0.999871809314247,0,3,calmodulin dependent kinase signaling pathway,BP,
18278,GO:0099010,1,0.991558613525695,0,4,modification of postsynaptic structure,BP,
18279,GO:0099011,1,0.997777736782225,0,4,neuronal dense core vesicle exocytosis,BP,
18280,GO:0099023,1,0.710551406448256,0,63,tethering complex,CC,
18281,GO:0099024,1,0.761359465629104,0,40,plasma membrane invagination,BP,
18282,GO:0099038,1,0.999751054145043,0,1,ceramide-translocating ATPase activity,MF,
18283,GO:0099039,1,0.999751054145043,0,1,sphingolipid translocation,BP,
18284,GO:0099040,1,0.999751054145043,0,1,ceramide translocation,BP,
18285,GO:0099046,1,0.9879274359181,0,1,clearance of foreign intracellular nucleic acids,BP,
18286,GO:0099053,1,0.982329363741983,0,3,activating signal cointegrator 1 complex,CC,
18287,GO:0099054,1,0.958843123529892,0,16,presynapse assembly,BP,
18288,GO:0099055,1,0.996672951968262,0,6,integral component of postsynaptic membrane,CC,
18289,GO:0099060,1,0.999591351050541,0,3,integral component of postsynaptic specialization membrane,CC,
18290,GO:0099061,1,0.999591351050541,0,3,integral component of postsynaptic density membrane,CC,
18291,GO:0099068,1,0.984688666491243,0,12,postsynapse assembly,BP,
18292,GO:0099072,1,0.961911000077377,0,6,regulation of postsynaptic specialization membrane neurotransmitter receptor levels,BP,
18293,GO:0099073,1,0.994521117565206,0,2,mitochondrion-derived vesicle,CC,
18294,GO:0099074,1,0.987335505482653,0,2,mitochondrion to lysosome transport,BP,
18295,GO:0099075,1,0.987335505482653,0,2,mitochondrion-derived vesicle mediated transport,BP,
18296,GO:0099078,1,0.95630791047306,0,4,BORC complex,CC,
18299,GO:0099082,1,0.99835484977967,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
18300,GO:0099084,1,0.969099770027489,0,13,postsynaptic specialization organization,BP,
18301,GO:0099086,1,0.794224701275855,0,32,synaptonemal structure,CC,
18303,GO:0099095,1,0.934182077412896,0,12,ligand-gated anion channel activity,MF,
18304,GO:0099106,1,0.565225825306989,0,85,ion channel regulator activity,MF,
18305,GO:0099111,1,0.542483648526999,0,121,microtubule-based transport,BP,
18306,GO:0099118,1,0.778366831331351,0,46,microtubule-based protein transport,BP,
18307,GO:0099122,1,0.989796779495028,0,2,RNA polymerase II C-terminal domain binding,MF,
18308,GO:0099131,1,0.682121125485414,0,68,ATP hydrolysis coupled ion transmembrane transport,BP,
18309,GO:0099132,1,0.692294584699467,0,56,ATP hydrolysis coupled cation transmembrane transport,BP,
18310,GO:0099133,1,0.98501516203938,0,13,ATP hydrolysis coupled anion transmembrane transport,BP,
18311,GO:0099142,1,0.999999996373532,0,1,intracellular ATP-gated ion channel activity,MF,
18312,GO:0099400,1,0.999999996391606,0,1,caveola neck,CC,
18313,GO:0099402,1,0.987233076566383,0,1,plant organ development,BP,
18314,GO:0099403,1,0.999999992794904,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18315,GO:0099404,1,0.999999992794904,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18316,GO:0099500,1,0.897609059298169,0,15,vesicle fusion to plasma membrane,BP,
18317,GO:0099501,1,0.61985004008758,0,74,exocytic vesicle membrane,CC,
18319,GO:0099504,1,0.58635445983263,0,118,synaptic vesicle cycle,BP,
18320,GO:0099509,1,0.991553937564633,0,1,regulation of presynaptic cytosolic calcium ion concentration,BP,
18323,GO:0099514,1,0.886389675539106,0,17,synaptic vesicle cytoskeletal transport,BP,
18324,GO:0099515,1,0.993432385657733,0,6,actin filament-based transport,BP,
18325,GO:0099516,1,0.752593993142032,0,59,ion antiporter activity,MF,
18326,GO:0099517,1,0.886389675539106,0,17,synaptic vesicle transport along microtubule,BP,
18327,GO:0099518,1,0.823106814378062,0,40,vesicle cytoskeletal trafficking,BP,
18328,GO:0099525,1,0.997777736782225,0,4,presynaptic dense core vesicle exocytosis,BP,
18329,GO:0099526,1,0.999999992855778,0,2,presynapse to nucleus signaling pathway,BP,
18330,GO:0099528,1,0.959319879203053,0,5,G-protein coupled neurotransmitter receptor activity,MF,
18331,GO:0099529,1,0.875652665453457,0,19,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18332,GO:0099530,1,0.999999996383913,0,1,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18333,GO:0099531,1,0.45655183885942,0,145,presynaptic process involved in chemical synaptic transmission,BP,
18334,GO:0099532,1,0.999690430692091,0,2,synaptic vesicle endosomal processing,BP,
18337,GO:0099538,1,0.99835484977967,0,1,synaptic signaling via neuropeptide,BP,
18338,GO:0099540,1,0.99835484977967,0,1,trans-synaptic signaling by neuropeptide,BP,
18339,GO:0099541,1,0.997393951354656,0,3,trans-synaptic signaling by lipid,BP,
18340,GO:0099542,1,0.997393951354656,0,3,trans-synaptic signaling by endocannabinoid,BP,
18341,GO:0099543,1,0.999999996379559,0,1,trans-synaptic signaling by soluble gas,BP,
18342,GO:0099545,1,0.999505838903296,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18343,GO:0099548,1,0.999999996379559,0,1,trans-synaptic signaling by nitric oxide,BP,
18344,GO:0099550,1,0.997130328334422,0,3,trans-synaptic signalling, modulating synaptic transmission,BP,
18345,GO:0099552,1,0.997393986176608,0,2,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18346,GO:0099553,1,0.997393986176608,0,2,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18347,GO:0099557,1,0.999735659335535,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18348,GO:0099558,1,0.976202899986612,0,2,maintenance of synapse structure,BP,
18349,GO:0099563,1,0.976249326743646,0,6,modification of synaptic structure,BP,
18351,GO:0099566,1,0.999999873692669,0,2,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18353,GO:0099569,1,0.999999992855778,0,2,presynaptic cytoskeleton,CC,
18354,GO:0099571,1,0.988472972149306,0,1,postsynaptic cytoskeleton,CC,
18355,GO:0099572,1,0.476422633378813,0,192,postsynaptic specialization,CC,
18356,GO:0099580,1,0.999944362664322,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18357,GO:0099583,1,0.999999873692669,0,2,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18358,GO:0099587,1,0.870556142541746,0,34,inorganic ion import into cell,BP,
18359,GO:0099589,1,0.738504911962286,0,29,serotonin receptor activity,MF,
18360,GO:0099590,1,0.977845873608783,0,4,neurotransmitter receptor internalization,BP,
18362,GO:0099601,1,0.835225249664725,0,34,regulation of neurotransmitter receptor activity,BP,
18363,GO:0099602,1,0.950002461700489,0,6,neurotransmitter receptor regulator activity,MF,
18364,GO:0099604,1,0.957104274787281,0,18,ligand-gated calcium channel activity,MF,
18365,GO:0099607,1,0.999999996388243,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18366,GO:0099609,1,0.99999996492356,0,2,microtubule lateral binding,MF,
18367,GO:0099612,1,0.986972882978231,0,7,protein localization to axon,BP,
18368,GO:0099617,1,0.99564152860859,0,1,matrix side of mitochondrial inner membrane,CC,
18369,GO:0099622,1,0.833269119524337,0,32,cardiac muscle cell membrane repolarization,BP,
18370,GO:0099623,1,0.898647586255409,0,22,regulation of cardiac muscle cell membrane repolarization,BP,
18371,GO:0099624,1,0.951528496852102,0,9,atrial cardiac muscle cell membrane repolarization,BP,
18372,GO:0099625,1,0.888894201162165,0,22,ventricular cardiac muscle cell membrane repolarization,BP,
18373,GO:0099628,1,0.988129204155051,0,1,neurotransmitter receptor diffusion trapping,BP,
18374,GO:0099634,1,0.963634470149655,0,9,postsynaptic specialization membrane,CC,
18375,GO:0099637,1,0.918079375394426,0,14,neurotransmitter receptor transport,BP,
18376,GO:0099638,1,0.960997863319057,0,7,endosome to plasma membrane protein transport,BP,
18377,GO:0099639,1,0.964342217363415,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18378,GO:0099640,1,0.987292882255767,0,1,axo-dendritic protein transport,BP,
18379,GO:0099641,1,0.987292882255767,0,1,anterograde axonal protein transport,BP,
18380,GO:0099643,1,0.498405172897571,0,135,signal release from synapse,BP,
18381,GO:0099738,1,0.931487768859147,0,16,cell cortex region,CC,
18382,GO:0100001,1,0.9999740992563,0,1,regulation of skeletal muscle contraction by action potential,BP,
18383,GO:0100002,1,0.993089732258129,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18384,GO:0100012,1,0.96998821468567,0,3,regulation of heart induction by canonical Wnt signaling pathway,BP,
18385,GO:0100057,1,0.999999996382348,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18387,GO:0101003,1,0.678221271917391,0,60,ficolin-1-rich granule membrane,CC,
18388,GO:0101005,1,0.570602677389153,0,111,ubiquitinyl hydrolase activity,MF,
18389,GO:0101020,1,0.952819764569089,0,5,estrogen 16-alpha-hydroxylase activity,MF,
18390,GO:0101023,1,0.98833394167051,0,1,vascular endothelial cell proliferation,BP,
18391,GO:0101030,1,0.987750629389171,0,1,tRNA-guanine transglycosylation,BP,
18392,GO:0101031,1,0.893519249949974,0,12,chaperone complex,CC,
18393,GO:0102005,1,0.988053174296799,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18395,GO:0102008,1,0.999835424792419,0,1,cytosolic dipeptidase activity,MF,
18397,GO:0102076,1,0.993055936423407,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18398,GO:0102077,1,0.979332370597168,0,2,oleamide hydrolase activity,MF,
18399,GO:0102084,1,0.98447983782341,0,2,L-dopa O-methyltransferase activity,MF,
18400,GO:0102132,1,0.999999996387332,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18401,GO:0102279,1,0.999742809095682,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18402,GO:0102320,1,0.992662520819034,0,1,1,8-cineole 2-exo-monooxygenase activity,MF,
18406,GO:0102339,1,0.99157641090153,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18407,GO:0102340,1,0.99157641090153,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18408,GO:0102341,1,0.99157641090153,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18409,GO:0102342,1,0.99157641090153,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18410,GO:0102390,1,0.992032818988262,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18411,GO:0102391,1,0.962412081320345,0,8,decanoate--CoA ligase activity,MF,
18412,GO:0102483,1,0.988448680688217,0,1,scopolin beta-glucosidase activity,MF,
18413,GO:0102490,1,0.982856265034944,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18414,GO:0102522,1,0.990184046308003,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18415,GO:0102549,1,0.988015696663845,0,1,1-18:1-2-16:0-monogalactosyldiacylglycerol lipase activity,MF,
18416,GO:0102571,1,0.999898639174517,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18417,GO:0102704,1,0.993288197418697,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18418,GO:0102867,1,0.992472632785116,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18419,GO:0102991,1,0.928974107159862,0,7,myristoyl-CoA hydrolase activity,MF,
18420,GO:0103046,1,0.999835424792419,0,1,alanylglutamate dipeptidase activity,MF,
18421,GO:0103053,1,0.979203521506563,0,2,1-ethyladenine demethylase activity,MF,
18422,GO:0103073,1,0.979332370597168,0,2,anandamide amidohydrolase activity,MF,
18423,GO:0103095,1,0.977826784221326,0,2,wax ester synthase activity,MF,
18424,GO:0106001,1,0.983920590984654,0,4,intestinal hexose absorption,BP,
18427,GO:1900003,1,0.87775009092042,0,13,regulation of serine-type endopeptidase activity,BP,
18428,GO:1900004,1,0.897660145192556,0,11,negative regulation of serine-type endopeptidase activity,BP,
18429,GO:1900005,1,0.977838789762376,0,3,positive regulation of serine-type endopeptidase activity,BP,
18430,GO:1900006,1,0.78891234916762,0,65,positive regulation of dendrite development,BP,
18431,GO:1900010,1,0.988877999150257,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18432,GO:1900011,1,0.988877999150257,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18433,GO:1900015,1,0.857993490644503,0,24,regulation of cytokine production involved in inflammatory response,BP,
18434,GO:1900016,1,0.939200858230018,0,9,negative regulation of cytokine production involved in inflammatory response,BP,
18435,GO:1900017,1,0.923213742131861,0,10,positive regulation of cytokine production involved in inflammatory response,BP,
18436,GO:1900019,1,0.978999036799777,0,4,regulation of protein kinase C activity,BP,
18437,GO:1900020,1,0.978999036799777,0,4,positive regulation of protein kinase C activity,BP,
18438,GO:1900024,1,0.774114598118989,0,42,regulation of substrate adhesion-dependent cell spreading,BP,
18439,GO:1900025,1,0.946720158798882,0,11,negative regulation of substrate adhesion-dependent cell spreading,BP,
18440,GO:1900026,1,0.818388991406255,0,30,positive regulation of substrate adhesion-dependent cell spreading,BP,
18441,GO:1900027,1,0.861399697816081,0,21,regulation of ruffle assembly,BP,
18442,GO:1900028,1,0.956446457558873,0,5,negative regulation of ruffle assembly,BP,
18443,GO:1900029,1,0.958362307359344,0,7,positive regulation of ruffle assembly,BP,
18444,GO:1900034,1,0.665854483962086,0,74,regulation of cellular response to heat,BP,
18445,GO:1900035,1,0.992380623680821,0,1,negative regulation of cellular response to heat,BP,
18446,GO:1900036,1,0.99068229285834,0,1,positive regulation of cellular response to heat,BP,
18447,GO:1900037,1,0.930218072344896,0,10,regulation of cellular response to hypoxia,BP,
18448,GO:1900038,1,0.967202239421611,0,5,negative regulation of cellular response to hypoxia,BP,
18449,GO:1900039,1,0.983248802225458,0,2,positive regulation of cellular response to hypoxia,BP,
18450,GO:1900040,1,0.966734485702702,0,7,regulation of interleukin-2 secretion,BP,
18451,GO:1900041,1,0.974669177022928,0,4,negative regulation of interleukin-2 secretion,BP,
18452,GO:1900042,1,0.991860753906237,0,3,positive regulation of interleukin-2 secretion,BP,
18453,GO:1900044,1,0.978259532194474,0,7,regulation of protein K63-linked ubiquitination,BP,
18454,GO:1900045,1,0.987207077720381,0,4,negative regulation of protein K63-linked ubiquitination,BP,
18456,GO:1900047,1,0.681950300353687,0,48,negative regulation of hemostasis,BP,
18457,GO:1900048,1,0.838263375627702,0,24,positive regulation of hemostasis,BP,
18458,GO:1900052,1,0.987594992920963,0,1,regulation of retinoic acid biosynthetic process,BP,
18459,GO:1900053,1,0.987594992920963,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18460,GO:1900060,1,0.967616272488737,0,4,negative regulation of ceramide biosynthetic process,BP,
18461,GO:1900062,1,0.997041743956183,0,1,regulation of replicative cell aging,BP,
18462,GO:1900063,1,0.98880217896874,0,3,regulation of peroxisome organization,BP,
18463,GO:1900073,1,0.988194969026752,0,1,regulation of neuromuscular synaptic transmission,BP,
18464,GO:1900075,1,0.988194969026752,0,1,positive regulation of neuromuscular synaptic transmission,BP,
18466,GO:1900077,1,0.821390056964809,0,32,negative regulation of cellular response to insulin stimulus,BP,
18468,GO:1900081,1,0.999999996389206,0,1,regulation of arginine catabolic process,BP,
18469,GO:1900082,1,0.999999996389206,0,1,negative regulation of arginine catabolic process,BP,
18470,GO:1900084,1,0.982293938877584,0,6,regulation of peptidyl-tyrosine autophosphorylation,BP,
18471,GO:1900085,1,0.992169805765653,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18472,GO:1900086,1,0.990046816261295,0,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18473,GO:1900087,1,0.846172705180004,0,27,positive regulation of G1/S transition of mitotic cell cycle,BP,
18474,GO:1900094,1,0.934631460971058,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18475,GO:1900095,1,0.999999996398594,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18476,GO:1900098,1,0.988781779731915,0,1,regulation of plasma cell differentiation,BP,
18477,GO:1900100,1,0.988781779731915,0,1,positive regulation of plasma cell differentiation,BP,
18478,GO:1900101,1,0.867438896533992,0,22,regulation of endoplasmic reticulum unfolded protein response,BP,
18479,GO:1900102,1,0.951549853863817,0,8,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18480,GO:1900103,1,0.920225388424355,0,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,
18481,GO:1900104,1,0.979883076088498,0,3,regulation of hyaluranon cable assembly,BP,
18482,GO:1900106,1,0.979883076088498,0,3,positive regulation of hyaluranon cable assembly,BP,
18483,GO:1900107,1,0.939244300142232,0,7,regulation of nodal signaling pathway,BP,
18484,GO:1900108,1,0.969871868251631,0,3,negative regulation of nodal signaling pathway,BP,
18485,GO:1900109,1,0.956977972690307,0,4,regulation of histone H3-K9 dimethylation,BP,
18486,GO:1900110,1,0.976236480793765,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18487,GO:1900111,1,0.980276420858725,0,2,positive regulation of histone H3-K9 dimethylation,BP,
18488,GO:1900112,1,0.946893801700201,0,11,regulation of histone H3-K9 trimethylation,BP,
18489,GO:1900113,1,0.96568319718007,0,6,negative regulation of histone H3-K9 trimethylation,BP,
18490,GO:1900114,1,0.987948226019087,0,3,positive regulation of histone H3-K9 trimethylation,BP,
18491,GO:1900115,1,0.902959017278963,0,14,extracellular regulation of signal transduction,BP,
18492,GO:1900116,1,0.902959017278963,0,14,extracellular negative regulation of signal transduction,BP,
18493,GO:1900117,1,0.85228903095299,0,23,regulation of execution phase of apoptosis,BP,
18494,GO:1900118,1,0.94579182073422,0,8,negative regulation of execution phase of apoptosis,BP,
18495,GO:1900119,1,0.913077970085041,0,12,positive regulation of execution phase of apoptosis,BP,
18496,GO:1900120,1,0.865431401119065,0,21,regulation of receptor binding,BP,
18497,GO:1900121,1,0.918894214162385,0,12,negative regulation of receptor binding,BP,
18498,GO:1900122,1,0.944591207378885,0,8,positive regulation of receptor binding,BP,
18499,GO:1900125,1,0.9728154409527,0,7,regulation of hyaluronan biosynthetic process,BP,
18500,GO:1900126,1,0.986217336459972,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18501,GO:1900127,1,0.986412304540033,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18502,GO:1900130,1,0.996629268245158,0,1,regulation of lipid binding,BP,
18503,GO:1900131,1,0.996629268245158,0,1,negative regulation of lipid binding,BP,
18504,GO:1900133,1,0.977959973003262,0,4,regulation of renin secretion into blood stream,BP,
18505,GO:1900134,1,0.997393990321769,0,1,negative regulation of renin secretion into blood stream,BP,
18506,GO:1900135,1,0.985898153716788,0,2,positive regulation of renin secretion into blood stream,BP,
18507,GO:1900138,1,0.977401449455048,0,3,negative regulation of phospholipase A2 activity,BP,
18508,GO:1900139,1,0.999851577236668,0,1,negative regulation of arachidonic acid secretion,BP,
18509,GO:1900141,1,0.991419841055254,0,1,regulation of oligodendrocyte apoptotic process,BP,
18510,GO:1900142,1,0.991419841055254,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18511,GO:1900145,1,0.954790423294012,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18512,GO:1900146,1,0.976269144304919,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18513,GO:1900147,1,0.991657595160864,0,2,regulation of Schwann cell migration,BP,
18514,GO:1900148,1,0.991657600429728,0,1,negative regulation of Schwann cell migration,BP,
18515,GO:1900149,1,0.99999999638,0,1,positive regulation of Schwann cell migration,BP,
18516,GO:1900151,1,0.902531601524101,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18517,GO:1900152,1,0.988824331714101,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18518,GO:1900153,1,0.902531601524101,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18519,GO:1900154,1,0.986949499260859,0,2,regulation of bone trabecula formation,BP,
18520,GO:1900155,1,0.986949499260859,0,2,negative regulation of bone trabecula formation,BP,
18521,GO:1900157,1,0.976692334422796,0,3,regulation of bone mineralization involved in bone maturation,BP,
18522,GO:1900158,1,0.985729047440636,0,2,negative regulation of bone mineralization involved in bone maturation,BP,
18523,GO:1900159,1,0.9908334975736,0,1,positive regulation of bone mineralization involved in bone maturation,BP,
18524,GO:1900161,1,0.992731713030342,0,1,regulation of phospholipid scramblase activity,BP,
18525,GO:1900163,1,0.992731713030342,0,1,positive regulation of phospholipid scramblase activity,BP,
18526,GO:1900164,1,0.934631460971058,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18527,GO:1900165,1,0.958953925816948,0,8,negative regulation of interleukin-6 secretion,BP,
18528,GO:1900166,1,0.984542673639574,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18529,GO:1900168,1,0.984542673639574,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18530,GO:1900169,1,0.991657595192334,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18531,GO:1900170,1,0.991657600429728,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18532,GO:1900175,1,0.954790423294012,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18533,GO:1900176,1,0.976269144304919,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18535,GO:1900181,1,0.621601739538166,0,77,negative regulation of protein localization to nucleus,BP,
18536,GO:1900182,1,0.472442021820193,0,125,positive regulation of protein localization to nucleus,BP,
18537,GO:1900186,1,0.983785435481992,0,3,negative regulation of clathrin-dependent endocytosis,BP,
18538,GO:1900190,1,0.982566967774119,0,2,regulation of single-species biofilm formation,BP,
18539,GO:1900191,1,0.982566967774119,0,2,negative regulation of single-species biofilm formation,BP,
18540,GO:1900193,1,0.948543701774102,0,6,regulation of oocyte maturation,BP,
18541,GO:1900194,1,0.977251267157717,0,3,negative regulation of oocyte maturation,BP,
18542,GO:1900195,1,0.979597950973043,0,2,positive regulation of oocyte maturation,BP,
18543,GO:1900200,1,0.988852515460617,0,3,mesenchymal cell apoptotic process involved in metanephros development,BP,
18544,GO:1900204,1,0.996047050278914,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18545,GO:1900205,1,0.996047050278914,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18546,GO:1900208,1,0.987663454066629,0,1,regulation of cardiolipin metabolic process,BP,
18547,GO:1900210,1,0.987663454066629,0,1,positive regulation of cardiolipin metabolic process,BP,
18548,GO:1900211,1,0.988852515460617,0,3,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18549,GO:1900212,1,0.988852515460617,0,3,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18550,GO:1900214,1,0.996047050278914,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18551,GO:1900215,1,0.996047050278914,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18552,GO:1900217,1,0.996047050278914,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18553,GO:1900218,1,0.996047050278914,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18554,GO:1900220,1,0.999315027024743,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18555,GO:1900221,1,0.967989324348589,0,6,regulation of beta-amyloid clearance,BP,
18556,GO:1900222,1,0.987119677626054,0,3,negative regulation of beta-amyloid clearance,BP,
18557,GO:1900223,1,0.999999996377838,0,1,positive regulation of beta-amyloid clearance,BP,
18558,GO:1900224,1,0.989695271812014,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18559,GO:1900225,1,0.94548833197201,0,10,regulation of NLRP3 inflammasome complex assembly,BP,
18560,GO:1900226,1,0.972727199529443,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18561,GO:1900227,1,0.979507125063707,0,5,positive regulation of NLRP3 inflammasome complex assembly,BP,
18562,GO:1900228,1,0.982566967774119,0,2,regulation of single-species biofilm formation in or on host organism,BP,
18563,GO:1900229,1,0.982566967774119,0,2,negative regulation of single-species biofilm formation in or on host organism,BP,
18564,GO:1900234,1,0.997405358818918,0,1,regulation of Kit signaling pathway,BP,
18565,GO:1900235,1,0.997405358818918,0,1,negative regulation of Kit signaling pathway,BP,
18566,GO:1900238,1,0.985848237531077,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18567,GO:1900239,1,0.993154977323939,0,3,regulation of phenotypic switching,BP,
18568,GO:1900241,1,0.993154987272083,0,1,positive regulation of phenotypic switching,BP,
18569,GO:1900242,1,0.966054118328829,0,8,regulation of synaptic vesicle endocytosis,BP,
18570,GO:1900243,1,0.999941928579223,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18571,GO:1900244,1,0.988897318018753,0,3,positive regulation of synaptic vesicle endocytosis,BP,
18572,GO:1900245,1,0.980273413095507,0,4,positive regulation of MDA-5 signaling pathway,BP,
18573,GO:1900246,1,0.970650586397846,0,7,positive regulation of RIG-I signaling pathway,BP,
18574,GO:1900247,1,0.99999634217974,0,2,regulation of cytoplasmic translational elongation,BP,
18575,GO:1900248,1,0.99999634217974,0,2,negative regulation of cytoplasmic translational elongation,BP,
18576,GO:1900259,1,0.989047655932762,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18577,GO:1900260,1,0.989047655932762,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18578,GO:1900262,1,0.941673328570128,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18579,GO:1900264,1,0.941673328570128,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18580,GO:1900271,1,0.915178912168813,0,20,regulation of long-term synaptic potentiation,BP,
18581,GO:1900272,1,0.974806942538528,0,4,negative regulation of long-term synaptic potentiation,BP,
18582,GO:1900273,1,0.96674722144959,0,11,positive regulation of long-term synaptic potentiation,BP,
18584,GO:1900275,1,0.995849236158319,0,2,negative regulation of phospholipase C activity,BP,
18585,GO:1900276,1,0.995850945276373,0,1,regulation of proteinase activated receptor activity,BP,
18586,GO:1900279,1,0.996075298321824,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18587,GO:1900281,1,0.996075298321824,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18588,GO:1900363,1,0.946810553625133,0,10,regulation of mRNA polyadenylation,BP,
18589,GO:1900364,1,0.967769617619629,0,7,negative regulation of mRNA polyadenylation,BP,
18590,GO:1900365,1,0.989974982439103,0,2,positive regulation of mRNA polyadenylation,BP,
18591,GO:1900368,1,0.998068123496301,0,3,regulation of RNA interference,BP,
18592,GO:1900369,1,0.998092388515377,0,2,negative regulation of RNA interference,BP,
18593,GO:1900370,1,0.999975689365767,0,1,positive regulation of RNA interference,BP,
18595,GO:1900372,1,0.726773029042058,0,45,negative regulation of purine nucleotide biosynthetic process,BP,
18597,GO:1900376,1,0.967817048026787,0,7,regulation of secondary metabolite biosynthetic process,BP,
18598,GO:1900377,1,0.988291378458569,0,3,negative regulation of secondary metabolite biosynthetic process,BP,
18599,GO:1900378,1,0.979285027777385,0,4,positive regulation of secondary metabolite biosynthetic process,BP,
18600,GO:1900383,1,0.995024612024025,0,1,regulation of synaptic plasticity by receptor localization to synapse,BP,
18601,GO:1900387,1,0.989739168452463,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18602,GO:1900390,1,0.976705746146419,0,2,regulation of iron ion import,BP,
18603,GO:1900402,1,0.969013568519242,0,9,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18607,GO:1900424,1,0.89739626821881,0,14,regulation of defense response to bacterium,BP,
18608,GO:1900425,1,0.976847670627173,0,4,negative regulation of defense response to bacterium,BP,
18609,GO:1900426,1,0.913399568038273,0,9,positive regulation of defense response to bacterium,BP,
18610,GO:1900449,1,0.841436862035797,0,34,regulation of glutamate receptor signaling pathway,BP,
18611,GO:1900451,1,0.979034904207548,0,6,positive regulation of glutamate receptor signaling pathway,BP,
18612,GO:1900452,1,0.98890164328825,0,7,regulation of long term synaptic depression,BP,
18613,GO:1900453,1,0.992014621290929,0,2,negative regulation of long term synaptic depression,BP,
18614,GO:1900454,1,0.997189108747777,0,2,positive regulation of long term synaptic depression,BP,
18615,GO:1900477,1,0.989673458219995,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18616,GO:1900483,1,0.991816710779969,0,1,regulation of protein targeting to vacuolar membrane,BP,
18617,GO:1900533,1,0.988094796714652,0,1,palmitic acid metabolic process,BP,
18618,GO:1900535,1,0.988094796714652,0,1,palmitic acid biosynthetic process,BP,
18620,GO:1900543,1,0.635640247116975,0,65,negative regulation of purine nucleotide metabolic process,BP,
18622,GO:1900619,1,0.977695461909994,0,4,acetate ester metabolic process,BP,
18623,GO:1900620,1,0.991960643412997,0,2,acetate ester biosynthetic process,BP,
18624,GO:1900623,1,0.994852048920976,0,3,regulation of monocyte aggregation,BP,
18625,GO:1900625,1,0.994852048920976,0,3,positive regulation of monocyte aggregation,BP,
18626,GO:1900673,1,0.980975907004996,0,3,olefin metabolic process,BP,
18627,GO:1900719,1,0.999833560951617,0,1,regulation of uterine smooth muscle relaxation,BP,
18628,GO:1900721,1,0.999833560951617,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18629,GO:1900736,1,0.962845101476287,0,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18630,GO:1900737,1,0.995850945276373,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18631,GO:1900738,1,0.966857719432009,0,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18632,GO:1900739,1,0.805688271703811,0,29,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18633,GO:1900740,1,0.805688271703811,0,29,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18634,GO:1900744,1,0.863947224721711,0,28,regulation of p38MAPK cascade,BP,
18635,GO:1900745,1,0.899341621621421,0,18,positive regulation of p38MAPK cascade,BP,
18636,GO:1900746,1,0.947572442702019,0,10,regulation of vascular endothelial growth factor signaling pathway,BP,
18637,GO:1900747,1,0.976649980124787,0,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18638,GO:1900748,1,0.999623921289057,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18639,GO:1900750,1,0.891831762225164,0,12,oligopeptide binding,MF,
18640,GO:1900756,1,0.992470263737801,0,2,protein processing in phagocytic vesicle,BP,
18641,GO:1900757,1,0.987342847912289,0,1,regulation of D-amino-acid oxidase activity,BP,
18642,GO:1900758,1,0.987342847912289,0,1,negative regulation of D-amino-acid oxidase activity,BP,
18643,GO:1900825,1,0.969067295357403,0,5,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18644,GO:1900826,1,0.987800053657777,0,1,negative regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18645,GO:1900827,1,0.999999996395232,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18647,GO:1900920,1,0.999987400791499,0,2,regulation of L-glutamate import,BP,
18648,GO:1901004,1,0.98765659061407,0,1,ubiquinone-6 metabolic process,BP,
18649,GO:1901006,1,0.98765659061407,0,1,ubiquinone-6 biosynthetic process,BP,
18650,GO:1901016,1,0.80231409751473,0,41,regulation of potassium ion transmembrane transporter activity,BP,
18651,GO:1901017,1,0.923973069872786,0,14,negative regulation of potassium ion transmembrane transporter activity,BP,
18652,GO:1901018,1,0.930714706074584,0,14,positive regulation of potassium ion transmembrane transporter activity,BP,
18654,GO:1901020,1,0.782287656725399,0,30,negative regulation of calcium ion transmembrane transporter activity,BP,
18656,GO:1901026,1,0.984039558086247,0,4,ripoptosome assembly involved in necroptotic process,BP,
18657,GO:1901028,1,0.697204228351048,0,45,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18658,GO:1901029,1,0.934500530407561,0,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18659,GO:1901030,1,0.75476995527873,0,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18661,GO:1901032,1,0.89783495884981,0,16,negative regulation of response to reactive oxygen species,BP,
18663,GO:1901042,1,0.991743775026976,0,1,positive regulation of L-arginine import,BP,
18666,GO:1901068,1,0.741577763074769,0,46,guanosine-containing compound metabolic process,BP,
18667,GO:1901069,1,0.97609427654716,0,2,guanosine-containing compound catabolic process,BP,
18668,GO:1901070,1,0.863787493022401,0,13,guanosine-containing compound biosynthetic process,BP,
18669,GO:1901071,1,0.872606534914302,0,19,glucosamine-containing compound metabolic process,BP,
18670,GO:1901072,1,0.963866943995018,0,4,glucosamine-containing compound catabolic process,BP,
18671,GO:1901073,1,0.997305198173563,0,2,glucosamine-containing compound biosynthetic process,BP,
18672,GO:1901074,1,0.992237492908181,0,2,regulation of engulfment of apoptotic cell,BP,
18673,GO:1901076,1,0.999999996377838,0,1,positive regulation of engulfment of apoptotic cell,BP,
18674,GO:1901077,1,0.918774236397219,0,12,regulation of relaxation of muscle,BP,
18675,GO:1901078,1,0.975015765298672,0,4,negative regulation of relaxation of muscle,BP,
18676,GO:1901079,1,0.980362899385402,0,3,positive regulation of relaxation of muscle,BP,
18677,GO:1901080,1,0.999833560951617,0,1,regulation of relaxation of smooth muscle,BP,
18678,GO:1901082,1,0.999833560951617,0,1,positive regulation of relaxation of smooth muscle,BP,
18679,GO:1901086,1,0.999871944703624,0,1,benzylpenicillin metabolic process,BP,
18680,GO:1901090,1,0.983840246060317,0,2,regulation of protein tetramerization,BP,
18681,GO:1901091,1,0.983840246060317,0,2,negative regulation of protein tetramerization,BP,
18682,GO:1901093,1,0.983840246060317,0,2,regulation of protein homotetramerization,BP,
18683,GO:1901094,1,0.983840246060317,0,2,negative regulation of protein homotetramerization,BP,
18684,GO:1901096,1,0.96808813909808,0,9,regulation of autophagosome maturation,BP,
18685,GO:1901097,1,0.98573663283466,0,2,negative regulation of autophagosome maturation,BP,
18686,GO:1901098,1,0.984638384881397,0,6,positive regulation of autophagosome maturation,BP,
18687,GO:1901099,1,0.773503639343167,0,33,negative regulation of signal transduction in absence of ligand,BP,
18688,GO:1901128,1,0.990352852801268,0,1,gentamycin metabolic process,BP,
18692,GO:1901142,1,0.973651413669014,0,6,insulin metabolic process,BP,
18693,GO:1901143,1,0.995925850915489,0,2,insulin catabolic process,BP,
18694,GO:1901145,1,0.987049297979811,0,4,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18695,GO:1901146,1,0.992777141015238,0,1,mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis,BP,
18696,GO:1901147,1,0.996047050278914,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18697,GO:1901159,1,0.952643268976188,0,5,xylulose 5-phosphate biosynthetic process,BP,
18698,GO:1901160,1,0.922297970674864,0,13,primary amino compound metabolic process,BP,
18699,GO:1901162,1,0.959837028373487,0,4,primary amino compound biosynthetic process,BP,
18700,GO:1901163,1,0.929761976783777,0,8,regulation of trophoblast cell migration,BP,
18701,GO:1901164,1,0.954489834284693,0,5,negative regulation of trophoblast cell migration,BP,
18702,GO:1901165,1,0.974102553274377,0,3,positive regulation of trophoblast cell migration,BP,
18703,GO:1901166,1,0.981555280716375,0,4,neural crest cell migration involved in autonomic nervous system development,BP,
18705,GO:1901185,1,0.7346653105661,0,52,negative regulation of ERBB signaling pathway,BP,
18707,GO:1901187,1,0.990776520395688,0,2,regulation of ephrin receptor signaling pathway,BP,
18708,GO:1901189,1,0.990776525842959,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18709,GO:1901193,1,0.987481725945693,0,1,regulation of formation of translation preinitiation complex,BP,
18710,GO:1901194,1,0.987481725945693,0,1,negative regulation of formation of translation preinitiation complex,BP,
18711,GO:1901201,1,0.962645111258322,0,12,regulation of extracellular matrix assembly,BP,
18712,GO:1901202,1,0.990749209826666,0,1,negative regulation of extracellular matrix assembly,BP,
18713,GO:1901203,1,0.979725726601178,0,9,positive regulation of extracellular matrix assembly,BP,
18714,GO:1901204,1,0.999999992768772,0,2,regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18715,GO:1901205,1,0.999999992768772,0,2,negative regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18716,GO:1901206,1,0.999999996379559,0,1,positive regulation of adrenergic receptor signaling pathway involved in heart process,BP,
18717,GO:1901207,1,0.993576524614866,0,2,regulation of heart looping,BP,
18718,GO:1901208,1,0.995571878996637,0,1,negative regulation of heart looping,BP,
18719,GO:1901210,1,0.995571878996637,0,1,regulation of cardiac chamber formation,BP,
18720,GO:1901211,1,0.995571878996637,0,1,negative regulation of cardiac chamber formation,BP,
18721,GO:1901213,1,0.925074099626105,0,13,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18724,GO:1901216,1,0.666657150444425,0,67,positive regulation of neuron death,BP,
18725,GO:1901219,1,0.995571878996637,0,1,regulation of cardiac chamber morphogenesis,BP,
18726,GO:1901220,1,0.995571878996637,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18727,GO:1901222,1,0.702877816617894,0,52,regulation of NIK/NF-kappaB signaling,BP,
18728,GO:1901223,1,0.932890282960153,0,10,negative regulation of NIK/NF-kappaB signaling,BP,
18729,GO:1901224,1,0.760530024045611,0,39,positive regulation of NIK/NF-kappaB signaling,BP,
18730,GO:1901228,1,0.988893912739052,0,4,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18731,GO:1901229,1,0.991798445845593,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18732,GO:1901231,1,0.991798445845593,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18733,GO:1901232,1,0.991798445845593,0,1,regulation of convergent extension involved in axis elongation,BP,
18734,GO:1901233,1,0.991798445845593,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18735,GO:1901246,1,0.979770505753807,0,2,regulation of lung ciliated cell differentiation,BP,
18736,GO:1901247,1,0.987667601272536,0,1,negative regulation of lung ciliated cell differentiation,BP,
18737,GO:1901248,1,0.992005081113284,0,1,positive regulation of lung ciliated cell differentiation,BP,
18738,GO:1901249,1,0.987667601272536,0,1,regulation of lung goblet cell differentiation,BP,
18739,GO:1901251,1,0.987667601272536,0,1,positive regulation of lung goblet cell differentiation,BP,
18740,GO:1901252,1,0.976711939815643,0,3,regulation of intracellular transport of viral material,BP,
18741,GO:1901253,1,0.97765188103041,0,2,negative regulation of intracellular transport of viral material,BP,
18742,GO:1901254,1,0.999038748781858,0,1,positive regulation of intracellular transport of viral material,BP,
18743,GO:1901255,1,0.988211570435686,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18744,GO:1901256,1,0.972055728329399,0,4,regulation of macrophage colony-stimulating factor production,BP,
18745,GO:1901257,1,0.990624122034123,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18746,GO:1901258,1,0.98479782711203,0,2,positive regulation of macrophage colony-stimulating factor production,BP,
18749,GO:1901269,1,0.987192131992394,0,1,lipooligosaccharide metabolic process,BP,
18750,GO:1901271,1,0.987192131992394,0,1,lipooligosaccharide biosynthetic process,BP,
18751,GO:1901291,1,0.989113028430245,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18754,GO:1901295,1,0.979650879079118,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18755,GO:1901296,1,0.988771600271842,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18756,GO:1901297,1,0.990776525842959,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18757,GO:1901298,1,0.933440340602521,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18758,GO:1901299,1,0.95705072635024,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18759,GO:1901300,1,0.975338549673949,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18760,GO:1901301,1,0.991811910380947,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18761,GO:1901303,1,0.992368855453696,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18762,GO:1901304,1,0.98848070233315,0,1,regulation of spermidine biosynthetic process,BP,
18763,GO:1901307,1,0.98848070233315,0,1,positive regulation of spermidine biosynthetic process,BP,
18764,GO:1901314,1,0.990950517501128,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18765,GO:1901315,1,0.990950517501128,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18768,GO:1901320,1,0.993409576390941,0,1,negative regulation of heart induction,BP,
18769,GO:1901321,1,0.976424478857125,0,2,positive regulation of heart induction,BP,
18770,GO:1901337,1,0.992116285519845,0,1,thioester transport,BP,
18771,GO:1901338,1,0.837101978769615,0,19,catecholamine binding,MF,
18772,GO:1901339,1,0.978244801098707,0,6,regulation of store-operated calcium channel activity,BP,
18773,GO:1901340,1,0.998460128225409,0,1,negative regulation of store-operated calcium channel activity,BP,
18774,GO:1901341,1,0.985180133731779,0,4,positive regulation of store-operated calcium channel activity,BP,
18775,GO:1901342,1,0.24459751028615,0,230,regulation of vasculature development,BP,
18776,GO:1901343,1,0.63636626169378,0,79,negative regulation of vasculature development,BP,
18777,GO:1901344,1,0.98767316499071,0,1,response to leptomycin B,BP,
18778,GO:1901350,1,0.999999996379063,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18779,GO:1901355,1,0.989971170114803,0,2,response to rapamycin,BP,
18784,GO:1901373,1,0.987886501186532,0,1,lipid hydroperoxide transport,BP,
18785,GO:1901374,1,0.939911546652339,0,7,acetate ester transport,BP,
18786,GO:1901375,1,0.971660905364249,0,3,acetate ester transmembrane transporter activity,MF,
18787,GO:1901376,1,0.990566313287312,0,1,organic heteropentacyclic compound metabolic process,BP,
18788,GO:1901379,1,0.714885164991284,0,62,regulation of potassium ion transmembrane transport,BP,
18789,GO:1901380,1,0.904239895453192,0,17,negative regulation of potassium ion transmembrane transport,BP,
18790,GO:1901381,1,0.884953200364529,0,26,positive regulation of potassium ion transmembrane transport,BP,
18791,GO:1901382,1,0.981613736613632,0,4,regulation of chorionic trophoblast cell proliferation,BP,
18792,GO:1901383,1,0.989695271802747,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18793,GO:1901385,1,0.790952828401387,0,32,regulation of voltage-gated calcium channel activity,BP,
18794,GO:1901386,1,0.891172063095823,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18795,GO:1901387,1,0.955895942538113,0,7,positive regulation of voltage-gated calcium channel activity,BP,
18796,GO:1901388,1,0.99158991158068,0,1,regulation of transforming growth factor beta activation,BP,
18797,GO:1901389,1,0.99158991158068,0,1,negative regulation of transforming growth factor beta activation,BP,
18798,GO:1901407,1,0.930930053303609,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18799,GO:1901409,1,0.931139944259779,0,8,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18800,GO:1901419,1,0.99899806074031,0,1,regulation of response to alcohol,BP,
18801,GO:1901421,1,0.99899806074031,0,1,positive regulation of response to alcohol,BP,
18802,GO:1901474,1,0.956503317380505,0,6,azole transmembrane transporter activity,MF,
18803,GO:1901475,1,0.971568363154374,0,4,pyruvate transmembrane transport,BP,
18804,GO:1901476,1,0.742961387222609,0,41,carbohydrate transporter activity,MF,
18805,GO:1901490,1,0.983554999526772,0,5,regulation of lymphangiogenesis,BP,
18806,GO:1901491,1,0.993807273866964,0,3,negative regulation of lymphangiogenesis,BP,
18807,GO:1901492,1,0.989684351602495,0,2,positive regulation of lymphangiogenesis,BP,
18808,GO:1901503,1,0.980306577289443,0,4,ether biosynthetic process,BP,
18810,GO:1901509,1,0.981270602429937,0,4,regulation of endothelial tube morphogenesis,BP,
18811,GO:1901522,1,0.859931391752302,0,26,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
18812,GO:1901523,1,0.957155801490691,0,5,icosanoid catabolic process,BP,
18813,GO:1901524,1,0.949171991967662,0,12,regulation of macromitophagy,BP,
18814,GO:1901525,1,0.995050090659567,0,3,negative regulation of macromitophagy,BP,
18815,GO:1901526,1,0.953895476104615,0,9,positive regulation of macromitophagy,BP,
18816,GO:1901529,1,0.998241558711531,0,3,positive regulation of anion channel activity,BP,
18817,GO:1901532,1,0.9065239635421,0,16,regulation of hematopoietic progenitor cell differentiation,BP,
18818,GO:1901533,1,0.941955180621121,0,7,negative regulation of hematopoietic progenitor cell differentiation,BP,
18819,GO:1901534,1,0.993863176492031,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18820,GO:1901535,1,0.975264123360878,0,3,regulation of DNA demethylation,BP,
18821,GO:1901536,1,0.975264123360878,0,3,negative regulation of DNA demethylation,BP,
18822,GO:1901538,1,0.958363345161811,0,7,changes to DNA methylation involved in embryo development,BP,
18823,GO:1901545,1,0.993838121320329,0,1,response to raffinose,BP,
18824,GO:1901550,1,0.936086211022621,0,12,regulation of endothelial cell development,BP,
18825,GO:1901551,1,0.998648243325891,0,1,negative regulation of endothelial cell development,BP,
18826,GO:1901552,1,0.971471169120586,0,5,positive regulation of endothelial cell development,BP,
18827,GO:1901555,1,0.999999996378359,0,1,response to paclitaxel,BP,
18828,GO:1901557,1,0.998041284082169,0,1,response to fenofibrate,BP,
18829,GO:1901558,1,0.988934114156686,0,2,response to metformin,BP,
18830,GO:1901561,1,0.997224430538685,0,1,response to benomyl,BP,
18831,GO:1901563,1,0.986527134907925,0,4,response to camptothecin,BP,
18835,GO:1901567,1,0.934485374110175,0,6,fatty acid derivative binding,MF,
18837,GO:1901569,1,0.957155801490691,0,5,fatty acid derivative catabolic process,BP,
18839,GO:1901571,1,0.701861285934986,0,45,fatty acid derivative transport,BP,
18842,GO:1901580,1,0.999999996401411,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18843,GO:1901581,1,0.999999996401411,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18844,GO:1901582,1,0.999999996401411,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18845,GO:1901585,1,0.992892219366774,0,1,regulation of acid-sensing ion channel activity,BP,
18846,GO:1901594,1,0.998479269538922,0,1,response to capsazepine,BP,
18850,GO:1901608,1,0.987739993295648,0,1,regulation of vesicle transport along microtubule,BP,
18851,GO:1901609,1,0.987739993295648,0,1,negative regulation of vesicle transport along microtubule,BP,
18852,GO:1901611,1,0.944131997865268,0,7,phosphatidylglycerol binding,MF,
18853,GO:1901612,1,0.957188933727699,0,5,cardiolipin binding,MF,
18855,GO:1901616,1,0.61725963816634,0,62,organic hydroxy compound catabolic process,BP,
18858,GO:1901620,1,0.956454711682042,0,8,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18859,GO:1901621,1,0.973185440291868,0,6,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18860,GO:1901622,1,0.991761977835266,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18861,GO:1901623,1,0.835508264612669,0,20,regulation of lymphocyte chemotaxis,BP,
18862,GO:1901624,1,0.966490321211099,0,4,negative regulation of lymphocyte chemotaxis,BP,
18863,GO:1901625,1,0.991657600429728,0,1,cellular response to ergosterol,BP,
18864,GO:1901626,1,0.935087297259974,0,9,regulation of postsynaptic membrane organization,BP,
18865,GO:1901627,1,0.990686461621172,0,1,negative regulation of postsynaptic membrane organization,BP,
18866,GO:1901628,1,0.967172868751082,0,4,positive regulation of postsynaptic membrane organization,BP,
18867,GO:1901629,1,0.987537361293892,0,2,regulation of presynaptic membrane organization,BP,
18868,GO:1901630,1,0.987537367367283,0,1,negative regulation of presynaptic membrane organization,BP,
18869,GO:1901631,1,0.999999996384591,0,1,positive regulation of presynaptic membrane organization,BP,
18870,GO:1901639,1,0.999999996372751,0,1,XDP catabolic process,BP,
18871,GO:1901640,1,0.999999996372751,0,1,XTP binding,MF,
18872,GO:1901641,1,0.999999996372751,0,1,ITP binding,MF,
18873,GO:1901642,1,0.938328093964199,0,7,nucleoside transmembrane transport,BP,
18878,GO:1901656,1,0.989715094729133,0,2,glycoside transport,BP,
18881,GO:1901659,1,0.62256578784605,0,49,glycosyl compound biosynthetic process,BP,
18882,GO:1901660,1,0.980585016803649,0,6,calcium ion export,BP,
18883,GO:1901661,1,0.732097303994759,0,30,quinone metabolic process,BP,
18884,GO:1901662,1,0.973183800234778,0,3,quinone catabolic process,BP,
18885,GO:1901663,1,0.874718316519291,0,13,quinone biosynthetic process,BP,
18886,GO:1901664,1,0.977950434949313,0,2,regulation of NAD+ ADP-ribosyltransferase activity,BP,
18887,GO:1901666,1,0.977950434949313,0,2,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
18890,GO:1901673,1,0.893709924998498,0,14,regulation of mitotic spindle assembly,BP,
18891,GO:1901674,1,0.997797154390557,0,2,regulation of histone H3-K27 acetylation,BP,
18892,GO:1901675,1,0.999999996376846,0,1,negative regulation of histone H3-K27 acetylation,BP,
18893,GO:1901676,1,0.997797158450476,0,1,positive regulation of histone H3-K27 acetylation,BP,
18894,GO:1901677,1,0.891485016822287,0,18,phosphate transmembrane transporter activity,MF,
18895,GO:1901678,1,0.91980578325003,0,12,iron coordination entity transport,BP,
18896,GO:1901679,1,0.946509980420368,0,7,nucleotide transmembrane transport,BP,
18897,GO:1901680,1,0.999999996393668,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
18899,GO:1901682,1,0.848688866011693,0,30,sulfur compound transmembrane transporter activity,MF,
18900,GO:1901684,1,0.990352852801268,0,1,arsenate ion transmembrane transport,BP,
18907,GO:1901702,1,0.906458067953575,0,10,salt transmembrane transporter activity,MF,
18908,GO:1901706,1,0.991789321085594,0,1,mesenchymal cell differentiation involved in bone development,BP,
18909,GO:1901707,1,0.98767316499071,0,1,leptomycin B binding,MF,
18910,GO:1901722,1,0.905993605777113,0,13,regulation of cell proliferation involved in kidney development,BP,
18911,GO:1901723,1,0.955493799998557,0,6,negative regulation of cell proliferation involved in kidney development,BP,
18912,GO:1901724,1,0.948212341966108,0,7,positive regulation of cell proliferation involved in kidney development,BP,
18913,GO:1901725,1,0.978958055281529,0,7,regulation of histone deacetylase activity,BP,
18914,GO:1901726,1,0.999999996400188,0,1,negative regulation of histone deacetylase activity,BP,
18915,GO:1901727,1,0.980441290836677,0,5,positive regulation of histone deacetylase activity,BP,
18916,GO:1901738,1,0.995571878996637,0,1,regulation of vitamin A metabolic process,BP,
18917,GO:1901739,1,0.822121423165798,0,20,regulation of myoblast fusion,BP,
18918,GO:1901740,1,0.976925519243706,0,2,negative regulation of myoblast fusion,BP,
18919,GO:1901741,1,0.841566365149114,0,18,positive regulation of myoblast fusion,BP,
18920,GO:1901748,1,0.991388739056542,0,1,leukotriene D4 metabolic process,BP,
18921,GO:1901750,1,0.991388739056542,0,1,leukotriene D4 biosynthetic process,BP,
18922,GO:1901751,1,0.990808137278926,0,1,leukotriene A4 metabolic process,BP,
18923,GO:1901796,1,0.359175226786322,0,163,regulation of signal transduction by p53 class mediator,BP,
18924,GO:1901797,1,0.812472948360662,0,27,negative regulation of signal transduction by p53 class mediator,BP,
18925,GO:1901798,1,0.880359514717225,0,19,positive regulation of signal transduction by p53 class mediator,BP,
18926,GO:1901799,1,0.812904832879342,0,31,negative regulation of proteasomal protein catabolic process,BP,
18927,GO:1901800,1,0.556720284440201,0,90,positive regulation of proteasomal protein catabolic process,BP,
18928,GO:1901804,1,0.990969801322254,0,1,beta-glucoside metabolic process,BP,
18929,GO:1901805,1,0.990969801322254,0,1,beta-glucoside catabolic process,BP,
18930,GO:1901834,1,0.988600021793749,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18931,GO:1901835,1,0.988600021793749,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18932,GO:1901836,1,0.931718717243458,0,10,regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18933,GO:1901837,1,0.97930759444434,0,2,negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18934,GO:1901838,1,0.951413448902163,0,8,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,BP,
18935,GO:1901841,1,0.941853689440914,0,10,regulation of high voltage-gated calcium channel activity,BP,
18936,GO:1901843,1,0.988904175809118,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
18937,GO:1901844,1,0.948177492113278,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
18938,GO:1901846,1,0.999286630435655,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
18939,GO:1901856,1,0.977948155845136,0,3,negative regulation of cellular respiration,BP,
18940,GO:1901857,1,0.946495180895743,0,6,positive regulation of cellular respiration,BP,
18941,GO:1901858,1,0.970083438934474,0,6,regulation of mitochondrial DNA metabolic process,BP,
18942,GO:1901859,1,0.987851791964428,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
18943,GO:1901860,1,0.98766344800805,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
18946,GO:1901863,1,0.718708994776566,0,64,positive regulation of muscle tissue development,BP,
18947,GO:1901873,1,0.999999996376584,0,1,regulation of post-translational protein modification,BP,
18948,GO:1901874,1,0.999999996376584,0,1,negative regulation of post-translational protein modification,BP,
18949,GO:1901876,1,0.975870160021411,0,2,regulation of calcium ion binding,BP,
18950,GO:1901877,1,0.975870160021411,0,2,negative regulation of calcium ion binding,BP,
18953,GO:1901881,1,0.908719841910822,0,14,positive regulation of protein depolymerization,BP,
18954,GO:1901888,1,0.721695109591946,0,73,regulation of cell junction assembly,BP,
18955,GO:1901889,1,0.942863706044844,0,19,negative regulation of cell junction assembly,BP,
18956,GO:1901890,1,0.863441752042431,0,30,positive regulation of cell junction assembly,BP,
18958,GO:1901895,1,0.986154585813664,0,2,negative regulation of calcium-transporting ATPase activity,BP,
18960,GO:1901897,1,0.96377989565958,0,7,regulation of relaxation of cardiac muscle,BP,
18961,GO:1901898,1,0.998818092848872,0,2,negative regulation of relaxation of cardiac muscle,BP,
18962,GO:1901899,1,0.980526126474018,0,2,positive regulation of relaxation of cardiac muscle,BP,
18963,GO:1901906,1,0.968037406610311,0,4,diadenosine pentaphosphate metabolic process,BP,
18964,GO:1901907,1,0.968037406610311,0,4,diadenosine pentaphosphate catabolic process,BP,
18965,GO:1901908,1,0.968037406610311,0,4,diadenosine hexaphosphate metabolic process,BP,
18966,GO:1901909,1,0.968037406610311,0,4,diadenosine hexaphosphate catabolic process,BP,
18967,GO:1901910,1,0.968037406610311,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
18968,GO:1901911,1,0.968037406610311,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
18969,GO:1901962,1,0.990243205478651,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
18970,GO:1901963,1,0.984545845604063,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
18971,GO:1901964,1,0.988714122281553,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
18972,GO:1901970,1,0.973661253766844,0,6,positive regulation of mitotic sister chromatid separation,BP,
18973,GO:1901976,1,0.794222857999679,0,31,regulation of cell cycle checkpoint,BP,
18974,GO:1901977,1,0.955216980734423,0,5,negative regulation of cell cycle checkpoint,BP,
18975,GO:1901978,1,0.940488466205588,0,9,positive regulation of cell cycle checkpoint,BP,
18976,GO:1901979,1,0.97951182558667,0,2,regulation of inward rectifier potassium channel activity,BP,
18978,GO:1901983,1,0.663498322032543,0,61,regulation of protein acetylation,BP,
18979,GO:1901984,1,0.856923995974345,0,22,negative regulation of protein acetylation,BP,
18980,GO:1901985,1,0.792361468558218,0,34,positive regulation of protein acetylation,BP,
18981,GO:1901986,1,0.987857176997207,0,1,response to ketamine,BP,
18984,GO:1901989,1,0.643785213890601,0,66,positive regulation of cell cycle phase transition,BP,
18987,GO:1901992,1,0.682900141624719,0,59,positive regulation of mitotic cell cycle phase transition,BP,
18988,GO:1901993,1,0.9548231473692,0,5,regulation of meiotic cell cycle phase transition,BP,
18989,GO:1901994,1,0.962858094277788,0,4,negative regulation of meiotic cell cycle phase transition,BP,
18990,GO:1901995,1,0.991657600429728,0,1,positive regulation of meiotic cell cycle phase transition,BP,
18993,GO:1902003,1,0.957227343685036,0,10,regulation of beta-amyloid formation,BP,
18994,GO:1902004,1,0.973012905253559,0,5,positive regulation of beta-amyloid formation,BP,
18995,GO:1902010,1,0.996070804472539,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
18996,GO:1902017,1,0.796689338602863,0,42,regulation of cilium assembly,BP,
18997,GO:1902018,1,0.956652243682463,0,9,negative regulation of cilium assembly,BP,
18998,GO:1902019,1,0.960383716109568,0,5,regulation of cilium-dependent cell motility,BP,
18999,GO:1902022,1,0.97134150757555,0,4,L-lysine transport,BP,
19000,GO:1902023,1,0.977427442977545,0,4,L-arginine transport,BP,
19001,GO:1902024,1,0.983970861356623,0,2,L-histidine transport,BP,
19002,GO:1902031,1,0.949306987679001,0,6,regulation of NADP metabolic process,BP,
19003,GO:1902033,1,0.956505805878545,0,7,regulation of hematopoietic stem cell proliferation,BP,
19004,GO:1902035,1,0.968253902801137,0,5,positive regulation of hematopoietic stem cell proliferation,BP,
19005,GO:1902036,1,0.966344480569596,0,6,regulation of hematopoietic stem cell differentiation,BP,
19006,GO:1902037,1,0.977851490420944,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19007,GO:1902038,1,0.995862366387371,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19011,GO:1902044,1,0.990169423976164,0,2,regulation of Fas signaling pathway,BP,
19012,GO:1902045,1,0.990766010795186,0,1,negative regulation of Fas signaling pathway,BP,
19013,GO:1902047,1,0.963204775369315,0,4,polyamine transmembrane transport,BP,
19014,GO:1902065,1,0.94386611093368,0,9,response to L-glutamate,BP,
19015,GO:1902071,1,0.987535078683988,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19016,GO:1902073,1,0.987535078683988,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19017,GO:1902074,1,0.888007278176986,0,14,response to salt,BP,
19018,GO:1902075,1,0.951815310212611,0,5,cellular response to salt,BP,
19019,GO:1902076,1,0.99999999640376,0,1,regulation of lateral motor column neuron migration,BP,
19020,GO:1902078,1,0.99999999640376,0,1,positive regulation of lateral motor column neuron migration,BP,
19021,GO:1902080,1,0.979498605089144,0,2,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19022,GO:1902081,1,0.979498605089144,0,2,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19023,GO:1902083,1,0.990000621527998,0,4,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19024,GO:1902093,1,0.925479510076429,0,7,positive regulation of flagellated sperm motility,BP,
19025,GO:1902098,1,0.999575264954682,0,1,calcitriol binding,MF,
19026,GO:1902099,1,0.737167209050615,0,45,regulation of metaphase/anaphase transition of cell cycle,BP,
19027,GO:1902100,1,0.802532800586702,0,31,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19028,GO:1902101,1,0.973661253766844,0,6,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19029,GO:1902102,1,0.981371220263603,0,2,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19030,GO:1902103,1,0.981371220263603,0,2,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19036,GO:1902110,1,0.651334729240096,0,54,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19038,GO:1902116,1,0.843757141163553,0,29,negative regulation of organelle assembly,BP,
19039,GO:1902117,1,0.771815640135635,0,57,positive regulation of organelle assembly,BP,
19040,GO:1902118,1,0.988722668707618,0,1,calcidiol binding,MF,
19041,GO:1902121,1,0.999575264954682,0,1,lithocholic acid binding,MF,
19042,GO:1902122,1,0.989936963505739,0,1,chenodeoxycholic acid binding,MF,
19043,GO:1902159,1,0.987242906408347,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19044,GO:1902161,1,0.999999996373532,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19045,GO:1902162,1,0.977984857845162,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19046,GO:1902164,1,0.977984857845162,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19047,GO:1902165,1,0.867499342526553,0,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19048,GO:1902166,1,0.884520176331437,0,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19049,GO:1902167,1,0.987171617364576,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19050,GO:1902170,1,0.882535272000835,0,19,cellular response to reactive nitrogen species,BP,
19051,GO:1902172,1,0.952685070955317,0,6,regulation of keratinocyte apoptotic process,BP,
19052,GO:1902173,1,0.994630564273451,0,1,negative regulation of keratinocyte apoptotic process,BP,
19053,GO:1902174,1,0.974886107933365,0,3,positive regulation of keratinocyte apoptotic process,BP,
19056,GO:1902177,1,0.955550531562024,0,6,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19057,GO:1902178,1,0.998880289974206,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
19058,GO:1902186,1,0.83357009591118,0,31,regulation of viral release from host cell,BP,
19059,GO:1902187,1,0.926456113596511,0,15,negative regulation of viral release from host cell,BP,
19060,GO:1902188,1,0.904005640189435,0,15,positive regulation of viral release from host cell,BP,
19061,GO:1902202,1,0.973255614082774,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19062,GO:1902203,1,0.999808721367601,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19063,GO:1902204,1,0.989433939482021,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19064,GO:1902205,1,0.988498849455759,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19065,GO:1902206,1,0.988498849455759,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19066,GO:1902211,1,0.980251644498302,0,2,regulation of prolactin signaling pathway,BP,
19067,GO:1902212,1,0.988498849455759,0,1,negative regulation of prolactin signaling pathway,BP,
19068,GO:1902213,1,0.991657600429728,0,1,positive regulation of prolactin signaling pathway,BP,
19069,GO:1902214,1,0.977277862981542,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
19070,GO:1902215,1,0.988498849455759,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19071,GO:1902216,1,0.988649491188727,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
19072,GO:1902217,1,0.987735473159644,0,1,erythrocyte apoptotic process,BP,
19073,GO:1902218,1,0.971953052646822,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19074,GO:1902219,1,0.98430851129342,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19075,GO:1902220,1,0.98744914291305,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19079,GO:1902225,1,0.991657600429728,0,1,negative regulation of acrosome reaction,BP,
19080,GO:1902226,1,0.967984026244245,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19081,GO:1902227,1,0.976700267596906,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19082,GO:1902228,1,0.991077486541396,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19083,GO:1902229,1,0.723815144200265,0,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19084,GO:1902230,1,0.784304261650349,0,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19085,GO:1902231,1,0.929040330455135,0,8,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19086,GO:1902232,1,0.980880477671773,0,2,regulation of positive thymic T cell selection,BP,
19087,GO:1902233,1,0.988498849455759,0,1,negative regulation of positive thymic T cell selection,BP,
19088,GO:1902235,1,0.801694766382447,0,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19089,GO:1902236,1,0.882280243871364,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19090,GO:1902237,1,0.920391438231971,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19091,GO:1902238,1,0.99863054261301,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19092,GO:1902239,1,0.99863054261301,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19093,GO:1902250,1,0.987735473159644,0,1,regulation of erythrocyte apoptotic process,BP,
19094,GO:1902251,1,0.987735473159644,0,1,negative regulation of erythrocyte apoptotic process,BP,
19095,GO:1902253,1,0.816367748901901,0,24,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19096,GO:1902254,1,0.87400011327374,0,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19097,GO:1902255,1,0.951784801217723,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19098,GO:1902256,1,0.984260602944353,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19099,GO:1902257,1,0.984334558761702,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19100,GO:1902259,1,0.912042083549094,0,15,regulation of delayed rectifier potassium channel activity,BP,
19101,GO:1902260,1,0.950900062662587,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19102,GO:1902261,1,0.984515726174523,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19103,GO:1902262,1,0.961783163913307,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19104,GO:1902263,1,0.987019861707386,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19105,GO:1902267,1,0.963204775369315,0,4,regulation of polyamine transmembrane transport,BP,
19106,GO:1902268,1,0.96432497651812,0,3,negative regulation of polyamine transmembrane transport,BP,
19107,GO:1902269,1,0.998838697547898,0,1,positive regulation of polyamine transmembrane transport,BP,
19108,GO:1902271,1,0.988302683665002,0,2,D3 vitamins binding,MF,
19109,GO:1902275,1,0.445884590673997,0,154,regulation of chromatin organization,BP,
19110,GO:1902282,1,0.942225609430117,0,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19111,GO:1902283,1,0.998142609797833,0,1,negative regulation of primary amine oxidase activity,BP,
19112,GO:1902284,1,0.950501621395086,0,21,neuron projection extension involved in neuron projection guidance,BP,
19113,GO:1902285,1,0.983326967691169,0,6,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19114,GO:1902287,1,0.983352800530488,0,5,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19115,GO:1902292,1,0.987538515029981,0,1,cell cycle DNA replication initiation,BP,
19116,GO:1902294,1,0.991657600429728,0,1,cell cycle DNA replication termination,BP,
19117,GO:1902296,1,0.995153211839766,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19118,GO:1902298,1,0.990292850721077,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19119,GO:1902299,1,0.980887951317669,0,2,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19120,GO:1902302,1,0.975693696696625,0,5,regulation of potassium ion export,BP,
19121,GO:1902303,1,0.988782204104944,0,2,negative regulation of potassium ion export,BP,
19122,GO:1902304,1,0.986922387121366,0,2,positive regulation of potassium ion export,BP,
19124,GO:1902306,1,0.945469335986082,0,11,negative regulation of sodium ion transmembrane transport,BP,
19126,GO:1902308,1,0.968159354382425,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19127,GO:1902309,1,0.988606619669105,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19128,GO:1902310,1,0.979318951586666,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19130,GO:1902315,1,0.987538515029981,0,1,nuclear cell cycle DNA replication initiation,BP,
19131,GO:1902317,1,0.991657600429728,0,1,nuclear DNA replication termination,BP,
19132,GO:1902319,1,0.995153211839766,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19133,GO:1902336,1,0.987566503022702,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19134,GO:1902337,1,0.957411465065211,0,10,regulation of apoptotic process involved in morphogenesis,BP,
19135,GO:1902338,1,0.971585141688999,0,6,negative regulation of apoptotic process involved in morphogenesis,BP,
19136,GO:1902339,1,0.985489173324558,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
19137,GO:1902340,1,0.979813889660978,0,2,negative regulation of chromosome condensation,BP,
19138,GO:1902356,1,0.989035033890079,0,1,oxaloacetate(2-) transmembrane transport,BP,
19139,GO:1902358,1,0.937403986559108,0,13,sulfate transmembrane transport,BP,
19140,GO:1902359,1,0.981999441152937,0,2,Notch signaling pathway involved in somitogenesis,BP,
19141,GO:1902361,1,0.975179379573793,0,3,mitochondrial pyruvate transmembrane transport,BP,
19142,GO:1902362,1,0.992777141015238,0,1,melanocyte apoptotic process,BP,
19143,GO:1902366,1,0.981999441152937,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19144,GO:1902367,1,0.981999441152937,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19145,GO:1902369,1,0.961164204262954,0,10,negative regulation of RNA catabolic process,BP,
19146,GO:1902373,1,0.969252104816069,0,8,negative regulation of mRNA catabolic process,BP,
19147,GO:1902378,1,0.991322336389918,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19148,GO:1902379,1,0.999999996371578,0,1,chemoattractant activity involved in axon guidance,MF,
19149,GO:1902380,1,0.991051548276411,0,1,positive regulation of endoribonuclease activity,BP,
19150,GO:1902396,1,0.997769351005497,0,1,protein localization to bicellular tight junction,BP,
19151,GO:1902400,1,0.639899965536829,0,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19152,GO:1902402,1,0.635839728222156,0,61,signal transduction involved in mitotic DNA damage checkpoint,BP,
19153,GO:1902403,1,0.635839728222156,0,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19154,GO:1902410,1,0.960428353378123,0,6,mitotic cytokinetic process,BP,
19155,GO:1902412,1,0.984929918090051,0,3,regulation of mitotic cytokinesis,BP,
19156,GO:1902414,1,0.976431584942918,0,8,protein localization to cell junction,BP,
19157,GO:1902415,1,0.935230698018977,0,9,regulation of mRNA binding,BP,
19158,GO:1902416,1,0.952084467160737,0,7,positive regulation of mRNA binding,BP,
19159,GO:1902423,1,0.989940756060877,0,1,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19160,GO:1902425,1,0.989940756060877,0,1,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19161,GO:1902426,1,0.992204790093199,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19162,GO:1902430,1,0.968555654810488,0,6,negative regulation of beta-amyloid formation,BP,
19163,GO:1902442,1,0.997137729107151,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19164,GO:1902443,1,0.997137729107151,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19165,GO:1902444,1,0.987547193311655,0,1,riboflavin binding,MF,
19166,GO:1902445,1,0.965233620659447,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19167,GO:1902455,1,0.96785212078341,0,6,negative regulation of stem cell population maintenance,BP,
19168,GO:1902459,1,0.983055977567487,0,5,positive regulation of stem cell population maintenance,BP,
19169,GO:1902460,1,0.999397164079137,0,1,regulation of mesenchymal stem cell proliferation,BP,
19170,GO:1902462,1,0.999397164079137,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19171,GO:1902463,1,0.964672156719279,0,3,protein localization to cell leading edge,BP,
19172,GO:1902464,1,0.999111091929371,0,1,regulation of histone H3-K27 trimethylation,BP,
19173,GO:1902466,1,0.999111091929371,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19174,GO:1902473,1,0.979433429522504,0,7,regulation of protein localization to synapse,BP,
19175,GO:1902474,1,0.979433429522504,0,7,positive regulation of protein localization to synapse,BP,
19178,GO:1902480,1,0.991064510071497,0,1,protein localization to mitotic spindle,BP,
19179,GO:1902488,1,0.999999996388895,0,1,cholangiocyte apoptotic process,BP,
19180,GO:1902490,1,0.989332793388196,0,1,regulation of sperm capacitation,BP,
19181,GO:1902493,1,0.56499801149402,0,88,acetyltransferase complex,CC,
19184,GO:1902498,1,0.993002872678395,0,4,regulation of protein autoubiquitination,BP,
19185,GO:1902499,1,0.993002882681095,0,2,positive regulation of protein autoubiquitination,BP,
19186,GO:1902504,1,0.99367726678093,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19187,GO:1902510,1,0.936506195421778,0,7,regulation of apoptotic DNA fragmentation,BP,
19188,GO:1902511,1,0.992368855453696,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19189,GO:1902512,1,0.965127933741293,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19190,GO:1902513,1,0.974278945589624,0,4,regulation of organelle transport along microtubule,BP,
19191,GO:1902514,1,0.97450600202966,0,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19192,GO:1902523,1,0.99093744173332,0,2,positive regulation of protein K63-linked ubiquitination,BP,
19194,GO:1902525,1,0.957896508038808,0,5,regulation of protein monoubiquitination,BP,
19195,GO:1902527,1,0.960790216070771,0,4,positive regulation of protein monoubiquitination,BP,
19196,GO:1902528,1,0.999999996386885,0,1,regulation of protein linear polyubiquitination,BP,
19197,GO:1902530,1,0.999999996386885,0,1,positive regulation of protein linear polyubiquitination,BP,
19201,GO:1902534,1,0.999999671031117,0,1,single-organism membrane invagination,BP,
19202,GO:1902544,1,0.982274506649808,0,2,regulation of DNA N-glycosylase activity,BP,
19203,GO:1902546,1,0.987262555038096,0,1,positive regulation of DNA N-glycosylase activity,BP,
19204,GO:1902547,1,0.947391104731138,0,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19205,GO:1902548,1,0.976463128256225,0,5,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19208,GO:1902559,1,0.979278681465154,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19209,GO:1902560,1,0.977207284934417,0,2,GMP reductase complex,CC,
19210,GO:1902562,1,0.787272082216207,0,34,H4 histone acetyltransferase complex,CC,
19211,GO:1902563,1,0.977467785182644,0,6,regulation of neutrophil activation,BP,
19212,GO:1902564,1,0.988980337717916,0,3,negative regulation of neutrophil activation,BP,
19213,GO:1902565,1,0.998490135981731,0,1,positive regulation of neutrophil activation,BP,
19214,GO:1902566,1,0.961955498522925,0,4,regulation of eosinophil activation,BP,
19215,GO:1902567,1,0.980514332653597,0,2,negative regulation of eosinophil activation,BP,
19216,GO:1902568,1,0.981075270396992,0,2,positive regulation of eosinophil activation,BP,
19217,GO:1902569,1,0.989031885238146,0,1,negative regulation of activation of JAK2 kinase activity,BP,
19218,GO:1902570,1,0.954211473082137,0,7,protein localization to nucleolus,BP,
19219,GO:1902571,1,0.87775009092042,0,13,regulation of serine-type peptidase activity,BP,
19220,GO:1902572,1,0.897660145192556,0,11,negative regulation of serine-type peptidase activity,BP,
19221,GO:1902573,1,0.977838789762376,0,3,positive regulation of serine-type peptidase activity,BP,
19222,GO:1902576,1,0.972197297826929,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19224,GO:1902579,1,0.63742549932548,0,71,multi-organism localization,BP,
19226,GO:1902581,1,0.659491839929147,0,66,multi-organism cellular localization,BP,
19228,GO:1902583,1,0.659491839929147,0,66,multi-organism intracellular transport,BP,
19229,GO:1902585,1,0.989404570639733,0,1,single-organism intercellular transport,BP,
19231,GO:1902590,1,0.813866333269997,0,24,multi-organism organelle organization,BP,
19232,GO:1902592,1,0.813866333269997,0,24,multi-organism membrane budding,BP,
19234,GO:1902594,1,0.999244306056699,0,2,multi-organism nuclear import,BP,
19235,GO:1902595,1,0.980182379006216,0,2,regulation of DNA replication origin binding,BP,
19236,GO:1902598,1,0.995771212335886,0,2,creatine transmembrane transport,BP,
19238,GO:1902603,1,0.963981508457039,0,4,carnitine transmembrane transport,BP,
19239,GO:1902605,1,0.992501019149847,0,1,heterotrimeric G-protein complex assembly,BP,
19240,GO:1902606,1,0.975076289972171,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19241,GO:1902608,1,0.975076289972171,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19242,GO:1902612,1,0.981563748229446,0,2,regulation of anti-Mullerian hormone signaling pathway,BP,
19243,GO:1902613,1,0.981563748229446,0,2,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19244,GO:1902616,1,0.979888534283067,0,2,acyl carnitine transmembrane transport,BP,
19245,GO:1902617,1,0.988445629079387,0,4,response to fluoride,BP,
19246,GO:1902618,1,0.999999996372412,0,1,cellular response to fluoride,BP,
19247,GO:1902622,1,0.718683690219672,0,34,regulation of neutrophil migration,BP,
19248,GO:1902623,1,0.991473944833211,0,2,negative regulation of neutrophil migration,BP,
19249,GO:1902624,1,0.743861160314087,0,29,positive regulation of neutrophil migration,BP,
19250,GO:1902626,1,0.963036307113023,0,3,assembly of large subunit precursor of preribosome,BP,
19251,GO:1902630,1,0.999999992750176,0,2,regulation of membrane hyperpolarization,BP,
19252,GO:1902631,1,0.99999999637854,0,1,negative regulation of membrane hyperpolarization,BP,
19253,GO:1902636,1,0.97928475859057,0,2,kinociliary basal body,CC,
19257,GO:1902659,1,0.976205119270312,0,3,regulation of glucose mediated signaling pathway,BP,
19258,GO:1902661,1,0.976205119270312,0,3,positive regulation of glucose mediated signaling pathway,BP,
19259,GO:1902667,1,0.929147358665087,0,21,regulation of axon guidance,BP,
19260,GO:1902668,1,0.967388921117389,0,10,negative regulation of axon guidance,BP,
19261,GO:1902669,1,0.976863362591742,0,7,positive regulation of axon guidance,BP,
19264,GO:1902683,1,0.977143076767345,0,3,regulation of receptor localization to synapse,BP,
19265,GO:1902684,1,0.987739993295648,0,1,negative regulation of receptor localization to synapse,BP,
19266,GO:1902685,1,0.998823843362666,0,1,positive regulation of receptor localization to synapse,BP,
19267,GO:1902686,1,0.651334729240096,0,54,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,
19268,GO:1902688,1,0.980842465086112,0,2,regulation of NAD metabolic process,BP,
19269,GO:1902690,1,0.993128389988697,0,1,positive regulation of NAD metabolic process,BP,
19270,GO:1902691,1,0.994257116074789,0,1,respiratory basal cell differentiation,BP,
19271,GO:1902692,1,0.868089744719542,0,27,regulation of neuroblast proliferation,BP,
19272,GO:1902710,1,0.899779342224557,0,18,GABA receptor complex,CC,
19273,GO:1902711,1,0.89977936517817,0,17,GABA-A receptor complex,CC,
19274,GO:1902713,1,0.927316203669604,0,10,regulation of interferon-gamma secretion,BP,
19275,GO:1902714,1,0.963865966609798,0,4,negative regulation of interferon-gamma secretion,BP,
19276,GO:1902715,1,0.951894020732044,0,7,positive regulation of interferon-gamma secretion,BP,
19277,GO:1902722,1,0.991437129598395,0,2,positive regulation of prolactin secretion,BP,
19278,GO:1902723,1,0.988215246065856,0,2,negative regulation of skeletal muscle satellite cell proliferation,BP,
19279,GO:1902725,1,0.992853806974366,0,2,negative regulation of satellite cell differentiation,BP,
19280,GO:1902728,1,0.999762169334549,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19281,GO:1902730,1,0.993814685798652,0,2,positive regulation of proteoglycan biosynthetic process,BP,
19282,GO:1902731,1,0.991838950341685,0,3,negative regulation of chondrocyte proliferation,BP,
19283,GO:1902732,1,0.969421160817309,0,3,positive regulation of chondrocyte proliferation,BP,
19284,GO:1902737,1,0.999038748781858,0,1,dendritic filopodium,CC,
19285,GO:1902739,1,0.985337515325025,0,2,regulation of interferon-alpha secretion,BP,
19286,GO:1902741,1,0.985337515325025,0,2,positive regulation of interferon-alpha secretion,BP,
19287,GO:1902742,1,0.883873994370081,0,29,apoptotic process involved in development,BP,
19288,GO:1902743,1,0.809229949680765,0,36,regulation of lamellipodium organization,BP,
19289,GO:1902744,1,0.976732709374533,0,5,negative regulation of lamellipodium organization,BP,
19290,GO:1902745,1,0.867313845181233,0,24,positive regulation of lamellipodium organization,BP,
19291,GO:1902746,1,0.969281214322222,0,4,regulation of lens fiber cell differentiation,BP,
19292,GO:1902747,1,0.98931586902311,0,1,negative regulation of lens fiber cell differentiation,BP,
19293,GO:1902748,1,0.999999996391085,0,1,positive regulation of lens fiber cell differentiation,BP,
19296,GO:1902751,1,0.874210891993096,0,21,positive regulation of cell cycle G2/M phase transition,BP,
19297,GO:1902765,1,0.991743769777111,0,2,L-arginine import into cell,BP,
19298,GO:1902766,1,0.976995306233717,0,2,skeletal muscle satellite cell migration,BP,
19299,GO:1902769,1,0.999999996400475,0,1,regulation of choline O-acetyltransferase activity,BP,
19300,GO:1902771,1,0.999999996400475,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19301,GO:1902773,1,0.993933191648242,0,1,GTPase activator complex,CC,
19302,GO:1902774,1,0.971597319576644,0,6,late endosome to lysosome transport,BP,
19303,GO:1902775,1,0.990223135835613,0,3,mitochondrial large ribosomal subunit assembly,BP,
19304,GO:1902803,1,0.830876321861802,0,37,regulation of synaptic vesicle transport,BP,
19305,GO:1902804,1,0.956810270384295,0,8,negative regulation of synaptic vesicle transport,BP,
19306,GO:1902805,1,0.983910535320151,0,5,positive regulation of synaptic vesicle transport,BP,
19307,GO:1902806,1,0.37540102447776,0,148,regulation of cell cycle G1/S phase transition,BP,
19308,GO:1902807,1,0.537347988361677,0,95,negative regulation of cell cycle G1/S phase transition,BP,
19309,GO:1902808,1,0.811345418997404,0,32,positive regulation of cell cycle G1/S phase transition,BP,
19310,GO:1902809,1,0.980693994044212,0,3,regulation of skeletal muscle fiber differentiation,BP,
19311,GO:1902811,1,0.987432154699133,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19312,GO:1902822,1,0.972132583529544,0,4,regulation of late endosome to lysosome transport,BP,
19313,GO:1902823,1,0.995172202454671,0,2,negative regulation of late endosome to lysosome transport,BP,
19314,GO:1902824,1,0.976849494679579,0,2,positive regulation of late endosome to lysosome transport,BP,
19315,GO:1902826,1,0.991743775026976,0,1,regulation of L-arginine import into cell,BP,
19316,GO:1902828,1,0.991743775026976,0,1,positive regulation of L-arginine import into cell,BP,
19317,GO:1902837,1,0.989368704250204,0,7,amino acid import into cell,BP,
19318,GO:1902847,1,0.992998068768905,0,1,regulation of neuronal signal transduction,BP,
19319,GO:1902850,1,0.597087648574143,0,87,microtubule cytoskeleton organization involved in mitosis,BP,
19320,GO:1902855,1,0.952124700288133,0,13,regulation of non-motile cilium assembly,BP,
19321,GO:1902856,1,0.9941682679208,0,3,negative regulation of non-motile cilium assembly,BP,
19322,GO:1902857,1,0.966024135938393,0,9,positive regulation of non-motile cilium assembly,BP,
19325,GO:1902861,1,0.999640847183594,0,1,copper ion import into cell,BP,
19326,GO:1902866,1,0.949543550174204,0,7,regulation of retina development in camera-type eye,BP,
19327,GO:1902867,1,0.99441261044449,0,1,negative regulation of retina development in camera-type eye,BP,
19328,GO:1902868,1,0.981068936115031,0,2,positive regulation of retina development in camera-type eye,BP,
19329,GO:1902869,1,0.975586492454828,0,3,regulation of amacrine cell differentiation,BP,
19330,GO:1902870,1,0.99441261044449,0,1,negative regulation of amacrine cell differentiation,BP,
19331,GO:1902871,1,0.981068936115031,0,2,positive regulation of amacrine cell differentiation,BP,
19335,GO:1902890,1,0.987233076566383,0,1,regulation of root hair elongation,BP,
19336,GO:1902891,1,0.987233076566383,0,1,negative regulation of root hair elongation,BP,
19337,GO:1902893,1,0.893338070580925,0,27,regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
19338,GO:1902894,1,0.973926616136379,0,10,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
19339,GO:1902895,1,0.910004878610443,0,19,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,BP,
19340,GO:1902896,1,0.984144960920374,0,3,terminal web assembly,BP,
19341,GO:1902897,1,0.987584724355435,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19342,GO:1902902,1,0.924474733756579,0,10,negative regulation of autophagosome assembly,BP,
19346,GO:1902908,1,0.987350161663811,0,2,regulation of melanosome transport,BP,
19347,GO:1902910,1,0.998851168465918,0,1,positive regulation of melanosome transport,BP,
19349,GO:1902913,1,0.987417807105176,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19351,GO:1902915,1,0.987207077720381,0,4,negative regulation of protein polyubiquitination,BP,
19354,GO:1902931,1,0.934598903643361,0,9,negative regulation of alcohol biosynthetic process,BP,
19357,GO:1902937,1,0.989198083647772,0,2,inward rectifier potassium channel complex,CC,
19358,GO:1902938,1,0.993225181092863,0,1,regulation of intracellular calcium activated chloride channel activity,BP,
19359,GO:1902939,1,0.993225181092863,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19360,GO:1902941,1,0.998490132055787,0,2,regulation of voltage-gated chloride channel activity,BP,
19361,GO:1902943,1,0.998490132055787,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19362,GO:1902946,1,0.9830287967847,0,6,protein localization to early endosome,BP,
19363,GO:1902947,1,0.982500242846101,0,3,regulation of tau-protein kinase activity,BP,
19364,GO:1902948,1,0.999999996400475,0,1,negative regulation of tau-protein kinase activity,BP,
19365,GO:1902949,1,0.992998068768905,0,1,positive regulation of tau-protein kinase activity,BP,
19366,GO:1902950,1,0.952756457472749,0,6,regulation of dendritic spine maintenance,BP,
19367,GO:1902951,1,0.97004577945969,0,3,negative regulation of dendritic spine maintenance,BP,
19368,GO:1902952,1,0.986946328859166,0,2,positive regulation of dendritic spine maintenance,BP,
19369,GO:1902953,1,0.978621894500378,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19370,GO:1902954,1,0.999999992782675,0,2,regulation of early endosome to recycling endosome transport,BP,
19371,GO:1902955,1,0.999999996400475,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19372,GO:1902956,1,0.967063514097543,0,4,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19373,GO:1902957,1,0.987262624889732,0,2,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19374,GO:1902958,1,0.979542344980115,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19375,GO:1902959,1,0.997371174299022,0,2,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19376,GO:1902960,1,0.999999996400475,0,1,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19377,GO:1902961,1,0.997371178419702,0,1,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19378,GO:1902962,1,0.997371174299022,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19379,GO:1902963,1,0.997371174299022,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19380,GO:1902965,1,0.991703794780613,0,4,regulation of protein localization to early endosome,BP,
19381,GO:1902966,1,0.991703794780613,0,4,positive regulation of protein localization to early endosome,BP,
19382,GO:1902969,1,0.935147277718715,0,10,mitotic DNA replication,BP,
19383,GO:1902975,1,0.987538515029981,0,1,mitotic DNA replication initiation,BP,
19384,GO:1902977,1,0.989140467245068,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19385,GO:1902979,1,0.991657600429728,0,1,mitotic DNA replication termination,BP,
19386,GO:1902983,1,0.995153211839766,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19387,GO:1902988,1,0.992998031144214,0,3,neurofibrillary tangle assembly,BP,
19388,GO:1902990,1,0.986306920538909,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19389,GO:1902991,1,0.937837485630894,0,13,regulation of amyloid precursor protein catabolic process,BP,
19390,GO:1902992,1,0.958288032853022,0,8,negative regulation of amyloid precursor protein catabolic process,BP,
19391,GO:1902993,1,0.973012905253559,0,5,positive regulation of amyloid precursor protein catabolic process,BP,
19392,GO:1902994,1,0.987537361287195,0,2,regulation of phospholipid efflux,BP,
19393,GO:1902995,1,0.987537361287195,0,2,positive regulation of phospholipid efflux,BP,
19394,GO:1902996,1,0.992998063784388,0,2,regulation of neurofibrillary tangle assembly,BP,
19395,GO:1902997,1,0.999999996400475,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19396,GO:1902998,1,0.992998068768905,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19397,GO:1903000,1,0.987537367367283,0,1,regulation of lipid transport across blood brain barrier,BP,
19398,GO:1903002,1,0.987537367367283,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19399,GO:1903003,1,0.977042602567716,0,4,positive regulation of protein deubiquitination,BP,
19400,GO:1903004,1,0.99763454673982,0,1,regulation of protein K63-linked deubiquitination,BP,
19401,GO:1903006,1,0.99763454673982,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19402,GO:1903007,1,0.99763454673982,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19403,GO:1903008,1,0.550518431361553,0,97,organelle disassembly,BP,
19406,GO:1903012,1,0.948376863600984,0,7,positive regulation of bone development,BP,
19407,GO:1903015,1,0.96534597373028,0,3,regulation of exo-alpha-sialidase activity,BP,
19408,GO:1903016,1,0.976629431674011,0,2,negative regulation of exo-alpha-sialidase activity,BP,
19409,GO:1903017,1,0.988448680688217,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19410,GO:1903018,1,0.740799465214359,0,41,regulation of glycoprotein metabolic process,BP,
19411,GO:1903019,1,0.89070804431689,0,13,negative regulation of glycoprotein metabolic process,BP,
19412,GO:1903020,1,0.882670754963704,0,19,positive regulation of glycoprotein metabolic process,BP,
19413,GO:1903025,1,0.922960559123346,0,10,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19414,GO:1903026,1,0.939222859643369,0,6,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19415,GO:1903027,1,0.977747519427692,0,3,regulation of opsonization,BP,
19416,GO:1903028,1,0.999999996382194,0,1,positive regulation of opsonization,BP,
19417,GO:1903031,1,0.981013468055048,0,2,regulation of microtubule plus-end binding,BP,
19418,GO:1903033,1,0.981013468055048,0,2,positive regulation of microtubule plus-end binding,BP,
19420,GO:1903035,1,0.605727716542842,0,75,negative regulation of response to wounding,BP,
19421,GO:1903036,1,0.68194283442599,0,53,positive regulation of response to wounding,BP,
19423,GO:1903038,1,0.469301205375053,0,98,negative regulation of leukocyte cell-cell adhesion,BP,
19425,GO:1903044,1,0.932013355948545,0,9,protein localization to membrane raft,BP,
19426,GO:1903045,1,0.999998974404281,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19427,GO:1903046,1,0.325060512068473,0,174,meiotic cell cycle process,BP,
19430,GO:1903051,1,0.746866135365176,0,42,negative regulation of proteolysis involved in cellular protein catabolic process,BP,
19432,GO:1903053,1,0.882318401801992,0,27,regulation of extracellular matrix organization,BP,
19433,GO:1903054,1,0.951217531225084,0,6,negative regulation of extracellular matrix organization,BP,
19434,GO:1903055,1,0.938110480671909,0,15,positive regulation of extracellular matrix organization,BP,
19435,GO:1903056,1,0.988485865643486,0,2,regulation of melanosome organization,BP,
19436,GO:1903059,1,0.967739507334532,0,5,regulation of protein lipidation,BP,
19437,GO:1903060,1,0.988803713154355,0,1,negative regulation of protein lipidation,BP,
19438,GO:1903061,1,0.978699165926366,0,4,positive regulation of protein lipidation,BP,
19439,GO:1903069,1,0.935678609586748,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19440,GO:1903070,1,0.977012434478085,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19441,GO:1903071,1,0.948718940720881,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19442,GO:1903072,1,0.98731767947796,0,1,regulation of death-inducing signaling complex assembly,BP,
19443,GO:1903073,1,0.98731767947796,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19444,GO:1903076,1,0.690340289371465,0,66,regulation of protein localization to plasma membrane,BP,
19445,GO:1903077,1,0.895093689010675,0,19,negative regulation of protein localization to plasma membrane,BP,
19446,GO:1903078,1,0.820658571884871,0,38,positive regulation of protein localization to plasma membrane,BP,
19447,GO:1903080,1,0.987408883959657,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19448,GO:1903082,1,0.987408883959657,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19449,GO:1903093,1,0.975154268758933,0,2,regulation of protein K48-linked deubiquitination,BP,
19450,GO:1903094,1,0.975154268758933,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19451,GO:1903095,1,0.990842310723319,0,2,ribonuclease III complex,CC,
19452,GO:1903096,1,0.993899064481029,0,1,protein localization to meiotic spindle midzone,BP,
19453,GO:1903115,1,0.860629531343188,0,39,regulation of actin filament-based movement,BP,
19454,GO:1903116,1,0.995514195547354,0,3,positive regulation of actin filament-based movement,BP,
19455,GO:1903118,1,0.990803916695749,0,1,urate homeostasis,BP,
19456,GO:1903121,1,0.976987357150677,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19457,GO:1903122,1,0.98731767947796,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19458,GO:1903123,1,0.999999996391606,0,1,regulation of thioredoxin peroxidase activity,BP,
19459,GO:1903124,1,0.999999996391606,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19460,GO:1903125,1,0.999999996391606,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19461,GO:1903126,1,0.989876584244267,0,1,negative regulation of centriole-centriole cohesion,BP,
19462,GO:1903131,1,0.805687099593838,0,33,mononuclear cell differentiation,BP,
19463,GO:1903135,1,0.977989096423268,0,3,cupric ion binding,MF,
19464,GO:1903136,1,0.950273320886725,0,6,cuprous ion binding,MF,
19465,GO:1903140,1,0.936086211022621,0,12,regulation of establishment of endothelial barrier,BP,
19466,GO:1903141,1,0.998648243325891,0,1,negative regulation of establishment of endothelial barrier,BP,
19467,GO:1903142,1,0.971471169120586,0,5,positive regulation of establishment of endothelial barrier,BP,
19468,GO:1903146,1,0.739826501072029,0,49,regulation of mitophagy,BP,
19469,GO:1903147,1,0.974601103087755,0,5,negative regulation of mitophagy,BP,
19470,GO:1903165,1,0.99227728643266,0,1,response to polycyclic arene,BP,
19471,GO:1903167,1,0.98731767947796,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19472,GO:1903168,1,0.98731767947796,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19474,GO:1903170,1,0.773360765052779,0,33,negative regulation of calcium ion transmembrane transport,BP,
19476,GO:1903176,1,0.98731767947796,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19477,GO:1903178,1,0.98731767947796,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19478,GO:1903179,1,0.98255063233457,0,2,regulation of dopamine biosynthetic process,BP,
19479,GO:1903181,1,0.98255063233457,0,2,positive regulation of dopamine biosynthetic process,BP,
19480,GO:1903182,1,0.987564328280312,0,1,regulation of SUMO transferase activity,BP,
19481,GO:1903184,1,0.98731767947796,0,1,L-dopa metabolic process,BP,
19482,GO:1903185,1,0.98731767947796,0,1,L-dopa biosynthetic process,BP,
19483,GO:1903189,1,0.98731767947796,0,1,glyoxal metabolic process,BP,
19484,GO:1903195,1,0.98731767947796,0,1,regulation of L-dopa biosynthetic process,BP,
19485,GO:1903197,1,0.98731767947796,0,1,positive regulation of L-dopa biosynthetic process,BP,
19486,GO:1903198,1,0.98731767947796,0,1,regulation of L-dopa decarboxylase activity,BP,
19487,GO:1903200,1,0.98731767947796,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19490,GO:1903203,1,0.928898878188041,0,16,regulation of oxidative stress-induced neuron death,BP,
19491,GO:1903204,1,0.935576035827039,0,13,negative regulation of oxidative stress-induced neuron death,BP,
19492,GO:1903205,1,0.873588092389993,0,21,regulation of hydrogen peroxide-induced cell death,BP,
19493,GO:1903206,1,0.89783495884981,0,16,negative regulation of hydrogen peroxide-induced cell death,BP,
19494,GO:1903207,1,0.979502352672235,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
19495,GO:1903208,1,0.979502352672235,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
19496,GO:1903209,1,0.919394164328135,0,12,positive regulation of oxidative stress-induced cell death,BP,
19497,GO:1903210,1,0.999999996374604,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19498,GO:1903214,1,0.516055080147379,0,91,regulation of protein targeting to mitochondrion,BP,
19499,GO:1903215,1,0.975794809384467,0,4,negative regulation of protein targeting to mitochondrion,BP,
19500,GO:1903216,1,0.9875271317409,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19501,GO:1903217,1,0.9875271317409,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19502,GO:1903223,1,0.994777194119801,0,2,positive regulation of oxidative stress-induced neuron death,BP,
19503,GO:1903224,1,0.961442610283672,0,6,regulation of endodermal cell differentiation,BP,
19504,GO:1903225,1,0.987513762595978,0,3,negative regulation of endodermal cell differentiation,BP,
19505,GO:1903232,1,0.954551624749137,0,5,melanosome assembly,BP,
19506,GO:1903233,1,0.999788913519489,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19507,GO:1903236,1,0.938366691990275,0,7,regulation of leukocyte tethering or rolling,BP,
19508,GO:1903237,1,0.951869868472582,0,4,negative regulation of leukocyte tethering or rolling,BP,
19509,GO:1903238,1,0.985819566937967,0,3,positive regulation of leukocyte tethering or rolling,BP,
19510,GO:1903242,1,0.9780852246648,0,6,regulation of cardiac muscle hypertrophy in response to stress,BP,
19511,GO:1903243,1,0.994364046927429,0,3,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19512,GO:1903244,1,0.995372793616996,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19513,GO:1903248,1,0.999999996389206,0,1,regulation of citrulline biosynthetic process,BP,
19514,GO:1903249,1,0.999999996389206,0,1,negative regulation of citrulline biosynthetic process,BP,
19515,GO:1903251,1,0.963737596044973,0,6,multi-ciliated epithelial cell differentiation,BP,
19516,GO:1903261,1,0.975442012215402,0,4,regulation of serine phosphorylation of STAT3 protein,BP,
19517,GO:1903262,1,0.981736401997741,0,2,negative regulation of serine phosphorylation of STAT3 protein,BP,
19518,GO:1903263,1,0.993589451625903,0,2,positive regulation of serine phosphorylation of STAT3 protein,BP,
19519,GO:1903265,1,0.960318941069255,0,5,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19524,GO:1903279,1,0.988387560958451,0,3,regulation of calcium:sodium antiporter activity,BP,
19525,GO:1903280,1,0.999987404419208,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19526,GO:1903281,1,0.988400013911148,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19527,GO:1903282,1,0.994565281223551,0,1,regulation of glutathione peroxidase activity,BP,
19528,GO:1903284,1,0.994565281223551,0,1,positive regulation of glutathione peroxidase activity,BP,
19529,GO:1903285,1,0.994565281223551,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19530,GO:1903286,1,0.973351050681636,0,4,regulation of potassium ion import,BP,
19531,GO:1903288,1,0.973507123245861,0,3,positive regulation of potassium ion import,BP,
19532,GO:1903293,1,0.77573426713144,0,45,phosphatase complex,CC,
19533,GO:1903294,1,0.999788917175458,0,1,regulation of glutamate secretion, neurotransmission,BP,
19534,GO:1903296,1,0.999788917175458,0,1,positive regulation of glutamate secretion, neurotransmission,BP,
19535,GO:1903297,1,0.974629820036197,0,4,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19536,GO:1903298,1,0.974629820036197,0,4,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19537,GO:1903299,1,0.931625784976737,0,8,regulation of hexokinase activity,BP,
19538,GO:1903300,1,0.966357738816644,0,4,negative regulation of hexokinase activity,BP,
19539,GO:1903301,1,0.964068477724072,0,4,positive regulation of hexokinase activity,BP,
19541,GO:1903306,1,0.886225824832949,0,21,negative regulation of regulated secretory pathway,BP,
19542,GO:1903307,1,0.757384239554944,0,44,positive regulation of regulated secretory pathway,BP,
19543,GO:1903311,1,0.437930719358556,0,131,regulation of mRNA metabolic process,BP,
19544,GO:1903312,1,0.789978126621307,0,38,negative regulation of mRNA metabolic process,BP,
19545,GO:1903313,1,0.726604701104199,0,49,positive regulation of mRNA metabolic process,BP,
19546,GO:1903314,1,0.989936963505739,0,1,regulation of nitrogen cycle metabolic process,BP,
19549,GO:1903319,1,0.884238610252548,0,19,positive regulation of protein maturation,BP,
19553,GO:1903332,1,0.953716897351447,0,7,regulation of protein folding,BP,
19554,GO:1903333,1,0.963726264701737,0,5,negative regulation of protein folding,BP,
19555,GO:1903335,1,0.964175564768036,0,5,regulation of vacuolar transport,BP,
19556,GO:1903336,1,0.995172202454671,0,2,negative regulation of vacuolar transport,BP,
19557,GO:1903337,1,0.976849494679579,0,2,positive regulation of vacuolar transport,BP,
19558,GO:1903347,1,0.986279061195279,0,4,negative regulation of bicellular tight junction assembly,BP,
19559,GO:1903348,1,0.987823657479492,0,3,positive regulation of bicellular tight junction assembly,BP,
19560,GO:1903349,1,0.97960012961774,0,4,omegasome membrane,CC,
19561,GO:1903350,1,0.940789860129669,0,13,response to dopamine,BP,
19562,GO:1903351,1,0.940789860129669,0,13,cellular response to dopamine,BP,
19563,GO:1903352,1,0.986035831611698,0,3,L-ornithine transmembrane transport,BP,
19564,GO:1903358,1,0.938357439778291,0,10,regulation of Golgi organization,BP,
19565,GO:1903361,1,0.95509127486297,0,5,protein localization to basolateral plasma membrane,BP,
19567,GO:1903363,1,0.704851696078105,0,51,negative regulation of cellular protein catabolic process,BP,
19569,GO:1903365,1,0.95751821211582,0,5,regulation of fear response,BP,
19570,GO:1903367,1,0.95751821211582,0,5,positive regulation of fear response,BP,
19571,GO:1903371,1,0.999788909855385,0,3,regulation of endoplasmic reticulum tubular network organization,BP,
19572,GO:1903373,1,0.99978891351438,0,2,positive regulation of endoplasmic reticulum tubular network organization,BP,
19573,GO:1903375,1,0.991321317877953,0,2,facioacoustic ganglion development,BP,
19574,GO:1903376,1,0.965001164707756,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19575,GO:1903377,1,0.971935708131027,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19576,GO:1903378,1,0.994777194119801,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19577,GO:1903381,1,0.999365756635023,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19578,GO:1903382,1,0.999365756635023,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19579,GO:1903383,1,0.979542344980115,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19580,GO:1903384,1,0.979542344980115,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19581,GO:1903385,1,0.995950959494498,0,2,regulation of homophilic cell adhesion,BP,
19582,GO:1903387,1,0.999952088593288,0,1,positive regulation of homophilic cell adhesion,BP,
19583,GO:1903391,1,0.825016488933425,0,53,regulation of adherens junction organization,BP,
19584,GO:1903392,1,0.959605439839129,0,15,negative regulation of adherens junction organization,BP,
19585,GO:1903393,1,0.900023211899693,0,25,positive regulation of adherens junction organization,BP,
19586,GO:1903394,1,0.990749209826666,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19587,GO:1903400,1,0.999999996382036,0,1,L-arginine transmembrane transport,BP,
19588,GO:1903401,1,0.979429223705299,0,3,L-lysine transmembrane transport,BP,
19589,GO:1903402,1,0.997652536752675,0,1,regulation of renal phosphate excretion,BP,
19590,GO:1903403,1,0.997652536752675,0,1,negative regulation of renal phosphate excretion,BP,
19591,GO:1903405,1,0.918303039071838,0,9,protein localization to nuclear body,BP,
19592,GO:1903406,1,0.996739200613543,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19593,GO:1903408,1,0.996739200613543,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19595,GO:1903410,1,0.991743769777111,0,2,L-lysine import into cell,BP,
19596,GO:1903411,1,0.999999996382036,0,1,L-ornithine import into cell,BP,
19597,GO:1903412,1,0.973455868629815,0,3,response to bile acid,BP,
19598,GO:1903413,1,0.973455868629815,0,3,cellular response to bile acid,BP,
19599,GO:1903414,1,0.995459856190394,0,1,iron cation export,BP,
19600,GO:1903416,1,0.971208052374211,0,6,response to glycoside,BP,
19601,GO:1903420,1,0.999999996375124,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19602,GO:1903421,1,0.934341042263393,0,14,regulation of synaptic vesicle recycling,BP,
19603,GO:1903422,1,0.997025200777453,0,3,negative regulation of synaptic vesicle recycling,BP,
19604,GO:1903423,1,0.983910542113353,0,4,positive regulation of synaptic vesicle recycling,BP,
19608,GO:1903429,1,0.890888753187873,0,20,regulation of cell maturation,BP,
19609,GO:1903430,1,0.950868569438852,0,8,negative regulation of cell maturation,BP,
19610,GO:1903431,1,0.976953188563971,0,6,positive regulation of cell maturation,BP,
19611,GO:1903432,1,0.864579842245003,0,21,regulation of TORC1 signaling,BP,
19612,GO:1903433,1,0.990397404695359,0,2,regulation of constitutive secretory pathway,BP,
19613,GO:1903434,1,0.997591064478756,0,1,negative regulation of constitutive secretory pathway,BP,
19614,GO:1903435,1,0.992789107802457,0,1,positive regulation of constitutive secretory pathway,BP,
19615,GO:1903436,1,0.995283483065169,0,2,regulation of mitotic cytokinetic process,BP,
19616,GO:1903438,1,0.995283483065169,0,2,positive regulation of mitotic cytokinetic process,BP,
19617,GO:1903441,1,0.951323035804987,0,7,protein localization to ciliary membrane,BP,
19618,GO:1903444,1,0.994512019025568,0,1,negative regulation of brown fat cell differentiation,BP,
19619,GO:1903445,1,0.968014568147616,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19620,GO:1903450,1,0.999999996388112,0,1,regulation of G1 to G0 transition,BP,
19621,GO:1903452,1,0.999999996388112,0,1,positive regulation of G1 to G0 transition,BP,
19622,GO:1903461,1,0.994261980236177,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19623,GO:1903463,1,0.985276995875679,0,3,regulation of mitotic cell cycle DNA replication,BP,
19624,GO:1903464,1,0.985278561678019,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19625,GO:1903465,1,0.999998413985746,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19626,GO:1903487,1,0.976345924894148,0,2,regulation of lactation,BP,
19627,GO:1903488,1,0.987424170039788,0,1,negative regulation of lactation,BP,
19628,GO:1903489,1,0.988781779731915,0,1,positive regulation of lactation,BP,
19629,GO:1903490,1,0.995283483065169,0,2,positive regulation of mitotic cytokinesis,BP,
19630,GO:1903504,1,0.900808437720853,0,13,regulation of mitotic spindle checkpoint,BP,
19636,GO:1903513,1,0.849773099189809,0,26,endoplasmic reticulum to cytosol transport,BP,
19638,GO:1903515,1,0.99999999638592,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19639,GO:1903516,1,0.993254256196027,0,1,regulation of single strand break repair,BP,
19640,GO:1903517,1,0.993254256196027,0,1,negative regulation of single strand break repair,BP,
19641,GO:1903519,1,0.985489173324558,0,3,regulation of mammary gland involution,BP,
19642,GO:1903521,1,0.985489173324558,0,3,positive regulation of mammary gland involution,BP,
19644,GO:1903523,1,0.852871135828974,0,28,negative regulation of blood circulation,BP,
19645,GO:1903524,1,0.631436282337626,0,63,positive regulation of blood circulation,BP,
19646,GO:1903525,1,0.994354444216859,0,5,regulation of membrane tubulation,BP,
19647,GO:1903526,1,0.995875753020765,0,2,negative regulation of membrane tubulation,BP,
19648,GO:1903527,1,0.99847244378944,0,3,positive regulation of membrane tubulation,BP,
19650,GO:1903531,1,0.30527032050252,0,169,negative regulation of secretion by cell,BP,
19653,GO:1903537,1,0.990846201281476,0,1,meiotic cell cycle process involved in oocyte maturation,BP,
19654,GO:1903538,1,0.990846201281476,0,1,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19655,GO:1903539,1,0.933914206975339,0,10,protein localization to postsynaptic membrane,BP,
19656,GO:1903540,1,0.933914206975339,0,10,establishment of protein localization to postsynaptic membrane,BP,
19657,GO:1903541,1,0.893811779641779,0,15,regulation of exosomal secretion,BP,
19658,GO:1903542,1,0.985886896327672,0,2,negative regulation of exosomal secretion,BP,
19659,GO:1903543,1,0.893811779641779,0,15,positive regulation of exosomal secretion,BP,
19660,GO:1903544,1,0.995747747758561,0,1,response to butyrate,BP,
19661,GO:1903545,1,0.995747747758561,0,1,cellular response to butyrate,BP,
19662,GO:1903546,1,0.951654028510358,0,7,protein localization to photoreceptor outer segment,BP,
19663,GO:1903547,1,0.975256931228504,0,2,regulation of growth hormone activity,BP,
19664,GO:1903551,1,0.959227562336231,0,6,regulation of extracellular exosome assembly,BP,
19665,GO:1903553,1,0.977005316057715,0,4,positive regulation of extracellular exosome assembly,BP,
19667,GO:1903556,1,0.695197407837878,0,44,negative regulation of tumor necrosis factor superfamily cytokine production,BP,
19670,GO:1903564,1,0.995678546307761,0,3,regulation of protein localization to cilium,BP,
19671,GO:1903565,1,0.995678555248455,0,1,negative regulation of protein localization to cilium,BP,
19672,GO:1903566,1,0.999999992771249,0,2,positive regulation of protein localization to cilium,BP,
19673,GO:1903567,1,0.995678555248455,0,1,regulation of protein localization to ciliary membrane,BP,
19674,GO:1903568,1,0.995678555248455,0,1,negative regulation of protein localization to ciliary membrane,BP,
19675,GO:1903570,1,0.996211551705491,0,1,regulation of protein kinase D signaling,BP,
19676,GO:1903572,1,0.996211551705491,0,1,positive regulation of protein kinase D signaling,BP,
19677,GO:1903573,1,0.777923891608774,0,37,negative regulation of response to endoplasmic reticulum stress,BP,
19678,GO:1903575,1,0.98366195142588,0,2,cornified envelope assembly,BP,
19679,GO:1903576,1,0.989640888480121,0,1,response to L-arginine,BP,
19680,GO:1903578,1,0.705922892732021,0,52,regulation of ATP metabolic process,BP,
19681,GO:1903579,1,0.885945337556634,0,19,negative regulation of ATP metabolic process,BP,
19682,GO:1903580,1,0.8447187138381,0,26,positive regulation of ATP metabolic process,BP,
19683,GO:1903584,1,0.999056693482752,0,1,regulation of histone deubiquitination,BP,
19684,GO:1903586,1,0.999056693482752,0,1,positive regulation of histone deubiquitination,BP,
19685,GO:1903587,1,0.979100586380038,0,4,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19686,GO:1903588,1,0.979100594110801,0,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19687,GO:1903589,1,0.999999996373769,0,1,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19688,GO:1903593,1,0.970844529503859,0,3,regulation of histamine secretion by mast cell,BP,
19689,GO:1903595,1,0.970844529503859,0,3,positive regulation of histamine secretion by mast cell,BP,
19690,GO:1903596,1,0.975834884388414,0,4,regulation of gap junction assembly,BP,
19691,GO:1903597,1,0.995494938141604,0,1,negative regulation of gap junction assembly,BP,
19692,GO:1903598,1,0.98025167805051,0,3,positive regulation of gap junction assembly,BP,
19693,GO:1903599,1,0.890893488109443,0,19,positive regulation of mitophagy,BP,
19694,GO:1903608,1,0.968167527848514,0,7,protein localization to cytoplasmic stress granule,BP,
19697,GO:1903613,1,0.999968197376022,0,1,regulation of protein tyrosine phosphatase activity,BP,
19698,GO:1903615,1,0.999968197376022,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19699,GO:1903618,1,0.998092392517714,0,1,regulation of transdifferentiation,BP,
19700,GO:1903620,1,0.998092392517714,0,1,positive regulation of transdifferentiation,BP,
19701,GO:1903621,1,0.989214029639955,0,1,protein localization to photoreceptor connecting cilium,BP,
19704,GO:1903626,1,0.965127933741293,0,3,positive regulation of DNA catabolic process,BP,
19709,GO:1903632,1,0.987583788526688,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19712,GO:1903636,1,0.987167312885023,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19713,GO:1903638,1,0.987167312885023,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19714,GO:1903639,1,0.98715967882579,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19715,GO:1903640,1,0.98715967882579,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19716,GO:1903644,1,0.978904362577472,0,2,regulation of chaperone-mediated protein folding,BP,
19717,GO:1903645,1,0.987167312885023,0,1,negative regulation of chaperone-mediated protein folding,BP,
19718,GO:1903649,1,0.912461050766824,0,19,regulation of cytoplasmic transport,BP,
19719,GO:1903650,1,0.9752133755306,0,2,negative regulation of cytoplasmic transport,BP,
19720,GO:1903651,1,0.977692088056089,0,9,positive regulation of cytoplasmic transport,BP,
19721,GO:1903659,1,0.966914415886558,0,3,regulation of complement-dependent cytotoxicity,BP,
19722,GO:1903660,1,0.966914415886558,0,3,negative regulation of complement-dependent cytotoxicity,BP,
19723,GO:1903670,1,0.879179217851746,0,28,regulation of sprouting angiogenesis,BP,
19724,GO:1903671,1,0.932620318601782,0,13,negative regulation of sprouting angiogenesis,BP,
19725,GO:1903672,1,0.951266238670761,0,13,positive regulation of sprouting angiogenesis,BP,
19726,GO:1903673,1,0.989127530690364,0,1,mitotic cleavage furrow formation,BP,
19727,GO:1903674,1,0.989104995185545,0,1,regulation of cap-dependent translational initiation,BP,
19728,GO:1903676,1,0.989104995185545,0,1,positive regulation of cap-dependent translational initiation,BP,
19729,GO:1903677,1,0.971536576254777,0,3,regulation of cap-independent translational initiation,BP,
19730,GO:1903679,1,0.971536576254777,0,3,positive regulation of cap-independent translational initiation,BP,
19731,GO:1903689,1,0.992464474633998,0,7,regulation of wound healing, spreading of epidermal cells,BP,
19732,GO:1903690,1,0.99999417857042,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19733,GO:1903691,1,0.99999999277657,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19734,GO:1903697,1,0.995445804867994,0,1,negative regulation of microvillus assembly,BP,
19735,GO:1903699,1,0.999999996404596,0,1,tarsal gland development,BP,
19736,GO:1903701,1,0.999924879762242,0,1,substantia propria of cornea development,BP,
19737,GO:1903704,1,0.998092392517714,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19741,GO:1903709,1,0.999999996404596,0,1,uterine gland development,BP,
19742,GO:1903712,1,0.997093914670211,0,1,cysteine transmembrane transport,BP,
19743,GO:1903715,1,0.970132145600883,0,7,regulation of aerobic respiration,BP,
19744,GO:1903717,1,0.999999934383817,0,1,response to ammonia,BP,
19745,GO:1903718,1,0.999999934383817,0,1,cellular response to ammonia,BP,
19746,GO:1903719,1,0.971444618423763,0,3,regulation of I-kappaB phosphorylation,BP,
19747,GO:1903721,1,0.971444618423763,0,3,positive regulation of I-kappaB phosphorylation,BP,
19748,GO:1903722,1,0.982935866185902,0,2,regulation of centriole elongation,BP,
19749,GO:1903723,1,0.987299002490663,0,1,negative regulation of centriole elongation,BP,
19750,GO:1903724,1,0.995581182218753,0,1,positive regulation of centriole elongation,BP,
19754,GO:1903729,1,0.659191929943206,0,76,regulation of plasma membrane organization,BP,
19755,GO:1903742,1,0.987739993295648,0,1,regulation of anterograde synaptic vesicle transport,BP,
19756,GO:1903743,1,0.987739993295648,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19757,GO:1903747,1,0.409051310527772,0,123,regulation of establishment of protein localization to mitochondrion,BP,
19758,GO:1903748,1,0.961196288219873,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19759,GO:1903749,1,0.444029248455054,0,111,positive regulation of establishment of protein localization to mitochondrion,BP,
19760,GO:1903750,1,0.967278771803514,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19761,GO:1903751,1,0.967278771803514,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19762,GO:1903753,1,0.985006478407744,0,4,negative regulation of p38MAPK cascade,BP,
19763,GO:1903755,1,0.987564328280312,0,1,positive regulation of SUMO transferase activity,BP,
19764,GO:1903756,1,0.990316912793203,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19765,GO:1903758,1,0.990316912793203,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19766,GO:1903759,1,0.994512019025568,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19767,GO:1903760,1,0.997052856582355,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19768,GO:1903762,1,0.997212694436933,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19769,GO:1903763,1,0.988930820749992,0,3,gap junction channel activity involved in cell communication by electrical coupling,MF,
19770,GO:1903764,1,0.98125267820065,0,3,regulation of potassium ion export across plasma membrane,BP,
19771,GO:1903765,1,0.994067229415098,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19772,GO:1903766,1,0.987267833101111,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19773,GO:1903767,1,0.983210307698125,0,2,sweet taste receptor complex,CC,
19774,GO:1903768,1,0.983210307698125,0,2,taste receptor complex,CC,
19775,GO:1903770,1,0.993254256196027,0,1,negative regulation of beta-galactosidase activity,BP,
19776,GO:1903772,1,0.950892680580179,0,5,regulation of viral budding via host ESCRT complex,BP,
19777,GO:1903774,1,0.970956801985396,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19778,GO:1903775,1,0.99554393926864,0,1,regulation of DNA double-strand break processing,BP,
19779,GO:1903778,1,0.991816705537361,0,2,protein localization to vacuolar membrane,BP,
19781,GO:1903781,1,0.995585271125556,0,3,positive regulation of cardiac conduction,BP,
19782,GO:1903786,1,0.992486821575225,0,1,regulation of glutathione biosynthetic process,BP,
19783,GO:1903788,1,0.992486821575225,0,1,positive regulation of glutathione biosynthetic process,BP,
19784,GO:1903789,1,0.984220601535555,0,2,regulation of amino acid transmembrane transport,BP,
19785,GO:1903792,1,0.890679343224699,0,23,negative regulation of anion transport,BP,
19786,GO:1903793,1,0.760036302720296,0,40,positive regulation of anion transport,BP,
19787,GO:1903795,1,0.982157499458072,0,5,regulation of inorganic anion transmembrane transport,BP,
19788,GO:1903796,1,0.993225176141585,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19789,GO:1903797,1,0.988857432453698,0,3,positive regulation of inorganic anion transmembrane transport,BP,
19790,GO:1903798,1,0.92132027150044,0,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19791,GO:1903799,1,0.977114626850751,0,7,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19792,GO:1903800,1,0.933604915857488,0,8,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19793,GO:1903802,1,0.997605327731425,0,5,L-glutamate(1-) import into cell,BP,
19794,GO:1903814,1,0.987267833101111,0,1,regulation of collecting lymphatic vessel constriction,BP,
19795,GO:1903815,1,0.987267833101111,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19796,GO:1903817,1,0.950900062662587,0,7,negative regulation of voltage-gated potassium channel activity,BP,
19797,GO:1903818,1,0.984351840926063,0,5,positive regulation of voltage-gated potassium channel activity,BP,
19798,GO:1903823,1,0.993254256196027,0,1,telomere single strand break repair,BP,
19799,GO:1903824,1,0.993254256196027,0,1,negative regulation of telomere single strand break repair,BP,
19801,GO:1903826,1,0.979429216045202,0,4,arginine transmembrane transport,BP,
19803,GO:1903828,1,0.408179854149321,0,142,negative regulation of cellular protein localization,BP,
19804,GO:1903829,1,0.107673794911711,0,357,positive regulation of cellular protein localization,BP,
19805,GO:1903830,1,0.920000000797776,0,17,magnesium ion transmembrane transport,BP,
19806,GO:1903831,1,0.854155225968502,0,21,signal transduction involved in cellular response to ammonium ion,BP,
19807,GO:1903837,1,0.991273856262465,0,1,regulation of mRNA 3'-UTR binding,BP,
19808,GO:1903839,1,0.991273856262465,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19809,GO:1903844,1,0.573437154518768,0,99,regulation of cellular response to transforming growth factor beta stimulus,BP,
19810,GO:1903845,1,0.693405747210526,0,66,negative regulation of cellular response to transforming growth factor beta stimulus,BP,
19811,GO:1903846,1,0.86677427911879,0,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
19812,GO:1903847,1,0.998917620685057,0,2,regulation of aorta morphogenesis,BP,
19813,GO:1903849,1,0.998917620685057,0,2,positive regulation of aorta morphogenesis,BP,
19814,GO:1903850,1,0.992125582633387,0,1,regulation of cristae formation,BP,
19815,GO:1903852,1,0.992125582633387,0,1,positive regulation of cristae formation,BP,
19816,GO:1903859,1,0.927713614226438,0,18,regulation of dendrite extension,BP,
19817,GO:1903860,1,0.985106938884644,0,2,negative regulation of dendrite extension,BP,
19818,GO:1903861,1,0.941745744607516,0,16,positive regulation of dendrite extension,BP,
19819,GO:1903862,1,0.933164939489774,0,7,positive regulation of oxidative phosphorylation,BP,
19820,GO:1903867,1,0.972438516662415,0,8,extraembryonic membrane development,BP,
19821,GO:1903874,1,0.99359017362349,0,3,ferrous iron transmembrane transport,BP,
19822,GO:1903881,1,0.997035697400361,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19823,GO:1903883,1,0.997035697400361,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19824,GO:1903884,1,0.997035697400361,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19825,GO:1903886,1,0.997035697400361,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19826,GO:1903888,1,0.987233076566383,0,1,regulation of plant epidermal cell differentiation,BP,
19827,GO:1903889,1,0.987233076566383,0,1,negative regulation of plant epidermal cell differentiation,BP,
19828,GO:1903891,1,0.994704858881644,0,2,regulation of ATF6-mediated unfolded protein response,BP,
19829,GO:1903892,1,0.996728693625204,0,1,negative regulation of ATF6-mediated unfolded protein response,BP,
19830,GO:1903894,1,0.926553545081507,0,12,regulation of IRE1-mediated unfolded protein response,BP,
19831,GO:1903895,1,0.988106373063508,0,2,negative regulation of IRE1-mediated unfolded protein response,BP,
19832,GO:1903896,1,0.951026383250166,0,8,positive regulation of IRE1-mediated unfolded protein response,BP,
19833,GO:1903897,1,0.933368412354858,0,10,regulation of PERK-mediated unfolded protein response,BP,
19834,GO:1903898,1,0.966168408325928,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19835,GO:1903899,1,0.968026602688357,0,4,positive regulation of PERK-mediated unfolded protein response,BP,
19838,GO:1903902,1,0.52253317619997,0,94,positive regulation of viral life cycle,BP,
19839,GO:1903903,1,0.984539661216429,0,2,regulation of establishment of T cell polarity,BP,
19840,GO:1903905,1,0.992009701125171,0,1,positive regulation of establishment of T cell polarity,BP,
19841,GO:1903906,1,0.992470268844801,0,1,regulation of plasma membrane raft polarization,BP,
19842,GO:1903909,1,0.953449658731062,0,6,regulation of receptor clustering,BP,
19843,GO:1903910,1,0.990686461621172,0,1,negative regulation of receptor clustering,BP,
19844,GO:1903911,1,0.969719366797563,0,4,positive regulation of receptor clustering,BP,
19845,GO:1903912,1,0.970742150118829,0,5,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19846,GO:1903916,1,0.99086740883784,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19847,GO:1903917,1,0.99086740883784,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19848,GO:1903918,1,0.999999996381853,0,1,regulation of actin filament severing,BP,
19849,GO:1903919,1,0.999999996381853,0,1,negative regulation of actin filament severing,BP,
19850,GO:1903921,1,0.992470263737801,0,2,regulation of protein processing in phagocytic vesicle,BP,
19851,GO:1903923,1,0.992470263737801,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19852,GO:1903924,1,0.99022738446262,0,1,estradiol binding,MF,
19853,GO:1903925,1,0.988966401454329,0,1,response to bisphenol A,BP,
19854,GO:1903926,1,0.988966401454329,0,1,cellular response to bisphenol A,BP,
19855,GO:1903935,1,0.960143815466393,0,5,response to sodium arsenite,BP,
19856,GO:1903936,1,0.963518568321301,0,4,cellular response to sodium arsenite,BP,
19857,GO:1903937,1,0.996297477724027,0,2,response to acrylamide,BP,
19858,GO:1903939,1,0.995398892184177,0,1,regulation of TORC2 signaling,BP,
19859,GO:1903943,1,0.989262143582812,0,1,regulation of hepatocyte apoptotic process,BP,
19860,GO:1903944,1,0.989262143582812,0,1,negative regulation of hepatocyte apoptotic process,BP,
19861,GO:1903946,1,0.994067229415098,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19862,GO:1903947,1,0.997212694436933,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19863,GO:1903949,1,0.996296020193453,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19864,GO:1903952,1,0.997995841968354,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19865,GO:1903954,1,0.997995841968354,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19866,GO:1903955,1,0.551682024003695,0,82,positive regulation of protein targeting to mitochondrion,BP,
19867,GO:1903959,1,0.843103951205622,0,32,regulation of anion transmembrane transport,BP,
19868,GO:1903960,1,0.970175209899409,0,9,negative regulation of anion transmembrane transport,BP,
19869,GO:1903961,1,0.988611236371631,0,4,positive regulation of anion transmembrane transport,BP,
19870,GO:1903963,1,0.783543454914486,0,29,arachidonate transport,BP,
19871,GO:1903969,1,0.967984026244245,0,3,regulation of response to macrophage colony-stimulating factor,BP,
19872,GO:1903970,1,0.976700267596906,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
19873,GO:1903971,1,0.991077486541396,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
19874,GO:1903972,1,0.967984026244245,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19875,GO:1903973,1,0.976700267596906,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19876,GO:1903974,1,0.991077486541396,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19877,GO:1903975,1,0.920283661722288,0,9,regulation of glial cell migration,BP,
19878,GO:1903976,1,0.958850316240619,0,4,negative regulation of glial cell migration,BP,
19879,GO:1903977,1,0.982542448943283,0,3,positive regulation of glial cell migration,BP,
19880,GO:1903978,1,0.975665392241285,0,2,regulation of microglial cell activation,BP,
19881,GO:1903979,1,0.987451572020687,0,1,negative regulation of microglial cell activation,BP,
19882,GO:1903980,1,0.975665392241285,0,2,positive regulation of microglial cell activation,BP,
19883,GO:1903984,1,0.989538038904388,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
19884,GO:1903988,1,0.995459856190394,0,1,ferrous iron export across plasma membrane,BP,
19885,GO:1903989,1,0.976705746146419,0,2,regulation of ferrous iron import into cell,BP,
19886,GO:1903991,1,0.976705746146419,0,2,positive regulation of ferrous iron import into cell,BP,
19887,GO:1903995,1,0.988065228259427,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19888,GO:1903997,1,0.988065228259427,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19889,GO:1903998,1,0.999930421462852,0,2,regulation of eating behavior,BP,
19890,GO:1903999,1,0.999930425087748,0,1,negative regulation of eating behavior,BP,
19891,GO:1904000,1,0.999999996388895,0,1,positive regulation of eating behavior,BP,
19892,GO:1904008,1,0.987857176997207,0,1,response to monosodium glutamate,BP,
19893,GO:1904009,1,0.987857176997207,0,1,cellular response to monosodium glutamate,BP,
19894,GO:1904010,1,0.987857176997207,0,1,response to Aroclor 1254,BP,
19895,GO:1904016,1,0.999999992751793,0,2,response to Thyroglobulin triiodothyronine,BP,
19896,GO:1904017,1,0.999999992751793,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
19897,GO:1904018,1,0.442328737113803,0,135,positive regulation of vasculature development,BP,
19898,GO:1904019,1,0.603418363048589,0,88,epithelial cell apoptotic process,BP,
19899,GO:1904020,1,0.99572471780941,0,1,regulation of G-protein coupled receptor internalization,BP,
19900,GO:1904021,1,0.99572471780941,0,1,negative regulation of G-protein coupled receptor internalization,BP,
19901,GO:1904023,1,0.993128389988697,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
19902,GO:1904025,1,0.993128389988697,0,1,positive regulation of glucose catabolic process to lactate via pyruvate,BP,
19903,GO:1904026,1,0.99153598406105,0,1,regulation of collagen fibril organization,BP,
19904,GO:1904027,1,0.99153598406105,0,1,negative regulation of collagen fibril organization,BP,
19905,GO:1904029,1,0.526585917082771,0,84,regulation of cyclin-dependent protein kinase activity,BP,
19906,GO:1904030,1,0.846825021872782,0,25,negative regulation of cyclin-dependent protein kinase activity,BP,
19907,GO:1904031,1,0.759588715623754,0,35,positive regulation of cyclin-dependent protein kinase activity,BP,
19908,GO:1904035,1,0.674805625529611,0,63,regulation of epithelial cell apoptotic process,BP,
19909,GO:1904036,1,0.795278107368365,0,36,negative regulation of epithelial cell apoptotic process,BP,
19910,GO:1904037,1,0.871017403019593,0,24,positive regulation of epithelial cell apoptotic process,BP,
19911,GO:1904041,1,0.995162711325382,0,1,regulation of cystathionine beta-synthase activity,BP,
19912,GO:1904042,1,0.995162711325382,0,1,negative regulation of cystathionine beta-synthase activity,BP,
19913,GO:1904044,1,0.974585718493829,0,4,response to aldosterone,BP,
19914,GO:1904045,1,0.990176193527876,0,1,cellular response to aldosterone,BP,
19915,GO:1904046,1,0.987287511472091,0,1,negative regulation of vascular endothelial growth factor production,BP,
19916,GO:1904047,1,0.975418641083898,0,3,S-adenosyl-L-methionine binding,MF,
19917,GO:1904048,1,0.99934732578334,0,2,regulation of spontaneous neurotransmitter secretion,BP,
19918,GO:1904049,1,0.999999996396041,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
19919,GO:1904050,1,0.999347329516822,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
19920,GO:1904054,1,0.999999996388895,0,1,regulation of cholangiocyte proliferation,BP,
19921,GO:1904056,1,0.999999996388895,0,1,positive regulation of cholangiocyte proliferation,BP,
19922,GO:1904057,1,0.980251257011078,0,2,negative regulation of sensory perception of pain,BP,
19923,GO:1904058,1,0.981443584002712,0,4,positive regulation of sensory perception of pain,BP,
19924,GO:1904059,1,0.995091370163325,0,2,regulation of locomotor rhythm,BP,
19926,GO:1904063,1,0.636537460075118,0,63,negative regulation of cation transmembrane transport,BP,
19928,GO:1904071,1,0.999770115718485,0,2,presynaptic active zone assembly,BP,
19929,GO:1904073,1,0.999999996380236,0,1,regulation of trophectodermal cell proliferation,BP,
19930,GO:1904075,1,0.999999996380236,0,1,positive regulation of trophectodermal cell proliferation,BP,
19931,GO:1904098,1,0.98253202637854,0,3,regulation of protein O-linked glycosylation,BP,
19932,GO:1904100,1,0.98253202637854,0,3,positive regulation of protein O-linked glycosylation,BP,
19933,GO:1904106,1,0.985907148448261,0,2,protein localization to microvillus,BP,
19934,GO:1904115,1,0.820888750201212,0,38,axon cytoplasm,CC,
19935,GO:1904116,1,0.987970713189641,0,3,response to vasopressin,BP,
19936,GO:1904117,1,0.987970713189641,0,3,cellular response to vasopressin,BP,
19937,GO:1904118,1,0.994281433998926,0,1,regulation of otic vesicle morphogenesis,BP,
19938,GO:1904120,1,0.994281433998926,0,1,positive regulation of otic vesicle morphogenesis,BP,
19939,GO:1904121,1,0.999751050476503,0,2,phosphatidylethanolamine transporter activity,MF,
19940,GO:1904124,1,0.967500387972668,0,3,microglial cell migration,BP,
19941,GO:1904139,1,0.967500387972668,0,3,regulation of microglial cell migration,BP,
19942,GO:1904140,1,0.988065228259427,0,1,negative regulation of microglial cell migration,BP,
19943,GO:1904141,1,0.991077486541396,0,1,positive regulation of microglial cell migration,BP,
19944,GO:1904149,1,0.988065228259427,0,1,regulation of microglial cell mediated cytotoxicity,BP,
19945,GO:1904151,1,0.988065228259427,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
19946,GO:1904152,1,0.917506273155633,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
19947,GO:1904153,1,0.942373366034868,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
19948,GO:1904154,1,0.977351764896015,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
19949,GO:1904155,1,0.995401240521461,0,1,DN2 thymocyte differentiation,BP,
19950,GO:1904156,1,0.995401240521461,0,1,DN3 thymocyte differentiation,BP,
19951,GO:1904158,1,0.988994304754965,0,3,axonemal central apparatus assembly,BP,
19952,GO:1904167,1,0.999999996398049,0,1,regulation of thyroid hormone receptor activity,BP,
19953,GO:1904168,1,0.999999996398049,0,1,negative regulation of thyroid hormone receptor activity,BP,
19954,GO:1904170,1,0.994441724162223,0,1,regulation of bleb assembly,BP,
19955,GO:1904172,1,0.994441724162223,0,1,positive regulation of bleb assembly,BP,
19957,GO:1904179,1,0.985813760988074,0,4,positive regulation of adipose tissue development,BP,
19958,GO:1904180,1,0.945432138817412,0,7,negative regulation of membrane depolarization,BP,
19959,GO:1904181,1,0.926279522110295,0,11,positive regulation of membrane depolarization,BP,
19960,GO:1904182,1,0.987527137809405,0,1,regulation of pyruvate dehydrogenase activity,BP,
19961,GO:1904192,1,0.999999996388895,0,1,regulation of cholangiocyte apoptotic process,BP,
19962,GO:1904193,1,0.999999996388895,0,1,negative regulation of cholangiocyte apoptotic process,BP,
19963,GO:1904195,1,0.999999996388895,0,1,regulation of granulosa cell proliferation,BP,
19964,GO:1904197,1,0.999999996388895,0,1,positive regulation of granulosa cell proliferation,BP,
19965,GO:1904199,1,0.998296792324339,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
19966,GO:1904200,1,0.999999996388895,0,1,iodide transmembrane transport,BP,
19967,GO:1904201,1,0.999999996388895,0,1,regulation of iodide transport,BP,
19968,GO:1904202,1,0.999999996388895,0,1,negative regulation of iodide transport,BP,
19969,GO:1904204,1,0.999999992762954,0,2,regulation of skeletal muscle hypertrophy,BP,
19970,GO:1904205,1,0.999999996374056,0,1,negative regulation of skeletal muscle hypertrophy,BP,
19971,GO:1904206,1,0.999999996388895,0,1,positive regulation of skeletal muscle hypertrophy,BP,
19972,GO:1904207,1,0.985279577211617,0,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,
19973,GO:1904209,1,0.985279577211617,0,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,
19974,GO:1904210,1,0.987826978146844,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19975,GO:1904211,1,0.988530367148455,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
19976,GO:1904212,1,0.999999996388895,0,1,regulation of iodide transmembrane transport,BP,
19977,GO:1904213,1,0.999999996388895,0,1,negative regulation of iodide transmembrane transport,BP,
19978,GO:1904217,1,0.973228758678599,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
19979,GO:1904219,1,0.973228758678599,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
19980,GO:1904220,1,0.965107956169167,0,4,regulation of serine C-palmitoyltransferase activity,BP,
19981,GO:1904222,1,0.973228758678599,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
19982,GO:1904226,1,0.990074869994379,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
19983,GO:1904227,1,0.990074869994379,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
19984,GO:1904229,1,0.987277710079769,0,2,regulation of succinate dehydrogenase activity,BP,
19985,GO:1904231,1,0.987277710079769,0,2,positive regulation of succinate dehydrogenase activity,BP,
19986,GO:1904232,1,0.987277710079769,0,2,regulation of aconitate hydratase activity,BP,
19987,GO:1904234,1,0.987277710079769,0,2,positive regulation of aconitate hydratase activity,BP,
19988,GO:1904235,1,0.999999996386781,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
19989,GO:1904237,1,0.999999996386781,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
19990,GO:1904238,1,0.944411559291877,0,8,pericyte cell differentiation,BP,
19991,GO:1904239,1,0.987826978146844,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19992,GO:1904240,1,0.987826978146844,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
19993,GO:1904245,1,0.982787335595234,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
19994,GO:1904246,1,0.988600021793749,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
19995,GO:1904247,1,0.994120818322568,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
19997,GO:1904252,1,0.974118102875242,0,3,negative regulation of bile acid metabolic process,BP,
19999,GO:1904259,1,0.999988742041713,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20000,GO:1904261,1,0.999988742041713,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20001,GO:1904262,1,0.926946499222872,0,11,negative regulation of TORC1 signaling,BP,
20002,GO:1904263,1,0.95402854577119,0,7,positive regulation of TORC1 signaling,BP,
20003,GO:1904264,1,0.945147664993086,0,12,ubiquitin protein ligase activity involved in ERAD pathway,MF,
20004,GO:1904265,1,0.999999996374212,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20005,GO:1904266,1,0.99999999638,0,1,regulation of Schwann cell chemotaxis,BP,
20006,GO:1904268,1,0.99999999638,0,1,positive regulation of Schwann cell chemotaxis,BP,
20007,GO:1904274,1,0.990223434331869,0,1,tricellular tight junction assembly,BP,
20008,GO:1904282,1,0.989215679571707,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20009,GO:1904283,1,0.989215679571707,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20010,GO:1904288,1,0.984887913473725,0,4,BAT3 complex binding,MF,
20011,GO:1904289,1,0.99367726678093,0,1,regulation of mitotic DNA damage checkpoint,BP,
20012,GO:1904292,1,0.853328481036438,0,27,regulation of ERAD pathway,BP,
20013,GO:1904293,1,0.920397279031874,0,13,negative regulation of ERAD pathway,BP,
20014,GO:1904294,1,0.922799672927551,0,13,positive regulation of ERAD pathway,BP,
20015,GO:1904298,1,0.998490135981731,0,1,regulation of transcytosis,BP,
20016,GO:1904300,1,0.998490135981731,0,1,positive regulation of transcytosis,BP,
20017,GO:1904301,1,0.998490135981731,0,1,regulation of maternal process involved in parturition,BP,
20018,GO:1904303,1,0.998490135981731,0,1,positive regulation of maternal process involved in parturition,BP,
20019,GO:1904304,1,0.998490135981731,0,1,regulation of gastro-intestinal system smooth muscle contraction,BP,
20020,GO:1904306,1,0.998490135981731,0,1,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20021,GO:1904313,1,0.9858227263321,0,2,response to methamphetamine hydrochloride,BP,
20022,GO:1904315,1,0.875652665453457,0,19,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20023,GO:1904316,1,0.998490135981731,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20024,GO:1904317,1,0.998490135981731,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20025,GO:1904321,1,0.986813198789498,0,9,response to forskolin,BP,
20026,GO:1904322,1,0.986813198789498,0,9,cellular response to forskolin,BP,
20027,GO:1904327,1,0.991657595157864,0,2,protein localization to cytosolic proteasome complex,BP,
20028,GO:1904338,1,0.930319344752126,0,10,regulation of dopaminergic neuron differentiation,BP,
20029,GO:1904339,1,0.981674086622214,0,3,negative regulation of dopaminergic neuron differentiation,BP,
20030,GO:1904340,1,0.958652020045491,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20031,GO:1904350,1,0.96530197766775,0,5,regulation of protein catabolic process in the vacuole,BP,
20032,GO:1904351,1,0.993270582337506,0,2,negative regulation of protein catabolic process in the vacuole,BP,
20033,GO:1904352,1,0.980700683428951,0,2,positive regulation of protein catabolic process in the vacuole,BP,
20034,GO:1904353,1,0.875331857601189,0,26,regulation of telomere capping,BP,
20035,GO:1904354,1,0.977948711836648,0,8,negative regulation of telomere capping,BP,
20036,GO:1904355,1,0.895102139120921,0,17,positive regulation of telomere capping,BP,
20037,GO:1904356,1,0.71447641810553,0,54,regulation of telomere maintenance via telomere lengthening,BP,
20038,GO:1904357,1,0.886334431752228,0,22,negative regulation of telomere maintenance via telomere lengthening,BP,
20039,GO:1904358,1,0.788207938223033,0,35,positive regulation of telomere maintenance via telomere lengthening,BP,
20040,GO:1904373,1,0.988124990132278,0,1,response to kainic acid,BP,
20041,GO:1904375,1,0.687348224784808,0,67,regulation of protein localization to cell periphery,BP,
20042,GO:1904376,1,0.891222183904214,0,20,negative regulation of protein localization to cell periphery,BP,
20043,GO:1904377,1,0.820658571884871,0,38,positive regulation of protein localization to cell periphery,BP,
20044,GO:1904378,1,0.981467143376554,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20045,GO:1904379,1,0.991657595157864,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20046,GO:1904380,1,0.889521640882484,0,20,endoplasmic reticulum mannose trimming,BP,
20047,GO:1904381,1,0.993196907733523,0,3,Golgi apparatus mannose trimming,BP,
20048,GO:1904382,1,0.981695383124525,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20049,GO:1904383,1,0.9771088541552,0,3,response to sodium phosphate,BP,
20050,GO:1904385,1,0.896536907398149,0,16,cellular response to angiotensin,BP,
20051,GO:1904386,1,0.980964594406335,0,5,response to L-phenylalanine derivative,BP,
20052,GO:1904387,1,0.991218873510729,0,2,cellular response to L-phenylalanine derivative,BP,
20053,GO:1904389,1,0.988124990132278,0,1,rod bipolar cell differentiation,BP,
20054,GO:1904391,1,0.988124990132278,0,1,response to ciliary neurotrophic factor,BP,
20055,GO:1904393,1,0.978921175781349,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20056,GO:1904394,1,0.990686461621172,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20057,GO:1904395,1,0.988124984174042,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20058,GO:1904396,1,0.95700892338859,0,8,regulation of neuromuscular junction development,BP,
20059,GO:1904397,1,0.978921183535901,0,2,negative regulation of neuromuscular junction development,BP,
20060,GO:1904398,1,0.988124978211752,0,3,positive regulation of neuromuscular junction development,BP,
20061,GO:1904399,1,0.988124990132278,0,1,heparan sulfate binding,MF,
20062,GO:1904400,1,0.994206026079447,0,1,response to Thyroid stimulating hormone,BP,
20063,GO:1904404,1,0.999999996380863,0,1,response to formaldehyde,BP,
20066,GO:1904408,1,0.98749644272876,0,1,melatonin binding,MF,
20067,GO:1904412,1,0.996656886905039,0,1,regulation of cardiac ventricle development,BP,
20068,GO:1904414,1,0.996656886905039,0,1,positive regulation of cardiac ventricle development,BP,
20069,GO:1904415,1,0.965114510929152,0,6,regulation of xenophagy,BP,
20070,GO:1904417,1,0.965114510929152,0,6,positive regulation of xenophagy,BP,
20071,GO:1904424,1,0.98430230789607,0,5,regulation of GTP binding,BP,
20072,GO:1904425,1,0.997263423287507,0,1,negative regulation of GTP binding,BP,
20073,GO:1904426,1,0.992692988489199,0,2,positive regulation of GTP binding,BP,
20075,GO:1904428,1,0.99999999639951,0,1,negative regulation of tubulin deacetylation,BP,
20076,GO:1904429,1,0.959440225056831,0,7,regulation of t-circle formation,BP,
20077,GO:1904430,1,0.988547394872576,0,3,negative regulation of t-circle formation,BP,
20078,GO:1904431,1,0.970558274998701,0,4,positive regulation of t-circle formation,BP,
20079,GO:1904432,1,0.976705746146419,0,2,regulation of ferrous iron binding,BP,
20080,GO:1904434,1,0.976705746146419,0,2,positive regulation of ferrous iron binding,BP,
20081,GO:1904435,1,0.976705746146419,0,2,regulation of transferrin receptor binding,BP,
20082,GO:1904437,1,0.976705746146419,0,2,positive regulation of transferrin receptor binding,BP,
20083,GO:1904447,1,0.999999996375592,0,1,folic acid import into cell,BP,
20084,GO:1904448,1,0.999768569133436,0,1,regulation of aspartate secretion,BP,
20085,GO:1904450,1,0.999768569133436,0,1,positive regulation of aspartate secretion,BP,
20086,GO:1904454,1,0.999999996384226,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20087,GO:1904455,1,0.999818137533508,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20088,GO:1904456,1,0.988975681364968,0,1,negative regulation of neuronal action potential,BP,
20089,GO:1904457,1,0.990969801322254,0,1,positive regulation of neuronal action potential,BP,
20090,GO:1904464,1,0.988581050160872,0,1,regulation of matrix metallopeptidase secretion,BP,
20091,GO:1904465,1,0.988581050160872,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20092,GO:1904467,1,0.952640774729696,0,7,regulation of tumor necrosis factor secretion,BP,
20093,GO:1904468,1,0.982329607494951,0,3,negative regulation of tumor necrosis factor secretion,BP,
20094,GO:1904469,1,0.969781330484836,0,4,positive regulation of tumor necrosis factor secretion,BP,
20095,GO:1904478,1,0.917814444250065,0,9,regulation of intestinal absorption,BP,
20096,GO:1904479,1,0.967793051873962,0,4,negative regulation of intestinal absorption,BP,
20097,GO:1904481,1,0.991208045963101,0,1,response to tetrahydrofolate,BP,
20098,GO:1904482,1,0.991208045963101,0,1,cellular response to tetrahydrofolate,BP,
20099,GO:1904491,1,0.956393269578729,0,5,protein localization to ciliary transition zone,BP,
20100,GO:1904492,1,0.991844146466664,0,1,Ac-Asp-Glu binding,MF,
20101,GO:1904493,1,0.991844146466664,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20102,GO:1904499,1,0.995784523078276,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20103,GO:1904501,1,0.995784523078276,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20104,GO:1904502,1,0.974797089698797,0,5,regulation of lipophagy,BP,
20105,GO:1904504,1,0.974797089698797,0,5,positive regulation of lipophagy,BP,
20106,GO:1904505,1,0.984516741116665,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20107,GO:1904506,1,0.984516741116665,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20108,GO:1904515,1,0.995398892184177,0,1,positive regulation of TORC2 signaling,BP,
20109,GO:1904526,1,0.960699920598262,0,6,regulation of microtubule binding,BP,
20110,GO:1904527,1,0.986315423760818,0,2,negative regulation of microtubule binding,BP,
20111,GO:1904528,1,0.971175638286867,0,4,positive regulation of microtubule binding,BP,
20112,GO:1904529,1,0.994228651569711,0,2,regulation of actin filament binding,BP,
20113,GO:1904530,1,0.994230358255577,0,1,negative regulation of actin filament binding,BP,
20114,GO:1904531,1,0.999998284657946,0,1,positive regulation of actin filament binding,BP,
20115,GO:1904533,1,0.986124844682088,0,3,regulation of telomeric loop disassembly,BP,
20116,GO:1904534,1,0.986724836327325,0,2,negative regulation of telomeric loop disassembly,BP,
20117,GO:1904535,1,0.999392003166225,0,1,positive regulation of telomeric loop disassembly,BP,
20118,GO:1904542,1,0.992125582633387,0,1,regulation of free ubiquitin chain polymerization,BP,
20119,GO:1904544,1,0.992125582633387,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20120,GO:1904562,1,0.999999992762223,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20121,GO:1904565,1,0.994361627722874,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20122,GO:1904566,1,0.994361627722874,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20123,GO:1904567,1,0.993794244072025,0,1,response to wortmannin,BP,
20124,GO:1904568,1,0.993794244072025,0,1,cellular response to wortmannin,BP,
20125,GO:1904569,1,0.975898292697516,0,2,regulation of selenocysteine incorporation,BP,
20126,GO:1904570,1,0.98859458603141,0,1,negative regulation of selenocysteine incorporation,BP,
20127,GO:1904571,1,0.987158387836758,0,1,positive regulation of selenocysteine incorporation,BP,
20128,GO:1904572,1,0.98859458603141,0,1,negative regulation of mRNA binding,BP,
20129,GO:1904573,1,0.98859458603141,0,1,regulation of selenocysteine insertion sequence binding,BP,
20130,GO:1904574,1,0.98859458603141,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20131,GO:1904576,1,0.981449054113195,0,2,response to tunicamycin,BP,
20132,GO:1904577,1,0.981449054113195,0,2,cellular response to tunicamycin,BP,
20133,GO:1904578,1,0.979661918017644,0,3,response to thapsigargin,BP,
20134,GO:1904579,1,0.979661918017644,0,3,cellular response to thapsigargin,BP,
20135,GO:1904580,1,0.982507836176894,0,2,regulation of intracellular mRNA localization,BP,
20136,GO:1904582,1,0.982507836176894,0,2,positive regulation of intracellular mRNA localization,BP,
20137,GO:1904585,1,0.989971175718913,0,1,response to putrescine,BP,
20138,GO:1904586,1,0.989971175718913,0,1,cellular response to putrescine,BP,
20139,GO:1904587,1,0.969540778100123,0,5,response to glycoprotein,BP,
20140,GO:1904588,1,0.987620565988309,0,1,cellular response to glycoprotein,BP,
20142,GO:1904590,1,0.66175873426457,0,64,negative regulation of protein import,BP,
20143,GO:1904591,1,0.584268588775156,0,96,positive regulation of protein import,BP,
20144,GO:1904594,1,0.999999996400838,0,1,regulation of termination of RNA polymerase II transcription,BP,
20145,GO:1904595,1,0.999999996400838,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20146,GO:1904596,1,0.987755226044422,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20147,GO:1904597,1,0.987755226044422,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20148,GO:1904599,1,0.987755226044422,0,1,advanced glycation end-product binding,MF,
20149,GO:1904602,1,0.979215987329314,0,2,serotonin-activated cation-selective channel complex,CC,
20150,GO:1904603,1,0.987755226044422,0,1,regulation of advanced glycation end-product receptor activity,BP,
20151,GO:1904604,1,0.987755226044422,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20152,GO:1904606,1,0.995779931099641,0,1,fat cell apoptotic process,BP,
20153,GO:1904612,1,0.994206026079447,0,1,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
20154,GO:1904616,1,0.994228651569711,0,2,regulation of actin binding,BP,
20155,GO:1904617,1,0.994230358255577,0,1,negative regulation of actin binding,BP,
20156,GO:1904618,1,0.999998284657946,0,1,positive regulation of actin binding,BP,
20157,GO:1904627,1,0.971360477444929,0,5,response to phorbol 13-acetate 12-myristate,BP,
20158,GO:1904628,1,0.971360477444929,0,5,cellular response to phorbol 13-acetate 12-myristate,BP,
20159,GO:1904631,1,0.990292856235842,0,1,response to glucoside,BP,
20160,GO:1904633,1,0.999999996374604,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20161,GO:1904635,1,0.999999996374604,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20162,GO:1904636,1,0.980350611531846,0,4,response to ionomycin,BP,
20163,GO:1904637,1,0.980350611531846,0,4,cellular response to ionomycin,BP,
20164,GO:1904638,1,0.999999996374604,0,1,response to resveratrol,BP,
20165,GO:1904639,1,0.999999996374604,0,1,cellular response to resveratrol,BP,
20166,GO:1904640,1,0.979612509255507,0,3,response to methionine,BP,
20169,GO:1904647,1,0.999999996390957,0,1,response to rotenone,BP,
20170,GO:1904649,1,0.995779931099641,0,1,regulation of fat cell apoptotic process,BP,
20171,GO:1904651,1,0.995779931099641,0,1,positive regulation of fat cell apoptotic process,BP,
20172,GO:1904659,1,0.883785321758361,0,19,glucose transmembrane transport,BP,
20176,GO:1904672,1,0.980054114628557,0,6,regulation of somatic stem cell population maintenance,BP,
20177,GO:1904673,1,0.987049297979811,0,4,negative regulation of somatic stem cell population maintenance,BP,
20178,GO:1904674,1,0.992913771796612,0,2,positive regulation of somatic stem cell population maintenance,BP,
20179,GO:1904675,1,0.993433878982438,0,1,regulation of somatic stem cell division,BP,
20180,GO:1904677,1,0.993433878982438,0,1,positive regulation of somatic stem cell division,BP,
20181,GO:1904680,1,0.805690711650335,0,27,peptide transmembrane transporter activity,MF,
20182,GO:1904681,1,0.99227728643266,0,1,response to 3-methylcholanthrene,BP,
20183,GO:1904683,1,0.986725020067849,0,6,regulation of metalloendopeptidase activity,BP,
20184,GO:1904684,1,0.996501507552547,0,4,negative regulation of metalloendopeptidase activity,BP,
20185,GO:1904685,1,0.990189468383655,0,2,positive regulation of metalloendopeptidase activity,BP,
20186,GO:1904688,1,0.959371851699936,0,4,regulation of cytoplasmic translational initiation,BP,
20187,GO:1904689,1,0.987481725945693,0,1,negative regulation of cytoplasmic translational initiation,BP,
20188,GO:1904690,1,0.971536576254777,0,3,positive regulation of cytoplasmic translational initiation,BP,
20189,GO:1904691,1,0.989861578723132,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20190,GO:1904692,1,0.996762267656411,0,1,positive regulation of type B pancreatic cell proliferation,BP,
20191,GO:1904693,1,0.995037185054623,0,3,midbrain morphogenesis,BP,
20192,GO:1904694,1,0.99165758990066,0,3,negative regulation of vascular smooth muscle contraction,BP,
20193,GO:1904700,1,0.991834996155373,0,1,granulosa cell apoptotic process,BP,
20194,GO:1904701,1,0.988771600271842,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20195,GO:1904705,1,0.846539299643562,0,24,regulation of vascular smooth muscle cell proliferation,BP,
20196,GO:1904706,1,0.928627901256527,0,8,negative regulation of vascular smooth muscle cell proliferation,BP,
20198,GO:1904708,1,0.991834996155373,0,1,regulation of granulosa cell apoptotic process,BP,
20199,GO:1904711,1,0.988771600271842,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20200,GO:1904713,1,0.991657595172371,0,2,beta-catenin destruction complex binding,MF,
20201,GO:1904714,1,0.94074178438183,0,8,regulation of chaperone-mediated autophagy,BP,
20202,GO:1904715,1,0.974255772985688,0,3,negative regulation of chaperone-mediated autophagy,BP,
20203,GO:1904716,1,0.990812359617748,0,1,positive regulation of chaperone-mediated autophagy,BP,
20204,GO:1904717,1,0.991151294342921,0,1,regulation of AMPA glutamate receptor clustering,BP,
20205,GO:1904719,1,0.991151294342921,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20206,GO:1904720,1,0.985210078261493,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20207,GO:1904721,1,0.994106205153046,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20208,GO:1904722,1,0.991051548276411,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20209,GO:1904723,1,0.988771600271842,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20211,GO:1904729,1,0.93390716117899,0,7,regulation of intestinal lipid absorption,BP,
20212,GO:1904730,1,0.984754892204901,0,2,negative regulation of intestinal lipid absorption,BP,
20213,GO:1904732,1,0.987149226600998,0,2,regulation of electron carrier activity,BP,
20214,GO:1904734,1,0.987149232747692,0,1,positive regulation of electron carrier activity,BP,
20215,GO:1904738,1,0.952289502227943,0,14,vascular associated smooth muscle cell migration,BP,
20216,GO:1904742,1,0.977156088738582,0,4,regulation of telomeric DNA binding,BP,
20217,GO:1904743,1,0.999999992770779,0,2,negative regulation of telomeric DNA binding,BP,
20218,GO:1904744,1,0.977156104931498,0,2,positive regulation of telomeric DNA binding,BP,
20219,GO:1904746,1,0.971585141688999,0,6,negative regulation of apoptotic process involved in development,BP,
20220,GO:1904747,1,0.985489173324558,0,3,positive regulation of apoptotic process involved in development,BP,
20221,GO:1904748,1,0.957411465065211,0,10,regulation of apoptotic process involved in development,BP,
20222,GO:1904749,1,0.967280494251397,0,5,regulation of protein localization to nucleolus,BP,
20223,GO:1904750,1,0.999999996376662,0,1,negative regulation of protein localization to nucleolus,BP,
20224,GO:1904751,1,0.967280504261396,0,4,positive regulation of protein localization to nucleolus,BP,
20225,GO:1904752,1,0.952289502227943,0,14,regulation of vascular associated smooth muscle cell migration,BP,
20226,GO:1904753,1,0.98130489782735,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
20227,GO:1904754,1,0.97043621451037,0,11,positive regulation of vascular associated smooth muscle cell migration,BP,
20228,GO:1904760,1,0.994726232061823,0,3,regulation of myofibroblast differentiation,BP,
20229,GO:1904761,1,0.996640133569783,0,2,negative regulation of myofibroblast differentiation,BP,
20230,GO:1904762,1,0.998079698694859,0,1,positive regulation of myofibroblast differentiation,BP,
20231,GO:1904764,1,0.98951607001257,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20232,GO:1904772,1,0.991993536302241,0,1,response to tetrachloromethane,BP,
20233,GO:1904779,1,0.974164046143782,0,6,regulation of protein localization to centrosome,BP,
20234,GO:1904780,1,0.999999996379296,0,1,negative regulation of protein localization to centrosome,BP,
20235,GO:1904781,1,0.98297835238446,0,4,positive regulation of protein localization to centrosome,BP,
20236,GO:1904783,1,0.987631058642231,0,1,positive regulation of NMDA glutamate receptor activity,BP,
20237,GO:1904790,1,0.993426587355053,0,1,regulation of shelterin complex assembly,BP,
20238,GO:1904792,1,0.993426587355053,0,1,positive regulation of shelterin complex assembly,BP,
20239,GO:1904793,1,0.995784523078276,0,1,regulation of euchromatin binding,BP,
20240,GO:1904796,1,0.955213120162847,0,7,regulation of core promoter binding,BP,
20241,GO:1904797,1,0.999999996373144,0,1,negative regulation of core promoter binding,BP,
20242,GO:1904798,1,0.955213132477179,0,6,positive regulation of core promoter binding,BP,
20243,GO:1904799,1,0.997933110681279,0,1,regulation of neuron remodeling,BP,
20244,GO:1904800,1,0.997933110681279,0,1,negative regulation of neuron remodeling,BP,
20245,GO:1904803,1,0.987171617364576,0,1,regulation of translation involved in cellular response to UV,BP,
20246,GO:1904806,1,0.983384249277821,0,2,regulation of protein oxidation,BP,
20247,GO:1904808,1,0.983384249277821,0,2,positive regulation of protein oxidation,BP,
20248,GO:1904812,1,0.997928106866493,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20250,GO:1904814,1,0.894717077942426,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20251,GO:1904815,1,0.982634660623084,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20252,GO:1904816,1,0.910540572929638,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20253,GO:1904823,1,0.973846464305785,0,3,purine nucleobase transmembrane transport,BP,
20254,GO:1904826,1,0.999999996382348,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20255,GO:1904828,1,0.999999996382348,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20256,GO:1904829,1,0.988606833667475,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20257,GO:1904831,1,0.988606833667475,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20259,GO:1904835,1,0.991322336389918,0,1,dorsal root ganglion morphogenesis,BP,
20260,GO:1904837,1,0.731230339581346,0,43,beta-catenin-TCF complex assembly,BP,
20261,GO:1904842,1,0.989974988047088,0,1,response to nitroglycerin,BP,
20262,GO:1904843,1,0.989974988047088,0,1,cellular response to nitroglycerin,BP,
20263,GO:1904844,1,0.976262735206528,0,3,response to L-glutamine,BP,
20264,GO:1904845,1,0.976262735206528,0,3,cellular response to L-glutamine,BP,
20266,GO:1904848,1,0.987564328280312,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20268,GO:1904850,1,0.993426587355053,0,1,negative regulation of establishment of protein localization to telomere,BP,
20269,GO:1904851,1,0.920141420424458,0,9,positive regulation of establishment of protein localization to telomere,BP,
20270,GO:1904854,1,0.990837730402527,0,1,proteasome core complex binding,MF,
20271,GO:1904861,1,0.978332706721566,0,9,excitatory synapse assembly,BP,
20272,GO:1904862,1,0.994705880830991,0,3,inhibitory synapse assembly,BP,
20273,GO:1904863,1,0.997380695482812,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20274,GO:1904864,1,0.997380695482812,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20275,GO:1904867,1,0.918303039071838,0,9,protein localization to Cajal body,BP,
20276,GO:1904868,1,0.999999992787366,0,2,telomerase catalytic core complex assembly,BP,
20277,GO:1904869,1,0.928584643924578,0,8,regulation of protein localization to Cajal body,BP,
20278,GO:1904871,1,0.928584643924578,0,8,positive regulation of protein localization to Cajal body,BP,
20279,GO:1904872,1,0.860698658180098,0,15,regulation of telomerase RNA localization to Cajal body,BP,
20280,GO:1904874,1,0.860698658180098,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20281,GO:1904875,1,0.993249409208299,0,1,regulation of DNA ligase activity,BP,
20282,GO:1904876,1,0.993249409208299,0,1,negative regulation of DNA ligase activity,BP,
20283,GO:1904878,1,0.999999996397891,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20284,GO:1904879,1,0.9893467563742,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20285,GO:1904882,1,0.999999992787366,0,2,regulation of telomerase catalytic core complex assembly,BP,
20286,GO:1904884,1,0.999999992787366,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20287,GO:1904885,1,0.981721027527586,0,5,beta-catenin destruction complex assembly,BP,
20288,GO:1904886,1,0.883186544616049,0,22,beta-catenin destruction complex disassembly,BP,
20289,GO:1904887,1,0.999999996391606,0,1,Wnt signalosome assembly,BP,
20290,GO:1904888,1,0.729234640601501,0,61,cranial skeletal system development,BP,
20291,GO:1904889,1,0.988522406864506,0,1,regulation of excitatory synapse assembly,BP,
20292,GO:1904891,1,0.988522406864506,0,1,positive regulation of excitatory synapse assembly,BP,
20294,GO:1904893,1,0.727983539861066,0,49,negative regulation of STAT cascade,BP,
20296,GO:1904895,1,0.988402199519739,0,1,ESCRT complex assembly,BP,
20297,GO:1904896,1,0.922795280551732,0,10,ESCRT complex disassembly,BP,
20298,GO:1904897,1,0.99529293247965,0,1,regulation of hepatic stellate cell proliferation,BP,
20299,GO:1904899,1,0.99529293247965,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20300,GO:1904902,1,0.988402199519739,0,1,ESCRT III complex assembly,BP,
20301,GO:1904903,1,0.922795280551732,0,10,ESCRT III complex disassembly,BP,
20302,GO:1904907,1,0.999999992794904,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20303,GO:1904908,1,0.999999992794904,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20304,GO:1904910,1,0.993426587355053,0,1,regulation of establishment of RNA localization to telomere,BP,
20305,GO:1904911,1,0.993426587355053,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20306,GO:1904913,1,0.993426587355053,0,1,regulation of establishment of macromolecular complex localization to telomere,BP,
20307,GO:1904914,1,0.993426587355053,0,1,negative regulation of establishment of macromolecular complex localization to telomere,BP,
20308,GO:1904923,1,0.92492522405799,0,13,regulation of mitophagy in response to mitochondrial depolarization,BP,
20309,GO:1904924,1,0.990980517857133,0,2,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20310,GO:1904925,1,0.92492522405799,0,13,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
20311,GO:1904928,1,0.999902614889866,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20312,GO:1904929,1,0.980401625769755,0,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,
20313,GO:1904933,1,0.9878286270944,0,2,regulation of cell proliferation in midbrain,BP,
20314,GO:1904934,1,0.999999996371578,0,1,negative regulation of cell proliferation in midbrain,BP,
20315,GO:1904935,1,0.987828633123592,0,1,positive regulation of cell proliferation in midbrain,BP,
20316,GO:1904936,1,0.966147455457638,0,6,interneuron migration,BP,
20317,GO:1904938,1,0.991245637641152,0,5,planar cell polarity pathway involved in axon guidance,BP,
20318,GO:1904947,1,0.993867374013756,0,1,folic acid import into mitochondrion,BP,
20319,GO:1904948,1,0.887831011493023,0,18,midbrain dopaminergic neuron differentiation,BP,
20321,GO:1904950,1,0.257940365133388,0,205,negative regulation of establishment of protein localization,BP,
20323,GO:1904953,1,0.925618814557058,0,12,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20324,GO:1904954,1,0.967770489148556,0,4,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20325,GO:1904955,1,0.999999996371578,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20326,GO:1904956,1,0.959813173486834,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20327,GO:1904958,1,0.970910140285997,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20328,GO:1904959,1,0.987149226600998,0,2,regulation of cytochrome-c oxidase activity,BP,
20329,GO:1904960,1,0.987149232747692,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20330,GO:1904970,1,0.980754442136988,0,5,brush border assembly,BP,
20331,GO:1904975,1,0.997800768974962,0,2,response to bleomycin,BP,
20332,GO:1904976,1,0.997800768974962,0,2,cellular response to bleomycin,BP,
20333,GO:1904978,1,0.98988416558719,0,3,regulation of endosome organization,BP,
20334,GO:1904979,1,0.990263027701851,0,1,negative regulation of endosome organization,BP,
20335,GO:1904980,1,0.999999996379246,0,1,positive regulation of endosome organization,BP,
20336,GO:1904990,1,0.991123018937076,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20337,GO:1904992,1,0.991123018937076,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20338,GO:1904994,1,0.916617526217866,0,11,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20339,GO:1904995,1,0.945594197423462,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20340,GO:1904996,1,0.969369518791702,0,6,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20341,GO:1904997,1,0.981887609827104,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20342,GO:1904998,1,0.993409576390941,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20343,GO:1904999,1,0.988402199519739,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20344,GO:1905000,1,0.999999996387591,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20345,GO:1905003,1,0.987629738760797,0,1,picolinic acid metabolic process,BP,
20346,GO:1905004,1,0.987629738760797,0,1,picolinic acid biosynthetic process,BP,
20347,GO:1905005,1,0.976608462268105,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20348,GO:1905006,1,0.988954434581258,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20349,GO:1905007,1,0.987443043606807,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20350,GO:1905008,1,0.991743775026976,0,1,regulation of L-lysine import into cell,BP,
20351,GO:1905010,1,0.991743775026976,0,1,positive regulation of L-lysine import into cell,BP,
20352,GO:1905012,1,0.987629738760797,0,1,regulation of 'de novo' NAD biosynthetic process from tryptophan,BP,
20353,GO:1905024,1,0.991137429380841,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20354,GO:1905025,1,0.994067229415098,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20355,GO:1905026,1,0.997212694436933,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20356,GO:1905030,1,0.968719610716689,0,23,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20357,GO:1905031,1,0.991137424016556,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20358,GO:1905032,1,0.994067229415098,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20359,GO:1905033,1,0.997212694436933,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20361,GO:1905038,1,0.901059928907708,0,13,regulation of membrane lipid metabolic process,BP,
20363,GO:1905040,1,0.991322336389918,0,1,otic placode development,BP,
20364,GO:1905041,1,0.999999996381749,0,1,regulation of epithelium regeneration,BP,
20365,GO:1905044,1,0.991657600429728,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20366,GO:1905045,1,0.991657600429728,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20367,GO:1905048,1,0.929109587107541,0,13,regulation of metallopeptidase activity,BP,
20368,GO:1905049,1,0.980678607757789,0,6,negative regulation of metallopeptidase activity,BP,
20369,GO:1905050,1,0.947422920915613,0,7,positive regulation of metallopeptidase activity,BP,
20370,GO:1905051,1,0.976083045525724,0,2,regulation of base-excision repair,BP,
20371,GO:1905053,1,0.976083045525724,0,2,positive regulation of base-excision repair,BP,
20372,GO:1905062,1,0.992340637996542,0,1,positive regulation of cardioblast proliferation,BP,
20373,GO:1905063,1,0.965370217364756,0,7,regulation of vascular smooth muscle cell differentiation,BP,
20374,GO:1905064,1,0.982066401156868,0,3,negative regulation of vascular smooth muscle cell differentiation,BP,
20375,GO:1905065,1,0.98300135402391,0,4,positive regulation of vascular smooth muscle cell differentiation,BP,
20376,GO:1905066,1,0.979650879079118,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20377,GO:1905067,1,0.988771600271842,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20378,GO:1905068,1,0.990776525842959,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20379,GO:1905069,1,0.988211744114575,0,2,allantois development,BP,
20380,GO:1905071,1,0.994645053528112,0,2,occluding junction disassembly,BP,
20381,GO:1905073,1,0.994645053528112,0,2,regulation of occluding junction disassembly,BP,
20382,GO:1905075,1,0.994645053528112,0,2,positive regulation of occluding junction disassembly,BP,
20383,GO:1905089,1,0.999999996406917,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20384,GO:1905090,1,0.999999996406917,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20385,GO:1905097,1,0.986861657455502,0,5,regulation of guanyl-nucleotide exchange factor activity,BP,
20386,GO:1905098,1,0.986861669885896,0,3,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20387,GO:1905099,1,0.999999996374813,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20388,GO:1905103,1,0.998089224294264,0,1,integral component of lysosomal membrane,CC,
20390,GO:1905122,1,0.998089224294264,0,1,polyamine import,BP,
20391,GO:1905123,1,0.997707398907913,0,2,regulation of glucosylceramidase activity,BP,
20392,GO:1905132,1,0.981371220263603,0,2,regulation of meiotic chromosome separation,BP,
20393,GO:1905133,1,0.981371220263603,0,2,negative regulation of meiotic chromosome separation,BP,
20394,GO:1905143,1,0.988144048101768,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20395,GO:1905144,1,0.854155225968502,0,21,response to acetylcholine,BP,
20396,GO:1905145,1,0.854155225968502,0,21,cellular response to acetylcholine,BP,
20397,GO:1905146,1,0.98263552635682,0,4,lysosomal protein catabolic process,BP,
20398,GO:1905150,1,0.994306164863954,0,3,regulation of voltage-gated sodium channel activity,BP,
20399,GO:1905152,1,0.999999996372022,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20400,GO:1905153,1,0.935840658866946,0,12,regulation of membrane invagination,BP,
20401,GO:1905154,1,0.988974443544066,0,2,negative regulation of membrane invagination,BP,
20402,GO:1905155,1,0.953684217626157,0,9,positive regulation of membrane invagination,BP,
20403,GO:1905161,1,0.999941928579223,0,1,protein localization to phagocytic vesicle,BP,
20404,GO:1905162,1,0.999941928579223,0,1,regulation of phagosome maturation,BP,
20405,GO:1905165,1,0.984300671571026,0,3,regulation of lysosomal protein catabolic process,BP,
20406,GO:1905166,1,0.993270582337506,0,2,negative regulation of lysosomal protein catabolic process,BP,
20407,GO:1905169,1,0.999941928579223,0,1,regulation of protein localization to phagocytic vesicle,BP,
20408,GO:1905171,1,0.999941928579223,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20409,GO:1905174,1,0.993154987272083,0,1,regulation of vascular smooth muscle cell dedifferentiation,BP,
20410,GO:1905176,1,0.993154987272083,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
20411,GO:1905202,1,0.98853215831179,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20412,GO:1905203,1,0.987258291866866,0,2,regulation of connective tissue replacement,BP,
20413,GO:1905204,1,0.987755226044422,0,1,negative regulation of connective tissue replacement,BP,
20414,GO:1905205,1,0.999496956963502,0,1,positive regulation of connective tissue replacement,BP,
20415,GO:1905206,1,0.97301687892255,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20416,GO:1905207,1,0.809210818491345,0,38,regulation of cardiocyte differentiation,BP,
20417,GO:1905208,1,0.921128318798038,0,15,negative regulation of cardiocyte differentiation,BP,
20418,GO:1905209,1,0.880957711568376,0,23,positive regulation of cardiocyte differentiation,BP,
20419,GO:1905214,1,0.935208878509016,0,11,regulation of RNA binding,BP,
20420,GO:1905215,1,0.98859458603141,0,1,negative regulation of RNA binding,BP,
20421,GO:1905216,1,0.952062277363576,0,8,positive regulation of RNA binding,BP,
20422,GO:1905217,1,0.994206026079447,0,1,response to astaxanthin,BP,
20423,GO:1905222,1,0.994410183649688,0,1,atrioventricular canal morphogenesis,BP,
20424,GO:1905223,1,0.999999996374811,0,1,epicardium morphogenesis,BP,
20425,GO:1905224,1,0.999295476660839,0,2,clathrin-coated pit assembly,BP,
20426,GO:1905225,1,0.981897754450286,0,2,response to thyrotropin-releasing hormone,BP,
20427,GO:1905229,1,0.987620565988309,0,1,cellular response to thyrotropin-releasing hormone,BP,
20428,GO:1905230,1,0.998041284082169,0,1,response to borneol,BP,
20429,GO:1905231,1,0.998041284082169,0,1,cellular response to borneol,BP,
20430,GO:1905232,1,0.990984799193344,0,3,cellular response to L-glutamate,BP,
20431,GO:1905233,1,0.998041284082169,0,1,response to codeine,BP,
20432,GO:1905235,1,0.998041284082169,0,1,response to quercetin,BP,
20433,GO:1905237,1,0.985284894457377,0,2,response to cyclosporin A,BP,
20434,GO:1905239,1,0.9998403269044,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20435,GO:1905240,1,0.9998403269044,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20436,GO:1905242,1,0.992223473798253,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
20437,GO:1905243,1,0.992223473798253,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20438,GO:1905244,1,0.994497478253564,0,2,regulation of modification of synaptic structure,BP,
20439,GO:1905245,1,0.997371174299022,0,2,regulation of aspartic-type peptidase activity,BP,
20440,GO:1905246,1,0.999999996400475,0,1,negative regulation of aspartic-type peptidase activity,BP,
20441,GO:1905247,1,0.997371178419702,0,1,positive regulation of aspartic-type peptidase activity,BP,
20442,GO:1905255,1,0.999999996375385,0,1,regulation of RNA binding transcription factor activity,BP,
20443,GO:1905258,1,0.975585875868086,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20444,GO:1905259,1,0.975585875868086,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20445,GO:1905267,1,0.987722884113335,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20446,GO:1905268,1,0.792856905020681,0,48,negative regulation of chromatin organization,BP,
20447,GO:1905269,1,0.611235245431252,0,88,positive regulation of chromatin organization,BP,
20448,GO:1905271,1,0.987181860145396,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20449,GO:1905273,1,0.987181860145396,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20450,GO:1905274,1,0.99999999638,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20451,GO:1905276,1,0.92992370370246,0,18,regulation of epithelial tube formation,BP,
20452,GO:1905277,1,0.994074538118583,0,1,negative regulation of epithelial tube formation,BP,
20453,GO:1905278,1,0.973713518315914,0,4,positive regulation of epithelial tube formation,BP,
20454,GO:1905279,1,0.999999996391606,0,1,regulation of retrograde transport, endosome to Golgi,BP,
20455,GO:1905285,1,0.996656886905039,0,1,fibrous ring of heart morphogenesis,BP,
20456,GO:1905286,1,0.976123092660762,0,3,serine-type peptidase complex,CC,
20457,GO:1905289,1,0.999999996391606,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20458,GO:1905301,1,0.999347329516822,0,1,regulation of macropinocytosis,BP,
20459,GO:1905302,1,0.999347329516822,0,1,negative regulation of macropinocytosis,BP,
20460,GO:1905304,1,0.999999996388895,0,1,regulation of cardiac myofibril assembly,BP,
20461,GO:1905305,1,0.999999996388895,0,1,negative regulation of cardiac myofibril assembly,BP,
20462,GO:1905313,1,0.990137054666132,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20463,GO:1905314,1,0.912810096058125,0,16,semi-lunar valve development,BP,
20464,GO:1905323,1,0.966482370421758,0,6,telomerase holoenzyme complex assembly,BP,
20465,GO:1905327,1,0.988187278153849,0,1,tracheoesophageal septum formation,BP,
20467,GO:1905331,1,0.919589541287795,0,18,negative regulation of morphogenesis of an epithelium,BP,
20468,GO:1905332,1,0.838268883685788,0,32,positive regulation of morphogenesis of an epithelium,BP,
20469,GO:1905333,1,0.988389825126606,0,1,regulation of gastric motility,BP,
20470,GO:1905335,1,0.999999996412681,0,1,regulation of aggrephagy,BP,
20471,GO:1905337,1,0.999999996412681,0,1,positive regulation of aggrephagy,BP,
20472,GO:1905340,1,0.963018477901576,0,4,regulation of protein localization to kinetochore,BP,
20473,GO:1905341,1,0.992204790093199,0,1,negative regulation of protein localization to kinetochore,BP,
20474,GO:1905342,1,0.963018477901576,0,4,positive regulation of protein localization to kinetochore,BP,
20475,GO:1905344,1,0.991657600429728,0,1,prostaglandin catabolic process,BP,
20477,GO:1905354,1,0.836997841740254,0,22,exoribonuclease complex,CC,
20478,GO:1905355,1,0.999900199325551,0,1,spine apparatus assembly,BP,
20479,GO:1905359,1,0.993899064481029,0,1,protein localization to meiotic spindle,BP,
20480,GO:1905360,1,0.764727579483593,0,35,GTPase complex,CC,
20481,GO:1905361,1,0.923631969941499,0,9,L-serine transporter activity,MF,
20482,GO:1905365,1,0.990263027701851,0,1,regulation of intralumenal vesicle formation,BP,
20483,GO:1905366,1,0.990263027701851,0,1,negative regulation of intralumenal vesicle formation,BP,
20486,GO:1905370,1,0.990980523232525,0,1,serine-type endopeptidase complex,CC,
20487,GO:1905371,1,0.988039238558463,0,2,ceramide phosphoethanolamine metabolic process,BP,
20488,GO:1905373,1,0.988039238558463,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20489,GO:1905383,1,0.96953625756276,0,3,protein localization to presynapse,BP,
20490,GO:1905384,1,0.982016640496325,0,2,regulation of protein localization to presynapse,BP,
20491,GO:1905386,1,0.982016640496325,0,2,positive regulation of protein localization to presynapse,BP,
20492,GO:1905392,1,0.987233076566383,0,1,plant organ morphogenesis,BP,
20493,GO:1905394,1,0.981538679955917,0,3,retromer complex binding,MF,
20494,GO:1905395,1,0.984637935512759,0,3,response to flavonoid,BP,
20495,GO:1905397,1,0.988114507603045,0,1,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20496,GO:1905402,1,0.988114507603045,0,1,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20497,GO:1905404,1,0.988114507603045,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20498,GO:1905407,1,0.984220601535555,0,2,regulation of creatine transmembrane transporter activity,BP,
20499,GO:1905408,1,0.984220601535555,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20500,GO:1905419,1,0.988849558772555,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20501,GO:1905421,1,0.987233076566383,0,1,regulation of plant organ morphogenesis,BP,
20502,GO:1905422,1,0.987233076566383,0,1,negative regulation of plant organ morphogenesis,BP,
20503,GO:1905424,1,0.981937307847331,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20504,GO:1905426,1,0.981937307847331,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20505,GO:1905432,1,0.99835484977967,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20506,GO:1905433,1,0.99835484977967,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20507,GO:1905438,1,0.987962356082147,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20508,GO:1905443,1,0.999268383379952,0,1,regulation of clathrin coat assembly,BP,
20509,GO:1905445,1,0.999268383379952,0,1,positive regulation of clathrin coat assembly,BP,
20510,GO:1905446,1,0.94621843340623,0,6,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20511,GO:1905447,1,0.987262624889732,0,2,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20512,GO:1905448,1,0.95843040630948,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20513,GO:1905449,1,0.988946375428385,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20514,GO:1905451,1,0.988946375428385,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20515,GO:1905453,1,0.994818561725759,0,1,regulation of myeloid progenitor cell differentiation,BP,
20516,GO:1905456,1,0.961405221944822,0,8,regulation of lymphoid progenitor cell differentiation,BP,
20517,GO:1905457,1,0.97578786700758,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20518,GO:1905458,1,0.997992570586687,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20519,GO:1905462,1,0.998360581988621,0,1,regulation of DNA duplex unwinding,BP,
20520,GO:1905464,1,0.998360581988621,0,1,positive regulation of DNA duplex unwinding,BP,
20521,GO:1905468,1,0.999941928579223,0,1,regulation of clathrin-coated pit assembly,BP,
20522,GO:1905469,1,0.999941928579223,0,1,negative regulation of clathrin-coated pit assembly,BP,
20523,GO:1905474,1,0.988025457538679,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20524,GO:1905475,1,0.42996964183166,0,131,regulation of protein localization to membrane,BP,
20525,GO:1905476,1,0.846569788859881,0,26,negative regulation of protein localization to membrane,BP,
20526,GO:1905477,1,0.544831688709102,0,93,positive regulation of protein localization to membrane,BP,
20527,GO:1905483,1,0.99999999640376,0,1,regulation of motor neuron migration,BP,
20528,GO:1905485,1,0.99999999640376,0,1,positive regulation of motor neuron migration,BP,
20529,GO:1905508,1,0.908337807644854,0,23,protein localization to microtubule organizing center,BP,
20530,GO:1905515,1,0.793367097339117,0,47,non-motile cilium assembly,BP,
20531,GO:1905516,1,0.929998201672645,0,9,positive regulation of fertilization,BP,
20532,GO:1905517,1,0.760584037457926,0,32,macrophage migration,BP,
20533,GO:1905518,1,0.999770119379547,0,1,regulation of presynaptic active zone assembly,BP,
20534,GO:1905520,1,0.999770119379547,0,1,positive regulation of presynaptic active zone assembly,BP,
20535,GO:1905521,1,0.841324502939278,0,22,regulation of macrophage migration,BP,
20536,GO:1905522,1,0.97601656876541,0,4,negative regulation of macrophage migration,BP,
20537,GO:1905523,1,0.87338478613168,0,16,positive regulation of macrophage migration,BP,
20538,GO:1905524,1,0.999999996382739,0,1,negative regulation of protein autoubiquitination,BP,
20539,GO:1905535,1,0.999937493070012,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20540,GO:1905537,1,0.999937493070012,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20541,GO:1905546,1,0.990459934296563,0,1,cellular response to phenylpropanoid,BP,
20542,GO:1905547,1,0.98833394167051,0,1,regulation of telomeric heterochromatin assembly,BP,
20543,GO:1905549,1,0.98833394167051,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20544,GO:1905550,1,0.97887543200099,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20545,GO:1905552,1,0.97887543200099,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20546,GO:1905553,1,0.98833394167051,0,1,regulation of blood vessel branching,BP,
20547,GO:1905555,1,0.98833394167051,0,1,positive regulation blood vessel branching,BP,
20548,GO:1905562,1,0.98833394167051,0,1,regulation of vascular endothelial cell proliferation,BP,
20549,GO:1905564,1,0.98833394167051,0,1,positive regulation of vascular endothelial cell proliferation,BP,
20550,GO:1905572,1,0.992949915143634,0,1,ganglioside GM1 transport to membrane,BP,
20551,GO:1905573,1,0.982137497873756,0,2,ganglioside GM1 binding,MF,
20552,GO:1905574,1,0.992949915143634,0,1,ganglioside GM2 binding,MF,
20553,GO:1905575,1,0.992949915143634,0,1,ganglioside GM3 binding,MF,
20554,GO:1905576,1,0.973288413944293,0,3,ganglioside GT1b binding,MF,
20555,GO:1905577,1,0.992949915143634,0,1,ganglioside GP1c binding,MF,
20556,GO:1905578,1,0.991138235779663,0,1,regulation of ERBB3 signaling pathway,BP,
20557,GO:1905580,1,0.991138235779663,0,1,positive regulation of ERBB3 signaling pathway,BP,
20558,GO:1905581,1,0.988332745727326,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
20559,GO:1905590,1,0.994378626543239,0,1,fibronectin fibril organization,BP,
20560,GO:1905594,1,0.98749644272876,0,1,resveratrol binding,MF,
20561,GO:1905595,1,0.985111765804823,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20562,GO:1905596,1,0.996741300368013,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20563,GO:1905597,1,0.988332745727326,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20564,GO:1905598,1,0.996741300368013,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20565,GO:1905599,1,0.988332745727326,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20566,GO:1905600,1,0.978647424693763,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20567,GO:1905601,1,0.996741300368013,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20568,GO:1905602,1,0.981847436659169,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20569,GO:1905603,1,0.999833560951617,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20570,GO:1905605,1,0.999833560951617,0,1,positive regulation of maintenance of permeability of blood-brain barrier,BP,
20571,GO:1905606,1,0.994274482102358,0,3,regulation of presynapse assembly,BP,
20572,GO:1905608,1,0.999770119379547,0,1,positive regulation of presynapse assembly,BP,
20573,GO:1905610,1,0.999937493070012,0,1,regulation of mRNA cap binding,BP,
20574,GO:1905612,1,0.999937493070012,0,1,positive regulation of mRNA cap binding,BP,
20575,GO:1905616,1,0.991595609174297,0,2,regulation of miRNA mediated inhibition of translation,BP,
20576,GO:1905618,1,0.991595609174297,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20577,GO:1905634,1,0.980495949860255,0,3,regulation of protein localization to chromatin,BP,
20578,GO:1905636,1,0.987628421255001,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20579,GO:1905642,1,0.988515837780714,0,1,negative regulation of DNA methylation,BP,
20580,GO:1905643,1,0.988515837780714,0,1,positive regulation of DNA methylation,BP,
20581,GO:1905651,1,0.998917620685057,0,2,regulation of artery morphogenesis,BP,
20582,GO:1905653,1,0.998917620685057,0,2,positive regulation of artery morphogenesis,BP,
20583,GO:1905661,1,0.986935798535064,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20584,GO:1905663,1,0.986935798535064,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20585,GO:1905664,1,0.98219622467152,0,2,regulation of calcium ion import across plasma membrane,BP,
20586,GO:1905666,1,0.991703794780613,0,4,regulation of protein localization to endosome,BP,
20587,GO:1905668,1,0.991703794780613,0,4,positive regulation of protein localization to endosome,BP,
20588,GO:1905671,1,0.989562021823634,0,2,regulation of lysosome organization,BP,
20589,GO:1905672,1,0.989940756060877,0,1,negative regulation of lysosome organization,BP,
20590,GO:1905687,1,0.999999968551553,0,1,regulation of diacylglycerol kinase activity,BP,
20591,GO:1905689,1,0.999999968551553,0,1,positive regulation of diacylglycerol kinase activity,BP,
20592,GO:1905693,1,0.989936963505739,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20593,GO:1905695,1,0.989936963505739,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20594,GO:1905696,1,0.999937493070012,0,1,regulation of polysome binding,BP,
20595,GO:1905705,1,0.999999996378359,0,1,cellular response to paclitaxel,BP,
20597,GO:1905710,1,0.63460591165179,0,57,positive regulation of membrane permeability,BP,
20598,GO:1905711,1,0.997376890728512,0,1,response to phosphatidylethanolamine,BP,
20599,GO:1905715,1,0.991580909742357,0,1,regulation of cornification,BP,
20600,GO:1905716,1,0.991580909742357,0,1,negative regulation of cornification,BP,
20601,GO:1905747,1,0.976169736435076,0,2,negative regulation of saliva secretion,BP,
20602,GO:1905748,1,0.976169736435076,0,2,hard palate morphogenesis,BP,
20603,GO:1905764,1,0.985115762489917,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20604,GO:1905765,1,0.985115762489917,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20605,GO:1905767,1,0.999999996377291,0,1,regulation of double-stranded telomeric DNA binding,BP,
20606,GO:1905768,1,0.999999996377291,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20607,GO:1905770,1,0.947575827139454,0,7,regulation of mesodermal cell differentiation,BP,
20608,GO:1905771,1,0.957066768601283,0,4,negative regulation of mesodermal cell differentiation,BP,
20609,GO:1905772,1,0.993409576390941,0,1,positive regulation of mesodermal cell differentiation,BP,
20610,GO:1905774,1,0.998360581988621,0,1,regulation of DNA helicase activity,BP,
20611,GO:1905776,1,0.998360581988621,0,1,positive regulation of DNA helicase activity,BP,
20612,GO:1905777,1,0.986724836327325,0,2,regulation of exonuclease activity,BP,
20613,GO:1905778,1,0.986724836327325,0,2,negative regulation of exonuclease activity,BP,
20614,GO:1905793,1,0.99976700829023,0,2,protein localization to pericentriolar material,BP,
20615,GO:1905794,1,0.999999996396069,0,1,response to puromycin,BP,
20616,GO:1905795,1,0.999999996396069,0,1,cellular response to puromycin,BP,
20617,GO:1905802,1,0.993026991574692,0,1,regulation of cellular response to manganese ion,BP,
20618,GO:1905809,1,0.946789702747929,0,12,negative regulation of synapse organization,BP,
20619,GO:1905818,1,0.731789120255649,0,47,regulation of chromosome separation,BP,
20620,GO:1905819,1,0.802532800586702,0,31,negative regulation of chromosome separation,BP,
20621,GO:1905820,1,0.973661253766844,0,6,positive regulation of chromosome separation,BP,
20622,GO:1905838,1,0.986724836327325,0,2,regulation of telomeric D-loop disassembly,BP,
20623,GO:1905839,1,0.986724836327325,0,2,negative regulation of telomeric D-loop disassembly,BP,
20624,GO:1905853,1,0.987537367367283,0,1,regulation of heparan sulfate binding,BP,
20625,GO:1905855,1,0.987537367367283,0,1,positive regulation of heparan sulfate binding,BP,
20626,GO:1905858,1,0.987537367367283,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20627,GO:1905860,1,0.987537367367283,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20628,GO:1905867,1,0.961522861830142,0,4,epididymis development,BP,
20629,GO:1905871,1,0.987631058642231,0,1,regulation of protein localization to cell leading edge,BP,
20630,GO:1905873,1,0.987631058642231,0,1,positive regulation of protein localization to cell leading edge,BP,
20631,GO:1905874,1,0.975368141776956,0,4,regulation of postsynaptic density organization,BP,
20632,GO:1905875,1,0.987631058642231,0,1,negative regulation of postsynaptic density organization,BP,
20633,GO:1905879,1,0.947094113005668,0,9,regulation of oogenesis,BP,
20634,GO:1905880,1,0.977251259074416,0,4,negative regulation of oogenesis,BP,
20635,GO:1905881,1,0.978101312237717,0,4,positive regulation of oogenesis,BP,
20636,GO:1905890,1,0.987537367367283,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20637,GO:1905891,1,0.992998068768905,0,1,regulation of cellular response to thapsigargin,BP,
20638,GO:1905892,1,0.992998068768905,0,1,negative regulation of cellular response to thapsigargin,BP,
20639,GO:1905894,1,0.992998068768905,0,1,regulation of cellular response to tunicamycin,BP,
20640,GO:1905895,1,0.992998068768905,0,1,negative regulation of cellular response to tunicamycin,BP,
20641,GO:1905897,1,0.641055570734914,0,69,regulation of response to endoplasmic reticulum stress,BP,
20642,GO:1905898,1,0.789974901141111,0,34,positive regulation of response to endoplasmic reticulum stress,BP,
20643,GO:1905899,1,0.988187278153849,0,1,regulation of smooth muscle tissue development,BP,
20644,GO:1905900,1,0.988187278153849,0,1,negative regulation of smooth muscle tissue development,BP,
20645,GO:1905901,1,0.988187278153849,0,1,positive regulation of smooth muscle tissue development,BP,
20646,GO:1905902,1,0.947575827139454,0,7,regulation of mesoderm formation,BP,
20647,GO:1905903,1,0.957066768601283,0,4,negative regulation of mesoderm formation,BP,
20648,GO:1905904,1,0.993409576390941,0,1,positive regulation of mesoderm formation,BP,
20649,GO:1905906,1,0.970461563759267,0,3,regulation of amyloid fibril formation,BP,
20650,GO:1905907,1,0.980286752422259,0,2,negative regulation of amyloid fibril formation,BP,
20651,GO:1905912,1,0.988890051139162,0,1,regulation of calcium ion export from cell,BP,
20652,GO:1905913,1,0.988890051139162,0,1,negative regulation of calcium ion export from cell,BP,
20653,GO:1905918,1,0.989978802561866,0,1,regulation of CoA-transferase activity,BP,
20654,GO:1905920,1,0.989978802561866,0,1,positive regulation of CoA-transferase activity,BP,
20655,GO:1905936,1,0.955354666296833,0,4,regulation of germ cell proliferation,BP,
20656,GO:1905937,1,0.96759844756856,0,3,negative regulation of germ cell proliferation,BP,
20657,GO:1905938,1,0.987349493956015,0,1,positive regulation of germ cell proliferation,BP,
20658,GO:1905939,1,0.885063018736289,0,17,regulation of gonad development,BP,
20659,GO:1905940,1,0.974655021772627,0,5,negative regulation of gonad development,BP,
20660,GO:1905941,1,0.928535509769447,0,10,positive regulation of gonad development,BP,
20661,GO:1905950,1,0.883785321758361,0,19,monosaccharide transmembrane transport,BP,
20665,GO:1905957,1,0.99899806074031,0,1,regulation of cellular response to alcohol,BP,
20666,GO:1905959,1,0.99899806074031,0,1,positive regulation of cellular response to alcohol,BP,
20667,GO:1990000,1,0.925253730365994,0,11,amyloid fibril formation,BP,
20669,GO:1990005,1,0.988519776894314,0,1,granular vesicle,CC,
20670,GO:1990008,1,0.988519776894314,0,1,neurosecretory vesicle,CC,
20671,GO:1990009,1,0.99690957882151,0,2,retinal cell apoptotic process,BP,
20672,GO:1990015,1,0.990991255587827,0,1,ensheathing process,CC,
20673,GO:1990022,1,0.965107265277663,0,3,RNA polymerase III complex localization to nucleus,BP,
20674,GO:1990023,1,0.955641508437144,0,10,mitotic spindle midzone,CC,
20675,GO:1990026,1,0.996264716953498,0,1,hippocampal mossy fiber expansion,CC,
20676,GO:1990029,1,0.994541078442231,0,1,vasomotion,BP,
20677,GO:1990030,1,0.997785017590943,0,1,pericellular basket,CC,
20678,GO:1990031,1,0.994526550883974,0,1,pinceau fiber,CC,
20679,GO:1990032,1,0.999243858965343,0,1,parallel fiber,CC,
20680,GO:1990034,1,0.9805850242316,0,5,calcium ion export from cell,BP,
20681,GO:1990035,1,0.959172755092783,0,11,calcium ion import into cell,BP,
20682,GO:1990036,1,0.979498597448069,0,3,calcium ion import into sarcoplasmic reticulum,BP,
20683,GO:1990037,1,0.968172025030018,0,3,Lewy body core,CC,
20684,GO:1990038,1,0.989257140818515,0,1,Lewy body corona,CC,
20685,GO:1990046,1,0.987663454066629,0,1,stress-induced mitochondrial fusion,BP,
20686,GO:1990047,1,0.99045180488886,0,1,spindle matrix,CC,
20687,GO:1990050,1,0.975242584847235,0,2,phosphatidic acid transporter activity,MF,
20688,GO:1990051,1,0.99577822208814,0,2,activation of protein kinase C activity,BP,
20689,GO:1990071,1,0.999999996378593,0,1,TRAPPII protein complex,CC,
20690,GO:1990072,1,0.991657600429728,0,1,TRAPPIII protein complex,CC,
20691,GO:1990074,1,0.996195997219427,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20692,GO:1990075,1,0.98861787188045,0,4,periciliary membrane compartment,CC,
20693,GO:1990079,1,0.987364001558719,0,1,cartilage homeostasis,BP,
20694,GO:1990081,1,0.987498579156066,0,1,trimethylamine receptor activity,MF,
20695,GO:1990086,1,0.983291255676286,0,4,lens fiber cell apoptotic process,BP,
20696,GO:1990089,1,0.777549129615637,0,45,response to nerve growth factor,BP,
20697,GO:1990090,1,0.790710601320588,0,42,cellular response to nerve growth factor stimulus,BP,
20698,GO:1990108,1,0.99999999638793,0,1,protein linear deubiquitination,BP,
20700,GO:1990117,1,0.987247606983837,0,1,B cell receptor apoptotic signaling pathway,BP,
20701,GO:1990118,1,0.95238988122834,0,13,sodium ion import into cell,BP,
20702,GO:1990123,1,0.997605327731425,0,5,L-glutamate import into cell,BP,
20703,GO:1990124,1,0.973824435955353,0,9,messenger ribonucleoprotein complex,CC,
20704,GO:1990126,1,0.900845556567712,0,18,retrograde transport, endosome to plasma membrane,BP,
20705,GO:1990127,1,0.99863054261301,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20706,GO:1990130,1,0.971751725889783,0,4,GATOR1 complex,CC,
20707,GO:1990134,1,0.999850708903641,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
20708,GO:1990136,1,0.991442100654539,0,1,linoleate 9S-lipoxygenase activity,MF,
20709,GO:1990138,1,0.557575453629182,0,137,neuron projection extension,BP,
20710,GO:1990144,1,0.963033372600633,0,5,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20711,GO:1990145,1,0.995100898158996,0,1,maintenance of translational fidelity,BP,
20712,GO:1990164,1,0.987163019042818,0,2,histone H2A phosphorylation,BP,
20713,GO:1990166,1,0.990789158510465,0,1,protein localization to site of double-strand break,BP,
20714,GO:1990167,1,0.988449940255658,0,3,protein K27-linked deubiquitination,BP,
20715,GO:1990168,1,0.988241279848548,0,3,protein K33-linked deubiquitination,BP,
20716,GO:1990169,1,0.987317673364274,0,2,stress response to copper ion,BP,
20717,GO:1990170,1,0.989449560760648,0,1,stress response to cadmium ion,BP,
20718,GO:1990172,1,0.999999996371812,0,1,G-protein coupled receptor catabolic process,BP,
20719,GO:1990173,1,0.918303039071838,0,9,protein localization to nucleoplasm,BP,
20720,GO:1990174,1,0.997580126899744,0,1,phosphodiesterase decapping endonuclease activity,MF,
20721,GO:1990175,1,0.997845331374933,0,1,EH domain binding,MF,
20722,GO:1990180,1,0.990435569307827,0,1,mitochondrial tRNA 3'-end processing,BP,
20723,GO:1990182,1,0.86874285251436,0,18,exosomal secretion,BP,
20724,GO:1990183,1,0.987267833101111,0,1,lymphatic vascular process in circulatory system,BP,
20725,GO:1990186,1,0.987267833101111,0,1,regulation of lymphatic vessel size,BP,
20726,GO:1990188,1,0.991956643343067,0,1,euchromatin binding,MF,
20727,GO:1990189,1,0.970978570744968,0,3,peptide-serine-N-acetyltransferase activity,MF,
20728,GO:1990190,1,0.975495328343631,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20729,GO:1990192,1,0.987267833101111,0,1,collecting lymphatic vessel constriction,BP,
20730,GO:1990204,1,0.394646253057294,0,96,oxidoreductase complex,CC,
20731,GO:1990226,1,0.951542307956975,0,6,histone methyltransferase binding,MF,
20733,GO:1990239,1,0.981293129028777,0,5,steroid hormone binding,MF,
20734,GO:1990246,1,0.983384249277821,0,2,uniplex complex,CC,
20735,GO:1990247,1,0.979667175708464,0,7,N6-methyladenosine-containing RNA binding,MF,
20736,GO:1990253,1,0.986776430869068,0,6,cellular response to leucine starvation,BP,
20737,GO:1990254,1,0.968851364584217,0,5,keratin filament binding,MF,
20738,GO:1990256,1,0.999999996404728,0,1,signal clustering,BP,
20739,GO:1990258,1,0.987526012197698,0,1,histone glutamine methylation,BP,
20740,GO:1990259,1,0.987526012197698,0,1,histone-glutamine methyltransferase activity,MF,
20741,GO:1990262,1,0.981563748229446,0,2,anti-Mullerian hormone signaling pathway,BP,
20742,GO:1990264,1,0.995285849228816,0,1,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20743,GO:1990266,1,0.418756791786034,0,93,neutrophil migration,BP,
20744,GO:1990267,1,0.994823369225241,0,1,response to transition metal nanoparticle,BP,
20745,GO:1990268,1,0.994823369225241,0,1,response to gold nanoparticle,BP,
20746,GO:1990269,1,0.989796779495028,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20747,GO:1990272,1,0.988957146665087,0,1,anti-Mullerian hormone receptor activity,MF,
20748,GO:1990275,1,0.993188860985684,0,1,preribosome binding,MF,
20749,GO:1990314,1,0.950082608735646,0,7,cellular response to insulin-like growth factor stimulus,BP,
20750,GO:1990316,1,0.987702307764594,0,6,ATG1/ULK1 kinase complex,CC,
20751,GO:1990332,1,0.998142609797833,0,1,Ire1 complex,CC,
20752,GO:1990349,1,0.989404570639733,0,1,gap junction-mediated intercellular transport,BP,
20754,GO:1990356,1,0.987564328280312,0,1,sumoylated E2 ligase complex,CC,
20755,GO:1990357,1,0.974484900269293,0,3,terminal web,CC,
20756,GO:1990379,1,0.977752181309879,0,2,lipid transport across blood brain barrier,BP,
20757,GO:1990380,1,0.984243249445694,0,7,Lys48-specific deubiquitinase activity,MF,
20758,GO:1990381,1,0.942011141725836,0,12,ubiquitin-specific protease binding,MF,
20759,GO:1990384,1,0.987664834036443,0,1,hyaloid vascular plexus regression,BP,
20760,GO:1990386,1,0.98932263108283,0,1,mitotic cleavage furrow ingression,BP,
20761,GO:1990390,1,0.995980586667751,0,1,protein K33-linked ubiquitination,BP,
20762,GO:1990391,1,0.805509338302348,0,37,DNA repair complex,CC,
20763,GO:1990393,1,0.984580560427008,0,5,3M complex,CC,
20764,GO:1990399,1,0.999999996381749,0,1,epithelium regeneration,BP,
20765,GO:1990401,1,0.992643465411783,0,1,embryonic lung development,BP,
20766,GO:1990402,1,0.990137054666132,0,1,embryonic liver development,BP,
20767,GO:1990403,1,0.954444661376549,0,9,embryonic brain development,BP,
20768,GO:1990404,1,0.987096535645984,0,2,protein ADP-ribosylase activity,MF,
20769,GO:1990405,1,0.973341804790095,0,5,protein antigen binding,MF,
20770,GO:1990414,1,0.987290871367212,0,2,replication-born double-strand break repair via sister chromatid exchange,BP,
20771,GO:1990415,1,0.981449969479126,0,2,Pex17p-Pex14p docking complex,CC,
20772,GO:1990416,1,0.967580400008477,0,7,cellular response to brain-derived neurotrophic factor stimulus,BP,
20773,GO:1990418,1,0.975214131423518,0,3,response to insulin-like growth factor stimulus,BP,
20774,GO:1990421,1,0.999999996401411,0,1,subtelomeric heterochromatin,CC,
20775,GO:1990423,1,0.988157262779752,0,3,RZZ complex,CC,
20776,GO:1990425,1,0.999999996379559,0,1,ryanodine receptor complex,CC,
20777,GO:1990426,1,0.990292850721077,0,2,mitotic recombination-dependent replication fork processing,BP,
20778,GO:1990427,1,0.99999999638094,0,1,stereocilia tip-link density,CC,
20779,GO:1990428,1,0.996934118973138,0,1,miRNA transport,BP,
20780,GO:1990429,1,0.981449969479126,0,2,peroxisomal importomer complex,CC,
20781,GO:1990430,1,0.979703868918736,0,4,extracellular matrix protein binding,MF,
20782,GO:1990435,1,0.99999999638094,0,1,upper tip-link density,CC,
20783,GO:1990439,1,0.993489804210426,0,1,MAP kinase threonine phosphatase activity,MF,
20784,GO:1990440,1,0.914078366947442,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20785,GO:1990441,1,0.960517420397622,0,5,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20786,GO:1990442,1,0.963194987052164,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
20787,GO:1990446,1,0.930373020746397,0,6,U1 snRNP binding,MF,
20788,GO:1990450,1,0.989717181009479,0,1,linear polyubiquitin binding,MF,
20789,GO:1990451,1,0.9912211801381,0,1,cellular stress response to acidic pH,BP,
20790,GO:1990452,1,0.991990174708881,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
20791,GO:1990454,1,0.987800684546642,0,6,L-type voltage-gated calcium channel complex,CC,
20792,GO:1990459,1,0.936042412726538,0,8,transferrin receptor binding,MF,
20793,GO:1990460,1,0.981284520709076,0,3,leptin receptor binding,MF,
20794,GO:1990462,1,0.995673931568172,0,1,omegasome,CC,
20795,GO:1990478,1,0.989163209201944,0,1,response to ultrasound,BP,
20797,GO:1990498,1,0.999999996387929,0,1,mitotic spindle microtubule,CC,
20798,GO:1990502,1,0.996762263387916,0,2,dense core granule maturation,BP,
20799,GO:1990504,1,0.99777773271454,0,5,dense core granule exocytosis,BP,
20800,GO:1990505,1,0.990292850721077,0,2,mitotic DNA replication maintenance of fidelity,BP,
20801,GO:1990511,1,0.992969168767015,0,1,piRNA biosynthetic process,BP,
20802,GO:1990512,1,0.995000727562481,0,1,Cry-Per complex,CC,
20803,GO:1990519,1,0.987473057819827,0,2,mitochondrial pyrimidine nucleotide import,BP,
20804,GO:1990523,1,0.973107882724284,0,4,bone regeneration,BP,
20805,GO:1990539,1,0.990619980762556,0,1,fructose import across plasma membrane,BP,
20807,GO:1990564,1,0.952986825639194,0,5,protein polyufmylation,BP,
20808,GO:1990565,1,0.988422165401928,0,1,HSP90-CDC37 chaperone complex,CC,
20809,GO:1990569,1,0.989948342177731,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
20810,GO:1990572,1,0.998092392517714,0,1,TERT-RMRP complex,CC,
20811,GO:1990573,1,0.947537910620168,0,9,potassium ion import across plasma membrane,BP,
20812,GO:1990578,1,0.999999996370066,0,1,perinuclear endoplasmic reticulum membrane,CC,
20813,GO:1990579,1,0.998142609797833,0,1,peptidyl-serine trans-autophosphorylation,BP,
20814,GO:1990583,1,0.98932263108283,0,1,phospholipase D activator activity,MF,
20815,GO:1990584,1,0.962434439511871,0,3,cardiac Troponin complex,CC,
20816,GO:1990589,1,0.988534274357424,0,2,ATF4-CREB1 transcription factor complex,CC,
20817,GO:1990590,1,0.979760430060375,0,2,ATF1-ATF4 transcription factor complex,CC,
20818,GO:1990592,1,0.952986825639194,0,5,protein K69-linked ufmylation,BP,
20819,GO:1990595,1,0.989501994193282,0,1,mast cell secretagogue receptor activity,MF,
20820,GO:1990597,1,0.9878725163628,0,3,AIP1-IRE1 complex,CC,
20821,GO:1990599,1,0.985115762489917,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
20822,GO:1990603,1,0.995162711325382,0,1,dark adaptation,BP,
20823,GO:1990604,1,0.9852984046798,0,4,IRE1-TRAF2-ASK1 complex,CC,
20824,GO:1990613,1,0.996227084658062,0,1,mitochondrial membrane fusion,BP,
20825,GO:1990614,1,0.995417670965192,0,1,mitochondrial magnesium ion transmembrane transport,BP,
20826,GO:1990617,1,0.97598023540381,0,2,CHOP-ATF4 complex,CC,
20827,GO:1990619,1,0.985896747429166,0,2,histone H3-K9 deacetylation,BP,
20828,GO:1990622,1,0.976988074347461,0,2,CHOP-ATF3 complex,CC,
20829,GO:1990630,1,0.998142609797833,0,1,IRE1-RACK1-PP2A complex,CC,
20830,GO:1990635,1,0.987198716844257,0,3,proximal dendrite,CC,
20831,GO:1990637,1,0.970144406275375,0,4,response to prolactin,BP,
20832,GO:1990641,1,0.976502497677895,0,2,response to iron ion starvation,BP,
20833,GO:1990646,1,0.981412919585678,0,2,cellular response to prolactin,BP,
20834,GO:1990654,1,0.999768957346146,0,1,sebum secreting cell proliferation,BP,
20835,GO:1990666,1,0.996691342148488,0,2,PCSK9-LDLR complex,CC,
20836,GO:1990667,1,0.985111765804823,0,2,PCSK9-AnxA2 complex,CC,
20837,GO:1990668,1,0.954445603137828,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
20838,GO:1990682,1,0.989183623958624,0,2,CSF1-CSF1R complex,CC,
20839,GO:1990696,1,0.989487951983213,0,2,USH2 complex,CC,
20840,GO:1990697,1,0.990219486254554,0,1,protein depalmitoleylation,BP,
20841,GO:1990698,1,0.986677254794654,0,2,palmitoleoyltransferase activity,MF,
20842,GO:1990699,1,0.990219486254554,0,1,palmitoleyl hydrolase activity,MF,
20843,GO:1990700,1,0.997889497515149,0,1,nucleolar chromatin organization,BP,
20844,GO:1990705,1,0.999999996388895,0,1,cholangiocyte proliferation,BP,
20845,GO:1990707,1,0.999999996401411,0,1,nuclear subtelomeric heterochromatin,CC,
20846,GO:1990708,1,0.999798273745579,0,1,conditioned place preference,BP,
20847,GO:1990709,1,0.987808130688874,0,3,presynaptic active zone organization,BP,
20848,GO:1990712,1,0.948933230995954,0,8,HFE-transferrin receptor complex,CC,
20849,GO:1990715,1,0.987691537487321,0,2,mRNA CDS binding,MF,
20850,GO:1990716,1,0.988530303692535,0,3,axonemal central apparatus,CC,
20851,GO:1990718,1,0.999999996394007,0,1,axonemal central pair projection,CC,
20852,GO:1990723,1,0.993896626772147,0,1,cytoplasmic periphery of the nuclear pore complex,CC,
20853,GO:1990726,1,0.953157564939705,0,4,Lsm1-7-Pat1 complex,CC,
20854,GO:1990729,1,0.989262143582812,0,1,primary miRNA modification,BP,
20855,GO:1990730,1,0.993993665020751,0,2,VCP-NSFL1C complex,CC,
20856,GO:1990736,1,0.998296792324339,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
20857,GO:1990737,1,0.986617393403018,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
20858,GO:1990739,1,0.999999996388895,0,1,granulosa cell proliferation,BP,
20859,GO:1990742,1,0.997957543163486,0,2,microvesicle,CC,
20860,GO:1990743,1,0.999999996396302,0,1,protein sialylation,BP,
20861,GO:1990744,1,0.989262143582812,0,1,primary miRNA methylation,BP,
20862,GO:1990745,1,0.985285747738338,0,3,EARP complex,CC,
20864,GO:1990751,1,0.99999999638,0,1,Schwann cell chemotaxis,BP,
20865,GO:1990752,1,0.935949078358107,0,22,microtubule end,CC,
20866,GO:1990755,1,0.991657600429728,0,1,mitotic spindle microtubule depolymerization,BP,
20867,GO:1990761,1,0.988065052096118,0,3,growth cone lamellipodium,CC,
20868,GO:1990763,1,0.991393172480872,0,2,arrestin family protein binding,MF,
20869,GO:1990769,1,0.983370477214827,0,2,proximal neuron projection,CC,
20870,GO:1990771,1,0.999999996373196,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
20871,GO:1990773,1,0.988581050160872,0,1,matrix metallopeptidase secretion,BP,
20872,GO:1990774,1,0.948614638414781,0,8,tumor necrosis factor secretion,BP,
20873,GO:1990776,1,0.89558306715175,0,18,response to angiotensin,BP,
20875,GO:1990778,1,0.278456428886435,0,229,protein localization to cell periphery,BP,
20876,GO:1990782,1,0.718511926369724,0,59,protein tyrosine kinase binding,MF,
20877,GO:1990784,1,0.99819499337964,0,1,response to dsDNA,BP,
20878,GO:1990785,1,0.995024602815223,0,3,response to water-immersion restraint stress,BP,
20879,GO:1990786,1,0.99819499337964,0,1,cellular response to dsDNA,BP,
20880,GO:1990790,1,0.987828633123592,0,1,response to glial cell derived neurotrophic factor,BP,
20881,GO:1990791,1,0.981627031947617,0,3,dorsal root ganglion development,BP,
20882,GO:1990792,1,0.987828633123592,0,1,cellular response to glial cell derived neurotrophic factor,BP,
20883,GO:1990796,1,0.993477643266988,0,1,photoreceptor cell terminal bouton,CC,
20884,GO:1990809,1,0.990391082169678,0,1,endoplasmic reticulum tubular network membrane organization,BP,
20885,GO:1990812,1,0.987115186710602,0,3,growth cone filopodium,CC,
20886,GO:1990822,1,0.95188298605972,0,6,basic amino acid transmembrane transport,BP,
20887,GO:1990823,1,0.999647572763174,0,1,response to leukemia inhibitory factor,BP,
20888,GO:1990825,1,0.946533770616732,0,8,sequence-specific mRNA binding,MF,
20889,GO:1990828,1,0.989971175718913,0,1,hepatocyte dedifferentiation,BP,
20890,GO:1990829,1,0.983860272871717,0,2,C-rich single-stranded DNA binding,MF,
20891,GO:1990830,1,0.999647572763174,0,1,cellular response to leukemia inhibitory factor,BP,
20892,GO:1990834,1,0.977610353448651,0,3,response to odorant,BP,
20894,GO:1990839,1,0.990566313287312,0,1,response to endothelin,BP,
20895,GO:1990841,1,0.875035339329069,0,28,promoter-specific chromatin binding,MF,
20896,GO:1990843,1,0.999999996374604,0,1,subsarcolemmal mitochondrion,CC,
20897,GO:1990844,1,0.999999996374604,0,1,interfibrillar mitochondrion,CC,
20898,GO:1990845,1,0.905338867058837,0,13,adaptive thermogenesis,BP,
20899,GO:1990851,1,0.987979010182922,0,4,Wnt-Frizzled-LRP5/6 complex,CC,
20900,GO:1990859,1,0.990566313287312,0,1,cellular response to endothelin,BP,
20901,GO:1990868,1,0.988267234202189,0,2,response to chemokine,BP,
20902,GO:1990869,1,0.988267234202189,0,2,cellular response to chemokine,BP,
20903,GO:1990874,1,0.846539299643562,0,24,vascular smooth muscle cell proliferation,BP,
20904,GO:1990876,1,0.999999996376454,0,1,cytoplasmic side of nuclear pore,CC,
20905,GO:1990879,1,0.983384249277821,0,2,CST complex,CC,
20906,GO:1990882,1,0.997928106866493,0,1,rRNA acetylation,BP,
20907,GO:1990883,1,0.997928106866493,0,1,rRNA cytidine N-acetyltransferase activity,MF,
20908,GO:1990884,1,0.997928106866493,0,1,RNA acetylation,BP,
20909,GO:1990889,1,0.988950990789635,0,1,H4K20me3 modified histone binding,MF,
20911,GO:1990907,1,0.989971977593751,0,3,beta-catenin-TCF complex,CC,
20912,GO:1990909,1,0.969447366835438,0,11,Wnt signalosome,CC,
20913,GO:1990910,1,0.976679119317291,0,3,response to hypobaric hypoxia,BP,
20914,GO:1990911,1,0.989974988047088,0,1,response to psychosocial stress,BP,
20915,GO:1990913,1,0.99158991158068,0,1,sperm head plasma membrane,CC,
20916,GO:1990917,1,0.99158991158068,0,1,ooplasm,CC,
20917,GO:1990918,1,0.979822080162934,0,3,double-strand break repair involved in meiotic recombination,BP,
20918,GO:1990922,1,0.99529293247965,0,1,hepatic stellate cell proliferation,BP,
20919,GO:1990923,1,0.979361708464191,0,3,PET complex,CC,
20920,GO:1990926,1,0.988923388512043,0,2,short-term synaptic potentiation,BP,
20921,GO:1990927,1,0.999264177392898,0,2,calcium ion regulated lysosome exocytosis,BP,
20922,GO:1990928,1,0.984992060969517,0,3,response to amino acid starvation,BP,
20923,GO:1990930,1,0.988187278153849,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
20924,GO:1990931,1,0.998869148299007,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
20925,GO:1990932,1,0.96215592960338,0,3,5.8S rRNA binding,MF,
20926,GO:1990936,1,0.993154987272083,0,1,vascular smooth muscle cell dedifferentiation,BP,
20927,GO:1990938,1,0.998089224294264,0,1,peptidyl-aspartic acid autophosphorylation,BP,
20928,GO:1990939,1,0.968893614815318,0,21,ATP-dependent microtubule motor activity,MF,
20929,GO:1990948,1,0.949916483811879,0,4,ubiquitin ligase inhibitor activity,MF,
20930,GO:1990955,1,0.998360581988621,0,1,G-rich single-stranded DNA binding,MF,
20931,GO:1990962,1,0.998041284082169,0,1,drug transport across blood-brain barrier,BP,
20932,GO:1990963,1,0.998041284082169,0,1,establishment of blood-retinal barrier,BP,
20933,GO:1990966,1,0.981827688097372,0,4,ATP generation from poly-ADP-D-ribose,BP,
20934,GO:1990967,1,0.988646717145047,0,1,multi-organism toxin transport,BP,
20935,GO:1990968,1,0.999999996375385,0,1,modulation by host of RNA binding by virus,BP,
20936,GO:1990969,1,0.999999996375385,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
20937,GO:1990971,1,0.997852161842949,0,1,EMILIN complex,CC,
20938,GO:1990983,1,0.991775643626691,0,1,tRNA demethylation,BP,
20939,GO:1990984,1,0.991775643626691,0,1,tRNA demethylase activity,MF,
20940,GO:2000001,1,0.904137306306511,0,13,regulation of DNA damage checkpoint,BP,
20941,GO:2000002,1,0.962723866924897,0,4,negative regulation of DNA damage checkpoint,BP,
20942,GO:2000004,1,0.988714122281553,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
20943,GO:2000005,1,0.988714122281553,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
20944,GO:2000006,1,0.988714122281553,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
20945,GO:2000007,1,0.988714122281553,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
20946,GO:2000008,1,0.83483696753,0,31,regulation of protein localization to cell surface,BP,
20947,GO:2000009,1,0.934494989646057,0,11,negative regulation of protein localization to cell surface,BP,
20948,GO:2000010,1,0.930450774432103,0,12,positive regulation of protein localization to cell surface,BP,
20949,GO:2000011,1,0.990148774377315,0,1,regulation of adaxial/abaxial pattern formation,BP,
20950,GO:2000015,1,0.976800043691323,0,3,regulation of determination of dorsal identity,BP,
20951,GO:2000016,1,0.987301496049375,0,1,negative regulation of determination of dorsal identity,BP,
20952,GO:2000017,1,0.98936455244322,0,2,positive regulation of determination of dorsal identity,BP,
20953,GO:2000018,1,0.9500667414139,0,9,regulation of male gonad development,BP,
20954,GO:2000019,1,0.99774836316084,0,1,negative regulation of male gonad development,BP,
20955,GO:2000020,1,0.952211615602844,0,8,positive regulation of male gonad development,BP,
20959,GO:2000035,1,0.953695825888671,0,5,regulation of stem cell division,BP,
20960,GO:2000036,1,0.914083369266419,0,22,regulation of stem cell population maintenance,BP,
20961,GO:2000040,1,0.988573214281861,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
20962,GO:2000041,1,0.988573214281861,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
20963,GO:2000042,1,0.981010927245295,0,6,negative regulation of double-strand break repair via homologous recombination,BP,
20964,GO:2000043,1,0.984194289605315,0,2,regulation of cardiac cell fate specification,BP,
20965,GO:2000044,1,0.993409576390941,0,1,negative regulation of cardiac cell fate specification,BP,
20966,GO:2000045,1,0.407559938311467,0,136,regulation of G1/S transition of mitotic cell cycle,BP,
20967,GO:2000047,1,0.911791046886088,0,11,regulation of cell-cell adhesion mediated by cadherin,BP,
20968,GO:2000048,1,0.959160031067385,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
20969,GO:2000049,1,0.95063001263272,0,7,positive regulation of cell-cell adhesion mediated by cadherin,BP,
20970,GO:2000050,1,0.921579522440259,0,20,regulation of non-canonical Wnt signaling pathway,BP,
20971,GO:2000051,1,0.981174729291647,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
20972,GO:2000052,1,0.949587165434352,0,11,positive regulation of non-canonical Wnt signaling pathway,BP,
20973,GO:2000053,1,0.989736849093967,0,3,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20974,GO:2000054,1,0.989736854724821,0,2,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20975,GO:2000055,1,0.999999996396015,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
20976,GO:2000056,1,0.989000550182656,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
20977,GO:2000057,1,0.989000550182656,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
20979,GO:2000059,1,0.900444944567035,0,13,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
20981,GO:2000061,1,0.988187278153849,0,1,regulation of ureter smooth muscle cell differentiation,BP,
20982,GO:2000062,1,0.988187278153849,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
20983,GO:2000063,1,0.988187278153849,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
20984,GO:2000064,1,0.971381857360323,0,6,regulation of cortisol biosynthetic process,BP,
20985,GO:2000065,1,0.974065838060062,0,4,negative regulation of cortisol biosynthetic process,BP,
20986,GO:2000066,1,0.99774836316084,0,1,positive regulation of cortisol biosynthetic process,BP,
20987,GO:2000067,1,0.987233076566383,0,1,regulation of root morphogenesis,BP,
20988,GO:2000074,1,0.943207006157536,0,8,regulation of type B pancreatic cell development,BP,
20989,GO:2000077,1,0.990074864413617,0,2,negative regulation of type B pancreatic cell development,BP,
20990,GO:2000078,1,0.969577068610949,0,3,positive regulation of type B pancreatic cell development,BP,
20991,GO:2000079,1,0.992623012822554,0,2,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20992,GO:2000080,1,0.99920826098847,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20993,GO:2000081,1,0.993409576390941,0,1,positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
20994,GO:2000095,1,0.945620147415553,0,12,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
20995,GO:2000096,1,0.967825957543764,0,7,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
20996,GO:2000097,1,0.973728961079556,0,3,regulation of smooth muscle cell-matrix adhesion,BP,
20997,GO:2000098,1,0.982086532106555,0,2,negative regulation of smooth muscle cell-matrix adhesion,BP,
20998,GO:2000101,1,0.993433878982438,0,1,regulation of mammary stem cell proliferation,BP,
20999,GO:2000103,1,0.993433878982438,0,1,positive regulation of mammary stem cell proliferation,BP,
21000,GO:2000104,1,0.915401353101621,0,18,negative regulation of DNA-dependent DNA replication,BP,
21001,GO:2000105,1,0.928773302536473,0,14,positive regulation of DNA-dependent DNA replication,BP,
21004,GO:2000108,1,0.796844441734299,0,30,positive regulation of leukocyte apoptotic process,BP,
21005,GO:2000109,1,0.953105666102347,0,7,regulation of macrophage apoptotic process,BP,
21006,GO:2000110,1,0.976316343869932,0,3,negative regulation of macrophage apoptotic process,BP,
21007,GO:2000111,1,0.985078580373172,0,3,positive regulation of macrophage apoptotic process,BP,
21010,GO:2000114,1,0.936885730096462,0,18,regulation of establishment of cell polarity,BP,
21013,GO:2000118,1,0.982539300557079,0,3,regulation of sodium-dependent phosphate transport,BP,
21014,GO:2000119,1,0.993613934542503,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21015,GO:2000120,1,0.990352852801268,0,1,positive regulation of sodium-dependent phosphate transport,BP,
21017,GO:2000124,1,0.990032325634762,0,2,regulation of endocannabinoid signaling pathway,BP,
21018,GO:2000134,1,0.551314212153868,0,92,negative regulation of G1/S transition of mitotic cell cycle,BP,
21019,GO:2000136,1,0.90330567116529,0,16,regulation of cell proliferation involved in heart morphogenesis,BP,
21020,GO:2000137,1,0.98871411645998,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21021,GO:2000138,1,0.958525488331875,0,6,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21023,GO:2000143,1,0.970213023599615,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21028,GO:2000152,1,0.960994055628677,0,4,regulation of ubiquitin-specific protease activity,BP,
21029,GO:2000156,1,0.990788959124785,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21030,GO:2000157,1,0.975154268758933,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21031,GO:2000158,1,0.985481875743497,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21032,GO:2000167,1,0.999976033648353,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21033,GO:2000169,1,0.984766796446745,0,6,regulation of peptidyl-cysteine S-nitrosylation,BP,
21034,GO:2000170,1,0.994713737176031,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21035,GO:2000171,1,0.913261397138962,0,27,negative regulation of dendrite development,BP,
21036,GO:2000172,1,0.983624978991869,0,4,regulation of branching morphogenesis of a nerve,BP,
21037,GO:2000173,1,0.997933110681279,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21038,GO:2000174,1,0.997992570586687,0,1,regulation of pro-T cell differentiation,BP,
21039,GO:2000176,1,0.997992570586687,0,1,positive regulation of pro-T cell differentiation,BP,
21040,GO:2000177,1,0.674127433089445,0,72,regulation of neural precursor cell proliferation,BP,
21041,GO:2000178,1,0.896149385188675,0,18,negative regulation of neural precursor cell proliferation,BP,
21042,GO:2000179,1,0.778982247332662,0,43,positive regulation of neural precursor cell proliferation,BP,
21043,GO:2000181,1,0.669127028314618,0,72,negative regulation of blood vessel morphogenesis,BP,
21044,GO:2000182,1,0.993891645362204,0,3,regulation of progesterone biosynthetic process,BP,
21045,GO:2000184,1,0.999999996374604,0,1,positive regulation of progesterone biosynthetic process,BP,
21046,GO:2000185,1,0.990352852801268,0,1,regulation of phosphate transmembrane transport,BP,
21047,GO:2000187,1,0.990352852801268,0,1,positive regulation of phosphate transmembrane transport,BP,
21048,GO:2000188,1,0.931115436194493,0,12,regulation of cholesterol homeostasis,BP,
21049,GO:2000189,1,0.976010844289574,0,4,positive regulation of cholesterol homeostasis,BP,
21050,GO:2000191,1,0.86230529029377,0,23,regulation of fatty acid transport,BP,
21051,GO:2000192,1,0.97711655194876,0,7,negative regulation of fatty acid transport,BP,
21052,GO:2000193,1,0.879637209832462,0,15,positive regulation of fatty acid transport,BP,
21053,GO:2000194,1,0.919733000470117,0,11,regulation of female gonad development,BP,
21054,GO:2000195,1,0.976854956231295,0,4,negative regulation of female gonad development,BP,
21055,GO:2000196,1,0.975145200315175,0,2,positive regulation of female gonad development,BP,
21056,GO:2000197,1,0.973238813808642,0,6,regulation of ribonucleoprotein complex localization,BP,
21057,GO:2000199,1,0.994227925325095,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21058,GO:2000200,1,0.994227925325095,0,1,regulation of ribosomal subunit export from nucleus,BP,
21059,GO:2000202,1,0.994227925325095,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21060,GO:2000206,1,0.994227925325095,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21061,GO:2000208,1,0.994227925325095,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21063,GO:2000210,1,0.939807207647719,0,7,positive regulation of anoikis,BP,
21064,GO:2000211,1,0.989790591816947,0,2,regulation of glutamate metabolic process,BP,
21065,GO:2000212,1,0.999852154250987,0,1,negative regulation of glutamate metabolic process,BP,
21066,GO:2000213,1,0.989936963505739,0,1,positive regulation of glutamate metabolic process,BP,
21067,GO:2000224,1,0.985371066217492,0,2,regulation of testosterone biosynthetic process,BP,
21068,GO:2000225,1,0.99774836316084,0,1,negative regulation of testosterone biosynthetic process,BP,
21069,GO:2000226,1,0.987942018230641,0,1,regulation of pancreatic A cell differentiation,BP,
21070,GO:2000227,1,0.987942018230641,0,1,negative regulation of pancreatic A cell differentiation,BP,
21071,GO:2000229,1,0.976737122536016,0,2,regulation of pancreatic stellate cell proliferation,BP,
21072,GO:2000230,1,0.988934119966093,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21073,GO:2000231,1,0.987667601272536,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21074,GO:2000232,1,0.962978942537587,0,8,regulation of rRNA processing,BP,
21075,GO:2000233,1,0.993026986568324,0,2,negative regulation of rRNA processing,BP,
21076,GO:2000234,1,0.969742622715377,0,6,positive regulation of rRNA processing,BP,
21077,GO:2000241,1,0.394409624850703,0,124,regulation of reproductive process,BP,
21078,GO:2000242,1,0.666394593187946,0,51,negative regulation of reproductive process,BP,
21079,GO:2000243,1,0.7263142454819,0,47,positive regulation of reproductive process,BP,
21080,GO:2000249,1,0.804475379174499,0,32,regulation of actin cytoskeleton reorganization,BP,
21081,GO:2000251,1,0.875957577911067,0,15,positive regulation of actin cytoskeleton reorganization,BP,
21082,GO:2000252,1,0.937059075051729,0,7,negative regulation of feeding behavior,BP,
21083,GO:2000253,1,0.961954313659872,0,6,positive regulation of feeding behavior,BP,
21084,GO:2000254,1,0.955354666296833,0,4,regulation of male germ cell proliferation,BP,
21085,GO:2000255,1,0.96759844756856,0,3,negative regulation of male germ cell proliferation,BP,
21086,GO:2000256,1,0.987349493956015,0,1,positive regulation of male germ cell proliferation,BP,
21088,GO:2000258,1,0.954997384592953,0,8,negative regulation of protein activation cascade,BP,
21089,GO:2000259,1,0.985538375697657,0,3,positive regulation of protein activation cascade,BP,
21090,GO:2000266,1,0.988245313455576,0,1,regulation of blood coagulation, intrinsic pathway,BP,
21091,GO:2000269,1,0.942802904344114,0,15,regulation of fibroblast apoptotic process,BP,
21092,GO:2000270,1,0.97286182411891,0,7,negative regulation of fibroblast apoptotic process,BP,
21093,GO:2000271,1,0.985971082904067,0,7,positive regulation of fibroblast apoptotic process,BP,
21094,GO:2000272,1,0.806046270705704,0,34,negative regulation of receptor activity,BP,
21095,GO:2000273,1,0.796022443346803,0,46,positive regulation of receptor activity,BP,
21096,GO:2000275,1,0.956638068221614,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21097,GO:2000276,1,0.978621226996028,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21098,GO:2000277,1,0.98731767947796,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21101,GO:2000280,1,0.987233076566383,0,1,regulation of root development,BP,
21102,GO:2000282,1,0.987317673366076,0,2,regulation of cellular amino acid biosynthetic process,BP,
21103,GO:2000283,1,0.999999996389206,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21104,GO:2000284,1,0.98731767947796,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21105,GO:2000286,1,0.981214361989181,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21106,GO:2000287,1,0.990306815099808,0,1,positive regulation of myotome development,BP,
21107,GO:2000288,1,0.950427280533264,0,6,positive regulation of myoblast proliferation,BP,
21108,GO:2000290,1,0.990306815099808,0,1,regulation of myotome development,BP,
21109,GO:2000291,1,0.914000775227085,0,10,regulation of myoblast proliferation,BP,
21110,GO:2000295,1,0.969788748832054,0,3,regulation of hydrogen peroxide catabolic process,BP,
21111,GO:2000296,1,0.975089141884186,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21112,GO:2000297,1,0.992427509236766,0,3,negative regulation of synapse maturation,BP,
21113,GO:2000298,1,0.98645981222517,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21114,GO:2000299,1,0.995487927097076,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21115,GO:2000300,1,0.885231068259614,0,27,regulation of synaptic vesicle exocytosis,BP,
21116,GO:2000301,1,0.971580322357322,0,4,negative regulation of synaptic vesicle exocytosis,BP,
21117,GO:2000302,1,0.999116042632373,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21118,GO:2000303,1,0.901059928907708,0,13,regulation of ceramide biosynthetic process,BP,
21119,GO:2000304,1,0.942511920613888,0,8,positive regulation of ceramide biosynthetic process,BP,
21120,GO:2000307,1,0.973113895942955,0,3,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21121,GO:2000308,1,0.9908334975736,0,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21122,GO:2000309,1,0.98211776229513,0,2,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21123,GO:2000310,1,0.928524191450586,0,16,regulation of NMDA receptor activity,BP,
21124,GO:2000311,1,0.907391777154306,0,19,regulation of AMPA receptor activity,BP,
21125,GO:2000312,1,0.987503432084473,0,3,regulation of kainate selective glutamate receptor activity,BP,
21126,GO:2000313,1,0.977549832052526,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21127,GO:2000314,1,0.988394765234882,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21128,GO:2000316,1,0.890523653836736,0,13,regulation of T-helper 17 type immune response,BP,
21129,GO:2000317,1,0.942363670414456,0,6,negative regulation of T-helper 17 type immune response,BP,
21130,GO:2000318,1,0.945014529765591,0,7,positive regulation of T-helper 17 type immune response,BP,
21131,GO:2000319,1,0.904485767472694,0,11,regulation of T-helper 17 cell differentiation,BP,
21132,GO:2000320,1,0.942363670414456,0,6,negative regulation of T-helper 17 cell differentiation,BP,
21133,GO:2000321,1,0.959823953610648,0,5,positive regulation of T-helper 17 cell differentiation,BP,
21134,GO:2000322,1,0.961498207529178,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21135,GO:2000323,1,0.974976848963862,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21136,GO:2000324,1,0.986178192280342,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21137,GO:2000325,1,0.999999996373717,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21138,GO:2000327,1,0.999999996373717,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21139,GO:2000328,1,0.943308774070778,0,6,regulation of T-helper 17 cell lineage commitment,BP,
21140,GO:2000329,1,0.981669840781294,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21141,GO:2000330,1,0.960928253485227,0,4,positive regulation of T-helper 17 cell lineage commitment,BP,
21142,GO:2000331,1,0.99300738741398,0,2,regulation of terminal button organization,BP,
21143,GO:2000332,1,0.978173000722563,0,2,regulation of blood microparticle formation,BP,
21144,GO:2000334,1,0.978173000722563,0,2,positive regulation of blood microparticle formation,BP,
21145,GO:2000338,1,0.98329042098342,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21146,GO:2000340,1,0.98329042098342,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21147,GO:2000341,1,0.924044334278319,0,8,regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21148,GO:2000342,1,0.984271526337675,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21149,GO:2000343,1,0.938817837679798,0,6,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21150,GO:2000344,1,0.929998201672645,0,9,positive regulation of acrosome reaction,BP,
21151,GO:2000345,1,0.906375970193461,0,14,regulation of hepatocyte proliferation,BP,
21152,GO:2000346,1,0.971711395961366,0,4,negative regulation of hepatocyte proliferation,BP,
21153,GO:2000347,1,0.949458455999784,0,7,positive regulation of hepatocyte proliferation,BP,
21154,GO:2000348,1,0.961714257647122,0,6,regulation of CD40 signaling pathway,BP,
21155,GO:2000349,1,0.988562159086137,0,2,negative regulation of CD40 signaling pathway,BP,
21156,GO:2000350,1,0.987408883959657,0,1,positive regulation of CD40 signaling pathway,BP,
21157,GO:2000351,1,0.778588175592103,0,39,regulation of endothelial cell apoptotic process,BP,
21158,GO:2000352,1,0.843781810992075,0,26,negative regulation of endothelial cell apoptotic process,BP,
21159,GO:2000353,1,0.922836472372482,0,13,positive regulation of endothelial cell apoptotic process,BP,
21160,GO:2000354,1,0.966080428406899,0,4,regulation of ovarian follicle development,BP,
21161,GO:2000355,1,0.989460002924806,0,1,negative regulation of ovarian follicle development,BP,
21162,GO:2000356,1,0.988187278153849,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21163,GO:2000357,1,0.988187278153849,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21164,GO:2000358,1,0.988187278153849,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21165,GO:2000359,1,0.9549610303398,0,4,regulation of binding of sperm to zona pellucida,BP,
21166,GO:2000360,1,0.9549610303398,0,4,negative regulation of binding of sperm to zona pellucida,BP,
21167,GO:2000361,1,0.9992549192931,0,1,regulation of prostaglandin-E synthase activity,BP,
21168,GO:2000363,1,0.9992549192931,0,1,positive regulation of prostaglandin-E synthase activity,BP,
21169,GO:2000364,1,0.983374055112207,0,3,regulation of STAT protein import into nucleus,BP,
21170,GO:2000366,1,0.983374055112207,0,3,positive regulation of STAT protein import into nucleus,BP,
21171,GO:2000367,1,0.987835279686974,0,1,regulation of acrosomal vesicle exocytosis,BP,
21172,GO:2000368,1,0.987835279686974,0,1,positive regulation of acrosomal vesicle exocytosis,BP,
21173,GO:2000369,1,0.930324270612991,0,21,regulation of clathrin-dependent endocytosis,BP,
21174,GO:2000370,1,0.984940476091451,0,6,positive regulation of clathrin-dependent endocytosis,BP,
21175,GO:2000371,1,0.977624391373183,0,4,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21176,GO:2000373,1,0.977624391373183,0,4,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21177,GO:2000374,1,0.97685388077346,0,2,regulation of oxygen metabolic process,BP,
21178,GO:2000376,1,0.987171207637524,0,1,positive regulation of oxygen metabolic process,BP,
21182,GO:2000380,1,0.881951452312481,0,16,regulation of mesoderm development,BP,
21183,GO:2000381,1,0.933857521343492,0,8,negative regulation of mesoderm development,BP,
21184,GO:2000382,1,0.958949285424199,0,5,positive regulation of mesoderm development,BP,
21185,GO:2000383,1,0.997547154876351,0,1,regulation of ectoderm development,BP,
21186,GO:2000384,1,0.997547154876351,0,1,negative regulation of ectoderm development,BP,
21187,GO:2000386,1,0.987835279686974,0,1,positive regulation of ovarian follicle development,BP,
21188,GO:2000387,1,0.987835279686974,0,1,regulation of antral ovarian follicle growth,BP,
21189,GO:2000388,1,0.987835279686974,0,1,positive regulation of antral ovarian follicle growth,BP,
21190,GO:2000389,1,0.9876784082677,0,3,regulation of neutrophil extravasation,BP,
21191,GO:2000391,1,0.9876784082677,0,3,positive regulation of neutrophil extravasation,BP,
21192,GO:2000392,1,0.972289703801145,0,8,regulation of lamellipodium morphogenesis,BP,
21193,GO:2000393,1,0.999909640901556,0,1,negative regulation of lamellipodium morphogenesis,BP,
21194,GO:2000394,1,0.972377591990566,0,7,positive regulation of lamellipodium morphogenesis,BP,
21195,GO:2000395,1,0.975629546561812,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21196,GO:2000397,1,0.975629546561812,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21198,GO:2000402,1,0.945606243324487,0,7,negative regulation of lymphocyte migration,BP,
21201,GO:2000405,1,0.98748484460217,0,1,negative regulation of T cell migration,BP,
21205,GO:2000410,1,0.972119396876225,0,3,regulation of thymocyte migration,BP,
21206,GO:2000412,1,0.98213120536199,0,2,positive regulation of thymocyte migration,BP,
21207,GO:2000413,1,0.994475671194365,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21208,GO:2000415,1,0.994475671194365,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21209,GO:2000416,1,0.946836031980678,0,6,regulation of eosinophil migration,BP,
21210,GO:2000417,1,0.984798565109706,0,2,negative regulation of eosinophil migration,BP,
21211,GO:2000418,1,0.961456063906764,0,4,positive regulation of eosinophil migration,BP,
21212,GO:2000419,1,0.995720107681049,0,1,regulation of eosinophil extravasation,BP,
21213,GO:2000420,1,0.995720107681049,0,1,negative regulation of eosinophil extravasation,BP,
21214,GO:2000422,1,0.979390539831936,0,2,regulation of eosinophil chemotaxis,BP,
21215,GO:2000424,1,0.979390539831936,0,2,positive regulation of eosinophil chemotaxis,BP,
21216,GO:2000425,1,0.950163393502519,0,10,regulation of apoptotic cell clearance,BP,
21217,GO:2000426,1,0.988649491188727,0,1,negative regulation of apoptotic cell clearance,BP,
21218,GO:2000427,1,0.957599322149841,0,8,positive regulation of apoptotic cell clearance,BP,
21219,GO:2000434,1,0.97473121934558,0,2,regulation of protein neddylation,BP,
21220,GO:2000435,1,0.97473121934558,0,2,negative regulation of protein neddylation,BP,
21221,GO:2000437,1,0.989430735597602,0,3,regulation of monocyte extravasation,BP,
21222,GO:2000438,1,0.999999996377419,0,1,negative regulation of monocyte extravasation,BP,
21223,GO:2000439,1,0.989430741306985,0,2,positive regulation of monocyte extravasation,BP,
21224,GO:2000446,1,0.998968907016289,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21229,GO:2000458,1,0.980193650515495,0,2,regulation of astrocyte chemotaxis,BP,
21230,GO:2000463,1,0.923005025853589,0,23,positive regulation of excitatory postsynaptic potential,BP,
21231,GO:2000464,1,0.991388739056542,0,1,positive regulation of astrocyte chemotaxis,BP,
21232,GO:2000465,1,0.966617042332498,0,8,regulation of glycogen (starch) synthase activity,BP,
21233,GO:2000466,1,0.984939685510121,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21234,GO:2000467,1,0.978061634626941,0,5,positive regulation of glycogen (starch) synthase activity,BP,
21235,GO:2000468,1,0.9945652765393,0,2,regulation of peroxidase activity,BP,
21236,GO:2000469,1,0.999999996391606,0,1,negative regulation of peroxidase activity,BP,
21237,GO:2000470,1,0.994565281223551,0,1,positive regulation of peroxidase activity,BP,
21238,GO:2000471,1,0.991242440180452,0,2,regulation of hematopoietic stem cell migration,BP,
21239,GO:2000473,1,0.991242440180452,0,2,positive regulation of hematopoietic stem cell migration,BP,
21240,GO:2000474,1,0.989353447083504,0,2,regulation of opioid receptor signaling pathway,BP,
21241,GO:2000477,1,0.999385324562941,0,1,regulation of metanephric glomerular visceral epithelial cell development,BP,
21242,GO:2000478,1,0.999385324562941,0,1,positive regulation of metanephric glomerular visceral epithelial cell development,BP,
21243,GO:2000479,1,0.918832288354354,0,14,regulation of cAMP-dependent protein kinase activity,BP,
21244,GO:2000480,1,0.941500897825858,0,8,negative regulation of cAMP-dependent protein kinase activity,BP,
21245,GO:2000481,1,0.996921087489247,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21247,GO:2000483,1,0.959152957075034,0,6,negative regulation of interleukin-8 secretion,BP,
21249,GO:2000485,1,0.987042228634373,0,2,regulation of glutamine transport,BP,
21250,GO:2000486,1,0.995779931099641,0,1,negative regulation of glutamine transport,BP,
21251,GO:2000487,1,0.991225561310078,0,1,positive regulation of glutamine transport,BP,
21252,GO:2000489,1,0.972261861170441,0,6,regulation of hepatic stellate cell activation,BP,
21253,GO:2000490,1,0.986345957890045,0,2,negative regulation of hepatic stellate cell activation,BP,
21254,GO:2000491,1,0.985722488894908,0,4,positive regulation of hepatic stellate cell activation,BP,
21255,GO:2000492,1,0.99367726678093,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21256,GO:2000494,1,0.99367726678093,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21257,GO:2000501,1,0.898109605429146,0,9,regulation of natural killer cell chemotaxis,BP,
21258,GO:2000502,1,0.967424397190434,0,3,negative regulation of natural killer cell chemotaxis,BP,
21259,GO:2000503,1,0.92836929992294,0,6,positive regulation of natural killer cell chemotaxis,BP,
21260,GO:2000504,1,0.979927756123566,0,3,positive regulation of blood vessel remodeling,BP,
21261,GO:2000505,1,0.940501522363062,0,19,regulation of energy homeostasis,BP,
21262,GO:2000506,1,0.97969207299493,0,2,negative regulation of energy homeostasis,BP,
21263,GO:2000507,1,0.969270277731865,0,6,positive regulation of energy homeostasis,BP,
21264,GO:2000508,1,0.898590605251294,0,10,regulation of dendritic cell chemotaxis,BP,
21265,GO:2000510,1,0.910232036019742,0,9,positive regulation of dendritic cell chemotaxis,BP,
21266,GO:2000511,1,0.98758750256206,0,1,regulation of granzyme A production,BP,
21267,GO:2000513,1,0.98758750256206,0,1,positive regulation of granzyme A production,BP,
21268,GO:2000514,1,0.718639328289132,0,44,regulation of CD4-positive, alpha-beta T cell activation,BP,
21269,GO:2000515,1,0.878061423015642,0,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21270,GO:2000516,1,0.790539759894815,0,29,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21271,GO:2000517,1,0.98758750256206,0,1,regulation of T-helper 1 cell activation,BP,
21272,GO:2000518,1,0.98758750256206,0,1,negative regulation of T-helper 1 cell activation,BP,
21273,GO:2000520,1,0.968822939840323,0,3,regulation of immunological synapse formation,BP,
21274,GO:2000521,1,0.978597634295572,0,2,negative regulation of immunological synapse formation,BP,
21275,GO:2000522,1,0.990013231248957,0,1,positive regulation of immunological synapse formation,BP,
21276,GO:2000523,1,0.986127415145644,0,2,regulation of T cell costimulation,BP,
21277,GO:2000525,1,0.986127415145644,0,2,positive regulation of T cell costimulation,BP,
21278,GO:2000526,1,0.990013231248957,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21279,GO:2000527,1,0.987281694667972,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21280,GO:2000529,1,0.987281694667972,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21281,GO:2000532,1,0.990810396412569,0,2,regulation of renal albumin absorption,BP,
21282,GO:2000533,1,0.991419841055254,0,1,negative regulation of renal albumin absorption,BP,
21283,GO:2000534,1,0.999385324562941,0,1,positive regulation of renal albumin absorption,BP,
21284,GO:2000535,1,0.9808994996972,0,5,regulation of entry of bacterium into host cell,BP,
21285,GO:2000536,1,0.999999996378359,0,1,negative regulation of entry of bacterium into host cell,BP,
21286,GO:2000537,1,0.986587679127718,0,2,regulation of B cell chemotaxis,BP,
21287,GO:2000538,1,0.986587679127718,0,2,positive regulation of B cell chemotaxis,BP,
21288,GO:2000539,1,0.991406502816634,0,1,regulation of protein geranylgeranylation,BP,
21289,GO:2000541,1,0.991406502816634,0,1,positive regulation of protein geranylgeranylation,BP,
21290,GO:2000542,1,0.954718385959056,0,7,negative regulation of gastrulation,BP,
21291,GO:2000543,1,0.946651657548387,0,6,positive regulation of gastrulation,BP,
21293,GO:2000545,1,0.987564328280312,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21295,GO:2000547,1,0.964905014924874,0,3,regulation of dendritic cell dendrite assembly,BP,
21296,GO:2000548,1,0.987281694667972,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21297,GO:2000549,1,0.987197241542771,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21298,GO:2000551,1,0.930913020161689,0,8,regulation of T-helper 2 cell cytokine production,BP,
21299,GO:2000552,1,0.974911317589374,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21300,GO:2000553,1,0.954878313439783,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21301,GO:2000554,1,0.98758750256206,0,1,regulation of T-helper 1 cell cytokine production,BP,
21302,GO:2000556,1,0.98758750256206,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21303,GO:2000557,1,0.98758750256206,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21304,GO:2000558,1,0.98758750256206,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21305,GO:2000559,1,0.999999996377419,0,1,regulation of CD24 biosynthetic process,BP,
21306,GO:2000560,1,0.999999996377419,0,1,positive regulation of CD24 biosynthetic process,BP,
21307,GO:2000561,1,0.966180664465728,0,5,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21308,GO:2000562,1,0.973410618480007,0,3,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21309,GO:2000563,1,0.9688971868782,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21310,GO:2000564,1,0.964310286731756,0,4,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21311,GO:2000566,1,0.967813523903509,0,3,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21312,GO:2000567,1,0.986262430477005,0,2,regulation of memory T cell activation,BP,
21313,GO:2000568,1,0.986262430477005,0,2,positive regulation of memory T cell activation,BP,
21314,GO:2000569,1,0.991162053583301,0,2,regulation of T-helper 2 cell activation,BP,
21315,GO:2000570,1,0.991162053583301,0,2,positive regulation of T-helper 2 cell activation,BP,
21316,GO:2000571,1,0.996075298321824,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21317,GO:2000572,1,0.996075298321824,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21318,GO:2000573,1,0.646964367930449,0,63,positive regulation of DNA biosynthetic process,BP,
21319,GO:2000574,1,0.987397145807971,0,3,regulation of microtubule motor activity,BP,
21320,GO:2000583,1,0.996926619768245,0,2,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21321,GO:2000584,1,0.996926619768245,0,2,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21322,GO:2000586,1,0.968272878591456,0,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21323,GO:2000587,1,0.968981995041348,0,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21324,GO:2000588,1,0.999268379615036,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21325,GO:2000589,1,0.985242189585903,0,4,regulation of metanephric mesenchymal cell migration,BP,
21326,GO:2000590,1,0.999385324562941,0,1,negative regulation of metanephric mesenchymal cell migration,BP,
21327,GO:2000591,1,0.985848237531077,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21328,GO:2000592,1,0.996047050278914,0,2,regulation of metanephric DCT cell differentiation,BP,
21329,GO:2000594,1,0.996047050278914,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21330,GO:2000595,1,0.998408769958625,0,1,regulation of optic nerve formation,BP,
21331,GO:2000597,1,0.998408769958625,0,1,positive regulation of optic nerve formation,BP,
21332,GO:2000601,1,0.97142782145385,0,7,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21333,GO:2000606,1,0.994074538118583,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21334,GO:2000607,1,0.994074538118583,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21335,GO:2000609,1,0.958974715637885,0,5,regulation of thyroid hormone generation,BP,
21336,GO:2000611,1,0.981493860794899,0,3,positive regulation of thyroid hormone generation,BP,
21337,GO:2000612,1,0.99763454673982,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21338,GO:2000615,1,0.952263310667871,0,9,regulation of histone H3-K9 acetylation,BP,
21339,GO:2000616,1,0.999917689882932,0,1,negative regulation of histone H3-K9 acetylation,BP,
21340,GO:2000617,1,0.959799087784492,0,7,positive regulation of histone H3-K9 acetylation,BP,
21341,GO:2000618,1,0.980198498165608,0,5,regulation of histone H4-K16 acetylation,BP,
21342,GO:2000619,1,0.980198513196753,0,3,negative regulation of histone H4-K16 acetylation,BP,
21343,GO:2000620,1,0.999999992751714,0,2,positive regulation of histone H4-K16 acetylation,BP,
21344,GO:2000622,1,0.988233639491865,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21345,GO:2000623,1,0.988233639491865,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21346,GO:2000625,1,0.99180399880636,0,2,regulation of miRNA catabolic process,BP,
21347,GO:2000627,1,0.99180399880636,0,2,positive regulation of miRNA catabolic process,BP,
21348,GO:2000628,1,0.956865538186381,0,7,regulation of miRNA metabolic process,BP,
21349,GO:2000630,1,0.969748220333948,0,5,positive regulation of miRNA metabolic process,BP,
21350,GO:2000631,1,0.994933742467394,0,1,regulation of pre-miRNA processing,BP,
21351,GO:2000632,1,0.994933742467394,0,1,negative regulation of pre-miRNA processing,BP,
21352,GO:2000637,1,0.885940592757823,0,20,positive regulation of gene silencing by miRNA,BP,
21353,GO:2000638,1,0.997137729107151,0,1,regulation of SREBP signaling pathway,BP,
21354,GO:2000639,1,0.997137729107151,0,1,negative regulation of SREBP signaling pathway,BP,
21355,GO:2000641,1,0.912461091185429,0,17,regulation of early endosome to late endosome transport,BP,
21356,GO:2000642,1,0.9752133755306,0,2,negative regulation of early endosome to late endosome transport,BP,
21357,GO:2000643,1,0.977692096036634,0,8,positive regulation of early endosome to late endosome transport,BP,
21358,GO:2000644,1,0.960808599113964,0,7,regulation of receptor catabolic process,BP,
21359,GO:2000645,1,0.986571840880566,0,3,negative regulation of receptor catabolic process,BP,
21360,GO:2000646,1,0.979678149445249,0,3,positive regulation of receptor catabolic process,BP,
21361,GO:2000647,1,0.941035513583383,0,10,negative regulation of stem cell proliferation,BP,
21362,GO:2000648,1,0.820446953874722,0,36,positive regulation of stem cell proliferation,BP,
21364,GO:2000650,1,0.95772595876629,0,10,negative regulation of sodium ion transmembrane transporter activity,BP,
21365,GO:2000651,1,0.939095980095777,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21366,GO:2000653,1,0.977171644413239,0,4,regulation of genetic imprinting,BP,
21367,GO:2000654,1,0.997534268301677,0,1,regulation of cellular response to testosterone stimulus,BP,
21368,GO:2000655,1,0.997534268301677,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21369,GO:2000656,1,0.989000550182656,0,1,regulation of apolipoprotein binding,BP,
21370,GO:2000657,1,0.989000550182656,0,1,negative regulation of apolipoprotein binding,BP,
21371,GO:2000659,1,0.944631343773786,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
21372,GO:2000660,1,0.955088282615024,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
21373,GO:2000661,1,0.999763876618055,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21374,GO:2000662,1,0.954267796546741,0,6,regulation of interleukin-5 secretion,BP,
21375,GO:2000663,1,0.984237579326342,0,2,negative regulation of interleukin-5 secretion,BP,
21376,GO:2000664,1,0.969554034003627,0,4,positive regulation of interleukin-5 secretion,BP,
21377,GO:2000665,1,0.931184933415483,0,8,regulation of interleukin-13 secretion,BP,
21378,GO:2000666,1,0.984237579326342,0,2,negative regulation of interleukin-13 secretion,BP,
21379,GO:2000667,1,0.94610432752113,0,6,positive regulation of interleukin-13 secretion,BP,
21380,GO:2000668,1,0.966986860060114,0,6,regulation of dendritic cell apoptotic process,BP,
21381,GO:2000669,1,0.984167337420677,0,3,negative regulation of dendritic cell apoptotic process,BP,
21382,GO:2000670,1,0.982545330124689,0,3,positive regulation of dendritic cell apoptotic process,BP,
21383,GO:2000671,1,0.978827607567847,0,4,regulation of motor neuron apoptotic process,BP,
21384,GO:2000672,1,0.981587147092565,0,3,negative regulation of motor neuron apoptotic process,BP,
21385,GO:2000674,1,0.939171051585894,0,10,regulation of type B pancreatic cell apoptotic process,BP,
21386,GO:2000675,1,0.969477460850982,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21387,GO:2000676,1,0.968747016074379,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
21388,GO:2000677,1,0.723274729752012,0,47,regulation of transcription regulatory region DNA binding,BP,
21389,GO:2000678,1,0.846803022610935,0,21,negative regulation of transcription regulatory region DNA binding,BP,
21390,GO:2000679,1,0.858596409811425,0,22,positive regulation of transcription regulatory region DNA binding,BP,
21391,GO:2000680,1,0.979443343505506,0,5,regulation of rubidium ion transport,BP,
21392,GO:2000681,1,0.991963556043033,0,3,negative regulation of rubidium ion transport,BP,
21393,GO:2000682,1,0.999999996382662,0,1,positive regulation of rubidium ion transport,BP,
21394,GO:2000683,1,0.987030039136003,0,2,regulation of cellular response to X-ray,BP,
21395,GO:2000685,1,0.992913843613084,0,1,positive regulation of cellular response to X-ray,BP,
21396,GO:2000686,1,0.991963550836685,0,4,regulation of rubidium ion transmembrane transporter activity,BP,
21397,GO:2000687,1,0.991963556043033,0,3,negative regulation of rubidium ion transmembrane transporter activity,BP,
21398,GO:2000688,1,0.999999996382662,0,1,positive regulation of rubidium ion transmembrane transporter activity,BP,
21399,GO:2000690,1,0.998778522807813,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21400,GO:2000691,1,0.998778522807813,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21401,GO:2000696,1,0.912749376925223,0,18,regulation of epithelial cell differentiation involved in kidney development,BP,
21402,GO:2000697,1,0.968900891474494,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21403,GO:2000698,1,0.959418417201158,0,8,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21404,GO:2000699,1,0.994074538118583,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21405,GO:2000701,1,0.994074538118583,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21406,GO:2000702,1,0.994074538118583,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21407,GO:2000703,1,0.994074538118583,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21408,GO:2000705,1,0.986400946519652,0,3,regulation of dense core granule biogenesis,BP,
21409,GO:2000706,1,0.99681652257502,0,1,negative regulation of dense core granule biogenesis,BP,
21410,GO:2000707,1,0.989551424847514,0,2,positive regulation of dense core granule biogenesis,BP,
21411,GO:2000721,1,0.994541148186413,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21412,GO:2000722,1,0.992167470531445,0,2,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21413,GO:2000723,1,0.992167475702351,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21414,GO:2000724,1,0.999999996377575,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21415,GO:2000725,1,0.850090835683537,0,29,regulation of cardiac muscle cell differentiation,BP,
21416,GO:2000726,1,0.943577174592296,0,11,negative regulation of cardiac muscle cell differentiation,BP,
21417,GO:2000727,1,0.900966911554785,0,18,positive regulation of cardiac muscle cell differentiation,BP,
21418,GO:2000729,1,0.980501893146459,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21419,GO:2000733,1,0.994074538118583,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21420,GO:2000734,1,0.994074538118583,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21421,GO:2000736,1,0.829824569949629,0,40,regulation of stem cell differentiation,BP,
21422,GO:2000737,1,0.918277170189136,0,18,negative regulation of stem cell differentiation,BP,
21423,GO:2000738,1,0.933387354422726,0,15,positive regulation of stem cell differentiation,BP,
21424,GO:2000739,1,0.992986275745503,0,6,regulation of mesenchymal stem cell differentiation,BP,
21425,GO:2000740,1,0.99681652257502,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21426,GO:2000741,1,0.996157625457061,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21427,GO:2000742,1,0.98026399733337,0,2,regulation of anterior head development,BP,
21428,GO:2000744,1,0.98026399733337,0,2,positive regulation of anterior head development,BP,
21429,GO:2000751,1,0.992729324129483,0,1,histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore,BP,
21430,GO:2000752,1,0.992731713030342,0,1,regulation of glucosylceramide catabolic process,BP,
21431,GO:2000753,1,0.992731713030342,0,1,positive regulation of glucosylceramide catabolic process,BP,
21432,GO:2000754,1,0.992731713030342,0,1,regulation of sphingomyelin catabolic process,BP,
21433,GO:2000755,1,0.992731713030342,0,1,positive regulation of sphingomyelin catabolic process,BP,
21434,GO:2000756,1,0.7099225735888,0,54,regulation of peptidyl-lysine acetylation,BP,
21435,GO:2000757,1,0.887743544884062,0,19,negative regulation of peptidyl-lysine acetylation,BP,
21436,GO:2000758,1,0.818280796397462,0,30,positive regulation of peptidyl-lysine acetylation,BP,
21437,GO:2000759,1,0.9997309631501,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21438,GO:2000761,1,0.9997309631501,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21439,GO:2000763,1,0.990803916695749,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21440,GO:2000764,1,0.990803916695749,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21441,GO:2000765,1,0.935289500394615,0,13,regulation of cytoplasmic translation,BP,
21442,GO:2000766,1,0.977061842247615,0,8,negative regulation of cytoplasmic translation,BP,
21443,GO:2000767,1,0.966248286490158,0,4,positive regulation of cytoplasmic translation,BP,
21444,GO:2000768,1,0.978478457824855,0,3,positive regulation of nephron tubule epithelial cell differentiation,BP,
21445,GO:2000769,1,0.987631058642231,0,1,regulation of establishment or maintenance of cell polarity regulating cell shape,BP,
21446,GO:2000771,1,0.987631058642231,0,1,positive regulation of establishment or maintenance of cell polarity regulating cell shape,BP,
21447,GO:2000772,1,0.849024354032668,0,28,regulation of cellular senescence,BP,
21448,GO:2000773,1,0.947205991089334,0,11,negative regulation of cellular senescence,BP,
21449,GO:2000774,1,0.933319352645648,0,8,positive regulation of cellular senescence,BP,
21450,GO:2000775,1,0.989720839770265,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21451,GO:2000777,1,0.980129616363117,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21453,GO:2000779,1,0.802056696348147,0,39,regulation of double-strand break repair,BP,
21454,GO:2000780,1,0.927867536622638,0,15,negative regulation of double-strand break repair,BP,
21455,GO:2000781,1,0.965624104893429,0,8,positive regulation of double-strand break repair,BP,
21456,GO:2000782,1,0.987631058642231,0,1,regulation of establishment of cell polarity regulating cell shape,BP,
21457,GO:2000784,1,0.987631058642231,0,1,positive regulation of establishment of cell polarity regulating cell shape,BP,
21459,GO:2000786,1,0.966794989409905,0,10,positive regulation of autophagosome assembly,BP,
21460,GO:2000790,1,0.997539791394272,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21461,GO:2000791,1,0.997539791394272,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21462,GO:2000793,1,0.988389813339121,0,3,cell proliferation involved in heart valve development,BP,
21463,GO:2000794,1,0.966051829127205,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21464,GO:2000795,1,0.999999996385453,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21465,GO:2000797,1,0.99681652257502,0,1,regulation of amniotic stem cell differentiation,BP,
21466,GO:2000798,1,0.99681652257502,0,1,negative regulation of amniotic stem cell differentiation,BP,
21467,GO:2000800,1,0.988389825126606,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21468,GO:2000802,1,0.988389825126606,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21469,GO:2000804,1,0.999999996400838,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21470,GO:2000806,1,0.999999996400838,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21471,GO:2000807,1,0.996122142628387,0,7,regulation of synaptic vesicle clustering,BP,
21472,GO:2000808,1,0.999994189436789,0,1,negative regulation of synaptic vesicle clustering,BP,
21473,GO:2000809,1,0.996127936040975,0,5,positive regulation of synaptic vesicle clustering,BP,
21474,GO:2000810,1,0.923866316520985,0,16,regulation of bicellular tight junction assembly,BP,
21476,GO:2000812,1,0.985330095407049,0,2,regulation of barbed-end actin filament capping,BP,
21477,GO:2000814,1,0.987631058642231,0,1,positive regulation of barbed-end actin filament capping,BP,
21478,GO:2000816,1,0.812794106147916,0,30,negative regulation of mitotic sister chromatid separation,BP,
21479,GO:2000818,1,0.981705022340993,0,2,negative regulation of myoblast proliferation,BP,
21480,GO:2000819,1,0.989486315538028,0,2,regulation of nucleotide-excision repair,BP,
21481,GO:2000820,1,0.982766342870873,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21482,GO:2000821,1,0.985114573413054,0,4,regulation of grooming behavior,BP,
21483,GO:2000822,1,0.95751821211582,0,5,regulation of behavioral fear response,BP,
21484,GO:2000823,1,0.951633366889653,0,6,regulation of androgen receptor activity,BP,
21485,GO:2000824,1,0.98847894185297,0,2,negative regulation of androgen receptor activity,BP,
21486,GO:2000825,1,0.962728341012822,0,4,positive regulation of androgen receptor activity,BP,
21487,GO:2000826,1,0.820155030465775,0,32,regulation of heart morphogenesis,BP,
21488,GO:2000827,1,0.991317921526807,0,1,mitochondrial RNA surveillance,BP,
21489,GO:2000828,1,0.989041346552512,0,2,regulation of parathyroid hormone secretion,BP,
21490,GO:2000830,1,0.999998413985746,0,1,positive regulation of parathyroid hormone secretion,BP,
21491,GO:2000831,1,0.860756256796962,0,17,regulation of steroid hormone secretion,BP,
21492,GO:2000832,1,0.99502938178594,0,2,negative regulation of steroid hormone secretion,BP,
21493,GO:2000833,1,0.914513433389232,0,9,positive regulation of steroid hormone secretion,BP,
21494,GO:2000834,1,0.995086611654992,0,1,regulation of androgen secretion,BP,
21495,GO:2000836,1,0.995086611654992,0,1,positive regulation of androgen secretion,BP,
21496,GO:2000843,1,0.995292927925586,0,2,regulation of testosterone secretion,BP,
21497,GO:2000845,1,0.995292927925586,0,2,positive regulation of testosterone secretion,BP,
21498,GO:2000846,1,0.885625402294667,0,14,regulation of corticosteroid hormone secretion,BP,
21499,GO:2000847,1,0.99502938178594,0,2,negative regulation of corticosteroid hormone secretion,BP,
21500,GO:2000848,1,0.930997512959586,0,7,positive regulation of corticosteroid hormone secretion,BP,
21501,GO:2000849,1,0.931061080496352,0,8,regulation of glucocorticoid secretion,BP,
21502,GO:2000850,1,0.99502938178594,0,2,negative regulation of glucocorticoid secretion,BP,
21503,GO:2000851,1,0.943577111405312,0,5,positive regulation of glucocorticoid secretion,BP,
21504,GO:2000852,1,0.967181790984056,0,3,regulation of corticosterone secretion,BP,
21505,GO:2000854,1,0.975306550868098,0,2,positive regulation of corticosterone secretion,BP,
21506,GO:2000855,1,0.951227054810453,0,6,regulation of mineralocorticoid secretion,BP,
21507,GO:2000857,1,0.986674277909149,0,2,positive regulation of mineralocorticoid secretion,BP,
21508,GO:2000858,1,0.951227054810453,0,6,regulation of aldosterone secretion,BP,
21509,GO:2000860,1,0.986674277909149,0,2,positive regulation of aldosterone secretion,BP,
21510,GO:2000864,1,0.987422903090434,0,3,regulation of estradiol secretion,BP,
21511,GO:2000866,1,0.987422909195958,0,2,positive regulation of estradiol secretion,BP,
21512,GO:2000870,1,0.976745776855955,0,2,regulation of progesterone secretion,BP,
21513,GO:2000872,1,0.987154884388351,0,1,positive regulation of progesterone secretion,BP,
21514,GO:2000878,1,0.980593473355691,0,2,positive regulation of oligopeptide transport,BP,
21515,GO:2000880,1,0.980593473355691,0,2,positive regulation of dipeptide transport,BP,
21516,GO:2000896,1,0.994495059883519,0,1,amylopectin metabolic process,BP,
21517,GO:2000909,1,0.966349364652607,0,3,regulation of sterol import,BP,
21518,GO:2000910,1,0.974480528254625,0,2,negative regulation of sterol import,BP,
21519,GO:2000969,1,0.991297058084531,0,4,positive regulation of AMPA receptor activity,BP,
21520,GO:2000970,1,0.991008449000678,0,1,regulation of detection of glucose,BP,
21521,GO:2000971,1,0.991008449000678,0,1,negative regulation of detection of glucose,BP,
21522,GO:2000973,1,0.968358406757444,0,6,regulation of pro-B cell differentiation,BP,
21523,GO:2000974,1,0.97578786700758,0,3,negative regulation of pro-B cell differentiation,BP,
21524,GO:2000977,1,0.965692939302865,0,4,regulation of forebrain neuron differentiation,BP,
21525,GO:2000978,1,0.975787875362413,0,2,negative regulation of forebrain neuron differentiation,BP,
21526,GO:2000979,1,0.994081846487967,0,1,positive regulation of forebrain neuron differentiation,BP,
21527,GO:2000980,1,0.943669887461684,0,7,regulation of inner ear receptor cell differentiation,BP,
21528,GO:2000981,1,0.971163901777346,0,4,negative regulation of inner ear receptor cell differentiation,BP,
21529,GO:2000982,1,0.987417807105176,0,1,positive regulation of inner ear receptor cell differentiation,BP,
21530,GO:2000983,1,0.974942110867543,0,2,regulation of ATP citrate synthase activity,BP,
21531,GO:2000984,1,0.974942110867543,0,2,negative regulation of ATP citrate synthase activity,BP,
21532,GO:2000987,1,0.95751821211582,0,5,positive regulation of behavioral fear response,BP,
21533,GO:2001012,1,0.943590460418465,0,8,mesenchymal cell differentiation involved in renal system development,BP,
21534,GO:2001013,1,0.99299374629367,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21537,GO:2001016,1,0.977329103481419,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21538,GO:2001020,1,0.342997957635383,0,155,regulation of response to DNA damage stimulus,BP,
21539,GO:2001021,1,0.65295095733419,0,57,negative regulation of response to DNA damage stimulus,BP,
21540,GO:2001022,1,0.636054907169325,0,67,positive regulation of response to DNA damage stimulus,BP,
21541,GO:2001023,1,0.982701230526005,0,5,regulation of response to drug,BP,
21542,GO:2001025,1,0.998041284082169,0,1,positive regulation of response to drug,BP,
21544,GO:2001027,1,0.976935934615396,0,4,negative regulation of endothelial cell chemotaxis,BP,
21546,GO:2001029,1,0.999992675718,0,1,regulation of cellular glucuronidation,BP,
21547,GO:2001031,1,0.999992675718,0,1,positive regulation of cellular glucuronidation,BP,
21548,GO:2001032,1,0.953498164437258,0,7,regulation of double-strand break repair via nonhomologous end joining,BP,
21549,GO:2001033,1,0.976322854093759,0,3,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21550,GO:2001034,1,0.983611294834628,0,3,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21551,GO:2001035,1,0.987432154699133,0,2,regulation of tongue muscle cell differentiation,BP,
21552,GO:2001037,1,0.987432154699133,0,2,positive regulation of tongue muscle cell differentiation,BP,
21553,GO:2001038,1,0.992913838589769,0,2,regulation of cellular response to drug,BP,
21554,GO:2001044,1,0.931954429442038,0,11,regulation of integrin-mediated signaling pathway,BP,
21555,GO:2001045,1,0.997267303844067,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21556,GO:2001046,1,0.971771062553885,0,5,positive regulation of integrin-mediated signaling pathway,BP,
21557,GO:2001049,1,0.989366833601249,0,1,regulation of tendon cell differentiation,BP,
21558,GO:2001051,1,0.989366833601249,0,1,positive regulation of tendon cell differentiation,BP,
21559,GO:2001053,1,0.92035522335854,0,12,regulation of mesenchymal cell apoptotic process,BP,
21560,GO:2001054,1,0.939699586193426,0,10,negative regulation of mesenchymal cell apoptotic process,BP,
21561,GO:2001055,1,0.979424360472001,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21564,GO:2001065,1,0.975280051610308,0,2,mannan binding,MF,
21565,GO:2001069,1,0.973421797170186,0,3,glycogen binding,MF,
21566,GO:2001070,1,0.991151880261334,0,2,starch binding,MF,
21567,GO:2001074,1,0.982555014997045,0,2,regulation of metanephric ureteric bud development,BP,
21568,GO:2001076,1,0.982555014997045,0,2,positive regulation of metanephric ureteric bud development,BP,
21569,GO:2001106,1,0.999999992751585,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21570,GO:2001108,1,0.999999996374813,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21571,GO:2001109,1,0.989315863302456,0,2,regulation of lens epithelial cell proliferation,BP,
21572,GO:2001111,1,0.989315863302456,0,2,positive regulation of lens epithelial cell proliferation,BP,
21573,GO:2001112,1,0.999808721367601,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21574,GO:2001113,1,0.999808721367601,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21575,GO:2001135,1,0.966080794746854,0,9,regulation of endocytic recycling,BP,
21576,GO:2001136,1,0.995431743094256,0,1,negative regulation of endocytic recycling,BP,
21577,GO:2001137,1,0.991774702007624,0,4,positive regulation of endocytic recycling,BP,
21578,GO:2001138,1,0.954066733444897,0,8,regulation of phospholipid transport,BP,
21579,GO:2001140,1,0.954066733444897,0,8,positive regulation of phospholipid transport,BP,
21581,GO:2001142,1,0.991680231264716,0,1,nicotinate transport,BP,
21582,GO:2001144,1,0.99006327088848,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21583,GO:2001145,1,0.99006327088848,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21584,GO:2001148,1,0.980593473355691,0,2,regulation of dipeptide transmembrane transport,BP,
21585,GO:2001150,1,0.980593473355691,0,2,positive regulation of dipeptide transmembrane transport,BP,
21586,GO:2001151,1,0.994813753533921,0,1,regulation of renal water transport,BP,
21587,GO:2001153,1,0.994813753533921,0,1,positive regulation of renal water transport,BP,
21588,GO:2001160,1,0.986514620900375,0,2,regulation of histone H3-K79 methylation,BP,
21589,GO:2001162,1,0.986514620900375,0,2,positive regulation of histone H3-K79 methylation,BP,
21590,GO:2001163,1,0.990425437849209,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21591,GO:2001165,1,0.990425437849209,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21592,GO:2001166,1,0.986940087663275,0,4,regulation of histone H2B ubiquitination,BP,
21593,GO:2001168,1,0.986940087663275,0,4,positive regulation of histone H2B ubiquitination,BP,
21594,GO:2001169,1,0.949473553680591,0,9,regulation of ATP biosynthetic process,BP,
21595,GO:2001170,1,0.982922804861851,0,3,negative regulation of ATP biosynthetic process,BP,
21596,GO:2001171,1,0.95860067765871,0,7,positive regulation of ATP biosynthetic process,BP,
21597,GO:2001176,1,0.983000591562766,0,2,regulation of mediator complex assembly,BP,
21598,GO:2001178,1,0.983000591562766,0,2,positive regulation of mediator complex assembly,BP,
21600,GO:2001180,1,0.978944367308363,0,3,negative regulation of interleukin-10 secretion,BP,
21602,GO:2001182,1,0.956228335484979,0,7,regulation of interleukin-12 secretion,BP,
21603,GO:2001183,1,0.980876943632228,0,3,negative regulation of interleukin-12 secretion,BP,
21604,GO:2001184,1,0.978392380336635,0,3,positive regulation of interleukin-12 secretion,BP,
21605,GO:2001185,1,0.942027063993024,0,8,regulation of CD8-positive, alpha-beta T cell activation,BP,
21606,GO:2001186,1,0.982374570726859,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21607,GO:2001187,1,0.965684378410927,0,4,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21608,GO:2001188,1,0.948830056782107,0,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21609,GO:2001189,1,0.971829379498414,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21610,GO:2001190,1,0.976339281952473,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21611,GO:2001191,1,0.993084902554068,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21612,GO:2001193,1,0.993084902554068,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21613,GO:2001197,1,0.999988742041713,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21616,GO:2001200,1,0.97125494312231,0,4,positive regulation of dendritic cell differentiation,BP,
21617,GO:2001201,1,0.992995773832574,0,3,regulation of transforming growth factor-beta secretion,BP,
21618,GO:2001202,1,0.993084897573021,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21619,GO:2001203,1,0.999910262013799,0,1,positive regulation of transforming growth factor-beta secretion,BP,
21620,GO:2001204,1,0.921393803359367,0,11,regulation of osteoclast development,BP,
21621,GO:2001205,1,0.978784707217105,0,5,negative regulation of osteoclast development,BP,
21622,GO:2001206,1,0.965159272640966,0,4,positive regulation of osteoclast development,BP,
21623,GO:2001207,1,0.997405358818918,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21624,GO:2001208,1,0.997405358818918,0,1,negative regulation of transcription elongation from RNA polymerase I promoter,BP,
21625,GO:2001212,1,0.915600948930624,0,14,regulation of vasculogenesis,BP,
21626,GO:2001213,1,0.999999912924884,0,1,negative regulation of vasculogenesis,BP,
21627,GO:2001214,1,0.931742197263077,0,10,positive regulation of vasculogenesis,BP,
21628,GO:2001222,1,0.92114713374272,0,27,regulation of neuron migration,BP,
21629,GO:2001223,1,0.975093661507221,0,8,negative regulation of neuron migration,BP,
21630,GO:2001224,1,0.978793456876058,0,9,positive regulation of neuron migration,BP,
21631,GO:2001225,1,0.958751002716896,0,8,regulation of chloride transport,BP,
21632,GO:2001226,1,0.983207528797284,0,3,negative regulation of chloride transport,BP,
21633,GO:2001228,1,0.999999996412706,0,1,regulation of response to gamma radiation,BP,
21634,GO:2001229,1,0.999999996412706,0,1,negative regulation of response to gamma radiation,BP,
21641,GO:2001239,1,0.700766298642988,0,47,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21642,GO:2001240,1,0.773503639343167,0,33,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21643,GO:2001241,1,0.903669322275994,0,14,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21646,GO:2001244,1,0.63129650964246,0,53,positive regulation of intrinsic apoptotic signaling pathway,BP,
21648,GO:2001246,1,0.997919750615008,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21649,GO:2001247,1,0.998919794455754,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21650,GO:2001248,1,0.989936963505739,0,1,regulation of ammonia assimilation cycle,BP,
21651,GO:2001250,1,0.989936963505739,0,1,positive regulation of ammonia assimilation cycle,BP,
21652,GO:2001251,1,0.536787940046127,0,113,negative regulation of chromosome organization,BP,
21653,GO:2001252,1,0.418455465556344,0,148,positive regulation of chromosome organization,BP,
21654,GO:2001253,1,0.993789369049204,0,1,regulation of histone H3-K36 trimethylation,BP,
21655,GO:2001256,1,0.978164581200724,0,6,regulation of store-operated calcium entry,BP,
21656,GO:2001257,1,0.499794546729694,0,122,regulation of cation channel activity,BP,
21657,GO:2001258,1,0.754196704570209,0,34,negative regulation of cation channel activity,BP,
21658,GO:2001259,1,0.825929489156672,0,41,positive regulation of cation channel activity,BP,
21659,GO:2001260,1,0.990803916695749,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21660,GO:2001262,1,0.990803916695749,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21661,GO:2001263,1,0.987175364342129,0,1,regulation of C-C chemokine binding,BP,
21662,GO:2001264,1,0.987175364342129,0,1,negative regulation of C-C chemokine binding,BP,
21664,GO:2001268,1,0.946790250867295,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21666,GO:2001270,1,0.975427516061854,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21667,GO:2001271,1,0.988013481718183,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21668,GO:2001272,1,0.987262555038096,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21670,GO:2001274,1,0.98397983340635,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21672,GO:2001279,1,0.965145276386986,0,6,regulation of unsaturated fatty acid biosynthetic process,BP,
21673,GO:2001280,1,0.973030897055912,0,4,positive regulation of unsaturated fatty acid biosynthetic process,BP,
21674,GO:2001286,1,0.971882938827436,0,5,regulation of caveolin-mediated endocytosis,BP,
21675,GO:2001287,1,0.985617936463954,0,2,negative regulation of caveolin-mediated endocytosis,BP,
21676,GO:2001288,1,0.987800047638095,0,2,positive regulation of caveolin-mediated endocytosis,BP,
21677,GO:2001293,1,0.990105883499709,0,3,malonyl-CoA metabolic process,BP,
21678,GO:2001294,1,0.990105894622013,0,1,malonyl-CoA catabolic process,BP,
21679,GO:2001295,1,0.999999992786115,0,2,malonyl-CoA biosynthetic process,BP,
21680,GO:2001300,1,0.943124140387999,0,6,lipoxin metabolic process,BP,
21681,GO:2001301,1,0.983116426281465,0,2,lipoxin biosynthetic process,BP,
21682,GO:2001302,1,0.983116426281465,0,2,lipoxin A4 metabolic process,BP,
21683,GO:2001303,1,0.983116426281465,0,2,lipoxin A4 biosynthetic process,BP,
21684,GO:2001304,1,0.990808137278926,0,1,lipoxin B4 metabolic process,BP,
21685,GO:2001306,1,0.990808137278926,0,1,lipoxin B4 biosynthetic process,BP,
21686,GO:2001311,1,0.988800779242827,0,1,lysobisphosphatidic acid metabolic process,BP,
3750,GO:0007274,1,0.835339960695379,0,29,neuromuscular synaptic transmission,BP,
20197,GO:1904707,1,0.900989184451505,0,17,positive regulation of vascular smooth muscle cell proliferation,BP,
